PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lanham, KA; Prasch, AL; Weina, KM; Peterson, RE; Heideman, W				Lanham, Kevin A.; Prasch, Amy L.; Weina, Kasia M.; Peterson, Richard E.; Heideman, Warren			A Dominant Negative Zebrafish Ahr2 Partially Protects Developing Zebrafish from Dioxin Toxicity	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; DEVELOPMENTAL TOXICITY; DANIO-RERIO; TRANSACTIVATION DOMAIN; DEFICIENT MICE; PAS DOMAIN; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN; IDENTIFICATION; EXPRESSION; MALFORMATION	The toxicity by 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) is thought to be caused by activation of the aryl hydrocarbon receptor (AHR). However, our understanding of how AHR activation by TCDD leads to toxic effects is poor. Ideally we would like to manipulate AHR activity in specific tissues and at specific times. One route to this is expressing dominant negative AHRs (dnAHRs). This work describes the construction and characterization of dominant negative forms of the zebrafish Ahr2 in which the C-terminal transactivation domain was either removed, or replaced with the inhibitory domain from the Drosophila engrailed repressor protein. One of these dnAhr2s was selected for expression from the ubiquitously active e2f alpha promoter in transgenic zebrafish. We found that these transgenic zebrafish expressing dnAhr2 had reduced TCDD induction of the Ahr2 target gene cyp1a, as measured by 7-ethoxyresorufin-O-deethylase activity. Furthermore, the cardiotoxicity produced by TCDD, pericardial edema, heart malformation, and reduced blood flow, were all mitigated in the zebrafish expressing the dnAhr2. These results provide in vivo proof-of-principle results demonstrating the effectiveness of dnAHRs in manipulating AHR activity in vivo, and demonstrating that this approach can be a means for blocking TCDD toxicity.	[Lanham, Kevin A.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Peterson, Richard E.; Heideman, Warren] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Prasch, Amy L.] NimbleGen, Madison, WI USA; [Weina, Kasia M.] Univ London, Sch Pharm, London WC1N 1AX, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Roche Holding; Roche NimbleGen; University of London; University College London; University of London School of Pharmacy	Lanham, KA (corresponding author), Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA.	wheidema@wisc.edu		Lanham, Kevin/0000-0001-6406-0019	National Institutes of Health (NIH) from the National Institute of Environmental Health Sciences (NIEHS) [R01 ES012716, T32 ES07015]; University of Wisconsin Sea Grant Institute, National Sea Grant College, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA 16RG2257];  [R/BT-20];  [R/BT-22]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012716, T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin Sea Grant Institute, National Sea Grant College, National Oceanic and Atmospheric Administration, U.S. Department of Commerce; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the National Institutes of Health (NIH) grant R01 ES012716 from the National Institute of Environmental Health Sciences (NIEHS) (W. H. and R. E. P.) and the University of Wisconsin Sea Grant Institute, National Sea Grant College Program, National Oceanic and Atmospheric Administration, U.S. Department of Commerce grant number NA 16RG2257, Sea Grant Project Numbers R/BT-20 and R/BT-22 (W. H. and R. E. P.) and NIH grant T32 ES07015 from the NIEHS (K. A. L.). The contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIEHS, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 1999, J BIOL CHEM, V274, P15159, DOI 10.1074/jbc.274.21.15159; Abnet CC, 1999, TOXICOL APPL PHARM, V159, P41, DOI 10.1006/taap.1999.8719; Andreasen EA, 2002, J BIOL CHEM, V277, P13210, DOI 10.1074/jbc.M200073200; Andreasen EA, 2002, MOL PHARMACOL, V62, P234, DOI 10.1124/mol.62.2.234; Andrysik Z, 2007, MUTAT RES-FUND MOL M, V615, P87, DOI 10.1016/j.mrfmmm.2006.10.004; Antkiewicz DS, 2005, TOXICOL SCI, V84, P368, DOI 10.1093/toxsci/kfi073; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Belair CD, 2001, DEV DYNAM, V222, P581, DOI 10.1002/dvdy.1213; Carney SA, 2006, BIRTH DEFECTS RES A, V76, P7, DOI 10.1002/bdra.20216; Carney SA, 2004, MOL PHARMACOL, V66, P512; CARVER LA, 1994, NUCLEIC ACIDS RES, V22, P3038, DOI 10.1093/nar/22.15.3038; Chang CY, 1998, MOL CELL BIOL, V18, P525, DOI 10.1128/MCB.18.1.525; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Flaveny C, 2008, ARCH BIOCHEM BIOPHYS, V471, P215, DOI 10.1016/j.abb.2008.01.014; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HAHN ME, 1995, BIOCHEM J, V310, P383, DOI 10.1042/bj3100383; Heideman W, 2005, CARDIOVASC TOXICOL, V5, P203, DOI 10.1385/CT:5:2:203; Henry TR, 1997, TOXICOL APPL PHARM, V142, P56, DOI 10.1006/taap.1996.8024; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; JAIN S, 1994, J BIOL CHEM, V269, P31518; Jones LC, 2001, J BIOL CHEM, V276, P25037, DOI 10.1074/jbc.M102910200; Karchner SI, 2005, BIOCHEM J, V392, P153, DOI 10.1042/BJ20050713; Kumar MB, 2001, J BIOL CHEM, V276, P42302, DOI 10.1074/jbc.M104798200; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Nacci D, 1998, ENVIRON TOXICOL CHEM, V17, P2481, DOI 10.1002/etc.5620171214; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Prasch AL, 2006, MOL PHARMACOL, V69, P776, DOI 10.1124/mol.105.016873; Prasch AL, 2003, TOXICOL SCI, V76, P138, DOI 10.1093/toxsci/kfg202; Ramadoss P, 2005, BIOCHEMISTRY-US, V44, P11148, DOI 10.1021/bi050948b; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Tanguay RL, 2000, BBA-GENE STRUCT EXPR, V1494, P117, DOI 10.1016/S0167-4781(00)00225-6; Tanguay RL, 1999, BBA-GENE STRUCT EXPR, V1444, P35, DOI 10.1016/S0167-4781(98)00252-8; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Thummel R, 2006, THESCIENTIFICWORLDJO, V6, P65, DOI 10.1100/tsw.2006.328; Vasquez Alejandro, 2003, Cardiovasc Toxicol, V3, P153, DOI 10.1385/CT:3:2:153; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Xiong KM, 2008, MOL PHARMACOL, V74, P1544, DOI 10.1124/mol.108.050435	41	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e28020	10.1371/journal.pone.0028020	http://dx.doi.org/10.1371/journal.pone.0028020			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194803	Green Submitted, gold, Green Published			2022-12-27	WOS:000298370400009
J	Schwab, C; Cristescu, B; Northrup, JM; Stenhouse, GB; Ganzle, M				Schwab, Clarissa; Cristescu, Bogdan; Northrup, Joseph M.; Stenhouse, Gordon B.; Gaenzle, Michael			Diet and Environment Shape Fecal Bacterial Microbiota Composition and Enteric Pathogen Load of Grizzly Bears	PLOS ONE			English	Article							CLOSTRIDIUM-PERFRINGENS; FECES; POPULATIONS; SORDELLII; DIVERSITY; HEALTH	Background: Diet and environment impact the composition of mammalian intestinal microbiota; dietary or health disturbances trigger alterations in intestinal microbiota composition and render the host susceptible to enteric pathogens. To date no long term monitoring data exist on the fecal microbiota and pathogen load of carnivores either in natural environments or in captivity. This study investigates fecal microbiota composition and the presence of pathogenic Escherichia coli and toxigenic clostridia in wild and captive grizzly bears (Ursus arctos) and relates these to food resources consumed by bears. Methodology/Principal Findings: Feces were obtained from animals of two wild populations and from two captive animals during an active bear season. Wild animals consumed a diverse diet composed of plant material, animal prey and insects. Captive animals were fed a regular granulated diet with a supplement of fruits and vegetables. Bacterial populations were analyzed using quantitative PCR. Fecal microbiota composition fluctuated in wild and in captive animals. The abundance of Clostridium clusters I and XI, and of C. perfringens correlated to regular diet protein intake. Enteroaggregative E. coli were consistently present in all populations. The C. sordellii phospholipase C was identified in three samples of wild animals and for the first time in Ursids. Conclusion: This is the first longitudinal study monitoring the fecal microbiota of wild carnivores and comparing it to that of captive individuals of the same species. Location and diet affected fecal bacterial populations as well as the presence of enteric pathogens.	[Schwab, Clarissa; Gaenzle, Michael] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Cristescu, Bogdan; Northrup, Joseph M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Stenhouse, Gordon B.] Foothills Res Inst, Hinton, AB, Canada	University of Alberta; University of Alberta	Schwab, C (corresponding author), Univ Vienna, Dept Genet Ecol, Vienna, Austria.	clarissa.schwab@univie.ac.at	schwab, clarissa/AAZ-4537-2020; Gänzle, Michael/F-1432-2017; Northrup, Joseph/G-5427-2012; Northrup, Joseph/AAM-2874-2020; Schwab, Clarissa/AGL-7943-2022	Gänzle, Michael/0000-0003-0972-928X; Northrup, Joseph/0000-0001-6319-4138; Northrup, Joseph/0000-0001-6319-4138; Cristescu, Bogdan/0000-0003-2964-5040	Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada; International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada; TD - Friends of the Environment Foundation; University of Alberta; Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; Yellowstone; Mountain Equipment Co-op; Royal Dutch Shell; Safari Club International - Northern Alberta Chapter; Teck Resources Limited	Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada(CGIAR); International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); TD - Friends of the Environment Foundation; University of Alberta(University of Alberta); Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; Yellowstone; Mountain Equipment Co-op; Royal Dutch Shell(Royal Dutch Shell); Safari Club International - Northern Alberta Chapter; Teck Resources Limited	This work was supported by the Alberta Conservation Association; Alberta's Conservation Collaboration; Alberta Ingenuity Fund; Alberta Sport, Recreation, Parks and Wildlife Foundation; American Society of Mammalogists; Canadian Wildlife Federation; Environment Canada; International Association for Bear Research and Management; Natural Sciences and Engineering Research Council of Canada; TD - Friends of the Environment Foundation; University of Alberta; Wild Sheep Foundation - Alberta Chapter; World Wildlife Fund; and Yellowstone to Yukon Foundation. We thank Alberta Tourism Parks and Recreation, Alberta Sustainable Resource Development, and Parks Canada for in-kind support. This study was funded by Mountain Equipment Co-op, Royal Dutch Shell, Safari Club International - Northern Alberta Chapter, Teck Resources Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2006, CLIN INFECT DIS, V43, P1436, DOI 10.1086/508866; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Beutin L, 1999, VET RES, V30, P285; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; de la Fe C, 2006, VET PATHOL, V43, P370, DOI 10.1354/vp.43-3-370; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Fujita S, 2007, J MED PRIMATOL, V36, P25, DOI 10.1111/j.1600-0684.2006.00191.x; Glad T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-10; *GOV ALB, 2010, GRIZZL BEAR CONS ALB; Greco G, 2005, J VET DIAGN INVEST, V17, P186, DOI 10.1177/104063870501700216; Jores J, 2008, J WILDLIFE DIS, V44, P155, DOI 10.7589/0090-3558-44.1.155; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; KOVACH WL, 1993, MVSP MULTIVARIATE ST, P3; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2003, J MICROBIOL METH, V54, P13, DOI 10.1016/S0167-7012(02)00260-9; Lubbs DC, 2009, J ANIM PHYSIOL AN N, V93, P113, DOI 10.1111/j.1439-0396.2007.00788.x; Mathews F, 2006, BIOL CONSERV, V131, P338, DOI 10.1016/j.biocon.2006.04.011; McCartney AL, 1996, APPL ENVIRON MICROB, V62, P4608, DOI 10.1128/AEM.62.12.4608-4613.1996; Metzler-Zebeli BU, 2010, APPL ENVIRON MICROB, V76, P3692, DOI 10.1128/AEM.00257-10; Milligan SR, 2009, PHILOS T R SOC B, V364, P3313, DOI 10.1098/rstb.2009.0175; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Nagy B, 1999, VET RES, V30, P259; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; PRITCHARD GT, 1990, CAN J ZOOL, V68, P1645, DOI 10.1139/z90-244; Schwab C, 2011, CAN J MICROBIOL, V57, P177, DOI 10.1139/W10-113; Schwab C, 2009, CAN J MICROBIOL, V55, P1335, DOI 10.1139/W09-083; STEVENS CE, 1995, COMP PHYSL VERTEBRAT, pCH4; Suchodolski JS, 2008, FEMS MICROBIOL ECOL, V66, P567, DOI 10.1111/j.1574-6941.2008.00521.x; Wei GF, 2007, MICROB ECOL, V54, P194, DOI 10.1007/s00248-007-9225-2; Zentek J, 2003, J ANIM PHYSIOL AN N, V87, P397, DOI 10.1046/j.0931-2439.2003.00451.x	35	48	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27905	10.1371/journal.pone.0027905	http://dx.doi.org/10.1371/journal.pone.0027905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194798	Green Published, Green Submitted, gold			2022-12-27	WOS:000298370400006
J	Gu, XC; Liu, B; Wu, XJ; Yan, Y; Zhang, Y; Wei, YQ; Pleasure, SJ; Zhao, CJ				Gu, Xiaochun; Liu, Bin; Wu, Xiaojing; Yan, Yan; Zhang, Ying; Wei, Yiquan; Pleasure, Samuel J.; Zhao, Chunjie			Inducible Genetic Lineage Tracing of Cortical Hem Derived Cajal-Retzius Cells Reveals Novel Properties	PLOS ONE			English	Article							CEREBRAL-CORTEX; MARGINAL ZONE; IN-VIVO; REELIN; EXPRESSION; MOUSE; FOXG1; FATE; CONNECTIONS; GENERATION	During cortical development, Cajal-Retzius (CR) cells are among the earliest-born subclasses of neurons. These enigmatic neurons play an important role in cortical development through their expression of the extracellular protein, reelin. CR cells arise from discrete sources within the telencephalon, including the pallial-subpallial border and the medial (cortical hem) regions of the pallium. Combined evidence suggests that CR cells derived from distinct origins may have different distributions and functions. By tracing CR cells derived from the cortical hem using the inducible Cre transgenic mouse tool, Frizzled 10-CreER (TM), we examined the specific properties of hem-derived CR cells during cortical development. Our results show that the progenitor zone for later production of CR cells from the hem can be specifically marked as early as embryonic day 6.5 (E6.5), a pre-neural period. Moreover, using our Cre line, we found that some hem-derived CR cells migrated out along the fimbrial radial glial scaffold, which was also derived from the cortical hem, and preferentially settled in the hippocampal marginal zone, which indicated specific roles for hem-derived CR cells in hippocampal development.	[Gu, Xiaochun; Liu, Bin; Wu, Xiaojing; Yan, Yan; Zhang, Ying; Wei, Yiquan; Zhao, Chunjie] Southeast Univ, Inst Life Sci, MOE, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Pleasure, Samuel J.] Dept Neurol, Program Neurosci, San Francisco, CA USA; [Pleasure, Samuel J.] Dept Neurol, Program Dev Biol, San Francisco, CA USA; [Pleasure, Samuel J.] Dept Neurol, Program Biomed Sci, San Francisco, CA USA	Southeast University - China	Gu, XC (corresponding author), Southeast Univ, Inst Life Sci, MOE, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China.	zhaocj@seu.edu.cn			National Nature Science Foundation of China [81000485, 30525017, 30770696, 81070904]; The Ministry of Science and Technology of China [2007CB512303]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by funds 81000485 to XG and 30525017, 30770696 and 81070904 from the National Nature Science Foundation of China, and 2007CB512303 from The Ministry of Science and Technology of China to CZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan A, 2010, CEREB CORTEX, V20, P1788, DOI 10.1093/cercor/bhp242; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Deller T, 1999, EXP NEUROL, V156, P239, DOI 10.1006/exnr.1999.7020; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Fatemi SH, 2000, MOL PSYCHIATR, V5, P571, DOI 10.1038/sj.mp.4000794; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gu XC, 2009, GENESIS, V47, P210, DOI 10.1002/dvg.20472; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hanashima C, 2007, J NEUROSCI, V27, P11103, DOI 10.1523/JNEUROSCI.1066-07.2007; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hong YL, 2000, OBES RES, V8, P151, DOI 10.1038/oby.2000.16; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kemp CR, 2007, DEV DYNAM, V236, P2011, DOI 10.1002/dvdy.21198; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002; Miquelajauregui A, 2010, J NEUROSCI, V30, P10551, DOI 10.1523/JNEUROSCI.5563-09.2010; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; Super H, 1998, J NEUROSCI, V18, P4616; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Yamazaki H, 2004, P NATL ACAD SCI USA, V101, P14509, DOI 10.1073/pnas.0406295101; Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209; Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042	30	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28653	10.1371/journal.pone.0028653	http://dx.doi.org/10.1371/journal.pone.0028653			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174859	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300018
J	Pereira, AM; Tudor, C; Kanger, JS; Subramaniam, V; Martin-Blanco, E				Pereira, Andrea Maria; Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod; Martin-Blanco, Enrique			Integrin-Dependent Activation of the JNK Signaling Pathway by Mechanical Stress	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; PHOSPHORYLATION NETWORKS; STRETCH; FLUORESCENCE; MATRIX; MAP; APOPTOSIS; TRANSDUCTION; EXPRESSION	Mechanical force is known to modulate the activity of the Jun N-terminal kinase (JNK) signaling cascade. However, the effect of mechanical stresses on JNK signaling activation has previously only been analyzed by in vitro detection methods. It still remains unknown how living cells activate the JNK signaling cascade in response to mechanical stress and what its functions are in stretched cells. We assessed in real-time the activity of the JNK pathway in Drosophila cells by Fluorescence Lifetime Imaging Microscopy (FLIM), using an intramolecular phosphorylation-dependent dJun-FRET (Fluorescence Resonance Energy Transfer) biosensor. We found that quantitative FRET-FLIM analysis and confocal microscopy revealed sustained dJun-FRET biosensor activation and stable morphology changes in response to mechanical stretch for Drosophila S2R+ cells. Further, these cells plated on different substrates showed distinct levels of JNK activity that associate with differences in cell morphology, integrin expression and focal adhesion organization. These data imply that alterations in the cytoskeleton and matrix attachments may act as regulators of JNK signaling, and that JNK activity might feed back to modulate the cytoskeleton and cell adhesion. We found that this dynamic system is highly plastic; at rest, integrins at focal adhesions and talin are key factors suppressing JNK activity, while multidirectional static stretch leads to integrin-dependent, and probably talin-independent, Jun sensor activation. Further, our data suggest that JNK activity has to coordinate with other signaling elements for the regulation of the cytoskeleton and cell shape remodeling associated with stretch.	[Pereira, Andrea Maria; Martin-Blanco, Enrique] CSIC, Inst Biol Mol Barcelona, Barcelona, Spain; [Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Tudor, Cicerone; Kanger, Johannes S.; Subramaniam, Vinod] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Twente; University of Twente	Pereira, AM (corresponding author), CSIC, Inst Biol Mol Barcelona, Parc Cient Barcelona, Barcelona, Spain.	v.subramaniam@utwente.nl; embbmc@ibmb.csic.es	Martin-Blanco, Enrique/ABH-1280-2020; Subramaniam, Vinod/B-4197-2010; Pereira, Andrea/AAL-2973-2020	Martin-Blanco, Enrique/0000-0002-6926-910X; Subramaniam, Vinod/0000-0001-6712-7266; 	Marie Curie Research Training Network IMMUNANOMAP [MRTNCT-2006-035946]; Spanish Ministry of Science (DGI and Consolider); European Union; Stichting voor Fundamenteel Onderzoek der Materie; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Spanish FPU	Marie Curie Research Training Network IMMUNANOMAP; Spanish Ministry of Science (DGI and Consolider); European Union(European Commission); Stichting voor Fundamenteel Onderzoek der Materie(FOM (The Netherlands)); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Spanish FPU(Spanish Government)	AMP held a Spanish FPU PhD studentship and CT was supported by the Marie Curie Research Training Network IMMUNANOMAP (MRTNCT-2006-035946). Research in the EMB laboratory is funded by grants of the Spanish Ministry of Science (DGI and Consolider) and the European Union. Research in the VS laboratory is supported by "Stichting voor Fundamenteel Onderzoek der Materie'', the "Nederlandse Organisatie voor Wetenschappelijk Onderzoek'', and the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Bost F, 1999, MOL CELL BIOL, V19, P1938; Chen NY, 2001, CANCER RES, V61, P3908; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Elul T, 1997, DEV BIOL, V191, P243, DOI 10.1006/dbio.1997.8711; Fosbrink M, 2010, P NATL ACAD SCI USA, V107, P5459, DOI 10.1073/pnas.0909671107; Frangos J. A., 1993, PHYS FORCES MAMMALIA; Giannone G, 2003, J CELL BIOL, V163, P409, DOI 10.1083/jcb.200302001; Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011; Grecco HE, 2010, NAT METHODS, V7, P467, DOI [10.1038/NMETH.1458, 10.1038/nmeth.1458]; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Hsieh MH, 2005, INT REV CYTOL, V245, P45, DOI 10.1016/S0074-7696(05)45003-2; Ingber DE, 2002, CIRC RES, V91, P877, DOI 10.1161/01.RES.0000039537.73816.E5; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kaunas R, 2006, CELL SIGNAL, V18, P1924, DOI 10.1016/j.cellsig.2006.02.008; Kaunas R, 2010, J THEOR BIOL, V264, P593, DOI 10.1016/j.jtbi.2010.02.020; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kippenberger S, 2000, J INVEST DERMATOL, V114, P408, DOI 10.1046/j.1523-1747.2000.00915.x; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Levitt JA, 2009, CURR OPIN BIOTECH, V20, P28, DOI 10.1016/j.copbio.2009.01.004; Li CH, 1999, J BIOL CHEM, V274, P25273, DOI 10.1074/jbc.274.36.25273; Li LF, 2003, AM J PHYSIOL-LUNG C, V285, pL464, DOI 10.1152/ajplung.00031.2003; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Milkiewicz M, 2007, J CELL BIOCHEM, V100, P750, DOI 10.1002/jcb.21055; Nguyen HT, 2000, AM J PHYSIOL-CELL PH, V279, pC1155, DOI 10.1152/ajpcell.2000.279.4.C1155; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Sawada Y, 2001, J CELL SCI, V114, P1221; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Schlachter S, 2009, OPT EXPRESS, V17, P1557, DOI 10.1364/OE.17.001557; Schreck I, 2011, BIOCHEM BIOPH RES CO, V407, P735, DOI 10.1016/j.bbrc.2011.03.092; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Sotoudeh M, 2002, AM J PHYSIOL-HEART C, V282, pH1709, DOI 10.1152/ajpheart.00744.2001; Suzuma I, 2007, HYPERTENSION, V49, P347, DOI 10.1161/01.HYP.0000253535.26659.2f; Tan JL, 2009, APOPTOSIS, V14, P764, DOI 10.1007/s10495-009-0345-7; Tran-Thi TH, 2000, CHEM PHYS LETT, V329, P421, DOI 10.1016/S0009-2614(00)01037-X; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Trepat X, 2004, AM J PHYSIOL-LUNG C, V287, pL1025, DOI 10.1152/ajplung.00077.2004; Wang BW, 2003, CARDIOVASC RES, V59, P460, DOI 10.1016/S0008-6363(03)00428-0; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Wessels JT, 2010, CYTOM PART A, V77A, P667, DOI 10.1002/cyto.a.20931; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; Yanagawa S, 1998, J BIOL CHEM, V273, P32353, DOI 10.1074/jbc.273.48.32353; Yu HM, 2011, TRENDS CELL BIOL, V21, P47, DOI 10.1016/j.tcb.2010.08.015	51	37	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e26182	10.1371/journal.pone.0026182	http://dx.doi.org/10.1371/journal.pone.0026182			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180774	Green Published, gold			2022-12-27	WOS:000298367300001
J	Hammer, EC; Rillig, MC				Hammer, Edith C.; Rillig, Matthias C.			The Influence of Different Stresses on Glomalin Levels in an Arbuscular Mycorrhizal Fungus-Salinity Increases Glomalin Content	PLOS ONE			English	Article							GLOMUS-INTRARADICES; PROTEIN GLOMALIN; FOLSOMIA-CANDIDA; SOIL FUNGI; PLANTS; AVAILABILITY; PHOSPHORUS	Glomalin is a glycoprotein produced by arbuscular mycorrhizal (AM) fungi, and the soil fraction containing glomalin is correlated with soil aggregation. Thus, factors potentially influencing glomalin production could be of relevance for this ecosystem process and for understanding AM fungal physiology. Previous work indicated that glomalin production in AM fungi may be a stress response, or related to suboptimal mycelium growth. We show here that environmental stress can enhance glomalin production in the mycelium of the AM fungus Glomus intraradices. We applied NaCl and glycerol in different intensities to the medium in which the fungus was grown in vitro, causing salinity stress and osmotic stress, respectively. As a third stress type, we simulated grazing on the extraradical hyphae of the fungus by mechanically injuring the mycelium by clipping. NaCl caused a strong increase, while the clipping treatment led to a marginally significant increase in glomalin production. Even though salinity stress includes osmotic stress, we found substantially different responses in glomalin production due to the NaCl and the glycerol treatment, as glycerol addition did not cause any response. Thus, our results indicate that glomalin is involved in inducible stress responses in AM fungi for salinity, and possibly grazing stress.	[Hammer, Edith C.] Lund Univ, Dept Biol, Lund, Sweden; [Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Berlin, Germany	Lund University; Free University of Berlin	Hammer, EC (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	Edith.Hammer@biol.lu.se	Rillig, Matthias C./B-3675-2009; Rillig, Matthias C./AAE-6980-2019; Hammer, Edith/K-4055-2014	Rillig, Matthias C./0000-0003-3541-7853; Rillig, Matthias C./0000-0003-3541-7853; Hammer, Edith/0000-0003-0892-2897	FORMAS [214-2007-994]	FORMAS(Swedish Research Council Formas)	Co-funding for ECH's salary was provided by FORMAS grant number 214-2007-994. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no other external funding sources for this study.	Adame MF, 2010, ESTUAR COAST SHELF S, V86, P21, DOI 10.1016/j.ecss.2009.10.013; BECARD G, 1991, NEW PHYTOL, V118, P547, DOI 10.1111/j.1469-8137.1991.tb00994.x; BECARD G, 1988, NEW PHYTOL, V108, P211, DOI 10.1111/j.1469-8137.1988.tb03698.x; Bollmann J, 2010, PEDOBIOLOGIA, V53, P107, DOI 10.1016/j.pedobi.2009.06.003; Bois G, 2006, MYCORRHIZA, V16, P99, DOI 10.1007/s00572-005-0020-y; Bolliger A, 2008, SOIL BIOL BIOCHEM, V40, P887, DOI 10.1016/j.soilbio.2007.10.019; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DONER LW, 1991, BIOTECHNOL TECH, V5, P25, DOI 10.1007/BF00152749; Driver JD, 2005, SOIL BIOL BIOCHEM, V37, P101, DOI 10.1016/j.soilbio.2004.06.011; Gadkar V, 2006, FEMS MICROBIOL LETT, V263, P93, DOI 10.1111/j.1574-6968.2006.00412.x; Hammer EC, 2011, FEMS MICROBIOL ECOL, V76, P236, DOI 10.1111/j.1574-6941.2011.01043.x; Hammer EC, 2011, MYCORRHIZA, V21, P117, DOI 10.1007/s00572-010-0316-4; Jahromi F, 2008, MICROB ECOL, V55, P45, DOI 10.1007/s00248-007-9249-7; Johnson D, 2005, SCIENCE, V309, P1047, DOI 10.1126/science.1114769; Klironomos JN, 1996, BIOL FERT SOILS, V21, P43, DOI 10.1007/BF00335992; Klironomos JN, 1999, FUNCT ECOL, V13, P756, DOI 10.1046/j.1365-2435.1999.00379.x; Larsen J, 2008, SOIL BIOL BIOCHEM, V40, P360, DOI 10.1016/j.soilbio.2007.08.016; Lovelock CE, 2004, J ECOL, V92, P278, DOI 10.1111/j.0022-0477.2004.00855.x; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Olsson PA, 2008, APPL ENVIRON MICROB, V74, P4144, DOI 10.1128/AEM.00376-08; Pfeffer PE, 1999, PLANT PHYSIOL, V120, P587, DOI 10.1104/pp.120.2.587; Porcel R, 2006, PLANT MOL BIOL, V60, P389, DOI 10.1007/s11103-005-4210-y; Purin S, 2008, SOIL BIOL BIOCHEM, V40, P1000, DOI 10.1016/j.soilbio.2007.11.010; Purin S, 2007, PEDOBIOLOGIA, V51, P123, DOI 10.1016/j.pedobi.2007.03.002; RAVEN JA, 1985, NEW PHYTOL, V101, P25, DOI 10.1111/j.1469-8137.1985.tb02816.x; Rillig MC, 2002, SOIL BIOL BIOCHEM, V34, P1371, DOI 10.1016/S0038-0717(02)00060-3; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Roda JJ, 2008, ARID LAND RES MANAG, V22, P310, DOI 10.1080/15324980802388199; Schindler FV, 2007, SOIL BIOL BIOCHEM, V39, P320, DOI 10.1016/j.soilbio.2006.08.017; SCHLESINGER MJ, 1990, J BIOL CHEM, V265, P12111; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Treseder KK, 2007, SOIL SCI SOC AM J, V71, P1257, DOI 10.2136/sssaj2006.0377; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003	33	58	64	9	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28426	10.1371/journal.pone.0028426	http://dx.doi.org/10.1371/journal.pone.0028426			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174803	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600016
J	Gilboa-Geffen, A; Wolf, Y; Hanin, G; Melamed-Book, N; Pick, M; Bennett, ER; Greenberg, DS; Lester, S; Rischmueller, M; Soreq, H				Gilboa-Geffen, Adi; Wolf, Yochai; Hanin, Geula; Melamed-Book, Naomi; Pick, Marjorie; Bennett, Estelle R.; Greenberg, David S.; Lester, Susan; Rischmueller, Maureen; Soreq, Hermona			Activation of the Alternative NFkB Pathway Improves Disease Symptoms in a Model of Sjogren's Syndrome	PLOS ONE			English	Article							KAPPA-B ACTIVATION; REGULATORY T-CELLS; AUTOIMMUNE-DISEASES; MYASTHENIA-GRAVIS; SALIVARY-GLANDS; ACINAR-CELLS; KINASE-ALPHA; ACETYLCHOLINESTERASE; TOLL-LIKE-RECEPTOR-9; INTERFERON	The purpose of our study was to understand if Toll-like receptor 9 (TLR9) activation could contribute to the control of inflammation in Sjogren's syndrome. To this end, we manipulated TLR9 signaling in non-obese diabetic (NOD) and TLR9(-/-) mice using agonistic CpG oligonucleotide aptamers, TLR9 inhibitors, and the in-house oligonucleotide BL-7040. We then measured salivation, inflammatory response markers, and expression of proteins downstream to NF-kappa B activation pathways. Finally, we labeled proteins of interest in salivary gland biopsies from Sjogren's syndrome patients, compared to Sicca syndrome controls. We show that in NOD mice BL-7040 activates TLR9 to induce an alternative NF-kappa B activation mode resulting in increased salivation, elevated anti-inflammatory response in salivary glands, and reduced peripheral AChE activity. These effects were more prominent and also suppressible by TLR9 inhibitors in NOD mice, but TLR9(-/-) mice were resistant to the salivation-promoting effects of CpG oligonucleotides and BL-7040. Last, salivary glands from Sjogren's disease patients showed increased inflammatory and decreased anti-inflammatory biomarkers, in addition to decreased levels of alternative NF-kB pathway proteins. In summary, we have demonstrated that activation of TLR9 by BL-7040 leads to non-canonical activation of NF-kB, promoting salivary functioning and down-regulating inflammation. We propose that BL-7040 could be beneficial in treating Sjogren's syndrome and may be applicable to additional autoimmune syndromes.	[Gilboa-Geffen, Adi; Wolf, Yochai; Hanin, Geula; Melamed-Book, Naomi; Pick, Marjorie; Bennett, Estelle R.; Greenberg, David S.; Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Lester, Susan; Rischmueller, Maureen] Queen Elizabeth Hosp, Rheumatol Unit, Woodville, SA 5011, Australia; [Soreq, Hermona] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Gilboa-Geffen, A (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	soreq@cc.huji.ac.il	Hanin, Geula/K-8973-2019; Bennett, Estelle R/A-5067-2017; gilboa-geffen, adi/E-3028-2013	gilboa-geffen, adi/0000-0001-9549-4194; Soreq, Hermona/0000-0002-0955-526X; Wolf, Yochai/0000-0003-0270-2025; Greenberg, David/0000-0001-8959-8640; Hanin, Geula/0000-0002-3198-7990	Israel Science Foundation [ISF1876/08]; European Community [LSHG-CT-2006-037277]; National Eshkol PhD fellowship	Israel Science Foundation(Israel Science Foundation); European Community(European Commission); National Eshkol PhD fellowship	This study was supported by grants from the Israel Science Foundation (ISF1876/08) and The European Community (Grant LSHG-CT-2006-037277) (to HS). AGG was an incumbent of a National Eshkol PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Argov Z, 2007, NEUROLOGY, V69, P699, DOI 10.1212/01.wnl.0000267884.39468.7a; Azuma M, 1997, LAB INVEST, V77, P269; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Ben-Zvi I, 2011, CLIN REV ALLERGY IMM; BENASSAYAG E, 2010, MOL MED IN PRESS; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Dawson LJ, 2005, RHEUMATOLOGY, V44, P449, DOI 10.1093/rheumatology/keh506; Dawson LJ, 2001, CLIN EXP IMMUNOL, V124, P480, DOI 10.1046/j.1365-2249.2001.01526.x; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Ehlers M, 2007, TRENDS IMMUNOL, V28, P74, DOI 10.1016/j.it.2006.12.006; Evron T, 2005, NEURODEGENER DIS, V2, P16, DOI 10.1159/000086427; Fallarino F, 2006, TRANSPL IMMUNOL, V17, P58, DOI 10.1016/j.trim.2006.09.017; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino F, 2009, J IMMUNOL, V183, P6303, DOI 10.4049/jimmunol.0901577; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; GARRETT JR, 1993, MICROSC RES TECHNIQ, V26, P75, DOI 10.1002/jemt.1070260108; Gilboa-Geffen A, 2007, BLOOD, V109, P4383, DOI 10.1182/blood-2006-07-033373; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; HOOKS JJ, 1979, NEW ENGL J MED, V301, P5, DOI 10.1056/NEJM197907053010102; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kinoshita D, 2006, J IMMUNOL, V176, P3995, DOI 10.4049/jimmunol.176.7.3995; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Lenert P, 2005, CLIN EXP IMMUNOL, V140, P1, DOI 10.1111/j.1365-2249.2004.02728.x; Lu LF, 2005, J IMMUNOL, V175, P1651, DOI 10.4049/jimmunol.175.3.1651; Nordmark G, 2006, NAT CLIN PRACT RHEUM, V2, P262, DOI 10.1038/ncprheum0173; Puccetti P, 2007, NAT REV IMMUNOL, V7, P817, DOI 10.1038/nri2163; Ramos-Casals M, 2005, RHEUMATOLOGY, V44, P1354, DOI 10.1093/rheumatology/keh714; Routsias JG, 2010, EUR J CLIN INVEST, V40, P1026, DOI 10.1111/j.1365-2362.2010.02342.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Soreq L, 2008, J NEUROIMMUNOL, V201, P227, DOI 10.1016/j.jneuroim.2008.06.019; Soyfool MS, 2007, ORAL DIS, V13, P366, DOI 10.1111/j.1601-0825.2007.01376.x; Sun Siquan, 2007, Inflammation & Allergy Drug Targets, V6, P223; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Tang QZ, 2006, NAT IMMUNOL, V7, P551, DOI 10.1038/ni0606-551; Tishler M, 1999, ANN RHEUM DIS, V58, P253, DOI 10.1136/ard.58.4.253; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Waterman SA, 2000, ARTHRITIS RHEUM, V43, P1647; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973	48	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28727	10.1371/journal.pone.0028727	http://dx.doi.org/10.1371/journal.pone.0028727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174879	gold, Green Submitted, Green Published			2022-12-27	WOS:000298365700067
J	Mraja, A; Unsicker, SB; Reichelt, M; Gershenzon, J; Roscher, C				Mraja, Anne; Unsicker, Sybille B.; Reichelt, Michael; Gershenzon, Jonathan; Roscher, Christiane			Plant Community Diversity Influences Allocation to Direct Chemical Defence in Plantago lanceolata	PLOS ONE			English	Article							EXPERIMENTAL GRASSLAND COMMUNITIES; CARBON NUTRIENT BALANCE; IRIDOID GLYCOSIDES; SPECIES RICHNESS; INVERTEBRATE HERBIVORY; BIODIVERSITY; COSTS; GENOTYPE; ALLELOCHEMICALS; PLANTAGINACEAE	Background: Forecasting the consequences of accelerating rates of changes in biodiversity for ecosystem functioning requires a mechanistic understanding of the relationships between the structure of biological communities and variation in plant functional characteristics. So far, experimental data of how plant species diversity influences the investment of individual plants in direct chemical defences against herbivores and pathogens is lacking. Methodology/Principal Findings: We used Plantago lanceolata as a model species in experimental grasslands differing in species richness and composition (Jena Experiment) to investigate foliar concentrations of the iridoid glycosides (IG), catalpol and its biosynthetic precursor aucubin. Total IG and aucubin concentrations decreased, while catalpol concentrations increased with increasing plant diversity in terms of species or functional group richness. Negative plant diversity effects on total IG and aucubin concentrations correlated with increasing specific leaf area of P. lanceolata, suggesting that greater allocation to light acquisition reduced the investment into these carbon-based defence components. In contrast, increasing leaf nitrogen concentrations best explained increasing concentrations of the biosynthetically more advanced IG, catalpol. Observed levels of leaf damage explained a significant proportion of variation in total IG and aucubin concentrations, but did not account for variance in catalpol concentrations. Conclusions/Significance: Our results clearly show that plants growing in communities of varying species richness and composition differ in their defensive chemistry, which may modulate plant susceptibility to enemy attack and consequently their interactions with higher trophic level organisms.	[Mraja, Anne; Unsicker, Sybille B.; Reichelt, Michael; Gershenzon, Jonathan] Max Planck Inst Chem Ecol, Jena, Germany; [Mraja, Anne; Roscher, Christiane] Max Planck Inst Biogeochem, Jena, Germany	Max Planck Society; Max Planck Society	Mraja, A (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	sunsicker@ice.mpg.de	Gershenzon, Jonathan/K-1331-2013; Unsicker, Sybille B./AAW-6968-2021	Gershenzon, Jonathan/0000-0002-1812-1551; Unsicker, Sybille B./0000-0002-9738-0075	Max-Planck Society; German Science Foundation [FOR 456]; University of Jena	Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); University of Jena	This study was funded by the Max-Planck Society, the German Science Foundation (FOR 456) with additional support from the University of Jena and coordinated by W. W. Weisser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Barton KE, 2007, AM J BOT, V94, P56, DOI 10.3732/ajb.94.1.56; Barton KE, 2006, OECOLOGIA, V150, P442, DOI 10.1007/s00442-006-0531-z; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; BOWERS MD, 1992, OECOLOGIA, V91, P201, DOI 10.1007/BF00317784; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cipollini DF, 2001, J CHEM ECOL, V27, P593, DOI 10.1023/A:1010384805014; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Damtoft S., 1983, BIOCHEM SOC T, V11, P594; Darrow K, 1999, J CHEM ECOL, V25, P1427, DOI 10.1023/A:1020991229072; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; FAJER ED, 1992, AM NAT, V140, P707, DOI 10.1086/285436; GERSHENZON J, 1994, J CHEM ECOL, V20, P1281, DOI 10.1007/BF02059810; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Harvey JA, 2005, J CHEM ECOL, V31, P287, DOI 10.1007/s10886-005-1341-1; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jarzomski CM, 2000, OIKOS, V88, P371, DOI 10.1034/j.1600-0706.2000.880216.x; Kluge G, 2000, BER DTSCH WETTERDIEN, V213, P1; Lipowsky A, 2011, BASIC APPL ECOL, V12, P360, DOI 10.1016/j.baae.2011.03.005; Lorentzen S, 2008, PERSPECT PLANT ECOL, V10, P73, DOI 10.1016/j.ppees.2007.12.001; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Mwangi PN, 2007, J ECOL, V95, P65, DOI 10.1111/j.1365-2745.2006.01189.x; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Poorter H, 2006, J EXP BOT, V57, P355, DOI 10.1093/jxb/erj002; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2007, OECOLOGIA, V154, P535, DOI 10.1007/s00442-007-0846-4; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Scherber C, 2006, OECOLOGIA, V147, P489, DOI 10.1007/s00442-005-0281-3; Scherber C, 2006, J ECOL, V94, P922, DOI 10.1111/j.1365-2745.2006.01144.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Shipley B., 2000, CAUSE CORRELATIONS B; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Stamp N, 2003, Q REV BIOL, V78, P23, DOI 10.1086/367580; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Unsicker SB, 2006, OECOLOGIA, V150, P233, DOI 10.1007/s00442-006-0511-3; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; VANTIENDEREN PH, 1991, J ECOL, V79, P27, DOI 10.2307/2260782; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099	57	38	38	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28055	10.1371/journal.pone.0028055	http://dx.doi.org/10.1371/journal.pone.0028055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174766	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700016
J	Di Fulvio, S; Azakir, BA; Therrien, C; Sinnreich, M				Di Fulvio, Sabrina; Azakir, Bilal A.; Therrien, Christian; Sinnreich, Michael			RETRACTED: Dysferlin Interacts with Histone Deacetylase 6 and Increases alpha-Tubulin Acetylation (Retracted article. See vol. 13, artn no. e0192239, 2018)	PLOS ONE			English	Article; Retracted Publication							MUSCULAR-DYSTROPHY; MEMBRANE REPAIR; SKELETAL-MUSCLE; MICROTUBULE ARRAY; T-TUBULE; HDAC6; EXPRESSION; DYNAMICS; BINDING; GENE	Dysferlin is a multi-C2 domain transmembrane protein involved in a plethora of cellular functions, most notably in skeletal muscle membrane repair, but also in myogenesis, cellular adhesion and intercellular calcium signaling. We previously showed that dysferlin interacts with alpha-tubulin and microtubules in muscle cells. Microtubules are heavily reorganized during myogenesis to sustain growth and elongation of the nascent muscle fiber. Microtubule function is regulated by posttranslational modifications, such as acetylation of its alpha-tubulin subunit, which is modulated by the histone deacetylase 6 (HDAC6) enzyme. In this study, we identified HDAC6 as a novel dysferlin-binding partner. Dysferlin prevents HDAC6 from deacetylating alpha-tubulin by physically binding to both the enzyme, via its C2D domain, and to the substrate, alpha-tubulin, via its C2A and C2B domains. We further show that dysferlin expression promotes alpha-tubulin acetylation, as well as increased microtubule resistance to, and recovery from, Nocodazole-and cold-induced depolymerization. By selectively inhibiting HDAC6 using Tubastatin A, we demonstrate that myotube formation was impaired when alpha-tubulin was hyperacetylated early in the myogenic process; however, myotube elongation occurred when alpha-tubulin was hyperacetylated in myotubes. This study suggests a novel role for dysferlin in myogenesis and identifies HDAC6 as a novel dysferlin-interacting protein.	[Di Fulvio, Sabrina; Azakir, Bilal A.; Sinnreich, Michael] Neuromuscular Res Grp, Dept Neurol, Dept Biomed, Basel, Switzerland; [Therrien, Christian; Sinnreich, Michael] McGill Univ, Neuromuscular Res Grp, Montreal Neurol Inst & Hosp, Montreal, PQ, Canada	McGill University	Di Fulvio, S (corresponding author), Neuromuscular Res Grp, Dept Neurol, Dept Biomed, Basel, Switzerland.	michael.sinnreich@unibas.ch		Sinnreich, Michael/0000-0002-9835-1276	Myosuisse, l'Association francaise contre les myopathies (AFM) [14994]; MDAC-ALS-CIHR Partnership; Swiss National Science Foundation (SNF) [31003A_130286]; l'Association francaise contre les myopathies (AFM) [15111]	Myosuisse, l'Association francaise contre les myopathies (AFM); MDAC-ALS-CIHR Partnership(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); l'Association francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies)	This study was supported by Myosuisse, l'Association francaise contre les myopathies (AFM) (grant number 14994), MDAC-ALS-CIHR Partnership and the Swiss National Science Foundation (SNF) (grant number 31003A_130286). The first author is funded by l'Association francaise contre les myopathies (AFM) (grant number 15111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Azakir BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010122; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Bazzaro M, 2008, CLIN CANCER RES, V14, P7340, DOI 10.1158/1078-0432.CCR-08-0642; Belanto JJ, 2010, NEUROMUSCULAR DISORD, V20, P111, DOI 10.1016/j.nmd.2009.12.003; Bertos NR, 2004, J BIOL CHEM, V279, P48246, DOI 10.1074/jbc.M408583200; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Covian-Nares JF, 2010, J CELL SCI, V123, P1884, DOI 10.1242/jcs.066084; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; de Luna N, 2006, J BIOL CHEM, V281, P17092, DOI 10.1074/jbc.M601885200; de Morree A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013854; Demonbreun AR, 2011, HUM MOL GENET, V20, P779, DOI 10.1093/hmg/ddq522; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Evans V, 2008, HUM GENE THER, V19, P569, DOI 10.1089/hum.2007.169; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Guerin CM, 2009, DEVELOPMENT, V136, P1411, DOI 10.1242/dev.031823; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Klinge L, 2010, MUSCLE NERVE, V41, P166, DOI 10.1002/mus.21166; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Krylyshkina O, 2002, J CELL BIOL, V156, P349, DOI 10.1083/jcb.200105051; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; Musa H, 2003, J MUSCLE RES CELL M, V24, P301; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rey M, 2011, EUR J CELL BIOL, V90, P128, DOI 10.1016/j.ejcb.2010.09.004; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; SAITOH O, 1988, CELL TISSUE RES, V252, P263; Sharma A, 2010, ARTERIOSCL THROM VAS, V30, P2196, DOI 10.1161/ATVBAHA.110.208108; Spangenburg EE, 2004, ENDOCRINOLOGY, V145, P2054, DOI 10.1210/en.2003-1476; Therrien C, 2009, BIOCHEMISTRY-US, V48, P2377, DOI 10.1021/bi802242r; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	48	35	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28563	10.1371/journal.pone.0028563	http://dx.doi.org/10.1371/journal.pone.0028563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174839	gold, Green Published			2022-12-27	WOS:000298163600035
J	Dreyer, AP; Shingleton, AW				Dreyer, Austin P.; Shingleton, Alexander W.			The Effect of Genetic and Environmental Variation on Genital Size in Male Drosophila: Canalized but Developmentally Unstable	PLOS ONE			English	Article							STATIC ALLOMETRY; FLUCTUATING ASYMMETRY; SEXUAL SELECTION; BODY-SIZE; EVOLUTION; VARIABILITY; VARIANCE; HYPOTHESES; COLEOPTERA; CHARACTER	The genitalia of most male arthropods scale hypoallometrically with body size, that is they are more or less the same size across large and small individuals in a population. Such scaling is expected to arise when genital traits show less variation than somatic traits in response to factors that generate size variation among individuals in a population. Nevertheless, there have been few studies directly examining the relative sensitivity of genital and somatic traits to factors that affect their size. Such studies are key to understanding genital evolution and the evolution of morphological scaling relationships more generally. Previous studies indicate that the size of genital traits in male Drosophila melanogaster show a relatively low response to variation in environmental factors that affect trait size. Here we show that the size of genital traits in male fruit flies also exhibit a relatively low response to variation in genetic factors that affect trait size. Importantly, however, this low response is only to genetic factors that affect body and organ size systemically, not those that affect organ size autonomously. Further, we show that the genital traits do not show low levels of developmental instability, which is the response to stochastic developmental errors that also influence organ size autonomously. We discuss these results in the context of current hypotheses on the proximate and ultimate mechanisms that generate genital hypoallometry.	[Dreyer, Austin P.; Shingleton, Alexander W.] Michigan State Univ, Dept Zool, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Michigan State University	Dreyer, AP (corresponding author), Michigan State Univ, Dept Zool, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA.	dreyerau@msu.edu		Shingleton, Alexander/0000-0001-9862-9947	National Science Foundation [IOS-0845847, IOS-0919855]; Michigan State University; College of Natural Science ( Michigan State University)	National Science Foundation(National Science Foundation (NSF)); Michigan State University; College of Natural Science ( Michigan State University)	This research was supported by National Science Foundation grants IOS-0845847 and IOS-0919855, and fellowship support from the Ecology, Evolution Biology and Behavior program (Michigan State University) and the College of Natural Science (Michigan State University) to APD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 1997, BIOL J LINN SOC, V60, P365; Bernstein S, 2002, EVOLUTION, V56, P1707, DOI 10.1111/j.0014-3820.2002.tb01483.x; Bertin A, 2007, EVOLUTION, V61, P825, DOI 10.1111/j.1558-5646.2007.00074.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; BULMER MG, 1976, GENET RES, V28, P101, DOI 10.1017/S0016672300016797; COOK RM, 1977, BEHAV GENET, V7, P349, DOI 10.1007/BF01077448; CRNOKRAK P, 1995, HEREDITY, V75, P530, DOI 10.1038/hdy.1995.169; Debat V, 2001, TRENDS ECOLOGY EVOLU; Dufour L, 1936, ANN SCI NATURELLE, V1, P244; Eberhard W, 2009, J EVOLUTION BIOL, V22, P435, DOI 10.1111/j.1420-9101.2008.01654.x; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Eberhard WG, 1999, EVOLUTION, V53, P1624, DOI 10.1111/j.1558-5646.1999.tb05428.x; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Eshel I, 1998, GENETICS, V149, P2119; Falconer D. S, 1996, INTRO QUANTITAVE GEN; Funke S, 2005, J ARACHNOL, V33, P870, DOI 10.1636/S04-16.1; GAVRILETS S, 1994, EVOLUTION, V48, P1478, DOI [10.2307/2410242, 10.1111/j.1558-5646.1994.tb02190.x]; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Green AJ, 1999, EVOLUTION, V53, P1621, DOI [10.2307/2640909, 10.1111/j.1558-5646.1999.tb05427.x]; Hosken DJ, 2005, EVOL ECOL, V19, P501, DOI 10.1007/s10682-005-1023-z; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Huber BA, 2003, ORG DIVERS EVOL, V3, P63, DOI 10.1078/1439-6092-00059; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; KAUFMAN PK, 1977, GENETICS, V87, P327; Kawano K, 2006, ANN ENTOMOL SOC AM, V99, P327, DOI 10.1603/0013-8746(2006)099[0327:SDATMO]2.0.CO;2; Merila J, 1999, HEREDITY, V83, P103, DOI 10.1038/sj.hdy.6885850; Ng CS, 2008, BEHAV GENET, V38, P195, DOI 10.1007/s10519-008-9190-7; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Oosthuizen WH, 2000, MAR MAMMAL SCI, V16, P124, DOI 10.1111/j.1748-7692.2000.tb00908.x; Palestrini C, 2000, CAN J ZOOL, V78, P1199, DOI 10.1139/cjz-78-7-1199; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1990, BIOL REV, V65, P131, DOI 10.1111/j.1469-185X.1990.tb01186.x; PATTERSON BD, 1982, J MAMMAL, V63, P1, DOI 10.2307/1380665; R Core Team, 2020, R LANG ENV STAT COMP; SCHARLOO W, 1967, GENETICS, V56, P709; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tatsuta H, 2007, BIOL J LINN SOC, V90, P573, DOI 10.1111/j.1095-8312.2007.00744.x; Uhl G, 2000, J ZOOL, V251, P7, DOI 10.1111/j.1469-7998.2000.tb00587.x; VANVALEN L, 1962, EVOLUTION, V16, P125; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Waddington CH, 1961, GENETIC ASSIMILATION; Wright S, 1952, QUANITITATIVE INHERI	49	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28278	10.1371/journal.pone.0028278	http://dx.doi.org/10.1371/journal.pone.0028278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174784	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600016
J	Ganal, MW; Durstewitz, G; Polley, A; Berard, A; Buckler, ES; Charcosset, A; Clarke, JD; Graner, EM; Hansen, M; Joets, J; Le Paslier, MC; McMullen, MD; Montalent, P; Rose, M; Schon, CC; Sun, Q; Walter, H; Martin, OC; Falque, M				Ganal, Martin W.; Durstewitz, Gregor; Polley, Andreas; Berard, Aurelie; Buckler, Edward S.; Charcosset, Alain; Clarke, Joseph D.; Graner, Eva-Maria; Hansen, Mark; Joets, Johann; Le Paslier, Marie-Christine; McMullen, Michael D.; Montalent, Pierre; Rose, Mark; Schoen, Chris-Carolin; Sun, Qi; Walter, Hildrun; Martin, Olivier C.; Falque, Matthieu			A Large Maize (Zea mays L.) SNP Genotyping Array: Development and Germplasm Genotyping, and Genetic Mapping to Compare with the B73 Reference Genome	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; DIVERSITY; ASSOCIATION; MAP; PATTERNS; INBREDS; REGION; DESIGN; ASSAY	SNP genotyping arrays have been useful for many applications that require a large number of molecular markers such as high-density genetic mapping, genome-wide association studies (GWAS), and genomic selection. We report the establishment of a large maize SNP array and its use for diversity analysis and high density linkage mapping. The markers, taken from more than 800,000 SNPs, were selected to be preferentially located in genes and evenly distributed across the genome. The array was tested with a set of maize germplasm including North American and European inbred lines, parent/F1 combinations, and distantly related teosinte material. A total of 49,585 markers, including 33,417 within 17,520 different genes and 16,168 outside genes, were of good quality for genotyping, with an average failure rate of 4% and rates up to 8% in specific germplasm. To demonstrate this array's use in genetic mapping and for the independent validation of the B73 sequence assembly, two intermated maize recombinant inbred line populations - IBM (B73 x Mo17) and LHRF (F2 x F252) - were genotyped to establish two high density linkage maps with 20,913 and 14,524 markers respectively. 172 mapped markers were absent in the current B73 assembly and their placement can be used for future improvements of the B73 reference sequence. Colinearity of the genetic and physical maps was mostly conserved with some exceptions that suggest errors in the B73 assembly. Five major regions containing non-colinearities were identified on chromosomes 2, 3, 6, 7 and 9, and are supported by both independent genetic maps. Four additional non-colinear regions were found on the LHRF map only; they may be due to a lower density of IBM markers in those regions or to true structural rearrangements between lines. Given the array's high quality, it will be a valuable resource for maize genetics and many aspects of maize breeding.	[Ganal, Martin W.; Durstewitz, Gregor; Polley, Andreas; Graner, Eva-Maria] TraitGenetics GmbH, Gatersleben, Germany; [Berard, Aurelie; Le Paslier, Marie-Christine] Ctr Natl Genotypage, Inst Genom, CEA, INRA,Etud Polymorphisme Genomes Vegetaux, Evry, France; [Buckler, Edward S.; Sun, Qi] Cornell Univ, Ithaca, NY USA; [Charcosset, Alain; Joets, Johann; Montalent, Pierre; Martin, Olivier C.; Falque, Matthieu] Univ Paris 11, CNRS, AgroParisTech, INRA,UMR Genet Vegetale, Gif Sur Yvette, France; [Clarke, Joseph D.; Rose, Mark] Syngenta Biotechnol Inc, Res Triangle Pk, NC USA; [Hansen, Mark] Illumina Inc, San Diego, CA USA; [McMullen, Michael D.] ARS, USDA, Plant Genet Res Unit, Columbia, MO USA; [Schoen, Chris-Carolin; Walter, Hildrun] Tech Univ Munich, Dept Plant Breeding, Freising Weihenstephan, Germany	CEA; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Cornell University; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Syngenta; Illumina; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; Technical University of Munich	Ganal, MW (corresponding author), TraitGenetics GmbH, Gatersleben, Germany.	falque@moulon.inra.fr	Martin, Olivier C/B-6656-2012; Schoen, Chris/G-1867-2011; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Martin, Olivier C/0000-0002-5295-5963; Schoen, Chris/0000-0001-6067-7900; Buckler, Edward/0000-0002-3100-371X; Walter, Hildrun/0000-0001-8720-3668; Charcosset, Alain/0000-0001-6125-503X; Falque, Matthieu/0000-0002-6444-858X; Joets, Johann/0000-0002-5353-5100	Agence Nationale de la Recherche [ANR-10-GENOMIQUE-SingleMeiosis]; German Federal Ministery for Education and Research [0315528]; USDA-ARS; Division Of Integrative Organismal Systems [0820619] Funding Source: National Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); German Federal Ministery for Education and Research; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work has been supported by a grant from the Agence Nationale de la Recherche http://www.agence-nationale-recherche.fr/ (ANR-10-GENOMIQUE-SingleMeiosis) to MF and OCM, a grant from the German Federal Ministery for Education and Research http://www.bmbf.de/en/ (AgroclustER Synbreed - Synergistic Plant and Animal Breeding, grant no. 0315528) to MWG and C-CS, and funds provided by USDA-ARS http://www.ars.usda.gov/main/main. htm to MDM and ESB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2011, THEOR APPL GENET, V123, P339, DOI 10.1007/s00122-011-1587-7; Anderson LK, 2003, GENETICS, V165, P849; Beavis W. D., 1992, Maize Genetics Cooperation Newsletter, P52; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; Bennetzen JL, 2007, CURR OPIN PLANT BIOL, V10, P176, DOI 10.1016/j.pbi.2007.01.010; BURR B, 1988, GENETICS, V118, P519; Ching A, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-19; de Givry S, 2005, BIOINFORMATICS, V21, P1703, DOI 10.1093/bioinformatics/bti222; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Falque M, 2005, BIOINFORMATICS, V21, P3441, DOI 10.1093/bioinformatics/bti543; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Jones E, 2009, MOL BREEDING, V24, P165, DOI 10.1007/s11032-009-9281-z; Jung M, 2004, THEOR APPL GENET, V109, P681, DOI 10.1007/s00122-004-1695-8; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; LI WH, 1991, GENETICS, V129, P513; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Meuwissen THE, 2001, GENETICS, V157, P1819; Nelson PT, 2008, CROP SCI, V48, P1673, DOI 10.2135/cropsci2008.02.0092; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000728; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Winkler CR, 2003, GENETICS, V164, P741; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zhao ZM, 2006, GENETICS, V174, P399, DOI 10.1534/genetics.106.060301; Zhou SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000711	41	408	436	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28334	10.1371/journal.pone.0028334	http://dx.doi.org/10.1371/journal.pone.0028334			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174790	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600020
J	Armon, L; Eisenbach, M				Armon, Leah; Eisenbach, Michael			Behavioral Mechanism during Human Sperm Chemotaxis: Involvement of Hyperactivation	PLOS ONE			English	Article							HUMAN-SPERMATOZOA; POSTNATAL-DEVELOPMENT; BACTERIAL CHEMOTAXIS; INTRACELLULAR CA2+; FOLLICULAR FACTORS; MALE-FERTILITY; MOUSE TESTIS; MOTILITY; PROGESTERONE; CHANNEL	When mammalian spermatozoa become capacitated they acquire, among other activities, chemotactic responsiveness and the ability to exhibit occasional events of hyperactivated motility-a vigorous motility type with large amplitudes of head displacement. Although a number of roles have been proposed for this type of motility, its function is still obscure. Here we provide evidence suggesting that hyperactivation is part of the chemotactic response. By analyzing tracks of spermatozoa swimming in a spatial chemoattractant gradient we demonstrate that, in such a gradient, the level of hyperactivation events is significantly lower than in proper controls. This suggests that upon sensing an increase in the chemoattractant concentration capacitated cells repress their hyperactivation events and thus maintain their course of swimming toward the chemoattractant. Furthermore, in response to a temporal concentration jump achieved by photorelease of the chemoattractant progesterone from its caged form, the responsive cells exhibited a delayed turn, often accompanied by hyperactivation events or an even more intense response in the form of flagellar arrest. This study suggests that the function of hyperactivation is to cause a rather sharp turn during the chemotactic response of capacitated cells so as to assist them to reorient according to the chemoattractant gradient. On the basis of these results a model for the behavior of spermatozoa responding to a spatial chemoattractant gradient is proposed.	[Armon, Leah; Eisenbach, Michael] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Armon, L (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	m.eisenbach@weizmann.ac.il		Eisenbach, Michael/0000-0001-9048-4720				Avidan N, 2003, EUR J HUM GENET, V11, P497, DOI 10.1038/sj.ejhg.5200991; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; BURKMAN LJ, 1984, ARCH ANDROLOGY, V13, P153, DOI 10.3109/01485018408987514; Chang HX, 2011, BIOL REPROD, V85, P296, DOI 10.1095/biolreprod.110.089789; COHENDAYAG A, 1994, BIOL REPROD, V50, P786, DOI 10.1095/biolreprod50.4.786; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; Davis RO, 1995, REPROD FERT DEVELOP, V7, P857, DOI 10.1071/RD9950857; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Eisenbach M, 1999, DEV GENET, V25, P87, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;87::AID-DVG2&gt;3.0.CO;2-4; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; Gakamsky A, 2008, INT J DEV BIOL, V52, P481, DOI 10.1387/ijdb.072520ag; Gakamsky A, 2009, HUM REPROD, V24, P1152, DOI 10.1093/humrep/den409; Hardy DM, 2002, FERTILIZATION, P3; HAUSER R, 1992, INT J ANDROL, V15, P498, DOI 10.1111/j.1365-2605.1992.tb01143.x; Ho HC, 2001, BIOL REPROD, V65, P1606, DOI 10.1095/biolreprod65.5.1606; HUNTER RHF, 1994, MOL REPROD DEV, V39, P176, DOI 10.1002/mrd.1080390209; Jaiswal BS, 2002, FERTILIZATION, P57, DOI DOI 10.1016/B978-012311629-1/50005-X; JANSEN RPS, 1980, AM J OBSTET GYNECOL, V136, P292, DOI 10.1016/0002-9378(80)90853-4; KHAN S, 1993, BIOPHYS J, V65, P2368, DOI 10.1016/S0006-3495(93)81317-1; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Li HG, 2007, MOL HUM REPROD, V13, P299, DOI 10.1093/molehr/gam009; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lobley Anna, 2003, Reprod Biol Endocrinol, V1, P53, DOI 10.1186/1477-7827-1-53; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Marquez B, 2004, BIOL REPROD, V70, P1626, DOI 10.1095/biolreprod.103.026476; Marquez B, 2007, DEV BIOL, V303, P214, DOI 10.1016/j.ydbio.2006.11.007; Mortimer ST, 1997, HUM REPROD UPDATE, V3, P403, DOI 10.1093/humupd/3.5.403; Mortimer ST, 1996, HUM REPROD, V11, P1049; MUJICA A, 1994, MOL REPROD DEV, V38, P285, DOI 10.1002/mrd.1080380309; Nikpoor P, 2004, HUM REPROD, V19, P124, DOI 10.1093/humrep/deh043; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; PACEY AA, 1995, HUM REPROD, V10, P2603, DOI 10.1093/oxfordjournals.humrep.a135754; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; RALT D, 1994, BIOL REPROD, V50, P774, DOI 10.1095/biolreprod50.4.774; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; ROBERTSON L, 1988, BIOL REPROD, V39, P797, DOI 10.1095/biolreprod39.4.797; STAUSS CR, 1995, BIOL REPROD, V53, P1280, DOI 10.1095/biolreprod53.6.1280; Strunker T, 2011, NATURE, V471, P382, DOI 10.1038/nature09769; Suarez SS, 2003, REPROD DOMEST ANIM, V38, P119, DOI 10.1046/j.1439-0531.2003.00397.x; SUAREZ SS, 1992, BIOL REPROD, V46, P686, DOI 10.1095/biolreprod46.4.686; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; UHLER ML, 1992, FERTIL STERIL, V58, P1191; *WHO, 1993, WHO LAB MAN EX HUM S; YONISHROUACH E, 1990, J IMMUNOL METHODS, V135, P147, DOI 10.1016/0022-1759(90)90267-Y	49	54	56	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28359	10.1371/journal.pone.0028359	http://dx.doi.org/10.1371/journal.pone.0028359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163296	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900032
J	Campan, M; Moffitt, M; Houshdaran, S; Shen, H; Widschwendter, M; Daxenbichler, G; Long, T; Marth, C; Laird-Offringa, IA; Press, MF; Dubeau, L; Siegmund, KD; Wu, AH; Groshen, S; Chandavarkar, U; Roman, LD; Berchuck, A; Pearce, CL; Laird, PW				Campan, Mihaela; Moffitt, Melissa; Houshdaran, Sahar; Shen, Hui; Widschwendter, Martin; Daxenbichler, Guenter; Long, Tiffany; Marth, Christian; Laird-Offringa, Ite A.; Press, Michael F.; Dubeau, Louis; Siegmund, Kimberly D.; Wu, Anna H.; Groshen, Susan; Chandavarkar, Uma; Roman, Lynda D.; Berchuck, Andrew; Pearce, Celeste L.; Laird, Peter W.			Genome-Scale Screen for DNA Methylation-Based Detection Markers for Ovarian Cancer	PLOS ONE			English	Article							BIOMARKERS; SERUM; CELL; EPIDEMIOLOGY; PREDICTION; MANAGEMENT; CARCINOMA; SPECIMENS; DIAGNOSIS	Background: The identification of sensitive biomarkers for the detection of ovarian cancer is of high clinical relevance for early detection and/or monitoring of disease recurrence. We developed a systematic multi-step biomarker discovery and verification strategy to identify candidate DNA methylation markers for the blood-based detection of ovarian cancer. Methodology/Principal Findings: We used the Illumina Infinium platform to analyze the DNA methylation status of 27,578 CpG sites in 41 ovarian tumors. We employed a marker selection strategy that emphasized sensitivity by requiring consistency of methylation across tumors, while achieving specificity by excluding markers with methylation in control leukocyte or serum DNA. Our verification strategy involved testing the ability of identified markers to monitor disease burden in serially collected serum samples from ovarian cancer patients who had undergone surgical tumor resection compared to CA-125 levels. We identified one marker, IFFO1 promoter methylation (IFFO1-M), that is frequently methylated in ovarian tumors and that is rarely detected in the blood of normal controls. When tested in 127 serially collected sera from ovarian cancer patients, IFFO1-M showed post-resection kinetics significantly correlated with serum CA-125 measurements in six out of 16 patients. Conclusions/Significance: We implemented an effective marker screening and verification strategy, leading to the identification of IFFO1-M as a blood-based candidate marker for sensitive detection of ovarian cancer. Serum levels of IFFO1-M displayed post-resection kinetics consistent with a reflection of disease burden. We anticipate that IFFO1-M and other candidate markers emerging from this marker development pipeline may provide disease detection capabilities that complement existing biomarkers.	[Campan, Mihaela; Long, Tiffany; Laird-Offringa, Ite A.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Moffitt, Melissa; Chandavarkar, Uma; Roman, Lynda D.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Los Angeles, CA 90033 USA; [Houshdaran, Sahar; Laird-Offringa, Ite A.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Widschwendter, Martin] UCL, Dept Gynecol Oncol, Elizabeth Garrett Anderson Inst Womens Hlth, London, England; [Daxenbichler, Guenter; Marth, Christian] Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Durham, NC 27710 USA; [Siegmund, Kimberly D.; Wu, Anna H.; Groshen, Susan; Pearce, Celeste L.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90033 USA; [Press, Michael F.; Dubeau, Louis] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of London; University College London; Medical University of Innsbruck; Duke University; University of Southern California; University of Southern California; University of Southern California	Campan, M (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA.	plaird@usc.edu	Offringa, Ite/R-4101-2019; Laird, Peter W/G-8683-2012; Shen, Hui/AAO-4387-2020	Laird, Peter W/0000-0001-9117-3641; Shen, Hui/0000-0001-9767-4084; moffitt, melissa/0000-0002-1270-0034; Widschwendter, Martin/0000-0002-7778-8380	Ovarian Cancer Research Fund [PPD/USC.06]; National Institutes of Health and National Cancer Institute [R01-CA096958]; NATIONAL CANCER INSTITUTE [R01CA096958] Funding Source: NIH RePORTER	Ovarian Cancer Research Fund; National Institutes of Health and National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Ovarian Cancer Research Fund, grant PPD/USC.06, and National Institutes of Health and National Cancer Institute, grant R01-CA096958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; [Anonymous], 2011, CANC GENOME ATLAS DA; Barton CA, 2008, GYNECOL ONCOL, V109, P129, DOI 10.1016/j.ygyno.2007.12.017; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Board RE, 2007, BIOMARK INSIGHTS, V2, P307; Brown PO, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000114; Byun HM, 2009, HUM MOL GENET, V18, P4808, DOI 10.1093/hmg/ddp445; Campan Mihhaela, 2009, V507, P325, DOI 10.1007/978-1-59745-522-0_23; Clarke-Pearson DL, 2009, NEW ENGL J MED, V361, P170, DOI 10.1056/NEJMcp0901926; de Caceres Inmaculada Ibanez, 2004, Cancer Research, V64, P6476, DOI 10.1158/0008-5472.CAN-04-1529; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Houshdaran S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009359; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kulasingam V, 2010, NAT REV CANCER, V10, P371, DOI 10.1038/nrc2831; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LEON SA, 1977, CANCER RES, V37, P646; Melnikov A, 2009, J MOL DIAGN, V11, P60, DOI 10.2353/jmoldx.2009.080072; Memarzadeh S, 2001, J REPROD MED, V46, P621; Moore RG, 2008, GYNECOL ONCOL, V108, P402, DOI 10.1016/j.ygyno.2007.10.017; Mutch DG, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.31589; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Schwartz Peter E, 2002, Cancer Treat Res, V107, P99; Sepulveda Antonia R, 2009, J Mol Diagn, V11, P266, DOI 10.2353/jmoldx.2009.080125; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Vineis P, 2007, CANCER EPIDEM BIOMAR, V16, P1954, DOI 10.1158/1055-9965.EPI-07-0457; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	35	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28141	10.1371/journal.pone.0028141	http://dx.doi.org/10.1371/journal.pone.0028141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163280	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900015
J	Hausswirth, C; Louis, J; Bieuzen, F; Pournot, H; Fournier, J; Filliard, JR; Brisswalter, J				Hausswirth, Christophe; Louis, Julien; Bieuzen, Francois; Pournot, Herve; Fournier, Jean; Filliard, Jean-Robert; Brisswalter, Jeanick			Effects of Whole-Body Cryotherapy vs. Far-Infrared vs. Passive Modalities on Recovery from Exercise-Induced Muscle Damage in Highly-Trained Runners	PLOS ONE			English	Article							REPEATED THERMAL THERAPY; COLD-WATER IMMERSION; DELAYED-ONSET; OXYGEN-UPTAKE; SINGLE BOUT; CRYOSTIMULATION; PERFORMANCE; SORENESS; MECHANISMS; SESSIONS	Enhanced recovery following physical activity and exercise-induced muscle damage (EIMD) has become a priority for athletes. Consequently, a number of post-exercise recovery strategies are used, often without scientific evidence of their benefits. Within this framework, the purpose of this study was to test the efficacy of whole body cryotherapy (WBC), far infrared (FIR) or passive (PAS) modalities in hastening muscular recovery within the 48 hours after a simulated trail running race. In 3 non-adjoining weeks, 9 well-trained runners performed 3 repetitions of a simulated trail run on a motorized treadmill, designed to induce muscle damage. Immediately (post), post 24 h, and post 48 h after exercise, all participants tested three different recovery modalities (WBC, FIR, PAS) in a random order over the three separate weeks. Markers of muscle damage (maximal isometric muscle strength, plasma creatine kinase [CK] activity and perceived sensations [i.e. pain, tiredness, well-being]) were recorded before, immediately after (post), post 1 h, post 24 h, and post 48 h after exercise. In all testing sessions, the simulated 48 min trail run induced a similar, significant amount of muscle damage. Maximal muscle strength and perceived sensations were recovered after the first WBC session (post 1 h), while recovery took 24 h with FIR, and was not attained through the PAS recovery modality. No differences in plasma CK activity were recorded between conditions. Three WBC sessions performed within the 48 hours after a damaging running exercise accelerate recovery from EIMD to a greater extent than FIR or PAS modalities.	[Hausswirth, Christophe; Louis, Julien; Bieuzen, Francois; Pournot, Herve; Fournier, Jean] Natl Inst Sport Expertise & Performance INSEP, Res Dept, Paris, France; [Louis, Julien; Pournot, Herve; Brisswalter, Jeanick] Univ Nice Sophia Antipolis, Lab Human Motr Educ & Hlth, Nice, France; [Filliard, Jean-Robert] Natl Inst Sport Expertise & Performance INSEP, Dept Med, Paris, France	UDICE-French Research Universities; Universite Cote d'Azur; Sanofi-Aventis; Sanofi France	Hausswirth, C (corresponding author), Natl Inst Sport Expertise & Performance INSEP, Res Dept, Paris, France.	christophe.hausswirth@insep.fr	Louis, Julien/AAI-4392-2021; Bieuzen, Francois/F-8162-2013	Louis, Julien/0000-0002-9109-0958; Bieuzen, Francois/0000-0002-9690-9168; BIEUZEN, Francois/0000-0002-8073-8421				Bailey DM, 2007, J SPORT SCI, V25, P1163, DOI 10.1080/02640410600982659; BANFI G, 2008, BRIT J SPORT MED, V42, P558; Banfi G, 2010, SPORTS MED, V40, P509, DOI 10.2165/11531940-000000000-00000; Banfi G, 2009, J SCI MED SPORT, V12, P609, DOI [10.1016/j.jsams.2008.06.004, 10.1016/j.jsams.2008.02.004]; Banfi G, 2009, J THERM BIOL, V34, P55, DOI 10.1016/j.jtherbio.2008.10.003; Barnett A, 2006, SPORTS MED, V36, P781, DOI 10.2165/00007256-200636090-00005; BEMBEN MG, 1990, RES Q EXERCISE SPORT, V61, P96, DOI 10.1080/02701367.1990.10607484; Braun WA, 2003, EUR J APPL PHYSIOL, V90, P29, DOI 10.1007/s00421-003-0857-8; Brenner IKM, 1999, J APPL PHYSIOL, V87, P699, DOI 10.1152/jappl.1999.87.2.699; Chen TC, 2008, J SCI MED SPORT, V11, P271, DOI 10.1016/j.jsams.2007.02.015; Cheung K, 2003, SPORTS MED, V33, P145, DOI 10.2165/00007256-200333020-00005; Costello JT, 2011, SCAND J MED IN PRESS; Duffield Rob, 2008, V53, P89, DOI 10.1159/000151552; Easthope CS, 2010, EUR J APPL PHYSIOL, V110, P1107, DOI 10.1007/s00421-010-1597-1; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Gauche E, 2006, MED SCI SPORT EXER, V38, P2110, DOI 10.1249/01.mss.0000235351.01438.5a; GREGOROWITCZ H, 1998, ACTA BIOOPTICA INFOR, V4, P119; Halson SL, 2004, SPORTS MED, V34, P967, DOI 10.2165/00007256-200434140-00003; Hirsch MS, 1998, PAIN, V77, P41, DOI 10.1016/S0304-3959(98)00080-3; Howatson G, 2008, SPORTS MED, V38, P483, DOI 10.2165/00007256-200838060-00004; Howatson G, 2009, EUR J APPL PHYSIOL, V105, P615, DOI 10.1007/s00421-008-0941-1; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Ingram J, 2009, J SCI MED SPORT, V12, P417, DOI 10.1016/j.jsams.2007.12.011; Jakeman JR, 2010, EUR J APPL PHYSIOL, V109, P1137, DOI 10.1007/s00421-010-1464-0; Jansky L, 1996, EUR J APPL PHYSIOL O, V72, P445, DOI 10.1007/BF00242274; Klimek AT, 2010, INT J OCCUP MED ENV, V23, P181, DOI 10.2478/v10001-010-0019-2; Kukkonen-Harjula K, 2006, INT J CIRCUMPOL HEAL, V65, P195, DOI 10.3402/ijch.v65i3.18102; Leppaluoto J, 2008, SCAND J CLIN LAB INV, V68, P145, DOI 10.1080/00365510701516350; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Lubkowska A, 2011, SCAND J CLIN LAB INV, V71, P419, DOI 10.3109/00365513.2011.580859; Lubkowska A, 2010, EUR J APPL PHYSIOL, V109, P67, DOI 10.1007/s00421-009-1207-2; Lubkowska A, 2008, J THERM BIOL, V33, P464, DOI 10.1016/j.jtherbio.2008.08.003; Masuda A, 2005, PSYCHOTHER PSYCHOSOM, V74, P288, DOI 10.1159/000086319; Masuda A, 2005, J PSYCHOSOM RES, V58, P383, DOI 10.1016/j.jpsychores.2004.11.005; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Miller E, 2011, EUR J APPL IN PRESS; Millet GY, 2003, J APPL PHYSIOL, V94, P193, DOI 10.1152/japplphysiol.00600.2002; Nicol C, 2006, SPORTS MED, V36, P977, DOI 10.2165/00007256-200636110-00004; Nosaka K, 1997, J SPORT SCI, V15, P477, DOI 10.1080/026404197367119; Nosaka K, 2002, MED SCI SPORT EXER, V34, P63, DOI 10.1097/00005768-200201000-00011; Overgaard K, 2004, MED SCI SPORT EXER, V36, P821, DOI 10.1249/01.MSS.0000126468.65714.60; Peiffer JJ, 2010, BRIT J SPORT MED, V44, P461, DOI 10.1136/bjsm.2008.048173; Peiffer JJ, 2009, J SCI MED SPORT, V12, P91, DOI 10.1016/j.jsams.2007.10.011; Pournot H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022748; Pringle JSM, 2003, EUR J APPL PHYSIOL, V89, P289, DOI 10.1007/s00421-003-0799-1; Rymaszewska J, 2008, ARCH IMMUNOL THER EX, V56, P63, DOI 10.1007/s00005-008-0006-5; SCHWANE JA, 1983, MED SCI SPORT EXER, V15, P51; Sellwood KL, 2007, BRIT J SPORT MED, V41, P392, DOI 10.1136/bjsm.2006.033985; Vaile J, 2008, EUR J APPL PHYSIOL, V102, P447, DOI 10.1007/s00421-007-0605-6; Warren GL, 1999, SPORTS MED, V27, P43, DOI 10.2165/00007256-199927010-00004; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Weerapong P, 2005, SPORTS MED, V35, P235, DOI 10.2165/00007256-200535030-00004; Westerlund T, 2004, J THERM BIOL, V29, P285, DOI 10.1016/j.jtherbio.2004.05.004; Wozniak A, 2007, EUR J APPL PHYSIOL, V100, P137, DOI 10.1007/s00421-007-0404-0	54	120	122	6	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27749	10.1371/journal.pone.0027749	http://dx.doi.org/10.1371/journal.pone.0027749			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163272	Green Published, Green Accepted, gold			2022-12-27	WOS:000298161900008
J	Starmans, MHW; Fung, G; Steck, H; Wouters, BG; Lambin, P				Starmans, Maud H. W.; Fung, Glenn; Steck, Harald; Wouters, Bradly G.; Lambin, Philippe			A Simple but Highly Effective Approach to Evaluate the Prognostic Performance of Gene Expression Signatures	PLOS ONE			English	Article							CELL-LUNG-CANCER; BREAST-CANCER; PATIENT SURVIVAL; DNA MICROARRAYS; CHEMOTHERAPY; PREDICTORS; HYPOXIA	Background: Highly parallel analysis of gene expression has recently been used to identify gene sets or 'signatures' to improve patient diagnosis and risk stratification. Once a signature is generated, traditional statistical testing is used to evaluate its prognostic performance. However, due to the dimensionality of microarrays, this can lead to false interpretation of these signatures. Principal Findings: A method was developed to test batches of a user-specified number of randomly chosen signatures in patient microarray datasets. The percentage of random generated signatures yielding prognostic value was assessed using ROC analysis by calculating the area under the curve (AUC) in six public available cancer patient microarray datasets. We found that a signature consisting of randomly selected genes has an average 10% chance of reaching significance when assessed in a single dataset, but can range from 1% to similar to 40% depending on the dataset in question. Increasing the number of validation datasets markedly reduces this number. Conclusions: We have shown that the use of an arbitrary cut-off value for evaluation of signature significance is not suitable for this type of research, but should be defined for each dataset separately. Our method can be used to establish and evaluate signature performance of any derived gene signature in a dataset by comparing its performance to thousands of randomly generated signatures. It will be of most interest for cases where few data are available and testing in multiple datasets is limited.	[Starmans, Maud H. W.; Wouters, Bradly G.; Lambin, Philippe] Maastricht Univ, Dept Radiat Oncol Maastro, GROW Sch Oncol & Dev Biol, Med Ctr, Maastricht, Netherlands; [Fung, Glenn; Steck, Harald] Siemens Med Solut, Dept CAD & Knowledge Solut, Malvern, PA USA; [Wouters, Bradly G.] Univ Hlth Network, Ontario Canc Inst, Princess Margaret Hosp, Toronto, ON, Canada	Maastricht University; Siemens AG; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Starmans, MHW (corresponding author), Maastricht Univ, Dept Radiat Oncol Maastro, GROW Sch Oncol & Dev Biol, Med Ctr, Maastricht, Netherlands.	maud.starmans@maastrichtuniversity.nl	Wouters, Bradly/T-1525-2017	Wouters, Bradly/0000-0002-8187-592X; Lambin, Philippe/0000-0001-7961-0191	Siemens Oncology Care Systems (OCS); CTMM	Siemens Oncology Care Systems (OCS); CTMM	The authors acknowledge financial support from Siemens Oncology Care Systems (OCS) and the CTMM framework (AIRFORCE project). G. Fung and H. Steck are employed by Siemens Medical Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Siemens OCS and Siemens Medical Solutions are separate divisions.	Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Boulesteix AL, 2009, BRIEF BIOINFORM, V10, P556, DOI 10.1093/bib/bbp034; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; FISHEL I, 2007, BIOINFORMATICS; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sanchez-Palencia A, 2010, INT J CANC; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Xu WW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-465; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325; Zien A, 2003, J COMPUT BIOL, V10, P653, DOI 10.1089/10665270360688246	29	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28320	10.1371/journal.pone.0028320	http://dx.doi.org/10.1371/journal.pone.0028320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163293	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900028
J	Vilela, ML; Azevedo, CG; Carvalho, BM; Rangel, EF				Vilela, Mauricio Luiz; Azevedo, Carina Graser; Carvalho, Bruno M.; Rangel, Elizabeth F.			Phlebotomine Fauna (Diptera: Psychodidae) and Putative Vectors of Leishmaniases in Impacted Area by Hydroelectric Plant, State of Tocantins, Brazil	PLOS ONE			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; SPECIES ABUNDANCE; CLIMATE	Background: Although leishmaniases are regarded as serious public health issues in the State of Tocantins, as consequence of the impact of environmental changes, small advances in taxonomic and ecological studies of Phlebotominae fauna are taking place in this state. The present study aimed to improve the knowledge about the sand flies, as well as about the aspects of the bioecology of leishmaniases vectors from Porto Nacional, a city that was directly impacted by the construction of Luis Eduardo Magalhaes Hydroelectric Plant (HEP - Lajeado). Methodology/Principal Findings: Sand flies were collected monthly using CDC light traps and Shannon traps for a period of 40 consecutive months, at different monitoring stations, where 7162 specimens were collected and 48 species were detected. Among the species found, 22 are first records in the state and seven are considered important vectors of leishmaniases. Lutzomyia longipalpis, the vector of American Visceral Leishmaniasis (AVL) showed higher frequency in urban compared to rural areas, and Nyssomyia whitmani, the vector of American Cutaneous Leishmaniasis (ACL), predominated in rural areas. The frequency and habits of sand fly vectors are discussed considering environmental characteristics and climatic factors. Conclusions/Significance: The construction of dams requires a great amount of labor, therefore attracting people from elsewhere. Increased migration, without adequate structure, leads to bad living conditions in new and unplanned settlements. It also leads to deforestation associated with environmental impacts, which can facilitate the spread of leishmaniases. This study discusses the importance of Lu. longipalpis and Ny. whitmani on the transmission cycles of leishmaniases in Porto Nacional and the record of Bi. flaviscutellata in periurban area of the city.	[Vilela, Mauricio Luiz; Carvalho, Bruno M.; Rangel, Elizabeth F.] Inst Oswaldo Cruz FIOCRUZ, Lab Transmissores Leishmanioses, Rio De Janeiro, Brazil; [Azevedo, Carina Graser] Secretaria Sau Estado Tocantins, Palmas, Tocantins, Brazil	Fundacao Oswaldo Cruz	Vilela, ML (corresponding author), Inst Oswaldo Cruz FIOCRUZ, Lab Transmissores Leishmanioses, Rio De Janeiro, Brazil.	mvilela@ioc.fiocruz.br	Carvalho, Bruno/G-9558-2013; Rangel, Elizabeth F/F-8355-2013	Carvalho, Bruno/0000-0002-0009-5770; Rangel, Elizabeth/0000-0002-9584-1202	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [025/2006, 014/2008]; Oswaldo Cruz Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation	The study was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq/MS-SCTIE-DECIT no 025/2006; MCT/CNPq no 014/2008) (www.cnpq.br) and Oswaldo Cruz Foundation (www.fiocruz.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade Filho J D, 2001, Rev Soc Bras Med Trop, V34, P323, DOI 10.1590/S0037-86822001000400003; Andrade JD, 2004, MEM I OSWALDO CRUZ, V99, P609, DOI 10.1590/S0074-02762004000600013; Barretto Mauro Pereira, 1946, REV BRASIL BIOL, V6, P427; Bigeli JG, 2010, AN 14 REUN PESQ APL, P148; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2007, MAN VIGL LEISHM TEG, P179; Brasil Ministerio da Saude . Secretaria de Vigilancia em Saude. Departamento de Vigilancia Epidemiologica, 2006, MAN VIG CONTR LEISHM; Campbell-Lendrum D, 2001, MEM I OSWALDO CRUZ, V96, P159, DOI 10.1590/S0074-02762001000200004; Chaves LF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000176; da Costa SM, 2007, MEM I OSWALDO CRUZ, V102, P149, DOI 10.1590/S0074-02762007005000016; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1995, B DIR MALARIOL SAN A, V35, P133; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Governo do Estado de Tocantins, 2010, INF ENT EP LEISHM; LAINSON R, 1994, MEM I OSWALDO CRUZ, V89, P435, DOI 10.1590/S0074-02761994000300027; Loiola CF, 2007, MEM I OSWALDO CRUZ, V102, P581, DOI 10.1590/S0074-02762007005000050; Lustosa ED, 1986, NOTA PREVIA I REV PA, V15, P7; Maia-Elkhoury ANS, 2008, CAD SAUDE PUBLICA, V24, P2941, DOI 10.1590/S0102-311X2008001200024; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; MARTINS A V, 1975, Revista Brasileira de Biologia, V35, P515; MARTINS A. V., 1964, REV BRASIL BIOL, V24, P321; MARTINS A. VIANNA, 1962, REV BRAS IL MALARIOL DOENCAS TROP, V14, P379; Rangel EF, 2010, WORKSH GEN BIOL MOL, P25; Rangel EF, 2008, CAD SAUDE PUBLICA, V24, P2948, DOI 10.1590/S0102-311X2008001200025; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Rede Grupo, 2003, US HIDR LUIS ED MAG; ROBERTS DR, 1979, ENVIRON ENTOMOL, V8, P1007, DOI 10.1093/ee/8.6.1007; RODRIGUES W. C., 2005, DIVES DIVERSIDADE ES; SUDIA WILLIAM D., 1962, MOSQUITO NEWS, V22, P126; Vilela ML, 2008, 6 INT S PHLEB SANDFL; WHO, 2010, WHO TECH REP SER, V949, P1	30	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27721	10.1371/journal.pone.0027721	http://dx.doi.org/10.1371/journal.pone.0027721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163271	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900007
J	Seidel, HS; Kimble, J				Seidel, Hannah S.; Kimble, Judith			The Oogenic Germline Starvation Response in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; EGG SIZE; PLASTICITY; PATHWAY; GROWTH	Many animals alter their reproductive strategies in response to environmental stress. Here we have investigated how L4 hermaphrodites of Caenorhabditis elegans respond to starvation. To induce starvation, we removed food at 2 h intervals from very early-to very late-stage L4 animals. The starved L4s molted into adulthood, initiated oogenesis, and began producing embryos; however, all three processes were severely delayed, and embryo viability was reduced. Most animals died via 'bagging,' because egg-laying was inhibited, and embryos hatched in utero, consuming their parent hermaphrodites from within. Some animals, however, avoided bagging and survived long term. Long-term survival did not rely on embryonic arrest but instead upon the failure of some animals to produce viable progeny during starvation. Regardless of the bagging fate, starved animals showed two major changes in germline morphology: All oogenic germlines were dramatically reduced in size, and these germlines formed only a single oocyte at a time, separated from the remainder of the germline by a tight constriction. Both changes in germline morphology were reversible: Upon re-feeding, the shrunken germlines regenerated, and multiple oocytes formed concurrently. The capacity for germline regeneration upon re-feeding was not limited to the small subset of animals that normally survive starvation: When bagging was prevented ectopically by par-2 RNAi, virtually all germlines still regenerated. In addition, germline shrinkage strongly correlated with oogenesis, suggesting that during starvation, germline shrinkage may provide material for oocyte production. Finally, germline shrinkage and regeneration did not depend upon crowding. Our study confirms previous findings that starvation uncouples germ cell proliferation from germline stem cell maintenance. Our study also suggests that when nutrients are limited, hermaphrodites scavenge material from their germlines to reproduce. We discuss our findings in light of the recently proposed state of dormancy, termed Adult Reproductive Diapause.	[Seidel, Hannah S.; Kimble, Judith] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Kimble, Judith] Howard Hughes Med Inst, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Seidel, HS (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	hsseidel@wisc.edu; jekimble@wisc.edu			National Institutes of Health [R01 GM069454]; NIH National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069454] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JK is supported by National Institutes of Health grant R01 GM069454. JK is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains, Jadwiga Forster for media preparation, and two reviewers for helpful comments on the manuscript.	Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen JJ, 2004, J NEMATOL, V36, P107; Chen JJ, 2003, NEMATOLOGY, V5, P641, DOI 10.1163/156854103322683355; Daniels SA, 2000, GENETICS, V156, P123; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Hong Y, 1998, DEVELOPMENT, V125, P3585; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Labbe JC, 2003, CURR BIOL, V13, P707, DOI 10.1016/S0960-9822(03)00251-3; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Nadarajan S, 2009, DEVELOPMENT, V136, P2223, DOI 10.1242/dev.034603; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Schafer William R, 2005, WormBook, P1; Stiernagle Theresa, 2006, WormBook, P1; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Waggoner LF, 2000, GENETICS, V154, P1181	21	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28074	10.1371/journal.pone.0028074	http://dx.doi.org/10.1371/journal.pone.0028074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164230	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400031
J	Akhtar, S; Wenborn, A; Brandner, S; Collinge, J; Lloyd, SE				Akhtar, Shaheen; Wenborn, Adam; Brandner, Sebastian; Collinge, John; Lloyd, Sarah E.			Sex Effects in Mouse Prion Disease Incubation Time	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; GENETIC-CONTROL; SCRAPIE; PERIOD; IDENTIFICATION; STRAINS; SINC; MICE; PRP	w Prion disease incubation time in mice is determined by many factors including PrP expression level, Prnp alleles, genetic background, prion strain and route of inoculation. Sex differences have been described in age of onset for vCJD and in disease duration for both vCJD and sporadic CJD and have also been shown in experimental models. The sex effects reported for mouse incubation times are often contradictory and detail only one strain of mice or prions, resulting in broad generalisations and a confusing picture. To clarify the effect of sex on prion disease incubation time in mice we have compared male and female transmission data from twelve different inbred lines of mice inoculated with at least two prion strains, representing both mouse-adapted scrapie and BSE. Our data show that sex can have a highly significant difference on incubation time. However, this is limited to particular mouse and prion strain combinations. No sex differences were seen in endogenous PrPC levels nor in the neuropathological markers of prion disease: PrPSc distribution, spongiosis, neuronal loss and gliosis. These data suggest that when comparing incubation times between between experimental groups, such as testing the effects of modifier genes or therapeutics, single sex groups should be used.	[Akhtar, Shaheen] UCL, Inst Neurol, Med Res Council Prion Unit, London, England; UCL, Inst Neurol, Dept Neurodegenerat Dis, London, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Akhtar, S (corresponding author), UCL, Inst Neurol, Med Res Council Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342	Medical Research Council, UK; MRC [MC_U123160652, MC_U123192748] Funding Source: UKRI; Medical Research Council [MC_U123192748, MC_U123160652] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, UK. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiola OO, 2002, INTERVIROLOGY, V45, P56, DOI 10.1159/000050088; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; BRUCE ME, 1992, PRION DIS HUMAN ANIM; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Grizenkova J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015019; HUNTER N, 1992, J GEN VIROL, V73, P2751, DOI 10.1099/0022-1317-73-10-2751; KINGSBURY DT, 1983, J IMMUNOL, V131, P491; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2004, J GEN VIROL, V85, P2471, DOI 10.1099/vir.0.79889-0; Lloyd SE, 2004, MAMM GENOME, V15, P383, DOI 10.1007/s00335-004-3041-5; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Loeuillet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013166; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Wadsworth JDF, 2006, BRAIN, V129, P1557, DOI 10.1093/brain/awl076; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6	31	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28741	10.1371/journal.pone.0028741	http://dx.doi.org/10.1371/journal.pone.0028741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174884	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300024
J	Leys, SP; Yahel, G; Reidenbach, MA; Tunnicliffe, V; Shavit, U; Reiswig, HM				Leys, Sally P.; Yahel, Gitai; Reidenbach, Matthew A.; Tunnicliffe, Verena; Shavit, Uri; Reiswig, Henry M.			The Sponge Pump: The Role of Current Induced Flow in the Design of the Sponge Body Plan	PLOS ONE			English	Article							CANADIAN CONTINENTAL-SHELF; HEXACTINELLID SPONGE; GLASS SPONGES; ENERGY-COST; RHABDOCALYPTUS-DAWSONI; CONDUCTION SYSTEM; WATER-FLOW; PORIFERA; REEFS; SEDIMENT	Sponges are suspension feeders that use flagellated collar-cells (choanocytes) to actively filter a volume of water equivalent to many times their body volume each hour. Flow through sponges is thought to be enhanced by ambient current, which induces a pressure gradient across the sponge wall, but the underlying mechanism is still unknown. Studies of sponge filtration have estimated the energetic cost of pumping to be <1% of its total metabolism implying there is little adaptive value to reducing the cost of pumping by using "passive'' flow induced by the ambient current. We quantified the pumping activity and respiration of the glass sponge Aphrocallistes vastus at a 150 m deep reef in situ and in a flow flume; we also modeled the glass sponge filtration system from measurements of the aquiferous system. Excurrent flow from the sponge osculum measured in situ and in the flume were positively correlated (r>0.75) with the ambient current velocity. During short bursts of high ambient current the sponges filtered two-thirds of the total volume of water they processed daily. Our model indicates that the head loss across the sponge collar filter is 10 times higher than previously estimated. The difference is due to the resistance created by a fine protein mesh that lines the collar, which demosponges also have, but was so far overlooked. Applying our model to the in situ measurements indicates that even modest pumping rates require an energetic expenditure of at least 28% of the total in situ respiration. We suggest that due to the high cost of pumping, current-induced flow is highly beneficial but may occur only in thin walled sponges living in high flow environments. Our results call for a new look at the mechanisms underlying current-induced flow and for reevaluation of the cost of biological pumping and its evolutionary role, especially in sponges.	[Leys, Sally P.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Yahel, Gitai; Tunnicliffe, Verena; Reiswig, Henry M.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Yahel, Gitai] Ruppin Acad Ctr, Sch Marine Sci, Michmoret, Israel; [Reidenbach, Matthew A.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Tunnicliffe, Verena] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC, Canada; [Shavit, Uri] Technion Israel Inst Technol, Dept Civil & Environm Engn, Haifa, Israel; [Reiswig, Henry M.] Royal British Columbia Museum, Nat Hist Sect, Victoria, BC, Canada	University of Alberta; University of Victoria; Ruppin Academic Center; University of Virginia; University of Victoria; Technion Israel Institute of Technology	Leys, SP (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	sleys@ualberta.ca	Tunnicliffe, Verena/D-1056-2014; Leys, Sally/A-2660-2014; Yahel, Gitai/A-3696-2012	Yahel, Gitai/0000-0003-2306-355X; Leys, Sally/0000-0001-9268-2181	NSERC; Rothschild fellowship	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rothschild fellowship	Funding for this research came from NSERC Discovery Grants to SPL, VT, and HMR; NSERC Ship Time grants to SPL and VT; and a Rothschild fellowship to GY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTIN W, SPONGE GARDENS HIDDE; Bergquist P.R., 1978, SPONGES; Bidder GP, 1923, Q J MICROSC SCI, V67, P293; Chu JWF, 2010, MAR ECOL PROG SER, V417, P97, DOI 10.3354/meps08794; Conway Kim W., 2004, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V6, P335; Conway KW, 2001, GEOSCI CAN, V28, P71; CONWAY KW, 2007, MAPPING SENSITIVE HA, P1; Cowen EA, 1997, EXP FLUIDS, V22, P199, DOI 10.1007/s003480050038; Dewey R, 2005, J PHYS OCEANOGR, V35, P1911, DOI 10.1175/JPO2799.1; FJERDINGSTAD EJ, 1961, Z ZELLFORSCH MIK ANA, V53, P645, DOI 10.1007/BF00339512; GERRODETTE T, 1979, MAR BIOL, V55, P103, DOI 10.1007/BF00397305; Hadas E, 2008, J EXP BIOL, V211, P2185, DOI 10.1242/jeb.015420; Jimenez E, 2007, LIMNOL OCEANOGR, V52, P948, DOI 10.4319/lo.2007.52.3.0948; JOHNSON AS, 1990, LIMNOL OCEANOGR, V35, P1395, DOI 10.4319/lo.1990.35.6.1395; JORGENSEN CB, 1983, MAR ECOL PROG SER, V11, P89, DOI 10.3354/meps011089; KILIAN EF, 1952, Z VERGL PHYSIOL, V34, P407, DOI 10.1007/BF00297877; Knott NA, 2004, BIOL BULL-US, V207, P217, DOI 10.2307/1543210; LARSEN PS, 1994, J THEOR BIOL, V168, P53, DOI 10.1006/jtbi.1994.1087; LAWN ID, 1981, SCIENCE, V211, P1169, DOI 10.1126/science.7466387; Leys SP, 2007, ADV MAR BIOL, V52, P1, DOI 10.1016/S0065-2881(06)52001-2; Leys SP, 1997, NATURE, V387, P29, DOI 10.1038/387029b0; Leys SP, 1999, INVERTEBR BIOL, V118, P221, DOI 10.2307/3226994; Leys SP, 1999, J EXP BIOL, V202, P1139; Leys SP, 2004, MAR ECOL PROG SER, V283, P133, DOI 10.3354/meps283133; MACKIE GO, 1983, PHILOS T ROY SOC B, V301, P365, DOI 10.1098/rstb.1983.0028; Mackie GO, 1995, MAR FRESHW BEHAV PHY, V26, P197, DOI 10.1080/10236249509378939; MACKIE GO, 1974, PROC R SOC SER B-BIO, V187, P1, DOI 10.1098/rspb.1974.0058; Miller C.B., 2004, BIOL OCEANOGRAPHY; MONISMITH SG, 1990, LIMNOL OCEANOGR, V35, P680, DOI 10.4319/lo.1990.35.3.0680; MURDOCK GR, 1978, COMP BIOCHEM PHYS A, V61, P227, DOI 10.1016/0300-9629(78)90102-0; ORIORDAN CA, 1993, LIMNOL OCEANOGR, V38, P1712, DOI 10.4319/lo.1993.38.8.1712; Pile AJ, 2006, DEEP-SEA RES PT I, V53, P1148, DOI 10.1016/j.dsr.2006.03.008; Reidenbach MA, 2008, J EXP BIOL, V211, P2849, DOI 10.1242/jeb.016394; REISWIG H M, 1974, Journal of Experimental Marine Biology and Ecology, V14, P231, DOI 10.1016/0022-0981(74)90005-7; REISWIG HM, 1975, J MORPHOL, V145, P493, DOI 10.1002/jmor.1051450407; REISWIG HM, 1991, ZOOMORPHOLOGY, V110, P301, DOI 10.1007/BF01668020; REISWIG HM, 1971, MAR BIOL, V9, P38, DOI 10.1007/BF00348816; REISWIG HM, 2002, SYSTEMA PORIFERA GUI, P1282; Riisgard HU, 1996, MAR ECOL PROG SER, V141, P47, DOI 10.3354/meps141047; RIISGARD HU, 1988, MAR ECOL PROG SER, V47, P129, DOI 10.3354/meps047129; Riisgard HU, 2000, J SEA RES, V44, P169, DOI 10.1016/S1385-1101(00)00054-X; RIISGARD HU, 1993, MAR ECOL PROG SER, V96, P177, DOI 10.3354/meps096177; RIISGARD HU, 1995, BIOL REV, V70, P67, DOI 10.1111/j.1469-185X.1995.tb01440.x; Savarese M, 1997, LIMNOL OCEANOGR, V42, P171; SILVESTER NR, 1983, J THEOR BIOL, V103, P265, DOI 10.1016/0022-5193(83)90028-0; Tompkins-MacDonald GJ, 2008, MAR BIOL, V154, P973, DOI 10.1007/s00227-008-0987-y; VOGEL S, 1973, J COMP PHYSIOL, V85, P1, DOI 10.1007/BF00694136; VOGEL S, 1978, J EXP BIOL, V76, P137; VOGEL S, 1974, BIOL BULL-US, V147, P443, DOI 10.2307/1540461; VOGEL S, 1977, P NATL ACAD SCI USA, V74, P2069, DOI 10.1073/pnas.74.5.2069; von Dassow M, 2005, J EXP BIOL, V208, P2931, DOI 10.1242/jeb.01738; Weisz JB, 2008, OECOLOGIA, V155, P367, DOI 10.1007/s00442-007-0910-0; White F.J.V.F.F, 1991, FLUID MECH-SOV RES, V39, P104; Whitney F, 2005, CONT SHELF RES, V25, P211, DOI 10.1016/j.csr.2004.09.003; Wyeth RC, 1999, INVERTEBR BIOL, V118, P236, DOI 10.2307/3226995; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; Yahel G, 2003, LIMNOL OCEANOGR, V48, P141, DOI 10.4319/lo.2003.48.1.0141; Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428; Yahel G, 2006, AQUAT MICROB ECOL, V45, P181, DOI 10.3354/ame045181; Yahel G, 2008, MAR ECOL PROG SER, V372, P195, DOI 10.3354/meps07688	60	96	101	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27787	10.1371/journal.pone.0027787	http://dx.doi.org/10.1371/journal.pone.0027787			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180779	gold, Green Published, Green Submitted			2022-12-27	WOS:000298367300007
J	Maunoury, N; Vaucheret, H				Maunoury, Nicolas; Vaucheret, Herve			AGO1 and AGO2 Act Redundantly in miR408-Mediated Plantacyanin Regulation	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; INTERFERING RNAS; ARGONAUTE; MECHANISMS; MICRORNAS; IMMUNITY	Background: In Arabidopsis, AGO1 and AGO2 associate with small RNAs that exhibit a Uridine and an Adenosine at their 5' end, respectively. Because most plant miRNAs have a 5'U, AGO1 plays many essential roles in miRNA-mediated regulation of development and stress responses. In contrast, AGO2 has only been implicated in antibacterial defense in association with miR393*, which has a 5'A. AGO2 also participates in antiviral defense in association with viral siRNAs. Principal Findings: This study reveals that miR408, which has a 5'A, regulates its target Plantacyanin through either AGO1 or AGO2. Indeed, neither ago1 nor ago2 single mutations abolish miR408-mediated regulation of Plantacyanin. Only an ago1 ago2 double mutant appears compromised in miR408-mediated regulation of Plantacyanin, suggesting that AGO1 and AGO2 have redundant roles in this regulation. Moreover, the nature of the 5' nucleotide of miR408 does not appear essential for its regulatory role because both a wildtype 5'A-MIR408 and a mutant 5'U-MIR408 gene complement a mir408 mutant. Conclusions/Significance: These results suggest that miR408 associates with both AGO1 and AGO2 based on criteria that differ from the 5' end rule, reminiscent of miR390-AGO7 and miR165/166-AGO10 associations, which are not based on the nature of the 5' nucleotide.	[Maunoury, Nicolas; Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Maunoury, N (corresponding author), INRA, Inst Jean Pierre Bourgin, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988	INRA; Agence Nationale de la Recherche (ANR) [ANR-10-BLAN-1707-03]	INRA; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by INRA (http://www.inra.fr/) (post-doctoral fellowship to NM) and the Agence Nationale de la Recherche (ANR: http://www.agence-nationale-recherche.fr/) (grant ANR-10-BLAN-1707-03 to HV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Jauvion V, 2010, PLANT CELL, V22, P2697, DOI 10.1105/tpc.110.076638; Lobbes D, 2006, EMBO REP, V7, P1052, DOI 10.1038/sj.embor.7400806; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; TAKEDA A, 2008, PLANT CELL PHYSL; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2011, PLANT J, V67, P292, DOI 10.1111/j.1365-313X.2011.04594.x; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Yamasaki H, 2009, PLANT CELL, V21, P347, DOI 10.1105/tpc.108.060137; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	28	45	50	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28729	10.1371/journal.pone.0028729	http://dx.doi.org/10.1371/journal.pone.0028729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174881	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300023
J	O'Connell, K; Hom, M; Aung, T; Theuss, M; Huntington, D				O'Connell, Kathryn; Hom, Mo; Aung, Tin; Theuss, Marc; Huntington, Dale			Using and Joining a Franchised Private Sector Provider Network in Myanmar	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; REPRODUCTIVE HEALTH; SERVICES	Background: Quality is central to understanding provider motivations to join and remain within a social franchising network. Quality also appears as a key issue from the client's perspective, and may influence why a client chooses to use a franchised provider over another type of provider. The dynamic relationships between providers of social franchising clinics and clients who use these services have not been thoroughly investigated in the context of Myanmar, which has an established social franchising network. This study examines client motivations to use a Sun Quality Health network provider and provider motivations to join and remain in the Sun Quality Health network. Taken together, these two aims provide an opportunity to explore the symbiotic relationship between client satisfaction and provider incentives to increase the utilization of reproductive health care services. Methods and Findings: Results from a series of focus group discussions with clients of reproductive health services and franchised providers shows that women chose health services provided by franchised private sector general practitioners because of its perceived higher quality, associated with the availability of effective, affordable, drugs. A key finding of the study is associated with providers. Provider focus group discussions indicate that a principle determinate for joining and remaining in the Sun Quality Health Network was serving the poor.	[O'Connell, Kathryn] Populat Serv Int, Nairobi, Kenya; [Hom, Mo; Aung, Tin; Theuss, Marc] Populat Serv Int Myanmar, Bahan Township, Yangon, Myanmar; [Huntington, Dale] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	World Health Organization	O'Connell, K (corresponding author), Populat Serv Int, Nairobi, Kenya.	huntingtond@who.int			Reproductive Health and Research Department, World Health Organization	Reproductive Health and Research Department, World Health Organization	This study was funded by a grant to Population Services International by the Reproductive Health and Research Department, World Health Organization, (http://www.who.int/reproductive-health). One of the authors is a staff member of WHO and participated in the study design, analysis of findings and reporting of results.	AGHA S, 1997, EVALUATION GREEN STA; BENNETT S, 1994, HEALTH POLICY PLANN, V9, P1; Bernhart MH, 1999, SOC SCI MED, V48, P989, DOI 10.1016/S0277-9536(98)00376-1; *DEP HLTH, 2009, DRAFT STRAT NAT PLAN; JANANI, 2001, JANANI PROGR REPORT; Leonard D, 2000, AFRICAS CHANGING MAR; LONNROTH K, 2007, SOCIAL FRANCHISING T, P156; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Montagu D, 2002, HEALTH POLICY PLANN, V17, P121, DOI 10.1093/heapol/17.2.121; Peters DH, 2004, HEALTH POLICY PLANN, V19, pI5, DOI 10.1093/heapol/czh041; Smith R., 2002, QUALTRICS XM LEADING; Stephenson R, 2004, HEALTH SERV RES, V39, P2053, DOI 10.1111/j.1475-6773.2004.00332.x; *UN MYANM, 2009, FERT REPR HLTH SURV; *UNDP, 2006, MYANM MILL DEV GOAL	14	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28364	10.1371/journal.pone.0028364	http://dx.doi.org/10.1371/journal.pone.0028364			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22180781	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300009
J	Alba-Ferrara, L; Hausmann, M; Mitchell, RL; Weis, S				Alba-Ferrara, Lucy; Hausmann, Markus; Mitchell, Rachel L.; Weis, Susanne			The Neural Correlates of Emotional Prosody Comprehension: Disentangling Simple from Complex Emotion	PLOS ONE			English	Article							SOCIAL COGNITION; FACIAL EXPRESSIONS; PREFRONTAL CORTEX; LANGUAGE FUNCTIONS; AUDITORY EMOTIONS; RIGHT-HEMISPHERE; MIRROR SYSTEM; HUMAN BRAIN; PERCEPTION; EMPATHY	Background: Emotional prosody comprehension (EPC), the ability to interpret another person's feelings by listening to their tone of voice, is crucial for effective social communication. Previous studies assessing the neural correlates of EPC have found inconsistent results, particularly regarding the involvement of the medial prefrontal cortex (mPFC). It remained unclear whether the involvement of the mPFC is linked to an increased demand in socio-cognitive components of EPC such as mental state attribution and if basic perceptual processing of EPC can be performed without the contribution of this region. Methods: fMRI was used to delineate neural activity during the perception of prosodic stimuli conveying simple and complex emotion. Emotional trials in general, as compared to neutral ones, activated a network comprising temporal and lateral frontal brain regions, while complex emotion trials specifically showed an additional involvement of the mPFC, premotor cortex, frontal operculum and left insula. Conclusion: These results indicate that the mPFC and premotor areas might be associated, but are not crucial to EPC. However, the mPFC supports socio-cognitive skills necessary to interpret complex emotion such as inferring mental states. Additionally, the premotor cortex involvement may reflect the participation of the mirror neuron system for prosody processing particularly of complex emotion.	[Alba-Ferrara, Lucy] Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA; [Alba-Ferrara, Lucy; Hausmann, Markus; Mitchell, Rachel L.; Weis, Susanne] Univ Durham, Dept Psychol, Durham DH1 3LE, England	State University System of Florida; University of South Florida; Durham University	Alba-Ferrara, L (corresponding author), Univ S Florida, Dept Psychiat & Neurosci, Tampa, FL 33620 USA.	lalbafer@health.usf.edu	alba-ferrara, lucy/I-4939-2012; Hausmann, Markus/F-4060-2014	Hausmann, Markus/0000-0002-2141-1154; alba-ferrara, lucy/0000-0003-1697-9535				Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Adolphs R, 1996, J NEUROSCI, V16, P7678; Adolphs R, 2010, CURR BIOL, V20, pR1071, DOI 10.1016/j.cub.2010.11.019; Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; ALBAFERRARA L, 2011, BRAIN SIMUL IN PRESS; Aziz-Zadeh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008759; Bach DR, 2008, NEUROIMAGE, V42, P919, DOI 10.1016/j.neuroimage.2008.05.034; Banissy MJ, 2010, J NEUROSCI, V30, P13552, DOI 10.1523/JNEUROSCI.0786-10.2010; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; Baumgartner T, 2006, BRAIN RES, V1075, P151, DOI 10.1016/j.brainres.2005.12.065; Bauminger N, 2005, J LEARN DISABIL-US, V38, P45, DOI 10.1177/00222194050380010401; Beatty WW, 2003, MULT SCLER, V9, P148, DOI 10.1191/1352458503ms897oa; Beaucousin V, 2007, CEREB CORTEX, V17, P339, DOI 10.1093/cercor/bhj151; Belin P, 2004, TRENDS COGN SCI, V8, P129, DOI 10.1016/j.tics.2004.01.008; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; CAPPS L, 1992, J CHILD PSYCHOL PSYC, V33, P1169, DOI 10.1111/j.1469-7610.1992.tb00936.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chakrabarti B, 2006, PROG BRAIN RES, V156, P403, DOI 10.1016/S0079-6123(06)56022-4; CUNNINGHAM WA, 2010, SOC COGN AFFECT NEUR; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ethofer T, 2006, NEUROIMAGE, V30, P580, DOI 10.1016/j.neuroimage.2005.09.059; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Golan O, 2006, SOC NEUROSCI-UK, V1, P111, DOI 10.1080/17470910600980986; Hoekert M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002244; Hooker CI, 2008, SOC COGN AFFECT NEUR, V3, P204, DOI 10.1093/scan/nsn019; Ischebeck AK, 2008, CEREB CORTEX, V18, P541, DOI 10.1093/cercor/bhm083; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Johnson-Laird PhilipN., 1989, COGNITION EMOTION, V3, P81, DOI [10.1080/02699938908408075, DOI 10.1080/02699938908408075]; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Kington JM, 2000, J PSYCHIAT RES, V34, P341, DOI 10.1016/S0022-3956(00)00029-7; Kotz SA, 2003, BRAIN LANG, V86, P366, DOI 10.1016/S0093-934X(02)00532-1; Lee L, 2005, J AFFECT DISORDERS, V86, P247, DOI 10.1016/j.jad.2005.02.007; Leitman DI, 2006, PSYCHOL MED, V36, P1075, DOI 10.1017/S0033291706007653; Leitman DI, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00096, 10.3389/fnhum.2010.00019]; LEITMAN DI, 2011, BIOL PSYCHIAT; Mah L, 2004, AM J PSYCHIAT, V161, P1247, DOI 10.1176/appi.ajp.161.7.1247; Mason RA, 2011, HUM BRAIN MAPP, V32, P313, DOI 10.1002/hbm.21021; Mitchell RLC, 2008, NEUROPSYCHOLOGIA, V46, P2880, DOI 10.1016/j.neuropsychologia.2008.05.024; Mitchell RLC, 2006, EUR J NEUROSCI, V24, P3611, DOI 10.1111/j.1460-9568.2006.05231.x; Mitchell RLC, 2003, NEUROPSYCHOLOGIA, V41, P1410, DOI 10.1016/S0028-3932(03)00017-4; MURPHY D, 1990, J NEUROL NEUROSUR PS, V53, P727, DOI 10.1136/jnnp.53.9.727; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramachandra V, 2009, PERCEPT MOTOR SKILL, V108, P30, DOI 10.2466/PMS.108.1.30-36; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; Ross ED, 2001, J NEUROL NEUROSUR PS, V70, P597, DOI 10.1136/jnnp.70.5.597; Ross ED, 2008, BRAIN LANG, V104, P51, DOI 10.1016/j.bandl.2007.04.007; Ross ED, 2011, NEUROPSYCHOLOGIA, V49, P866, DOI 10.1016/j.neuropsychologia.2010.12.024; Rubinow DR, 2006, FRONT NEUROENDOCRIN, V27, P210, DOI 10.1016/j.yfrne.2006.02.003; Sander D, 2005, NEUROIMAGE, V28, P848, DOI 10.1016/j.neuroimage.2005.06.023; Sander K, 2005, J COGNITIVE NEUROSCI, V17, P1519, DOI 10.1162/089892905774597227; Schirmer A, 2006, TRENDS COGN SCI, V10, P24, DOI 10.1016/j.tics.2005.11.009; Schirmer A, 2004, NEUROIMAGE, V21, P1114, DOI 10.1016/j.neuroimage.2003.10.048; Seitz RJ, 2008, NEUROSCIENCE, V152, P713, DOI 10.1016/j.neuroscience.2007.10.066; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; van Hooren S, 2008, SCHIZOPHR RES, V103, P257, DOI 10.1016/j.schres.2008.02.022; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Weis S, 2011, HUM BRAIN MAPP, V32, P1544, DOI 10.1002/hbm.21126; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Willems RM, 2010, PSYCHOL SCI, V21, P8, DOI 10.1177/0956797609355563; Zinck A, 2008, CONSCIOUS COGN, V17, P496, DOI 10.1016/j.concog.2008.03.014; Zinck A, 2008, SYNTHESE, V161, P1, DOI 10.1007/s11229-006-9149-2	74	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28701	10.1371/journal.pone.0028701	http://dx.doi.org/10.1371/journal.pone.0028701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FT	22174872	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000298366600030
J	Holm, S; Ueland, T; Dahl, TB; Michelsen, AE; Skjelland, M; Russell, D; Nymo, SH; Krohg-Sorensen, K; Clausen, OP; Atar, D; Januzzi, JL; Aukrust, P; Jensen, JK; Halvorsen, B				Holm, Sverre; Ueland, Thor; Dahl, Tuva B.; Michelsen, Annika E.; Skjelland, Mona; Russell, David; Nymo, Stale H.; Krohg-Sorensen, Kirsten; Clausen, Ole Petter; Atar, Dan; Januzzi, James L.; Aukrust, Pal; Jensen, Jesper K.; Halvorsen, Bente			Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke	PLOS ONE			English	Article							EXPRESSION; PLAQUE; AP2; INFLAMMATION; MACROPHAGES; PLATELET; MICE	Background and Purpose: Fatty acid binding protein 4 (FABP4) has been shown to play an important role in macrophage cholesterol trafficking and associated inflammation. To further elucidate the role of FABP4 in atherogenesis in humans, we examined the regulation of FABP4 in carotid atherosclerosis and ischemic stroke. Methods: We examined plasma FABP4 levels in asymptomatic (n = 28) and symptomatic (n = 31) patients with carotid atherosclerosis, as well as in 202 subjects with acute ischemic stroke. In a subgroup of patients we also analysed the expression of FABP4 within the atherosclerotic lesion. In addition, we investigated the ability of different stimuli with relevance to atherosclerosis to regulate FABP4 expression in monocytes/macrophages. Results: FABP4 levels were higher in patients with carotid atherosclerosis, both systemically and within the atherosclerotic lesion, with particular high mRNA levels in carotid plaques from patients with the most recent symptoms. Immunostaining of carotid plaques localized FABP4 to macrophages, while activated platelets and oxidized LDL were potent stimuli for FABP4 expression in monocytes/macrophages in vitro. When measured at the time of acute ischemic stroke, high plasma levels of FABP4 were significantly associated with total and cardiovascular mortality during follow-up, although we did not find that addition of FABP4 to the fully adjusted multivariate model had an effect on the prognostic discrimination for allcause mortality as assessed by c-statistics. Conclusions: FABP4 is linked to atherogenesis, plaque instability and adverse outcome in patients with carotid atherosclerosis and acute ischemic stroke.	[Holm, Sverre; Ueland, Thor; Dahl, Tuva B.; Michelsen, Annika E.; Nymo, Stale H.; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Skjelland, Mona; Russell, David] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Neurol, N-0027 Oslo, Norway; [Krohg-Sorensen, Kirsten] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Thorac & Cardiovasc Surg, N-0027 Oslo, Norway; [Clausen, Ole Petter] Univ Oslo, Rikshosp, Oslo Univ Hosp, Inst Pathol, N-0027 Oslo, Norway; [Aukrust, Pal] Univ Oslo, Rikshosp, Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0027 Oslo, Norway; [Atar, Dan] Univ Oslo, Hosp Ulleval, Div Cardiol, Oslo, Norway; [Russell, David; Clausen, Ole Petter; Atar, Dan; Aukrust, Pal; Halvorsen, Bente] Univ Oslo, Fac Med, Oslo, Norway; [Januzzi, James L.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Jensen, Jesper K.] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Harvard University; Massachusetts General Hospital; University of Southern Denmark; Odense University Hospital	Holm, S (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway.	sverre.holm@rr-research.no	Januzzi, James/Y-2436-2019; jensen, jesper K/AFP-0493-2022; Skjelland, Mona/B-7362-2016; Skjelland, Mona/Q-4674-2017	Krohg-Sorensen, Kirsten/0000-0002-5713-809X; Holm, Sverre/0000-0003-1064-3926; Dahl, Tuva/0000-0001-7818-9411; Khedri Jensen, Jesper/0000-0001-7426-4437; Skjelland, Mona/0000-0001-7950-4882	Research Council of Norway; University of Oslo; Norwegian Council of Cardiovascular Research; Helse Sor-Ost; Medinnova Foundation	Research Council of Norway(Research Council of Norway); University of Oslo; Norwegian Council of Cardiovascular Research; Helse Sor-Ost; Medinnova Foundation	This work was supported by grants from the Research Council of Norway, University of Oslo, Norwegian Council of Cardiovascular Research, Helse Sor-Ost, and Medinnova Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh HE, 2011, J INTERN MED, V269, P200, DOI 10.1111/j.1365-2796.2010.02304.x; Breland UM, 2010, CARDIOVASC RES, V86, P265, DOI 10.1093/cvr/cvq044; Dahl TB, 2007, CIRCULATION, V115, P972, DOI 10.1161/CIRCULATIONAHA.106.665893; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Jensen JK, 2007, AM J CARDIOL, V99, P108, DOI 10.1016/j.amjcard.2006.07.071; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Otterdal K, 2006, BLOOD, V108, P928, DOI 10.1182/blood-2005-09-010629; PEETERS W, 2010, EUR HEART J IN PRESS; Skjelland M, 2007, ATHEROSCLEROSIS, V195, pE142, DOI 10.1016/j.atherosclerosis.2007.05.001; STROKE, V16, P885	18	45	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28785	10.1371/journal.pone.0028785	http://dx.doi.org/10.1371/journal.pone.0028785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174896	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700073
J	Madden, DT; Davila-Kruger, D; Melov, S; Bredesen, DE				Madden, David T.; Davila-Kruger, Diana; Melov, Simon; Bredesen, Dale E.			Human Embryonic Stem Cells Express Elevated Levels of Multiple Pro-Apoptotic BCL-2 Family Members	PLOS ONE			English	Article							DEATH MACHINERY; INHIBITS APOPTOSIS; SIGNALING PATHWAY; BH3-ONLY PROTEIN; BAD COUPLES; PHOSPHORYLATION; SURVIVAL; P53; GENE; ACTIVATION	Two of the greatest challenges in regenerative medicine today remain (1) the ability to culture human embryonic stem cells (hESCs) at a scale sufficient to satisfy clinical demand and (2) the ability to eliminate teratoma-forming cells from preparations of cells with clinically desirable phenotypes. Understanding the pathways governing apoptosis in hESCs may provide a means to address these issues. Limiting apoptosis could aid scaling efforts, whereas triggering selective apoptosis in hESCs could eliminate unwanted teratoma-forming cells. We focus here on the BCL-2 family of proteins, which regulate mitochondrial-dependent apoptosis. We used quantitative PCR to compare the steady-state expression profile of all human BCL-2 family members in hESCs with that of human primary cells from various origins and two cancer lines. Our findings indicate that hESCs express elevated levels of the pro-apoptotic BH3-only BCL-2 family members NOXA, BIK, BIM, BMF and PUMA when compared with differentiated cells and cancer cells. However, compensatory expression of pro-survival BCL-2 family members in hESCs was not observed, suggesting a possible explanation for the elevated rates of apoptosis observed in proliferating hESC cultures, as well as a mechanism that could be exploited to limit hESC-derived neoplasms.	[Madden, David T.] Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA; [Madden, David T.; Davila-Kruger, Diana; Melov, Simon; Bredesen, Dale E.] Buck Inst Res Aging, Novato, CA USA; [Bredesen, Dale E.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Touro University California; Buck Institute for Research on Aging; University of California System; University of California San Francisco	Madden, DT (corresponding author), Touro Univ Calif, Coll Pharm, Vallejo, CA 94592 USA.	david.madden.tu@gmail.com	Melov, Simon/AAC-9469-2020	Melov, Simon/0000-0001-8554-2834	California Institute of Regenerative Medicine [RS1-00163-1]; Larry L. Hillblom Foundation	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Larry L. Hillblom Foundation	The work was supported by a SEED grant from the California Institute of Regenerative Medicine (RS1-00163-1), as well as a postdoctoral fellowship from the Larry L. Hillblom Foundation (D.T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardehali R, 2011, P NATL ACAD SCI USA, V108, P3282, DOI 10.1073/pnas.1019047108; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Conradt B, 2009, ANNU REV GENET, V43, P493, DOI 10.1146/annurev.genet.42.110807.091533; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; delPeso L, 1997, SCIENCE, V278, P687; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Hasegawa K, 2010, CELL STEM CELL, V6, P521, DOI 10.1016/j.stem.2010.05.010; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li YM, 2003, CANCER RES, V63, P7630; Lopez H, 2010, J BIOL CHEM, V285, P15016, DOI 10.1074/jbc.M109.086231; Lowman XH, 2010, MOL CELL, V40, P823, DOI 10.1016/j.molcel.2010.11.035; Madden DT, 2007, AUTOPHAGY, V3, P519; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; MIYASHITA T, 1995, CELL, V80, P293; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Peng YW, 2003, J BIOL CHEM, V278, P8385, DOI 10.1074/jbc.M213156200; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umetani M, 2001, ARTERIOSCL THROM VAS, V21, P917, DOI 10.1161/01.ATV.21.6.917; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verma S, 2001, J BIOL CHEM, V276, P4671, DOI 10.1074/jbc.M008983200; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410; Zhang L, 2011, CELL DEATH DIFFER, V18, P864, DOI 10.1038/cdd.2010.152	49	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28530	10.1371/journal.pone.0028530	http://dx.doi.org/10.1371/journal.pone.0028530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174832	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700045
J	Marchesini, MI; Connolly, J; Delpino, MV; Baldi, PC; Mujer, CV; DelVecchio, VG; Comerci, DJ				Ines Marchesini, Maria; Connolly, Joseph; Victoria Delpino, Maria; Baldi, Pablo C.; Mujer, Cesar V.; DelVecchio, Vito G.; Comerci, Diego J.			Brucella abortus Choloylglycine Hydrolase Affects Cell Envelope Composition and Host Cell Internalization	PLOS ONE			English	Article							BILE-SALT HYDROLASE; OMP25/OMP31 FAMILY; VIRB; IDENTIFICATION; PROTEINS; OVIS	Choloylglycine hydrolase (CGH, E.C. 3.5.1.24) is a conjugated bile salt hydrolase that catalyses the hydrolysis of the amide bond in conjugated bile acids. Bile salt hydrolases are expressed by gastrointestinal bacteria, and they presumably decrease the toxicity of host's conjugated bile salts. Brucella species are the causative agents of brucellosis, a disease affecting livestock and humans. CGH confers Brucella the ability to deconjugate and resist the antimicrobial action of bile salts, contributing to the establishment of a successful infection through the oral route in mice. Additionally, cgh-deletion mutant was also attenuated in intraperitoneally inoculated mice, which suggests that CGH may play a role during systemic infection other than hydrolyzing conjugated bile acids. To understand the role CGH plays in B. abortus virulence, we infected phagocytic and epithelial cells with a cgh-deletion mutant (Delta cgh) and found that it is defective in the internalization process. This defect along with the increased resistance of Delta cgh to the antimicrobial action of polymyxin B, prompted an analysis of the cell envelope of this mutant. Two-dimensional electrophoretic profiles of Delta cgh cell envelope-associated proteins showed an altered expression of Omp2b and different members of the Omp25/31 family. These results were confirmed by Western blot analysis with monoclonal antibodies. Altogether, the results indicate that Brucella CGH not only participates in deconjugation of bile salts but also affects overall membrane composition and host cell internalization.	[Ines Marchesini, Maria; Comerci, Diego J.] Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina; [Connolly, Joseph; Mujer, Cesar V.; DelVecchio, Vito G.] Vital Probes Inc, Mayfield, PA USA; [Victoria Delpino, Maria; Baldi, Pablo C.] Univ Buenos Aires, Fac Farm & Bioquim, Consejo Nacl Invest Cient & Tecn, Inst Estudios Inmunidad Humoral, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Marchesini, MI (corresponding author), Univ Nacl San Martin, Consejo Nacl Invest Cient & Tecn, Inst Invest Biotecnol, Inst Tecnol Chascomus, Buenos Aires, DF, Argentina.	dcomerci@iibintech.com.ar	Baldi, Pablo/AAS-4736-2020	Marchesini, Ines/0000-0002-8540-2337; Baldi, Pablo/0000-0002-2500-6682; Comerci, Diego J./0000-0003-1949-4226; Delpino, M. Victoria/0000-0003-2077-8509	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This study has been supported by grant PICT 2005 and PICT 2007 from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina, (http://www.agencia.gov.ar/) to DC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bukata L, 2008, J BACTERIOL, V190, P8197, DOI 10.1128/JB.01069-08; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; Connolly JP, 2006, PROTEOMICS, V6, P3767, DOI 10.1002/pmic.200500730; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Delpino MV, 2007, INFECT IMMUN, V75, P299, DOI 10.1128/IAI.00952-06; Delpino MV, 2009, ARCH MICROBIOL, V191, P571, DOI 10.1007/s00203-009-0484-9; Fugier E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000487; GAMAZO C, 1993, FEMS MICROBIOL LETT, V112, P141, DOI 10.1111/j.1574-6968.1993.tb06439.x; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Martin-Martin AI, 2008, MICROBES INFECT, V10, P706, DOI 10.1016/j.micinf.2008.02.013; Nicoletti P, 1989, RELATIONSHIP ANIMAL, P41; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Bonomi HR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009435; Salhi I, 2003, INFECT IMMUN, V71, P4326, DOI 10.1128/IAI.71.8.4326-4332.2003; Vizcaino N, 2004, MICROBES INFECT, V6, P821, DOI 10.1016/j.micinf.2004.04.009; Wang YF, 2010, FEMS MICROBIOL LETT, V303, P92, DOI 10.1111/j.1574-6968.2009.01866.x; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	17	13	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28480	10.1371/journal.pone.0028480	http://dx.doi.org/10.1371/journal.pone.0028480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174816	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600024
J	Magwere, T; Burchill, SA				Magwere, Tapiwanashe; Burchill, Susan A.			Heterogeneous Role of the Glutathione Antioxidant System in Modulating the Response of ESFT to Fenretinide in Normoxia and Hypoxia	PLOS ONE			English	Article							EWINGS-SARCOMA FAMILY; INDUCED CELL-DEATH; GAMMA-GLUTAMYL-TRANSFERASE; PHASE-I TRIAL; OXIDATIVE STRESS; ORAL FENRETINIDE; DRUG-RESISTANCE; TUMORS; CANCER; THERAPY	Glutathione (GSH) is implicated in drug resistance mechanisms of several cancers and is a key regulator of cell death pathways within cells. We studied Ewing's sarcoma family of tumours (ESFT) cell lines and three mechanistically distinct anticancer agents (fenretinide, doxorubicin, and vincristine) to investigate whether the GSH antioxidant system is involved in the reduced sensitivity to these chemotherapeutic agents in hypoxia. Cell viability and death were assessed by the trypan blue exclusion assay and annexin V-PI staining, respectively. Hypoxia significantly decreased the sensitivity of all ESFT cell lines to fenretinide-induced death, whereas the effect of doxorubicin or vincristine was marginal and cell-line-specific. The response of the GSH antioxidant system in ESFT cell lines to hypoxia was variable and also cell-line-specific, although the level of GSH appeared to be most dependent on de novo biosynthesis rather than recycling. RNAi-mediated knockdown of key GSH regulatory enzymes gamma-glutamylcysteine synthetase or glutathione disulfide reductase partially reversed the hypoxia-induced resistance to fenretinide, and increasing GSH levels using N-acetylcysteine augmented the hypoxia-induced resistance in a cell line-specific manner. These observations are consistent with the conclusion that the role of the GSH antioxidant system in modulating the sensitivity of ESFT cells to fenretinide is heterogeneous depending on environment and cell type. This is likely to limit the value of targeting GSH as a therapeutic strategy to overcome hypoxia-induced drug resistance in ESFT. Whether targeting the GSH antioxidant system in conjunction with other therapeutics may benefit some patients with ESFT remains to be seen.	[Magwere, Tapiwanashe; Burchill, Susan A.] St James Univ Hosp, LIMM, Childrens Canc Res Grp, Leeds, W Yorkshire, England	Saint James's University Hospital; University of Leeds	Magwere, T (corresponding author), St James Univ Hosp, LIMM, Childrens Canc Res Grp, Leeds, W Yorkshire, England.	t.magwere@leeds.ac.uk			University of Leeds; Candlelighter's Trust	University of Leeds; Candlelighter's Trust	The University of Leeds and the Candlelighter's Trust funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Anderson CP, 2002, BONE MARROW TRANSPL, V30, P135, DOI 10.1038/sj.bmt.1703605; ANDREWS PA, 1988, CHEM-BIOL INTERACT, V65, P51, DOI 10.1016/0009-2797(88)90030-0; Aryee DNT, 2010, CANCER RES, V70, P4015, DOI 10.1158/0008-5472.CAN-09-4333; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Burchill SA, 2008, EXPERT REV ANTICANC, V8, P1675, DOI 10.1586/14737140.8.10.1675; DeClerck K, 2010, FRONT BIOSCI-LANDMRK, V15, P213, DOI 10.2741/3616; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; FACCHINETTI T, 1978, CHEM-BIOL INTERACT, V20, P97, DOI 10.1016/0009-2797(78)90084-4; Fojo T, 2003, ONCOGENE, V22, P7512, DOI 10.1038/sj.onc.1206951; FORMELLI F, 1993, CANCER RES, V53, P5374; FORMELLI F, 1993, J CLIN ONCOL, V11, P2036, DOI 10.1200/JCO.1993.11.10.2036; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Garaventa A, 2003, CLIN CANCER RES, V9, P2032; Goto H, 2003, INT J HEMATOL, V78, P219, DOI 10.1007/BF02983798; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Liu XW, 2010, PHARMACOL RES, V62, P416, DOI 10.1016/j.phrs.2010.07.002; Mackintosh C, 2010, CANCER BIOL THER, V9, P655, DOI 10.4161/cbt.9.9.11511; Magwere T, 2008, EUR J CANCER, V44, P2276, DOI 10.1016/j.ejca.2008.06.008; Malone W, 2003, EXPERT OPIN INV DRUG, V12, P1829, DOI 10.1517/eoid.12.11.1829.21882; MEISTER A, 1995, METHOD ENZYMOL, V252, P26; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Myatt SS, 2008, ONCOGENE, V27, P985, DOI 10.1038/sj.onc.1210705; Myatt SS, 2005, CLIN CANCER RES, V11, P3136, DOI 10.1158/1078-0432.CCR-04-2050; Pienta KJ, 1997, AM J CLIN ONCOL-CANC, V20, P36, DOI 10.1097/00000421-199702000-00008; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pompella A, 2006, BIOCHEM PHARMACOL, V71, P231, DOI 10.1016/j.bcp.2005.10.005; Shentu JZ, 2007, ANTI-CANCER DRUG, V18, P47, DOI 10.1097/CAD.0b013e32800feeb5; SILBER PM, 1986, ANAL BIOCHEM, V158, P68, DOI 10.1016/0003-2697(86)90590-7; Smith DG, 2011, EXPERT REV ANTICANC, V11, P229, DOI [10.1586/era.10.224, 10.1586/ERA.10.224]; Sohn EJ, 2010, CANC RES, P0008; Soltaninassab SR, 2000, J CELL PHYSIOL, V182, P163, DOI 10.1002/(SICI)1097-4652(200002)182:2<163::AID-JCP4>3.0.CO;2-1; Song JR, 2011, J CELL BIOCHEM, V112, P3406, DOI 10.1002/jcb.23274; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Thacker MM, 2005, EXPERT REV ANTICANC, V5, P319, DOI 10.1586/14737140.5.2.319; Villablanca JG, 2006, J CLIN ONCOL, V24, P3423, DOI 10.1200/JCO.2005.03.9271; Wachtel M, 2010, CANCER TREAT REV, V36, P318, DOI 10.1016/j.ctrv.2010.02.007; White CC, 2003, ANAL BIOCHEM, V318, P175, DOI 10.1016/S0003-2697(03)00143-X; White DE, 2010, BRIT J CANCER, V103, P1380, DOI 10.1038/sj.bjc.6605896; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Zhou X J, 1992, Drugs, V44 Suppl 4, P1	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28558	10.1371/journal.pone.0028558	http://dx.doi.org/10.1371/journal.pone.0028558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174837	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600034
J	Hijazi, K; Wang, YF; Scala, C; Jeffs, S; Longstaff, C; Stieh, D; Haggarty, B; Vanham, G; Schols, D; Balzarini, J; Jones, IM; Hoxie, J; Shattock, R; Kelly, CG				Hijazi, Karolin; Wang, Yufei; Scala, Carlo; Jeffs, Simon; Longstaff, Colin; Stieh, Daniel; Haggarty, Beth; Vanham, Guido; Schols, Dominique; Balzarini, Jan; Jones, Ian M.; Hoxie, James; Shattock, Robin; Kelly, Charles G.			DC-SIGN Increases the Affinity of HIV-1 Envelope Glycoprotein Interaction with CD4	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; IMMATURE DENDRITIC CELLS; C-TYPE LECTIN; LANGERHANS CELLS; T-CELLS; BINDING-SITE; TYPE-1 GP120; IN-VITRO; CARBOHYDRATE-RECOGNITION	Mannose-binding C-type lectin receptors, expressed on Langerhans cells and subepithelial dendritic cells (DCs) of cervicovaginal tissues, play an important role in HIV-1 capture and subsequent dissemination to lymph nodes. DC-SIGN has been implicated in both productive infection of DCs and the DC-mediated trans infection of CD4(+) T cells that occurs in the absence of replication. However, the molecular events that underlie this efficient transmission have not been fully defined. In this study, we have examined the effect of the extracellular domains of DC-SIGN and Langerin on the stability of the interaction of the HIV-1 envelope glycoprotein with CD4 and also on replication in permissive cells. Surface plasmon resonance analysis showed that DC-SIGN increases the binding affinity of trimeric gp140 envelope glycoproteins to CD4. In contrast, Langerin had no effect on the stability of the gp140: CD4 complex. In vitro infection experiments to compare DC-SIGN enhancement of CD4-dependent and CD4-independent strains demonstrated significantly lower enhancement of the CD4-independent strain. In addition DC-SIGN increased the relative rate of infection of the CD4-dependent strain but had no effect on the CD4-independent strain. DC-SIGN binding to the HIV envelope protein effectively increases exposure of the CD4 binding site, which in turn contributes to enhancement of infection.	[Hijazi, Karolin; Wang, Yufei; Scala, Carlo; Kelly, Charles G.] Guys Hosp, Kings Coll London, Inst Dent, London SE1 9RT, England; [Jeffs, Simon] Univ London Imperial Coll Sci Technol & Med, Jefferiss Trust Res Labs, Wright Fleming Inst, Div Med,Fac Med, London, England; [Longstaff, Colin] Natl Inst Biol Stand & Controls, Biotherapeut Sect, Potters Bar, Herts, England; [Stieh, Daniel; Shattock, Robin] Univ London, Ctr Infect, Dept Cellular & Mol Med, London, England; [Haggarty, Beth; Hoxie, James] Univ Penn, Penn Ctr AIDS Res, Philadelphia, PA 19104 USA; [Vanham, Guido] Inst Trop Med, Virol Unit, Div Microbiol, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Vanham, Guido] Free Univ Brussels, Fac Med & Pharm, Brussels, Belgium; [Schols, Dominique; Balzarini, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Balzarini, Jan] Univ Reading, Sch Biol Sci, Reading, Berks, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Imperial College London; National Institute for Biological Standards & Control; University of London; University of Pennsylvania; Institute of Tropical Medicine (ITM); University of Antwerp; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; University of Reading	Hijazi, K (corresponding author), Univ Aberdeen Dent Sch & Hosp, Coll Life Sci & Med, Foresterhill, Aberdeen, Scotland.	charles.kelly@kcl.ac.uk	Longstaff, Colin/D-2413-2013; Jones, Ian/AAF-4986-2019; Schols, Dominique/S-9057-2017; Schols, Dominique/AAC-1309-2021	Longstaff, Colin/0000-0001-7608-208X; Jones, Ian/0000-0002-7738-2516; Schols, Dominique/0000-0003-3256-5850; Schols, Dominique/0000-0003-3256-5850; Hijazi, Karolin/0000-0002-8589-2129	European Commission [LSHP-CT-2003-503558, LSHP-CT-2006-037611, 242135]; Fondation Dormeur; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre; King's College London; Centers of Excellence [PF-10/18]; Fonds voor Wetenschappelijk Onderzoek [G-485-08, G-0125-06 N]; Medical Research Council [G0200000] Funding Source: researchfish; MRC [G0200000] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Fondation Dormeur; Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); King's College London; Centers of Excellence; Fonds voor Wetenschappelijk Onderzoek(FWO); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the European Commission LSHP-CT-2003-503558, LSHP-CT-2006-037611, 242135 (7th Framework Programme) and supported by an equipment grant from the Fondation Dormeur. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' NHS Foundation Trust in partnership with King's College London. JB and DS were supported by the Centers of Excellence (PF-10/18) and Fonds voor Wetenschappelijk Onderzoek (G-485-08) and GV by Fonds voor Wetenschappelijk Onderzoek (G-0125-06 N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astoul CH, 2000, BIOCHEM BIOPH RES CO, V274, P455, DOI 10.1006/bbrc.2000.3166; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chatwell L, 2008, MOL IMMUNOL, V45, P1981, DOI 10.1016/j.molimm.2007.10.030; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Gummuluru S, 2003, J VIROL, V77, P12865, DOI 10.1128/JVI.77.23.12865-12874.2003; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hoffman TL, 1999, P NATL ACAD SCI USA, V96, P6359, DOI 10.1073/pnas.96.11.6359; HOLLA A, 2011, PROTEIN ENG DES SEL; Hong PWP, 2007, J VIROL, V81, P8325, DOI 10.1128/JVI.01765-06; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Jeffs SA, 2007, MED ANIMAL CELL CULT, P59; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Keele BF, 2011, BLOOD, V118, P839, DOI 10.1182/blood-2010-12-325860; Kong L, 2010, J MOL BIOL, V403, P131, DOI 10.1016/j.jmb.2010.08.033; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; LaBranche CC, 1999, J VIROL, V73, P10310, DOI 10.1128/JVI.73.12.10310-10319.1999; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lekkerkerker AN, 2004, VIROLOGY, V329, P465, DOI 10.1016/j.virol.2004.08.028; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Moog C, 1997, AIDS RES HUM RETROV, V13, P19, DOI 10.1089/aid.1997.13.19; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Platt EJ, 2005, J VIROL, V79, P4347, DOI 10.1128/JVI.79.7.4347-4356.2005; POPE M, 1995, J EXP MED, V182, P2045, DOI 10.1084/jem.182.6.2045; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Thepaut M, 2009, BIOCHEMISTRY-US, V48, P2684, DOI 10.1021/bi802151w; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Van Herrewege Y, 2002, AIDS RES HUM RETROV, V18, P1091, DOI 10.1089/088922202320567833; VANDAMME EJM, 1988, PHYSIOL PLANTARUM, V73, P52, DOI 10.1111/j.1399-3054.1988.tb09192.x; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Zaitseva M, 1997, NAT MED, V3, P1369, DOI 10.1038/nm1297-1369; Zhang WT, 2001, BIOCHEMISTRY-US, V40, P1662, DOI 10.1021/bi001397m; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	71	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28307	10.1371/journal.pone.0028307	http://dx.doi.org/10.1371/journal.pone.0028307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163292	Green Submitted, gold, Green Published			2022-12-27	WOS:000298161900027
J	Stanley, JA; Radford, CA; Jeffs, AG				Stanley, Jenni A.; Radford, Craig A.; Jeffs, Andrew G.			Behavioural Response Thresholds in New Zealand Crab Megalopae to Ambient Underwater Sound	PLOS ONE			English	Article							ENDOGENOUS SWIMMING RHYTHMS; JUVENILE BLUE CRABS; CALLINECTES-SAPIDUS; OLFACTORY ABILITIES; DECAPOD CRUSTACEANS; FISH LARVAE; REEF FISHES; HEARING; ORIENTATION; SENSITIVITY	A small number of studies have demonstrated that settlement stage decapod crustaceans are able to detect and exhibit swimming, settlement and metamorphosis responses to ambient underwater sound emanating from coastal reefs. However, the intensity of the acoustic cue required to initiate the settlement and metamorphosis response, and therefore the potential range over which this acoustic cue may operate, is not known. The current study determined the behavioural response thresholds of four species of New Zealand brachyuran crab megalopae by exposing them to different intensity levels of broadcast reef sound recorded from their preferred settlement habitat and from an unfavourable settlement habitat. Megalopae of the rocky-reef crab, Leptograpsus variegatus, exhibited the lowest behavioural response threshold (highest sensitivity), with a significant reduction in time to metamorphosis (TTM) when exposed to underwater reef sound with an intensity of 90 dB re 1 mu Pa and greater (100, 126 and 135 dB re 1 mu Pa). Megalopae of the mud crab, Austrohelice crassa, which settle in soft sediment habitats, exhibited no response to any of the underwater reef sound levels. All reef associated species exposed to sound levels from an unfavourable settlement habitat showed no significant change in TTM, even at intensities that were similar to their preferred reef sound for which reductions in TTM were observed. These results indicated that megalopae were able to discern and respond selectively to habitat-specific acoustic cues. The settlement and metamorphosis behavioural response thresholds to levels of underwater reef sound determined in the current study of four species of crabs, enables preliminary estimation of the spatial range at which an acoustic settlement cue may be operating, from 5 m to 40 km depending on the species. Overall, these results indicate that underwater sound is likely to play a major role in influencing the spatial patterns of settlement of coastal crab species.	[Stanley, Jenni A.; Radford, Craig A.; Jeffs, Andrew G.] Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand	University of Auckland	Stanley, JA (corresponding author), Univ Auckland, Leigh Marine Lab, Warkworth, New Zealand.	ja.stanley@auckland.ac.nz	Jeffs, Andrew G/D-9474-2012	Radford, Craig/0000-0001-7949-9497; Jeffs, Andrew/0000-0002-8504-1949	Glenn Family Foundation; Stanley Wishart Low Memorial Scholarship	Glenn Family Foundation; Stanley Wishart Low Memorial Scholarship	Thanks to the Glenn Family Foundation, as well as the Stanley Wishart Low Memorial Scholarship for financial support for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; BREITHAUPT T, 1990, ADV LIF SCI, P114; BREITHAUPT T, 1988, NATURWISSENSCHAFTEN, V75, P310, DOI 10.1007/BF00367325; CRONIN TW, 1986, AM ZOOL, V26, P403; Egner SA, 2005, MAR ECOL PROG SER, V285, P213, DOI 10.3354/meps285213; FAO, 2009, GLOB CAPT PROD 1950; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Forward RB, 2005, J EXP MAR BIOL ECOL, V316, P91, DOI 10.1016/j.jembe.2004.10.005; Forward RB, 2004, J EXP MAR BIOL ECOL, V299, P63, DOI 10.1016/j.jembe.2003.09.002; Forward RB, 2001, AM ZOOL, V41, P1108, DOI 10.1668/0003-1569(2001)041[1108:CFMOBC]2.0.CO;2; Forward RB, 2000, J EXP MAR BIOL ECOL, V245, P277, DOI 10.1016/S0022-0981(99)00169-0; Hadfield MG, 2001, AM ZOOL, V41, P1123, DOI 10.1668/0003-1569(2001)041[1123:MCAMAC]2.0.CO;2; Hickford MJH, 1999, MAR ECOL PROG SER, V186, P293, DOI 10.3354/meps186293; Higgs Dennis M., 2002, Bioacoustics, V12, P180; Higgs DM, 2004, J EXP BIOL, V207, P155, DOI 10.1242/jeb.00735; Horodysky AZ, 2008, J EXP BIOL, V211, P1504, DOI 10.1242/jeb.016196; Houser DS, 2006, J ACOUST SOC AM, V120, P1713, DOI 10.1121/1.2229286; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Lovell JM, 2005, COMP BIOCHEM PHYS A, V140, P89, DOI 10.1016/j.cbpb.2004.11.003; Mann David A., 2006, P107; McLay CL, 1988, LAB B U AUCKLAND NZ, V22; Meekan MG, 2001, MAR BIOL, V139, P373; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Montgomery JC, 2001, FISH FISH, V2, P261, DOI 10.1046/j.1467-2960.2001.00053.x; Mulsow J, 2010, J ACOUST SOC AM, V127, P2692, DOI 10.1121/1.3327662; Popper AN, 2001, J COMP PHYSIOL A, V187, P83, DOI 10.1007/s003590100184; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Radford CA, 2007, B MAR SCI, V80, P369; Radford CA, 2011, MAR ECOL PROG SER, V438, P167, DOI 10.3354/meps09312; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Shanks AL, 2001, IDENTIFICATION GUIDE; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2004, MAR ECOL PROG SER, V276, P263, DOI 10.3354/meps276263; Stanley JA, 2011, AMBIENT UNDERWATER S; Stanley JA, 2010, BEHAV ECOL, V21, P113, DOI 10.1093/beheco/arp159; Tolimieri Nicholas, 2002, Bioacoustics, V12, P214; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; Valero J, 1999, J SHELLFISH RES, V18, P663; Wear R. G., 1985, NZ OCEANOGRAPHIC I M, V92; Wright KJ, 2008, J FISH BIOL, V72, P2543, DOI 10.1111/j.1095-8649.2008.01864.x; Wright KJ, 2007, MAR BIOL, V150, P1049, DOI 10.1007/s00227-006-0515-x; Wright KJ, 2010, CORAL REEFS, V29, P235, DOI 10.1007/s00338-009-0572-y; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z; Zar J.R., 1999, BIOSTAT ANAL	46	42	42	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28572	10.1371/journal.pone.0028572	http://dx.doi.org/10.1371/journal.pone.0028572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163314	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900050
J	Zhao, J; Wang, CX; Bedair, M; Welti, R; Sumner, LW; Baxter, I; Wang, XM				Zhao, Jian; Wang, Cunxi; Bedair, Mohamed; Welti, Ruth; Sumner, Lloyd W.; Baxter, Ivan; Wang, Xuemin			Suppression of Phospholipase D gamma s Confers Increased Aluminum Resistance in Arabidopsis thaliana	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; LIPID-COMPOSITION; MEMBRANE-LIPIDS; MALATE TRANSPORTER; GENE-EXPRESSION; D-ALPHA; TOLERANCE; STRESS; PLANTS; INHIBITION	Aluminum (Al) toxicity is the major stress in acidic soil that comprises about 50% of the world's arable land. The complex molecular mechanisms of Al toxicity have yet to be fully determined. As a barrier to Al entrance, plant cell membranes play essential roles in plant interaction with Al, and lipid composition and membrane integrity change significantly under Al stress. Here, we show that phospholipase D gamma s (PLD gamma s) are induced by Al stress and contribute to Al-induced membrane lipid alterations. RNAi suppression of PLD gamma resulted in a decrease in both PLD gamma 1 and PLD gamma 2 expression and an increase in Al resistance. Genetic disruption of PLD gamma 1 also led to an increased tolerance to Al while knockout of PLD gamma 2 did not. Both RNAi-suppressed and pld gamma 1-1 mutants displayed better root growth than wild-type under Al stress conditions, and PLD gamma 1-deficient plants had less accumulation of callose, less oxidative damage, and less lipid peroxidation compared to wild-type plants. Most phospholipids and glycolipids were altered in response to Al treatment of wild-type plants, whereas fewer changes in lipids occurred in response to Al stress in PLD gamma mutant lines. Our results suggest that PLD gamma s play a role in membrane lipid modulation under Al stress and that high activities of PLD gamma s negatively modulate plant tolerance to Al.	[Zhao, Jian; Wang, Cunxi; Wang, Xuemin] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Welti, Ruth] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Zhao, Jian; Bedair, Mohamed; Sumner, Lloyd W.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Baxter, Ivan] ARS, USDA, Plant Genet Res Unit, St Louis, MO USA; [Baxter, Ivan; Wang, Xuemin] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Wang, Xuemin] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Kansas State University; Kansas State University; Noble Research Institute; United States Department of Agriculture (USDA); Donald Danforth Plant Science Center; University of Missouri System; University of Missouri Saint Louis	Zhao, J (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	wangxue@umsl.edu	Sumner, Lloyd W/A-3270-2013; Wang, Xuemin/M-2853-2013; Zhao, Jian/Q-8591-2019; Baxter, Ivan R/A-1052-2009; Zhao, Jian/M-4237-2014	Sumner, Lloyd W/0000-0002-4086-663X; Zhao, Jian/0000-0002-4416-7334; Baxter, Ivan R/0000-0001-6680-1722; Zhao, Jian/0000-0002-4416-7334; wang, xuemin/0000-0002-6251-6745; Bedair, Mohamed/0000-0002-2667-5845; Welti, Ruth/0000-0003-4373-2538	National Science Foundation [IOS 0818740, CMB 0922879, EPS 0236913, MCB 0920663, DBI 0521587]; USDA [2007-35318-18393]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health [P20RR16475]; Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work was supported by grants from National Science Foundation (IOS 0818740; CMB 0922879) and USDA (2007-35318-18393). Equipment acquisition and method development at the Kansas Lipidomics Research Center were funded by National Science Foundation (EPS 0236913, MCB 0920663, DBI 0521587), Kansas Technology Enterprise Corporation, K-IDeA Networks of Biomedical Research Excellence (INBRE) of National Institute of Health (P20RR16475), and Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000492; Chaffai R, 2005, PHYTOCHEMISTRY, V66, P1903, DOI 10.1016/j.phytochem.2005.06.028; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; da Silva ALS, 2006, J PLANT PHYSIOL, V163, P26, DOI 10.1016/j.jplph.2005.03.009; Degenhardt J, 1998, PLANT PHYSIOL, V117, P19, DOI 10.1104/pp.117.1.19; Delhaize E, 1999, J BIOL CHEM, V274, P7082, DOI 10.1074/jbc.274.11.7082; Ezaki B, 2004, PLANT PHYSIOL, V134, P1672, DOI 10.1104/pp.103.037135; Ezaki B, 2001, PLANT PHYSIOL, V127, P918, DOI 10.1104/pp.010399; EZAKI B, 2000, PLANT PHYSIOL, V122, P657; Fan L, 1999, PLANT PHYSIOL, V119, P1371, DOI 10.1104/pp.119.4.1371; Gunse B, 1997, PLANT PHYSIOL, V113, P595, DOI 10.1104/pp.113.2.595; Hernandez LE, 1997, J EXP BOT, V48, P1375, DOI 10.1093/jxb/48.7.1375; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; HONG YY, 2008, MOL PLANT, V1, P262, DOI DOI 10.1093/mp/ssm025; Jones DL, 2006, PLANT CELL ENVIRON, V29, P1309, DOI 10.1111/j.1365-3040.2006.01509.x; JONES DL, 1995, PLANT CELL, V7, P1913, DOI 10.1105/tpc.7.11.1913; Kobayashi Y, 2007, PLANT PHYSIOL, V145, P843, DOI 10.1104/pp.107.102335; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Larsen PB, 1998, PLANT PHYSIOL, V117, P9, DOI 10.1104/pp.117.1.9; Li L, 1999, FEBS LETT, V458, P419, DOI 10.1016/S0014-5793(99)01196-5; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Martinez-Estevez M, 2003, J PLANT PHYSIOL, V160, P1297, DOI 10.1078/0176-1617-01168; Meriga B., 2010, ACAD J PLANT SCI, V3, P53; Milla MAR, 2002, PLANT PHYSIOL, V130, P1706, DOI 10.1104/pp.009969; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Novotna Z, 2003, FEBS LETT, V554, P50, DOI 10.1016/S0014-5793(03)01093-7; Ouariti O, 1997, PHYTOCHEMISTRY, V45, P1343, DOI 10.1016/S0031-9422(97)00159-3; Peixoto Paulo Henrique Pereira, 1999, Revista Brasileira de Fisiologia Vegetal, V11, P137; Pejchar P, 2008, CELL BIOL INT, V32, P554, DOI 10.1016/j.cellbi.2007.11.008; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; Qin CB, 2002, PLANT PHYSIOL, V128, P1057, DOI 10.1104/pp.010928; Qin CB, 2006, BBA-MOL CELL BIOL L, V1761, P1450, DOI 10.1016/j.bbalip.2006.09.017; Qin WS, 1997, J BIOL CHEM, V272, P28267, DOI 10.1074/jbc.272.45.28267; Quartacci MF, 2000, PHYSIOL PLANTARUM, V108, P87, DOI 10.1034/j.1399-3054.2000.108001087.x; Quartacci MF, 2001, J EXP BOT, V52, P77, DOI 10.1093/jexbot/52.354.77; Quintal-Tun F, 2007, J INORG BIOCHEM, V101, P362, DOI 10.1016/j.jinorgbio.2006.10.010; Ramos-Diaz A, 2007, PLANTA, V225, P393, DOI 10.1007/s00425-006-0348-3; Rounds MA, 2008, CURR BIOL, V18, P1495, DOI 10.1016/j.cub.2008.08.050; Ryan PR, 2007, PLANT PHYSIOL, V144, P1968, DOI 10.1104/pp.107.100446; Ryan PR, 2009, PLANT PHYSIOL, V149, P340, DOI 10.1104/pp.108.129155; Sarin S, 1997, BIOL TRACE ELEM RES, V59, P133, DOI 10.1007/BF02783238; Shen H, 2005, PLANT PHYSIOL, V138, P287, DOI 10.1104/pp.104.058065; VIERSTRA R, 1978, BIOCHEM BIOPH RES CO, V84, P138, DOI 10.1016/0006-291X(78)90274-7; Wang XM, 2000, PROG LIPID RES, V39, P109, DOI 10.1016/S0163-7827(00)00002-3; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Yamaguchi M, 2005, PLANT CELL PHYSIOL, V46, P812, DOI 10.1093/pcp/pci083; Yamamoto Y, 2002, PLANT PHYSIOL, V128, P63, DOI 10.1104/pp.010417; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Zhang GC, 1997, PHYSIOL PLANTARUM, V99, P302, DOI 10.1034/j.1399-3054.1997.990213.x; Zhang GC, 1996, PHYSIOL PLANTARUM, V96, P683, DOI 10.1111/j.1399-3054.1996.tb00243.x; Zhao J, 2005, BIOTECHNOL BIOENG, V90, P621, DOI 10.1002/bit.20465; ZHAO XJ, 1987, PLANT PHYSIOL, V83, P159, DOI 10.1104/pp.83.1.159; [No title captured]; [No title captured]	57	31	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28086	10.1371/journal.pone.0028086	http://dx.doi.org/10.1371/journal.pone.0028086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163277	Green Published, gold			2022-12-27	WOS:000298161900012
J	Chatterjee, S; Kumar, D				Chatterjee, Samrat; Kumar, Dhiraj			Unraveling the Design Principle for Motif Organization in Signaling Networks	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FEEDBACK LOOPS; COMPLEX NETWORKS; OSCILLATIONS; THRESHOLD; DECISIONS; SPACE; CELLS; TIME; RAS	Cellular signaling networks display complex architecture. Defining the design principle of this architecture is crucial for our understanding of various biological processes. Using a mathematical model for three-node feed-forward loops, we identify that the organization of motifs in specific manner within the network serves as an important regulator of signal processing. Further, incorporating a systemic stochastic perturbation to the model we could propose a possible design principle, for higher-order organization of motifs into larger networks in order to achieve specific biological output. The design principle was then verified in a large, complex human cancer signaling network. Further analysis permitted us to classify signaling nodes of the network into robust and vulnerable nodes as a result of higher order motif organization. We show that distribution of these nodes within the network at strategic locations then provides for the range of features displayed by the signaling network.	[Chatterjee, Samrat; Kumar, Dhiraj] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Chatterjee, S (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India.	dhiraj@icgeb.res.in			Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was supported by the IYBA grant from Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bar-Yam Y, 2004, P NATL ACAD SCI USA, V101, P4341, DOI 10.1073/pnas.0400673101; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Bruggeman FJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000506; Chaudhri VK, 2009, J BIOL CHEM; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Eungdamrong NJ, 2007, BIOPHYS J, V92, P808, DOI 10.1529/biophysj.106.093104; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Justman QA, 2009, SCIENCE, V324, P509, DOI 10.1126/science.1169498; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2000, EUR J BIOCHEM, V267, P1583, DOI 10.1046/j.1432-1327.2000.01197.x; Kumar D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100197; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Qiao L, 2007, PLOS COMPUT BIOL, V3, P1819, DOI 10.1371/journal.pcbi.0030184; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28606	10.1371/journal.pone.0028606	http://dx.doi.org/10.1371/journal.pone.0028606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164309	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400111
J	Finsen, AV; Lunde, IG; Sjaastad, I; Ostli, EK; Lyngra, M; Jarstadmarken, HO; Hasic, A; Nygard, S; Wilcox-Adelman, SA; Goetinck, PF; Lyberg, T; Skrbic, B; Florholmen, G; Tonnessen, T; Louch, WE; Djurovic, S; Carlson, CR; Christensen, G				Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Ostli, Even K.; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Wilcox-Adelman, Sarah A.; Goetinck, Paul F.; Lyberg, Torstein; Skrbic, Biljana; Florholmen, Geir; Tonnessen, Theis; Louch, William E.; Djurovic, Srdjan; Carlson, Cathrine R.; Christensen, Geir			Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway	PLOS ONE			English	Article							INDUCED CARDIAC-HYPERTROPHY; GLYCOGEN-SYNTHASE KINASE-3; PHOSPHATASE-ACTIVITY; PRESSURE-OVERLOAD; AUTOINHIBITORY DOMAIN; FOCAL ADHESIONS; HEART-FAILURE; PROTEIN; MECHANISMS; INHIBITION	Sustained pressure overload leads to compensatory myocardial hypertrophy and subsequent heart failure, a leading cause of morbidity and mortality. Further unraveling of the cellular processes involved is essential for development of new treatment strategies. We have investigated the hypothesis that the transmembrane Z-disc proteoglycan syndecan-4, a co-receptor for integrins, connecting extracellular matrix proteins to the cytoskeleton, is an important signal transducer in cardiomyocytes during development of concentric myocardial hypertrophy following pressure overload. Echocardiographic, histochemical and cardiomyocyte size measurements showed that syndecan-4(-/-) mice did not develop concentric myocardial hypertrophy as found in wild-type mice, but rather left ventricular dilatation and dysfunction following pressure overload. Protein and gene expression analyses revealed diminished activation of the central, pro-hypertrophic calcineurin-nuclear factor of activated T-cell (NFAT) signaling pathway. Cardiomyocytes from syndecan-4(-/-)-NFAT-luciferase reporter mice subjected to cyclic mechanical stretch, a hypertrophic stimulus, showed minimal activation of NFAT (1.6-fold) compared to 5.8-fold increase in NFAT-luciferase control cardiomyocytes. Accordingly, overexpression of syndecan-4 or introducing a cell-permeable membrane-targeted syndecan-4 polypeptide (gain of function) activated NFATc4 in vitro. Pull-down experiments demonstrated a direct intracellular syndecan-4-calcineurin interaction. This interaction and activation of NFAT were increased by dephosphorylation of serine 179 (pS179) in syndecan-4. During pressure overload, phosphorylation of syndecan-4 was decreased, and association between syndecan-4, calcineurin and its co-activator calmodulin increased. Moreover, calcineurin dephosphorylated pS179, indicating that calcineurin regulates its own binding and activation. Finally, patients with hypertrophic myocardium due to aortic stenosis had increased syndecan-4 levels with decreased pS179 which was associated with increased NFAT activation. In conclusion, our data show that syndecan-4 is essential for compensatory hypertrophy in the pressure overloaded heart. Specifically, syndecan-4 regulates stretch-induced activation of the calcineurin-NFAT pathway in cardiomyocytes. Thus, our data suggest that manipulation of syndecan-4 may provide an option for therapeutic modulation of calcineurin-NFAT signaling.	[Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Skrbic, Biljana; Florholmen, Geir; Louch, William E.; Carlson, Cathrine R.; Christensen, Geir] Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway; [Finsen, Alexandra V.; Lunde, Ida G.; Sjaastad, Ivar; Lyngra, Marianne; Jarstadmarken, Hilde O.; Hasic, Almira; Nygard, Stale; Skrbic, Biljana; Florholmen, Geir; Tonnessen, Theis; Louch, William E.; Carlson, Cathrine R.; Christensen, Geir] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Finsen, Alexandra V.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Cardiol, N-0027 Oslo, Norway; [Finsen, Alexandra V.] Univ Oslo, Rikshosp, Oslo Univ Hosp, Internal Med Res Inst, N-0027 Oslo, Norway; [Ostli, Even K.; Djurovic, Srdjan] Oslo Univ Hosp Ulleval, Dept Med Genet, Oslo, Norway; [Sjaastad, Ivar] Oslo Univ Hosp Ulleval, Dept Cardiol, Oslo, Norway; [Nygard, Stale] Univ Oslo, Dept Math, Oslo, Norway; [Nygard, Stale] Oslo Univ Hosp, Bioinformat Core Facil, Oslo, Norway; [Wilcox-Adelman, Sarah A.] Boston Biomed Res Inst, Watertown, MA USA; [Goetinck, Paul F.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Lyberg, Torstein] Oslo Univ Hosp Ulleval, Clin Res Ctr, Oslo, Norway; [Skrbic, Biljana; Tonnessen, Theis] Oslo Univ Hosp Ulleval, Dept Cardiothorac Surg, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Boston Biomedical Research Institute; Harvard University; Massachusetts General Hospital; University of Oslo; University of Oslo	Finsen, AV (corresponding author), Oslo Univ Hosp Ulleval, Expt Med Res Inst, Oslo, Norway.	a.v.finsen@medisin.uio.no	Nygård, Ståle/AGU-4330-2022; Nygård, Ståle/H-2148-2012; Lunde, Ida Gjervold/ABN-5567-2022	Nygard, Stale/0000-0002-5263-4748; Lunde, Ida Gjervold/0000-0001-9502-6841; Djurovic, Srdjan/0000-0002-8140-8061	Norwegian Research Council; South-Eastern Regional Health Authority; University of Oslo, Rakel; Otto Kr. Bruun's Fund; Joh. H. Andresens Medical Fund; Ella and Kristian Nyrrod Fund; American Heart Association [0250523N]; National Institutes of Health [HD-37490]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037490] Funding Source: NIH RePORTER	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Regional Health Authority; University of Oslo, Rakel; Otto Kr. Bruun's Fund; Joh. H. Andresens Medical Fund; Ella and Kristian Nyrrod Fund; American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by the Norwegian Research Council, the South-Eastern Regional Health Authority, Anders Jahre's Fund for the Promotion of Science, Molecular Life Sciences at the University of Oslo, Rakel and Otto Kr. Bruun's Fund, Joh. H. Andresens Medical Fund, Ella and Kristian Nyrrod Fund, the American Heart Association; AHA Grant 0250523N and National Institutes of Health; NICHD Grant HD-37490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bellin RM, 2009, P NATL ACAD SCI USA, V106, P22102, DOI 10.1073/pnas.0902639106; Bourajjaj M, 2008, J BIOL CHEM, V283, P22295, DOI 10.1074/jbc.M801296200; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Deng XF, 2000, CIRC RES, V87, P781, DOI 10.1161/01.RES.87.9.781; Diedrichs H, 2007, J INT MED RES, V35, P803, DOI 10.1177/147323000703500609; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Echtermeyer F, 2011, CARDIOVASC RES, V92, P123, DOI 10.1093/cvr/cvr149; Finsen AV, 2004, PHYSIOL GENOMICS, V16, P301, DOI 10.1152/physiolgenomics.00144.2002; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Futaki S, 2005, ADV DRUG DELIVER REV, V57, P547, DOI 10.1016/j.addr.2004.10.009; HASHIMOTO Y, 1990, J BIOL CHEM, V265, P1924; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; KISSINGER CR, 1995, NATURE, V378, P641, DOI 10.1038/378641a0; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Lai MM, 1998, J BIOL CHEM, V273, P18325, DOI 10.1074/jbc.273.29.18325; LETOHA T, 2010, BIOCH BIOPHYS ACTA; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; Matsui Y, 2011, CIRC RES, V108, P1328, DOI 10.1161/CIRCRESAHA.110.235689; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Oh M, 2010, J BIOL CHEM, V285, P16623, DOI 10.1074/jbc.M109.098236; PARSONS JN, 1994, J BIOL CHEM, V269, P19610; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; Ruwhof C, 2000, CARDIOVASC RES, V47, P23, DOI 10.1016/S0008-6363(00)00076-6; Sagoo JK, 1996, BIOCHEM J, V320, P879, DOI 10.1042/bj3200879; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Sharp WW, 1997, AM J PHYSIOL-HEART C, V273, pH546, DOI 10.1152/ajpheart.1997.273.2.H546; Simons M, 2001, CELL SIGNAL, V13, P855, DOI 10.1016/S0898-6568(01)00190-5; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Sun L, 1998, IMMUNITY, V8, P703, DOI 10.1016/S1074-7613(00)80575-0; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; van Rooij E, 2002, J BIOL CHEM, V277, P48617, DOI 10.1074/jbc.M206532200; VanWinkle WB, 2002, ANAT RECORD, V268, P38, DOI 10.1002/ar.10130; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wilkins BJ, 2002, MOL CELL BIOL, V22, P7603, DOI 10.1128/MCB.22.21.7603-7613.2002; YAMAZAKI T, 1995, J CLIN INVEST, V96, P438, DOI 10.1172/JCI118054; Zobel C, 2007, CARDIOLOGY, V107, P281, DOI 10.1159/000099063; Zou YZ, 2002, ENDOCR J, V49, P1, DOI 10.1507/endocrj.49.1	53	60	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28302	10.1371/journal.pone.0028302	http://dx.doi.org/10.1371/journal.pone.0028302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164265	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400066
J	Grigoleit, JS; Kullmann, JS; Wolf, OT; Hammes, F; Wegner, A; Jablonowski, S; Engler, H; Gizewski, E; Oberbeck, R; Schedlowski, M				Grigoleit, Jan-Sebastian; Kullmann, Jennifer S.; Wolf, Oliver T.; Hammes, Florian; Wegner, Alexander; Jablonowski, Stephanie; Engler, Harald; Gizewski, Elke; Oberbeck, Reiner; Schedlowski, Manfred			Dose-Dependent Effects of Endotoxin on Neurobehavioral Functions in Humans	PLOS ONE			English	Article							HEALTHY-YOUNG MEN; WORKING-MEMORY; PREFRONTAL CORTEX; SHORT-TERM; SYSTEMIC INFLAMMATION; DECLARATIVE MEMORY; HUMAN BRAIN; CYTOKINES; STRESS; LIPOPOLYSACCHARIDE	Clinical and experimental evidence document that inflammation and increased peripheral cytokine levels are associated with depression-like symptoms and neuropsychological disturbances in humans. However, it remains unclear whether and to what extent cognitive functions likememory and attention are affected by and related to the dose of the inflammatory stimulus. Thus, in a cross-over, double-blind, experimental approach, healthy male volunteers were administered with either placebo or bacterial lipopolysaccharide (LPS) at doses of 0.4 (n = 18) or 0.8 ng/kg of body weight (n = 16). Pro-and anti-inflammatory cytokines, norephinephrine and cortisol concentrations were analyzed before and 1, 1.75, 3, 4, 6, and 24 h after injection. In addition, changes in mood and anxiety levels were determined together with working memory (n-back task) and long term memory performance (recall of emotional and neutral pictures of the International Affective Picture System). Endotoxin administration caused a profound transient physiological response with dose-related elevations in body temperature and heart rate, increases in plasma interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha and IL-1 receptor antagonist (IL-1ra), salivary and plasma cortisol, and plasma norepinephrine. These changes were accompanied by dose-related decreased mood and increased anxiety levels. LPS administration did not affect accuracy in working memory performance but improved reaction time in the high-dose LPS condition compared to the control conditon. In contrast, long-term memory performance was impaired selectively for emotional stimuli after administration of the lower but not of the higher dose of LPS. These data suggest the existence of at least two counter-acting mechanisms, one promoting and one inhibiting cognitive performance during acute systemic inflammation.	[Grigoleit, Jan-Sebastian; Kullmann, Jennifer S.; Jablonowski, Stephanie; Engler, Harald; Schedlowski, Manfred] Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany; [Kullmann, Jennifer S.; Gizewski, Elke] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Wolf, Oliver T.] Univ Bochum, Dept Cognit Psychol, Bochum, Germany; [Hammes, Florian; Wegner, Alexander; Oberbeck, Reiner] Univ Hosp Essen, Dept Trauma Surg, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; Ruhr University Bochum; University of Duisburg Essen	Grigoleit, JS (corresponding author), Univ Duisburg Essen, Inst Med Psychol & Behav Immunobiol, Essen, Germany.	manfred.schedlowski@uk-essen.de	Engler, Harald/H-8773-2017	Engler, Harald/0000-0001-6329-1990; Gizewski, Elke Ruth/0000-0001-6859-8377; Wolf, Oliver T./0000-0002-9320-2124	German Research Foundation [Sche 341/14-1]	German Research Foundation(German Research Foundation (DFG))	This study was supported by a grant from the German Research Foundation (grant number: Sche 341/14-1, URL: www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez XA, 1996, MOL CHEM NEUROPATHOL, V29, P237, DOI 10.1007/BF02815005; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bahador M, 2007, J ENDOTOXIN RES, V13, P251, DOI 10.1177/0968051907085986; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; Brunner R, 2005, NEUROLOGY, V64, P335, DOI 10.1212/01.WNL.0000149523.35039.4C; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Capuron L, 2004, BIOL PSYCHIAT, V56, P819, DOI 10.1016/j.biopsych.2004.02.009; Cohen O, 2003, J MOL NEUROSCI, V21, P199, DOI 10.1385/JMN:21:3:199; Cornelisse S, 2011, PSYCHONEUROENDOCRINO, V36, P569, DOI 10.1016/j.psyneuen.2010.09.002; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; Dantzer R, 2000, AUTON NEUROSCI-BASIC, V85, P60, DOI 10.1016/S1566-0702(00)00220-4; Dantzer R, 2001, BRAIN BEHAV IMMUN, V15, P7, DOI 10.1006/brbi.2000.0613; DellaGioia N, 2010, NEUROSCI BIOBEHAV R, V34, P130, DOI 10.1016/j.neubiorev.2009.07.014; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Doenlen R, 2011, P ROY SOC B-BIOL SCI, V278, P1864, DOI 10.1098/rspb.2010.2040; Drexhage RC, 2010, EXPERT REV NEUROTHER, V10, P59, DOI [10.1586/ern.09.144, 10.1586/ERN.09.144]; Dunn AJ, 2006, CLIN NEUROSCI RES, V6, P52, DOI 10.1016/j.cnr.2006.04.002; Eisenberger NI, 2009, NEUROIMAGE, V47, P881, DOI 10.1016/j.neuroimage.2009.04.040; Engelhart MJ, 2004, ARCH NEUROL-CHICAGO, V61, P668, DOI 10.1001/archneur.61.5.668; Engler H, 2011, BRAIN BEHAV IMMUN, V25, P1384, DOI 10.1016/j.bbi.2011.04.005; GIBERTINI M, 1995, P SOC EXP BIOL MED, V210, P7, DOI 10.3181/00379727-210-43917; Grigoleit JS, 2010, NEUROBIOL LEARN MEM, V94, P561, DOI 10.1016/j.nlm.2010.09.011; Henckens MJAG, 2011, P NATL ACAD SCI USA, V108, P5801, DOI 10.1073/pnas.1019128108; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; Keedwell P, 1996, ACTA PSYCHIAT SCAND, V93, P177, DOI 10.1111/j.1600-0447.1996.tb10627.x; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Krabbe KS, 2005, BRAIN BEHAV IMMUN, V19, P453, DOI 10.1016/j.bbi.2005.04.010; Kuhlmann S, 2006, BEHAV NEUROSCI, V120, P217, DOI 10.1037/0735-7044.120.1.217; Kullmann J.S., 2011, Z MED PSYCHOL, V20, P108; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lee B, 2000, BRAIN RES, V856, P129, DOI 10.1016/S0006-8993(99)02381-1; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Meyer JM, 2009, BIOL PSYCHIAT, V66, P1013, DOI 10.1016/j.biopsych.2009.06.005; Meyers CA, 1999, ADV EXP MED BIOL, V461, P75; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mullington J, 2000, AM J PHYSIOL-REG I, V278, pR947, DOI 10.1152/ajpregu.2000.278.4.R947; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Payne JD, 2007, LEARN MEMORY, V14, P861, DOI 10.1101/lm.743507; Pollmacher T, 2002, BRAIN BEHAV IMMUN, V16, P525, DOI 10.1016/S0889-1591(02)00004-1; POLLOCK V, 1979, J NERV MENT DIS, V167, P612, DOI 10.1097/00005053-197910000-00004; Pugh CR, 1998, BRAIN BEHAV IMMUN, V12, P212, DOI 10.1006/brbi.1998.0524; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Reichenberg A, 2001, ARCH GEN PSYCHIAT, V58, P445, DOI 10.1001/archpsyc.58.5.445; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schoofs D, 2009, BEHAV NEUROSCI, V123, P1066, DOI 10.1037/a0016980; Shaw KN, 2001, BEHAV BRAIN RES, V124, P47, DOI 10.1016/S0166-4328(01)00232-7; Sparkman NL, 2005, PHYSIOL BEHAV, V85, P278, DOI 10.1016/j.physbeh.2005.04.015; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Steyer, 1997, MEHRDIMENSIONALE BEF; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Turnbull AV, 1995, BRAIN BEHAV IMMUN, V9, P253, DOI 10.1006/brbi.1995.1026; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; van den Boogaard M, 2010, CRIT CARE, V14, DOI 10.1186/cc9001; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Wright CE, 2005, BRAIN BEHAV IMMUN, V19, P345, DOI 10.1016/j.bbi.2004.10.003; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106	63	147	148	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28330	10.1371/journal.pone.0028330	http://dx.doi.org/10.1371/journal.pone.0028330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164271	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400072
J	Jonsson, ME; Woodin, BR; Stegeman, JJ; Brunstrom, B				Jonsson, Maria E.; Woodin, Bruce R.; Stegeman, John J.; Brunstrom, Bjorn			Cytochrome P450 1 Genes in Birds: Evolutionary Relationships and Transcription Profiles in Chicken and Japanese Quail Embryos	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; WHITE LEGHORN CHICKEN; PHEASANT PHASIANUS-COLCHICUS; GALLUS-DOMESTICUS EMBRYOS; ZEBRAFISH DANIO-RERIO; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; COMMON PHEASANT; OVO EXPOSURE; PCR DATA; POLYCHLORINATED-BIPHENYLS	Background: Cytochrome P450 1 (CYP1) genes are biomarkers for aryl hydrocarbon receptor (AHR) agonists and may be involved in some of their toxic effects. CYP1s other than the CYP1As are poorly studied in birds. Here we characterize avian CYP1B and CYP1C genes and the expression of the identified CYP1 genes and AHR1, comparing basal and induced levels in chicken and quail embryos. Methodology/Principal Findings: We cloned cDNAs of chicken CYP1C1 and quail CYP1B1 and AHR1. CYP1Cs occur in several bird genomes, but we found no CYP1C gene in quail. The CYP1C genomic region is highly conserved among vertebrates. This region also shares some synteny with the CYP1B region, consistent with CYP1B and CYP1C genes deriving from duplication of a common ancestor gene. Real-time RT-PCR analyses revealed similar tissue distribution patterns for CYP1A4, CYP1A5, CYP1B1, and AHR1 mRNA in chicken and quail embryos, with the highest basal expression of the CYP1As in liver, and of CYP1B1 in eye, brain, and heart. Chicken CYP1C1 mRNA levels were appreciable in eye and heart but relatively low in other organs. Basal transcript levels of the CYP1As were higher in quail than in chicken, while CYP1B1 levels were similar in the two species. 3,3',4,5,5'-Pentachlorobiphenyl induced all CYP1s in chicken; in quail a 1000-fold higher dose induced the CYP1As, but not CYP1B1. Conclusions/Significance: The apparent absence of CYP1C1 in quail, and weak expression and induction of CYP1C1 in chicken suggest that CYP1Cs have diminishing roles in tetrapods; similar tissue expression suggests that such roles may be met by CYP1B1. Tissue distribution of CYP1B and CYP1C transcripts in birds resembles that previously found in zebrafish, suggesting that these genes serve similar functions in diverse vertebrates. Determining CYP1 catalytic functions in different species should indicate the evolving roles of these duplicated genes in physiological and toxicological processes.	[Jonsson, Maria E.; Brunstrom, Bjorn] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Jonsson, Maria E.; Woodin, Bruce R.; Stegeman, John J.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Uppsala University; Woods Hole Oceanographic Institution	Jonsson, ME (corresponding author), Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden.	maria.jonsson@ebc.uu.se			Carl Tryggers Stiftelse; Swedish Research Council Formas; United States National Institutes of Health (National Institute of Environmental Health Sciences) [R01ES015912, P42ES007381]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015912, P42ES007381] Funding Source: NIH RePORTER	Carl Tryggers Stiftelse; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); United States National Institutes of Health (National Institute of Environmental Health Sciences); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding to MEJ and BB was from the Carl Tryggers Stiftelse and The Swedish Research Council Formas. Funding for BRW and JJS was from the United States National Institutes of Health (National Institute of Environmental Health Sciences), grants R01ES015912 and P42ES007381 to JJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beedanagari SR, 2010, MOL PHARMACOL, V78, P608, DOI 10.1124/mol.110.064899; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; BRUNSTROM B, 1988, POULTRY SCI, V67, P52, DOI 10.3382/ps.0670052; BRUNSTROM B, 1983, TOXICOLOGY, V27, P103, DOI 10.1016/0300-483X(83)90015-X; Brunstrom B, 1998, COMP BIOCHEM PHYS C, V121, P213, DOI 10.1016/S0742-8413(98)10042-7; BRUNSTROM B, 1988, ARCH TOXICOL, V62, P263, DOI 10.1007/BF00332485; BRUNSTROM B, 1988, COMP BIOCHEM PHYS C, V91, P507, DOI 10.1016/0742-8413(88)90069-2; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chiaro CR, 2007, MOL PHARMACOL, V72, P1369, DOI 10.1124/mol.107.038968; Choudhary D, 2006, DRUG METAB REV, V38, P337, DOI 10.1080/03602530600570149; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Choudhary D, 2004, DRUG METAB DISPOS, V32, P840, DOI 10.1124/dmd.32.8.840; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Choudhary D, 2007, DRUG METAB DISPOS, V35, P987, DOI 10.1124/dmd.106.014282; Cohen-Barnhouse AM, 2011, ENVIRON TOXICOL CHEM, V30, P1659, DOI 10.1002/etc.551; Cohen-Barnhouse AM, 2011, TOXICOL SCI, V119, P93, DOI 10.1093/toxsci/kfq289; Dey A, 1999, BIOCHEM PHARMACOL, V58, P525, DOI 10.1016/S0006-2952(99)00110-0; Gao K, 2011, COMP BIOCHEM PHYS C, V154, P42, DOI 10.1016/j.cbpc.2011.02.005; Gilday D, 1998, TOXICOL APPL PHARM, V150, P106, DOI 10.1006/taap.1997.8360; Gilday D, 1996, J BIOL CHEM, V271, P33054, DOI 10.1074/jbc.271.51.33054; Godard CAJ, 2005, BIOCHEM BIOPH RES CO, V331, P1016, DOI 10.1016/j.bbrc.2005.03.231; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; Goldstone JV, 2009, ARCH BIOCHEM BIOPHYS, V482, P7, DOI 10.1016/j.abb.2008.12.002; Goldstone JV, 2007, MOL BIOL EVOL, V24, P2619, DOI 10.1093/molbev/msm200; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031; Head JA, 2008, ENVIRON SCI TECHNOL, V42, P7535, DOI 10.1021/es801082a; Jonsson ME, 2007, TOXICOL SCI, V100, P180, DOI 10.1093/toxsci/kfm207; Jonsson ME, 2007, TOXICOL APPL PHARM, V221, P29, DOI 10.1016/j.taap.2007.02.017; Jonsson ME, 2010, AQUAT TOXICOL, V98, P311, DOI 10.1016/j.aquatox.2010.03.003; Jonsson ME, 2011, TOXICOL APPL PHARM; Jung RE, 1997, ENVIRON TOXICOL CHEM, V16, P230, DOI 10.1002/etc.5620160219; Karchner SI, 2006, P NATL ACAD SCI USA, V103, P6252, DOI 10.1073/pnas.0509950103; Kawai YK, 2010, MAMM GENOME, V21, P320, DOI 10.1007/s00335-010-9263-9; Lavine JA, 2005, TOXICOL SCI, V88, P60, DOI 10.1093/toxsci/kfi228; Lee JS, 2009, TOXICOL APPL PHARM, V234, P1, DOI 10.1016/j.taap.2008.09.007; Lewis DFV, 2003, CHEM-BIOL INTERACT, V145, P281, DOI 10.1016/S0009-2797(03)00021-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthews Jason, 2006, Nucl Recept Signal, V4, pe016; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2008, J BIOL CHEM, V283, P36061, DOI 10.1074/jbc.R800053200; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; POLAND A, 1994, MOL PHARMACOL, V46, P915; Powell DC, 1996, ARCH ENVIRON CON TOX, V31, P404, DOI 10.1007/BF00212680; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimada T, 2003, TOXICOL APPL PHARM, V187, P1, DOI 10.1016/S0041-008X(02)00035-2; Uno Y, 2011, BIOCHEM PHARMACOL, V81, P442, DOI 10.1016/j.bcp.2010.11.003; Wei YD, 1998, CHEM-BIOL INTERACT, V110, P39, DOI 10.1016/S0009-2797(97)00111-7; Wincent E, 2009, J BIOL CHEM, V284, P2690, DOI 10.1074/jbc.M808321200; Yang YF, 2010, ENVIRON TOXICOL CHEM, V29, P1490, DOI 10.1002/etc.171; Yasui T, 2007, TOXICOL SCI, V99, P101, DOI 10.1093/toxsci/kfm139; Zanette J, 2009, AQUAT TOXICOL, V93, P234, DOI 10.1016/j.aquatox.2009.05.008; ZeRuth G, 2007, CHEM-BIOL INTERACT, V170, P100, DOI 10.1016/j.cbi.2007.07.003; Zeruth G, 2005, ZEBRAFISH, V2, P197, DOI 10.1089/zeb.2005.2.197; Zhou SF, 2009, CURR MED CHEM, V16, P3480, DOI 10.2174/092986709789057635	63	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28257	10.1371/journal.pone.0028257	http://dx.doi.org/10.1371/journal.pone.0028257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164255	Green Published, gold			2022-12-27	WOS:000298171400056
J	Lin, HN; Notredame, C; Chang, JM; Sung, TY; Hsu, WL				Lin, Hsin-Nan; Notredame, Cedric; Chang, Jia-Ming; Sung, Ting-Yi; Hsu, Wen-Lian			Improving the Alignment Quality of Consistency Based Aligners with an Evaluation Function Using Synonymous Protein Words	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; STRUCTURE PREDICTION; TWILIGHT ZONE; CONSTRUCTION; GENERATION; PROFILES; ACCURACY; MATRICES; SATCHMO; FOLD	Most sequence alignment tools can successfully align protein sequences with higher levels of sequence identity. The accuracy of corresponding structure alignment, however, decreases rapidly when considering distantly related sequences (<20% identity). In this range of identity, alignments optimized so as to maximize sequence similarity are often inaccurate from a structural point of view. Over the last two decades, most multiple protein aligners have been optimized for their capacity to reproduce structure-based alignments while using sequence information. Methods currently available differ essentially in the similarity measurement between aligned residues using substitution matrices, Fourier transform, sophisticated profile-profile functions, or consistency-based approaches, more recently. In this paper, we present a flexible similarity measure for residue pairs to improve the quality of protein sequence alignment. Our approach, called SymAlign, relies on the identification of conserved words found across a sizeable fraction of the considered dataset, and supported by evolutionary analysis. These words are then used to define a position specific substitution matrix that better reflects the biological significance of local similarity. The experiment results show that the SymAlign scoring scheme can be incorporated within T-Coffee to improve sequence alignment accuracy. We also demonstrate that SymAlign is less sensitive to the presence of structurally non-similar proteins. In the analysis of the relationship between sequence identity and structure similarity, SymAlign can better differentiate structurally similar proteins from non-similar proteins. We show that protein sequence alignments can be significantly improved using a similarity estimation based on weighted n-grams. In our analysis of the alignments thus produced, sequence conservation becomes a better indicator of structural similarity. SymAlign also provides alignment visualization that can display sub-optimal alignments on dot-matrices. The visualization makes it easy to identify well-supported alternative alignments that may not have been identified by dynamic programming. SymAlign is available at http://bio-cluster.iis.sinica.edu.tw/SymAlign/.	[Lin, Hsin-Nan; Sung, Ting-Yi; Hsu, Wen-Lian] Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan; [Notredame, Cedric; Chang, Jia-Ming] UPF, CRG, Barcelona, Spain	Academia Sinica - Taiwan; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Lin, HN (corresponding author), Acad Sinica, Inst Informat Sci, Bioinformat Lab, Taipei, Taiwan.	tsung@iis.sinica.edu.tw; hsu@iis.sinica.edu.tw	Hsu, Wen-Lian/ABB-2851-2020; Chang, Jia-Ming/A-5642-2008; Lin, Hsin-Nan/AFI-7411-2022; Lin, Hsin-Nan/AFL-1244-2022; Sung, Ting-Yi/AAQ-5413-2021; notredame, cedric/G-3868-2010	Hsu, Wen-Lian/0000-0001-7061-3513; Chang, Jia-Ming/0000-0002-6711-1739; Lin, Hsin-Nan/0000-0001-7225-7161; Sung, Ting-Yi/0000-0002-6028-0409; notredame, cedric/0000-0003-1461-0988	Academia Sinica [AS95ASIA03]; National Science Council [NSC97-2627-P-001-004]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by the thematic program of Academia Sinica (AS95ASIA03) and the National Science Council (NSC97-2627-P-001-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armougom F, 2006, BIOINFORMATICS, V22, pE35, DOI 10.1093/bioinformatics/btl218; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2004, BIOINFORMATICS, V20, P1301, DOI 10.1093/bioinformatics/bth090; Edgar RC, 2004, BIOINFORMATICS, V20, P1309, DOI 10.1093/bioinformatics/bth091; Edgar RC, 2003, BIOINFORMATICS, V19, P1404, DOI 10.1093/bioinformatics/btg158; Edgar RC, 2010, NUCLEIC ACIDS RES, V38, P2145, DOI 10.1093/nar/gkp1196; Edgar RC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-396; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hagopian R, 2010, NUCLEIC ACIDS RES, V38, pW29, DOI 10.1093/nar/gkq298; Hara T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-235; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HOGEWEG P, 1984, J MOL EVOL, V20, P175, DOI 10.1007/BF02257378; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin HN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S4; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Muller T, 2000, J COMPUT BIOL, V7, P761, DOI 10.1089/10665270050514918; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2003, BIOINFORMATICS, V19, pi215, DOI 10.1093/bioinformatics/btg1029; Panchenko AR, 2003, NUCLEIC ACIDS RES, V31, P683, DOI 10.1093/nar/gkg154; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pei JM, 2006, NUCLEIC ACIDS RES, V34, P4364, DOI 10.1093/nar/gkl514; Pei JM, 2003, BIOINFORMATICS, V19, P427, DOI 10.1093/bioinformatics/btg008; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Rychlewski L, 1998, FOLD DES, V3, P229, DOI 10.1016/S1359-0278(98)00034-0; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Skolnick J, 2001, PROTEINS, V42, P319; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sternberg MJE, 1999, CURR OPIN STRUC BIOL, V9, P368, DOI 10.1016/S0959-440X(99)80050-5; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2005, BIOINFORMATICS, V21, P3615, DOI 10.1093/bioinformatics/bti582	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27872	10.1371/journal.pone.0027872	http://dx.doi.org/10.1371/journal.pone.0027872			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22163274	Green Published, gold			2022-12-27	WOS:000298171400017
J	Mishra, RR; Chaudhary, JK; Bajaj, GD; Rath, PC				Mishra, Rasmi Rekha; Chaudhary, Jitendra Kumar; Bajaj, Gagan Deep; Rath, Pramod C.			A Novel Human TPIP Splice-Variant (TPIP-C2) mRNA, Expressed in Human and Mouse Tissues, Strongly Inhibits Cell Growth in HeLa Cells	PLOS ONE			English	Article							PTEN TUMOR-SUPPRESSOR; TYROSINE-PHOSPHATASE; MEMBRANE-BINDING; C2 DOMAIN; GENE; BREAST; P53; PHOSPHORYLATION; STABILIZATION; ASSOCIATION	Alternative splicing of mRNAs is known to involve a major regulation of gene expression at RNA level in mammalian cells. The PTEN (Phosphatase and TENsin homologue deleted from the human chromosome 10), TPTE (Transmembrane Phosphatase with TEnsin homology) and TPIP (TPTE and PTEN homologous Inositol lipid Phosphatase) belong to a family of dual-specific lipid and protein phosphatases. PTEN is a well characterized tumor suppressor, which plays crucial role in cell survival, cell cycle regulation, cell proliferation as well as adhesion, motility and migration of cells. The C2-domain of PTEN is essential for PTEN-functions. We have isolated a novel 1019 bp human TPIP cDNA (TPIP-C2) from a human testis cDNA library. In silico analysis of the cDNA revealed that it is produced from the TPIP-locus on the human chromosome 13 by alternative RNA-splicing. It has a unique 59-Alu sequence, a LINE sequence followed by a 582 bp Open Reading Frame (ORF) encoding a 193 aa polypeptide with a partial phosphatase domain and a C2-domain. TPIP-C2 mRNA is expressed in human testis and in mouse tissues. Mouse testis and brain showed higher levels of TPIP-C2 mRNA in comparison to the heart, liver and kidney under normal physiological conditions. TPIP-C2 mRNAs from human and mouse testes show extensive sequence identity. Over-expression of TPIP-C2 cDNA in HeLa cells strongly (up to 85%) inhibited cell growth/proliferation and caused apoptosis in a caspase 3-dependent manner. These findings suggest for the first time that a TPIP splice-variant mRNA with a partial phosphatase domain and a C2-domain is expressed in cells and tissues of human and murine origins under normal physiological conditions. Inhibition of cell growth/proliferation and induction of apoptosis by overexpression of TPIP-C2 mRNA in HeLa cells suggest that it may be involved in negative regulation of cell growth/proliferation.	[Mishra, Rasmi Rekha; Chaudhary, Jitendra Kumar; Bajaj, Gagan Deep; Rath, Pramod C.] Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Mishra, RR (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi 110067, India.	pcrath@mail.jnu.ac.in	RATH, PRAMOD/AAP-5565-2020	CHAUDHARY, JITENDRA/0000-0001-8499-9656	Capacity Buildup; UGC-Research Network Resource Centre; Government of India; Council of Scientific and Industrial Research (CSIR); UGC	Capacity Buildup; UGC-Research Network Resource Centre; Government of India; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); UGC(University Grants Commission, India)	This work is supported by the Capacity Buildup, UGC-Research Network Resource Centre and DST-Purse grants of the Government of India to JNU/SLS and PCR. RRM and GDB were supported by fellowships (JRF and SRF) from the Council of Scientific and Industrial Research (CSIR) and UGC respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, HUM MOL GENET, V15, P777, DOI 10.1093/hmg/ddi492; Babich V, 1999, GENE, V239, P341, DOI 10.1016/S0378-1119(99)00391-1; Bajaj GD, 2002, THESIS J NEHRU U NEW; Cabarcas Stephanie, 2010, Online J Biol Sci, V10, P114; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chen HM, 1999, HUM GENET, V105, P399, DOI 10.1007/s004390051122; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dey I, 2005, BIOCHEM BIOPH RES CO, V327, P276, DOI 10.1016/j.bbrc.2004.12.015; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Georgescu MM, 2000, CANCER RES, V60, P7033; Gildea JJ, 2004, ONCOGENE, V23, P6788, DOI 10.1038/sj.onc.1207599; Guipponi H, 2000, HUM GENET, V107, P127, DOI 10.1007/s004390000343; Gustafson S, 2007, SEMIN ONCOL, V34, P428, DOI 10.1053/j.seminoncol.2007.07.009; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lehman JA, 2011, J BIOL CHEM, V286, P36631, DOI 10.1074/jbc.M110.217620; Leslie NR, 2005, BIOCHEM SOC T, V33, P1507, DOI 10.1042/BST0331507; Li AG, 2006, MOL CELL, V23, P575, DOI 10.1016/j.molcel.2006.06.028; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maier D, 1999, CANCER RES, V59, P5479; Mehenni H, 2005, HUM MOL GENET, V14, P2209, DOI 10.1093/hmg/ddi225; Meuillet EJ, 2004, ARCH BIOCHEM BIOPHYS, V429, P123, DOI 10.1016/j.abb.2004.04.020; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Raftopoulou M, 2004, SCIENCE, V303, P1179, DOI 10.1126/science.1092089; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sambrook J., 2001, MOL CLONING LAB MANU; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Tian T, 2010, CARCINOGENESIS, V31, P1211, DOI 10.1093/carcin/bgq085; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; Zhou MX, 2003, CANCER RES, V63, P6357	44	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28433	10.1371/journal.pone.0028433	http://dx.doi.org/10.1371/journal.pone.0028433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164291	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400092
J	Kelly, FD; Nurse, P				Kelly, Felice D.; Nurse, Paul			De Novo Growth Zone Formation from Fission Yeast Spheroplasts	PLOS ONE			English	Article							CELL-WALL FORMATION; SCHIZOSACCHAROMYCES-POMBE; SYMMETRY-BREAKING; CDC42P; ACTIN; MORPHOGENESIS; LOCALIZATION; POLARIZATION; MICROTUBULES; CYTOSKELETON	Eukaryotic cells often form polarized growth zones in response to internal or external cues. To understand the establishment of growth zones with specific dimensions we used fission yeast, which grows as a rod-shaped cell of near-constant width from growth zones located at the cell tips. Removing the cell wall creates a round spheroplast with a disorganized cytoskeleton and depolarized growth proteins. As spheroplasts recover, new growth zones form that resemble normal growing cell tips in shape and width, and polarized growth resumes. Regulators of the GTPase Cdc42, which control width in exponentially growing cells, also control spheroplast growth zone width. During recovery the Cdc42 scaffold Scd2 forms a polarized patch in the rounded spheroplast, demonstrating that a growth zone protein can organize independent of cell shape. Rga4, a Cdc42 GTPase activating protein (GAP) that is excluded from cell tips, is initially distributed throughout the spheroplast membrane, but is excluded from the growth zone after a stable patch of Scd2 forms. These results provide evidence that growth zones with normal width and protein localization can form de novo through sequential organization of cellular domains, and that the size of these growth zones is genetically controlled, independent of preexisting cell shape.	[Kelly, Felice D.] Rockefeller Univ, New York, NY 10021 USA; [Nurse, Paul] Francis Crick Inst, London, England	Rockefeller University; Francis Crick Institute	Kelly, FD (corresponding author), Stanford Sch Med, Stanford, CA USA.	felice.kelly@gmail.com			Breast Cancer Research Foundation; Anderson Center for Cancer Research; Rockefeller University	Breast Cancer Research Foundation; Anderson Center for Cancer Research; Rockefeller University	This study was supported by the Breast Cancer Research Foundation, the Anderson Center for Cancer Research, and the Rockefeller University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Castagnetti S, 2007, J CELL SCI, V120, P2205, DOI 10.1242/jcs.03464; Castagnetti S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000512; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298; Hayles J, 2001, NAT REV MOL CELL BIO, V2, P647, DOI 10.1038/35089520; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; KELLY FD, 2011, MOL BIOL CELL; KOBORI H, 1989, J CELL SCI, V94, P635; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Murray JM, 2001, J BIOL CHEM, V276, P3004, DOI 10.1074/jbc.M007389200; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; OSUMI M, 1989, J ELECTRON MICROSC, V38, P457; OSUMI M, 1992, J ELECTRON MICROSC, P392; Pelham RJ, 2001, NAT CELL BIOL, V3, P235, DOI 10.1038/35060020; Sawin KE, 1998, J CELL BIOL, V142, P457, DOI 10.1083/jcb.142.2.457; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; STYRKARSDOTTIR U, 1993, CURR GENET, V23, P184, DOI 10.1007/BF00352020; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Tatebe H, 2001, MICRON, V32, P67, DOI 10.1016/S0968-4328(00)00023-8; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Terenna CR, 2008, CURR BIOL, V18, P1748, DOI 10.1016/j.cub.2008.09.047; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944	31	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27977	10.1371/journal.pone.0027977	http://dx.doi.org/10.1371/journal.pone.0027977			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194800	Green Published, gold, Green Submitted			2022-12-27	WOS:000298370400008
J	Inada, H; Watanabe, M; Uchida, T; Ishibashi, H; Wake, H; Nemoto, T; Yanagawa, Y; Fukuda, A; Nabekura, J				Inada, Hiroyuki; Watanabe, Miho; Uchida, Taku; Ishibashi, Hitoshi; Wake, Hiroaki; Nemoto, Tomomi; Yanagawa, Yuchio; Fukuda, Atsuo; Nabekura, Junichi			GABA Regulates the Multidirectional Tangential Migration of GABAergic Interneurons in Living Neonatal Mice	PLOS ONE			English	Article							NEURONAL MIGRATION; CORTICAL INTERNEURONS; A RECEPTORS; CHLORIDE; CELL; COTRANSPORTERS; EXPRESSION; NEOCORTEX; PROMOTES; RELEASE	Cortical GABAergic interneurons originate from ganglionic eminences and tangentially migrate into the cortical plate at early developmental stages. To elucidate the characteristics of this migration of GABAergic interneurons in living animals, we established an experimental design specialized for in vivo time-lapse imaging of the neocortex of neonate mice with two-photon laser-scanning microscopy. In vesicular GABA/glycine transporter (VGAT)-Venus transgenic mice from birth (P0) through P3, we observed multidirectional tangential migration of genetically-defined GABAergic interneurons in the neocortical marginal zone. The properties of this migration, such as the motility rate (distance/hr), the direction moved, and the proportion of migrating neurons to stationary neurons, did not change through P0 to P3, although the density of GABAergic neurons at the marginal zone decreased with age. Thus, the characteristics of the tangential motility of individual GABAergic neurons remained constant in development. Pharmacological block of GABA(A) receptors and of the Na+-K+-Cl- cotransporters, and chelating intracellular Ca2+, all significantly reduced the motility rate in vivo. The motility rate and GABA content within the cortex of neonatal VGAT-Venus transgenic mice were significantly greater than those of GAD67-GFP knock-in mice, suggesting that extracellular GABA concentration could facilitate the multidirectional tangential migration. Indeed, diazepam applied to GAD67-GFP mice increased the motility rate substantially. In an in vitro neocortical slice preparation, we confirmed that GABA induced a NKCC sensitive depolarization of GABAergic interneurons in VGAT-Venus mice at P0-P3. Thus, activation of GABA(A)R by ambient GABA depolarizes GABAergic interneurons, leading to an acceleration of their multidirectional motility in vivo.	[Inada, Hiroyuki; Watanabe, Miho; Ishibashi, Hitoshi; Wake, Hiroaki; Nabekura, Junichi] Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan; [Inada, Hiroyuki; Nabekura, Junichi] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi, Japan; [Uchida, Taku; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan; [Nemoto, Tomomi] Hokkaido Univ, Res Inst Elect Sci, Lab Mol & Cellular Biophys, Sapporo, Hokkaido, Japan; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Hamamatsu University School of Medicine; Hokkaido University; Gunma University	Inada, H (corresponding author), Natl Inst Physiol Sci, Dept Dev Physiol, Okazaki, Aichi 444, Japan.	nabekura@nips.ac.jp	Nemoto, Tomomi/B-4412-2012; Fukuda, Atsuo/ABA-6843-2020	Nemoto, Tomomi/0000-0001-6102-1495; Fukuda, Atsuo/0000-0001-7112-4834; WAKE, Hiroaki/0000-0002-8543-4590	Spectrography and Bioimaging Facility; NIBB Core Research Facilities	Spectrography and Bioimaging Facility; NIBB Core Research Facilities	We are grateful to Dr. A. Miyawaki (Laboratory for Cell Function and Dynamics, Brain Science Institute, RIKEN) for providing pCS2-Venus and to Dr. A. Moorhouse (University of South Wales, Australia) for critical discussion and grammatical corrections. This work was supported by Spectrography and Bioimaging Facility, NIBB Core Research Facilities.	Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Ang ESBC, 2003, J NEUROSCI, V23, P5805; Behar TN, 1996, J NEUROSCI, V16, P1808; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Carlson VCC, 2011, CEREB CORTEX, V21, P1792, DOI 10.1093/cercor/bhq247; Chowdhury TG, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.010.2010; Cuzon VC, 2006, CEREB CORTEX, V16, P1377, DOI 10.1093/cercor/bhj084; DEDIEGO I, 1994, EUR J NEUROSCI, V6, P983, DOI 10.1111/j.1460-9568.1994.tb00593.x; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; GHOSH A, 1992, J NEUROSCI, V12, P39; Heck N, 2007, CEREB CORTEX, V17, P138, DOI 10.1093/cercor/bhj135; Hevner RF, 2004, NEUROSCIENCE, V124, P605, DOI 10.1016/j.neuroscience.2003.11.033; Kakazu Y, 2000, J NEUROPHYSIOL, V84, P281, DOI 10.1152/jn.2000.84.1.281; Kakazu Y, 1999, J NEUROSCI, V19, P2843; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Kumada T, 2004, P NATL ACAD SCI USA, V101, P8479, DOI 10.1073/pnas.0401000101; Li GN, 2008, J NEUROSCI, V28, P1085, DOI 10.1523/JNEUROSCI.4602-07.2008; Lopez-Bendito G, 2003, CEREB CORTEX, V13, P932, DOI 10.1093/cercor/13.9.932; Lopez-Bendito G, 2008, J NEUROSCI, V28, P1613, DOI 10.1523/JNEUROSCI.4651-07.2008; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Manent JB, 2005, J NEUROSCI, V25, P4755, DOI 10.1523/JNEUROSCI.0553-05.2005; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marty S, 1996, NEURON, V16, P565, DOI 10.1016/S0896-6273(00)80075-6; Metin C, 2006, EUR J NEUROSCI, V23, P894, DOI 10.1111/j.1460-9568.2006.04630.x; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Nadarajah B, 2002, NAT NEUROSCI, V5, P218, DOI 10.1038/nn813; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; PAXINOS G, ATLAS DEV MOUSE BRAI; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka D, 2003, DEVELOPMENT, V130, P5803, DOI 10.1242/dev.00825; Tanaka DH, 2006, DEVELOPMENT, V133, P2167, DOI 10.1242/dev.02382; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Wang GY, 2000, J NEUROSCI, V20, P5358, DOI 10.1523/JNEUROSCI.20-14-05358.2000; Wang Y, 2009, NEUROSCIENCE, V164, P1031, DOI 10.1016/j.neuroscience.2009.09.010; Whiting PJ, 2006, CURR OPIN PHARMACOL, V6, P24, DOI 10.1016/j.coph.2005.08.005; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Yokota Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000794	46	46	47	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27048	10.1371/journal.pone.0027048	http://dx.doi.org/10.1371/journal.pone.0027048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180776	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300003
J	Halachev, MR; Loman, NJ; Pallen, MJ				Halachev, Mihail R.; Loman, Nicholas J.; Pallen, Mark J.			Calculating Orthologs in Bacteria and Archaea: A Divide and Conquer Approach	PLOS ONE			English	Article							MICROBIAL PAN-GENOME; PROTEIN FAMILIES; PHYLOGENETIC TREES; EUKARYOTIC GENOMES; EVOLUTION; GENES; DATABASE; SYSTEM; RECONSTRUCTION; INPARALOGS	Among proteins, orthologs are defined as those that are derived by vertical descent from a single progenitor in the last common ancestor of their host organisms. Our goal is to compute a complete set of protein orthologs derived from all currently available complete bacterial and archaeal genomes. Traditional approaches typically rely on all-against-all BLAST searching which is prohibitively expensive in terms of hardware requirements or computational time (requiring an estimated 18 months or more on a typical server). Here, we present xBASE-Orth, a system for ongoing ortholog annotation, which applies a "divide and conquer" approach and adopts a pragmatic scheme that trades accuracy for speed. Starting at species level, xBASE-Orth carefully constructs and uses pan-genomes as proxies for the full collections of coding sequences at each level as it progressively climbs the taxonomic tree using the previously computed data. This leads to a significant decrease in the number of alignments that need to be performed, which translates into faster computation, making ortholog computation possible on a global scale. Using xBASE-Orth, we analyzed an NCBI collection of 1,288 bacterial and 94 archaeal complete genomes with more than 4 million coding sequences in 5 weeks and predicted more than 700 million ortholog pairs, clustered in 175,531 orthologous groups. We have also identified sets of highly conserved bacterial and archaeal orthologs and in so doing have highlighted anomalies in genome annotation and in the proposed composition of the minimal bacterial genome. In summary, our approach allows for scalable and efficient computation of the bacterial and archaeal ortholog annotations. In addition, due to its hierarchical nature, it is suitable for incorporating novel complete genomes and alternative genome annotations. The computed ortholog data and a continuously evolving set of applications based on it are integrated in the xBASE database, available at http://www.xbase.ac.uk/.	[Halachev, Mihail R.; Loman, Nicholas J.; Pallen, Mark J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of Birmingham	Halachev, MR (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	m.pallen@bham.ac.uk	Loman, Nicholas/Z-1573-2019	Pallen, Mark/0000-0003-1807-3657; Loman, Nicholas/0000-0002-9843-8988	Biotechnology and Biological Sciences Research Council [BBE0111791]; BBSRC [BB/E011179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E011179/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), grant number BBE0111791. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Charlebois RL, 2003, FEMS MICROBIOL LETT, V225, P213, DOI 10.1016/S0378-1097(03)00512-3; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; DeLuca TF, 2006, BIOINFORMATICS, V22, P2044, DOI 10.1093/bioinformatics/btl286; Deng XY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-500; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fischer W, 2010, NUCLEIC ACIDS RES, V38, P6089, DOI 10.1093/nar/gkq378; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Fu Zheng, 2008, Journal of Bioinformatics and Computational Biology, V6, P573, DOI 10.1142/S0219720008003540; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2010, GENOME BIOL EVOL, V2, P646, DOI 10.1093/gbe/evq048; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Makarova KS, 1999, GENOME RES, V9, P608; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Muzzi A, 2007, DRUG DISCOV TODAY, V12, P429, DOI 10.1016/j.drudis.2007.04.008; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Penel S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S3; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; Shi GQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-10; Siew N, 2003, STRUCTURE, V11, P7, DOI 10.1016/S0969-2126(02)00938-3; SIEW N, 2006, BMC EVOL BIOL, V6, P63, DOI DOI 10.1186/1471-2148-6-63; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Storm CEV, 2002, BIOINFORMATICS, V18, P92, DOI 10.1093/bioinformatics/18.1.92; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Thompson JD, 2001, J MOL BIOL, V314, P937, DOI 10.1006/jmbi.2001.5187; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Wilson GA, 2005, MICROBIOL-SGM, V151, P2499, DOI 10.1099/mic.0.28146-0; Zmasek CM, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-14	54	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28388	10.1371/journal.pone.0028388	http://dx.doi.org/10.1371/journal.pone.0028388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174796	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600013
J	Lee, B; Mann, P; Grover, V; Treuner-Lange, A; Kahnt, J; Higgs, PI				Lee, Bongsoo; Mann, Petra; Grover, Vidhi; Treuner-Lange, Anke; Kahnt, Joerg; Higgs, Penelope I.			The Myxococcus xanthus Spore Cuticula Protein C Is a Fragment of FibA, an Extracellular Metalloprotease Produced Exclusively in Aggregated Cells	PLOS ONE			English	Article							FRUITING-BODY DEVELOPMENT; SOCIAL GLIDING MOTILITY; ZINC METALLOPROTEASE; GENE-EXPRESSION; DIF GENES; DIFFERENTIATION; DOMAINS; CHEMOTAXIS; BACTERIUM; FIBRILS	Myxococcus xanthus is a soil bacterium with a complex life cycle involving distinct cell fates, including production of environmentally resistant spores to withstand periods of nutrient limitation. Spores are surrounded by an apparently self-assembling cuticula containing at least Proteins S and C; the gene encoding Protein C is unknown. During analyses of cell heterogeneity in M. xanthus, we observed that Protein C accumulated exclusively in cells found in aggregates. Using mass spectrometry analysis of Protein C either isolated from spore cuticula or immunoprecipitated from aggregated cells, we demonstrate that Protein C is actually a proteolytic fragment of the previously identified but functionally elusive zinc metalloprotease, FibA. Subpopulation specific FibA accumulation is not due to transcriptional regulation suggesting post-transcriptional regulation mechanisms mediate its heterogeneous accumulation patterns.	[Lee, Bongsoo; Mann, Petra; Grover, Vidhi; Kahnt, Joerg; Higgs, Penelope I.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Treuner-Lange, Anke] Univ Giessen, Inst Microbiol & Mol Biol, Giessen, Germany	Max Planck Society; Justus Liebig University Giessen	Lee, B (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	higgs@mpi-marburg.mpg.de	Higgs, Penelope/Y-8862-2019; Lee, BongSoo/AAP-3262-2020; Treuner-Lange, Anke U/AFQ-5368-2022	Higgs, Penelope/0000-0003-4726-3329; Treuner-Lange, Anke U/0000-0001-6435-5642	Max Planck Society; German Research Federation [DFG Tr429/4-1]	Max Planck Society(Max Planck Society); German Research Federation	This work was supported by the Max Planck Society (http://www.mpg.de/en) to PIH and the German Research Federation (http://www.dfg.de/en/index.jsp)(DFG Tr429/4-1) to AT-L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Goodger C, 2005, NUCLEIC ACIDS RES, V33, pW690, DOI 10.1093/nar/gki445; ARNOLD JW, 1988, J BACTERIOL, V170, P5771, DOI 10.1128/jb.170.12.5771-5777.1988; BEHMLANDER RM, 1994, J BACTERIOL, V176, P6304, DOI 10.1128/jb.176.20.6304-6311.1994; BEHMLANDER RM, 1991, J BACTERIOL, V173, P7810, DOI 10.1128/jb.173.24.7810-7820.1991; Bellenger K, 2002, J BACTERIOL, V184, P5654, DOI 10.1128/JB.184.20.5654-5660.2002; Black WP, 2004, J BACTERIOL, V186, P1001, DOI 10.1128/JB.186.4.1001-1008.2004; Bonner PJ, 2006, MOL MICROBIOL, V61, P1283, DOI 10.1111/j.1365-2958.2006.05298.x; Bonner PJ, 2005, MOL MICROBIOL, V57, P1499, DOI 10.1111/j.1365-2958.2005.04785.x; Bulyha I, 2009, MOL MICROBIOL, V74, P691, DOI 10.1111/j.1365-2958.2009.06891.x; Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x; Curtis PD, 2007, J BACTERIOL, V189, P7634, DOI 10.1128/JB.01007-07; Curtis PD, 2006, ENVIRON MICROBIOL, V8, P1935, DOI 10.1111/j.1462-2920.2006.01073.x; DOWNARD JS, 1984, J MOL BIOL, V175, P469, DOI 10.1016/0022-2836(84)90180-3; DWORKIN M, 1964, SCIENCE, V146, P243, DOI 10.1126/science.146.3641.243; Higgs PI, 2008, J BACTERIOL, V190, P4416, DOI 10.1128/JB.00265-08; INOUYE M, 1979, P NATL ACAD SCI USA, V76, P209, DOI 10.1073/pnas.76.1.209; Jing H, 2002, STRUCTURE, V10, P1453, DOI 10.1016/S0969-2126(02)00840-7; Julien B, 2000, P NATL ACAD SCI USA, V97, P9098, DOI 10.1073/pnas.97.16.9098; Kahnt J, 2010, J PROTEOME RES, V9, P5197, DOI 10.1021/pr1004983; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kearns DB, 2001, P NATL ACAD SCI USA, V98, P13990, DOI 10.1073/pnas.251484598; Kearns DB, 2001, TRENDS MICROBIOL, V9, P126, DOI 10.1016/S0966-842X(01)01948-5; Kearns DB, 1998, P NATL ACAD SCI USA, V95, P11957, DOI 10.1073/pnas.95.20.11957; Kearns DB, 2002, J BACTERIOL, V184, P1678, DOI 10.1128/JB.184.6.1678-1684.2002; KOMANO T, 1984, J BACTERIOL, V158, P1195, DOI 10.1128/JB.158.3.1195-1197.1984; KOTTEL RH, 1975, J BACTERIOL, V124, P550, DOI 10.1128/JB.124.1.550-557.1975; Lancero H, 2002, J BACTERIOL, V184, P1462, DOI 10.1128/JB.184.5.1462-1465.2002; Lee B, 2010, METHOD ENZYMOL, V471, P253, DOI 10.1016/S0076-6879(10)71014-4; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; LIU YN, 1990, MOL GEN GENET, V220, P433, DOI 10.1007/BF00391750; Magrini V, 1999, J BACTERIOL, V181, P4050, DOI 10.1128/JB.181.13.4050-4061.1999; Maniatis T., 1982, MOL CLONING; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; MCCLEARY WR, 1991, J BACTERIOL, V173, P2141, DOI 10.1128/jb.173.6.2141-2145.1991; Miyoshi S, 1997, J BACTERIOL, V179, P7606, DOI 10.1128/jb.179.23.7606-7609.1997; Muller FD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-264; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIMKETS LJ, 1986, J BACTERIOL, V166, P842, DOI 10.1128/jb.166.3.842-848.1986; Shimkets LJ, 1999, ANNU REV MICROBIOL, V53, P525, DOI 10.1146/annurev.micro.53.1.525; Simunovic V, 2003, J BACTERIOL, V185, P5066, DOI 10.1128/JB.185.17.5066-5075.2003; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsujibo H, 1996, BIOSCI BIOTECH BIOCH, V60, P1284, DOI 10.1271/bbb.60.1284; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; WISTOW G, 1985, NATURE, V315, P771, DOI 10.1038/315771a0; Wu SS, 1997, J BACTERIOL, V179, P7748, DOI 10.1128/jb.179.24.7748-7758.1997; Yan BQ, 2009, EXTREMOPHILES, V13, P725, DOI 10.1007/s00792-009-0263-1; Yang ZM, 2000, J BACTERIOL, V182, P5793, DOI 10.1128/JB.182.20.5793-5798.2000; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	53	8	8	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28968	10.1371/journal.pone.0028968	http://dx.doi.org/10.1371/journal.pone.0028968			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174937	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600053
J	O'Reilly, V; Zeng, SJG; Bricard, G; Atzberger, A; Hogan, AE; Jackson, J; Feighery, C; Porcelli, SA; Doherty, DG				O'Reilly, Vincent; Zeng, Shijuan G.; Bricard, Gabriel; Atzberger, Ann; Hogan, Andrew E.; Jackson, John; Feighery, Conleth; Porcelli, Steven A.; Doherty, Derek G.			Distinct and Overlapping Effector Functions of Expanded Human CD4(+), CD8 alpha(+) and CD4(-)CD8 alpha(-) Invariant Natural Killer T Cells	PLOS ONE			English	Article							LIGAND ALPHA-GALACTOSYLCERAMIDE; MATURE DENDRITIC CELLS; V(ALPHA)14 NKT CELLS; B-CELLS; PHASE-I; RECEPTOR EXPRESSION; CANCER-PATIENTS; CUTTING EDGE; LUNG-CANCER; T(H)2 BIAS	CD1d-restricted invariant natural killer T (iNKT) cells have diverse immune stimulatory/regulatory activities through their ability to release cytokines and to kill or transactivate other cells. Activation of iNKT cells can protect against multiple diseases in mice but clinical trials in humans have had limited impact. Clinical studies to date have targeted polyclonal mixtures of iNKT cells and we proposed that their subset compositions will influence therapeutic outcomes. We sorted and expanded iNKT cells from healthy donors and compared the phenotypes, cytotoxic activities and cytokine profiles of the CD4(+), CD8 alpha(+) and CD4(+)CD8 alpha(-) double-negative (DN) subsets. CD4(+) iNKT cells expanded more readily than CD8 alpha(+) and DN iNKT cells upon mitogen stimulation. CD8 alpha(+) and DN iNKT cells most frequently expressed CD56, CD161 and NKG2D and most potently killed CD1d(+) cell lines and primary leukemia cells. All iNKT subsets released Th1 (IFN-gamma and TNF-alpha) and Th2 (IL-4, IL-5 and IL-13) cytokines. Relative amounts followed a CD8 alpha>DN>CD4 pattern for Th1 and CD4>DN>CD8 alpha for Th2. All iNKT subsets could simultaneously produce IFN-gamma and IL-4, but single-positivity for IFN-gamma or IL-4 was strikingly rare in CD4(+) and CD8 alpha(+) fractions, respectively. Only CD4(+) iNKT cells produced IL-9 and IL-10; DN cells released IL-17; and none produced IL-22. All iNKT subsets upregulated CD40L upon glycolipid stimulation and induced IL-10 and IL-12 secretion by dendritic cells. Thus, subset composition of iNKT cells is a major determinant of function. Use of enriched CD8 alpha(+), DN or CD4(+) iNKT cells may optimally harness the immunoregulatory properties of iNKT cells for treatment of disease.	[O'Reilly, Vincent; Zeng, Shijuan G.; Atzberger, Ann; Jackson, John; Feighery, Conleth; Doherty, Derek G.] St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland; [O'Reilly, Vincent; Zeng, Shijuan G.; Atzberger, Ann; Jackson, John; Feighery, Conleth; Doherty, Derek G.] St James Hosp, Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [Bricard, Gabriel; Porcelli, Steven A.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Hogan, Andrew E.] St Vincents Univ Hosp, Obes Immunol Grp, Educ & Res Ctr, Dublin 4, Ireland; [Hogan, Andrew E.] Univ Coll Dublin, Dublin 2, Ireland	Trinity College Dublin; Trinity College Dublin; Yeshiva University; Albert Einstein College of Medicine; University College Dublin; Saint Vincent's University Hospital; University College Dublin	O'Reilly, V (corresponding author), St James Hosp, Trinity Coll Dublin, Dept Immunol, Dublin, Ireland.	derek.doherty@tcd.ie	Hogan, Andrew/K-1521-2013	Hogan, Andrew/0000-0001-5875-230X; Doherty, Derek/0000-0002-4394-658X	Irish Health Research Board [PHD/2004/2]; Science Foundation Ireland [05/RFP/BIC0015]; National Institute of Health [RO1 AI45889]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045889] Funding Source: NIH RePORTER	Irish Health Research Board; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Irish Health Research Board (PHD/2004/2), Science Foundation Ireland (05/RFP/BIC0015) and the National Institute of Health (RO1 AI45889). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2006, NEW ENGL J MED, V354, P1117, DOI 10.1056/NEJMoa053614; Araki M, 2003, INT IMMUNOL, V15, P279, DOI 10.1093/intimm/dxg029; Behar SM, 2007, CURR TOP MICROBIOL, V314, P215; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Bricard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014374; Bricard G, 2009, J IMMUNOL, V182, P5140, DOI 10.4049/jimmunol.0711086; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Chang DH, 2005, J EXP MED, V201, P1503, DOI 10.1084/jem.20042592; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fujii SI, 2007, IMMUNOL REV, V220, P183, DOI 10.1111/j.1600-065X.2007.00561.x; Galli G, 2003, J EXP MED, V197, P1051, DOI 10.1084/jem.20021616; Giaccone G, 2002, CLIN CANCER RES, V8, P3702; Goto M, 2009, CELL IMMUNOL, V254, P81, DOI 10.1016/j.cellimm.2008.10.002; Grubor-Bauk B, 2003, J IMMUNOL, V170, P1430, DOI 10.4049/jimmunol.170.3.1430; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hammond KJL, 1998, J EXP MED, V187, P1047, DOI 10.1084/jem.187.7.1047; Ho LP, 2004, J IMMUNOL, V172, P7350, DOI 10.4049/jimmunol.172.12.7350; Hogan AE, 2011, CLIN IMMUNOL, V140, P196, DOI 10.1016/j.clim.2011.03.016; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Im JS, 2008, CLIN IMMUNOL, V127, P214, DOI 10.1016/j.clim.2007.12.005; Ishikawa A, 2005, CLIN CANCER RES, V11, P1910, DOI 10.1158/1078-0432.CCR-04-1453; Jiang X, 2007, AM J TRANSPLANT, V7, P1482, DOI 10.1111/j.1600-6143.2007.01827.x; Jones TG, 2009, J IMMUNOL, V183, P5251, DOI 10.4049/jimmunol.0901471; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kenna T, 2003, J IMMUNOL, V171, P1775, DOI 10.4049/jimmunol.171.4.1775; Kim CH, 2002, TRENDS IMMUNOL, V23, P516, DOI 10.1016/S1471-4906(02)02323-2; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Lee PT, 2002, J CLIN INVEST, V110, P793, DOI 10.1172/JCI200215832; Lin H, 2006, EXP HEMATOL, V34, P289, DOI 10.1016/j.exphem.2005.12.008; Lin H, 2004, EUR J IMMUNOL, V34, P2664, DOI 10.1002/eji.200324834; Lin H, 2006, J LEUKOCYTE BIOL, V80, P164, DOI 10.1189/jlb.0705421; Liu TY, 2008, EUR J IMMUNOL, V38, P1012, DOI 10.1002/eji.200737838; Metelitsa LS, 2001, J IMMUNOL, V167, P3114, DOI 10.4049/jimmunol.167.6.3114; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Monteiro M, 2010, J IMMUNOL, V185, P2157, DOI 10.4049/jimmunol.1000359; Montoya CJ, 2007, IMMUNOLOGY, V122, P1, DOI 10.1111/j.1365-2567.2007.02647.x; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Moreira-Teixeira L, 2011, J IMMUNOL, V186, P5758, DOI 10.4049/jimmunol.1003043; Motohashi S, 2006, CLIN CANCER RES, V12, P6079, DOI 10.1158/1078-0432.CCR-06-0114; Noelle RJ, 2010, NAT REV IMMUNOL, V10, P683, DOI 10.1038/nri2848; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Osada T, 2005, INT IMMUNOL, V17, P1143, DOI 10.1093/intimm/dxh292; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Sakuishi K, 2007, J IMMUNOL, V179, P3452, DOI 10.4049/jimmunol.179.6.3452; Schmieg J, 2003, J EXP MED, V198, P1631, DOI 10.1084/jem.20031192; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; Takahashi T, 2002, J IMMUNOL, V168, P3140, DOI 10.4049/jimmunol.168.7.3140; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	61	74	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28648	10.1371/journal.pone.0028648	http://dx.doi.org/10.1371/journal.pone.0028648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174854	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000298366600029
J	Turner, L; Wang, CW; Lavstsen, T; Mwakalinga, SB; Sauerwein, RW; Hermsen, CC; Theander, TG				Turner, Louise; Wang, Christian W.; Lavstsen, Thomas; Mwakalinga, Steven B.; Sauerwein, Robert W.; Hermsen, Cornelus C.; Theander, Thor G.			Antibodies against PfEMP1, RIFIN, MSP3 and GLURP Are Acquired during Controlled Plasmodium falciparum Malaria Infections in Naive Volunteers	PLOS ONE			English	Article							ERYTHROCYTE-MEMBRANE PROTEIN-1; GLUTAMATE-RICH PROTEIN; VAR GENES; SURFACE-ANTIGENS; SPOROZOITE INOCULATION; TANZANIAN CHILDREN; CROSS-REACTIVITY; IMMUNOGLOBULIN-G; EXPRESSION; PROTECTION	Antibodies to polymorphic antigens expressed during the parasites erythrocytic stages are important mediators of protective immunity against P. falciparum malaria. Therefore, polymorphic blood stage antigens like MSP3, EBA-175 and GLURP and variant surface antigens PfEMP1 and RIFIN are considered vaccine candidates. However, to what extent these antibodies to blood stage antigens are acquired during naive individuals' first infections has not been studied in depth. Using plasma samples collected from controlled experimental P. falciparum infections we show that antibodies against variant surface antigens, PfEMP1 and RIFIN as well as MSP3 and GLURP, are acquired during a single short low density P. falciparum infection in non-immune individuals including strain transcendent PfEMP1 immune responses. These data indicate that the immunogenicity of the variant surface antigens is similar to the less diverse merozoite antigens. The acquisition of a broad and strain transcendent repertoire of PfEMP1 antibodies may reflect a parasite strategy of expressing most or all PfEMP1 variants at liver release optimizing the likelihood of survival and establishment of chronic infections in the new host.	[Turner, Louise; Wang, Christian W.; Lavstsen, Thomas; Mwakalinga, Steven B.; Theander, Thor G.] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Turner, Louise; Wang, Christian W.; Lavstsen, Thomas; Mwakalinga, Steven B.; Theander, Thor G.] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Sauerwein, Robert W.; Hermsen, Cornelus C.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands	University of Copenhagen; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen	Turner, L (corresponding author), Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	cwang@sund.ku.dk	Hermsen, C.C./L-4368-2015; Sauerwein, Robert/C-8519-2013; Theander, Thor/F-6714-2015	Theander, Thor/0000-0002-3509-7514; Wang, Christian/0000-0003-3140-6989; Lavstsen, Thomas/0000-0002-3044-4249; Turner, Louise/0000-0003-4494-2289	Copenhagen University; The Danish Medical Research Council [271-08-0540]; Global Health program	Copenhagen University; The Danish Medical Research Council(Danish Medical Research Council); Global Health program	LT was funded by Copenhagen University Star program. CWW was supported by The Danish Medical Research Council (grant reference number 271-08-0540). TL was supported by the Grand Challenges in Global Health program and The Danish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; Cham GKK, 2010, INFECT IMMUN, V78, P4653, DOI 10.1128/IAI.00593-10; Cham GKK, 2009, J IMMUNOL, V183, P3356, DOI 10.4049/jimmunol.0901331; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; DAY KP, 1991, IMMUNOPARASITOL TOD, pA68, DOI 10.1016/S0167-5699(05)80020-9; Dzikowski R, 2006, PLOS PATHOG, V2, P184, DOI 10.1371/journal.ppat.0020022; Eisen DP, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-86; Elliott SR, 2007, AM J TROP MED HYG, V76, P860, DOI 10.4269/ajtmh.2007.76.860; Falk N, 2009, J INFECT DIS, V200, P347, DOI 10.1086/600071; Felger I, 2003, PARASITE IMMUNOL, V25, P531, DOI 10.1111/j.0141-9838.2004.00664.x; Giha HA, 2000, IMMUNOL LETT, V71, P117, DOI 10.1016/S0165-2478(99)00173-X; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Heegaard ED, 2002, J MED VIROL, V66, P246, DOI 10.1002/jmv.2137; Hermsen CC, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.2.0700196; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Jakobsen PH, 1998, INFECT IMMUN, V66, P4203; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; Lavstsen T, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-27; Lusingu JPA, 2006, INFECT IMMUN, V74, P2867, DOI 10.1128/IAI.74.5.2867-2875.2006; Magistrado PA, 2007, INFECT IMMUN, V75, P2415, DOI 10.1128/IAI.00951-06; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; McCall MBB, 2007, J IMMUNOL, V179, P162, DOI 10.4049/jimmunol.179.1.162; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nielsen MA, 2009, INFECT IMMUN, V77, P2482, DOI 10.1128/IAI.00159-09; ONG CSL, 1990, PARASITE IMMUNOL, V12, P447, DOI 10.1111/j.1365-3024.1990.tb00980.x; Rask TS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000933; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Rottmann M, 2006, INFECT IMMUN, V74, P3904, DOI 10.1128/IAI.02073-05; Salanti A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-11; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Theisen M, 2004, VACCINE, V22, P1188, DOI 10.1016/j.vaccine.2003.09.017; Theisen M, 2001, INFECT IMMUN, V69, P5223, DOI 10.1128/IAI.69.9.5223-5229.2001; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Verhage DF, 2005, NETH J MED, V63, P52; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; Wang CW, 2009, PARASITOL INT, V58, P478, DOI 10.1016/j.parint.2009.07.004; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014	53	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29025	10.1371/journal.pone.0029025	http://dx.doi.org/10.1371/journal.pone.0029025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174947	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600058
J	Wu, PC; Zhao, R; Ye, YF; Wu, JQ				Wu, Pengcheng; Zhao, Ran; Ye, Yanfang; Wu, Jian-Qiu			Roles of the DYRK Kinase Pom2 in Cytokinesis, Mitochondrial Morphology, and Sporulation in Fission Yeast	PLOS ONE			English	Article							FORESPORE MEMBRANE FORMATION; DYNAMIN-RELATED GTPASE; SPINDLE POLE BODIES; PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CONTRACTILE RING; CELL-CYCLE; DOWN-SYNDROME; ASCOSPORE FORMATION	Pom2 is predicted to be a dual-specificity tyrosine-phosphorylation regulated kinase (DYRK) related to Pom1 in Schizosaccharomyces pombe. DYRKs share a kinase domain capable of catalyzing autophosphorylation on tyrosine and exogenous phosphorylation on serine/threonine residues. Here we show that Pom2 is functionally different from the well-characterized Pom1, although they share 55% identity in the kinase domain and the Pom2 kinase domain functionally complements that of Pom1. Pom2 localizes to mitochondria throughout the cell cycle and to the contractile ring during late stages of cytokinesis. Overexpression but not deletion of pom2 results in severe defects in cytokinesis, indicating that Pom2 might share an overlapping function with other proteins in regulating cytokinesis. Gain and loss of function analyses reveal that Pom2 is required for maintaining mitochondrial morphology independently of microtubules. Intriguingly, most meiotic pom2 Delta cells form aberrant asci with meiotic and/or forespore membrane formation defects. Taken together, Pom2 is a novel DYRK kinase involved in regulating cytokinesis, mitochondrial morphology, meiosis, and sporulation in fission yeast.	[Wu, Pengcheng; Zhao, Ran; Ye, Yanfang; Wu, Jian-Qiu] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Ye, Yanfang; Wu, Jian-Qiu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wu, PC (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	wu.620@osu.edu	Wu, Jian-qiu/G-6835-2012		National Institutes of Health (NIH) [R01GM086546]; National BioResource Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086546] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National BioResource Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by the National Institutes of Health (NIH) grant R01GM086546 to J-QW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jurg Bahler, John Pringle, Takashi Toda, and the Yeast Genetic Resource Center Japan (supported by the National BioResource Project) for strains; Valerie Coffman for critical reading of the manuscript; and members of the Wu laboratory for valuable discussion. We are extremely grateful to John Pringle's generous support when this work was initiated in his laboratory.	Almonacid M, 2011, CURR BIOL, V21, P473, DOI 10.1016/j.cub.2011.02.003; Almonacid M, 2009, CURR BIOL, V19, P961, DOI 10.1016/j.cub.2009.04.024; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Baryshnikova A, 2010, METHOD ENZYMOL, V470, P145, DOI 10.1016/S0076-6879(10)70007-0; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; BECKER W, 1998, PROGR NUCL ACID RES, P1; Benard G, 2009, SEMIN CELL DEV BIOL, V20, P365, DOI 10.1016/j.semcdb.2008.12.012; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; BRESCH C, 1968, MOL GEN GENET, V102, P301, DOI 10.1007/BF00433721; Campbell LE, 2002, FEBS LETT, V510, P31, DOI 10.1016/S0014-5793(01)03221-5; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336; GARRETT S, 1991, MOL CELL BIOL, V11, P4045, DOI 10.1128/MCB.11.8.4045; Gorsich SW, 2004, MOL BIOL CELL, V15, P4369, DOI 10.1091/mbc.E03-12-0875; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hachet O, 2011, CELL, V145, P1116, DOI 10.1016/j.cell.2011.05.014; Hachet O, 2008, GENE DEV, V22, P3205, DOI 10.1101/gad.1697208; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; HIRATA A, 1994, YEAST, V10, P173, DOI 10.1002/yea.320100205; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Huang YY, 2008, J CELL BIOL, V183, P979, DOI 10.1083/jcb.200806151; Ikemoto S, 2000, J CELL SCI, V113, P545; Jambhekar A, 2008, CURR BIOL, V18, P969, DOI 10.1016/j.cub.2008.05.047; Jourdain I, 2009, CELL MOTIL CYTOSKEL, V66, P509, DOI 10.1002/cm.20351; Kentrup H, 1996, J BIOL CHEM, V271, P3488; KISHIDA M, 1986, CURR GENET, V10, P443, DOI 10.1007/BF00419871; Krapp A, 2006, J CELL SCI, V119, P2882, DOI 10.1242/jcs.03025; Krapp A, 2010, J CELL SCI, V123, P3284, DOI 10.1242/jcs.069112; Laporte D, 2011, J CELL BIOL, V192, P1005, DOI 10.1083/jcb.201008171; Laporte D, 2010, SEMIN CELL DEV BIOL, V21, P892, DOI 10.1016/j.semcdb.2010.08.004; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Leupold U., 1970, METHODS CELL PHYSL, V4, P169; Li WZ, 2010, MOL BIOL CELL, V21, P4349, DOI 10.1091/mbc.E10-01-0079; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; May-Panloup P, 2005, HUM REPROD, V20, P593, DOI 10.1093/humrep/deh667; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; MUNDY AJ, 1995, HUM REPROD, V10, P116, DOI 10.1093/humrep/10.1.116; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakamura-Kubo M, 2003, MOL BIOL CELL, V14, P1109, DOI 10.1091/mbc.E02-08-0504; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nakase Y, 2008, MOL BIOL CELL, V19, P2476, DOI 10.1091/mbc.E08-02-0118; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Ohtaka A, 2008, J CELL SCI, V121, P1547, DOI 10.1242/jcs.022830; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Onishi M, 2010, MOL CELL BIOL, V30, P2057, DOI 10.1128/MCB.01529-09; Padmanabhan A, 2011, CURR BIOL, V21, P467, DOI 10.1016/j.cub.2011.01.059; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Pellettieri J, 2003, DEV CELL, V5, P451, DOI 10.1016/S1534-5807(03)00231-4; Perez-Hidalgo L, 2008, J CELL SCI, V121, P1383, DOI 10.1242/jcs.023812; Piasecka M, 2003, FOLIA HISTOCHEM CYTO, V41, P125; Piasecka Malgorzata, 2003, Folia Morphol (Warsz), V62, P479; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Raich WB, 2003, GENETICS, V163, P571; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; Sato M, 2009, METHODS MOL BIOL, V545, P185, DOI 10.1007/978-1-60327-993-2_11; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shimoda C, 2004, J CELL SCI, V117, P389, DOI 10.1242/jcs.00980; SHIMODA C, 1985, MOL GEN GENET, V200, P252, DOI 10.1007/BF00425432; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Souza GM, 1998, DEVELOPMENT, V125, P2291; Souza GM, 1999, DEVELOPMENT, V126, P3263; Taminato A, 2002, MOL BIOL CELL, V13, P2266, DOI 10.1091/mbc.01-11-0555; TANAKA K, 1982, J CELL SCI, V56, P263; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; van Es S, 2001, J BIOL CHEM, V276, P30761, DOI 10.1074/jbc.M103365200; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Vilela M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001036; Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2001, MOL BIOL CELL, V12, P1061, DOI 10.1091/mbc.12.4.1061; Yaffe MP, 2003, P NATL ACAD SCI USA, V100, P11424, DOI 10.1073/pnas.1534703100; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; Yan HY, 2008, MOL BIOL CELL, V19, P3676, DOI 10.1091/mbc.E07-10-1060; Ye YF, 2007, MOL BIOL CELL, V18, P3568, DOI 10.1091/mbc.e07-02-0112; Yoshida K, 2008, BIOCHEM PHARMACOL, V76, P1389, DOI 10.1016/j.bcp.2008.05.021	92	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28000	10.1371/journal.pone.0028000	http://dx.doi.org/10.1371/journal.pone.0028000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174761	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600006
J	Yanagisawa, S; Kondo, N; Miki, A; Matsumiya, W; Kusuhara, S; Tsukahara, Y; Honda, S; Negi, A				Yanagisawa, Suiho; Kondo, Naoshi; Miki, Akiko; Matsumiya, Wataru; Kusuhara, Sentaro; Tsukahara, Yasutomo; Honda, Shigeru; Negi, Akira			A Common Complement C3 Variant Is Associated with Protection against Wet Age-Related Macular Degeneration in a Japanese Population	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; FACTOR-H POLYMORPHISM; GENE POLYMORPHISMS; FACTOR-I; R102G POLYMORPHISM; CHINESE POPULATION; HUMAN GENOME; FACTOR-B; RISK; COMPONENT	Background: Genetic variants in the complement component 3 gene (C3) have been shown to be associated with age-related macular degeneration (AMD) in Caucasian populations of European descent. In particular, a nonsynonymous coding variant, rs2230199 (R102G), is presumed to be the most likely causal variant in the C3 locus based on strong statistical evidence for disease association and mechanistic functional evidence. However, the risk allele is absent or rare (<1%) in Japanese and Chinese populations, and the association of R102G with AMD has not been reported in Asian populations. Genetic heterogeneity of disease-associated variants among different ethnicities is common in complex diseases. Here, we sought to examine whether other common variants in C3 are associated with wet AMD, a common advanced-stage manifestation of AMD, in a Japanese population. Methodology/Principal Findings: We genotyped 13 tag single nucleotide polymorphisms (SNPs) that capture the majority of common variations in the C3 locus and tested for associations between these SNPs and wet AMD in a Japanese population comprising 420 case subjects and 197 controls. A noncoding variant in C3 (rs2241394) exhibited statistically significant evidence of association (allelic P = 8.32x10(-4); odds ratio = 0.48 [95% CI = 0.31-0.74] for the rs2241394 C allele). Multilocus logistic regression analysis confirmed that the effect of rs2241394 was independent of the previously described loci at ARMS2 and CFH, and that the model including variants in ARMS2 and CFH plus C3 rs2241394 provided a better fit than the model without rs2241394. We found no evidence of epistasis between variants in C3 and CFH, despite the fact that they are involved in the same biological pathway. Conclusions: Our study provides evidence that C3 is a common AMD-associated locus that transcends racial boundaries and provides an impetus for more detailed genetic characterization of the C3 locus in Asian populations.	[Yanagisawa, Suiho; Kondo, Naoshi; Miki, Akiko; Matsumiya, Wataru; Kusuhara, Sentaro; Tsukahara, Yasutomo; Honda, Shigeru; Negi, Akira] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan	Kobe University	Yanagisawa, S (corresponding author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan.	nskondo@gmail.com	Honda, Shigeru/W-4761-2019	Kusuhara, Sentaro/0000-0002-6458-539X; Kondo, Naoshi/0000-0001-6025-3876	Ministry of Education, Science, and Culture, Tokyo, Japan [23592567]	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in Aid for (C) 23592567 from the Ministry of Education, Science, and Culture, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; ARAKAWA S, 2011, NAT GENET IN PRESS; ARVILOMMI H, 1974, NATURE, V251, P740, DOI 10.1038/251740a0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ennis S, 2010, EUR J HUM GENET, V18, P15, DOI 10.1038/ejhg.2009.113; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Goto Asako, 2009, J Ocul Biol Dis Infor, V2, P164; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kim NR, 2008, INVEST OPHTH VIS SCI, V49, P2071, DOI 10.1167/iovs.07-1195; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kondo N, 2011, OPHTHALMOLOGY, V118, P339, DOI 10.1016/j.ophtha.2010.06.040; Kondo N, 2010, EUR J HUM GENET, V18, P634, DOI 10.1038/ejhg.2009.243; Liu XQ, 2010, RETINA-J RET VIT DIS, V30, P1177, DOI 10.1097/IAE.0b013e3181cea676; Liu Y, 2007, GRAEF ARCH CLIN EXP, V245, P1441, DOI 10.1007/s00417-007-0575-8; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; Mori K, 2007, INVEST OPHTH VIS SCI, V48, P5315, DOI 10.1167/iovs.07-0426; Ng TK, 2008, INVEST OPHTH VIS SCI, V49, P3312, DOI 10.1167/iovs.07-1517; Pei XT, 2009, CURR EYE RES, V34, P615, DOI 10.1080/02713680903003484; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds R, 2009, INVEST OPHTH VIS SCI, V50, P5818, DOI 10.1167/iovs.09-3928; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tam POS, 2008, INVEST OPHTH VIS SCI, V49, P2357, DOI 10.1167/iovs.07-1520; Thakkinstian A, 2011, AM J EPIDEMIOL, V173, P1365, DOI 10.1093/aje/kwr025; WELCH TR, 1990, J PEDIATR-US, V116, pS92, DOI 10.1016/S0022-3476(05)82709-X; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zerbib J, 2010, MOL VIS, V16, P1324	53	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28847	10.1371/journal.pone.0028847	http://dx.doi.org/10.1371/journal.pone.0028847			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174912	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600043
J	Riviere, G; Fellous, A; Franco, A; Bernay, B; Favrel, P				Riviere, Guillaume; Fellous, Alexandre; Franco, Alban; Bernay, Benoit; Favrel, Pascal			A Crucial Role in Fertility for the Oyster Angiotensin-Converting Enzyme Orthologue CgACE	PLOS ONE			English	Article							2 ACTIVE-SITES; CRASSOSTREA-GIGAS; CRYSTAL-STRUCTURE; DROSOPHILA-MELANOGASTER; RECEPTOR ORTHOLOGUE; MOLECULAR-CLONING; N-DOMAIN; IN-VITRO; EXPRESSION; GENE	Angiotensin-converting enzyme (ACE) is a highly conserved metallopeptidase. In mammals, the somatic isoform governs blood pressure whereas the germinal isoform (tACE) is required for fertility. In Ecdysozoans, ACE-like enzymes are implicated in reproduction. Despite ACE orthologues being present from bacteria to humans, their function(s) remain(s) unknown in distant organisms such as Lophotrochozoans. In silico analysis of an oyster (Crassostrea gigas) EST library suggested the presence of an ACE orthologue in molluscs. Primer walking and 59-RACE revealed that the 1.9 kb cDNA encodes CgACE, a 632 amino acid protein displaying a conserved single active site and a putative C-terminal transmembrane anchor, thus resembling human tACE, as supported by molecular modelling. FRET activity assays and Maldi-TOF spectrometry indicated that CgACE is a functional dipeptidyl-carboxypeptidase which is active on Angiotensin I and sensitive to ACE inhibitors and chloride ion concentration. Immunocytochemistry revealed that, as its human counterpart, recombinant CgACE is synthesised as a transmembrane enzyme. RT-qPCR, in-situ hybridization and immunohistochemistry shed light on a tissue, and development stage, specific expression pattern for CgACE, which is increased in the gonad during spermatogenesis. The use of ACE inhibitors in vivo indicates that the dipeptidase activity of CgACE is crucial for the oyster fertilization. Our study demonstrates that a transmembrane active ACE is present in the oyster Crassostrea gigas, and for the first time ascribes a functional role for ACE in Lophotrochozoans. Its biological function in reproduction is conserved from molluscs to humans, a finding of particular evolutionary interest especially since oysters represent the most important aquaculture resource worldwide.	[Riviere, Guillaume; Fellous, Alexandre; Franco, Alban; Favrel, Pascal] Univ Caen Basse Normandie, IFREMER, UMR Physiol & Ecophysiol Mollusques Marins M100, Caen, France; [Bernay, Benoit] IFR 146 ICORE, Caen, France	Ifremer; Universite de Caen Normandie	Riviere, G (corresponding author), Univ Caen Basse Normandie, IFREMER, UMR Physiol & Ecophysiol Mollusques Marins M100, Caen, France.	guillaume.riviere@unicaen.fr		Favrel, Pascal/0000-0002-2504-9957	French National Research Agency [ANR -08-GENM-041 "Gametogenes"]; European 7th Framework Program [245119 "REPROSEED"]; Regional Council of Basse-Normandie (France)	French National Research Agency(French National Research Agency (ANR)); European 7th Framework Program; Regional Council of Basse-Normandie (France)(Region Normandie)	This work was supported by grants from the French National Research Agency (ANR -08-GENM-041 "Gametogenes"), the European 7th Framework Program (FP7 ref 245119 "REPROSEED") and the Regional Council of Basse-Normandie (France) (fifth research regional program and a doctoral grant to AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham RJ, 2006, FEBS J, V273, P362, DOI 10.1111/j.1742-4658.2005.05069.x; BROOKS DR, 2003, J BIOL CHEM; Carmona AK, 2006, NAT PROTOC, V1, P1971, DOI 10.1038/nprot.2006.306; Coates D, 2000, BIOCHEMISTRY-US, V39, P8963, DOI 10.1021/bi000593q; CORNEL MJ, 1995, J BIOL CHEM, V270, P13613, DOI 10.1074/jbc.270.23.13613; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; CORVOL P, 2004, HDB PROTEOLYTIC ENZY, P332; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dive V, 1999, P NATL ACAD SCI USA, V96, P4330, DOI 10.1073/pnas.96.8.4330; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Ekbote U, 1999, FEBS LETT, V455, P219, DOI 10.1016/S0014-5793(99)00870-4; ERICKSON RP, 1990, TRENDS GENET, V6, P264, DOI 10.1016/0168-9525(90)90209-O; Eyries M, 2001, J BIOL CHEM, V276, P5525, DOI 10.1074/jbc.M007706200; Fabioux C, 2004, BIOCHEM BIOPH RES CO, V315, P897, DOI 10.1016/j.bbrc.2004.01.145; FELSENSTEIN, 1989, CLADISTICS, V5, P164; Fleury E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-341; Franco A, 2010, CELL TISSUE RES, V340, P201, DOI 10.1007/s00441-009-0923-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Houard X, 1998, EUR J BIOCHEM, V257, P599, DOI 10.1046/j.1432-1327.1998.2570599.x; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Hurst D, 2003, DEV BIOL, V254, P238, DOI 10.1016/S0012-1606(02)00082-9; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Kawano N, 2010, BIOL REPROD, V83, P359, DOI 10.1095/biolreprod.109.083089; KIERSZENBAUM AL, 1978, FED PROC, V37, P2512; Kim HM, 2003, FEBS LETT, V538, P65, DOI 10.1016/S0014-5793(03)00128-5; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Le Quere H, 2009, GENE, V436, P101, DOI 10.1016/j.gene.2009.01.010; LOBBAN M, 1994, BIOCHEM J, V304, P399, DOI 10.1042/bj3040399; Natesh R, 2004, BIOCHEMISTRY-US, V43, P8718, DOI 10.1021/bi049480n; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; OPPONG SY, 1993, BIOCHEM J, V292, P597, DOI 10.1042/bj2920597; Parkin ET, 2002, BIOCHEMISTRY-US, V41, P4972, DOI 10.1021/bi015936e; Parvathy S, 1997, BIOCHEM J, V327, P37, DOI 10.1042/bj3270037; Quan GX, 2001, INSECT BIOCHEM MOLEC, V31, P97, DOI 10.1016/S0965-1748(00)00112-0; Riviere G, 2005, HYPERTENSION, V46, P1169, DOI 10.1161/01.HYP.0000185148.27901.fe; Riviere G, 2004, BIOCHEM J, V382, P565, DOI 10.1042/BJ20040522; Riviere G, 2007, GENE, V399, P81, DOI 10.1016/j.gene.2007.05.010; Rodet F, 2005, BBA-GENE STRUCT EXPR, V1730, P187, DOI 10.1016/j.bbaexp.2005.05.012; Schwager SL, 2006, NAT PROTOC, V1, P1961, DOI 10.1038/nprot.2006.305; Simunic J, 2009, FEBS J, V276, P4727, DOI 10.1111/j.1742-4658.2009.07169.x; TATEI K, 1995, MECH DEVELOP, V51, P157, DOI 10.1016/0925-4773(95)00349-5; Taylor CAM, 1996, GENE, V181, P191, DOI 10.1016/S0378-1119(96)00503-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Turner AJ, 2002, TRENDS PHARMACOL SCI, V23, P177, DOI 10.1016/S0165-6147(00)01994-5; Wijffels G, 1996, EUR J BIOCHEM, V237, P414, DOI 10.1111/j.1432-1033.1996.0414k.x; Zhu W, 2001, INSECT BIOCHEM MOLEC, V31, P87, DOI 10.1016/S0965-1748(00)00111-9	51	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27833	10.1371/journal.pone.0027833	http://dx.doi.org/10.1371/journal.pone.0027833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174750	gold, Green Submitted, Green Published			2022-12-27	WOS:000298365700009
J	So, MT; Leon, TYY; Cheng, G; Tang, CSM; Miao, XP; Cornes, BK; Ngo, DN; Cui, L; Ngan, ESW; Lui, VCH; Wu, XZ; Wang, B; Wang, HL; Yuan, ZW; Huang, LM; Li, L; Xia, HM; Zhu, DL; Liu, JC; Nguyen, TL; Chan, IHY; Chung, PHY; Liu, XL; Zhang, RZ; Wong, KKY; Sham, PC; Cherny, SS; Tam, PKH; Garcia-Barcelo, MM				So, Man-Ting; Leon, Thomas Yuk-Yu; Cheng, Guo; Tang, Clara Sze-Man; Miao, Xiao-Ping; Cornes, Belinda K.; Diem Ngoc Ngo; Cui, Long; Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Wu, Xuan-Zhao; Wang, Bin; Wang, Hualong; Yuan, Zheng-Wei; Huang, Liu-Ming; Li, Long; Xia, Huimin; Zhu, Deli; Liu, Juncheng; Thanh Liem Nguyen; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Zhang, Ruizhong; Wong, Kenneth Kak-Yuen; Sham, Pak-Chung; Cherny, Stacey S.; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			RET Mutational Spectrum in Hirschsprung Disease: Evaluation of 601 Chinese Patients	PLOS ONE			English	Article							PROTOONCOGENE; DYSFUNCTION; EXPRESSION; RECEPTOR; KINASE; COMMON; RISK; GENE	Rare (RVs) and common variants of the RET gene contribute to Hirschsprung disease (HSCR; congenital aganglionosis). While RET common variants are strongly associated with the commonest manifestation of the disease (males; short-segment aganglionosis; sporadic), rare coding sequence (CDS) variants are more frequently found in the lesser common and more severe forms of the disease (females; long/total colonic aganglionosis; familial). Here we present the screening for RVs in the RET CDS and intron/exon boundaries of 601 Chinese HSCR patients, the largest number of patients ever reported. We identified 61 different heterozygous RVs (50 novel) distributed among 100 patients (16.64%). Those include 14 silent, 29 missense, 5 nonsense, 4 frame-shifts, and one in-frame amino-acid deletion in the CDS, two splice-site deletions, 4 nucleotide substitutions and a 22-bp deletion in the intron/exon boundaries and 1 single-nucleotide substitution in the 59 untranslated region. Exonic variants were mainly clustered in RET the extracellular domain. RET RVs were more frequent among patients with the most severe phenotype (24% vs. 15% in short-HSCR). Phasing RVs with the RET HSCR-associated haplotype suggests that RVs do not underlie the undisputable association of RET common variants with HSCR. None of the variants were found in 250 Chinese controls.	[So, Man-Ting; Leon, Thomas Yuk-Yu; Cheng, Guo; Cornes, Belinda K.; Cui, Long; Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Chan, Ivy Hau-Yee; Chung, Patrick Ho-Yu; Liu, Xue-Lai; Zhang, Ruizhong; Wong, Kenneth Kak-Yuen; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Tang, Clara Sze-Man; Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ngan, Elly Sau-Wai; Lui, Vincent Chai-Hang; Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Wu, Xuan-Zhao] Affiliated Hosp, Guiyang Med Coll, Dept Surg, Guiyang, Peoples R China; [Wang, Bin] Shenzhen Childrens Hosp, Shenzhen, Peoples R China; [Wang, Hualong] Changchun Childrens Hosp, Changchun, Peoples R China; [Yuan, Zheng-Wei] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China; [Huang, Liu-Ming] Beijing BAYI Childrens Hosp, Beijing, Peoples R China; [Li, Long] Capital Inst Pediat, Beijing, Peoples R China; [Xia, Huimin; Zhu, Deli] Guangzhou Women & Childrens Med Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Juncheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pediat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Diem Ngoc Ngo; Thanh Liem Nguyen] Natl Hosp Pediat, Dept Human Genet, Hanoi, Vietnam	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Huazhong University of Science & Technology; Guizhou Medical University; China Medical University; Capital Institute of Pediatrics (CIP); Sun Yat Sen University	So, MT (corresponding author), Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	mmgarcia@hku.hk	Ngan, Elly/N-1543-2019; Wong, Kenneth K. Y./B-9920-2008; Cherny, Stacey S/B-3315-2008; miao, xiaoping/C-4336-2011; Zhang, Ruizhong/GOE-6855-2022	Ngan, Elly/0000-0002-0022-7999; Cherny, Stacey S/0000-0002-0269-3352; miao, xiaoping/0000-0002-6818-9722; Zhang, Ruizhong/0000-0002-4954-7192; CHUNG, Patrick Ho Yu/0000-0003-2382-5681; Tang, Clara/0000-0003-0265-2638	Hong Kong Research Grants Council [HKU 765407M, HKU 778610M]; University of Hong Kong [200611159028]; University of Hong Kong Genomics Strategic Research Theme	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); University of Hong Kong Genomics Strategic Research Theme	This work was supported by research grants from the Hong Kong Research Grants Council HKU 765407M to M-MG-B and HKU 778610M to PK-HT; and from The University of Hong Kong Seed Funding Programme 200611159028 to M-MG-B. Support was also obtained from The University of Hong Kong Genomics Strategic Research Theme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Cornes BK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010918; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2004, CLIN CHEM, V50, P93, DOI 10.1373/clinchem.2003.022061; Garcia-Barcelo MM, 2009, P NATL ACAD SCI USA, V106, P2694, DOI 10.1073/pnas.0809630105; Garcia-Barcelo MM, 2003, J MED GENET, V40; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; Iwashita T, 2001, GASTROENTEROLOGY, V121, P24, DOI 10.1053/gast.2001.25515; Iwashita T, 1996, HUM MOL GENET, V5, P1577, DOI 10.1093/hmg/5.10.1577; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pelet A, 1998, J CLIN INVEST, V101, P1415, DOI 10.1172/JCI375; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Seri M, 1997, HUM MUTAT, V9, P243; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Won HH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003575	27	20	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28986	10.1371/journal.pone.0028986	http://dx.doi.org/10.1371/journal.pone.0028986			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174939	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700085
J	Zhang, Y; Hong, H; Engle, JW; Bean, J; Yang, YN; Leigh, BR; Barnhart, TE; Cai, WB				Zhang, Yin; Hong, Hao; Engle, Jonathan W.; Bean, Jero; Yang, Yunan; Leigh, Bryan R.; Barnhart, Todd E.; Cai, Weibo			Positron Emission Tomography Imaging of CD105 Expression with a Cu-64-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA	PLOS ONE			English	Article							ENDOGLIN CD105; BEARING MICE; SOLID TUMORS; PET; THERAPY; CANCER; COMPLEXES; RADIOPHARMACEUTICALS; VASCULATURE; STABILITIES	Optimizing the in vivo stability of positron emission tomography (PET) tracers is of critical importance to cancer diagnosis. In the case of Cu-64-labeled monoclonal antibodies (mAb), in vivo behavior and biodistribution is critically dependent on the performance of the bifunctional chelator used to conjugate the mAb to the radiolabel. This study compared the in vivo characteristics of Cu-64-labeled TRC105 (a chimeric mAb that binds to both human and murine CD105), through two commonly used chelators: 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA). Flow cytometry analysis confirmed that chelator conjugation of TRC105 did not affect its CD105 binding affinity or specificity. PET imaging and biodistribution studies in 4T1 murine breast tumor-bearing mice revealed that Cu-64-NOTA-TRC105 exhibited better stability than Cu-64-DOTA-TRC105 in vivo, which resulted in significantly lower liver uptake without compromising the tumor targeting efficiency. In conclusion, this study confirmed that NOTA is a superior chelator to DOTA for PET imaging with Cu-64-labeled TRC105.	[Zhang, Yin; Engle, Jonathan W.; Barnhart, Todd E.; Cai, Weibo] Univ Wisconsin, Dept Med Phys, Madison, WI 53706 USA; [Hong, Hao; Bean, Jero; Yang, Yunan; Cai, Weibo] Univ Wisconsin, Dept Radiol, Madison, WI 53706 USA; [Leigh, Bryan R.] TRACON Pharmaceut Inc, San Diego, CA USA; [Cai, Weibo] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, Y (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.	wcai@uwhealth.org	Zhang, Yin/E-6547-2015; Yang, Yunan/I-3451-2014; Hong, Hao/K-6035-2012; Cai, Weibo/B-9174-2008	Cai, Weibo/0000-0003-4641-0833; Engle, Jonathan W/0000-0002-3399-7228; Barnhart, Todd/0000-0002-9981-2150	University of Wisconsin Carbone Cancer Center; Department of Defense [W81XWH-11-1-0644, W81XWH-11-1-0648]; National Center for Research Resources [1UL1RR025011]; National Institutes of Health (NIH) through the UW [5 T32 CA009206-32]; NATIONAL CANCER INSTITUTE [T32CA009206] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	University of Wisconsin Carbone Cancer Center; Department of Defense(United States Department of Defense); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH) through the UW; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported, in part, by the University of Wisconsin Carbone Cancer Center, the Department of Defense (W81XWH-11-1-0644 and W81XWH-11-1-0648), National Center for Research Resources 1UL1RR025011, and the National Institutes of Health (NIH) through the UW Radiological Sciences Training Program 5 T32 CA009206-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ait-Mohand S, 2011, BIOCONJUGATE CHEM, V22, P1729, DOI 10.1021/bc2002665; Anderson CJ, 2001, J NUCL MED, V42, P213; Blower PJ, 1996, NUCL MED BIOL, V23, P957, DOI 10.1016/S0969-8051(96)00130-8; Boswell CA, 2004, J MED CHEM, V47, P1465, DOI 10.1021/jm030383m; Cai W, 2008, EUR J NUCL MED MOL I, V35, P186, DOI 10.1007/s00259-007-0560-9; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P2024, DOI 10.1007/s00259-007-0503-5; Cai WB, 2007, EUR J NUCL MED MOL I, V34, P850, DOI 10.1007/s00259-006-0361-6; Cai WB, 2006, CANCER RES, V66, P9673, DOI 10.1158/0008-5472.CAN-06-1480; CLARKE ET, 1991, INORG CHIM ACTA, V190, P27, DOI 10.1016/S0020-1693(00)80228-5; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Dearling JLJ, 2011, NUCL MED BIOL, V38, P29, DOI 10.1016/j.nucmedbio.2010.07.003; DELGADO R, 1993, INORG CHEM, V32, P3320, DOI 10.1021/ic00067a022; Fonsatti E, 2000, CLIN CANCER RES, V6, P2037; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Garrison JC, 2007, J NUCL MED, V48, P1327, DOI 10.2967/jnumed.107.039487; HONG H, 2011, EUR J NUCL MED MOL I; Hong H, 2011, AM J TRANSL RES, V3, P392; Hong H, 2011, EUR J NUCL MED MOL I, V38, P1335, DOI 10.1007/s00259-011-1765-5; Huang CW, 2011, BIOCONJUGATE CHEM, V22, P256, DOI 10.1021/bc100388g; Liu ZF, 2009, J NUCL MED, V50, P1168, DOI 10.2967/jnumed.108.061739; MCCARDLE RJ, 1966, J NUCL MED, V7, P837; Mendelson DS, 2010, J CLIN ONCOL, V28, p15s; Niu G, 2009, J NUCL MED, V50, P1116, DOI 10.2967/jnumed.109.061820; Prasanphanich AF, 2007, P NATL ACAD SCI USA, V104, P12462, DOI 10.1073/pnas.0705347104; Seo JW, 2008, BIOCONJUGATE CHEM, V19, P2577, DOI 10.1021/bc8002937; Seon BK, 2011, CURR DRUG DELIV, V8, P135; Takahashi N, 2001, CANCER RES, V61, P7846; TANNOCK IF, 1989, CANCER RES, V49, P4373; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Wadas TJ, 2006, NAT PROTOC, V1, P3062, DOI 10.1038/nprot.2006.431; Wadas TJ, 2010, CHEM REV, V110, P2858, DOI 10.1021/cr900325h; Wang H, 2007, EUR J NUCL MED MOL I, V34, P2001, DOI 10.1007/s00259-007-0524-0; Wei L, 2009, NUCL MED BIOL, V36, P277, DOI 10.1016/j.nucmedbio.2008.12.008; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yang XQ, 2011, BIOMATERIALS, V32, P4151, DOI 10.1016/j.biomaterials.2011.02.006; Yang YA, 2011, EUR J NUCL MED MOL I, V38, P2066, DOI 10.1007/s00259-011-1886-x; Zhang Y, 2011, INT J CLIN EXP MED, V4, P32	38	88	93	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28005	10.1371/journal.pone.0028005	http://dx.doi.org/10.1371/journal.pone.0028005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174762	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700014
J	Hutson, CL; Carroll, DS; Gallardo-Romero, N; Weiss, S; Clemmons, C; Hughes, CM; Salzer, JS; Olson, VA; Abel, J; Karem, KL; Damon, IK				Hutson, Christina L.; Carroll, Darin S.; Gallardo-Romero, Nadia; Weiss, Sonja; Clemmons, Cody; Hughes, Christine M.; Salzer, Johanna S.; Olson, Victoria A.; Abel, Jason; Karem, Kevin L.; Damon, Inger K.			Monkeypox Disease Transmission in an Experimental Setting: Prairie Dog Animal Model	PLOS ONE			English	Article							VIRUS; CONGO	Monkeypox virus (MPXV) is considered the most significant human public health threat in the genus Orthopoxvirus since the eradication of variola virus (the causative agent of smallpox). MPXV is a zoonotic agent endemic to forested areas of Central and Western Africa. In 2003, MPXV caused an outbreak in the United States due to the importation of infected African rodents, and subsequent sequential infection of North American prairie dogs (Cynomys ludovicianus) and humans. In previous studies, the prairie dog MPXV model has successfully shown to be very useful for understanding MPXV since the model emulates key characteristics of human monkeypox disease. In humans, percutaneous exposure to animals has been documented but the primary method of human-to-human MPXV transmission is postulated to be by respiratory route. Only a few animal model studies of MPXV transmission have been reported. Herein, we show that MPXV infected prairie dogs are able to transmit the virus to naive animals through multiple transmission routes. All secondarily exposed animals were infected with MPXV during the course of the study. Notably, animals secondarily exposed appeared to manifest more severe disease; however, the disease course was very similar to those of experimentally challenged animals including inappetence leading to weight loss, development of lesions, production of orthopoxvirus antibodies and shedding of similar levels or in some instances higher levels of MPXV from the oral cavity. Disease was transmitted via exposure to contaminated bedding, co-housing, or respiratory secretions/nasal mucous (we could not definitively say that transmission occurred via respiratory route exclusively). Future use of the model will allow us to evaluate infection control measures, vaccines and antiviral strategies to decrease disease transmission.	[Hutson, Christina L.; Carroll, Darin S.; Gallardo-Romero, Nadia; Weiss, Sonja; Clemmons, Cody; Hughes, Christine M.; Salzer, Johanna S.; Olson, Victoria A.; Abel, Jason; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA; [Salzer, Johanna S.] Emory Univ, Program Populat Biol Ecol & Evolut, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; Emory University	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Dis, Atlanta, GA 30333 USA.	CHutson1@cdc.gov						BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; BREMAN JG, 1977, AM J TROP MED HYG, V26, P273, DOI 10.4269/ajtmh.1977.26.273; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P561; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; FOSTER SO, 1972, B WORLD HEALTH ORGAN, V46, P569; HEBERLING RL, 1971, J INFECT DIS, V124, P33, DOI 10.1093/infdis/124.1.33; Huhn GD, 2005, CLIN INFECT DIS, V41, P1742, DOI 10.1086/498115; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2010, VIRUSES-BASEL, V2, P2763, DOI 10.3390/v2122763; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Shchelkunov SN, 2005, ORTHOPOXVIRUSES PATH, P303; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106	19	30	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28295	10.1371/journal.pone.0028295	http://dx.doi.org/10.1371/journal.pone.0028295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164263	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400064
J	Jin, KT; Li, GL; Cui, BB; Zhang, J; Lan, HR; Han, N; Xie, BJ; Cao, FL; He, KF; Wang, HH; Xu, ZZ; Teng, LS; Zhu, TM				Jin, Ketao; Li, Guangliang; Cui, Binbin; Zhang, Jing; Lan, Huanrong; Han, Na; Xie, Bojian; Cao, Feilin; He, Kuifeng; Wang, Haohao; Xu, Zhenzhen; Teng, Lisong; Zhu, Tieming			Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases	PLOS ONE			English	Article							PRIMARY COLORECTAL-CANCER; IN-SITU HYBRIDIZATION; CORRESPONDING METASTASES; ENDOTHELIAL SPROUTS; NODE METASTASIS; BREAST-CANCER; BLOOD-VESSELS; HER-2 STATUS; EGFR; HETEROGENEITY	The lack of appropriate tumor models of primary tumors and corresponding metastases that can reliably predict for response to anticancer agents remains a major deficiency in the clinical practice of cancer therapy. It was the aim of our study to establish patient-derived tumor tissue (PDTT) xenograft models of colon carcinoma with lymphatic and hepatic metastases useful for testing of novel molecularly targeted agents. PDTT of primary colon carcinoma, lymphatic and hepatic metastases were used to create xenograft models. Hematoxylin and eosin staining, immunohistochemical staining, genome-wide gene expression analysis, pyrosequencing, qRT-PCR, and western blotting were used to determine the biological stability of the xenografts during serial transplantation compared with the original tumor tissues. Early passages of the PDTT xenograft models of primary colon carcinoma, lymphatic and hepatic metastases revealed a high degree of similarity with the original clinical tumor samples with regard to histology, immunohistochemistry, genes expression, and mutation status as well as mRNA expression. After we have ascertained that these xenografts models retained similar histopathological features and molecular signatures as the original tumors, drug sensitivities of the xenografts to a novel VEGF targeted agent, FP3 was evaluated. In this study, PDTT xenograft models of colon carcinoma with lymphatic and hepatic metastasis have been successfully established. They provide appropriate models for testing of novel molecularly targeted agents.	[Jin, Ketao; Li, Guangliang; Zhang, Jing; He, Kuifeng; Wang, Haohao; Xu, Zhenzhen; Teng, Lisong] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Ketao; Lan, Huanrong; Zhu, Tieming] Wenzhou Med Coll, Affiliated Zhuji Hosp, Dept Surg, Zhuji, Zhejiang, Peoples R China; [Cui, Binbin; Xie, Bojian; Cao, Feilin] Wenzhou Med Coll, Taizhou Hosp, Dept Surg Oncol, Taizhou, Zhejiang, Peoples R China; [Han, Na] Zhejiang Univ Tradit & Chinese Med, Zhejiang Prov Canc Hosp, Ctr Canc Chemotherapy, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University; Wenzhou Medical University; Zhejiang Cancer Hospital; Zhejiang Chinese Medical University	Teng, LS (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Surg Oncol, Hangzhou 310003, Zhejiang, Peoples R China.; Zhu, TM (corresponding author), Wenzhou Med Coll, Affiliated Zhuji Hosp, Dept Surg, Zhuji, Zhejiang, Peoples R China.	jinketao2001@zju.edu.cn; doctm@163.com	Li, Guangliang/B-6715-2011		State Key Basic Research and Development Program of China (973 Program) [2009CB521704]; National High-tech Research AMP; Development Program of China (863 Program) [2006AA02A245]; National Natural Science Foundation of China [81000894]; Zhejiang Provincial Science and Technology Project [2009C13021]	State Key Basic Research and Development Program of China (973 Program)(National Basic Research Program of China); National High-tech Research AMP; Development Program of China (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Science and Technology Project	This work was supported by the State Key Basic Research and Development Program of China (973 Program, Grant No. 2009CB521704), National High-tech Research & Development Program of China (863 Program, Grant No. 2006AA02A245), National Natural Science Foundation of China (Grant No. 81000894) and Zhejiang Provincial Science and Technology Project (Grant No. 2009C13021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakanat A, 2008, CANCER-AM CANCER SOC, V112, P2352, DOI 10.1002/cncr.23456; Baffert F, 2004, CIRC RES, V94, P984, DOI 10.1161/01.RES.0000125295.43813.1F; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Baluk P, 2003, AM J PATHOL, V163, P1801, DOI 10.1016/S0002-9440(10)63540-7; Bozzetti C, 2003, CANCER CYTOPATHOL, V99, P310, DOI 10.1002/cncr.11731; Fichtner I, 2008, CLIN CANCER RES, V14, P6456, DOI 10.1158/1078-0432.CCR-08-0138; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Gong Y, 2005, CANCER-AM CANCER SOC, V103, P1763, DOI 10.1002/cncr.20987; Huang JZ, 2003, P NATL ACAD SCI USA, V100, P7785, DOI 10.1073/pnas.1432908100; Huynh H, 2002, CELL GROWTH DIFFER, V13, P115; JIN K, 2011, CLIN TRANSL IN PRESS; Jin KT, 2011, HEPATO-GASTROENTEROL, V58, P1814, DOI 10.5754/hge11136; Jin KT, 2011, PERS MED, V8, P175, DOI [10.2217/pme.10.81, 10.2217/PME.10.81]; Jin KT, 2010, PERS MED, V7, P597, DOI [10.2217/pme.10.48, 10.2217/PME.10.48]; Jin KT, 2010, CLIN TRANSL ONCOL, V12, P473, DOI 10.1007/s12094-010-0540-6; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Li ZQ, 2011, HEPATO-GASTROENTEROL, V58, P411; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Molinari F, 2009, BRIT J CANCER, V100, P1087, DOI 10.1038/sj.bjc.6604848; Monaco SE, 2010, HUM PATHOL, V41, P94, DOI 10.1016/j.humpath.2009.06.019; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Morton CL, 2007, NAT PROTOC, V2, P247, DOI 10.1038/nprot.2007.25; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Perez-Soler R, 2000, CLIN CANCER RES, V6, P4932; Regitnig P, 2004, J PATHOL, V203, P918, DOI 10.1002/path.1592; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Sasatomi E, 2002, CANCER RES, V62, P2681; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Scartozzi M, 2007, BRIT J CANCER, V97, P92, DOI 10.1038/sj.bjc.6603847; Scartozzi M, 2004, J CLIN ONCOL, V22, P4772, DOI 10.1200/JCO.2004.00.117; Schneider S, 2005, J AM COLL SURGEONS, V200, P336, DOI 10.1016/j.jamcollsurg.2004.10.035; Tanner M, 2001, CANCER RES, V61, P5345; Tapia C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1676; Teng LS, 2010, J CHIN MED ASSOC, V73, P281, DOI 10.1016/S1726-4901(10)70062-9; Voskoglou-Nomikos T, 2003, CLIN CANCER RES, V9, P4227; Wang YW, 2005, LAB INVEST, V85, P1392, DOI 10.1038/labinvest.3700335; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Zhang M, 2008, MOL VIS, V14, P37; Zhang M, 2011, OPHTHALMOLOGY, V118, P672, DOI 10.1016/j.ophtha.2010.08.008; Zhang M, 2009, PHARM RES-DORDR, V26, P204, DOI 10.1007/s11095-008-9718-9	43	30	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28384	10.1371/journal.pone.0028384	http://dx.doi.org/10.1371/journal.pone.0028384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164281	Green Published, gold			2022-12-27	WOS:000298171400082
J	Wong, LC; Schedl, P				Wong, Li Chin; Schedl, Paul			Cup Blocks the Precocious Activation of the Orb Autoregulatory Loop	PLOS ONE			English	Article							OSKAR MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; BINDING-PROTEIN; TRANSLATIONAL REPRESSION; DROSOPHILA OOGENESIS; OOCYTE; BRUNO; CPEB; GENE; RECRUITMENT	Translational regulation of localized mRNAs is essential for patterning and axes determination in many organisms. In the Drosophila ovary, the germline-specific Orb protein mediates the translational activation of a variety of mRNAs localized in the oocyte. One of the Orb target mRNAs is orb itself, and this autoregulatory activity ensures that Orb proteins specifically accumulate in the developing oocyte. Orb is an RNA-binding protein and is a member of the cytoplasmic polyadenylation element binding (CPEB) protein family. We report here that Cup forms a complex in vivo with Orb. We also show that cup negatively regulates orb and is required to block the precocious activation of the orb positive autoregulatory loop. In cup mutant ovaries, high levels of Orb accumulate in the nurse cells, leading to what appears to be a failure in oocyte specification as a number of oocyte markers inappropriately accumulate in nurse cells. In addition, while orb mRNA is mislocalized and destabilized, a longer poly(A) tail is maintained than in wild type ovaries. Analysis of Orb phosphoisoforms reveals that loss of cup leads to the accumulation of hyperphosphorylated Orb, suggesting that an important function of cup in orb-dependent mRNA localization pathways is to impede Orb activation.	[Wong, Li Chin; Schedl, Paul] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Wong, LC (corresponding author), NYU, Sch Med, Smilow Neurosci Program, New York, NY USA.	lichin.wong@nyumc.org			National Institutes of Health [GM56937, GM043432]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056937, R01GM043432, R56GM043432] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was initially supported by grant number GM56937 from National Institutes of Health until it was terminated in 2009. Subsequent support came from National Institutes of Health grant number GM043432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit P, 2008, DEVELOPMENT, V135, P1969, DOI 10.1242/dev.021444; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Castagnetti S, 2003, DEVELOPMENT, V130, P835, DOI 10.1242/dev.00309; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; Chang JS, 2001, DEVELOPMENT, V128, P3169; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Dickson KS, 2001, J BIOL CHEM, V276, P41810, DOI 10.1074/jbc.M103030200; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Huynh JR, 2000, DEVELOPMENT, V127, P2785; Igreja C, 2011, GENE DEV, V25, P1955, DOI 10.1101/gad.17136311; KARPEN GH, 1992, GENETICS, V132, P737; Keyes LN, 1997, DEVELOPMENT, V124, P1419; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; LANTZ V, 1992, DEVELOPMENT, V115, P75; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Radford HE, 2008, BBA-GENE REGUL MECH, V1779, P217, DOI 10.1016/j.bbagrm.2008.02.002; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; SCHUPBACH T, 1986, DEV BIOL, V113, P443, DOI 10.1016/0012-1606(86)90179-X; Snee MJ, 2009, DEV DYNAM, V238, P918, DOI 10.1002/dvdy.21914; Tan LH, 2001, DEVELOPMENT, V128, P1159; Van Buskirk C, 2000, DEVELOPMENT, V127, P4753; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Wong LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024355; Zappavigna V, 2004, P NATL ACAD SCI USA, V101, P14800, DOI 10.1073/pnas.0406451101	31	14	15	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28261	10.1371/journal.pone.0028261	http://dx.doi.org/10.1371/journal.pone.0028261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164257	Green Published, gold			2022-12-27	WOS:000298171400058
J	Beck, EJ; Mandalia, S; Sangha, R; Sharott, P; Youle, M; Baily, G; Brettle, R; Gompels, M; Johnson, M; McCarron, B; Ong, E; Pozniak, A; Schwenk, A; Taylor, S; Walsh, J; Wilkins, E; Williams, I; Gazzard, B				Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Sharott, Peter; Youle, Mike; Baily, Guy; Brettle, Ray; Gompels, Mark; Johnson, Margaret; McCarron, Brendan; Ong, Ed; Pozniak, Anton; Schwenk, Achim; Taylor, Stephen; Walsh, John; Wilkins, Ed; Williams, Ian; Gazzard, Brian		NPMS-HHC Steering Grp	The Cost-Effectiveness of Early Access to HIV Services and Starting cART in the UK 1996-2008	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; LATE DIAGNOSIS; ENGLAND; WALES	Aim: To calculate use, cost and cost-effectiveness of people living with HIV (PLHIV) starting routine treatment and care before starting combination antiretroviral therapy (cART) and PLHIV starting first-line 2NRTIs+NNRTI or 2NRTIs+PIboosted, comparing PLHIV with CD4 <= 200 cells/mm(3) and CD4>200 cells/mm(3). Few studies have calculated the use, cost and cost-effectiveness of routine treatment and care before starting cART and starting cART above and below CD4 200 cells/mm(3). Methods: Use, costs and cost-effectiveness were calculated for PLHIV in routine pre-cART and starting first-line cART, comparing CD4 <= 200 cells/mm3 with CD4>200 cells/mm(3) (2008 UK prices). Results: cART naive patients CD4 <= 200 cells/mm(3) had an annual cost of 6,407 pound (95% CI 6,382 pound to 6,425) pound PPY compared with 2,758 pound (95% CI 2,752 pound to 2,761) pound PPY for those with CD4>200 cells/mm3; cost per life year gained of pre-cART treatment and care for those with CD4>200 cells/mm(3) was 1,776 pound (cost-saving to 2,752) pound. Annual cost for starting 2NRTIs+NNRTI or 2NRTIs+PIboosted with CD4 <= 200 cells/mm(3) was 12,812 pound (95% CI 12,685- pound 12,937) pound compared with 10,478 pound (95% CI 10,376- pound 10,581) pound for PLHIV with CD4>200 cells/mm(3). Cost per additional life-year gained on first-line therapy for those with CD4>200 cells/mm(3) was 4639 pound (3,967 pound to 2,960) pound. Conclusion: PLHIV starting to use HIV services before CD4 <= 200 cells/mm(3) is cost-effective and enables them to be monitored so they start cART with a CD4>200 cells/mm3, which results in better outcomes and is cost-effective. However, 25% of PLHIV accessing services continue to present with CD4 <= 200 cells/mm3. This highlights the need to investigate the cost-effectiveness of testing and early treatment programs for key populations in the UK.	[Beck, Eduard J.; Mandalia, Sundhiya; Sangha, Roshni; Youle, Mike; Gazzard, Brian] NPMS HHC CIC, Coordinating & Analyt Ctr, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England; [Mandalia, Sundhiya; Gazzard, Brian] Univ London Imperial Coll Sci Technol & Med, London, England; [Sharott, Peter] London Procurement Programme, London Specialised Commissioning Grp, London, England; [Youle, Mike; Johnson, Margaret] Royal Free Hosp, London NW3 2QG, England; [Baily, Guy] Royal London Hosp, London E1 1BB, England; [Baily, Guy] Barts Hosp, London, England; [Brettle, Ray] Edinburgh Gen Hosp, Edinburgh, Midlothian, Scotland; [Gompels, Mark] Southmead Hosp, Bristol, Avon, England; [McCarron, Brendan] James Cook Univ Hosp, Middlesbrough, England; [Ong, Ed] Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Beck, Eduard J.; Mandalia, Sundhiya; Pozniak, Anton; Gazzard, Brian] Chelsea & Westminster Hosp, London, England; [Schwenk, Achim] N Middlesex Hosp, London N18 1QX, England; [Taylor, Stephen] Birmingham Heartland Hosp, Birmingham, W Midlands, England; [Walsh, John] St Marys Hosp, London, England; [Wilkins, Ed] N Manchester Grp Hosp, N Manchester, England; [Williams, Ian] Mortimer Market Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Barts Health NHS Trust; Royal London Hospital; Southmead Hospital; James Cook University Hospital; Newcastle General Hospital; Imperial College London; Heart of England NHS Foundation Trust; Imperial College London	Beck, EJ (corresponding author), NPMS HHC CIC, Coordinating & Analyt Ctr, London, England.	becke@unaids.org		Ong, Edmund/0000-0002-6594-0509	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	During 2010/2011, the NPMS-HHC was financially supported through a non-restrictive grant from Bristol-Myers Squibb, with no influence on the independence of the Steering Group and its editorial policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2009, AIDS CARE, V21, P284, DOI 10.1080/09540120802183537; [Anonymous], 2011, NIH NEWS        0512; Badri M, 2006, PLOS MED, V3, P48, DOI 10.1371/journal.pmed.0030004; BAJKO MS, 2011, HIV STUD 76 DROP CAS; Beck EJ, 2008, INT J STD AIDS, V19, P297, DOI 10.1258/ijsa.2007.007236; Beck E.J., 2001, EFFECTIVE MANAGEMENT, P113; Beck EJ, 2004, AIDS, V18, P2411; BECK EJ, 2006, HIV PANDEMIC LOCAL G, P769; BECK EJ, 2010, USE COST HIV SERVICE; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Chadborn TR, 2005, AIDS, V19, P513, DOI 10.1097/01.aids.0000162340.43310.08; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; *HLTH PROT AG, 2011, HLTH PROTECTION REPO, V4; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Mandalia S, 2002, HIV Med, V3, P254, DOI 10.1046/j.1468-1293.2002.00110.x; NEATON JD, 2009, STRATEGIC TIMING ANT; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; THAKKAR B, 1998, 226 SUGI; WHO, 2010, ANT THER HIV INF AD	24	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27830	10.1371/journal.pone.0027830	http://dx.doi.org/10.1371/journal.pone.0027830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194795	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100015
J	Shabel, SJ; Schairer, W; Donahue, RJ; Powell, V; Janak, PH				Shabel, Steven J.; Schairer, Will; Donahue, Rachel J.; Powell, Victoria; Janak, Patricia H.			Similar Neural Activity during Fear and Disgust in the Rat Basolateral Amygdala	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; PRIMATE AMYGDALA; EXTRACELLULAR RECORDINGS; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; RESPONSES; STIMULI; EMOTION; NEURONS; REINFORCEMENT	Much research has focused on how the amygdala processes individual affects, yet little is known about how multiple types of positive and negative affects are encoded relative to one another at the single-cell level. In particular, it is unclear whether different negative affects, such as fear and disgust, are encoded more similarly than negative and positive affects, such as fear and pleasure. Here we test the hypothesis that the basolateral nucleus of the amygdala (BLA), a region known to be important for learned fear and other affects, encodes affective valence by comparing neuronal activity in the BLA during a conditioned fear stimulus (fear CS) with activity during intraoral delivery of an aversive fluid that induces a disgust response and a rewarding fluid that induces a hedonic response. Consistent with the hypothesis, neuronal activity during the fear CS and aversive fluid infusion, but not during the fear CS and rewarding fluid infusion, was more similar than expected by chance. We also found that the greater similarity in activity during the fear-and disgust-eliciting stimuli was specific to a subpopulation of cells and a limited window of time. Our results suggest that a subpopulation of BLA neurons encodes affective valence during learned fear, and furthermore, within this subpopulation, different negative affects are encoded more similarly than negative and positive affects in a time-specific manner.	[Shabel, Steven J.; Schairer, Will; Donahue, Rachel J.; Powell, Victoria; Janak, Patricia H.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Shabel, Steven J.; Janak, Patricia H.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; [Janak, Patricia H.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA; [Janak, Patricia H.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shabel, SJ (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	sshabel@ucsd.edu; pjanak@gallo.ucsf.edu		Shabel, Steven/0000-0002-2746-5399; Janak, Patricia/0000-0002-3333-9049; Schairer, William/0000-0001-6162-9329	State of California; University of California San Francisco [DAMD17-01-1-0739]; Affective Science Predoctoral Training Program [NIMH T32MH020006]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020006] Funding Source: NIH RePORTER	State of California; University of California San Francisco(University of California System); Affective Science Predoctoral Training Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by funds from the State of California for medical research on alcohol and substance abuse through University of California San Francisco, by award # DAMD17-01-1-0739 awarded and administered by the U.S. Army Medical Research Acquisition Activity, 820 Chandler St., Fort Detrick, MD 21702, and by the Affective Science Predoctoral Training Program (S.J.S.; NIMH T32MH020006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barot SK, 2008, P NATL ACAD SCI USA, V105, P20959, DOI 10.1073/pnas.0808996106; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Belova MA, 2008, J NEUROSCI, V28, P10023, DOI 10.1523/JNEUROSCI.1400-08.2008; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berridge KC, 2000, NEUROSCI BIOBEHAV R, V24, P173, DOI 10.1016/S0149-7634(99)00072-X; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Bromberg-Martin ES, 2010, NEURON, V67, P144, DOI 10.1016/j.neuron.2010.06.016; BURNS LH, 1993, BEHAV BRAIN RES, V55, P167, DOI 10.1016/0166-4328(93)90113-5; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Chapman HA, 2009, SCIENCE, V323, P1222, DOI 10.1126/science.1165565; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 2000, AMYGDALA FUNCTIONAL, P287; Ekman P., 1975, UNMASKING FACE; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; GRILL HJ, 1978, BRAIN RES, V143, P263, DOI 10.1016/0006-8993(78)90568-1; Grossman SE, 2008, J NEUROSCI, V28, P2864, DOI 10.1523/JNEUROSCI.4063-07.2008; Hatfield T, 1996, J NEUROSCI, V16, P5256; IWATA J, 1986, BRAIN RES, V383, P195, DOI 10.1016/0006-8993(86)90020-X; Kim MJ, 2010, NEUROBIOL LEARN MEM, V93, P406, DOI 10.1016/j.nlm.2009.12.007; Lamprecht R, 2000, AMYGDALA FUNCTIONAL, P331; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; Likhtik E, 2006, J NEUROPHYSIOL, V96, P3257, DOI 10.1152/jn.00577.2006; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MURAMOTO K, 1993, NEUROSCIENCE, V52, P621, DOI 10.1016/0306-4522(93)90411-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Pare D, 2000, J NEUROSCI, V20, P2701; PARKER LA, 1982, LEARN MOTIV, V13, P281, DOI 10.1016/0023-9690(82)90011-X; Parkinson JA, 2001, J NEUROSCI, V21, P7770, DOI 10.1523/JNEUROSCI.21-19-07770.2001; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Roesch MR, 2010, J NEUROSCI, V30, P2464, DOI 10.1523/JNEUROSCI.5781-09.2010; Rosenkranz JA, 1999, J NEUROSCI, V19, P11027, DOI 10.1523/JNEUROSCI.19-24-11027.1999; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; SPECTOR AC, 1988, BEHAV NEUROSCI, V102, P942, DOI 10.1037/0735-7044.102.6.942; St Andre J, 2007, BRAIN RES, V1135, P122, DOI 10.1016/j.brainres.2006.12.010; Tye KM, 2007, J NEUROSCI, V27, P3937, DOI 10.1523/JNEUROSCI.5281-06.2007; Wang SH, 2005, J NEUROSCI, V25, P830, DOI 10.1523/JNEUROSCI.4716-04.2005; Yasoshima Y, 1995, NEUROREPORT, V6, P2424, DOI 10.1097/00001756-199511270-00034	44	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27797	10.1371/journal.pone.0027797	http://dx.doi.org/10.1371/journal.pone.0027797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194792	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100012
J	Kigera, JWM; Mukwaya, S				Kigera, James W. M.; Mukwaya, Stephen			Frequency of Agenesis Palmaris Longus through Clinical Examination - An East African Study	PLOS ONE			English	Article							CHINESE POPULATION; TENDON; MUSCLE; ABSENCE; ANOMALIES; SIGN	Introduction: The Palmaris longus, one of the most variable muscles in the body both flexes the wrist and tenses the palmar fascia. It is used by surgeons as a source of tendon graft and racial differences in its variation have been documented. We sought to determine the frequency of the absence of the Palmaris longus in an East African population. Methods: A prospective study was conducted using ten common clinical tests among patients and students in a large teaching hospital in East Africa to determine the presence of a Palmaris longus. Results: The overall rate of absence was 4.4% with unilateral absence at 3.3% and bilateral absence at 1.1%. The overall difference between males and females was not statistically significant (p = 0.605). Participants were more likely to have absence in their non dominant hand. Discussion: Our findings though in contrast to many studies worldwide, it concurs with most studies done in the African setting. These differences may be due to the higher levels of manual labour and the more use of the right hand in these activities. The frequency of the absence of Palmaris longus in East Africa has been determined. Surgeons should acquaint themselves with prevalence in their areas of practice.	[Kigera, James W. M.] Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda; [Kigera, James W. M.] PCEA Kikuyu Hosp, Orthopaed Rehabil Unit, Kikuyu, Kenya; [Mukwaya, Stephen] Mulago Paramed Sch, Kampala, Uganda	Makerere University	Kigera, JWM (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Orthopaed, Kampala, Uganda.	jameskigera@yahoo.co.uk						Acikel C, 2007, SCAND J PLAST RECONS, V41, P45, DOI 10.1080/02844310500453708; Bhattacharya V, 2005, BRIT J PLAST SURG, V58, P419, DOI 10.1016/j.bjps.2004.09.004; Ceyhan O, 1997, Indian J Med Sci, V51, P156; ERIC M, SURG RADIOL ANAT, V32, P357; ERIC M, SURG RADIOL ANAT, V33, P481; GANGATA H, CLIN ANAT, V23, P431; Gangata H, 2009, CLIN ANAT, V22, P230, DOI 10.1002/ca.20751; Mbaka Godwin O, 2009, Ulster Med J, V78, P90; MISHRA S, 2001, INDIAN J PLAST SURG, V34, P12; NDOU R, CLIN ANAT, V23, P437; Oudit D, 2005, PLAST RECONSTR SURG, V116, P691, DOI 10.1097/01.prs.0000175967.01538.3a; Pushpakumar SB, 2004, BRIT J PLAST SURG, V57, P184, DOI 10.1016/j.bjps.2003.11.024; SANKAR KD, INDIAN J PLAST SURG, V44, P134; Schaeffer JP, 1909, ANAT REC, V3, P275; Sebastin SJ, 2006, ANN ACAD MED SINGAP, V35, P249; Sebastin SJ, 2005, J HAND SURG-BRIT EUR, V30B, P525, DOI 10.1016/j.jhsb.2005.05.003; Thompson JW, 1921, AM J PHYS ANTHROPOL, V4, P205, DOI 10.1002/ajpa.1330040207; Thompson NW, 2001, ULSTER MED J, V70, P22; TROHA F, 1990, ANN PLAS SURG, V25, P477, DOI 10.1097/00000637-199012000-00008	19	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28997	10.1371/journal.pone.0028997	http://dx.doi.org/10.1371/journal.pone.0028997			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174943	gold, Green Submitted, Green Published			2022-12-27	WOS:000298367300038
J	Gagliani, N; Gregori, S; Jofra, T; Valle, A; Stabilini, A; Rothstein, DM; Atkinson, M; Roncarolo, MG; Battaglia, M				Gagliani, Nicola; Gregori, Silvia; Jofra, Tatiana; Valle, Andrea; Stabilini, Angela; Rothstein, David M.; Atkinson, Mark; Roncarolo, Maria Grazia; Battaglia, Manuela			Rapamycin Combined with Anti-CD45RB mAb and IL-10 or with G-CSF Induces Tolerance in a Stringent Mouse Model of Islet Transplantation	PLOS ONE			English	Article							REGULATORY T-CELLS; COLONY-STIMULATING FACTOR; INDUCTION; INTERLEUKIN-10; ANTIBODY; GENERATION; SURVIVAL; FOXP3(+); MICE	Background: A large pool of preexisting alloreactive effector T cells can cause allogeneic graft rejection following transplantation. However, it is possible to induce transplant tolerance by altering the balance between effector and regulatory T (Treg) cells. Among the various Treg-cell types, Foxp3(+)Treg and IL-10-producing T regulatory type 1 (Tr1) cells have frequently been associated with tolerance following transplantation in both mice and humans. Previously, we demonstrated that rapamycin+IL-10 promotes Tr1-cell-associated tolerance in Balb/c mice transplanted with C57BL/6 pancreatic islets. However, this same treatment was unsuccessful in C57BL/6 mice transplanted with Balb/c islets (classified as a stringent transplant model). We accordingly designed a protocol that would be effective in the latter transplant model by simultaneously depleting effector T cells and fostering production of Treg cells. We additionally developed and tested a clinically translatable protocol that used no depleting agent. Methodology/Principal Findings: Diabetic C57BL/6 mice were transplanted with Balb/c pancreatic islets. Recipient mice transiently treated with anti-CD45RB mAb+rapamycin+IL-10 developed antigen-specific tolerance. During treatment, Foxp3(+)Treg cells were momentarily enriched in the blood, followed by accumulation in the graft and draining lymph node, whereas CD4(+)IL-10(+)IL-4(-) T (i.e., Tr1) cells localized in the spleen. In long-term tolerant mice, only CD4(+)IL-10(+)IL-4(-) T cells remained enriched in the spleen and IL-10 was key in the maintenance of tolerance. Alternatively, recipient mice were treated with two compounds routinely used in the clinic (namely, rapamycin and G-CSF); this drug combination promoted tolerance associated with CD4(+)IL-10(+)IL-4(-) T cells. Conclusions/Significance: The anti-CD45RB mAb+rapamycin+IL-10 combined protocol promotes a state of tolerance that is IL-10 dependent. Moreover, the combination of rapamycin+G-CSF induces tolerance and such treatment could be readily translatable into the clinic.	[Gagliani, Nicola; Jofra, Tatiana; Valle, Andrea; Stabilini, Angela; Battaglia, Manuela] Ist Sci San Raffaele, San Raffaele Diabet Res Inst, I-20132 Milan, Italy; [Gagliani, Nicola; Gregori, Silvia; Roncarolo, Maria Grazia] Ist Sci San Raffaele, San Raffaele Telethon Inst Gene Therapy, I-20132 Milan, Italy; [Gagliani, Nicola; Valle, Andrea; Roncarolo, Maria Grazia] Univ Vita Salute San Raffaele, Milan, Italy; [Rothstein, David M.] Univ Pittsburgh, Med Ctr, Starzl Transplantat Inst, Pittsburgh, PA USA; [Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida	Gagliani, N (corresponding author), Ist Sci San Raffaele, San Raffaele Diabet Res Inst, I-20132 Milan, Italy.	manuela.battaglia@hsr.it	SILVIA, GREGORI/J-7718-2016; Stabilini, Angela/AAN-2002-2020; Jofra, Tatiana/AAN-4727-2020	SILVIA, GREGORI/0000-0002-3517-9683; Jofra, Tatiana/0000-0003-2825-155X; Battaglia, Manuela/0000-0003-4535-3152; RONCAROLO, Maria Grazia/0000-0002-2193-9186; Gagliani, Nicola/0000-0001-8514-1395	Juvenile Diabetes Research Foundation [7-2006-328]; Fondazione Telethon Funding Source: Custom	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Fondazione Telethon(Fondazione Telethon)	This work has been supported by the Juvenile Diabetes Research Foundation Grant 7-2006-328. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyan C, 2003, J IMMUNOL, V171, P5673, DOI 10.4049/jimmunol.171.11.5673; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Basadonna GP, 1998, P NATL ACAD SCI USA, V95, P3821, DOI 10.1073/pnas.95.7.3821; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Battaglia M, 2010, TRANSPL INT, V23, P761, DOI 10.1111/j.1432-2277.2010.01127.x; Davies JD, 1999, J IMMUNOL, V163, P5353; Dijke IE, 2008, HUM IMMUNOL, V69, P389, DOI 10.1016/j.humimm.2008.05.006; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gagliani N, 2010, DIABETES, V59, P433, DOI 10.2337/db09-1168; Grinyo JM, 2009, AM J TRANSPLANT, V9, P2447, DOI 10.1111/j.1600-6143.2009.02812.x; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hadaya K, 2005, J AUTOIMMUN, V24, P125, DOI 10.1016/j.jaut.2005.01.001; Kared H, 2005, DIABETES, V54, P78, DOI 10.2337/diabetes.54.1.78; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Luke PPW, 2006, AM J TRANSPLANT, V6, P2023, DOI 10.1111/j.1600-6143.2006.01451.x; Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Monti P, 2008, DIABETES, V57, P2341, DOI 10.2337/db08-0138; Morris ES, 2004, BLOOD, V103, P3573, DOI 10.1182/blood-2003-08-2864; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Ponticelli C, 2004, J NEPHROL, V17, P762; Pot C, 2010, J INTERF CYTOK RES, V30, P381, DOI 10.1089/jir.2010.0047; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Rutella S, 2002, BLOOD, V100, P2562, DOI 10.1182/blood-2001-12-0291; Rutella S, 2007, TRANSPLANTATION, V84, pS26, DOI 10.1097/01.tp.0000269611.66517.bf; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sanchez-Fueyo A, 2011, GASTROENTEROLOGY, V140, P51, DOI 10.1053/j.gastro.2010.10.059; Turka LA, 2009, NAT REV IMMUNOL, V9, P521, DOI 10.1038/nri2568; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Walsh PT, 2004, J CLIN INVEST, V114, P1398, DOI 10.1172/JCI200423238; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	37	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28434	10.1371/journal.pone.0028434	http://dx.doi.org/10.1371/journal.pone.0028434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174806	Green Accepted, gold, Green Published			2022-12-27	WOS:000298365700036
J	Han, QJ; Zhang, C; Zhang, J; Tian, ZG				Han, Qiuju; Zhang, Cai; Zhang, Jian; Tian, Zhigang			Involvement of Activation of PKR in HBx-siRNA-Mediated Innate Immune Effects on HBV Inhibition	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DEPENDENT PROTEIN-KINASE; SHORT INTERFERING RNA; PLASMACYTOID DENDRITIC CELLS; INDUCIBLE GENE-I; RIG-I; X PROTEIN; IFN-ALPHA; INDUCTION; INFECTION	RNA interference (RNAi) of virus-specific genes offers the possibility of developing a new anti-hepatitis B virus (anti-HBV) therapy. Recent studies have revealed that siRNAs can induce an innate immune response in vitro and in vivo. Here, HBVx (HBx) mRNA expression and HBV replication were significantly inhibited, followed by the enhancement of expression of type I interferons (IFNs), IFN-stimulated genes (ISG15 and ISG56) and proinflammatory cytokines after HepG2.2.15 cells were transfected with chemically synthesized HBx-siRNAs. Transfection with HBx-siRNAs also significantly increased expression of dsRNA-dependent protein kinase R (PKR) in HepG2.2.15 cells, followed by activation of downstream signaling events such as eukaryotic initiation factor 2 alpha (eIF2-alpha). In PKR-over-expressing HepG2.2.15 cells, HBx-siRNAs exerted more potent inhibitory effects on HBV replication and greater production of type I IFNs. By contrast, the inhibitory effect of HBx-siRNAs on HBV replication was attenuated when PKR was inhibited or silenced, demonstrating that HBx-siRNAs greatly promoted PKR activation, leading to the higher production of type I IFN. Therefore, we concluded that PKR is involved in the innate immune effects mediated by HBx-siRNAs and further contributes to HBV inhibition. The bifunctional siRNAs with both gene silencing and innate immune activation properties may represent a new potential strategy for treatment of HBV.	[Han, Qiuju; Zhang, Cai; Zhang, Jian; Tian, Zhigang] Shandong Univ, Sch Pharmaceut Sci, Inst Immunopharmacol & Immunotherapy, Jinan 250100, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Dept Immunol, Sch Life Sci, Hefei 230026, Peoples R China	Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Han, QJ (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Inst Immunopharmacol & Immunotherapy, Jinan 250100, Peoples R China.	caizhangsd@sdu.edu.cn; tzg@ustc.edu.cn	Zhang, Jian/AAQ-3068-2021; Tian, Zhigang/J-3512-2013		National Natural Science Foundation of China [90713033, 30901307, 30772497]; National 973 Basic Research Program of China [2007CB815803]; National 115 Key Project for HBV Research [2008ZX10002-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National 115 Key Project for HBV Research	National Natural Science Foundation of China (90713033, 30901307, and 30772497), the National 973 Basic Research Program of China (2007CB815803) and the National 115 Key Project for HBV Research (2008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong ME, 2008, J IMMUNOL, V180, P7125, DOI 10.4049/jimmunol.180.11.7125; Balachandran S, 1998, EMBO J, V17, P6888, DOI 10.1093/emboj/17.23.6888; Balachandran S, 2000, IMMUNITY, V13, P129, DOI 10.1016/S1074-7613(00)00014-5; Bourquin C, 2009, J IMMUNOL, V183, P6078, DOI 10.4049/jimmunol.0901594; Cho WG, 2009, P NATL ACAD SCI USA, V106, P7137, DOI 10.1073/pnas.0812317106; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Davis AM, 2008, J IMMUNOL, V180, P6923, DOI 10.4049/jimmunol.180.10.6923; Donze O, 1999, VIROLOGY, V256, P322, DOI 10.1006/viro.1999.9618; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gorina R, 2009, GLIA, V57, P93, DOI 10.1002/glia.20738; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Han QJ, 2011, HEPATOLOGY, V54, P1179, DOI 10.1002/hep.24505; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hosel M, 2009, HEPATOLOGY, V50, P1773, DOI 10.1002/hep.23226; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang JY, 2010, PROTEIN CELL, V1, P1106, DOI 10.1007/s13238-010-0141-8; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Khairuddin N, 2011, IMMUNOL CELL BIOL; Konishi M, 2003, HEPATOLOGY, V38, P842, DOI 10.1053/jhep.2003.50416; Kuo TM, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-41; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Morrissey DV, 2005, HEPATOLOGY, V41, P1349, DOI 10.1002/hep.20702; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Nayak R, 2007, J VIROL, V81, P11908, DOI 10.1128/JVI.01132-07; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saelens X, 2001, J BIOL CHEM, V276, P41620, DOI 10.1074/jbc.M103674200; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shlomai A, 2003, HEPATOLOGY, V37, P764, DOI 10.1053/jhep.2003.50146; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wang XM, 2010, CELL MOL IMMUNOL, V7, P341, DOI 10.1038/cmi.2010.36; Wei CW, 2010, J IMMUNOL, V185, P1158, DOI 10.4049/jimmunol.0903874; Wu J, 2009, HEPATOLOGY, V49, P1132, DOI 10.1002/hep.22751; Xu Y, 2009, MOL IMMUNOL, V46, P2640, DOI 10.1016/j.molimm.2009.04.031; Yu SY, 2010, J GEN VIROL, V91, P2080, DOI 10.1099/vir.0.020552-0; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174; Zhang ZR, 2006, J CELL BIOCHEM, V97, P1217, DOI 10.1002/jcb.20716	45	43	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27931	10.1371/journal.pone.0027931	http://dx.doi.org/10.1371/journal.pone.0027931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174754	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600009
J	Hemsley, PA; Grierson, CS				Hemsley, Piers A.; Grierson, Claire S.			The Ankyrin Repeats and DHHC S-acyl Transferase Domain of AKR1 Act Independently to Regulate Switching from Vegetative to Mating States in Yeast	PLOS ONE			English	Article							PHEROMONE RESPONSE PATHWAY; 2-STEP REACTION-MECHANISM; CONTAINING PROTEIN AKR1P; DUAL LIPID MODIFICATION; G-BETA-GAMMA; SACCHAROMYCES-CEREVISIAE; PALMITOYL TRANSFERASE; PLASMA-MEMBRANE; KINASE; LOCALIZATION	Signal transduction from G-protein coupled receptors to MAPK cascades through heterotrimeric G-proteins has been described for many eukaryotic systems. One of the best-characterised examples is the yeast pheromone response pathway, which is negatively regulated by AKR1. AKR1-like proteins are present in all eukaryotes and contain a DHHC domain and six ankyrin repeats. Whilst the DHHC domain dependant S-acyl transferase (palmitoyl transferase) function of AKR1 is well documented it is not known whether the ankyrin repeats are also required for this activity. Here we show that the ankyrin repeats of AKR1 are required for full suppression of the yeast pheromone response pathway, by sequestration of the G beta gamma dimer, and act independently of AKR1 S-acylation function. Importantly, the functions provided by the AKR1 ankyrin repeats and DHHC domain are not required on the same molecule to fully restore WT phenotypes and function. We also show that AKR1 molecules are S-acylated at locations other than the DHHC cysteine, increasing the abundance of AKR1 in the cell. Our results have important consequences for studies of AKR1 function, including recent attempts to characterise S-acylation enzymology and kinetics. Proteins similar to AKR1 are found in all eukaryotes and our results have broad implications for future work on these proteins and the control of switching between G beta gamma regulated pathways.	[Hemsley, Piers A.; Grierson, Claire S.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Hemsley, PA (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	piers.hemsley@bristol.ac.uk		Hemsley, Piers/0000-0003-2950-0634	Biotechnology and Biological Sciences Research Council UK [BB/D013585/1]; Biotechnology and Biological Sciences Research Council [BB/D013585/1] Funding Source: researchfish; BBSRC [BB/D013585/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded in the UK by grant number BB/D013585/1 from the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu P, 2004, J BIOL CHEM, V279, P27138, DOI 10.1074/jbc.M403071200; Brachmann CB, 1998, YEAST, V14, P115; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Feng Y, 2000, MOL CELL BIOL, V20, P5350, DOI 10.1128/MCB.20.14.5350-5359.2000; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Givan SA, 1997, MOL BIOL CELL, V8, P1317, DOI 10.1091/mbc.8.7.1317; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Harada T, 2003, GENES CELLS, V8, P493, DOI 10.1046/j.1365-2443.2003.00650.x; Hemsley PA, 2005, PLANT CELL, V17, P2554, DOI 10.1105/tpc.105.031237; Hemsley Piers A, 2008, Plant Methods, V4, P2, DOI 10.1186/1746-4811-4-2; Hirschman JE, 1999, MOL CELL BIOL, V19, P7705; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Kao LR, 1996, MOL CELL BIOL, V16, P168; Kihara A, 2005, MOL CELL BIOL, V25, P9189, DOI 10.1128/MCB.25.21.9189-9197.2005; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Manahan CL, 2000, MOL BIOL CELL, V11, P957, DOI 10.1091/mbc.11.3.957; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Pryciak PM, 1996, MOL CELL BIOL, V16, P2614; Robinson LC, 1999, MOL BIOL CELL, V10, P1077, DOI 10.1091/mbc.10.4.1077; ROBINSON LC, 1992, P NATL ACAD SCI USA, V89, P28, DOI 10.1073/pnas.89.1.28; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Seo M, 2002, J BIOL CHEM, V277, P24197, DOI 10.1074/jbc.M201717200; SIKORSKI RS, 1989, GENETICS, V122, P19; Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Stahlberg A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-170; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Yang W, PROTEOME SCALE CHARA, P54	42	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28799	10.1371/journal.pone.0028799	http://dx.doi.org/10.1371/journal.pone.0028799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174902	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600045
J	Torok, ME; Bang, ND; Tran, THC; Nguyen, TBY; Thwaites, GE; Quy, HT; Dung, NH; Hien, TT; Chinh, NT; Hoang, HTT; Wolbers, M; Farrar, JJ				Toeroek, M. Estee; Nguyen Duc Bang; Tran Thi Hong Chau; Nguyen Thi Bich Yen; Thwaites, Guy E.; Hoang Thi Quy; Nguyen Huy Dung; Tran Tinh Hien; Nguyen Tran Chinh; Hoang Thi Thanh Hoang; Wolbers, Marcel; Farrar, Jeremy J.			Dexamethasone and Long-Term Outcome of Tuberculous Meningitis in Vietnamese Adults and Adolescents	PLOS ONE			English	Article								Background: Dexamethasone has been shown to reduce mortality in patients with tuberculous meningitis but the long-term outcome of the disease is unknown. Methods: Vietnamese adults and adolescents with tuberculous meningitis recruited to a randomised, double-blind, placebo-controlled trial of adjunctive dexamethasone were followed-up at five years, to determine the effect of dexamethasone on long-term survival and neurological disability. Results: 545 patients were randomised to receive either dexamethasone (274 patients) or placebo (271 patients). 50 patients (9.2%) were lost to follow-up at five years. In all patients two-year survival, probabilities tended to be higher in the dexamethasone arm (0.63 versus 0.55; p = 0.07) but five-year survival rates were similar (0.54 versus 0.51, p = 0.51) in both groups. In patients with grade 1 TBM, but not with grade 2 or grade 3 TBM, the benefit of dexamethasone treatment tended to persist over time (five-year survival probabilities 0.69 versus 0.55, p = 0.07) but there was no conclusive evidence of treatment effect heterogeneity by TBM grade (p = 0.36). The dexamethasone group had a similar proportion of severely disabled patients among survivors at five years as the placebo group (17/128, 13.2% vs. 17/116, 14.7%) and there was no significant association between dexamethasone treatment and disability status at five years (p = 0.32). Conclusions: Adjunctive dexamethasone appears to improve the probability of survival in patients with TBM, until at least two years of follow-up. We could not demonstrate a five-year survival benefit of dexamethasone treatment which may be confined to patients with grade 1 TBM.	[Toeroek, M. Estee] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Nguyen Duc Bang; Nguyen Thi Bich Yen; Hoang Thi Quy; Nguyen Huy Dung] Pham Ngoc Thach Hosp, Ho Chi Minh City, Vietnam; [Tran Thi Hong Chau; Tran Tinh Hien; Nguyen Tran Chinh] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Thwaites, Guy E.] Kings Coll London, St Thomass Hosp, Ctr Clin Infect & Diagnost Res, London WC2R 2LS, England; [Hoang Thi Thanh Hoang; Wolbers, Marcel; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam; [Wolbers, Marcel; Farrar, Jeremy J.] Univ Oxford, Ctr Trop Med, Oxford, England	University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; University of Oxford	Torok, ME (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	estee.torok@addenbrookes.nhs.uk	Thwaites, Guy E/R-4993-2019; Farrar, Jeremy J./HGA-7610-2022	Thwaites, Guy E/0000-0002-2858-2087; Farrar, Jeremy/0000-0002-2700-623X; Torok, Mili Estee/0000-0001-9098-8590	Wellcome Trust, United Kingdom; NIHR Cambridge Biomedical Research Centre	Wellcome Trust, United Kingdom(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	The study was supported by the Wellcome Trust, United Kingdom. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the patients and their relatives for participating in the study and the clinical and laboratory staff of Pham Ngoc Thach hospital and the Hospital for Tropical Diseases for assisting with the study. MET would also like to acknowledge the support of the NIHR Cambridge Biomedical Research Centre.	[Anonymous], 1958, LANCET, V2, P837; [Anonymous], 2009, LANG ENV STAT COMP; ASHBY M, 1955, LANCET, V1, P65; ESCOBAR JA, 1975, PEDIATRICS, V56, P1050; GIRGIS NI, 1991, PEDIATR INFECT DIS J, V10, P179, DOI 10.1097/00006454-199103000-00002; LEPPER MH, 1963, ANN NY ACAD SCI, V106, P106, DOI 10.1111/j.1749-6632.1963.tb16629.x; National Institute for Health and Clinical Excellence, 2011, NICE CLIN GUID; OTOOLE RD, 1969, ANN INTERN MED, V70, P39, DOI 10.7326/0003-4819-70-1-39; Prasad K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub3; Schoeman J, 2002, DEV MED CHILD NEUROL, V44, P522, DOI 10.1017/S0012162201002493; Schoeman JF, 1997, PEDIATRICS, V99, P226, DOI 10.1542/peds.99.2.226; SHANE SJ, 1953, NEW ENGL J MED, V249, P829, DOI 10.1056/NEJM195311192492101; Simmons CP, 2005, J IMMUNOL, V175, P579, DOI 10.4049/jimmunol.175.1.579; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites G, 2009, J INFECTION, V59, P167, DOI 10.1016/j.jinf.2009.06.011; [No title captured], DOI DOI 10.1002/14651858.CD002244	16	55	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27821	10.1371/journal.pone.0027821	http://dx.doi.org/10.1371/journal.pone.0027821			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174748	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600006
J	Duran-Pinedo, AE; Paster, B; Teles, R; Frias-Lopez, J				Duran-Pinedo, Ana E.; Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge			Correlation Network Analysis Applied to Complex Biofilm Communities	PLOS ONE			English	Article							GENE-COEXPRESSION NETWORK; MICROBIAL COMMUNITIES; BACTERIAL DIVERSITY; SUBGINGIVAL PLAQUE; ANALYSIS REVEALS; IDENTIFICATION; TRANSCRIPTOME; ORGANIZATION; MODULARITY; FRAMEWORK	The complexity of the human microbiome makes it difficult to reveal organizational principles of the community and even more challenging to generate testable hypotheses. It has been suggested that in the gut microbiome species such as Bacteroides thetaiotaomicron are keystone in maintaining the stability and functional adaptability of the microbial community. In this study, we investigate the interspecies associations in a complex microbial biofilm applying systems biology principles. Using correlation network analysis we identified bacterial modules that represent important microbial associations within the oral community. We used dental plaque as a model community because of its high diversity and the well known species-species interactions that are common in the oral biofilm. We analyzed samples from healthy individuals as well as from patients with periodontitis, a polymicrobial disease. Using results obtained by checkerboard hybridization on cultivable bacteria we identified modules that correlated well with microbial complexes previously described. Furthermore, we extended our analysis using the Human Oral Microbe Identification Microarray (HOMIM), which includes a large number of bacterial species, among them uncultivated organisms present in the mouth. Two distinct microbial communities appeared in healthy individuals while there was one major type in disease. Bacterial modules in all communities did not overlap, indicating that bacteria were able to effectively re-associate with new partners depending on the environmental conditions. We then identified hubs that could act as keystone species in the bacterial modules. Based on those results we then cultured a not-yet-cultivated microorganism, Tannerella sp.OT286 (clone BU063). After two rounds of enrichment by a selected helper (Prevotella oris OT311) we obtained colonies of Tannerella sp.OT286 growing on blood agar plates. This system-level approach would open the possibility of manipulating microbial communities in a targeted fashion as well as associating certain bacterial modules to clinical traits (e. g.: obesity, Crohn's disease, periodontal disease, etc).	[Duran-Pinedo, Ana E.; Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge] Forsyth Inst, Cambridge, MA 02142 USA; [Paster, Bruce; Teles, Ricardo; Frias-Lopez, Jorge] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Forsyth Institute; Harvard University; Harvard School of Dental Medicine	Duran-Pinedo, AE (corresponding author), Forsyth Inst, Cambridge, MA 02142 USA.	jfrias@forsyth.org	Paster, Bruce J/AAP-8559-2021	Frias-Lopez, Jorge/0000-0002-2097-3171; Duran-Pinedo, Ana/0000-0001-5648-6597				Allen E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-62; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Choi JK, 2005, BIOINFORMATICS, V21, P4348, DOI 10.1093/bioinformatics/bti722; Chung HC, 2010, ISME J, V4, P817, DOI 10.1038/ismej.2009.157; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Frias J, 2001, INFECT IMMUN, V69, P3431, DOI 10.1128/IAI.69.5.3431-3434.2001; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Haffajee AD, 2008, ORAL MICROBIOL IMMUN, V23, P148, DOI 10.1111/j.1399-302X.2007.00403.x; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Haffajee AD, 2005, PERIODONTOL 2000, V38, P9, DOI 10.1111/j.1600-0757.2005.00112.x; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jordan F, 2009, PHILOS T R SOC B, V364, P1733, DOI 10.1098/rstb.2008.0335; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631; Kolenbrander PE, 2000, ANNU REV MICROBIOL, V54, P413, DOI 10.1146/annurev.micro.54.1.413; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lin CY, 2008, NUCLEIC ACIDS RES, V36, pW438, DOI 10.1093/nar/gkn257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sissons CH, 2007, CARIES RES, V41, P413, DOI 10.1159/000104801; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Steele JA, 2011, ISME J; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P648, DOI 10.1034/j.1600-051x.2000.027009648.x; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou JZ, 2011, MBIO, V2, DOI 10.1128/mBio.00122-11; Zuger J, 2007, MICROBIOL-SGM, V153, P3809, DOI 10.1099/mic.0.2007/010926-0	49	81	86	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28438	10.1371/journal.pone.0028438	http://dx.doi.org/10.1371/journal.pone.0028438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163302	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900039
J	Lenz, G; Doron-Faigenboim, A; Ron, EZ; Tuller, T; Gophna, U				Lenz, Gal; Doron-Faigenboim, Adi; Ron, Eliora Z.; Tuller, Tamir; Gophna, Uri			Sequence Features of E. coli mRNAs Affect Their Degradation	PLOS ONE			English	Article							CODON USAGE BIAS; ESCHERICHIA-COLI; GENE-EXPRESSION; STRESS-RESPONSE; DECAY; TRANSLATION; STABILITY; PROTEINS; BACTERIA; BINDING	Degradation of mRNA in bacteria is a regulatory mechanism, providing an efficient way to fine-tune protein abundance in response to environmental changes. While the mechanisms responsible for initiation and subsequent propagation of mRNA degradation are well studied, the mRNA features that affect its stability are yet to be elucidated. We calculated three properties for each mRNA in the E. coli transcriptome: G+C content, tRNA adaptation index (tAI) and folding energy. Each of these properties were then correlated with the experimental transcript half life measured for each transcript and detected significant correlations. A sliding window analysis identified the regions that displayed the maximal signal. The correlation between transcript half life and both G+C content and folding energy was strongest at the 59 termini of the mRNAs. Partial correlations showed that each of the parameters contributes separately to mRNA half life. Notably, mRNAs of recently-acquired genes in the E. coli genome, which have a distinct nucleotide composition, tend to be highly stable. This high stability may aid the evolutionary fixation of horizontally acquired genes.	[Lenz, Gal; Doron-Faigenboim, Adi; Ron, Eliora Z.; Gophna, Uri] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel; [Tuller, Tamir] Tel Aviv Univ, Iby & Aladar Fleischman Fac Engn, Ramat Aviv, Israel	Tel Aviv University; Tel Aviv University	Lenz, G (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, George S Wise Fac Life Sci, Ramat Aviv, Israel.	urigo@post.tau.ac.il	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652; Tuller, Tamir/0000-0003-4194-7068				Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Braun F, 1998, EMBO J, V17, P4790, DOI 10.1093/emboj/17.16.4790; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; El-Sharoud Walid M., 2007, Science Progress, V90, P15, DOI 10.3184/003685007780440549; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Feng L, 2007, BIOCHEM GENET, V45, P131, DOI 10.1007/s10528-006-9059-5; GROSS G, 1990, J BIOL CHEM, V265, P17627; Gu W, PLOS COMPUT BIOL, V6, pe100; Guisbert E, 2007, J BACTERIOL, V189, P1963, DOI 10.1128/JB.01243-06; Jia MW, 2005, FEBS LETT, V579, P5333, DOI 10.1016/j.febslet.2005.08.059; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Nakamura Y, 2004, NAT GENET, V36, P760, DOI 10.1038/ng1381; Nierlich DP, 1996, PROG NUCLEIC ACID RE, V52, P153, DOI 10.1016/S0079-6603(08)60967-8; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Phadtare S, 2009, J MOL MICROB BIOTECH, V17, P110, DOI 10.1159/000226587; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shenhar Y, 2009, ENVIRON MICROBIOL, V11, P2989, DOI 10.1111/j.1462-2920.2009.01993.x; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tuller T, CELL, V141, P344; Tuller T, P NATL ACAD SCI US, V107, P3645; Tuller T, GENOME BIOL IN PRESS; Vytvytska O, 2000, GENE DEV, V14, P1109	31	18	19	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28544	10.1371/journal.pone.0028544	http://dx.doi.org/10.1371/journal.pone.0028544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163312	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900048
J	O'Bryant, SE; Xiao, GH; Barber, R; Huebinger, R; Wilhelmsen, K; Edwards, M; Graff-Radford, N; Doody, R; Diaz-Arrastia, R				O'Bryant, Sid E.; Xiao, Guanghua; Barber, Robert; Huebinger, Ryan; Wilhelmsen, Kirk; Edwards, Melissa; Graff-Radford, Neill; Doody, Rachelle; Diaz-Arrastia, Ramon		Texas Alzheimer's Res Care; Alzheimer's Dis Neuroimaging	A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CEREBROSPINAL-FLUID; BIOMARKERS; DIAGNOSIS; DEMENTIA; MARKER; ALGORITHM; BDNF; MCI	Context: There is no rapid and cost effective tool that can be implemented as a front-line screening tool for Alzheimer's disease (AD) at the population level. Objective: To generate and cross-validate a blood-based screener for AD that yields acceptable accuracy across both serum and plasma. Design, Setting, Participants: Analysis of serum biomarker proteins were conducted on 197 Alzheimer's disease (AD) participants and 199 control participants from the Texas Alzheimer's Research Consortium (TARC) with further analysis conducted on plasma proteins from 112 AD and 52 control participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). The full algorithm was derived from a biomarker risk score, clinical lab (glucose, triglycerides, total cholesterol, homocysteine), and demographic (age, gender, education, APOE*E4 status) data. Major Outcome Measures: Alzheimer's disease. Results: 11 proteins met our criteria and were utilized for the biomarker risk score. The random forest (RF) biomarker risk score from the TARC serum samples (training set) yielded adequate accuracy in the ADNI plasma sample (training set) (AUC = 0.70, sensitivity (SN) = 0.54 and specificity (SP) = 0.78), which was below that obtained from ADNI cerebral spinal fluid (CSF) analyses (t-tau/A beta ratio AUC = 0.92). However, the full algorithm yielded excellent accuracy (AUC = 0.88, SN = 0.75, and SP = 0.91). The likelihood ratio of having AD based on a positive test finding (LR+) = 7.03 (SE = 1.17; 95% CI = 4.49-14.47), the likelihood ratio of not having AD based on the algorithm (LR-) = 3.55 (SE = 1.15; 2.22-5.71), and the odds ratio of AD were calculated in the ADNI cohort (OR) = 28.70 (1.55; 95% CI = 11.86-69.47). Conclusions: It is possible to create a blood-based screening algorithm that works across both serum and plasma that provides a comparable screening accuracy to that obtained from CSF analyses.	[O'Bryant, Sid E.] Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, F Marie Hall Inst Rural & Community Hlth,Garrison, Lubbock, TX 79430 USA; [Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Barber, Robert] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Huebinger, Ryan] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Wilhelmsen, Kirk] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Edwards, Melissa] Texas Tech Univ, Dept Psychol, Lubbock, TX 79430 USA; [Graff-Radford, Neill] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Doody, Rachelle] Baylor Coll Med, Dept Neurol, Alzheimers Dis & Memory Disorders Ctr, Houston, TX 77030 USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD USA	Texas Tech University System; Texas Tech University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Texas System; University of North Texas Health Science Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Texas Tech University System; Texas Tech University; Mayo Clinic; Baylor College of Medicine; Uniformed Services University of the Health Sciences - USA	O'Bryant, SE (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Neurol, F Marie Hall Inst Rural & Community Hlth,Garrison, Lubbock, TX 79430 USA.	Sid.Obryant@ttuhsc.edu		O'Bryant, Sid/0000-0003-0582-5266; Ballantyne, Christie/0000-0002-6432-1730; Diaz-Arrastia, Ramon/0000-0001-6051-3594	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; NIH, NIA [P30AG12300]; Cynthia and George Mitchell Foundation; CH Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; GlaxoSmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co.; Medpace, Inc.; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; U.S. Food and Drug Administration; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG010129, U19AG010483, U01AG024904, P30AG012300] Funding Source: NIH RePORTER	state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders; NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Cynthia and George Mitchell Foundation(General Electric); CH Foundation; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); GlaxoSmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co.(Eli Lilly); Medpace, Inc.; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; U.S. Food and Drug Administration; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was made possible by the Texas Alzheimer's Research Consortium funded by the state of Texas through the Texas Council on Alzheimer's Disease and Related Disorders. Investigators at the UTSW acknowledge NIH, NIA grant P30AG12300. The investigations at Baylor's Alzheimer's Disease and Memory Disorders Center were supported by the Cynthia and George Mitchell Foundation. Investigators at Texas Tech University Health Sciences Center were supported by The CH Foundation. ADNI. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interest: In the TARC, a patent has been submitted on this blood-based screener. There are no other products in development or marketed products to declare. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ADNI has received funding from the following commercial sources: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. ADNI data is freely available to any interested scientists.	Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; [Anonymous], 1998, Neurobiol Aging, V19, P109; [Anonymous], 1998, NEUROBIOL AGING, V19, P285; Boustani M, 2005, J GEN INTERN MED, V20, P572, DOI 10.1007/s11606-005-0103-7; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, MANUAL SETTING USING; Brys M, 2009, J ALZHEIMERS DIS, V16, P351, DOI 10.3233/JAD-2009-0968; Buerger K, 2009, BIOL PSYCHIAT, V65, P979, DOI 10.1016/j.biopsych.2009.01.032; Cui YF, 2011, PANCREATOLOGY, V11, P279, DOI 10.1159/000329188; Doody R, CLIN DRUG I IN PRESS; Ewers M, 2010, EXP GERONTOL, V45, P75, DOI 10.1016/j.exger.2009.09.005; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Galimberti D, 2006, NEUROBIOL AGING, V27, P1763, DOI 10.1016/j.neurobiolaging.2005.10.007; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gustafson DR, 2010, J NEUROL SCI, V299, P30, DOI 10.1016/j.jns.2010.08.036; Hu WT, 2010, ACTA NEUROPATHOL, V119, P669, DOI 10.1007/s00401-010-0667-0; Komulainen P, 2008, NEUROBIOL LEARN MEM, V90, P596, DOI 10.1016/j.nlm.2008.07.014; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Luis CA, 2009, AGING NEUROPSYCHOL C, V16, P203, DOI 10.1080/13825580802411766; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Midwood KS, 2011, CELL MOL LIFE SCI, V68, P3175, DOI 10.1007/s00018-011-0783-6; O'Bryant S, ARCH NEUROL IN PRESS; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; O'Bryant SE, 2011, DEMENT GERIATR COGN, V32, P55, DOI 10.1159/000330750; O'Bryant SE, 2011, DEMENT GERIATR COGN, V31, P31, DOI 10.1159/000321980; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; O'Bryant SE, 2010, J GERIATR PSYCH NEUR, V23, P49, DOI 10.1177/0891988709351832; O'Bryant SE, 2009, J ALZHEIMERS DIS, V17, P337, DOI 10.3233/JAD-2009-1051; Osborne J.W., 2010, PRACT ASSESS RES EVA, V15, P1, DOI [10.7275/qbpc-gk17, DOI 10.7275/QBPC-GK17]; R Core Team, 2021, R LANGUAGE ENV STAT; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Reddy MM, 2011, CELL, V144, P132, DOI 10.1016/j.cell.2010.11.054; Schneider P, 2009, CNS NEUROSCI THER, V15, P358, DOI 10.1111/j.1755-5949.2009.00104.x; Soares HD, 2009, IDENTIFYING EARLY MA, P56; Sokolova A, 2009, BRAIN PATHOL, V19, P392, DOI 10.1111/j.1750-3639.2008.00188.x; Steinacker P, 2004, NEUROSCI LETT, V370, P36, DOI 10.1016/j.neulet.2004.07.061; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; Teunissen CE, 2011, EUR J NEUROL, V18, P865, DOI 10.1111/j.1468-1331.2010.03273.x; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2008, NEUROIMAGE, V39, P1186, DOI 10.1016/j.neuroimage.2007.09.073; Waring S., 2008, TEX PUBLIC HLTH J, V60, P9; Zellner M, 2009, ACTA NEUROPATHOL, V118, P181, DOI 10.1007/s00401-009-0502-7; Zhang D, 2011, NEUROIMAGE; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011	48	105	108	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28092	10.1371/journal.pone.0028092	http://dx.doi.org/10.1371/journal.pone.0028092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163278	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900013
J	Andrews, N; Waight, PA; Borrow, R; Ladhani, S; George, RC; Slack, MPE; Miller, E				Andrews, Nick; Waight, Pauline A.; Borrow, Ray; Ladhani, Shamez; George, Robert C.; Slack, Mary P. E.; Miller, Elizabeth			Using the Indirect Cohort Design to Estimate the Effectiveness of the Seven Valent Pneumococcal Conjugate Vaccine in England and Wales	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; INFANTS; DISEASE; IMMUNOGENICITY; SCHEDULE; EFFICACY; CHILDREN	Background: The 7-valent pneumococcal conjugate vaccine (PCV-7) was introduced in the United Kingdom in 2006 with a 2,3 and 13month schedule, and has led to large decreases in invasive pneumococcal disease (IPD) caused by the vaccine serotypes in both vaccinated and unvaccinated cohorts. We estimated the effectiveness of PCV-7 against IPD. Methods and Findings: We used enhanced surveillance data, collated at the Health Protection Agency, on vaccine type (n = 153) and non vaccine type (n = 919) IPD cases eligible for PCV-7. The indirect cohort method, a case-control type design which uses non vaccine type cases as controls, was used to estimate effectiveness of various numbers of doses as well as for each vaccine serotype. Possible bias with this design, caused by differential serotype replacement in vaccinated and unvaccinated individuals, was estimated after deriving formulae to quantify the bias. The results showed good effectiveness, increasing from 56% (95% confidence interval (CI): -7-82) for a single dose given under one year of age to 93% (95% CI: 7098) for two doses under one year of age plus a booster dose in the second year of life. Serotype specific estimates indicated higher effectiveness against serotypes 4, 14 and 18C and lower effectiveness against 6B. Under the assumption of complete serotype replacement by non vaccine serotypes in carriage, we estimated that effectiveness estimates may be overestimated by about 2 to 5%. Conclusions: This study shows high effectiveness of PCV-7 under the reduced schedule used in the UK. This finding agrees with the large reductions seen in vaccine type IPD in recent years in England and Wales. The formulae derived to assess the bias of the indirect cohort method for PCV-7 can also be used when using the design for other vaccines that affect carriage such as the recently introduced 13 valent pneumococcal conjugate vaccine.	[Andrews, Nick] Hlth Protect Agcy, Stat Modelling & Econ Dept, Hlth Protect Serv, London, England; [Waight, Pauline A.; Ladhani, Shamez; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, Hlth Protect Serv, London, England; [Borrow, Ray] Hlth Protect Agcy, Microbiol Serv Div, Vaccine Evaluat Unit, Manchester, Lancs, England; [George, Robert C.; Slack, Mary P. E.] Hlth Protect Agcy, Microbiol Serv Div, Resp & Syst Infect Lab, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency	Andrews, N (corresponding author), Hlth Protect Agcy, Stat Modelling & Econ Dept, Hlth Protect Serv, London, England.	nick.andrews@hpa.org.uk		Ladhani, Shamez/0000-0002-0856-2476	Health Protection Agency; Pfizer; GlaxoSmithKline; Sanofi Pasteur; Merck	Health Protection Agency; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Sanofi Pasteur; Merck(Merck & Company)	Funding was provided by the Health Protection Agency. The funder had no role in study design, data collection and analysis or preparation of the manuscript. The funder approved the submission of the manuscript.; RB has performed contract research on behalf of the Health Protection Agency that was funded by Pfizer, GlaxoSmithKline, Sanofi Pasteur, and Merck. MS has received assistance to attend scientific meetings from Pfizer and GlaxoSmithKline and research funding from Pfizer and GlaxoSmithKline. RG has received support for conference attendance from Pfizer and GlaxoSmithKline, and his laboratory has received research funding from Pfizer and GlaxoSmithKline. SL has received assistance to attend scientific meetings from Pfizer and GlaxoSmithKline. This declaration does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. None of the funding from Pfizer, GlaxoSmithKline, Sanofi Pasteur, or Merck was used specifically for this study.	[Anonymous], 2006, IMMUNISATION INFECT; [Anonymous], 2005, NHS MAT STAT 2005 06; Barricarte A, 2007, CLIN INFECT DIS, V44, P1436, DOI 10.1086/516779; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Deceuninck G, 2010, PEDIATR INFECT DIS J, V29, P546, DOI 10.1097/INF.0b013e3181cffa2a; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Goldblatt D, 2006, PEDIATR INFECT DIS J, V25, P312, DOI 10.1097/01.inf.0000207483.60267.e7; Goldblatt D, 2010, PEDIATR INFECT DIS J, V29, P401, DOI 10.1097/INF.0b013e3181c67f04; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Lucero MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2; Mahon BE, 2006, VACCINE, V24, P2514, DOI 10.1016/j.vaccine.2005.12.025; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Pilishvili T, 2010, PEDIATRICS, V126, pE9, DOI 10.1542/peds.2009-2150; Rinta-Kokko H, 2009, VACCINE, V27, P3831, DOI 10.1016/j.vaccine.2009.04.009; Ruckinger S, 2010, VACCINE, V28, P5012, DOI 10.1016/j.vaccine.2010.05.021; Salisbury DS, CHANGES CHILDHOOD PN; Sheppard CL, 2011, J MED MICROBIOL, V60, P49, DOI 10.1099/jmm.0.023150-0; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Weinberger DM, 2011, LANCET IN PRESS; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2	22	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28435	10.1371/journal.pone.0028435	http://dx.doi.org/10.1371/journal.pone.0028435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164292	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400093
J	Castaldo, E; Sabato, D; Lauro, D; Sesti, G; Marini, MA				Castaldo, Ersilia; Sabato, Donata; Lauro, Davide; Sesti, Giorgio; Marini, Maria Adelaide			Hypoglycemia Assessed by Continuous Glucose Monitoring Is Associated with Preclinical Atherosclerosis in Individuals with Impaired Glucose Tolerance	PLOS ONE			English	Article							CAROTID-ARTERY INTIMA; CARDIOVASCULAR OUTCOMES; MEDIA THICKNESS; TYPE-2; MORTALITY; RISK; HYPERGLYCEMIA; HEALTHY; EVENTS; SYSTEM	Hypoglycemia is associated with increased risk of cardiovascular adverse clinical outcomes. There is evidence that impaired glucose tolerance (IGT) is associated with cardiovascular morbidity and mortality. Whether IGT individuals have asymptomatic hypoglycemia under real-life conditions that are related to early atherosclerosis is unknown. To this aim, we measured episodes of hypoglycemia during continuous interstitial glucose monitoring (CGM) and evaluated their relationship with early manifestation of vascular atherosclerosis in glucose tolerant and intolerant individuals. An oral glucose tolerance test (OGTT) was performed in 79 non-diabetic subjects. Each individual underwent continuous glucose monitoring for 72 h. Cardiovascular risk factors and ultrasound measurement of carotid intima-media thickness (IMT) were evaluated. IGT individuals had a worse cardiovascular risk profile, including higher IMT, and spent significantly more time in hypoglycemia than glucose-tolerant individuals. IMT was significantly correlated with systolic (r = 0.22; P = 0.05) and diastolic blood pressure (r = 0.28; P = 0.01), total (r = 0.26; P = 0.02) and LDL cholesterol (r = 0.27; P = 0.01), 2-h glucose (r = 0.39; P<0.0001), insulin sensitivity (r = 20.26; P = 0.03), and minutes spent in hypoglycemia (r = 0.45; P<0.0001). In univariate analyses adjusted for gender, minutes spent in hypoglycemia were significantly correlated with age (r = 0.26; P = 0.01), waist circumference (r = 0.33; P = 0.003), 2-h glucose (r = 0.58; P<0.0001), and 2-h insulin (r = 0.27; P = 0.02). In a stepwise multivariate regression analysis, the variables significantly associated with IMT were minutes spent in hypoglycemia (r(2) = 0.252; P<0.0001), and ISI index (r(2) = 0.089; P = 0.004), accounting for 34.1% of the variation. Episodes of hypoglycemia may be considered as a new potential cardiovascular risk factor for IGT individuals.	[Castaldo, Ersilia; Sabato, Donata; Lauro, Davide; Marini, Maria Adelaide] Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy; [Sesti, Giorgio] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy	University of Rome Tor Vergata; Magna Graecia University of Catanzaro	Castaldo, E (corresponding author), Univ Roma Tor Vergata, Dept Internal Med, Rome, Italy.	sesti@unicz.it	Sesti, Giorgio/B-1509-2012; Lauro, Davide/K-4683-2018	Sesti, Giorgio/0000-0002-1618-7688; Lauro, Davide/0000-0002-8597-4415				Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Cardellini M, 2007, AM J PHYSIOL-ENDOC M, V292, pE347, DOI 10.1152/ajpendo.00291.2006; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Derosa G, 2009, DIABETES TECHNOL THE, V11, P159, DOI 10.1089/dia.2008.0101; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HILSTED J, 1984, DIABETOLOGIA, V26, P328; Johnston SS, 2011, DIABETES CARE, V34, P1164, DOI 10.2337/dc10-1915; Joy NG, 2010, DIABETES CARE, V33, P1529, DOI 10.2337/dc09-0354; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; Saydah SH, 2001, DIABETES CARE, V24, P1397, DOI 10.2337/diacare.24.8.1397; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	25	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28312	10.1371/journal.pone.0028312	http://dx.doi.org/10.1371/journal.pone.0028312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164268	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400069
J	Jung, IH; Jung, DE; Park, YN; Song, SY; Park, SW				Jung, In Hye; Jung, Dawoon E.; Park, Young Nyun; Song, Si Young; Park, Seung Woo			Aberrant Hedgehog Ligands Induce Progressive Pancreatic Fibrosis by Paracrine Activation of Myofibroblasts and Ductular Cells in Transgenic Zebrafish	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SONIC HEDGEHOG; SIGNALING PATHWAY; INDIAN HEDGEHOG; GENE-EXPRESSION; STELLATE CELLS; TGF-BETA; CANCER; PROMOTES; GLI1	Hedgehog (Hh) signaling is frequently up-regulated in fibrogenic pancreatic diseases including chronic pancreatitis and pancreatic cancer. Although recent series suggest exclusive paracrine activation of stromal cells by Hh ligands from epithelial components, debates still exist on how Hh signaling works in pathologic conditions. To explore how Hh signaling affects the pancreas, we investigated transgenic phenotypes in zebrafish that over-express either Indian Hh or Sonic Hh along with green fluorescence protein (GFP) to enable real-time observation, or GFP alone as control, at the ptf1a domain. Transgenic embryos and zebrafish were serially followed for transgenic phenotypes, and investigated using quantitative reverse transcription-polymerase chain reaction (qRT-PCR), in situ hybridization, and immunohistochemistry. Overexpression of Ihh or Shh reveals virtually identical phenotypes. Hh induces morphologic changes in a developing pancreas without derangement in acinar differentiation. In older zebrafish, Hh induces progressive pancreatic fibrosis intermingled with proliferating ductular structures, which is accompanied by the destruction of the acinar structures. Both myofibroblasts and ductular are activated and proliferated by paracrine Hh signaling, showing restricted expression of Hh downstream components including Patched1 (Ptc1), Smoothened (Smo), and Gli1/2 in those Hh-responsive cells. Hh ligands induce matrix metalloproteinases (MMPs), especially MMP9 in all Hh-responsive cells, and transform growth factor-beta 1 (TGF beta 1) only in ductular cells. Aberrant Hh over-expression, however, does not induce pancreatic tumors. On treatment with inhibitors, embryonic phenotypes are reversed by either cyclopamine or Hedgehog Primary Inhibitor-4 (HPI-4). Pancreatic fibrosis is only prevented by HPI-4. Our study provides strong evidence of Hh signaling which induces pancreatic fibrosis through paracrine activation of Hh-responsive cells in vivo. Induction of MMPs and TGF beta 1 by Hh signaling expands on the current understanding of how Hh signaling affects fibrosis and tumorigenesis. These transgenic models will be a valuable platform in exploring the mechanism of fibrogenic pancreatic diseases which are induced by Hh signaling activation.	[Jung, In Hye] Yonsei Univ, Coll Med, Inst Gastroenterol, Postgrad Sch,Natl Core Res Ctr Nanomed Technol, Seoul, South Korea; [Jung, Dawoon E.] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Pathol, Seoul, South Korea; [Song, Si Young; Park, Seung Woo] Yonsei Univ, Coll Med, Inst Gastroenterol, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jung, IH (corresponding author), Yonsei Univ, Coll Med, Inst Gastroenterol, Postgrad Sch,Natl Core Res Ctr Nanomed Technol, Seoul, South Korea.	swoopark@yuhs.ac	Lee, In Sook/J-9324-2013; Song, SY/E-2891-2012	Park, Young Nyun/0000-0003-0357-7967; Song, Si Young/0000-0002-1417-4314; Park, Seung Woo/0000-0001-8230-964X	National Research Foundation [72010-0025]; National R&D Program for Cancer [0720390]; National Research Foundation; National Core Research Center for Nanomedical Technology [R15-2004-024-00000-0]; Yonsei University College of Medicine [6-2010-0041]	National Research Foundation; National R&D Program for Cancer; National Research Foundation; National Core Research Center for Nanomedical Technology; Yonsei University College of Medicine(General Electric)	National Research Foundation, Mid-career Researcher Program 72010-0025, National R&D Program for Cancer Control Grant 0720390, National Research Foundation, National Core Research Center for Nanomedical Technology R15-2004-024-00000-0, and an Institutional Grant of Yonsei University College of Medicine 6-2010-0041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bigelow RLH, 2005, J INVEST DERMATOL, V124, P457, DOI 10.1111/j.0022-202X.2004.23590.x; Bitgood MJ, 1996, CURR BIOL, V6, P298, DOI 10.1016/S0960-9822(02)00480-3; Cheng PY, 2008, DEVELOPMENT, V135, P941, DOI 10.1242/dev.010595; Davison JM, 2008, METHOD ENZYMOL, V438, P391, DOI 10.1016/S0076-6879(07)38027-0; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Deshpande G, 2001, CELL, V106, P759, DOI 10.1016/S0092-8674(01)00488-3; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Du SJ, 2001, DIFFERENTIATION, V67, P84, DOI 10.1046/j.1432-0436.2001.067003084.x; Dyer MA, 2001, DEVELOPMENT, V128, P1717; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hao LT, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-24; Haramis APG, 2006, EMBO REP, V7, P444, DOI 10.1038/sj.embor.7400638; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kayed H, 2004, INT J CANCER, V110, P668, DOI 10.1002/ijc.20194; Kayed H, 2003, J ENDOCRINOL, V178, P467, DOI 10.1677/joe.0.1780467; Kolpak A, 2005, J NEUROSCI, V25, P3432, DOI 10.1523/JNEUROSCI.4938-04.2005; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; Liao XY, 2009, CARCINOGENESIS, V30, P131, DOI 10.1093/carcin/bgn230; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Nagai S, 2008, CANCER SCI, V99, P1377, DOI 10.1111/j.1349-7006.2008.00822.x; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ober EA, 2003, MECH DEVELOP, V120, P5, DOI 10.1016/S0925-4773(02)00327-1; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Park SW, 2008, GASTROENTEROLOGY, V134, P2080, DOI 10.1053/j.gastro.2008.02.084; Pisharath Harshan, 2009, V546, P133, DOI 10.1007/978-1-60327-977-2_9; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Shinozaki S, 2008, J CELL PHYSIOL, V216, P38, DOI 10.1002/jcp.21372; Sicklick JK, 2005, LAB INVEST, V85, P1368, DOI 10.1038/labinvest.3700349; Stewart GA, 2003, J PATHOL, V199, P488, DOI 10.1002/path.1295; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Wicking C, 1999, ONCOGENE, V18, P7844, DOI 10.1038/sj.onc.1203282; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311; Yang L, 2008, J HEPATOL, V48, P98, DOI 10.1016/j.jhep.2007.07.032; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	54	38	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27941	10.1371/journal.pone.0027941	http://dx.doi.org/10.1371/journal.pone.0027941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164219	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400020
J	Krishna, S; Ray, A; Dubey, SK; Larrouy-Maumus, G; Chalut, C; Castanier, R; Noguera, A; Gilleron, M; Puzo, G; Vercellone, A; Nampoothiri, KM; Nigou, J				Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nampoothiri, K. Madhavan; Nigou, Jerome			Lipoglycans Contribute to Innate Immune Detection of Mycobacteria	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; LIPOTEICHOIC ACID; TUBERCULOSIS; BIOSYNTHESIS; TLR2; LIPOPROTEINS; LIPOARABINOMANNAN; RECOGNITION; BINDING	Innate immune recognition is based on the detection, by pattern recognition receptors (PRRs), of molecular structures that are unique to microorganisms. Lipoglycans are macromolecules specific to the cell envelope of mycobacteria and related genera. They have been described to be ligands, as purified molecules, of several PRRs, including the C-type lectins Mannose Receptor and DC-SIGN, as well as TLR2. However, whether they are really sensed by these receptors in the context of a bacterium infection remains unclear. To address this question, we used the model organism Mycobacterium smegmatis to generate mutants altered for the production of lipoglycans. Since their biosynthesis cannot be fully abrogated, we manipulated the biosynthesis pathway of GDP-Mannose to obtain some strains with either augmented (similar to 1.7 fold) or reduced (similar to 2 fold) production of lipoglycans. Interestingly, infection experiments demonstrated a direct correlation between the amount of lipoglycans in the bacterial cell envelope on one hand and the magnitude of innate immune signaling in TLR2 reporter cells, monocyte/macrophage THP-1 cell line and human dendritic cells, as revealed by NF-kappa B activation and IL-8 production, on the other hand. These data establish that lipoglycans are bona fide Microbe-Associated Molecular Patterns contributing to innate immune detection of mycobacteria, via TLR2 among other PRRs.	[Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nigou, Jerome] CNRS, IPBS, Toulouse, France; [Krishna, Shyam; Ray, Aurelie; Dubey, Shiv K.; Larrouy-Maumus, Gerald; Chalut, Christian; Castanier, Romain; Noguera, Audrey; Gilleron, Martine; Puzo, Germain; Vercellone, Alain; Nigou, Jerome] Univ Toulouse, UPS, IPBS, Toulouse, France; [Krishna, Shyam; Nampoothiri, K. Madhavan] CSIR, Natl Inst Interdisciplinary Sci & Technol, Div Biotechnol, Thiruvananthapuram, Kerala, India	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST)	Krishna, S (corresponding author), INRS, Quebec City, PQ, Canada.	madhavan85@hotmail.com; jerome.nigou@ipbs.fr	Nigou, Jérôme/D-6802-2019; Nampoothiri, K.Madhavan/J-4727-2017	Nigou, Jérôme/0000-0002-6233-2487; Dubey, Shiv/0000-0001-5841-2807; Larrouy-Maumus, Gerald/0000-0001-6614-8698; Chalut, Christian/0000-0002-4849-1369; GILLERON, Martine/0000-0002-2581-3302; Nampoothiri, K.Madhavan/0000-0003-4151-0974	Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) [3403-1]; CEFIPRA; Embassy of France in India to perform research at IPBS; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM)	Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)(Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA)); CEFIPRA; Embassy of France in India to perform research at IPBS; French Ministere de l'Enseignement Superieur et de la Recherche; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Indo-French Centre for the Promotion of Advanced Research (IFCPAR/CEFIPRA) grant 3403-1. S. K. and S. K. D. are CEFIPRA-sponsored PhD student and post-doc respectively. S. K. was awarded a "Sandwich PhD" scholarship of the Embassy of France in India to perform research at IPBS (Toulouse). A. R. is a recipient of PhD fellowships from the French Ministere de l'Enseignement Superieur et de la Recherche and from Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Banaiee N, 2006, J IMMUNOL, V176, P3019, DOI 10.4049/jimmunol.176.5.3019; Beutler B, 2003, IMMUNITY, V19, P155, DOI 10.1016/S1074-7613(03)00212-7; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cot M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026316; Drage MG, 2010, NAT STRUCT MOL BIOL, V17, P1088, DOI 10.1038/nsmb.1869; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gilleron M, 2006, CHEM BIOL, V13, P39, DOI 10.1016/j.chembiol.2005.10.013; Gilleron M, 2008, MYCOBACTERIAL CELL ENVELOPE, P75; GRACY RW, 1968, J BIOL CHEM, V243, P3161; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Keiser TL, 2011, INFECT IMMUN, V79, P4668, DOI 10.1128/IAI.05635-11; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lyakh L, 2008, IMMUNOL REV, V226, P112, DOI 10.1111/j.1600-065X.2008.00700.x; Ma YF, 2001, ANTIMICROB AGENTS CH, V45, P1407, DOI 10.1128/AAC.45.5.1407-1416.2001; Malaga W, 2003, FEMS MICROBIOL LETT, V219, P261, DOI 10.1016/S0378-1097(03)00003-X; McCarthy TR, 2005, MOL MICROBIOL, V58, P774, DOI 10.1111/j.1365-2958.2005.04862.x; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; MUNCHPETERSEN A, 1962, METHOD ENZYMOL, V5, P171, DOI 10.1016/S0076-6879(62)05203-9; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Nigou J, 2000, J MOL BIOL, V299, P1353, DOI 10.1006/jmbi.2000.3821; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; Nigou J, 2008, J IMMUNOL, V180, P6696, DOI 10.4049/jimmunol.180.10.6696; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Patterson JH, 2003, BIOCHEM J, V372, P77, DOI 10.1042/BJ20021700; PINDAR DF, 1975, BIOCHEM J, V152, P617, DOI 10.1042/bj1520617; Pitarque S, 2008, TUBERCULOSIS, V88, P560, DOI 10.1016/j.tube.2008.04.002; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Rezwan M, 2007, MICROBIOL-SGM, V153, P652, DOI 10.1099/mic.0.2006/000216-0; Sander P, 2004, MOL MICROBIOL, V52, P1543, DOI 10.1111/j.1365-2958.2004.04041.x; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sutcliffe L, 2005, TUBERCULOSIS, V85, P205, DOI 10.1016/j.tube.2004.12.002; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	45	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28476	10.1371/journal.pone.0028476	http://dx.doi.org/10.1371/journal.pone.0028476			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164297	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400098
J	Uthman, OA; Moradi, T; Lawoko, S				Uthman, Olalekan A.; Moradi, Tahereh; Lawoko, Stephen			Are Individual and Community Acceptance and Witnessing of Intimate Partner Violence Related to Its Occurrence? Multilevel Structural Equation Model	PLOS ONE			English	Article							DOMESTIC VIOLENCE; CHILD; ATTITUDES; WOMEN	Background: Intimate partner violence against women (IPVAW) is a serious and widespread problem worldwide. Much of the research on IPVAW focused on individual-level factors and attention has been paid to the contextual factors. The aim of this study was to develop and test a model of individual-and community-level factors associated with IPVAW. Methods and Findings: We conducted a (multivariate) multilevel structural equation analysis on 8731 couples nested within 883 communities in Nigerian Demographic and Health Survey 2008. Variables included in the model were derived from respondents' answers to the experience of IPVAW, attitudes towards wife beating and witnessing physical violence in childhood. We found that women that witnessed physical violence were more likely to have tolerant attitudes towards IPVAW and women with tolerant attitudes were more likely to have reported spousal IPVAW abuse. Women with husbands with tolerant attitudes towards IPVAW were more likely to have reported spousal abuse. We found that an increasing proportion of women in the community with tolerant attitudes was significantly positively associated with spousal sexual and emotional abuse, but not significantly associated with spousal physical abuse. In addition, we found that an increasing proportion of men in the community with tolerant attitudes and an increasing proportion of women who had witnessed physical violence in the community was significantly positively associated with spousal physical abuse, but not significantly associated with spousal sexual and emotional abuse. There was a positive correlation between all three types of IPVAW at individual-and community-level. Conclusions: We found that community tolerant attitudes context in which people live is associated with exposure to IPVAW even after taking into account individual tolerant attitudes. Public health interventions designed to reduce IPVAW must address people and the communities in which they live in order to be successful.	[Uthman, Olalekan A.; Lawoko, Stephen] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden; [Moradi, Tahereh] Karolinska Inst, Div Epidemiol, Dept Environm Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Uthman, OA (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden.	uthlekan@yahoo.com	Uthman, Olalekan/N-5584-2019	Uthman, Olalekan/0000-0002-8567-3081				ALIGA A, 2006, INT C TEACH STAT ICO; ANDERSON JC, 1992, SOCIOL METHOD RES, V20, P321, DOI 10.1177/0049124192020003002; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 2009, NIG DEM HLTH SURV 20; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bawdekar M, 2008, J BIOSOC SCI, V40, P771, DOI 10.1017/S0021932008002757; Bell KM, 2008, CLIN PSYCHOL REV, V28, P1096, DOI 10.1016/j.cpr.2008.03.003; BELSKY J, 1980, AM PSYCHOL, V35, P320, DOI 10.1037/0003-066X.35.4.320; Bowen M, 1978, FAMILY THERAPY CLIN; Boyle MH, 2009, SOC SCI MED, V69, P691, DOI 10.1016/j.socscimed.2009.06.039; Bryan A, 2007, AIDS BEHAV, V11, P365, DOI 10.1007/s10461-006-9150-2; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P113; *CTR COMM PROGR, 1999, ISS WORLD HLTH L; Ellsberg M, 2001, STUD FAMILY PLANN, V32, P1, DOI 10.1111/j.1728-4465.2001.00001.x; Faramarzi M, 2005, EUR J OBSTET GYN R B, V122, P225, DOI 10.1016/j.ejogrb.2004.11.047; Gage AJ, 2006, ARCH SEX BEHAV, V35, P11, DOI 10.1007/s10508-006-8991-0; Gage AJ, 2005, SOC SCI MED, V61, P343, DOI 10.1016/j.socscimed.2004.11.078; Garcia-Moreno C, 2005, WHO MULTICOUNTRY STU; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Gracia E, 2004, J EPIDEMIOL COMMUN H, V58, P536, DOI 10.1136/jech.2003.019604; Griffiths P, 2004, HEALTH PLACE, V10, P183, DOI 10.1016/j.healthplace.2003.07.001; Hanson R K, 1997, Violence Vict, V12, P191; Heise L L, 1998, Violence Against Women, V4, P262, DOI 10.1177/1077801298004003002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kravdal O, 2006, DEMOGR RES, V15, P1, DOI 10.4054/DemRes.2006.15.1; Lawoko S, 2008, J INTERPERS VIOLENCE, V23, P1056, DOI 10.1177/0886260507313972; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lewis SF, 2001, CLIN PSYCHOL REV, V21, P105, DOI 10.1016/S0272-7358(99)00042-2; *MEAS DHS, 2005, DEM HLTH SURV QUEST; Mihalic SW, 1997, J FAM VIOLENCE, V12, P21, DOI 10.1023/A:1021941816102; Muthen L.K., 2009, MPLUS USERS GUIDE; Sampson RJ, 2003, PERSPECT BIOL MED, V46, pS53, DOI 10.1353/pbm.2003.0073; SMITH MD, 1994, GENDER SOC, V8, P109, DOI 10.1177/089124394008001007; Straus M.A., 1990, PHYS VIOLENCE AM FAM, P29, DOI [10.4324/9781315126401-4, DOI 10.4324/9781315126401-4]; Wong CS, 1999, ORGAN RES METHODS, V2, P69, DOI 10.1177/109442819921005; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V	37	57	58	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27738	10.1371/journal.pone.0027738	http://dx.doi.org/10.1371/journal.pone.0027738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194791	gold, Green Published, Green Submitted			2022-12-27	WOS:000298369100011
J	Djouani-Tahri, EB; Sanchez, F; Lozano, JC; Bouget, FY				Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves			A Phosphate-Regulated Promoter for Fine-Tuned and Reversible Overexpression in Ostreococcus: Application to Circadian Clock Functional Analysis	PLOS ONE			English	Article							TRANSCRIPTION; RHYTHMS; GENE; IDENTIFICATION; TRANSPORTER; EXPRESSION; INSIGHTS	Background: The green picoalga Ostreococcus tauri (Prasinophyceae), which has been described as the smallest free-living eukaryotic organism, has minimal cellular ultra-structure and a very small genome. In recent years, O. tauri has emerged as a novel model organism for systems biology approaches that combine functional genomics and mathematical modeling, with a strong emphasis on light regulated processes and circadian clock. These approaches were made possible through the implementation of a minimal molecular toolbox for gene functional analysis including overexpression and knockdown strategies. We have previously shown that the promoter of the High Affinity Phosphate Transporter (HAPT) gene drives the expression of a luciferase reporter at high and constitutive levels under constant light. Methodology/Principal Findings: Here we report, using a luciferase reporter construct, that the HAPT promoter can be finely and reversibly tuned by modulating the level and nature of phosphate in culture medium. This HAPT regulation was additionally used to analyze the circadian clock gene Time of Cab expression 1 (TOC1). The phenotype of a TOC1ox/CCA1:Luc line was reverted from arrhythmic to rhythmic simply by adding phosphate to the culture medium. Furthermore, since the time of phosphate injection had no effect on the phase of CCA1:Luc expression, this study suggests further that TOC1 is a central clock gene in Ostreococcus. Conclusions/Perspectives: We have developed a phosphate-regulated expression system that allows fine gene function analysis in Ostreococcus. Recently, there has been a growing interest in microalgae as cell factories. This non-toxic phosphate-regulated system may prove useful in tuning protein expression levels quantitatively and temporally for biotechnological applications.	[Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves] Univ Paris 06, Observ Oceanol, Banyuls Sur Mer, France; [Djouani-Tahri, El Batoul; Sanchez, Frederic; Lozano, Jean-Claude; Bouget, Francois-Yves] CNRS, UMR, UMR7621, LOMIC,Lab Oceanog Microbienne, Banyuls Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Djouani-Tahri, EB (corresponding author), Univ Paris 06, Observ Oceanol, Banyuls Sur Mer, France.	fy.bouget@obs-banyuls.fr			Agence Nationale de la Recherche Miniclock [F005466]; EU [227799]; CNRS-Region Languedoc Roussillon	Agence Nationale de la Recherche Miniclock(French National Research Agency (ANR)); EU(European Commission); CNRS-Region Languedoc Roussillon(Centre National de la Recherche Scientifique (CNRS)Region Occitanie)	This work was supported by Agence Nationale de la Recherche Miniclock F005466, EU FP7 ASSEMBLE (227799) and by a CNRS-Region Languedoc Roussillon doctoral fellowship to EBD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2009, APPL ENVIRON MICROB, V75, P3528, DOI 10.1128/AEM.02913-08; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Chung CC, 2003, APPL ENVIRON MICROB, V69, P754, DOI 10.1128/AEM.69.2.754-759.2003; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Djouani-Tahri EB, 2011, PLANT J, V65, P578, DOI 10.1111/j.1365-313X.2010.04444.x; Heijde M, 2010, PLANT CELL ENVIRON, V33, P1614, DOI 10.1111/j.1365-3040.2010.02168.x; Huang TK, 2009, BIOTECHNOL BIOENG, V102, P508, DOI 10.1002/bit.22061; Knowles SM, 2008, J BIOL RHYTHM, V23, P463, DOI 10.1177/0748730408326749; MANN BJ, 1989, GENE, V83, P281, DOI 10.1016/0378-1119(89)90114-5; Martinez P, 1998, MOL GEN GENET, V258, P628, DOI 10.1007/s004380050776; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Morant PE, 2010, CHAOS, V20, DOI 10.1063/1.3530118; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Moulager M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000957; Navarre C, 2011, TRANSGENIC RES, V20, P799, DOI 10.1007/s11248-010-9459-5; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; Quinn JM, 2003, EUKARYOT CELL, V2, P995, DOI 10.1128/EC.2.5.995-1002.2003; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Sorokina O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-36; Thommen Q, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000990; Troein C, 2011, PLANT J, V66, P375, DOI 10.1111/j.1365-313X.2011.04489.x; Weynberg KD, 2011, J VIROL, V85, P4520, DOI 10.1128/JVI.02131-10	26	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28471	10.1371/journal.pone.0028471	http://dx.doi.org/10.1371/journal.pone.0028471			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174815	gold, Green Submitted, Green Published			2022-12-27	WOS:000298366600020
J	Gombos, I; Crul, T; Piotto, S; Gungor, B; Torok, Z; Balogh, G; Peter, M; Slotte, JP; Campana, F; Pilbat, AM; Hunya, A; Toth, N; Literati-Nagy, Z; Vigh, L; Glatz, A; Brameshuber, M; Schutz, GJ; Hevener, A; Febbraio, MA; Horvath, I; Vigh, L				Gombos, Imre; Crul, Tim; Piotto, Stefano; Guengoer, Burcin; Toeroek, Zsolt; Balogh, Gabor; Peter, Maria; Slotte, J. Peter; Campana, Federica; Pilbat, Ana-Maria; Hunya, Akos; Toth, Noemi; Literati-Nagy, Zsuzsanna; Vigh, Laszlo, Jr.; Glatz, Attila; Brameshuber, Mario; Schueutz, Gerhard J.; Hevener, Andrea; Febbraio, Mark A.; Horvath, Ibolya; Vigh, Laszlo			Membrane-Lipid Therapy in Operation: The HSP Co-Inducer BGP-15 Activates Stress Signal Transduction Pathways by Remodeling Plasma Membrane Rafts	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; CHOLESTEROL; HYPERFLUIDIZATION; BIMOCLOMOL; MODULATION; GTPASE; STEROL; MODEL; RAC1; ACTS	Aging and pathophysiological conditions are linked to membrane changes which modulate membrane-controlled molecular switches, causing dysregulated heat shock protein (HSP) expression. HSP co-inducer hydroxylamines such as BGP-15 provide advanced therapeutic candidates for many diseases since they preferentially affect stressed cells and are unlikely have major side effects. In the present study in vitro molecular dynamic simulation, experiments with lipid monolayers and in vivo ultrasensitive fluorescence microscopy showed that BGP-15 alters the organization of cholesterol-rich membrane domains. Imaging of nanoscopic long-lived platforms using the raft marker glycosylphosphatidylinositol-anchored monomeric green fluorescent protein diffusing in the live Chinese hamster ovary (CHO) cell plasma membrane demonstrated that BGP-15 prevents the transient structural disintegration of rafts induced by fever-type heat stress. Moreover, BGP-15 was able to remodel cholesterol-enriched lipid platforms reminiscent of those observed earlier following non-lethal heat priming or membrane stress, and were shown to be obligate for the generation and transmission of stress signals. BGP-15 activation of HSP expression in B16-F10 mouse melanoma cells involves the Rac1 signaling cascade in accordance with the previous observation that cholesterol affects the targeting of Rac1 to membranes. Finally, in a human embryonic kidney cell line we demonstrate that BGP-15 is able to inhibit the rapid heat shock factor 1 (HSF1) acetylation monitored during the early phase of heat stress, thereby promoting a prolonged duration of HSF1 binding to heat shock elements. Taken together, our results indicate that BGP-15 has the potential to become a new class of pharmaceuticals for use in 'membrane-lipid therapy' to combat many various protein-misfolding diseases associated with aging.	[Gombos, Imre; Crul, Tim; Guengoer, Burcin; Toeroek, Zsolt; Balogh, Gabor; Peter, Maria; Pilbat, Ana-Maria; Toth, Noemi; Literati-Nagy, Zsuzsanna; Vigh, Laszlo, Jr.; Glatz, Attila; Horvath, Ibolya; Vigh, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Piotto, Stefano; Campana, Federica] Univ Salerno, Dept Pharmaceut & Biomed Sci, I-84100 Salerno, Italy; [Slotte, J. Peter] Abo Akad Univ, Dept Biosci, Turku, Finland; [Hunya, Akos] LipidArt Ltd, Szeged, Hungary; [Brameshuber, Mario; Schueutz, Gerhard J.] Vienna Univ Technol, Inst Appl Phys, A-1040 Vienna, Austria; [Hevener, Andrea] Univ Calif Los Angeles, Dept Med, Div Endocrinol, Los Angeles, CA 90024 USA; [Febbraio, Mark A.] Baker Heart & Diabet Inst, Cellular & Mol Metab Lab, Prahran, Vic, Australia	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Salerno; Abo Akademi University; Technische Universitat Wien; University of California System; University of California Los Angeles	Gombos, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	vigh@brc.hu	Schuetz, Gerhard/B-1243-2008; Piotto, Stefano P/A-8210-2011; Balogh, Gábor/AIC-8192-2022; Piotto, Stefano/AAZ-4641-2021; Crul, Tim/AAE-8966-2020; Febbraio, Mark/AAE-9632-2019; Güngör, Burçin/AAF-6654-2021; Güngör, Burçin/AAF-8288-2021; Piotto, Stefano/AAE-4031-2020	Schuetz, Gerhard/0000-0003-1542-1089; Balogh, Gábor/0000-0002-4565-6850; Piotto, Stefano/0000-0002-3102-1918; Crul, Tim/0000-0002-6053-7016; Güngör, Burçin/0000-0001-7725-5835; Piotto, Stefano/0000-0002-3102-1918; Febbraio, Mark/0000-0002-9296-4418; Brameshuber, Mario/0000-0001-8672-2255	European Union [HEALTH-F4-2008-202272]; Hungarian National Scientific Research Foundation (OTKA) [NN 76716, K82097, K84257]; Hungarian National Development Agency [TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002, TAMOP-4.2.2/08/1-2008-0013]; Austrian Science Fund (FWF) [Y250-B03, I301-B12]; Austrian Science Fund (FWF) [Y 250, I 301] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078760, R01DK089109] Funding Source: NIH RePORTER	European Union(European Commission); Hungarian National Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Development Agency; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the European Union Project LipidomicNet (HEALTH-F4-2008-202272), by the Hungarian National Scientific Research Foundation (OTKA NN 76716, K82097 and K84257), by the "Social Renewal Operational Programme" of the Hungarian National Development Agency (TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002 and TAMOP-4.2.2/08/1-2008-0013), and by the Austrian Science Fund (FWF project Y250-B03 and I301-B12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Akiyama H, 2011, CYTOLOGIA, V76, P19, DOI 10.1508/cytologia.76.19; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Cerezo A, 2009, MOL CELL BIOL, V29, P5046, DOI 10.1128/MCB.00315-09; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Escriba PV, 2006, TRENDS MOL MED, V12, P34, DOI 10.1016/j.molmed.2005.11.004; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Haldimann P, 2011, J BIOL CHEM, V286, P18784, DOI 10.1074/jbc.M111.234773; Halling KK, 2008, BBA-BIOMEMBRANES, V1778, P1100, DOI 10.1016/j.bbamem.2008.01.001; Han SI, 2001, J BIOL CHEM, V276, P1889, DOI 10.1074/jbc.M006042200; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; Jerabek H, 2010, J AM CHEM SOC, V132, P7990, DOI 10.1021/ja910843d; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; KLAMT A, 1995, J PHYS CHEM-US, V99, P2224, DOI 10.1021/j100007a062; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lancelot E, 2007, COLLOID SURFACE B, V59, P81, DOI 10.1016/j.colsurfb.2007.04.017; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Monastyrskaya K, 2009, CELL MOL LIFE SCI, V66, P2623, DOI 10.1007/s00018-009-0027-1; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Nagy G, 2010, TOXICOL APPL PHARM, V243, P96, DOI 10.1016/j.taap.2009.11.017; Noonan EJ, 2007, J CELL PHYSIOL, V210, P201, DOI 10.1002/jcp.20875; Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816; Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097; Sato SB, 2004, J BIOL CHEM, V279, P23790, DOI 10.1074/jbc.M313568200; Shibata S, 2011, J CLIN INVEST, V121, P3233, DOI 10.1172/JCI43124; Sloan LA, 2009, CURR OPIN DRUG DISC, V12, P666; Soti C, 2005, BRIT J PHARMACOL, V146, P769, DOI 10.1038/sj.bjp.0706396; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Szabados E, 2000, BIOCHEM PHARMACOL, V59, P937, DOI 10.1016/S0006-2952(99)00418-9; Vattulainen I, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004655; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Vigh L, 1998, TRENDS BIOCHEM SCI, V23, P369, DOI 10.1016/S0968-0004(98)01279-1; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Voellmy R, 2007, ADV EXP MED BIOL, V594, P89; VOROBYOV I, 2010, BIOCHIM BIOPHYS ACTA, V1808, P1673; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zhang DL, 2011, J MOL CELL CARDIOL, V51, P381, DOI 10.1016/j.yjmcc.2011.06.008	50	58	58	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28818	10.1371/journal.pone.0028818	http://dx.doi.org/10.1371/journal.pone.0028818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174906	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600041
J	Zigmond, E; Halpern, Z; Elinav, E; Brazowski, E; Jung, S; Varol, C				Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Jung, Steffen; Varol, Chen			Utilization of Murine Colonoscopy for Orthotopic Implantation of Colorectal Cancer	PLOS ONE			English	Article							COLON CARCINOGENESIS; MOUSE MODELS; MICE; AZOXYMETHANE; MUTATION; SITE	Background: Colorectal-cancer (CRC) research has greatly benefited from the availability of small animal tumor models. Spontaneous and chemically-induced CRC models are widely used yet limited in their resemblance to human disease and are often prolonged, not accurately repetitive, and associated with inflammatory side effects. In-situ murine or human tumor implantation in the gastrointestinal tract of mice is extremely challenging, and limited by inter-animal variability and procedure-related complications and mortality. As a result, in frequent studies CRC is implanted in distal sites, most commonly the subcutaneous region, an approach that is greatly limited by the absence of normal gastrointestinal tumor milieu and has substantial effects on tumor development. Aims: In this study we aimed to develop a well-tolerated repetitive tool to study CRC in small animals by adapting the murine colonoscopy system to serve as a platform for colonic sub-mucosal orthotopic implantation of human and murine CRC tumor cells. Results: We report the establishment of a novel small-animal CRC model that is minimally invasive, rapid, well-tolerated, highly reproducible, and confers precise control of tumor number, location and growth rate. Moreover, we show that this model uniquely allows the side-by-side induction of distinct genetically manipulated tumors, enabling the mechanistic study of tumor interaction and cross-talk within the native intestinal microenvironment. Conclusions: Employment of this new approach may represent a major technical advance for the in-vivo study of CRC.	[Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Varol, Chen] Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; [Zigmond, Ehud; Halpern, Zamir; Elinav, Eran; Brazowski, Eli; Varol, Chen] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Zigmond, Ehud; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Weizmann Institute of Science	Zigmond, E (corresponding author), Tel Aviv Univ, Res Ctr Digest Tract & Liver Dis, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel.	ehudz@tasmc.health.gov.il; chenv@tasmc.health.gov.il	Varol, Chen/ABH-6487-2020; Varol, Chen/AAW-4202-2021; Elinav, Eran/ABE-8881-2020; Jung, Steffen/K-1409-2012	Elinav, Eran/0000-0002-5775-2110; Jung, Steffen/0000-0003-4290-5716	Crohn's & Colitis Foundation of America (CCFA) [7108160101]	Crohn's & Colitis Foundation of America (CCFA)	This study was supported by the Crohn's & Colitis Foundation of America (CCFA) (to S.J., number - 7108160101; website: www.ccfa.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar H, 2005, INT J CANCER, V117, P335, DOI 10.1002/ijc.21185; Becker C, 2006, NAT PROTOC, V1, P2900, DOI 10.1038/nprot.2006.446; CORBETT TH, 1975, CANCER RES, V35, P2434; Edelmann L, 2004, AM J MED GENET C, V129C, P91, DOI 10.1002/ajmg.c.30021; Farre L, 2002, FASEB J, V16, P975, DOI 10.1096/fj.01-0973com; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Issa AY, 2007, CARCINOGENESIS, V28, P1978, DOI 10.1093/carcin/bgm161; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nakanishi M, 2007, PROTEOM CLIN APPL, V1, P1660, DOI 10.1002/prca.200700545; Nambiar PR, 2003, INT J ONCOL, V22, P145; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Neurath MF, 2010, GASTROENTEROLOGY, V139, P1837, DOI 10.1053/j.gastro.2010.10.007; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Shapira Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004776; Suzui M, 2002, CANCER LETT, V183, P31, DOI 10.1016/S0304-3835(02)00114-3; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Cespedes MV, 2007, AM J PATHOL, V170, P1077, DOI 10.2353/ajpath.2007.060773; WHITE AC, 1982, CANCER RES, V42, P906	20	44	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28858	10.1371/journal.pone.0028858	http://dx.doi.org/10.1371/journal.pone.0028858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174916	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600046
J	Ebner, S; Lang, R; Mueller, EE; Eder, W; Oeller, M; Moser, A; Koller, J; Paulweber, B; Mayr, JA; Sperl, W; Kofler, B				Ebner, Sabine; Lang, Roland; Mueller, Edith E.; Eder, Waltraud; Oeller, Michaela; Moser, Alexandra; Koller, Josef; Paulweber, Bernhard; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara			Mitochondrial Haplogroups, Control Region Polymorphisms and Malignant Melanoma: A Study in Middle European Caucasians	PLOS ONE			English	Article							DNA D-LOOP; BRESLOW THICKNESS; SOMATIC MUTATIONS; COPY NUMBER; CANCER; VARIANT; ASSOCIATION; BREAST; RISK; SUSCEPTIBILITY	Background: Because mitochondria play an essential role in energy metabolism, generation of reactive oxygen species (ROS), and apoptosis, sequence variation in the mitochondrial genome has been postulated to be a contributing factor to the etiology of multifactorial age-related diseases, including cancer. The aim of the present study was to compare the frequencies of mitochondrial DNA (mtDNA) haplogroups as well as control region (CR) polymorphisms of patients with malignant melanoma (n = 351) versus those of healthy controls (n = 1598) in Middle Europe. Methodology and Principal Findings: Using primer extension analysis and DNA sequencing, we identified all nine major European mitochondrial haplogroups and known CR polymorphisms. The frequencies of the major mitochondrial haplogroups did not differ significantly between patients and control subjects, whereas the frequencies of the one another linked CR polymorphisms A16183C, T16189C, C16192T, C16270T and T195C were significantly higher in patients with melanoma compared to the controls. Regarding clinical characteristics of the patient cohort, none of the nine major European haplogroups was associated with either Breslow thickness or distant metastasis. The CR polymorphisms A302CC-insertion and T310C-insertion were significantly associated with mean Breslow thickness, whereas the CR polymorphism T16519C was associated with metastasis. Conclusions and Significance: Our results suggest that mtDNA variations could be involved in melanoma etiology and pathogenesis, although the functional consequence of CR polymorphisms remains to be elucidated.	[Ebner, Sabine; Mueller, Edith E.; Eder, Waltraud; Oeller, Michaela; Moser, Alexandra; Mayr, Johannes A.; Sperl, Wolfgang; Kofler, Barbara] Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria; [Lang, Roland; Koller, Josef] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Paulweber, Bernhard] Paracelsus Med Univ, Dept Internal Med, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Ebner, S (corresponding author), Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Dept Pediat, Salzburg, Austria.	b.kofler@salk.at		Mayr, Johannes/0000-0001-6970-336X; Kofler, Barbara/0000-0002-1198-4776	Paracelsus Medical University Salzburg [07/05/027]	Paracelsus Medical University Salzburg	This study was supported by a grant from the Paracelsus Medical University Salzburg (07/05/027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Berger C, 2011, FORENSIC SCI INT-GEN, V5, P142, DOI 10.1016/j.fsigen.2010.10.002; Birch-Machin MA, 2006, CLIN EXP DERMATOL, V31, P548, DOI 10.1111/j.1365-2230.2006.02161.x; Booker LM, 2006, J UROLOGY, V175, P468, DOI 10.1016/S0022-5347(05)00163-1; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Copeland WC, 2002, CANCER INVEST, V20, P557, DOI 10.1081/CNV-120002155; Czarnecka AM, 2010, ONCOL REP, V24, P1521, DOI 10.3892/or_00001014; De Vries E, 2008, ANN ONCOL, V19, P583, DOI 10.1093/annonc/mdm498; Deichmann M, 2004, INT J ONCOL, V24, P137; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kang DC, 1997, J BIOL CHEM, V272, P15275, DOI 10.1074/jbc.272.24.15275; Khogali SS, 2001, LANCET, V357, P1265, DOI 10.1016/S0140-6736(00)04422-6; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Lee HC, 2004, MUTAT RES-FUND MOL M, V547, P71, DOI 10.1016/j.mrfmmm.2003.12.011; Li XY, 2011, MITOCHONDRION, V11, P27, DOI 10.1016/j.mito.2010.06.005; Liou CW, 2010, J MED GENET, V47, P723, DOI 10.1136/jmg.2010.077552; Liu VWS, 2003, HUM MUTAT, V22, P173, DOI 10.1002/humu.10244; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mithani SK, 2008, MELANOMA RES, V18, P214, DOI 10.1097/CMR.0b013e3282f88a56; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Mueller EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016455; Murray CS, 2005, BRIT J DERMATOL, V152, P104, DOI 10.1111/J.1365-2133.2005.06409.X; Navaglia F, 2006, AM J CLIN PATHOL, V126, P593, DOI 10.1309/GQFCCJMH5KHNVX73; Osborne JE, 2001, BRIT J DERMATOL, V144, P476, DOI 10.1046/j.1365-2133.2001.04071.x; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Penta JS, 2001, MUTAT RES-REV MUTAT, V488, P119, DOI 10.1016/S1383-5742(01)00053-9; Poetsch M, 2004, MELANOMA RES, V14, P501, DOI 10.1097/00008390-200412000-00010; Poulton J, 2002, HUM MOL GENET, V11, P1581, DOI 10.1093/hmg/11.13.1581; Raule N, 2007, MITOCHONDRION, V7, P29, DOI 10.1016/j.mito.2006.11.013; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Roberti M, 1998, BIOCHEM BIOPH RES CO, V243, P36, DOI 10.1006/bbrc.1997.8052; Singh Keshav K., 2009, V471, P291, DOI 10.1007/978-1-59745-416-2_15; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takeuchi H, 2004, ANN NY ACAD SCI, V1022, P50, DOI 10.1196/annals.1318.009; Theodoratou E, 2010, CARCINOGENESIS, V31, P296, DOI 10.1093/carcin/bgp237; Verma M, 2007, CLIN CHIM ACTA, V383, P41, DOI 10.1016/j.cca.2007.04.018; Weitgasser R, 2004, BIOMED PHARMACOTHER, V58, P619, DOI 10.1016/j.biopha.2004.09.010; Weng SW, 2005, J CLIN ENDOCR METAB, V90, P5037, DOI 10.1210/jc.2005-0227; Wiesbauer M, 2006, ELECTROPHORESIS, V27, P3864, DOI 10.1002/elps.200600086; Xu L, 2006, INT J GYNECOL CANCER, V16, P1661, DOI 10.1111/j.1525-1438.2006.00641.x; Yoneyama H, 2005, MOL CANCER RES, V3, P14	45	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27192	10.1371/journal.pone.0027192	http://dx.doi.org/10.1371/journal.pone.0027192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174736	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700003
J	Morgillo, F; Martinelli, E; Troiani, T; Orditura, M; De Vita, F; Ciardiello, F				Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato			Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors (Publication with Expression of Concern. See vol. 14, 2019) (Publication with Expression of Concern. See vol. 14, 2019)	PLOS ONE			English	Article; Publication with Expression of Concern							LUNG-CANCER; RAF/MEK/ERK PATHWAY; TUMOR-CELLS; COMBINATION; GEFITINIB; APOPTOSIS; TRIAL	Treatment of non small cell lung cancer (NSCLC) and colorectal cancer (CRC) have substantially changed in the last years with the introduction of epidermal growth factor receptor (EGFR) inhibitors in the clinical practice. The understanding of mechanisms which regulate cells sensitivity to these drugs is necessary for their optimal use. An in vitro model of acquired resistance to two tyrosine kinase inhibitors (TKI) targeting the EGFR, erlotinib and gefitinib, and to a TKI targeting EGFR and VEGFR, vandetanib, was developed by continuously treating the human NSCLC cell line CALU-3 and the human CRC cell line HCT116 with escalating doses of each drug. MTT, western blot analysis, migration, invasion and anchorage-independent colony forming assays were conducted in vitro and experiments with established xenografts in athymic nude mice were performed in vivo in sensitive, wild type (WT) and TKI-resistant CALU-3 and HCT116 cell lines. As compared to WT CALU-3 and HCT116 human cancer cells, TKI-resistant cell lines showed a significant increase in the levels of activated, phosphorylated AKT, MAPK, and of survivin. Considering the role of RAS and RAF as downstream signals of both the EGFR and VEGFR pathways, we treated resistant cells with sorafenib, an inhibitor of C-RAF, B-RAF, c-KIT, FLT-3, RET, VEGFR-2, VEGFR-3, and PDGFR-beta. Sorafenib reduced the activation of MEK and MAPK and caused an inhibition of cell proliferation, invasion, migration, anchorage-independent growth in vitro and of tumor growth in vivo of all TKI-resistant CALU-3 and HCT116 cell lines. These data suggest that resistance to EGFR inhibitors is predominantly driven by the RAS/RAF/MAPK pathway and can be overcame by treatment with sorafenib.	[Morgillo, Floriana; Martinelli, Erika; Troiani, Teresa; Orditura, Michele; De Vita, Ferdinando; Ciardiello, Fortunato] Univ Naples 2, Div Med Oncol, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy	Universita della Campania Vanvitelli	Morgillo, F (corresponding author), Univ Naples 2, Div Med Oncol, Dept Clin & Expt Med & Surg F Magrassi & A Lanzar, Naples, Italy.	florianamorgillo@yahoo.it		MORGILLO, Floriana/0000-0002-9167-323X; Ciardiello, Fortunato/0000-0002-3369-4841; Erika, Martinelli/0000-0002-0291-475X; ORDITURA, Michele/0000-0001-9105-8563; troiani, teresa/0000-0002-0646-4901	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy; European Society of Medical Oncology (ESMO)	Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy(Fondazione AIRC per la ricerca sul cancro); European Society of Medical Oncology (ESMO)	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC), Milan, Italy. Floriana Morgillo is the recipient of an European Society of Medical Oncology (ESMO) translational research fellowship. the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Bianco R, 2008, CLIN CANCER RES, V14, P5069, DOI 10.1158/1078-0432.CCR-07-4905; Ciardiello F, 2004, CLIN CANCER RES, V10, P784, DOI 10.1158/1078-0432.CCR-1100-03; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; DEROOCK A, 2010, JAMA-J AM MED ASSOC, V304, P1812; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2008, CLIN CANCER RES, V14, P4836, DOI 10.1158/1078-0432.CCR-07-4123; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Herbst RS, 2005, J CLIN ONCOL, V23, P2544, DOI 10.1200/JCO.2005.02.477; HEYMACH JV, 2006, P AM SOC CLIN ONCO S, V18, P7016; Janmaat ML, 2003, CLIN CANCER RES, V9, P2316; Janmaat ML, 2006, INT J CANCER, V118, P209, DOI 10.1002/ijc.21290; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Magne N, 2002, BRIT J CANCER, V86, P1518, DOI 10.1038/sj/bjc/6600299; Martinelli E, 2010, CLIN CANCER RES, V16, P4990, DOI 10.1158/1078-0432.CCR-10-0923; MORGILLO F, 2006, CANCER RES, P66; MORGILLO F, 2010, LUNG CANCER, P8; Morgillo F, 2007, DIFFERENTIATION, V75, P788, DOI 10.1111/j.1432-0436.2007.00200.x; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Natale RB, 2006, J CLIN ONCOL, V24, p364S; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Roberts PJ, 2010, J CLIN ONCOL, V28, P4769, DOI 10.1200/JCO.2009.27.4365; ROOCK WD, 2010, LANCET ONCOL; Schiller JH, 2006, J CLIN ONCOL, V24, P7194, DOI [DOI 10.1200/JCO.2006.24.18_SUPPL.7194, 10.1200/jco.2006.24.18_suppl.7194]; Stein RC, 2001, ENDOCR-RELAT CANCER, V8, P237, DOI 10.1677/erc.0.0080237; Weickhardt AJ, 2010, CURR CANCER DRUG TAR, V10, P824; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	29	35	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28841	10.1371/journal.pone.0028841	http://dx.doi.org/10.1371/journal.pone.0028841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174910	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700076
J	Rabenold, D; Pearson, OM				Rabenold, Diana; Pearson, Osbjorn M.			Abrasive, Silica Phytoliths and the Evolution of Thick Molar Enamel in Primates, with Implications for the Diet of Paranthropus boisei	PLOS ONE			English	Article							UNDERGROUND-STORAGE ORGANS; DENTAL MICROWEAR; EARLY HOMINID; AUSTRALOPITHECUS-ANAMENSIS; MECHANICAL-PROPERTIES; ISOTOPIC EVIDENCE; TOOTH WEAR; AYE-AYES; ECOLOGY; PAPIO	Background: Primates-including fossil species of apes and hominins-show variation in their degree of molar enamel thickness, a trait long thought to reflect a diet of hard or tough foods. The early hominins demonstrated molar enamel thickness of moderate to extreme degrees, which suggested to most researchers that they ate hard foods obtained on or near the ground, such as nuts, seeds, tubers, and roots. We propose an alternative hypothesis-that the amount of phytoliths in foods correlates with the evolution of thick molar enamel in primates, although this effect is constrained by a species' degree of folivory. Methodology/Principal Findings: From a combination of dietary data and evidence for the levels of phytoliths in plant families in the literature, we calculated the percentage of plant foods rich in phytoliths in the diets of twelve extant primates with wide variation in their molar enamel thickness. Additional dietary data from the literature provided the percentage of each primate's diet made up of plants and of leaves. A statistical analysis of these variables showed that the amount of abrasive silica phytoliths in the diets of our sample primates correlated positively with the thickness of their molar enamel, constrained by the amount of leaves in their diet (R-2 = 0.875; p<.0006). Conclusions/Significance: The need to resist abrasion from phytoliths appears to be a key selective force behind the evolution of thick molar enamel in primates. The extreme molar enamel thickness of the teeth of the East African hominin Paranthropus boisei, long thought to suggest a diet comprising predominantly hard objects, instead appears to indicate a diet with plants high in abrasive silica phytoliths.	[Rabenold, Diana; Pearson, Osbjorn M.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA	University of New Mexico	Rabenold, D (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	drabenol@unm.edu		Pearson, Osbjorn/0000-0002-1814-7663				ANDREWS P, 1991, PHILOS T R SOC B, V334, P199, DOI 10.1098/rstb.1991.0109; Andrews P., 1976, HUMAN ORIGINS L LEAK, P279; ANDRIAMASIMANANA M, 1994, FOLIA PRIMATOL, V62, P37, DOI 10.1159/000156761; [Anonymous], 2003, MET MAT CONV HARDN V; BAKER G, 1959, NATURE, V184, P1583, DOI 10.1038/1841583b0; Bamford MK, 2006, QUATERN INT, V148, P95, DOI 10.1016/j.quaint.2005.11.027; Bentley-Condit VK, 2009, AM J PRIMATOL, V71, P432, DOI 10.1002/ajp.20670; Bowes G, 2002, FUNCT PLANT BIOL, V29, P379, DOI 10.1071/PP01219; BOYDE A, 1984, ANAT EMBRYOL, V170, P57, DOI 10.1007/BF00319458; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; CHALMERS NR, 1968, FOLIA PRIMATOL, V8, P247, DOI 10.1159/000155157; Ciochon RL, 1990, PALEOANTHROPOLOGY AN, P47; Conklin-Brittain Nancy Lou, 2002, P61; Constantino P, 2007, EVOL ANTHROPOL, V16, P49, DOI 10.1002/evan.20130; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; DOUGALL H. W., 1964, EAST AFRICAN WILDLIFE J, V2, P86; Dumont Elizabeth R, 2011, Proc Biol Sci, V278, P3654, DOI 10.1098/rspb.2011.0528; Eck GG, 1987, FAUNES PLIO PLEISTOC, P18; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; ERICKSON CJ, 1994, FOLIA PRIMATOL, V62, P125, DOI 10.1159/000156769; Fashing PJ, 2001, INT J PRIMATOL, V22, P579, DOI 10.1023/A:1010737601922; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; Gantt DG, 1977, ENAMEL PRIMATE TEETH; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Grine F.E., 1988, P3; Grine FE, 2004, S AFR J SCI, V100, P389; Grine FE, 2006, S AFR J SCI, V102, P301; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Gugel IL, 2001, AM J PHYS ANTHROPOL, V114, P124, DOI 10.1002/1096-8644(200102)114:2&lt;124::AID-AJPA1012&gt;3.0.CO;2-S; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Hummel J, 2011, P ROY SOC B-BIOL SCI, V278, P1742, DOI 10.1098/rspb.2010.1939; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; JONES L. H. P., 1967, Advances in agronomy. Vol. 19., P107, DOI 10.1016/S0065-2113(08)60734-8; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; KELLEY J, 1990, FOLIA PRIMATOL, V55, P73, DOI 10.1159/000156502; King SJ, 2005, P NATL ACAD SCI USA, V102, P16579, DOI 10.1073/pnas.0508377102; Kojola I, 1998, OECOLOGIA, V117, P26, DOI 10.1007/s004420050627; Kuroda Suehisa, 1996, P71, DOI 10.1017/CBO9780511752414.008; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Lanning FC, 1965, ADV FRONTIERS PLANT, V12, P55; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas P, 2008, BIOESSAYS, V30, P374, DOI 10.1002/bies.20729; Lucas PW, 2009, AM J PHYS ANTHROPOL, V140, P643, DOI 10.1002/ajpa.21026; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Martin, 1983, RELATIONSHIPS LATER; MARTIN L, 1985, NATURE, V314, P260, DOI 10.1038/314260a0; Mau M, 2009, AM J PRIMATOL, V71, P663, DOI 10.1002/ajp.20701; MCNAUGHTON SJ, 1985, ECOLOGY, V66, P528, DOI 10.2307/1940401; Merceron G, 2004, PALAEOGEOGR PALAEOCL, V207, P143, DOI 10.1016/j.palaeo.2004.02.008; Merceron G, 2007, J HUM EVOL, V53, P331, DOI 10.1016/j.jhevol.2007.04.008; Metcalfe C. R., 1950, Anatomy of the Dicotyledons: leaves, stem, and wood, in relation to taxonomy, with notes on economic uses.; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Milton K., 1978, P535; Nystrom P, 2004, AM J PHYS ANTHROPOL, V125, P279, DOI 10.1002/ajpa.10274; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2006, ANAT REC PART A, V288A, P263, DOI 10.1002/ar.a.20307; Olejniczak AJ, 2008, J HUM EVOL, V54, P187, DOI 10.1016/j.jhevol.2007.09.014; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Peters C. R., 1992, EDIBLE WILD PLANTS S; Peters CR, 2005, J HUM EVOL, V48, P219, DOI 10.1016/j.jhevol.2004.11.003; PETERS CR, 1981, CURR ANTHROPOL, V22, P127, DOI 10.1086/202631; Peters CR, 1999, AFRICAN PLANTS BIODI, P483; Piperno D.R., 2006, PHYTOLITH COMPREHENS; Piperno D.R., 1988, PHYTOLITH ANAL ARCHA; PIPERNO DR, 1989, REV PALAEOBOT PALYNO, V61, P147, DOI 10.1016/0034-6667(89)90067-5; PIPERNO DR, 1985, REV PALAEOBOT PALYNO, V45, P185, DOI 10.1016/0034-6667(85)90002-8; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; RICHARDS.RC, 1968, WEAR, V11, P245, DOI 10.1016/0043-1648(68)90175-0; ROSENBERGER AL, 1976, AM J PHYS ANTHROPOL, V45, P281, DOI 10.1002/ajpa.1330450214; Samsonov GV, 1968, HDB PHYSICOCHEMICAL; Sanson GD, 2007, J ARCHAEOL SCI, V34, P526, DOI 10.1016/j.jas.2006.06.009; Schwartz GT, 2000, AM J PHYS ANTHROPOL, V111, P221, DOI 10.1002/(SICI)1096-8644(200002)111:2<221::AID-AJPA8>3.0.CO;2-G; Shellis RP, 1998, J HUM EVOL, V35, P507, DOI 10.1006/jhev.1998.0238; Shipman P., 1988, P343; Shumway CA., 1999, FORGOTTEN WATERS FRE; SKOGLAND T, 1988, OIKOS, V51, P238, DOI 10.2307/3565648; Smith C. C., 1977, P97; Solounias N, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)366<0001:AITROU>2.0.CO;2; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; STERLING EJ, 1994, FOLIA PRIMATOL, V62, P115, DOI 10.1159/000156768; STERLING EJ, 1994, FOLIA PRIMATOL, V62, P142, DOI 10.1159/000156771; Stromberg CAE, 2006, PALEOBIOLOGY, V32, P236, DOI 10.1666/0094-8373(2006)32[236:EOHIET]2.0.CO;2; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Teaford MF, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P433; TEAFORD MF, 1993, THEROPITHECUS, P331, DOI 10.1017/CBO9780511565540.013; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; Terborgh J, 5 NEW WORLD PRIMATES; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; UNGAR PS, 1995, INT J PRIMATOL, V16, P221, DOI 10.1007/BF02735479; UNGAR PS, 1995, AM J PHYS ANTHROPOL, V97, P93, DOI 10.1002/ajpa.1330970202; Ungar PS, 2003, P NATL ACAD SCI USA, V100, P3874, DOI 10.1073/pnas.0637016100; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; Wahungu GM, 1998, AFR J ECOL, V36, P159, DOI 10.1046/j.1365-2028.1998.00120.x; WALKER A, 1978, SCIENCE, V201, P908, DOI 10.1126/science.684415; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; WRANGHAM RW, 1991, PHILOS T ROY SOC B, V334, P171, DOI 10.1098/rstb.1991.0106; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006	115	67	71	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28379	10.1371/journal.pone.0028379	http://dx.doi.org/10.1371/journal.pone.0028379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163299	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900035
J	Itoh, H; Tatematsu, M; Watanabe, A; Iwano, K; Funami, K; Seya, T; Matsumoto, M				Itoh, Hiroki; Tatematsu, Megumi; Watanabe, Ayako; Iwano, Katsunori; Funami, Kenji; Seya, Tsukasa; Matsumoto, Misako			UNC93B1 Physically Associates with Human TLR8 and Regulates TLR8-Mediated Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEIN; DENDRITIC CELLS; STRANDED-RNA; RECOGNITION; EXPRESSION; ACTIVATION; RESPONSES; SYSTEM	Toll-like receptors (TLRs) 3, 7, 8, and 9 are localized to intracellular compartments where they encounter foreign or self nucleic acids and activate innate and adaptive immune responses. The endoplasmic reticulum (ER)-resident membrane protein, UNC93B1, is essential for intracellular trafficking and endolysosomal targeting of TLR7 and TLR9. TLR8 is phylogenetically and structurally related to TLR7 and TLR9, but little is known about its localization or function. In this study, we demonstrate that TLR8 localized to the early endosome and the ER but not to the late endosome or lysosome in human monocytes and HeLa transfectants. UNC93B1 physically associated with human TLR8, similar to TLRs 3, 7, and 9, and played a critical role in TLR8-mediated signaling. Localization analyses of TLR8 tail-truncated mutants revealed that the transmembrane domain and the Toll/interleukin-1 receptor domain were required for proper targeting of TLR8 to the early endosome. Hence, although UNC93B1 participates in intracellular trafficking and signaling for all nucleotide-sensing TLRs, the mode of regulation of TLR localization differs for each TLR.	[Itoh, Hiroki; Tatematsu, Megumi; Watanabe, Ayako; Iwano, Katsunori; Funami, Kenji; Seya, Tsukasa; Matsumoto, Misako] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan	Hokkaido University	Itoh, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	matumoto@pop.med.hokudai.ac.jp	美佐子, 松本/A-4497-2012; Funami, Kenji/A-4284-2012; Seya, Tsukasa/A-4336-2012		Ministry of Education, Science, and Culture; Ministry of Health, Labor, and Welfare of Japan; Akiyama Life Science Foundation; Grants-in-Aid for Scientific Research [23590558] Funding Source: KAKEN	Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Akiyama Life Science Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid from the Ministry of Education, Science, and Culture, the Ministry of Health, Labor, and Welfare of Japan, and by the Akiyama Life Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Ebihara T, 2010, J EXP MED, V207, P2675, DOI 10.1084/jem.20091573; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Funami K, 2004, INT IMMUNOL, V16, P1143, DOI 10.1093/intimm/dxh115; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gibbard RJ, 2006, J BIOL CHEM, V281, P27503, DOI 10.1074/jbc.M605003200; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Leifer CA, 2006, J BIOL CHEM, V281, P35585, DOI 10.1074/jbc.M607511200; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhu J, 2009, MOL IMMUNOL, V46, P884, DOI 10.1016/j.molimm.2008.09.020	34	52	54	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28500	10.1371/journal.pone.0028500	http://dx.doi.org/10.1371/journal.pone.0028500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164301	gold, Green Published			2022-12-27	WOS:000298171400102
J	Jaeckisch, N; Yang, I; Wohlrab, S; Glockner, G; Kroymann, J; Vogel, H; Cembella, A; John, U				Jaeckisch, Nina; Yang, Ines; Wohlrab, Sylke; Gloeckner, Gernot; Kroymann, Juergen; Vogel, Heiko; Cembella, Allan; John, Uwe			Comparative Genomic and Transcriptomic Characterization of the Toxigenic Marine Dinoflagellate Alexandrium ostenfeldii	PLOS ONE			English	Article							SEQUENCE TAG ANALYSIS; GENE-EXPRESSION; CRYPTHECODINIUM-COHNII; DNA; ORGANIZATION; PROTEIN; CHROMOSOMES; EVOLUTION; LIBRARY; NUMBER	Many dinoflagellate species are notorious for the toxins they produce and ecological and human health consequences associated with harmful algal blooms (HABs). Dinoflagellates are particularly refractory to genomic analysis due to the enormous genome size, lack of knowledge about their DNA composition and structure, and peculiarities of gene regulation, such as spliced leader (SL) trans-splicing and mRNA transposition mechanisms. Alexandrium ostenfeldii is known to produce macrocyclic imine toxins, described as spirolides. We characterized the genome of A. ostenfeldii using a combination of transcriptomic data and random genomic clones for comparison with other dinoflagellates, particularly Alexandrium species. Examination of SL sequences revealed similar features as in other dinoflagellates, including Alexandrium species. SL sequences in decay indicate frequent retro-transposition of mRNA species. This probably contributes to overall genome complexity by generating additional gene copies. Sequencing of several thousand fosmid and bacterial artificial chromosome (BAC) ends yielded a wealth of simple repeats and tandemly repeated longer sequence stretches which we estimated to comprise more than half of the whole genome. Surprisingly, the repeats comprise a very limited set of 7997 bp sequences; in part the genome is thus a relatively uniform sequence space interrupted by coding sequences. Our genomic sequence survey (GSS) represents the largest genomic data set of a dinoflagellate to date. Alexandrium ostenfeldii is a typical dinoflagellate with respect to its transcriptome and mRNA transposition but demonstrates Alexandrium-like stop codon usage. The large portion of repetitive sequences and the organization within the genome is in agreement with several other studies on dinoflagellates using different approaches. It remains to be determined whether this unusual composition is directly correlated to the exceptionally genome organization of dinoflagellates with a low amount of histones and histone-like proteins.	[Jaeckisch, Nina; Wohlrab, Sylke; Cembella, Allan; John, Uwe] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Yang, Ines] Hannover Med Sch, Inst Med Mikrobiol & Krankenhaushyg, D-30623 Hannover, Germany; [Gloeckner, Gernot] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Gloeckner, Gernot] Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Kroymann, Juergen] Univ Paris 11, CNRS, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Vogel, Heiko] Max Planck Inst Chem Ecol, Jena, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Hannover Medical School; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Max Planck Society	Jaeckisch, N (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Nina.Jaeckisch@awi.de; Uwe.john@awi.de	Wohlrab, Sylke/R-7435-2016; Yang, Ines/D-6904-2012; Kroymann, Juergen/B-4317-2013; Glöckner, Gernot/A-7800-2010; john, uwe/S-3009-2016; Kroymann, Juergen/AAY-8562-2021	Wohlrab, Sylke/0000-0003-3190-0880; Yang, Ines/0000-0002-3812-2690; Glöckner, Gernot/0000-0002-9061-1061; john, uwe/0000-0002-1297-4086; Kroymann, Juergen/0000-0002-4573-6498; Cembella, Allan/0000-0002-1297-2240	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU [GOCE-CT-2004-511154, GOCE-CT-2004-505403]	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU(European Commission)	Financial support was provided by the PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment, and by the EU-Project ESTTAL (GOCE-CT-2004-511154) and Marine Genomics (GOCE-CT-2004-505403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JR, 1975, CELL, V6, P161, DOI 10.1016/0092-8674(75)90006-9; Anderson D.M., 1989, P11; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Bairoch A, 1998, NUCLEIC ACIDS RES, V26, P38, DOI 10.1093/nar/26.1.38; Bhaud Y, 2000, J CELL SCI, V113, P1231; Cembella Allan, 2008, P561; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; DAVIES W, 1988, J PROTOZOOL, V35, P418, DOI 10.1111/j.1550-7408.1988.tb04120.x; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Drummond A. J., 2009, GENEIOUS V4 6; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Gregory TR, 1999, GENOME RES, V9, P317; Guillebault D, 2002, J BIOL CHEM, V277, P40881, DOI 10.1074/jbc.M205624200; Hackett JD, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-80; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Henikoff S, 1996, BIOESSAYS, V18, P401, DOI 10.1002/bies.950180510; HINNEBUSCH AG, 1980, BIOCHEMISTRY-US, V19, P1744, DOI 10.1021/bi00550a004; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Imanian B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-172; Figueroa RI, 2010, DEEP-SEA RES PT II, V57, P301, DOI 10.1016/j.dsr2.2009.09.008; Kato KH, 1997, BIOL CELL, V89, P43, DOI 10.1016/S0248-4900(99)80080-X; KELLER MD, 1987, J PHYCOL, V23, P633; KNUDSEN B, CLC SEQUENCE VIEWER; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kremp A, 2009, HARMFUL ALGAE, V8, P318, DOI 10.1016/j.hal.2008.07.004; LEE DH, 1993, J BIOL CHEM, V268, P8842; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Lin SJ, 2010, P NATL ACAD SCI USA, V107, P20033, DOI 10.1073/pnas.1007246107; MARONEY PA, 1995, RNA, V1, P714; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; Palenchar JB, 2006, MOL BIOCHEM PARASIT, V146, P135, DOI 10.1016/j.molbiopara.2005.12.008; Petrov DA, 2001, TRENDS GENET, V17, P23, DOI 10.1016/S0168-9525(00)02157-0; Pontecorvo G, 1944, NATURE, V153, P365, DOI 10.1038/153365a0; RILL RL, 1989, CHROMOSOMA, V98, P280, DOI 10.1007/BF00327314; RIZZO PJ, 1991, J PROTOZOOL, V38, P246, DOI 10.1111/j.1550-7408.1991.tb04437.x; ROBERTS TM, 1974, NATURE, V248, P446, DOI 10.1038/248446a0; Satou Y, 2006, NUCLEIC ACIDS RES, V34, P3378, DOI 10.1093/nar/gkl418; SCHLOTTERER C, 1992, NUCLEIC ACIDS RES, V20, P211, DOI 10.1093/nar/20.2.211; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Smit A., REPEATMASKER OPEN 3; SMITH GP, 1976, SCIENCE, V191, P528, DOI 10.1126/science.1251186; SOYERGOBILLARD MO, 1990, J CELL BIOL, V111, P293, DOI 10.1083/jcb.111.2.293; STEELE RE, 1980, NUCLEIC ACIDS RES, V8, P4709, DOI 10.1093/nar/8.20.4709; Sun JC, 2005, J MOL EVOL, V61, P437, DOI 10.1007/s00239-004-0277-3; Tanikawa N, 2004, PHOTOCHEM PHOTOBIOL, V80, P31, DOI 10.1562/2004-03-12-RA-110.1; TARTOF KD, 1989, DEV GENET, V10, P162, DOI 10.1002/dvg.1020100306; Taylor F.J.R., 1998, NATO ASI Series Series G Ecological Sciences, V41, P3; Uribe P, 2008, MAR BIOTECHNOL, V10, P692, DOI 10.1007/s10126-008-9107-8; Waller RF, 2009, BIOESSAYS, V31, P237, DOI 10.1002/bies.200800164; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wong JTY, 2003, EUKARYOT CELL, V2, P646, DOI 10.1128/EC.2.3.646-650.2003; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248; Ye F, 1996, P NATL ACAD SCI USA, V93, P10881, DOI 10.1073/pnas.93.20.10881; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, MOL BIOL EVOL, V26, P1757, DOI 10.1093/molbev/msp083; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099	64	77	80	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28012	10.1371/journal.pone.0028012	http://dx.doi.org/10.1371/journal.pone.0028012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164224	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400025
J	Takayama, T; Ebinuma, H; Tada, S; Yamagishi, Y; Wakabayashi, K; Ojiro, K; Kanai, T; Saito, H; Hibi, T				Takayama, Tetsuro; Ebinuma, Hirotoshi; Tada, Shinichiro; Yamagishi, Yoshiyuki; Wakabayashi, Kanji; Ojiro, Keisuke; Kanai, Takanori; Saito, Hidetsugu; Hibi, Toshifumi		Keio Assoc Study Liver Dis	Prediction of Effect of Pegylated Interferon Alpha-2b plus Ribavirin Combination Therapy in Patients with Chronic Hepatitis C Infection	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; LOWER-GASTROINTESTINAL HEMORRHAGE; VIRUS GENOTYPES; PEGINTERFERON ALPHA-2B; VIROLOGICAL RESPONSE; TREATMENT DURATION; GASTROENTEROLOGY; POLYMORPHISMS; OPTIMIZATION; EXPERIENCE	Treatment with pegylated interferon alpha-2b (PEGIFN) plus ribavirin (RBV) is standard therapy for patients with chronic hepatitis C. Although the effectiveness, patients with high titres of group Ib hepatitis C virus (HCV) respond poorly compared to other genotypes. At present, we cannot predict the effect in an individual. Previous studies have used traditional statistical analysis by assuming a linear relationship between clinical features, but most phenomena in the clinical situation are not linearly related. The aim of this study is to predict the effect of PEG IFN plus RBV therapy on an individual patient level using an artificial neural network system (ANN). 156 patients with HCV group 1b from multiple centres were treated with PEGIFN (1.5 mg/kg) plus RBV (400-1000 mg) for 48 weeks. Data on the patients' demographics, laboratory tests, PEGIFN, and RBV doses, early viral responses (EVR), and sustained viral responses were collected. Clinical data were randomly divided into training data set and validation data set and analyzed using multiple logistic regression analysis (MLRs) and ANN to predict individual outcomes. The sensitivities of predictive expression were 0.45 for the MLRs models and 0.82 for the ANNs and specificities were 0.55 for the MLR and 0.88 for the ANN. Non-linear relation analysis showed that EVR, serum creatinine, initial dose of Ribavirin, gender and age were important predictive factors, suggesting non-linearly related to outcome. In conclusion, ANN was more accurate than MLRs in predicting the outcome of PEGIFN plus RBV therapy in patients with group 1b HCV.	[Takayama, Tetsuro; Ebinuma, Hirotoshi; Tada, Shinichiro; Yamagishi, Yoshiyuki; Wakabayashi, Kanji; Ojiro, Keisuke; Kanai, Takanori; Saito, Hidetsugu; Hibi, Toshifumi; Keio Assoc Study Liver Dis] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo, Japan	Keio University	Takayama, T (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo, Japan.	thibi@sc.itc.keio.ac.jp			Japanese Ministry of Education, Culture and Science; Japanese Ministry of Health, Labor and Welfare; Keio University; Keio Medical Foundation, Tokyo, Japan	Japanese Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare; Keio University; Keio Medical Foundation, Tokyo, Japan	Supported in part by grants-in-aid from the Japanese Ministry of Education, Culture and Science; the Japanese Ministry of Health, Labor and Welfare; Keio University; and Keio Medical Foundation, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2007, J MED VIROL, V79, P1686, DOI 10.1002/jmv.20979; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; BAXT WG, 1995, LANCET, V346, P1135, DOI 10.1016/S0140-6736(95)91804-3; BAXT WG, 1991, ANN INTERN MED, V115, P843, DOI 10.7326/0003-4819-115-11-843; Berg T, 2006, GASTROENTEROLOGY, V130, P1086, DOI 10.1053/j.gastro.2006.02.015; CROSS SS, 1995, LANCET, V346, P1075, DOI 10.1016/S0140-6736(95)91746-2; Cyr DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021854; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Das A, 2007, EUR J GASTROEN HEPAT, V19, P1064, DOI 10.1097/MEG.0b013e3282f198f7; Dusheiko G, 1996, J HEPATOL, V25, P591, DOI 10.1016/S0168-8278(96)80225-X; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grossi E, 2007, DIGEST LIVER DIS, V39, P278, DOI 10.1016/j.dld.2006.10.003; Grossi E, 2007, EUR J GASTROEN HEPAT, V19, P1046, DOI 10.1097/MEG.0b013e3282f198a0; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Haydon GH, 1998, J VIRAL HEPATITIS, V5, P255, DOI 10.1046/j.1365-2893.1998.00108.x; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; Lin CY, 2011, PLOS ONE, V6; Liu SH, 2006, J GEN VIROL, V87, P323, DOI 10.1099/vir.0.81407-0; Maiellaro PA, 2004, CURR PHARM DESIGN, V10, P2101, DOI 10.2174/1381612043384240; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Nakamura M, 2008, J MED VIROL, V80, P632, DOI 10.1002/jmv.21125; NOUSBAUM JB, 1995, ANN INTERN MED, V122, P161, DOI 10.7326/0003-4819-122-3-199502010-00001; O'Brien TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020904; Pace F, 2007, EUR J GASTROEN HEPAT, V19, P1043, DOI 10.1097/MEG.0b013e3282f198e5; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Saito H, 2002, J INTERF CYTOK RES, V22, P693, DOI 10.1089/10799900260100196; Saito H, 2000, J VIRAL HEPATITIS, V7, P64; Sanchez-Tapias JM, 2006, GASTROENTEROLOGY, V131, P451, DOI 10.1053/j.gastro.2006.05.016; Shirakawa H, 2008, HEPATOLOGY, V48, P1753, DOI 10.1002/hep.22543; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; TAKADA N, 1993, J HEPATOL, V17, P277, DOI 10.1016/S0168-8278(05)80205-3; Takagaki K, 2010, J PHARM SCI-US, V99, P4201, DOI 10.1002/jps.22135; Takayama K, 2000, J CONTROL RELEASE, V68, P175, DOI 10.1016/S0168-3659(00)00248-0; Takayama K, 2003, ADV DRUG DELIVER REV, V55, P1217, DOI 10.1016/S0169-409X(03)00120-0; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Yamamura S, 2003, ADV DRUG DELIVER REV, V55, P1233, DOI 10.1016/S0169-409X(03)00121-2; Zein NN, 1996, ANN INTERN MED, V125, P634, DOI 10.7326/0003-4819-125-8-199610150-00002; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033	42	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27223	10.1371/journal.pone.0027223	http://dx.doi.org/10.1371/journal.pone.0027223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164207	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400007
J	Yoshida, Y; Iigusa, H; Wang, NY; Hasunuma, K				Yoshida, Yusuke; Iigusa, Hideo; Wang, Niyan; Hasunuma, Kohji			Cross-Talk between the Cellular Redox State and the Circadian System in Neurospora	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; WHITE COLLAR-1; DNA-BINDING; RHYTHMS; CLOCK; CRASSA; TRANSCRIPTION; FREQUENCY; OXYGEN; EXPRESSION	The circadian system is composed of a number of feedback loops, and multiple feedback loops in the form of oscillators help to maintain stable rhythms. The filamentous fungus Neurospora crassa exhibits a circadian rhythm during asexual spore formation (conidiation banding) and has a major feedback loop that includes the FREQUENCY (FRQ)/WHITE COLLAR (WC) -1 and -2 oscillator (FWO). A mutation in superoxide dismutase (sod)-1, an antioxidant gene, causes a robust and stable circadian rhythm compared with that of wild-type (Wt). However, the mechanisms underlying the functions of reactive oxygen species (ROS) remain unknown. Here, we show that cellular ROS concentrations change in a circadian manner (ROS oscillation), and the amplitudes of ROS oscillation increase with each cycle and then become steady (ROS homeostasis). The ROS oscillation and homeostasis are produced by the ROS-destroying catalases (CATs) and ROS-generating NADPH oxidase (NOX). cat-1 is also induced by illumination, and it reduces ROS levels. Although ROS oscillation persists in the absence of frq, wc-1 or wc-2, its homeostasis is altered. Furthermore, genetic and biochemical evidence reveals that ROS concentration regulates the transcriptional function of WCC and a higher ROS concentration enhances conidiation banding. These findings suggest that the circadian system engages in cross-talk with the cellular redox state via ROS-regulatory factors.	[Yoshida, Yusuke; Iigusa, Hideo; Wang, Niyan; Hasunuma, Kohji] Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan	Yokohama City University	Yoshida, Y (corresponding author), Yokohama City Univ, Grad Sch Integrated Sci, Kihara Inst Biol Res, Totsuka Ku, Yokohama, Kanagawa 232, Japan.	yyoshida@yokohama-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [21790227]	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (No. 21790227) for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Bai ZH, 2001, BIOTECHNOL BIOENG, V75, P204, DOI 10.1002/bit.1180; Ballario P, 1996, EMBO J, V15, P1650, DOI 10.1002/j.1460-2075.1996.tb00510.x; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brody S, 2010, FUNGAL GENET BIOL, V47, P159, DOI 10.1016/j.fgb.2009.09.006; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Christensen MK, 2004, J BIOL RHYTHM, V19, P280, DOI 10.1177/0748730404265532; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Paula RM, 2007, COLD SPRING HARB SYM, V72, P345, DOI 10.1101/sqb.2007.72.002; Dunlap JC, 2008, GENETICS, V178, P1, DOI 10.1534/genetics.104.86496; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Granshaw T, 2003, J BIOL RHYTHM, V18, P287, DOI 10.1177/0748730403255934; HARDING RW, 1981, PLANT PHYSIOL, V68, P745, DOI 10.1104/pp.68.3.745; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Hirayama J, 2007, P NATL ACAD SCI USA, V104, P15747, DOI 10.1073/pnas.0705614104; Iigusa H, 2005, FEBS LETT, V579, P4012, DOI 10.1016/j.febslet.2005.06.014; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Jalil JE, 2005, HYPERTENSION, V46, P1362, DOI 10.1161/01.HYP.0000188980.57312.63; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lakin-Thomas PL, 2000, P NATL ACAD SCI USA, V97, P256, DOI 10.1073/pnas.97.1.256; LALORAYA MM, 1994, BIOCHEM MOL BIOL INT, V33, P543; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Lee B, 2009, FEBS LETT, V583, P3291, DOI 10.1016/j.febslet.2009.09.026; Lledias F, 1999, FREE RADICAL BIO MED, V26, P1396, DOI 10.1016/S0891-5849(98)00341-4; MASKIEWICZ R, 1979, J AM CHEM SOC, V101, P5347, DOI 10.1021/ja00512a040; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Michan S, 2003, EUKARYOT CELL, V2, P798, DOI 10.1128/EC.2.4.798-808.2003; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; SARGENT ML, 1969, J BACTERIOL, V97, P861, DOI 10.1128/JB.97.2.861-866.1969; Schliebs W, 2006, EUKARYOT CELL, V5, P1490, DOI 10.1128/EC.00113-06; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Taylor BL, 2007, MOL MICROBIOL, V65, P1415, DOI 10.1111/j.1365-2958.2007.05889.x; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Wang NY, 2007, MOL GENET GENOMICS, V277, P13, DOI 10.1007/s00438-006-0170-4; Yamashita K, 2007, GENES GENET SYST, V82, P301, DOI 10.1266/ggs.82.301; Yoshida Y, 2004, J BIOL CHEM, V279, P6986, DOI 10.1074/jbc.M310060200; Yoshida Y, 2008, MOL GENET GENOMICS, V279, P193, DOI 10.1007/s00438-007-0308-z; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	50	39	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28227	10.1371/journal.pone.0028227	http://dx.doi.org/10.1371/journal.pone.0028227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164247	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400048
J	Czachowski, S; Seed, P; Schofield, P; Ashworth, M				Czachowski, Slawomir; Seed, Paul; Schofield, Peter; Ashworth, Mark			Measuring Psychological Change during Cognitive Behaviour Therapy in Primary Care: A Polish Study Using 'PSYCHLOPS' (Psychological Outcome Profiles)	PLOS ONE			English	Article								Background: Psychological outcome measures are evolving into measures that depict progress over time. Interval measurement during therapy has not previously been reported for a patient-generated measure in primary care. We aimed to determine the sensitivity to change throughout therapy, using 'PSYCHLOPS' (Psychological Outcome Profiles), and to determine if new problems appearing during therapy diminish overall improvement. Methods: Responses to PSYCHLOPS, pre-, during-and post-therapy were compared. Setting: patients offered brief cognitive behaviour therapy in primary care in Poland. Results: 238 patients completed the pre-therapy questionnaire, 194 (81.5%) the during-therapy questionnaire and 142 the post-therapy questionnaire (59.7%). For those completing all three questionnaires (n = 135), improvement in total scores produced an overall Effect Size of 3.1 (2.7 to 3.4). We estimated change using three methods for dealing with missing values. Single and multiple imputation did not significantly change the Effect Size; 'Last Value Carried Forward', the most conservative method, produced an overall Effect Size of 2.3 (1.9 to 2.6). New problems during therapy were reported by 81 patients (60.0%): new problem and original problem scores were of similar magnitude and change scores were not significantly different when compared to patients who did not report new problems. Conclusion: A large proportion of outcome data is lost when outcome measures depend upon completed end of therapy questionnaires. The use of a during-therapy measure increases data capture. Missing data still produce difficulties in interpreting overall effect sizes for change. We found no evidence that new problems appearing during therapy hampered overall recovery.	[Czachowski, Slawomir] Nicolaus Copernicus Univ, Coll Med, Torun, Poland; [Seed, Paul; Schofield, Peter; Ashworth, Mark] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England	Nicolaus Copernicus University; University of London; King's College London	Czachowski, S (corresponding author), Nicolaus Copernicus Univ, Coll Med, Torun, Poland.	mark.ashworth@kcl.ac.uk	Czachowski, Slawomir/H-7702-2014; Schofield, Peter/B-7821-2011; Seed, Paul T/C-4435-2008	Czachowski, Slawomir/0000-0002-8055-4833; Schofield, Peter/0000-0003-1201-527X; Seed, Paul T/0000-0001-7904-7933; Ashworth, Mark/0000-0001-6514-9904	Family Doctor Department, Medical College, Nicolaus Copernicus University, Torun, Poland	Family Doctor Department, Medical College, Nicolaus Copernicus University, Torun, Poland	This work was funded through departmental funds from the Family Doctor Department, Medical College, Nicolaus Copernicus University, Torun, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth M., 2005, PRIM CARE MENTAL HLT, V3, P261, DOI DOI 10.1080/09638230701879144; Ashworth M, 2009, J MENT HEALTH, V18, P169, DOI 10.1080/09638230701879144; Barkham M, 2006, J CONSULT CLIN PSYCH, V74, P160, DOI 10.1037/0022-006X.74.1.160; BARKHAM M, 1992, BEHAV PSYCHOTHER, V20, P147, DOI 10.1017/S014134730001692X; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Devlin N., 2010, GETTING MOST OUT PRO; Evans C, 2003, CLIN PSYCHOL PSYCHOT, V10, P374, DOI 10.1002/cpp.384; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Hamer RM, 2009, AM J PSYCHIAT, V166, P639, DOI 10.1176/appi.ajp.2009.09040458; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Little R. J. A., 1987, STAT ANAL MISSING DA; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Miller S. D., 2003, J BRIEF THERAPY, V2, P91; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P1362; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schlomer GL, 2010, J COUNS PSYCHOL, V57, P1, DOI 10.1037/a0018082	17	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27378	10.1371/journal.pone.0027378	http://dx.doi.org/10.1371/journal.pone.0027378			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866HE	22194783	Green Published, gold, Green Submitted			2022-12-27	WOS:000298370400003
J	Markus, MA; Marques, FZ; Morris, BJ				Markus, M. Andrea; Marques, Francine Z.; Morris, Brian J.			Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAs	PLOS ONE			English	Article							IN-VIVO; HUMAN-DISEASE; LIFE-SPAN; PROTEIN; RESTRICTION; RELEVANCE; CANCER; SIRT1; CONNECTION; ACTIVATORS	Alternative pre-mRNA splicing defects can contribute to, or result from, various diseases, including cancer. Aberrant mRNAs, splicing factors and other RNA processing factors have therefore become targets for new therapeutic interventions. Here we report that the natural polyphenol resveratrol can modulate alternative splicing in a target-specific manner. We transfected minigenes of several alternatively spliceable primary mRNAs into HEK293 cells in the presence or absence of 1, 5, 20 and 50 mu M resveratrol and measured exon levels by semi-quantitative PCR after separation by agarose gel electrophoresis. We found that 20 mu g/ml and 50 mu g/ml of resveratrol affected exon inclusion of SRp20 and SMN2 pre-mRNAs, but not CD44v5 or tau pre-mRNAs. By Western blotting and immunofluorescence we showed that this effect may be due to the ability of resveratrol to change the protein level but not the localization of several RNA processing factors. The processing factors that increased significantly were ASF/SF2, hnRNPA1 and HuR, but resveratrol did not change the levels of RBM4, PTBP1 and U2AF35. By means of siRNA-mediated knockdown we depleted cells of SIRT1, regarded as a major target of resveratrol, and showed that the effect on splicing was not dependent on SIRT1. Our results suggest that resveratrol might be an attractive small molecule to treat diseases in which aberrant splicing has been implicated, and justify more extensive research on the effects of resveratrol on the splicing machinery.	[Markus, M. Andrea] Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Markus, MA (corresponding author), Univ Sydney, Sch Med Sci, Basic & Clin Genom Lab, Sydney, NSW 2006, Australia.	brian.morris@sydney.edu.au	Marques, Francine/AAA-5767-2020; Marques, Francine/AAH-1562-2021	Marques, Francine/0000-0003-4920-9991; Markus, Andrea/0000-0003-2305-3394	Cure Cancer Australia Foundation; Endeavour International Postgraduate Research Scholarship	Cure Cancer Australia Foundation; Endeavour International Postgraduate Research Scholarship(Australian Government)	This work was supported by a Cure Cancer Australia Foundation grant (to MAM) and an Endeavour International Postgraduate Research Scholarship (to FZM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Allard JS, 2009, MOL CELL ENDOCRINOL, V299, P58, DOI 10.1016/j.mce.2008.10.018; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bracco L, 2003, TRENDS BIOTECHNOL, V21, P346, DOI 10.1016/S0167-7799(03)00146-X; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chabot B, 2003, Prog Mol Subcell Biol, V31, P59; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Graveley BR, 2001, RNA, V7, P806, DOI 10.1017/S1355838201010317; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Gurusamy N, 2010, CARDIOVASC RES, V86, P103, DOI 10.1093/cvr/cvp384; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Jumaa H, 2000, BBA-GENE STRUCT EXPR, V1494, P137, DOI 10.1016/S0167-4781(00)00233-5; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Leiro JM, 2010, MOL IMMUNOL, V47, P1114, DOI 10.1016/j.molimm.2009.10.030; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Markus MA, 2006, EXP CELL RES, V312, P3379, DOI 10.1016/j.yexcr.2006.07.008; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pozo-Guisado E, 2004, INT J CANCER, V109, P167, DOI 10.1002/ijc.11720; Sakla MS, 2008, HUM GENET, V122, P635, DOI 10.1007/s00439-007-0441-0; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Shi J, 2008, MOL CELL BIOL, V28, P883, DOI 10.1128/MCB.01345-07; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Usha S, 2005, J BIOCHEM MOL BIOL, V38, P198; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	45	36	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28926	10.1371/journal.pone.0028926	http://dx.doi.org/10.1371/journal.pone.0028926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174926	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300032
J	Weisenberg, SA; Schuetz, AN; Alexander, EA; Eiss, B; Behta, M; Saiman, L; Larone, DH; Jenkins, SG; Rhee, KY				Weisenberg, Scott A.; Schuetz, Audrey N.; Alexander, Elizabeth A.; Eiss, Brain; Behta, Maryam; Saiman, Lisa; Larone, Davise H.; Jenkins, Stephen G.; Rhee, Kyu Y.			Endemic Acinetobacter baumannii in a New York Hospital	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; MOLECULAR EPIDEMIOLOGY; RESISTANCE; INTEGRONS; STRAINS; MECHANISMS; CITY	Background: Acinetobacter baumannii is an increasingly multidrug-resistant (MDR) cause of hospital-acquired infections, often associated with limited therapeutic options. We investigated A. baumannii isolates at a New York hospital to characterize genetic relatedness. Methods: Thirty A. baumannii isolates from geographically-dispersed nursing units within the hospital were studied. Isolate relatedness was assessed by repetitive sequence polymerase chain reaction (rep-PCR). The presence and characteristics of integrons were assessed by PCR. Metabolomic profiles of a subset of a prevalent strain isolates and sporadic isolates were characterized and compared. Results: We detected a hospital-wide group of closely related carbapenem resistant MDR A. baumannii isolates. Compared with sporadic isolates, the prevalent strain isolates were more likely to be MDR (p = 0.001). Isolates from the prevalent strain carried a novel Class I integron sequence. Metabolomic profiles of selected prevalent strain isolates and sporadic isolates were similar. Conclusion: The A. baumannii population at our hospital represents a prevalent strain of related MDR isolates that contain a novel integron cassette. Prevalent strain and sporadic isolates did not segregate by metabolomic profiles. Further study of environmental, host, and bacterial factors associated with the persistence of prevalent endemic A. baumannii strains is needed to develop effective prevention strategies.	[Weisenberg, Scott A.; Alexander, Elizabeth A.; Eiss, Brain; Rhee, Kyu Y.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Schuetz, Audrey N.; Larone, Davise H.; Jenkins, Stephen G.] Weill Cornell Med Coll, Dept Pathol, New York, NY USA; [Behta, Maryam] New York Presbyterian Healthcare Med Ctr, Dept Informat Serv, New York, NY USA; [Saiman, Lisa] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Saiman, Lisa] New York Presbyterian Hosp, Dept Infect Prevent & Control, New York, NY USA	Cornell University; Cornell University; Columbia University; NewYork-Presbyterian Hospital	Weisenberg, SA (corresponding author), Alta Bates Summit Med Ctr, Oakland, CA USA.	scottweisenberg@gmail.com		Weisenberg, Scott/0000-0002-4839-1296	Clinical and Translation Science Center at Weill Cornell Medical College [KL2RR024997]; Merck; Cubist; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024997] Funding Source: NIH RePORTER	Clinical and Translation Science Center at Weill Cornell Medical College; Merck(Merck & Company); Cubist; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This investigation was supported by grant KL2RR024997 of the Clinical and Translation Science Center at Weill Cornell Medical College (SAW). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; The authors have read the journal's policy and have the following conflicts: Scott Weisenberg has received an investigator initiated grant from Merck for an unrelated study (related to international travel and importation of ESBL producing bacteria). Kyu Rhee has received support for unrelated studies on Enterococci from Cubist. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BAANG JH, 2011, AM J INFECT CONTROL; Barlow RS, 2004, ANTIMICROB AGENTS CH, V48, P838, DOI 10.1128/AAC.48.3.838-842.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Huang LY, 2008, CLIN MICROBIOL INFEC, V14, P1010, DOI 10.1111/j.1469-0691.2008.02077.x; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jones RN, 2004, DIAGN MICR INFEC DIS, V49, P211, DOI 10.1016/j.diagmicrobio.2004.03.016; JUNI E, 1978, ANNU REV MICROBIOL, V32, P349, DOI 10.1146/annurev.mi.32.100178.002025; Kim HU, 2010, MOL BIOSYST, V6, P339, DOI 10.1039/b916446d; Landman D, 2009, EPIDEMIOL INFECT, V137, P174, DOI 10.1017/S0950268808000824; Landman D, 2007, J ANTIMICROB CHEMOTH, V60, P78, DOI 10.1093/jac/dkm129; Lee YT, 2009, J MICROBIOL IMMUNOL, V42, P210; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Martinez-Freijo P, 1998, J ANTIMICROB CHEMOTH, V42, P689, DOI 10.1093/jac/42.6.689; Morgan DJ, 2009, INFECT CONT HOSP EP, V30, P196, DOI 10.1086/593207; Oh JY, 2002, APMIS, V110, P247, DOI 10.1034/j.1600-0463.2002.100307.x; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Quale J, 2003, CLIN INFECT DIS, V37, P214, DOI 10.1086/375821; Rodriguez-Bano J, 2004, INFECT CONT HOSP EP, V25, P819, DOI 10.1086/502302; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Saeed S, 2006, INFECT CONT HOSP EP, V27, P981, DOI 10.1086/507286; Sana Theodore R, 2008, J Biomol Tech, V19, P258; SOARES N, 2010, J PROTEOME RES; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Weisenberg SA, 2009, J SEP SCI, V32, P2262, DOI 10.1002/jssc.200900256	31	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28566	10.1371/journal.pone.0028566	http://dx.doi.org/10.1371/journal.pone.0028566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180786	gold, Green Published, Green Submitted			2022-12-27	WOS:000298367300014
J	Chatterjee, SS; Chen, L; Joo, HS; Cheung, GYC; Kreiswirth, BN; Otto, M				Chatterjee, Som S.; Chen, Liang; Joo, Hwang-Soo; Cheung, Gordon Y. C.; Kreiswirth, Barry N.; Otto, Michael			Distribution and Regulation of the Mobile Genetic Element-Encoded Phenol-Soluble Modulin PSM-mec in Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							VIRULENCE; AGR; IDENTIFICATION; EVOLUTION; PEPTIDES	The phenol-soluble modulin PSM-mec is the only known staphylococcal toxin that is encoded on a mobile antibiotic resistance determinant, namely the staphylococcal cassette chromosome (SCC) element mec encoding resistance to methicillin. Here we show that the psm-mec gene is found frequently among methicillin-resistant Staphylococcus aureus (MRSA) strains of SCCmec types II, III, and VIII, and is a conserved part of the class A mec gene complex. Controlled expression of AgrA versus RNAIII in agr mutants of all 3 psm-mec-positive SCCmec types demonstrated that expression of psm-mec, which is highly variable, is controlled by AgrA in an RNAIII-independent manner. Furthermore, psm-mec isogenic deletion mutants showed only minor changes in PSM alpha peptide production and unchanged (or, as previously described, diminished) virulence compared to the corresponding wild-type strains in a mouse model of skin infection. This indicates that the recently reported regulatory impact of the psm-mec locus on MRSA virulence, which is opposite to that of the PSM-mec peptide and likely mediated by a regulatory RNA, is minor when analyzed in the original strain background. Our study gives new insight in the distribution, regulation, and role in virulence of the PSM-mec peptide and the psm-mec gene locus.	[Chatterjee, Som S.; Joo, Hwang-Soo; Cheung, Gordon Y. C.; Otto, Michael] NIAID, Lab Human Bacterial Pathogenesis, NIH, Bethesda, MD 20892 USA; [Chen, Liang; Kreiswirth, Barry N.] Univ Med & Dent New Jersey, Publ Hlth Res Inst, TB Ctr, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center	Chatterjee, SS (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	motto@niaid.nih.gov	Cheung, Yiu Chong/K-3565-2012; Chen, Liang/D-3583-2009	Otto, Michael/0000-0002-2222-4115; JOO, HWANG-SOO/0000-0003-4668-3225; Chen, Liang/0000-0001-5845-2235	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), The National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Cheung GYC, 2011, INFECT IMMUN, V79, P1927, DOI 10.1128/IAI.00046-11; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Novick RP, 2001, MICROBES INFECT, V3, P585, DOI 10.1016/S1286-4579(01)01414-9; Otto M, 2010, VIRULENCE, V1, P49, DOI 10.4161/viru.1.1.10453; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520	22	55	70	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28781	10.1371/journal.pone.0028781	http://dx.doi.org/10.1371/journal.pone.0028781			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174895	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600038
J	Dellinger, MT; Brekken, RA				Dellinger, Michael T.; Brekken, Rolf A.			Phosphorylation of Akt and ERK1/2 Is Required for VEGF-A/VEGFR2-Induced Proliferation and Migration of Lymphatic Endothelium	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE; ACTIN REORGANIZATION; VESSEL ENLARGEMENT; VEGF RECEPTOR-2; DNA-SYNTHESIS; GROWTH; CELLS; LYMPHANGIOGENESIS; MICE	There is growing evidence that vascular endothelial growth factor-A (VEGF-A), a ligand of the receptor tyrosine kinases VEGFR1 and VEGFR2, promotes lymphangiogenesis. However, the underlying mechanisms by which VEGF-A induces the growth of lymphatic vessels remain poorly defined. Here we report that VEGFR2, not VEGFR1, is the primary receptor regulating VEGF-A-induced lymphangiogenesis. We show that specific inhibition of VEGF-A/VEGFR2 signaling with the fully human monoclonal antibody r84 significantly inhibits lymphangiogenesis in MDA-MB-231 tumors. In vitro experiments with primary human dermal lymphatic endothelial cells (LECs) demonstrate that blocking VEGF-A activation of VEGFR2, not VEGFR1, significantly inhibits VEGF-A-induced proliferation and migration of LECs. We show that VEGF-A stimulation of LECs leads to the phosphorylation of VEGFR2 (Tyr 951, 1054, 1059, 1175, and 1214) which subsequently triggers PKC dependent phosphorylation of ERK1/2 and PI3-K dependent phosphorylation of Akt. Additionally, we demonstrate that inhibitors that suppress the phosphorylation of ERK1/2 and Akt significantly block VEGF-A- induced proliferation and migration of LECs. Together, these results shed light on the mechanisms regulating VEGF-A-induced proliferation and migration of LECs, reveal that VEGFR2 is the primary signaling VEGF-A receptor on lymphatic endothelium, and suggest that therapeutic agents targeting the VEGF-A/VEGFR2 axis could be useful in blocking the pathological formation of lymphatic vessels.	[Dellinger, Michael T.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA; [Dellinger, Michael T.; Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Brekken, Rolf A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Dellinger, MT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu		Dellinger, Michael/0000-0002-3315-4239	National Institutes of Health [R01CA118240]; Effie Marie Cain Scholarship; Department of Defense; Affitech AS; Peregrine Pharmaceuticals Inc.; NATIONAL CANCER INSTITUTE [R01CA118240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Effie Marie Cain Scholarship; Department of Defense(United States Department of Defense); Affitech AS; Peregrine Pharmaceuticals Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health R01CA118240 (R. A. Brekken), Effie Marie Cain Scholarship (R. A. Brekken), and Department of Defense Postdoctoral Fellowship for Breast Cancer Research (M. T. Dellinger). Funding from Affitech AS and Peregrine Pharmaceuticals Inc. was not used to support this study. The funders did not participate in the design, execution, or interpretation of experiments.	Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Dellinger MT, 2007, DEV DYNAM, V236, P2346, DOI 10.1002/dvdy.21208; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Hirakawa S, 2005, BLOOD, V105, P2392, DOI 10.1182/blood-2004-06-2435; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Ichise T, 2010, DEVELOPMENT, V137, P1003, DOI 10.1242/dev.043489; Jones D, 2010, ARTERIOSCL THROM VAS, V30, P2553, DOI 10.1161/ATVBAHA.110.214999; Kajiya K, 2008, FASEB J, V22, P530, DOI 10.1096/fj.07-8873com; Kajiya K, 2006, AM J PATHOL, V169, P1496, DOI 10.2353/ajpath.2006.060197; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lahdenranta J, 2009, CANCER RES, V69, P2801, DOI 10.1158/0008-5472.CAN-08-4051; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Morales-Ruiz M, 2000, CIRC RES, V86, P892, DOI 10.1161/01.RES.86.8.892; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nojiri H, 1999, MICROCIRCULATION, V6, P75, DOI 10.1080/713773929; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Saaristo A, 2002, FASEB J, V16, P1041, DOI 10.1096/fj.01-1042com; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sullivan LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012031; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Veikkola T, 2003, FASEB J, V17, P2006, DOI 10.1096/fj.03-0179com; Whitehurst Brandt, 2006, Lymphatic Research and Biology, V4, P119, DOI 10.1089/lrb.2006.4.119; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Witte M H, 1997, EXS, V79, P65; Yuen D, 2011, INVEST OPHTH VIS SCI, V52, P2593, DOI 10.1167/iovs.10-6408; Zhou F, 2010, AM J PATHOL, V177, P2124, DOI 10.2353/ajpath.2010.091301	43	65	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28947	10.1371/journal.pone.0028947	http://dx.doi.org/10.1371/journal.pone.0028947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174934	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600051
J	Matsumoto, H; Terao, Y; Yugeta, A; Fukuda, H; Emoto, M; Furubayashi, T; Okano, T; Hanajima, R; Ugawa, Y				Matsumoto, Hideyuki; Terao, Yasuo; Yugeta, Akihiro; Fukuda, Hideki; Emoto, Masaki; Furubayashi, Toshiaki; Okano, Tomoko; Hanajima, Ritsuko; Ugawa, Yoshikazu			Where Do Neurologists Look When Viewing Brain CT Images? An Eye-Tracking Study Involving Stroke Cases	PLOS ONE			English	Article							VISUAL-ATTENTION; SALIENCY; PERCEPTION; SEARCH; SHIFTS; MODEL	The aim of this study was to investigate where neurologists look when they view brain computed tomography (CT) images and to evaluate how they deploy their visual attention by comparing their gaze distribution with saliency maps. Brain CT images showing cerebrovascular accidents were presented to 12 neurologists and 12 control subjects. The subjects' ocular fixation positions were recorded using an eye-tracking device (Eyelink 1000). Heat maps were created based on the eye-fixation patterns of each group and compared between the two groups. The heat maps revealed that the areas on which control subjects frequently fixated often coincided with areas identified as outstanding in saliency maps, while the areas on which neurologists frequently fixated often did not. Dwell time in regions of interest (ROI) was likewise compared between the two groups, revealing that, although dwell time on large lesions was not different between the two groups, dwell time in clinically important areas with low salience was longer in neurologists than in controls. Therefore it appears that neurologists intentionally scan clinically important areas when reading brain CT images showing cerebrovascular accidents. Both neurologists and control subjects used the "bottom-up salience" form of visual attention, although the neurologists more effectively used the "top-down instruction" form.	[Matsumoto, Hideyuki; Terao, Yasuo; Yugeta, Akihiro; Okano, Tomoko; Hanajima, Ritsuko] Univ Tokyo, Dept Neurol, Tokyo, Japan; [Fukuda, Hideki] Segawa Neurol Clin Children, Tokyo, Japan; [Emoto, Masaki] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan; [Furubayashi, Toshiaki; Ugawa, Yoshikazu] Fukushima Med Univ, Sch Med, Dept Neurol, Fukushima, Japan	University of Tokyo; University of Tokyo; Fukushima Medical University	Matsumoto, H (corresponding author), Univ Tokyo, Dept Neurol, Tokyo, Japan.	hideyukimatsumoto.jp@gmail.com	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline; Boehringer Ingelheim; Ministry of Health and Welfare of Japan; Ministry of Public Management, Home Affairs, Post and Telecommunications; Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; Dainippon Sumitomo Pharma. Co., Ltd.	Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Management, Home Affairs, Post and Telecommunications; Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; Dainippon Sumitomo Pharma. Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.)	Dr. Terao is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received speaker's honoraria from Boehringer Ingelheim. Dr. Hanajima is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and has received speaker's honoraria from Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd. Dr. Ugawa is supported by supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; by grants for the Research Committee on the Best rTMS Treatment of Parkinson's Disease from the Ministry of Health and Welfare of Japan; by the Research Committee on Dystonia of the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications. Dr. Matsumoto, Mr. Furubayashi, Dr. Yugeta, Mr. Fukuda, Mr. Emoto, and Ms. Okano have no disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding from a commercial source (GlaxoSmithKline, Boehringer Ingelheim, Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd.). Dr. Terao is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and GlaxoSmithKline and Boehringer Ingelheim, and has received speaker's honoraria from Boehringer Ingelheim. Dr. Hanajima is supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research and has received speaker's honoraria from Medtronic Japan Co., Ltd; Novartis Japan Co., Ltd; and Dainippon Sumitomo Pharma. Co., Ltd. Dr. Ugawa is supported by supported by a Research Project Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan Research; by grants for the Research Committee on the Best rTMS Treatment of Parkinson's Disease from the Ministry of Health and Welfare of Japan; by the Research Committee on Dystonia of the Ministry of Health and Welfare of Japan; by a grant from the Committee of the Study of Human Exposure to EMF from the Ministry of Public Management, Home Affairs, Post and Telecommunications. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Beard D V, 1990, J Digit Imaging, V3, P230; Beard D V, 1994, J Digit Imaging, V7, P189; Ellis SM, 2006, EUR J RADIOL, V59, P257, DOI 10.1016/j.ejrad.2006.05.006; Foulsham T, 2008, J VISION, V8, DOI 10.1167/8.2.6; Foulsham T, 2009, NEUROPSYCHOLOGIA, V47, P1994, DOI 10.1016/j.neuropsychologia.2009.03.013; Harel J., 2006, GRAPH BASED VISUAL S; Harel J., SALIENCY IMPLEMENTAT; HENDERSON JM, 1997, EYE MOVEMENT RES INS, P537; Hu C H, 1994, Acad Radiol, V1, P25, DOI 10.1016/S1076-6332(05)80780-9; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kundel HL, 2008, ACAD RADIOL, V15, P881, DOI 10.1016/j.acra.2008.01.023; Kundel HL, 2007, RADIOLOGY, V242, P396, DOI 10.1148/radiol.2422051997; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Mahajan V, 2008, AM J NEURORADIOL, V29, P1144, DOI 10.3174/ajnr.A0995; Matsumoto H, 2011, MOVEMENT DISORD, V26, P1619, DOI 10.1002/mds.23683; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nodine CF, 2002, AM J ROENTGENOL, V179, P917, DOI 10.2214/ajr.179.4.1790917; Peterson M. A., 2003, PERCEPTION FACES OBJ; Suwa K, 2001, Odontology, V89, P54, DOI 10.1007/s10266-001-8186-z; van Zoest W, 2004, PERCEPTION, V33, P927, DOI 10.1068/p5158; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3	25	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28928	10.1371/journal.pone.0028928	http://dx.doi.org/10.1371/journal.pone.0028928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FT	22174928	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600049
J	Fong, V; Osterbur, M; Capella, C; Kim, YE; Hine, C; Gorbunova, V; Seluanov, A; Dewhurst, S				Fong, Vincent; Osterbur, Marika; Capella, Cristina; Kim, Yo-El; Hine, Christopher; Gorbunova, Vera; Seluanov, Andrei; Dewhurst, Stephen			Adenoviral Vector Driven by a Minimal Rad51 Promoter Is Selective for p53-Deficient Tumor Cells	PLOS ONE			English	Article							CANCER GENE-THERAPY; DNA-REPAIR; TRANSCRIPTIONAL REGULATION; HOMOLOGOUS RECOMBINATION; BINDING PROTEIN; BREAK REPAIR; P53; EXPRESSION; OVEREXPRESSION; INSTABILITY	Background: The full length Rad51 promoter is highly active in cancer cells but not in normal cells. We therefore set out to assess whether we could confer this tumor-selectivity to an adenovirus vector. Methodology/Principal Findings: Expression of an adenovirally-vectored luciferase reporter gene from the Rad51 promoter was up to 50 fold higher in cancer cells than in normal cells. Further evaluations of a panel of truncated promoter mutants identified a 447 bp minimal core promoter element that retained the full tumor selectivity and transcriptional activity of the original promoter, in the context of an adenovirus vector. This core Rad51 promoter was highly active in cancer cells that lack functional p53, but less active in normal cells and in cancer cell lines with intact p53 function. Exogenous expression of p53 in a p53 null cell line strongly suppressed activity of the Rad51 core promoter, underscoring the selectivity of this promoter for p53-deficient cells. Follow-up experiments showed that the p53-dependent suppression of the Rad51 core promoter was mediated via an indirect, p300 coactivator dependent mechanism. Finally, transduction of target cells with an adenovirus vector encoding the thymidine kinase gene under transcriptional control of the Rad51 core promoter resulted in efficient killing of p53 defective cancer cells, but not of normal cells, upon addition of ganciclovir. Conclusions/Significance: Overall, these experiments demonstrated that a small core domain of the Rad51 promoter can be used to target selective transgene expression from adenoviral vectors to tumor cells lacking functional p53.	[Fong, Vincent; Osterbur, Marika; Capella, Cristina; Kim, Yo-El; Dewhurst, Stephen] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA; [Hine, Christopher; Gorbunova, Vera; Seluanov, Andrei] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Fong, V (corresponding author), Univ Rochester, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	stephen_dewhurst@urmc.rochester.edu		Hine, Christopher/0000-0003-1926-7939; Dewhurst, Stephen/0000-0001-7729-7920; Gorbunova, Vera/0000-0001-8979-0333; Seluanov, Andrei/0000-0003-3400-538X	U.S. National Institutes of Health (NIH) [T32 GM07356]; NIH [R21 CA122213, R01 AG031227, R01 AG27237, T32 GM068411]; NATIONAL CANCER INSTITUTE [R21CA122213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, T32GM007356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027237, R01AG031227] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	VF is a trainee in the Medical Scientist Training Program, funded by the U.S. National Institutes of Health (NIH) award T32 GM07356. This work was also supported by NIH awards R21 CA122213 (SD), R01 AG031227, R01 AG27237 (VG) and T32 GM068411 (VF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Lopez C, 2006, EMBO REP, V7, P219, DOI 10.1038/sj.embor.7400587; Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Barbano R, 2010, INT J CANC; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; BODNER SM, 1992, ONCOGENE, V7, P743; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grossman SR, 2001, EUR J BIOCHEM, V268, P2773, DOI 10.1046/j.1432-1327.2001.02226.x; Hainaut P, 1997, NUCLEIC ACIDS RES, V25, P151, DOI 10.1093/nar/25.1.151; Hannay JAF, 2007, MOL CANCER THER, V6, P1650, DOI 10.1158/1535-7163.MCT-06-0636; Hasselbach L, 2005, EUR J GYNAECOL ONCOL, V26, P589; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hine CM, 2008, P NATL ACAD SCI USA, V105, P20810, DOI 10.1073/pnas.0807990106; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iwanaga R, 2004, ONCOGENE, V23, P8581, DOI 10.1038/sj.onc.1207976; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; KALTHOFF H, 1993, ONCOGENE, V8, P289; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Klein HL, 2008, DNA REPAIR, V7, P686, DOI 10.1016/j.dnarep.2007.12.008; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Lu WG, 2002, CANCER RES, V62, P1305; Maacke H, 2000, INT J CANCER, V88, P907, DOI 10.1002/1097-0215(20001215)88:6<907::AID-IJC11>3.0.CO;2-4; Maacke H, 2000, ONCOGENE, V19, P2791, DOI 10.1038/sj.onc.1203578; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Mitra A, 2009, HISTOPATHOLOGY, V55, P696, DOI 10.1111/j.1365-2559.2009.03448.x; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; OConnor PM, 1997, CANCER RES, V57, P4285; Pastorcic M, 2000, J BIOL CHEM, V275, P34938, DOI 10.1074/jbc.M005411200; Pfitzner E, 1998, MOL ENDOCRINOL, V12, P1582, DOI 10.1210/mend.12.10.0180; Raderschall E, 2002, CANCER RES, V62, P219; Richardson C, 2005, CANCER LETT, V218, P127, DOI 10.1016/j.canlet.2004.08.009; Richardson C, 2004, ONCOGENE, V23, P546, DOI 10.1038/sj.onc.1207098; Sadeghi H, 2005, CURR GENE THER, V5, P411, DOI 10.2174/1566523054546189; Saukkonen K, 2004, EXPERT OPIN BIOL TH, V4, P683, DOI 10.1517/eobt.4.5.683.31060; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shirakawa T, 2008, MOL CELLS, V25, P462; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Smith AC, 2009, J VIROL, V83, P2025, DOI 10.1128/JVI.01644-08; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Xia SJJ, 1997, MOL CELL BIOL, V17, P7151, DOI 10.1128/MCB.17.12.7151; Yuan Ying, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P248	48	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28714	10.1371/journal.pone.0028714	http://dx.doi.org/10.1371/journal.pone.0028714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174876	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700065
J	Liu, YW; Dai, B; Xu, CG; Fu, LL; Hua, ZH; Mei, CL				Liu, Yawei; Dai, Bing; Xu, Chenggang; Fu, Lili; Hua, Zhenhao; Mei, Changlin			Rosiglitazone Inhibits Transforming Growth Factor-beta 1 Mediated Fibrogenesis in ADPKD Cyst-Lining Epithelial Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; AUTOSOMAL-DOMINANT; TGF-BETA; MESANGIAL CELLS; GROWTH-FACTOR; CROSS-TALK; SIGNALING PATHWAYS; PPAR-GAMMA; MAP KINASE; EXPRESSION	Background: Interstitial fibrosis plays an important role in progressive renal dysfunction in autosomal dominant polycystic kidney disease (ADPKD). In our previous studies, we confirmed that PPAR-gamma agonist, rosiglitazone could protect renal function and prolong the survival of a slowly progressive ADPKD animal model by reducing renal fibrosis. However, the mechanism remains unknown. Methods: Primary culture epithelial cells pretreated with TGF-beta 1 were incubated with rosiglitazone. Extracellular matrix proteins were detected using real-time PCR and Western blotting. MAPK and Smad2 phosphorylation were measured with western blot. ERK1/2 pathway and P38 pathway were inhibited with the specific inhibitors PD98059 and SB203580. The Smad2 pathway was blocked with the siRNA. To address whether PPAR-gamma agonist-mediated inhibition of TGF-beta 1-induced collagen type I expression was mediated through a PPAR-gamma dependent mechanism, genetic and pharmaceutical approaches were used to block the activity of endogenous PPAR gamma. Results: TGF-beta 1-stimulated collagen type I and fibronectin expression of ADPKD cyst-lining epithelia were inhibited by rosiglitazone in a dosage-dependent manner. Smad2, ERK1/2 and P38 pathways were activated in response to TGF-beta 1; however, TGF-beta 1 had little effect on JNK pathway. Rosiglitazone suppressed TGF-beta 1 induced Smad2 activation, while ERK1/2 and P38MAPK signals remained unaffected. Rosiglitazone could also attenuate TGF-beta 1-stimulated collagen type I and fibronectin expression in primary renal tubular epithelial cells, but had no effect on TGF-beta 1-induced activation of Smad2, ERK1/2 and P38 pathways. There was no crosstalk between the Smad2 and MAPK pathways in ADPKD cyst-lining epithelial cells. These inhibitory effects of rosiglitazone were reversed by the PPAR gamma specific antagonist GW9662 and PPAR gamma siRNA. Conclusion: ADPKD cyst-lining epithelial cells participate in TGF-beta 1 mediated fibrogenesis. Rosiglitazone could suppress TGF-beta 1-induced collagen type I and fibronectin expression in ADPKD cyst-lining epithelia through modulation of the Smad2 pathway. Our study may provide therapeutic basis for clinical applications of rosiglitazone in retarding the progression of ADPKD.	[Liu, Yawei; Dai, Bing; Xu, Chenggang; Fu, Lili; Hua, Zhenhao; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Nephrol Inst PLA, Shanghai, Peoples R China	Naval Medical University	Liu, YW (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Div Nephrol, Nephrol Inst PLA, Shanghai, Peoples R China.	chlmei1954@yahoo.com.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X	National Natural Science Foundation of China [30900692, 81000283]; Shanghai Leading Academic Discipline Project [B902]; National 863 Plan in High Technology Progress [2007AA02Z3 Z1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National 863 Plan in High Technology Progress(National High Technology Research and Development Program of China)	This work was supported by grants from the National Natural Science Foundation of China (30900692, 81000283), Shanghai Leading Academic Discipline Project (B902) and National 863 Plan in High Technology Progress (2007AA02Z3 Z1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Border WA, 1997, KIDNEY INT, V51, P1388, DOI 10.1038/ki.1997.190; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chea SW, 2009, YONSEI MED J, V50, P105, DOI 10.3349/ymj.2009.50.1.105; Chin BY, 2001, AM J PHYSIOL-RENAL, V280, pF495, DOI 10.1152/ajprenal.2001.280.3.F495; Dai B, 2010, CLIN SCI, V119, P323, DOI 10.1042/CS20100113; DETRISAC CJ, 1984, KIDNEY INT, V25, P383, DOI 10.1038/ki.1984.28; Elberg G, 2008, CELL TISSUE RES, V331, P495, DOI 10.1007/s00441-007-0521-4; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Haraguchi Kazutaka, 2003, Clin Exp Nephrol, V7, P27, DOI 10.1007/s101570300003; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hartsough MT, 1996, J BIOL CHEM, V271, P22368, DOI 10.1074/jbc.271.37.22368; Hassane S, 2010, J PATHOL, V222, P21, DOI 10.1002/path.2734; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hocevar BA, 1999, EMBO J, V18, P1345, DOI 10.1093/emboj/18.5.1345; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li FF, 2009, BIOCHEM BIOPH RES CO, V386, P289, DOI 10.1016/j.bbrc.2009.05.084; Li J, 2009, J RECEPT SIG TRANSD, V29, P280, DOI 10.1080/10799890903078465; Li YJ, 2006, J AM SOC NEPHROL, V17, P54, DOI 10.1681/ASN.2005030257; LIESKE JC, 1993, J AM SOC NEPHROL, V3, P1442; Loghman-Adham M, 2003, AM J PHYSIOL-RENAL, V285, pF397, DOI 10.1152/ajprenal.00310.2002; Ma LJ, 2001, KIDNEY INT, V59, P1899, DOI 10.1046/j.1523-1755.2001.0590051899.x; McCarthy KJ, 2000, KIDNEY INT, V58, P2341, DOI 10.1046/j.1523-1755.2000.00418.x; Miyazono K, 2000, CYTOKINE GROWTH F R, V11, P15, DOI 10.1016/S1359-6101(99)00025-8; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Routh RE, 2002, KIDNEY INT, V61, P1365, DOI 10.1046/j.1523-1755.2002.00277.x; Schieren G, 2006, NEPHROL DIAL TRANSPL, V21, P1816, DOI 10.1093/ndt/gfl071; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Song XW, 2009, HUM MOL GENET, V18, P2328, DOI 10.1093/hmg/ddp165; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Uchiyama-Tanaka Y, 2001, KIDNEY INT, V60, P2153, DOI 10.1046/j.1523-1755.2001.00067.x; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wang W, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/62641; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Watnick T, 2010, NEW ENGL J MED, V363, P879, DOI 10.1056/NEJMe1006925; WILSON PD, 1991, AM J KIDNEY DIS, V17, P634, DOI 10.1016/S0272-6386(12)80338-6; WILSON PD, 1992, J CELL PHYSIOL, V150, P360, DOI 10.1002/jcp.1041500220; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200; Yamaguchi T, 2000, KIDNEY INT, V57, P1460, DOI 10.1046/j.1523-1755.2000.00991.x; Yoshihara D, 2011, AM J PHYSIOL-RENAL, V300, pF465, DOI 10.1152/ajprenal.00460.2010; Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250	50	22	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28915	10.1371/journal.pone.0028915	http://dx.doi.org/10.1371/journal.pone.0028915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174924	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700082
J	Strap, JL; Latos, A; Shim, I; Bonetta, DT				Strap, Janice L.; Latos, Andrew; Shim, Isaac; Bonetta, Dario T.			Characterization of Pellicle Inhibition in Gluconacetobacter xylinus 53582 by a Small Molecule, Pellicin, Identified by a Chemical Genetics Screen	PLOS ONE			English	Article							GMP-BINDING-PROTEIN; ACETOBACTER-XYLINUM; CELLULOSE BIOSYNTHESIS; BACTERIAL CELLULOSE; ESCHERICHIA-COLI; DI-GMP; MICROBIAL CELLULOSE; CELL-GROWTH; SYNTHASE; CRYSTALLIZATION	Pellicin ([2E]-3-phenyl-1-[ 2,3,4,5-tetrahydro-1,6-benzodioxocin-8-yl]prop-2-en-1-one) was identified in a chemical genetics screen of 10,000 small molecules for its ability to completely abolish pellicle production in Gluconacetobacter xylinus. Cells grown in the presence of pellicin grew 1.5 times faster than untreated cells. Interestingly, growth in pellicin also caused G. xylinus cells to elongate. Measurement of cellulose synthesis in vitro showed that cellulose synthase activity was not directly inhibited by pellicin. Rather, when cellulose synthase activity was measured in cells that were pre-treated with the compound, the rate of cellulose synthesis increased eight-fold over that observed for untreated cells. This phenomenon was also apparent in the rapid production of cellulose when cells grown in the presence of pellicin were washed and transferred to media lacking the inhibitor. The rate at which cellulose was produced could not be accounted for by growth of the organism. Pellicin was not detected when intracellular contents were analyzed. Furthermore, it was found that pellicin exerts its effect extracellularly by interfering with the crystallization of pre-cellulosic tactoidal aggregates. This interference of the crystallization process resulted in enhanced production of cellulose II as evidenced by the ratio of acid insoluble to acid soluble product in in vitro assays and confirmed in vivo by scanning electron microscopy and powder X-ray diffraction. The relative crystallinity index, RCI, of pellicle produced by untreated G. xylinus cultures was 70% while pellicin-grown cultures had RCI of 38%. Mercerized pellicle of untreated cells had RCI of 42%, which further confirms the mechanism of action of pellicin as an inhibitor of the cellulose I crystallization process. Pellicin is a useful tool for the study of cellulose biosynthesis in G. xylinus.	[Strap, Janice L.; Latos, Andrew; Shim, Isaac; Bonetta, Dario T.] Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada	Ontario Tech University	Strap, JL (corresponding author), Univ Ontario, Fac Sci, Inst Technol, Oshawa, ON, Canada.	janice.strap@uoit.ca; dario.bonetta@uoit.ca	Strap, Janice L/H-2395-2012		University of Ontario Institute of Technology; Natural Sciences and Engineering Research Council of Canada	University of Ontario Institute of Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by University of Ontario Institute of Technology start-up funds to JLS and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to DTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448; Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x; Bae SO, 2004, APPL MICROBIOL BIOT, V65, P315, DOI 10.1007/s00253-004-1593-7; BENZIMAN M, 1980, P NATL ACAD SCI-BIOL, V77, P6678, DOI 10.1073/pnas.77.11.6678; BENZIMAN M, 1983, J APPL POLYM SCI, V37, P131; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUREAU TE, 1987, P NATL ACAD SCI USA, V84, P6985, DOI 10.1073/pnas.84.20.6985; COLVIN JR, 1983, PROTOPLASMA, V116, P34, DOI 10.1007/BF01294228; Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035; Delmer DP, 2002, METAB ENG, V4, P22, DOI 10.1006/mben.2001.0206; Fu GZ, 2003, INT J LIFE CYCLE ASS, V8, P137, DOI 10.1007/BF02978458; Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x; GLASER L, 1958, J BIOL CHEM, V232, P627; HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003; Hesse-Ertelt S, 2008, MAGN RESON CHEM, V46, P1030, DOI 10.1002/mrc.2311; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Hu SQ, 2008, PROTEIN PEPTIDE LETT, V15, P115; Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10; Kawano S, 2002, J BIOSCI BIOENG, V94, P275, DOI 10.1263/jbb.94.275; Kawano S, 2008, J BIOSCI BIOENG, V106, P88, DOI 10.1263/jbb.106.88; Kim MK, 2002, APPL MICROBIOL BIOT, V60, P134, DOI 10.1007/s00253-002-1102-9; KUGA S, 1993, POLYMER, V34, P3293, DOI 10.1016/0032-3861(93)90404-X; Le Quere B, 2009, MOL MICROBIOL, V72, P724, DOI 10.1111/j.1365-2958.2009.06678.x; LIN FC, 1990, J BIOL CHEM, V265, P4782; Nakai T, 2002, BIOCHEM BIOPH RES CO, V295, P458, DOI 10.1016/S0006-291X(02)00696-4; Rattee I.D., 1974, PHYS CHEM DYE ABSORP; ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; SAXENA IM, 1990, PLANT MOL BIOL, V15, P673, DOI 10.1007/BF00016118; SAXENA IM, 1994, J BACTERIOL, V176, P5735, DOI 10.1128/JB.176.18.5735-5752.1994; SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6; Shibazaki H, 1997, CELLULOSE, V4, P75, DOI 10.1023/A:1024273218783; STANDAL R, 1994, J BACTERIOL, V176, P665, DOI 10.1128/jb.176.3.665-672.1994; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Tahara N, 1997, J FERMENT BIOENG, V83, P389, DOI 10.1016/S0922-338X(97)80148-1; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; WILLIAMS WS, 1989, APPL ENVIRON MICROB, V55, P2448, DOI 10.1128/AEM.55.10.2448-2452.1989; WONG HC, 1990, P NATL ACAD SCI USA, V87, P8130, DOI 10.1073/pnas.87.20.8130; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; Yu XC, 1996, INT J BIOL MACROMOL, V19, P145, DOI 10.1016/0141-8130(96)01109-9; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	46	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28015	10.1371/journal.pone.0028015	http://dx.doi.org/10.1371/journal.pone.0028015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174763	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700015
J	Claessen, JHL; Ploegh, HL				Claessen, Jasper H. L.; Ploegh, Hidde L.			BAT3 Guides Misfolded Glycoproteins Out of the Endoplasmic Reticulum	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; MEMBRANE-PROTEIN; QUALITY-CONTROL; ER; CYTOSOL; DISLOCATION; DEGRADATION; PROTEASOME; TRANSLOCATION; RECOGNITION	Secretory and membrane proteins that fail to acquire their native conformation within the lumen of the Endoplasmic Reticulum (ER) are usually targeted for ubiquitin-dependent degradation by the proteasome. How partially folded polypeptides are kept from aggregation once ejected from the ER into the cytosol is not known. We show that BAT3, a cytosolic chaperone, is recruited to the site of dislocation through its interaction with Derlin2. Furthermore, we observe cytoplasmic BAT3 in a complex with a polypeptide that originates in the ER as a glycoprotein, an interaction that depends on the cytosolic disposition of both, visualized even in the absence of proteasomal inhibition. Cells depleted of BAT3 fail to degrade an established dislocation substrate. We thus implicate a cytosolic chaperone as an active participant in the dislocation of ER glycoproteins.	[Claessen, Jasper H. L.; Ploegh, Hidde L.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Claessen, JHL (corresponding author), MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA.	ploegh@wi.mit.edu			National Institutes of Health; Boehringer Ingelheim Fonds	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by a research grant from the National Institutes of Health and a fellowship from the Boehringer Ingelheim Fonds to JHLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Claessen JHL, 2010, J BIOL CHEM, V285, P20732, DOI 10.1074/jbc.M110.120766; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Ernst R, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000605; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Huppa JB, 1997, IMMUNITY, V7, P113, DOI 10.1016/S1074-7613(00)80514-2; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	30	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28542	10.1371/journal.pone.0028542	http://dx.doi.org/10.1371/journal.pone.0028542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174835	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600032
J	Escalante, T; Ortiz, N; Rucavado, A; Sanchez, EF; Richardson, M; Fox, JW; Gutierrez, JM				Escalante, Teresa; Ortiz, Natalia; Rucavado, Alexandra; Sanchez, Eladio F.; Richardson, Michael; Fox, Jay W.; Maria Gutierrez, Jose			Role of Collagens and Perlecan in Microvascular Stability: Exploring the Mechanism of Capillary Vessel Damage by Snake Venom Metalloproteinases	PLOS ONE			English	Article							BOTHROPS-ASPER TERCIOPELO; VON-WILLEBRAND-FACTOR; CROTALUS-ATROX VENOM; CYSTEINE-RICH DOMAIN; LOCAL TISSUE-DAMAGE; WEAK HEMORRHAGIC ACTIVITY; BASEMENT-MEMBRANES; HUMAN ALPHA-2-MACROGLOBULIN; CRYSTAL-STRUCTURE; ACUTUS VENOM	Hemorrhage is a clinically important manifestation of viperid snakebite envenomings, and is induced by snake venom metalloproteinases (SVMPs). Hemorrhagic and non-hemorrhagic SVMPs hydrolyze some basement membrane (BM) and associated extracellular matrix (ECM) proteins. Nevertheless, only hemorrhagic SVMPs are able to disrupt microvessels; the mechanisms behind this functional difference remain largely unknown. We compared the proteolytic activity of the hemorrhagic P-I SVMP BaP1, from the venom of Bothrops asper, and the non-hemorrhagic P-I SVMP leucurolysin-a (leuc-a), from the venom of Bothrops leucurus, on several substrates in vitro and in vivo, focusing on BM proteins. When incubated with Matrigel, a soluble extract of BM, both enzymes hydrolyzed laminin, nidogen and perlecan, albeit BaP1 did it at a faster rate. Type IV collagen was readily digested by BaP1 while leuc-a only induced a slight hydrolysis. Degradation of BM proteins in vivo was studied in mouse gastrocnemius muscle. Western blot analysis of muscle tissue homogenates showed a similar degradation of laminin chains by both enzymes, whereas nidogen was cleaved to a higher extent by BaP1, and perlecan and type IV collagen were readily digested by BaP1 but not by leuc-a. Immunohistochemistry of muscle tissue samples showed a decrease in the immunostaining of type IV collagen after injection of BaP1, but not by leuc-a. Proteomic analysis by LC/MS/MS of exudates collected from injected muscle revealed higher amounts of perlecan, and types VI and XV collagens, in exudates from BaP1-injected tissue. The differences in the hemorrhagic activity of these SVMPs could be explained by their variable ability to degrade key BM and associated ECM substrates in vivo, particularly perlecan and several non-fibrillar collagens, which play a mechanical stabilizing role in microvessel structure. These results underscore the key role played by these ECM components in the mechanical stability of microvessels.	[Escalante, Teresa; Ortiz, Natalia; Rucavado, Alexandra; Maria Gutierrez, Jose] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Ortiz, Natalia] Univ Costa Rica, Escuela Med, Dept Bioquim, San Jose, Costa Rica; [Sanchez, Eladio F.; Richardson, Michael] Fundacao Ezequiel Dias FUNED, Ctr Pesquisa & Desenvolvimento, Belo Horizonte, MG, Brazil; [Fox, Jay W.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Universidad Costa Rica; Universidad Costa Rica; University of Virginia	Escalante, T (corresponding author), Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica.	jose.gutierrez@ucr.ac.cr	Gutiérrez, José/GSJ-1846-2022; Sanchez, Eladio Flores/E-6942-2013; Rucavado, Alexandra/AGY-1867-2022	Flores Sanchez, Eladio Oswaldo/0000-0003-1637-9345; Escalante, Teresa/0000-0003-4140-1620; Gutierrez, Jose Maria/0000-0001-8385-3081	Vicerrectoria de Investigacion, Universidad de Costa Rica [741-A7-502, 741-B0-606]; International Foundation for Science (IFS); Organisation for the Prohibition of Chemical Weapons (OPCW) [F/4096-1, 2-N-2008, 01N-2010]; Brazilian agency CNPq; Brazilian agency FAPEMIG; University of Virginia School of Medicine	Vicerrectoria de Investigacion, Universidad de Costa Rica; International Foundation for Science (IFS)(International Foundation for Science); Organisation for the Prohibition of Chemical Weapons (OPCW); Brazilian agency CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); University of Virginia School of Medicine	This study was supported by Vicerrectoria de Investigacion, Universidad de Costa Rica (projects 741-A7-502 and 741-B0-606), the International Foundation for Science (IFS) and the Organisation for the Prohibition of Chemical Weapons (OPCW) (projectF/4096-1), NeTropica (projects 2-N-2008 and 01N-2010), Brazilian agencies CNPq and FAPEMIG, and the University of Virginia School of Medicine (J.W.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Baldo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000727; BARAMOVA EN, 1990, BIOCHEMISTRY-US, V29, P1069, DOI 10.1021/bi00456a032; BARAMOVA EN, 1991, BIOMED BIOCHIM ACTA, V50, P763; BARAMOVA EN, 1990, MATRIX, V10, P91, DOI 10.1016/S0934-8832(11)80175-7; BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0; Bello CA, 2006, BIOCHIMIE, V88, P189, DOI 10.1016/j.biochi.2005.07.008; Bilguvar K, 2009, J PEDIATR-US, V155, P743, DOI 10.1016/j.jpeds.2009.04.014; BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3; BJARNASON JB, 1988, BIOL CHEM H-S, V369, P121; Bolger MB, 2001, AAPS PHARMSCI, V3; Calvete JJ, 2009, FEBS LETT, V583, P1736, DOI 10.1016/j.febslet.2009.03.029; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Escalante T, 2004, TOXICON, V43, P213, DOI 10.1016/j.toxicon.2003.11.012; Escalante T, 2003, TOXICOL APPL PHARM, V193, P17, DOI 10.1016/S0041-008X(03)00337-5; Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018; Escalante T, 2009, J PROTEOME RES, V8, P5120, DOI 10.1021/pr900489m; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; GUTIERREZ JM, 1995, TOXICON, V33, P19, DOI 10.1016/0041-0101(94)00138-X; Gutierrez JM, 2006, MICROVASC RES, V71, P55, DOI 10.1016/j.mvr.2005.10.007; Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029; GUTIERREZ JM, 1985, TOXICON, V23, P887, DOI 10.1016/0041-0101(85)90380-0; Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9; Gutierrez JM, 2010, HDB VENOMS TOXINS RE, P114; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; KAMIGUTI AS, 1994, BBA-GEN SUBJECTS, V1200, P307, DOI 10.1016/0304-4165(94)90172-4; Kamiguti AS, 2005, TOXICON, V45, P1041, DOI 10.1016/j.toxicon.2005.02.026; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; KURECKI T, 1985, TOXICON, V23, P855, DOI 10.1016/0041-0101(85)90016-9; Kvansakul M, 2001, EMBO J, V20, P5342, DOI 10.1093/emboj/20.19.5342; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lingott T, 2009, BIOCHEMISTRY-US, V48, P6166, DOI 10.1021/bi9002315; Liu A, 2009, MICROVASC RES, V77, P13, DOI 10.1016/j.mvr.2008.08.008; Mackessy SP, 2002, J TOXICOL-TOXIN REV, V21, P43, DOI 10.1081/TXR-120004741; MARUYAMA M, 1992, TOXICON, V30, P1387, DOI 10.1016/0041-0101(92)90514-6; Miyoshi S, 1998, INFECT IMMUN, V66, P4851, DOI 10.1128/IAI.66.10.4851-4855.1998; Mokkapati S, 2008, J INVEST DERMATOL, V128, P2259, DOI 10.1038/jid.2008.65; MOREIRA L, 1994, TOXICON, V32, P977, DOI 10.1016/0041-0101(94)90376-X; Moura-da-Silva AM, 2008, BIOCHIMIE, V90, P484, DOI 10.1016/j.biochi.2007.11.009; Niiyama T, 2003, ACTA NEUROPATHOL, V106, P137, DOI 10.1007/s00401-003-0714-1; OHSAKA A, 1973, BIOCHIM BIOPHYS ACTA, V323, P415, DOI 10.1016/0005-2736(73)90187-9; Oliveira AK, 2010, THROMB HAEMOSTASIS, V104, P485, DOI 10.1160/TH09-12-0855; OWNBY CL, 1978, AM J PATHOL, V93, P201; Leme AFP, 2011, J PROTEOMICS, V74, P401, DOI 10.1016/j.jprot.2010.12.002; Pinto AFM, 2007, ARCH BIOCHEM BIOPHYS, V465, P11, DOI 10.1016/j.abb.2007.04.037; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Ramos OHP, 2004, TOXICON, V44, P529, DOI 10.1016/j.toxicon.2004.07.005; Rochat H., 2009, ANIMAL TOXINS STATE, P525; Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958; Rucavado A, 1998, INT J EXP PATHOL, V79, P245; Rucavado A, 1999, TOXICON, V37, P1297, DOI 10.1016/S0041-0101(98)00268-2; Rucavado A, 1995, EXP MOL PATHOL, V63, P186, DOI 10.1006/exmp.1995.1042; Sanchez E.F., 2009, DRUG DESIGN ZINC ENZ, P789; Sanchez EF, 2010, ARCH BIOCHEM BIOPHYS, V496, P9, DOI 10.1016/j.abb.2010.01.010; Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483; Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x; Serrano SMT, 2006, J BIOL CHEM, V281, P39746, DOI 10.1074/jbc.M604855200; Souza CT, 2001, COMP BIOCHEM PHYS B, V130, P155, DOI 10.1016/S1096-4959(01)00421-3; Specks U, 2001, CURR OPIN RHEUMATOL, V13, P12, DOI 10.1097/00002281-200101000-00003; Tanjoni I, 2010, TOXICON, V55, P1093, DOI 10.1016/j.toxicon.2009.12.010; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tsai IH, 2000, EUR J BIOCHEM, V267, P1359, DOI 10.1046/j.1432-1327.2000.01129.x; Wallnoefer HG, 2010, J AM CHEM SOC, V132, P10330, DOI 10.1021/ja909908y; Wang WJ, 2004, BIOCHEM BIOPH RES CO, V324, P224, DOI 10.1016/j.bbrc.2004.09.031; Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	72	60	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28017	10.1371/journal.pone.0028017	http://dx.doi.org/10.1371/journal.pone.0028017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174764	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600011
J	Galeano, CH; Fernandez, AC; Franco-Herrera, N; Cichy, KA; McClean, PE; Vanderleyden, J; Blair, MW				Galeano, Carlos H.; Fernandez, Andrea C.; Franco-Herrera, Natalia; Cichy, Karen A.; McClean, Phillip E.; Vanderleyden, Jos; Blair, Matthew W.			Saturation of an Intra-Gene Pool Linkage Map: Towards a Unified Consensus Linkage Map for Fine Mapping and Synteny Analysis in Common Bean	PLOS ONE			English	Article							PHASEOLUS-VULGARIS L.; QUANTITATIVE TRAIT LOCI; ROOT ARCHITECTURE TRAITS; UNGUICULATA L WALP.; MICROSATELLITE MARKERS; CROP IMPROVEMENT; GENOME SEQUENCE; SNP; QTL; INFORMATION	Map-based cloning and fine mapping to find genes of interest and marker assisted selection (MAS) requires good genetic maps with reproducible markers. In this study, we saturated the linkage map of the intra-gene pool population of common bean DOR364xBAT477 (DB) by evaluating 2,706 molecular markers including SSR, SNP, and gene-based markers. On average the polymorphism rate was 7.7% due to the narrow genetic base between the parents. The DB linkage map consisted of 291 markers with a total map length of 1,788 cM. A consensus map was built using the core mapping populations derived from inter-gene pool crosses: DOR364xG19833 (DG) and BAT93xJALO EEP558 (BJ). The consensus map consisted of a total of 1,010 markers mapped, with a total map length of 2,041 cM across 11 linkage groups. On average, each linkage group on the consensus map contained 91 markers of which 83% were single copy markers. Finally, a synteny analysis was carried out using our highly saturated consensus maps compared with the soybean pseudo-chromosome assembly. A total of 772 marker sequences were compared with the soybean genome. A total of 44 syntenic blocks were identified. The linkage group Pv6 presented the most diverse pattern of synteny with seven syntenic blocks, and Pv9 showed the most consistent relations with soybean with just two syntenic blocks. Additionally, a co-linear analysis using common bean transcript map information against soybean coding sequences (CDS) revealed the relationship with 787 soybean genes. The common bean consensus map has allowed us to map a larger number of markers, to obtain a more complete coverage of the common bean genome. Our results, combined with synteny relationships provide tools to increase marker density in selected genomic regions to identify closely linked polymorphic markers for indirect selection, fine mapping or for positional cloning.	[Galeano, Carlos H.; Vanderleyden, Jos] Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Heverlee, Belgium; [Fernandez, Andrea C.; Cichy, Karen A.] ARS, Sugarbeet & Bean Res Unit, USDA, E Lansing, MI USA; [Franco-Herrera, Natalia; Blair, Matthew W.] CIAT, Bean Project, Cali, Colombia; [McClean, Phillip E.] N Dakota State Univ, Genom & Bioinformat Program, Fargo, ND 58105 USA; [McClean, Phillip E.] N Dakota State Univ, Dept Plant Sci, Fargo, ND 58105 USA	KU Leuven; United States Department of Agriculture (USDA); Alliance; International Center for Tropical Agriculture - CIAT; North Dakota State University Fargo; North Dakota State University Fargo	Galeano, CH (corresponding author), Katholieke Univ Leuven, Ctr Microbial & Plant Genet, Dept Microbial & Mol Syst, Heverlee, Belgium.	galeanomendoza@gmail.com; mwb1@cornell.edu		Cichy, Karen/0000-0002-4311-0774	Generation Challenge Program and International Center for Tropical Agriculture; IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven)	Generation Challenge Program and International Center for Tropical Agriculture; IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven)	This work was funded by the Generation Challenge Program and International Center for Tropical Agriculture. Carlos H. Galeano is supported by a doctoral research fellowship from IRO (Interfaculty Council for Development Co-operation of the Catholic University of Leuven). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett MJ, 1991, THEOR APPL GENET, V74, P346; BEAVIS WD, 1991, THEOR APPL GENET, V82, P636, DOI 10.1007/BF00226803; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; Blair M, 2010, MOL BREEDING, P1; Blair MW, 2006, THEOR APPL GENET, V113, P100, DOI 10.1007/s00122-006-0276-4; Blair M, 2009, MOL BREEDING, V23, P197, DOI 10.1007/s11032-008-9225-z; Blair M, 2008, THEOR APPL GENET, V118, P91, DOI 10.1007/s00122-008-0879-z; Blair MW, 2009, CROP SCI, V49, P237, DOI 10.2135/cropsci2008.05.0246; Blair MW, 2003, THEOR APPL GENET, V107, P1362, DOI 10.1007/s00122-003-1398-6; Buso GSC, 2006, MOL ECOL NOTES, V6, P252, DOI 10.1111/j.1471-8286.2006.01210.x; Caixeta E. T., 2005, Crop Breeding and Applied Biotechnology, V5, P125; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cichy KA, 2009, CROP SCI, V49, P59, DOI 10.2135/cropsci2008.03.0142; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cordoba JM, 2010, PLANT GENOME-US, V3, P154, DOI 10.3835/plantgenome2010.06.0013; Cordoba JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-436; Cuevas HE, 2009, THEOR APPL GENET, V119, P741, DOI 10.1007/s00122-009-1085-3; de Campos T, 2007, PESQUI AGROPECU BRAS, V42, P589, DOI 10.1590/S0100-204X2007000400018; Frei A, 2005, CROP SCI, V45, P379, DOI 10.2135/cropsci2005.0379; Freyre R, 1998, THEOR APPL GENET, V97, P847, DOI 10.1007/s001220050964; Gaitan-Solis E, 2002, CROP SCI, V42, P2128, DOI 10.2135/cropsci2002.2128; Galeano CH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-629; Galeano CH, 2009, CROP SCI, V49, P381, DOI 10.2135/cropsci2008.07.0413; GEPTS P, 1988, ANN REP BEAN IMPROV, V31, P20; Grisi MCM, 2007, GENET MOL RES, V6, P691; Guerra-Sanz JM, 2004, PLANT BREEDING, V123, P87, DOI 10.1046/j.0179-9541.2003.00929.x; Gustafson JP, 2009, THEOR APPL GENET, V118, P793, DOI 10.1007/s00122-008-0939-4; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Hougaard BK, 2008, GENETICS, V179, P2299, DOI 10.1534/genetics.108.090084; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Jackson BN, 2005, 2005 IEEE Computational Systems Bioinformatics Conference, Proceedings, P35, DOI 10.1109/CSB.2005.26; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liao H, 2004, FUNCT PLANT BIOL, V31, P959, DOI 10.1071/FP03255; Lopez-Marin HD, 2009, THEOR APPL GENET, V119, P449, DOI 10.1007/s00122-009-1051-0; Mace ES, 2011, THEOR APPL GENET, V123, P169, DOI 10.1007/s00122-011-1575-y; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Marino CL, 1996, GENOME, V39, P359, DOI 10.1139/g96-046; McClean PE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-184; McConnell M, 2010, THEOR APPL GENET, V121, P1103, DOI 10.1007/s00122-010-1375-9; Muchero W, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-8; Muchero W, 2009, P NATL ACAD SCI USA, V106, P18159, DOI 10.1073/pnas.0905886106; NODARI RO, 1993, GENETICS, V134, P341; Quraishi UM, 2011, PLANT J, V65, P745, DOI 10.1111/j.1365-313X.2010.04461.x; Remans R, 2008, PLANT SOIL, V302, P149, DOI 10.1007/s11104-007-9462-7; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Spiller M, 2011, THEOR APPL GENET, V122, P489, DOI 10.1007/s00122-010-1463-x; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Tohme J, 1996, CROP SCI, V36, P1375, DOI 10.2135/cropsci1996.0011183X003600050048x; VALLEJOS CE, 1992, GENETICS, V131, P733; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Caldas GV, 2009, THEOR APPL GENET, V119, P131, DOI 10.1007/s00122-009-1023-4; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-101; Wu YH, 2011, IEEE ACM T COMPUT BI, V8, P381, DOI 10.1109/TCBB.2010.35; Yaish MWF, 2003, GENET MOL BIOL, V26, P337, DOI 10.1590/S1415-47572003000300019; Yap IV, 2003, GENETICS, V165, P2235	60	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28135	10.1371/journal.pone.0028135	http://dx.doi.org/10.1371/journal.pone.0028135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174773	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163600013
J	Ewald, JC; Reich, S; Baumann, S; Frommer, WB; Zamboni, N				Ewald, Jennifer C.; Reich, Sabrina; Baumann, Stephan; Frommer, Wolf B.; Zamboni, Nicola			Engineering Genetically Encoded Nanosensors for Real-Time In Vivo Measurements of Citrate Concentrations	PLOS ONE			English	Article							FLUORESCENT PROTEIN FRET; SENSOR KINASE CITA; PERIPLASMIC DOMAIN; ESCHERICHIA-COLI; LIVING CELLS; ATP LEVELS; HOMEOSTASIS; GLUCOSE; VISUALIZATION; ACCUMULATION	Citrate is an intermediate in catabolic as well as biosynthetic pathways and is an important regulatory molecule in the control of glycolysis and lipid metabolism. Mass spectrometric and NMR based metabolomics allow measuring citrate concentrations, but only with limited spatial and temporal resolution. Methods are so far lacking to monitor citrate levels in real-time in-vivo. Here, we present a series of genetically encoded citrate sensors based on Forster resonance energy transfer (FRET). We screened databases for citrate-binding proteins and tested three candidates in vitro. The citrate binding domain of the Klebsiella pneumoniae histidine sensor kinase CitA, inserted between the FRET pair Venus/CFP, yielded a sensor highly specific for citrate. We optimized the peptide linkers to achieve maximal FRET change upon citrate binding. By modifying residues in the citrate binding pocket, we were able to construct seven sensors with different affinities spanning a concentration range of three orders of magnitude without losing specificity. In a first in vivo application we show that E. coli maintains the capacity to take up glucose or acetate within seconds even after long-term starvation.	[Ewald, Jennifer C.; Reich, Sabrina; Baumann, Stephan; Zamboni, Nicola] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Ewald, Jennifer C.] ETH, PhD Program Syst Biol Complex Dis, Zurich, Switzerland; [Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Carnegie Institution for Science	Ewald, JC (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	zamboni@imsb.biol.ethz.ch	Zamboni, Nicola/K-3042-2012; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Zamboni, Nicola/0000-0003-1271-1021; Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Reich, Sabrina/0000-0003-0543-648X	National Institutes of Health (NIDDK) [1RO1DK079109]; National Science Foundation (NSF) [1045185]; Boehringer Ingelheim; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079109] Funding Source: NIH RePORTER	National Institutes of Health (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation (NSF)(National Science Foundation (NSF)); Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge support from the National Institutes of Health (NIDDK 1RO1DK079109) and the National Science Foundation (NSF 1045185) to WBF and a travel grant from the commercial funder Boehringer Ingelheim Fonds (http://www.boehringer-ingelheim.com/research_development/awards_fellowships/boehringer_ingelheimfonds.html#) to JCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bermejo C, 2011, BIOCH J IN PRESS; Bermejo C, 2011, NATURE PROT IN PRESS; Bermejo C, 2010, BIOCHEM J, V432, P399, DOI 10.1042/BJ20100946; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Dulla C, 2008, J NEUROSCI METH, V168, P306, DOI 10.1016/j.jneumeth.2007.10.017; Evellin Sandrine, 2004, Methods Mol Biol, V284, P259; Fehr M, 2004, J FLUORESC, V14, P603, DOI 10.1023/B:JOFL.0000039347.94943.99; Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; GEELEN MJH, 1993, HORM METAB RES, V25, P525, DOI 10.1055/s-2007-1002166; Gerharz T, 2003, BIOCHEMISTRY-US, V42, P5917, DOI 10.1021/bi0340595; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Kaper T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-11; Kaspar S, 1999, MOL MICROBIOL, V33, P858, DOI 10.1046/j.1365-2958.1999.01536.x; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; NEWSHOLME EA, 1977, BIOCHEM J, V166, P123, DOI 10.1042/bj1660123; Niittylae T, 2009, METHODS MOL BIOL, V553, P355, DOI 10.1007/978-1-60327-563-7_19; Okumoto S, 2008, NEW PHYTOL, V180, P271, DOI 10.1111/j.1469-8137.2008.02611.x; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Pos KM, 1998, J BACTERIOL, V180, P4160, DOI 10.1128/JB.180.16.4160-4165.1998; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Zamboni N, 2009, CURR OPIN MICROBIOL, V12, P553, DOI 10.1016/j.mib.2009.08.003	34	46	46	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28245	10.1371/journal.pone.0028245	http://dx.doi.org/10.1371/journal.pone.0028245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164251	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400052
J	Hempel, F; Lau, J; Klingl, A; Maier, UG				Hempel, Franziska; Lau, Julia; Klingl, Andreas; Maier, Uwe G.			Algae as Protein Factories: Expression of a Human Antibody and the Respective Antigen in the Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							B SURFACE-ANTIGEN; HUMAN MONOCLONAL-ANTIBODY; NICOTIANA-TABACUM PLANTS; TRANSGENIC PLANTS; PHARMACEUTICAL PROTEINS; MICROALGAL BIOFUELS; CELLS; BIOREACTORS; YEAST; BIOPHARMACEUTICALS	Microalgae are thought to offer great potential as expression system for various industrial, therapeutic and diagnostic recombinant proteins as they combine high growth rates with all benefits of eukaryotic expression systems. Moreover, microalgae exhibit a phototrophic lifestyle like land plants, hence protein expression is fuelled by photosynthesis, which is CO(2)-neutral and involves only low production costs. So far, however, research on algal bioreactors for recombinant protein expression is very rare calling for further investigations in this highly promising field. In this study, we present data on the expression of a monoclonal human IgG antibody against the Hepatitis B surface protein and the respective antigen in the diatom Phaeodactylum tricornutum. Antibodies are fully-assembled and functional and accumulate to 8.7% of total soluble protein, which complies with 21 mg antibody per gram algal dry weight. The Hepatitis B surface protein is functional as well and is recognized by algae-produced and commercial antibodies.	[Hempel, Franziska; Klingl, Andreas; Maier, Uwe G.] LOEWE Res Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany; [Lau, Julia; Maier, Uwe G.] Univ Marburg, Cell Biol Lab, Marburg, Germany	Philipps University Marburg	Hempel, F (corresponding author), LOEWE Res Ctr Synthet Microbiol SYNMIKRO, Marburg, Germany.	franziska.hempel@synmikro.uni-marburg.de	Klingl, Andreas/K-6675-2014	Klingl, Andreas/0000-0001-8414-8317	LOEWE program of the State of Hessen (Germany)	LOEWE program of the State of Hessen (Germany)	This work was supported by the LOEWE program of the State of Hessen (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; BIEMANS R, 1992, DNA CELL BIOL, V11, P621, DOI 10.1089/dna.1992.11.621; Bozarth A, 2009, APPL MICROBIOL BIOT, V82, P195, DOI 10.1007/s00253-008-1804-8; Bruss V, 1996, INTERVIROLOGY, V39, P23, DOI 10.1159/000150471; Chadd HE, 2001, CURR OPIN BIOTECH, V12, P188, DOI 10.1016/S0958-1669(00)00198-1; Chiba Y, 2007, CURR OPIN CHEM BIOL, V11, P670, DOI 10.1016/j.cbpa.2007.08.037; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Chu L, 2001, CURR OPIN BIOTECH, V12, P180, DOI 10.1016/S0958-1669(00)00197-X; Daniell H, 2009, TRENDS PLANT SCI, V14, P669, DOI 10.1016/j.tplants.2009.09.009; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; De Muynck B, 2009, TRANSGENIC RES, V18, P467, DOI 10.1007/s11248-008-9240-1; Decker EL, 2008, BIOPROC BIOSYST ENG, V31, P3, DOI 10.1007/s00449-007-0151-y; Dogan B, 2000, BIOTECHNOL PROGR, V16, P435, DOI 10.1021/bp0000454; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Fischer R, 2000, TRANSGENIC RES, V9, P279, DOI 10.1023/A:1008975123362; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; FUJISAWA Y, 1983, NUCLEIC ACIDS RES, V11, P3581, DOI 10.1093/nar/11.11.3581; GODDIJN OJM, 1995, TRENDS BIOTECHNOL, V13, P379, DOI 10.1016/S0167-7799(00)88985-4; Guan ZJ, 2010, VACCINE, V28, P7351, DOI 10.1016/j.vaccine.2010.08.100; Hempel F, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-81; Hempel F, 2009, MOL BIOL EVOL, V26, P1781, DOI 10.1093/molbev/msp079; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Kumar GBS, 2005, PLANTA, V222, P484, DOI 10.1007/s00425-005-1556-y; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Maeda F, 1999, J MED VIROL, V58, P338, DOI 10.1002/(SICI)1096-9071(199908)58:4<338::AID-JMV4>3.0.CO;2-5; MASON HS, 1992, P NATL ACAD SCI USA, V89, P11745, DOI 10.1073/pnas.89.24.11745; Mayfield SP, 2005, VACCINE, V23, P1828, DOI 10.1016/j.vaccine.2004.11.013; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; MCALEER WJ, 1984, NATURE, V307, P178, DOI 10.1038/307178a0; Milich DR, 1997, J VIRAL HEPATITIS, V4, P25, DOI 10.1111/j.1365-2893.1997.tb00177.x; Morweiser M, 2010, APPL MICROBIOL BIOT, V87, P1291, DOI 10.1007/s00253-010-2697-x; PATZER EJ, 1986, J VIROL, V58, P884, DOI 10.1128/JVI.58.3.884-892.1986; Potvin G, 2010, BIOTECHNOL ADV, V28, P910, DOI 10.1016/j.biotechadv.2010.08.006; Raja R, 2008, CRIT REV MICROBIOL, V34, P77, DOI [10.1080/10408410802086783, 10.1080/10408410802086783 ]; Ramirez N, 2003, BIOTECHNOL APPL BIOC, V38, P223, DOI 10.1042/BA20030028; Richter LJ, 2000, NAT BIOTECHNOL, V18, P1167, DOI 10.1038/81153; Sharp JM, 2001, BIOTECHNOL PROGR, V17, P979, DOI 10.1021/bp010104t; Sojikul P, 2003, P NATL ACAD SCI USA, V100, P2209, DOI 10.1073/pnas.0438037100; Stephens E, 2010, NAT BIOTECHNOL, V28, P126, DOI 10.1038/nbt0210-126; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; Ugwu CU, 2008, BIORESOURCE TECHNOL, V99, P4021, DOI 10.1016/j.biortech.2007.01.046; VALENZUELA P, 1982, NATURE, V298, P347, DOI 10.1038/298347a0; Verma R, 1998, J IMMUNOL METHODS, V216, P165, DOI 10.1016/S0022-1759(98)00077-5; Walker TL, 2005, PLANT CELL REP, V24, P629, DOI 10.1007/s00299-005-0004-6; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yano A, 2004, J MED VIROL, V73, P208, DOI 10.1002/jmv.20077	51	106	110	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28424	10.1371/journal.pone.0028424	http://dx.doi.org/10.1371/journal.pone.0028424			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164289	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400090
J	Rankovic, V; Landgraf, P; Kanyshkova, T; Ehling, P; Meuth, SG; Kreutz, MR; Budde, T; Munsch, T				Rankovic, Vladan; Landgraf, Peter; Kanyshkova, Tatyana; Ehling, Petra; Meuth, Sven G.; Kreutz, Michael R.; Budde, Thomas; Munsch, Thomas			Modulation of Calcium-Dependent Inactivation of L-Type Ca2+ Channels via beta-Adrenergic Signaling in Thalamocortical Relay Neurons	PLOS ONE			English	Article							CARDIAC CA(V)1.2 CHANNELS; PROTEIN PHOSPHATASE 2A; CA2+-DEPENDENT INACTIVATION; ION CHANNELS; PHOSPHORYLATION; VOLTAGE; CALCINEURIN; KINASE; CELLS; CURRENTS	Neuronal high-voltage-activated (HVA) Ca2+ channels are rapidly inactivated by a mechanism that is termed Ca2+-dependent inactivation (CDI). In this study we have shown that b-adrenergic receptor (bAR) stimulation inhibits CDI in rat thalamocortical (TC) relay neurons. This effect can be blocked by inhibition of cAMP-dependent protein kinase (PKA) with a cell-permeable inhibitor (myristoylated protein kinase inhibitor-(14-22)-amide) or A-kinase anchor protein (AKAP) St-Ht31 inhibitory peptide, suggesting a critical role of these molecules downstream of the receptor. Moreover, inhibition of protein phosphatases (PP) with okadaic acid revealed the involvement of phosphorylation events in modulation of CDI after bAR stimulation. Double fluorescence immunocytochemistry and pull down experiments further support the idea that modulation of CDI in TC neurons via bAR stimulation requires a protein complex consisting of CaV1.2, PKA and proteins from the AKAP family. All together our data suggest that AKAPs mediate targeting of PKA to L-type Ca2+ channels allowing their phosphorylation and thereby modulation of CDI.	[Rankovic, Vladan; Munsch, Thomas] Univ Magdeburg, Inst Physiol, D-39106 Magdeburg, Germany; [Landgraf, Peter; Kreutz, Michael R.] Leibniz Inst Neurobiol, PG Neuroplast, Magdeburg, Germany; [Kanyshkova, Tatyana; Ehling, Petra; Budde, Thomas] Inst Physiol 1, Munster, Germany; [Ehling, Petra; Meuth, Sven G.] Inst Neuropathophysiol, Munster, Germany; [Ehling, Petra; Meuth, Sven G.] Neurol Clin, Dept Inflammatory Disorders Nervous Syst & Neuroo, Munster, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Rankovic, V (corresponding author), Univ Magdeburg, Inst Physiol, D-39106 Magdeburg, Germany.	vladan.rankovic@lin-magdeburg.de	Meuth, Sven G/HHM-8941-2022; Rankovic, Vladan/S-4353-2019	Meuth, Sven G/0000-0003-2571-3501; Rankovic, Vladan/0000-0003-0285-5232	Deutsche Forschungsgemeinschaft [GRK 1167-P1, BU 1019/8-1, DFG Kr1879/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GRK 1167-P1 to TM; BU 1019/8-1 to TB; DFG Kr1879/3-1 to MK). VR was a fellow of the GRK 1167, Magdeburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DL, 1989, TRENDS NEUROSCI, V12, P117, DOI 10.1016/0166-2236(89)90168-9; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Bauman AL, 2004, NEUROPHARMACOLOGY, V46, P299, DOI 10.1016/j.neuropharm.2003.09.016; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Biella Gerardo, 2001, Thalamus & Related Systems, V1, P157, DOI 10.1017/S1472928801000152; Branchaw JL, 1997, J NEUROSCI, V17, P5772; Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013; Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005; Budde T, 2000, NEURON, V26, P483, DOI 10.1016/S0896-6273(00)81180-0; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Budde T, 1998, EUR J NEUROSCI, V10, P586, DOI 10.1046/j.1460-9568.1998.00067.x; Burley JR, 2000, EUR J NEUROSCI, V12, P2881, DOI 10.1046/j.1460-9568.2000.00178.x; Catterall WA, 1997, ADV SEC MESS PHOSPH, V31, P159; Cens T, 2006, PROG BIOPHYS MOL BIO, V90, P104, DOI 10.1016/j.pbiomolbio.2005.05.013; CHAD JE, 1986, J PHYSIOL-LONDON, V378, P31, DOI 10.1113/jphysiol.1986.sp016206; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2000, J BIOL CHEM, V275, P39710, DOI 10.1074/jbc.M005462200; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Di Biase V, 2008, J NEUROSCI, V28, P13845, DOI 10.1523/JNEUROSCI.3213-08.2008; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Guerini D, 1997, BIOCHEM BIOPH RES CO, V235, P271, DOI 10.1006/bbrc.1997.6802; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Herzig S, 2000, PHYSIOL REV, V80, P173, DOI 10.1152/physrev.2000.80.1.173; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; KALMAN D, 1988, J GEN PHYSIOL, V92, P531, DOI 10.1085/jgp.92.4.531; KAWAI M, 1993, FEBS LETT, V316, P107, DOI 10.1016/0014-5793(93)81196-7; Lacinova L, 2005, GEN PHYSIOL BIOPHYS, V24, P3; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lukyanetz EA, 1998, J PHYSIOL-LONDON, V510, P371, DOI 10.1111/j.1469-7793.1998.371bk.x; Marshall MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175257; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; Meuth S, 2002, EUR J NEUROSCI, V15, P1603, DOI 10.1046/j.1460-9568.2002.01999.x; Meuth SG, 2005, PFLUG ARCH EUR J PHY, V450, P111, DOI 10.1007/s00424-004-1377-z; Meuth Sven, 2001, Thalamus & Related Systems, V1, P31, DOI 10.1017/S1472928801000061; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; PAPE HC, 1994, J PHYSIOL-LONDON, V478, P403, DOI 10.1113/jphysiol.1994.sp020261; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Rankovic V, 2010, EUR J NEUROSCI, V31, P439, DOI 10.1111/j.1460-9568.2010.07081.x; Rossie S, 1999, ADV SEC MESS PHOSPH, V33, P23; Schuhmann K, 1997, J GEN PHYSIOL, V110, P503, DOI 10.1085/jgp.110.5.503; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; Soldatov MM, 2003, TRENDS PHARMACOL SCI, V24, P167, DOI 10.1016/S0165-6147(03)00065-8; Steriade M, 1997, THALAMUS RELATED SYS; Victor RG, 1997, J MEMBRANE BIOL, V156, P53, DOI 10.1007/s002329900187; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659; Xu H, 2010, BIOCHEMISTRY-US, V49, P10298, DOI 10.1021/bi101018c; You YD, 1995, BIOPHYS J, V69, P1838, DOI 10.1016/S0006-3495(95)80054-8; Zeilhofer HU, 2000, NEUROSCIENCE, V95, P235	55	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27474	10.1371/journal.pone.0027474	http://dx.doi.org/10.1371/journal.pone.0027474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164209	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400009
J	Samanta, S; Dutta, D; Ghoshal, A; Mukhopadhyay, S; Saha, B; Sundar, S; Jarmalavicius, S; Forgber, M; Mandal, C; Walden, P; Mandal, C				Samanta, Sajal; Dutta, Devawati; Ghoshal, Angana; Mukhopadhyay, Sumi; Saha, Bibhuti; Sundar, Shyam; Jarmalavicius, Saulius; Forgber, Michael; Mandal, Chhabinath; Walden, Peter; Mandal, Chitra			Glycosylation of Erythrocyte Spectrin and Its Modification in Visceral Leishmaniasis	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; SIALIC ACIDS; COMPLEMENT PATHWAY; IDENTIFICATION; MEMBRANE; BINDING; ASSAY; SIALOGLYCANS; ACHATININ(H); ACTIVATION	Using a lectin, Achatinin-H, having preferential specificity for glycoproteins with terminal 9-O-acetyl sialic acid derivatives linked in alpha 2-6 linkages to subterminal N-acetylgalactosamine, eight distinct disease-associated 9-O-acetylated sialoglycoproteins was purified from erythrocytes of visceral leishmaniaisis (VL) patients (RBCVL). Analyses of tryptic fragments by mass spectrometry led to the identification of two high-molecular weight 9-O-acetylated sialoglycoproteins as human erythrocytic alpha- and beta-spectrin. Total spectrin purified from erythrocytes of VL patients (spectrin(VL)) was reactive with Achatinin-H. Interestingly, along with two high molecular weight bands corresponding to alpha- and beta-spectrin another low molecular weight 60 kDa band was observed. Total spectrin was also purified from normal human erythrocytes (spectrin(N)) and insignificant binding with Achatinin-H was demonstrated. Additionally, this 60 kDa fragment was totally absent in spectrin(N). Although the presence of both N- and O-glycosylations was found both in spectrin(N) and spectrin(VL), enhanced sialylation was predominantly induced in spectrin(VL). Sialic acids accounted for approximately 1.25 kDa mass of the 60 kDa polypeptide. The demonstration of a few identified sialylated tryptic fragments of alpha- and beta-spectrin(VL) confirmed the presence of terminal sialic acids. Molecular modelling studies of spectrin suggest that a sugar moiety can fit into the potential glycosylation sites. Interestingly, highly sialylated spectrin(VL) showed decreased binding with spectrin-depleted inside-out membrane vesicles of normal erythrocytes compared to spectrin(N) suggesting functional abnormality. Taken together this is the first report of glycosylated eythrocytic spectrin in normal erythrocytes and its enhanced sialylation in RBCVL. The enhanced sialylation of this cytoskeleton protein is possibly related to the fragmentation of spectrin(VL) as evidenced by the presence of an additional 60 kDa fragment, absent in spectrin(N) which possibly affects the biology of RBCVL linked to both severe distortion of erythrocyte development and impairment of erythrocyte membrane integrity and may provide an explanation for their sensitivity to hemolysis and anemia in VL patients.	[Samanta, Sajal; Dutta, Devawati; Ghoshal, Angana; Mukhopadhyay, Sumi; Mandal, Chitra] Indian Inst Chem Biol, Council Sci & Ind Research, Canc & Cell Biol Div, Kolkata, India; [Saha, Bibhuti] Sch Trop Med, Dept Trop Med, Kolkata, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India; [Jarmalavicius, Saulius; Forgber, Michael; Walden, Peter] Humboldt Univ, Charite Univ Med Berlin, Dept Dermatol, D-10099 Berlin, Germany; [Mandal, Chhabinath] Indian Inst Chem Biol, Council Sci & Ind Research, Natl Inst Pharmaceut Educ & Res, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Calcutta School of Tropical Medicine (CSTM); Banaras Hindu University (BHU); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); National Institute of Pharmaceutical Education & Research (NIPER)	Samanta, S (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Research, Canc & Cell Biol Div, Kolkata, India.	chitra_mandal@yahoo.com		, NIPERKolkata/0000-0003-4906-3988	Council of Scientific and Industrial Research-Indian Institute of Chemical Biology; Indian Council of Medical Research, New Delhi [GAP266]; Department of Science and Technology, Government of India [P90807]; Tropical Medical Research Centre [P50AI074321]; Volkswagen Foundation, Germany; German Research Council (DFG); ProFit programme; European Union/Berlin and the Federal Ministry for Research and Education of Germany; Department of Biotechnology [GAP235]	Council of Scientific and Industrial Research-Indian Institute of Chemical Biology; Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Tropical Medical Research Centre; Volkswagen Foundation, Germany(Volkswagen); German Research Council (DFG)(German Research Foundation (DFG)); ProFit programme; European Union/Berlin and the Federal Ministry for Research and Education of Germany; Department of Biotechnology	This work received financial support from the Council of Scientific and Industrial Research-Indian Institute of Chemical Biology, Department of Biotechnology (GAP235)(dbtindia.nic.in/index.asp), Indian Council of Medical Research (GAP266)(www.icmr.nic.in/), New Delhi, J. C. Bose Fellowship, Department of Science and Technology (P90807)(www.dst.gov.in/), Government of India, Tropical Medical Research Centre Grant number P50AI074321, the Volkswagen Foundation, Germany, German Research Council (DFG), the ProFit programme, European Union/Berlin and the Federal Ministry for Research and Education of Germany (www.bmbf.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar W, 2009, GLYCOCONJUGATE J, V26, P1151, DOI 10.1007/s10719-009-9236-y; Bandyopadhyay S, 2004, J INFECT DIS, V190, P2010, DOI 10.1086/425519; Bandyopadhyay S, 2004, DIAGN MICR INFEC DIS, V50, P15, DOI 10.1016/j.diagmicrobio.2004.04.014; Bandyopadhyay SMN, 2008, ADV EXP MED BIOL, V625, P87; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bossi D, 1996, MOL ASPECTS MED, V17, P171, DOI 10.1016/0098-2997(96)88346-4; Bulai T, 2003, BIOCHIMIE, V85, P241, DOI 10.1016/S0300-9084(03)00059-2; Bulai T, 2002, BIOCHIMIE, V84, P655, DOI 10.1016/S0300-9084(02)01436-0; Chatterjee M, 1998, GLYCOCONJUGATE J, V15, P1141, DOI 10.1023/A:1006963806318; Chatterjee M, 2003, GLYCOBIOLOGY, V13, P351, DOI 10.1093/glycob/cwg027; Chava AK, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P71; Chava AK, 2003, GLYCOCONJUGATE J, V20, P199, DOI 10.1023/B:GLYC.0000024251.30100.08; Chava AK, 2004, J INFECT DIS, V189, P1257, DOI 10.1086/382752; Chava AK, 2004, BIOL CHEM, V385, P59, DOI 10.1515/BC.2004.008; Chava AK, 2002, J IMMUNOL METHODS, V270, P1, DOI 10.1016/S0022-1759(02)00216-8; Das T, 2003, BIOCHEM J, V373, P345, DOI 10.1042/BJ20021701; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Domingues CC, 2008, BRAZ J MED BIOL RES, V41, P758, DOI 10.1590/S0100-879X2008000900003; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Ghosh S, 2007, GLYCOCONJUGATE J, V24, P17, DOI 10.1007/s10719-006-9007-y; Ghoshal A, 2009, PARASITOLOGY, V136, P159, DOI 10.1017/S0031182008005180; Ghoshal A, 2008, MINI-REV MED CHEM, V8, P358, DOI 10.2174/138955708783955980; Ghoshal A, 2010, GLYCOBIOLOGY, V20, P553, DOI 10.1093/glycob/cwp207; Ghoshal A, 2009, CLIN VACCINE IMMUNOL, V16, P889, DOI 10.1128/CVI.00453-08; Ghoshal A, 2009, GLYCOCONJUGATE J, V26, P675, DOI 10.1007/s10719-008-9223-8; Grossin N, 2009, BIORHEOLOGY, V46, P63, DOI 10.3233/BIR-2009-0519; Haudek VJ, 2009, J PROTEOME RES, V8, P3834, DOI 10.1021/pr801085g; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khatua B, 2010, FEBS LETT, V584, P555, DOI 10.1016/j.febslet.2009.11.087; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LINDBERG G, 1991, BRIT MED J, V302, P143, DOI 10.1136/bmj.302.6769.143; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mandal C, 2000, BRIT J HAEMATOL, V110, P801, DOI 10.1046/j.1365-2141.2000.02105.x; Mandal C, MODELYN MOL MODELLIN; Mukhopadhyay S, 2006, INDIAN J MED RES, V123, P203; Nigam PK, 2006, INDIAN J CLIN BIOCHE, V21, P54, DOI 10.1007/BF02913067; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Raval GN, 2003, ORAL DIS, V9, P119, DOI 10.1034/j.1601-0825.2003.01795.x; Resmi H, 2001, CLIN EXP MED, V1, P187, DOI 10.1007/s102380100002; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SCHWARTZ RS, 1991, DIABETES, V40, P701, DOI 10.2337/diabetes.40.6.701; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEN GT, 1995, CARBOHYD RES, V268, P115, DOI 10.1016/0008-6215(94)00311-3; Sharma V, 1998, AM J TROP MED HYG, V58, P551, DOI 10.4269/ajtmh.1998.58.551; Sharma V, 2000, GLYCOCONJUGATE J, V17, P887, DOI 10.1023/A:1010925414222; Spencer K, 2002, PRENATAL DIAG, V22, P656, DOI 10.1002/pd.351; Starodubtseva MN, 2008, B EXP BIOL MED+, V145, P99, DOI 10.1007/s10517-008-0036-3; Stehling P, 1998, GLYCOCONJUGATE J, V15, P339, DOI 10.1023/A:1006965600322; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; WARREN L, 1959, J BIOL CHEM, V234, P1971; World Health Organization, 2010, TECH REP SER, V949, P186; ZAIL SS, 1984, J CLIN INVEST, V74, P753, DOI 10.1172/JCI111491	54	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28169	10.1371/journal.pone.0028169	http://dx.doi.org/10.1371/journal.pone.0028169			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164239	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400040
J	Leychenko, A; Konorev, E; Jijiwa, M; Matter, ML				Leychenko, Anna; Konorev, Eugene; Jijiwa, Mayumi; Matter, Michelle L.			Stretch-Induced Hypertrophy Activates NFkB-Mediated VEGF Secretion in Adult Cardiomyocytes	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; RAT CARDIAC MYOCYTES; KAPPA-B; TRANSCRIPTIONAL REGULATION; MYOCARDIAL-INFARCTION; PROTEIN-KINASE; MAP KINASE; EXPRESSION; CELLS	Hypertension and myocardial infarction are associated with the onset of hypertrophy. Hypertrophy is a compensatory response mechanism to increases in mechanical load due to pressure or volume overload. It is characterized by extracellular matrix remodeling and hypertrophic growth of adult cardiomyocytes. Production of Vascular Endothelial Growth Factor (VEGF), which acts as an angiogenic factor and a modulator of cardiomyocyte function, is regulated by mechanical stretch. Mechanical stretch promotes VEGF secretion in neonatal cardiomyocytes. Whether this effect is retained in adult cells and the molecular mechanism mediating stretch-induced VEGF secretion has not been elucidated. Our objective was to investigate whether cyclic mechanical stretch induces VEGF secretion in adult cardiomyocytes and to identify the molecular mechanism mediating VEGF secretion in these cells. Isolated primary adult rat cardiomyocytes (ARCMs) were subjected to cyclic mechanical stretch at an extension level of 10% at 30 cycles/min that induces hypertrophic responses. Cyclic mechanical stretch induced a 3-fold increase in VEGF secretion in ARCMs compared to non-stretch controls. This increase in stretch-induced VEGF secretion correlated with NFkB activation. Cyclic mechanical stretch-mediated VEGF secretion was blocked by an NFkB peptide inhibitor and expression of a dominant negative mutant IkB alpha, but not by inhibitors of the MAPK/ERK1/2 or PI3K pathways. Chromatin immunoprecipitation assays demonstrated an interaction of NFkB with the VEGF promoter in stretched primary cardiomyocytes. Moreover, VEGF secretion is increased in the stretched myocardium during pressure overload-induced hypertrophy. These findings are the first to demonstrate that NFkB activation plays a role in mediating VEGF secretion upon cyclic mechanical stretch in adult cardiomyocytes. Signaling by NFkB initiated in response to cyclic mechanical stretch may therefore coordinate the hypertrophic response in adult cardiomyocytes. Elucidation of this novel mechanism may provide a target for developing future pharmacotherapy to treat hypertension and heart disease.	[Leychenko, Anna; Jijiwa, Mayumi; Matter, Michelle L.] Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA; [Leychenko, Anna; Jijiwa, Mayumi; Matter, Michelle L.] Univ Hawaii, John A Burns Sch Med, Cardiovasc Res Ctr, Honolulu, HI 96822 USA; [Leychenko, Anna] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Konorev, Eugene] Univ Hawaii, Hilo Coll Pharm, Hilo, HI 96720 USA	University of Hawaii System; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University Hawaii Hilo	Leychenko, A (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.	matter@hawaii.edu	Matter, Michelle/GSN-9703-2022	Matter, Michelle/0000-0002-5988-9663	NCRR [P20-RR016453]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the NCRR P20-RR016453 (MLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 2002, HYPERTENSION, V39, P233, DOI 10.1161/hy0202.102699; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Duquesnes N, 2009, INT J BIOCHEM CELL B, V41, P1173, DOI 10.1016/j.biocel.2008.09.032; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; KATZ AM, 1994, ANN INTERN MED, V121, P363, DOI 10.7326/0003-4819-121-5-199409010-00009; Kudoh S, 1998, J BIOL CHEM, V273, P24037, DOI 10.1074/jbc.273.37.24037; Kumar R, 1999, J PHARMACOL EXP THER, V291, P967; Lal H, 2007, J MOL CELL CARDIOL, V43, P137, DOI 10.1016/j.yjmcc.2007.05.012; Lammerding J, 2004, ANN NY ACAD SCI, V1015, P53, DOI 10.1196/annals.1302.005; Li J, 1997, J CLIN INVEST, V100, P18, DOI 10.1172/JCI119510; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Pages G, 2005, CARDIOVASC RES, V65, P564, DOI 10.1016/j.cardiores.2004.09.032; Pikkarainen S, 2006, AM J PHYSIOL-REG I, V290, pR1639, DOI 10.1152/ajpregu.00559.2005; Pimentel RC, 2002, CIRC RES, V90, P671, DOI 10.1161/01.RES.0000014823.75393.4D; PIPER HM, 1990, CELL CULTURE TECHNIQ; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ross RS, 2002, J CARD FAIL, V8, pS326, DOI 10.1054/jcaf.2002.129263; SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x; SADOSHIMA J, 1993, J RECEPTOR RES, V13, P777, DOI 10.3109/10799899309073692; Sasaki H, 2000, TOXICOLOGY, V155, P27, DOI 10.1016/S0300-483X(00)00274-2; Seko Y, 1999, BIOCHEM BIOPH RES CO, V259, P8, DOI 10.1006/bbrc.1999.0720; Seko Y, 1999, BIOCHEM BIOPH RES CO, V254, P462, DOI 10.1006/bbrc.1998.9969; Seko Y, 1997, CLIN SCI, V92, P453, DOI 10.1042/cs0920453; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Sugden PH, 1998, J MOL MED, V76, P725, DOI 10.1007/s001090050275; TADA H, 1986, J IMMUNOL METHODS, V93, P157, DOI 10.1016/0022-1759(86)90183-3; Torsoni AS, 2003, CIRC RES, V93, P140, DOI 10.1161/01.RES.0000081595.25297.1B; van Wamel AJ, 2000, ARCH BIOCHEM BIOPHYS, V381, P67, DOI 10.1006/abbi.2000.1947; Yamada K, 2005, CIRC RES, V97, P346, DOI 10.1161/01.RES.0000178788.76568.8a; Zentilin L, 2010, FASEB J, V24, P1467, DOI 10.1096/fj.09-143180; Zheng W, 2001, AM J PHYSIOL-HEART C, V280, pH909, DOI 10.1152/ajpheart.2001.280.2.H909	35	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29055	10.1371/journal.pone.0029055	http://dx.doi.org/10.1371/journal.pone.0029055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174951	Green Submitted, Green Published, gold			2022-12-27	WOS:000298367300043
J	Capello, M; Soria, M; Cotel, P; Deneubourg, JL; Dagorn, L				Capello, Manuela; Soria, Marc; Cotel, Pascal; Deneubourg, Jean-Louis; Dagorn, Laurent			Quantifying the Interplay between Environmental and Social Effects on Aggregated-Fish Dynamics	PLOS ONE			English	Article							PELAGIC FISH; POINT HYPOTHESIS; DECISION-MAKING; ANIMAL GROUPS; INDIAN-OCEAN; DEVICES FADS; MODEL; BEHAVIOR; MOVEMENT; DENSITY	Demonstrating and quantifying the respective roles of social interactions and external stimuli governing fish dynamics is key to understanding fish spatial distribution. If seminal studies have contributed to our understanding of fish spatial organization in schools, little experimental information is available on fish in their natural environment, where aggregations often occur in the presence of spatial heterogeneities. Here, we applied novel modeling approaches coupled to accurate acoustic tracking for studying the dynamics of a group of gregarious fish in a heterogeneous environment. To this purpose, we acoustically tracked with submeter resolution the positions of twelve small pelagic fish (Selar crumenophthalmus) in the presence of an anchored floating object, constituting a point of attraction for several fish species. We constructed a field-based model for aggregated-fish dynamics, deriving effective interactions for both social and external stimuli from experiments. We tuned the model parameters that best fit the experimental data and quantified the importance of social interactions in the aggregation, providing an explanation for the spatial structure of fish aggregations found around floating objects. Our results can be generalized to other gregarious species and contexts as long as it is possible to observe the fine-scale movements of a subset of individuals.	[Capello, Manuela; Soria, Marc; Cotel, Pascal] IRD, UMR EME, St Denis, Reunion, France; [Deneubourg, Jean-Louis] Univ Libre Bruxelles, USE, Unit Social Ecol, Brussels, Belgium; [Dagorn, Laurent] IRD, UMR EME, Victoria, Seychelles	Institut de Recherche pour le Developpement (IRD); Universite Libre de Bruxelles; Institut de Recherche pour le Developpement (IRD)	Capello, M (corresponding author), IRD, UMR EME, St Denis, Reunion, France.	manuela.capello@ird.fr	Dagorn, Laurent/K-1002-2016; Capello, Manuela/G-7360-2016	Dagorn, Laurent/0000-0003-3896-8589; Capello, Manuela/0000-0002-9206-011X	Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science [229968]; MADE: Mitigating adverse ecological impacts of open ocean fisheries [210496]; Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science [229968]; MADE: Mitigating adverse ecological impacts of open ocean fisheries [210496]	Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science; MADE: Mitigating adverse ecological impacts of open ocean fisheries; Regional Council of Reunion Island; French Ministry of Overseas; Run Sea Science; MADE: Mitigating adverse ecological impacts of open ocean fisheries	This work was supported by the Regional Council of Reunion Island, the French Ministry of Overseas, the 'Run Sea Science' (Theme - Capacity Building, contract 229968) and the 'MADE: Mitigating adverse ecological impacts of open ocean fisheries' (Theme 2 Food, Agriculture, Fisheries and Biotechnology, contract 210496) FP7 European projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida P., 2007, P 6 C FISH TEL HELD; BREDER C, 1959, AM MUS NAT HIST, V117, P397; Cavagna A, 2008, MATH BIOSCI, V214, P32, DOI 10.1016/j.mbs.2008.05.006; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Chandler D., 1987, INTRO MODERN STAT ME; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Doray M, 2006, FISH RES, V82, P162, DOI 10.1016/j.fishres.2006.06.025; DURVILLE P, 2001, SPC LIVE REEF FISH I, V9, P17; Freon P, 2000, REV FISH BIOL FISHER, V10, P183, DOI 10.1023/A:1016666108540; FreuEn P., 1999, DYNAMICS PELAGIC FIS; Gautrais J, 2009, J MATH BIOL, V58, P429, DOI 10.1007/s00285-008-0198-7; Girard C, 2007, AQUAT LIVING RESOUR, V20, P313, DOI 10.1051/alr:2008005; Grunbaum Daniel, 1994, Lecture Notes in Biomathematics, V100, P296; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; Josse E, 2000, AQUAT LIVING RESOUR, V13, P183, DOI 10.1016/S0990-7440(00)00051-6; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; KATZ Y, 2011, P NATL ACAD IN PRESS; Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657; Krause J, 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Lukeman R, 2009, B MATH BIOL, V71, P352, DOI 10.1007/s11538-008-9365-7; MARSAC F, 2001, ACTES COLLOQUES IFRE, V28; Martinelli TL, 1998, HYDROBIOLOGIA, V372, P79, DOI 10.1023/A:1017019006039; MCCULLOCH CE, 1989, ECOLOGY, V70, P383, DOI 10.2307/1937543; Moreno G, 2007, AQUAT LIVING RESOUR, V20, P343, DOI 10.1051/alr:2008015; NIWA HS, 1994, J THEOR BIOL, V171, P123, DOI 10.1006/jtbi.1994.1218; Parrish J., 1997, ANIMAL GROUPS 3 DIME; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Roos D, 2007, SCI MAR, V71, P137, DOI 10.3989/scimar.2007.71n1137; Schellinck J, 2011, ECOL MODEL, V222, P1897, DOI 10.1016/j.ecolmodel.2011.03.013; Soria M, 2007, J FISH BIOL, V71, P1257, DOI 10.1111/j.1095-8649.2007.01554.x; Soria M, 2009, ANIM BEHAV, V78, P1441, DOI 10.1016/j.anbehav.2009.09.025; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Taquet M, 2007, AQUAT LIVING RESOUR, V20, P331, DOI 10.1051/alr:2008007; TYLER JA, 1994, REV FISH BIOL FISHER, V4, P91, DOI 10.1007/BF00043262	39	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28109	10.1371/journal.pone.0028109	http://dx.doi.org/10.1371/journal.pone.0028109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174770	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600009
J	Mabragana, E; de Astarloa, JMD; Hanner, R; Zhang, JB; Castro, MG				Mabragana, Ezequiel; Martin Diaz de Astarloa, Juan; Hanner, Robert; Zhang, Junbin; Gonzalez Castro, Mariano			DNA Barcoding Identifies Argentine Fishes from Marine and Brackish Waters	PLOS ONE			English	Article							NUCLEOTIDE; TAXONOMY; BIRDS	Background: DNA barcoding has been advanced as a promising tool to aid species identification and discovery through the use of short, standardized gene targets. Despite extensive taxonomic studies, for a variety of reasons the identification of fishes can be problematic, even for experts. DNA barcoding is proving to be a useful tool in this context. However, its broad application is impeded by the need to construct a comprehensive reference sequence library for all fish species. Here, we make a regional contribution to this grand challenge by calibrating the species discrimination efficiency of barcoding among 125 Argentine fish species, representing nearly one third of the known fauna, and examine the utility of these data to address several key taxonomic uncertainties pertaining to species in this region. Methodology/Principal Findings: Specimens were collected and morphologically identified during crusies conducted between 2005 and 2008. The standard BARCODE fragment of COI was amplified and bi-directionally sequenced from 577 specimens (mean of 5 specimens/species), and all specimens and sequence data were archived and interrogated using analytical tools available on the Barcode of Life Data System (BOLD; www.barcodinglife.org). Nearly all species exhibited discrete clusters of closely related haplogroups which permitted the discrimination of 95% of the species (i.e. 119/125) examined while cases of shared haplotypes were detected among just three species-pairs. Notably, barcoding aided the identification of a new species of skate, Dipturus argentinensis, permitted the recognition of Genypterus brasiliensis as a valid species and questions the generic assignment of Paralichthys isosceles. Conclusions/Significance: This study constitutes a significant contribution to the global barcode reference sequence library for fishes and demonstrates the utility of barcoding for regional species identification. As an independent assessment of alpha taxonomy, barcodes provide robust support for most morphologically based taxon concepts and also highlight key areas of taxonomic uncertainty worthy of reappraisal.	[Mabragana, Ezequiel; Martin Diaz de Astarloa, Juan; Gonzalez Castro, Mariano] Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Inst Invest Marinas & Costeras, Lab Biotaxon Morfol & Mol Peces, Mar Del Plata, Buenos Aires, Argentina; [Hanner, Robert] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Zhang, Junbin] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China	National University of Mar del Plata; University of Guelph; University of Guelph; Shanghai Ocean University	Mabragana, E (corresponding author), Univ Nacl Mar del Plata, Fac Ciencias Exactas & Nat, Inst Invest Marinas & Costeras, Lab Biotaxon Morfol & Mol Peces, Mar Del Plata, Buenos Aires, Argentina.	emabraga@mdp.edu.ar	de Astarloa, Juan Diaz/F-5395-2012; González-Castro, Mariano/AAG-8103-2019	Mabragana, Ezequiel/0000-0002-4089-9888; Gonzalez-Castro, Mariano/0000-0003-2403-3168	Argentina iBOL funds; Comision de Investigaciones Cientificas; Universidad Nacional de Mardel Plata funds (Argentina); Genome (through the Ontario Genomics Institute); Natural Sciences and Engineering Research Council of Canada	Argentina iBOL funds; Comision de Investigaciones Cientificas; Universidad Nacional de Mardel Plata funds (Argentina); Genome (through the Ontario Genomics Institute); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported through funding to Consejo Nacional de Investigaciones Cientificas y Tecnicas, under the Argentina iBOL funds, Comision de Investigaciones Cientificas and Universidad Nacional de Mardel Plata funds (Argentina), and through funding to the Canadian Barcode of Life Network from Genome (through the Ontario Genomics Institute) and Natural Sciences and Engineering Research Council of Canada. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral AR, 2007, MAR FRESHWATER RES, V58, P505, DOI 10.1071/MF07050; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; COMPAGNO LJ, 1999, SHARKS SKATES RAYS; COUSSEAU MB, 2007, PUBLICACIONES ESPECI; COUSSEAU MB, 2004, MAR ARGENTINO SUS RE, V4, P17; De Astarloa JMD, 2004, COPEIA, P326; DEASTARLOA JMD, 1993, U CATOLICA NORTE FAC, V2, P47; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Eschmeyer WN, 2010, CATALOG FISHES ELECT; Garcia ML, 2002, J APPL ICHTHYOL, V18, P216, DOI 10.1046/j.1439-0426.2002.00326.x; Golding GB, 2009, MOL ECOLOGY RESOURCE, V9, pIV; GON O, 1990, FISHES SO OCEAN; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Jarnegren J, 2007, MAR BIOL, V152, P43, DOI 10.1007/s00227-007-0651-y; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; MABRAGANA E, 2007, THESIS U NACL MAR PL; De Astarloa JMD, 2008, ZOOTAXA, P35, DOI 10.11646/zootaxa.1921.1.3; McEachran JD, 2004, CRC MAR BIOL SER, P79; MCEACHRAN JD, 1983, ARCH FISCHEREIWISS, V34, P23; McEachran JD, 1998, COPEIA, P271; MENNI RC, 1984, PECES MARINOS ARGENT; MENNI RC, 2007, SERIE TECNICA DIDACT, V11, P1; Menni Roberto C., 2000, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V2, P69; Menni Roberto C., 2008, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V10, P161; Nakamura I, 1986, IMPORTANT FISHES TRA; Nelson JS, 2006, FISHES WORLD; NIELSEN JG, 1999, FAO FISHERIES SYNOPS, V125; Norman J. R., 1938, Discovery Reports Cambridge, V18, P1; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Solari A, 2010, J APPL ICHTHYOL, V26, P137, DOI 10.1111/j.1439-0426.2009.01292.x; Spies IB, 2006, J FISH BIOL, V69, P283, DOI 10.1111/j.1095-8649.2006.01286.x; Stehmann M., 1986, P261; Steinke D, 2011, MITOCHONDR DNA, V22, P10, DOI 10.3109/19401736.2010.536538; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; Victor Benjamin C., 2007, Zootaxa, V1526, P51; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Webb KE, 2006, DEEP-SEA RES PT II, V53, P1053, DOI 10.1016/j.dsr2.2006.02.013; Wohler OC, 2006, CYBIUM, V30, P285; YEARSLEY GK, 2003, AUSTR SEAFOOD, P44; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	62	75	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28655	10.1371/journal.pone.0028655	http://dx.doi.org/10.1371/journal.pone.0028655			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174860	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700057
J	Miyake, T; McDermott, JC; Gramolini, AO				Miyake, Tetsuaki; McDermott, John C.; Gramolini, Anthony O.			A Method for the Direct Identification of Differentiating Muscle Cells by a Fluorescent Mitochondrial Dye	PLOS ONE			English	Article							DYSFUNCTION; MYOGENESIS; MYOBLASTS; APOPTOSIS; PATHWAY; DOMAIN; MICE; MYOD	Identification of differentiating muscle cells generally requires fixation, antibodies directed against muscle specific proteins, and lengthy staining processes or, alternatively, transfection of muscle specific reporter genes driving GFP expression. In this study, we examined the possibility of using the robust mitochondrial network seen in maturing muscle cells as a marker of cellular differentiation. The mitochondrial fluorescent tracking dye, MitoTracker, which is a cell-permeable, low toxicity, fluorescent dye, allowed us to distinguish and track living differentiating muscle cells visually by epi-fluorescence microscopy. MitoTracker staining provides a robust and simple detection strategy for living differentiating cells in culture without the need for fixation or biochemical processing.	[Miyake, Tetsuaki; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Best Inst Med Res, Toronto, ON, Canada; [McDermott, John C.] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	University of Toronto; York University - Canada	Miyake, T (corresponding author), Univ Toronto, Dept Physiol, Best Inst Med Res, Toronto, ON, Canada.	tetsuaki.miyake@rogers.com; anthony.gramolini@utoronto.ca			Heart and Stroke Foundation (HSF) of Ontario [T-6281]; Canadian Institutes of Health Research (CIHR) [MOP-84267]; Canadian Foundation for Innovation	Heart and Stroke Foundation (HSF) of Ontario(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This study was supported by grants from the Heart and Stroke Foundation (HSF) of Ontario (#T-6281; to AOG), Canadian Institutes of Health Research (CIHR) (to AOG; MOP-84267), and Canadian Foundation for Innovation to AOG. AOG is a Canada Research Chair and a New Investigator of the HSF of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Davis R L, 1989, Princess Takamatsu Symp, V20, P267; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736; Miyake T, 2010, MOL CELL BIOL, V30, P722, DOI 10.1128/MCB.01005-09; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Ostrovsky O, 2002, J BIOL CHEM, V277, P40043, DOI 10.1074/jbc.M205494200; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; Wallace LM, 2011, ANN NEUROL, V69, P540, DOI 10.1002/ana.22275; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yoshida N, 1998, J CELL SCI, V111, P769	23	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28628	10.1371/journal.pone.0028628	http://dx.doi.org/10.1371/journal.pone.0028628			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174849	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700052
J	Rodriguez-Jato, S; Busturia, A; Herr, W				Rodriguez-Jato, Sara; Busturia, Ana; Herr, Winship			Drosophila melanogaster dHCF Interacts with both PcG and TrxG Epigenetic Regulators	PLOS ONE			English	Article							HOST-CELL FACTOR; GENE-EXPRESSION; POLYCOMB GROUP; TRANSCRIPTION FACTOR; MLL FAMILY; C-ELEGANS; FACTOR-I; COMPLEX; TRITHORAX; HCF-1	Repression and activation of gene transcription involves multiprotein complexes that modify chromatin structure. The integration of these complexes at regulatory sites can be assisted by co-factors that link them to DNA-bound transcriptional regulators. In humans, one such co-factor is the herpes simplex virus host-cell factor 1 (HCF-1), which is implicated in both activation and repression of transcription. We show here that disruption of the gene encoding the Drosophila melanogaster homolog of HCF-1, dHCF, leads to a pleiotropic phenotype involving lethality, sterility, small size, apoptosis, and morphological defects. In Drosophila, repressed and activated transcriptional states of cell fate-determining genes are maintained throughout development by Polycomb Group (PcG) and Trithorax Group (TrxG) genes, respectively. dHCF mutant flies display morphological phenotypes typical of TrxG mutants and dHCF interacts genetically with both PcG and TrxG genes. Thus, dHCF inactivation enhances the mutant phenotypes of the Pc PcG as well as brm and mor TrxG genes, suggesting that dHCF possesses Enhancer of TrxG and PcG (ETP) properties. Additionally, dHCF interacts with the previously established ETP gene skd. These pleiotropic phenotypes are consistent with broad roles for dHCF in both activation and repression of transcription during fly development.	[Rodriguez-Jato, Sara; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Busturia, Ana] Ctr Biol Mol Severo Ochoa, Madrid, Spain	University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Jato, S (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546	Fonds National Suisse (FNS); University of Lausanne; Fundacion Mutua Madrilena; Spanish Ministry of Science and Innovation [BFU-2008-01154, CSD-2007-0008]	Fonds National Suisse (FNS)(Swiss National Science Foundation (SNSF)); University of Lausanne; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Fonds National Suisse (FNS), the University of Lausanne, the Fundacion Mutua Madrilena (FMM-2006), and the Spanish Ministry of Science and Innovation (BFU-2008-01154, CSD-2007-0008 and Postdoctoral Fellowship Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellosta Paola, 2010, Genes Cancer, V1, P542; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; BRIZUELA BJ, 1994, GENETICS, V137, P803; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Croker JA, 2006, DEV BIOL, V291, P368, DOI 10.1016/j.ydbio.2005.12.020; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; DENELL RE, 1973, GENETICS, V75, P279; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUNCAN IM, 1982, GENETICS, V102, P49; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Furrer M, 2010, J BIOL CHEM; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; HANNAHALAVA A, 1958, GENETICS, V43, P878; INGHAM P, 1980, MOL GEN GENET, V179, P607, DOI 10.1007/BF00271751; Izeta A, 2003, GENE, V305, P175, DOI 10.1016/S0378-1119(03)00380-9; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mahajan SS, 2003, J CELL PHYSIOL, V194, P117, DOI 10.1002/jcp.10193; Marenda DR, 2004, DEV BIOL, V267, P279, DOI 10.1016/j.ydbio.2003.10.040; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Narayanan A, 2007, P NATL ACAD SCI USA, V104, P10835, DOI 10.1073/pnas.0704351104; Poux S, 2001, GENE DEV, V15, P2509, DOI 10.1101/gad.208901; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; SHEARN A, 1989, GENETICS, V121, P517; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Sullivan W, 2000, DROSOPHILA; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Treisman JE, 2001, DEVELOPMENT, V128, P603; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wichmann A, 2010, DEV BIOL, V346, P80, DOI 10.1016/j.ydbio.2010.07.023; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	52	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27479	10.1371/journal.pone.0027479	http://dx.doi.org/10.1371/journal.pone.0027479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174740	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163600002
J	Sanchez, CJ; Kumar, N; Lizcano, A; Shivshankar, P; Hotopp, JCD; Jorgensen, JH; Tettelin, H; Orihuela, CJ				Sanchez, Carlos J.; Kumar, Nikhil; Lizcano, Anel; Shivshankar, Pooja; Hotopp, Julie C. Dunning; Jorgensen, James H.; Tettelin, Herve; Orihuela, Carlos J.			Streptococcus pneumoniae in Biofilms Are Unable to Cause Invasive Disease Due to Altered Virulence Determinant Production	PLOS ONE			English	Article							CHOLINE-BINDING-PROTEINS; PHASE VARIATION; MIDDLE-EAR; CAPSULAR POLYSACCHARIDE; ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; COLONY MORPHOLOGY; CHILDREN; RECEPTOR; NEURAMINIDASE	It is unclear whether Streptococcus pneumoniae in biofilms are virulent and contribute to development of invasive pneumococcal disease (IPD). Using electron microscopy we confirmed the development of mature pneumococcal biofilms in a continuous-flow-through line model and determined that biofilm formation occurred in discrete stages with mature biofilms composed primarily of dead pneumococci. Challenge of mice with equal colony forming units of biofilm and planktonic pneumococci determined that biofilm bacteria were highly attenuated for invasive disease but not nasopharyngeal colonization. Biofilm pneumococci of numerous serotypes were hyper-adhesive and bound to A549 type II pneumocytes and Detroit 562 pharyngeal epithelial cells at levels 2 to 11-fold greater than planktonic counterparts. Using genomic microarrays we examined the pneumococcal transcriptome and determined that during biofilm formation S. pneumoniae down-regulated genes involved in protein synthesis, energy production, metabolism, capsular polysaccharide (CPS) production, and virulence. We confirmed these changes by measuring CPS by ELISA and immunoblotting for the toxin pneumolysin and the bacterial adhesins phosphorylcholine (ChoP), choline-binding protein A (CbpA), and Pneumococcal serine-rich repeat protein (PsrP). We conclude that biofilm pneumococci were avirulent due to reduced CPS and pneumolysin production along with increased ChoP, which is known to bind C-reactive protein and is opsonizing. Likewise, biofilm pneumococci were hyper-adhesive due to selection for the transparent phase variant, reduced CPS, and enhanced production of PsrP, CbpA, and ChoP. These studies suggest that biofilms do not directly contribute to development of IPD and may instead confer a quiescent mode of growth during colonization.	[Sanchez, Carlos J.; Lizcano, Anel; Shivshankar, Pooja; Jorgensen, James H.; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Kumar, Nikhil; Hotopp, Julie C. Dunning; Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Inst Genome Sci, Baltimore, MD 21201 USA; [Jorgensen, James H.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Health San Antonio	Sanchez, CJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	orihuela@uthscsa.edu	Dunning Hotopp, Julie/E-7762-2010	Dunning Hotopp, Julie/0000-0003-3862-986X	National Institutes of Health [DE14318, AI078972]; University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants DE14318 to CJS and AI078972 to CJO. Work completed by NK, JCDH and HT was supported by University of Maryland internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Allegrucci M, 2007, J BACTERIOL, V189, P2030, DOI 10.1128/JB.01369-06; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; [Anonymous], 1999, Wkly Epidemiol Rec, V74, P177; Bensing BA, 2005, MOL MICROBIOL, V58, P1468, DOI 10.1111/j.1365-2958.2005.04919.x; Bensing BA, 2004, J BACTERIOL, V186, P638, DOI 10.1128/JB.186.3.638-645.2004; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; CAMARA M, 1994, INFECT IMMUN, V62, P3688; Camilli R, 2011, EUR J CLIN MICROBIOL, V30, P97, DOI 10.1007/s10096-010-1060-6; Casey R, 2008, INFECT IMMUN, V76, P1298, DOI 10.1128/IAI.00741-07; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Crook DW, 2004, PNEUMOCCOCUS, P136; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Cundell DR, 1996, ADV EXP MED BIOL, V416, P89; del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016; Garcia-Castillo M, 2007, J ANTIMICROB CHEMOTH, V59, P301, DOI 10.1093/jac/dkl482; Gilbert P, 2002, ADV MICROB PHYSIOL, V46, P203, DOI 10.1016/S0065-2911(02)46005-5; Glover DT, 2008, INFECT IMMUN, V76, P2767, DOI 10.1128/IAI.01126-07; Gosink KK, 2000, INFECT IMMUN, V68, P5690, DOI 10.1128/IAI.68.10.5690-5695.2000; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hall-Stoodley L, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-173; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Harro JM, 2010, FEMS IMMUNOL MED MIC, V59, P306, DOI 10.1111/j.1574-695X.2010.00708.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; Heo SM, 2008, CLIN INFECT DIS, V47, P1562, DOI 10.1086/593193; Hoa M, 2009, INT J PEDIATR OTORHI, V73, P1242, DOI 10.1016/j.ijporl.2009.05.016; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; King SJ, 2004, MOL MICROBIOL, V54, P159, DOI 10.1111/j.1365-2958.2004.04252.x; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Li-Korotky HS, 2010, MICROB PATHOGENESIS, V49, P204, DOI 10.1016/j.micpath.2010.05.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maruyama T, 2010, RESP MED, V104, P584, DOI 10.1016/j.rmed.2009.12.008; Moschioni M, 2010, INFECT IMMUN, V78, P5033, DOI 10.1128/IAI.00601-10; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; OVERTURF G, 1980, TEX REP BIOL MED, V40, P283; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Ramirez P, 2007, CURR OPIN INFECT DIS, V20, P190, DOI 10.1097/QCO.0b013e328014daac; Reid SD, 2009, J INFECT DIS, V199, P786, DOI 10.1086/597042; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Roush SW, 2007, JAMA-J AM MED ASSOC, V298, P2155, DOI 10.1001/jama.298.18.2155; RUBINS JB, 1995, J CLIN INVEST, V95, P142, DOI 10.1172/JCI117631; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tapiainen T, 2010, APMIS, V118, P255, DOI 10.1111/j.1600-0463.2010.02587.x; Tong HH, 2001, MICROB PATHOGENESIS, V31, P309, DOI 10.1006/mpat.2001.0473; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; Trappetti C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-75; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Weiser JN, 1996, INFECT IMMUN, V64, P2240, DOI 10.1128/IAI.64.6.2240-2245.1996; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; WONG WY, 1992, CLIN INFECT DIS, V14, P1124, DOI 10.1093/clinids/14.5.1124; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	70	84	89	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28738	10.1371/journal.pone.0028738	http://dx.doi.org/10.1371/journal.pone.0028738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174882	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600041
J	Wang, Y; Zocchi, G				Wang, Yong; Zocchi, Giovanni			Viscoelastic Transition and Yield Strain of the Folded Protein	PLOS ONE			English	Article							GUANYLATE KINASE; FORCES; MOLECULES; DYNAMICS; REVEALS	For proteins, the mechanical properties of the folded state are directly related to function, which generally entails conformational motion. Through sub-Angstrom resolution measurements of the AC mechanical susceptibility of a globular protein we describe a new fundamental materials property of the folded state. For increasing amplitude of the forcing, there is a reversible transition from elastic to viscoelastic response. At fixed frequency, the amplitude of the deformation is piecewise linear in the force, with different slopes in the elastic and viscoelastic regimes. Effectively, the protein softens beyond a yield point defined by this transition. We propose that ligand induced conformational changes generally operate in this viscoelastic regime, and that this is a universal property of the folded state.	[Wang, Yong; Zocchi, Giovanni] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Wang, Y (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	zocchi@physics.ucla.edu	Wang, Yong/B-8528-2011	Wang, Yong/0000-0002-8601-8302	UC Lab; National Science Foundation [DMR-1006162]	UC Lab; National Science Foundation(National Science Foundation (NSF))	This work was supported by the UC Lab Research Program and by National Science Foundation grant DMR-1006162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Choi B, 2007, BIOPHYS J, V92, P1651, DOI 10.1529/biophysj.106.092866; Cui Y, 2000, P NATL ACAD SCI USA, V97, P127, DOI 10.1073/pnas.97.1.127; Delalande O, 2011, BIOPHYS J, V101, P1440, DOI 10.1016/j.bpj.2011.07.048; Deshpande AP, 2010, RHEOLOGY OF COMPLEX FLUIDS, P87, DOI 10.1007/978-1-4419-6494-6_4; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; HOPFIELD JJ, 1973, J MOL BIOL, V77, P207, DOI 10.1016/0022-2836(73)90332-X; Kawakami M, 2005, LANGMUIR, V21, P4765, DOI 10.1021/la0469699; Kawakami M, 2004, LANGMUIR, V20, P9299, DOI 10.1021/la0486178; Kawakami M, 2006, BIOPHYS J, V91, pL16, DOI 10.1529/biophysj.106.085019; KHOLODENKO AL, 1995, PHYS REV E, V51, P1081, DOI 10.1103/PhysRevE.51.1081; Levine AJ, 2000, PHYS REV LETT, V85, P1774, DOI 10.1103/PhysRevLett.85.1774; Levine AJ, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041510; NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020; RADMACHER M, 1994, LANGMUIR, V10, P3809, DOI 10.1021/la00022a068; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Russel W.B., 1889, COLLOIDAL DISPERSION, P456; Sacquin-Mora S, 2010, BIOPHYS J, V99, P3412, DOI 10.1016/j.bpj.2010.09.026; Sekulic N, 2002, J BIOL CHEM, V277, P30236, DOI 10.1074/jbc.M204668200; Singh-Zocchi M, 2003, P NATL ACAD SCI USA, V100, P7605, DOI 10.1073/pnas.1337215100; Taton TA, 2002, PREPARATION GOLD NAN, DOI 10.1002s0471142700; Tseng CY, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/18005; Tseng CY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061912; Wang Y, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/18003; Wang Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238104; Wang Y, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/33/335103; Weltmann RN, 1943, J APPL PHYS, V14, P569, DOI 10.1063/1.1714935; Yang GL, 2000, P NATL ACAD SCI USA, V97, P139, DOI 10.1073/pnas.97.1.139; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zocchi G, 2009, ANNU REV BIOPHYS, V38, P75, DOI 10.1146/annurev.biophys.050708.133637	34	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28097	10.1371/journal.pone.0028097	http://dx.doi.org/10.1371/journal.pone.0028097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174767	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600012
J	Connolly, KL; Braden, AK; Holder, RC; Reid, SD				Connolly, Kristie L.; Braden, Amy K.; Holder, Robert C.; Reid, Sean D.			Srv Mediated Dispersal of Streptococcal Biofilms Through SpeB Is Observed in CovRS plus Strains	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SHOCK-LIKE SYNDROME; SEROTYPE M3 STRAIN; RESPONSE REGULATOR; VIRULENCE FACTOR; IN-VIVO; UNITED-STATES; PYOGENES; IDENTIFICATION; EXPRESSION	Group A Streptococcus (GAS) is a human specific pathogen capable of causing both mild infections and severe invasive disease. We and others have shown that GAS is able to form biofilms during infection. That is to say, they form a three-dimensional, surface attached structure consisting of bacteria and a multi-component extracellular matrix. The mechanisms involved in regulation and dispersal of these GAS structures are still unclear. Recently we have reported that in the absence of the transcriptional regulator Srv in the MGAS5005 background, the cysteine protease SpeB is constitutively produced, leading to increased tissue damage and decreased biofilm formation during a subcutaneous infection in a mouse model. This was interesting because MGAS5005 has a naturally occurring mutation that inactivates the sensor kinase domain of the two component regulatory system CovRS. Others have previously shown that strains lacking covS are associated with decreased SpeB production due to CovR repression of speB expression. Thus, our results suggest the inactivation of srv can bypass CovR repression and lead to constitutive SpeB production. We hypothesized that Srv control of SpeB production may be a mechanism to regulate biofilm dispersal and provide a mechanism by which mild infection can transition to severe disease through biofilm dispersal. The question remained however, is this mechanism conserved among GAS strains or restricted to the unique genetic makeup of MGAS5005. Here we show that Srv mediated control of SpeB and biofilm dispersal is conserved in the invasive clinical isolates RGAS053 (serotype M1) and MGAS315 (serotype M3), both of which have covS intact. This work provides additional evidence that Srv regulated control of SpeB may mediate biofilm formation and dispersal in diverse strain backgrounds.	[Connolly, Kristie L.; Holder, Robert C.; Reid, Sean D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA; [Braden, Amy K.] Wake Forest Univ, Bowman Gray Sch Med, Program Mol Genet, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Connolly, KL (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Microbiol & Immunol, Winston Salem, NC 27103 USA.	sreid@wfubmc.edu		Connolly, Kristie/0000-0002-7516-4427	National Institutes of Health [R01AI063453]; American Heart Association [11GRNT7980017]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01AI063453 from the National Institutes of Health and American Heart Association Grant in Aid 11GRNT7980017 to S.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2003, J DERMATOL SCI, V32, P193, DOI 10.1016/S0923-1811(03)00096-3; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaussee MS, 1997, INFECT IMMUN, V65, P1956, DOI 10.1128/IAI.65.5.1956-1959.1997; Chiang-Ni C, 2008, J FORMOS MED ASSOC, V107, P677, DOI 10.1016/S0929-6646(08)60112-6; Cho KH, 2005, MOL MICROBIOL, V57, P1545, DOI 10.1111/j.1365-2958.2005.04786.x; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Churchward G, 2009, MICROBIOL-SGM, V155, P566, DOI 10.1099/mic.0.024620-0; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Connolly KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018984; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Doern CD, 2008, MICROBIOL-SGM, V154, P1998, DOI 10.1099/mic.0.2007/013466-0; Doern CD, 2009, MICROBIOL-SGM, V155, P46, DOI 10.1099/mic.0.021048-0; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Gao JX, 2005, J BIOL CHEM, V280, P38948, DOI 10.1074/jbc.M506121200; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gusa AA, 2006, J BACTERIOL, V188, P4620, DOI 10.1128/JB.00198-06; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOGE CW, 1993, JAMA-J AM MED ASSOC, V269, P384, DOI 10.1001/jama.269.3.384; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1999, INFECT IMMUN, V67, P1779; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Miller AA, 2001, MOL MICROBIOL, V40, P976, DOI 10.1046/j.1365-2958.2001.02441.x; MUSSER JM, 1993, J INFECT DIS, V167, P337, DOI 10.1093/infdis/167.2.337; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; Reid SD, 2004, INFECT IMMUN, V72, P1799, DOI 10.1128/IAI.72.3.1799-1803.2004; Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003; Reid SD, 2006, FEMS IMMUNOL MED MIC, V48, P283, DOI 10.1111/j.1574-695X.2006.00150.x; Richter SS, 2005, CLIN INFECT DIS, V41, P599, DOI 10.1086/432473; Roberts AL, 2010, INFECT IMMUN; Roberts Amity L, 2010, BMC Res Notes, V3, P281, DOI 10.1186/1756-0500-3-281; Roberts SA, 2007, J BACTERIOL, V189, P1459, DOI 10.1128/JB.01026-06; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tamura F, 2004, INFECT IMMUN, V72, P4836, DOI 10.1128/IAI.72.8.4836-4847.2004; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	55	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28640	10.1371/journal.pone.0028640	http://dx.doi.org/10.1371/journal.pone.0028640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163320	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900056
J	Kuchibhatla, A; Bhattacharya, A; Panda, D				Kuchibhatla, Anuradha; Bhattacharya, Anusri; Panda, Dulal			ZipA Binds to FtsZ with High Affinity and Enhances the Stability of FtsZ Protofilaments	PLOS ONE			English	Article							BACTERIAL-CELL-DIVISION; ESCHERICHIA-COLI; ASSEMBLY DYNAMICS; PROTEIN FTSZ; SEPTAL RING; INHIBITORS; SCATTERING; RESONANCE; TURNOVER; POLYMERS	A bacterial membrane protein ZipA that tethers FtsZ to the membrane is known to promote FtsZ assembly. In this study, the binding of ZipA to FtsZ was monitored using fluorescence spectroscopy. ZipA was found to bind to FtsZ with high affinities at three different (6.0, 6.8 and 8.0) pHs, albeit the binding affinity decreased with increasing pH. Further, thick bundles of FtsZ protofilaments were observed in the presence of ZipA under the pH conditions used in this study indicating that ZipA can promote FtsZ assembly and stabilize FtsZ polymers under unfavorable conditions. Bis-ANS, a hydrophobic probe, decreased the interaction of FtsZ and ZipA indicating that the interaction between FtsZ and ZipA is hydrophobic in nature. ZipA prevented the dilution induced disassembly of FtsZ polymers suggesting that it stabilizes FtsZ protofilaments. Fluorescein isothiocyanate-labeled ZipA was found to be uniformly distributed along the length of the FtsZ protofilaments indicating that ZipA stabilizes FtsZ protofilaments by cross-linking them.	[Kuchibhatla, Anuradha; Bhattacharya, Anusri; Panda, Dulal] Indian Inst Technol, Wadhwani Res Ctr, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kuchibhatla, A (corresponding author), Indian Inst Technol, Wadhwani Res Ctr, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	panda@iitb.ac.in			Board of Research in Nuclear Sciences, Government of India	Board of Research in Nuclear Sciences, Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	This work was supported by a grant from the Board of Research in Nuclear Sciences, Government of India. http://www.barc.ernet.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 2002, J MOL BIOL, V318, P219, DOI 10.1016/S0022-2836(02)00024-4; Beuria TK, 2006, INT J BIOL MACROMOL, V40, P30, DOI 10.1016/j.ijbiomac.2006.05.006; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2002, J BACTERIOL, V184, P2552, DOI 10.1128/JB.184.9.2552-2556.2002; Harry E, 2006, INT REV CYTOL, V253, P27, DOI [DOI 10.1016/S0074-7696(06)53002-5, 10.1016/S0074-7696(06)53002-5.]; Jennings LD, 2004, BIOORGAN MED CHEM, V12, P5115, DOI 10.1016/j.bmc.2004.07.031; Jennings LD, 2004, BIOORG MED CHEM LETT, V14, P1427, DOI 10.1016/j.bmcl.2004.01.028; Kapoor S, 2009, EXPERT OPIN THER TAR, V13, P1037, DOI 10.1517/14728220903173257; Kenny CH, 2003, ANAL BIOCHEM, V323, P224, DOI 10.1016/j.ab.2003.08.033; Kuchibhatla A, 2011, INT J BIOL MACROMOL, V49, P737, DOI 10.1016/j.ijbiomac.2011.07.008; Kuchibhatla A, 2011, INDIAN J CHEM A, V50, P491; Kuchibhatla A, 2009, LANGMUIR, V25, P3775, DOI 10.1021/la8036605; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Santra MK, 2007, PROTEINS, V67, P177, DOI 10.1002/prot.21178; Santra MK, 2004, J BIOL CHEM, V279, P25959, DOI 10.1074/jbc.M312473200; SHI L, 1994, BIOCHEMISTRY-US, V33, P7536, DOI 10.1021/bi00190a006; Singh JK, 2008, J BIOL CHEM, V283, P31116, DOI 10.1074/jbc.M805910200; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Sutherland AG, 2003, ORG BIOMOL CHEM, V1, P4138, DOI 10.1039/b312016c; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x	33	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28262	10.1371/journal.pone.0028262	http://dx.doi.org/10.1371/journal.pone.0028262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164258	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400059
J	Lawing, AM; Polly, PD				Lawing, A. Michelle; Polly, P. David			Pleistocene Climate, Phylogeny, and Climate Envelope Models: An Integrative Approach to Better Understand Species' Response to Climate Change	PLOS ONE			English	Article							WESTERN RATTLESNAKE; CROTALUS-VIRIDIS; VIPERIDAE; EVOLUTION; RANGE; BIOGEOGRAPHY; ECOLOGY; RECONSTRUCTION; DISTRIBUTIONS; CONSTRAINTS	Mean annual temperature reported by the Intergovernmental Panel on Climate Change increases at least 1.1 degrees C to 6.4 degrees C over the next 90 years. In context, a change in climate of 6 degrees C is approximately the difference between the mean annual temperature of the Last Glacial Maximum (LGM) and our current warm interglacial. Species have been responding to changing climate throughout Earth's history and their previous biological responses can inform our expectations for future climate change. Here we synthesize geological evidence in the form of stable oxygen isotopes, general circulation paleoclimate models, species' evolutionary relatedness, and species' geographic distributions. We use the stable oxygen isotope record to develop a series of temporally high-resolution paleoclimate reconstructions spanning the Middle Pleistocene to Recent, which we use to map ancestral climatic envelope reconstructions for North American rattlesnakes. A simple linear interpolation between current climate and a general circulation paleoclimate model of the LGM using stable oxygen isotope ratios provides good estimates of paleoclimate at other time periods. We use geologically informed rates of change derived from these reconstructions to predict magnitudes and rates of change in species' suitable habitat over the next century. Our approach to modeling the past suitable habitat of species is general and can be adopted by others. We use multiple lines of evidence of past climate (isotopes and climate models), phylogenetic topology (to correct the models for long-term changes in the suitable habitat of a species), and the fossil record, however sparse, to cross check the models. Our models indicate the annual rate of displacement in a clade of rattlesnakes over the next century will be 2 to 3 orders of magnitude greater (430-2,420 m/yr) than it has been on average for the past 320 ky (2.3 m/yr).	[Lawing, A. Michelle; Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Lawing, A. Michelle] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Lawing, AM (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	alawing@indiana.edu	Polly, P. David/ABC-6597-2020; Lawing, Michelle/F-7453-2019	Polly, P. David/0000-0001-7338-8526; Lawing, Michelle/0000-0003-4041-6177	National Science Foundation [EAR-0843935]; CEA; CNRS; MOTIF; Programme National d'Etude de la Dynamique du Climat; Directorate For Geosciences [0843935] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); MOTIF; Programme National d'Etude de la Dynamique du Climat; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation Research Grant EAR-0843935. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank S.C. Brassell, A.K. Bormet, C. Casola, E.S. Gercke, R.M. Green, C.C. Johnson, E.P. Martins, J.M. Meik, L.C. Moyle, K.D. Nold, J.-Y. Peterschmitt, and L.M. Pratt for assistance, advice and thoughtful discussion. J.M. Meik kindly provided an insightful review of this manuscript, as well as two anonymous reviewers. We acknowledge the Paleobiology Database (paleodb.org) and the Laboratoire des Sciences du Climat et de l'Environnement (pmip2.lsce.ipsl.fr/) for collecting and archiving data. The PMIP2 Data Archive is supported by CEA, CNRS, MOTIF, and the Programme National d'Etude de la Dynamique du Climat.	Ashton KG, 2001, MOL PHYLOGENET EVOL, V21, P176, DOI 10.1006/mpev.2001.1013; AUSTIN MP, 1984, VEGETATIO, V55, P11, DOI 10.1007/BF00039976; Bennett KD, 1997, BIOL RESPONSE EVOLUT, P154; Bennett SH, 1995, ECOLOGY STATUS E DIA; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Campbell J. A., 2004, VENOMOUS REPTILES W; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Clark AM, 2003, J HERPETOL, V37, P145, DOI 10.1670/0022-1511(2003)037[0145:POTTRC]2.0.CO;2; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Douglas ME, 2006, MOL ECOL, V15, P3353, DOI 10.1111/j.1365-294X.2006.03007.x; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hardy CR, 2005, SYST BIOL, V54, P299, DOI 10.1080/10635150590923317; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Heikinheimo H, 2007, J BIOGEOGR, V34, P1053, DOI 10.1111/j.1365-2699.2006.01664.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Holman JA, 2000, FOSSIL SNAKES N AM; Holt RD, 2003, EVOL ECOL RES, V5, P159; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Knouft JH, 2006, ECOLOGY, V87, pS29, DOI 10.1890/0012-9658(2006)87[29:PAOTEO]2.0.CO;2; Lawton JL, 2000, CONCLUDING REMARKS R, P401; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Martinez-Meyer E, 2004, GLOBAL ECOL BIOGEOGR, V13, P305, DOI 10.1111/j.1466-822X.2004.00107.x; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Means DB, 1986, SPECIAL CONCERN E DI; Meik JM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-35; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murphy Robert W., 2002, P69; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PEASE CM, 1989, ECOLOGY, V70, P1657, DOI 10.2307/1938100; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Polly P. David, 2008, P167, DOI 10.1007/978-1-4020-6997-0_9; Polly PD, 2010, CARNIVORAN EVOLUTION; Polly PD, 2004, SIMULATION MORPHOLOG, p7A; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Ruddiman WF, 1989, PALEOCEANOGRAPHY, V4, P353, DOI 10.1029/PA004i004p00353; Solomon S, 2007, INT PAN CLIM CHANG C; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI 10.1111/j.1365-2486.2005.001018.x; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P19715, DOI 10.1073/pnas.0902956106; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	64	63	63	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28554	10.1371/journal.pone.0028554	http://dx.doi.org/10.1371/journal.pone.0028554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164305	Green Published, gold			2022-12-27	WOS:000298171400107
J	Marion, ZH; Hay, ME				Marion, Zachary H.; Hay, Mark E.			Chemical Defense of the Eastern Newt (Notophthalmus viridescens): Variation in Efficiency against Different Consumers and in Different Habitats	PLOS ONE			English	Article							RED-SPOTTED NEWT; EXPERIMENTAL COMMUNITIES; SALAMANDER PREDATION; TARICHA-GRANULOSA; GARTER SNAKES; POISON FROGS; TETRODOTOXIN; PREY; SKIN; PALATABILITY	Amphibian secondary metabolites are well known chemically, but their ecological functions are poorly understood-even for well-studied species. For example, the eastern newt (Notophthalmus viridescens) is a well known secretor of tetrodotoxin (TTX), with this compound hypothesized to facilitate this salamander's coexistence with a variety of aquatic consumers across the eastern United States. However, this assumption of chemical defense is primarily based on observational data with low replication against only a few predator types. Therefore, we tested the hypothesis that N. viridescens is chemically defended against co-occurring fishes, invertebrates, and amphibian generalist predators and that this defense confers high survivorship when newts are transplanted into both fish-containing and fishless habitats. We found that adult eastern newts were unpalatable to predatory fishes (Micropterus salmoides, Lepomis macrochirus) and a crayfish (Procambarus clarkii), but were readily consumed by bullfrogs (Lithobates catesbeianus). The eggs and neonate larvae were also unpalatable to fish (L. macrochirus). Bioassay-guided fractionation confirmed that deterrence is chemical and that ecologically relevant concentrations of TTX would deter feeding. Despite predatory fishes rejecting eastern newts in laboratory assays, field experiments demonstrated that tethered newts suffered high rates of predation in fish-containing ponds. We suggest that this may be due to predation by amphibians (frogs) and reptiles (turtles) that co-occur with fishes rather than from fishes directly. Fishes suppress invertebrate consumers that prey on bullfrog larvae, leading to higher bullfrog densities in fish containing ponds and thus considerable consumption of newts due to bullfrog tolerance of newt chemical defenses. Amphibian chemical defenses, and consumer responses to them, may be more complex and indirect than previously appreciated.	[Marion, Zachary H.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Marion, Zachary H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University System of Georgia; Georgia Institute of Technology; University of Tennessee System; University of Tennessee Knoxville	Marion, ZH (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	mark.hay@biology.gatech.edu	Marion, Zachary/I-9102-2016; Hay, Mark/D-9752-2011	Marion, Zachary/0000-0002-7351-1819; Hay, Mark/0000-0002-6130-9349	National Science Foundation [DGE 0114400]; FOGARTY INTERNATIONAL CENTER [U19TW007401] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship Program award (DGE 0114400), http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 12759, and the Teasley Endowment to the Georgia Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CK, 2011, AM MIDL NAT, V166, P211, DOI 10.1674/0003-0031-166.1.211; Adams MJ, 2003, ECOL LETT, V6, P343, DOI 10.1046/j.1461-0248.2003.00435.x; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2010, SALAMANDERS US CANAD; Bates D., 2010, IME4 LINEAR MIXED EF; Benard MF, 2003, ECOLOGY, V84, P68, DOI 10.1890/0012-9658(2003)084[0068:AIDCCO]2.0.CO;2; BRANDON RA, 1979, HERPETOLOGICA, V35, P289; BRODIE ED, 1990, EVOLUTION, V44, P651, DOI 10.1111/j.1558-5646.1990.tb05945.x; BRODIE ED, 1968, AM MIDL NAT, V80, P276, DOI 10.2307/2423618; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Clark VC, 2005, P NATL ACAD SCI USA, V102, P11617, DOI 10.1073/pnas.0503502102; Conant R., 1991, FIELD GUIDE REPTILES; DALY JW, 1995, P NATL ACAD SCI USA, V92, P9, DOI 10.1073/pnas.92.1.9; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0; DUFFY JE, 2001, MARINE COMMUNITY ECO, P131; Eisner T, 2000, P NATL ACAD SCI USA, V97, P11313, DOI 10.1073/pnas.190335397; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Etnier DA, 1993, FISHES TENNESSEE, Vxiv, P681; Fay MP, 2010, R J, V2, P53; Fordyce JA, 2005, J CHEM ECOL, V31, P2835, DOI 10.1007/s10886-005-8397-9; FOX J, 2010, CAR COMPANION APPL R; Gamradt SC, 1997, CONSERV BIOL, V11, P793, DOI 10.1046/j.1523-1739.1997.96230.x; GATES JE, 1982, J HERPETOL, V16, P7, DOI 10.2307/1563901; Glendinning JI, 2007, BIOL BULL-US, V213, P252, DOI 10.2307/25066643; Gunzburger MS, 2005, J HERPETOL, V39, P547, DOI 10.1670/1-05A.1; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Hanifin CT, 2004, TOXICON, V43, P243, DOI 10.1016/j.toxicon.2003.11.025; Hanifin CT, 2003, J CHEM ECOL, V29, P1729, DOI 10.1023/A:1024885824823; Hay M. E, 1998, METHODS CHEM ECOLOGY, P39; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; Hecnar SJ, 1997, BIOL CONSERV, V79, P123, DOI 10.1016/S0006-3207(96)00113-9; HOLT RD, 1984, AM NAT, V124, P377, DOI 10.1086/284280; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HURLBERT S H, 1970, Journal of Herpetology, V4, P47, DOI 10.2307/1562702; KRUSE KC, 1977, T AM FISH SOC, V106, P248, DOI 10.1577/1548-8659(1977)106<248:APDILO>2.0.CO;2; Kuchta SR, 2008, EVOLUTION, V62, P984, DOI 10.1111/j.1558-5646.2008.00338.x; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; LEVENSON CH, 1979, TOXICON, V17, P184, DOI 10.1016/0041-0101(79)90301-5; LICHT L E, 1968, Herpetologica, V24, P93; Lindquist N, 1996, ECOL MONOGR, V66, P431, DOI 10.2307/2963489; Lodge DM, 2000, FISHERIES, V25, P7, DOI 10.1577/1548-8446(2000)025<0007:NCTNAF>2.0.CO;2; MORIN PJ, 1981, SCIENCE, V212, P1284, DOI 10.1126/science.212.4500.1284; MORIN PJ, 1983, ECOL MONOGR, V53, P119, DOI 10.2307/1942491; MORIN PJ, 1983, ECOLOGY, V64, P1430, DOI 10.2307/1937497; MOSHER HS, 1964, SCIENCE, V144, P1100, DOI 10.1126/science.144.3622.1100; Murdoch W.W., 2003, CONSUMER RESOURCE DY; Myers CW, 1978, DANGEROUSLY TOXIC NE; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; ORIANS GH, 1974, AM NAT, V108, P581, DOI 10.1086/282937; Page LM, 1991, FIELD GUIDE FRESHWAT; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Parker JD, 2006, J CHEM ECOL, V32, P815, DOI 10.1007/s10886-006-9038-7; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Post DM, 2008, ECOLOGY, V89, P2019, DOI 10.1890/07-1216.1; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rosenthal GA., 1992, HERBIVORES THEIR INT; SARGEANT AB, 1975, AM MIDL NAT, V94, P108, DOI 10.2307/2424542; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Smith GR, 1999, FRESHWATER BIOL, V41, P829, DOI 10.1046/j.1365-2427.1999.00445.x; Stachowicz JJ, 2001, MARINE CHEM ECOLOGY; Stoks R, 2003, ECOLOGY, V84, P1576, DOI 10.1890/0012-9658(2003)084[1576:PALHSL]2.0.CO;2; Szuroczki D, 2011, HERPETOLOGICA, V67, P213, DOI 10.1655/HERPETOLOGICA-D-10-00059.1; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Vonesh JR, 2009, OIKOS, V118, P1219, DOI 10.1111/j.1600-0706.2009.17369.x; WAKELY JANE FAIL, 1966, TOXICON, V3, P195, DOI 10.1016/0041-0101(66)90021-3; WEBSTER DA, 1960, COPEIA, P74; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WILBUR HM, 1983, ECOLOGY, V64, P1423, DOI 10.2307/1937496; Williams BL, 2010, CHEMOECOLOGY, V20, P285, DOI 10.1007/s00049-010-0057-z; Williams BL, 2003, HERPETOLOGICA, V59, P155, DOI 10.1655/0018-0831(2003)059[0155:CODTAP]2.0.CO;2; YOTSU M, 1990, TOXICON, V28, P238, DOI 10.1016/0041-0101(90)90419-8; Yotsu-Yamashita M, 2003, TOXICON, V41, P893, DOI 10.1016/S0041-0101(03)00068-0; Yotsu-Yamashita M, 2001, TOXICON, V39, P1261, DOI 10.1016/S0041-0101(00)00263-4; ZARET TM, 1980, PREDATION FRESHWATER; [No title captured]; [No title captured]	81	8	8	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27581	10.1371/journal.pone.0027581	http://dx.doi.org/10.1371/journal.pone.0027581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164212	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400012
J	Romeo, S; Zeni, L; Sarti, M; Sannino, A; Scarfi, MR; Vernier, PT; Zeni, O				Romeo, Stefania; Zeni, Luigi; Sarti, Maurizio; Sannino, Anna; Scarfi, Maria Rosaria; Vernier, P. Thomas; Zeni, Olga			DNA Electrophoretic Migration Patterns Change after Exposure of Jurkat Cells to a Single Intense Nanosecond Electric Pulse	PLOS ONE			English	Article							DAMAGE; APOPTOSIS; FIELDS	Intense nanosecond pulsed electric fields (nsPEFs) interact with cellular membranes and intracellular structures. Investigating how cells respond to nanosecond pulses is essential for a) development of biomedical applications of nsPEFs, including cancer therapy, and b) better understanding of the mechanisms underlying such bioelectrical effects. In this work, we explored relatively mild exposure conditions to provide insight into weak, reversible effects, laying a foundation for a better understanding of the interaction mechanisms and kinetics underlying nsPEF bio-effects. In particular, we report changes in the nucleus of Jurkat cells (human lymphoblastoid T cells) exposed to single pulses of 60 ns duration and 1.0, 1.5 and 2.5 MV/m amplitudes, which do not affect cell growth and viability. A dose-dependent reduction in alkaline comet-assayed DNA migration is observed immediately after nsPEF exposure, accompanied by permeabilization of the plasma membrane (YO-PRO-1 uptake). Comet assay profiles return to normal within 60 minutes after pulse delivery at the highest pulse amplitude tested, indicating that our exposure protocol affects the nucleus, modifying DNA electrophoretic migration patterns.	[Romeo, Stefania; Zeni, Luigi; Sarti, Maurizio; Sannino, Anna; Scarfi, Maria Rosaria] CNR, Inst Electromagnet Sensing Environm, I-80125 Naples, Italy; [Romeo, Stefania; Zeni, Luigi] Univ Naples 2, Dept Informat Engn, Aversa, Italy; [Sannino, Anna] Univ Salerno, Dept Pharmaceut Sci, Fisciano, Italy; [Vernier, P. Thomas; Zeni, Olga] Univ So Calif, Viterbi Sch Engn, Ming Hsieh Dept Elect Engn, Los Angeles, CA USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Rilevamento Elettromagnetico Dell'Ambiente (IREA-CNR); Universita della Campania Vanvitelli; University of Salerno; University of Southern California	Romeo, S (corresponding author), CNR, Inst Electromagnet Sensing Environm, I-80125 Naples, Italy.	zeni.o@irea.cnr.it	Zeni, Luigi/AAC-5044-2022; Zeni, Olga/ABH-5688-2020; Sarti, Maurizio/AAL-7105-2021; Romeo, Stefania/I-6664-2019; Vernier, P. Thomas/D-7926-2016	Zeni, Luigi/0000-0001-8356-7480; Zeni, Olga/0000-0002-2432-2384; Sarti, Maurizio/0000-0002-5063-4154; Romeo, Stefania/0000-0002-9849-3637; Vernier, P. Thomas/0000-0003-2335-1500				Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Bowman AM, 2010, J MEMBRANE BIOL, V236, P15, DOI 10.1007/s00232-010-9269-y; Buescher ES, 2003, IEEE T DIELECT EL IN, V10, P788, DOI 10.1109/TDEI.2003.1237328; Chen NY, 2004, BIOCHEM BIOPH RES CO, V317, P421, DOI 10.1016/j.bbrc.2004.03.063; Chen XH, 2010, PIGM CELL MELANOMA R, V23, P554, DOI 10.1111/j.1755-148X.2010.00704.x; Collins AR, 2001, ACTA BIOCHIM POL, V48, P611; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; IDZIOREK T, 1995, J IMMUNOL METHODS, V185, P249, DOI 10.1016/0022-1759(95)00172-7; Joshi R. P., 2010, Critical Reviews in Biomedical Engineering, V38, P255, DOI 10.1615/CritRevBiomedEng.v38.i3.20; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Lovell DP, 2008, MUTAGENESIS, V23, P171, DOI 10.1093/mutage/gen015; MATZKE AJM, 1991, BIOELECTROCH BIOENER, V25, P357, DOI 10.1016/0302-4598(91)80002-K; Merk O, 1999, ENVIRON MOL MUTAGEN, V33, P167, DOI 10.1002/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Palumbo R, 2008, RADIAT RES, V170, P327, DOI 10.1667/RR1098.1; PORSCHKE D, 1984, BIOPHYS CHEM, V20, P225, DOI 10.1016/0301-4622(84)87027-1; Schoenbach KH, 2001, BIOELECTROMAGNETICS, V22, P440, DOI 10.1002/bem.71; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Tekle E, 2005, BIOPHYS J, V89, P274, DOI 10.1529/biophysj.104.054494; Tice RR, 1997, MUTAT RES-REV MUTAT, V386, P315, DOI 10.1016/S1383-5742(97)00004-5; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2006, PHYS BIOL, V3, P233, DOI 10.1088/1478-3975/3/4/001; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; White JA, 2011, EUR BIOPHYS J BIOPHY, V40, P947, DOI 10.1007/s00249-011-0710-7; Zeni O, 2010, METHODS MOL BIOL, V625, P109, DOI 10.1007/978-1-60761-579-8_10	32	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28419	10.1371/journal.pone.0028419	http://dx.doi.org/10.1371/journal.pone.0028419			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164287	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400088
J	Wang, Z; Chen, J; Boyd, JE; Zhang, HY; Jia, XZ; Qiu, JY; Xiao, ZP				Wang, Zhen; Chen, Jue; Boyd, Jennifer E.; Zhang, Haiyin; Jia, Xiuzhen; Qiu, Jianyin; Xiao, Zeping			Psychometric Properties of the Chinese Version of the Perceived Stress Scale in Policewomen	PLOS ONE			English	Article							PSYCHOLOGICAL STRESS; DEPRESSION; VALIDATION; ANXIETY; DISEASE; WOMEN	Background: The 10-item Perceived Stress Scale (PSS-10) is one of most widely used instruments to measure a global level of perceived stress in a range of clinical and research settings. This study was conducted to examine the psychometric properties of the Simplified Chinese version of the PSS-10 in policewomen. Methodology: A total of 240 policewomen were recruited in this study. The Simplified Chinese versions of the PSS-10, the Beck Depression Inventory Revised (BDI-II), and the Beck Anxiety Inventory (BAI) were administered to all participants, and 36 of the participants were re-tested two weeks after the initial testing. Principal Findings: The overall Cronbach's alpha was 0.86, and the test-retest reliability coefficient was 0.68. Exploratory Factor Analysis (EFA) yielded 2 factors with eigenvalues of 4.76 and 1.48, accounting for 62.41% of variance. Factor 1 consisted of 6 items representing "negative feelings''; whereas Factor 2 consisted of 4 items representing "positive feelings''. The item loadings ranged from 0.72 to 0.83. The Confirmatory factor analysis (CFA) indicated a very good fit of this two-factor model to this sample. The PSS-10 significantly correlated with both BDI-II and BAI, indicating an acceptable concurrent validity. Conclusions: The Simplified Chinese version of the PSS-10 demonstrated adequate psychometric properties for evaluating stress levels. The results support its use among the Chinese population.	[Wang, Zhen; Chen, Jue; Zhang, Haiyin; Jia, Xiuzhen; Qiu, Jianyin; Xiao, Zeping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Boyd, Jennifer E.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Boyd, Jennifer E.] San Francisco VA Med Ctr, San Francisco, CA USA	Shanghai Jiao Tong University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	xiaozeping@gmail.com	Wang, Zhen/A-2389-2011; Boyd, Jennifer/V-5096-2019	Wang, Zhen/0000-0003-4319-5314; 	National Natural Science Fundation [30800370]; Shanghai Pujiang Program [09PJ1408900]	National Natural Science Fundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This study was supported by grants from the National Natural Science Fundation (30800370) and the Shanghai Pujiang Program (09PJ1408900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolo JLA, 2011, REV LAT-AM ENFERM, V19, P348, DOI 10.1590/S0104-11692011000200017; Beck A.T., 1996, BDI 2 BECK DEPRESSIO, V6; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Chaaya M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-111; Chen CH, 2000, J PSYCHOSOM RES, V49, P395, DOI 10.1016/S0022-3999(00)00180-X; Cheng K, 2002, J CLIN PSYCHOL, V10, P12; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cohen S., 1995, MEASURING STRESS GUI, VXII; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Danzer SC, 2011, EXP NEUROL; Hsieh Yi-Hsuan, 2011, Chang Gung Med J, V34, P278; Lazarus RS, 1984, STRESS APPRAISAL COP, Vxiii; Leung DYP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-513; Lombard JH, 2010, J APPL PHYSIOL, V108, P1025, DOI 10.1152/japplphysiol.00203.2010; Mimura C, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-85; Mitchell AM, 2008, RES NURS HEALTH, V31, P576, DOI 10.1002/nur.20284; Morash M, 2006, POLICING, V29, P541, DOI 10.1108/13639510610684755; Reis RS, 2010, J HEALTH PSYCHOL, V15, P107, DOI 10.1177/1359105309346343; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Sharp LK, 2007, J ASTHMA, V44, P311, DOI 10.1080/02770900701344165; Sims Regina, 2008, Eat Behav, V9, P137, DOI 10.1016/j.eatbeh.2007.06.006; Stauder A, 2006, SUMMARY VALIDITY STU; Violanti JM, 2006, ANN EPIDEMIOL, V16, P148, DOI 10.1016/j.annepidem.2005.07.054; Wang Z., 2011, CHIN MENT HLTH J, V25, P476; Wang Z, 2010, PSYCHIAT RES, V175, P211, DOI 10.1016/j.psychres.2008.11.010; Wongpakaran N, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-6; Yu R., 2010, PSYCHOLOGY, V1, P1, DOI [DOI 10.4236/PSYCH.2010.11001, 10.4236/psych.2010.11001]	28	124	133	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28610	10.1371/journal.pone.0028610	http://dx.doi.org/10.1371/journal.pone.0028610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164311	Green Published, gold			2022-12-27	WOS:000298171400113
J	Rooman, M; Albert, J; Dehouck, Y; Haye, A				Rooman, Marianne; Albert, Jaroslav; Dehouck, Yves; Haye, Alexandre			Detection of Perturbation Phases and Developmental Stages in Organisms from DNA Microarray Time Series Data	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-CYCLE; DROSOPHILA-MELANOGASTER; ESCHERICHIA-COLI; NORMALIZATION; NETWORKS	Available DNA microarray time series that record gene expression along the developmental stages of multicellular eukaryotes, or in unicellular organisms subject to external perturbations such as stress and diauxie, are analyzed. By pairwise comparison of the gene expression profiles on the basis of a translation-invariant and scale-invariant distance measure corresponding to least-rectangle regression, it is shown that peaks in the average distance values are noticeable and are localized around specific time points. These points systematically coincide with the transition points between developmental phases or just follow the external perturbations. This approach can thus be used to identify automatically, from microarray time series alone, the presence of external perturbations or the succession of developmental stages in arbitrary cell systems. Moreover, our results show that there is a striking similarity between the gene expression responses to these a priori very different phenomena. In contrast, the cell cycle does not involve a perturbation-like phase, but rather continuous gene expression remodeling. Similar analyses were conducted using three other standard distance measures, showing that the one we introduced was superior. Based on these findings, we set up an adapted clustering method that uses this distance measure and classifies the genes on the basis of their expression profiles within each developmental stage or between perturbation phases.	[Rooman, Marianne; Albert, Jaroslav; Dehouck, Yves; Haye, Alexandre] Univ Libre Bruxelles, BioSyst BioModeling & BioProc Dept, Brussels, Belgium; [Dehouck, Yves] Fritz Haber Inst Max Planck Gesell, Complex Syst Grp, Berlin, Germany	Universite Libre de Bruxelles; Max Planck Society; Fritz Haber Institute of the Max Planck Society	Rooman, M (corresponding author), Univ Libre Bruxelles, BioSyst BioModeling & BioProc Dept, Brussels, Belgium.	mrooman@ulb.ac.be		Dehouck, Yves/0000-0002-7401-104X	Belgian State Science Policy Office	Belgian State Science Policy Office(Belgian Federal Science Policy Office)	This work was supported by the Belgian State Science Policy Office through an Interuniversity Attraction Poles Program (DYSCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Azumi K, 2007, DEV BIOL, V308, P572, DOI 10.1016/j.ydbio.2007.05.022; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BROADIE KS, 1993, J NEUROSCI, V13, P167; CAMPOSORTEGA JA, EMBRYONIC DEV DROSOP; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kauffman S.A., 1993, ORIGINS ORDER; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Mariani TJ, 2002, AM J RESP CELL MOL, V26, P541, DOI 10.1165/ajrcmb.26.5.2001-00080c; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stein T, 2004, BREAST CANCER RES, V6, pR75, DOI 10.1186/bcr753; Zhao WT, 2006, BIOINFORMATICS, V22, P2129, DOI 10.1093/bioinformatics/btl364	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27948	10.1371/journal.pone.0027948	http://dx.doi.org/10.1371/journal.pone.0027948			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194799	Green Published, gold, Green Submitted			2022-12-27	WOS:000298370400007
J	Deeg, CA; Eberhardt, C; Hofmaier, F; Amann, B; Hauck, SM				Deeg, Cornelia A.; Eberhardt, Christina; Hofmaier, Florian; Amann, Barbara; Hauck, Stefanie M.			Osteopontin and Fibronectin Levels Are Decreased in Vitreous of Autoimmune Uveitis and Retinal Expression of Both Proteins Indicates ECM Re-Modeling	PLOS ONE			English	Article							EQUINE RECURRENT UVEITIS; EXTRACELLULAR-MATRIX; PIGMENT EPITHELIUM; MULLER CELLS; AUTOANTIGENS; MEMBRANE; NEUROPROTECTION; ADHESION; LAMININ; TISSUE	Autoimmune uveitis is an intraocular inflammation that arises through autoreactive T-cells attacking the inner eye, eventually leading to blindness. However, the contributing molecular pathomechanisms within the affected tissues remain as yet elusive. The extracellular matrix (ECM) is a highly dynamic structure that varies tremendously and influences the encompassing tissue. In order to assess ECM re-modeling in autoimmune uveitis, we investigated the expression of ECM molecules fibronectin and osteopontin in vitreous and retina samples. This was carried out in the only spontaneous animal model for human autoimmue uveitis, namely equine recurrent uveitis (ERU) that resembles the human disease in clinical as well as in immunopathological aspects. ERU is a naturally occurring autoimmune disease in horses that develops frequently and has already proved its value to study disease-related pathomechanisms. Western blot analysis of fibronectin and osteopontin in healthy and uveitic vitreous revealed significant reduction of both proteins in uveitis. Immunohistochemical expression of fibronectin in healthy retinas was restricted to the inner limiting membrane abutting vimentin positive Muller cell endfeet, while in uveitic sections, a disintegration of the ILM was observed changing the fibronectin expression to a dispersed pattern extending toward the vitreous. Retinal expression of osteopontin in control tissue was found in a characteristic Muller cell pattern illustrated by co-localization with vimentin. In uveitic retinas, the immunoreactivity of osteopontin in gliotic Muller cells was almost absent. The ability of Muller cells to express fibronectin and osteopontin was additionally shown by immunocytochemistry of primary cultured equine Muller cells and the equine Muller cell line eqMC-7. In conclusion, severe ECM re-modeling in autoimmune uveitis reported here, might affect the adhesive function of fibronectin and thus the anchoring of Muller cell endfeet to the ILM. Furthermore, the absence of osteopontin in gliotic Muller cells might represent reduced neuroprotection, an osteopontin attribute that is intensively discussed.	[Deeg, Cornelia A.; Eberhardt, Christina; Hofmaier, Florian; Amann, Barbara] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Hauck, Stefanie M.] German Res Ctr Environm Hlth GmbH, Res Unit Prot Sci, Helmholtz Zentrum Munchen, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Deeg, CA (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	deeg@tiph.vetmed.uni-muenchen.de	Deeg, Cornelia A/G-4940-2010; Hauck, Stefanie/B-3300-2013; Deeg, Cornelia/U-4216-2019; Eberhardt, Christina/AAS-4593-2020	Deeg, Cornelia A/0000-0003-0375-3190; Hauck, Stefanie/0000-0002-1630-6827; Eberhardt, Christina/0000-0002-8133-2116	Deutsche Forschungsgemeinschaft (DFG) [SFB 571/A5 Deeg, DE 719/2-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (http://www.dfg.de) SFB 571/A5 Deeg and DFG DE 719/2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; Chen WQ, 2011, STROKE, V42, P764, DOI 10.1161/STROKEAHA.110.599118; Chen W, 2009, CURR EYE RES, V34, P1057, DOI 10.3109/02713680903308487; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; CHOWDHURY UR, 2011, INVEST OPHTHALMOL VI; Deeg CA, 2002, EXP EYE RES, V75, P127, DOI 10.1006/exer.2002.2011; Deeg CA, 2001, INVEST OPHTH VIS SCI, V42, P393; Deeg CA, 2008, OPHTHAL RES, V40, P151, DOI 10.1159/000119867; Deeg CA, 2007, MOL IMMUNOL, V44, P3291, DOI 10.1016/j.molimm.2007.02.027; Deeg CA, 2007, PROTEOMICS, V7, P1540, DOI 10.1002/pmic.200600795; Deeg CA, 2006, MOL CELL PROTEOMICS, V5, P1462, DOI 10.1074/mcp.M500352-MCP200; Deeg CA, 2009, VET IMMUNOL IMMUNOP, V128, P132, DOI 10.1016/j.vetimm.2008.10.302; Deeg CA, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/39245; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Dunkle ET, 2007, EXP EYE RES, V84, P707, DOI 10.1016/j.exer.2006.12.014; Eberhardt C, 2012, J ANIM PHYSIOL AN N, V96, P260, DOI 10.1111/j.1439-0396.2011.01147.x; Eberhardt C, 2011, GLIA, V59, P697, DOI 10.1002/glia.21139; Ehrenhofer MCA, 2002, VET OPHTHALMOL, V5, P39, DOI 10.1046/j.1463-5224.2002.00210.x; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Franze K, 2007, P NATL ACAD SCI USA, V104, P8287, DOI 10.1073/pnas.0611180104; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Hauck SM, 2007, J PROTEOME RES, V6, P2121, DOI 10.1021/pr060668y; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Hikita ST, 2006, INVEST OPHTH VIS SCI, V47, P4435, DOI 10.1167/iovs.06-0064; HISCOTT P, 1992, CELL TISSUE RES, V267, P185, DOI 10.1007/BF00318703; Ho TC, 1997, INVEST OPHTH VIS SCI, V38, P1110; Hofmaier F, 2011, INVEST OPHTH VIS SCI, V52, P2314, DOI 10.1167/iovs.10-6475; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Iwata D, 2010, EXP EYE RES, V90, P41, DOI 10.1016/j.exer.2009.09.008; Kase S, 2007, OPHTHAL RES, V39, P143, DOI 10.1159/000102936; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kitamura M, 2007, J IMMUNOL, V178, P6567, DOI 10.4049/jimmunol.178.10.6567; KOHNO T, 1987, INVEST OPHTH VIS SCI, V28, P506; Kunii Y, 2009, MED MOL MORPHOL, V42, P155, DOI 10.1007/s00795-009-0459-6; Ljubimov AV, 1996, J HISTOCHEM CYTOCHEM, V44, P1469, DOI 10.1177/44.12.8985139; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; NUSSENBLATT RB, 1990, INT OPHTHALMOL, V14, P303, DOI 10.1007/BF00163549; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Roehlecke C, 2009, MOL VIS, V15, P1929; Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; SEILER MJ, 1995, CURR EYE RES, V14, P199, DOI 10.3109/02713689509033515; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stocks SZ, 1999, AUST NZ J OPHTHALMOL, V27, P247, DOI 10.1046/j.1440-1606.1999.00199.x; Sugitani Hideki, 2003, J Atheroscler Thromb, V10, P48; Tezel TH, 2004, INVEST OPHTH VIS SCI, V45, P3337, DOI 10.1167/iovs.04-0193; Uede T, 2011, PATHOL INT, V61, P265, DOI 10.1111/j.1440-1827.2011.02649.x; UGA S, 1973, INVEST OPHTH VISUAL, V12, P295; Wang XL, 2009, CELL MOL NEUROBIOL, V29, P549, DOI 10.1007/s10571-009-9346-x; Zipplies JK, 2009, J PROTEOME RES, V8, P992, DOI 10.1021/pr800694y	56	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27674	10.1371/journal.pone.0027674	http://dx.doi.org/10.1371/journal.pone.0027674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194789	Green Published, gold, Green Submitted			2022-12-27	WOS:000298369100009
J	Mihoub, JB; Robert, A; Le Gouar, P; Sarrazin, F				Mihoub, Jean-Baptiste; Robert, Alexandre; Le Gouar, Pascaline; Sarrazin, Francois			Post-Release Dispersal in Animal Translocations: Social Attraction and the "Vacuum Effect"	PLOS ONE			English	Article							BREEDING HABITAT SELECTION; EASTERN NORTH-AMERICA; METAPOPULATION DYNAMICS; CONSPECIFIC ATTRACTION; PUBLIC INFORMATION; DENSITY-DEPENDENCE; GYPS-FULVUS; WILD DOGS; POPULATION; REINTRODUCTION	Animal translocations are human-induced colonizations that can represent opportunities to contribute to the knowledge on the behavioral and demographic processes involved in the establishment of animal populations. Habitat selection behaviors, such as social cueing, have strong implications on dispersal and affect the establishment success of translocations. Using modeling simulations with a two-population network model (a translocated population and a remnant population), we investigated the consequences of four habitat selection strategies on post-translocation establishment probabilities in short-and long-lived species. Two dispersal strategies using social cues (conspecific attraction and habitat copying) were compared to random and quality-based strategies. We measured the sensitivity of local extinctions to dispersal strategies, life cycles, release frequencies, remnant population and release group sizes, the proportion of breeders and the connectivity between populations. Our results indicate that social behaviors can compromise establishment as a result of post-release dispersal, particularly in long-lived species. This behavioral mechanism, the "vacuum effect", arises from increased emigration in populations that are small relative to neighboring populations, reducing their rate of population growth. The vacuum effect can drive small remnant populations to extinction when a translocated group is large. In addition, the magnitude of the vacuum effect varies non-linearly with connectivity. The vacuum effect represents a novel form of the behaviorally mediated Allee effect that can cause unexpected establishment failures or population extinctions in response to social cueing. Accounting for establishment probabilities as a conditional step to the persistence of populations would improve the accuracy of predicting the fates of translocated or natural (meta) populations.	[Mihoub, Jean-Baptiste; Robert, Alexandre; Sarrazin, Francois] UPMC, CNRS, UMR MNHN 7204, Paris, France; [Le Gouar, Pascaline] Univ Rennes 1, CNRS, UMR Ecobio 6553, Paimpont, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Mihoub, JB (corresponding author), UPMC, CNRS, UMR MNHN 7204, Paris, France.	mihoub@mnhn.fr	Mihoub, Jb/B-7708-2015; Sarrazin, Francois/B-7593-2013; Sarrazin, François/AAB-4227-2019; Le Gouar, Pascaline/A-6209-2010	Mihoub, Jb/0000-0002-5354-850X; Sarrazin, Francois/0000-0001-5901-4819; Sarrazin, François/0000-0001-5901-4819; Le Gouar, Pascaline/0000-0001-5309-3667	French Ministries of Research and of Ecology	French Ministries of Research and of Ecology	French Ministries of Research and of Ecology provided fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; BERGERUD AT, 1989, WILDLIFE SOC B, V17, P111; Bessa-Gomes C, 2004, ECOL LETT, V7, P802, DOI 10.1111/j.1461-0248.2004.00632.x; Bielby J, 2007, AM NAT, V169, P748, DOI 10.1086/516847; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Burns CE, 2005, BEHAV ECOL, V16, P898, DOI 10.1093/beheco/ari070; Caswell, 2000, MATRIX POPULATION MO; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Dickens MJ, 2009, ANIM CONSERV, V12, P418, DOI 10.1111/j.1469-1795.2009.00265.x; Dolev A, 2002, J WILDLIFE MANAGE, V66, P737, DOI 10.2307/3803139; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Fieberg J, 2001, ECOL LETT, V4, P244, DOI 10.1046/j.1461-0248.2001.00202.x; Fletcher RJ, 2006, AM NAT, V168, P207, DOI 10.1086/505764; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gerber LR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012230; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2009, BIOL CONSERV, V142, P2774, DOI 10.1016/j.biocon.2009.07.007; HANSKI I, 1997, METAPOPULATION BIOL; Hanski Ilkka, 1997, P69, DOI 10.1016/B978-012323445-2/50007-9; Kokko H, 2001, EVOL ECOL RES, V3, P537; Le Gouar P, 2008, ECOL APPL, V18, P859, DOI 10.1890/07-0854.1; Legendre S, 1999, AM NAT, V153, P449, DOI 10.1086/303195; LEGOUAR P, REINTRODUCT IN PRESS; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; McPeek MA, 2001, OIKOS, V94, P417, DOI 10.1034/j.1600-0706.2001.940304.x; Mihoub JB, 2009, OIKOS, V118, P663, DOI 10.1111/j.1600-0706.2008.17142.x; Moller AP., 1994, SEXUAL SELECTION BAR; Nocera JJ, 2009, ECOGRAPHY, V32, P143, DOI 10.1111/j.1600-0587.2008.05614.x; Oro D, 2011, BIOL CONSERV, V144, P851, DOI 10.1016/j.biocon.2010.11.018; RAY C, 1991, BIOL J LINN SOC, V42, P123, DOI 10.1111/j.1095-8312.1991.tb00555.x; Reed JM, 2005, ECOL MODEL, V183, P411, DOI 10.1016/j.ecolmodel.2004.02.025; Reinert HK, 1999, J HERPETOL, V33, P45, DOI 10.2307/1565542; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Robert A, 2009, OIKOS, V118, P1590, DOI 10.1111/j.1600-0706.2009.17818.x; Russell JC, 2010, ANIM BEHAV, V79, P159, DOI 10.1016/j.anbehav.2009.10.020; Sarrazin F, 1996, TRENDS ECOL EVOL, V11, P474, DOI 10.1016/0169-5347(96)20092-8; Sarrazin F, 2000, CONSERV BIOL, V14, P488, DOI 10.1046/j.1523-1739.2000.97305.x; SARRAZIN F, 1994, AUK, V111, P853; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Somers MJ, 2008, OECOLOGIA, V158, P239, DOI 10.1007/s00442-008-1134-7; Stamps JA, 2007, APPL ANIM BEHAV SCI, V102, P392, DOI 10.1016/j.applanim.2006.05.038; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stoen OG, 2009, ORYX, V43, P580, DOI 10.1017/S0030605309990202; Tavecchia G, 2009, BIOL CONSERV, V142, P3005, DOI 10.1016/j.biocon.2009.07.035; van Heezik Y, 2009, ORYX, V43, P639, DOI 10.1017/S0030605309990081; Veit RR, 1996, AM NAT, V148, P255, DOI 10.1086/285924; Vuilleumier S, 2007, THEOR POPUL BIOL, V72, P77, DOI 10.1016/j.tpb.2006.11.001; Weilenmann M, 2010, WILDLIFE RES, V37, P702, DOI 10.1071/WR10013	51	39	39	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27453	10.1371/journal.pone.0027453	http://dx.doi.org/10.1371/journal.pone.0027453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194784	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100005
J	Schloss, PD; Gevers, D; Westcott, SL				Schloss, Patrick D.; Gevers, Dirk; Westcott, Sarah L.			Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies	PLOS ONE			English	Article							HUMAN MICROBIOME PROJECT; RARE BIOSPHERE; CLONE LIBRARIES; DIVERSITY; GENES; BIAS; IDENTIFICATION; WRINKLES; QUALITY; SAMPLE	The advent of next generation sequencing has coincided with a growth in interest in using these approaches to better understand the role of the structure and function of the microbial communities in human, animal, and environmental health. Yet, use of next generation sequencing to perform 16S rRNA gene sequence surveys has resulted in considerable controversy surrounding the effects of sequencing errors on downstream analyses. We analyzed 2.7x10(6) reads distributed among 90 identical mock community samples, which were collections of genomic DNA from 21 different species with known 16S rRNA gene sequences; we observed an average error rate of 0.0060. To improve this error rate, we evaluated numerous methods of identifying bad sequence reads, identifying regions within reads of poor quality, and correcting base calls and were able to reduce the overall error rate to 0.0002. Implementation of the PyroNoise algorithm provided the best combination of error rate, sequence length, and number of sequences. Perhaps more problematic than sequencing errors was the presence of chimeras generated during PCR. Because we knew the true sequences within the mock community and the chimeras they could form, we identified 8% of the raw sequence reads as chimeric. After quality filtering the raw sequences and using the Uchime chimera detection program, the overall chimera rate decreased to 1%. The chimeras that could not be detected were largely responsible for the identification of spurious operational taxonomic units (OTUs) and genus-level phylotypes. The number of spurious OTUs and phylotypes increased with sequencing effort indicating that comparison of communities should be made using an equal number of sequences. Finally, we applied our improved quality-filtering pipeline to several benchmarking studies and observed that even with our stringent data curation pipeline, biases in the data generation pipeline and batch effects were observed that could potentially confound the interpretation of microbial community data.	[Schloss, Patrick D.; Westcott, Sarah L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gevers, Dirk] Broad Inst MIT & Harvard, Genome Sequencing & Anal Program, Cambridge, MA USA	University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	pschloss@umich.edu	Gevers, Dirk/C-1451-2009	Schloss, Patrick/0000-0002-6935-4275	National Institutes for Health [1R01HG005975-01, NIHU54HG004969]; National Science Foundation [0743432]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004969, R01HG005975] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	PDS and SLW were supported by grants from the National Institutes for Health (1R01HG005975-01) and National Science Foundation (award #0743432), and DG was supported by a grant from the National Institutes for Health (NIHU54HG004969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chandler DP, 1997, MOL ECOL, V6, P475, DOI 10.1046/j.1365-294X.1997.00205.x; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAENEL H, 1959, Z Kinderheilkd, V82, P595, DOI 10.1007/BF00444718; Hansen MC, 1998, FEMS MICROBIOL ECOL, V26, P141, DOI 10.1016/S0168-6496(98)00031-2; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Magurran A.E., 2004, MEASURING BIOL DIVER; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; PACE NR, 1985, ASM NEWS, V51, P4; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	42	1564	1696	4	358	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27310	10.1371/journal.pone.0027310	http://dx.doi.org/10.1371/journal.pone.0027310			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194782	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100004
J	Elbez, R; McNaughton, BH; Patel, L; Pienta, KJ; Kopelman, R				Elbez, Remy; McNaughton, Brandon H.; Patel, Lalit; Pienta, Kenneth J.; Kopelman, Raoul			Nanoparticle Induced Cell Magneto-Rotation: Monitoring Morphology, Stress and Drug Sensitivity of a Suspended Single Cancer Cell	PLOS ONE			English	Article							IRON-OXIDE NANOPARTICLES; MICROPARTICLE; MECHANISMS; EXPRESSION; DYNAMICS; CULTURE	Single cell analysis has allowed critical discoveries in drug testing, immunobiology and stem cell research. In addition, a change from two to three dimensional growth conditions radically affects cell behavior. This already resulted in new observations on gene expression and communication networks and in better predictions of cell responses to their environment. However, it is still difficult to study the size and shape of single cells that are freely suspended, where morphological changes are highly significant. Described here is a new method for quantitative real time monitoring of cell size and morphology, on single live suspended cancer cells, unconfined in three dimensions. The precision is comparable to that of the best optical microscopes, but, in contrast, there is no need for confining the cell to the imaging plane. The here first introduced cell magnetorotation (CM) method is made possible by nanoparticle induced cell magnetization. By using a rotating magnetic field, the magnetically labeled cell is actively rotated, and the rotational period is measured in real-time. A change in morphology induces a change in the rotational period of the suspended cell (e.g. when the cell gets bigger it rotates slower). The ability to monitor, in real time, cell swelling or death, at the single cell level, is demonstrated. This method could thus be used for multiplexed real time single cell morphology analysis, with implications for drug testing, drug discovery, genomics and three-dimensional culturing.	[Elbez, Remy; McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Appl Phys, Ann Arbor, MI 48109 USA; [McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Patel, Lalit; Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Pienta, Kenneth J.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Elbez, Remy; McNaughton, Brandon H.; Kopelman, Raoul] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Elbez, R (corresponding author), Univ Michigan, Dept Appl Phys, Ann Arbor, MI 48109 USA.	kopelman@umich.edu	McNaughton, Brandon/H-2593-2012; Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186; Patel, Lalit/0000-0002-9064-5560	National Institutes of Health [NIH-R01-EB007977, NIH-R33CA125297-03S1, NIH-R21EB009550]; NATIONAL CANCER INSTITUTE [R33CA125297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009550, R01EB007977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health (NIH-R01-EB007977 (RK), NIH-R33CA125297-03S1 (RK) and NIH-R21EB009550 (RK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Bertorelle F, 2006, LANGMUIR, V22, P5385, DOI 10.1021/la052710u; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Gfeller KY, 2005, APPL ENVIRON MICROB, V71, P2626, DOI 10.1128/AEM.71.5.2626-2631.2005; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Ho VHB, 2009, EXP BIOL MED, V234, P332, DOI 10.3181/0809-RM-273; Hsieh HB, 2006, BIOSENS BIOELECTRON, V21, P1893, DOI 10.1016/j.bios.2005.12.024; Janssen XJA, 2009, BIOSENS BIOELECTRON, V24, P1937, DOI 10.1016/j.bios.2008.09.024; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Markx GH, 1999, ENZYME MICROB TECH, V25, P161, DOI 10.1016/S0141-0229(99)00008-3; MCMANUS M, 1993, AM J PHYSIOL, V265, pC562, DOI 10.1152/ajpcell.1993.265.2.C562; McNaughton BH, 2007, SENSOR ACTUAT B-CHEM, V121, P330, DOI 10.1016/j.snb.2006.09.043; McNaughton BH, 2006, J PHYS CHEM B, V110, P18958, DOI 10.1021/jp060139h; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Ramser K, 2010, J BIOPHOTONICS, V3, P187, DOI 10.1002/jbio.200910050; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Souza GR, 2010, NAT NANOTECHNOL, V5, P291, DOI 10.1038/nnano.2010.23; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Valet G, 2006, DRUG DISCOV TODAY, V11, P785, DOI 10.1016/j.drudis.2006.07.003; Villanueva A, 2010, J PHYS CHEM C, V114, P1976, DOI 10.1021/jp907046f; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilhelm C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.061908; Wilhelm C, 2008, BIOMATERIALS, V29, P3161, DOI 10.1016/j.biomaterials.2008.04.016; Wilhelm C, 2009, J MAGN MAGN MATER, V321, P671, DOI 10.1016/j.jmmm.2008.11.022; Yu MK, 2008, ANGEW CHEM INT EDIT, V47, P5362, DOI 10.1002/anie.200800857; Zhang H, 2008, J R SOC INTERFACE, V5, P671, DOI 10.1098/rsif.2008.0052	36	30	35	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28475	10.1371/journal.pone.0028475	http://dx.doi.org/10.1371/journal.pone.0028475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180784	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300012
J	Mapelli, D; Bardi, L; Mojoli, M; Volpe, B; Gerosa, G; Amodio, P; Daliento, L				Mapelli, Daniela; Bardi, Lara; Mojoli, Marco; Volpe, Biancarosa; Gerosa, Gino; Amodio, Piero; Daliento, Luciano			Neuropsychological Profile in a Large Group of Heart Transplant Candidates	PLOS ONE			English	Article							MINI-MENTAL-STATE; CARDIAC TRANSPLANTATION; COGNITIVE IMPAIRMENT; FAILURE; NEUROPATHOLOGY; ABNORMALITIES; DISEASE; AGE	Background: Recent studies have reported that patients with end-stage heart disease can have cognitive deficits ranging from mild to severe. Little is known, however, about the relationship between cognitive performance, neurophysiological characteristics and relevant clinical and instrumental indexes for an extensive evaluation of patients with heart failure, such as: left ventricular ejection fraction (LVEF) and other haemodynamic measures, maximum oxygen uptake during cardiopulmonary exercise testing, comorbidities, major cardiovascular risk factors and disease duration. Our purpose was to outline the cognitive profiles of end-stage heart disease patients in order to identify the cognitive deficits that could compromise the quality of life and the therapeutic adherence in end-stage heart disease patients, and to identify the variables associated with an increased risk of cognitive deficits in these patients. Methods: 207 patients with end-stage cardiac disease, candidates for heart transplant, were assessed by complete neuropsychological evaluation and by electroencephalographic recording with EEG spectral analysis. Results: Pathological scores in one or more of the cognitive tests were obtained by 86% of the patients, while 36% performed within the impaired range on five or more tests, indicating poor performance across a broad range of cognitive domains. The executive functions were the cognitive domain most impaired (70%). Poor performances were not related to the aetiology of heart disease, but rather to cerebral dysfunction secondary to haemodynamic impairment and to comorbidities. Conclusions: Severe heart failure induces significant neurophysiological and neuropsychological alterations, which may produce an impairment of cognitive functioning and possibly compromise the quality of life of patients and the therapeutic adherence.	[Mapelli, Daniela; Bardi, Lara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Mapelli, Daniela; Amodio, Piero; Daliento, Luciano] Univ Padua, Interdept Ctr Res Modelling Neuropsychol Disorder, Padua, Italy; [Mojoli, Marco; Volpe, Biancarosa; Gerosa, Gino; Daliento, Luciano] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Padua, Italy; [Amodio, Piero] Univ Padua, Dept Clin & Expt Med, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua	Mapelli, D (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	daniela.mapelli@unipd.it	Gerosa, Gino/M-8106-2014; volpe, b/U-8409-2019	Gerosa, Gino/0000-0002-6261-699X; Bardi, Lara/0000-0002-1678-647X; MAPELLI, DANIELA/0000-0003-2168-1426; Mojoli, Marco/0000-0002-6851-5946; Amodio, Piero/0000-0002-2395-7599	Ministry of Education of the Italian government	Ministry of Education of the Italian government	The study was funded by the Ministry of Education of the Italian government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 1999, CLIN NEUROPHYSIOL, V110, P1334, DOI 10.1016/S1388-2457(99)00076-0; ANG LC, 1989, CAN J NEUROL SCI, V16, P291, DOI 10.1017/S0317167100029115; [Anonymous], 1977, LANCET, V1, P27; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett Susan J, 2003, J Cardiovasc Nurs, V18, P219; BORNSTEIN RA, 1995, ACTA NEUROL SCAND, V91, P260, DOI 10.1111/j.1600-0404.1995.tb07001.x; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Butcher J., 1989, MMPI 2 MANUAL; Cohen RA, 2009, J CLIN EXP NEUROPSYC, V31, P96, DOI 10.1080/13803390802014594; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Deshields TL, 1996, GEN HOSP PSYCHIAT, V18, pS62; Fahlander K, 2000, J GERONTOL B-PSYCHOL, V55, pP259, DOI 10.1093/geronb/55.5.P259; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Lee CW, 1999, J AM COLL CARDIOL, V33, P1196, DOI 10.1016/S0735-1097(98)00701-3; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; McDonald-Miszczak L, 2009, J APPL GERONTOL, V28, P560, DOI 10.1177/0733464808330821; Mondini S., 2003, ENB ESAME NEUROPSICO; MONTERO CG, 1986, NEUROLOGY, V36, P1149, DOI 10.1212/WNL.36.9.1149; Moscovitch Morris, 1994, P269; Niedermeyer E., 2011, NIEDERMEYERS ELECTRO, V6; Putzke JD, 1997, J CLIN PSYCHOL MED S, V4, P343, DOI 10.1023/A:1026293517271; Putzke JD, 2000, J CLIN EXP NEUROPSYC, V22, P95, DOI 10.1076/1380-3395(200002)22:1;1-8;FT095; Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016; SCHALL RR, 1989, J AM COLL CARDIOL, V14, P1666; Schillerstrom JE, 2005, PSYCHOSOMATICS, V46, P508, DOI 10.1176/appi.psy.46.6.508; SPINNLER M, 1987, ITAL J NEUROL SCI S8; Trojano L, 2003, J NEUROL, V250, P1456, DOI 10.1007/s00415-003-0249-3; Verhaeghen P, 2003, HEALTH PSYCHOL, V22, P559, DOI 10.1037/0278-6133.22.6.559; Vogels RLC, 2007, EUR J HEART FAIL, V9, P1003, DOI 10.1016/j.ejheart.2007.07.006; Vogels RLC, 2007, EUR J HEART FAIL, V9, P440, DOI 10.1016/j.ejheart.2006.11.001; Wang HL, 2004, NEUROBIOL AGING, V25, pS279, DOI 10.1016/S0197-4580(04)80929-1	34	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28313	10.1371/journal.pone.0028313	http://dx.doi.org/10.1371/journal.pone.0028313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22180780	Green Submitted, Green Published, gold			2022-12-27	WOS:000298367300008
J	Teare, MD; Pinyakorn, S; Heighway, J; Koref, MFS				Teare, Marion Dawn; Pinyakorn, Suteeraporn; Heighway, James; Koref, Mauro F. Santibanez			Comparing Methods for Mapping cis Acting Polymorphisms Using Allelic Expression Ratios	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; IMBALANCE; LIGATION; TISSUE; CELLS	Genome wide association studies frequently reveal associations between disease susceptibility and polymorphisms outside coding regions. Such associations cannot always be explained by linkage disequilibrium with changes affecting the transcription products. This has stimulated the interest in characterising sequence variation influencing gene expression levels, in particular in changes acting in cis. Differences in transcription between the two alleles at an autosomal locus can be used to test the association between candidate polymorphisms and the modulation of gene expression in cis. This type of approach requires at least one transcribed polymorphism and one candidate polymorphism. In the past five years, different methods have been proposed to analyse such data. Here we use simulations and real data sets to compare the power of some of these methods. The results show that when it is not possible to determine the phase between the transcribed and potentially cis acting allele there is some advantage in using methods that estimate phased genotype and effect on expression simultaneously. However when the phase can be determined, simple regression models seem preferable because of their simplicity and flexibility. The simulations and the analysis of experimental data suggest that in the majority of situations, methods that assume a lognormal distribution of the allelic expression ratios are both robust to deviations from this assumption and more powerful than alternatives that do not make these assumptions.	[Teare, Marion Dawn; Pinyakorn, Suteeraporn] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Pinyakorn, Suteeraporn] HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Heighway, James] Canc Commun & Consultancy Ltd, Knutsford, Cheshire, England; [Koref, Mauro F. Santibanez] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England	University of Sheffield; Newcastle University - UK	Teare, MD (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	m.d.teare@sheffield.ac.uk		Teare, Marion Dawn/0000-0003-3994-0051	Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Rajvithi Road, Rajthevi, Bangkok Thailand	Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Rajvithi Road, Rajthevi, Bangkok Thailand	University of Sheffield (www.shef.ac.uk). University of Newcastle (www.ncl.ac.uk). SP was funded by a scholarship from the Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Road, Rajthevi, Bangkok 10400 Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUONOCORE F, 2010, HUM MOL GENET; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; Chen XW, 2008, HUM MOL GENET, V17, P1336, DOI 10.1093/hmg/ddn022; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Cheung VG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000480; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Curia MC, 1999, CANCER RES, V59, P3570; DING C, 2003, P NATL ACAD SCI US; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heap GA, 2009, HUM MOL GENET, V18, pR101, DOI [10.1093/hmg/ddp001, 10.1093/hmg/ddp473]; Heighway J, 2005, ANN HUM GENET, V69, P127, DOI 10.1046/j.1529-8817.2004.00135.x; Higasa K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000468; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Loh AX, 2010, ANN HUM GENET, V74, P498, DOI 10.1111/j.1469-1809.2010.00613.x; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Mei MX, 2010, CANCER EPIDEMIOL, V34, P93, DOI 10.1016/j.canep.2009.12.009; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Parker-Katiraee L, 2008, HUM MOL GENET, V17, P3263, DOI 10.1093/hmg/ddn222; Rutter JL, 1998, CANCER RES, V58, P5321; Santibanez Koref M, 2010, ANN HUM GENET, V74, P479, DOI 10.1111/j.1469-1809.2010.00603.x; Schneider M, 2009, CLIN CHIM ACTA, V402, P47, DOI 10.1016/j.cca.2008.12.017; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Stewart J, 1998, NUCLEIC ACIDS RES, V26, P961, DOI 10.1093/nar/26.4.961; Tan AC, 2008, CANCER BIOL THER, V7, P137, DOI 10.4161/cbt.7.1.5199; Tao H, 2006, PLOS GENET, V2, P848, DOI 10.1371/journal.pgen.0020093; Teare MD, 2006, AM J HUM GENET, V79, P539, DOI 10.1086/506968; Tomsic J, 2010, CARCINOGENESIS, V31, P1800, DOI 10.1093/carcin/bgq165; Tournier I, 2004, HUM MUTAT, V23, P379, DOI 10.1002/humu.20008; Wilkins JM, 2007, HUM MOL GENET, V16, P537, DOI 10.1093/hmg/ddl488; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28636	10.1371/journal.pone.0028636	http://dx.doi.org/10.1371/journal.pone.0028636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174852	Green Published, gold, Green Accepted			2022-12-27	WOS:000298367300015
J	Gil-Ranedo, J; Mendiburu-Elicabe, M; Garcia-Villanueva, M; Medina, D; del Alamo, M; Izquierdo, M				Gil-Ranedo, Jon; Mendiburu-Elicabe, Marina; Garcia-Villanueva, Mercedes; Medina, Diego; del Alamo, Marta; Izquierdo, Marta			An Off-Target Nucleostemin RNAi Inhibits Growth in Human Glioblastoma-Derived Cancer Stem Cells	PLOS ONE			English	Article							CYCLE ARREST; PROSPECTIVE IDENTIFICATION; GENE-EXPRESSION; PROSTATE-CANCER; KNOCKING-DOWN; BRAIN; PROLIFERATION; TRANSPLANTATION; SUBPOPULATION; MODELS	Glioblastomas (GBM) may contain a variable proportion of active cancer stem cells (CSCs) capable of self-renewal, of aggregating into CD133(+) neurospheres, and to develop intracranial tumors that phenocopy the original ones. We hypothesized that nucleostemin may contribute to cancer stem cell biology as these cells share characteristics with normal stem cells. Here we report that nucleostemin is expressed in GBM-CSCs isolated from patient samples, and that its expression, conversely to what it has been described for ordinary stem cells, does not disappear when cells are differentiated. The significance of nucleostemin expression in CSCs was addressed by targeting the corresponding mRNA using lentivirally transduced short hairpin RNA (shRNA). In doing so, we found an off-target nucleostemin RNAi (shRNA22) that abolishes proliferation and induces apoptosis in GBM-CSCs. Furthermore, in the presence of shRNA22, GBM-CSCs failed to form neurospheres in vitro or grow on soft agar. When these cells are xenotransplanted into the brains of nude rats, tumor development is significantly delayed. Attempts were made to identify the primary target/s of shRNA22, suggesting a transcription factor involved in one of the MAP-kinases signaling-pathways or multiple targets. The use of this shRNA may contribute to develop new therapeutic approaches for this incurable type of brain tumor.	[Gil-Ranedo, Jon; Mendiburu-Elicabe, Marina; Izquierdo, Marta] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Inst Sanitario Ramon y Cajal,CSIC, Madrid, Spain; [Garcia-Villanueva, Mercedes] Hosp Univ Ramon y Cajal, Serv Anat Patol, Madrid, Spain; [Medina, Diego; del Alamo, Marta] Hosp Univ Ramon y Cajal, Serv Neurocirugia, Inst Sanitario Ramon y Cajal, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Gil-Ranedo, J (corresponding author), Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa, Inst Sanitario Ramon y Cajal,CSIC, Madrid, Spain.	mizquierdo@cbm.uam.es		Mendiburu-Elicabe, Marina/0000-0003-2573-8709; Gil-Ranedo, Jon/0000-0002-7365-3411	Ministerio de Ciencia e Innovacion Spain [SAF 2009-07259]; Fundacion Eugenio Rodriguez Pascual (Madrid); Ramon Areces Foundation; Gobierno Vasco, Spain	Ministerio de Ciencia e Innovacion Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Eugenio Rodriguez Pascual (Madrid); Ramon Areces Foundation; Gobierno Vasco, Spain(Basque Government)	This work was supported by funds from: Ministerio de Ciencia e Innovacion (SAF 2009-07259) Spain, and Fundacion Eugenio Rodriguez Pascual (Madrid). The Centro de Biologia Molecular S.O. is also the recipient of an institutional grant from the Ramon Areces Foundation. JG-R was the recipient of a predoctoral fellowship from the Gobierno Vasco, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, DOI 10.1038/nrc2419-c2; Beekman C, 2006, MOL CELL BIOL, V26, P9291, DOI 10.1128/MCB.01183-06; Charles N, 2009, EXPERT REV NEUROTHER, V9, P1447, DOI 10.1586/ERN.09.91; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; GRUPTA PB, 2009, NAT MED, V15, P1010; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; IRVIN DK, 2010, PLOS ONE, V7, P1; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jafarnejad SM, 2008, CELL PROLIFERAT, V41, P28, DOI 10.1111/j.1365-2184.2007.00505.x; Kafienah W, 2006, STEM CELLS, V24, P1113, DOI 10.1634/stemcells.2005-0416; Kim YW, 2011, NEURO-ONCOLOGY, V13, P367, DOI 10.1093/neuonc/nor012; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lin T, 2010, CANCER RES, V70, P9444, DOI 10.1158/0008-5472.CAN-10-2159; Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu RL, 2008, CHINESE MED J-PEKING, V121, P299, DOI 10.1097/00029330-200802020-00004; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Malakootian M, 2010, MOL CARCINOGEN, V49, P818, DOI 10.1002/mc.20658; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Nomura J, 2009, STEM CELLS, V27, P1066, DOI 10.1002/stem.44; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Schultz N., 2011, SILENCE, V2; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	48	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28753	10.1371/journal.pone.0028753	http://dx.doi.org/10.1371/journal.pone.0028753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174890	Green Published, gold			2022-12-27	WOS:000298366600036
J	Wagner, TU; Fischer, A; Thoma, EC; Schartl, M				Wagner, Toni U.; Fischer, Andreas; Thoma, Eva C.; Schartl, Manfred			CrossQuery: A Web Tool for Easy Associative Querying of Transcriptome Data	PLOS ONE			English	Article							MICROARRAY	Enormous amounts of data are being generated by modern methods such as transcriptome or exome sequencing and microarray profiling. Primary analyses such as quality control, normalization, statistics and mapping are highly complex and need to be performed by specialists. Thereafter, results are handed back to biomedical researchers, who are then confronted with complicated data lists. For rather simple tasks like data filtering, sorting and cross-association there is a need for new tools which can be used by non-specialists. Here, we describe CrossQuery, a web tool that enables straight forward, simple syntax queries to be executed on transcriptome sequencing and microarray datasets. We provide deep-sequencing data sets of stem cell lines derived from the model fish Medaka and microarray data of human endothelial cells. In the example datasets provided, mRNA expression levels, gene, transcript and sample identification numbers, GO-terms and gene descriptions can be freely correlated, filtered and sorted. Queries can be saved for later reuse and results can be exported to standard formats that allow copy-and-paste to all widespread data visualization tools such as Microsoft Excel. CrossQuery enables researchers to quickly and freely work with transcriptome and microarray data sets requiring only minimal computer skills. Furthermore, CrossQuery allows growing association of multiple datasets as long as at least one common point of correlated information, such as transcript identification numbers or GO-terms, is shared between samples. For advanced users, the object-oriented plug-in and event-driven code design of both server-side and client-side scripts allow easy addition of new features, data sources and data types.	[Wagner, Toni U.; Thoma, Eva C.; Schartl, Manfred] Univ Wurzburg, Bioctr, Wurzburg, Germany; [Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim, Heidelberg, Germany; [Fischer, Andreas] German Canc Res Ctr Heidelberg DKFZ ZMBH Alliance, Heidelberg, Germany	University of Wurzburg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Wagner, TU (corresponding author), Univ Wurzburg, Bioctr, Wurzburg, Germany.	toni.wagner@biozentrum.uni-wuerzburg.de		Schartl, Manfred/0000-0001-9882-5948	Deutsche Forschungsgemeinschaft [SFB-TR23, GRK880, GRK1048]; Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT); European Commision [018673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT); European Commision	This work was funded by the Deutsche Forschungsgemeinschaft SFB-TR23, GRK880 (AF), GRK1048, Boehringer Ingelheim Fonds Foundation for Basic Research in Medicine (ECT) and the European Commision 6th Framework Programme (Plurigenes #018673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Battke F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016345; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Dietzsch J, 2006, BIOINFORMATICS, V22, P1010, DOI 10.1093/bioinformatics/btl070; Ding LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013287; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P588, DOI 10.1111/j.1755-148X.2008.00494.x; Hong YH, 1998, P NATL ACAD SCI USA, V95, P3679, DOI 10.1073/pnas.95.7.3679; Hong YH, 2004, P NATL ACAD SCI USA, V101, P8011, DOI 10.1073/pnas.0308668101; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; Kapushesky M, 2004, NUCLEIC ACIDS RES, V32, pW465, DOI 10.1093/nar/gkh470; Rees CA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-141; Saal LH, 2002, GENOME BIOL, V3; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Stavrum Anne Kristin, 2008, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0703s21; Thoma EC, 2011, STEM CELLS DEV, V20, P1425, DOI 10.1089/scd.2010.0290; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28990	10.1371/journal.pone.0028990	http://dx.doi.org/10.1371/journal.pone.0028990			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174941	gold, Green Submitted, Green Published			2022-12-27	WOS:000298366600055
J	Yang, SC; Chang, SS; Chen, CYC				Yang, Shun-Chieh; Chang, Su-Sen; Chen, Calvin Yu-Chian			Identifying HER2 Inhibitors from Natural Products Database	PLOS ONE			English	Article							PROTEIN-TYROSINE KINASES; PYRROLOTRIAZINE DUAL INHIBITORS; METASTATIC BREAST-CANCER; DRUG DESIGN; RECEPTOR; EGFR; EXPRESSION; DISCOVERY; TRASTUZUMAB; LAPATINIB	The relationship between abnormal HER2 expression and cancer is important in cancer therapeutics. Formation and spread of cancer cells may be restricted by inhibiting HER2. We conducted ligand-based and structure-based studies to assess the potency of natural compounds as potential HER2 inhibitors. Multiple linear regression (MLR) and support vector machine (SVM) models were constructed to predict biological activities of natural compounds, and molecular dynamics (MD) was used to assess their stability with HER2 under a dynamic environment. Predicted bioactivities of the natural compounds ranged from 6.014-9.077 using MLR (r(2) = 0.7954) and 5.122-6.950 using SVM (r(2) = 0.8620). Both models were in agreement and suggest bioactivity based on candidate structure. Conformation changes caused by MD favored the formation of stabilizing H-bonds. All candidates had higher stability than Lapinatib, which may be due to the number and spatial distribution of additional H-bonds and hydrophobic interactions. Amino acids Lys724 and Lys736 are critical for binding in HER2, and Thr798, Cys805, and Asp808 are also important for increased stability. Candidates may block the entrance to the ATP binding site located within the inner regions and prevent downstream activation of HER2. Our multidirectional approach indicates that the natural compounds have good ligand efficacy in addition to stable binding affinities to HER2, and should be potent candidates of HER2 inhibitors. With regard to drug design, designing HER2 inhibitors with carboxyl or carbonyl groups available for H-bond formation with Lys724 and Lys736, and benzene groups for hydrophobic contact with Cys805 may improve protein-ligand stability.	[Yang, Shun-Chieh; Chang, Su-Sen; Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Bioinformat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ, Beigang Hosp, Yunlin, Taiwan; [Chen, Calvin Yu-Chian] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Chen, Calvin Yu-Chian] MIT, Cambridge, MA 02139 USA	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Yang, SC (corresponding author), China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan.	ycc929@MIT.EDU	Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0003-3306-250X; Chen, Calvin Yu-Chian/0000-0001-9213-9832	National Science Council of Taiwan [NSC 99-2221-E-039-013-]; Committee on Chinese Medicine and Pharmacy [CCMP100-RD-030]; Asia University [CMU98-TCM, CMU99-TCM, CMU99-S-02, CMU99-ASIA-25, CMU99-ASIA-26, CMU99-ASIA-27, CMU99-ASIA-28]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH100-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH100-TD-C-111-005]; China Medical University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy; Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence; China Medical University(China Medical University)	The research was supported by grants from the National Science Council of Taiwan (NSC 99-2221-E-039-013-), the Committee on Chinese Medicine and Pharmacy (CCMP100-RD-030), the China Medical University and Asia University (CMU98-TCM, CMU99-TCM, CMU99-S-02, CMU99-ASIA-25, CMU99-ASIA-26 CMU99-ASIA-27 CMU99-ASIA-28). This study is also supported in part by the Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004) and the Taiwan Department of Health Cancer Research Center of Excellence (DOH100-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai X, 2010, J MED CHEM, V53, P2000, DOI 10.1021/jm901453q; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen CYC, 2010, J BIOMOL STRUCT DYN, V27, P627, DOI 10.1080/07391102.2010.10508577; Chen CYC, 2009, J MOL GRAPH MODEL, V28, P261, DOI 10.1016/j.jmgm.2009.08.004; Chen CY, 2010, J MOL GRAPH MODEL, V29, P21, DOI 10.1016/j.jmgm.2010.04.002; Chen CY, 2009, ACTA PHARMACOL SIN, V30, P1186, DOI 10.1038/aps.2009.100; Cheng ZY, 2007, BIOORGAN MED CHEM, V15, P1533, DOI 10.1016/j.bmc.2006.09.041; Chiosis G, 2002, BIOORGAN MED CHEM, V10, P3555, DOI 10.1016/S0968-0896(02)00253-5; Chou YS, 2009, J ASIAN NAT PROD RES, V11, P110, DOI 10.1080/02615470802573368; Curran MP, 2010, DRUGS, V70, P1411, DOI 10.2165/11204550-000000000-00000; de Oliveira AN, 2010, EUR J MED CHEM, V45, P4339, DOI 10.1016/j.ejmech.2010.04.034; Engel RH, 2007, DRUGS, V67, P1329, DOI 10.2165/00003495-200767090-00006; Fink BE, 2005, BIOORG MED CHEM LETT, V15, P4774, DOI 10.1016/j.bmcl.2005.07.027; Huang HJ, 2010, J BIOMOL STRUCT DYN, V28, P23, DOI 10.1080/07391102.2010.10507341; Hughes TV, 2008, BIOORG MED CHEM LETT, V18, P4896, DOI 10.1016/j.bmcl.2008.07.057; Kroep JR, 2010, NETH J MED, V68, P371; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Liao PC, 2010, J AGR FOOD CHEM, V58, P10445, DOI 10.1021/jf102812t; Lippa B, 2007, BIOORG MED CHEM LETT, V17, P3081, DOI 10.1016/j.bmcl.2007.03.046; Lv PC, 2010, BIOORGAN MED CHEM, V18, P314, DOI 10.1016/j.bmc.2009.10.051; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P4947, DOI 10.1016/j.bmcl.2007.06.019; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P2828, DOI 10.1016/j.bmcl.2007.02.050; Mastalerz H, 2007, BIOORG MED CHEM LETT, V17, P2036, DOI 10.1016/j.bmcl.2007.01.002; Neve RM, 2001, ANN ONCOL, V12, P9, DOI 10.1023/A:1011199404516; Orman JS, 2007, DRUGS, V67, P2781, DOI 10.2165/00003495-200767180-00009; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; SAKAI K, 1986, J NATL CANCER I, V77, P1047; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; Steffensen KD, 2007, INT J GYNECOL CANCER, V17, P798, DOI 10.1111/j.1525-1438.2006.00855.x; Sun L, 2002, BIOORG MED CHEM LETT, V12, P2153, DOI 10.1016/S0960-894X(02)00364-5; Sun MF, 2011, MOL SIMULAT, V37, P884, DOI 10.1080/08927022.2011.569550; Theillet C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2571; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P4615, DOI 10.1016/j.bmcl.2008.07.020; Xu GZ, 2008, BIOORG MED CHEM LETT, V18, P3495, DOI 10.1016/j.bmcl.2008.05.024; Yang HL, 2011, FOOD CHEM TOXICOL, V49, P290, DOI 10.1016/j.fct.2010.10.031	36	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28793	10.1371/journal.pone.0028793	http://dx.doi.org/10.1371/journal.pone.0028793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174899	Green Submitted, Green Published, gold			2022-12-27	WOS:000298366600039
J	Alam-Faruque, Y; Huntley, RP; Khodiyar, VK; Camon, EB; Dimmer, EC; Sawford, T; Martin, MJ; O'Donovan, C; Talmud, PJ; Scambler, P; Apweiler, R; Lovering, RC				Alam-Faruque, Yasmin; Huntley, Rachael P.; Khodiyar, Varsha K.; Camon, Evelyn B.; Dimmer, Emily C.; Sawford, Tony; Martin, Maria J.; O'Donovan, Claire; Talmud, Philippa J.; Scambler, Peter; Apweiler, Rolf; Lovering, Ruth C.			The Impact of Focused Gene Ontology Curation of Specific Mammalian Systems	PLOS ONE			English	Article							EXPRESSION; TOOL; NETWORK; GO	The Gene Ontology (GO) resource provides dynamic controlled vocabularies to provide an information-rich resource to aid in the consistent description of the functional attributes and subcellular locations of gene products from all taxonomic groups (www.geneontology.org). System-focused projects, such as the Renal and Cardiovascular GO Annotation Initiatives, aim to provide detailed GO data for proteins implicated in specific organ development and function. Such projects support the rapid evaluation of new experimental data and aid in the generation of novel biological insights to help alleviate human disease. This paper describes the improvement of GO data for renal and cardiovascular research communities and demonstrates that the cardiovascular-focused GO annotations, created over the past three years, have led to an evident improvement of microarray interpretation. The reanalysis of cardiovascular microarray datasets confirms the need to continue to improve the annotation of the human proteome.	[Alam-Faruque, Yasmin; Huntley, Rachael P.; Dimmer, Emily C.; Sawford, Tony; Martin, Maria J.; O'Donovan, Claire; Apweiler, Rolf] EMBL European Bioinformat Inst, Cambridge, England; [Khodiyar, Varsha K.; Camon, Evelyn B.; Talmud, Philippa J.; Lovering, Ruth C.] UCL, Ctr Cardiovasc Genet, Inst Cardiovasc Sci, London, England; [Scambler, Peter] UCL, Mol Med Unit, Inst Child Hlth, London, England	European Molecular Biology Laboratory (EMBL); University of London; University College London; University of London; University College London	Alam-Faruque, Y (corresponding author), EMBL European Bioinformat Inst, Cambridge, England.	r.lovering@ucl.ac.uk	Huntley, Rachael/J-4951-2019; Martín, María/HDL-9512-2022; Scambler, Peter/AAZ-6026-2020; Huntley, Rachael/R-1036-2016	Huntley, Rachael/0000-0001-6718-3559; Scambler, Peter/0000-0002-1487-4628; Huntley, Rachael/0000-0001-6718-3559; Lovering, Ruth/0000-0002-9791-0064; Khodiyar, Varsha/0000-0002-2743-6918; Apweiler, Rolf/0000-0001-7078-200X; O'Donovan, Claire/0000-0001-8051-7429; Talmud, Philippa/0000-0002-5560-1933; Martin, Maria-Jesus/0000-0001-5454-2815	Kidney Research UK [RP26/2008]; British Heart Foundation [SP/07/007/23671]; National Institutes of Health [R01HG02273-02]; European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002273] Funding Source: NIH RePORTER; British Heart Foundation [RG/10/13/28570] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); British Heart Foundation(British Heart Foundation)	The Renal GOA Initiative is funded by the Kidney Research UK www.kidneyresearchuk.org Project Grant RP26/2008. The Cardiovascular GOA Initiative is funded by the British Heart Foundation www.bhf.org.uk Grant SP/07/007/23671. The UniProtKB-GOA project is supported by the National Institutes of Health www.nih.gov grant number R01HG02273-02 and European Molecular Biology Laboratory www.embl.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam-Faruque Y, 2010, ORGANOGENESIS, V6, P71, DOI 10.4161/org.6.2.11294; Antonov AV, 2008, NUCLEIC ACIDS RES, V36, pW347, DOI 10.1093/nar/gkn239; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Ashburner M, 2001, GENOME RES, V11, P1425; Ashley EA, 2006, CIRCULATION, V114, P2644, DOI 10.1161/CIRCULATIONAHA.106.637025; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Diehl AD, 2007, BIOINFORMATICS, V23, P913, DOI 10.1093/bioinformatics/btm029; Dimmer Emily, 2007, V406, P495; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Gaudet P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000431; Grigoryev DN, 2008, TRANSL RES, V151, P197, DOI 10.1016/j.trsl.2007.12.010; Grossmann S, 2007, BIOINFORMATICS, V23, P3024, DOI 10.1093/bioinformatics/btm440; Hill DP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S2; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huntley RP, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap010; Khodiyar VK, 2011, DEV BIOL, V354, P9, DOI 10.1016/j.ydbio.2011.03.011; Kim MJ, 2011, NEPHRON EXP NEPHROL, V119, pE1, DOI 10.1159/000324223; Kongchanagul A, 2011, J MED VIROL, V83, P1410, DOI 10.1002/jmv.22105; Lambrecht S, 2008, OSTEOARTHR CARTILAGE, V16, P163, DOI 10.1016/j.joca.2007.06.005; Lee JA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-237; Lovering RC, 2008, PROTEOMICS, V8, P1950, DOI 10.1002/pmic.200800078; Pappa KI, 2011, TRANSL ONCOL, V4, P301, DOI 10.1593/tlo.11148; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; STABLES MJ, 2011, BLOOD IN PRESS; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Zuckerbraun BS, 2011, CARDIOVASC RES, V89, P542, DOI 10.1093/cvr/cvq370	37	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27541	10.1371/journal.pone.0027541	http://dx.doi.org/10.1371/journal.pone.0027541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174742	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700005
J	Ben-Dor, M; Gopher, A; Hershkovitz, I; Barkai, R				Ben-Dor, Miki; Gopher, Avi; Hershkovitz, Israel; Barkai, Ran			Man the Fat Hunter: The Demise of Homo erectus and the Emergence of a New Hominin Lineage in the Middle Pleistocene (ca. 400 kyr) Levant	PLOS ONE			English	Article							GESHER-BENOT-YAAQOV; QESEM CAVE; BODY-SIZE; ACID-COMPOSITION; LARGE HERBIVORE; LIFE-HISTORY; HABITUAL USE; FIRE-MAKING; EVOLUTION; DIET	The worldwide association of H. erectus with elephants is well documented and so is the preference of humans for fat as a source of energy. We show that rather than a matter of preference, H. erectus in the Levant was dependent on both elephants and fat for his survival. The disappearance of elephants from the Levant some 400 kyr ago coincides with the appearance of a new and innovative local cultural complex - the Levantine Acheulo-Yabrudian and, as is evident from teeth recently found in the Acheulo-Yabrudian 400-200 kyr site of Qesem Cave, the replacement of H. erectus by a new hominin. We employ a bio-energetic model to present a hypothesis that the disappearance of the elephants, which created a need to hunt an increased number of smaller and faster animals while maintaining an adequate fat content in the diet, was the evolutionary drive behind the emergence of the lighter, more agile, and cognitively capable hominins. Qesem Cave thus provides a rare opportunity to study the mechanisms that underlie the emergence of our post-erectus ancestors, the fat hunters.	[Ben-Dor, Miki; Gopher, Avi; Barkai, Ran] Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel; [Hershkovitz, Israel] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, Dan David Lab Search & Study Modern Humans, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Ben-Dor, M (corresponding author), Tel Aviv Univ, Inst Archaeol, IL-69978 Tel Aviv, Israel.	barkaran@post.tau.ac.il	Hershkovitz, Israel/ABH-4511-2020; Barkai, Ran/L-6495-2019	Hershkovitz, Israel/0000-0001-5841-6090; BARKAI, RAN/0000-0002-8125-8788; Ben-Dor, Miki/0000-0001-9512-1160	Israel science Foundation [820/02, 256/05, 19/10]; Dan Daviv Foundation [04740001/2011]; Thyssen foundation [R 17386]; Wenner-Gren Foundation; Leakey foundation; CARE Archaeologucal Foundation	Israel science Foundation(Israel Science Foundation); Dan Daviv Foundation; Thyssen foundation; Wenner-Gren Foundation; Leakey foundation; CARE Archaeologucal Foundation	The Qesem Cave research project is supported by the following granting agencies: The Israel science Foundation (Grants 820/02; 256/05; 19/10) http://www.isf.org.il/; The Dan Daviv Foundation (Grant 04740001/2011) http://www.dandavidprize.org/dan-david-foundation.html; The Thyssen foundation (Grant R 17386) http://www.fritz-thyssen-stiftung.de/; The Wenner-Gren Foundation http://www.wennergren.org/; The Leakey foundation http://leakeyfoundation.org/ and the CARE Archaeologucal Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LC, 2002, ANNU REV ANTHROPOL, V31, P323, DOI 10.1146/annurev.anthro.31.040402.085403; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; Alperson-Afil N, 2009, SCIENCE, V326, P1677, DOI 10.1126/science.1180695; AlpersonAfil N, 2010, VERTEBR PALEOBIOL PA, P1; Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Anton SC, 2003, YEARB PHYS ANTHROPOL, V46, P126, DOI 10.1002/ajpa.10399; Bar-Yosef O, 2011, QUATERNARY SCI REV, V30, P1318, DOI 10.1016/j.quascirev.2010.02.016; Barkai R., 2009, HUMAN EVOL, V24, P57; Barkai R., 2010, ANTIQUITY, V84; Barkal R, 2003, NATURE, V423, P977, DOI 10.1038/nature01718; BARYOSEF O, 2008, PREHISTORY ISRAEL; Bate D. M. A., 1937, P137; Beaumont PB, 2011, CURR ANTHROPOL, V52, P585, DOI 10.1086/660919; Bello SM, 2009, J ARCHAEOL SCI, V36, P1869, DOI 10.1016/j.jas.2009.04.014; BEYENE Y, 2010, P BRIT ACAD, V158, P43; Birkett A, 1996, AM J CLIN NUTR, V63, P766, DOI 10.1093/ajcn/63.5.766; Bock J, 2002, HUM NATURE-INT BIOS, V13, P161, DOI 10.1007/s12110-002-1007-4; Brink JW, 2008, IMAGINING HEAD-SMASHED-IN: ABORIGINAL BUFFALO HUNTING ON THE NORTHERN PLAINS, P1; BUNN HT, 1993, J ARCHAEOL SCI, V20, P365, DOI 10.1006/jasc.1993.1023; Byers DA, 2005, J ARCHAEOL SCI, V32, P1624, DOI 10.1016/j.jas.2005.05.003; Caluwe E., 2010, AFRIKA FOCUS, V23, P11, DOI [10.1163/2031356X-02301005, DOI 10.1163/2031356X-02301005]; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; CARTMILL M, 2009, HUMAN LINEAGE; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; Churchill Steven E., 1993, ARCHAEOLOGICAL PAPER, V4, P11; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; CONKLINBRITTAIN NL, 2002, HUMAN DIET ITS ORIGI, P206; Coppens Y., 1978, P336; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; COURSEY DG, 1973, MAN, V8, P634; CRAWFORD MA, 1970, INT J BIOCHEM, V1, P295, DOI 10.1016/0020-711X(70)90072-8; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; Cyran KA, 2010, THEOR POPUL BIOL, V78, P165, DOI 10.1016/j.tpb.2010.06.001; Delagnes A, 2006, J ANTHROPOL ARCHAEOL, V25, P448, DOI 10.1016/j.jaa.2006.03.002; Dennell RW, 2010, QUATERN INT, V223, P439, DOI 10.1016/j.quaint.2009.07.010; Dennell R, 2010, NATURE, V468, P512, DOI 10.1038/468512a; EADES MR, 1996, PROTEIN POWER; Endicott P, 2010, J HUM EVOL, V59, P87, DOI 10.1016/j.jhevol.2010.04.005; FOLEY RA, 1991, PHILOS T R SOC B, V334, P223, DOI 10.1098/rstb.1991.0111; Gaman P. M., 1996, SCI FOOD INTRO FOOD; Gamble C, 2011, CAMB ARCHAEOL J, V21, P115, DOI 10.1017/S0959774311000072; Gaudzinski S, 2005, QUATERN INT, V126, P179, DOI 10.1016/j.quaint.2004.04.022; GILBERST WH, HOMO ERECTUS PLEISTO; Gopher A, 2010, QUAT GEOCHRONOL, V5, P644, DOI 10.1016/j.quageo.2010.03.003; Goren-Inbar N, 2004, SCIENCE, V304, P725, DOI 10.1126/science.1095443; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; GORENIBNAR N, 2011, PHILOS T R SOC B, P1038; GOWLETT JAJ, 2010, SOCIAL BRAIN DISTRIB, P341; Graves RR, 2010, J HUM EVOL, V59, P542, DOI 10.1016/j.jhevol.2010.06.007; Guthrie R. D., 2007, GUTS BRAINS INTEGRAT, P133; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; HARDING R, 1997, PROGR POPULATION GEN, P15; Harding RM, 1997, AM J HUM GENET, V60, P772; HATLEY T, 1980, HUM ECOL, V8, P371, DOI 10.1007/BF01561000; Hawks JD, 2001, QUATERN INT, V75, P41, DOI 10.1016/S1040-6182(00)00076-8; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; HO KJ, 1971, ARCH PATHOL, V91, P387; Hou YM, 2010, QUATERN INT, V223, P10, DOI 10.1016/j.quaint.2009.09.025; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Ichikawa M, 1983, AFR STUDY MONOGR, V4, P55, DOI [10.14989/68001, DOI 10.14989/68001]; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; Jorgensen H, 2000, J NUTR, V130, P852, DOI 10.1093/jn/130.4.852; Kaplan H, 2000, EVOL ANTHROPOL, V9, P156, DOI 10.1002/1520-6505(2000)9:4<156::AID-EVAN5>3.0.CO;2-7; Kaplan H., 2007, GUTS BRAINS INTEGRAT, P47; Karkanas P, 2007, J HUM EVOL, V53, P197, DOI 10.1016/j.jhevol.2007.04.002; Klein R. G., 1988, AFR ARCHAEOL REV, V6, P3, DOI [10.1007/BF01117110., DOI 10.1007/BF01117110]; KLEIN RG, 1983, ANNU REV ANTHROPOL, V12, P25, DOI 10.1146/annurev.an.12.100183.000325; Klein RG, 2007, J HUM EVOL, V52, P164, DOI 10.1016/j.jhevol.2006.08.006; Klein RG, 2008, EVOL ANTHROPOL, V17, P267, DOI 10.1002/evan.20181; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Lawrie R., 1991, MEAT SCI; LEDGER HP, 1968, P S HELD ZOOL SOC LO, V21, P289; Lee-Thorp J, 2006, YEARB PHYS ANTHROPOL, V49, P131, DOI 10.1002/ajpa.20519; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; LIEBERMAN DE, 2009, 1 HUM OR EARL EV GEN; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Lucas PW, 2009, VERTEBR PALEOBIOL PA, P31, DOI 10.1007/978-1-4020-9699-0_3; Lyons SK, 2004, EVOL ECOL RES, V6, P339; Machin AJ, 2007, J ARCHAEOL SCI, V34, P883, DOI 10.1016/j.jas.2006.09.008; Marder O, 2011, J HUM EVOL, V60, P508, DOI 10.1016/j.jhevol.2010.01.007; MARIN A, 2011, INT J OSTEO IN PRESS; MARKS SA, 1976, LARGE MAMMALS BRAVE; Martin P.S., 1984, P354; Martinon-Torres M, 2011, J HUM EVOL, V60, P251, DOI 10.1016/j.jhevol.2010.10.005; MCBREARTY S, 2003, J HUM EVOL, V3, P1; McClellan WS, 1930, J BIOL CHEM, V87, P651; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McHenry H.M., 1988, P133; McHenry Henry M., 2009, P256; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Mellars P, 2011, SCIENCE, V333, P623, DOI 10.1126/science.1206930; Metges CC, 2000, J NUTR, V130, P886, DOI 10.1093/jn/130.4.886; MILTON K, 1987, FOOD EVOLUTION THEOR, P96; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Movius HL, 1950, SOUTHWEST J ANTHROP, V6, P139, DOI 10.1086/soutjanth.6.2.3628638; NOLI D, 1988, J ARCHAEOL SCI, V15, P395, DOI 10.1016/0305-4403(88)90037-4; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pitts G, 1968, BODY COMPOSITION ANI, P45; Popovich DG, 1997, J NUTR, V127, P2000, DOI 10.1093/jn/127.10.2000; PORAT N, 2007, AM SCH PREHISTORIC R, V50, P27; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Preece RC, 2006, J QUATERNARY SCI, V21, P485, DOI 10.1002/jqs.1043; Rabinovich R, 2011, J HUM EVOL, V60, P357, DOI 10.1016/j.jhevol.2010.12.002; Reich D, 2011, AM J HUM GENET; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2009, VERTEBR PALEOBIOL PA, P251, DOI 10.1007/978-1-4020-9699-0_20; Richter D, 2011, ARCHAEOMETRY, V53, P842, DOI 10.1111/j.1475-4754.2010.00581.x; RIGHTMIRE GP, 2008, EVOLUTIONARY ANTHR, V17, P218; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, pE299, DOI 10.1073/pnas.1108129108; Roebroeks W, 2011, P NATL ACAD SCI USA, V108, P5209, DOI 10.1073/pnas.1018116108; Rolland Nicolas, 2004, Asian Perspectives, V43, P248, DOI 10.1353/asi.2004.0027; RUDMAN D, 1973, J CLIN INVEST, V52, P2241, DOI 10.1172/JCI107410; Ruxton GD, 2011, J HUM EVOL, V61, P169, DOI 10.1016/j.jhevol.2011.02.012; Sandgathe DM, 2011, P NATL ACAD SCI USA, V108, pE298, DOI 10.1073/pnas.1106759108; Schwartz JH, 2010, YEARB PHYS ANTHROPOL, V53, P94; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Sharon G, 2011, J HUM EVOL, V60, P387, DOI 10.1016/j.jhevol.2009.11.012; SHIMELMITZ R, 2011, J HUMAN EVO IN PRESS; Smil V, 2002, POPUL DEV REV, V28, P599, DOI 10.1111/j.1728-4457.2002.00599.x; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; SPETH JD, 1983, J ANTHROPOL ARCHAEOL, V2, P1, DOI 10.1016/0278-4165(83)90006-5; Speth JohnD., 2010, INTERD CONTRIB ARCH; Stanford CB, 2001, MEAT EATING HUMAN EV; Stanford Craig B., 1999, HUNTING APES MEAT EA; Steudel-Numbers KL, 2007, J HUM EVOL, V53, P191, DOI 10.1016/j.jhevol.2007.04.001; Stiner MC, 2011, J HUM EVOL, V60, P213, DOI 10.1016/j.jhevol.2010.10.006; Stiner MC, 2009, VERTEBR PALEOBIOL PA, P157, DOI 10.1007/978-1-4020-9699-0_11; Stiner MC, 2009, P NATL ACAD SCI USA, V106, P13207, DOI 10.1073/pnas.0900564106; STINER MC, 1990, J ANTHROPOL ARCHAEOL, V9, P305, DOI 10.1016/0278-4165(90)90010-B; STROHLE A, 2011, NUTRITION; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Templeton AR, 2002, NATURE, V416, P45, DOI 10.1038/416045a; Thieme H, 1997, NATURE, V385, P807, DOI 10.1038/385807a0; Ungar P, 1998, EVOL ANTHROPOL, V6, P205, DOI 10.1002/(SICI)1520-6505(1998)6:6<205::AID-EVAN3>3.3.CO;2-G; UNGAR P, 2004, HUMAN EVOLUTION, V4, P605; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; UNGAR PS, 2011, J HUMAN EVO IN PRESS; White MJ, 2011, J WORLD PREHIST, V24, P25, DOI 10.1007/s10963-011-9043-9; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wood B, 2010, P NATL ACAD SCI USA, V107, P8902, DOI 10.1073/pnas.1001649107; Woolnough AP, 1997, WILDLIFE RES, V24, P649, DOI 10.1071/WR97010; Wrangham R, 2010, EVOL ANTHROPOL, V19, P187, DOI 10.1002/evan.20275; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Yravedra J, 2010, J ARCHAEOL SCI, V37, P2469, DOI 10.1016/j.jas.2010.05.007; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795; CHAILLU B EXPLORATIO; NUTRITIONDATA	159	105	107	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28689	10.1371/journal.pone.0028689	http://dx.doi.org/10.1371/journal.pone.0028689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	866FK	22174868	gold, Green Submitted, Green Published			2022-12-27	WOS:000298365700061
J	Carrascal, L; Nieto-Gonzalez, JL; Torres, B; Nunez-Abades, P				Carrascal, Livia; Luis Nieto-Gonzalez, Jose; Torres, Blas; Nunez-Abades, Pedro			Diminution of Voltage Threshold Plays a Key Role in Determining Recruitment of Oculomotor Nucleus Motoneurons during Postnatal Development	PLOS ONE			English	Article							MOTOR-UNIT RECRUITMENT; AXON INITIAL SEGMENT; DETERMINING INPUT RESISTANCE; RAT HYPOGLOSSAL MOTONEURONS; BRAIN-STEM MOTONEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; IN-VITRO; GENIOGLOSSAL MOTONEURONS; PERSISTENT SODIUM; SYNAPTIC INPUT	The size principle dictates the orderly recruitment of motoneurons (Mns). This principle assumes that Mns of different sizes have a similar voltage threshold, cell size being the crucial property in determining neuronal recruitment. Thus, smaller neurons have higher membrane resistance and require a lower depolarizing current to reach spike threshold. However, the cell size contribution to recruitment in Mns during postnatal development remains unknown. To investigate this subject, rat oculomotor nucleus Mns were intracellularly labeled and their electrophysiological properties recorded in a brain slice preparation. Mns were divided into 2 age groups: neonatal (1-7 postnatal days, n = 14) and adult (20-30 postnatal days, n = 10). The increase in size of Mns led to a decrease in input resistance with a strong linear relationship in both age groups. A well-fitted inverse correlation was also found between input resistance and rheobase in both age groups. However, input resistance versus rheobase did not correlate when data from neonatal and adult Mns were combined in a single group. This lack of correlation is due to the fact that decrease in input resistance of developing Mns did not lead to an increase in rheobase. Indeed, a diminution in rheobase was found, and it was accompanied by an unexpected decrease in voltage threshold. Additionally, the decrease in rheobase co-varied with decrease in voltage threshold in developing Mns. These data support that the size principle governs the recruitment order in neonatal Mns and is maintained in adult Mns of the oculomotor nucleus; but during postnatal development the crucial property in determining recruitment order in these Mns was not the modifications of cell size-input resistance but of voltage threshold.	[Carrascal, Livia; Torres, Blas; Nunez-Abades, Pedro] Univ Seville, Dept Fisiol, Seville, Spain; [Luis Nieto-Gonzalez, Jose] Univ Seville, Dept Fisiol Med & Biofis, Seville, Spain	University of Sevilla; University of Sevilla	Carrascal, L (corresponding author), Univ Seville, Dept Fisiol, Seville, Spain.	pnunez@us.es	Nieto-Gonzalez, Jose L/B-7165-2013; IBIS, FISIOLOGIA/O-9485-2015; Carrascal, Livia/L-5716-2014; Torres, Blas/B-9668-2015	Nieto-Gonzalez, Jose L/0000-0003-1757-4951; Carrascal, Livia/0000-0003-4222-5550; Torres, Blas/0000-0003-4508-4546; Nunez Abades, Pedro A./0000-0003-0947-8492	Ministerio de Ciencia y Tecnologia de Espana (MYCT) [BFU 2009-07867]; Proyectos de Excelencia de la Junta de Andalucia [P08-CVI-039, P09-CVI-4617]	Ministerio de Ciencia y Tecnologia de Espana (MYCT); Proyectos de Excelencia de la Junta de Andalucia(Junta de Andalucia)	This work was supported by a grant from the Ministerio de Ciencia y Tecnologia de Espana (MYCT; BFU 2009-07867) and Proyectos de Excelencia de la Junta de Andalucia (P08-CVI-039 and P09-CVI-4617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MJ, 1999, J NEUROSCI, V19, P9975; BAWA P, 1984, J NEUROPHYSIOL, V52, P410, DOI 10.1152/jn.1984.52.3.410; Berger AJ, 1996, J APPL PHYSIOL, V81, P1039, DOI 10.1152/jappl.1996.81.3.1039; Binder MD, 2002, ADV EXP MED BIOL, V508, P207; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; CAMERON WE, 1991, J NEUROPHYSIOL, V65, P671, DOI 10.1152/jn.1991.65.3.671; Cameron WE, 2000, J NEUROPHYSIOL, V84, P2330, DOI 10.1152/jn.2000.84.5.2330; Cameron WE, 2000, BRAIN RES BULL, V53, P523, DOI 10.1016/S0361-9230(00)00385-3; Carrascal L, 2006, NEUROSCIENCE, V140, P1223, DOI 10.1016/j.neuroscience.2006.03.006; Carrascal L, 2005, BRAIN RES REV, V49, P377, DOI 10.1016/j.brainresrev.2005.02.003; Carrascal L, 2010, NEUROSCIENCE, V171, P613, DOI 10.1016/j.neuroscience.2010.09.001; Carrascal L, 2009, J COMP NEUROL, V514, P189, DOI 10.1002/cne.21996; COPE TC, 1991, J NEUROPHYSIOL, V66, P1127, DOI 10.1152/jn.1991.66.4.1127; CURTHOYS IS, 1981, ACTA OTO-LARYNGOL, V92, P323, DOI 10.3109/00016488109133268; CURTHOYS IS, 1979, ACTA OTO-LARYNGOL, V87, P484, DOI 10.3109/00016487909126456; DAVIES L, 1993, BRAIN RES, V602, P104, DOI 10.1016/0006-8993(93)90248-L; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; Duchateau J, 2011, BRAIN RES, V1409, P42, DOI 10.1016/j.brainres.2011.06.011; ElBasiouny SM, 2010, J NEUROSCI, V30, P5544, DOI 10.1523/JNEUROSCI.0434-10.2010; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; FLESHMAN JW, 1981, J NEUROPHYSIOL, V46, P1326, DOI 10.1152/jn.1981.46.6.1326; Fox MA, 2011, J COMP NEUROL, V519, P2907, DOI 10.1002/cne.22700; Gabriel JP, 2011, NAT NEUROSCI, V14, P93, DOI 10.1038/nn.2704; Gabrielaitis M, 2011, BRAIN RES, V1373, P11, DOI 10.1016/j.brainres.2010.12.011; GRANTYN R, 1978, EXP BRAIN RES, V31, P249; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Grundemann J, 2010, NATURE, V465, P1022, DOI 10.1038/4651022a; GUERITAUD JP, 1988, NEUROSCIENCE, V24, P837, DOI 10.1016/0306-4522(88)90072-3; GUSTAFSSON B, 1984, J PHYSIOL-LONDON, V356, P401, DOI 10.1113/jphysiol.1984.sp015473; Haftel VK, 2001, J NEUROPHYSIOL, V86, P616, DOI 10.1152/jn.2001.86.2.616; HECKMAN CJ, 1993, J NEUROPHYSIOL, V70, P1827, DOI 10.1152/jn.1993.70.5.1827; HENNEMAN E, 1965, J NEUROPHYSIOL, V28, P560, DOI 10.1152/jn.1965.28.3.560; Hornby TG, 2002, J NEUROPHYSIOL, V88, P86, DOI 10.1152/jn.2002.88.1.86; Kang YN, 2010, PROG BRAIN RES, V187, P163, DOI [10.1016/B978-0-444-53613-6.00011-3, 10.1016/S0079-6123(10)87011-6]; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; LAURSEN AM, 1989, NEUROSCIENCE, V30, P619, DOI 10.1016/0306-4522(89)90156-5; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Mantilla CB, 2011, RESP PHYSIOL NEUROBI, V179, P57, DOI 10.1016/j.resp.2011.06.028; Mendell LM, 2005, J NEUROPHYSIOL, V93, P3024, DOI 10.1152/classicessays.00025.2005; Nieto-Gonzalez JL, 2007, EUR J NEUROSCI, V25, P2682, DOI 10.1111/j.1460-9568.2007.05516.x; Nieto-Gonzalez JL, 2009, J NEUROPHYSIOL, V101, P100, DOI 10.1152/jn.90239.2008; Nunez-Abades PA, 2000, J NEUROPHYSIOL, V84, P2317, DOI 10.1152/jn.2000.84.5.2317; NunezAbades PA, 1997, NEUROSCI LETT, V223, P41, DOI 10.1016/S0304-3940(97)13398-5; NUNEZABADES PA, 1995, J COMP NEUROL, V353, P129, DOI 10.1002/cne.903530112; NUNEZABADES PA, 1993, J NEUROPHYSIOL, V70, P1401, DOI 10.1152/jn.1993.70.4.1401; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Powers RK, 2008, J NEUROPHYSIOL, V100, P292, DOI 10.1152/jn.90296.2008; Powers RK, 2003, J NEUROPHYSIOL, V89, P615, DOI 10.1152/jn.00241.2002; POWERS RK, 1993, J NEUROPHYSIOL, V70, P1460, DOI 10.1152/jn.1993.70.4.1460; Rusch A, 1998, J NEUROSCI, V18, P7487; Russo RE, 1999, PROG BIOPHYS MOL BIO, V72, P329, DOI 10.1016/S0079-6107(99)00011-5; Seelke AMH, 2005, EUR J NEUROSCI, V22, P911, DOI 10.1111/j.1460-9568.2005.04322.x; Spencer RF, 2006, PROG BRAIN RES, V151, P43, DOI 10.1016/S0079-6123(05)51002-1; TSUZUKI S, 1995, NEUROSCI RES, V23, P389, DOI 10.1016/0168-0102(95)00966-W; VIANA F, 1993, J NEUROPHYSIOL, V69, P2137, DOI 10.1152/jn.1993.69.6.2137	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28748	10.1371/journal.pone.0028748	http://dx.doi.org/10.1371/journal.pone.0028748			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174887	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700069
J	Muratoglu, SC; Belgrave, S; Lillis, AP; Migliorini, M; Robinson, S; Smith, E; Zhang, L; Strickland, DK				Muratoglu, Selen Catania; Belgrave, Shani; Lillis, Anna P.; Migliorini, Mary; Robinson, Susan; Smith, Elizabeth; Zhang, Li; Strickland, Dudley K.			Macrophage LRP1 Suppresses Neo-Intima Formation during Vascular Remodeling by Modulating the TGF-beta Signaling Pathway	PLOS ONE			English	Article							TRANSFORMING-GROWTH-FACTOR; RECEPTOR-RELATED PROTEIN; SMOOTH-MUSCLE-CELLS; ALPHA-2-MACROGLOBULIN RECEPTOR; MOLECULAR-MECHANISMS; CORECEPTOR FUNCTION; CAROTID-ARTERY; GENE; PDGF; ATHEROSCLEROSIS	Background: Vascular remodeling in response to alterations in blood flow has been shown to modulate the formation of neo-intima. This process results from a proliferative response of vascular smooth muscle cells and is influenced by macrophages, which potentiate the development of the intima. The LDL receptor-related protein 1 (LRP1) is a large endocytic and signaling receptor that recognizes a number of ligands including apoE-containing lipoproteins, proteases and protease-inhibitor complexes. Macrophage LRP1 is known to influence the development of atherosclerosis, but its role in vascular remodeling has not been investigated. Methodology/Principal Findings: To define the contribution of macrophage LRP1 to vascular remodeling, we generated macrophage specific LRP1-deficient mice (macLRP1-/-) on an LDL receptor (LDLr) knock-out background. Using a carotid ligation model, we detected a 2-fold increase in neointimal thickening and a 2-fold increase in the intima/media ratio in macLRP1-/- mice. Quantitative RT-PCR arrays of the remodeled vessel wall identified increases in mRNA levels of the TGF-beta 2 gene as well as the Pdgfa gene in macLRP1-/- mice which could account for the alterations in vascular remodeling. Immunohistochemistry analysis revealed increased activation of the TGF-beta signaling pathway in macLRP1-/- mice. Further, we observed that LRP1 binds TGF-beta 2 and macrophages lacking LRP1 accumulate twice as much TGF-beta 2 in conditioned media. Finally, TNF-alpha modulation of the TGF-beta 2 gene in macrophages is attenuated when LRP1 is expressed. Together, the data reveal that LRP1 modulates both the expression and protein levels of TGF-beta 2 in macrophages. Conclusions/Significance: Our data demonstrate that macrophage LRP1 protects the vasculature by limiting remodeling events associated with flow. This appears to occur by the ability of macrophage LRP1 to reduce TGF-beta 2 protein levels and to attenuate expression of the TGF-beta 2 gene resulting in suppression of the TGF-beta signaling pathway.	[Muratoglu, Selen Catania; Belgrave, Shani; Lillis, Anna P.; Migliorini, Mary; Robinson, Susan; Smith, Elizabeth; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Muratoglu, Selen Catania; Belgrave, Shani; Migliorini, Mary; Robinson, Susan; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Lillis, Anna P.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Duke University	Muratoglu, SC (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu	Lillis, Anna/AAI-6942-2021	Lillis, Anna/0000-0003-4810-9577; Muratoglu Catania, Selen/0000-0002-1804-4875	National Health Institute [PO1 HL54710, HL50784]; Maryland Stem Cell Research Fund postdoctoral fellowship;  [T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054710, T32HL007698, R01HL050784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078365] Funding Source: NIH RePORTER	National Health Institute; Maryland Stem Cell Research Fund postdoctoral fellowship; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Health Institute grants PO1 HL54710 and HL50784 awarded to DKS. SCM was supported by a Maryland Stem Cell Research Fund postdoctoral fellowship. SB was supported by T32 HL007698. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; ASSOIAN RK, 1986, J CELL BIOL, V102, P1217, DOI 10.1083/jcb.102.4.1217; BATTEGAY EJ, 1990, CELL, V63, P515, DOI 10.1016/0092-8674(90)90448-N; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Bray P, 1998, HYPERTENSION, V31, P986, DOI 10.1161/01.HYP.31.4.986; Brizzi MF, 2001, CIRCULATION, V103, P549, DOI 10.1161/01.CIR.103.4.549; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Danielpour D, 2000, METH MOL B, V142, P29; Dear AE, 1996, EUR J BIOCHEM, V241, P93, DOI 10.1111/j.1432-1033.1996.0093t.x; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Eschert H, 2009, ATHEROSCLEROSIS, V204, P96, DOI 10.1016/j.atherosclerosis.2008.08.025; Gordts PLSM, 2009, ARTERIOSCL THROM VAS, V29, P1258, DOI 10.1161/ATVBAHA.109.192211; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Hu YH, 1997, ARTERIOSCL THROM VAS, V17, P2808, DOI 10.1161/01.ATV.17.11.2808; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ivan E, 2002, CIRCULATION, V105, P2686, DOI 10.1161/01.CIR.0000016825.17448.11; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; MCGOWAN SE, 1990, AM J RESP CELL MOL, V3, P369, DOI 10.1165/ajrcmb/3.4.369; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; NABEL EG, 1993, P NATL ACAD SCI USA, V90, P10759, DOI 10.1073/pnas.90.22.10759; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Orlandi A, 2010, BIOCHEM PHARMACOL, V79, P1706, DOI 10.1016/j.bcp.2010.01.027; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; POMPILI VJ, 1995, ARTERIOSCL THROM VAS, V15, P2254, DOI 10.1161/01.ATV.15.12.2254; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; SHARMA S, 2010, PHARMACOL THERAPEUT, V129, P260; Smith JD, 1999, CIRC RES, V84, P1212, DOI 10.1161/01.RES.84.10.1212; STOUFFER GA, 1993, J BIOL CHEM, V268, P18340; STOUFFER GA, 1994, J CLIN INVEST, V93, P2048, DOI 10.1172/JCI117199; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263; 2001, J BIOL CHEM, V276, P29632	45	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28846	10.1371/journal.pone.0028846	http://dx.doi.org/10.1371/journal.pone.0028846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174911	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700077
J	Arriola, CS; Guere, ME; Larsen, J; Skov, RL; Gilman, RH; Gonzaiez, AE; Silbergeld, EK				Arriola, Carmen S.; Gueere, Mariella E.; Larsen, Jesper; Skov, Robert L.; Gilman, Robert H.; Gonzaiez, Armando E.; Silbergeld, Ellen K.			Presence of Methicillin-Resistant Staphylococcus aureus in Pigs in Peru	PLOS ONE			English	Article							MEC	We report the first detection of methicillin-resistant Staphylococcus aureus isolates in pigs in Peru. The isolates belong to a livestock-associated lineage previously reported in North America and Europe, CC398, and a highly virulent USA300-like ST8-IV variant, which is the predominant community-associated lineage in Latin America.	[Arriola, Carmen S.; Gueere, Mariella E.; Gonzaiez, Armando E.] San Marcos Major Natl Univ, Sch Vet Med, Lima, Peru; [Arriola, Carmen S.; Gilman, Robert H.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Larsen, Jesper; Skov, Robert L.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Silbergeld, Ellen K.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Universidad Nacional Mayor de San Marcos; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Arriola, CS (corresponding author), San Marcos Major Natl Univ, Sch Vet Med, Lima, Peru.	carriola@jhsph.edu	Larsen, Jesper/AAJ-3161-2021; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Skov, Robert/0000-0002-6079-5381; Guere, Mariella/0000-0002-0966-2524; Gonzalez, Armando/0000-0003-1909-1873	Center for a Livable Future; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; International Foundation for Science, Stockholm, Sweden; Fogarty International Center/National Institutes of Health [5 D43 TW008273, 5 D43 TW006581]; FOGARTY INTERNATIONAL CENTER [D43TW008273, D43TW006581] Funding Source: NIH RePORTER	Center for a Livable Future; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; International Foundation for Science, Stockholm, Sweden(International Foundation for Science); Fogarty International Center/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, and the International Foundation for Science, Stockholm, Sweden. CA was supported in part by Fogarty International Center/National Institutes of Health training grants 5 D43 TW008273 and 5 D43 TW006581. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argudin MA, 2011, APPL ENVIRON MICROB, V77, P3052, DOI 10.1128/AEM.02260-10; Arias CA, 2008, NEW ENGL J MED, V359, P2177, DOI 10.1056/NEJMc0804021; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bens CCPM, 2006, J CLIN MICROBIOL, V44, P1875, DOI 10.1128/JCM.44.5.1875-1876.2006; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; EFSA (European Food Safety Authority), 2010, EFSA J, V8, P1597, DOI [10.2903/j.efsa.2010.1597, DOI 10.2903/J.EFSA.2010.1597]; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/World Bank, 2010, 169 UN FAO WORLD ORG; Garcia C, J INFECT IN PRESS; Hallin M, 2011, INFECT GENET EVOL, V11, P290, DOI 10.1016/j.meegid.2010.10.021; Jimenez JN, 2011, EMERG INFECT DIS OCT; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Maes N, 2002, J CLIN MICROBIOL, V40, P1514, DOI 10.1128/JCM.40.4.1514-1517.2002; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428	22	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28529	10.1371/journal.pone.0028529	http://dx.doi.org/10.1371/journal.pone.0028529			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174831	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600031
J	Gramegna, P; Latronico, T; Brana, MT; Di Bari, G; Mengoni, F; Belvisi, V; Mascellino, MT; Lichtner, M; Vullo, V; Mastroianni, CM; Liuzzi, GM				Gramegna, Pasqua; Latronico, Tiziana; Brana, Maria Teresa; Di Bari, Gaetano; Mengoni, Fabio; Belvisi, Valeria; Mascellino, Maria T.; Lichtner, Miriam; Vullo, Vincenzo; Mastroianni, Claudio M.; Liuzzi, Grazia M.			In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; ANTIRETROVIRAL THERAPY; GELATINASE-B; TISSUE INHIBITORS; ASTROCYTES; MICROGLIA; MACROPHAGES; BIOCHEMISTRY; MECHANISMS; MONOCYTES	Background: Matrix metalloproteinases (MMPs) released by glial cells are important mediators of neuroinflammation and neurologic damage in HIV infection. The use of antiretroviral drugs able to combat the detrimental effect of chronic inflammation and target the exaggerated MMP activity might represent an attractive therapeutic challenge. Recent studies suggest that CCR5 antagonist maraviroc (MVC) exerts immunomodulant and anti-inflammatory activity beyond its anti-HIV properties. We investigated the in vitro effect of MVC on the activity of MMPs in astrocyte and microglia cultures. Methodology/Principal Findings: Primary cultures of rat astrocytes and microglia were activated by exposure to phorbol myristate acetate (PMA) or lypopolysaccharide (LPS) and treated in vitro with MVC. Culture supernatants were subjected to gelatin zymography and quantitative determination of MMP-9 and MMP-2 was done by computerized scanning densitometry. MMP-9 levels were significantly elevated in culture supernatants from both LPS- and PMA-activated astrocytes and microglia in comparison to controls. The treatment with MVC significantly inhibited in a dose-dependent manner the levels and expression of MMP-9 in PMA-activated astrocytes (p<0,05) and, to a lesser extent, in PMA-activated microglia. By contrast, levels of MMP-2 did not significantly change, although a tendency to decrease was seen in PMA-activated astrocytes after treatment with MVC. The inhibition of levels and expression of MMP-9 in PMA-activated glial cells did not depend on cytotoxic effects of MVC. No inhibition of MMP-9 and MMP-2 were found in both LPS-activated astrocytes and microglia. Conclusions: The present in vitro study suggests that CCR5 antagonist compounds, through their ability to inhibit MMP-9 expression and levels, might have a great potential for the treatment of HIV-associated neurologic damage.	[Gramegna, Pasqua; Latronico, Tiziana; Brana, Maria Teresa; Di Bari, Gaetano; Liuzzi, Grazia M.] Univ Bari, Dept Biochem & Mol Biol, Bari, Italy; [Mengoni, Fabio; Mascellino, Maria T.; Vullo, Vincenzo] Sapienza Univ, Dept Publ Hlth & Infect Dis, Rome, Italy; [Belvisi, Valeria; Lichtner, Miriam; Mastroianni, Claudio M.] Sapienza Univ, Infect Dis Unit, Fdn Eleonora Lorillard Spencer Cenci, Latina, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Sapienza University Rome	Gramegna, P (corresponding author), Univ Bari, Dept Biochem & Mol Biol, Bari, Italy.	claudio.mastroianni@uniroma1.it	Liuzzi, Grazia Maria/GVR-7164-2022; mascellino, maria teresa/AAB-1971-2020; MASTROIANNI, Claudio Maria/O-9741-2019; Branà, Maria Teresa/P-6874-2018	mascellino, maria teresa/0000-0001-7684-3088; MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Branà, Maria Teresa/0000-0002-0878-9363; Belvisi, Valeria/0000-0002-5835-1597; Latronico, Tiziana/0000-0001-6971-5416; Liuzzi, Grazia Maria/0000-0001-5692-9335	Programma Nazionale AIDS, ISS, Italy [40H8]	Programma Nazionale AIDS, ISS, Italy	The work was supported by a grant of Programma Nazionale AIDS 2009-2010, ISS, Italy (N. 40H8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal L, 2009, J GEN VIROL, V90, P710, DOI 10.1099/vir.0.006205-0; Cardenas VA, 2009, J NEUROVIROL, V15, P324, DOI 10.1080/13550280902973960; Corbeau P, 2009, AIDS, V23, P1931, DOI 10.1097/QAD.0b013e32832e71cd; Eden A, 2010, J INFECT DIS, V202, P1819, DOI 10.1086/657342; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; GEBICKEHAERTER PJ, 1989, J NEUROSCI, V9, P183; Gilliam BL, 2010, J TRANSL MED, V9, P1; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hisatomi T, 2008, J CLIN INVEST, V118, P2025, DOI 10.1172/JCI34267; Hunt Peter W, 2007, Curr HIV/AIDS Rep, V4, P42, DOI 10.1007/s11904-007-0007-8; Kraft-Terry SD, 2010, NEUROBIOL DIS, V37, P542, DOI 10.1016/j.nbd.2009.12.015; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Lee WJ, 2003, GLIA, V41, P15, DOI 10.1002/glia.10131; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; MASURE S, 1990, BIOCHIM BIOPHYS ACTA, V1054, P317, DOI 10.1016/0167-4889(90)90103-K; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKAJIMA K, 1989, BIOMED RES-TOKYO, V10, P411; Rizza SA, 2008, MED CHEM, V4, P75, DOI 10.2174/157340608783331443; Rossi R, 2011, CLIN EXP IMMUNOL, V166, P184, DOI 10.1111/j.1365-2249.2011.04409.x; Rossi R, 2010, JAIDS-J ACQ IMM DEF, V54, pE13, DOI 10.1097/QAI.0b013e3181ed18f6; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; Sorce S, 2011, PROG NEUROBIOL, V93, P297, DOI 10.1016/j.pneurobio.2010.12.003; Soriano V, 2008, AIDS, V22, P2231, DOI 10.1097/QAD.0b013e3283136d95; Soriano V, 2009, AIDS, V23, P2377, DOI 10.1097/QAD.0b013e328332d32d; Suryadevara R, 2003, GLIA, V44, P47, DOI 10.1002/glia.10266; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Valcour Victor, 2011, Curr HIV/AIDS Rep, V8, P54, DOI 10.1007/s11904-010-0070-4; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Webster NL, 2006, J LEUKOCYTE BIOL, V80, P1052, DOI 10.1189/jlb.0306152; Weeks BS, 1998, INT J MOL MED, V1, P361	39	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28499	10.1371/journal.pone.0028499	http://dx.doi.org/10.1371/journal.pone.0028499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174822	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163600027
J	Jung, H; Lyons, RE; Dinh, H; Hurwood, DA; McWilliam, S; Mather, PB				Jung, Hyungtaek; Lyons, Russell E.; Dinh, Hung; Hurwood, David A.; McWilliam, Sean; Mather, Peter B.			Transcriptomics of a Giant Freshwater Prawn (Macrobrachium rosenbergii): De Novo Assembly, Annotation and Marker Discovery	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; JUVENILE-HORMONE BIOSYNTHESIS; MYOSIN HEAVY-CHAIN; BLACK TIGER SHRIMP; METHYL FARNESOATE; PENAEUS-MONODON; MICROSATELLITE MARKERS; ALKALOID BIOSYNTHESIS; DEVELOPMENTAL-CHANGES; INVERTEBRATE MUSCLES	Background: Giant freshwater prawn (Macrobrachium rosenbergii or GFP), is the most economically important freshwater crustacean species. However, as little is known about its genome, 454 pyrosequencing of cDNA was undertaken to characterise its transcriptome and identify genes important for growth. Methodology and Principal Findings: A collection of 787,731 sequence reads (244.37 Mb) obtained from 454 pyrosequencing analysis of cDNA prepared from muscle, ovary and testis tissues taken from 18 adult prawns was assembled into 123,534 expressed sequence tags (ESTs). Of these, 46% of the 8,411 contigs and 19% of 115,123 singletons possessed high similarity to sequences in the GenBank non-redundant database, with most significant (E value < 1e(-5)) contig (80%) and singleton (84%) matches occurring with crustacean and insect sequences. KEGG analysis of the contig open reading frames identified putative members of several biological pathways potentially important for growth. The top InterProScan domains detected included RNA recognition motifs, serine/threonine-protein kinase-like domains, actin-like families, and zinc finger domains. Transcripts derived from genes such as actin, myosin heavy and light chain, tropomyosin and troponin with fundamental roles in muscle development and construction were abundant. Amongst the contigs, 834 single nucleotide polymorphisms, 1198 indels and 658 simple sequence repeats motifs were also identified. Conclusions: The M. rosenbergii transcriptome data reported here should provide an invaluable resource for improving our understanding of this species' genome structure and biology. The data will also instruct future functional studies to manipulate or select for genes influencing growth that should find practical applications in aquaculture breeding programs.	[Jung, Hyungtaek; Dinh, Hung; Hurwood, David A.; Mather, Peter B.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Lyons, Russell E.; McWilliam, Sean] Commonwealth Sci & Ind Res Org Livestock Ind, St Lucia, Qld, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Jung, H (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	h7.jung@qut.edu.au	McWilliam, Sean M/H-8978-2013; Lyons, Russell E/AAH-4097-2020; Lyons, Russell E/A-7051-2011; Lyons, Russell/H-7942-2013; Hurwood, David/I-9923-2012	McWilliam, Sean M/0000-0002-3148-0428; Lyons, Russell E/0000-0002-0795-7994; Lyons, Russell/0000-0002-0795-7994; Jung, Hyungtaek/0000-0003-2464-1235; Hurwood, David/0000-0001-9143-360X	International Postgraduate Research Scholarship (Australia); Queensland University of Technology [N7333978]	International Postgraduate Research Scholarship (Australia)(Australian Government); Queensland University of Technology	This research forms part of H. Jung's Ph.D project, and is supported by an International Postgraduate Research Scholarship (Australia) and a Queensland University of Technology Postgraduate Award (N7333978). Additional funding for this work was provided by Queensland University of Technology awarded to P. Mather (QUT VC NPSG award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bach I, 2002, MECH DEVELOP, V91, P5; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Barat-Houari M, 2002, DIABETES, V51, P1640, DOI 10.2337/diabetes.51.5.1640; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Baruah K, 2009, AQUACULTURE, V288, P233, DOI 10.1016/j.aquaculture.2008.11.034; Bekal S, 2008, MOL GENET GENOMICS, V279, P535, DOI 10.1007/s00438-008-0331-8; Belfiore M, 2004, DEVELOPMENT, V131, P2935, DOI 10.1242/dev.01154; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; BOCHKAREV A, 1995, CELL, V83, P39, DOI 10.1016/0092-8674(95)90232-5; BORST DW, 1987, INSECT BIOCHEM, V17, P1123, DOI 10.1016/0020-1790(87)90133-8; Bouhouche N, 2000, TRENDS MICROBIOL, V8, P77, DOI 10.1016/S0966-842X(99)01679-0; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; BUSS F, 1992, CELL MOTIL CYTOSKEL, V22, P51, DOI 10.1002/cm.970220106; Cam DTV, 2009, AQUACULTURE, V294, P5; Chand V, 2005, MOL ECOL NOTES, V5, P308, DOI 10.1111/j.1471-8286.2005.00910.x; Chromczynski P., 1995, BIOTECHNIQUES, V19, P942; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Critchley DR, 1999, BIOCHEM SOC SYMP, V65, P79; de Bruyn M, 2004, MOL PHYLOGENET EVOL, V30, P251, DOI 10.1016/S1055-7903(03)00176-3; De Bruyn M, 2007, MOL ECOL, V16, P4295, DOI 10.1111/j.1365-294X.2007.03481.x; Dechklar M, 2008, BIOCHEM BIOPH RES CO, V367, P768, DOI 10.1016/j.bbrc.2008.01.031; DENARDI C, 1993, J CELL BIOL, V123, P823, DOI 10.1083/jcb.123.4.823; Divu D, 2008, AQUACULTURE, V284, P281, DOI 10.1016/j.aquaculture.2008.07.023; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Du ZQ, 2010, ANIM GENET, V41, P286, DOI 10.1111/j.1365-2052.2009.02002.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; FAO, 2009, FISH STAT DAT GLOB A; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; FEYEREISEN R, 1981, INSECT BIOCHEM, V11, P401, DOI 10.1016/0020-1790(81)90073-1; Gnaiger E, 2000, P NATL ACAD SCI USA, V97, P11080, DOI 10.1073/pnas.97.20.11080; Gorbach DM, 2010, ANIM BIOTECHNOL, V21, P100, DOI 10.1080/10495390903323968; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gunawardene YINS, 2003, PEPTIDES, V24, P1591, DOI 10.1016/j.peptides.2003.07.022; Hagel JM, 2008, PLANT PHYSIOL, V147, P1805, DOI 10.1104/pp.108.120493; Hale MC, 2010, GENETICA, V138, P745, DOI 10.1007/s10709-010-9455-y; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hamasaki K, 2008, REV FISH SCI, V16, P164, DOI 10.1080/10641260701681722; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; HAUNERLAND NH, 1993, MOL CELL BIOCHEM, V123, P153, DOI 10.1007/BF01076487; HAYASHIDA M, 1991, J BIOCHEM-TOKYO, V110, P54, DOI 10.1093/oxfordjournals.jbchem.a123543; Holford KC, 2004, INSECT BIOCHEM MOLEC, V34, P785, DOI 10.1016/j.ibmb.2004.04.003; Hooper SL, 2008, PROG NEUROBIOL, V86, P72, DOI 10.1016/j.pneurobio.2008.06.004; Hooper SL, 2005, PHYSIOL REV, V85, P1001, DOI 10.1152/physrev.00019.2004; Huber K, 2009, ENDOCRINOLOGY, V150, P4135, DOI 10.1210/en.2009-0125; Hui JHL, 2008, PEPTIDES, V29, P252, DOI 10.1016/j.peptides.2007.08.033; Dinh H, 2012, AQUAC RES, V43, P1471, DOI 10.1111/j.1365-2109.2011.02949.x; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Jung HH, 1998, AM J PHYSIOL-CELL PH, V275, pC68, DOI 10.1152/ajpcell.1998.275.1.C68; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Kamimura MT, 2008, AQUAC RES, V39, P200, DOI 10.1111/j.1365-2109.2007.01885.x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kashman Y, 2010, MAR DRUGS, V8, P2810, DOI 10.3390/md8112810; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Kim BK, 2009, COMP BIOCHEM PHYS B, V153, P178, DOI 10.1016/j.cbpb.2009.02.013; Kim WJ, 2011, MAR BIOTECHNOL, V13, P127, DOI 10.1007/s10126-010-9280-4; Kraemer B, 1999, CURR BIOL, V9, P1009, DOI 10.1016/S0960-9822(99)80449-7; Kuballa AV, 2007, GEN COMP ENDOCR, V150, P48, DOI 10.1016/j.ygcen.2006.07.020; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; LAUFER H, 1987, INSECT BIOCHEM, V17, P1129, DOI 10.1016/0020-1790(87)90134-X; Leekitcharoenphon Pimlapas, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-295; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Leu JH, 2011, MAR BIOTECHNOL, V13, P608, DOI 10.1007/s10126-010-9286-y; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liang HY, 2008, TREE GENET GENOMES, V4, P419, DOI 10.1007/s11295-007-0120-2; Lyons RE, 2007, MAR BIOTECHNOL, V9, P712, DOI 10.1007/s10126-007-9022-4; MACLEOD AR, 1987, BIOESSAYS, V6, P208, DOI 10.1002/bies.950060504; MAGDOLEN V, 1988, MOL CELL BIOL, V8, P5108, DOI 10.1128/MCB.8.12.5108; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McNeil GP, 2001, GENETICS, V159, P229; Medler S, 2005, BIOL BULL-US, V208, P127, DOI 10.2307/3593121; Medler S, 2004, J EXP BIOL, V207, P2755, DOI 10.1242/jeb.01094; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Meyer-Rochow VB, 2002, MICROSC RES TECHNIQ, V58, P504, DOI 10.1002/jemt.10169; Miller AD, 2005, MAR BIOTECHNOL, V7, P339, DOI 10.1007/s10126-004-4077-8; Minet-Quinared R, 2004, AM J PHYSIOL-ENDOC M, V287, pE671, DOI 10.1152/ajpendo.00185.2003; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morton BR, 2006, GENETICS, V172, P569, DOI 10.1534/genetics.105.049916; Ngernsoungnern P, 2009, AQUACULTURE, V296, P143, DOI 10.1016/j.aquaculture.2009.08.011; Nguyen MT, 2010, AQUACULTURE, V301, P7, DOI 10.1016/j.aquaculture.2010.02.001; Nhan DT, 2009, AQUACULTURE, V298, P36, DOI 10.1016/j.aquaculture.2009.09.011; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Perry MJ, 2009, J EXP BIOL, V212, P673, DOI 10.1242/jeb.023481; Pollard TD, 2008, BIOCHEM SOC T, V36, P425, DOI 10.1042/BST0360425; Postel U, 2010, J EXP BIOL, V213, P1740, DOI 10.1242/jeb.033829; Potapov V, 2004, J MOL BIOL, V342, P665, DOI 10.1016/j.jmb.2004.06.072; PRINJHA RK, 1994, CELL MOTIL CYTOSKEL, V28, P243, DOI 10.1002/cm.970280307; Rahman AMA, 2010, RAPID COMMUN MASS SP, V24, P2462, DOI 10.1002/rcm.4664; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Robalino J, 2009, VET IMMUNOL IMMUNOP, V128, P110, DOI 10.1016/j.vetimm.2008.10.329; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruddell CJ, 2003, BIOL BULL-US, V205, P308, DOI 10.2307/1543294; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; SAGI A, 1991, COMP BIOCHEM PHYS B, V99, P879, DOI 10.1016/0305-0491(91)90157-9; SCHEFFZEK K, 1995, NATURE, V374, P378, DOI 10.1038/374378a0; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schwantes VS, 2009, AQUACULTURE, V287, P120, DOI 10.1016/j.aquaculture.2008.10.017; See LM, 2009, BIOCHEM GENET, V47, P722, DOI 10.1007/s10528-009-9270-2; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; SOLWAY J, 1995, J BIOL CHEM, V270, P13460, DOI 10.1074/jbc.270.22.13460; Soonthornchai W, 2010, DEV COMP IMMUNOL, V34, P19, DOI 10.1016/j.dci.2009.07.007; Staelens J, 2008, GENETICS, V179, P917, DOI 10.1534/genetics.107.080150; STRASSER P, 1993, FEBS LETT, V330, P13, DOI 10.1016/0014-5793(93)80909-E; Su JS, 2008, FISH SHELLFISH IMMUN, V24, P223, DOI 10.1016/j.fsi.2007.11.006; Sung HH, 2009, FISH SHELLFISH IMMUN, V26, P256, DOI 10.1016/j.fsi.2008.11.017; Sutherland LC, 2005, J CELL BIOCHEM, V94, P5, DOI 10.1002/jcb.20204; Tamone SL, 1997, GEN COMP ENDOCR, V105, P168, DOI 10.1006/gcen.1996.6815; Tangprasittipap A, 2010, AQUACULTURE, V307, P150, DOI 10.1016/j.aquaculture.2010.07.008; Tassanakajon A, 2006, GENE, V384, P104, DOI 10.1016/j.gene.2006.07.012; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; Thanh NM, 2010, AQUACULTURE, V299, P30, DOI 10.1016/j.aquaculture.2009.12.011; Thanh NM, 2009, AQUACULTURE, V287, P75, DOI 10.1016/j.aquaculture.2008.10.051; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; VANDERHORST DJ, 1990, BIOCHIM BIOPHYS ACTA, V1047, P195, DOI 10.1016/0005-2760(90)90518-3; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VERHEYEN EM, 1994, DEVELOPMENT, V120, P717; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; WANG ZW, 1994, J INSECT PHYSIOL, V40, P217, DOI 10.1016/0022-1910(94)90045-0; Wheat CW, 2010, GENETICA, V138, P433, DOI 10.1007/s10709-008-9326-y; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Wolska BM, 2003, PFLUG ARCH EUR J PHY, V446, P1, DOI 10.1007/s00424-002-0900-3; Wu P, 2009, COMP BIOCHEM PHYS D, V4, P111, DOI 10.1016/j.cbd.2008.12.004; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu XJ, 2005, COMP BIOCHEM PHYS B, V140, P599, DOI 10.1016/j.cbpc.2004.12.010; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	141	94	99	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27938	10.1371/journal.pone.0027938	http://dx.doi.org/10.1371/journal.pone.0027938			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174756	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600010
J	Lillo, AM; Ayriss, JE; Shou, YL; Graves, SW; Bradbury, ARM; Pavlik, P				Lillo, Antonietta M.; Ayriss, Joanne E.; Shou, Yulin; Graves, Steven W.; Bradbury, Andrew R. M.; Pavlik, Peter			Development of Phage-Based Single Chain Fv Antibody Reagents for Detection of Yersinia pestis	PLOS ONE			English	Article							IMMUNOCHEMICAL REAGENTS; DISPLAY LIBRARY; FLOW-CYTOMETRY; IN-VITRO; SELECTION; SEQUENCE; PROTEIN; PLAGUE; FRAGMENTS; BINDING	Background: Most Yersinia pestis strains are known to express a capsule-like antigen, fraction 1 (F1). F1 is encoded by the caf1 gene located on the large 100-kb pFra plasmid, which is found in Y. pestis but not in closely related species such as Yersinia enterocolytica and Yersinia pseudotuberculosis. In order to find antibodies specifically binding to Y. pestis we screened a large single chain Fv antibody fragment (scFv) phage display library using purified F1 antigen as a selection target. Different forms of the selected antibodies were used to establish assays for recombinant F1 antigen and Y. pestis detection. Methods: Phage antibody panning was performed against F1 in an automated fashion using the Kingfisher magnetic bead system. Selected scFvs were screened for F1-binding specificity by one-step alkaline phosphatase enzyme linked immunosorbant assay (ELISA), and assayed for binding to recombinant antigen and/or Y. pestis by flow cytometry and whole-cell ELISA. Results: Seven of the eight selected scFvs were shown to specifically bind both recombinant F1 and a panel of F1-positive Yersinia cells. The majority of the soluble scFvs were found to be difficult to purify, unstable and prone to cross-reactivity with F1-negative Yersinia strains, whereas phage displayed scFvs were found to be easy to purify/label and remarkably stable. Furthermore direct fluorescent labeling of phage displaying scFv allowed for an easy one-step flow cytometry assay. Slight cross-reactivity was observed when fixed cells were used in ELISA. Conclusions: Our high throughput methods of selection and screening allowed for time and cost effective discovery of seven scFvs specifically binding Y. pestis F1 antigen. We describe implementation of different methods for phage-based immunoassay. Based on the success of these methods and the proven stability of phage, we indicate that the use of phage-displayed, rather than phage-free proteins, might generally overcome the shortcomings of scFv antibodies.	[Lillo, Antonietta M.; Ayriss, Joanne E.; Shou, Yulin; Graves, Steven W.; Bradbury, Andrew R. M.; Pavlik, Peter] Los Alamos Natl Lab, Div Biosci, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Lillo, AM (corresponding author), Los Alamos Natl Lab, Div Biosci, Los Alamos, NM 87545 USA.	amb@lanl.gov		Bradbury, Andrew/0000-0002-5567-8172	Department of Homeland Security, Los Alamos National Laboratory Directed Research and development [20070010DR]	Department of Homeland Security, Los Alamos National Laboratory Directed Research and development	This work was supported by the Department of Homeland Security, Los Alamos National Laboratory Directed Research and development funds 20070010DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ayriss J, 2007, J PROTEOME RES, V6, P1072, DOI 10.1021/pr0604108; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Chao HM, 1998, J CHROMATOGR B, V715, P307, DOI 10.1016/S0378-4347(98)00172-8; Chasteen L, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl772; Cherepanov P A, 1991, Mol Gen Mikrobiol Virusol, P19; CLACKSON T, 1994, TRENDS BIOTECHNOL, V12, P173, DOI 10.1016/0167-7799(94)90079-5; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Goncharov A Iu, 1992, Mol Gen Mikrobiol Virusol, P10; Jawetz E, 1943, J INFECT DIS, V73, P124, DOI 10.1093/infdis/73.2.124; Jaye DL, 2004, J IMMUNOL METHODS, V295, P119, DOI 10.1016/j.jim.2004.09.011; Kehoe JW, 2006, MOL CELL PROTEOMICS, V5, P2350, DOI 10.1074/mcp.M600314-MCP200; Lindler LE, 1998, INFECT IMMUN, V66, P5731, DOI 10.1128/IAI.66.12.5731-5742.1998; Loset GA, 2008, BIOTECHNIQUES, V44, P551, DOI 10.2144/000112724; Lou JL, 2001, J IMMUNOL METHODS, V253, P233, DOI 10.1016/S0022-1759(01)00385-4; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Marzari R, 2002, EUR J IMMUNOL, V32, P2773, DOI 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G; Neri D, 1998, METH MOL B, V80, P475; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Sblattero D, 2002, EUR J BIOCHEM, V269, P5175, DOI 10.1046/j.1432-1033.2002.03215.x; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Velappan N, 2007, J IMMUNOL METHODS, V321, P60, DOI 10.1016/j.jim.2007.01.011	26	27	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27756	10.1371/journal.pone.0027756	http://dx.doi.org/10.1371/journal.pone.0027756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174746	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600004
J	Subach, OM; Cranfill, PJ; Davidson, MW; Verkhusha, VV				Subach, Oksana M.; Cranfill, Paula J.; Davidson, Michael W.; Verkhusha, Vladislav V.			An Enhanced Monomeric Blue Fluorescent Protein with the High Chemical Stability of the Chromophore	PLOS ONE			English	Article							PHOTOSTABILITY	Commonly used monomeric blue fluorescent proteins suffer from moderate brightness. The brightest of them, mTagBFP, has a notably low chemical stability over time. Prolonged incubation of mTagBFP leads to its transition from a blue fluorescent state with absorbance at 401 nm to a non-fluorescent state with absorbance at 330 nm. Here, we have determined the chemical structure of the degraded product of the blue mTagBFP-like chromophore. On the basis of mTagBFP we have developed an improved variant, named mTagBFP2. mTagBFP2 exhibits 2-fold greater chemical stability and substantially higher brightness in live cells than mTagBFP. mTagBFP2 is also 1.2-fold and 1.7-fold more photostable than mTagBFP in widefield and confocal microscopy setups, respectively. mTagBFP2 maintains all other beneficial properties of the parental mTagBFP including the high pH stability and fast chromophore formation. The enhanced photostability and chromophore chemical stability of mTagBFP2 make it a superior protein tag. mTagBFP2 performs well in the numerous protein fusions and surpasses mTagBFP as a donor in Forster resonance energy transfer with several green fluorescent protein acceptors.	[Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA; [Subach, Oksana M.; Verkhusha, Vladislav V.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, New York, NY USA; [Cranfill, Paula J.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Cranfill, Paula J.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	Yeshiva University; Yeshiva University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Subach, OM (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, New York, NY USA.	vladislav.verkhusha@einstein.yu.edu	Subach, Oksana (Gritsenko)/K-7086-2014; Verkhusha, Vladislav/AAU-7784-2020	Verkhusha, Vladislav/0000-0002-2083-8121	United States National Institutes of Health [GM073913]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073913] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grant GM073913 from the United States National Institutes of Health: http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Bastiaens PIH, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 3, P136; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hsu STD, 2009, CHEM SOC REV, V38, P2951, DOI 10.1039/b908170b; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Mena MA, 2006, NAT BIOTECHNOL, V24, P1569, DOI 10.1038/nbt1264; Piatkevich KD, 2010, CURR OPIN CHEM BIOL, V14, P23, DOI 10.1016/j.cbpa.2009.10.011; Pletnev S, 2010, J AM CHEM SOC, V132, P2243, DOI 10.1021/ja908418r; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Snedecor GW, 1980, STAT METHODS, V7th; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2010, CHEM BIOL, V17, P333, DOI 10.1016/j.chembiol.2010.03.005; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/NMETH.1317, 10.1038/nmeth.1317]; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Wu B, 2011, CURR OPIN CELL BIOL, V23, P310, DOI 10.1016/j.ceb.2010.12.004	21	166	177	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28674	10.1371/journal.pone.0028674	http://dx.doi.org/10.1371/journal.pone.0028674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174863	Green Published, gold			2022-12-27	WOS:000298163600038
J	Marks, DS; Colwell, LJ; Sheridan, R; Hopf, TA; Pagnani, A; Zecchina, R; Sander, C				Marks, Debora S.; Colwell, Lucy J.; Sheridan, Robert; Hopf, Thomas A.; Pagnani, Andrea; Zecchina, Riccardo; Sander, Chris			Protein 3D Structure Computed from Evolutionary Sequence Variation	PLOS ONE			English	Article							ALL-ATOM REFINEMENT; STRUCTURE PREDICTION; RESIDUE CONTACTS; INFORMATION; RESOLUTION; NETWORKS; CONFORMATION; BOTTLENECKS; PROGRESS; DYNAMICS	The evolutionary trajectory of a protein through sequence space is constrained by its function. Collections of sequence homologs record the outcomes of millions of evolutionary experiments in which the protein evolves according to these constraints. Deciphering the evolutionary record held in these sequences and exploiting it for predictive and engineering purposes presents a formidable challenge. The potential benefit of solving this challenge is amplified by the advent of inexpensive high-throughput genomic sequencing. In this paper we ask whether we can infer evolutionary constraints from a set of sequence homologs of a protein. The challenge is to distinguish true co-evolution couplings from the noisy set of observed correlations. We address this challenge using a maximum entropy model of the protein sequence, constrained by the statistics of the multiple sequence alignment, to infer residue pair couplings. Surprisingly, we find that the strength of these inferred couplings is an excellent predictor of residue-residue proximity in folded structures. Indeed, the top-scoring residue couplings are sufficiently accurate and well-distributed to define the 3D protein fold with remarkable accuracy. We quantify this observation by computing, from sequence alone, all-atom 3D structures of fifteen test proteins from different fold classes, ranging in size from 50 to 260 residues., including a G-protein coupled receptor. These blinded inferences are de novo, i.e., they do not use homology modeling or sequence-similar fragments from known structures. The co-evolution signals provide sufficient information to determine accurate 3D protein structure to 2.7-4.8 A Ca-RMSD error relative to the observed structure, over at least two-thirds of the protein (method called EVfold, details at http://EVfold.org). This discovery provides insight into essential interactions constraining protein evolution and will facilitate a comprehensive survey of the universe of protein structures, new strategies in protein and drug design, and the identification of functional genetic variants in normal and disease genomes.	[Marks, Debora S.; Hopf, Thomas A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA; [Colwell, Lucy J.] MRC Lab Mol Biol, Cambridge, England; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Pagnani, Andrea; Zecchina, Riccardo] Human Genet Fdn, Turin, Italy; [Zecchina, Riccardo] Politecn Torino, Turin, Italy	Harvard University; Harvard Medical School; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center; Polytechnic University of Turin	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA.	foldingproteins@cbio.mskcc.org	Pagnani, Andrea/J-2363-2015	Pagnani, Andrea/0000-0002-6509-0807; ZECCHINA, Riccardo/0000-0002-1221-5207	Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center [NIH U54-CA143798]; Engineering and Physical Sciences Research Council [EP/H028064/1]; German National Academic Foundation; European Community [267915]; EPSRC [EP/H028064/1] Funding Source: UKRI; MRC [MC_U105161047] Funding Source: UKRI; Medical Research Council [MC_U105161047] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German National Academic Foundation; European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CS and RS have support from the Dana Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center (NIH U54-CA143798). LC is supported by an Engineering and Physical Sciences Research Council fellowship (EP/H028064/1). TH has support from the German National Academic Foundation. RZ has support from European Community grant 267915. No other financial support was received for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1988, PROTEIN ENG, V2, P193, DOI 10.1093/protein/2.3.193; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Bradley P, 2003, PROTEINS, V53, P457, DOI 10.1002/prot.10552; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; CHOTHIA C, 1973, J MOL BIOL, V75, P295, DOI 10.1016/0022-2836(73)90022-3; Cozzetto D, 2005, FEBS J, V272, P881, DOI 10.1111/j.1742-4658.2005.04549.x; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; DeBartolo J, 2009, P NATL ACAD SCI USA, V106, P3734, DOI 10.1073/pnas.0811363106; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Duan Y, 1998, P NATL ACAD SCI USA, V95, P9897, DOI 10.1073/pnas.95.17.9897; Duarte JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-283; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Giraud BG, 1999, PHYS REV E, V59, P4983, DOI 10.1103/PhysRevE.59.4983; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; HAVEL TF, 1983, J THEOR BIOL, V104, P359, DOI 10.1016/0022-5193(83)90112-1; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Joost P, 2002, GENOME BIOL, V3; Kamat AP, 2007, PROTEINS, V66, P869, DOI 10.1002/prot.21241; Kappen HJ, 1998, NEURAL COMPUT, V10, P1137, DOI 10.1162/089976698300017386; Kim DE, 2009, J MOL BIOL, V393, P249, DOI 10.1016/j.jmb.2009.07.063; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740; Lezon TR, 2006, P NATL ACAD SCI USA, V103, P19033, DOI 10.1073/pnas.0609152103; Liu LC, 1999, MONOGRAPH SERIES I M, P236; Locasale JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006522; Mezard M, 2009, J PHYSIOL-PARIS, V103, P107, DOI 10.1016/j.jphysparis.2009.05.013; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Miyano M, 2001, Tanpakushitsu Kakusan Koso, V46, P687; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Morea V, 1997, BIOPHYS CHEM, V68, P9, DOI 10.1016/S0301-4622(96)02266-1; Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Nair Rajesh, 2009, Journal of Structural and Functional Genomics, V10, P181, DOI 10.1007/s10969-008-9055-6; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ortiz AR, 1998, P NATL ACAD SCI USA, V95, P1020, DOI 10.1073/pnas.95.3.1020; Ortiz AR, 1999, PROTEINS, P177; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Poon AFY, 2008, BIOINFORMATICS, V24, P1949, DOI 10.1093/bioinformatics/btn313; Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Ravikumar P, 2010, ANN STAT, V38, P1287, DOI 10.1214/09-AOS691; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Roudi Y, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.022.2009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sathyapriya R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000584; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Schrodinger L., 2020, PYMOL; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Sessak V, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/5/055001; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Simons KT, 1999, PROTEINS, P171; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skolnick J, 1997, J MOL BIOL, V265, P217, DOI 10.1006/jmbi.1996.0720; Taylor WR, 2007, COMPUT BIOL CHEM, V31, P151, DOI 10.1016/j.compbiolchem.2007.03.002; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Wu ST, 2011, STRUCTURE, V19, P1182, DOI 10.1016/j.str.2011.05.004; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	80	683	697	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28766	10.1371/journal.pone.0028766	http://dx.doi.org/10.1371/journal.pone.0028766			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163331	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900067
J	Takeda, A; Takada, S; Nakamura, M; Suzuki, M; Tamano, H; Ando, M; Oku, N				Takeda, Atsushi; Takada, Shunsuke; Nakamura, Masatoshi; Suzuki, Miki; Tamano, Haruna; Ando, Masaki; Oku, Naoto			Transient Increase in Zn2+ in Hippocampal CA1 Pyramidal Neurons Causes Reversible Memory Deficit	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; OBJECT-RECOGNITION; CHELATABLE ZINC; MODULATION; CLIOQUINOL; CHANNELS; AMYGDALA; ACCUMULATION; IMPAIRMENT	The translocation of synaptic Zn2+ to the cytosolic compartment has been studied to understand Zn2+ neurotoxicity in neurological diseases. However, it is unknown whether the moderate increase in Zn2+ in the cytosolic compartment affects memory processing in the hippocampus. In the present study, the moderate increase in cytosolic Zn2+ in the hippocampus was induced with clioquinol (CQ), a zinc ionophore. Zn2+ delivery by Zn-CQ transiently attenuated CA1 long-term potentiation (LTP) in hippocampal slices prepared 2 h after i.p. injection of Zn-CQ into rats, when intracellular Zn2+ levels was transiently increased in the CA1 pyramidal cell layer, followed by object recognition memory deficit. Object recognition memory was transiently impaired 30 min after injection of ZnCl2 into the CA1, but not after injection into the dentate gyrus that did not significantly increase intracellular Zn2+ in the granule cell layer of the dentate gyrus. Object recognition memory deficit may be linked to the preferential increase in Zn2+ and/or the preferential vulnerability to Zn2+ in CA1 pyramidal neurons. In the case of the cytosolic increase in endogenous Zn2+ in the CA1 induced by 100 mM KCl, furthermore, object recognition memory was also transiently impaired, while ameliorated by co-injection of CaEDTA to block the increase in cytosolic Zn2+. The present study indicates that the transient increase in cytosolic Zn2+ in CA1 pyramidal neurons reversibly impairs object recognition memory.	[Takeda, Atsushi; Takada, Shunsuke; Nakamura, Masatoshi; Suzuki, Miki; Tamano, Haruna; Ando, Masaki; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Shizuoka 4228526, Japan	University of Shizuoka	Takeda, A (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, Global COE-21, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172	Global COE	Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The source of funding is Global COE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aggleton JP, 2005, Q J EXP PSYCHOL-B, V58, P218, DOI 10.1080/02724990444000131; Andersson DA, 2009, P NATL ACAD SCI USA, V106, P8374, DOI 10.1073/pnas.0812675106; Ando M, 2010, NEUROCHEM INT, V57, P608, DOI 10.1016/j.neuint.2010.07.010; Bareggi SR, 2009, BRAIN RES, V1280, P195, DOI 10.1016/j.brainres.2009.05.031; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Dias CP, 2007, NEUROSCIENCE, V146, P1719, DOI 10.1016/j.neuroscience.2007.03.018; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; FREDERICKSON CJ, 1990, PROG BRAIN RES, V83, P71; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Howland JG, 2008, PROG BRAIN RES, V169, P145, DOI 10.1016/S0079-6123(07)00008-8; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krezel A, 2008, J BIOL INORG CHEM, V13, P401, DOI 10.1007/s00775-007-0330-y; Krezel A, 2007, ARCH BIOCHEM BIOPHYS, V463, P188, DOI 10.1016/j.abb.2007.02.017; Lee JY, 2000, J NEUROSCI, V20; Lengyel I, 2000, J NEUROCHEM, V75, P594, DOI 10.1046/j.1471-4159.2000.0750594.x; Liu J, 1999, J NEUROSCI, V19, P8292; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; MURRAY EA, 1984, J NEUROSCI, V4, P2565; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Rossato JI, 2007, LEARN MEMORY, V14, P36, DOI 10.1101/lm.422607; Sekler I, 2002, J COMP NEUROL, V447, P201, DOI 10.1002/cne.10224; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1997, J NEUROSCI, V17, P9554; SMART TG, 1994, PROG NEUROBIOL, V42, P393, DOI 10.1016/0301-0082(94)90082-5; Takeda A, 2003, J NEUROSCI RES, V72, P537, DOI 10.1002/jnr.10600; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A., 2011, INT J ALZHEIMERS DIS, V2011; Takeda A, 2008, J NEUROSCI RES, V86, P2906, DOI 10.1002/jnr.21732; Takeda A, 2007, J NEUROSCI RES, V85, P3666, DOI 10.1002/jnr.21449; Takeda A, 2007, J NEUROSCI RES, V85, P1310, DOI 10.1002/jnr.21233; Takeda A, 2006, J NEUROCHEM, V99, P670, DOI 10.1111/j.1471-4159.2006.04092.x; Takeda A, 2011, MOL NEUROBIOL, V44, P166, DOI 10.1007/s12035-010-8158-9; Takeda A, 2010, BRAIN RES, V1354, P188, DOI 10.1016/j.brainres.2010.07.039; Takeda A, 2010, BRAIN RES, V1323, P59, DOI 10.1016/j.brainres.2010.01.085; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Takeda A, 2009, NEUROTOXICOLOGY, V30, P712, DOI 10.1016/j.neuro.2009.05.009; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; ZOLAMORGAN S, 1982, SCIENCE, V218, P1337, DOI 10.1126/science.6890713	55	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28615	10.1371/journal.pone.0028615	http://dx.doi.org/10.1371/journal.pone.0028615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163318	gold, Green Submitted, Green Published			2022-12-27	WOS:000298161900054
J	Kobayashi, T; Washiyama, K; Ikeda, K				Kobayashi, Toru; Washiyama, Kazuo; Ikeda, Kazutaka			Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Different Classes of Antidepressants	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; HERG POTASSIUM CHANNELS; IN-VIVO; FUNCTIONAL EXPRESSION; GIRK CHANNELS; TRICYCLIC ANTIDEPRESSANTS; BRAIN PHARMACOKINETICS; RELATIVE TOXICITY; MESSENGER-RNAS; FLUOXETINE	Various antidepressants are commonly used for the treatment of depression and several other neuropsychiatric disorders. In addition to their primary effects on serotonergic or noradrenergic neurotransmitter systems, antidepressants have been shown to interact with several receptors and ion channels. However, the molecular mechanisms that underlie the effects of antidepressants have not yet been sufficiently clarified. G protein-activated inwardly rectifying K+ (GIRK, Kir3) channels play an important role in regulating neuronal excitability and heart rate, and GIRK channel modulation has been suggested to have therapeutic potential for several neuropsychiatric disorders and cardiac arrhythmias. In the present study, we investigated the effects of various classes of antidepressants on GIRK channels using the Xenopus oocyte expression assay. In oocytes injected with mRNA for GIRK1/GIRK2 or GIRK1/GIRK4 subunits, extracellular application of sertraline, duloxetine, and amoxapine effectively reduced GIRK currents, whereas nefazodone, venlafaxine, mianserin, and mirtazapine weakly inhibited GIRK currents even at toxic levels. The inhibitory effects were concentration-dependent, with various degrees of potency and effectiveness. Furthermore, the effects of sertraline were voltage-independent and time-independent during each voltage pulse, whereas the effects of duloxetine were voltage-dependent with weaker inhibition with negative membrane potentials and time-dependent with a gradual decrease in each voltage pulse. However, Kir2.1 channels were insensitive to all of the drugs. Moreover, the GIRK currents induced by ethanol were inhibited by sertraline but not by intracellularly applied sertraline. The present results suggest that GIRK channel inhibition may reveal a novel characteristic of the commonly used antidepressants, particularly sertraline, and contributes to some of the therapeutic effects and adverse effects.	[Kobayashi, Toru; Washiyama, Kazuo] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Project Programs, Niigata, Japan; [Kobayashi, Toru; Ikeda, Kazutaka] Tokyo Metropolitan Inst Med Sci, Res Project Addict Subst, Tokyo 113, Japan	Niigata University; Tokyo Metropolitan Institute of Medical Science	Kobayashi, T (corresponding author), Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Dept Project Programs, Niigata, Japan.	torukoba@bri.niigata-u.ac.jp	Ikeda, Kazutaka/I-4694-2013	Ikeda, Kazutaka/0000-0001-8342-0278	Ministry of Education, Culture, Sports Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by research grants from the Ministry of Education, Culture, Sports Science and Technology of Japan and the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2008, J NEUROCHEM, V105, P497, DOI 10.1111/j.1471-4159.2007.05153.x; ALTAMURA AC, 1987, PROG NEURO-PSYCHOPH, V11, P23, DOI 10.1016/0278-5846(87)90028-5; Baldessarini R.J., 2001, GOODMAN GILMANS PHAR, P447; Bettahi H, 2002, J BIOL CHEM, V277, P48282, DOI 10.1074/jbc.M209599200; Blednov YA, 2001, J PHARMACOL EXP THER, V298, P521; Bolo NR, 2000, NEUROPSYCHOPHARMACOL, V23, P428, DOI 10.1016/S0893-133X(00)00116-0; Bymaster FP, 2005, CURR PHARM DESIGN, V11, P1475, DOI 10.2174/1381612053764805; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Choi BH, 2001, NEUROPHARMACOLOGY, V41, P443, DOI 10.1016/S0028-3908(01)00088-0; Cruz HG, 2008, J NEUROSCI, V28, P4069, DOI 10.1523/JNEUROSCI.0267-08.2008; Cuellar-Quintero JL, 2001, NEUROREPORT, V12, P2195, DOI 10.1097/00001756-200107200-00030; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; Deak F, 2000, NEUROPHARMACOLOGY, V39, P1029, DOI 10.1016/S0028-3908(99)00206-3; Dreixler JC, 2000, EUR J PHARMACOL, V401, P1, DOI 10.1016/S0014-2999(00)00401-5; FAN P, 1994, BRIT J PHARMACOL, V112, P741, DOI 10.1111/j.1476-5381.1994.tb13140.x; FROMMER DA, 1987, JAMA-J AM MED ASSOC, V257, P521, DOI 10.1001/jama.257.4.521; Goeringer KE, 2000, J FORENSIC SCI, V45, P633; Gray AM, 2002, EUR NEUROPSYCHOPHARM, V12, P245, DOI 10.1016/S0924-977X(02)00028-7; GULLEY JM, 1995, ALCOHOL, V12, P177, DOI 10.1016/0741-8329(94)00079-S; Harada Yoshimitsu, 2006, Folia Pharmacologica Japonica, V128, P417, DOI 10.1254/fpj.128.417; Hashimoto N, 2006, PHARMACOL RES, V54, P136, DOI 10.1016/j.phrs.2006.03.021; He YL, 2010, J PHARMACOL EXP THER, V332, P437, DOI 10.1124/jpet.109.159160; Henry ME, 2005, NEUROPSYCHOPHARMACOL, V30, P1576, DOI 10.1038/sj.npp.1300749; Henry ME, 2000, AM J PSYCHIAT, V157, P1506, DOI 10.1176/appi.ajp.157.9.1506; Heurteaux C, 2006, NAT NEUROSCI, V9, P1134, DOI 10.1038/nn1749; Hill KG, 2003, PSYCHOPHARMACOLOGY, V169, P108, DOI 10.1007/s00213-003-1472-4; Holzbach R, 1998, BIOL PSYCHIAT, V44, P925, DOI 10.1016/S0006-3223(98)00081-X; Ikeda K, 2003, METH MOLEC MED, V84, P53; Inanobe A, 1999, J NEUROSCI, V19, P1006; Isbister GK, 2004, J TOXICOL-CLIN TOXIC, V42, P277, DOI 10.1081/CLT-120037428; Karschin C, 1996, J NEUROSCI, V16, P3559; KARSON CN, 1993, J NEUROPSYCH CLIN N, V5, P322; Kent J, 2000, LANCET, V355, P2000; Kobayashi T, 2004, NEUROPSYCHOPHARMACOL, V29, P1841, DOI 10.1038/sj.npp.1300484; Kobayashi T, 2000, BRIT J PHARMACOL, V129, P1716, DOI 10.1038/sj.bjp.0703224; Kobayashi T, 2003, BRIT J PHARMACOL, V138, P1119, DOI 10.1038/sj.bjp.0705172; Kobayashi T, 2002, BRIT J PHARMACOL, V135, P313, DOI 10.1038/sj.bjp.0704475; KOBAYASHI T, 1995, BIOCHEM BIOPH RES CO, V208, P1166, DOI 10.1006/bbrc.1995.1456; Kobayashi T, 1999, NAT NEUROSCI, V2, P1091, DOI 10.1038/16019; Kobayashi T, 2006, J PHARMACOL SCI, V102, P278, DOI 10.1254/jphs.FP0060708; Kobayashi T, 2006, CURR PHARM DESIGN, V12, P4513, DOI 10.2174/138161206779010468; Kobayashi T, 2010, NEUROPSYCHOPHARMACOL, V35, P1560, DOI 10.1038/npp.2010.27; KOVOOR A, 1995, J BIOL CHEM, V270, P589, DOI 10.1074/jbc.270.2.589; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Lee K, 1997, BRIT J PHARMACOL, V121, P1810, DOI 10.1038/sj.bjp.0701333; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Levine B, 1996, J ANAL TOXICOL, V20, P502, DOI 10.1093/jat/20.6.502; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liao YJ, 1996, J NEUROSCI, V16, P7137; LITOVITZ TL, 1983, JAMA-J AM MED ASSOC, V250, P1069, DOI 10.1001/jama.250.8.1069; Lobo ED, 2008, CLIN PHARMACOKINET, V47, P191, DOI 10.2165/00003088-200847030-00005; Lott RS, 2003, ADV PHARMACOL, V1, P228; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Maertens C, 1999, BRIT J PHARMACOL, V126, P508, DOI 10.1038/sj.bjp.0702314; Maertens C, 2002, N-S ARCH PHARMACOL, V366, P158, DOI 10.1007/s00210-002-0567-5; Mann JJ, 2005, NEW ENGL J MED, V353, P1819, DOI 10.1056/NEJMra050730; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Montgomery SA, 2005, INT J CLIN PRACT, V59, P1435, DOI 10.1111/j.1368-5031.2005.00731.x; Morgan AD, 2003, NEUROPSYCHOPHARMACOL, V28, P932, DOI 10.1038/sj.npp.1300100; Musshoff F, 2004, FORENSIC SCI INT, V142, P161, DOI 10.1016/j.forsciint.2004.02.017; Nacca A, 1996, BRIT J PHARMACOL, V125, P1617; Nakazawa K, 1999, NEUROSCI LETT, V264, P93, DOI 10.1016/S0304-3940(99)00183-4; Ni YG, 1997, P NATL ACAD SCI USA, V94, P2036, DOI 10.1073/pnas.94.5.2036; NORTH RA, 1989, BRIT J PHARMACOL, V98, P13, DOI 10.1111/j.1476-5381.1989.tb16855.x; OGATA N, 1989, BRAIN RES, V476, P140, DOI 10.1016/0006-8993(89)91546-1; Pabon A, 2000, J BIOL CHEM, V275, P30677, DOI 10.1074/jbc.M005338200; Pancrazio JJ, 1998, J PHARMACOL EXP THER, V284, P208; Pettinati HM, 2000, ALCOHOL CLIN EXP RES, V24, P1041, DOI 10.1111/j.1530-0277.2000.tb04648.x; Reimann F, 1999, CURR OPIN CELL BIOL, V11, P503, DOI 10.1016/S0955-0674(99)80073-8; Sanchez C, 1997, PSYCHOPHARMACOLOGY, V129, P197, DOI 10.1007/s002130050181; Schatzberg AF, 2000, J CLIN PSYCHIAT, V61, P9; Scherer D, 2008, N-S ARCH PHARMACOL, V378, P73, DOI 10.1007/s00210-008-0289-4; SEDGWICK P, 1982, J ANAL TOXICOL, V6, P82, DOI 10.1093/jat/6.2.82; SERNAGOR E, 1989, NEURON, V2, P1221, DOI 10.1016/0896-6273(89)90306-1; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; SIGEL E, 1990, J MEMBRANE BIOL, V117, P201, DOI 10.1007/BF01868451; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Stahl SM, 2005, CNS SPECTRUMS, V10, P732, DOI 10.1017/S1092852900019726; TAYLOR RL, 1982, J ANAL TOXICOL, V6, P309, DOI 10.1093/jat/6.6.309; Terstappen GC, 2001, NEUROPHARMACOLOGY, V40, P772, DOI 10.1016/S0028-3908(01)00007-7; Teschemacher AG, 1999, BRIT J PHARMACOL, V128, P479, DOI 10.1038/sj.bjp.0702800; TREMAINE LM, 1989, DRUG METAB DISPOS, V17, P542; Uhr M, 2003, BIOL PSYCHIAT, V54, P840, DOI 10.1016/S0006-3223(03)00074-X; Vey EL, 2010, J FORENSIC LEG MED, V17, P175, DOI 10.1016/j.jflm.2010.02.002; WELZEN M, 2004, TIAFT REFERENCE BLOO; Whyte IM, 2003, QJM-INT J MED, V96, P369, DOI 10.1093/qjmed/hcg062	90	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28208	10.1371/journal.pone.0028208	http://dx.doi.org/10.1371/journal.pone.0028208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164246	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400047
J	Liu, S; Schwarzinger, M; Carrat, F; Goldhaber-Fiebert, JD				Liu, Shan; Schwarzinger, Michael; Carrat, Fabrice; Goldhaber-Fiebert, Jeremy D.			Cost Effectiveness of Fibrosis Assessment Prior to Treatment for Chronic Hepatitis C Patients	PLOS ONE			English	Article							HEALTH-STATE UTILITIES; QUALITY-OF-LIFE; LIVER FIBROSIS; BIOCHEMICAL MARKERS; VIRUS-INFECTION; UNITED-STATES; BLOOD-TESTS; BIOPSY; FIBROTEST; POPULATION	Background and Aims: Chronic hepatitis C (HCV) is a liver disease affecting over 3 million Americans. Liver biopsy is the gold standard for assessing liver fibrosis and is used as a benchmark for initiating treatment, though it is expensive and carries risks of complications. FibroTest is a non-invasive biomarker assay for fibrosis, proposed as a screening alternative to biopsy. Methods: We assessed the cost-effectiveness of FibroTest and liver biopsy used alone or sequentially for six strategies followed by treatment of eligible U. S. patients: FibroTest only; FibroTest with liver biopsy for ambiguous results; FibroTest followed by biopsy to rule in; or to rule out significant fibrosis; biopsy only (recommended practice); and treatment without screening. We developed a Markov model of chronic HCV that tracks fibrosis progression. Outcomes were expressed as expected lifetime costs (2009 USD), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICER). Results: Treatment of chronic HCV without fibrosis screening is preferred for both men and women. For genotype 1 patients treated with pegylated interferon and ribavirin, the ICERs are $ 5,400/QALY (men) and $ 6,300/QALY (women) compared to FibroTest only; the ICERs increase to $ 27,200/QALY (men) and $ 30,000/QALY (women) with the addition of telaprevir. For genotypes 2 and 3, treatment is more effective and less costly than all alternatives. In clinical settings where testing is required prior to treatment, FibroTest only is more effective and less costly than liver biopsy. These results are robust to multi-way and probabilistic sensitivity analyses. Conclusions: Early treatment of chronic HCV is superior to the other fibrosis screening strategies. In clinical settings where testing is required, FibroTest screening is a cost-effective alternative to liver biopsy.	[Liu, Shan] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA; [Schwarzinger, Michael] Paris Diderot Univ, INSERM, Equipe ATIP, AVENIR,UMR S 738, Paris, France; [Carrat, Fabrice] Univ Paris 06, INSERM, UMR S 707, Paris, France; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Dept Med, Ctr Hlth Policy, Stanford, CA 94305 USA; [Goldhaber-Fiebert, Jeremy D.] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University	Liu, S (corresponding author), Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA.	shanliu@stanford.edu	Carrat, Fabrice/AAU-8480-2020; Schwarzinger, Michael/F-7367-2011; Liu, Sheng/K-2815-2013	Carrat, Fabrice/0000-0002-8672-7918; Schwarzinger, Michael/0000-0002-0573-6856; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	U.S. National Institutes of Health National Institute on Aging [K01 AG037593-01A1]; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Ms. Liu was supported by a Stanford Graduate Fellowship. Dr. Goldhaber- Fiebert was supported in part by a U.S. National Institutes of Health National Institute on Aging Career Development Award (K01 AG037593-01A1: PI; Goldhaber-Fiebert). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHFS Drug Information, BETHESDA MD AMERICAN; Andriulli A, 2004, J VIRAL HEPATITIS, V11, P536, DOI 10.1111/j.1365-2893.2004.00519.x; Arias E:, 2007, NATL VITAL STAT REPO; Armstrong EP, 2004, CURR MED RES OPIN, V20, P671, DOI 10.1185/030079904125003485; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bedossa P, 2009, J HEPATOL, V50, P1, DOI 10.1016/j.jhep.2008.10.014; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Boursier J, 2009, EUR J GASTROEN HEPAT, V21, P28, DOI 10.1097/MEG.0b013e32830cebd7; Cales P, 2008, LIVER INT, V28, P1352, DOI 10.1111/j.1478-3231.2008.01789.x; Carlson JJ, 2009, J GASTROEN HEPATOL, V24, P786, DOI 10.1111/j.1440-1746.2009.05778.x; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Fattovich G, 1996, J HEPATOL, V24, P38, DOI 10.1016/S0168-8278(96)80184-X; Federal Supply Schedule, 2011, FEDERAL SUPPLY SCHED; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; GOLD MR, 1996, COST EFFECTIVENESS H, V23; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Halfon P, 2006, AM J GASTROENTEROL, V101, P547, DOI 10.1111/j.1572-0241.2006.00411.x; Halfon P, 2007, J HEPATOL, V46, P395, DOI 10.1016/j.jhep.2006.09.020; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Jacobson IM, N ENGL J MED, V364, P2405; Levinson DR., 2005, MED DRUG PRICE COMPA; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Melita SH, 2009, J HEPATOL, V50, P36, DOI 10.1016/j.jhep.2008.07.039; MITRA D, 2010, VALUE HLTH; Narasimhan G, 2006, J VIRAL HEPATITIS, V13, P783, DOI 10.1111/j.1365-2893.2006.00763.x; NIH, 2002, JUN 10 12, V19, P1; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; Pollack A, 2011, 2 DRUG WINS APPROVAL; Poret AW, 2002, DIS MANAG, V5, P95; Poynard T, 2004, CLIN CHEM, V50, P1344, DOI 10.1373/clinchem.2004.032227; Poynard T, 2000, CAN J GASTROENTEROL, V14, P543, DOI 10.1155/2000/107982; Poynard T, 2004, COMP HEPATOLOGY; Poynard T, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-40; Practice of FibroTest for hepatitis C, PRACT FIBR TEST HEPA; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rossi E, 2003, CLIN CHEM, V49, P450, DOI 10.1373/49.3.450; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Sebastiani G, 2006, J HEPATOL, V44, P686, DOI 10.1016/j.jhep.2006.01.007; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Shaheen AAM, 2007, AM J GASTROENTEROL, V102, P2589, DOI 10.1111/j.1572-0241.2007.01466.x; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Siddiqui FA, 2008, HEPATOL INT, V2, P376, DOI 10.1007/s12072-008-9086-x; Sporea I, 2008, WORLD J GASTROENTERO, V14, P3396, DOI 10.3748/wjg.14.3396; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Tan JA, 2008, HEPATOLOGY, V48, P1387, DOI 10.1002/hep.22509; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Thomson Corporation, 2009, RED BOOK PHARM FUND; United States Department of Labor, BUR LAB STAT CONS PR; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 1998, JAMA-J AM MED ASSOC, V280, P2088, DOI 10.1001/jama.280.24.2088	55	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26783	10.1371/journal.pone.0026783	http://dx.doi.org/10.1371/journal.pone.0026783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164204	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400004
J	Munneke, J; Heslenfeld, DJ; Usrey, WM; Theeuwes, J; Mangun, GR				Munneke, Jaap; Heslenfeld, Dirk J.; Usrey, W. Martin; Theeuwes, Jan; Mangun, George R.			Preparatory Effects of Distractor Suppression: Evidence from Visual Cortex	PLOS ONE			English	Article							SPATIAL SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; FUNCTIONAL MRI; INHIBITORY SURROUNDS; SIGNAL ENHANCEMENT; DIRECTED ATTENTION; BRAIN ACTIVITY; FIELD; FMRI	Spatial selective attention is the mechanism that facilitates the selection of relevant information over irrelevant information in the visual field. The current study investigated whether foreknowledge of the presence or absence of distractors surrounding an impending target stimulus results in preparatory changes in visual cortex. We cued the location of the target and the presence or absence of distractors surrounding the target while changes in blood oxygen level dependent (BOLD) signals were measured. In line with prior work, we found that top-down spatial attention resulted in an increased contralateral BOLD response, evoked by the cue throughout early visual cortex (areas V1, V2 and V3). In addition, cues indicating distractor presence evoked a substantial increase in the magnitude of the BOLD signal in visual area V3, but not in V2 or V1. This study shows that prior knowledge concerning the presence of a distractor results in enhanced attentional modulation of visual cortex, in visual areas where neuronal receptive fields are large enough to encompass both targets and distractors. We interpret these findings as evidence that top-down attentional control processes include active preparatory suppression mechanisms for irrelevant, distracting information in the visual scene.	[Munneke, Jaap; Heslenfeld, Dirk J.; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Usrey, W. Martin] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Usrey, W. Martin; Mangun, George R.] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA; [Usrey, W. Martin] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Mangun, George R.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Mangun, George R.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	Vrije Universiteit Amsterdam; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Munneke, J (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	JA.Munneke@psy.vu.nl	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020	Theeuwes, Jan/0000-0002-5849-7721; Munneke, Jaap/0000-0002-3117-6186	National Institutes of Health [MH057714, EY013588]; National Science Foundation [BCS0727115]; NATIONAL EYE INSTITUTE [R01EY013588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants MH057714 to George R. Mangun and EY013588 to W. Martin Usrey, and by National Science Foundation grant BCS0727115 to George R. Mangun and W. Martin Usrey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2003, J EXP PSYCHOL HUMAN, V29, P52, DOI 10.1037/0096-1523.29.1.52; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Bahcall DO, 1999, VISION RES, V39, P71, DOI 10.1016/S0042-6989(98)00090-X; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; Carrasco M, 2000, VISION RES, V40, P1203, DOI 10.1016/S0042-6989(00)00024-9; Couperus JW, 2010, BRAIN RES, V1359, P155, DOI 10.1016/j.brainres.2010.08.076; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Downing C. J., 1985, ATTENTION PERFORM, P171; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hopf JM, 2006, J NEUROSCI, V26, P3532, DOI 10.1523/JNEUROSCI.4510-05.2006; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Luck SJ, 1996, J EXP PSYCHOL HUMAN, V22, P725, DOI 10.1037/0096-1523.22.3.725; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mounts JRW, 2000, PERCEPT PSYCHOPHYS, V62, P1485, DOI 10.3758/BF03212148; Mounts JRW, 2000, PERCEPT PSYCHOPHYS, V62, P969, DOI 10.3758/BF03212082; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Munneke J, 2008, ACTA PSYCHOL, V129, P101, DOI 10.1016/j.actpsy.2008.05.004; Munneke J, 2008, BRAIN RES, V1222, P184, DOI 10.1016/j.brainres.2008.05.039; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Ruff CC, 2006, J COGNITIVE NEUROSCI, V18, P522, DOI 10.1162/jocn.2006.18.4.522; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; SHIU LP, 1994, J EXP PSYCHOL HUMAN, V20, P1037, DOI 10.1037/0096-1523.20.5.1037; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Slotnick SD, 2003, HUM BRAIN MAPP, V18, P22, DOI 10.1002/hbm.10077; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; van der Heijden AHC., 1992, SELECTIVE ATTENTION; Vandenberghe R, 1997, J NEUROSCI, V17, P3739; Woldorff MG, 2004, J COGNITIVE NEUROSCI, V16, P149, DOI 10.1162/089892904322755638	46	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27700	10.1371/journal.pone.0027700	http://dx.doi.org/10.1371/journal.pone.0027700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164213	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400013
J	Augustinos, AA; Santos-Garcia, D; Dionyssopoulou, E; Moreira, M; Papapanagiotou, A; Scarvelakis, M; Doudoumis, V; Ramos, S; Aguiar, AF; Borges, PAV; Khadem, M; Latorre, A; Tsiamis, G; Bourtzis, K				Augustinos, Antonis A.; Santos-Garcia, Diego; Dionyssopoulou, Eva; Moreira, Marta; Papapanagiotou, Aristeidis; Scarvelakis, Marios; Doudoumis, Vangelis; Ramos, Silvia; Aguiar, Antonio F.; Borges, Paulo A. V.; Khadem, Manhaz; Latorre, Amparo; Tsiamis, George; Bourtzis, Kostas			Detection and Characterization of Wolbachia Infections in Natural Populations of Aphids: Is the Hidden Diversity Fully Unraveled?	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LIFE-SHORTENING WOLBACHIA; BACTERIAL ENDOSYMBIONTS; CYTOPLASMIC INCOMPATIBILITY; FACULTATIVE SYMBIONTS; PHYLOGENETIC ANALYSIS; BUCHNERA-APHIDICOLA; CULEX-PIPIENS; TYPING SYSTEM; PEA APHID	Aphids are a serious threat to agriculture, despite being a rather small group of insects. The about 4,000 species worldwide engage in highly interesting and complex relationships with their microbial fauna. One of the key symbionts in arthropods is Wolbachia, an alpha-Proteobacterium implicated in many important biological processes and believed to be a potential tool for biological control. Aphids were thought not to harbour Wolbachia; however, current data suggest that its presence in aphids has been missed, probably due to the low titre of the infection and/or to the high divergence of the Wolbachia strains of aphids. The goal of the present study is to map the Wolbachia infection status of natural aphids populations, along with the characterization of the detected Wolbachia strains. Out of 425 samples from Spain, Portugal, Greece, Israel and Iran, 37 were found to be infected. Our results, based mainly on 16S rRNA gene sequencing, indicate the presence of two new Wolbachia supergroups prevailing in aphids, along with some strains belonging either to supergroup B or to supergroup A.	[Augustinos, Antonis A.; Dionyssopoulou, Eva; Scarvelakis, Marios; Doudoumis, Vangelis; Tsiamis, George; Bourtzis, Kostas] Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece; [Santos-Garcia, Diego; Ramos, Silvia; Latorre, Amparo] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Moreira, Marta; Khadem, Manhaz] Univ Madeira, ISOPlexis Gene Bank, Funchal, Portugal; [Papapanagiotou, Aristeidis] Technol Educ Inst Messolonghi, Dept Greenhouse Crops & Floriculture, Mesolongion, Greece; [Aguiar, Antonio F.] Nucleo Fitopatol, Lab Qualidade Agr, Madeira, Portugal; [Borges, Paulo A. V.] Univ Acores, Azorean Biodivers Grp, Dept Ciencias Agr CITA A, Angra Do Heroismo, Terceira Azores, Portugal; [Latorre, Amparo] CSISP, Area Genom & Salud, Valencia, Spain; [Bourtzis, Kostas] Biomed Sci Res Ctr, Vari, Greece; [Augustinos, Antonis A.; Dionyssopoulou, Eva; Doudoumis, Vangelis; Tsiamis, George] Univ Western Greece, Dept Environm & Nat Resources Management, Agrinion, Greece	University of Ioannina; University of Valencia; Universidade da Madeira; Western Greece University of Applied Sciences (TEI of Western Greece); Universidade dos Acores	Augustinos, AA (corresponding author), Univ Ioannina, Dept Environm & Nat Resources Management, Agrinion, Greece.	kbourtz@uoi.gr	Augustinos, Antonios/C-1318-2019; Borges, Paulo/B-2780-2008; Borges, Paulo/H-5153-2019; Aguiar, Antonio/GQC-6073-2022; Latorre, Amparo/E-4997-2015; Aguiar, António/ACZ-6595-2022; Santos-Garcia, Diego/N-9032-2017	Augustinos, Antonios/0000-0003-3682-6077; Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Aguiar, Antonio/0000-0002-9572-2967; Latorre, Amparo/0000-0002-9146-7284; Aguiar, António/0000-0002-9572-2967; Santos-Garcia, Diego/0000-0002-3401-2662	European Community [203590]; Ministerio de Ciencia e Innovacion-Spain [BFU2009-12895-C02-01]; Foundation for Science and Technology-Portugal [FCT-PTDC/AGR-AAM/108312/2008]; EU [FA0701]	European Community(European Commission); Ministerio de Ciencia e Innovacion-Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation for Science and Technology-Portugal(Portuguese Foundation for Science and Technology); EU(European Commission)	This research was supported in part by the European Community's Seventh Framework Programme CSA-SA_ REGPROT-2007-1 under grant agreement no 203590 (KB), Project BFU2009-12895-C02-01 from the Ministerio de Ciencia e Innovacion-Spain (AL) and Project FCT-PTDC/AGR-AAM/108312/2008 by Foundation for Science and Technology-Portugal (MK). MM and VD received a travel grant from EU COST Action FA0701 "Arthropod Symbiosis: from fundamental studies to pest and disease management''. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIAR FM, 2001, B SANIDADE VEGETAL P, V27, P323; Apostolaki A, 2011, J APPL ENTOMOL, V135, P546, DOI 10.1111/j.1439-0418.2011.01614.x; Arthofer W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022198; Arthofer W, 2009, MOL ECOL, V18, P3816, DOI 10.1111/j.1365-294X.2009.04321.x; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BLACKMAN R.L., 1984, ORIENT INSECTS; Blackman R.L., 2000, J ECON ENTOMOL, V2; Bordenstein S, 2005, CURR MICROBIOL, V51, P393, DOI 10.1007/s00284-005-0084-0; Bourtzis K, 1998, NATURE, V391, P852, DOI 10.1038/36017; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; Brault V, 2010, J GEN VIROL, V91, P802, DOI 10.1099/vir.0.012856-0; Breeuwer J.A.J., 1992, Insect Molecular Biology, V1, P25, DOI 10.1111/j.1365-2583.1993.tb00074.x; Brinza L, 2009, CR BIOL, V332, P1034, DOI 10.1016/j.crvi.2009.09.007; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Burke GR, 2009, APPL ENVIRON MICROB, V75, P5328, DOI 10.1128/AEM.00717-09; Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0; Cook PE, 2010, TRENDS PARASITOL, V26, P373, DOI 10.1016/j.pt.2010.05.006; Degnan PH, 2010, ENVIRON MICROBIOL, V12, P2060, DOI 10.1111/j.1462-2920.2009.02085.x; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; DIXON AFG, 1987, AM NAT, V129, P580, DOI 10.1086/284659; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; DOUDOUMIS V, 2011, BMC MICROBI IN PRESS; Douglas AE, 1997, FEMS MICROBIOL ECOL, V24, P1, DOI 10.1111/j.1574-6941.1997.tb00418.x; Douglas AE, 2006, J EXP BOT, V57, P747, DOI 10.1093/jxb/erj067; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dunn AK, 2005, APPL ENVIRON MICROB, V71, P8784, DOI 10.1128/AEM.71.12.8784-8794.2005; Duron O, 2005, MOL ECOL, V14, P1561, DOI 10.1111/j.1365-294X.2005.02495.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Gosalbes MJ, 2008, J BACTERIOL, V190, P6026, DOI 10.1128/JB.00525-08; Haegeman A, 2009, INT J PARASITOL, V39, P1045, DOI 10.1016/j.ijpara.2009.01.006; Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121; Hanner R, 1997, J CRUSTACEAN BIOL, V17, P174, DOI 10.2307/1549471; Hartley J.L., 2003, FOCUS, V25, P18; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HEIE OE, 2004, HIST STUDIES APHID P; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P6082, DOI 10.1128/AEM.69.10.6082-6090.2003; Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Lamelas A, 2011, APPL ENVIRON MICROB, V77, P4446, DOI 10.1128/AEM.00141-11; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Li ZX, 2007, CURR MICROBIOL, V54, P467, DOI 10.1007/s00284-007-0011-7; Li ZX, 2005, EUR J ENTOMOL, V102, P293, DOI 10.14411/eje.2005.041; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; Lo N, 2002, MOL BIOL EVOL, V19, P341, DOI 10.1093/oxfordjournals.molbev.a004087; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Miller WJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001214; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 2010, SCIENCE, V328, P624, DOI 10.1126/science.1187113; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2003, MOL ECOL, V12, P3459, DOI 10.1046/j.1365-294X.2003.02015.x; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Nikoh N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000827; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Ortiz-Rivas B, 2010, MOL PHYLOGENET EVOL, V55, P305, DOI 10.1016/j.ympev.2009.12.005; Paraskevopoulos C, 2006, CURR MICROBIOL, V53, P388, DOI 10.1007/s00284-006-0054-1; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Reed DW, 2002, APPL ENVIRON MICROB, V68, P3759, DOI 10.1128/AEM.68.8.3759-3770.2002; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Reuter M, 2003, MOL BIOL EVOL, V20, P748, DOI 10.1093/molbev/msg082; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros VID, 2009, APPL ENVIRON MICROB, V75, P1036, DOI 10.1128/AEM.01109-08; Rowley SM, 2004, CURR MICROBIOL, V49, P208, DOI 10.1007/s00284-004-4346-z; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Schadler M, 2007, ECOLOGY, V88, P1490, DOI 10.1890/06-0647; Simoes PM, 2011, MOL ECOL RESOUR, V11, P567, DOI 10.1111/j.1755-0998.2010.02955.x; SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154; STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuchida T, 2002, MOL ECOL, V11, P2123, DOI 10.1046/j.1365-294X.2002.01606.x; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Vaishampayan PA, 2007, MOL PHYLOGENET EVOL, V44, P1346, DOI 10.1016/j.ympev.2007.01.003; Vandekerckhove TTM, 1999, FEMS MICROBIOL LETT, V180, P279, DOI 10.1111/j.1574-6968.1999.tb08807.x; Vautrin E, 2009, TRENDS MICROBIOL, V17, P95, DOI 10.1016/j.tim.2008.12.002; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Wang Z, 2009, EUR J ENTOMOL, V106, P49, DOI 10.14411/eje.2009.007; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren JH, 2000, P ROY SOC B-BIOL SCI, V267, P1277, DOI 10.1098/rspb.2000.1139; West SA, 1998, MOL ECOL, V7, P1457, DOI 10.1046/j.1365-294x.1998.00467.x; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zabalou S, 2009, ENTOMOL EXP APPL, V132, P232, DOI 10.1111/j.1570-7458.2009.00886.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	108	143	153	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28695	10.1371/journal.pone.0028695	http://dx.doi.org/10.1371/journal.pone.0028695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174869	Green Published, gold			2022-12-27	WOS:000298367300022
J	Schiff, M; Benit, P; El-Khoury, R; Schlemmer, D; Benoist, JF; Rustin, P				Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Schlemmer, Dimitri; Benoist, Jean-Francois; Rustin, Pierre			Mouse Studies to Shape Clinical Trials for Mitochondrial Diseases: High Fat Diet in Harlequin Mice	PLOS ONE			English	Article							APOPTOSIS-INDUCING FACTOR; MYOPATHY; ACIDS; IDENTIFICATION; DISORDERS; PHENOTYPE; OXIDATION; INCREASE; DELETION; GENE	Background: Therapeutic options in human mitochondrial oxidative phosphorylation (OXPHOS) diseases have been poorly evaluated mostly because of the scarcity of cohorts and the inter-individual variability of disease progression. Thus, while a high fat diet (HFD) is often recommended, data regarding efficacy are limited. Our objectives were 1) to determine our ability to evaluate therapeutic options in the Harlequin OXPHOS complex I (CI)-deficient mice, in the context of a mitochondrial disease with human hallmarks and 2) to assess the effects of a HFD. Methods and Findings: Before launching long and expensive animal studies, we showed that palmitate afforded long-term death-protection in 3 CI-mutant human fibroblasts cell lines. We next demonstrated that using the Harlequin mouse, it was possible to draw solid conclusions on the efficacy of a 5-month-HFD on neurodegenerative symptoms. Moreover, we could identify a group of highly responsive animals, echoing the high variability of the disease progression in Harlequin mice. Conclusions: These results suggest that a reduced number of patients with identical genetic disease should be sufficient to reach firm conclusions as far as the potential existence of responders and non responders is recognized. They also positively prefigure HFD-trials in OXPHOS-deficient patients.	[Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Benoist, Jean-Francois; Rustin, Pierre] INSERM, U676, Paris, France; [Schiff, Manuel; Benit, Paule; El-Khoury, Riyad; Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, IFR02, Paris, France; [Schiff, Manuel; Schlemmer, Dimitri; Benoist, Jean-Francois] Hop Robert Debre, APHP, Ctr Reference Malad Hereditaires Metab, F-75019 Paris, France; [Schlemmer, Dimitri; Benoist, Jean-Francois] Hop Robert Debre, APHP, Biochim Lab, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Schiff, M (corresponding author), INSERM, U676, Paris, France.	pierre.rustin@inserm.fr	Schiff, Manuel/G-3596-2017	Schiff, Manuel/0000-0001-8272-232X; benoist, jean-francois/0000-0002-5389-8585	INSERM; CNRS; ANR (Agence Nationale de la Recherche, France); Leducq Transatlantic Network (CarDiaNet)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR (Agence Nationale de la Recherche, France)(French National Research Agency (ANR)); Leducq Transatlantic Network (CarDiaNet)(Leducq Foundation)	This work was supported by INSERM, CNRS, ANR (Agence Nationale de la Recherche, France, http://www.agence-nationale-recherche.fr/), and the Leducq Transatlantic Network (CarDiaNet, http://cardianet.org/). The authors are grateful to AFM (Association Francaise contre les Myopathies, http://www.afm-telethon.fr/), AMMi (Association contre les Maladies Mitochondriales, http://www.association-ammi.org/) and AFAF (Association Francaise contre l'Ataxie de Friedreich, http://www.afaf.asso.fr/) for their constant support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola-Erkkila S, 2010, HUM MOL GENET, V19, P1974, DOI 10.1093/hmg/ddq076; Benit P, 2003, HUM GENET, V112, P563, DOI 10.1007/s00439-002-0884-2; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Benit P, 2010, TRENDS MOL MED, V16, P210, DOI 10.1016/j.molmed.2010.03.001; Benit P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003208; BERGER I, 2011, MOL GENETIC IN PRESS; BOUAITA A, 2011, BRAIN IN PRESS; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Ciapaite J, 2011, BBA-MOL CELL BIOL L, V1811, P441, DOI 10.1016/j.bbalip.2011.05.005; de Meer K, 2005, J INHERIT METAB DIS, V28, P95, DOI 10.1007/s10545-005-1485-8; Djouadi F, 2003, MOL GENET METAB, V78, P112, DOI 10.1016/S1096-7192(03)00017-9; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Guyenet S.J., 2010, J VIS EXP; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; HE M, 2011, MOL GENET METAB; HOEKS J, 2011, J CELL PHYSL; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; McFarland R, 2010, LANCET NEUROL, V9, P829, DOI 10.1016/S1474-4422(10)70116-2; Munnich A, 2001, AM J MED GENET, V106, P4, DOI 10.1002/ajmg.1391; Panetta J, 2004, J INHERIT METAB DIS, V27, P487, DOI 10.1023/B:BOLI.0000037354.66587.38; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rafael JA, 2000, MAMM GENOME, V11, P725, DOI 10.1007/s003350010149; Roef MJ, 2002, AM J CLIN NUTR, V75, P237, DOI 10.1093/ajcn/75.2.237; Roef MJ, 2002, NEUROLOGY, V58, P1088, DOI 10.1212/WNL.58.7.1088; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; SALAHUDEEN AK, 1991, J CLIN INVEST, V88, P1886, DOI 10.1172/JCI115511; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schiff M, 2011, NUTR REV, V69, P65, DOI 10.1111/j.1753-4887.2010.00363.x; Schonfeld P, 2007, BBA-BIOENERGETICS, V1767, P1032, DOI 10.1016/j.bbabio.2007.04.005; Suomalainen A, 2011, SEMIN FETAL NEONAT M, V16, P236, DOI 10.1016/j.siny.2011.05.003; TZAGOLOFF A, 1982, MITOCHONDRIA, P1; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Valsecchi F, 2010, DEV DISABIL RES REV, V16, P175, DOI 10.1002/ddrr.107; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	45	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28823	10.1371/journal.pone.0028823	http://dx.doi.org/10.1371/journal.pone.0028823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174907	Green Published, Green Submitted			2022-12-27	WOS:000298367300028
J	Han, SW; Sriariyanun, M; Lee, SW; Sharma, M; Bahar, O; Bower, Z; Ronald, PC				Han, Sang-Wook; Sriariyanun, Malinee; Lee, Sang-Won; Sharma, Manoj; Bahar, Ofir; Bower, Zachary; Ronald, Pamela C.			Small Protein-Mediated Quorum Sensing in a Gram-Negative Bacterium	PLOS ONE			English	Article							ORYZAE PV. ORYZAE; CYCLIC-DI-GMP; XANTHOMONAS-ORYZAE; INNATE IMMUNITY; ESCHERICHIA-COLI; AVRXA21 ACTIVITY; RICE; GENES; RESISTANCE; VIRULENCE	The rice XA21 pattern recognition receptor binds a type I secreted sulfated peptide, called axY(S)22, derived from the Ax21 ((a) under bar ctivator of (X) under barA (21) under bar -mediated immunity) protein. The conservation of Ax21 in all sequenced Xanthomonas spp. and closely related genera suggests that Ax21 serves a key biological function. Here we show that the predicted N-terminal sequence of Ax21 is cleaved prior to secretion outside the cell and that mature Ax21 serves as a quorum sensing (QS) factor in Xanthomonas oryzae pv. oryzae. Ax21-mediated QS controls motility, biofilm formation and virulence. We provide genetic evidence that the Xoo RaxH histidine kinase serves as the bacterial receptor for Ax21. This work establishes a critical role for small protein-mediated QS in a Gram-negative bacterium.	[Han, Sang-Wook; Sriariyanun, Malinee; Lee, Sang-Won; Sharma, Manoj; Bahar, Ofir; Bower, Zachary; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Han, Sang-Wook; Sriariyanun, Malinee; Lee, Sang-Won; Sharma, Manoj; Bahar, Ofir; Bower, Zachary; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Lee, Sang-Won; Ronald, Pamela C.] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, South Korea; [Lee, Sang-Won; Ronald, Pamela C.] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea	University of California System; University of California Davis; University of California System; University of California Davis; Kyung Hee University; Kyung Hee University	Han, SW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Sriariyanun, Malinee/AEX-7648-2022; Sriariyanun, Malinee/B-6767-2016; Ronald, Pamela/AAK-7664-2020; Bahar, Ofir/AAW-8844-2021	Sriariyanun, Malinee/0000-0002-3088-9256; 	NIH [GM55962]; Next-Generation BioGreen 21 Program [PJ0080982011]; Mid-Career Researcher Program [2010-0026679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Mid-Career Researcher Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM55962 to PCR. S-WL's work, in part, was supported by the Next-Generation BioGreen 21 Program (PJ0080982011) and the Mid-Career Researcher Program (2010-0026679). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burdman S, 2004, MOL PLANT MICROBE IN, V17, P602, DOI 10.1094/MPMI.2004.17.6.602; Crossman L, 2004, MICROBES INFECT, V6, P623, DOI 10.1016/j.micinf.2004.01.013; da Silva FG, 2004, MOL PLANT MICROBE IN, V17, P593, DOI 10.1094/MPMI.2004.17.6.593; DARDICK C, 2006, PLOS PATHOG, V2; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378; Han SW, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-164; Jeong KS, 2008, PLANT PATHOLOGY J, V24, P143, DOI 10.5423/PPJ.2008.24.2.143; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lee SW, 2008, J BACTERIOL, V190, P2183, DOI 10.1128/JB.01406-07; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; LEE SW, 2006, METHODS MOL BIOL MOL, P11; Lim SH, 2008, J MICROBIOL, V46, P214, DOI 10.1007/s12275-007-0173-9; MCCARTHY Y, 1921, J BACTERIOL, V193, P6375; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; MIZUKAMI TAKEYUKL, 1961, AGRIC BULL SAGA UNIV, V13, P1; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Rocke DM, 2004, SEMIN CELL DEV BIOL, V15, P703, DOI 10.1016/j.semcdb.2004.09.007; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Shen YW, 2002, MOL MICROBIOL, V44, P37, DOI 10.1046/j.1365-2958.2002.02862.x; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Swem LR, 2008, CELL, V134, P461, DOI 10.1016/j.cell.2008.06.023; TSUCHIYA K, 1982, PHYTOPATHOLOGY, V72, P43, DOI 10.1094/Phyto-72-43; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	32	24	26	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29192	10.1371/journal.pone.0029192	http://dx.doi.org/10.1371/journal.pone.0029192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174954	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600061
J	Sicuri, E; Bardaji, A; Sigauque, B; Maixenchs, M; Nhacolo, A; Nhalungo, D; Macete, E; Alonso, PL; Menendez, C				Sicuri, Elisa; Bardaji, Azucena; Sigauque, Betuel; Maixenchs, Maria; Nhacolo, Ariel; Nhalungo, Delino; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara			Costs Associated with Low Birth Weight in a Rural Area of Southern Mozambique	PLOS ONE			English	Article							INFANT-MORTALITY; NORTHEAST BRAZIL; PRETERM; CARE; MORBIDITY; PREGNANCY; CHILDREN; OUTCOMES; MALARIA; DETERMINANTS	Background: Low Birth Weight (LBW) is prevalent in low-income countries. Even though the economic evaluation of interventions to reduce this burden is essential to guide health policies, data on costs associated with LBW are scarce. This study aims to estimate the costs to the health system and to the household and the Disability Adjusted Life Years (DALYs) arising from infant deaths associated with LBW in Southern Mozambique. Methods and Findings: Costs incurred by the households were collected through exit surveys. Health system costs were gathered from data obtained onsite and from published information. DALYs due to death of LBW babies were based on local estimates of prevalence of LBW (12%), very low birth weight (VLBW) (1%) and of case fatality rates compared to non-LBW weight babies [for LBW (12%) and VLBW (80%)]. Costs associated with LBW excess morbidity were calculated on the incremental number of hospital admissions in LBW babies compared to non-LBW-weight babies. Direct and indirect household costs for routine health care were 24.12 US$ (CI 95% 21.51; 26.26). An increase in birth weight of 100 grams would lead to a 53% decrease in these costs. Direct and indirect household costs for hospital admissions were 8.50 US$ (CI 95% 6.33; 10.72). Of the 3,322 live births that occurred in one year in the study area, health system costs associated to LBW (routine health care and excess morbidity) and DALYs were 169,957.61 US$ (CI 95% 144,900.00; 195,500.00) and 2,746.06, respectively. Conclusions: This first cost evaluation of LBW in a low-income country shows that reducing the prevalence of LBW would translate into important cost savings to the health system and the household. These results are of relevance for similar settings and should serve to promote interventions aimed at improving maternal care.	[Sicuri, Elisa; Bardaji, Azucena; Maixenchs, Maria; Alonso, Pedro L.; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Sicuri, Elisa; Alonso, Pedro L.; Menendez, Clara] CIBERESP, Barcelona, Spain; [Sigauque, Betuel; Maixenchs, Maria; Nhacolo, Ariel; Nhalungo, Delino; Macete, Eusebio; Alonso, Pedro L.; Menendez, Clara] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [Sigauque, Betuel] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Sigauque, Betuel] Minist Hlth, Natl Directorate Hlth, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro de Investigacao em Saude de Manhica	Sicuri, E (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	elisa.sicuri@cresib.cat	Bardají, Azucena/AAE-9145-2019; Alonso, Pedro L/AAZ-3645-2020; Sicuri, Elisa/L-8012-2014; Menendez, Clara/Q-3446-2016; Bardaji Alonso, Azucena/V-5978-2018	Alonso, Pedro L/0000-0003-3292-3443; Maixenchs, Maria/0000-0002-5782-8197; Sicuri, Elisa/0000-0002-2499-2732; Menendez, Clara/0000-0002-2641-6907; Bardaji Alonso, Azucena/0000-0002-5135-0540	MiP Consortium; Bill & Melinda Gates Foundation; CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica); Spanish Agency for International Cooperation (AECI)	MiP Consortium; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica); Spanish Agency for International Cooperation (AECI)	Elisa Sicuri is supported by a grant from the MiP Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the Liverpool School of Tropical Medicine, and by a CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica) fellowship. The Centro de Investigacao em Saude de Manhica (CISM) receives major core funding from the Spanish Agency for International Cooperation (AECI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERMAN H, 2004, ESTIMATED EC BENEFIT; Alonso PL, 2002, MANHICA DEMOGRAPHIC, P189; Anchieta LM, 2003, BRAZ J MED BIOL RES, V36, P761, DOI 10.1590/S0100-879X2003000600012; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Ashworth A, 1998, EUR J CLIN NUTR, V52, P223, DOI 10.1038/sj.ejcn.1600553; Ballot DE, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-30; Bardaji A, 2011, J INFECT DIS, V203, P691, DOI 10.1093/infdis/jiq049; BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; BLOND MH, 1994, ARCH PEDIATRIE, V1, P1079; BOYLE MH, 1983, NEW ENGL J MED, V308, P1330, DOI 10.1056/NEJM198306023082206; Briggs A, 1998, J Health Serv Res Policy, V3, P233; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Cheah Irene Guat Sim, 2005, J Perinatol, V25, P47; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Guyer B, 1999, PEDIATRICS, V104, P1229, DOI 10.1542/peds.104.6.1229; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; International Labour Organization, 2008, GLOB WAG REP 2008 09; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawoyin TO, 2001, J R SOC PROMO HEALTH, V121, P114, DOI 10.1177/146642400112100213; LEWIT EM, 1995, FUTURE CHILD, V5, P35, DOI 10.2307/1602506; Lira PIC, 1996, J PEDIATR-US, V128, P497, DOI 10.1016/S0022-3476(96)70360-8; Management Sciences for Health, 2007, INT DRUG PRIC IND GU; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; *MISAU, 2002, EST AN CUST CORR UN; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Pedercini M., 2010, SOCIO-ECON PLAN SCI, V44, P89, DOI [10.1016/j.seps.2009.08.002, DOI 10.1016/J.SEPS.2009.08.002]; Petrou S, 2001, CHILD CARE HLTH DEV, V27, P97, DOI 10.1046/j.1365-2214.2001.00203.x; Profit J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000379; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rogowski J, 1998, PEDIATRICS, V102, P35, DOI 10.1542/peds.102.1.35; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Sicuri E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013407; TAYLOR B, 1982, LANCET, V1, P1227; Teles T P, 1995, Acta Med Port, V8, P23; Tongo OO, 2009, J TROP PEDIATRICS, V55, P262, DOI 10.1093/tropej/fmn107; TUDEHOPE DI, 1989, AUST PAEDIATR J, V25, P61; TYRRELL A, ESTIMATIVA CUSTOS PL; UNICEF, 2004, LOW BIRTHW COUNTR RE; VICTORA CG, 1990, AM J CLIN NUTR, V52, P391, DOI 10.1093/ajcn/52.2.391; *WHO, 2005, BRIT MED J, V329, P1179; *WHO, 2009, GLOB HLTH STAT 2009; World Health Organization, 2006, NEON PER MORT COUNTR; 2009, WHO GLOBAL ATLAS HLT; 2007, INT DRUG PRICE INDIC; OANDA CURRENCY CONVE	53	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28744	10.1371/journal.pone.0028744	http://dx.doi.org/10.1371/journal.pone.0028744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FT	22174885	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600034
J	Brinkley, TE; Jerosch-Herold, M; Folsom, AR; Carr, JJ; Hundley, WG; Allison, MA; Bluemke, DA; Burke, GL; Szklo, M; Ding, JZ				Brinkley, Tina E.; Jerosch-Herold, Michael; Folsom, Aaron R.; Carr, J. Jeffrey; Hundley, W. Gregory; Allison, Matthew A.; Bluemke, David A.; Burke, Gregory L.; Szklo, Moyses; Ding, Jingzhong			Pericardial Fat and Myocardial Perfusion in Asymptomatic Adults from the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							PERIVASCULAR ADIPOSE-TISSUE; NORMAL CORONARY-ARTERIES; BLOOD-FLOW; COMPUTED-TOMOGRAPHY; VASCULAR FUNCTION; RISK-FACTORS; RESERVE; HEART; CALCIUM; DISEASE	Background: Pericardial fat has adverse effects on the surrounding vasculature. Previous studies suggest that pericardial fat may contribute to myocardial ischemia in symptomatic individuals. However, it is unknown if pericardial fat has similar effects in asymptomatic individuals. Methods: We determined the association between pericardial fat and myocardial blood flow (MBF) in 214 adults with no prior history of cardiovascular disease from the Minnesota field center of the Multi-Ethnic Study of Atherosclerosis (43% female, 56% Caucasian, 44% Hispanic). Pericardial fat volume was measured by computed tomography. MBF was measured by MRI at rest and during adenosine-induced hyperemia. Myocardial perfusion reserve (PR) was calculated as the ratio of hyperemic to resting MBF. Results: Gender-stratified analyses revealed significant differences between men and women including less pericardial fat (71.9 +/- 31.3 vs. 105.2 +/- 57.5 cm(3), p<0.0001) and higher resting MBF (1.12 +/- 0.23 vs. 0.93 +/- 0.19 ml/min/g, p<0.0001), hyperemic MBF (3.49 +/- 0.76 vs. 2.65 +/- 0.72 ml/min/g, p<0.0001), and PR (3.19 +/- 0.78 vs. 2.93 +/- 0.89, p = 0.03) in women. Correlations between pericardial fat and clinical and hemodynamic variables were stronger in women. In women only (p = 0.01 for gender interaction) higher pericardial fat was associated with higher resting MBF (p = 0.008). However, this association was attenuated after accounting for body mass index or rate-pressure product. There were no significant associations between pericardial fat and hyperemic MBF or PR after multivariate adjustment in either gender. In logistic regression analyses there was also no association between impaired coronary vasoreactivity, defined as having a PR <2.5, and pericardial fat in men (OR, 1.18; 95% CI, 0.82-1.70) or women (OR, 1.11; 95% CI, 0.68-1.82). Conclusions: Our data fail to support an independent association between pericardial fat and myocardial perfusion in adults without symptomatic cardiovascular disease. Nevertheless, these findings highlight potentially important differences between asymptomatic and symptomatic individuals with respect to the underlying subclinical disease burden.	[Brinkley, Tina E.; Hundley, W. Gregory; Ding, Jingzhong] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA; [Jerosch-Herold, Michael] Univ Minnesota, Sch Med, Dept Radiol, Minneapolis, MN 55455 USA; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Carr, J. Jeffrey] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Allison, Matthew A.] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Bluemke, David A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, Bethesda, MD USA; [Burke, Gregory L.] Wake Forest Sch Med, Div Publ Hlth Sci, Winston Salem, NC USA; [Szklo, Moyses] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Wake Forest University; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Wake Forest University; Johns Hopkins University	Brinkley, TE (corresponding author), Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC USA.	tbrinkle@wakehealth.edu	Carr, John Jeffrey/A-1938-2012; Carr, John/AAN-7531-2021; Brinkley, Tina/AAT-9256-2021; Jerosch-Herold, Michael/R-9824-2019; Bluemke, David/GYU-8169-2022	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Allison, Matthew/0000-0003-0777-8272; Bluemke, David/0000-0002-8323-8086; Szklo, Moyses/0000-0001-9433-6266	Oristano Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health [N01-HC-95159, N01-HC-95169];  [R01-HL-085323];  [R01-HL-65580];  [K01-AG-033652]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	Oristano Foundation; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	This research was supported by the Oristano Foundation, as well as grants R01-HL-085323, R01-HL-65580, and K01-AG-033652, and contracts N01-HC-95159 through N01-HC-95169 from the National Heart, Lung, and Blood Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Barandier C, 2005, AM J PHYSIOL-HEART C, V289, pH1807, DOI 10.1152/ajpheart.01259.2004; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Breen JF, 2001, J THORAC IMAG, V16, P47, DOI 10.1097/00005382-200101000-00007; Bucci M, 2011, ARTERIOSCL THROM VAS, V31, P211, DOI 10.1161/ATVBAHA.110.213827; Burke AP, 2001, HERZ, V26, P239, DOI 10.1007/PL00002026; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Date H, 2006, CLIN CARDIOL, V29, P211, DOI 10.1002/clc.4960290508; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Ding JZ, 2009, AM J CLIN NUTR, V90, P499, DOI 10.3945/ajcn.2008.27358; Eringa EC, 2007, MICROCIRCULATION, V14, P389, DOI 10.1080/10739680701303584; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; GELTMAN EM, 1990, J AM COLL CARDIOL, V16, P586, DOI 10.1016/0735-1097(90)90347-R; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Guerci AD, 1997, AM J CARDIOL, V79, P128, DOI 10.1016/S0002-9149(96)00698-4; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Janik M, 2010, J NUCL CARDIOL, V17, P841, DOI 10.1007/s12350-010-9235-1; Jerosch-Herold M, 2004, J MAGN RESON IMAGING, V19, P758, DOI 10.1002/jmri.20065; Jerosch-Herold M, 2003, J MAGN RESON IMAGING, V18, P544, DOI 10.1002/jmri.10384; Jerosch-Herold M, 2002, MED PHYS, V29, P886, DOI 10.1118/1.1473135; Jerosch-Herold M, 2008, INVEST RADIOL, V43, P155, DOI 10.1097/RLI.0b013e31815abebd; KLOCKE FJ, 1987, CIRCULATION, V76, P1183, DOI 10.1161/01.CIR.76.6.1183; Mathieu P, 2008, INT J BIOCHEM CELL B, V40, P821, DOI 10.1016/j.biocel.2007.12.001; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Montani JP, 2004, INT J OBESITY, V28, pS58, DOI 10.1038/sj.ijo.0802858; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Nelson AJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-15; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sade LE, 2009, ATHEROSCLEROSIS, V204, P580, DOI 10.1016/j.atherosclerosis.2008.09.038; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Tamarappoo B, 2010, JACC-CARDIOVASC IMAG, V3, P1104, DOI 10.1016/j.jcmg.2010.07.014; Thanassoulis G, 2010, CIRC-CARDIOVASC IMAG, V3, P559, DOI 10.1161/CIRCIMAGING.110.956706; Wang L, 2006, J AM COLL CARDIOL, V47, P565, DOI 10.1016/j.jacc.2005.09.036; Wang L, 2006, J AM COLL CARDIOL, V48, P1018, DOI 10.1016/j.jacc.2006.04.089; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Zierler K, 2000, ANN BIOMED ENG, V28, P836, DOI 10.1114/1.1308496	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28410	10.1371/journal.pone.0028410	http://dx.doi.org/10.1371/journal.pone.0028410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174800	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700031
J	Sarmiento, J; Shumate, C; Suetomi, K; Ravindran, A; Villegas, L; Rajarathnam, K; Navarro, J				Sarmiento, Jose; Shumate, Christie; Suetomi, Katsutoshi; Ravindran, Aishwarya; Villegas, Leon; Rajarathnam, Krishna; Navarro, Javier			Diverging Mechanisms of Activation of Chemokine Receptors Revealed by Novel Chemokine Agonists	PLOS ONE			English	Article							HIGH-AFFINITY BINDING; INTERLEUKIN-8 RECEPTOR; N-TERMINUS; CXCR2; SELECTIVITY; NEUTROPHILS; IL-8	CXCL8/interleukin-8 is a pro-inflammatory chemokine that triggers pleiotropic responses, including inflammation, angiogenesis, wound healing and tumorigenesis. We engineered the first selective CXCR1 agonists on the basis of residue substitutions in the conserved ELR triad and CXC motif of CXCL8. Our data reveal that the molecular mechanisms of activation of CXCR1 and CXCR2 are distinct: the N-loop of CXCL8 is the major determinant for CXCR1 activation, whereas the N-terminus of CXCL8 (ELR and CXC) is essential for CXCR2 activation. We also found that activation of CXCR1 cross-desensitized CXCR2 responses in human neutrophils co-expressing both receptors, indicating that these novel CXCR1 agonists represent a new class of anti-inflammatory agents. Further, these selective CXCR1 agonists will aid at elucidating the functional significance of CXCR1 in vivo under pathophysiological conditions.	[Sarmiento, Jose; Shumate, Christie; Navarro, Javier] Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA; [Sarmiento, Jose; Shumate, Christie; Navarro, Javier] Univ Texas Med Branch, Dept Cell Biol, Galveston, TX USA; [Ravindran, Aishwarya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Biochem, Galveston, TX USA; [Ravindran, Aishwarya; Rajarathnam, Krishna] Univ Texas Med Branch, Dept Mol Biol, Galveston, TX USA; [Rajarathnam, Krishna; Navarro, Javier] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX USA; [Rajarathnam, Krishna; Navarro, Javier] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX USA; [Sarmiento, Jose] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; [Suetomi, Katsutoshi] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi 48011, Japan; [Villegas, Leon] Univ Peruana Cayetano Heredia, Dept Pharmaceut Sci, Lima, Peru	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Universidad Austral de Chile; Aichi Medical University; Universidad Peruana Cayetano Heredia	Sarmiento, J (corresponding author), Univ Texas Med Branch, Dept Neurosci, Galveston, TX 77555 USA.	jnavarro@utmb.edu		Navarro, Javier/0000-0001-7098-4373; Villegas Vilchez, Leon Faustino/0000-0001-6030-2877	National Institutes of Health (NIH) [R01EY14218, R01GM081798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NIH) grants R01EY14218 and R01GM081798 to Dr. Navarro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja SK, 1996, J BIOL CHEM, V271, P225, DOI 10.1074/jbc.271.1.225; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Catusse J, 2004, BIOCHEM PHARMACOL, V68, P1947, DOI 10.1016/j.bcp.2004.07.003; CLARKLEWIS I, 1993, P NATL ACAD SCI USA, V90, P3574, DOI 10.1073/pnas.90.8.3574; CLORE GM, 1995, FASEB J, V9, P57, DOI 10.1096/fasebj.9.1.7821760; FORREST MJ, 1986, BRIT J PHARMACOL, V89, P719, DOI 10.1111/j.1476-5381.1986.tb11176.x; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kraemer S, 2011, FASEB J, V25, P894, DOI 10.1096/fj.10-168559; LAROSA GJ, 1992, J BIOL CHEM, V267, P25402; LEE J, 1995, J IMMUNOL, V155, P2158; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; LU ZH, 1995, J BIOL CHEM, V270, P26239; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; PRADO GN, 1994, J BIOL CHEM, V269, P12391; Ragnarsdottir B, 2008, EUR J CLIN INVEST, V38, P12, DOI 10.1111/j.1365-2362.2008.02004.x; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; SUZUKI H, 1994, J BIOL CHEM, V269, P18263; White JR, 1998, J BIOL CHEM, V273, P10095, DOI 10.1074/jbc.273.17.10095	21	14	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27967	10.1371/journal.pone.0027967	http://dx.doi.org/10.1371/journal.pone.0027967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174759	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700012
J	Hiremath, S; Knoll, G; Weinstein, MC				Hiremath, Swapnil; Knoll, Greg; Weinstein, Milton C.			Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; INCIDENT HEMODIALYSIS-PATIENTS; VASCULAR ACCESS TYPE; REFER PATIENTS; CATHETER USE; MORTALITY; OUTCOMES; DEATH; RISK; ASSOCIATION	Background: An arteriovenous fistula (AVF) is considered the vascular access of choice, but uncertainty exists about the optimal time for its creation in pre-dialysis patients. The aim of this study was to determine the optimal vascular access referral strategy for stage 4 (glomerular filtration rate <30 ml/min/1.73 m(2)) chronic kidney disease patients using a decision analytic framework. Methods: A Markov model was created to compare two strategies: refer all stage 4 chronic kidney disease patients for an AVF versus wait until the patient starts dialysis. Data from published observational studies were used to estimate the probabilities used in the model. A Markov cohort analysis was used to determine the optimal strategy with life expectancy and quality adjusted life expectancy as the outcomes. Sensitivity analyses, including a probabilistic sensitivity analysis, were performed using Monte Carlo simulation. Results: The wait strategy results in a higher life expectancy (66.6 versus 65.9 months) and quality adjusted life expectancy (38.9 versus 38.5 quality adjusted life months) than immediate AVF creation. It was robust across all the parameters except at higher rates of progression and lower rates of ischemic steal syndrome. Conclusions: Early creation of an AVF, as recommended by most guidelines, may not be the preferred strategy in all pre-dialysis patients. Further research on cost implications and patient preferences for treatment options needs to be done before recommending early AVF creation.	[Hiremath, Swapnil; Knoll, Greg] Ottawa Hosp Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada; [Hiremath, Swapnil; Knoll, Greg] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Hiremath, Swapnil; Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; Harvard University; Harvard T.H. Chan School of Public Health	Hiremath, S (corresponding author), Ottawa Hosp Res Inst, Div Nephrol, Kidney Res Ctr, Ottawa, ON, Canada.	shiremath@toh.on.ca	Hiremath, Swapnil/H-3492-2019	Hiremath, Swapnil/0000-0003-0010-3416; Knoll, Greg/0000-0001-5442-9310				Barlow AD, 2008, J VASC ACCESS, V9, P129, DOI 10.1177/112972980800900209; BECK JR, 1983, MED DECIS MAKING, V3, P3, DOI 10.1177/0272989X8300300102; Besarab A, 2008, J AM SOC NEPHROL, V19, P1629, DOI 10.1681/ASN.2008020172; Besarab Anatole, 2004, Hemodial Int, V8, P199, DOI 10.1111/j.1492-7535.2004.01096.x; Bradbury BD, 2009, AM J KIDNEY DIS, V53, P804, DOI 10.1053/j.ajkd.2008.11.031; Briggs AH, 2004, EUR J GASTROEN HEPAT, V16, P551, DOI 10.1097/00042737-200406000-00007; Canadian Institute For Health Information, 2008, 2007 ANN REP TREATM; Conway B, 2009, NEPHROL DIAL TRANSPL, V24, P1930, DOI 10.1093/ndt/gfn772; Davison SN, 2008, VALUE HLTH; Dhingra RK, 2001, KIDNEY INT, V60, P1443, DOI 10.1046/j.1523-1755.2001.00947.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Graham J, 2008, NEPHROL DIAL TRANSPL, V23, P3585, DOI 10.1093/ndt/gfn317; Group K.W., 2002, AM J KIDNEY DIS, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943; Hawkins N, 2005, MED DECIS MAKING, V25, P511, DOI 10.1177/0272989X05280562; Huijbregts HJT, 2008, CLIN J AM SOC NEPHRO, V3, P714, DOI 10.2215/CJN.02950707; Jindal Kailash, 2006, J Am Soc Nephrol, V17, pS1; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P188, DOI 10.1177/0272989X9401400212; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Keough-Ryan TM, 2008, KIDNEY INT, V74, P356, DOI 10.1038/ki.2008.190; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Luxton G, 2010, NEPHROLOGY, V15, pS2, DOI 10.1111/j.1440-1797.2010.01224.x; MacRae JM, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2004.01.016; Moist LM, 2008, CLIN J AM SOC NEPHRO, V3, P1726, DOI 10.2215/CJN.01240308; Murad MH, 2008, J VASC SURG, V48, p31S, DOI 10.1016/j.jvs.2008.08.046; Naimark DMJ, 2008, MED DECIS MAKING, V28, P706, DOI 10.1177/0272989X08315241; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; O'Hare AM, 2007, KIDNEY INT, V71, P555, DOI 10.1038/sj.ki.5002078; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; O'Hare AM, 2010, SEMIN DIALYSIS, V23, P452, DOI 10.1111/j.1525-139X.2010.00783.x; Pastan S, 2002, KIDNEY INT, V62, P620, DOI 10.1046/j.1523-1755.2002.00460.x; Patel ST, 2003, J VASC SURG, V38, P439, DOI 10.1016/S0741-5214(03)00732-8; Patel UD, 2005, AM J KIDNEY DIS, V46, P406, DOI 10.1053/j.ajkd.2005.05.027; Pisoni RL, 2002, KIDNEY INT, V61, P305, DOI 10.1046/j.1523-1755.2002.00117.x; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Roderick PJ, 2009, AM J KIDNEY DIS, V53, P950, DOI 10.1053/j.ajkd.2008.12.036; Scheltinga MR, 2009, NEPHROL DIAL TRANSPL; Tordoir J, 2007, NEPHROL DIAL TRANSPL, V22, P88, DOI 10.1093/ndt/gfm021; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Vachharajani TJ, 2011, CLIN J AM SOC NEPHRO, V6, P1663, DOI 10.2215/CJN.05830710; Vascular Access 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS176, DOI [DOI 10.1053/J.AJKD.2006.04.029, 10.1053/j.ajkd.2006.04.029]; Xi W, 2011, NEPHROL DIAL TRANSPL, V26, P3302, DOI 10.1093/ndt/gfr055; Xue H, 2010, CLIN J AM SOC NEPHRO, V5, P2289, DOI 10.2215/CJN.03210410; Xue JL, 2003, AM J KIDNEY DIS, V42, P1013, DOI 10.1016/j.ajkd.2003.07.004	43	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28453	10.1371/journal.pone.0028453	http://dx.doi.org/10.1371/journal.pone.0028453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163305	gold, Green Published			2022-12-27	WOS:000298161900042
J	Powers-Fletcher, MV; Jambunathan, K; Brewer, JL; Krishnan, K; Feng, XZ; Galande, AK; Askew, DS				Powers-Fletcher, Margaret V.; Jambunathan, Kalyani; Brewer, Jordan L.; Krishnan, Karthik; Feng, Xizhi; Galande, Amit K.; Askew, David S.			Impact of the Lectin Chaperone Calnexin on the Stress Response, Virulence and Proteolytic Secretome of the Fungal Pathogen Aspergillus fumigatus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; BLAST FUNGUS; GENE; HOMOLOG; THERMOTOLERANCE; TRANSLOCATION; CALRETICULIN	Calnexin is a membrane-bound lectin chaperone in the endoplasmic reticulum (ER) that is part of a quality control system that promotes the accurate folding of glycoproteins entering the secretory pathway. We have previously shown that ER homeostasis is important for virulence of the human fungal pathogen Aspergillus fumigatus, but the contribution of calnexin has not been explored. Here, we determined the extent to which A. fumigatus relies on calnexin for growth under conditions of environmental stress and for virulence. The calnexin gene, clxA, was deleted from A. fumigatus and complemented by reconstitution with the wild type gene. Loss of clxA altered the proteolytic secretome of the fungus, but had no impact on growth rates in either minimal or complex media at 37 degrees C. However, the Delta clxA mutant was growth impaired at temperatures above 42 degrees C and was hypersensitive to acute ER stress caused by the reducing agent dithiothreitol. In contrast to wild type A. fumigatus, Delta clxA hyphae were unable to grow when transferred to starvation medium. In addition, depleting the medium of cations by chelation prevented Delta clxA from sustaining polarized hyphal growth, resulting in blunted hyphae with irregular morphology. Despite these abnormal stress responses, the Delta clxA mutant remained virulent in two immunologically distinct models of invasive aspergillosis. These findings demonstrate that calnexin functions are needed for growth under conditions of thermal, ER and nutrient stress, but are dispensable for surviving the stresses encountered in the host environment.	[Powers-Fletcher, Margaret V.; Brewer, Jordan L.; Krishnan, Karthik; Feng, Xizhi; Askew, David S.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA; [Jambunathan, Kalyani; Galande, Amit K.] SRI Int, Harrisonburg, VA USA	University System of Ohio; University of Cincinnati; SRI International	Powers-Fletcher, MV (corresponding author), Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA.	David.Askew@uc.edu		Askew, David/0000-0002-6477-2515; Mosur Krishnan, Karthik/0000-0003-4411-4029	National Institutes of Health [R01AI072297]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01AI072297 to DSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima H, 1998, FEBS LETT, V440, P89, DOI 10.1016/S0014-5793(98)01437-9; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Chang YC, 2004, FUNGAL GENET BIOL, V41, P888, DOI 10.1016/j.fgb.2004.06.004; Chen Kuo-Shu, 2007, Journal of Microbiology Immunology and Infection, V40, P462; COVE DJ, 1966, BIOCHIM BIOPHYS ACTA, V113, P51, DOI 10.1016/S0926-6593(66)80120-0; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; Denning DW, 2011, CLIN INFECT DIS, V52, P1123, DOI 10.1093/cid/cir179; Ellis CD, 2004, J CELL BIOL, V166, P325, DOI 10.1083/jcb.200401157; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Hajjar F, 2007, YEAST, V24, P89, DOI 10.1002/yea.1440; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; JANNATIPOUR M, 1995, J BIOL CHEM, V270, P4845, DOI 10.1074/jbc.270.9.4845; JOUBERT A, 2011, MOL MICROBIOL; Kimata Y, 2011, CURR OPIN CELL BIOL, V23, P135, DOI 10.1016/j.ceb.2010.10.008; Kimura S, 2010, FUNGAL GENET BIOL, V47, P1044, DOI 10.1016/j.fgb.2010.09.003; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Marechal A, 2004, BIOCHEM J, V380, P441, DOI 10.1042/BJ20031546; Moreno MA, 2007, MOL MICROBIOL, V64, P1182, DOI 10.1111/j.1365-2958.2007.05726.x; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; PARLATI F, 1995, J BIOL CHEM, V270, P244, DOI 10.1074/jbc.270.1.244; PARLATI F, 1995, EMBO J, V14, P3064, DOI 10.1002/j.1460-2075.1995.tb07309.x; Ramos ER, 2011, ONCOLOGIST, V16, P1049, DOI 10.1634/theoncologist.2010-0290; Richie DL, 2007, EUKARYOT CELL, V6, P2437, DOI 10.1128/EC.00224-07; Richie DL, 2011, VIRULENCE, V2, P12, DOI 10.4161/viru.2.1.13345; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Schrettl M, 2010, PLOS PATHOG, V6, DOI DOI E1001124; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Shahinian S, 1998, GENETICS, V149, P843; Song YT, 2002, FEBS LETT, V512, P213, DOI 10.1016/S0014-5793(02)02258-5; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Wang H, 2003, MOL GENET GENOMICS, V268, P684, DOI 10.1007/s00438-002-0790-2; Watson DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021001; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988	44	9	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28865	10.1371/journal.pone.0028865	http://dx.doi.org/10.1371/journal.pone.0028865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163332	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900068
J	Vidovic, S; Horsman, GB; Liao, MM; Dillon, JAR				Vidovic, Sinisa; Horsman, Greg B.; Liao, Mingmin; Dillon, Jo-Anne R.			Influence of Conserved and Hypervariable Genetic Markers on Genotyping Circulating Strains of Neisseria gonorrhoeae	PLOS ONE			English	Article							ISOLATES REQUIRING PROLINE; FIELD GEL-ELECTROPHORESIS; PLASMID CONTENT; RECOMBINATION; DIVERSITY; CLUSTERS; SEROVAR; URACIL; EPIDEMIOLOGY; POPULATION	Presently there is no vaccine against Neisseria gonorrhoeae and therefore accurate information on gonococcal transmission plays a crucial role for interventions designed to limit the spread of infections caused by this microorganism. We evaluated the impact of two different categories of genetic markers, (i) concatenated sequences of 10 housekeeping genes and (ii) hypervariable porB DNA sequences, on the genetic relatedness and subsequently on genotyping analysis of this human pathogen. Eighty gonococcal isolates from Canada, China, the US, Argentina, Venezuela and Chile, collected over different times, were analyzed. Our results show that the choice of genetic marker had a profound effect on the interpretation of genotyping results associated with N. gonorrhoeae. The concatenated sequences of the housekeeping genes preserved the genetic relatedness of closely related isolates, enabling detection of the predominant strains circulating within a community (Saskatchewan, Canada) over an extended period of time. In contrast, a genetic marker based on antigen gene, porB, may lead to a failure to detect these predominant circulating strains. Based on the analysis of the DNA sequences of the 10 housekeeping genes, we identified two major clonal complexes, CC33 and CC22, which comprised STs from China, and Argentina as well as two STs from Canada. Several minor clonal complexes were observed among isolates from Saskatchewan. eBURST analysis suggested that the majority of the tested gonococcal isolates from Saskatchewan, Canada were endemic, with only a couple of genotypes introduced.	[Vidovic, Sinisa; Liao, Mingmin; Dillon, Jo-Anne R.] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Horsman, Greg B.] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Dillon, Jo-Anne R.] Univ Saskatchewan, Dept Biol, Saskatoon, SK S7N 0W0, Canada	University of Saskatchewan; University of Saskatchewan	Vidovic, S (corresponding author), Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada.	j.dillon@usask.ca		Vidovic, Sinisa/0000-0001-8264-3859	Saskatchewan Health Research Foundation [9127]	Saskatchewan Health Research Foundation	This work was supported by the Saskatchewan Health Research Foundation (Grant # 9127, the 2007-08 Health Research Team Grant Competition, Research Alliance for the Prevention of Infectious Disease [RAPID]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JS, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-35; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; CAMARENA JJ, 1995, SEX TRANSM DIS, V22, P128, DOI 10.1097/00007435-199503000-00009; CATLIN BW, 1973, J INFECT DIS, V128, P178, DOI 10.1093/infdis/128.2.178; DILLON JR, 1987, GENITOURIN MED, V63, P160; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fudyk TC, 1999, J BACTERIOL, V181, P5591, DOI 10.1128/JB.181.18.5591-5599.1999; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; HENDRY AT, 1979, CAN J MICROBIOL, V25, P512, DOI 10.1139/m79-075; Hobbs MM, 1999, J INFECT DIS, V179, P371, DOI 10.1086/314608; Holmes EC, 1999, MOL BIOL EVOL, V16, P405, DOI 10.1093/oxfordjournals.molbev.a026121; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KNAPP JS, 1984, J INFECT DIS, V150, P44, DOI 10.1093/infdis/150.1.44; LI H, 1995, J MED MICROBIOL, V43, P208, DOI 10.1099/00222615-43-3-208; Liao MM, 2008, J ANTIMICROB CHEMOTH, V61, P478, DOI 10.1093/jac/dkm544; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; MEE BJ, 1993, J GEN MICROBIOL, V139, P2613, DOI 10.1099/00221287-139-11-2613; NEI M, 1986, MOL BIOL EVOL, V3, P418; NG LK, 1993, J CLIN MICROBIOL, V31, P1555, DOI 10.1128/JCM.31.6.1555-1561.1993; NG LK, 1995, J CLIN MICROBIOL, V33, P1039, DOI 10.1128/JCM.33.4.1039-1041.1995; OROURKE M, 1995, MOL MICROBIOL, V17, P865, DOI 10.1111/j.1365-2958.1995.mmi_17050865.x; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; PICARD FJ, 1989, CAN J MICROBIOL, V35, P1069, DOI 10.1139/m89-179; Poh CL, 1996, J CLIN MICROBIOL, V34, P292, DOI 10.1128/JCM.34.2.292-295.1996; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rozen S, 2000, Methods Mol Biol, V132, P365; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SMITH JM, 1992, J MOL EVOL, V34, P126; Sneath P.H.A., 1973, NUMERICAL TAXONOMY F; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Unemo M, 2011, CLIN MICROBIOL REV, V24, P447, DOI 10.1128/CMR.00040-10; Viscidi RP, 2003, J CLIN MICROBIOL, V41, P197, DOI 10.1128/JCM.41.1.197-204.2003; Viscidi RP, 2000, J CLIN MICROBIOL, V38, P4430, DOI 10.1128/JCM.38.12.4430-4438.2000; Wang IN, 1999, GENETICS, V151, P15; WEST SEH, 1989, CLIN MICROBIOL REV, V2, pS92, DOI 10.1128/CMR.2.Suppl.S92-103.1989; World Health Organization collaborating centre for STD and HIV Sydney Australia, 2001, ANT RES NEISS GON; XIA MS, 1995, J INFECT DIS, V171, P455, DOI 10.1093/infdis/171.2.455	44	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28259	10.1371/journal.pone.0028259	http://dx.doi.org/10.1371/journal.pone.0028259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163288	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900023
J	Feligioni, M; Brambilla, E; Camassa, A; Sclip, A; Arnaboldi, A; Morelli, F; Antoniou, X; Borsello, T				Feligioni, Marco; Brambilla, Elisa; Camassa, Agata; Sclip, Alessandra; Arnaboldi, Andrea; Morelli, Federica; Antoniou, Xanthi; Borsello, Tiziana			Crosstalk between JNK and SUMO Signaling Pathways: deSUMOylation Is Protective against H2O2-Induced Cell Injury	PLOS ONE			English	Article							N-TERMINAL KINASE; OXIDATIVE STRESS; C-JUN; CEREBRAL-ISCHEMIA; PROTEIN SUMOYLATION; ACTIVATION; DEATH; ANTIOXIDANTS; CONJUGATION; OXIDANTS	Background: Oxidative stress is a key feature in the pathogenesis of several neurological disorders. Following oxidative stress stimuli a wide range of pathways are activated and contribute to cellular death. The mechanism that couples c-Jun N-terminal kinase (JNK) signaling, a key pathway in stress conditions, to the small ubiquitin-related modifier (SUMO), an emerging protein in the field, is largely unknown. Methodology/ Principal Findings: With this study we investigated if SUMOylation participates in the regulation of JNK activation as well as cellular death in a model of H2O2 induced-oxidative stress. Our data show that H2O2 modulates JNK activation and induces cellular death in neuroblastoma SH-SY5Y cells. Inhibition of JNK's action with the D-JNKI1 peptide rescued cells from death. Following H2O2, SUMO-1 over-expression increased phosphorylation of JNK and exacerbated cell death, although only in conditions of mild oxidative stress. Furthermore inhibition of SUMOylation, following transfection with SENP1, interfered with JNK activation and rescued cells from H2O2 induced death. Importantly, in our model, direct interaction between these proteins can occur. Conclusions/Significance: Taken together our results show that SUMOylation may significantly contribute to modulation of JNK activation and contribute to cell death in oxidative stress conditions.	[Feligioni, Marco; Brambilla, Elisa; Camassa, Agata; Sclip, Alessandra; Arnaboldi, Andrea; Morelli, Federica; Antoniou, Xanthi; Borsello, Tiziana] Mario Negri Inst Pharmacol Res, Dept Neurosci, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Feligioni, M (corresponding author), Mario Negri Inst Pharmacol Res, Dept Neurosci, Via Eritrea 62, Milan, Italy.	tiziana.borsello@marionegri.it	Brambilla, Elisabeth MP/L-8796-2013; Borsello, Tiziana/ABG-7759-2020; Feligioni, Marco/F-8649-2012; Stefanadis, Christodoulos/ABH-2232-2020; Borsello, Tiziana/J-8232-2016	Stefanadis, Christodoulos/0000-0001-5974-6454; Borsello, Tiziana/0000-0002-9729-7642	San Paolo [2008-2437]; Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system); CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation [2009-2425]	San Paolo; Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system); CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation(Fondazione Cariplo)	This study was supported by San Paolo 2008-2437, the Marie Curie Industry-Academia Partnerships and Pathways (IAPP) CPADS (Cell permeable peptides as drug delivery system) and CARIPLO (Cassa di risparmio delle provincie Lombarde) Foundation 2009-2425. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2006, BRIT J HAEMATOL, V132, P108, DOI 10.1111/j.1365-2141.2005.05834.x; Bagatini MD, 2011, HEART VESSELS, V26, P55, DOI 10.1007/s00380-010-0029-9; Behl C, 1999, INT J VITAM NUTR RES, V69, P213, DOI 10.1024/0300-9831.69.3.213; Bitanihirwe BKY, 2011, NEUROSCI BIOBEHAV R, V35, P878, DOI 10.1016/j.neubiorev.2010.10.008; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Diego-Otero Y, 2009, NEUROPSYCHOPHARMACOL, V34, P1011, DOI 10.1038/npp.2008.152; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Garaude J, 2008, J IMMUNOL, V180, P5983, DOI 10.4049/jimmunol.180.9.5983; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Golbidi S, 2011, CURR DIABETES REV, V7, P106, DOI 10.2174/157339911794940729; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Lee YS, 2005, EMBO REP, V6, P949, DOI 10.1038/sj.embor.7400511; Leitao BB, 2011, FASEB J; Melchior F, 2003, TRENDS BIOCHEM SCI, V28, P612, DOI 10.1016/j.tibs.2003.09.002; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Navascues J, 2007, CHROMOSOMA, V116, P441, DOI 10.1007/s00412-007-0107-7; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Repici M, 2009, NEUROSCIENCE, V159, P94, DOI 10.1016/j.neuroscience.2008.11.049; Ryan CM, 2010, BIOCHEM BIOPH RES CO, V391, P1136, DOI 10.1016/j.bbrc.2009.12.040; Vogiatzi G, 2009, HELL J CARDIOL, V50, P402; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yang W, 2008, J CEREBR BLOOD F MET, V28, P892, DOI 10.1038/sj.jcbfm.9600601; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	35	45	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28185	10.1371/journal.pone.0028185	http://dx.doi.org/10.1371/journal.pone.0028185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164242	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400043
J	Imberger, G; Vejlby, AD; Hansen, SB; Moller, AM; Wetterslev, J				Imberger, Georgina; Vejlby, Alexandra Damgaard; Hansen, Sara Bohnstedt; Moller, Ann M.; Wetterslev, Jorn			Statistical Multiplicity in Systematic Reviews of Anaesthesia Interventions: A Quantification and Comparison between Cochrane and Non-Cochrane Reviews	PLOS ONE			English	Review							CLINICAL-TRIALS; QUALITY; METAANALYSIS; BONFERRONI; EFFICACY; ISSUES	Background: Systematic reviews with meta-analyses often contain many statistical tests. This multiplicity may increase the risk of type I error. Few attempts have been made to address the problem of statistical multiplicity in systematic reviews. Before the implications are properly considered, the size of the issue deserves clarification. Because of the emphasis on bias evaluation and because of the editorial processes involved, Cochrane reviews may contain more multiplicity than their non-Cochrane counterparts. This study measured the quantity of statistical multiplicity present in a population of systematic reviews and aimed to assess whether this quantity is different in Cochrane and non-Cochrane reviews. Methods/Principal Findings: We selected all the systematic reviews published by the Cochrane Anaesthesia Review Group containing a meta-analysis and matched them with comparable non-Cochrane reviews. We counted the number of statistical tests done in each systematic review. The median number of tests overall was 10 (interquartile range (IQR) 6 to 18). The median was 12 in Cochrane and 8 in non-Cochrane reviews (difference in medians 4 (95% confidence interval (CI) 2.0-19.0). The proportion that used an assessment of risk of bias as a reason for doing extra analyses was 42% in Cochrane and 28% in non-Cochrane reviews (difference in proportions 14% (95% CI 28 to 36). The issue of multiplicity was addressed in 6% of all the reviews. Conclusion/Significance: Statistical multiplicity in systematic reviews requires attention. We found more multiplicity in Cochrane reviews than in non-Cochrane reviews. Many of the reasons for the increase in multiplicity may well represent improved methodological approaches and greater transparency, but multiplicity may also cause an increased risk of spurious conclusions. Few systematic reviews, whether Cochrane or non-Cochrane, address the issue of multiplicity.	[Imberger, Georgina; Moller, Ann M.] Copenhagen Univ Hosp, Rigshosp, Cochrane Anaesthesia Review Grp, Copenhagen, Denmark; [Imberger, Georgina; Wetterslev, Jorn] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Imberger, Georgina; Vejlby, Alexandra Damgaard; Hansen, Sara Bohnstedt; Moller, Ann M.] Copenhagen Univ Hosp, Herlev Hosp, Herlev, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Imberger, G (corresponding author), Copenhagen Univ Hosp, Rigshosp, Cochrane Anaesthesia Review Grp, Copenhagen, Denmark.	gimberger@gmail.com	Wetterslev, Jørn/ABF-1251-2020; Moller, Ann Merete/AAO-6020-2021	Wetterslev, Jørn/0000-0001-7778-1771; 	Herlev Hospital, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Denmark	Herlev Hospital, Denmark; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Denmark	Georgina Imberger receiving funding from Herlev Hospital, Denmark and The Copenhagen Trial Unit, Centre for Clinical Intervention Research, Denmark. The other authors received no funding in connection with this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2009, COCHRANE HDB SYSTEMA; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bender R, 2008, J CLIN EPIDEMIOL, V61, P857, DOI 10.1016/j.jclinepi.2008.03.004; Biester K, 2005, 13 COCHR C 2005 OCT, P153; Block BM, 2003, JAMA-J AM MED ASSOC, V290, P2455, DOI 10.1001/jama.290.18.2455; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; FLEMING TR, 1993, CONTROL CLIN TRIALS, V14, P183, DOI 10.1016/0197-2456(93)90002-U; Gordi T, 2004, CLIN THER, V26, P780, DOI 10.1016/S0149-2918(04)90078-1; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2009, COCHRANE HDB SYSTEMA, P481; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2000, ONKOLOGIE, V23, P597, DOI 10.1159/000055014; Myles PGT, 2000, STAT METHODS ANAESTH; O'Connor D., 2009, COCHRANE HDB SYSTEMA; Ottenbacher KJ, 1998, AM J EPIDEMIOL, V147, P615; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; Petty William Clayton, 2002, AANA J, V70, P193; Phan TD, 2008, J AM COLL SURGEONS, V207, P935, DOI 10.1016/j.jamcollsurg.2008.08.007; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Proschan MA, 2000, CONTROL CLIN TRIALS, V21, P527, DOI 10.1016/S0197-2456(00)00106-9; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shah MR, 2005, JAMA-J AM MED ASSOC, V294, P1664, DOI 10.1001/jama.294.13.1664; Sharp SJ, 2006, SYSTEMATIC REV HLTH; Sterne JA, 2006, SYSTEMATIC REV HLTH; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; TUKEY JW, 1977, SCIENCE, V198, P679, DOI 10.1126/science.333584; Turk DC, 2008, PAIN, V139, P485, DOI 10.1016/j.pain.2008.06.025; Wetterslev J, 2008, DANISH ANAESTHESIA D; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013	36	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28422	10.1371/journal.pone.0028422	http://dx.doi.org/10.1371/journal.pone.0028422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164288	Green Published, gold			2022-12-27	WOS:000298171400089
J	Sun, HP; Zhang, QJ; Luo, X; Quan, HD; Zhang, F; Liu, C; Liu, MN				Sun, Hongpeng; Zhang, Qiuju; Luo, Xiao; Quan, Hude; Zhang, Feng; Liu, Chang; Liu, Meina			Changes of Adult Population Health Status in China from 2003 to 2008	PLOS ONE			English	Article							PUBLIC-HEALTH; SYSTEM REFORM; CARE-SYSTEM; INSURANCE; PREVALENCE; OBESITY; HYPERTENSION; ADOLESCENTS; TRANSITION; CHALLENGES	Objectives: The purpose of this study was to examine the change in health status of China's adult population between the years of 2003 and 2008 due to rapid economic growth and medical system improvement. Methods: Data from the third and fourth Chinese national health services surveys covering 141,927 residents in 2003 and 136,371 residents in 2008 who were aged >18 years were analyzed. Results: Chinese respondents in 2008 were more likely to report disease than in 2003. Smoking slightly decreased among men and women, and regular exercise showed much improvement. Stratified analyses revealed significant subpopulation disparities in rate ratios for 2008/2003 in the presence of chronic disease, with greater increases among women, elderly, the Han nationality, unmarried and widow, illiterate, rural, and regions east of China than other groups. Conclusions: Chinese adults in 2008 had worse health status than in 2003 in terms of presence of chronic disease. China's reform of health care will face more complex challenges in coming years from the deteriorating health status in Chinese adults.	[Sun, Hongpeng; Zhang, Qiuju; Luo, Xiao; Zhang, Feng; Liu, Chang; Liu, Meina] Harbin Med Univ, Sch Publ Hlth, Dept Biostat, Harbin, Peoples R China; [Quan, Hude] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Quan, Hude] Univ Calgary, Ctr Hlth & Policy Studies, Calgary, AB, Canada	Harbin Medical University; University of Calgary; University of Calgary	Liu, MN (corresponding author), Harbin Med Univ, Sch Publ Hlth, Dept Biostat, Harbin, Peoples R China.	liumeina369@163.com	zhang, qiu/GXG-5600-2022	Quan, Hude/0000-0002-7848-7256	National Natural Science Foundation of China [70873031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (70873031 to ML; http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 6 NAT POP CENS MAIN; Attane I, 2002, STUD FAMILY PLANN, V33, P103, DOI 10.1111/j.1728-4465.2002.00103.x; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; China Ministry of Health, 2003, 3 NAT HLTH SERV SURV; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Cook IG, 2004, HEALTH POLICY, V67, P329, DOI 10.1016/j.healthpol.2003.07.005; Du SF, 2002, PUBLIC HEALTH NUTR, V5, P169, DOI 10.1079/PHN2001290; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Health Ministry of China, 2008, CHIN HLTH DEV REP 20, P2003; Hu SL, 2008, LANCET, V372, P1846, DOI 10.1016/S0140-6736(08)61368-9; Hui Ka Kit, 2011, Zhongguo Zhong Xi Yi Jie He Za Zhi, V31, P107; Li B, 1998, China Popul Today, V15, P2; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Liu MN, 2007, MED CARE, V45, P767, DOI 10.1097/MLR.0b013e3180618b9a; Liu YL, 2004, B WORLD HEALTH ORGAN, V82, P532; Liu YL, 2004, HEALTH POLICY PLANN, V19, P159, DOI 10.1093/heapol/czh019; Liu YL, 2002, HEALTH POLICY, V60, P133, DOI 10.1016/S0168-8510(01)00207-X; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Ma J, 2008, HEALTH AFFAIR, V27, P937, DOI 10.1377/hlthaff.27.4.937; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Shi J, 2008, MALE FEMALE ADULT PO; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sun F, 1998, Asia Pac Popul J, V13, P75; Tan XD, 2004, HEALTH EDUC RES, V19, P576, DOI 10.1093/her/cyg074; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Tang Yao-wu, 2008, Zhonghua Yufang Yixue Zazhi, V42, P3; TAO SQ, 1995, CHINESE MED J-PEKING, V108, P483; Wang LD, 2005, COMPREHENSIVE REPORT; Wang LD, 2007, LANCET, V369, P691, DOI 10.1016/S0140-6736(07)60316-X; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; Wang Y, 1998, EUR J CLIN NUTR, V52, P908, DOI 10.1038/sj.ejcn.1600664; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Wu Yang-feng, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P564; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yi HM, 2009, HEALTH ECON, V18, pS119, DOI 10.1002/hec.1510; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip W, 2009, HEALTH ECON, V18, pS3, DOI 10.1002/hec.1525; Zhu MM, 2008, HEALTH POLICY, V88, P371, DOI 10.1016/j.healthpol.2008.04.008	43	14	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28411	10.1371/journal.pone.0028411	http://dx.doi.org/10.1371/journal.pone.0028411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164286	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400087
J	Tadesse, T; Demissie, M; Berhane, Y; Kebede, Y; Abebe, M				Tadesse, Takele; Demissie, Meaza; Berhane, Yemane; Kebede, Yigzaw; Abebe, Markos			Two-Thirds of Smear-Positive Tuberculosis Cases in the Community Were Undiagnosed in Northwest Ethiopia: Population Based Cross-Sectional Study	PLOS ONE			English	Article							PREVALENCE	Background: Tuberculosis (TB) case detection rate remains low in Ethiopia. One of the underlying reasons is the emphasis on passive case finding strategy which may seriously underestimate the burden of the disease. Estimating the prevalence of smear-positive pulmonary TB through active case finding at population level can help assessing the degree to which passive case detection is successful. Methods and findings: This is population based cross-sectional study. The study population was all individuals aged >= 14 years. Interviews using a uniform questionnaire were done initially to identify individuals with chronic cough (>= 15 days) and the two sputum (spot and morning) samples were gathered for standard smear microscopy. A total of 23,590 individuals aged >= 14 years were interviewed and 984 had a chronic cough for >= 15 days. Of 831 individuals who provided two sputum samples for acid fast bacilli (AFB), 41 had positive smears. A total of 22 smear-positive TB cases detected through passive case finding were on anti-TB treatment. The prevalence of new smear-positive TB was 174 per 100,000 in persons aged >= 14 years (95% CI: 121-227). The ratio of active to passive case finding was 2:1. Higher rates of smear-positivity were observed among females [AOR: 3.28, 95% CI (1.54-6.77)], and in the age group >= 45 years [AOR: 2.26, 95% CI (1.12-4.59). Conclusions: The study revealed that about two-thirds of patients with active TB remain undiagnosed and thus untreated. This may indicate the need for strengthening case detection at the community level. Furthermore, the high burden of TB among females and in the age group >= 45 years warrants appropriate measures to control the disease.	[Tadesse, Takele; Kebede, Yigzaw] Univ Gondar, Sch Publ Hlth, Gondar, Ethiopia; [Demissie, Meaza; Berhane, Yemane] Addis Continental Inst Publ Hlth, Addis Ababa, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	University of Gondar; Addis Continental Institute of Public Health	Tadesse, T (corresponding author), Univ Gondar, Sch Publ Hlth, Gondar, Ethiopia.	takele_tadesse@yahoo.com	Berhane, Yemane/ABB-8154-2020	Berhane, Yemane/0000-0002-2527-1339	University of Gondar; Armeaur Hansen Research Institute; World Health Organization	University of Gondar; Armeaur Hansen Research Institute; World Health Organization(World Health Organization)	Financial support was obtained from the University of Gondar, Armeaur Hansen Research Institute and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Statistical Authority, 2007, POP HOUS CENS ETH RE; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Ditah IC, 2008, THORAX, V63, P440, DOI 10.1136/thx.2006.073916; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Federal Ministry of Health, 2010, ANN HLTH SERV REP; Federal Ministry of Health Ethiopia, 2008, TUB LEPR TB HIV PREV; Gustafson P, 2004, INT J EPIDEMIOL, V33, P163, DOI 10.1093/ije/dyh026; Horie T, 2007, INT J TUBERC LUNG D, V11, P562; Jianming W, 2008, BMC PUBLIC HEALTH, V8, P1; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Ministry of Health, 2007, SINGL POINT HIV PREV; Murray E, 2005, INT J TUBERC LUNG D, V13, P767; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Norval PY, 2004, INT J TUBERC LUNG D, V8, P299; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Sebhatu M, 2007, B WORLD HEALTH ORGAN, V85, P593, DOI 10.2471/BLT.06.038604; Shargie B, 2009, B WORLD HEALTH ORGAN, V84, P112; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; Tadesse T, 2011, EJHBS IN PRESS; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Thomas N, 2005, MALAWI MED J, V17, P33; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; van der Werf MJ, 2007, TROP MED INT HEALTH, V12, P475, DOI 10.1111/j.1365-3156.2006.01799.x; Van Leth F, 2008, B WORLD HEALTH ORGAN, V86, P20, DOI 10.2471/BLT.06.037804; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; WHO, 2009, STOP TB PARTN WHO GL; World Health Organization, 2010, TUB PREV SURV HDB; World Health Organization, 2010, WHOHTMTB20107; World Health Organization (WHO), 2009, WHOHTMTB2009426; Yimer S, 2009, INT J TUBERC LUNG D, V13, P1399; Zaman K, 2006, EPIDEMIOL INFECT, V134, P1052, DOI 10.1017/S0950268806006108	35	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28258	10.1371/journal.pone.0028258	http://dx.doi.org/10.1371/journal.pone.0028258			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164256	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400057
J	Tanadini, LG; Schmidt, BR				Tanadini, Lorenzo G.; Schmidt, Benedikt R.			Population Size Influences Amphibian Detection Probability: Implications for Biodiversity Monitoring Programs	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPECIES DETECTION PROBABILITY; BIOLOGICAL DIVERSITY; COUNT DATA; MODELS; ABUNDANCE; SCALE; DISTRIBUTIONS; FLUCTUATIONS; EXTINCTION	Monitoring is an integral part of species conservation. Monitoring programs must take imperfect detection of species into account in order to be reliable. Theory suggests that detection probability may be determined by population size but this relationship has not yet been assessed empirically. Population size is particularly important because it may induce heterogeneity in detection probability and thereby cause bias in estimates of biodiversity. We used a site occupancy model to analyse data from a volunteer-based amphibian monitoring program to assess how well different variables explain variation in detection probability. An index to population size best explained detection probabilities for four out of six species (to avoid circular reasoning, we used the count of individuals at a previous site visit as an index to current population size). The relationship between the population index and detection probability was positive. Commonly used weather variables best explained detection probabilities for two out of six species. Estimates of site occupancy probabilities differed depending on whether the population index was or was not used to model detection probability. The relationship between the population index and detectability has implications for the design of monitoring and species conservation. Most importantly, because many small populations are likely to be overlooked, monitoring programs should be designed in such a way that small populations are not overlooked. The results also imply that methods cannot be standardized in such a way that detection probabilities are constant. As we have shown here, one can easily account for variation in population size in the analysis of data from long-term monitoring programs by using counts of individuals from surveys at the same site in previous years. Accounting for variation in population size is important because it can affect the results of long-term monitoring programs and ultimately the conservation of imperiled species.	[Tanadini, Lorenzo G.; Schmidt, Benedikt R.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Schmidt, Benedikt R.] KARCH, Neuchatel, Switzerland	University of Zurich	Tanadini, LG (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	benedikt.schmidt@ieu.uzh.ch	Tanadini, Lorenzo/E-7290-2015; Schmidt, Benedikt R./B-8491-2008	Tanadini, Lorenzo/0000-0003-4337-0637; Schmidt, Benedikt R./0000-0002-4023-1001	MAVA Fondation pour la nature	MAVA Fondation pour la nature	BRS was supported by the "MAVA Fondation pour la nature.'' The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpizar-Jara R, 2004, OECOLOGIA, V141, P652, DOI 10.1007/s00442-004-1641-0; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; BLANKENHORN HJ, 1972, OECOLOGIA, V9, P223, DOI 10.1007/BF00345233; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dorazio RM, 2007, ECOLOGY, V88, P2773, DOI 10.1890/07-0006.1; Fletcher D.J., 1994, STAT ECOLOGY ENV MON, P105; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2004, BASIC APPL ECOL, V5, P65, DOI 10.1078/1439-1791-00194; Kery M, 2002, J WILDLIFE MANAGE, V66, P330, DOI 10.2307/3803165; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kropfli M, 2010, AMPHIBIA-REPTILIA, V31, P403, DOI 10.1163/156853810791769374; Lindenmayer DB, 2010, EFFECTIVE ECOLOGICAL MONITORING, P1; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marsh DM, 2001, BIOL CONSERV, V101, P327, DOI 10.1016/S0006-3207(01)00076-3; Mazerolle MJ, 2007, J HERPETOL, V41, P672, DOI 10.1670/07-061.1; Mcclintock BT, 2010, J WILDLIFE MANAGE, V74, P1882, DOI 10.2193/2009-321; Meier C., 1999, MITT AARGAUER NAT GE, V35, P41; Meyer A, 2009, SCHLANGENSPUREN KROT; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; Nichols J. D., 2008, J ECOLOGICAL ENV STA, V3, P201; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Pellet J, 2005, BIOL CONSERV, V123, P27, DOI 10.1016/j.biocon.2004.10.005; Pellet J, 2008, J INSECT CONSERV, V12, P155, DOI 10.1007/s10841-007-9075-8; Pellet J, 2006, OECOLOGIA, V149, P65, DOI 10.1007/s00442-006-0432-1; Peterson James T., 2004, P173; Pollock Kenneth H., 2004, P43; Pollock KH, 2002, ENVIRONMETRICS, V13, P105, DOI 10.1002/env.514; PRESTON FW, 1979, ECOLOGY, V60, P451, DOI 10.2307/1936061; Royle JA, 2006, J AGR BIOL ENVIR ST, V11, P249, DOI 10.1198/108571106X129153; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2006, BIOMETRICS, V62, P97, DOI 10.1111/j.1541-0420.2005.00439.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Salvidio S, 2009, BIOL CONSERV, V142, P455, DOI 10.1016/j.biocon.2008.10.035; SANDLAND RL, 1981, BIOMETRIKA, V68, P531, DOI 10.1093/biomet/68.2.531; Schmidt BR, 2005, J WILDLIFE MANAGE, V69, P884, DOI 10.2193/0022-541X(2005)069[0884:RIOPPA]2.0.CO;2; Schmidt BR, 2005, AQUAT CONSERV, V15, P681, DOI 10.1002/aqc.740; Schmidt BR, 2004, HERPETOL J, V14, P167; Sewell D, 2010, BIOL CONSERV, V143, P2102, DOI 10.1016/j.biocon.2010.05.019; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Vences Miguel, 2007, Zeitschrift fuer Feldherpetologie, V14, P153; Weber D, 2004, GLOBAL ECOL BIOGEOGR, V13, P97, DOI 10.1111/j.1466-882X.2004.00078.x; Weir LA, 2005, J HERPETOL, V39, P627; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	46	53	55	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28244	10.1371/journal.pone.0028244	http://dx.doi.org/10.1371/journal.pone.0028244			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164250	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000298171400051
J	Jenkins, RKB; Keane, A; Rakotoarivelo, AR; Rakotomboavonjy, V; Randrianandrianina, FH; Razafimanahaka, HJ; Ralaiarimalala, SR; Jones, JPG				Jenkins, Richard K. B.; Keane, Aidan; Rakotoarivelo, Andrinajoro R.; Rakotomboavonjy, Victor; Randrianandrianina, Felicien H.; Razafimanahaka, H. Julie; Ralaiarimalala, Sylvain R.; Jones, Julia P. G.			Analysis of Patterns of Bushmeat Consumption Reveals Extensive Exploitation of Protected Species in Eastern Madagascar	PLOS ONE			English	Article							WILDLIFE LAWS; RECALL BIAS; RIO-MUNI; WEALTH; CONSERVATION; INCOME; POPULATION; FORESTS; DECLINE; MAMMALS	Understanding the patterns of wild meat consumption from tropical forests is important for designing approaches to address this major threat to biodiversity and mitigate potential pathways for transmission of emerging diseases. Bushmeat consumption has been particularly poorly studied in Madagascar, one of the world's hottest biodiversity hotspots. Studying bushmeat consumption is challenging as many species are protected and researchers must consider the incentives faced by informants. Using interviews with 1154 households in 12 communes in eastern Madagascar, as well as local monitoring data, we investigated the importance of socio-economic variables, taste preference and traditional taboos on consumption of 50 wild and domestic species. The majority of meals contain no animal protein. However, respondents consume a wide range of wild species and 95% of respondents have eaten at least one protected species (and nearly 45% have eaten more than 10). The rural/urban divide and wealth are important predictors of bushmeat consumption, but the magnitude and direction of the effect varies between species. Bushmeat species are not preferred and are considered inferior to fish and domestic animals. Taboos have provided protection to some species, particularly the Endangered Indri, but we present evidence that this taboo is rapidly eroding. By considering a variety of potential influences on consumption in a single study we have improved understanding of who is eating bushmeat and why. Evidence that bushmeat species are not generally preferred meats suggest that projects which increase the availability of domestic meat and fish may have success at reducing demand. We also suggest that enforcement of existing wildlife and firearm laws should be a priority, particularly in areas undergoing rapid social change. The issue of hunting as an important threat to biodiversity in Madagascar is only now being fully recognised. Urgent action is required to ensure that heavily hunted species are adequately protected.	[Jenkins, Richard K. B.; Keane, Aidan; Jones, Julia P. G.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Jenkins, Richard K. B.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury CT2 7NZ, Kent, England; [Jenkins, Richard K. B.; Rakotoarivelo, Andrinajoro R.; Rakotomboavonjy, Victor; Randrianandrianina, Felicien H.; Razafimanahaka, H. Julie; Ralaiarimalala, Sylvain R.] Madagasikara Voakajy, Antananarivo, Madagascar	Bangor University; University of Kent	Jenkins, RKB (corresponding author), Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales.	julia.jones@bangor.ac.uk	Jenkins, Richard KB/A-4567-2012; Keane, Aidan/Q-5153-2019; Keane, Aidan/B-4098-2011; Jones, Julia P G/ABD-5629-2021; Jones, Julia P G/A-3031-2011	Keane, Aidan/0000-0002-9704-5576; Keane, Aidan/0000-0002-9704-5576; Jones, Julia P G/0000-0002-5199-3335; Jones, Julia P G/0000-0002-5199-3335	United Kingdom government Darwin Initiative [17-1127]; Disney Wildlife Conservation Fund; National Geographic Society; IUCN Netherlands; Rufford Foundation; SeaWorld and Busch Gardens	United Kingdom government Darwin Initiative; Disney Wildlife Conservation Fund; National Geographic Society(National Geographic Society); IUCN Netherlands; Rufford Foundation; SeaWorld and Busch Gardens	The work was funded by the United Kingdom government Darwin Initiative (grant 17-1127) (http://darwin.defra.gov.uk/), Disney Wildlife Conservation Fund (http://disney.go.com/disneyhand/environmentality/dwcf/apply.html), National Geographic Society (http://www.nationalgeographic.com/field/grants-programs/cre-application.html), IUCN Netherlands (http://www.terravivagrants.org/Home/funding-news/new-and-changed-grants-programs/iucn-netherlandssmallconservationgrantsin2011), Rufford Foundation (http://www.rufford.org/) and SeaWorld and Busch Gardens (http://www.swbg-conservationfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ambatovy Minerals provided some matched funding to the authors' project on the condition that the authors included areas covered by their mine in the study. However, they did not have any involvement in the design of the survey or in selecting specific study villages (just the communes in which the authors were to work; communes are large administrative units covering many 1000s of people). Conservation International similarly had no involvement in the design of the study or selecting of study villages or households. However, they also provided funding to the project on the condition that the authors included communes within their zone of intervention around a new protected area.	Allebone-Webb SM, 2011, CONSERV BIOL, V25, P597, DOI 10.1111/j.1523-1739.2011.01681.x; ANDRIAFIDISON D, 2008, IUCN 2010 IUCN RED L; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bennett EL, 2000, BIOL RESOURCE MANAGE, P499; BERNARD AR, 2000, SOCIAL RES METHODS Q; Bouche P, 2010, AFR J ECOL, V48, P994, DOI 10.1111/j.1365-2028.2009.01202.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burney DA, 2004, J HUM EVOL, V47, P25, DOI 10.1016/j.jhevol.2004.05.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Coad L, 2010, CONSERV BIOL, V24, P1510, DOI 10.1111/j.1523-1739.2010.01525.x; Colding J, 2001, ECOL APPL, V11, P584; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Crowley BE, 2010, QUATERNARY SCI REV, V29, P2591, DOI 10.1016/j.quascirev.2010.06.030; DRAPER R, 2010, NATL GEOGR, V218, P80; Duffy R, 2005, DEV CHANGE, V36, P825, DOI 10.1111/j.0012-155X.2005.00437.x; Dunham AE, 2008, BIOL CONSERV, V141, P287, DOI 10.1016/j.biocon.2007.10.006; East T, 2005, BIOL CONSERV, V126, P206, DOI 10.1016/j.biocon.2005.05.012; Ehrlich I., 1996, J EC PERSPECTIVES, V10; Ekholm O, 2004, EUR J CLIN NUTR, V58, P60, DOI 10.1038/sj.ejcn.1601746; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; FAVRE JC, 1996, PRIMATE REPORT, V46, P33; Garcia G, 2003, ORYX, V37, P115, DOI 10.1017/S0030605303000206; GELMAN A, 2007, DATA ANAL USING REGR, P466; Gilland B, 2002, FOOD POLICY, V27, P47, DOI 10.1016/S0306-9192(02)00002-7; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; John FAVS, 2010, BIOL CONSERV, V143, P1025, DOI 10.1016/j.biocon.2010.01.018; Jones JPG, 2008, CONSERV BIOL, V22, P976, DOI 10.1111/j.1523-1739.2008.00970.x; Karp A, 2007, SMALL ARMS SURVEY 20; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; LAMBEK M, 1992, MAN, V27, P245, DOI 10.2307/2804053; Levitt SD, 1998, ECON INQ, V36, P353, DOI 10.1111/j.1465-7295.1998.tb01720.x; Lindsey PA, 2011, ORYX, V45, P84, DOI 10.1017/S0030605310001274; Mazurkiewicz SM, 1996, WILDLIFE SOC B, V24, P140; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; *MIN FIN, 2006, ENQ PER AUPR MEN 200; Mutschler T, 2001, ORYX, V35, P152, DOI 10.1046/j.1365-3008.2001.00167.x; Nicoll M.E., 2003, NATURAL HIST MADAGAS, P1283; O'Brien S, 2003, ORYX, V37, P338, DOI 10.1017/S0030605303000590; Osborn MF, 2010, N AM J FISH MANAGE, V30, P665, DOI 10.1577/M09-196.1; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Quinn Aleta, 2002, Mammalian Species, P1; R Core Development Team, 2010, R LANG ENV STAT COMP; Rabearivony Jeanneney, 2008, Madagascar Conservation & Development, V3, P7; Rakotoarivelo Andrinajoro R., 2011, Madagascar Conservation & Development, V6, P37; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Smith RJ, 2006, ORYX, V40, P400, DOI 10.1017/S0030605306001232; Takasaki Y, 2000, WORLD DEV, V28, P1961, DOI 10.1016/S0305-750X(00)00062-0; THALMANN U, 1993, INT J PRIMATOL, V14, P357, DOI 10.1007/BF02192772; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Wilkie DS, 2001, CONSERV BIOL, V15, P761, DOI 10.1046/j.1523-1739.2001.015003761.x; Willcox AS, 2007, BIOL CONSERV, V134, P251, DOI 10.1016/j.biocon.2006.08.016; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Wolfe ND, 2004, LANCET, V363, P932, DOI 10.1016/S0140-6736(04)15787-5; Yee TW, 1996, J ROY STAT SOC B MET, V58, P481	64	93	97	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27570	10.1371/journal.pone.0027570	http://dx.doi.org/10.1371/journal.pone.0027570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194787	Green Published, gold, Green Submitted			2022-12-27	WOS:000298369100007
J	Redanz, S; Standar, K; Podbielski, A; Kreikemeyer, B				Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd			A Five-Species Transcriptome Array for Oral Mixed-Biofilm Studies	PLOS ONE			English	Article							COPPER-TRANSPORT OPERON; COMMUNITIES; GINGIVALIS; EXPRESSION; GENES; SUMMARIES; PROTEINS; DISEASES; COPYAZ; HSP70	Background: Oral polymicrobial interactions and biofilm formation are associated with initiation and progression of caries, gingivitis, and periodontitis. Transcriptome studies of such interactions, allowing a first mechanistic insight, are hampered by current single-species array designs. Methodology/Principal Findings: In this study we used 385 K NimbleGene (TM) technology for design and evaluation of an array covering the full genomes of 5 important physiological-, cariogenic-, and periodontitis-associated microorganisms (Streptococcus sanguinis, Streptococcus mutans, Fusobacterium nucleatum, Aggregatibacter actinomycetemcomitans, and Porphyromonas gingivalis). Array hybridization was done with cDNA from cultures grown for 24 h anaerobically. Single species experiments identified cross-species hybridizing array probes. These probes could be neglected in a mixed-species experimental setting without the need to exclude the whole genes from the analysis. Between 69% and almost 99% of the genomes were actively transcribed under the mono-species planktonic, monolayer, and biofilm conditions. The influence of Streptococcus mitis (not represented on the array) on S. mutans gene transcription was determined as a test for a dualspecies mixed biofilm setup. Phenotypically, under the influence of S. mitis an increase in S. mutans biofilm mass and a decrease in media pH-value were noticed, thereby confirming previously published data. Employing a stringent cut-off (2fold, p, 0.05), 19 S. mutans transcripts were identified with increased abundance, and 11 with decreased abundance compared to a S. mutans mono-species biofilm. Several of these genes have previously been found differentially regulated under general and acid stress, thereby confirming the value of this array. Conclusions/Significance: This new array allows transcriptome studies on multi-species oral biofilm interactions. It may become an important asset in future oral biofilm and inhibitor/therapy studies.	[Redanz, Sylvio; Standar, Kerstin; Podbielski, Andreas; Kreikemeyer, Bernd] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Redanz, S (corresponding author), Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Kreikemeyer, Bernd/0000-0001-9527-5098; Redanz, Sylvio/0000-0003-1541-2545	German Federal Ministry of Education and Research (BMBF) [FKZ 0313801M, FKZ 0313936B]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the German Federal Ministry of Education and Research (BMBF) grants in the framework of the PathoGenoMic Plus program (FKZ 0313801M) and ERANet PathoGenoMics I program (FKZ 0313936B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Albandar JM, 2002, PERIODONTOL 2000, V29, P7, DOI 10.1034/j.1600-0757.2002.290101.x; Beikler T, 2011, PERIODONTOL 2000, V55, P87, DOI 10.1111/j.1600-0757.2010.00360.x; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; De Stoppelaar J D, 1970, Caries Res, V4, P114; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong YX, 2009, MICROBIOL-SGM, V155, P3322, DOI 10.1099/mic.0.031591-0; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Haffajee AD, 2006, PERIODONTOL 2000, V42, P7, DOI 10.1111/j.1600-0757.2006.00190.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jayaraman GC, 1997, MOL MICROBIOL, V25, P329, DOI 10.1046/j.1365-2958.1997.4671835.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3204, DOI 10.1128/IAI.57.10.3204-3209.1989; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lamont RJ, 2002, MICROBIOL-SGM, V148, P1627, DOI 10.1099/00221287-148-6-1627; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JAC, 2005, CURR ISSUES MOL BIOL, V7, P95; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Maeda K, 2004, MICROBES INFECT, V6, P1163, DOI 10.1016/j.micinf.2004.06.005; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Martinez AR, 2010, MOL ORAL MICROBIOL, V25, P331, DOI 10.1111/j.2041-1014.2010.00580.x; Mitrakul K, 2004, ORAL MICROBIOL IMMUN, V19, P395, DOI 10.1111/j.1399-302x.2004.00176.x; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; Paramonova E, 2009, J DENT RES, V88, P922, DOI 10.1177/0022034509344569; Shah DSH, 2004, MICROBIOL-SGM, V150, P1947, DOI 10.1099/mic.0.26955-0; Shemesh M, 2007, MICROBIOL-SGM, V153, P1307, DOI 10.1099/mic.0.2006/002030-0; Spratt D. A., 2003, Reviews in Environmental Science and Bio/Technology, V2, P109, DOI 10.1023/B:RESB.0000040466.82937.df; Standar K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013135; Vats N, 2001, MICROBIOL-UK, V147, P653, DOI 10.1099/00221287-147-3-653; Wen ZT, 2011, MOL ORAL MICROBIOL, V26, P2, DOI 10.1111/j.2041-1014.2010.00581.x; Zanin ICJ, 2006, EUR J ORAL SCI, V114, P64, DOI 10.1111/j.1600-0722.2006.00263.x	41	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27827	10.1371/journal.pone.0027827	http://dx.doi.org/10.1371/journal.pone.0027827			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194794	gold, Green Submitted, Green Published			2022-12-27	WOS:000298369100014
J	Beauvais, G; Atwell, K; Jayanthi, S; Ladenheim, B; Cadet, JL				Beauvais, Genevieve; Atwell, Kenisha; Jayanthi, Subramaniam; Ladenheim, Bruce; Cadet, Jean Lud			Involvement of Dopamine Receptors in Binge Methamphetamine-Induced Activation of Endoplasmic Reticulum and Mitochondrial Stress Pathways	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; INDUCED NEURONAL APOPTOSIS; HEAT-SHOCK-PROTEIN; INDUCED NEUROTOXICITY; RAT-BRAIN; INDUCED HYPERTHERMIA; MESSENGER-RNA; CELL-DEATH; HYBRIDIZATION HISTOCHEMISTRY; TRANSGENIC MICE	Single large doses of methamphetamine ( METH) cause endoplasmic reticulum ( ER) stress and mitochondrial dysfunctions in rodent striata. The dopamine D(1) receptor appears to be involved in these METH-mediated stresses. The purpose of this study was to investigate if dopamine D(1) and D(2) receptors are involved in ER and mitochondrial stresses caused by single-day METH binges in the rat striatum. Male Sprague-Dawley rats received 4 injections of 10 mg/kg of METH alone or in combination with a putative D(1) or D(2) receptor antagonist, SCH23390 or raclopride, respectively, given 30 min prior to each METH injection. Rats were euthanized at various timepoints afterwards. Striatal tissues were used in quantitative RT-PCR and western blot analyses. We found that binge METH injections caused increased expression of the pro-survival genes, BiP/GRP-78 and P58(IPK), in a SCH23390-sensitive manner. METH also caused up-regulation of ER-stress genes, Atf2, Atf3, Atf4, CHOP/Gadd153 and Gadd34. The expression of heat shock proteins ( HSPs) was increased after METH injections. SCH23390 completely blocked induction in all analyzed ER stress-related proteins that included ATF3, ATF4, CHOP/Gadd153, HSPs and caspase-12. The dopamine D(2)-like antagonist, raclopride, exerted small to moderate inhibitory influence on some METH-induced changes in ER stress proteins. Importantly, METH caused decreases in the mitochondrial anti-apoptotic protein, Bcl-2, but increases in the pro-apoptotic proteins, Bax, Bad and cytochrome c, in a SCH23390-sensitive fashion. In contrast, raclopride provided only small inhibition of METH-induced changes in mitochondrial proteins. These findings indicate that METH-induced activation of striatal ER and mitochondrial stress pathways might be more related to activation of SCH23390-sensitive receptors.	[Beauvais, Genevieve; Atwell, Kenisha; Jayanthi, Subramaniam; Ladenheim, Bruce; Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, Baltimore, MD USA; [Beauvais, Genevieve] Univ Paris 05, Fac Pharm, Paris, France	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); UDICE-French Research Universities; Universite Paris Cite	Beauvais, G (corresponding author), NIDA, Mol Neuropsychiat Res Branch, Intramural Res Program, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Jayanthi, Subramaniam/0000-0002-5209-303X	National Institutes of Health/National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000551] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health/National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; ANDERSEN PH, 1986, LIFE SCI, V38, P1507, DOI 10.1016/0024-3205(86)90564-3; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BISCHOFF S, 1986, EUR J PHARMACOL, V129, P367, DOI 10.1016/0014-2999(86)90449-8; BISCHOFF S, 1988, J RECEPTOR RES, V8, P107, DOI 10.3109/10799898809048981; Bourne JA, 2001, CNS DRUG REV, V7, P399; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Bowyer JF, 1999, ANN NY ACAD SCI, V890, P314, DOI 10.1111/j.1749-6632.1999.tb08009.x; Cadet JL, 2010, CNS NEUROL DISORD-DR, V9, P526; CADET JL, 1994, ANN NY ACAD SCI, V738, P388; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Cadet JL, 1997, SYNAPSE, V25, P176; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Deng XL, 1999, J NEUROSCI, V19, P10107; Deng XL, 2002, NEUROPHARMACOLOGY, V42, P837, DOI 10.1016/S0028-3908(02)00034-5; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; GANDOLFI O, 1988, NEUROSCI LETT, V92, P192, DOI 10.1016/0304-3940(88)90059-6; Gold MS, 2009, BIOL PSYCHIAT, V66, P118, DOI 10.1016/j.biopsych.2009.02.021; GOTO S, 1993, BRAIN RES, V626, P351, DOI 10.1016/0006-8993(93)90602-J; Gregersen N, 2010, METHODS MOL BIOL, V648, P3, DOI 10.1007/978-1-60761-756-3_1; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HALL H, 1988, PROG NEURO-PSYCHOPH, V12, P559, DOI 10.1016/0278-5846(88)90001-2; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayashi T, 2010, J PHARMACOL EXP THER, V332, P1054, DOI 10.1124/jpet.109.159244; HURST HC, 1991, NUCLEIC ACIDS RES, V19, P4601, DOI 10.1093/nar/19.17.4601; Jayanthi S, 1998, ANN NY ACAD SCI, V844, P92, DOI 10.1111/j.1749-6632.1998.tb08224.x; Jayanthi S, 2001, FASEB J, V15, P1745, DOI 10.1096/fj.01-0025com; Jayanthi S, 2004, FASEB J, V18, P238, DOI 10.1096/fj.03-0295com; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; JOHNSON M, 1994, J PHARMACOL EXP THER, V270, P97; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KIYATKIN EA, 2010, J NEURAL TRANSM; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOHLER C, 1985, BIOCHEM PHARMACOL, V34, P2251, DOI 10.1016/0006-2952(85)90778-6; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Kuhn DM, 2008, ANN NY ACAD SCI, V1139, P118, DOI 10.1196/annals.1432.026; Kuperman DI, 1997, BRAIN RES, V771, P221, DOI 10.1016/S0006-8993(97)00710-5; Lachowicz JE, 1997, PHARMACOL TOXICOL, V81, P105, DOI 10.1111/j.1600-0773.1997.tb00039.x; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; LANDWEHRMEYER B, 1993, EUR J NEUROSCI, V5, P145, DOI 10.1111/j.1460-9568.1993.tb00480.x; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; MEADORWOODRUFF JH, 1992, NEUROSCI LETT, V145, P209, DOI 10.1016/0304-3940(92)90024-2; Melville MW, 1997, P NATL ACAD SCI USA, V94, P97, DOI 10.1073/pnas.94.1.97; Melville MW, 2000, CELL MOL LIFE SCI, V57, P311, DOI 10.1007/PL00000692; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; ODELL SJ, 1993, J NEUROCHEM, V60, P1792, DOI 10.1111/j.1471-4159.1993.tb13405.x; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; Rutkowski DT, 2007, MOL BIOL CELL, V18, P3681, DOI 10.1091/mbc.e07-03-0272; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Simon SL, 2000, AM J ADDICTION, V9, P222; Smith DJ, 2008, IUBMB LIFE, V60, P383, DOI 10.1002/iub.44; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SONSALLA PK, 1986, J PHARMACOL EXP THER, V238, P932; Thiriet N, 2005, J NEUROSCI, V25, P5273, DOI 10.1523/JNEUROSCI.4893-04.2005; Thomas DM, 2010, J NEUROCHEM, V115, P595, DOI 10.1111/j.1471-4159.2010.06950.x; Thomas M, 2010, SYNAPSE, V64, P579, DOI 10.1002/syn.20763; Valjent E, 2009, TRENDS NEUROSCI, V32, P538, DOI 10.1016/j.tins.2009.06.005; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Yu XW, 1999, BRAIN RES, V823, P213, DOI 10.1016/S0006-8993(99)01154-3; Zhu JPQ, 2006, NEUROTOXICOLOGY, V27, P131, DOI 10.1016/j.neuro.2005.05.014	77	74	76	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28946	10.1371/journal.pone.0028946	http://dx.doi.org/10.1371/journal.pone.0028946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174933	gold, Green Published, Green Submitted			2022-12-27	WOS:000298367300035
J	Nouri, J; Diaz-Martinez, I; Perez-Lorente, F				Nouri, Jaouad; Diaz-Martinez, Ignacio; Perez-Lorente, Felix			Tetradactyl Footprints of an Unknown Affinity Theropod Dinosaur from the Upper Jurassic of Morocco	PLOS ONE			English	Article							CENTRAL HIGH ATLAS; IOUARIDENE FORMATION; TRACKWAYS	Background: New tetradactyl theropod footprints from Upper Jurassic (Oxfordian-Kimmeridgian) have been found in the louaridene syncline (Morocco). The tracksites are at several layers in the intermediate lacustrine unit of louaridene Formation. The footprints were named informally in previous works "Eutynichnium atlasipodus''. We consider as nomen nudum. Methodology/Principal Findings: Boutakioutichnium atlasicus ichnogen. et ichnosp. nov. is mainly characterized by the hallux impression. It is long, strong, directed medially or forward, with two digital pads and with the proximal part of the first pad in lateral position. More than 100 footprints in 15 trackways have been studied with these features. The footprints are large, 38-48 cm in length, and 26-31 cm in width. Conclusions/Significance: Boutakioutichnium mainly differs from other ichnotaxa with hallux impression in lacking metatarsal marks and in not being a very deep footprint. The distinct morphology of the hallux of the Boutakioutichnium trackmaker -i.e. size and hallux position-are unique in the dinosaur autopodial record to date.	[Nouri, Jaouad] Univ Mohammed 5, Fac Sci, Rabat, Morocco; [Diaz-Martinez, Ignacio; Perez-Lorente, Felix] Univ La Rioja, Fac Ciencas, Logrono, La Rioja, Spain; [Diaz-Martinez, Ignacio; Perez-Lorente, Felix] Fdn Patrimonio Paleontol La Rioja, Enciso, La Rioja, Spain	Mohammed V University in Rabat; Universidad de La Rioja	Nouri, J (corresponding author), Univ Mohammed 5, Fac Sci, Rabat, Morocco.	felix.perez@unirioja.es	Martínez, Ignacio Díaz/I-2766-2015; Nouri, Professor J./B-2614-2008	Martínez, Ignacio Díaz/0000-0001-5301-8384; Nouri, Professor J./0000-0002-9982-3546; Environmental Science and Management, Global Journal of/0000-0003-0365-1696	Governement of La Rioja; Paleontological Heritage of La Rioja Foundation; University of La Rioja; Fomenta [2008/02]	Governement of La Rioja; Paleontological Heritage of La Rioja Foundation; University of La Rioja; Fomenta	This article forms part of the projects: Fomenta 2008/02 and Oficina de Transferencia de Resultados de Investigacion (Bureau Transfer Results Investigations) University of La Rioja and EMpresa (enterprise) Foundation Paleontological Heritage of La Rioja 2009. This work was subsidized by the Governement of La Rioja, the Paleontological Heritage of La Rioja Foundation and the University of La Rioja. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1976, NATURE, V261, P129, DOI 10.1038/261129a0; [Anonymous], 1889, P BOSTON SOC NATURAL; BELVEDERE M, 2008, 2 INT C ICHN ICHN 20; BELVEDERE M, 2008, THESIS U STUDI PADOV; BELVEDERE M, 2007, DINOSAUR TRACKS UPPE; Belvedere M, 2010, GEOL Q, V54, P367; Belvedere M, 2010, PALAEONTOLOGY, V53, P233, DOI 10.1111/j.1475-4983.2009.00928.x; Bogdanovich A. I., 2007, Vestnik Zoologii, V41, P283; Boutakiout Mohamed, 2009, Geogaceta, V47, P33; Boutakiout Mohamed, 2008, Geogaceta, V45, P51; Boutakiout Mohamed, 2009, Revista Espanola de Paleontologia, V24, P31; CALVO J O, 1991, Ameghiniana, V28, P241; Castanera D., 2010, 5 JORN INT PAL DIN E, P47; Charriere A, 2005, CR PALEVOL, V4, P385, DOI 10.1016/j.crpv.2005.04.009; CHOUBERT G, 1956, CR HEBD ACAD SCI, V243, P1639; COPE ED, 1887, AM NAT, V21, P367, DOI DOI 10.1086/274464; Csiki Z, 2010, P NATL ACAD SCI USA, V107, P15357, DOI 10.1073/pnas.1006970107; DEMATHIEU GR, 1986, GEOBIOS-LYON, V19, P327, DOI 10.1016/S0016-6995(86)80021-3; DUTUIT JM, 1980, MEM SOC GEOL FRANCE, V139, P95; Fornos JJ, 2002, PALAEOGEOGR PALAEOCL, V180, P277, DOI 10.1016/S0031-0182(01)00431-X; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Gatesy Stephen M., 2003, Ichnos, V10, P91, DOI 10.1080/10420940390255484; GOMES JP, 1915, COMUNICACOES COMISIO, V9, P132; Haddoumi H, 2010, GEOBIOS-LYON, V43, P433, DOI 10.1016/j.geobios.2010.01.001; Harris JD, 1996, CRETACEOUS RES, V17, P381, DOI 10.1006/cres.1996.0024; Harris JD, 1997, CRETACEOUS RES, V18, P139, DOI 10.1006/cres.1996.0053; Haubold H., 1971, HDB PALAOHERPETOLOGI; HEILMANN G, 1926, ORIGIN BIRDS; HITCHCOCK E, 1858, ICHNOLOGY NEW ENGALN; Ishigaki S., 1989, P83; Ishigaki S., 1988, NOTES SERVICE GEOLOG, V44, P79; Ishigaki Shinobu, 2009, Memoir of the Fukui Prefectural Dinosaur Museum, V8, P1; JENNY J, 1982, CR ACAD SCI II, V294, P223; Kuhn O., 1958, FAHRTEN VORZEITLICHE; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; LAPPARENT AFD, 1945, B MUSEUM NATL HIST N, V17, P268; Leonardi G., 1987, GLOSARY MANUAL TETRA; Lockley M.G., 1990, Ichnos, V1, P81; Lockley Martin G., 2004, Ichnos, V11, P229, DOI 10.1080/10420940490428625; Lockley Martin G., 2000, Gaia (Lisboa), V15, P313; Lockley MG, 2009, GEOL SOC SPEC PUBL, V315, P255, DOI 10.1144/SP315.18; Lockley Martin G., 1994, Ichnos, V3, P213; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; Marsh O.C., 1881, AM J SCI 3, V23, P81, DOI DOI 10.2475/AJS.S3-23.133.81; MEYER CA, 2002, 7 EUR WOKSH VERT PAL; Middleton KM, 2001, J MORPHOL, V250, P51, DOI 10.1002/jmor.1058; MOJON PO, 2009, NOUVELLES DONNEES CH; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Nopcsa, 1923, FORTSCHRITTE GEOLOGI, V2, P1; Nouri J., 2001, Geogaceta, V29, P83; Nouri J., 2007, THESIS U MOHAMMED 5; NOURI J, 2009, INVENTAIRE ICHNOLOGI; OSBORN H.F., 1924, AM MUS NOVIT, V144, P1; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul G., 1988, PREDATORY DINOSAURS; Perez-Lorente F., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P161; Perez-Lorente F., 2001, PALEOICNOLOGIA DINOS; Perez-Lorente Felix, 2007, Revista Espanola de Paleontologia, V22, P157; Pereziorente Fp, 1993, ZUBIA MONOGRAFICO, V5, p181 228; PERLE A, 1982, PROBLEMS GEOLOGY MON, V5, P94; PLATEAU H, 1937, COMPTES RENDUS SOMMA, P241; REQUETA LE, 2006, ZUBIA MONOGRAFICO, V18, P21; Romero Molina M.M., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P13; TARSITANO S, 1983, Acta Palaeontologica Polonica, V28, P251; Thulborn RA., 1990, DINOSAUR TRACKS; Thulborn Tony, 2001, Ichnos, V8, P207; Torcida F., 2003, Ciencias de la Tierra Instituto de Estudios Riojanos, V26, P109; WAGNER A, 1861, PHYSIKALISCHEN CLASS, V9, P1; Weems R.E., 1992, P 26 FORUM GEOLOGY I, V119, P113; Woodward A. S., 1907, P GEOLOGICAL SOC LON, V63, P140, DOI DOI 10.1144/GSL.JGS.1907.063.01-04.12; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Yang XL, 1987, DINOSAUR FOOTPRINTS	72	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e26882	10.1371/journal.pone.0026882	http://dx.doi.org/10.1371/journal.pone.0026882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180775	gold, Green Submitted, Green Published			2022-12-27	WOS:000298367300002
J	Rijkenberg, MJA; Langlois, RJ; Mills, MM; Patey, MD; Hill, PG; Nielsdottir, MC; Compton, TJ; LaRoche, J; Achterberg, EP				Rijkenberg, Micha J. A.; Langlois, Rebecca J.; Mills, Matthew M.; Patey, Matthew D.; Hill, Polly G.; Nielsdottir, Maria C.; Compton, Tanya J.; LaRoche, Julie; Achterberg, Eric P.			Environmental Forcing of Nitrogen Fixation in the Eastern Tropical and Sub-Tropical North Atlantic Ocean	PLOS ONE			English	Article							DISSOLVED ORGANIC NITROGEN; N-2 FIXATION; UNICELLULAR CYANOBACTERIA; COMMUNITY STRUCTURE; GLOBAL DISTRIBUTION; SAHARAN DUST; TRICHODESMIUM; IRON; PHOSPHORUS; CULTURES	During the winter of 2006 we measured nifH gene abundances, dinitrogen (N-2) fixation rates and carbon fixation rates in the eastern tropical and sub-tropical North Atlantic Ocean. The dominant diazotrophic phylotypes were filamentous cyanobacteria, which may include Trichodesmium and Katagnymene, with up to 10(6) L-1 nifH gene copies, unicellular group A cyanobacteria with up to 10(5) L-1 nifH gene copies and gamma A proteobacteria with up to 10(4) L-1 nifH gene copies. N-2 fixation rates were low and ranged between 0.032-1.28 nmol N L-1 d(-1) with a mean of 0.30 +/- 0.29 nmol N L-1 d(-1) (1 sigma, n = 65). CO2-fixation rates, representing primary production, appeared to be nitrogen limited as suggested by low dissolved inorganic nitrogen to phosphate ratios (DIN: DIP) of about 2 +/- 3.2 in surface waters. Nevertheless, N-2 fixation rates contributed only 0.55 +/- 0.87% (range 0.03-5.24%) of the N required for primary production. Boosted regression trees analysis (BRT) showed that the distribution of the gamma A proteobacteria and filamentous cyanobacteria nifH genes was mainly predicted by the distribution of Prochlorococcus, Synechococcus, picoeukaryotes and heterotrophic bacteria. In addition, BRT indicated that multiple a-biotic environmental variables including nutrients DIN, dissolved organic nitrogen (DON) and DIP, trace metals like dissolved aluminum (DAl), as a proxy of dust inputs, dissolved iron (DFe) and Fe-binding ligands as well as oxygen and temperature influenced N-2 fixation rates and the distribution of the dominant diazotrophic phylotypes. Our results suggest that lower predicted oxygen concentrations and higher temperatures due to climate warming may increase N-2 fixation rates. However, the balance between a decreased supply of DIP and DFe from deep waters as a result of more pronounced stratification and an enhanced supply of these nutrients with a predicted increase in deposition of Saharan dust may ultimately determine the consequences of climate warming for N-2 fixation in the North Atlantic.	[Rijkenberg, Micha J. A.; Patey, Matthew D.; Hill, Polly G.; Nielsdottir, Maria C.; Achterberg, Eric P.] Univ Southampton, Sch Ocean & Earth Sci, Natl Oceanog Ctr Southampton, Southampton, Hants, England; [Langlois, Rebecca J.; LaRoche, Julie] Leibniz Inst Marine Sci, D-24105 Kiel, Germany; [Mills, Matthew M.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; [Compton, Tanya J.] Natl Inst Water & Atmospher Res, Hamilton, New Zealand	NERC National Oceanography Centre; University of Southampton; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Stanford University; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Rijkenberg, MJA (corresponding author), Royal Netherlands Inst Sea Res, Den Hoorn, Texel, Netherlands.	Micha.Rijkenberg@nioz.nl	Rijkenberg, Micha/C-3245-2012; Achterberg, Eric P/C-5820-2009; Compton, Tanya/G-6230-2012; LaRoche, Julie/A-1109-2010; Patey, Matthew D/N-3001-2015	Achterberg, Eric P/0000-0002-3061-2767; Patey, Matthew D/0000-0001-8677-2818; Langlois, Rebecca/0000-0002-8382-4448; Hill, Polly/0000-0003-3122-7892; LaRoche, Julie/0000-0003-4809-6411	NERC as part of the UKSOLAS [NE/C001931/1]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [NE/C001931/1, noc010009, NE/C001737/1] Funding Source: researchfish	NERC as part of the UKSOLAS; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by NERC as part of the UKSOLAS programme (NE/C001931/1). Website address: http://www.nerc.ac.uk/research/programmes/solas/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atallah ZK, 2007, PHYTOPATHOLOGY, V97, P865, DOI 10.1094/PHYTO-97-7-0865; Avak H., 1999, EA IRMS PRECISE ACCU; Badr ESA, 2003, TRAC-TREND ANAL CHEM, V22, P819, DOI 10.1016/S0165-9936(03)01202-0; Bartoli G, 2005, DEEP-SEA RES PT I, V52, P2005, DOI 10.1016/j.dsr.2005.06.006; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002331; Capone DG, 2001, CURR OPIN MICROBIOL, V4, P341, DOI 10.1016/S1369-5274(00)00215-0; CAPONE DG, 1994, APPL ENVIRON MICROB, V60, P3989, DOI 10.1128/AEM.60.11.3989-3995.1994; CHIAPELLO I, 1995, GEOPHYS RES LETT, V22, P3191, DOI 10.1029/95GL03313; de Baar HJW, 2008, MAR ECOL PROG SER, V364, P269, DOI 10.3354/meps07548; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Fu FX, 2003, FEMS MICROBIOL ECOL, V45, P203, DOI 10.1016/S0168-6496(03)00157-0; Hamme RC, 2004, DEEP-SEA RES PT I, V51, P1517, DOI 10.1016/j.dsr.2004.06.009; Hirata T, 2011, BIOGEOSCIENCES, V8, P311, DOI 10.5194/bg-8-311-2011; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Holl CM, 2007, DEEP-SEA RES PT II, V54, P1045, DOI 10.1016/j.dsr2.2007.02.002; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; HYDES DJ, 1976, ANALYST, V101, P922, DOI 10.1039/an9760100922; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Kirkwood D, 1996, NUTR PRACTICAL NOTES, P25; Kustka A, 2002, RES MICROBIOL, V153, P255, DOI 10.1016/S0923-2508(02)01325-6; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; LaRoche J, 2005, J SEA RES, V53, P67, DOI 10.1016/j.seares.2004.05.005; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mahowald NM, 2009, ANNU REV MAR SCI, V1, P245, DOI 10.1146/annurev.marine.010908.163727; Maldonado MT, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002481; Mather RL, 2008, NAT GEOSCI, V1, P439, DOI 10.1038/ngeo232; Mills MM, 2010, NAT GEOSCI, V3, P412, DOI 10.1038/NGEO856; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Montoya JP, 2007, BIOGEOSCIENCES, V4, P369, DOI 10.5194/bg-4-369-2007; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moore CM, 2009, NAT GEOSCI, V2, P867, DOI 10.1038/ngeo667; Mulholland MR, 2004, AQUAT MICROB ECOL, V37, P85, DOI 10.3354/ame037085; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; Mulholland MR, 1999, MAR ECOL PROG SER, V188, P33, DOI 10.3354/meps188033; Mulholland MR, 2000, TRENDS PLANT SCI, V5, P148, DOI 10.1016/S1360-1385(00)01576-4; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Ridgeway G., 2004, GBM GEN BOOSTED REGR; Rijkenberg MJA, 2008, MAR CHEM, V109, P29, DOI 10.1016/j.marchem.2007.12.001; Rijkenberg MJA, 2008, MAR CHEM, V110, P56, DOI 10.1016/j.marchem.2008.02.006; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Staal M, 2003, NATURE, V425, P504, DOI 10.1038/nature01999; Staal M, 2007, LIMNOL OCEANOGR, V52, P1305, DOI 10.4319/lo.2007.52.4.1305; Staal M, 2007, ENVIRON MICROBIOL, V9, P727, DOI 10.1111/j.1462-2920.2006.01195.x; Stal LJ, 2009, ENVIRON MICROBIOL, V11, P1632, DOI 10.1111/j.1758-2229.2009.00016.x; Stramma L, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002939; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Tagliabue A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003929; Turk KA, 2011, ISME J, V5, P1201, DOI 10.1038/ismej.2010.205; Voss M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020127; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zubkov MV, 2000, PROG OCEANOGR, V45, P369, DOI 10.1016/S0079-6611(00)00008-2; Zubkov MV, 2003, APPL ENVIRON MICROB, V69, P1299, DOI 10.1128/AEM.69.2.1299-1304.2003	68	29	30	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28989	10.1371/journal.pone.0028989	http://dx.doi.org/10.1371/journal.pone.0028989			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174940	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300037
J	Philipp, U; Lupp, B; Momke, S; Stein, V; Tipold, A; Eule, JC; Rehage, J; Distl, O				Philipp, Ute; Lupp, Bettina; Moemke, Stefanie; Stein, Veronika; Tipold, Andrea; Eule, Johanna Corinna; Rehage, Juergen; Distl, Ottmar			A MITF Mutation Associated with a Dominant White Phenotype and Bilateral Deafness in German Fleckvieh Cattle	PLOS ONE			English	Article							WAARDENBURG-SYNDROME; INCOMPLETE ALBINISM; TIETZ-SYNDROME; HETEROCHROMIA IRIDES; GENE; RECOGNITION; DOMAIN; SOX10; PAX3; DNA	A dominantly inherited syndrome associated with hypopigmentation, heterochromia irides, colobomatous eyes and bilateral hearing loss has been ascertained in Fleckvieh cattle (German White Fleckvieh syndrome). This syndrome has been mapped to bovine chromosome (BTA) 22 using a genome-wide association study with the bovine high density single nucleotide polymorphism array. An R210I missense mutation has been identified within microphthalmia-associated transcription factor (MITF) as responsible for this syndrome. The mutation is located in the highly conserved basic region of the protein and causes a negative-dominant effect. SOX10 and PAX3 promoter binding site mutations in MITF could be ruled out as causative for the German White Fleckvieh syndrome. Molecular characterization of this newly detected bovine syndrome means a large animal model is now available for the Tietz syndrome in humans.	[Philipp, Ute; Lupp, Bettina; Moemke, Stefanie; Distl, Ottmar] Univ Vet Med Hannover, Inst Genet & Anim Breeding, Hannover, Germany; [Stein, Veronika; Tipold, Andrea] Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany; [Eule, Johanna Corinna] Free Univ Berlin, Small Anim Clin, Berlin, Germany; [Rehage, Juergen] Univ Vet Med Hannover, Clin Cattle, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; University of Veterinary Medicine Hannover, Foundation	Philipp, U (corresponding author), Univ Vet Med Hannover, Inst Genet & Anim Breeding, Hannover, Germany.	ottmar.distl@tiho-hannover.de						Amiel J, 1998, CLIN DYSMORPHOL, V7, P17; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; Izumi K, 2008, CLIN GENET, V74, P93, DOI 10.1111/j.1399-0004.2008.01010.x; LEIPOLD HW, 1969, CORNELL VET, V59, P69; LEIPOLD HW, 1968, J HERED, V59, P3, DOI 10.1093/oxfordjournals.jhered.a107635; LEIPOLD HW, 1968, J HERED, V59, P223, DOI 10.1093/oxfordjournals.jhered.a107698; Luscher B, 1999, ONCOGENE, V18, P2955, DOI 10.1038/sj.onc.1202750; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TIETZ W, 1963, AM J HUM GENET, V15, P259; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	19	45	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28857	10.1371/journal.pone.0028857	http://dx.doi.org/10.1371/journal.pone.0028857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174915	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600045
J	Bauer, I; Crewther, DP; Pipingas, A; Rowsell, R; Cockerell, R; Crewther, SG				Bauer, Isabelle; Crewther, David P.; Pipingas, Andrew; Rowsell, Renee; Cockerell, Robyn; Crewther, Sheila G.			Omega-3 Fatty Acids Modify Human Cortical Visual Processing-A Double-Blind, Crossover Study	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; COGNITIVE PERFORMANCE; DOCOSAHEXAENOIC ACID; CONTROLLED-TRIAL; DIETARY SUPPLEMENTATION; SUSTAINED ATTENTION; FISH-OIL; N-3; OMEGA-3; PLASMA	While cardiovascular and mood benefits of dietary omega-3 fatty acids such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are manifest, direct neurophysiological evidence of their effects on cortical activity is still limited. Hence we chose to examine the effects of two proprietary fish oil products with different EPA: DHA ratios (EPA-rich, high EPA: DHA; DHA-rich) on mental processing speed and visual evoked brain activity. We proposed that nonlinear multifocal visual evoked potentials (mfVEP) would be sensitive to any alteration of the neural function induced by omega-3 fatty acid supplementation, because the higher order kernel responses directly measure the degree of recovery of the neural system as a function of time following stimulation. Twenty-two healthy participants aged 18-34, with no known neurological or psychiatric disorder and not currently taking any nutritional supplementation, were recruited. A double-blind, crossover design was utilized, including a 30-day washout period, between two 30-day supplementation periods of the EPA-rich and DHA-rich diets (with order of diet randomized). Psychophysical choice reaction times and multi-focal nonlinear visual evoked potential (VEP) testing were performed at baseline (No Diet), and after each supplementation period. Following the EPA-rich supplementation, for stimulation at high luminance contrast, a significant reduction in the amplitude of the first slice of the second order VEP kernel response, previously related to activation in the magnocellular pathway, was observed. The correlations between the amplitude changes of short latency second and first order components were significantly different for the two supplementations. Significantly faster choice reaction times were observed psychophysically (compared with baseline performance) under the EPA-rich (but not DHA-rich) supplementation, while simple reaction times were not affected. The reduced nonlinearities observed under the EPA-rich diet suggest a mechanism involving more efficient neural recovery of magnocellular-like visual responses following cortical activation.	[Bauer, Isabelle; Crewther, David P.; Pipingas, Andrew; Rowsell, Renee; Cockerell, Robyn] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia; [Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia	Swinburne University of Technology; La Trobe University	Bauer, I (corresponding author), Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia.	dcrewther@swin.edu.au	Crewther, Sheila G/A-2165-2008; Bauer, Isabelle Esther/C-5839-2015	Bauer, Isabelle Esther/0000-0001-9613-9354	Novasel Australia	Novasel Australia	Novasel Australia provided partial funding for this study as part of a collaborative agreement with Swinburne University. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Antypa N, 2009, J PSYCHOPHARMACOL, V23, P831, DOI 10.1177/0269881108092120; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Baseler HA, 1997, VISION RES, V37, P675, DOI 10.1016/S0042-6989(96)00209-X; Berger GE, 2008, NEUROPSYCHOPHARMACOL, V33, P2467, DOI 10.1038/sj.npp.1301628; BIRCH DG, 1992, INVEST OPHTH VIS SCI, V33, P2365; Birch EE, 2000, DEV MED CHILD NEUROL, V42, P174, DOI 10.1017/S0012162200000311; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Calderon F, 2004, J NEUROCHEM, V90, P979, DOI 10.1111/j.1471-4159.2004.02520.x; Cao J, 2006, CLIN CHEM, V52, P2265, DOI 10.1373/clinchem.2006.072322; de Groot RHM, 2007, PROSTAG LEUKOTR ESS, V76, P165, DOI 10.1016/j.plefa.2007.01.001; Fontani G, 2005, EUR J CLIN INVEST, V35, P691, DOI 10.1111/j.1365-2362.2005.01570.x; Fontani G, 2009, J AM COLL NUTR, V28, p473S, DOI 10.1080/07315724.2009.10718114; Grintal B, 2009, NEUROCHEM INT, V54, P535, DOI 10.1016/j.neuint.2009.02.018; Holtzheimer Paul E, 2008, Curr Psychiatry Rep, V10, P465; Howell D. C., 2010, FUNDAMENTAL STAT BEH; JACKSON PA, BRIT J NUTR IN PRESS; JACQUES C, 2010, J PEDIAT; Klistorner A, 1997, VISION RES, V37, P2161, DOI 10.1016/S0042-6989(97)00003-5; Koletzko B, 2009, PROSTAG LEUKOTR ESS, V81, P159, DOI 10.1016/j.plefa.2009.06.006; Laycock R, 2007, NEUROSCI BIOBEHAV R, V31, P363, DOI 10.1016/j.neubiorev.2006.10.003; Liu CSJ, 2006, AM J NEURORADIOL, V27, P1628; MARANGONI F, 1993, BIOCHIM BIOPHYS ACTA, V1210, P55, DOI 10.1016/0005-2760(93)90049-F; McCabe GP., 2003, BOOTSTRAP METHODS PE; McNamara RK, 2010, AM J CLIN NUTR, V91, P1060, DOI 10.3945/ajcn.2009.28549; Nassi JJ, 2007, NEURON, V55, P799, DOI 10.1016/j.neuron.2007.07.037; Pascoe MC, 2011, INT J STROKE, V6, P128, DOI 10.1111/j.1747-4949.2010.00565.x; Pipingas A, 2008, PHYTOTHER RES, V22, P1168, DOI 10.1002/ptr.2388; Pipingas A, 2010, CURR TOP NUTRACEUT R, V8, P79; Rapoport SI, 2008, J NUTR, V138, P2515, DOI 10.1093/jn/138.12.2515; Richardson AJ, 2005, PEDIATRICS, V115, P1360, DOI 10.1542/peds.2004-2164; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; Sinn N, 2008, BIOSCI HYPOTHESES, V1, P103, DOI DOI 10.1016/j.bihy.2008.02.003; Skottun BC, 2011, SCHIZOPHRENIA BULL, V37, P23, DOI 10.1093/schbul/sbq114; Song C, 2004, J LIPID RES, V45, P1112, DOI [10.1194/jlr.M300526-JLR200, 10.1194/jlr.M300526-JLr200]; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; STOUGH C, 2011, NEUROBIOLOG IN PRESS; Sutherland A, 2010, BRAIN, V133, P2089, DOI 10.1093/brain/awq122; SUTTER EE, 1992, NONLINEAR VISION; Sutter Erich, 2000, Documenta Ophthalmologica, V100, P49, DOI 10.1023/A:1002702917233; Vaisman N, 2008, AM J CLIN NUTR, V87, P1170, DOI 10.1093/ajcn/87.5.1170; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86; Weisinger HS, 1996, ANN NUTR METAB, V40, P91, DOI 10.1159/000177900	43	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28214	10.1371/journal.pone.0028214	http://dx.doi.org/10.1371/journal.pone.0028214			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174778	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700022
J	Hu, J; Zhang, JH; Zhao, W; Zhang, YL; Zhang, L; Shang, HC				Hu, Jing; Zhang, Junhua; Zhao, Wei; Zhang, Yongling; Zhang, Li; Shang, Hongcai			Cochrane Systematic Reviews of Chinese Herbal Medicines: An Overview	PLOS ONE			English	Review							COMPLEMENTARY MEDICINE; QUALITY; METAANALYSES; METHODOLOGY	Objectives: Our study had two objectives: a) to systematically identify all existing systematic reviews of Chinese herbal medicines (CHM) published in Cochrane Library; b) to assess the methodological quality of included reviews. Methodology/Principal Findings: We performed a systematic search of the Cochrane Database of Systematic Reviews (CDSR, Issue 5, 2010) to identify all reviews of CHM. A total of fifty-eight reviews were eligible for our study. Twenty-one of the included reviews had at least one Traditional Chinese Medicine (TCM) practitioner as its co-author. 7 reviews didn't include any primary study, the remaining reviews (n = 51) included a median of 9 studies and 936 participants. 50% of reviews were last assessed as up-to-date prior to 2008. The questions addressed by 39 reviews were broad in scope, in which 9 reviews combined studies with different herbal medicines. For OQAQ, the mean of overall quality score (item 10) was 5.05 (95% CI; 4.58-5.52). All reviews assessed the methodological quality of primary studies, 16% of included primary studies used adequate sequence generation and 7% used adequate allocation concealment. Of the 51 nonempty reviews, 23 reviews were reported as being inconclusive, while 27 concluded that there might be benefit of CHM, which was limited by the poor quality or inadequate quantity of included studies. 58 reviews reported searching a median of seven electronic databases, while 10 reviews did not search any Chinese database. Conclusions: Now CDSR has included large numbers of CHM reviews, our study identified some areas which could be improved, such as almost half of included reviews did not have the participation of TCM practitioners and were not up-to-date according to Cochrane criteria, some reviews pooled the results of different herbal medicines and ignored the searching of Chinese databases.	[Hu, Jing; Zhang, Junhua; Zhao, Wei; Zhang, Yongling; Zhang, Li; Shang, Hongcai] Tianjin Univ Tradit Chinese Med, Res Inst Tradit Chinese Med, Tianjin, Peoples R China; [Hu, Jing] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	Tianjin University of Traditional Chinese Medicine; Peking University	Shang, HC (corresponding author), Tianjin Univ Tradit Chinese Med, Res Inst Tradit Chinese Med, Tianjin, Peoples R China.	shanghongcai@foxmail.com	shang, hongcai/H-1257-2014	zhang, Junhua/0000-0003-4043-1967	National Significant Projects of New Drugs Creation [2008ZX09312-001]; program of New Century Excellent Talents in University [NCET-09-0900]	National Significant Projects of New Drugs Creation; program of New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study was supported in part by the National Significant Projects of New Drugs Creation (No. 2008ZX09312-001) and the program of New Century Excellent Talents in University (NCET-09-0900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS D, 2009, COCHRANE DB SYST REV, V4; ARNOLD E, 2008, COCHRANE DB SYST REV, V4; BIRKS J, 2009, COCHRANE DB SYST REV, V2; Cao WZ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005568.pub2; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; CHEN J, 2009, COCHRANE DB SYST REV, V1; Chen X, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006305.pub2; CHEN XY, 2010, COCHRANE DB SYST REV, V2; Cui X, 2010, COCHRANE DB SYST REV, V1; Delaney A, 2007, CRIT CARE MED, V35, P589, DOI 10.1097/01.CCM.0000253394.15628.FD; DONG R, 2009, COCHRANE DB SYST REV, V1; DUAN X, 2009, COCHRANE DB SYST REV, V4; EVANS JR, 2009, COCHRANE DB SYST REV, V2; Ezzo J, 1998, JAMA-J AM MED ASSOC, V280, P1628, DOI 10.1001/jama.280.18.1628; Firenzuoli F, 2007, EVID-BASED COMPL ALT, V4, P37, DOI 10.1093/ecam/nem096; FLOWER A, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651868; GAGNIER JJ, 2010, COCHRANE DB SYST REV, V2; GAN T, 2010, COCHRANE DB SYST REV, V1; Grant SJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006690.pub2; GREEN S, 2008, COCHRANE HDB; GUO RL, 2009, COCHRANE DB SYST REV, V1; HILTON MP, 2010, COCHRANE DB SYST REV, V3; [胡丹 Hu Dan], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P488; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; JING Z, 2009, COCHRANE DB SYST REV, V3; Li Q, 2009, COCHRANE DB SYST REV, V3; [李廷谦 LI Tingqian], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P180; LI W, 2009, COCHRANE DB SYST REV, V3; LI WJ, 2010, COCHRANE DB SYST REV, V1; Liu Jian-ping, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P306; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU JP, 2009, COCHRANE DB SYST REV, V2; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU JP, 2008, COCHRANE DB SYST REV, V4; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU JP, 2009, COCHRANE DB SYST REV, V1; LIU XM, 2008, COCHRANE DB SYST REV, V4; Lui S, 2010, ACUPUNCT MED, V28, P149, DOI 10.1136/aim.2010.002444; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Nicolai S. P. A., 2009, COCHRANE DB SYST REV, V2; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; [艾昌林 Ai Changlin], 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P749; RATHBONE J, 2008, COCHRANE DB SYST REV, V3; SHI YY, 2010, COCHRANE DB SYST REV, V2; TAN Y, 2009, COCHRANE DB SYST REV, V1; Tindle HA, 2005, ALTERN THER HEALTH M, V11, P42; UAN W, 2009, COCHRANE DB SYST REV, V3; Vickers A, 1999, BRIT MED J, V319, P1050, DOI 10.1136/bmj.319.7216.1050; WANG DF, 2009, COCHRANE DB SYST REV, V1; WANG Q, 2009, COCHRANE DB SYST REV, V3; WANG Q, 2009, COCHRANE DB SYST REV, V1; WEI JF, 2010, COCHRANE DB SYST REV, V2; WU B, 2008, COCHRANE DB SYST REV, V4; WU HM, 2009, COCHRANE DB SYST REV, V2; WU T, 2009, COCHRANE DB SYST REV, V2, P5382; WU TX, 2009, COCHRANE DB SYST REV, V1; WU TX, 2008, COCHRANE DB SYST REV, V4; WU TX, 2009, COCHRANE DB SYST REV, V1; Yang W, 2009, COCHRANE DB SYST REV, V2; YANG X, 2010, COCHRANE DB SYST REV, V1; Yuan Y, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005569.pub2; YUE JR, 2008, COCHRANE DB SYST REV, V3; ZENG XR, 2009, COCHRANE DB SYST REV, V1; ZENG XX, 2009, COCHRANE DB SYST REV, V1; Zhang JH, 2007, J ALTERN COMPLEM MED, V13, P797, DOI 10.1089/acm.2007.7195; ZHANG MM, 2009, COCHRANE DB SYST REV, V1; ZHANG WY, 2009, COCHRANE DB SYST REV, V4; ZHANG XG, 2010, COCHRANE DB SYST REV, V2; ZHENG YL, 2010, COCHRANE DB SYST REV, V2; ZHU ZS, 2009, COCHRANE DB SYST REV, V1; Zhuo Q., 2010, COCHRANE DB SYST REV, V5; ZHUO Q, 2008, COCHRANE DB SYST REV, V4; 商洪才, 2010, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V10, P640	76	43	45	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28696	10.1371/journal.pone.0028696	http://dx.doi.org/10.1371/journal.pone.0028696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174870	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700062
J	Marston, CK; Allen, CA; Beaudry, J; Price, EP; Wolken, SR; Pearson, T; Keim, P; Hoffmaster, AR				Marston, Chung K.; Allen, Christina A.; Beaudry, Jodi; Price, Erin P.; Wolken, Spenser R.; Pearson, Talima; Keim, Paul; Hoffmaster, Alex R.			Molecular Epidemiology of Anthrax Cases Associated with Recreational Use of Animal Hides and Yarn in the United States	PLOS ONE			English	Article								To determine potential links between the clinical isolate to animal products and their geographic origin, we genotyped (MLVA-8, MVLA-15, and canSNP analysis) 80 environmental and 12 clinical isolates and 2 clinical specimens from five cases of anthrax (California in 1976 [n = 1], New York in 2006 [n = 1], Connecticut in 2007 [n = 2], and New Hampshire in 2009[n = 1]) resulting from recreational handling of animal products. For the California case, four clinical isolates were identified as MLVA-8 genotype (GT) 76 and in the canSNP A.Br.Vollum lineage, which is consistent with the Pakistani origin of the yarn. Twenty eight of the California isolates were in the A.Br.Vollum canSNP lineage and one isolate was in the A.Br.003/004 canSNP sub-group. All 52 isolates and both clinical specimens related to the New York and Connecticut cases were MLVA-8 GT 1. The animal products associated with the NY and CT cases were believed to originate from West Africa, but no isolates from this region are available to be genotyped for comparison. All isolates associated with the New Hampshire case were identical and had a new genotype (GT 149). Isolates from the NY, CT and NH cases diverge from the established canSNP phylogeny near the base of the A.Br.011/009. This report illustrates the power of the current genotyping methods and the dramatically different epidemiological conditions that can lead to infections (i.e., contamination by a single genotype versus widespread contamination of numerous genotypes). These cases illustrate the need to acquire and genotype global isolates so that accurate assignments can be made about isolate origins.	[Marston, Chung K.; Hoffmaster, Alex R.] Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Allen, Christina A.; Beaudry, Jodi; Price, Erin P.; Wolken, Spenser R.; Pearson, Talima; Keim, Paul] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Centers for Disease Control & Prevention - USA; Northern Arizona University	Marston, CK (corresponding author), Ctr Dis Control & Prevent, Bacterial Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	cdk5@cdc.gov	Price, Erin/N-2336-2013; Pearson, Talima/O-7840-2019	Price, Erin/0000-0002-1079-4882; Pearson, Talima/0000-0003-3696-041X	U.S. Department of Homeland Security S&T CB Division Bioforensics	U.S. Department of Homeland Security S&T CB Division Bioforensics(United States Department of Homeland Security (DHS))	Portions of this work were supported by the U.S. Department of Homeland Security S&T CB Division Bioforensics R&D Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this report.	*CDC, 1976, MMWR-MORBID MORTAL W, V25, P33; *CDCP, 2007, MMWR-MORBID MORTAL W, V57, P628; *CDCP, 1974, MMWR-MORBID MORTAL W, V23, P142; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P280; *ED TEAM, 2006, EURO SURVEILL, V11; Germer S, 1999, GENOME RES, V9, P72; Germer S, 2000, GENOME RES, V10, P258, DOI 10.1101/gr.10.2.258; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Marston CK, 2005, APPL ENVIRON MICROB, V71, P7778, DOI 10.1128/AEM.71.12.7778-7780.2005; Mayo L., 2010, Morbidity and Mortality Weekly Report, V59, P872; Opare C, 2000, ACTA TROP, V76, P49, DOI 10.1016/S0001-706X(00)00089-9; SUFFIN SC, 1978, HUM PATHOL, V9, P594, DOI 10.1016/S0046-8177(78)80140-3; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	13	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28274	10.1371/journal.pone.0028274	http://dx.doi.org/10.1371/journal.pone.0028274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174783	Green Published, gold			2022-12-27	WOS:000298365700026
J	Porter, SS; Stanton, ML; Rice, KJ				Porter, Stephanie S.; Stanton, Maureen L.; Rice, Kevin J.			Mutualism and Adaptive Divergence: Co-Invasion of a Heterogeneous Grassland by an Exotic Legume-Rhizobium Symbiosis	PLOS ONE			English	Article							GENERAL-PURPOSE GENOTYPES; LOCAL ADAPTATION; MEDICAGO-POLYMORPHA; PLANT INVASIONS; MYCORRHIZAL SYMBIOSES; PARASITISM CONTINUUM; SERPENTINE SOILS; PARTNER CHOICE; SUILLUS-LUTEUS; TRADE-OFFS	Species interactions play a critical role in biological invasions. For example, exotic plant and microbe mutualists can facilitate each other's spread as they co-invade novel ranges. Environmental context may influence the effect of mutualisms on invasions in heterogeneous environments, however these effects are poorly understood. We examined the mutualism between the legume, Medicago polymorpha, and the rhizobium, Ensifer medicae, which have both invaded California grasslands. Many of these invaded grasslands are composed of a patchwork of harsh serpentine and relatively benign non-serpentine soils. We grew legume genotypes collected from serpentine or non-serpentine soil in both types of soil in combination with rhizobium genotypes from serpentine or non-serpentine soils and in the absence of rhizobia. Legumes invested more strongly in the mutualism in the home soil type and trends in fitness suggested that this ecotypic divergence was adaptive. Serpentine legumes had greater allocation to symbiotic root nodules in serpentine soil than did non-serpentine legumes and non-serpentine legumes had greater allocation to nodules in non-serpentine soil than did serpentine legumes. Therefore, this invasive legume has undergone the rapid evolution of divergence for soil-specific investment in the mutualism. Contrary to theoretical expectations, the mutualism was less beneficial for legumes grown on the stressful serpentine soil than on the non-serpentine soil, possibly due to the inhibitory effects of serpentine on the benefits derived from the interaction. The soil-specific ability to allocate to a robust microbial mutualism may be a critical, and previously overlooked, adaptation for plants adapting to heterogeneous environments during invasion.	[Porter, Stephanie S.; Stanton, Maureen L.] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; [Porter, Stephanie S.; Stanton, Maureen L.; Rice, Kevin J.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Rice, Kevin J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Porter, SS (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA.	ssporter@ucdavis.edu	Stanton, Maureen L/E-1204-2012		National Science Foundation [0909154]; UC Davis	National Science Foundation(National Science Foundation (NSF)); UC Davis	This material is based upon work supported by the National Science Foundation under Grant No. 0909154 and a UC Davis Mathias Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; AKCAY E, AM NATURALIST; [Anonymous], 1970, MANUAL PRACTICAL STU; Bailly X, 2006, MOL ECOL, V15, P2719, DOI 10.1111/j.1365-294X.2006.02969.x; Baythavong BS, 2009, ECOLOGY, V90, P2118, DOI 10.1890/08-0307.1; Berglund ABN, 2004, NEW PHYTOL, V161, P199, DOI 10.1046/j.1469-8137.2003.00934.x; Bever JD, 2010, TRENDS ECOL EVOL, V25, P468, DOI 10.1016/j.tree.2010.05.004; Brady KU, 2005, ANNU REV ECOL EVOL S, V36, P243, DOI 10.1146/annurev.ecolsys.35.021103.105730; Callaway RM, 2011, ECOLOGY, V92, P1027, DOI 10.1890/i0012-9658-92-5-1027; Charman N, 2004, SOIL BIOL BIOCHEM, V36, P1331, DOI 10.1016/j.soilbio.2004.04.014; Chen WM, 2005, NEW PHYTOL, V168, P661, DOI 10.1111/j.1469-8137.2005.01533.x; De Haan RL, 1998, CROP SCI, V38, P1558, DOI 10.2135/cropsci1998.0011183X003800060025x; del Pozo A, 2000, ANN BOT-LONDON, V85, P809, DOI 10.1006/anbo.2000.1141; Dickie IA, 2010, NEW PHYTOL, V187, P475, DOI 10.1111/j.1469-8137.2010.03277.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Graziano D, 2010, CROP PASTURE SCI, V61, P59, DOI 10.1071/CP09116; Gubry-Rangin C, 2010, P ROY SOC B-BIOL SCI, V277, P1947, DOI 10.1098/rspb.2009.2072; Harrison S, 1999, OECOLOGIA, V121, P99, DOI 10.1007/s004420050910; Harrison S, 2003, CONSERV BIOL, V17, P837, DOI 10.1046/j.1523-1739.2003.01633.x; Heath KD, 2007, P ROY SOC B-BIOL SCI, V274, P1905, DOI 10.1098/rspb.2007.0495; Heath KD, 2009, EVOLUTION, V63, P652, DOI 10.1111/j.1558-5646.2008.00582.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; KIESTER AR, 1984, AM NAT, V124, P220, DOI 10.1086/284265; KRUCKEBERG AR, 1951, AM J BOT, V38, P408, DOI 10.2307/2438248; KRUCKEBERG AR, 1967, BRITTONIA, V19, P133, DOI 10.2307/2805271; Krznaric E, 2009, ENVIRON POLLUT, V157, P1581, DOI 10.1016/j.envpol.2008.12.030; Kurten EL, 2008, BIOL INVASIONS, V10, P19, DOI 10.1007/s10530-007-9101-5; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lesins KA, 1979, GENUS MEDICAGO LEGUM; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Neuhauser C, 2004, ECOL MODEL, V177, P337, DOI 10.1016/j.ecolmodel.2004.02.010; Oldroyd GED, 2009, SCIENCE, V324, P753, DOI 10.1126/science.1171644; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Parker Matthew A., 2001, Diversity and Distributions, V7, P125, DOI 10.1046/j.1472-4642.2001.00103.x; Perret X, 2000, MICROBIOL MOL BIOL R, V64, P180, DOI 10.1128/MMBR.64.1.180-201.2000; Pringle A, 2009, ANNU REV ECOL EVOL S, V40, P699, DOI 10.1146/annurev.ecolsys.39.110707.173454; Reinhart KO, 2006, NEW PHYTOL, V170, P445, DOI 10.1111/j.1469-8137.2006.01715.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez-Echeverria S, 2011, DIVERS DISTRIB, V17, P946, DOI 10.1111/j.1472-4642.2011.00787.x; Rodriguez-Echeverria S, 2010, J BIOGEOGR, V37, P1611, DOI 10.1111/j.1365-2699.2010.02284.x; Rodriguez-Echeverria S, 2009, BIOL INVASIONS, V11, P651, DOI 10.1007/s10530-008-9280-8; Rome S, 1996, INT J SYST BACTERIOL, V46, P972, DOI 10.1099/00207713-46-4-972; Ross CA, 2009, BIOL INVASIONS, V11, P441, DOI 10.1007/s10530-008-9261-y; Salon C, 2001, AGRONOMIE, V21, P539, DOI 10.1051/agro:2001143; *SAS I, 2006, SAS SOFTW VERS 9 1 3; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; Silva C, 2007, FEMS MICROBIOL ECOL, V60, P477, DOI 10.1111/j.1574-6941.2007.00301.x; Simms EL, 2006, P ROY SOC B-BIOL SCI, V273, P77, DOI 10.1098/rspb.2005.3292; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; SPIRA TP, 1983, AM J BOT, V70, P303, DOI 10.2307/2443276; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stanton ML, 2005, NEW PHYTOL, V166, P319, DOI 10.1111/j.1469-8137.2004.01311.x; SULLIVAN JT, 1995, P NATL ACAD SCI USA, V92, P8985, DOI 10.1073/pnas.92.19.8985; Thompson JN, 2002, NATURE, V417, P735, DOI 10.1038/nature00810; Thrall PH, 2008, J ECOL, V96, P746, DOI 10.1111/j.1365-2745.2008.01381.x; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; Thrall PH, 2009, AUSTRAL ECOL, V34, P950, DOI 10.1111/j.1442-9993.2009.01998.x; Van Riper LC, 2010, BIOL INVASIONS, V12, P2735, DOI 10.1007/s10530-009-9678-y; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; WAREMBOURG FR, 1982, PHYSIOL PLANTARUM, V56, P46, DOI 10.1111/j.1399-3054.1982.tb04898.x; Weir BS, 2004, APPL ENVIRON MICROB, V70, P5980, DOI 10.1128/AEM.70.10.5980-5987.2004; West SA, 2002, P ROY SOC B-BIOL SCI, V269, P685, DOI 10.1098/rspb.2001.1878; Wright JW, 2006, EVOL ECOL RES, V8, P1; WU L, 1990, NEW PHYTOL, V116, P531, DOI 10.1111/j.1469-8137.1990.tb00537.x	75	37	37	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27935	10.1371/journal.pone.0027935	http://dx.doi.org/10.1371/journal.pone.0027935			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174755	Green Submitted, gold, Green Published			2022-12-27	WOS:000298365700010
J	Tirumurugaan, KG; Kapgate, S; Vinupriya, MK; Vijayarani, K; Kumanan, K; Elankumaran, S				Tirumurugaan, Krishnaswamy G.; Kapgate, Sunil; Vinupriya, Manavalan K.; Vijayarani, Kumanan; Kumanan, Kathaperumal; Elankumaran, Subbiah			Genotypic and Pathotypic Characterization of Newcastle Disease Viruses from India	PLOS ONE			English	Article							CLEAVAGE-ACTIVATION SITE; PROTEIN GENE SEQUENCE; HEMAGGLUTININ-NEURAMINIDASE; MONOCLONAL-ANTIBODIES; PHYLOGENETIC ANALYSIS; FUSION GLYCOPROTEIN; NUCLEOTIDE-SEQUENCE; STRAINS; VIRULENT; OUTBREAKS	Newcastle disease virus (NDV) is an avian paramyxovirus that causes significant economic losses to the poultry industry in most parts of the world. The susceptibility of a wide variety of avian species coupled with synanthropic bird reservoirs has contributed to the vast genomic diversity of this virus as well as diagnostic failures. Since the first panzootic in 1926, Newcastle disease (ND) became enzootic in India with recurrent outbreaks in multiple avian species. The genetic characteristics of circulating strains in India, however, are largely unknown. To understand the nature of NDV genotypes in India, we characterized two representative strains isolated 13 years apart from a chicken and a pigeon by complete genome sequence analysis and pathotyping. The viruses were characterized as velogenic by pathogenicity indices devised to distinguish these strains. The genome length was 15,186 nucleotides (nt) and consisted of six non-overlapping genes, with conserved and complementary 3' leader and 5' trailer regions, conserved gene starts, gene stops, and intergenic sequences similar to those in avian paramyxovirus 1 (APMV-1) strains. Matrix gene sequence analysis grouped the pigeon isolate with APMV-1 strains. Phylogeny based on the fusion (F), and hemagglutinin (HN) genes and complete genome sequence grouped these viruses into genotype IV. Genotype IV strains are considered to have "died out'' after the first panzootic (1926-1960) of ND. But, our results suggest that there is persistence of genotype IV strains in India.	[Tirumurugaan, Krishnaswamy G.; Kapgate, Sunil; Vinupriya, Manavalan K.; Vijayarani, Kumanan; Kumanan, Kathaperumal] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India; [Elankumaran, Subbiah] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Tamil Nadu Veterinary & Animal Sciences University; Virginia Polytechnic Institute & State University	Tirumurugaan, KG (corresponding author), Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Anim Biotechnol, Madras, Tamil Nadu, India.	kumarans@vt.edu			Indian Council of Agriculture; United States-India Agricultural Knowledge Initiative	Indian Council of Agriculture; United States-India Agricultural Knowledge Initiative	This study has been supported by funds from the Indian Council of Agriculture, Niche-area of excellence awarded to KK. Partial support from United States-India Agricultural Knowledge Initiative to SE as co-investigator. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFZAL MA, 1994, J GEN VIROL, V75, P1169, DOI 10.1099/0022-1317-75-5-1169; Aldous EW, 2003, AVIAN PATHOL, V32, P239, DOI 10.1080/030794503100009783; Aldous EW, 2001, AVIAN PATHOL, V30, P117, DOI 10.1080/03079450120044515; Alexander D, 2001, BRIT POULTRY SCI, V42, P5, DOI 10.1080/713655022; Alexander D.J., 1989, LAB MANUAL ISOLATION; ALEXANDER DJ, 1984, VET REC, V114, P466, DOI 10.1136/vr.114.19.466; Alexander DJ, 2003, DIS POULTRY, P63; Allan W H, 1978, FAO ANIMAL PRODUCTIO; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Connaris H, 2002, J VIROL, V76, P1816, DOI 10.1128/JVI.76.4.1816-1824.2002; Czegledi A, 2003, AVIAN PATHOL, V32, P271, DOI 10.1080/0307945031000097868; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Herczeg J, 1999, ARCH VIROL, V144, P2087, DOI 10.1007/s007050050624; Hooper PT, 1999, AUST VET J, V77, P50, DOI 10.1111/j.1751-0813.1999.tb12432.x; Huang ZH, 2004, J VIROL, V78, P4176, DOI 10.1128/JVI.78.8.4176-4184.2004; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; Ito T, 1999, J VET MED SCI, V61, P951, DOI 10.1292/jvms.61.951; Ito T, 1997, VIROLOGY, V227, P493, DOI 10.1006/viro.1996.8323; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; Kapczynski DR, 2005, VACCINE, V23, P3424, DOI 10.1016/j.vaccine.2005.01.140; Kattenbelt JA, 2006, VIRUS RES, V116, P168, DOI 10.1016/j.virusres.2005.10.001; Khattar SK, 2009, J VIROL, V83, P7779, DOI 10.1128/JVI.00536-09; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Kumanan K, 2005, ACTA VIROL, V49, P105; KUMANAN K, 1992, J VET MED B, V39, P383, DOI 10.1111/j.1439-0450.1992.tb01184.x; Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Lomniczi B, 1998, ARCH VIROL, V143, P49, DOI 10.1007/s007050050267; Maminiaina OF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013987; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Miller PJ, 2007, VACCINE, V25, P7238, DOI 10.1016/j.vaccine.2007.07.017; Miller PJ, 2010, INFECT GENET EVOL, V10, P26, DOI 10.1016/j.meegid.2009.09.012; PRITZER E, 1990, VIRUS RES, V15, P237, DOI 10.1016/0168-1702(90)90031-6; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Rout SN, 2008, J VIROL, V82, P7828, DOI 10.1128/JVI.00578-08; Roy P, 2000, VET RES COMMUN, V24, P135, DOI 10.1023/A:1006416724050; SEAL BS, 1995, J CLIN MICROBIOL, V33, P2624, DOI 10.1128/JCM.33.10.2624-2630.1995; Seal BS, 1995, VIRUS GENES, V11, P217, DOI 10.1007/BF01728661; Snoeck CJ, 2009, ARCH VIROL, V154, P47, DOI 10.1007/s00705-008-0269-5; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tirumurugaan KG, 2011, INDIAN J VIROL, V22, P131, DOI 10.1007/s13337-011-0044-1; TOYODA T, 1987, VIROLOGY, V158, P242, DOI 10.1016/0042-6822(87)90261-3; Ujvari D, 2003, VIRUS RES, V96, P63, DOI 10.1016/S0168-1702(03)00173-4; WINSLOW NS, 1950, P SOC EXP BIOL MED, V74, P174, DOI 10.3181/00379727-74-17845; Yu L, 2001, J CLIN MICROBIOL, V39, P3512, DOI 10.1128/JCM.39.10.3512-3519.2001; YUSOFF K, 1988, VIRUS RES, V11, P319, DOI 10.1016/0168-1702(88)90005-6; Zanetti F, 2003, VIRUS GENES, V26, P199, DOI 10.1023/A:1023495615729	53	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28414	10.1371/journal.pone.0028414	http://dx.doi.org/10.1371/journal.pone.0028414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174801	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700032
J	Tashiro, K; Teissier, A; Kobayashi, N; Nakanishi, A; Sasaki, T; Yan, K; Tarabykin, V; Vigier, L; Sumiyama, K; Hirakawa, M; Nishihara, H; Pierani, A; Okada, N				Tashiro, Kensuke; Teissier, Anne; Kobayashi, Naoki; Nakanishi, Akiko; Sasaki, Takeshi; Yan, Kuo; Tarabykin, Victor; Vigier, Lisa; Sumiyama, Kenta; Hirakawa, Mika; Nishihara, Hidenori; Pierani, Alessandra; Okada, Norihiro			A Mammalian Conserved Element Derived from SINE Displays Enhancer Properties Recapitulating Satb2 Expression in Early-Born Callosal Projection Neurons	PLOS ONE			English	Article							NON-GENIC SEQUENCES; ULTRACONSERVED ELEMENTS; TRANSPOSABLE ELEMENTS; CORPUS-CALLOSUM; HUMAN GENOME; MOUSE; DNA; IDENTIFICATION; EVOLUTION; CELLS	Short interspersed repetitive elements (SINEs) are highly repeated sequences that account for a significant proportion of many eukaryotic genomes and are usually considered "junk DNA". However, we previously discovered that many AmnSINE1 loci are evolutionarily conserved across mammalian genomes, suggesting that they may have acquired significant functions involved in controlling mammalian-specific traits. Notably, we identified the AS021 SINE locus, located 390 kbp upstream of Satb2. Using transgenic mice, we showed that this SINE displays specific enhancer activity in the developing cerebral cortex. The transcription factor Satb2 is expressed by cortical neurons extending axons through the corpus callosum and is a determinant of callosal versus subcortical projection. Mouse mutants reveal a crucial function for Sabt2 in corpus callosum formation. In this study, we compared the enhancer activity of the AS021 locus with Satb2 expression during telencephalic development in the mouse. First, we showed that the AS021 enhancer is specifically activated in early-born Satb2(+) neurons. Second, we demonstrated that the activity of the AS021 enhancer recapitulates the expression of Satb2 at later embryonic and postnatal stages in deep-layer but not superficial-layer neurons, suggesting the possibility that the expression of Satb2 in these two subpopulations of cortical neurons is under genetically distinct transcriptional control. Third, we showed that the AS021 enhancer is activated in neurons projecting through the corpus callosum, as described for Satb2+ neurons. Notably, AS021 drives specific expression in axons crossing through the ventral (TAG1(-)/NPY+) portion of the corpus callosum, confirming that it is active in a subpopulation of callosal neurons. These data suggest that exaptation of the AS021 SINE locus might be involved in enhancement of Satb2 expression, leading to the establishment of interhemispheric communication via the corpus callosum, a eutherian-specific brain structure.	[Tashiro, Kensuke; Kobayashi, Naoki; Nakanishi, Akiko; Sasaki, Takeshi; Nishihara, Hidenori; Okada, Norihiro] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Teissier, Anne; Vigier, Lisa; Pierani, Alessandra] Univ Paris Diderot, Inst Jacques Monod, Ctr Natl Rech Sci, Unite Mixte Rech 7592, Paris, France; [Sumiyama, Kenta] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Hirakawa, Mika] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Uji, Kyoto, Japan; [Yan, Kuo; Tarabykin, Victor] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany	Tokyo Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; Max Planck Society	Tashiro, K (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 227, Japan.	pierani.alessandra@ijm.univ-paris-diderot.fr; nokada@bio.titech.ac.jp	Tarabykin, Victor/F-9467-2014; Teissier, Anne/K-2075-2019; Nishihara, Hidenori/B-9324-2015; Sumiyama, Kenta/ABD-5577-2020; Pierani, Alessandra/O-6136-2017; Sumiyama, Kenta/L-5902-2013	Nishihara, Hidenori/0000-0002-5843-9994; Sumiyama, Kenta/0000-0001-8785-5439; Pierani, Alessandra/0000-0002-4872-4791; Sumiyama, Kenta/0000-0001-8785-5439; Teissier, Anne/0000-0002-5172-9489; Tarabykin, Viktor/0000-0001-8931-7263	French Ministry of Education; Agence Nationale de la Recherche [ANR-07-NEURO-046-01]; Fondation pour la Recherche Medicale [INE20060306503]; Association pour la Recherche sur le Cancer [4940]; Ville de Paris [2006 ASES 102]; Ministry of Education, Culture, Sports, Science and Technology of Japan; DFG [SFB665, TA 303/3, Exzellenzcluster 257]; Grants-in-Aid for Scientific Research [23123504] Funding Source: KAKEN	French Ministry of Education; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ville de Paris; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); DFG(German Research Foundation (DFG)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	AT was the recipient of a fellowship from the French Ministry of Education. AP is a Centre National de la Recherche Scientifique Investigator. This work was supported by grants from the Agence Nationale de la Recherche (ANR-07-NEURO-046-01), Fondation pour la Recherche Medicale (INE20060306503), the Association pour la Recherche sur le Cancer (grant # 4940), Ville de Paris (2006 ASES 102) to AP and Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to NO. In addition, this work was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan to HN, and by SFB665, DFG Heusenberg program, DFG grant TA 303/3 and Exzellenzcluster 257 to VT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2003, BRAZ J MED BIOL RES, V36, P409, DOI 10.1590/S0100-879X2003000400002; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Alcamo EA, 2008, NEURON, V57, P364, DOI 10.1016/j.neuron.2007.12.012; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Britanova O, 2006, DEV BIOL, V298, P299, DOI 10.1016/j.ydbio.2006.06.040; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Britten RJ, 1996, P NATL ACAD SCI USA, V93, P9374, DOI 10.1073/pnas.93.18.9374; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; DEININGER PL, 1993, EVOL BIOL, V27, P157; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Donahoo ALS, 2009, SEMIN PEDIATR NEUROL, V16, P127, DOI 10.1016/j.spen.2009.07.003; Fame RM, 2011, TRENDS NEUROSCI, V34, P41, DOI 10.1016/j.tins.2010.10.002; Ferrigno O, 2001, NAT GENET, V28, P77, DOI 10.1038/ng0501-77; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gentles AJ, 2007, GENOME RES, V17, P992, DOI 10.1101/gr.6070707; Ghiasvand NM, 2011, NAT NEUROSCI, V14, P578, DOI 10.1038/nn.2798; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; GRANGER EM, 1985, J COMP NEUROL, V241, P82, DOI 10.1002/cne.902410107; HAMBOR JE, 1993, MOL CELL BIOL, V13, P7056, DOI 10.1128/MCB.13.11.7056; Hirakawa M, 2009, GENE, V441, P100, DOI 10.1016/j.gene.2008.12.009; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Kamal M, 2006, P NATL ACAD SCI USA, V103, P2740, DOI 10.1073/pnas.0511238103; Kamnasaran D, 2005, CLIN INVEST MED, V28, P267; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; MERRY DE, 1994, DEVELOPMENT, V120, P301; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Niquille M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000230; Nishihara H, 2006, GENOME RES, V16, P864, DOI 10.1101/gr.5255506; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; OKADA N, 1991, TRENDS ECOL EVOL, V6, P358, DOI 10.1016/0169-5347(91)90226-N; Okada N, 2010, GENES CELLS, V15, P801, DOI 10.1111/j.1365-2443.2010.01429.x; Okada N, 1991, CURR OPIN GENET DEV, V1, P498, DOI 10.1016/S0959-437X(05)80198-4; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Price DJ, 1996, J NEUROSCI, V16, P3247; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rattenborg NC, 2009, NEUROSCI BIOBEHAV R, V33, P253, DOI 10.1016/j.neubiorev.2008.08.010; Richards LJ, 2004, CLIN GENET, V66, P276, DOI 10.1111/j.1399-0004.2004.00354.x; SAFFER JD, 1989, MOL CELL BIOL, V9, P355, DOI 10.1128/MCB.9.2.355; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Sasaki T, 2008, P NATL ACAD SCI USA, V105, P4220, DOI 10.1073/pnas.0709398105; Sebastiano V, 2010, DEVELOPMENT, V137, P3551, DOI 10.1242/dev.047027; Shimamura M, 1998, MOL BIOL EVOL, V15, P923, DOI 10.1093/oxfordjournals.molbev.a025997; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SINGER MF, 1982, CELL, V28, P433, DOI 10.1016/0092-8674(82)90194-5; Sumiyama K, 2002, P NATL ACAD SCI USA, V99, P780, DOI 10.1073/pnas.012584999; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104	73	41	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28497	10.1371/journal.pone.0028497	http://dx.doi.org/10.1371/journal.pone.0028497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174821	Green Published, gold			2022-12-27	WOS:000298163600026
J	Wang, L; Chen, W; Feng, Y; Ren, Y; Gu, ZN; Chen, HQ; Wang, HC; Thomas, MJ; Zhang, BX; Berquin, IM; Li, Y; Wu, JS; Zhang, HX; Song, YD; Liu, X; Norris, JS; Wang, S; Du, P; Shen, JG; Wang, N; Yang, YL; Wang, W; Feng, L; Ratledge, C; Zhang, H; Chen, YQ				Wang, Lei; Chen, Wei; Feng, Yun; Ren, Yan; Gu, Zhennan; Chen, Haiqin; Wang, Hongchao; Thomas, Michael J.; Zhang, Baixi; Berquin, Isabelle M.; Li, Yang; Wu, Jiansheng; Zhang, Huanxin; Song, Yuanda; Liu, Xiang; Norris, James S.; Wang, Suriguga; Du, Peng; Shen, Junguo; Wang, Na; Yang, Yanlin; Wang, Wei; Feng, Lu; Ratledge, Colin; Zhang, Hao; Chen, Yong Q.			Genome Characterization of the Oleaginous Fungus Mortierella alpina	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; TANDEM MASS-SPECTROMETRY; CELL OIL PRODUCTION; ARACHIDONIC-ACID; HETEROLOGOUS EXPRESSION; QUANTITATIVE-ANALYSIS; LIPID-ACCUMULATION; MALIC ENZYME; PHYLOGENETIC CLASSIFICATION; SACCHAROMYCES-CEREVISIAE	Mortierella alpina is an oleaginous fungus which can produce lipids accounting for up to 50% of its dry weight in the form of triacylglycerols. It is used commercially for the production of arachidonic acid. Using a combination of high throughput sequencing and lipid profiling, we have assembled the M. alpina genome, mapped its lipogenesis pathway and determined its major lipid species. The 38.38 Mb M. alpina genome shows a high degree of gene duplications. Approximately 50% of its 12,796 gene models, and 60% of genes in the predicted lipogenesis pathway, belong to multigene families. Notably, M. alpina has 18 lipase genes, of which 11 contain the class 2 lipase domain and may share a similar function. M. alpina's fatty acid synthase is a single polypeptide containing all of the catalytic domains required for fatty acid synthesis from acetyl-CoA and malonyl-CoA, whereas in many fungi this enzyme is comprised of two polypeptides. Major lipids were profiled to confirm the products predicted in the lipogenesis pathway. M. alpina produces a complex mixture of glycerolipids, glycerophospholipids and sphingolipids. In contrast, only two major sterol lipids, desmosterol and 24(28)-methylene-cholesterol, were detected. Phylogenetic analysis based on genes involved in lipid metabolism suggests that oleaginous fungi may have acquired their lipogenic capacity during evolution after the divergence of Ascomycota, Basidiomycota, Chytridiomycota and Mucoromycota. Our study provides the first draft genome and comprehensive lipid profile for M. alpina, and lays the foundation for possible genetic engineering of M. alpina to produce higher levels and diverse contents of dietary lipids.	[Wang, Lei; Feng, Yun; Ren, Yan; Li, Yang; Zhang, Huanxin; Wang, Suriguga; Wang, Wei; Feng, Lu] Nankai Univ, Tianjin Econ Technol Dev Area, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Chen, Wei; Chen, Haiqin; Wang, Hongchao; Zhang, Baixi; Song, Yuanda; Zhang, Hao] Jiangnan Univ, Sch Food Sci & Technol, State Key Lab Food Sci & Technol, Wuxi, Peoples R China; [Wang, Lei; Feng, Yun; Feng, Lu] Tianjin Res Ctr Funct Genom & Biochip, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Wang, Lei; Feng, Lu] Nankai Univ, Key Lab Mol Microbiol & Technol, TEDA Sch Biol Sci & Biotechnol, Minist Educ, Tianjin 300071, Peoples R China; [Gu, Zhennan; Chen, Haiqin; Berquin, Isabelle M.; Wu, Jiansheng; Chen, Yong Q.] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC USA; [Thomas, Michael J.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Liu, Xiang; Norris, James S.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Du, Peng; Shen, Junguo; Wang, Na; Yang, Yanlin] Tianjin Biochip Corp, Tianjin Econ Technol Dev Area, Tianjin, Peoples R China; [Ratledge, Colin] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	Nankai University; Jiangnan University; Nankai University; Wake Forest University; Wake Forest University; Medical University of South Carolina; University of Hull	Wang, L (corresponding author), Nankai Univ, Tianjin Econ Technol Dev Area, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China.	zhanghao@jiangnan.edu.cn; yqchen@wfubmc.edu	feng, lu/M-5113-2015; Wang, Lei/C-5176-2009; Chen, Yong Q/AAI-9864-2021; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wang, Lei/0000-0003-4427-0881; Chen, Yong Q/0000-0003-4747-4708; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Wang, Wei/0000-0002-6660-8540	National Science Foundation of China (NSFC) [31030002, 30530010, 20836003, 20536040, 30670038, 30870078, 30771175, 30871952, 30900041]; Chinese National Science Fund for Distinguished Young Scholars [30788001]; National Key Programs for Infectious Diseases of China [2009ZX10004-108]; National High Technology Research and Development Program of China [2010AA1000693002, 2006AA020703, 2006AA06Z409]; State Key Laboratory of Food Science and Technology [SKLF-MB-200802]; 111 Project [B07029]; American Institute for Cancer Research [07B087]; National Institutes of Health [R21CA124511, R01CA107668, P01CA106742]; National Science Fund for Distinguished Young Scholars [31125021]; NATIONAL CANCER INSTITUTE [R01CA107668, P01CA106742, R21CA124511] Funding Source: NIH RePORTER	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Key Programs for Infectious Diseases of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Laboratory of Food Science and Technology; 111 Project(Ministry of Education, China - 111 Project); American Institute for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Science Foundation of China (NSFC) Key Program Grants 31030002, 30530010, 20836003 and 20536040, NSFC General Program Grants 30670038, 30870078, 30771175, 30871952 and 30900041, the Chinese National Science Fund for Distinguished Young Scholars (30788001), the National Key Programs for Infectious Diseases of China (2009ZX10004-108), the National High Technology Research and Development Program of China 2010AA1000693002, 2006AA020703 and 2006AA06Z409, the Research Program of State Key Laboratory of Food Science and Technology (SKLF-MB-200802), the 111 Project B07029 and Program for Changjiang Scholars, American Institute for Cancer Research grant 07B087, National Institutes of Health grants R21CA124511, R01CA107668 and P01CA106742, and the National Science Fund for Distinguished Young Scholars (31125021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Ando A, 2009, APPL ENVIRON MICROB, V75, P5529, DOI 10.1128/AEM.00648-09; Attwood TK, 2003, NUCLEIC ACIDS RES, V31, P400, DOI 10.1093/nar/gkg030; BAJPAI PK, 1991, APPL ENVIRON MICROB, V57, P1255, DOI 10.1128/AEM.57.4.1255-1258.1991; Berquin IM, 2008, CANCER LETT, V269, P363, DOI 10.1016/j.canlet.2008.03.044; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burns RA, 1999, FOOD CHEM TOXICOL, V37, P23, DOI 10.1016/S0278-6915(98)00104-5; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chaisson MJ, 2009, GENOME RES, V19, P336, DOI 10.1101/gr.079053.108; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chen YQ, 2007, CANCER METAST REV, V26, P535, DOI 10.1007/s10555-007-9075-x; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hempenius RA, 2000, FOOD CHEM TOXICOL, V38, P127, DOI 10.1016/S0278-6915(99)00144-1; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Ho SY, 2007, J AGR FOOD CHEM, V55, P3960, DOI 10.1021/jf0700071; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jang HD, 2005, BIORESOURCE TECHNOL, V96, P1633, DOI 10.1016/j.biortech.2004.12.027; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Jenni S, 2006, SCIENCE, V311, P1263, DOI 10.1126/science.1123251; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li YH, 2005, MYCOL RES, V109, P461, DOI 10.1017/S0953756205002480; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Maier T, 2006, SCIENCE, V311, P1258, DOI 10.1126/science.1123248; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; Michaelson LV, 1998, J BIOL CHEM, V273, P19055, DOI 10.1074/jbc.273.30.19055; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Pettus BJ, 2004, RAPID COMMUN MASS SP, V18, P577, DOI 10.1002/rcm.1373; Ratledge C, 2004, BIOCHIMIE, V86, P807, DOI 10.1016/j.biochi.2004.09.017; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Ratledge C, 2002, BIOCHEM SOC T, V30, P1047, DOI 10.1042/bst0301047; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Sakuradani E, 2005, APPL MICROBIOL BIOT, V66, P648, DOI 10.1007/s00253-004-1760-x; Sakuradani E, 1999, GENE, V238, P445, DOI 10.1016/S0378-1119(99)00359-5; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; Sakuradani E, 1999, EUR J BIOCHEM, V260, P208, DOI 10.1046/j.1432-1327.1999.00131.x; Sakuradani E, 2009, J BIOTECHNOL, V144, P31, DOI 10.1016/j.jbiotec.2009.04.012; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Seif E, 2005, NUCLEIC ACIDS RES, V33, P734, DOI 10.1093/nar/gki199; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Streekstra H, 1997, J BIOTECHNOL, V56, P153, DOI 10.1016/S0168-1656(97)00109-0; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; THATCHER LF, 2011, MOL PLANT MICROBE IN; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Van Kessel W S, 1977, Biochim Biophys Acta, V486, P524; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2008, MYCOL RES, V112, P725, DOI 10.1016/j.mycres.2008.01.003; Zhang Y, 2007, MICROBIOL-SGM, V153, P2013, DOI 10.1099/mic.0.2006/002683-0	94	104	125	6	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28319	10.1371/journal.pone.0028319	http://dx.doi.org/10.1371/journal.pone.0028319			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174787	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600018
J	Norscia, I; Palagi, E				Norscia, Ivan; Palagi, Elisabetta			Yawn Contagion and Empathy in Homo sapiens	PLOS ONE			English	Article							SEX-DIFFERENCES; INFANTS; BRAIN; RECOGNITION; CHIMPANZEES; EXPRESSION; ALTRUISM; CHILDREN; BEHAVIOR; MOTHERS	The ability to share others' emotions, or empathy, is crucial for complex social interactions. Clinical, psychological, and neurobiological clues suggest a link between yawn contagion and empathy in humans (Homo sapiens). However, no behavioral evidence has been provided so far. We tested the effect of different variables (e.g., country of origin, sex, yawn characteristics) on yawn contagion by running mixed models applied to observational data collected over 1 year on adult (> 16 years old) human subjects. Only social bonding predicted the occurrence, frequency, and latency of yawn contagion. As with other measures of empathy, the rate of contagion was greatest in response to kin, then friends, then acquaintances, and lastly strangers. Related individuals (r >= 0.25) showed the greatest contagion, in terms of both occurrence of yawning and frequency of yawns. Strangers and acquaintances showed a longer delay in the yawn response (latency) compared to friends and kin. This outcome suggests that the neuronal activation magnitude related to yawn contagion can differ as a function of subject familiarity. In conclusion, our results demonstrate that yawn contagion is primarily driven by the emotional closeness between individuals and not by other variables, such as gender and nationality.	[Norscia, Ivan; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Palagi, Elisabetta] ISTC CNR, Unita Primatol Cognit, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Norscia, I (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; GIGANTI F, 2009, CURR PSYCHOL LETT, V25, P1; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Harrison F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018338; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; KAPLAN HB, 1960, J NERV MENT DIS, V131, P128, DOI 10.1097/00005053-196008000-00006; Kaufman AB, 2009, ANIM BEHAV, V78, P1487, DOI 10.1016/j.anbehav.2009.09.014; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Meno P, 2003, CURR PSYCHOL LETT, V11, P1; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Moore JE, 1942, J GEN PSYCHOL, V27, P289, DOI 10.1080/00221309.1942.10544414; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Paukner A, 2006, BIOL LETTERS, V2, P36, DOI 10.1098/rsbl.2005.0411; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Provine Robert R., 1996, P179, DOI 10.1016/B978-012273965-1/50010-8; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1989, B PSYCHONOMIC SOC, V27, P211, DOI 10.3758/BF03334587; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Schulte-Ruther M, 2008, NEUROIMAGE, V42, P393, DOI 10.1016/j.neuroimage.2008.04.180; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Stenberg RJ, 2009, COGNITIVE PSYCHOL; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; WIGGERS M, 1985, DEV PSYCHOL, V21, P338, DOI 10.1037/0012-1649.21.2.338; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; [No title captured]	46	101	102	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28472	10.1371/journal.pone.0028472	http://dx.doi.org/10.1371/journal.pone.0028472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163307	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900044
J	Rodrigues, CR; Cabrini, M; Lenicov, FR; Sabatte, J; Ceballos, A; Jancic, C; Raiden, S; Ostrowski, M; Silberstein, C; Geffner, J				Rodriguez Rodrigues, Christian; Cabrini, Mercedes; Remes Lenicov, Federico; Sabatte, Juan; Ceballos, Ana; Jancic, Carolina; Raiden, Silvina; Ostrowski, Matias; Silberstein, Claudia; Geffner, Jorge			Epithelial Cells Activate Plasmacytoid Dendritic Cells Improving Their Anti-HIV Activity	PLOS ONE			English	Article							VIRAL-INFECTION; NUCLEIC-ACIDS; CUTTING EDGE; T-CELLS; RECEPTORS; INNATE; VIRUS; TRANSMISSION; REPLICATION; COMPLEXES	Plasmacytoid dendritic cells (pDCs) play a major role in anti-viral immunity by virtue of their ability to produce high amounts of type I interferons (IFNs) and a variety of inflammatory cytokines and chemokines in response to viral infections. Since recent studies have established that pDCs accumulate at the site of virus entry in the mucosa, here we analyzed whether epithelial cells were able to modulate the function of pDCs. We found that the epithelial cell lines HT-29 and Caco-2, as well as a primary culture of human renal tubular epithelial cells (HRTEC), induced the phenotypic maturation of pDCs stimulating the production of inflammatory cytokines. By contrast, epithelial cells did not induce any change in the phenotype of conventional or myeloid DCs (cDCs) while significantly stimulated the production of the anti-inflammatory cytokine IL-10. Activation of pDCs by epithelial cells was prevented by Bafilomycin A1, an inhibitor of endosomal acidification as well as by the addition of RNase to the culture medium, suggesting the participation of endosomal TLRs. Interestingly, the cross-talk between both cell populations was shown to be associated to an increased expression of TLR7 and TLR9 by pDCs and the production of LL37 by epithelial cells, an antimicrobial peptide able to bind and transport extracellular nucleic acids into the endosomal compartments. Interestingly, epithelium-activated pDCs impaired the establishment of a productive HIV infection in two susceptible target cells through the stimulation of the production of type I IFNs, highlighting the anti-viral efficiency of this novel activation pathway.	[Rodriguez Rodrigues, Christian; Cabrini, Mercedes; Remes Lenicov, Federico; Sabatte, Juan; Ceballos, Ana; Ostrowski, Matias; Geffner, Jorge] Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, RA-1053 Buenos Aires, DF, Argentina; [Jancic, Carolina; Raiden, Silvina; Geffner, Jorge] Acad Nacl Med Buenos Aires, IIHEMA, Buenos Aires, DF, Argentina; [Silberstein, Claudia] Univ Buenos Aires, Fac Med, Dept Fisiol, Lab Fisiopatogenia, RA-1425 Buenos Aires, DF, Argentina	University of Buenos Aires; Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires	Rodrigues, CR (corresponding author), Univ Buenos Aires, Fac Med, Ctr Nacl Referencia SIDA, RA-1053 Buenos Aires, DF, Argentina.	larageffner@yahoo.com.ar	Remes Lenicov, Federico/J-2694-2012	Remes Lenicov, Federico/0000-0003-4108-6341; Rodriguez Rodrigues, Christian/0000-0001-8720-2083; Ostrowski, Matias/0000-0002-3982-1338	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Buenos Aires University School of Medicine; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Buenos Aires University School of Medicine(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This study was supported by grants from the Consejo Nacional de Investigaciones Cientificas y Tecnicas, the Buenos Aires University School of Medicine, and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelot F, 2009, HAEMATOL-HEMATOL J, V94, P1502, DOI 10.3324/haematol.2009.010934; Asselin-Paturel C, 2005, J EXP MED, V202, P461, DOI 10.1084/jem.20051395; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bave U, 2000, J IMMUNOL, V165, P3519, DOI 10.4049/jimmunol.165.6.3519; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Charles J, 2010, EUR J DERMATOL, V20, P16, DOI 10.1684/ejd.2010.0816; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; CHULUYAN HE, 1993, J CLIN INVEST, V92, P2768, DOI 10.1172/JCI116895; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Groot F, 2006, BLOOD, V108, P1957, DOI 10.1182/blood-2006-03-010918; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Gutzmer R, 2006, J INVEST DERMATOL, V126, P2422, DOI 10.1038/sj.jid.5700416; Hartmann E, 2006, CLIN VACCINE IMMUNOL, V13, P1278, DOI 10.1128/CVI.00172-06; Iliev ID, 2009, GUT, V58, P1481, DOI 10.1136/gut.2008.175166; Iliev ID, 2007, J EXP MED, V204, P2253, DOI 10.1084/jem.20062535; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; Kim JM, 2006, SCAND J IMMUNOL, V63, P453, DOI 10.1111/j.1365-3083.2006.001756.x; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Liu YJ, 2000, BLOOD, V95, P2482, DOI 10.1182/blood.V95.8.2482.008a38_2482_2483; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Lund JM, 2006, J IMMUNOL, V177, P7510, DOI 10.4049/jimmunol.177.11.7510; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Russo C, 2011, BLOOD, V117, P5683, DOI 10.1182/blood-2010-12-328138; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Sabatte J, 2007, CYTOKINE GROWTH F R, V18, P5, DOI 10.1016/j.cytogfr.2007.01.002; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schnurr M, 2004, BLOOD, V103, P1391, DOI 10.1182/blood-2003-06-1959; Silberstein C, 2008, PEDIATR NEPHROL, V23, P1981, DOI 10.1007/s00467-008-0896-9; Skrzeczynska-Moncznik J, 2009, ACTA BIOCHIM POL, V56, P355; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; SOZZANI S, TRENDS IMMUNOL; Swiecki M, 2010, IMMUNOL REV, V234, P142, DOI 10.1111/j.0105-2896.2009.00881.x; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Vodros D, 2001, VIROLOGY, V291, P1, DOI 10.1006/viro.2001.1163; Wang HW, 2006, J IMMUNOL, V177, P6263, DOI 10.4049/jimmunol.177.9.6263; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28709	10.1371/journal.pone.0028709	http://dx.doi.org/10.1371/journal.pone.0028709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163327	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900063
J	Roukens, AH; Soonawala, D; Joosten, SA; de Visser, AW; Jiang, XH; Dirksen, K; de Gruijter, M; van Dissel, JT; Bredenbeek, PJ; Visser, LG				Roukens, Anna H.; Soonawala, Darius; Joosten, Simone A.; de Visser, Adriette W.; Jiang, Xiaohong; Dirksen, Kees; de Gruijter, Marjolein; van Dissel, Jaap T.; Bredenbeek, Peter J.; Visser, Leo G.			Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study	PLOS ONE			English	Article							SERIOUS ADVERSE EVENTS; VISCEROTROPIC DISEASE; 17D VACCINE; IMMUNE-RESPONSES; RISK-FACTOR; IMMUNOGENICITY; SAFETY; FAILURE; BIOLOGY; ENOUGH	Background: Yellow fever vaccination (YF-17D) can cause serious adverse events (SAEs). The mechanism of these SAEs is poorly understood. Older age has been identified as a risk factor. We tested the hypothesis that the humoral immune response to yellow fever vaccine develops more slowly in elderly than in younger subjects. Method: We vaccinated young volunteers (18-28 yrs, N = 30) and elderly travelers (60-81 yrs, N = 28) with YF-17D and measured their neutralizing antibody titers and plasma YF-17D RNA copy numbers before vaccination and 3, 5, 10, 14 and 28 days after vaccination. Results: Ten days after vaccination seroprotection was attained by 77% (23/30) of the young participants and by 50% (14/28) of the elderly participants (p = 0.03). Accordingly, the Geometric Mean Titer of younger participants was higher than the GMT of the elderly participants. At day 10 the difference was +2.9 IU/ml (95% CI 1.8-4.7, p = 0.00004) and at day 14 + 1.8 IU/ml (95% CI 1.1-2.9, p = 0.02, using a mixed linear model. Viraemia was more common in the elderly (86%, 24/28) than in the younger participants (60%, 14/30) (p = 0.03) with higher YF-17D RNA copy numbers in the elderly participants. Conclusions: We found that elderly subjects had a delayed antibody response and higher viraemia levels after yellow fever primovaccination. We postulate that with older age, a weaker immune response to yellow fever vaccine allows the attenuated virus to cause higher viraemia levels which may increase the risk of developing SAEs. This may be one piece in the puzzle of the pathophysiology of YEL-AVD.	[Roukens, Anna H.; Soonawala, Darius; Joosten, Simone A.; de Visser, Adriette W.; van Dissel, Jaap T.; Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Jiang, Xiaohong; Bredenbeek, Peter J.] Leiden Univ, Med Ctr, Dept Med Microbiol, Leiden, Netherlands; [Dirksen, Kees] Municipal Hlth Ctr Hollands Midden, The Hague, Netherlands; [de Gruijter, Marjolein] Municipal Hlth Ctr Leiden, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Roukens, AH (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	a.h.e.roukens@lumc.nl	Joosten, Simone/E-4731-2011; Joosten, Simone A/F-1357-2011; Visser, Leo/AAH-5755-2021	Joosten, Simone A/0000-0002-9878-0863; Visser, Leo/0000-0002-3600-9782	department of Infectious Diseases of the Leiden University Medical Center	department of Infectious Diseases of the Leiden University Medical Center	This study was funded by the department of Infectious Diseases of the Leiden University Medical Center. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, WKLY EPIDEMIOL REC, V80, P3; Barrett ADT, 2008, VACCINE, V26, P5441, DOI 10.1016/j.vaccine.2008.06.025; Belsher JL, 2007, VACCINE, V25, P8480, DOI 10.1016/j.vaccine.2007.08.061; Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7; DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113; Doblas A, 2006, J CLIN VIROL, V36, P156, DOI 10.1016/j.jcv.2006.02.005; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Eidex RB, 2004, LANCET, V364, P936, DOI 10.1016/S0140-6736(04)17017-7; Gerasimon G, 2005, SOUTH MED J, V98, P653, DOI 10.1097/01.SMJ.0000157537.11806.DC; Hayes EB, 2007, T ROY SOC TROP MED H, V101, P967, DOI 10.1016/j.trstmh.2007.06.013; Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131; Khromava AY, 2005, VACCINE, V23, P3256, DOI 10.1016/j.vaccine.2005.01.089; Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045; Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2; Martins RM, 2007, VACCINE, V25, P10, DOI 10.1016/j.vaccine.2005.12.052; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002; MMWR, 2010, MMWR, V59, P7; Monath TP, 2005, HUM VACCINES, V1, P207, DOI 10.4161/hv.1.5.2221; Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; Monath TP CM, 2008, VACCINES; National Coordiantion Centre for Traveller's health (LCR), 2008, NAT GUID VACC MAL PR; Pawelec G, 2006, EXP GERONTOL, V41, P1239, DOI 10.1016/j.exger.2006.09.005; Pulendran B, 2008, J INFECT DIS, V198, P500, DOI 10.1086/590187; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Roukens AH, 2009, VACCINE, V27, P2408, DOI 10.1016/j.vaccine.2009.02.049; Silva ML, 2011, VACCINE, V29, P583, DOI 10.1016/j.vaccine.2010.08.046; Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0; Veit O, 2009, CLIN INFECT DIS, V48, P659, DOI 10.1086/597006; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Zhou Qiang, 2005, Zhonghua Yi Xue Za Zhi, V85, P936	35	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27753	10.1371/journal.pone.0027753	http://dx.doi.org/10.1371/journal.pone.0027753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163273	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900009
J	Kim, S; Nguon, C; Guillard, B; Duong, S; Chy, S; Sum, S; Nhem, S; Bouchier, C; Tichit, M; Christophel, E; Taylor, WRJ; Baird, JK; Menard, D				Kim, Saorin; Nguon, Chea; Guillard, Bertrand; Duong, Socheat; Chy, Sophy; Sum, Sarorn; Nhem, Sina; Bouchier, Christiane; Tichit, Magali; Christophel, Eva; Taylor, Walter R. J.; Baird, John Kevin; Menard, Didier			Performance of the CareStart (TM) G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; DEHYDROGENASE-DEFICIENCY; INTERNATIONAL COMMITTEE; ARTEMISININ RESISTANCE; CAMBODIAN POPULATION; SOUTHEAST-ASIA; MALARIA; 871G-GREATER-THAN-A; STANDARDIZATION; HEMATOLOGY	Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareStart (TM) G6PD deficiency screening test (Access Bio, New Jersey, USA) by comparing its performance to quantitative G6PD enzyme activity using a standardized spectrophotometric method ('gold standard'). Blood samples (n = 903) were collected from Cambodian adults living in Pailin province, western Cambodia. G6PD enzyme activities ranged from 0 to 20.5 U/g Hb (median 12.0 U/g Hg). Based on a normal haemoglobin concentration and wild-type G6PD gene, the normal values of G6PD enzymatic activity for this population was 3.6 to 20.5 U/g Hg (95(th) percentiles from 5.5 to 17.2 U/g Hg). Ninety-seven subjects (10.7%) had <3.6 U/g Hg and were classified as G6PD deficient. Prevalence of deficiency was 15.0% (64/425) among men and 6.9% (33/478) among women. Genotype was analyzed in 66 G6PD-deficient subjects and 63 of these exhibited findings consistent with Viangchang genotype. The sensitivity and specificity of the CareStart (TM) G6PD deficiency screening test was 0.68 and 1.0, respectively. Its detection threshold was <2.7 U/g Hg, well within the range of moderate and severe enzyme deficiencies. Thirteen subjects (1.4%, 12 males and 1 female) with G6PD enzyme activities,2 U/g Hg were falsely classified as "normal" by RDT. This experimental RDT test here evaluated outside of the laboratory for the first time shows real promise, but safe application of it will require lower rates of falsely "normal" results.	[Kim, Saorin; Chy, Sophy; Sum, Sarorn; Nhem, Sina; Menard, Didier] Pasteur Inst Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Nguon, Chea; Duong, Socheat] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Guillard, Bertrand] Pasteur Inst Cambodia, Med Lab, Phnom Penh, Cambodia; [Bouchier, Christiane; Tichit, Magali] Inst Pasteur, Paris, France; [Christophel, Eva] WHO Reg Off Western Pacific, Manila, Philippines; [Taylor, Walter R. J.] Hop Univ Geneve, Serv Med Int & Humanitaire, Geneva, Switzerland; [Baird, John Kevin] Eijkman Oxford Clin Res Unit, Jakarta, Indonesia; [Baird, John Kevin] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; WHO Western Pacific Regional Office; World Health Organization; University of Geneva; Eijkman Institute; University of Oxford	Kim, S (corresponding author), Pasteur Inst Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia.	dmenard@pasteur-kh.org	Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495	WHO Regional Office for the Western Pacific; French Ministry of Foreign Affairs; Wellcome Trust	WHO Regional Office for the Western Pacific; French Ministry of Foreign Affairs; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grant from WHO Regional Office for the Western Pacific. Didier Menard is supported by the French Ministry of Foreign Affairs and Kevin Baird by the Wellcome Trust. The CareStart (TM) G6PD deficiency screening test was provided by the manufacturer (Access Bio). Access Bio has developed the second generation of CareStart (TM) G6PD deficiency screening test. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainoon O, 2003, Hum Mutat, V21, P101, DOI 10.1002/humu.9103; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Baird JK, 2011, TRENDS PARASITOL, V27, P11, DOI 10.1016/j.pt.2010.08.005; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 1979, BRIT J HAEMATOL, V43, P465, DOI 10.1111/j.1365-2141.1979.tb03774.x; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2008, BLOOD, V111, P16, DOI 10.1182/blood-2007-04-077412; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; DERN RJ, 1981, J LAB CLIN MED, V97, P750; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Goueffon S, 1969, Bull Soc Pathol Exot Filiales, V62, P1118; Iwai K, 2001, HUM GENET, V108, P445, DOI 10.1007/s004390100527; Kornberg A, 1955, GLUCOSE 6 PHOSPHATE; LOHR GW, 1957, KLIN WOCHENSCHR, V35, P871, DOI 10.1007/BF01481476; Louicharoen C, 2005, J HUM GENET, V50, P448, DOI 10.1007/s10038-005-0276-2; *MALERA CONS GROUP, 2011, PLOS MED, V0008; Matsuoka H, 2005, J HUM GENET, V50, P468, DOI 10.1007/s10038-005-0279-z; Monchy D, 2004, Med Trop (Mars), V64, P355; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nuchprayoon I, 2002, Hum Mutat, V19, P185, DOI 10.1002/humu.9010; Shekalaghe S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001023; Shekalaghe SA, 2010, ANTIMICROB AGENTS CH, V54, P1762, DOI 10.1128/AAC.01135-09; Tinley KE, 2010, AM J TROP MED HYG, V82, P210, DOI 10.4269/ajtmh.2010.09-0416; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; World Health Organization, 2007, MAL EL FIELD MAN LOW; World Health Organization, 2010, METH MAN LAB QUAL CO	32	80	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28357	10.1371/journal.pone.0028357	http://dx.doi.org/10.1371/journal.pone.0028357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164279	Green Published, gold			2022-12-27	WOS:000298171400080
J	Winge, MCG; Hoppe, T; Berne, B; Vahlquist, A; Nordenskjold, M; Bradley, M; Torma, H				Winge, Marten C. G.; Hoppe, Torborg; Berne, Berit; Vahlquist, Anders; Nordenskjold, Magnus; Bradley, Maria; Torma, Hans			Filaggrin Genotype Determines Functional and Molecular Alterations in Skin of Patients with Atopic Dermatitis and Ichthyosis Vulgaris	PLOS ONE			English	Article							BARRIER FUNCTION; GENE; EXPRESSION; MUTATIONS; ECZEMA; DIFFERENTIATION; CALCIUM	Background: Several common genetic and environmental disease mechanisms are important for the pathophysiology behind atopic dermatitis (AD). Filaggrin (FLG) loss-of-function is of great significance for barrier impairment in AD and ichthyosis vulgaris (IV), which is commonly associated with AD. The molecular background is, however, complex and various clusters of genes are altered, including inflammatory and epidermal-differentiation genes. Objective: The objective was to study whether the functional and molecular alterations in AD and IV skin depend directly on FLG loss-of-function, and whether FLG genotype determines the type of downstream molecular pathway affected. Methods and Findings: Patients with AD/IV (n = 43) and controls (n = 15) were recruited from two Swedish outpatient clinics and a Swedish AD family material with known FLG genotype. They were clinically examined and their medical history recorded using a standardized questionnaire. Blood samples and punch biopsies were taken and trans-epidermal water loss (TEWL) and skin pH was assessed with standard techniques. In addition to FLG genotyping, the STS gene was analyzed to exclude X-linked recessive ichthyosis (XLI). Microarrays and quantitative real-time PCR were used to compare differences in gene expression depending on FLG genotype. Several different signalling pathways were altered depending on FLG genotype in patients suffering from AD or AD/IV. Disease severity, TEWL and pH follow FLG deficiency in the skin; and the number of altered genes and pathways are correlated to FLG mRNA expression. Conclusions: We emphasize further the role of FLG in skin-barrier integrity and the complex compensatory activation of signalling pathways. This involves inflammation, epidermal differentiation, lipid metabolism, cell signalling and adhesion in response to FLG-dependent skin-barrier dysfunction.	[Winge, Marten C. G.; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med Solna, Dermatol Unit, Stockholm, Sweden; [Winge, Marten C. G.; Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Hoppe, Torborg; Berne, Berit; Vahlquist, Anders; Torma, Hans] Uppsala Univ, Dept Med Sci Dermatol & Venereol, Uppsala, Sweden; [Winge, Marten C. G.; Nordenskjold, Magnus; Bradley, Maria] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Karolinska Institutet; Karolinska University Hospital	Winge, MCG (corresponding author), Karolinska Inst, Karolinska Univ Hosp Solna, Dept Med Solna, Dermatol Unit, Stockholm, Sweden.	marten.winge@ki.se	Törmä, Hans/F-8152-2011	Törmä, Hans/0000-0002-3617-8551; Bradley, Maria/0000-0001-7192-5041; Nordenskjold, Magnus/0000-0002-4974-425X; Winge, Marten/0000-0001-6119-6009	Welander and Finsen foundations; Centre of Allergy Research (CFA); Stockholm County Council; Karolinska Institutet; Uppsala County Council; Uppsala University	Welander and Finsen foundations; Centre of Allergy Research (CFA); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Uppsala County Council; Uppsala University	The study was performed with grants from Welander and Finsen foundations, the Centre of Allergy Research (CFA) and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet and Uppsala County Council and Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix Inc, 2007, QUAL ASS EX GEN ARR; Akiyama M, 2010, HUM MUTAT, V31, P1090, DOI 10.1002/humu.21326; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Brown SJ, 2009, J INVEST DERMATOL, V129, P543, DOI 10.1038/jid.2008.413; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; Ekelund E, 2008, ACTA DERM-VENEREOL, V88, P15, DOI 10.2340/00015555-0383; Elias PM, 2008, J ALLERGY CLIN IMMUN, V121, P1337, DOI 10.1016/j.jaci.2008.01.022; Elias PM, 2008, J INVEST DERMATOL, V128, P1067, DOI 10.1038/jid.2008.88; Elias PM, 2002, J INVEST DERMATOL, V119, P1128, DOI 10.1046/j.1523-1747.2002.19512.x; Gamero AM, 2010, CANCER PREV RES, V3, P495, DOI 10.1158/1940-6207.CAPR-09-0105; Ginger RS, 2005, ARCH DERMATOL RES, V297, P235, DOI 10.1007/s00403-005-0590-8; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Howell MD, 2009, J ALLERGY CLIN IMMUN, V124, pR7, DOI 10.1016/j.jaci.2009.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jungersted JM, 2010, ALLERGY, V65, P911, DOI 10.1111/j.1398-9995.2010.02326.x; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Kim BE, 2011, J INVEST DERMATOL, V131, P1272, DOI 10.1038/jid.2011.24; Kolsch A, 2009, CELL MOTIL CYTOSKEL, V66, P976, DOI 10.1002/cm.20395; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; Mathay C, 2011, J INVEST DERMATOL, V131, P46, DOI 10.1038/jid.2010.272; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Nardi A, 2009, J STEROID BIOCHEM, V115, P68, DOI 10.1016/j.jsbmb.2009.02.017; Neuber K, 2006, CLIN EXP IMMUNOL, V146, P262, DOI 10.1111/j.1365-2249.2006.03218.x; Novak N, 2011, ALLERGY, V66, P830, DOI 10.1111/j.1398-9995.2011.02571.x; Ohman H, 1998, J INVEST DERMATOL, V111, P674, DOI 10.1046/j.1523-1747.1998.00356.x; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Posteraro P, 1998, BIOCHEM BIOPH RES CO, V243, P758, DOI 10.1006/bbrc.1998.8180; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Torma H, 2008, J INVEST DERMATOL, V128, P1212, DOI 10.1038/sj.jid.5701170; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Voegeli R, 2009, BRIT J DERMATOL, V161, P70, DOI 10.1111/j.1365-2133.2009.09142.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; Winge MCG, 2011, J DERMATOL SCI, V63, P62, DOI 10.1016/j.jdermsci.2011.03.011; Zhu AJ, 1996, J CELL SCI, V109, P3013	42	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28254	10.1371/journal.pone.0028254	http://dx.doi.org/10.1371/journal.pone.0028254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164253	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400054
J	Zhao, Y; Zhou, YQ; Jiang, HY; Li, XY; Gan, DF; Peng, XJ; Zhu, SW; Cheng, BJ				Zhao, Yang; Zhou, Yuqiong; Jiang, Haiyang; Li, Xiaoyu; Gan, Defang; Peng, Xiaojian; Zhu, Suwen; Cheng, Beijiu			Systematic Analysis of Sequences and Expression Patterns of Drought-Responsive Members of the HD-Zip Gene Family in Maize	PLOS ONE			English	Article							HOMEOBOX GENE; TRANSCRIPTION FACTOR; DEPENDENT EXPRESSION; DRAFT SEQUENCE; WATER-DEFICIT; HOMEODOMAIN; ARABIDOPSIS; PROTEIN; RICE; DOMAINS	Background: Members of the homeodomain-leucine zipper (HD-Zip) gene family encode transcription factors that are unique to plants and have diverse functions in plant growth and development such as various stress responses, organ formation and vascular development. Although systematic characterization of this family has been carried out in Arabidopsis and rice, little is known about HD-Zip genes in maize (Zea mays L.). Methods and Findings: In this study, we described the identification and structural characterization of HD-Zip genes in the maize genome. A complete set of 55 HD-Zip genes (Zmhdz1-55) were identified in the maize genome using Blast search tools and categorized into four classes (HD-Zip I-IV) based on phylogeny. Chromosomal location of these genes revealed that they are distributed unevenly across all 10 chromosomes. Segmental duplication contributed largely to the expansion of the maize HD-ZIP gene family, while tandem duplication was only responsible for the amplification of the HD-Zip II genes. Furthermore, most of the maize HD-Zip I genes were found to contain an overabundance of stress-related cis-elements in their promoter sequences. The expression levels of the 17 HD-Zip I genes under drought stress were also investigated by quantitative real-time PCR (qRT-PCR). All of the 17 maize HD-ZIP I genes were found to be regulated by drought stress, and the duplicated genes within a sister pair exhibited the similar expression patterns, suggesting their conserved functions during the process of evolution. Conclusions: Our results reveal a comprehensive overview of the maize HD-Zip gene family and provide the first step towards the selection of Zmhdz genes for cloning and functional research to uncover their roles in maize growth and development.	[Zhao, Yang; Zhou, Yuqiong; Jiang, Haiyang; Li, Xiaoyu; Gan, Defang; Peng, Xiaojian; Zhu, Suwen; Cheng, Beijiu] Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China	Anhui Agricultural University	Zhao, Y (corresponding author), Anhui Agr Univ, Key Lab Crop Biol Anhui Prov, Hefei, Peoples R China.	bjchengahau@163.com			National Key Technologies R & D Program of China [2009BADA6B]; Research Fund for the Doctoral Program of Higher Education of China [20103418120001]	National Key Technologies R & D Program of China(National Key Technology R&D Program); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The research work was supported by grants from the National Key Technologies R & D Program of China during the Eleventh Five-Year Plan Period (2009BADA6B) (http://finance.most.gov.cn) and Research Fund for the Doctoral Program of Higher Education of China (20103418120001) (http://finance.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chan RL, 1998, BBA-GENE STRUCT EXPR, V1442, P1, DOI 10.1016/S0167-4781(98)00119-5; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Cote CL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-273; Depege-Fargeix N, 2011, J EXP BOT, V62, P293, DOI 10.1093/jxb/erq267; Dezar CA, 2005, TRANSGENIC RES, V14, P429, DOI 10.1007/s11248-005-5076-0; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Guan XY, 2008, PHYSIOL PLANTARUM, V134, P174, DOI 10.1111/j.1399-3054.2008.01115.x; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Harris JC, 2011, NEW PHYTOL IN PRESS; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Ingram GC, 1999, PLANT MOL BIOL, V40, P343, DOI 10.1023/A:1006271332400; Ingram GC, 2000, PLANT J, V22, P401, DOI 10.1046/j.1365-313X.2000.00755.x; Ito M, 2002, PLANT J, V29, P497, DOI 10.1046/j.1365-313x.2002.01234.x; Jain M, 2008, FEBS J, V275, P2845, DOI 10.1111/j.1742-4658.2008.06424.x; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Johannesson H, 2003, PLANT MOL BIOL, V51, P719, DOI 10.1023/A:1022567625228; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Lee YH, 2001, BIOCHEM BIOPH RES CO, V284, P133, DOI 10.1006/bbrc.2001.4904; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li FQ, 2008, PLANT PHYSIOL, V146, P1333, DOI 10.1104/pp.107.111120; Lin ZF, 2008, PLANT J, V55, P301, DOI 10.1111/j.1365-313X.2008.03505.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Magnani E, 2011, PLANT CELL, V23, P567, DOI 10.1105/tpc.110.080754; Mayda E, 1999, PLANT J, V20, P591, DOI 10.1046/j.1365-313X.1999.00633.x; Mehan Michael R., 2004, Human Genomics, V1, P335; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Mukherjee K, 2006, PLANT PHYSIOL, V140, P1142, DOI 10.1104/pp.105.073833; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Ni YX, 2008, ACTA BIOCH BIOPH SIN, V40, P78, DOI 10.1111/j.1745-7270.2008.00371.x; Olsson ASB, 2004, PLANT MOL BIOL, V55, P663, DOI 10.1007/s11103-004-1581-4; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Qin YF, 2010, PLANT CELL REP, V29, P1147, DOI 10.1007/s00299-010-0901-1; Raes Jeroen, 2003, Journal of Structural and Functional Genomics, V3, P117, DOI 10.1023/A:1022666020026; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Rueda EC, 2005, PLANT CELL PHYSIOL, V46, P1954, DOI 10.1093/pcp/pci210; Sakakibara K, 2001, MOL BIOL EVOL, V18, P491, DOI 10.1093/oxfordjournals.molbev.a003828; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; SCHENA M, 1992, P NATL ACAD SCI USA, V89, P3894, DOI 10.1073/pnas.89.9.3894; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schrick K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r41; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Sessa G, 2005, GENE DEV, V19, P2811, DOI 10.1101/gad.364005; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Soderman E, 1999, PLANT MOL BIOL, V40, P1073, DOI 10.1023/A:1006267013170; Steindler C, 1999, DEVELOPMENT, V126, P4235; Swigonova Z, 2004, GENOME RES, V14, P1916, DOI 10.1101/gr.2332504; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tron AE, 2002, J BIOL CHEM, V277, P34800, DOI 10.1074/jbc.M203297200; Vernoud V, 2009, PLANT J, V59, P883, DOI 10.1111/j.1365-313X.2009.03916.x; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; Wang LQ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-282; Wang Y, 2003, DEV BIOL, V264, P228, DOI 10.1016/j.ydbio.2003.07.017; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang XH, 2011, MOL GENET GENOMICS, V285, P79, DOI 10.1007/s00438-010-0587-7	77	102	131	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28488	10.1371/journal.pone.0028488	http://dx.doi.org/10.1371/journal.pone.0028488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164299	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400100
J	Kovalchin, J; Krieger, J; Genova, M; Kawamoto, N; Augustyniak, M; Collins, K; Bloom, T; Masci, A; Hittinger, T; Dufour, I; Strominger, JL; Zanelli, E				Kovalchin, Joseph; Krieger, Jeffrey; Genova, Michelle; Kawamoto, Norio; Augustyniak, Michael; Collins, Kathryn; Bloom, Troy; Masci, Allyson; Hittinger, Tara; Dufour, Ingrid; Strominger, Jack L.; Zanelli, Eric			Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; REGULATORY T-CELLS; MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; SUPPRESSOR-CELLS; DENDRITIC CELLS; SYSTEM; MICE; ACTIVATION	The random amino acid copolymer poly(Y,E,A, K)(n) (Copaxone (R)) is widely used in multiple sclerosis treatment and a second generation copolymer poly(Y, F, A, K) n with enhanced efficacy in experimental autoimmune encephalomyelitis in mice has been described. A major mechanism through which copolymers function to ameliorate disease is the generation of immunosuppressive IL-10-secreting regulatory T cells entering the CNS. In addition, the antigen presenting cell to which these copolymers bind through MHC Class II proteins may have an important role. Here, both CCL22 (a Th2 cell chemoattractant) in large amounts and CXCL13 in much smaller amounts are shown to be secreted after administration of YFAK to mice and to a smaller extent by YEAK parallel to their serum concentrations. Moreover, bone marrow-derived macrophages secrete CCL22 in vitro in response to YFAK and to higher concentrations of YEAK. Strikingly, these chemokines are also secreted into serum of MHC Class II -/- mice, indicating that an innate immune receptor on these cells also has an important role. Thus, both the innate and the adaptive immune systems are involved in the mechanism of EAE amelioration by YFAK. The enhanced ability of YFAK to stimulate the innate immune system may account for its enhanced efficacy in EAE treatment.	[Kovalchin, Joseph; Krieger, Jeffrey; Genova, Michelle; Augustyniak, Michael; Collins, Kathryn; Bloom, Troy; Masci, Allyson; Hittinger, Tara; Dufour, Ingrid; Zanelli, Eric] Peptimmune Inc, Cambridge, MA USA; [Kawamoto, Norio; Strominger, Jack L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Kovalchin, J (corresponding author), Peptimmune Inc, Cambridge, MA USA.	jlstrom@fas.harvard.edu	Kawamoto, Norio/AAN-5302-2021	Kawamoto, Norio/0000-0002-3482-7781	National Institutes of Health [AI-049524]; Peptimmune, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peptimmune, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NK and JLS were supported by a research grant from the National Institutes of Health (AI-049524). Due to the collaborative nature of this study, Peptimmune, Inc. ceded study design to the corresponding author but paid salaries and expenses associated with some of the experiments for this research. All manuscript preparation was performed by the Harvard and Peptimmune scientists on their own time and without compensation. The funders, Peptimmune, Inc. and the National Institutes of Health, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161; Chen CH, 2009, J IMMUNOL, V183, P246, DOI 10.4049/jimmunol.0900193; Fridkis-Hareli M, 1998, J IMMUNOL, V160, P4386; Fridkis-Hareli M, 2002, J CLIN INVEST, V109, P1635, DOI 10.1172/JCI200215402; FRIDKISHARELI M, 1994, P NATL ACAD SCI USA, V91, P4872, DOI 10.1073/pnas.91.11.4872; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Glabinski AR, 2004, AUTOIMMUNITY, V37, P465, DOI 10.1080/08916930400001859; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Hussien Y, 2001, J NEUROIMMUNOL, V121, P102, DOI 10.1016/S0165-5728(01)00432-5; Illies Z, 2004, P NATL ACAD SCI USA, V101, P11749, DOI 10.1073/pnas.0403833101; Jee Y, 2007, CLIN IMMUNOL, V125, P34, DOI 10.1016/j.clim.2007.05.020; Kala M, 2010, EXP NEUROL, V221, P136, DOI 10.1016/j.expneurol.2009.10.015; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; Kovalchin J, 2010, J NEUROIMMUNOL, V225, P153, DOI 10.1016/j.jneuroim.2010.04.008; Kovalchin J, 2011, J CLIN PHARMACOL, V51, P649, DOI 10.1177/0091270010373930; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Li QD, 1998, EUR J PHARMACOL, V342, P303, DOI 10.1016/S0014-2999(97)01509-4; Makarenkova VP, 2006, J IMMUNOL, V176, P2085, DOI 10.4049/jimmunol.176.4.2085; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mohamadzadeh M, 1996, J IMMUNOL, V156, P3102; Newcomb DC, 2009, J IMMUNOL, V182, P5317, DOI 10.4049/jimmunol.0803868; Racke MK, 2010, NEUROLOGY, V74, pS25, DOI 10.1212/WNL.0b013e3181c97e39; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Sethi G, 2009, ADV EXP MED BIOL, V647, P37, DOI 10.1007/978-0-387-89520-8_3; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; Stern JNH, 2004, P NATL ACAD SCI USA, V101, P11743, DOI 10.1073/pnas.0403832101; Stern JNH, 2008, P NATL ACAD SCI USA, V105, P5172, DOI 10.1073/pnas.0712131105; TEITELBAUM D, 1971, European Journal of Immunology, V1, P242, DOI 10.1002/eji.1830010406; TEITELBAUM D, 2005, EUR J IMMUNOL, V1, P242; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Vieira PL, 2003, J IMMUNOL, V170, P4483, DOI 10.4049/jimmunol.170.9.4483; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wu CY, 2006, INT IMMUNOPHARMACOL, V6, P610, DOI 10.1016/j.intimp.2005.09.010; Yin H, 2009, J NEUROIMMUNOL, V215, P43, DOI 10.1016/j.jneuroim.2009.08.002; Zhang H, 2009, P NATL ACAD SCI USA, V106, P3336, DOI 10.1073/pnas.0813197106; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e26274	10.1371/journal.pone.0026274	http://dx.doi.org/10.1371/journal.pone.0026274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194778	Green Published, gold, Green Submitted			2022-12-27	WOS:000298370400001
J	Samuelson, LK; Smith, LB; Perry, LK; Spencer, JP				Samuelson, Larissa K.; Smith, Linda B.; Perry, Lynn K.; Spencer, John P.			Grounding Word Learning in Space	PLOS ONE			English	Article							DYNAMIC FIELD-THEORY; EYE-MOVEMENTS; SPATIAL LOCATION; TEMPORAL CORTEX; VISUAL AREAS; INFANTS; NEURONS; OBJECTS; PERCEPTION; ATTENTION	Humans and objects, and thus social interactions about objects, exist within space. Words direct listeners' attention to specific regions of space. Thus, a strong correspondence exists between where one looks, one's bodily orientation, and what one sees. This leads to further correspondence with what one remembers. Here, we present data suggesting that children use associations between space and objects and space and words to link words and objects-space binds labels to their referents. We tested this claim in four experiments, showing that the spatial consistency of where objects are presented affects children's word learning. Next, we demonstrate that a process model that grounds word learning in the known neural dynamics of spatial attention, spatial memory, and associative learning can capture the suite of results reported here. This model also predicts that space is special, a prediction supported in a fifth experiment that shows children do not use color as a cue to bind words and objects. In a final experiment, we ask whether spatial consistency affects word learning in naturalistic word learning contexts. Children of parents who spontaneously keep objects in a consistent spatial location during naming interactions learn words more effectively. Together, the model and data show that space is a powerful tool that can effectively ground word learning in social contexts.	[Samuelson, Larissa K.; Perry, Lynn K.; Spencer, John P.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Samuelson, Larissa K.; Perry, Lynn K.; Spencer, John P.] Univ Iowa, Delta Ctr, Iowa City, IA 52242 USA; [Smith, Linda B.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	University of Iowa; University of Iowa; Indiana University System; Indiana University Bloomington	Samuelson, LK (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	larissa-samuelson@uiowa.edu		Perry, Lynn/0000-0001-6976-3741; Spencer, John/0000-0002-7320-144X; Samuelson, Larissa/0000-0002-9141-3286	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007475, R21HD068475, R01HD045713, R01HD028675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062480] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD028675, T32 HD007475, R01HD28675, R01HD045713, R01 HD045713, R21 HD068475] Funding Source: Medline; NIMH NIH HHS [R01 MH062480, R01MH62480] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggelopoulos NC, 2005, EUR J NEUROSCI, V22, P2903, DOI 10.1111/j.1460-9568.2005.04487.x; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; BALDWIN DA, 1993, DEV PSYCHOL, V29, P832, DOI 10.1037/0012-1649.29.5.832; Bloom Lois., 1970, LANGUAGE DEV FUNCTIO; Bloom P, 2002, MIND LANG, V17, P37, DOI 10.1111/1468-0017.00188; BROWN R, 1964, HARVARD EDUC REV, V34, P133, DOI 10.17763/haer.34.2.c5263w0q03222r14; BUSHNELL EW, 1995, CHILD DEV, V66, P937, DOI 10.2307/1131790; DAMASIO AR, 1989, COGNITION, V33, P25, DOI 10.1016/0010-0277(89)90005-X; Deak GO, 2000, DEV PSYCHOL, V36, P511, DOI 10.1037/0012-1649.36.4.511; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DiCarlo JJ, 2003, J NEUROPHYSIOL, V89, P3264, DOI 10.1152/jn.00358.2002; Erlhagen W, 2002, PSYCHOL REV, V109, P545, DOI 10.1037//0033-295X.109.3.545; Estes Z, 2008, PSYCHOL SCI, V19, P93, DOI 10.1111/j.1467-9280.2008.02051.x; Faubel C, 2008, NEURAL NETWORKS, V21, P562, DOI 10.1016/j.neunet.2008.03.007; Ferreira F, 2008, TRENDS COGN SCI, V12, P405, DOI 10.1016/j.tics.2008.07.007; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2011, PERSPECT PSYCHOL SCI, V6, P369, DOI 10.1177/1745691611413392; Gelade G., 1980, COGNITIVE PSYCHOL, V12, P136; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; HUTTENLOCHER J, 1994, COGNITIVE PSYCHOL, V27, P115, DOI 10.1006/cogp.1994.1014; Jancke D, 1999, J NEUROSCI, V19, P9016, DOI 10.1523/JNEUROSCI.19-20-09016.1999; Johnson JS, 2008, J EXP PSYCHOL HUMAN, V34, P41, DOI 10.1037/0096-1523.34.1.41; Johnson JS, 2009, BRAIN RES, V1299, P17, DOI 10.1016/j.brainres.2009.07.008; Johnson JS, 2009, PSYCHOL SCI, V20, P568, DOI 10.1111/j.1467-9280.2009.02329.x; Knoeferle P, 2007, J MEM LANG, V57, P519, DOI 10.1016/j.jml.2007.01.003; Kravitz DJ, 2008, TRENDS COGN SCI, V12, P114, DOI 10.1016/j.tics.2007.12.006; LANDAU B, 1988, COGNITIVE DEV, V3, P299, DOI 10.1016/0885-2014(88)90014-7; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; Lipinski J, 2012, J EXP PSYCHOL LEARN, V38, P1490, DOI 10.1037/a0022643; Lipinski J, 2010, PSYCHON B REV, V17, P581, DOI 10.3758/PBR.17.4.581; Luck SJ, 1997, COGNITIVE PSYCHOL, V33, P64, DOI 10.1006/cogp.1997.0660; MCMURRAY B, 2009, NEW GRAND THEORY DEV, P218; Mel BW, 1997, NEURAL COMPUT, V9, P777, DOI 10.1162/neco.1997.9.4.777; Newcombe N, 1998, COGNITIVE DEV, V13, P185, DOI 10.1016/S0885-2014(98)90038-7; Newcombe N, 1999, INFANT BEHAV DEV, V22, P483, DOI 10.1016/S0163-6383(00)00011-4; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; Papafragou A, 2002, MIND LANG, V17, P55, DOI 10.1111/1468-0017.00189_17_1-2; Pereira AF, 2008, CONNECT SCI, V20, P73, DOI 10.1080/09540090802091891; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Regier T, 2005, COGNITIVE SCI, V29, P819, DOI 10.1207/s15516709cog0000_31; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson DC, 2004, J EXP PSYCHOL GEN, V133, P46, DOI 10.1037/0096-3445.133.1.46; Richardson DC, 2000, COGNITION, V76, P269, DOI 10.1016/S0010-0277(00)00084-6; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; SALVERDA AP, J EXP PSYCH IN PRESS; Samuelson LK, 2009, COGNITION, V110, P322, DOI 10.1016/j.cognition.2008.10.017; Samuelson LK, 2002, DEV PSYCHOL, V38, P1016, DOI 10.1037//0012-1649.38.6.1016; Schutte AR, 2009, J EXP PSYCHOL HUMAN, V35, P1698, DOI 10.1037/a0015794; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; SIGMAN M, 1999, MONOGRAPHS SOC RES C, V64, P114, DOI DOI 10.1111/1540-5834.00001; Simmering VR, 2008, BRAIN RES, V1202, P68, DOI 10.1016/j.brainres.2007.06.081; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Singer W., 2004, VISUAL NEUROSCIENCES, P1665; Smith LB, 2007, DEVELOPMENTAL SCI, V10, P61, DOI 10.1111/j.1467-7687.2007.00565.x; Tomasello M, 2007, LANG LEARN DEV, V3, P133, DOI 10.1080/15475440701225451; von der Malsburg C, 1999, NEURON, V24, P95, DOI 10.1016/S0896-6273(00)80825-9; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Waxman SR, 2009, TRENDS COGN SCI, V13, P258, DOI 10.1016/j.tics.2009.03.006; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Woodward AL, 1999, CHILD DEV, V70, P65, DOI 10.1111/1467-8624.00006; Zmigrod S, 2010, ATTEN PERCEPT PSYCHO, V72, P142, DOI 10.3758/APP.72.1.142	62	66	66	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28095	10.1371/journal.pone.0028095	http://dx.doi.org/10.1371/journal.pone.0028095			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194807	gold, Green Published			2022-12-27	WOS:000298369100022
J	Newman, LA; Korol, DL; Gold, PE				Newman, Lori A.; Korol, Donna L.; Gold, Paul E.			Lactate Produced by Glycogenolysis in Astrocytes Regulates Memory Processing	PLOS ONE			English	Article							HIPPOCAMPAL ACETYLCHOLINE-RELEASE; CEREBRAL CORTICAL ASTROCYTES; LONG-TERM POTENTIATION; ENERGY-METABOLISM; SPONTANEOUS-ALTERNATION; NEURONAL-ACTIVITY; GLUCOSE INJECTIONS; BRAIN GLUCOSE; MONOCARBOXYLATE TRANSPORTERS; PRIMARY CULTURES	When administered either systemically or centrally, glucose is a potent enhancer of memory processes. Measures of glucose levels in extracellular fluid in the rat hippocampus during memory tests reveal that these levels are dynamic, decreasing in response to memory tasks and loads; exogenous glucose blocks these decreases and enhances memory. The present experiments test the hypothesis that glucose enhancement of memory is mediated by glycogen storage and then metabolism to lactate in astrocytes, which provide lactate to neurons as an energy substrate. Sensitive bioprobes were used to measure brain glucose and lactate levels in 1-sec samples. Extracellular glucose decreased and lactate increased while rats performed a spatial working memory task. Intrahippocampal infusions of lactate enhanced memory in this task. In addition, pharmacological inhibition of astrocytic glycogenolysis impaired memory and this impairment was reversed by administration of lactate or glucose, both of which can provide lactate to neurons in the absence of glycogenolysis. Pharmacological block of the monocarboxylate transporter responsible for lactate uptake into neurons also impaired memory and this impairment was not reversed by either glucose or lactate. These findings support the view that astrocytes regulate memory formation by controlling the provision of lactate to support neuronal functions.	[Newman, Lori A.; Korol, Donna L.; Gold, Paul E.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Korol, Donna L.; Gold, Paul E.] Univ Illinois, Inst Genom Biol, Champaign, IL 61820 USA; [Newman, Lori A.; Korol, Donna L.; Gold, Paul E.] Univ Illinois, Dept Psychol, Champaign, IL 61820 USA; [Korol, Donna L.; Gold, Paul E.] Univ Illinois, Dept Mol & Integrat Physiol, Champaign, IL 61820 USA; [Gold, Paul E.] Univ Illinois, Dept Psychiat, Champaign, IL 61820 USA; [Gold, Paul E.] Univ Illinois, Dept Biomed Engn, Champaign, IL 61820 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Newman, LA (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL 61820 USA.	lanewman@illinois.edu	Newman, Lori/J-6974-2015	Newman, Lori/0000-0002-8368-7690	National Science Foundation (NSF) [IOS 1052464, IOS 0843175]; National Institutes of Health (NIH) [HD007333, AG07648]; Alzheimer's Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007648] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0843175] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The following supported this research: National Science Foundation (NSF) IOS 1052464, NSF IOS 0843175, National Institutes of Health (NIH) Training Grant HD007333, NIH grant AG07648, and an Alzheimer's Association Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTON D, 1994, NEUROPSYCHOLOGIA, V32, P595, DOI 10.1016/0028-3932(94)90147-3; BENTON D, 1993, PSYCHOPHARMACOLOGY, V113, P83, DOI 10.1007/BF02244338; Benton D, 2008, BIOL PSYCHOL, V78, P242, DOI 10.1016/j.biopsycho.2008.03.007; Benton D, 2007, PHYSIOL BEHAV, V92, P717, DOI 10.1016/j.physbeh.2007.05.065; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; BORKE RC, 1984, DEV BRAIN RES, V16, P277, DOI 10.1016/0165-3806(84)90032-4; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Brown AM, 2004, NEUROCHEM INT, V45, P529, DOI 10.1016/j.neuint.2003.11.005; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Brunet JF, 2010, J CEREBR BLOOD F MET, V30, P51, DOI 10.1038/jcbfm.2009.207; BRUNJES PC, 1991, DEV BRAIN RES, V62, P239, DOI 10.1016/0165-3806(91)90171-E; BULMER D, 1959, STAIN TECHNOL, V34, P95, DOI 10.3109/10520295909114656; Butz CE, 2004, J APPL PHYSIOL, V97, P1059, DOI 10.1152/japplphysiol.00009.2004; Canal CE, 2005, LEARN MEMORY, V12, P367, DOI 10.1101/lm.88205; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chang Q, 2006, J NEUROCHEM, V97, P697, DOI 10.1111/j.1471-4159.2006.03765.x; Chang Q, 2004, HIPPOCAMPUS, V14, P170, DOI 10.1002/hipo.10160; Chiry O, 2006, BRAIN RES, V1070, P65, DOI 10.1016/j.brainres.2005.11.064; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Chuquet J, 2010, J NEUROSCI, V30, P15298, DOI 10.1523/JNEUROSCI.0762-10.2010; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; Darvesh AS, 2003, EUR J PHARMACOL, V464, P135, DOI 10.1016/S0014-2999(03)01432-8; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Debernardi R, 2003, J NEUROSCI RES, V73, P141, DOI 10.1002/jnr.10660; DeRuisseau LR, 2009, P NATL ACAD SCI USA, V106, P9419, DOI 10.1073/pnas.0902534106; Donohoe RT, 2000, PHYSIOL BEHAV, V71, P395, DOI 10.1016/S0031-9384(00)00359-0; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Duelli R, 1998, J NEURAL TRANSM, V105, P1017, DOI 10.1007/s007020050109; DURHAM D, 1985, J COMP NEUROL, V231, P446, DOI 10.1002/cne.902310404; DWYER DS, 2002, INT REV NEUROBIOL, P159; Elekes O, 1996, NEUROSCI LETT, V208, P69, DOI 10.1016/0304-3940(96)12553-2; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; FELLOWS LK, 1992, J NEUROCHEM, V59, P2141; Fillenz M, 2005, NEUROCHEM INT, V47, P413, DOI 10.1016/j.neuint.2005.05.011; Fillenz M, 1999, ACTA PHYSIOL SCAND, V167, P275; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; FRIEDE RL, 1962, J NEUROPATH EXP NEUR, V21, P471, DOI 10.1097/00005072-196207000-00015; Gibbs ME, 2008, NEUROSCI BIOBEHAV R, V32, P927, DOI 10.1016/j.neubiorev.2008.02.001; Gibbs ME, 2008, NEUROCHEM INT, V52, P1012, DOI 10.1016/j.neuint.2007.10.014; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gold PE, 2006, LEARN MEMORY, V13, P506, DOI 10.1101/lm.277406; Gold PE, 2005, NEUROBIOL AGING, V26, pS60, DOI 10.1016/j.neurobiolaging.2005.09.002; GOLD PE, 1978, BEHAV BIOL, V23, P509, DOI 10.1016/S0091-6773(78)91614-0; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALL JL, 1986, BEHAV NEURAL BIOL, V46, P156, DOI 10.1016/S0163-1047(86)90640-0; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hertz L, 2010, NEUROCHEM INT, V57, P411, DOI 10.1016/j.neuint.2010.03.019; Hertz L, 2009, J NEUROCHEM, V109, P10, DOI 10.1111/j.1471-4159.2009.05939.x; HOSLI L, 1992, PROG BRAIN RES, V94, P317; Hu YB, 1997, J NEUROCHEM, V68, P1745; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Huja SS, 1999, J BIOMECH, V32, P1243, DOI 10.1016/S0021-9290(99)00047-0; Hutchinson DS, 2008, BRAIN RES BULL, V76, P224, DOI 10.1016/j.brainresbull.2008.02.019; KAGEYAMA GH, 1982, NEUROSCIENCE, V7, P2337, DOI 10.1016/0306-4522(82)90199-3; Kaplan RJ, 2000, AM J CLIN NUTR, V72, P825; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kong JM, 2002, J NEUROSCI, V22, P5581; Korol DL, 2008, HIPPOCAMPUS, V18, P81, DOI 10.1002/hipo.20372; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Laureys G, 2010, PROG NEUROBIOL, V91, P189, DOI 10.1016/j.pneurobio.2010.01.011; Loaiza A, 2003, J NEUROSCI, V23, P7337; Lynch CM, 2005, J HISTOCHEM CYTOCHEM, V53, P63, DOI 10.1369/jhc.4A6365.2005; Mackay P, 2003, DIABETES OBES METAB, V5, P397, DOI 10.1046/j.1463-1326.2003.00293.x; Magistretti PJ, 2009, SCIENCE, V325, P1349, DOI 10.1126/science.1180102; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MAGISTRETTI PJ, 1986, J NEUROSCI, V6, P2558; MAGISTRETTI PJ, 1981, P NATL ACAD SCI-BIOL, V78, P6535, DOI 10.1073/pnas.78.10.6535; MANNING CA, 1993, NEUROBIOL AGING, V14, P523, DOI 10.1016/0197-4580(93)90034-9; Manning CA, 1998, NEUROPSYCHOLOGY, V12, P479, DOI 10.1037/0894-4105.12.3.479; Manning CA, 1998, BEHAV BRAIN RES, V93, P71, DOI 10.1016/S0166-4328(97)00136-8; MAXWELL DS, 1965, J CELL BIOL, V25, P141, DOI 10.1083/jcb.25.2.141; McNay EC, 1999, J NEUROCHEM, V72, P785, DOI 10.1046/j.1471-4159.1999.720785.x; McNay EC, 2006, PHYSIOL BEHAV, V87, P298, DOI 10.1016/j.physbeh.2005.10.016; McNay EC, 2001, J GERONTOL A-BIOL, V56, pB66, DOI 10.1093/gerona/56.2.B66; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; McNay EC, 2000, P NATL ACAD SCI USA, V97, P2881, DOI 10.1073/pnas.050583697; McNay Ewan C, 2002, Behav Cogn Neurosci Rev, V1, P264, DOI 10.1177/1534582302238337; Messier C, 2004, EUR J PHARMACOL, V490, P33, DOI 10.1016/j.ejphar.2004.02.043; MJAATVEDT AE, 1988, J COMP NEUROL, V277, P155, DOI 10.1002/cne.902770202; MORRIS KA, 2010, 39 ANN M SAN DIEG 20; Morris KA, 2010, NEUROBIOL AGING, V31, P2136, DOI 10.1016/j.neurobiolaging.2008.12.003; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Payne RS, 2007, NEUROSCI LETT, V424, P111, DOI 10.1016/j.neulet.2007.07.006; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; da Silva APP, 2009, BIOCHEM J, V417, P717, DOI 10.1042/BJ20080805; Petersen K. U., 1969, CELL TISSUE RES, V100, P616; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; PHELPS CH, 1972, BRAIN RES, V39, P225, DOI 10.1016/0006-8993(72)90797-4; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; PIHLMAN K, 1983, HISTOCHEMISTRY, V79, P157, DOI 10.1007/BF00489778; POBLETE JC, 1995, BRAIN RES, V680, P9, DOI 10.1016/0006-8993(95)00201-Z; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; RAGOZZINO ME, 1995, NEUROSCIENCE, V68, P981, DOI 10.1016/0306-4522(95)00204-V; Ragozzino ME, 1998, J NEUROSCI, V18, P1595; Ragozzino ME, 1996, P NATL ACAD SCI USA, V93, P4693, DOI 10.1073/pnas.93.10.4693; REVEL JP, 1960, J BIOPHYS BIOCHEM CY, V8, P575, DOI 10.1083/jcb.8.3.575; RICHMAN C L, 1986, Current Psychological Research and Reviews, V5, P358, DOI 10.1007/BF02686603; Schousboe A, 2007, NEUROTOX RES, V12, P263, DOI 10.1007/BF03033909; Sickmann HM, 2009, J NEUROCHEM, V109, P80, DOI 10.1111/j.1471-4159.2009.05915.x; Sidman RL, 2008, J NEUROPATH EXP NEUR, V67, P803, DOI 10.1097/NEN.0b013e3181815994; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; SORG O, 1995, NEUROSCI LETT, V188, P109, DOI 10.1016/0304-3940(95)11410-X; Stefani MR, 2001, J NEUROSCI, V21, P609, DOI 10.1523/JNEUROSCI.21-02-00609.2001; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Talley CEP, 2000, NEUROBIOL LEARN MEM, V73, P79, DOI 10.1006/nlme.1999.3920; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; VERVERKEN D, 1982, J NEUROCHEM, V38, P1286, DOI 10.1111/j.1471-4159.1982.tb07903.x; Walls AB, 2009, NEUROSCIENCE, V158, P284, DOI 10.1016/j.neuroscience.2008.09.058; Walls AB, 2008, J NEUROCHEM, V105, P1462, DOI 10.1111/j.1471-4159.2008.05250.x; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	121	305	311	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28427	10.1371/journal.pone.0028427	http://dx.doi.org/10.1371/journal.pone.0028427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180782	Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300010
J	Yun, CH; Kim, JG; Park, BS; Lee, HM; Kim, DH; Kim, EO; Park, JJ; Park, JW; Damante, G; Kim, YI; Lee, BJ				Yun, Chang Ho; Kim, Jae Geun; Park, Byong Seo; Lee, Hye Myeong; Kim, Dong Hee; Kim, Eun Ok; Park, Joong Jean; Park, Jeong Woo; Damante, Giuseppe; Kim, Young Il; Lee, Byung Ju			TTF-1 Action on the Transcriptional Regulation of Cyclooxygenase-2 Gene in the Rat Brain	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; LPS-INDUCED FEVER; THYROGLOBULIN PROMOTER; PROTEIN EXPRESSION; FEBRILE RESPONSE; MESSENGER-RNA; GLIOMA-CELLS; FACTOR-I; SYNTHASE	We have recently found that thyroid transcription factor-1 (TTF-1), a homeodomain-containing transcription factor, is postnatally expressed in discrete areas of the hypothalamus and closely involved in neuroendocrine functions. We now report that transcription of cyclooxygenase-2 (COX-2), the rate limiting enzyme in prostaglandin biosynthesis, was inhibited by TTF-1. Double immunohistochemistry demonstrated that TTF-1 was expressed in the astrocytes and endothelial cells of blood vessel in the hypothalamus. Promoter assays and electrophoretic mobility shift assays showed that TTF-1 inhibited COX-2 transcription by binding to specific binding domains in the COX-2 promoter. Furthermore, blocking TTF-1 synthesis by intracerebroventricular injection of an antisense oligomer induced an increase of COX-2 synthesis in non-neuronal cells of the rat hypothalamus, and resulted in animals' hyperthermia. These results suggest that TTF-1 is physiologically involved in the control of thermogenesis by regulating COX-2 transcription in the brain.	[Yun, Chang Ho; Kim, Jae Geun; Park, Byong Seo; Lee, Hye Myeong; Kim, Dong Hee; Kim, Eun Ok; Park, Jeong Woo; Lee, Byung Ju] Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea; [Park, Jeong Woo] Korea Univ, Coll Med, Dept Physiol, Seoul 136705, South Korea; [Damante, Giuseppe] Univ Udine, Dept Biomed Sci & Technol, I-33100 Udine, Italy; [Kim, Young Il] Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea	University of Ulsan; Korea University; Korea University Medicine (KU Medicine); University of Udine; University of Ulsan; Ulsan University Hospital	Yun, CH (corresponding author), Univ Ulsan, Coll Nat Sci, Dept Biol Sci, Ulsan 680749, South Korea.	yikuls@uuh.ulsan.ac.kr; bjlee@ulsan.ac.kr	Damante, Giuseppe/AAC-5200-2022	Park, Joong-Jean/0000-0002-4534-3002; Damante, Giuseppe/0000-0003-2312-4009; Park, Byong Seo/0000-0001-6463-9645	NRF [KRF-2008-313-C00756]; MEST [2010-0009998]	NRF; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	BJL was supported by Mid-career Researcher Program through NRF grant funded by the MEST (2010-0009998). JGK was supported by the Basic Science Research Program through the NRF (KRF-2008-313-C00756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Boulant JA, 2000, CLIN INFECT DIS, V31, pS157, DOI 10.1086/317521; Cao CY, 1998, MOL BRAIN RES, V56, P45, DOI 10.1016/S0169-328X(98)00025-4; Cao CY, 1997, AM J PHYSIOL-REG I, V272, pR1712, DOI 10.1152/ajpregu.1997.272.6.R1712; CIVITAREALE D, 1989, EMBO J, V8, P2537, DOI 10.1002/j.1460-2075.1989.tb08391.x; Conti B, 2004, FRONT BIOSCI-LANDMRK, V9, P1433, DOI 10.2741/1341; Damante G, 1996, EMBO J, V15, P4992, DOI 10.1002/j.1460-2075.1996.tb00879.x; DEWITT DL, 1991, BIOCHIM BIOPHYS ACTA, V1083, P121, DOI 10.1016/0005-2760(91)90032-D; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; Inoue W, 2006, EUR J NEUROSCI, V24, P2233, DOI 10.1111/j.1460-9568.2006.05105.x; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kim JG, 2007, J BIOL CHEM, V282, P14923, DOI 10.1074/jbc.M701411200; Kim JG, 2011, DIABETES, V60, P710, DOI 10.2337/db10-0183; Kim MS, 2002, J BIOL CHEM, V277, P36863, DOI 10.1074/jbc.M206443200; Kimura S, 1996, TRENDS ENDOCRIN MET, V7, P247, DOI 10.1016/S1043-2760(96)00115-4; Kramer SG, 1999, DEVELOPMENT, V126, P191; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lee BJ, 2001, MOL CELL NEUROSCI, V17, P107, DOI 10.1006/mcne.2000.0933; Li S, 1999, BRAIN RES, V825, P86, DOI 10.1016/S0006-8993(99)01225-1; Lindstrom T, 2004, PROSTAG LEUKOTR ESS, V70, P115, DOI 10.1016/j.plefa.2003.04.003; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Magno L, 2009, BRAIN RES, V1304, P164, DOI 10.1016/j.brainres.2009.09.050; Matsumura K, 1998, J NEUROSCI, V18, P6279; Morrison SF, 2008, EXP PHYSIOL, V93, P773, DOI 10.1113/expphysiol.2007.041848; Nadjar A, 2005, J CEREBR BLOOD F MET, V25, P1047, DOI 10.1038/sj.jcbfm.9600106; Ohmori M, 1999, ENDOCRINOLOGY, V140, P4651, DOI 10.1210/en.140.10.4651; Otey CA, 2003, METHOD CELL BIOL, V71, P287, DOI 10.1016/S0091-679X(03)01013-6; Pellizzari L, 1999, BIOCHEM J, V337, P253, DOI 10.1042/0264-6021:3370253; Ray MK, 1996, MOL CELL BIOL, V16, P2056; ROSER K, 1991, EXP CELL RES, V197, P200, DOI 10.1016/0014-4827(91)90423-R; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Scammell TE, 1996, J NEUROSCI, V16, P6246; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Son YJ, 2003, J BIOL CHEM, V278, P27043, DOI 10.1074/jbc.M303157200; Steiner AA, 2005, AM J PHYSIOL-REG I, V289, pR1253, DOI 10.1152/ajpregu.00371.2005; Steiner AA, 2001, NEUROIMMUNOMODULAT, V9, P263, DOI 10.1159/000054289; Trentin AG, 1998, BRAZ J MED BIOL RES, V31, P1281, DOI 10.1590/S0100-879X1998001000008; Tzeng Shun-Fen, 2005, Current Drug Targets - Inflammation and Allergy, V4, P335, DOI 10.2174/1568010054022051; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wisse BE, 2004, AM J PHYSIOL-ENDOC M, V287, pE1107, DOI 10.1152/ajpendo.00038.2004; XIE WL, 1991, P NATL ACAD SCI USA, V88, P2692, DOI 10.1073/pnas.88.7.2692	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28959	10.1371/journal.pone.0028959	http://dx.doi.org/10.1371/journal.pone.0028959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174936	Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300036
J	Barthelson, R; McFarlin, AJ; Rounsley, SD; Young, S				Barthelson, Roger; McFarlin, Adam J.; Rounsley, Steven D.; Young, Sarah			Plantagora: Modeling Whole Genome Sequencing and Assembly of Plant Genomes	PLOS ONE			English	Article							ARABIDOPSIS GENOME; CHALLENGES	Background: Genomics studies are being revolutionized by the next generation sequencing technologies, which have made whole genome sequencing much more accessible to the average researcher. Whole genome sequencing with the new technologies is a developing art that, despite the large volumes of data that can be produced, may still fail to provide a clear and thorough map of a genome. The Plantagora project was conceived to address specifically the gap between having the technical tools for genome sequencing and knowing precisely the best way to use them. Methodology/Principal Findings: For Plantagora, a platform was created for generating simulated reads from several different plant genomes of different sizes. The resulting read files mimicked either 454 or Illumina reads, with varying paired end spacing. Thousands of datasets of reads were created, most derived from our primary model genome, rice chromosome one. All reads were assembled with different software assemblers, including Newbler, Abyss, and SOAPdenovo, and the resulting assemblies were evaluated by an extensive battery of metrics chosen for these studies. The metrics included both statistics of the assembly sequences and fidelity-related measures derived by alignment of the assemblies to the original genome source for the reads. The results were presented in a website, which includes a data graphing tool, all created to help the user compare rapidly the feasibility and effectiveness of different sequencing and assembly strategies prior to testing an approach in the lab. Some of our own conclusions regarding the different strategies were also recorded on the website. Conclusions/Significance: Plantagora provides a substantial body of information for comparing different approaches to sequencing a plant genome, and some conclusions regarding some of the specific approaches. Plantagora also provides a platform of metrics and tools for studying the process of sequencing and assembly further.	[Barthelson, Roger; Rounsley, Steven D.] Univ Arizona, Inst BiO5, Tucson, AZ 85721 USA; [McFarlin, Adam J.] Apple Inc, Cupertino, CA USA; [Rounsley, Steven D.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Young, Sarah] Broad Inst, Cambridge, MA USA	University of Arizona; Apple Inc; University of Arizona; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Barthelson, R (corresponding author), Univ Arizona, Inst BiO5, Tucson, AZ 85721 USA.	rogerab@email.arizona.edu			National Science Foundation (NSF) [0930455]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) EAGER Grant: Plantagora: A Plant Genome Assembly Simulation Platform, 0930455, Steven Rounsley, PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan M, 2001, CURR OPIN PLANT BIOL, V4, P105, DOI 10.1016/S1369-5266(00)00144-8; Devos KM, 2005, P NATL ACAD SCI USA, V102, P19243, DOI 10.1073/pnas.0509473102; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hossain MS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S16; Imelfort M, 2009, BRIEF BIOINFORM, V10, P609, DOI 10.1093/bib/bbp039; Kurtz S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-517; LANDER E S, 1988, Genomics, V2, P231; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Pop M, 2009, BRIEF BIOINFORM, V10, P354, DOI 10.1093/bib/bbp026; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Sappl PG, 2004, PHYTOCHEMISTRY, V65, P1517, DOI 10.1016/j.phytochem.2004.04.021; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Settles AM, 1998, GENOME RES, V8, P83, DOI 10.1101/gr.8.2.83; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	18	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28436	10.1371/journal.pone.0028436	http://dx.doi.org/10.1371/journal.pone.0028436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174807	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600017
J	Coffa, S; Breitman, M; Hanson, SM; Callaway, K; Kook, S; Dalby, KN; Gurevich, VV				Coffa, Sergio; Breitman, Maya; Hanson, Susan M.; Callaway, Kari; Kook, Seunghyi; Dalby, Kevin N.; Gurevich, Vsevolod V.			The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SIGNAL-REGULATED KINASES; CRYSTAL-STRUCTURE; VISUAL ARRESTIN; BETA-ARRESTIN; METARHODOPSIN-II; TERNARY COMPLEX; 48-KDA PROTEIN; CONE ARRESTIN; BINDING	Arrestins are multifunctional signaling adaptors originally discovered as proteins that "arrest" G protein activation by G protein-coupled receptors (GPCRs). Recently GPCR complexes with arrestins have been proposed to activate G protein-independent signaling pathways. In particular, arrestin-dependent activation of extracellular signal-regulated kinase 1/2 (ERK1/2) has been demonstrated. Here we have performed in vitro binding assays with pure proteins to demonstrate for the first time that ERK2 directly binds free arrestin-2 and -3, as well as receptor-associated arrestins-1, -2, and -3. In addition, we showed that in COS-7 cells arrestin-2 and -3 association with beta(2)-adrenergic receptor (beta 2AR) significantly enhanced ERK2 binding, but showed little effect on arrestin interactions with the upstream kinases c-Raf1 and MEK1. Arrestins exist in three conformational states: free, receptor-bound, and microtubule-associated. Using conformationally biased arrestin mutants we found that ERK2 preferentially binds two of these: the "constitutively inactive" arrestin-Delta 7 mimicking microtubule-bound state and arrestin-3A, a mimic of the receptor-bound conformation. Both rescue arrestin-mediated ERK1/2/activation in arrestin-2/3 double knockout fibroblasts. We also found that arrestin-2-c-Raf1 interaction is enhanced by receptor binding, whereas arrestin-3-c-Raf1 interaction is not.	[Coffa, Sergio; Breitman, Maya; Hanson, Susan M.; Kook, Seunghyi; Gurevich, Vsevolod V.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA; [Callaway, Kari; Dalby, Kevin N.] Univ Texas Austin, Div Med Chem, Austin, TX 78712 USA	Vanderbilt University; University of Texas System; University of Texas Austin	Coffa, S (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37203 USA.	vsevolod.gurevich@vanderbilt.edu	Gurevich, Vsevolod/A-3236-2008; Dalby, Kevin N/A-1905-2013	Gurevich, Vsevolod/0000-0002-3950-5351; Dalby, Kevin N/0000-0001-9272-5129	National Institutes of Health [GM081756, GM077561, EY011500, GM059802]; Welch Foundation [F-1390]; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM059802, R01GM081756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by National Institutes of Health grants GM081756, GM077561, and EY011500 (VVG), and GM059802 and the Welch Foundation (F-1390) (KND). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2011, BIOCHEMISTRY-US, V50, P3749, DOI 10.1021/bi200175q; Ahn S, 2004, J BIOL CHEM, V279, P7807, DOI 10.1074/jbc.C300443200; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Dinculescu A, 2002, J BIOL CHEM, V277, P11703, DOI 10.1074/jbc.M111833200; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich V. V., 2008, V186, P15, DOI 10.1007/978-3-540-72843-6_2; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Gurevich VV, 1998, J BIOL CHEM, V273, P15501, DOI 10.1074/jbc.273.25.15501; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, J BIOL CHEM, V281, P9765, DOI 10.1074/jbc.M510738200; Hanson SM, 2006, J BIOL CHEM, V281, P3458, DOI 10.1074/jbc.M512148200; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, EMBO J, V26, P1726, DOI 10.1038/sj.emboj.7601614; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pulvermuller A, 2000, J BIOL CHEM, V275, P37679, DOI 10.1074/jbc.M006776200; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Song X, 2007, J NEUROCHEM, V103, P1053, DOI 10.1111/j.1471-4159.2007.04842.x; Song X, 2009, CURR BIOL, V19, P700, DOI 10.1016/j.cub.2009.02.065; Song XF, 2009, J BIOL CHEM, V284, P685, DOI 10.1074/jbc.M806124200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Waas WF, 2003, BIOCHEMISTRY-US, V42, P12273, DOI 10.1021/bi0348617; WILDEN U, 1995, BIOCHEMISTRY-US, V34, P1446, DOI 10.1021/bi00004a040; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; ZHAN X, 2011, BIOCHEMISTR IN PRESS, V50; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034	60	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28723	10.1371/journal.pone.0028723	http://dx.doi.org/10.1371/journal.pone.0028723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174878	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600032
J	Rajasekharan, A; Gummadi, SN				Rajasekharan, Archita; Gummadi, Sathyanarayana N.			Flip-Flop of Phospholipids in Proteoliposomes Reconstituted from Detergent Extract of Chloroplast Membranes: Kinetics and Phospholipid Specificity	PLOS ONE			English	Article							TRANSBILAYER MOVEMENT; ENDOPLASMIC-RETICULUM; LIPID TRAFFICKING; LABELED PHOSPHOLIPIDS; CHEMICAL-MODIFICATION; ERYTHROCYTE-MEMBRANE; PROTEIN; BIOSYNTHESIS; MECHANISMS	Eukaryotic cells are compartmentalized into distinct sub-cellular organelles by lipid bilayers, which are known to be involved in numerous cellular processes. The wide repertoire of lipids, synthesized in the biogenic membranes like the endoplasmic reticulum and bacterial cytoplasmic membranes are initially localized in the cytosolic leaflet and some of these lipids have to be translocated to the exoplasmic leaflet for membrane biogenesis and uniform growth. It is known that phospholipid (PL) translocation in biogenic membranes is mediated by specific membrane proteins which occur in a rapid, bi-directional fashion without metabolic energy requirement and with no specificity to PL head group. A recent study reported the existence of biogenic membrane flippases in plants and that the mechanism of plant membrane biogenesis was similar to that found in animals. In this study, we demonstrate for the first time ATP independent and ATP dependent flippase activity in chloroplast membranes of plants. For this, we generated proteoliposomes from Triton X-100 extract of intact chloroplast, envelope membrane and thylakoid isolated from spinach leaves and assayed for flippase activity using fluorescent labeled phospholipids. Half-life time of flipping was found to be 6 +/- 1 min. We also show that: (a) intact chloroplast and envelope membrane reconstituted proteoliposomes can flip fluorescent labeled analogs of phosphatidylcholine in ATP independent manner, (b) envelope membrane and thylakoid reconstituted proteoliposomes can flip phosphatidylglycerol in ATP dependent manner, (c) Biogenic membrane ATP independent PC flipping activity is protein mediated and (d) the kinetics of PC translocation gets affected differently upon treatment with protease and protein modifying reagents.	[Rajasekharan, Archita; Gummadi, Sathyanarayana N.] Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Rajasekharan, A (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	gummadi@iitm.ac.in	Gummadi, Sathyanarayana/W-5354-2019; Gummadi, Sathyanarayana Naidu/K-2303-2019	Gummadi, Sathyanarayana Naidu/0000-0003-0707-5710	Department of Biotechnology, Government of India, New Delhi	Department of Biotechnology, Government of India, New Delhi(Department of Biotechnology (DBT) India)	This work was supported by a research grant from Department of Biotechnology, Government of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS J, 1983, PLANT PHYSIOL, V72, P735, DOI 10.1104/pp.72.3.735; Awai K, 2006, BIOCHEM SOC T, V34, P395, DOI 10.1042/BST0340395; BACKER JM, 1987, NATURE, V327, P341, DOI 10.1038/327341a0; Barr SC, 2003, J PARASITOL, V89, P385, DOI 10.1645/0022-3395(2003)089[0385:COASPA]2.0.CO;2; Basse F, 1996, J BIOL CHEM, V271, P17205, DOI 10.1074/jbc.271.29.17205; BELL RM, 1981, J LIPID RES, V22, P391; Benning C, 2006, CURR OPIN PLANT BIOL, V9, P241, DOI 10.1016/j.pbi.2006.03.012; Benning C, 2008, PROG LIPID RES, V47, P381, DOI 10.1016/j.plipres.2008.04.001; Benning C, 2009, ANNU REV CELL DEV BI, V25, P71, DOI 10.1146/annurev.cellbio.042308.113414; BISHOP WR, 1985, CELL, V42, P51, DOI 10.1016/S0092-8674(85)80100-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Buton X, 1996, J BIOL CHEM, V271, P6651, DOI 10.1074/jbc.271.12.6651; Chang QL, 2004, BIOCHEMISTRY-US, V43, P10710, DOI 10.1021/bi049063a; DIETRICH WE, 2003, ABLEWEB, V24, P131; DORNE AJ, 1990, P NATL ACAD SCI USA, V87, P71, DOI 10.1073/pnas.87.1.71; DORNE AM, 1985, MOL GEN GENET, V198, P521, DOI 10.1007/BF00332950; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Fadeel B, 2009, CRIT REV BIOCHEM MOL, V44, P264, DOI 10.1080/10409230903193307; Follmer C, 2005, ARCH BIOCHEM BIOPHYS, V435, P15, DOI 10.1016/j.abb.2004.12.001; Gummadi SN, 2005, CELL MOL BIOL LETT, V10, P101; Gummadi SN, 2002, J BIOL CHEM, V277, P25337, DOI 10.1074/jbc.M203809200; Hartel H, 2000, P NATL ACAD SCI USA, V97, P10649, DOI 10.1073/pnas.180320497; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Hrafnsdottir S, 2000, J BACTERIOL, V182, P4198, DOI 10.1128/JB.182.15.4198-4206.2000; Hrafnsdottir S, 1997, BIOCHEMISTRY-US, V36, P4969, DOI 10.1021/bi962513h; Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3; KAGAWA T, 1973, PLANT PHYSIOL, V51, P61, DOI 10.1104/pp.51.1.61; KAPLAN RS, 1989, METHOD ENZYMOL, V172, P393; KENNETH K, 1982, PLANT PHYSIOL, V70, P232; Kol MA, 2004, BIOCHEMISTRY-US, V43, P2673, DOI 10.1021/bi036200f; Kubelt J, 2002, BIOCHEMISTRY-US, V41, P5605, DOI 10.1021/bi0118714; Lakowicz J.R., 2006, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; Lang EGE, 2011, PLANT CELL REP, V30, P205, DOI 10.1007/s00299-010-0935-4; LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7; MENON A, 1995, TRENDS CELL BIOL, V5, P355, DOI 10.1016/S0962-8924(00)89069-8; Menon AK, 2000, CURR BIOL, V10, P241, DOI 10.1016/S0960-9822(00)00356-0; Miyagishima S, 1999, PLANTA, V209, P371, DOI 10.1007/s004250050645; Moreau P, 1998, PROG LIPID RES, V37, P371, DOI 10.1016/S0163-7827(98)00016-2; MORKIN E, 1979, J BIOL CHEM, V254, P2647; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; RIGAUD JL, 1988, BIOCHEMISTRY-US, V27, P2677, DOI 10.1021/bi00408a007; ROCHA V, 1970, ARCH BIOCHEM BIOPHYS, V140, P398, DOI 10.1016/0003-9861(70)90081-0; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; ROUGHAN G, 1984, TRENDS BIOCHEM SCI, V9, P383, DOI 10.1016/0968-0004(84)90220-2; Sahu SK, 2008, BIOCHEMISTRY-US, V47, P10481, DOI 10.1021/bi8014339; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; SEIGNEURET M, 1984, P NATL ACAD SCI-BIOL, V81, P3751, DOI 10.1073/pnas.81.12.3751; VANDOR SL, 1968, CAN J BIOCHEM CELL B, V46, P1309, DOI 10.1139/o68-196; Vehring S, 2007, EUKARYOT CELL, V6, P1625, DOI 10.1128/EC.00198-07	51	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28401	10.1371/journal.pone.0028401	http://dx.doi.org/10.1371/journal.pone.0028401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174798	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600014
J	Addis, RC; Hsu, FC; Wright, RL; Dichter, MA; Coulter, DA; Gearhart, JD				Addis, Russell C.; Hsu, Fu-Chun; Wright, Rebecca L.; Dichter, Marc A.; Coulter, Douglas A.; Gearhart, John D.			Efficient Conversion of Astrocytes to Functional Midbrain Dopaminergic Neurons Using a Single Polycistronic Vector	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; SUBSTANTIA-NIGRA; FIRING PATTERN; IN-VIVO; MOUSE; TRANSPLANTATION	Direct cellular reprogramming is a powerful new tool for regenerative medicine. In efforts to understand and treat Parkinson's Disease (PD), which is marked by the degeneration of dopaminergic neurons in the midbrain, direct reprogramming provides a valuable new source of these cells. Astrocytes, the most plentiful cells in the central nervous system, are an ideal starting population for the direct generation of dopaminergic neurons. In addition to their potential utility in cell replacement therapies for PD or in modeling the disease in vitro, astrocyte-derived dopaminergic neurons offer the prospect of direct in vivo reprogramming within the brain. As a first step toward this goal, we report the reprogramming of astrocytes to dopaminergic neurons using three transcription factors - ASCL1, LMX1B, and NURR1 - delivered in a single polycistronic lentiviral vector. The process is efficient, with 18.261.5% of cells expressing markers of dopaminergic neurons after two weeks. The neurons exhibit expression profiles and electrophysiological characteristics consistent with midbrain dopaminergic neurons, notably including spontaneous pacemaking activity, stimulated release of dopamine, and calcium oscillations. The present study is the first demonstration that a single vector can mediate reprogramming to dopaminergic neurons, and indicates that astrocytes are an ideal starting population for the direct generation of dopaminergic neurons.	[Addis, Russell C.; Wright, Rebecca L.; Gearhart, John D.] Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Addis, Russell C.; Wright, Rebecca L.; Gearhart, John D.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Dichter, Marc A.; Coulter, Douglas A.] Univ Penn, Sch Med, Mahoney Inst Neurol Sci, Philadelphia, PA 19104 USA; [Dichter, Marc A.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Coulter, Douglas A.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; [Hsu, Fu-Chun; Coulter, Douglas A.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Addis, RC (corresponding author), Univ Penn, Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA.	raddis@mail.med.upenn.edu		Coulter, Douglas/0000-0002-1486-119X	University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Health Research Formula Fund	University of Pennsylvania Institute for Regenerative Medicine; Pennsylvania Health Research Formula Fund	This work was funded by the University of Pennsylvania Institute for Regenerative Medicine and the Pennsylvania Health Research Formula Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Arenas E, 2010, BIOCHEM BIOPH RES CO, V396, P152, DOI 10.1016/j.bbrc.2010.04.037; Berninger B, 2007, J NEUROSCI, V27, P8654, DOI 10.1523/JNEUROSCI.1615-07.2007; Berninger B, 2010, NEUROPHARMACOLOGY, V58, P894, DOI 10.1016/j.neuropharm.2009.11.004; Burbach JPH, 2003, ANN NY ACAD SCI, V991, P61; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1980, SCIENCE, V210, P654, DOI 10.1126/science.7433992; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hagell P, 2001, J NEUROPATH EXP NEUR, V60, P741, DOI 10.1093/jnen/60.8.741; Heinrich C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000373; Kim J, 2011, CELL STEM CELL, V9, P413, DOI 10.1016/j.stem.2011.09.011; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Putzier I, 2009, J NEUROSCI, V29, P15414, DOI 10.1523/JNEUROSCI.4742-09.2009; Sasai Yoshiki, 2002, Journal of Neurology, V249, P41; Simon HH, 2003, ANN NY ACAD SCI, V991, P36; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Tian CH, 2011, PROTEIN CELL, V2, P128, DOI 10.1007/s13238-011-1012-7; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wakeman DR, 2011, MT SINAI J MED, V78, P126, DOI 10.1002/msj.20233; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yasumoto F, 2004, CELL MOL NEUROBIOL, V24, P51, DOI 10.1023/B:CEMN.0000012724.79184.b6	39	108	114	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28719	10.1371/journal.pone.0028719	http://dx.doi.org/10.1371/journal.pone.0028719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174877	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700066
J	Han, YX; Wu, JB; Bi, LX; Xiong, SD; Gao, SM; Yin, LH; Jiang, L; Chen, CQ; Yu, K; Zhang, SH				Han, Yixiang; Wu, Jianbo; Bi, Laixi; Xiong, Shudao; Gao, Shenmeng; Yin, Lihui; Jiang, Lei; Chen, Chiqi; Yu, Kang; Zhang, Shenghui			Malignant B Cells Induce the Conversion of CD4(+)CD25(-) T Cells to Regulatory T Cells in B-Cell Non-Hodgkin Lymphoma	PLOS ONE			English	Article							FOLLICULAR LYMPHOMA; HEPATOCELLULAR-CARCINOMA; MEDIATED SUPPRESSION; FOXP3 EXPRESSION; HIGH NUMBERS; SURVIVAL; POPULATION; PROGNOSIS; LEUKEMIA; IMMUNITY	Recent evidence has demonstrated that regulatory T cells (Treg) were enriched in the tumor sites of patients with B-cell non-Hodgkin lymphoma (NHL). However, the causes of enrichment and suppressive mechanisms need to be further elucidated. Here we demonstrated that CD4(+)CD25(+)FoxP3(+)CD127(lo) Treg were markedly increased and their phenotypes were different in peripheral blood (PB) as well as bone marrow (BM) from newly diagnosed patients with B-cell NHL compared with those from healthy volunteers (HVs). Involved lymphatic tissues also showed higher frequencies of Treg than benign lymph nodes. Moreover, the frequencies of Treg were significantly higher in involved lymphatic tissues than those from PB as well as BM in the same patients. Suppression mediated by CD4(+)CD25(+) Treg co-cultured with allogeneic CFSE-labeled CD4(+)CD25(-) responder cells was also higher in involved lymphatic tissues from B-cell NHL than that mediated by Treg from HVs. In addition, we found that malignant B cells significantly induced FoxP3 expression and regulatory function in CD4(+)CD25(-) T cells in vitro. In contrast, normal B cells could not induce the conversion of CD4(+)CD25(-) T cells to Treg. We also showed that the PD-1/B7-H1 pathway might play an important role in Treg induction. Taken together, our results suggest that malignant B cells induce the conversion of CD4(+)CD25(-) T cells to Treg, which may play a role in the pathogenesis of B-cell NHL and represent a promising therapeutic target.	[Han, Yixiang; Wu, Jianbo; Gao, Shenmeng; Yin, Lihui; Jiang, Lei; Chen, Chiqi; Zhang, Shenghui] Wenzhou Med Coll, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Peoples R China; [Bi, Laixi; Yu, Kang] Wenzhou Med Coll, Affiliated Hosp 1, Dept Hematol, Wenzhou, Peoples R China; [Xiong, Shudao] Anhui Med Univ, Hosp 2, Dept Hematol Oncol, Hefei, Peoples R China; [Zhang, Shenghui] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Zhang, Shenghui] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Anhui Medical University; Fudan University; Fudan University	Han, YX (corresponding author), Wenzhou Med Coll, Affiliated Hosp 1, Lab Internal Med, Wenzhou, Peoples R China.	shenghuizhang1@126.com	Zhang, Shenghui/AAI-7388-2021		National Natural Science of Foundation of China [81100355]; Administration of Traditional Chinese Medicine of Zhejiang Province, China [2010ZQ008]	National Natural Science of Foundation of China(National Natural Science Foundation of China (NSFC)); Administration of Traditional Chinese Medicine of Zhejiang Province, China	This work was supported by National Natural Science of Foundation of China (no. 81100355) and Administration of Traditional Chinese Medicine of Zhejiang Province, China (no. 2010ZQ008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2008, BLOOD, V112, P4953, DOI 10.1182/blood-2008-06-163048; Ai WZ, 2009, INT J CANCER, V124, P239, DOI 10.1002/ijc.23881; Burger JA, 2009, BLOOD, V114, P3367, DOI 10.1182/blood-2009-06-225326; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; Coe D, 2010, CANCER IMMUNOL IMMUN, V59, P1367, DOI 10.1007/s00262-010-0866-5; Curran MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019499; de Lafaille MAC, 2002, CURR OPIN IMMUNOL, V14, P771; Finney OC, 2010, EUR J IMMUNOL, V40, P47, DOI 10.1002/eji.200939708; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Franceschini D, 2009, J CLIN INVEST, V119, P551, DOI 10.1172/JCI36604; Frimpong-Boateng K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012281; Hirano F, 2005, CANCER RES, V65, P1089; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jak M, 2009, LEUKEMIA LYMPHOMA, V50, P788, DOI 10.1080/10428190902803677; Ju SW, 2009, CELL CYCLE, V8, P2578, DOI 10.4161/cc.8.16.9302; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Li X, 2007, CANCER LETT, V253, P144, DOI 10.1016/j.canlet.2007.01.024; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Mittal S, 2008, BLOOD, V111, P5359, DOI 10.1182/blood-2007-08-105395; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Pang YL, 2009, CANCER IMMUNOL IMMUN, V58, P877, DOI 10.1007/s00262-008-0603-5; Piccirillo CA, 2004, SEMIN IMMUNOL, V16, P81, DOI 10.1016/j.smim.2003.12.003; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Suarez N, 2011, INT J CANCER, V129, P374, DOI 10.1002/ijc.25681; Takata Y, 2011, CANCER LETT, V307, P165, DOI 10.1016/j.canlet.2011.03.029; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trzonkowski P, 2004, CLIN IMMUNOL, V112, P258, DOI 10.1016/j.clim.2004.04.003; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu L, 2010, CLIN IMMUNOL, V135, P466, DOI 10.1016/j.clim.2010.01.014; Yang ZZ, 2007, BLOOD, V110, P2537, DOI 10.1182/blood-2007-03-082578; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Yu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022450; Yuan XL, 2011, WORLD J GASTROENTERO, V17, P2019, DOI 10.3748/wjg.v17.i15.2019; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zhang SH, 2011, INT J CANCER, V129, P1373, DOI 10.1002/ijc.25791; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	41	2	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28649	10.1371/journal.pone.0028649	http://dx.doi.org/10.1371/journal.pone.0028649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174855	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700055
J	Kang, MJ; Yu, H; Kim, SK; Park, SR; Yang, I				Kang, Min-Jung; Yu, Hannah; Kim, Sook-Kyung; Park, Sang-Ryoul; Yang, Inchul			Quantification of Trace-Level DNA by Real-Time Whole Genome Amplification	PLOS ONE			English	Article							HOST-CELL DNA; QUANTITATION; ASSAY; PCR; PROTEINS	Quantification of trace amounts of DNA is a challenge in analytical applications where the concentration of a target DNA is very low or only limited amounts of samples are available for analysis. PCR-based methods including real-time PCR are highly sensitive and widely used for quantification of low-level DNA samples. However, ordinary PCR methods require at least one copy of a specific gene sequence for amplification and may not work for a sub-genomic amount of DNA. We suggest a real-time whole genome amplification method adopting the degenerate oligonucleotide primed PCR (DOP-PCR) for quantification of sub-genomic amounts of DNA. This approach enabled quantification of sub-picogram amounts of DNA independently of their sequences. When the method was applied to the human placental DNA of which amount was accurately determined by inductively coupled plasma-optical emission spectroscopy (ICP-OES), an accurate and stable quantification capability for DNA samples ranging from 80 fg to 8 ng was obtained. In blind tests of laboratory-prepared DNA samples, measurement accuracies of 7.4%, -2.1%, and -13.9% with analytical precisions around 15% were achieved for 400-pg, 4-pg, and 400-fg DNA samples, respectively. A similar quantification capability was also observed for other DNA species from calf, E. coli, and lambda phage. Therefore, when provided with an appropriate standard DNA, the suggested real-time DOP-PCR method can be used as a universal method for quantification of trace amounts of DNA.	[Kang, Min-Jung; Kim, Sook-Kyung; Park, Sang-Ryoul; Yang, Inchul] Korea Res Inst Stand & Sci, Ctr Bioanal, Taejon, South Korea; [Yu, Hannah] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon, South Korea	Korea Research Institute of Standards & Science (KRISS)	Kang, MJ (corresponding author), Korea Res Inst Stand & Sci, Ctr Bioanal, Taejon, South Korea.	icy@kriss.re.kr	Yu, Hannah/AAH-6002-2021		Korea Research Institute of Standards and Science	Korea Research Institute of Standards and Science	This work was supported by the Basic Research Projects of Korea Research Institute of Standards and Science, "Development of Protein Measurement Standards". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIGGS J, 1991, ANAL CHEM, V63, P850, DOI 10.1021/ac00009a003; Cikos S, 2009, ANAL BIOCHEM, V384, P1, DOI 10.1016/j.ab.2008.08.031; Desjardins P., 2010, J VIS EXP, V45, P2565; DIPAOLO B, 1999, PHARM TECHNOLOGY HIG; DNA Advisory Board, 2000, FORENSIC SCI COMMUN, V2; *EU, 2001, CPMPBWP114300; Gallagher S. R., 2001, CURRENT PROTOCOLS MO; Holden MJ, 2009, J AGR FOOD CHEM, V57, P7221, DOI 10.1021/jf901165h; Ikeda Y, 2009, J PHARMACEUT BIOMED, V49, P997, DOI 10.1016/j.jpba.2009.01.022; KASS DH, 1995, ANAL BIOCHEM, V228, P185, DOI 10.1006/abio.1995.1338; Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9; KUNG VT, 1990, ANAL BIOCHEM, V187, P220, DOI 10.1016/0003-2697(90)90447-H; KURKELA S, 2009, J AM SOC MASS SPECTR, V37, P535; KURODA S, 1988, BIOCHEM BIOPH RES CO, V152, P9, DOI 10.1016/S0006-291X(88)80672-7; Lovatt Archie, 2002, J Biotechnol, V82, P279; Nicklas JA, 2003, ANAL BIOANAL CHEM, V376, P1160, DOI 10.1007/s00216-003-1924-z; Nissom PM, 2007, BIOLOGICALS, V35, P211, DOI 10.1016/j.biologicals.2006.09.001; Pharmaceuticals and Medical Devices Agency, 2018, POINTS CONSIDER ENSU; Rathore AS, 2003, J PHARMACEUT BIOMED, V32, P1199, DOI 10.1016/S0731-7085(03)00157-2; Schroeder KL, 2006, PHYTOPATHOLOGY, V96, P637, DOI 10.1094/PHYTO-96-0637; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Timken MD, 2005, J FORENSIC SCI, V50, P1044; Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2; WOLTER T, 2005, BIO PROCESS INT, V2, P2; Yang I, 2004, ANAL BIOCHEM, V335, P150, DOI 10.1016/j.ab.2004.08.038	26	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28661	10.1371/journal.pone.0028661	http://dx.doi.org/10.1371/journal.pone.0028661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174862	gold, Green Submitted, Green Published			2022-12-27	WOS:000298365700058
J	Kim, KS; Kim, YS; Han, I; Kim, MH; Jung, MH; Park, HK				Kim, Kyung Sook; Kim, Young-Sun; Han, Ihn; Kim, Mi-Hyun; Jung, Min Hyung; Park, Hun-Kuk			Quantitative and Qualitative Analyses of the Cell Death Process in Candida albicans Treated by Antifungal Agents	PLOS ONE			English	Article								The death process of Candida albicans was investigated after treatment with the antifungal agents flucytosine and amphotericin B by assessing morphological and biophysical properties associated with cell death. C. albicans was treated varying time periods (from 6 to 48 hours) and examined by scanning electron microscopy (SEM) and atomic force microscopy (AFM). SEM and AFM images clearly showed changes in morphology and biophysical properties. After drug treatment, the membrane of C. albicans was perforated, deformed, and shrunken. Compared to the control, C. albicans treated with flucytosine was softer and initially showed a greater adhesive force. Conversely, C. albicans treated with amphotericin B was harder and had a lower adhesive force. In both cases, the surface roughness increased as the treatment time increased. The relationships between morphological changes and the drugs were observed by AFM clearly; the surface of C. albicans treated with flucytosine underwent membrane collapse, expansion of holes, and shrinkage, while the membranes of cells treated with amphotericin B peeled off. According to these observations, the death process of C. albicans was divided into 4 phases, CDP0, CDP1, CDP2, and CDP4, which were determined based on morphological changes. Our results could be employed to further investigate the antifungal activity of compounds derived from natural sources.	[Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea; [Kim, Kyung Sook; Kim, Mi-Hyun; Park, Hun-Kuk] Kyung Hee Univ, Healthcare Ind Res Inst, Seoul, South Korea; [Kim, Young-Sun; Jung, Min Hyung] Kyung Hee Univ, Dept Obstet & Gynecol, Sch Med, Kyung Hee Univ Hosp, Seoul, South Korea; [Han, Ihn] Kyung Hee Univ, Coll Oriental Med, Seoul, South Korea; [Park, Hun-Kuk] Kyung Hee Univ, Program Med Engn, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University	Kim, KS (corresponding author), Kyung Hee Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	webhospital@naver.com; sigmoidus@khu.ac.kr	Kim, Youngsun/AAY-5946-2021; Han, Ihn/ABH-6275-2020	Kim, Youngsun/0000-0002-1725-0968; Han, Ihn/0000-0002-1372-7319	Kyung Hee University [KHU-20110093]; Seoul Research and Business Development program [CR070054]	Kyung Hee University; Seoul Research and Business Development program(Seoul RBD program)	This study was supported by a grant from Kyung Hee University in 2011 (KHU-20110093) and the Seoul Research and Business Development program (Grant No. CR070054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIREZA K, 2009, MYCOPATHOLOGIA, V169, P287; AMIT KT, 2010, TYAGI MALIK BMC COMP, V10, P1; AMIT KT, 2010, MICRON, V41, P797; ANTONIO MV, 2001, SURF INTERFACE ANAL, V31, P1027; Brito GNB, 2011, BRAZ ORAL RES, V25, P28, DOI 10.1590/S1806-83242011005000001; Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Bhushan B, 2000, J APPL PHYS, V87, P1201, DOI 10.1063/1.371998; Boonaert CJP, 2000, SURF INTERFACE ANAL, V30, P32, DOI 10.1002/1096-9918(200008)30:1<32::AID-SIA774>3.3.CO;2-P; ELISABETTA C, 2006, FEMS MICROBIOL LETT, V255, P308; GRUNDNER M, 1986, APPL PHYS A-MATER, V39, P73, DOI 10.1007/BF00616822; JOCHEN G, 2005, BIOPHYS J, V88, P3689; KENNEDY MJ, 1985, INFECT IMMUN, V49, P654, DOI 10.1128/IAI.49.3.654-663.1985; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Lee Jeong Ah, 2010, Mycobiology, V38, P328, DOI 10.4489/MYCO.2010.38.4.328; MARUZZELLA JC, 1958, J AM PHARM ASSOC, V47, P250, DOI 10.1002/jps.3030470407; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Vermes A, 2000, J ANTIMICROB CHEMOTH, V46, P171, DOI 10.1093/jac/46.2.171; Volle CB, 2008, LANGMUIR, V24, P8102, DOI 10.1021/la8009354; WILBUR AL, 2007, BLOOD, V109, P3505; Zakaria Z, 2011, ASIAN PACIFIC J TROP, V1, P20; Zhang JD, 2006, J ETHNOPHARMACOL, V103, P76, DOI 10.1016/j.jep.2005.07.006	21	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28176	10.1371/journal.pone.0028176	http://dx.doi.org/10.1371/journal.pone.0028176			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174777	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700021
J	Li, HQ; Xu, J; Bian, YH; Rotllant, P; Shen, TS; Chu, WY; Zhang, JS; Schneider, M; Du, SJ				Li, Huiqing; Xu, Jin; Bian, Yue-Hong; Rotllant, Pep; Shen, Tiansheng; Chu, Wuying; Zhang, Jianshe; Schneider, Martin; Du, Shao Jun			Smyd1b_tv1, a Key Regulator of Sarcomere Assembly, Is Localized on the M-Line of Skeletal Muscle Fibers	PLOS ONE			English	Article							PROTEIN; GENE; BOP; HSP90A; PHOSPHORYLATION; METHYLATION; EXPRESSION; INTERACTS; SEQUENCE; ENCODES	Background: Smyd1b is a member of the Smyd family that plays a key role in sarcomere assembly during myofibrillogenesis. Smyd1b encodes two alternatively spliced isoforms, smyd1b_tv1 and smyd1b_tv2, that are expressed in skeletal and cardiac muscles and play a vital role in myofibrillogenesis in skeletal muscles of zebrafish embryos. Methodology/Principal Findings: To better understand Smyd1b function in myofibrillogenesis, we analyzed the subcellular localization of Smyd1b_tv1 and Smyd1b_tv2 in transgenic zebrafish expressing a myc-tagged Smyd1b_tv1 or Smyd1b_tv2. The results showed a dynamic change of their subcellular localization during muscle cell differentiation. Smyd1b_tv1 and Smyd1b_tv2 were primarily localized in the cytosol of myoblasts and myotubes at early stage zebrafish embryos. However, in mature myofibers, Smyd1b_tv1, and to a small degree of Smyd1b_tv2, exhibited a sarcomeric localization. Double staining with sarcomeric markers revealed that Smyd1b_tv1 was localized on the M-lines. The sarcomeric localization was confirmed in zebrafish embryos expressing the Smyd1b_tv1-GFP or Smyd1b_tv2-GFP fusion proteins. Compared with Smyd1b_tv1, Smyd1b_tv2, however, showed a weak sarcomeric localization. Smyd1b_tv1 differs from Smyd1b_tv2 by a 13 amino acid insertion encoded by exon 5, suggesting that some residues within the 13 aa insertion may be critical for the strong sarcomeric localization of Smyd1b_tv1. Sequence comparison with Smyd1b_tv1 orthologs from other vertebrates revealed several highly conserved residues (Phe223, His224 and Gln226) and two potential phosphorylation sites (Thr221 and Ser225) within the 13 aa insertion. To determine whether these residues are involved in the increased sarcomeric localization of Smyd1b_tv1, we mutated these residues into alanine. Substitution of Phe223 or Ser225 with alanine significantly reduced the sarcomeric localization of Smyd1b_tv1. In contrast, other substitutions had no effect. Moreover, replacing Ser225 with threonine (S225T) retained the strong sarcomeric localization of Smyd1b_tv1. Conclusion/Significance: Together, these data indicate that Phe223 and Ser225 are required for the M-line localization of Smyd1b_tv1.	[Li, Huiqing; Xu, Jin; Bian, Yue-Hong; Rotllant, Pep; Shen, Tiansheng; Schneider, Martin; Du, Shao Jun] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chu, Wuying; Zhang, Jianshe] Changsha Univ, Dept Bioengn & Environm Sci, Changsha, Hunan, Peoples R China	University System of Maryland; University of Maryland Baltimore; Changsha University	Du, SJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	sdu@som.umaryland.edu	Rotllant, Josep/K-1146-2014; Xu, Jin/GRF-5111-2022	Rotllant, Josep/0000-0001-5331-807X; Xu, Jin/0000-0002-9860-7796; du, Jim/0000-0001-9227-4153	Israel Binational Agricultural Research and Development Fund, the United States (BARD) [IS-8713-08]; University of Maryland Biotechnology Institute	Israel Binational Agricultural Research and Development Fund, the United States (BARD); University of Maryland Biotechnology Institute	This research was supported by research grant No IS-8713-08 from the Israel Binational Agricultural Research and Development Fund, the United States (BARD), and an intercenter collaboration grant (Du-Fang) from University of Maryland Biotechnology Institute. (http://www.bard-isus.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Codina M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008416; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Etard C, 2008, J CELL BIOL, V180, P1163, DOI 10.1083/jcb.200709128; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Garcia-Cozar FJ, 1998, J BIOL CHEM, V273, P23877, DOI 10.1074/jbc.273.37.23877; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; HARDY MF, 1970, BIOCHEM J, V120, P653, DOI 10.1042/bj1200653; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; HUSZAR G, 1969, NATURE, V223, P834, DOI 10.1038/223834a0; Hwang I, 1997, J IMMUNOL, V158, P1165; HWANG I, 1995, IMMUNOGENETICS, V42, P353, DOI 10.1007/BF00179396; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Saad JS, 2007, PROTEIN SCI, V16, P1793, DOI 10.1110/ps.072987607; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787	27	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28524	10.1371/journal.pone.0028524	http://dx.doi.org/10.1371/journal.pone.0028524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174829	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700043
J	Llop, P; Cabrefiga, J; Smits, THM; Dreo, T; Barbe, S; Pulawska, J; Bultreys, A; Blom, J; Duffy, B; Montesinos, E; Lopez, MM				Llop, Pablo; Cabrefiga, Jordi; Smits, Theo H. M.; Dreo, Tanja; Barbe, Silvia; Pulawska, Joanna; Bultreys, Alain; Blom, Jochen; Duffy, Brion; Montesinos, Emilio; Lopez, Maria M.			Erwinia amylovora Novel Plasmid pEI70: Complete Sequence, Biogeography, and Role in Aggressiveness in the Fire Blight Phytopathogen	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE; GENETIC ELEMENTS; SP. NOV.; PATHOGEN; RESISTANCE; STRAINS; GENOME; PEAR; DIFFERENTIATION; ORGANIZATION	Comparative genomics of several strains of Erwinia amylovora, a plant pathogenic bacterium causal agent of fire blight disease, revealed that its diversity is primarily attributable to the flexible genome comprised of plasmids. We recently identified and sequenced in full a novel 65.8 kb plasmid, called pEI70. Annotation revealed a lack of known virulence-related genes, but found evidence for a unique integrative conjugative element related to that of other plant and human pathogens. Comparative analyses using BLASTN showed that pEI70 is almost entirely included in plasmid pEB102 from E. billingiae, an epiphytic Erwinia of pome fruits, with sequence identities superior to 98%. A duplex PCR assay was developed to survey the prevalence of plasmid pEI70 and also that of pEA29, which had previously been described in several E. amylovora strains. Plasmid pEI70 was found widely dispersed across Europe with frequencies of 5-92%, but it was absent in E. amylovora analyzed populations from outside of Europe. Restriction analysis and hybridization demonstrated that this plasmid was identical in at least 13 strains. Curing E. amylovora strains of pEI70 reduced their aggressiveness on pear, and introducing pEI70 into low-aggressiveness strains lacking this plasmid increased symptoms development in this host. Discovery of this novel plasmid offers new insights into the biogeography, evolution and virulence determinants in E. amylovora.	[Llop, Pablo; Barbe, Silvia; Lopez, Maria M.] IVIA, Moncada, Spain; [Cabrefiga, Jordi; Montesinos, Emilio] Univ Girona, CIDSAV CeRTA, INTEA, Inst Food & Agr Technol, Girona, Spain; [Smits, Theo H. M.; Duffy, Brion] Swiss Natl Competence Ctr Fire Blight, Wadenswil, Switzerland; [Dreo, Tanja] NIB, SI-1000 Ljubljana, Slovenia; [Pulawska, Joanna] Inst Hort, Skierniewice, Poland; [Bultreys, Alain] Ctr Wallon Rech Agron, Dept Sci Vivant, Gembloux, Belgium; [Blom, Jochen] Univ Bielefeld, CeBiTec, D-33615 Bielefeld, Germany	Universitat de Girona; Research Institute of Horticulture; University of Bielefeld	Llop, P (corresponding author), IVIA, Moncada, Spain.	mlopez@ivia.es	Cabrefiga, Jordi/H-3340-2015; Cabrefiga, Jordi/AAV-7844-2021; Llop, Pablo/H-3032-2017; Llop, Pablo/ABD-5403-2022; Pulawska, Joanna/S-3663-2019; López, Maria M/D-2584-2015; Puławska, Joanna/S-6091-2018; Montesinos, Emili/H-5246-2015; Bultreys, Alain/HHS-2296-2022; Lopez, Maria/HHC-3659-2022; Dreo, Tanja/X-1638-2019	Cabrefiga, Jordi/0000-0002-8913-2573; Cabrefiga, Jordi/0000-0002-8913-2573; Llop, Pablo/0000-0003-3075-8376; Pulawska, Joanna/0000-0001-5327-1056; Puławska, Joanna/0000-0001-5327-1056; Montesinos, Emili/0000-0003-4455-8332; Dreo, Tanja/0000-0002-0850-4874; Barbe, Silvia/0000-0002-2929-6410; Smits, Theo H.M./0000-0002-1237-235X	Spanish Ministry of Science [CICYT AGL2008-05723-C02-01/AGR]; EUPHRESCO ERA-Net ErwinDect; Swiss Federal Office of Agriculture; COST Action [864]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); EUPHRESCO ERA-Net ErwinDect; Swiss Federal Office of Agriculture; COST Action(European Cooperation in Science and Technology (COST))	This work was financed by the Spanish Ministry of Science project CICYT AGL2008-05723-C02-01/AGR, EUPHRESCO ERA-Net ErwinDect Project, The Swiss Federal Office of Agriculture, and COST Action 864 (http://www.cost864.eu/). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge P, 1997, MOL GEN GENET, V256, P611, DOI 10.1007/s004380050609; Arnold DL, 2003, MOL PLANT PATHOL, V4, P407, DOI [10.1046/j.1364-3703.2003.00187.x, 10.1046/J.1364-3703.2003.00187.X]; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; Beer S. V., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P53; Brennan JM, 2002, J PHYTOPATHOL, V150, P414, DOI 10.1046/j.1439-0434.2002.00789.x; Cabrefiga J, 2005, PHYTOPATHOLOGY, V95, P1430, DOI 10.1094/PHYTO-95-1430; CHIOU CS, 1991, PHYTOPATHOLOGY, V81, P710, DOI 10.1094/Phyto-81-710; Foster GC, 2004, APPL ENVIRON MICROB, V70, P7539, DOI 10.1128/AEM.70.12.7539-7544.2004; Gaillard M, 2006, J BACTERIOL, V188, P1999, DOI 10.1128/JB.188.5.1999-2013.2006; Hauben L., 2005, BERGEYS MANUAL SYSTE, V2, P670; Kim J.-H., 1995, Phytopathology, V85, P1148; Kim WS, 1999, INT J SYST BACTERIOL, V49, P899, DOI 10.1099/00207713-49-2-899; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kube M, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-110, 10.1186/1471-2164-11-393]; LAURENT J, 1989, Molecular Plant-Microbe Interactions, V2, P160, DOI 10.1094/MPMI-2-160; Llop P, 2008, ACTA HORTIC, V793, P145, DOI 10.17660/ActaHortic.2008.793.18; Llop P, 2006, PHYTOPATHOLOGY, V96, P900, DOI 10.1094/PHYTO-96-0900; Lopez MM, 2011, INT J SYST EVOL MICR, V61, P561, DOI 10.1099/ijs.0.020479-0; Maniatis T., 1982, MOL CLONING; Mavrodi DV, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-8; McGhee GC, 2008, ACTA HORTIC, V793, P271; McGhee GC, 2000, APPL ENVIRON MICROB, V66, P4897, DOI 10.1128/AEM.66.11.4897-4907.2000; McGhee GC, 2002, APPL ENVIRON MICROB, V68, P6182, DOI 10.1128/AEM.68.12.6182-6192.2002; MCGHEE GC, 2001, ACTA HORTIC, V590, P413; McHardy AC, 2004, BIOINFORMATICS, V20, P1622, DOI 10.1093/bioinformatics/bth137; MCMANUS PS, 1995, PHYTOPATHOLOGY, V85, P618, DOI 10.1094/Phyto-85-618; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Mohammadi M, 2010, PLANT PATHOL, V59, P252, DOI 10.1111/j.1365-3059.2009.02182.x; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; NORELLI JL, 1984, PHYTOPATHOLOGY, V74, P136, DOI 10.1094/Phyto-74-136; Oh CS, 2005, FEMS MICROBIOL LETT, V253, P185, DOI 10.1016/j.femsle.2005.09.051; Palmer EL, 1997, APPL ENVIRON MICROB, V63, P4604, DOI 10.1128/AEM.63.11.4604-4607.1997; PAULIN J-P, 1973, Annales de Phytopathologie, V5, P389; Powney R, 2011, J BACTERIOL, V193, P785, DOI 10.1128/JB.01352-10; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sebaihia M, 2010, J Bacteriol, V192, P2020, DOI 10.1128/JB.00022-10; Sholberg PL, 2001, CAN J PLANT PATHOL, V23, P60; Smits THM, 2011, J BIOTECHNOL, V155, P34, DOI 10.1016/j.jbiotec.2010.10.075; Smits THM, 2010, MOL PLANT MICROBE IN, V23, P384, DOI 10.1094/MPMI-23-4-0384; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; STEINBERGER EM, 1990, PLASMID, V24, P12, DOI 10.1016/0147-619X(90)90021-4; Sundin GW, 2007, ANNU REV PHYTOPATHOL, V45, P129, DOI 10.1146/annurev.phyto.45.062806.094317; SUNDIN GW, 2004, ACTA HORTIC, V704, P423; Toth IK, 2006, ANNU REV PHYTOPATHOL, V44, P305, DOI 10.1146/annurev.phyto.44.070505.143444; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Van der Zwet T, 1979, USDA AGR HDB, V510; Vanneste J.L., 2000, FIRE BLIGHT DIS ITS; Weinthal DM, 2007, APPL ENVIRON MICROB, V73, P7552, DOI 10.1128/AEM.01511-07; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; Zhang YX, 1997, APPL ENVIRON MICROB, V63, P4421, DOI 10.1128/AEM.63.11.4421-4426.1997; Zhao YF, 2005, J BACTERIOL, V187, P2113, DOI 10.1128/JB.187.6.2113-2126.2005; ZHOU C, 1990, BIOTECHNIQUES, V8, P172	53	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28651	10.1371/journal.pone.0028651	http://dx.doi.org/10.1371/journal.pone.0028651			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174857	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700056
J	Mammen, AL; Mahoney, JA; St Germain, A; Badders, N; Taylor, JP; Rosen, A; Spinette, S				Mammen, Andrew L.; Mahoney, James A.; St Germain, Amanda; Badders, Nisha; Taylor, J. Paul; Rosen, Antony; Spinette, Sarah			A Novel Conserved Isoform of the Ubiquitin Ligase UFD2a/UBE4B Is Expressed Exclusively in Mature Striated Muscle Cells	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; PROTEASOME PATHWAY; UNC-45 CHAPERONE; U-BOX; MYOSIN; DIFFERENTIATION; MAINTENANCE; DOMAIN; HEART	Yeast Ufd2p was the first identified E4 multiubiquitin chain assembly factor. Its vertebrate homologues later referred to as UFD2a, UBE4B or E4B were also shown to have E3 ubiquitin ligase activity. UFD2a function in the brain has been well established in vivo, and in vitro studies have shown that its activity is essential for proper condensation and segregation of chromosomes during mitosis. Here we show that 2 alternative splice forms of UFD2a, UFD2a-7 and -7/7a, are expressed sequentially during myoblast differentiation of C2C12 cell cultures and during cardiotoxin-induced regeneration of skeletal muscle in mice. UFD2a-7 contains an alternate exon 7, and UFD2a-7/7a, the larger of the 2 isoforms, contains an additional novel exon 7a. Analysis of protein or mRNA expression in mice and zebrafish revealed that a similar pattern of isoform switching occurs during developmental myogenesis of cardiac and skeletal muscle. In vertebrates (humans, rodents, zebrafish), UFD2a-7/7a is expressed only in mature striated muscle. This unique tissue specificity is further validated by the conserved presence of 2 muscle-specific splicing regulatory motifs located in the 3' introns of exons 7 and 7a. UFD2a interacts with VCP/p97, an AAA-type ATPase implicated in processes whose functions appear to be regulated, in part, through their interaction with one or more of 15 previously identified cofactors. UFD2a-7/7a did not interact with VCP/p97 in yeast 2-hybrid experiments, which may allow the ATPase to bind cofactors that facilitate its muscle-specific functions. We conclude that the regulated expression of these UFD2a isoforms most likely imparts divergent functions that are important for myogenisis.	[Mammen, Andrew L.; Mahoney, James A.; Rosen, Antony] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA; [Mammen, Andrew L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Badders, Nisha; Taylor, J. Paul] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN USA; [St Germain, Amanda; Spinette, Sarah] Rhode Isl Coll, Dept Biol, Providence, RI 02908 USA	Johns Hopkins University; Johns Hopkins University; St Jude Children's Research Hospital	Mammen, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA.	sspinette@ric.edu	Mammen, Andrew/AAF-2885-2021; Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349	National Institutes of Health [P01HL056091, R37DE012354, R01AR044684, R01 AG031587]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [P20RR016457]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE012354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031587] Funding Source: NIH RePORTER; Office Of The Director [1004057] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by National Institutes of Health grants P01HL056091, R37DE012354, R01AR044684, R01 AG031587 and RI-INBRE Grant # P20RR016457 from the National Center for Research Resources (NCRR http://ncrr.nih.gov/), a component of the National Institutes of Health (NIH http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; Aravind L, 2000, CURR BIOL, V10, pR132, DOI 10.1016/S0960-9822(00)00398-5; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; BENIRSCHKE RC, STRUCTURE, V18, P955; BERNICK EP, BMC CELL BIOL, V11, P70; Bland CS, 2010, NUCLEIC ACIDS RES, V38, P7651, DOI 10.1093/nar/gkq614; Brand-Saberi B, 2005, ANN ANAT, V187, P199, DOI 10.1016/j.aanat.2004.12.018; Campos Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009866; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Cao PR, 2005, INT J BIOCHEM CELL B, V37, P2088, DOI 10.1016/j.biocel.2004.11.010; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; COUTEAUX R, 1988, BIOL CELL, V62, P171, DOI 10.1016/0248-4900(88)90034-2; CUSTER SK, HUM MOL GENET, V19; Etheridge L, 2002, DEV DYNAM, V224, P457, DOI 10.1002/dvdy.10123; Guinto JB, 2007, ACTA NEUROPATHOL, V114, P55, DOI 10.1007/s00401-007-0224-7; Heuze ML, 2008, BLOOD, V112, P5130, DOI 10.1182/blood-2007-12-128744; Higgins D G, 1994, Methods Mol Biol, V25, P307; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; JU JS, HUM MOL GENET, V19, pR38; Kachur T, 2004, J CELL SCI, V117, P5313, DOI 10.1242/jcs.01389; Kachur TM, 2008, INT J MOL SCI, V9, P1863, DOI 10.3390/ijms9091863; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Kaneko-Oshikawa C, 2005, MOL CELL BIOL, V25, P10953, DOI 10.1128/MCB.25.24.10953-10964.2005; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Ladd AN, 2005, DEV DYNAM, V233, P783, DOI 10.1002/dvdy.20382; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Lindon C, 1998, J CELL BIOL, V140, P111, DOI 10.1083/jcb.140.1.111; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Matsumoto M, 2004, EMBO J, V23, P659, DOI 10.1038/sj.emboj.7600081; MCAULIFFE JJ, 1990, CIRC RES, V66, P1204, DOI 10.1161/01.RES.66.5.1204; McElhinny AS, 2004, J CELL SCI, V117, P3175, DOI 10.1242/jcs.01158; Ni WM, 2011, J CELL SCI, V124, P3164, DOI 10.1242/jcs.087320; NORDQUIST KA, BIOCHEMISTRY, V49, P347; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Spinette S, 2004, CELL CYCLE, V3, P1638; Spinette S, 2006, BIOCHEM BIOPH RES CO, V347, P1103, DOI 10.1016/j.bbrc.2006.06.194; Srikakulam R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002137; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Sun L, 2007, ONCOGENE, V26, P441, DOI 10.1038/sj.onc.1209793; Sun LP, 2005, J BIOL CHEM, V280, P26448, DOI 10.1074/jbc.M500373200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOWNSEND PJ, 1995, J MOL CELL CARDIOL, V27, P2223, DOI 10.1016/S0022-2828(95)91587-7; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Warren CM, 2004, MECH DEVELOP, V121, P1301, DOI 10.1016/j.mod.2004.07.003; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x	62	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28861	10.1371/journal.pone.0028861	http://dx.doi.org/10.1371/journal.pone.0028861			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174917	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700079
J	Sato, T; Aiyama, Y; Ishii-Inagaki, M; Hara, K; Tsunekawa, N; Harikae, K; Uemura-Kamata, M; Shinomura, M; Zhu, XB; Maeda, S; Kuwahara-Otani, S; Kudo, A; Kawakami, H; Kanai-Azuma, M; Fujiwara, M; Miyamae, Y; Yoshida, S; Seki, M; Kurohmaru, M; Kanai, Y				Sato, Takeshi; Aiyama, Yoshimi; Ishii-Inagaki, Mayuko; Hara, Kenshiro; Tsunekawa, Naoki; Harikae, Kyoko; Uemura-Kamata, Mami; Shinomura, Mai; Zhu, Xiao Bo; Maeda, Seishi; Kuwahara-Otani, Sachi; Kudo, Akihiko; Kawakami, Hayato; Kanai-Azuma, Masami; Fujiwara, Michio; Miyamae, Yoichi; Yoshida, Shosei; Seki, Makoto; Kurohmaru, Masamichi; Kanai, Yoshiakira			Cyclical and Patch-Like GDNF Distribution along the Basal Surface of Sertoli Cells in Mouse and Hamster Testes	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; MALE GERM-LINE; LONG-TERM CULTURE; SELF-RENEWAL; JUNCTION DYNAMICS; SHORT PHOTOPERIOD; GOLDEN-HAMSTER; MESSENGER-RNA; SPERMATOGENESIS; TRANSPLANTATION	Background and Aims: In mammalian spermatogenesis, glial cell line-derived neurotrophic factor (GDNF) is one of the major Sertoli cell-derived factors which regulates the maintenance of undifferentiated spermatogonia including spermatogonial stem cells (SSCs) through GDNF family receptor alpha 1 (GFR alpha 1). It remains unclear as to when, where and how GDNF molecules are produced and exposed to the GFR alpha 1-positive spermatogonia in vivo. Methodology and Principal Findings: Here we show the cyclical and patch-like distribution of immunoreactive GDNF-positive signals and their close co-localization with a subpopulation of GFR alpha 1-positive spermatogonia along the basal surface of Sertoli cells in mice and hamsters. Anti-GDNF section immunostaining revealed that GDNF-positive signals are mainly cytoplasmic and observed specifically in the Sertoli cells in a species-specific as well as a seminiferous cycle- and spermatogenic activity-dependent manner. In contrast to the ubiquitous GDNF signals in mouse testes, high levels of its signals were cyclically observed in hamster testes prior to spermiation. Whole-mount anti-GDNF staining of the seminiferous tubules successfully visualized the cyclical and patch-like extracellular distribution of GDNF-positive granular deposits along the basal surface of Sertoli cells in both species. Double-staining of GDNF and GFR alpha 1 demonstrated the close co-localization of GDNF deposits and a subpopulation of GFR alpha 1-positive spermatogonia. In both species, GFR alpha 1-positive cells showed a slender bipolar shape as well as a tendency for increased cell numbers in the GDNF-enriched area, as compared with those in the GDNF-low/negative area of the seminiferous tubules. Conclusion/Significance: Our data provide direct evidence of regionally defined patch-like GDNF-positive signal site in which GFR alpha 1-positive spermatogonia possibly interact with GDNF in the basal compartment of the seminiferous tubules.	[Sato, Takeshi; Aiyama, Yoshimi; Ishii-Inagaki, Mayuko; Tsunekawa, Naoki; Harikae, Kyoko; Uemura-Kamata, Mami; Shinomura, Mai; Zhu, Xiao Bo; Kurohmaru, Masamichi; Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Tokyo, Japan; [Sato, Takeshi; Fujiwara, Michio; Miyamae, Yoichi] Astellas Pharma Inc, Drug Safety Res Labs, Osaka, Japan; [Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Div Germ Biol, Natl Inst Basic Biol, Okazaki, Aichi, Japan; [Hara, Kenshiro; Yoshida, Shosei] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi, Japan; [Uemura-Kamata, Mami; Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Tokyo, Japan; [Maeda, Seishi; Kuwahara-Otani, Sachi; Seki, Makoto] Hyogo Coll Med, Dept Anat, Div Cell Biol, Nishinomiya, Hyogo 6638501, Japan; [Kudo, Akihiko; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan	University of Tokyo; Astellas Pharmaceuticals; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Tokyo Medical & Dental University (TMDU); Hyogo College of Medicine; Kyorin University	Sato, T (corresponding author), Univ Tokyo, Dept Vet Anat, Tokyo, Japan.	aykanai@mail.ecc.u-tokyo.ac.jp	Kudo, Akihiko/ACZ-3340-2022	Kudo, Akihiko/0000-0002-2630-5991; Yoshida, Shosei/0000-0001-8861-1866; Kanai, Yoshiakira/0000-0003-2116-7806	 [21116501];  [3116702];  [20116004]; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) on Innovative Areas (no. 21116501; 23116702; 20116004)(http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoyunlu G, 2007, ACTA HISTOCHEM, V109, P130, DOI 10.1016/j.acthis.2006.11.003; Aponte PM, 2008, REPRODUCTION, V136, P543, DOI 10.1530/REP-07-0419; Aponte PM, 2005, THERIOGENOLOGY, V64, P1440, DOI 10.1016/j.theriogenology.2005.03.016; BERNDTSON WE, 1974, ENDOCRINOLOGY, V95, P195, DOI 10.1210/endo-95-1-195; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; Brinster RL, 2002, SCIENCE, V296, P2174, DOI 10.1126/science.1071607; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303; CHANDRASHEKAR V, 1989, BIOL REPROD, V40, P300, DOI 10.1095/biolreprod40.2.300; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; De Rooij DG, 2000, J ANDROL, V21, P776; de Rooij DG, 1998, CURR OPIN CELL BIOL, V10, P694, DOI 10.1016/S0955-0674(98)80109-9; He ZP, 2007, BIOL REPROD, V77, P723, DOI 10.1095/biolreprod.107.062513; Hiramatsu R, 2003, DEV DYNAM, V228, P247, DOI 10.1002/dvdy.10379; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Hofmann MC, 2005, DEV BIOL, V279, P114, DOI 10.1016/j.ydbio.2004.12.006; Ishii M, 2007, DEVELOPMENT, V134, P449, DOI 10.1242/dev.02751; Kanai Y, 1996, J CELL BIOL, V133, P667, DOI 10.1083/jcb.133.3.667; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; KIRBY JD, 1993, BIOL REPROD, V49, P483, DOI 10.1095/biolreprod49.3.483; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JM, 2005, BIOL REPROD, V72, P358, DOI 10.1095/biolreprod.104.030783; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496; Ogawa T, 1999, BIOL REPROD, V60, P515, DOI 10.1095/biolreprod60.2.515; Palasz A, 2009, ADV MED SCI-POLAND, V54, P143, DOI 10.2478/v10039-009-0032-5; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Sato T, 2005, ANAT HISTOL EMBRYOL, V34, P220, DOI 10.1111/j.1439-0264.2005.00599.x; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Simoni M, 1997, ENDOCR REV, V18, P739, DOI 10.1210/er.18.6.739; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Tadokoro Y, 2002, MECH DEVELOP, V113, P29, DOI 10.1016/S0925-4773(02)00004-7; TOPPARI J, 1991, J ELECTRON MICR TECH, V19, P203, DOI 10.1002/jemt.1060190207; TSUTSUI K, 1988, ENDOCRINOLOGY, V122, P1094, DOI 10.1210/endo-122-3-1094; Wong CH, 2005, CURR TOP DEV BIOL, V71, P263, DOI 10.1016/S0070-2153(05)71008-5; Yoshida S, 2010, DEV GROWTH DIFFER, V52, P311, DOI 10.1111/j.1440-169X.2010.01174.x	53	41	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28367	10.1371/journal.pone.0028367	http://dx.doi.org/10.1371/journal.pone.0028367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174794	Green Submitted, gold, Green Published			2022-12-27	WOS:000298365700029
J	Yoshida, S; Yasuda, M; Miyashita, H; Ogawa, Y; Yoshida, T; Matsuzaki, Y; Tsubota, K; Okano, H; Shimmura, S				Yoshida, Satoru; Yasuda, Miyuki; Miyashita, Hideyuki; Ogawa, Yoko; Yoshida, Tetsu; Matsuzaki, Yumi; Tsubota, Kazuo; Okano, Hideyuki; Shimmura, Shigeto			Generation of Stratified Squamous Epithelial Progenitor Cells from Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							OCULAR SURFACE DISORDERS; DOPAMINERGIC-NEURONS; CORNEAL EPITHELIUM; AMNIOTIC MEMBRANE; ES CELLS; DIFFERENTIATION; INDUCTION; TRANSPLANTATION; FIBROBLASTS; TRANSDIFFERENTIATION	Background: Application of induced pluripotent stem (iPS) cells in regenerative medicine will bypass ethical issues associated with use of embryonic stem cells. In addition, patient-specific IPS cells can be useful to elucidate the pathophysiology of genetic disorders, drug screening, and tailor-made medicine. However, in order to apply iPS cells to mitotic tissue, induction of tissue stem cells that give rise to progeny of the target organ is required. Methodology/Principal Findings: We induced stratified epithelial cells from mouse iPS cells by co-culture with PA6 feeder cells (SDIA-method) with use of BMP4. Clusters of cells positive for the differentiation markers KRT1 or KRT12 were observed in KRT14-positive colonies. We successfully cloned KRT14 and p63 double-positive stratified epithelial progenitor cells from iPS-derived epithelial cells, which formed stratified epithelial sheets consisting of five-to six-polarized epithelial cells in vitro. When these clonal cells were cultured on denuded mouse corneas, a robust stratified epithelial layer was observed with physiological cell polarity including high levels of E-cadherin, p63 and K15 expression in the basal layer and ZO-1 in the superficial layer, recapitulating the apico-basal polarity of the epithelium in vivo. Conclusions/Significance: These results suggest that KRT14 and p63 double-positive epithelial progenitor cells can be cloned from iPS cells in order to produce polarized multilayer epithelial cell sheets.	[Yoshida, Satoru; Yasuda, Miyuki; Miyashita, Hideyuki; Ogawa, Yoko; Yoshida, Tetsu; Tsubota, Kazuo; Shimmura, Shigeto] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Matsuzaki, Yumi; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Keio University; Keio University	Yoshida, S (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	shige@sc.itc.keio.ac.jp	Shimmura, Shigeto/J-4678-2013; Okano, Hideyuki/I-7584-2019	Matsuzaki, Yumi/0000-0002-3729-2997	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) to S.S. and H.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Bilousova G, 2010, J INVEST DERMATOL; Blazejewska EA, 2009, STEM CELLS, V27, P642, DOI 10.1634/stemcells.2008-0721; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189; Coraux C, 2003, CURR BIOL, V13, P849, DOI 10.1016/S0960-9822(03)00296-3; Davies SB, 2010, STEM CELLS DEV, V19, P1651, DOI 10.1089/scd.2010.0201; Davies SB, 2009, STEM CELLS, V27, P2781, DOI 10.1002/stem.209; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; HEFTON JM, 1983, LANCET, V2, P428; Ji L, 2006, TISSUE ENG, V12, P665, DOI 10.1089/ten.2006.12.665; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Lee CH, 2011, BIOMATERIALS, V32, P6683, DOI 10.1016/j.biomaterials.2011.05.070; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Montserrat N, 2011, J CARDIOVASC TRANSL, V4, P121, DOI 10.1007/s12265-010-9233-3; Nakamura T, 2003, INVEST OPHTH VIS SCI, V44, P106, DOI 10.1167/iovs.02-0195; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Connor N, 1981, LANCET, V317, P75; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okita K, 2010, NAT PROTOC, V5, P418, DOI 10.1038/nprot.2009.231; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Pearton DJ, 2004, INT J DEV BIOL, V48, P197, DOI 10.1387/ijdb.15272385; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Sakurai M, 2011, J ARTIF ORGANS, V14, P58, DOI 10.1007/s10047-010-0547-3; Shimazaki J, 2002, OPHTHALMOLOGY, V109, P1285, DOI 10.1016/S0161-6420(02)01089-8; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	37	23	30	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28856	10.1371/journal.pone.0028856	http://dx.doi.org/10.1371/journal.pone.0028856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174914	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700078
J	Hu, CW; Chang, YL; Chen, SJ; Kuo-Huang, LL; Liao, JC; Huang, HC; Juan, HF				Hu, Chia-Wei; Chang, Ya-Ling; Chen, Shiang Jiuun; Kuo-Huang, Ling-Long; Liao, James C.; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Revealing the Functions of the Transketolase Enzyme Isoforms in Rhodopseudomonas palustris Using a Systems Biology Approach	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; RIBULOSE-BISPHOSPHATE CARBOXYLASE; AMINO-ACID PERMEASE; ESCHERICHIA-COLI; PHOSPHOENOLPYRUVATE CARBOXYKINASE; ENHANCES PHOTOSYNTHESIS; RHIZOBIUM-LEGUMINOSARUM; BREAST-CARCINOMA; GENE-EXPRESSION; CARBON	Background: Rhodopseudomonas palustris (R. palustris) is a purple non-sulfur anoxygenic phototrophic bacterium that belongs to the class of proteobacteria. It is capable of absorbing atmospheric carbon dioxide and converting it to biomass via the process of photosynthesis and the Calvin-Benson-Bassham (CBB) cycle. Transketolase is a key enzyme involved in the CBB cycle. Here, we reveal the functions of transketolase isoforms I and II in R. palustris using a systems biology approach. Methodology/Principal Findings: By measuring growth ability, we found that transketolase could enhance the autotrophic growth and biomass production of R. palustris. Microarray and real-time quantitative PCR revealed that transketolase isoforms I and II were involved in different carbon metabolic pathways. In addition, immunogold staining demonstrated that the two transketolase isoforms had different spatial localizations: transketolase I was primarily associated with the intracytoplasmic membrane (ICM) but transketolase II was mostly distributed in the cytoplasm. Comparative proteomic analysis and network construction of transketolase over-expression and negative control (NC) strains revealed that protein folding, transcriptional regulation, amino acid transport and CBB cycle-associated carbon metabolism were enriched in the transketolase I over-expressed strain. In contrast, ATP synthesis, carbohydrate transport, glycolysis-associated carbon metabolism and CBB cycle-associated carbon metabolism were enriched in the transketolase II over-expressed strain. Furthermore, ATP synthesis assays showed a significant increase in ATP synthesis in the transketolase II over-expressed strain. A PEPCK activity assay showed that PEPCK activity was higher in transketolase over-expressed strains than in the negative control strain. Conclusions/Significance: Taken together, our results indicate that the two isoforms of transketolase in R. palustris could affect photoautotrophic growth through both common and divergent metabolic mechanisms.	[Hu, Chia-Wei; Chang, Ya-Ling; Juan, Hsueh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Chen, Shiang Jiuun; Kuo-Huang, Ling-Long; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Kuo-Huang, Ling-Long] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; University of California System; University of California Los Angeles; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hu, CW (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hsuangcheng@ym.edu.tw; yukijuan@ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Liao, James/0000-0002-4580-7276; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council, Taiwan [NSC 98-2627-M-010-001-, NSC 98-2627-M-002-001-, NSC 98-2627-M002-004, 99-2621-B-002-005-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC 98-2627-M-010-001-, NSC 98-2627-M-002-001-, NSC 98-2627-M002-004 and 99-2621-B-002-005-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; Barbosa MJ, 2001, J BIOTECHNOL, V85, P25, DOI 10.1016/S0168-1656(00)00368-0; Bowien B, 2002, ARCH MICROBIOL, V178, P85, DOI 10.1007/s00203-002-0441-3; BUBLITZ C, 1988, J BIOL CHEM, V263, P12849; Carlozzi P, 2010, BIORESOURCE TECHNOL, V101, P3115, DOI 10.1016/j.biortech.2009.12.049; Chinnasamy S, 2009, INT J MOL SCI, V10, P518, DOI 10.3390/ijms10020518; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; DISPENSA M, 1992, J BACTERIOL, V174, P5803, DOI 10.1128/jb.174.18.5803-5813.1992; Dongen SM, 2000, THESIS U UTRECHT NET; Ellis RJ, 2005, CURR BIOL, V15, pR661, DOI 10.1016/j.cub.2005.08.025; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Garcia B, 1999, J BIOL CHEM, V274, P29228, DOI 10.1074/jbc.274.41.29228; Gibson JL, 1996, ARCH MICROBIOL, V166, P141, DOI 10.1007/s002030050369; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Hanash SM, 2002, PROTEOMICS, V2, P69, DOI 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.3.CO;2-#; Hara KY, 2009, METAB ENG, V11, P1, DOI 10.1016/j.ymben.2008.07.003; Hara KY, 2006, J BIOMOL SCREEN, V11, P310, DOI 10.1177/1087057105285112; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hosie AHF, 2001, MOL MICROBIOL, V40, P1449, DOI 10.1046/j.1365-2958.2001.02497.x; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inui M, 1997, J BACTERIOL, V179, P4942, DOI 10.1128/jb.179.15.4942-4945.1997; Jaubert M, 2004, J BIOL CHEM, V279, P44407, DOI 10.1074/jbc.M408039200; Joshi GS, 2009, J BACTERIOL, V191, P4243, DOI 10.1128/JB.01795-08; Juan HF, 2006, PROTEOMICS, V6, P2991, DOI 10.1002/pmic.200500435; Jung YM, 2004, J BIOSCI BIOENG, V98, P224, DOI 10.1263/jbb.98.224; Kamada N, 2001, APPL MICROBIOL BIOT, V56, P710, DOI 10.1007/s002530100738; Kim P, 2004, APPL ENVIRON MICROB, V70, P1238, DOI 10.1128/AEM.70.2.1238-1241.2004; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kwon YD, 2007, J APPL MICROBIOL, V103, P2340, DOI 10.1111/j.1365-2672.2007.03485.x; Laguna R, 2011, ARCH MICROBIOL, V193, P151, DOI 10.1007/s00203-010-0652-y; Laguna R, 2010, ADV EXP MED BIOL, V675, P265, DOI 10.1007/978-1-4419-1528-3_15; Larimer FW, 2004, NAT BIOTECHNOL, V22, P55, DOI 10.1038/nbt923; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Leegood RC, 2003, ARCH BIOCHEM BIOPHYS, V414, P204, DOI 10.1016/S0003-9861(03)00093-6; Li M, 2010, CURR MICROBIOL, V61, P429, DOI 10.1007/s00284-010-9634-1; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Lui Y, 2005, ACTA BIOCH BIOPH SIN, V37, P406, DOI 10.1111/j.1745-7270.2005.00060.x; Lynch HC, 1995, MICROBIOL-UK, V141, P3105, DOI 10.1099/13500872-141-12-3105; Ma WM, 2008, J APPL PHYCOL, V20, P437, DOI 10.1007/s10811-007-9286-0; Ma WM, 2005, J APPL PHYCOL, V17, P273, DOI 10.1007/s10811-005-4850-y; McKinlay JB, 2010, P NATL ACAD SCI USA, V107, P11669, DOI 10.1073/pnas.1006175107; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; Mukhopadhyay B, 1999, APPL ENVIRON MICROB, V65, P301; NICOLAS MT, 1989, J HISTOCHEM CYTOCHEM, V37, P663, DOI 10.1177/37.5.2703702; Paoli GC, 1998, J BACTERIOL, V180, P4258, DOI 10.1128/JB.180.16.4258-4269.1998; Romagnoli S, 2006, J BACTERIOL, V188, P2780, DOI 10.1128/JB.188.8.2780-2791.2006; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Schenk G, 1998, INT J BIOCHEM CELL B, V30, P1297, DOI 10.1016/S1357-2725(98)00095-8; Schocke L, 1997, ARCH MICROBIOL, V167, P289, DOI 10.1007/s002030050446; Seth A, 2000, J BACTERIOL, V182, P919, DOI 10.1128/JB.182.4.919-927.2000; Shruthi H, 2010, J MOL EVOL, V70, P359, DOI 10.1007/s00239-010-9334-2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Sprenger GA, 1995, ARCH MICROBIOL, V164, P324, DOI 10.1007/BF02529978; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tabita FR, 2007, CELL, V129, P1039, DOI 10.1016/j.cell.2007.06.002; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Teige M, 1998, EUR J BIOCHEM, V252, P237, DOI 10.1046/j.1432-1327.1998.2520237.x; Veitch NJ, 2004, BIOCHEM J, V382, P759, DOI 10.1042/BJ20040459; Wall JD, 2004, NAT BIOTECHNOL, V22, P40, DOI 10.1038/nbt0104-40; Walshaw DL, 1997, FEMS MICROBIOL LETT, V152, P57, DOI 10.1111/j.1574-6968.1997.tb10409.x; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; WANG X, 1992, J BACTERIOL, V174, P3607, DOI 10.1128/JB.174.11.3607-3611.1992; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Yakandawala N, 2008, APPL MICROBIOL BIOT, V78, P283, DOI 10.1007/s00253-007-1307-z; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	74	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28329	10.1371/journal.pone.0028329	http://dx.doi.org/10.1371/journal.pone.0028329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174789	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600019
J	Abreu-Rodriguez, I; Silva, RS; Martins, AP; Soveral, G; Toledo-Aral, JJ; Lopez-Barneo, J; Echevarria, M				Abreu-Rodriguez, Irene; Sanchez Silva, Rocio; Martins, Ana Paula; Soveral, Graca; Jose Toledo-Aral, Juan; Lopez-Barneo, Jose; Echevarria, Miriam			Functional and Transcriptional Induction of Aquaporin-1 Gene by Hypoxia; Analysis of Promoter and Role of Hif-1 alpha	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; WATER CHANNEL; HUMAN BRAIN; EXPRESSION; OVEREXPRESSION; ANGIOGENESIS; PERMEABILITY; MECHANISMS; COMPLEX; KINASE	Aquaporin-1 (AQP1) is a water channel that is highly expressed in tissues with rapid O-2 transport. It has been reported that this protein contributes to gas permeation (CO2, NO and O-2) through the plasma membrane. We show that hypoxia increases Aqp1 mRNA and protein levels in tissues, namely mouse brain and lung, and in cultured cells, the 9L glioma cell line. Stopped-flow light-scattering experiments confirmed an increase in the water permeability of 9L cells exposed to hypoxia, supporting the view that hypoxic Aqp1 up-regulation has a functional role. To investigate the molecular mechanisms underlying this regulatory process, transcriptional regulation was studied by transient transfections of mouse endothelial cells with a 1297 bp 5' proximal Aqp1 promoter-luciferase construct. Incubation in hypoxia produced a dose- and time-dependent induction of luciferase activity that was also obtained after treatments with hypoxia mimetics (DMOG and CoCl2) and by overexpressing stabilized mutated forms of HIF-1 alpha. Single mutations or full deletions of the three putative HIF binding domains present in the Aqp1 promoter partially reduced its responsiveness to hypoxia, and transfection with HIf-1 alpha siRNA decreased the in vitro hypoxia induction of Aqp1 mRNA and protein levels. Our results indicate that HIF-1 alpha participates in the hypoxic induction of AQP1. However, we also demonstrate that the activation of Aqp1 promoter by hypoxia is complex and multifactorial and suggest that besides HIF-1 alpha other transcription factors might contribute to this regulatory process. These data provide a conceptual framework to support future research on the involvement of AQP1 in a range of pathophysiological conditions, including edema, tumor growth, and respiratory diseases.	[Abreu-Rodriguez, Irene; Sanchez Silva, Rocio; Jose Toledo-Aral, Juan; Lopez-Barneo, Jose; Echevarria, Miriam] Univ Seville, Inst Biomed Sevilla IBiS, Hosp Univ Virgen Rocio, CSIC,Dept Fisiol Med & Biofis, Seville, Spain; [Martins, Ana Paula; Soveral, Graca] FCT UNL, Dept Quim, REQUIMTE, Caparica, Portugal; [Soveral, Graca] Univ Lisbon, Fac Farm, P-1699 Lisbon, Portugal; [Jose Toledo-Aral, Juan; Lopez-Barneo, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Universidade de Lisboa; CIBERNED	Abreu-Rodriguez, I (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	irusta@us.es	Martins, Ana Paula/A-5657-2013; Toledo-Aral, Juan J/F-2613-2015; IBIS, NEUROBIOLOGIA/O-9922-2015; Soveral, Graça/L-1550-2013; IBIS, TERAPIA CELULA/P-3297-2015; Echevarría, Miriam/E-6682-2010	Martins, Ana Paula/0000-0002-5064-6171; Toledo-Aral, Juan J/0000-0001-7512-7135; Soveral, Graça/0000-0001-8487-110X; Echevarría, Miriam/0000-0002-4758-9428	Instituto de Salud Carlos III [PI PI060511, PS09/00605]; La Junta de Andalucia; Consejeria de Salud [0144, 0192]; Consejeria de Innovacion Ciencia y Empresa [P08-CTS-03574]; Spanish Ministry of Science and Innovation	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); La Junta de Andalucia(Junta de Andalucia); Consejeria de Salud; Consejeria de Innovacion Ciencia y Empresa; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by grants from the "Instituto de Salud Carlos III" PI PI060511 and PS09/00605, and by grants from "La Junta de Andalucia", Consejeria de Salud (exp. # 0144 and # 0192) and Consejeria de Innovacion Ciencia y Empresa (P08-CTS-03574). IAR was supported by a predoctoral fellowship from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Belkacemi L, 2008, LIFE SCI, V82, P1272, DOI 10.1016/j.lfs.2008.04.014; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Damert A, 1997, BIOCHEM J, V327, P419, DOI 10.1042/bj3270419; Del Toro R, 2003, J BIOL CHEM, V278, P22316, DOI 10.1074/jbc.M212576200; del Valle-Rodriguez A, 2003, EMBO J, V22, P4337; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Finkelstein A, 1987, WATER MOVEMENT LIPID, P166; Han ZQ, 2000, BIOCHEM BIOPH RES CO, V273, P328, DOI 10.1006/bbrc.2000.2944; Hayashi Y, 2007, NEOPLASIA, V9, P777, DOI 10.1593/neo.07454; Herrera M, 2006, HYPERTENSION, V48, P157, DOI 10.1161/01.HYP.0000223652.29338.77; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaneko K, 2008, MICROVASC RES, V75, P297, DOI 10.1016/j.mvr.2007.12.003; Kaur C, 2006, GLIA, V54, P826, DOI 10.1002/glia.20420; Kim JG, 2007, J BIOL CHEM, V282, P14923, DOI 10.1074/jbc.M701411200; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Longatti PL, 2004, PEDIATR NEUROSURG, V40, P277, DOI 10.1159/000083740; Lopez-Barneo J, 2001, ANNU REV PHYSIOL, V63, P259, DOI 10.1146/annurev.physiol.63.1.259; Lopez-Campos JL, 2011, HISTOL HISTOPATHOL, V26, P451, DOI 10.14670/HH-26.451; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Mou KJ, 2010, J NEURO-ONCOL, V100, P375, DOI 10.1007/s11060-010-0205-x; Munoz-Cabello AM, 2005, J NEUROSCI, V25, P6631, DOI 10.1523/JNEUROSCI.1139-05.2005; Munoz-Cabello AM, 2010, PFLUG ARCH EUR J PHY, V459, P775, DOI 10.1007/s00424-009-0774-8; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Nakhoul NL, 1998, AM J PHYSIOL-CELL PH, V274, pC543, DOI 10.1152/ajpcell.1998.274.2.C543; Nesic O, 2008, J NEUROCHEM, V105, P628, DOI 10.1111/j.1471-4159.2007.05177.x; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Oshio K, 2005, NEUROSURGERY, V56, P375, DOI 10.1227/01.NEU.0000148904.57841.6B; Papadopoulos MC, 2004, NEUROSCIENCE, V129, P1011, DOI 10.1016/j.neuroscience.2004.05.044; Saadoun S, 2002, BRIT J CANCER, V87, P621, DOI 10.1038/sj.bjc.6600512; Semenza G L, 2000, Respir Res, V1, P159, DOI 10.1186/rr27; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Toledo-Aral JJ, 2003, J NEUROSCI, V23, P141; Vacca A, 2001, BRIT J HAEMATOL, V113, P415, DOI 10.1046/j.1365-2141.2001.02738.x; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; Verkman AS, 2005, J CELL SCI, V118, P3225, DOI 10.1242/jcs.02519; Wanner RM, 2000, BLOOD, V96, P1558, DOI 10.1182/blood.V96.4.1558.h8001558_1558_1565; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yamamoto N, 2001, MOL BRAIN RES, V90, P26, DOI 10.1016/S0169-328X(01)00064-X; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Yatsushige H, 2007, J NEUROSCI RES, V85, P1436, DOI 10.1002/jnr.21281	48	58	64	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28385	10.1371/journal.pone.0028385	http://dx.doi.org/10.1371/journal.pone.0028385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22174795	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900036
J	Roff, G; Kvennefors, ECE; Fine, M; Ortiz, J; Davy, JE; Hoegh-Guldberg, O				Roff, George; Kvennefors, E. Charlotte E.; Fine, Maoz; Ortiz, Juan; Davy, Joanne E.; Hoegh-Guldberg, Ove			The Ecology of 'Acroporid White Syndrome', a Coral Disease from the Southern Great Barrier Reef	PLOS ONE			English	Article							BLACK BAND DISEASE; INDO-PACIFIC REEFS; PLAGUE TYPE-II; POPULATION-DYNAMICS; FLORIDA-KEYS; SCLERACTINIAN CORALS; ERODING BAND; HOST-RANGE; RED-SEA; SIZE	Outbreaks of coral disease have increased worldwide over the last few decades. Despite this, remarkably little is known about the ecology of disease in the Indo-Pacific Region. Here we report the spatiotemporal dynamics of a coral disease termed 'Acroporid white syndrome' observed to affect tabular corals of the genus Acropora on the southern Great Barrier Reef. The syndrome is characterised by rapid tissue loss initiating in the basal margins of colonies, and manifests as a distinct lesion boundary between apparently healthy tissue and exposed white skeleton. Surveys of eight sites around Heron Reef in 2004 revealed a mean prevalence of 8.1 +/- 0.9%, affecting the three common species (Acropora cytherea, A. hyacinthus, A. clathrata) and nine other tabular Acropora spp. While all sizes of colonies were affected, white syndrome disproportionately affected larger colonies of tabular Acroporids (> 80 cm). The prevalence of white syndrome was strongly related to the abundance of tabular Acroporids within transects, yet the incidence of the syndrome appears unaffected by proximity to other colonies, suggesting that while white syndrome is density dependant, it does not exhibit a strongly aggregated spatial pattern consistent with previous coral disease outbreaks. Acroporid white syndrome was not transmitted by either direct contact in the field or by mucus in aquaria experiments. Monitoring of affected colonies revealed highly variable rates of tissue loss ranging from 0 to 1146 cm(-2) week(-1), amongst the highest documented for a coral disease. Contrary to previous links between temperature and coral disease, rates of tissue loss in affected colonies increased threefold during the winter months. Given the lack of spatial pattern and non-infectious nature of Acroporid white syndrome, further studies are needed to determine causal factors and longer-term implications of disease outbreaks on the Great Barrier Reef.	[Roff, George; Ortiz, Juan] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Roff, George; Kvennefors, E. Charlotte E.; Ortiz, Juan; Davy, Joanne E.; Hoegh-Guldberg, Ove] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia, Qld, Australia; [Fine, Maoz] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Fine, Maoz] Interuniversity, Inst Marine Sci, Elat, Israel; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland; Bar Ilan University; University of Queensland	Roff, G (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	g.roff@uq.edu.au	Hoegh-Guldberg, Ove/H-6169-2011; Roff, George/ABB-4406-2021; Hoegh-Guldberg, Ove/ABA-5420-2020; Fine, Maoz/S-5582-2019; Kvennefors, Eva Charlotte E/B-9585-2013; Roff, George/C-8766-2015; Ortiz Cuellar, Juan carlos/GQZ-3899-2022	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Roff, George/0000-0002-2823-0575; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Fine, Maoz/0000-0003-4911-4562; Roff, George/0000-0002-2823-0575; 	ARC Centre of Excellence for Coral Reef Studies; Coral Reef Targeted Research Program	ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); Coral Reef Targeted Research Program	This project was supported by funding from the ARC Centre of Excellence for Coral Reef Studies as well as the Coral Reef Targeted Research Program to OH-G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2005, CORAL REEFS, V24, P481, DOI 10.1007/s00338-005-0493-3; Ainsworth TD, 2007, MAR BIOL, V151, P19, DOI 10.1007/s00227-006-0449-3; Antonius A., 1988, P293; Antonius A, 1999, CORAL REEFS, V18, P300, DOI 10.1007/s003380050199; ANTONIUS A, 1985, Marine Ecology, V6, P197, DOI 10.1111/j.1439-0485.1985.tb00322.x; Antonius A, 1981, P 4 INT COR REEF S, V2, P7; Antonius A.A., 2001, ATOLL RES BULL, V481, P1, DOI [10.5479/si.00775630.481, DOI 10.5479/SI.00775630.481]; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; BABCOCK RC, 1984, CORAL REEFS, V2, P187; Baird AH, 2000, J EXP MAR BIOL ECOL, V251, P117, DOI 10.1016/S0022-0981(00)00209-4; Borger JL, 2005, CORAL REEFS, V24, P139, DOI 10.1007/s00338-004-0434-6; Bourne DG, 2008, APPL ENVIRON MICROB, V74, P883, DOI 10.1128/AEM.01124-07; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Bythell J, 2004, CORAL HEALTH AND DISEASE, P351; Bythell JC, 2002, LETT APPL MICROBIOL, V34, P359, DOI 10.1046/j.1472-765X.2002.01097.x; Coles S, 1994, CORAL REEFS, V13, P242, DOI DOI 10.1007/BF00303638; Connell JH, 1973, BIOLOGY GEOLOGY CORA, VII, P205; Croquer A, 2006, DIS AQUAT ORGAN, V69, P75, DOI 10.3354/dao069075; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fine M, 2006, CORAL REEFS, V25, P577, DOI 10.1007/s00338-006-0143-4; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Haapkyla J, 2010, CORAL REEFS, V29, P1035, DOI 10.1007/s00338-010-0660-z; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; Hayes RL, 1998, REV BIOL TROP, V46, P173; Hobbs JPA, 2010, DIS AQUAT ORGAN, V89, P1, DOI 10.3354/dao02181; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; HUGHES TP, 1984, AM NAT, V123, P778, DOI 10.1086/284239; HUGHES TP, 1987, AM NAT, V129, P818, DOI 10.1086/284677; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Jones RJ, 2004, MAR ECOL PROG SER, V281, P63, DOI 10.3354/meps281063; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kvennefors ECE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010401; Lirman D, 2000, J EXP MAR BIOL ECOL, V251, P41, DOI 10.1016/S0022-0981(00)00205-7; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; MEESTERS EH, 1995, MAR ECOL PROG SER, V121, P203, DOI 10.3354/meps121203; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Muko S, 2001, J ANIM ECOL, V70, P579, DOI 10.1046/j.1365-2656.2001.00513.x; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Nugues MM, 2009, CORAL REEFS, V28, P507, DOI 10.1007/s00338-009-0468-x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Oren U, 1997, MAR ECOL PROG SER, V146, P101, DOI 10.3354/meps146101; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Pandolfi JM, 2002, CORAL REEFS, V21, P13, DOI 10.1007/s00338-001-0204-7; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Richardson LL, 2002, P 9 INT COR REEF S, V1, P1225; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Rodriguez-Martinez RE, 2001, AQUATIC, V47, P229; Roff G, 2008, CORAL REEFS, V27, P373, DOI 10.1007/s00338-007-0339-2; Roff G, 2006, CORAL REEFS, V25, P255, DOI 10.1007/s00338-006-0099-4; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Shenkar N, 2005, MAR ECOL PROG SER, V294, P181, DOI 10.3354/meps294181; Sokal R.R., 2012, BIOMETRY; STIMSON J, 1985, ECOLOGY, V66, P40, DOI 10.2307/1941305; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweatman H.H., 2008, 8 AUSTR I MAR SCI; Szmant-Froelich A, 1985, P 5 INT COR REEF C T, V4, P399; Ulstrup KE, 2007, APPL ENVIRON MICROB, V73, P1968, DOI 10.1128/AEM.02292-06; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Veron JEN, 1984, SCLERACTINIA AUSTR V; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wegley L, 2004, MAR ECOL PROG SER, V273, P89, DOI 10.3354/meps273089; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Winkler R, 2004, MAR ECOL-P S Z N I, V25, P129, DOI 10.1111/j.1439-0485.2004.00020.x	81	25	28	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e26829	10.1371/journal.pone.0026829	http://dx.doi.org/10.1371/journal.pone.0026829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163267	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900003
J	Vethanayagam, RR; Almyroudis, NG; Grimm, MJ; Lewandowski, DC; Pham, CTN; Blackwell, TS; Petraitiene, R; Petraitis, V; Walsh, TJ; Urban, CF; Segal, BH				Vethanayagam, R. Robert; Almyroudis, Nikolaos G.; Grimm, Melissa J.; Lewandowski, David C.; Pham, Christine T. N.; Blackwell, Timothy S.; Petraitiene, Ruta; Petraitis, Vidmantas; Walsh, Thomas J.; Urban, Constantin F.; Segal, Brahm H.			Role of NADPH Oxidase versus Neutrophil Proteases in Antimicrobial Host Defense	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; PAPILLON-LEFEVRE-SYNDROME; P47(PHOX-/-) MOUSE MODEL; PULMONARY ASPERGILLOSIS; INFLAMMATORY RESPONSE; BURKHOLDERIA-CEPACIA; FUNGAL-INFECTIONS; AMPHOTERICIN-B; GENE-TRANSFER; ELASTASE	NADPH oxidase is a crucial enzyme in mediating antimicrobial host defense and in regulating inflammation. Patients with chronic granulomatous disease, an inherited disorder of NADPH oxidase in which phagocytes are defective in generation of reactive oxidant intermediates (ROIs), suffer from life-threatening bacterial and fungal infections. The mechanisms by which NADPH oxidase mediate host defense are unclear. In addition to ROI generation, neutrophil NADPH oxidase activation is linked to the release of sequestered proteases that are posited to be critical effectors of host defense. To definitively determine the contribution of NADPH oxidase versus neutrophil serine proteases, we evaluated susceptibility to fungal and bacterial infection in mice with engineered disruptions of these pathways. NADPH oxidase-deficient mice (p47(phox-/-)) were highly susceptible to pulmonary infection with Aspergillus fumigatus. In contrast, double knockout neutrophil elastase (NE)(-/-) x cathepsin G (CG)(-/-) mice and lysosomal cysteine protease cathepsin C/dipeptidyl peptidase I (DPPI)-deficient mice that are defective in neutrophil serine protease activation demonstrated no impairment in antifungal host defense. In separate studies of systemic Burkholderia cepacia infection, uniform fatality occurred in p47(phox-/-) mice, whereas NE-/- x CG(-/-) mice cleared infection. Together, these results show a critical role for NADPH oxidase in antimicrobial host defense against A. fumigatus and B. cepacia, whereas the proteases we evaluated were dispensable. Our results indicate that NADPH oxidase dependent pathways separate from neutrophil serine protease activation are required for host defense against specific pathogens.	[Vethanayagam, R. Robert; Almyroudis, Nikolaos G.; Grimm, Melissa J.; Lewandowski, David C.; Segal, Brahm H.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Almyroudis, Nikolaos G.; Segal, Brahm H.] SUNY Buffalo, Dept Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Pham, Christine T. N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Blackwell, Timothy S.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Petraitiene, Ruta; Petraitis, Vidmantas; Walsh, Thomas J.] Weill Cornell Univ, Med Ctr, Transplantat Oncol Infect Dis Program, New York, NY USA; [Urban, Constantin F.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Segal, Brahm H.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Washington University (WUSTL); Vanderbilt University; Cornell University; Umea University; Roswell Park Cancer Institute	Vethanayagam, RR (corresponding author), Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA.	brahm.segal@roswellpark.org	Segal, Brahm/AAW-2706-2020; Urban, Constantin/H-5121-2019	Urban, Constantin/0000-0003-1438-1134	Chronic Granulomatous Disorder Research Trust, NIAID [R01AI079253, R0AI049261]; NCI Cancer Center [CA016056]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079253, R01AI049261, R56AI049261] Funding Source: NIH RePORTER	Chronic Granulomatous Disorder Research Trust, NIAID; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Chronic Granulomatous Disorder Research Trust (BHS), NIAID R01AI079253 (BHS) and R0AI049261 (CTNP). This research was supported, in part, by the NCI Cancer Center Support Grant to Roswell Park Cancer Institute (CA016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkison AM, 2002, J CLIN INVEST, V109, P363, DOI 10.1172/JCI13462; Akk AM, 2008, J IMMUNOL, V180, P3535, DOI 10.4049/jimmunol.180.5.3535; Almuneef M, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e85; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BAEHNER RL, 1967, SCIENCE, V155, P835, DOI 10.1126/science.155.3764.835; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Bianchi M, 2011, J ALLERGY CLIN IMMUN, V127, P1243, DOI 10.1016/j.jaci.2011.01.021; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bignell E, 2005, INFECT IMMUN, V73, P5204, DOI 10.1128/IAI.73.8.5204-5207.2005; Boyle KB, 2011, J IMMUNOL, V186, P2978, DOI 10.4049/jimmunol.1002268; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; Dalgic B, 2011, EUR J PEDIATR, V170, P803, DOI 10.1007/s00431-010-1368-3; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dennis CG, 2006, ANTIMICROB AGENTS CH, V50, P422, DOI 10.1128/AAC.50.2.422-427.2006; Dinauer MC, 2001, BLOOD, V97, P3738, DOI 10.1182/blood.V97.12.3738; DIXON DM, 1989, INFECT IMMUN, V57, P1452, DOI 10.1128/IAI.57.5.1452-1456.1989; Francesconi A, 2006, J CLIN MICROBIOL, V44, P2475, DOI 10.1128/JCM.02693-05; FRANCIS P, 1994, J INFECT DIS, V169, P356, DOI 10.1093/infdis/169.2.356; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gallin JI, 2003, NEW ENGL J MED, V348, P2416, DOI 10.1056/NEJMoa021931; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Hakkim A, 2011, NAT CHEM BIOL, V7, P75, DOI 10.1038/NCHEMBIO.496; Hu Y, 2005, ARTHRITIS RHEUM-US, V52, P2553, DOI 10.1002/art.21192; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jann NJ, 2009, J LEUKOCYTE BIOL, V86, P1159, DOI 10.1189/jlb.0209053; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; Marcos V, 2011, NAT MED, V17, P899, DOI 10.1038/nm0711-899a; Mardiney M, 1997, BLOOD, V89, P2268, DOI 10.1182/blood.V89.7.2268; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Petraitiene R, 2001, ANTIMICROB AGENTS CH, V45, P857, DOI 10.1128/AAC.45.3.857-869.2001; Pham CTN, 2004, J IMMUNOL, V173, P7277, DOI 10.4049/jimmunol.173.12.7277; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Segal BH, 2003, INFECT IMMUN, V71, P205, DOI 10.1128/IAI.71.1.205-210.2003; Segal BH, 1998, MEDICINE, V77, P345, DOI 10.1097/00005792-199809000-00004; Segal BH, 2000, INFECT IMMUN, V68, P2374, DOI 10.1128/IAI.68.4.2374-2378.2000; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Segal BH, 2011, BIOL BLOOD MARROW TR, V17, pS123, DOI 10.1016/j.bbmt.2010.09.008; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; SPEERT DP, 1994, J INFECT DIS, V170, P1524, DOI 10.1093/infdis/170.6.1524; THRASHER AJ, 1994, BBA-MOL BASIS DIS, V1227, P1, DOI 10.1016/0925-4439(94)90100-7; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Weinrauch Y, 2002, NATURE, V417, P91, DOI 10.1038/417091a; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yamada M, 2011, AM J RESP CRIT CARE, V183, P1391, DOI 10.1164/rccm.201004-0592OC; Zaas AK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000101; Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367	65	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28149	10.1371/journal.pone.0028149	http://dx.doi.org/10.1371/journal.pone.0028149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163282	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900017
J	Ullah, N; Lee, HY; Naseer, MI; Ullah, I; Suh, JW; Kim, MO				Ullah, Najeeb; Lee, Hae Young; Naseer, Muhammad Imran; Ullah, Ikram; Suh, Joo Won; Kim, Myeong Ok			Nicotinamide Inhibits Alkylating Agent-Induced Apoptotic Neurodegeneration in the Developing Rat Brain	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CELL-DEATH; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE-1; HEMATOLOGICAL MALIGNANCIES; ANTICANCER AGENTS; NAD(+) DEPLETION; NERVOUS-SYSTEM; INDUCED INJURY; CYTOCHROME-C	Background: Exposure to the chemotherapeutic alkylating agent thiotepa during brain development leads to neurological complications arising from neurodegeneration and irreversible damage to the developing central nerve system (CNS). Administration of single dose of thiotepa in 7-d postnatal (P7) rat triggers activation of apoptotic cascade and widespread neuronal death. The present study was aimed to elucidate whether nicotinamide may prevent thiotepa-induced neurodegeneration in the developing rat brain. Methodology/Principal Findings: Neuronal cell death induced by thiotepa was associated with the induction of Bax, release of cytochrome-c from mitochondria into the cytosol, activation of caspase-3 and cleavage of poly (ADP-ribose) polymerase (PARP-1). Post-treatment of developing rats with nicotinamide suppressed thiotepa-induced upregulation of Bax, reduced cytochrome-c release into the cytosol and reduced expression of activated caspase-3 and cleavage of PARP-1. Cresyl violet staining showed numerous dead cells in the cortex hippocampus and thalamus; post-treatment with nicotinamide reduced the number of dead cells in these brain regions. Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labeling (TUNEL) and immunohistochemical analysis of caspase-3 show that thiotepa-induced cell death is apoptotic and that it is inhibited by nicotinamide treatment. Conclusion: Nicotinamide (Nic) treatment with thiotepa significantly improved neuronal survival and alleviated neuronal cell death in the developing rat. These data demonstrate that nicotinamide shows promise as a therapeutic and neuroprotective agent for the treatment of neurodegenerative disorders in newborns and infants.	[Ullah, Najeeb; Lee, Hae Young; Naseer, Muhammad Imran; Ullah, Ikram; Kim, Myeong Ok] Gyeongsang Natl Univ, Coll Nat Sci RINS & Appl Life Sci Brain Korea 21, Div Life Sci, Chinju, South Korea; [Suh, Joo Won] Myongji Univ, Div Biosci & Bioinformat, Yongin, Kyonggido, South Korea	Gyeongsang National University; Myongji University	Ullah, N (corresponding author), Gyeongsang Natl Univ, Coll Nat Sci RINS & Appl Life Sci Brain Korea 21, Div Life Sci, Chinju, South Korea.	mokim@gsnu.ac.kr	Kim, Myeong Ok/AAS-1488-2021; Ullah, Najeeb/AAU-3677-2021; Naseer, Muhammad Imran/AAG-4921-2020; Naseer, Muhammad Imran/H-9477-2012	Kim, Myeong Ok/0000-0003-4317-1072; Ullah, Najeeb/0000-0001-7875-6834; Naseer, Muhammad Imran/0000-0002-9343-5825	Rural Development Administration [PJ008075, PJ007361]	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next Generation Biogreen 21 program (PJ008075) and Agenda PJ007361 of Rural Development Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2002, P NATL ACAD SCI USA, V99, P245, DOI 10.1073/pnas.012460399; Albers J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub2; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Ayoub IA, 1999, NEUROSCI LETT, V259, P21, DOI 10.1016/S0304-3940(98)00881-7; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Brown RT, 1999, J DEV BEHAV PEDIATR, V20, P373, DOI 10.1097/00004703-199910000-00013; Burkle A, 2001, CHEMBIOCHEM, V2, P725, DOI 10.1002/1439-7633(20011001)2:10<725::AID-CBIC725>3.0.CO;2-3; Cavaliere R, 2006, CURR NEUROL NEUROSCI, V6, P218, DOI 10.1007/s11910-006-0009-8; Chang DTW, 2006, PROG NEUROBIOL, V80, P241, DOI 10.1016/j.pneurobio.2006.09.003; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; CHETSANGA CJ, 1979, NUCLEIC ACIDS RES, V6, P3673, DOI 10.1093/nar/6.11.3673; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Chong ZZ, 2002, J VASC RES, V39, P131, DOI 10.1159/000057762; Davoodi J, 2010, INT J BIOCHEM CELL B, V42, P958, DOI 10.1016/j.biocel.2010.02.008; Debatin KM, 2002, ONCOGENE, V21, P8786, DOI 10.1038/sj.onc.1206039; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Formigli L, 2000, J CELL PHYSIOL, V182, P41, DOI 10.1002/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; Hu YM, 1999, EMBO J, V18, P3586, DOI 10.1093/emboj/18.13.3586; Ieraci A, 2006, PLOS MED, V3, P547, DOI 10.1371/journal.pmed.0030101; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; Klaidman LK, 2001, BBA-GEN SUBJECTS, V1525, P136, DOI 10.1016/S0304-4165(00)00181-1; Klaidman LK, 1996, NEUROSCI LETT, V206, P5, DOI 10.1016/0304-3940(96)12446-0; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Mukherjee SK, 1997, EUR J PHARMACOL, V330, P27, DOI 10.1016/S0014-2999(97)00171-4; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Olney JW, 2003, CURR OPIN PHARMACOL, V3, P101, DOI 10.1016/S1471-4892(02)00002-4; Pui CH, 2003, NEW ENGL J MED, V349, P640, DOI 10.1056/NEJMoa035091; Reddy Alyssa T, 2003, Curr Neurol Neurosci Rep, V3, P137, DOI 10.1007/s11910-003-0065-2; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Sairanen T, 2009, ACTA NEUROPATHOL, V118, P541, DOI 10.1007/s00401-009-0559-3; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SCHRAUFSTATTER IU, 1986, P NATL ACAD SCI USA, V83, P4908, DOI 10.1073/pnas.83.13.4908; Solary E, 2000, LEUKEMIA, V14, P1833, DOI 10.1038/sj.leu.2401902; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Uehara N, 2006, EXP EYE RES, V82, P488, DOI 10.1016/j.exer.2005.08.006; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Van Gool SW, 2000, LEUKEMIA, V14, P2076, DOI 10.1038/sj.leu.2401934; Vercammen D, 1998, J EXP MED, V188, P919, DOI 10.1084/jem.188.5.919; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Wisessmith W, 2009, J PINEAL RES, V46, P433, DOI 10.1111/j.1600-079X.2009.00680.x; Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Yu SW, 2003, NEUROBIOL DIS, V14, P303, DOI 10.1016/j.nbd.2003.08.008; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989	60	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27093	10.1371/journal.pone.0027093	http://dx.doi.org/10.1371/journal.pone.0027093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164206	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400006
J	Garza, MC; Fernandez-Borges, N; Bolea, R; Badiola, JJ; Castilla, J; Monleon, E				Carmen Garza, Maria; Fernandez-Borges, Natalia; Bolea, Rosa; Jose Badiola, Juan; Castilla, Joaquin; Monleon, Eva			Detection of PrPres in Genetically Susceptible Fetuses from Sheep with Natural Scrapie	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; PRPSC ACCUMULATION; PRION PROTEIN; LYMPHOID-TISSUES; TRANSMISSION; AMPLIFICATION; FERRITIN; PLACENTA; ANIMALS; BRAIN	Scrapie is a transmissible spongiform encephalopathy with a wide PrPres dissemination in many non-neural tissues and with high levels of transmissibility within susceptible populations. Mechanisms of transmission are incompletely understood. It is generally assumed that it is horizontally transmitted by direct contact between animals or indirectly through the environment, where scrapie can remain infectious for years. In contrast, in utero vertical transmission has never been demonstrated and has rarely been studied. Recently, the use of the protein misfolding cyclic amplification technique (PMCA) has allowed prion detection in various tissues and excretions in which PrPres levels have been undetectable by traditional assays. The main goal of this study was to detect PrPres in fetal tissues and the amniotic fluid from natural scrapie infected ewes using the PMCA technique. Six fetuses from three infected pregnant ewes in an advanced clinical stage of the disease were included in the study. From each fetus, amniotic fluid, brain, spleen, ileo-cecal valve and retropharyngeal lymph node samples were collected and analyzed using Western blotting and PMCA. Although all samples were negative using Western blotting, PrPres was detected after in vitro amplification. Our results represent the first time the biochemical detection of prions in fetal tissues, suggesting that the in utero transmission of scrapie in natural infected sheep might be possible.	[Carmen Garza, Maria; Bolea, Rosa; Jose Badiola, Juan; Monleon, Eva] Univ Zaragoza, Ctr Invest Encefalopatias Espongiformes Transmisi, Zaragoza, Spain; [Fernandez-Borges, Natalia; Castilla, Joaquin] CIC BioGUNE, Derio, Spain; [Castilla, Joaquin] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Monleon, Eva] Univ Lleida, Lleida, Spain	University of Zaragoza; CIC bioGUNE; Basque Foundation for Science; Universitat de Lleida	Garza, MC (corresponding author), Univ Zaragoza, Ctr Invest Encefalopatias Espongiformes Transmisi, Zaragoza, Spain.	emonleon@unizar.es	Garza, M Carmen/ABI-8266-2020; Fernández-Borges, Natalia/H-1875-2012; Castilla, Joaquín/J-8414-2019; Castilla, Joaquin/D-5261-2011; Castilla, Joaquin/E-6952-2012; MONZÓN, MARTA/R-6162-2017	Garza, M Carmen/0000-0001-7098-2327; Castilla, Joaquín/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; MONZÓN, MARTA/0000-0002-2787-9671; Fernandez-Borges, Natalia/0000-0001-6274-0096	Spain [AGL2009-11553-C02-01]; Basque government [PI2010-18]; Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia County; FPU, Spanish Ministry of Education [AP2007-03842]	Spain; Basque government(Basque Government); Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country; Innovation Technology Department of the Bizkaia County; FPU, Spanish Ministry of Education(Spanish Government)	This study was supported by a national grant from Spain (AGL2009-11553-C02-01), a Basque government grant (PI2010-18) and the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2011/2013), from the Innovation Technology Department of the Bizkaia County. Dr. Garza was supported by a FPU doctoral grant from the Spanish Ministry of Education (AP2007-03842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson J, 2006, J GEN VIROL, V87, P1035, DOI 10.1099/vir.0.81418-0; Andreoletti O, 2002, J GEN VIROL, V83, P2607, DOI 10.1099/0022-1317-83-10-2607; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Caplazi P, 2004, J VET DIAGN INVEST, V16, P489, DOI 10.1177/104063870401600601; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; DICKINSON AG, 1974, J COMP PATHOL, V84, P19, DOI 10.1016/0021-9975(74)90023-1; Ersdal C, 2005, VET PATHOL, V42, P258, DOI 10.1354/vp.42-3-258; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Hoinville LJ, 2010, PREV VET MED, V93, P121, DOI 10.1016/j.prevetmed.2009.10.013; Hoinville LJ, 1996, REV SCI TECH OIE, V15, P827, DOI 10.20506/rst.15.3.959; HOURRIGAN JL, 1990, J AM VET MED ASSOC, V196, P1678; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; Kruger D, 2009, VET RES, V40, DOI 10.1051/vetres:2008042; Lacroux C, 2007, J GEN VIROL, V88, P1056, DOI 10.1099/vir.0.82218-0; Lacroux C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000238; Leiser R, 1997, J ANAT, V191, P517, DOI 10.1046/j.1469-7580.1997.19140517.x; Maddison BC, 2010, J INFECT DIS, V201, P1672, DOI 10.1086/652457; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Mishra RS, 2004, J NEUROSCI, V24, P11280, DOI 10.1523/JNEUROSCI.2864-04.2004; Monleon E, 2004, J HISTOCHEM CYTOCHEM, V52, P145, DOI 10.1177/002215540405200201; Monleon E, 2011, VET MICROBIOL, V147, P237, DOI 10.1016/j.vetmic.2010.06.028; MYAGKAYA G, 1981, CELL TISSUE RES, V214, P501, DOI 10.1007/BF00233491; ONODERA T, 1993, MICROBIOL IMMUNOL, V37, P311, DOI 10.1111/j.1348-0421.1993.tb03215.x; Peralta OA, 2011, DIFFERENTIATION, V81, P68, DOI 10.1016/j.diff.2010.09.181; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Spraker TR, 2006, J VET DIAGN INVEST, V18, P553, DOI 10.1177/104063870601800605; Sunkesula SRB, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-14; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Tuo WB, 2002, P NATL ACAD SCI USA, V99, P6310, DOI 10.1073/pnas.072071199; Vargas F, 2005, VET REC, V156, P318, DOI 10.1136/vr.156.10.318; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; WOODING P, 2008, COMP PLACENTATION ST, P17; Wrathall AE, 2008, THERIOGENOLOGY, V70, P725, DOI 10.1016/j.theriogenology.2008.05.049	42	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27525	10.1371/journal.pone.0027525	http://dx.doi.org/10.1371/journal.pone.0027525			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194786	Green Published, Green Submitted, gold			2022-12-27	WOS:000298369100006
J	Scholz, NL; Myers, MS; McCarthy, SG; Labenia, JS; McIntyre, JK; Ylitalo, GM; Rhodes, LD; Laetz, CA; Stehr, CM; French, BL; McMillan, B; Wilson, D; Reed, L; Lynch, KD; Damm, S; Davis, JW; Collier, TK				Scholz, Nathaniel L.; Myers, Mark S.; McCarthy, Sarah G.; Labenia, Jana S.; McIntyre, Jenifer K.; Ylitalo, Gina M.; Rhodes, Linda D.; Laetz, Cathy A.; Stehr, Carla M.; French, Barbara L.; McMillan, Bill; Wilson, Dean; Reed, Laura; Lynch, Katherine D.; Damm, Steve; Davis, Jay W.; Collier, Tracy K.			Recurrent Die-Offs of Adult Coho Salmon Returning to Spawn in Puget Sound Lowland Urban Streams	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; SOCKEYE-SALMON; PACIFIC-NORTHWEST; FRASER-RIVER; TOXICITY; EXPOSURE; ASSAY; HYDROCARBONS; THRESHOLDS; MORTALITY	Several Seattle-area streams in Puget Sound were the focus of habitat restoration projects in the 1990s. Post-project effectiveness monitoring surveys revealed anomalous behaviors among adult coho salmon returning to spawn in restored reaches. These included erratic surface swimming, gaping, fin splaying, and loss of orientation and equilibrium. Affected fish died within hours, and female carcasses generally showed high rates (>90%) of egg retention. Beginning in the fall of 2002, systematic spawner surveys were conducted to 1) assess the severity of the adult die-offs, 2) compare spawner mortality in urban vs. non-urban streams, and 3) identify water quality and spawner condition factors that might be associated with the recurrent fish kills. The forensic investigation focused on conventional water quality parameters (e. g., dissolved oxygen, temperature, ammonia), fish condition, pathogen exposure and disease status, and exposures to metals, polycyclic aromatic hydrocarbons, and current use pesticides. Daily surveys of a representative urban stream (Longfellow Creek) from 2002-2009 revealed premature spawner mortality rates that ranged from 60-100% of each fall run. The comparable rate in a non-urban stream was,1% (Fortson Creek, surveyed in 2002). Conventional water quality, pesticide exposure, disease, and spawner condition showed no relationship to the syndrome. Coho salmon did show evidence of exposure to metals and petroleum hydrocarbons, both of which commonly originate from motor vehicles in urban landscapes. The weight of evidence suggests that freshwater-transitional coho are particularly vulnerable to an as-yet unidentified toxic contaminant (or contaminant mixture) in urban runoff. Stormwater may therefore place important constraints on efforts to conserve and recover coho populations in urban and urbanizing watersheds throughout the western United States.	[Scholz, Nathaniel L.; Myers, Mark S.; Labenia, Jana S.; McIntyre, Jenifer K.; Ylitalo, Gina M.; Rhodes, Linda D.; Laetz, Cathy A.; Stehr, Carla M.; French, Barbara L.; Collier, Tracy K.] NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA; [McCarthy, Sarah G.; Wilson, Dean] King Cty, Dept Nat Resources & Pk, Seattle, WA USA; [McMillan, Bill] Wild Fish Conservancy, Duvall, WA USA; [Reed, Laura; Lynch, Katherine D.] City Seattle, Seattle Publ Util, Seattle, WA USA; [Damm, Steve; Davis, Jay W.] US Fish & Wildlife Serv, Washington Fish & Wildlife Off, Lacey, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service	Scholz, NL (corresponding author), NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA.	Nathaniel.Scholz@noaa.gov	, Jenifer/AAA-2614-2022; McCarthy, Sarah/HCI-8963-2022; Scholz, Nathaniel L/L-1642-2013	, Jenifer/0000-0003-3480-7083; Scholz, Nathaniel L/0000-0001-6207-0272; Rhodes, Linda/0000-0003-4995-9426	National Oceanic and Atmospheric Administration; U.S. Fish and Wildlife Service National Contaminants Program; U.S. Environmental Protection Agency Region; King Conservation District	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Fish and Wildlife Service National Contaminants Program; U.S. Environmental Protection Agency Region(United States Environmental Protection Agency); King Conservation District	This project received agency funding from the National Oceanic and Atmospheric Administration (Coastal Storms Program), the U.S. Fish and Wildlife Service National Contaminants Program, the U.S. Environmental Protection Agency Region 10, and the King Conservation District. Funds were delivered via interagency agreements, so grant numbers are not applicable. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Richard O., 1996, P447; Arkoosh MR, 2004, J AQUAT ANIM HEALTH, V16, P186, DOI 10.1577/H03-071.1; Booth DB, 1997, J AM WATER RESOUR AS, V33, P1077, DOI 10.1111/j.1752-1688.1997.tb04126.x; *CA DEP FISH GAM, 2004, SEPT 2002 KLAM RIV F; Carr RL, 1997, ENVIRON TOXICOL CHEM, V16, P2369, DOI [10.1002/etc.5620161124, 10.1897/1551-5028(1997)016&lt;2369:STOCTS&gt;2.3.CO;2]; Chase DM, 1998, DIS AQUAT ORGAN, V34, P223, DOI 10.3354/dao034223; Claireaux G, 2010, AQUAT TOXICOL, V98, P113, DOI 10.1016/j.aquatox.2010.02.006; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crossin GT, 2008, CAN J ZOOL, V86, P127, DOI 10.1139/Z07-122; Docker MF, 1997, DIS AQUAT ORGAN, V29, P41, DOI 10.3354/dao029041; Fairgrieve WT, 2005, DIS AQUAT ORGAN, V64, P99, DOI 10.3354/dao064099; Feist BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023424; Fournie John W., 2000, P569, DOI 10.1016/B978-012529650-2/50043-3; Gilhousen P, 1990, B INT PACIFIC SALMON, V26; Hoffman RS, 2000, ENVIRON TOXICOL CHEM, V19, P2249, DOI [10.1002/etc.5620190915, 10.1897/1551-5028(2000)019&lt;2249:COPIEU&gt;2.3.CO;2]; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Jackson CR, 2010, BIOSCIENCE, V60, P37, DOI 10.1525/bio.2010.60.1.8; KENT ML, 1985, J PROTOZOOL, V32, P254; KRAHN MM, 1984, XENOBIOTICA, V14, P633, DOI 10.3109/00498258409151461; Laetz CA, 2009, ENVIRON HEALTH PERSP, V117, P348, DOI 10.1289/ehp.0800096; Lavado R, 2011, ENVIRON SCI TECHNOL, V45, P4623, DOI 10.1021/es200451j; Lough GC, 2005, ENVIRON SCI TECHNOL, V39, P826, DOI 10.1021/es048715f; Luna L, 1992, HISTOPATHOLOGIC METH; MCMILLAN B, 2007, SPAWNING SURVEY FIND; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Palenzuela O, 1999, DIS AQUAT ORGAN, V36, P45, DOI 10.3354/dao036045; Quinn TP, 2007, CAN J FISH AQUAT SCI, V64, P574, DOI 10.1139/F07-035; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Sandahl JF, 2005, ENVIRON TOXICOL CHEM, V24, P136, DOI 10.1897/04-195R.1; Sloan C. A, 2006, NMFSNWFSC77 NOAA US; Sokal R. R, 1981, BIOMETRY; Spromberg Julann A., 2011, Integrated Environmental Assessment and Management, V7, P648, DOI 10.1002/ieam.219; St-Hilaire S, 2002, J FISH DIS, V25, P107, DOI 10.1046/j.1365-2761.2002.00344.x; Stein ED, 2006, ENVIRON TOXICOL CHEM, V25, P373, DOI 10.1897/05-285R.1; Tiefenthaler LL, 2008, ENVIRON TOXICOL CHEM, V27, P277, DOI 10.1897/07-126R.1; Uchida K, 1997, MAR BIOL, V129, P247, DOI 10.1007/s002270050165; Van Genderen EJ, 2005, ENVIRON TOXICOL CHEM, V24, P408, DOI 10.1897/03-494.1; *WA TROUT, 2004, LAND US COL PRESP MO; Wagner RJ, 2000, GUIDELINES STANDARD; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140; 2007, STATE WATERS 2007, V1	43	65	65	10	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28013	10.1371/journal.pone.0028013	http://dx.doi.org/10.1371/journal.pone.0028013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194802	Green Submitted, gold, Green Published			2022-12-27	WOS:000298369100018
J	Liu, DF; Lian, B; Wang, B; Jiang, GF				Liu, Dianfeng; Lian, Bin; Wang, Bin; Jiang, Guofang			Degradation of Potassium Rock by Earthworms and Responses of Bacterial Communities in Its Gut and Surrounding Substrates after Being Fed with Mineral	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; DIVERSITY MEASURES; SOIL INGESTION; AVAILABILITY; METALS	Background: Earthworms are an ecosystem's engineers, contributing to a wide range of nutrient cycling and geochemical processes in the ecosystem. Their activities can increase rates of silicate mineral weathering. Their intestinal microbes usually are thought to be one of the key drivers of mineral degradation mediated by earthworms, but the diversities of the intestinal microorganisms which were relevant with mineral weathering are unclear. Methodology/Principal Findings: In this report, we show earthworms' effect on silicate mineral weathering and the responses of bacterial communities in their gut and surrounding substrates after being fed with potassium-bearing rock powder (PBRP). Determination of water-soluble and HNO3-extractable elements indicated some elements such as Al, Fe and Ca were significantly released from mineral upon the digestion of earthworms. The microbial communities in earthworms' gut and the surrounding substrates were investigated by amplified ribosomal DNA restriction analysis (ARDRA) and the results showed a higher bacterial diversity in the guts of the earthworms fed with PBRP and the PBRP after being fed to earthworms. UPGMA dendrogram with unweighted UniFrac analysis, considering only taxa that are present, revealed that earthworms' gut and their surrounding substrate shared similar microbiota. UPGMA dendrogram with weighted UniFrac, considering the relative abundance of microbial lineages, showed the two samples from surrounding substrate and the two samples from earthworms' gut had similarity in microbial community, respectively. Conclusions/Significance: Our results indicated earthworms can accelerate degradation of silicate mineral. Earthworms play an important role in ecosystem processe since they not only have some positive effects on soil structure, but also promote nutrient cycling of ecosystem by enhancing the weathering of minerals.	[Liu, Dianfeng; Lian, Bin; Jiang, Guofang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Peoples R China; [Lian, Bin] Chinese Acad Sci, Inst Geochem, State Key Lab Environm Geochem, Guiyang, Peoples R China; [Wang, Bin] Henan Inst Sci & Technol, Dept Bioengn, Xinxiang, Peoples R China	Nanjing Normal University; Chinese Academy of Sciences; Guiyang Institute of Geochemistry, CAS; Henan Institute of Science & Technology	Liu, DF (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Engn & Technol Res Ctr Microbiol, Jiangsu Key Lab Microbes & Funct Genom, Nanjing, Peoples R China.	bin2368@vip.163.com	Jiang, Guo-Fang/I-5236-2019	Jiang, Guo-Fang/0000-0003-0164-0950	Jiangsu Higher Education Institutions; National High Technology Research and Development Program of China [2008AA06Z108]; National Science Fund for Creative Research Groups [40721002]	Jiangsu Higher Education Institutions; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Science Fund for Creative Research Groups(Science Fund for Creative Research Groups)	The work was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the National High Technology Research and Development Program of China (2008AA06Z108), and the National Science Fund for Creative Research Groups (40721002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2003, PEDOBIOLOGIA, V47, P877, DOI 10.1016/S0031-4056(04)70283-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amtmann A, 2007, CELL RES, V17, P483, DOI 10.1038/cr.2007.49; Banfield JF, 1999, P NATL ACAD SCI USA, V96, P3404, DOI 10.1073/pnas.96.7.3404; Basak BB, 2009, PLANT SOIL, V317, P235, DOI 10.1007/s11104-008-9805-z; Basak BB, 2010, BIOL FERT SOILS, V46, P641, DOI 10.1007/s00374-010-0456-x; BASKER A, 1992, BIOL FERT SOILS, V14, P300, DOI 10.1007/BF00395467; BASKER A, 1994, BIOL FERT SOILS, V17, P154, DOI 10.1007/BF00337748; Burford EP, 2003, MINERAL MAG, V67, P1127, DOI 10.1180/0026461036760154; Carpenter D, 2008, MINERAL MAG, V72, P33, DOI 10.1180/minmag.2008.072.1.33; Carpenter D, 2007, EUR J SOIL BIOL, V43, pS176, DOI 10.1016/j.ejsobi.2007.08.053; CHEN J., 2000, GEOLOGY CHEM MINERAL, V22, P58; [谌书 CHEN Shu], 2008, [矿物学报, Acta Mineralogica Sinica], V28, P77; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; EDWARDS CA, 1996, BIOL ECOLOGY EARTHWO, P151; Gadd GM, 2007, MYCOL RES, V111, P3, DOI 10.1016/j.mycres.2006.12.001; Goudie AS, 1996, J ARID ENVIRON, V32, P103, DOI 10.1006/jare.1996.0010; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hosseinifard SJ, 2010, GEODERMA, V155, P289, DOI 10.1016/j.geoderma.2009.12.013; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li S, 2006, MINERAL RESOURCES GE, V20, P577; Liu Weiqi, 2008, Weishengwu Xuebao, V48, P1344; Liu WX, 2006, ENVIRON GEOCHEM HLTH, V28, P133, DOI 10.1007/s10653-005-9022-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mathur J, 2007, APPL ENVIRON MICROB, V73, P2612, DOI 10.1128/AEM.02567-06; Needham SJ, 2004, BIOGEOSCIENCES, V1, P113, DOI 10.5194/bg-1-113-2004; Price GW, 2008, APPL SOIL ECOL, V38, P230, DOI 10.1016/j.apsoil.2007.10.014; Sanz-Montero ME, 2009, GEOL MAG, V146, P527, DOI 10.1017/S0016756808005906; Sugumaran P., 2007, World Journal of Agricultural Sciences, V3, P350; [孙爱文 SUN Ai-wen], 2009, [现代化工, Modern Chemical Industry], V29, P10; SUN AW, 2009, MOD CHEM IND, V29, P16; Suzuki Y, 2003, GEODERMA, V112, P131, DOI 10.1016/S0016-7061(02)00300-2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tian G, 2000, SOIL SCI SOC AM J, V64, P222, DOI 10.2136/sssaj2000.641222x; Udovic M, 2007, ENVIRON POLLUT, V148, P663, DOI 10.1016/j.envpol.2006.11.010; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wust PK, 2009, APPL ENVIRON MICROB, V75, P1852, DOI 10.1128/AEM.02745-08; XU JY, 2010, ACTA MICROBIOL SIN, V50, P438; Yin HQ, 2008, ARCH MICROBIOL, V189, P101, DOI 10.1007/s00203-007-0298-6; Zhang B G, 2000, ACTA ECOLOGICA SINIC, V20, P168; Zhang SK, 2001, J AGR U HEBEI, V24, P16; Zhang Weixin, 2007, Shengwu Duoyangxing, V15, P142, DOI 10.1360/biodiv.060294; Zhao Fei, 2010, Weishengwu Xuebao, V50, P647	45	24	29	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28803	10.1371/journal.pone.0028803	http://dx.doi.org/10.1371/journal.pone.0028803			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174903	gold, Green Submitted, Green Published			2022-12-27	WOS:000298367300026
J	Dodds, PS; Harris, KD; Kloumann, IM; Bliss, CA; Danforth, CM				Dodds, Peter Sheridan; Harris, Kameron Decker; Kloumann, Isabel M.; Bliss, Catherine A.; Danforth, Christopher M.			Temporal Patterns of Happiness and Information in a Global Social Network: Hedonometrics and Twitter	PLOS ONE			English	Article								Individual happiness is a fundamental societal metric. Normally measured through self-report, happiness has often been indirectly characterized and overshadowed by more readily quantifiable economic indicators such as gross domestic product. Here, we examine expressions made on the online, global microblog and social networking service Twitter, uncovering and explaining temporal variations in happiness and information levels over timescales ranging from hours to years. Our data set comprises over 46 billion words contained in nearly 4.6 billion expressions posted over a 33 month span by over 63 million unique users. In measuring happiness, we construct a tunable, real-time, remote-sensing, and non-invasive, text-based hedonometer. In building our metric, made available with this paper, we conducted a survey to obtain happiness evaluations of over 10,000 individual words, representing a tenfold size improvement over similar existing word sets. Rather than being ad hoc, our word list is chosen solely by frequency of usage, and we show how a highly robust and tunable metric can be constructed and defended.	[Dodds, Peter Sheridan; Harris, Kameron Decker; Kloumann, Isabel M.; Bliss, Catherine A.; Danforth, Christopher M.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Ctr Complex Syst, Burlington, VT 05405 USA; [Dodds, Peter Sheridan; Danforth, Christopher M.] Univ Vermont, Vermont Adv Comp Ctr, Burlington, VT 05405 USA; [Kloumann, Isabel M.] Univ Vermont, Dept Phys, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Dodds, PS (corresponding author), Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA.	peter.dodds@uvm.edu; chris.danforth@uvm.edu	Dodds, Peter S/C-9119-2014	Dodds, Peter S/0000-0003-1973-8614	NASA [NNX 08A096G]; VT-NASA EPSCoR; NSF [0846668]	NASA(National Aeronautics & Space Administration (NASA)); VT-NASA EPSCoR; NSF(National Science Foundation (NSF))	The authors are grateful for the computational resources provided by the Vermont Advanced Computing Center which is supported by NASA (NNX 08A096G). KDH was supported by VT-NASA EPSCoR. PSD was supported by NSF CAREER Award # 0846668. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INS TWITT IN DEPTH L; [Anonymous], 2011, PULSE NATION US MOOD; [Anonymous], NY TIMES; [Anonymous], 2011, TWITTER UPDATE 2011; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; Balog K., 2006, 11 M EUR CHAPT ASS C; Balog K, 2006, 3 ANN WORKSH WEBL EC; Bell G, 2009, SCIENCE, V323, P1297, DOI 10.1126/science.1170411; Bollen J, 2009, P 5 INT AAAI C WEBL; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Bollen J, 2011, ARTIF LIFE, V17, P237, DOI 10.1162/artl_a_00034; Choi Y, 2006, C EMP METH NAT LANG; Choi Yejin, 2005, HLT EMNLP; Collins JP, 2010, SCIENCE, V327, P1455, DOI 10.1126/science.1186123; Dodds P. S., 2009, J HAPPINESS STUDIES; Dodds PS, 2011, TEMPORAL PATTERNS HA; Edgeworth F.Y., 1881, MATH PHYS ESSAY APPL; Fowler JH, 2008, BMJ, V337; Fox S, 2006, TWITTER STATUS UPDAT; Gilbert D, 2006, STUMBLING HAPPINESS; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Harris J., 2009, WE FEEL FINE ALMANAC; Hedstrom P, 2006, SCIENCE, V311, P786, DOI 10.1126/science.1124707; Hey T., 2009, 4 PARADIGM DATA INTE; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kahneman D., 2005, SCI WELL BEING, V1, P285, DOI DOI 10.1093/ACPROF:OSO/9780198567523.003.0011; Kahneman D, 2006, SCIENCE, V312, P1908, DOI 10.1126/science.1129688; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Kloumann IM, 2011, POSITIVITY ENGLISH L; Kramer ADI, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P287; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lang, 2017, AFFECTIVE NORMS ENGL; Layard R., 2005, HAPPINESS; Lee L., 2004, COMPUTER SCI REFLECT, P111; List J. A., 2006, BE J ECON ANAL POLI, V6, P8; Lyubomirsky, 2007, HAPPINESS; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mihalcea R, 2010, AAAI 2006 SPRING S C, P591; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; Mishne G., 2006, AAAI 2006 SPRING S C; Mishne G, 2006, 5 INT C NAT LANG PRO; Mishne G, 2005, AAAI 2006 SPRING S C; Mishne G, 2005, STYLE2005 1 WORKSH S; Mitrovic M, QUANTITATIVE ANAL BL; O'Connor B., 2010, 4 INT AAAI C WEBL SO; Osgood C.E., 1957, MEASUREMENT MEANING; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Rentfrow PJ, 2008, PERSPECT PSYCHOL SCI, V3, P339, DOI 10.1111/j.1745-6924.2008.00084.x; Sandhaus Evan, 2008, NEW YORK TIMES ANNOT, V6; Seaford C, 2011, NATURE, V477, P532, DOI 10.1038/477532a; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Skitka LJ, 2006, ANNU REV PSYCHOL, V57, P529, DOI 10.1146/annurev.psych.57.102904.190048; Stephens M, 2008, REGISTER; Varian, 2009, PREDICTING PRESENT G; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WILBUR WJ, 1992, J INF SCI, V18, P45, DOI 10.1177/016555159201800106; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	61	374	388	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e26752	10.1371/journal.pone.0026752	http://dx.doi.org/10.1371/journal.pone.0026752			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163266	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900002
J	Komarova, NL; Thalhauser, CJ				Komarova, Natalia L.; Thalhauser, Craig J.			Calculating Stage Duration Statistics in Multistage Diseases	PLOS ONE			English	Article							ALZHEIMERS ASSOCIATION WORKGROUPS; RATING-SCALE SUM; NONPARAMETRIC-ESTIMATION; COGNITIVE DETERIORATION; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; CLINICAL-FEATURES; PROGRESSION RATE; BRAIN ATROPHY; DEMENTIA	Many human diseases are characterized by multiple stages of progression. While the typical sequence of disease progression can be identified, there may be large individual variations among patients. Identifying mean stage durations and their variations is critical for statistical hypothesis testing needed to determine if treatment is having a significant effect on the progression, or if a new therapy is showing a delay of progression through a multistage disease. In this paper we focus on two methods for extracting stage duration statistics from longitudinal datasets: an extension of the linear regression technique, and a counting algorithm. Both are non-iterative, non-parametric and computationally cheap methods, which makes them invaluable tools for studying the epidemiology of diseases, with a goal of identifying different patterns of progression by using bioinformatics methodologies. Here we show that the regression method performs well for calculating the mean stage durations under a wide variety of assumptions, however, its generalization to variance calculations fails under realistic assumptions about the data collection procedure. On the other hand, the counting method yields reliable estimations for both means and variances of stage durations. Applications to Alzheimer disease progression are discussed.	[Komarova, Natalia L.; Thalhauser, Craig J.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu						Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bhargava D, 2006, J GERIATR PSYCH NEUR, V19, P78, DOI 10.1177/0891988706286505; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Capitani E, 2004, NEUROL SCI, V25, P198, DOI 10.1007/s10072-004-0322-4; CHUI HC, 1987, J NEURAL TRANSM, P57; Craft S, 1998, NEUROLOGY, V51, P149, DOI 10.1212/WNL.51.1.149; DEGRUTTOLA V, 1989, BIOMETRICS, V45, P1; Doody RS, 2010, ALZHEIMERS RES THER, V2, DOI [10.1186/alzrt25, 10.1186/alzrt38]; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P449, DOI 10.1001/archneur.58.3.449; DURAY PH, 1988, ANN NY ACAD SCI, V539, P65, DOI 10.1111/j.1749-6632.1988.tb31839.x; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; FARRER LA, 1995, ARCH NEUROL-CHICAGO, V52, P918, DOI 10.1001/archneur.1995.00540330100021; FERGUSON TS, 1973, ANN STAT, V1, P209, DOI 10.1214/aos/1176342360; Forstl H, 1999, EUR ARCH PSY CLIN N, V249, P288, DOI 10.1007/s004060050101; FRIEDLAND RP, 1988, ANN INTERN MED, V109, P298, DOI 10.7326/0003-4819-109-4-298; GOMEZ G, 1994, BIOMETRICS, V50, P204, DOI 10.2307/2533210; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Ito K, 2011, ALZHEIMERS DEMENT, V7, P151, DOI 10.1016/j.jalz.2010.03.018; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KNESEVICH JW, 1985, PSYCHIAT RES, V14, P255, DOI 10.1016/0165-1781(85)90020-4; Komarova NL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002251; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; LISTER TA, 1989, J CLIN ONCOL, V7, P1630, DOI 10.1200/JCO.1989.7.11.1630; MANN UM, 1992, J NEUROL NEUROSUR PS, V55, P956, DOI 10.1136/jnnp.55.10.956; MAYEUX R, 1985, NEUROLOGY, V35, P453, DOI 10.1212/WNL.35.4.453; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Murphy GM, 2001, NEUROLOGY, V56, P1595, DOI 10.1212/WNL.56.11.1595; Na HR, 2010, J ALZHEIMERS DIS, V22, P151, DOI 10.3233/JAD-2010-100072; Nagahama Y, 2003, EUR NEUROL, V50, P1, DOI 10.1159/000070851; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P746, DOI 10.1001/archneurol.2010.115; Prolo P, 2007, BIOINFORMATION, V1, P363, DOI 10.6026/97320630001363; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; REISBERG B, 1986, GERIATRICS, V41, P30; Reisberg B, 1996, Int Psychogeriatr, V8, P291, DOI 10.1017/S1041610296002657; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Rikkert MGMO, 2011, AM J ALZHEIMERS DIS, V26, P357, DOI 10.1177/1533317511418954; ROYCE RA, 1991, AIDS, V5, P355, DOI 10.1097/00002030-199104000-00001; Sclan S G, 1992, Int Psychogeriatr, V4 Suppl 1, P55; Shay K A, 1991, J Geriatr Psychiatry Neurol, V4, P18, DOI 10.1177/089198879100400104; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sluimer JD, 2008, NEUROLOGY, V70, P1836, DOI 10.1212/01.wnl.0000311446.61861.e3; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; SUSARLA V, 1976, J AM STAT ASSOC, V71, P897, DOI 10.2307/2286858; THALHAUSER CJ, 2011, J R SOC INTERFACE; TURNBULL BW, 1974, J AM STAT ASSOC, V69, P169, DOI 10.2307/2285518; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; VANDENBRUAENE M, 1993, AIDS, V7, P1613, DOI 10.1097/00002030-199312000-00011; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49	56	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28298	10.1371/journal.pone.0028298	http://dx.doi.org/10.1371/journal.pone.0028298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163291	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900026
J	Marei, HES; Althani, A; Afifi, N; Michetti, F; Pescatori, M; Pallini, R; Casalbore, P; Cenciarelli, C; Schwartz, P; Ahmed, AE				Marei, Hany E. S.; Althani, Asma; Afifi, Nahla; Michetti, Fabrizio; Pescatori, Mario; Pallini, Roberto; Casalbore, Patricia; Cenciarelli, Carlo; Schwartz, Philip; Ahmed, Abd-Elmaksoud			Gene Expression Profiling of Embryonic Human Neural Stem Cells and Dopaminergic Neurons from Adult Human Substantia Nigra	PLOS ONE			English	Article							PROGENITOR CELLS; EFFICIENT GENERATION; TARGETED DISRUPTION; PARKINSONS-DISEASE; IN-VITRO; DIFFERENTIATION; MIDBRAIN; INDUCTION; MOUSE; NEUROGENESIS	Neural stem cells (NSC) with self-renewal and multipotent properties serve as an ideal cell source for transplantation to treat neurodegenerative insults such as Parkinson's disease. We used Agilent's and Illumina Whole Human Genome Oligonucleotide Microarray to compare the genomic profiles of human embryonic NSC at a single time point in culture, and a multicellular tissue from postmortem adult substantia nigra (SN) which are rich in dopaminergic (DA) neurons. We identified 13525 up-regulated genes in both cell types of which 3737 (27.6%) genes were up-regulated in the hENSC, 4116 (30.4%) genes were up-regulated in the human substantia nigra dopaminergic cells, and 5672 (41.93%) were significantly up-regulated in both cell population. Careful analysis of the data that emerged using DAVID has permitted us to distinguish several genes and pathways that are involved in dopaminergic (DA) differentiation, and to identify the crucial signaling pathways that direct the process of differentiation. The set of genes expressed more highly at hENSC is enriched in molecules known or predicted to be involved in the M phase of the mitotic cell cycle. On the other hand, the genes enriched in SN cells include a different set of functional categories, namely synaptic transmission, central nervous system development, structural constituents of the myelin sheath, the internode region of axons, myelination, cell projection, cell somata, ion transport, and the voltage-gated ion channel complex. Our results were also compared with data from various databases, and between different types of arrays, Agilent versus Illumina. This approach has allowed us to confirm the consistency of our obtained results for a large number of genes that delineate the phenotypical differences of embryonic NSCs, and SN cells.	[Marei, Hany E. S.; Ahmed, Abd-Elmaksoud] Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt; [Althani, Asma; Afifi, Nahla] Qatar Univ, Dept Hlth Sci, Coll Arts & Sci, Doha, Qatar; [Michetti, Fabrizio; Pescatori, Mario] Univ Cattolica Sacro Cuore, Inst Anat & Cell Biol, Rome, Italy; [Pallini, Roberto] Univ Cattolica Sacro Cuore, Inst Neurosurg, Rome, Italy; [Casalbore, Patricia] Natl Res Council Italy, Inst Cell Biol & Neurobiol, Rome, Italy; [Cenciarelli, Carlo] Natl Res Council Italy, Inst Translat Pharmacol, Rome, Italy; [Schwartz, Philip] Childrens Hosp Orange Cty, Res Inst, Orange, CA 92668 USA	Egyptian Knowledge Bank (EKB); Mansoura University; Qatar University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Childrens Hospital of Orange County	Marei, HES (corresponding author), Mansoura Univ, Dept Cytol & Histol, Fac Vet Med, Mansoura, Egypt.	hany800@yahoo.com	pescatori, mario/H-3986-2012; PALLINI, Roberto/AAA-3747-2019; CENCIARELLI, CARLO/AAC-1603-2019; Marei, Hany E/AAC-7076-2019; Pallini, Roberto/AAA-3760-2019	PALLINI, Roberto/0000-0002-4611-8827; CENCIARELLI, CARLO/0000-0001-7480-4608; Marei, Hany E/0000-0002-0069-4212; 	Science and Technology Development Fund (STDF) [99]; Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt; NSC [HD059967]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059967] Funding Source: NIH RePORTER	Science and Technology Development Fund (STDF)(Science and Technology Development Fund (STDF)); Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt; NSC(Ministry of Science and Technology, Taiwan); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Science and Technology Development Fund (STDF, Egypt: ID:99). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their appreciation and recognize to the staff at the Department of Cytology, Faculty of Veterinary Medicine, Mansoura University, Egypt, for their support. We thank Alexander Stover and Dr. David Brick who provide us with an additional three samples of human embryonic NSC (NIH grant HD059967). We thank Dr. Ahmed Abd El-Wahed for assistance with purchasing the Invitrogen's NSC line from Invitrogen's Germany. We also thank the staff at Institute of Virology Georg-August-University-Goettingen Kreuzbergring 57, 37075 Goettingen, Germany, for performing the DNA microarray experiments and data analysis.	Ahn SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003917; Arai Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1155; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; Cai JL, 2004, EXP HEMATOL, V32, P585, DOI 10.1016/j.exphem.2004.03.013; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carvey PM, 2001, EXP NEUROL, V171, P98, DOI 10.1006/exnr.2001.7735; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Castillo SO, 1998, MOL CELL NEUROSCI, V11, P36, DOI 10.1006/mcne.1998.0673; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chung S, 2005, MOL CELL NEUROSCI, V28, P241, DOI 10.1016/j.mcn.2004.09.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; GERMAN DC, 1989, ANN NEUROL, V26, P507, DOI 10.1002/ana.410260403; GIBB WRG, 1992, BRAIN RES, V581, P283, DOI 10.1016/0006-8993(92)90719-P; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kawasoe T, 2000, CANCER RES, V60, P3354; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Lum M, 2009, J NEUROSCI RES, V87, P2201, DOI 10.1002/jnr.22047; Maisel M, 2007, STEM CELLS, V25, P1231, DOI 10.1634/stemcells.2006-0617; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106; Ota M, 2003, DEV DYNAM, V227, P544, DOI 10.1002/dvdy.10336; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Prakash N, 2007, NEURODEGENER DIS, V4, P333, DOI 10.1159/000101891; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Sato Hiromi, 2005, Curr Drug Discov Technol, V2, P89, DOI 10.2174/1570163054064701; Satoh J, 2010, CELL MOL NEUROBIOL, V30, P415, DOI 10.1007/s10571-009-9466-3; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schein JC, 1998, DEV BIOL, V204, P432, DOI 10.1006/dbio.1998.9076; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499; Tago K, 2000, GENE DEV, V14, P1741; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thorsteinsdottir U, 2001, MOL CELL BIOL, V21, P224, DOI 10.1128/MCB.21.1.224-234.2001; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Wagner J, 1999, NAT BIOTECHNOL, V17, P653, DOI 10.1038/10862; Wang X, 2004, INT J DEV NEUROSCI, V22, P175, DOI 10.1016/j.ijdevneu.2004.05.008; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; YAMADA T, 1990, BRAIN RES, V526, P303, DOI 10.1016/0006-8993(90)91236-A; Yang YH, 2001, SPIE BIOS 2001 JAN 2; Yen G, 2001, MOL BRAIN RES, V96, P59, DOI 10.1016/S0169-328X(01)00267-4; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	75	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28420	10.1371/journal.pone.0028420	http://dx.doi.org/10.1371/journal.pone.0028420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163301	Green Published, gold			2022-12-27	WOS:000298161900038
J	Recio, MR; Mathieu, R; Denys, P; Sirguey, P; Seddon, PJ				Recio, Mariano R.; Mathieu, Renaud; Denys, Paul; Sirguey, Pascal; Seddon, Philip J.			Lightweight GPS-Tags, One Giant Leap for Wildlife Tracking? An Assessment Approach	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; RADIO-COLLAR PERFORMANCE; LOCATION SYSTEM; FIX INTERVAL; 3 BRANDS; HABITAT; TELEMETRY; MOVEMENT; BIAS; RADIOTELEMETRY	Recent technological improvements have made possible the development of lightweight GPS-tagging devices suitable to track medium-to-small sized animals. However, current inferences concerning GPS performance are based on heavier designs, suitable only for large mammals. Lightweight GPS-units are deployed close to the ground, on species selecting micro-topographical features and with different behavioural patterns in comparison to larger mammal species. We assessed the effects of vegetation, topography, motion, and behaviour on the fix success rate for lightweight GPS-collar across a range of natural environments, and at the scale of perception of feral cats (Felis catus). Units deployed at 20 cm above the ground in sites of varied vegetation and topography showed that trees (native forest) and shrub cover had the largest influence on fix success rate (89% on average); whereas tree cover, sky availability, number of satellites and horizontal dilution of position (HDOP) were the main variables affecting location error (+/- 39.5 m and +/- 27.6 m before and after filtering outlier fixes). Tests on HDOP or number of satellites-based screening methods to remove inaccurate locations achieved only a small reduction of error and discarded many accurate locations. Mobility tests were used to simulate cats' motion, revealing a slightly lower performance as compared to the fixed sites. GPS-collars deployed on 43 cats showed no difference in fix success rate by sex or season. Overall, fix success rate and location error values were within the range of previous tests carried out with collars designed for larger species. Lightweight GPS-tags are a suitable method to track medium to small size species, hence increasing the range of opportunities for spatial ecology research. However, the effects of vegetation, topography and behaviour on location error and fix success rate need to be evaluated prior to deployment, for the particular study species and their habitats.	[Recio, Mariano R.; Denys, Paul; Sirguey, Pascal] Univ Otago, Sch Surveying, Dunedin, New Zealand; [Recio, Mariano R.; Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Mathieu, Renaud] CSIR Nat Resource Environm, Earth Observat Res Grp, Pretoria, South Africa	University of Otago; University of Otago; Council for Scientific & Industrial Research (CSIR) - South Africa	Recio, MR (corresponding author), Univ Otago, Sch Surveying, Dunedin, New Zealand.	mariano.recio@otago.ac.nz	denys, Paul/C-6120-2008; Seddon, Philip/G-8659-2011	denys, Paul/0000-0002-1427-9538; Seddon, Philip/0000-0001-9076-9566; Mathieu, Renaud/0000-0001-8520-7358; /0000-0002-9449-2952	Department of Zoology and the School of Surveying at the University of Otago; Foundation for Research Science and Technology (FRST) [UOOX0904]; Hellaby Grassland Research Trust; University of Otago	Department of Zoology and the School of Surveying at the University of Otago; Foundation for Research Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology); Hellaby Grassland Research Trust; University of Otago	This work was supported by a PBRF Grant from the Department of Zoology and the School of Surveying at the University of Otago, a Foundation for Research Science and Technology (FRST) Grant UOOX0904, and a Hellaby Grassland Research Trust Fellowship Grant. Mariano R. Recio was funded by a PhD scholarship from the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, INTRO GPS GLOBAL POS; [Anonymous], 2000, APPL LOGISTIC REGRES, P373, DOI DOI 10.1002/0471722146; Belant JL, 2009, NORTHEAST NAT, V16, P577, DOI 10.1656/045.016.n407; Biggs JR, 2001, WEST N AM NATURALIST, V61, P213; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Dennis T.E., 2010, Wildlife Biology in Practice, V6, P14; Department of Conservation, 2010, RIV LIF EXPL EC BRAI, P28; DOZIER J, 1981, COMPUT GEOSCI, V7, P145, DOI 10.1016/0098-3004(81)90026-1; Edenius L, 1997, WILDLIFE BIOL, V3, P39, DOI 10.2981/wlb.1997.006; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gelman A., 2007, DATA ANAL USING REGR; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Guthrie JD, 2011, J WILDLIFE MANAGE, V75, P539, DOI 10.1002/jwmg.137; Haines AM, 2006, EUR J WILDLIFE RES, V52, P216, DOI 10.1007/s10344-006-0043-5; Heard DC, 2008, J WILDLIFE MANAGE, V72, P596, DOI 10.2193/2007-175; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hulbert IAR, 2001, J APPL ECOL, V38, P869, DOI 10.1046/j.1365-2664.2001.00624.x; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Korhonen L, 2006, SILVA FENN, V40, P577, DOI 10.14214/sf.315; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Moen R, 1996, J WILDLIFE MANAGE, V60, P659, DOI 10.2307/3802085; Moseby KE, 2009, WILDLIFE RES, V36, P422, DOI 10.1071/WR08098; Paletto A, 2009, EUR J FOREST RES, V128, P265, DOI 10.1007/s10342-009-0262-x; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; R Core Team, 2020, R LANG ENV STAT COMP; Recio MR, 2010, NEW ZEAL J ECOL, V34, P288; Recio MR, 2011, EUR J WILDL IN PRESS; REMPEL RS, 1995, J WILDLIFE MANAGE, V59, P543, DOI 10.2307/3802461; Rose E, 2005, BIRD STUDY, V52, P145, DOI 10.1080/00063650509461384; Schwartz CC, 2009, J WILDLIFE MANAGE, V73, P1174, DOI 10.2193/2008-514; Sirguey P, 2009, REMOTE SENS ENVIRON, V113, P160, DOI 10.1016/j.rse.2008.09.008; Skrondal A., 2004, GEN LATENT VARIABLE; Sprague DS, 2004, PRIMATES, V45, P151, DOI 10.1007/s10329-003-0071-7; SPRINGER JT, 1979, J WILDLIFE MANAGE, V43, P926, DOI 10.2307/3808276; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; van Heezik Y, 2010, BIOL CONSERV, V143, P121, DOI 10.1016/j.biocon.2009.09.013; Wegge P, 2007, WILDLIFE BIOL, V13, P87, DOI 10.2981/0909-6396(2007)13[87:GSTPNI]2.0.CO;2; Zar JH, 1999, BIOSTATISTICAL ANAL	48	77	78	3	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28225	10.1371/journal.pone.0028225	http://dx.doi.org/10.1371/journal.pone.0028225			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163286	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900021
J	Roedig, JV; Rapp, E; Hoper, D; Genzel, Y; Reichl, U				Roedig, Jana Verena; Rapp, Erdmann; Hoeper, Dirk; Genzel, Yvonne; Reichl, Udo			Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							VACCINE PRODUCTION; RECEPTOR-BINDING; MEMBRANE-FUSION; MDCK CELLS; NUCLEOTIDE-SEQUENCE; ELECTRON-MICROSCOPY; GLYCAN ANALYSIS; RNA VIRUSES; ELEVATED PH; CGE-LIF	The genome of influenza A viruses is constantly changing (genetic drift) resulting in small, gradual changes in viral proteins. Alterations within antibody recognition sites of the viral membrane glycoproteins hemagglutinin (HA) and neuraminidase (NA) result in an antigenetic drift, which requires the seasonal update of human influenza virus vaccines. Generally, virus adaptation is necessary to obtain sufficiently high virus yields in cell culture-derived vaccine manufacturing. In this study detailed HA N-glycosylation pattern analysis was combined with in-depth pyrosequencing analysis of the virus genomic RNA. Forward and backward adaptation from Madin-Darby Canine Kidney (MDCK) cells to African green monkey kidney (Vero) cells was investigated for two closely related influenza A virus PR/8/34 (H1N1) strains: from the National Institute for Biological Standards and Control (NIBSC) or the Robert Koch Institute (RKI). Furthermore, stability of HA N-glycosylation patterns over ten consecutive passages and different harvest time points is demonstrated. Adaptation to Vero cells finally allowed efficient influenza A virus replication in Vero cells. In contrast, during back-adaptation the virus replicated well from the very beginning. HA N-glycosylation patterns were cell line dependent and stabilized fast within one (NIBSC-derived virus) or two (RKI-derived virus) successive passages during adaptation processes. However, during adaptation new virus variants were detected. These variants carried "rescue" mutations on the genomic level within the HA stem region, which result in amino acid substitutions. These substitutions finally allowed sufficient virus replication in the new host system. According to adaptation pressure the composition of the virus populations varied. In Vero cells a selection for "rescue" variants was characteristic. After back-adaptation to MDCK cells some variants persisted at indifferent frequencies, others slowly diminished and even dropped below the detection limit.	[Roedig, Jana Verena; Rapp, Erdmann; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Hoeper, Dirk] Friedrich Loeffler Inst FLI, Greifswald, Germany; [Reichl, Udo] Otto von Guericke Univ, Chair Bioproc Engn, Magdeburg, Germany	Max Planck Society; Friedrich Loeffler Institute; Otto von Guericke University	Roedig, JV (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	rapp@mpi-magdeburg.mpg.de		Reichl, Udo/0000-0001-6538-1332; Hoper, Dirk/0000-0001-8408-2274; Rapp, Erdmann/0000-0001-6618-2626; Genzel, Yvonne/0000-0002-2652-5943	Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS); Friedrich Loeffler Institute (FLI)	Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS); Friedrich Loeffler Institute (FLI)	The funders, which are solely the authors' home institutions: Max Planck Institute for Dynamics of Complex Technical Systems (MPI-DCTS) and Friedrich Loeffler Institute (FLI), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2004, J VIROL, V78, P9605, DOI 10.1128/JVI.78.18.9605-9611.2004; Biebricher CK, 2006, CURR TOP MICROBIOL, V299, P1; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Bull JJ, 1997, GENETICS, V147, P1497; Chen ZY, 2008, VACCINE, V26, P361, DOI 10.1016/j.vaccine.2007.11.013; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; de Wit E, 2010, J VIROL, V84, P1597, DOI 10.1128/JVI.01783-09; Domingo E, 2006, CURR TOP MICROBIOL, V299, P51; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; Domingo E, 1998, EMERG INFECT DIS, V4, P521, DOI 10.3201/eid0404.980402; DOMS RW, 1986, J VIROL, V57, P603, DOI 10.1128/JVI.57.2.603-613.1986; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Genzel Y, 2004, VACCINE, V22, P2202, DOI 10.1016/j.vaccine.2003.11.041; Genzel Y, 2010, APPL MICROBIOL BIOT, V88, P461, DOI 10.1007/s00253-010-2742-9; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Heynisch B, 2010, VACCINE, V28, P8210, DOI 10.1016/j.vaccine.2010.07.076; HIRST GK, 1947, J EXP MED, V86, P357, DOI 10.1084/jem.86.5.357; Hoper D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019075; Hoper D, 2009, J CLIN MICROBIOL, V47, P674, DOI 10.1128/JCM.01028-08; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; Kalbfuss B, 2008, BIOLOGICALS, V36, P145, DOI 10.1016/j.biologicals.2007.10.002; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Klenk HD, 2002, VIRUS RES, V82, P73; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Leifer I, 2010, J GEN VIROL, V91, P2687, DOI 10.1099/vir.0.023200-0; Lin YP, 1997, VIROLOGY, V233, P402, DOI 10.1006/viro.1997.8626; Opitz L, 2008, J VIROL METHODS, V154, P61, DOI 10.1016/j.jviromet.2008.09.004; Reed ML, 2010, J VIROL, V84, P1527, DOI 10.1128/JVI.02069-09; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; ROTT R, 1984, EMBO J, V3, P3329, DOI 10.1002/j.1460-2075.1984.tb02299.x; Rudd PM, 1997, CRIT REV BIOCHEM MOL, V32, P1, DOI 10.3109/10409239709085144; Ruhaak LR, 2010, J PROTEOME RES, V9, P6655, DOI 10.1021/pr100802f; RUIGROK RWH, 1986, EMBO J, V5, P41, DOI 10.1002/j.1460-2075.1986.tb04175.x; RUIGROK RWH, 1986, VIROLOGY, V155, P484, DOI 10.1016/0042-6822(86)90210-2; Saito T, 2004, J MED VIROL, V74, P336, DOI 10.1002/jmv.20178; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Scholtissek C, 1995, VIRUS GENES, V11, P209, DOI 10.1007/BF01728660; Schulze-Horsel J, 2009, VACCINE, V27, P2712, DOI 10.1016/j.vaccine.2009.02.027; Schwarzer J, 2008, ELECTROPHORESIS, V29, P4203, DOI 10.1002/elps.200800042; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Seitz C, 2010, J GEN VIROL, V91, P1754, DOI 10.1099/vir.0.020370-0; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Vester D, 2010, J PROTEOMICS, V73, P1656, DOI 10.1016/j.jprot.2010.04.006; Wagner R, 2002, J GEN VIROL, V83, P601, DOI 10.1099/0022-1317-83-3-601; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; Wiley G., 2009, CURR PROTOC HUM GENE; WINTER G, 1981, NATURE, V292, P72, DOI 10.1038/292072a0; WRIGLEY NG, 1979, BRIT MED BULL, V35, P35, DOI 10.1093/oxfordjournals.bmb.a071539	54	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27989	10.1371/journal.pone.0027989	http://dx.doi.org/10.1371/journal.pone.0027989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163276	Green Published, gold			2022-12-27	WOS:000298161900011
J	Galan-Moya, EM; de la Cruz-Morcillo, MA; Valero, ML; Callejas-Valera, JL; Melgar-Rojas, P; Losa, JH; Salcedo, M; Fernandez-Aramburo, A; Cajal, SRY; Sanchez-Prieto, R				Galan-Moya, Eva M.; de la Cruz-Morcillo, Miguel A.; Llanos Valero, Maria; Callejas-Valera, Juan L.; Melgar-Rojas, Pedro; Hernadez Losa, Javier; Salcedo, Mayte; Fernandez-Aramburo, Antonio; Ramon y Cajal, Santiago; Sanchez-Prieto, Ricardo			Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL LUNG-CANCER; GENOTOXIC STRESS; DNA-REPAIR; P38-ALPHA; PATHWAY; SENSITIVITY; SURVIVAL; GROWTH; CHEMOTHERAPY	The p38 MAPK signaling pathway has been proposed as a critical mediator of the therapeutic effect of several antitumor agents, including cisplatin. Here, we found that sensitivity to cisplatin, in a system of 7 non-small cell lung carcinoma derived cell lines, correlated with high levels of MKK6 and marked activation of p38 MAPK. However, knockdown of MKK6 modified neither the response to cisplatin nor the activation of p38 MAPK. Deeper studies showed that resistant cell lines also displayed higher basal levels of MKK3. Interestingly, MKK3 knockdown significantly decreased p38 phosphorylation upon cisplatin exposure and consequently reduced the response to the drug. Indeed, cisplatin poorly activated MKK3 in resistant cells, while in sensitive cell lines MKK3 showed the opposite pattern in response to the drug. Our data also demonstrate that the low levels of MKK6 expressed in resistant cell lines are the consequence of high basal activity of p38 MAPK mediated by the elevated levels of MKK3. This finding supports the existence of a regulatory mechanism between both MAPK kinases through their MAPK. Furthermore, our results were also mirrored in head and neck carcinoma derived cell lines, suggesting our observations boast a potential universal characteristic in cancer resistance of cisplatin. Altogether, our work provides evidence that MKK3 is the major determinant of p38 MAPK activation in response to cisplatin and, hence, the resistance associated with this MAPK. Therefore, these data suggest that the balance between both MKK3 and MKK6 could be a novel mechanism which explains the cellular response to cisplatin.	[Galan-Moya, Eva M.; de la Cruz-Morcillo, Miguel A.; Llanos Valero, Maria; Callejas-Valera, Juan L.; Melgar-Rojas, Pedro; Fernandez-Aramburo, Antonio; Sanchez-Prieto, Ricardo] PCYTA UCLM, Ctr Reg Invest Biomed, Lab Oncol Mol, Albacete, Spain; [Hernadez Losa, Javier; Salcedo, Mayte; Ramon y Cajal, Santiago] Fundacio Inst Recerca Hosp Vall Hebron, Dept Pathol, Barcelona, Spain; [Fernandez-Aramburo, Antonio] Serv Oncol CHUA, Albacete, Spain	Hospital Universitari Vall d'Hebron	Galan-Moya, EM (corresponding author), PCYTA UCLM, Ctr Reg Invest Biomed, Lab Oncol Mol, Albacete, Spain.	ricardo.sanchez@uclm.es	Javier, Hernandez Losa/C-1173-2008; Ramon y Cajal, Santiago/H-4955-2016; Salcedo-Allende, M Teresa/N-7091-2014; Sanchez-Prieto, Ricardo/B-6877-2008; Sanchez-Prieto, Ricardo/AAY-4271-2021; Galan-Moya, Eva M/I-2912-2015; Prieto, Ricardo/AAZ-7221-2021; Romo, José A./J-3024-2012	Javier, Hernandez Losa/0000-0003-1526-3201; Ramon y Cajal, Santiago/0000-0002-3867-1390; Salcedo-Allende, M Teresa/0000-0002-4822-5060; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Sanchez-Prieto, Ricardo/0000-0003-0882-9780; Galan-Moya, Eva M/0000-0001-5758-7592; Romo, José A./0000-0003-2907-580X; de la Cruz-Morcillo, Miguel Angel/0000-0002-6674-1333; Fernandez Aramburo, Antonio/0000-0003-3897-2262	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Inovacion [SAF2009-07329]; RSP Research Institute; European Community	Fundacion Leticia Castillejo Castillo; Ministerio de Ciencia e Inovacion(Spanish Government); RSP Research Institute; European Community(European Commission)	This work was supported by grants from Fundacion Leticia Castillejo Castillo and Ministerio de Ciencia e Inovacion (SAF2009-07329) and the RSP Research Institute, and the work carried out in this laboratory receive support from the European Community through the regional development funding program (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Ahmad S, 2010, CHEM BIODIVERS, V7, P543, DOI 10.1002/cbdv.200800340; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Benedetti V, 2008, MOL CANCER THER, V7, P679, DOI 10.1158/1535-7163.MCT-07-0450; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brozovic A, 2007, CANCER LETT, V251, P1, DOI 10.1016/j.canlet.2006.10.007; Callejas-Valera JL, 2008, J BIOL CHEM, V283, P13450, DOI 10.1074/jbc.M709230200; Chattopadhyay S, 2006, ONCOGENE, V25, P3335, DOI 10.1038/sj.onc.1209364; Chen ZH, 1999, ONCOGENE, V18, P173, DOI 10.1038/sj.onc.1202276; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; de la Cruz-Morcillo MA, 2012, ONCOGENE, V31, P1073, DOI 10.1038/onc.2011.321; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Dienstmann R, 2011, ONCOTARGET, V2, P165; Dolado I, 2007, CANCER CELL, V11, P191, DOI 10.1016/j.ccr.2006.12.013; Francescato HDC, 2009, LIFE SCI, V84, P590, DOI 10.1016/j.lfs.2009.02.004; Fukuda K, 2008, LAB INVEST, V88, P398, DOI 10.1038/labinvest.2008.10; Girnun GD, 2008, CLIN CANCER RES, V14, P6478, DOI 10.1158/1078-0432.CCR-08-1128; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Greenberg AK, 2002, AM J RESP CELL MOL, V26, P558, DOI 10.1165/ajrcmb.26.5.4689; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Ishida S, 2010, CANCER CELL, V17, P574, DOI 10.1016/j.ccr.2010.04.011; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Losa JH, 2003, ONCOGENE, V22, P3998, DOI 10.1038/sj.onc.1206608; Mountzios G, 2008, CLIN CANCER RES, V14, P4096, DOI 10.1158/1078-0432.CCR-07-4150; Mountzios G, 2010, CRIT REV ONCOL HEMAT, V75, P94, DOI 10.1016/j.critrevonc.2009.10.002; Nijwening JH, 2011, CELL CYCLE, V10, P380, DOI 10.4161/cc.10.3.14642; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Olaussen KA, 2007, CURR OPIN PULM MED, V13, P284, DOI 10.1097/MCP.0b013e32816b5c63; Olson JM, 2004, TRENDS MOL MED, V10, P125, DOI 10.1016/j.molmed.2004.01.007; Pan Q, 2009, EXPERT OPIN PHARMACO, V10, P2291, DOI 10.1517/14656560903136754; Pandey P, 1996, J BIOL CHEM, V271, P23775, DOI 10.1074/jbc.271.39.23775; Patel V, 2007, CARCINOGENESIS, V28, P1145, DOI 10.1093/carcin/bgm008; Pio R, 2004, CANCER RES, V64, P4171, DOI 10.1158/0008-5472.CAN-03-2982; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rosell R, 2006, CURR OPIN PHARMACOL, V6, P323, DOI 10.1016/j.coph.2006.01.011; Sanchez-Prieto R, 2000, CANCER RES, V60, P2464; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2009, CELL CYCLE, V8, P3191, DOI 10.4161/cc.8.19.9751; Wang L, 2002, J BIOL CHEM, V277, P47257, DOI 10.1074/jbc.M208573200; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang Y, 2009, REDOX REP, V14, P243, DOI 10.1179/135100009X12525712409896; Winograd-Katz SE, 2006, ONCOGENE, V25, P7381, DOI 10.1038/sj.onc.1209737; Zhang Q, 2007, MOL CANCER THER, V6, P1414, DOI 10.1158/1535-7163.MCT-06-0678; Zhang ZF, 2010, ONCOTARGET, V1, P497; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297; 2010, NEOPLASIA, V12, P527	54	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28406	10.1371/journal.pone.0028406	http://dx.doi.org/10.1371/journal.pone.0028406			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164285	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400086
J	Muralla, R; Lloyd, J; Meinke, D				Muralla, Rosanna; Lloyd, Johnny; Meinke, David			Molecular Foundations of Reproductive Lethality in Arabidopsis thaliana	PLOS ONE			English	Article							MALE GAMETOPHYTE DEVELOPMENT; MEDEA POLYCOMB GENE; EMBRYO DEVELOPMENT; SEED DEVELOPMENT; MATURE POLLEN; ENDOSPERM DEVELOPMENT; FEMALE GAMETOPHYTE; PATERNAL GENOME; TUBE GROWTH; IDENTIFICATION	The SeedGenes database (www.seedgenes.org) contains information on more than 400 genes required for embryo development in Arabidopsis. Many of these EMBRYO-DEFECTIVE (EMB) genes encode proteins with an essential function required throughout the life cycle. This raises a fundamental question. Why does elimination of an essential gene in Arabidopsis often result in embryo lethality rather than gametophyte lethality? In other words, how do mutant (emb) gametophytes survive and participate in fertilization when an essential cellular function is disrupted? Furthermore, why do some mutant embryos proceed further in development than others? To address these questions, we first established a curated dataset of genes required for gametophyte development in Arabidopsis based on information extracted from the literature. This provided a basis for comparison with EMB genes obtained from the SeedGenes dataset. We also identified genes that exhibited both embryo and gametophyte defects when disrupted by a loss-of-function mutation. We then evaluated the relationship between mutant phenotype, gene redundancy, mutant allele strength, gene expression pattern, protein function, and intracellular protein localization to determine what factors influence the phenotypes of lethal mutants in Arabidopsis. After removing cases where continued development potentially resulted from gene redundancy or residual function of a weak mutant allele, we identified numerous examples of viable mutant (emb) gametophytes that required further explanation. We propose that the presence of gene products derived from transcription in diploid (heterozygous) sporocytes often enables mutant gametophytes to survive the loss of an essential gene in Arabidopsis. Whether gene disruption results in embryo or gametophyte lethality therefore depends in part on the ability of residual, parental gene products to support gametophyte development. We also highlight here 70 preglobular embryo mutants with a zygotic pattern of inheritance, which provide valuable insights into the maternal-to-zygotic transition in Arabidopsis and the timing of paternal gene activation during embryo development.	[Muralla, Rosanna; Lloyd, Johnny; Meinke, David] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Muralla, R (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	david.meinke@okstate.edu		Lloyd, John/0000-0003-0454-4374	National Science Foundation [DBI-0618166]; Oklahoma Center for the Advancement of Science and Technology	National Science Foundation(National Science Foundation (NSF)); Oklahoma Center for the Advancement of Science and Technology	This research was supported by National Science Foundation grant DBI-0618166 through the Arabidopsis 2010 Program, and by the Oklahoma Center for the Advancement of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Autran D, 2011, CELL, V145, P707, DOI 10.1016/j.cell.2011.04.014; Aw SJ, 2010, DEVELOPMENT, V137, P2683, DOI 10.1242/dev.052928; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Brown SDM, 2009, ANNU REV GENET, V43, P305, DOI 10.1146/annurev-genet-102108-134143; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Chen CB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-280; Chen SD, 2010, SCIENCE, V330, P1682, DOI 10.1126/science.1196380; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Drews GN, 2011, J EXP BOT, V62, P1593, DOI 10.1093/jxb/erq385; FRANZMANN LH, 1995, PLANT J, V7, P341, DOI 10.1046/j.1365-313X.1995.7020341.x; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Grimanelli D, 2005, PLANT CELL, V17, P1061, DOI 10.1105/tpc.104.029819; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Holmes-Davis R, 2005, PROTEOMICS, V5, P4864, DOI 10.1002/pmic.200402011; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Jahnke S, 2009, CURR BIOL, V19, P1677, DOI 10.1016/j.cub.2009.08.053; Ji YD, 2001, SCIENCE, V293, P2266, DOI 10.1126/science.1063566; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Johnston AJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r204; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kinoshita T, 1999, PLANT CELL, V11, P1945, DOI 10.1105/tpc.11.10.1945; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Lalanne E, 2004, GENETICS, V167, P1975, DOI 10.1534/genetics.104.030270; Liang H, 2009, TRENDS GENET, V25, P441, DOI 10.1016/j.tig.2009.08.001; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Libeau P, 2011, PLANT BIOLOGY, V13, P784, DOI 10.1111/j.1438-8677.2010.00435.x; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; MASCARENHAS JP, 1989, PLANT CELL, V1, P657, DOI 10.1105/tpc.1.7.657; McElver J, 2001, GENETICS, V159, P1751; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Meinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007386; Meinke D, 2009, TRENDS PLANT SCI, V14, P414, DOI 10.1016/j.tplants.2009.06.001; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; MEINKE DW, 1979, DEV BIOL, V72, P50, DOI 10.1016/0012-1606(79)90097-6; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; MEINKE DW, 1982, THEOR APPL GENET, V63, P381, DOI 10.1007/BF00303912; Meyer S, 2007, CURR BIOL, V17, P1686, DOI 10.1016/j.cub.2007.08.046; Msadek T, 2009, J BACTERIOL, V191, P4701, DOI 10.1128/JB.00572-09; MULLER A. J., 1963, BIOL ZENTRALBL, V82, P133; Muralla R, 2008, PLANT PHYSIOL, V146, P60, DOI 10.1104/pp.107.107409; Muralla R, 2007, PLANT PHYSIOL, V144, P890, DOI 10.1104/pp.107.096511; Noir S, 2005, BIOCHEM BIOPH RES CO, V337, P1257, DOI 10.1016/j.bbrc.2005.09.185; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Osterman Andrei L., 2008, V416, P459, DOI 10.1007/978-1-59745-321-9_31; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Park D, 2008, GENOMICS, V92, P414, DOI 10.1016/j.ygeno.2008.08.001; Perrimon N, 1996, GENETICS, V144, P1681; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Pillot M, 2010, PLANT CELL, V22, P307, DOI 10.1105/tpc.109.071647; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Procissi A, 2001, GENETICS, V158, P1773; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Schmidt A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001155; Sheoran IS, 2006, SEX PLANT REPROD, V19, P185, DOI 10.1007/s00497-006-0035-3; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Teng C, 2008, PLANT PHYSIOL, V146, P1322, DOI 10.1104/pp.107.113506; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Weijers D, 2001, NATURE, V414, P709, DOI 10.1038/414709a; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xiang DQ, 2011, PLANT PHYSIOL, V156, P346, DOI 10.1104/pp.110.171702; Yang HX, 2011, PLANT J, V65, P503, DOI 10.1111/j.1365-313X.2010.04439.x; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zou JJ, 2009, J INTEGR PLANT BIOL, V51, P438, DOI 10.1111/j.1744-7909.2009.00823.x	83	67	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28398	10.1371/journal.pone.0028398	http://dx.doi.org/10.1371/journal.pone.0028398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164284	Green Published, gold			2022-12-27	WOS:000298171400085
J	Veiga, RSL; Jansa, J; Frossard, E; van der Heijden, MGA				Veiga, Rita S. L.; Jansa, Jan; Frossard, Emmanuel; van der Heijden, Marcel G. A.			Can Arbuscular Mycorrhizal Fungi Reduce the Growth of Agricultural Weeds?	PLOS ONE			English	Article							COMMUNITY STRUCTURE; PHOSPHORUS UPTAKE; SOIL; DIVERSITY; COLONIZATION; WHEAT; RESPONSES; PRODUCTIVITY; DEPRESSIONS; ACQUISITION	Background: Arbuscular mycorrhizal fungi (AMF) are known for their beneficial effects on plants. However, there is increasing evidence that some ruderal plants, including several agricultural weeds, respond negatively to AMF colonization. Here, we investigated the effect of AMF on the growth of individual weed species and on weed-crop interactions. Methodology/Principal Findings: First, under controlled glasshouse conditions, we screened growth responses of nine weed species and three crops to a widespread AMF, Glomus intraradices. None of the weeds screened showed a significant positive mycorrhizal growth response and four weed species were significantly reduced by the AMF (growth responses between -22 and -35%). In a subsequent experiment, we selected three of the negatively responding weed species Echinochloa crus-galli, Setaria viridis and Solanum nigrum - and analyzed their responses to a combination of three AMF (Glomus intraradices, Glomus mosseae and Glomus claroideum). Finally, we tested whether the presence of a crop (maize) enhanced the suppressive effect of AMF on weeds. We found that the growth of the three selected weed species was also reduced by a combination of AMF and that the presence of maize amplified the negative effect of AMF on the growth of E. crus-galli. Conclusions/Significance: Our results show that AMF can negatively influence the growth of some weed species indicating that AMF have the potential to act as determinants of weed community structure. Furthermore, mycorrhizal weed growth reductions can be amplified in the presence of a crop. Previous studies have shown that AMF provide a number of beneficial ecosystem services. Taken together with our current results, the maintenance and promotion of AMF activity may thereby contribute to sustainable management of agroecosystems. However, in order to further the practical and ecological relevance of our findings, additional experiments should be performed under field conditions.	[Veiga, Rita S. L.; van der Heijden, Marcel G. A.] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland; [Veiga, Rita S. L.; van der Heijden, Marcel G. A.] Univ Utrecht, Fac Sci, Inst Environm Biol, Utrecht, Netherlands; [Jansa, Jan; Frossard, Emmanuel] Swiss Fed Inst Technol, Inst Agr Sci, Lindau, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture; Utrecht University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Veiga, RSL (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	rita.lopesdeveiga@art.admin.ch	Jansa, Jan/H-3161-2014; van der Heijden, Marcel G.A./H-5243-2011; van der Heijden, Marcel/AAY-1593-2021	Jansa, Jan/0000-0002-0331-1774; van der Heijden, Marcel/0000-0001-7040-1924	Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART); Swiss National Science Foundation [315230_ 130764/1]	Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss Federal Government (Agroscope Reckenholz-Tanikon Research Station ART) and a grant from the Swiss National Science Foundation (grant number: 315230_ 130764/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN MF, 1989, NEW PHYTOL, V111, P45, DOI 10.1111/j.1469-8137.1989.tb04216.x; [Anonymous], 2009, LANG ENV STAT COMP; [Anonymous], 2006, ACKERFLORA WICHTIGE; Baker H. G., 1975, Annual Review of Ecology and Systematics, V5, P1, DOI 10.1146/annurev.es.05.110174.000245; Boyetchko SM, 1996, PHYTOPROTECTION, V77, P41, DOI 10.7202/706099ar; Cameron DD, 2010, PLANT SOIL, V333, P1, DOI 10.1007/s11104-010-0361-y; FRANCIS R, 1994, PLANT SOIL, V159, P11, DOI 10.1007/BF00000091; FRANCIS R, 1995, CAN J BOT, V73, pS1301, DOI 10.1139/b95-391; Gamper HA, 2009, NEW PHYTOL, V182, P495, DOI 10.1111/j.1469-8137.2008.02750.x; Gianinazzi S, 2010, MYCORRHIZA, V20, P519, DOI 10.1007/s00572-010-0333-3; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Grace EJ, 2009, NEW PHYTOL, V181, P938, DOI 10.1111/j.1469-8137.2008.02720.x; Graham JH, 2000, PLANT SOIL, V220, P207, DOI 10.1023/A:1004709209009; Grundy AC, 2011, WEED RES, V51, P187, DOI 10.1111/j.1365-3180.2010.00831.x; Hebeisen T, 1997, GLOB CHANGE BIOL, V3, P149, DOI 10.1046/j.1365-2486.1997.00073.x; HETRICK BAD, 1992, CAN J BOT, V70, P2032, DOI 10.1139/b92-253; HOLM S, 1979, SCAND J STAT, V6, P65; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Jansa J, 2005, PLANT SOIL, V276, P163, DOI 10.1007/s11104-005-4274-0; Jansa J, 2003, ECOL APPL, V13, P1164, DOI 10.1890/1051-0761(2003)13[1164:STATCS]2.0.CO;2; Jansa J, 2008, NEW PHYTOL, V177, P779, DOI 10.1111/j.1469-8137.2007.02294.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jordan N, 2008, RENEW AGR FOOD SYST, V23, P108, DOI 10.1017/S1742170508002226; Jordan NR, 2000, WEED RES, V40, P397, DOI 10.1046/j.1365-3180.2000.00207.x; Klironomos JN, 2000, ECOL LETT, V3, P137, DOI 10.1046/j.1461-0248.2000.00131.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; KOIDE R, 1985, NEW PHYTOL, V99, P449, DOI 10.1111/j.1469-8137.1985.tb03672.x; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Li HY, 2008, NEW PHYTOL, V178, P852, DOI 10.1111/j.1469-8137.2008.02410.x; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Maherali H, 2007, SCIENCE, V316, P1746, DOI 10.1126/science.1143082; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Munkvold L, 2004, NEW PHYTOL, V164, P357, DOI 10.1111/j.1469-8137.2004.01169.x; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Opik M, 2006, J ECOL, V94, P778, DOI 10.1111/j.1365-2745.2006.01136.x; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Plenchette C, 1996, BIOL FERT SOILS, V21, P303, DOI 10.1007/BF00334907; PLENCHETTE C, 1983, PLANT SOIL, V70, P199, DOI 10.1007/BF02374780; Pringle A, 2008, NEW PHYTOL, V180, P162, DOI 10.1111/j.1469-8137.2008.02537.x; READ DJ, 1989, P ROY SOC EDINB B, V96, P89, DOI 10.1017/S0269727000010873; Read DJ, 2002, ECOL STU AN, V157, P3; Rinaudo V, 2010, PLANT SOIL, V333, P7, DOI 10.1007/s11104-009-0202-z; Ryan MH, 2002, AUST J AGR RES, V53, P1173, DOI 10.1071/AR02005; SANDERS IR, 1994, FUNCT ECOL, V8, P77, DOI 10.2307/2390114; Scheublin TR, 2007, J ECOL, V95, P631, DOI 10.1111/j.1365-2745.2007.01244.x; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; TEMPLETON GE, 1979, ANNU REV PHYTOPATHOL, V17, P301, DOI 10.1146/annurev.py.17.090179.001505; van der Heijden MGA, 2006, NEW PHYTOL, V172, P739, DOI 10.1111/j.1469-8137.2006.01862.x; van der Heijden MGA, 2009, J ECOL, V97, P1139, DOI 10.1111/j.1365-2745.2009.01570.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 2002, ECOL STU AN, V157, P243; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Vatovec C, 2005, RENEW AGR FOOD SYST, V20, P181, DOI 10.1079/RAF2005115; Verbruggen E, 2012, PLANT SOIL, V350, P43, DOI 10.1007/s11104-011-0828-5; Vogelsang KM, 2006, NEW PHYTOL, V172, P554, DOI 10.1111/j.1469-8137.2006.01854.x; Wagg C, 2011, ECOLOGY, V92, P1303, DOI 10.1890/10-1915.1; WAPSHERE AJ, 1974, ANN APPL BIOL, V77, P201, DOI 10.1111/j.1744-7348.1974.tb06886.x; WYSE DL, 1994, WEED TECHNOL, V8, P403, DOI 10.1017/S0890037X00039014	64	62	69	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27825	10.1371/journal.pone.0027825	http://dx.doi.org/10.1371/journal.pone.0027825			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164216	gold, Green Published			2022-12-27	WOS:000298171400016
J	Williams, M; Vannier, J; Corbari, L; Massabuau, JC				Williams, Mark; Vannier, Jean; Corbari, Laure; Massabuau, Jean-Charles			Oxygen as a Driver of Early Arthropod Micro-Benthos Evolution	PLOS ONE			English	Article							PHYLLOPOD BED COMMUNITY; FUNCTIONAL-MORPHOLOGY; BRADORIID ARTHROPODS; PHOSPHATOCOPID CRUSTACEAN; ORDOVICIAN OSTRACODS; MYODOCOPID OSTRACOD; CIRCULATORY-SYSTEM; TISSUE-OXYGENATION; OLENID TRILOBITES; BURGESS SHALE	Background: We examine the physiological and lifestyle adaptations which facilitated the emergence of ostracods as the numerically dominant Phanerozoic bivalve arthropod micro-benthos. Methodology/Principal Findings: The PO2 of modern normoxic seawater is 21 kPa (air-equilibrated water), a level that would cause cellular damage if found in the tissues of ostracods and much other marine fauna. The PO2 of most aquatic breathers at the cellular level is much lower, between 1 and 3 kPa. Ostracods avoid oxygen toxicity by migrating to waters which are hypoxic, or by developing metabolisms which generate high consumption of O-2. Interrogation of the Cambrian record of bivalve arthropod micro-benthos suggests a strong control on ecosystem evolution exerted by changing seawater O-2 levels. The PO2 of air-equilibrated Cambrian-seawater is predicted to have varied between 10 and 30 kPa. Three groups of marine shelf-dwelling bivalve arthropods adopted different responses to Cambrian seawater O-2. Bradoriida evolved cardiovascular systems that favoured colonization of oxygenated marine waters. Their biodiversity declined during intervals associated with black shale deposition and marine shelf anoxia and their diversity may also have been curtailed by elevated late Cambrian (Furongian) oxygen-levels that increased the PO2 gradient between seawater and bradoriid tissues. Phosphatocopida responded to Cambrian anoxia differently, reaching their peak during widespread seabed dysoxia of the SPICE event. They lacked a cardiovascular system and appear to have been adapted to seawater hypoxia. As latest Cambrian marine shelf waters became well oxygenated, phosphatocopids went extinct. Changing seawater oxygen-levels and the demise of much of the seabed bradoriid micro-benthos favoured a third group of arthropod micro-benthos, the ostracods. These animals adopted lifestyles that made them tolerant of changes in seawater O-2. Ostracods became the numerically dominant arthropod micro-benthos of the Phanerozoic. Conclusions/Significance: Our work has implications from an evolutionary context for understanding how oxygen-level in marine ecosystems drives behaviour.	[Williams, Mark] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Vannier, Jean] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France; [Corbari, Laure] Museum Natl Hist Nat, CNRS, UMR 7138, Paris, France; [Massabuau, Jean-Charles] Univ Bordeaux 1, CNRS, EPOC, UMR 5805, Arcachon, France	University of Leicester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Williams, M (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mri@le.ac.uk	Williams, Mark/B-7590-2009	Williams, Mark/0000-0002-7987-6069; Massabuau, Jean-Charles/0000-0003-1302-1719; Corbari, Laure/0000-0002-3323-6162	Agence Nationale de la Recherche [ANR] [ORECO-BLAN06-3-136294]	Agence Nationale de la Recherche [ANR](French National Research Agency (ANR))	This study was supported by Agence Nationale de la Recherche [ANR] grant ORECO-BLAN06-3-136294 'RALI' The Rise of Animal Life [http://www.agence-nationale-recherche.fr/Intl]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1995, MAR BIOL, V124, P51, DOI 10.1007/BF00349146; Ahlberg P, 2005, ACTA PALAEONTOL POL, V50, P429; Ahlberg P, 2009, LETHAIA, V42, P2, DOI 10.1111/j.1502-3931.2008.00127.x; Alvarez MED, 2008, ACTA PALAEONTOL POL, V53, P647; ANGEL MV, 1993, SYNOPSES BRIT FAUNA, V48, P1; Bennett Carys, 2008, Senckenbergiana Lethaea, V88, P37; Bennett MB, 1997, INT J PARASITOL, V27, P275, DOI 10.1016/S0020-7519(96)00201-9; Berg-Madsen V., 1985, Bulletin of the Geological Society of Denmark, V34, P133; Bottjer D.J., 2000, GSA TODAY, V10, P1; Caron JB, 2008, PALAEOGEOGR PALAEOCL, V258, P222, DOI 10.1016/j.palaeo.2007.05.023; Caron JB, 2006, PALAIOS, V21, P451, DOI 10.2110/palo.2003.P05-070R; COHEN AC, 1989, J CRUSTACEAN BIOL, V9, P297, DOI 10.2307/1548508; Corbari L, 2005, MAR BIOL, V147, P1377, DOI 10.1007/s00227-005-0040-3; Corbari L, 2005, J EXP BIOL, V208, P661, DOI 10.1242/jeb.01427; Corbari L, 2004, J EXP BIOL, V207, P4415, DOI 10.1242/jeb.01290; Droser ML, 2003, INTEGR COMP BIOL, V43, P178, DOI 10.1093/icb/43.1.178; Fortey R, 2000, P NATL ACAD SCI USA, V97, P6574, DOI 10.1073/pnas.97.12.6574; Gill BC, 2011, NATURE, V469, P80, DOI 10.1038/nature09700; GRUNDEL J, 1981, FREIBERGER FORSCH C, V363, P57; Harvey THP, 2011, J GEOL SOC LONDON, V168, P705, DOI 10.1144/0016-76492010-031; Hinz-Schallreuter I, 1996, ARCH GESCHIEBEKUNDE, V2, P841; Hinz-Schallreuter Ingelore, 1993, Archiv fuer Geschiebekunde, V1, P385; Hinz-Schallreuter Ingelore, 1998, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V1, P103; Hinz-Schallreuter Ingelore C.U., 1996, Stereo-Atlas of Ostracod Shells, V23, P85; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Hou XG, 2002, T ROY SOC EDIN-EARTH, V92, P347; Hou XG, 2010, P ROY SOC B-BIOL SCI, V277, P1835, DOI 10.1098/rspb.2009.2194; Hull SL, 1998, J NAT HIST, V32, P501, DOI 10.1080/00222939800770271; Jago J.B., 2006, Palaeoworld, V15, P406, DOI 10.1016/j.palwor.2006.10.014; Salas MJ, 2007, J PALEONTOL, V81, P1384, DOI 10.1666/05-134.1; Loughlin JD, 2011, PALAEOGEOGR PALAEOCL, V297, P239; Maas Andreas, 2003, Fossils and Strata, V49, P1; Massabuau JC, 2003, MECH AGEING DEV, V124, P857, DOI 10.1016/S0047-6374(03)00147-7; Massabuau JC, 2001, RESP PHYSIOL, V128, P249, DOI 10.1016/S0034-5687(01)00305-X; Massabuau JC, 2011, OXIDATIVE S IN PRESS; Melnikova LM, 1997, J MICROPALAEONTOL, V16, P179, DOI 10.1144/jm.16.2.179; MONTAGNA PA, 1995, J EXP MAR BIOL ECOL, V185, P149, DOI 10.1016/0022-0981(94)00138-4; MULLER KJ, 1979, LETHAIA, V12, P1, DOI 10.1111/j.1502-3931.1979.tb01234.x; Narbonne GM, 2005, ANNU REV EARTH PL SC, V33, P421, DOI 10.1146/annurev.earth.33.092203.122519; Orr PJ, 2003, GEOLOGY, V31, P769, DOI 10.1130/G19193.1; Perrier V, 2011, PALAEONTOLO IN PRESS; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Pour MG, 2011, ALCHERINGA, V35, P517, DOI 10.1080/03115518.2011.538909; Rushton AWA, 2011, SPECIAL REPORT GEOLO, V25, P1; Saltzman MR, 2011, P NATL ACAD SCI USA, V108, P3876, DOI 10.1073/pnas.1011836108; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Shu DG, 1999, LETHAIA, V32, P279; Siveter D.J., 1991, Journal of Micropalaeontology, V10, P151; Siveter DJ, 2007, P ROY SOC B-BIOL SCI, V274, P465, DOI 10.1098/rspb.2006.3756; Siveter David J., 1997, Special Papers in Palaeontology, V57, P1; Siveter DJ, 2010, P ROY SOC B-BIOL SCI, V277, P1539, DOI 10.1098/rspb.2009.2122; Siveter DJ, 2001, SCIENCE, V293, P479, DOI 10.1126/science.1061697; Siveter DJ, 2003, SPEC PAP PALAEONTOL, P9; Siveter DJ, 1996, T ROY SOC EDIN-EARTH, V86, P113, DOI 10.1017/S0263593300006374; Siveter DJ, 2003, SCIENCE, V302, P1749, DOI 10.1126/science.1091376; SIVETER DJ, 1995, J GEOL SOC LONDON, V152, P221, DOI 10.1144/gsjgs.152.2.0221; SOHN IG, 1979, J PALEONTOL, V53, P578; Sylvester-Bradley P. C., 1961, TREATISE INVERTEBR Q, pQ100; Terfelt F, 2008, NORW J GEOL, V88, P73; Tinn O, 2004, PALAEONTOLOGY, V47, P199, DOI 10.1111/j.0031-0239.2004.00369.x; Topper TP, 2011, GONDWANA RES, V19, P310, DOI 10.1016/j.gr.2010.05.012; VANDERKOOI JM, 1991, AM J PHYSIOL, V260, pC1131, DOI 10.1152/ajpcell.1991.260.6.C1131; Vannier J, 2005, PALAIOS, V20, P3, DOI 10.2110/palo.2003.p03-40; VANNIER J, 1993, J CRUSTACEAN BIOL, V13, P51, DOI 10.2307/1549122; Vannier J, 1995, PALAEONTOLOGY, V38, P843; Vannier J, 1997, LETHAIA, V30, P169; Vannier J, 1998, MAR BIOL, V132, P391, DOI 10.1007/s002270050406; Vannier J, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P81; Vannier J, 2010, GEOLOGY, V38, P711, DOI 10.1130/G30829.1; Waloszek Dieter, 2003, P69; Weitschat W., 1983, Stereo-Atlas of Ostracod Shells, V10, P127; Whatley R., 1991, Journal of Micropalaeontology, V10, P181; Williams M, 2006, PALAEOGEOGR PALAEOCL, V230, P299, DOI 10.1016/j.palaeo.2005.07.021; WILLIAMS M, 1994, T ROY SOC EDIN-EARTH, V85, P123, DOI 10.1017/S0263593300003527; Williams M, 2007, PALAEOGEOGR PALAEOCL, V248, P202, DOI 10.1016/j.palaeo.2006.12.004; Williams Mark, 1998, Monograph of the Palaeontographical Society, V152, P1; Williams Mark, 2008, Senckenbergiana Lethaea, V88, P11; Woods MA, 2011, J GEOL SOC LONDON, V168, P851, DOI 10.1144/0016-76492010-111; Wrona R, 2009, POL POLAR RES, V30, P347, DOI 10.4202/ppres.2009.19; Zhang H.Q., 2010, NEUES JB GEOLOGIE PA, V259, P157; Zhang XG, 2007, PALAEONTOGR ABT A, V281, P93, DOI 10.1127/pala/281/2007/93; Zhu Mao-Yan, 2006, Palaeoworld, V15, P217, DOI 10.1016/j.palwor.2006.10.016; Zhuravlev AY, 1996, GEOLOGY, V24, P311, DOI 10.1130/0091-7613(1996)024<0311:AATCOT>2.3.CO;2	84	27	29	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28183	10.1371/journal.pone.0028183	http://dx.doi.org/10.1371/journal.pone.0028183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164241	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400042
J	Chen, Q; Prior, M; Dargusch, R; Roberts, A; Riek, R; Eichmann, C; Chiruta, C; Akaishi, T; Abe, K; Maher, P; Schubert, D				Chen, Qi; Prior, Marguerite; Dargusch, Richard; Roberts, Amanda; Riek, Roland; Eichmann, Cedric; Chiruta, Chandramouli; Akaishi, Tatsuhiro; Abe, Kazuho; Maher, Pamela; Schubert, David			A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; AMYLOID-BETA-PROTEIN; MOUSE MODEL; HIPPOCAMPAL-LESIONS; LEARNING-DEFICITS; TRANSGENIC MOUSE; MEMORY DEFICITS; STRESS-RESPONSE; CNS DISORDERS; MICE LACKING	Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (A beta) that mediates familial Alzheimer's disease pathology. However, given that age is the greatest risk factor for AD, we explored an alternative drug discovery scheme that is based upon efficacy in multiple cell culture models of age-associated pathologies rather than exclusively amyloid metabolism. Using this approach, we identified an exceptionally potent, orally active, neurotrophic molecule that facilitates memory in normal rodents, and prevents the loss of synaptic proteins and cognitive decline in a transgenic AD mouse model.	[Chen, Qi; Prior, Marguerite; Dargusch, Richard; Chiruta, Chandramouli; Maher, Pamela; Schubert, David] Salk Inst Biol Studies, Cellular Neurobiol Lab, La Jolla, CA 92037 USA; [Riek, Roland] Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA; [Akaishi, Tatsuhiro; Abe, Kazuho] Musashino Univ, Pharmacol Lab, Pharmaceut Sci Res Inst, Nishitokyo, Tokyo, Japan; [Roberts, Amanda] Scripps Res Inst, La Jolla, CA 92037 USA; [Riek, Roland; Eichmann, Cedric] ETH, Phys Chem Lab, Zurich, Switzerland	Salk Institute; Salk Institute; Scripps Research Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Chen, Q (corresponding author), Salk Inst Biol Studies, Cellular Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	Schubert@salk.edu	Eichmann, Cédric/U-1360-2018; Chiruta, Chandramouli/D-9155-2013	Eichmann, Cédric/0000-0002-8476-1936; Akaishi, Tatsuhiro/0000-0003-4169-4398	National Institutes of Health [R21NS064334, R01AG035055]; Fritz B. Burns Foundation; Bundy Foundation; Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fritz B. Burns Foundation; Bundy Foundation; Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from The National Institutes of Health (R21NS064334, R01AG035055) (DS), the Fritz B. Burns Foundation (DS and PM), the Bundy Foundation, (MP and QC), and The Alzheimer's Association (www.alz.org) (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1990, JPN J PHARMACOL, V53, P221, DOI 10.1254/jjp.53.221; Abe K, 1996, J NEUROSCI, V16, P1066; AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Allen GL, 2004, PERCEPT PSYCHOPHYS, V66, P170, DOI 10.3758/BF03194870; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bonda DJ, 2010, NEUROPHARMACOLOGY, V59, P290, DOI 10.1016/j.neuropharm.2010.04.005; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Cole GM, 2007, ADV EXP MED BIOL, V595, P197; Coma M, 2010, NEUROBIOL DIS, V38, P482, DOI 10.1016/j.nbd.2010.01.019; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; Dore S, 2002, FREE RADICAL BIO MED, V32, P1276, DOI 10.1016/S0891-5849(02)00805-5; DUGICHDJORDJEVIC MM, 1995, EUR J NEUROSCI, V7, P1831, DOI 10.1111/j.1460-9568.1995.tb00703.x; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Frautschy SA, 2010, MOL NEUROBIOL, V41, P392, DOI 10.1007/s12035-010-8137-1; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; GUERREIRO RJ, 2010, NEUROBIOL AGING 0620; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Ikonomovic MD, 2008, J HISTOCHEM CYTOCHEM, V56, P1065, DOI 10.1369/jhc.2008.951855; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2007, J BIOL CHEM, V282, P22707, DOI 10.1074/jbc.M611050200; Krafft GA, 2010, NEUROPHARMACOLOGY, V59, P230, DOI 10.1016/j.neuropharm.2010.07.012; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; Lanni C, 2008, PHARMACOL RES, V57, P196, DOI 10.1016/j.phrs.2008.02.004; Lapchak PA, 2011, J NEUROCHEM, V116, P122, DOI 10.1111/j.1471-4159.2010.07090.x; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Liu YB, 2008, J NEUROCHEM, V105, P1336, DOI 10.1111/j.1471-4159.2008.05236.x; Maher P., 2010, MICRONUTRIENTS BRAIN, P189; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Olin D, 2005, NEUROSCI LETT, V381, P275, DOI 10.1016/j.neulet.2005.02.017; Oromo-Ibarra M, 2006, REV NEUROLOGIA, V43, P556, DOI 10.33588/rn.4309.2005487; Pajouhesh Hassan, 2005, NeuroRx, V2, P541, DOI 10.1602/neurorx.2.4.541; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Pezet S, 2004, EXPERT OPIN THER TAR, V8, P391, DOI 10.1517/14728222.8.5.391; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Radak Z, 2010, J ALZHEIMERS DIS, V20, P777, DOI 10.3233/JAD-2010-091531; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Rossler OG, 2004, J NEUROCHEM, V88, P1240, DOI 10.1046/j.1471-4159.2003.02255.x; Sarnyai Z, 2000, P NATL ACAD SCI USA, V97, P14731, DOI 10.1073/pnas.97.26.14731; Sato M, 2001, J NEUROSCI, V21, P3797, DOI 10.1523/JNEUROSCI.21-11-03797.2001; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schipper HM, 2009, J NEUROCHEM, V110, P469, DOI 10.1111/j.1471-4159.2009.06160.x; SCHUBERT D, 2002, Patent No. 6472436; Shia CS, 2009, J AGR FOOD CHEM, V57, P83, DOI 10.1021/jf802378q; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; van Groen T, 2006, NEUROBIOL DIS, V23, P653, DOI 10.1016/j.nbd.2006.05.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang F, 2009, NEUROSCI LETT, V454, P212, DOI 10.1016/j.neulet.2009.03.030; Winkler BS, 2003, EXP EYE RES, V76, P715, DOI 10.1016/S0014-4835(03)00052-6; Wollen KA, 2010, ALTERN MED REV, V15, P223; Woodruff-Pak DS, 2001, P NATL ACAD SCI USA, V98, P2089, DOI 10.1073/pnas.031584398; Yamagata Y, 2003, J PHARMACOL SCI, V93, P22, DOI 10.1254/jphs.93.22; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yao YM, 2005, ANN NEUROL, V58, P623, DOI 10.1002/ana.20558; Yoshimura Y, 2002, BIOCHEM BIOPH RES CO, V290, P948, DOI 10.1006/bbrc.2001.6320; Young JW, 2009, PHARMACOL THERAPEUT, V122, P150, DOI 10.1016/j.pharmthera.2009.02.004; Zahs KR, 2010, TRENDS NEUROSCI, V33, P381, DOI 10.1016/j.tins.2010.05.004; Zhang HT, 2005, PSYCHOPHARMACOLOGY, V179, P613, DOI 10.1007/s00213-004-2085-2; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	84	87	92	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27865	10.1371/journal.pone.0027865	http://dx.doi.org/10.1371/journal.pone.0027865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194796	Green Published, gold, Green Submitted			2022-12-27	WOS:000298369100016
J	Mockford, EJ; Marshall, RC; Dabelsteen, T				Mockford, Emily J.; Marshall, Rupert C.; Dabelsteen, Torben			Degradation of Rural and Urban Great Tit Song: Testing Transmission Efficiency	PLOS ONE			English	Article							PARUS-MAJOR SONG; SOUND-TRANSMISSION; ACOUSTIC-SIGNALS; NOISE; COMMUNICATION; HABITAT; WREN; DIVERGENCE; FOREST; BIRDS	Acoustic signals play a fundamental role in avian territory defence and mate attraction. Several studies have now shown that spectral properties of bird song differ between urban and rural environments. Previously this has been attributed to competition for acoustic space as a result of low-frequency noise present in cities. However, the physical structure of urban areas may have a contributory effect. Here we investigate the sound degradation properties of woodland and city environments using both urban and rural great tit song. We show that although urban surroundings caused significantly less degradation to both songs, the transmission efficiency of rural song compared to urban song was significantly lower in the city. While differences between the two songs in woodland were generally minimal, some measures of the transmission efficiency of rural song were significantly lower than those of urban song, suggesting additional benefits to singing rural songs in this setting. In an attempt to create artificial urban song, we mimicked the increase in minimum frequency found several times previously in urban song. However, this did not replicate the same transmission properties as true urban song, suggesting changes in other song characteristics, such as temporal adjustments, are needed to further increase transmission of an avian signal in the city. We suggest that the structure of the acoustic environment, in addition to the background noise, plays an important role in signal adaptation.	[Mockford, Emily J.; Marshall, Rupert C.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Dabelsteen, Torben] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Mockford, Emily J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); University of Copenhagen; University of Sheffield	Marshall, RC (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.	rmm@aber.ac.uk	Dabelsteen, Torben/D-9854-2015; Marshall, Rupert/C-7093-2008	Dabelsteen, Torben/0000-0001-7162-3924; Marshall, Rupert/0000-0002-1019-465X	NERC [NE/F012756/1]; URF from Aberystwyth University; Danish Council for Independent Research [272-07-0477]	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); URF from Aberystwyth University; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	E.J.M. was supported by NERC studentship NE/F012756/1 (http://www.nerc.ac.uk/). Additional financial support was provided by a URF grant from Aberystwyth University to R. C. M. (http://www.aber.ac.uk/en/). T. D. was supported by Framework Grant No. 272-07-0477 from the Danish Council for Independent Research (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER MC, 1986, AM NAT, V128, P491, DOI 10.1086/284582; Balsby TJS, 2003, BEHAVIOUR, V140, P695, DOI 10.1163/156853903322370634; Barker NKS, 2009, BEHAVIOUR, V146, P1093, DOI 10.1163/156853909X406446; Bermudez-Cuamatzin E, 2009, BEHAVIOUR, V146, P1269, DOI 10.1163/156853909X423104; Blumenrath SH, 2004, BEHAVIOUR, V141, P935, DOI 10.1163/1568539042360152; DABELSTEEN T, 1993, J ACOUST SOC AM, V93, P2206, DOI 10.1121/1.406682; Dabelsteen Torben, 2002, Acta Ethologica, V4, P65; Dingle C, 2008, J EVOLUTION BIOL, V21, P1079, DOI 10.1111/j.1420-9101.2008.01536.x; Fernandez-Juricic Esteban, 2005, Urban Habitats, V3, P49; Garamszegi LZ, 2005, OECOLOGIA, V143, P167, DOI 10.1007/s00442-004-1784-z; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Halfwerk W, 2009, ANIM BEHAV, V78, P1301, DOI 10.1016/j.anbehav.2009.09.015; Hamao S, 2011, ETHOL ECOL EVOL, V23, P111, DOI 10.1080/03949370.2011.554881; Holland J, 1998, J ACOUST SOC AM, V103, P2154, DOI 10.1121/1.421361; Holland J, 2001, BEHAVIOUR, V138, P189, DOI 10.1163/15685390151074375; Holland Jo, 2001, Bioacoustics, V12, P3; HUNTER ML, 1979, J ANIM ECOL, V48, P759, DOI 10.2307/4194; KREBS J, 1978, NATURE, V271, P539, DOI 10.1038/271539a0; Krebs J.R., 1977, P47; Kroodsma D.E., 1996, ECOLOGY EVOLUTION AC; LARSEN ON, 1997, BIOACOUSTICS, V8, P323; MCGREGOR PK, 1984, BEHAV ECOL SOCIOBIOL, V16, P49, DOI 10.1007/BF00293103; MCGREGOR PK, 1983, AUK, V100, P898, DOI 10.1093/auk/100.4.898; Mockford EJ, 2009, P ROY SOC B-BIOL SCI, V276, P2979, DOI 10.1098/rspb.2009.0586; Moller AP, 2006, BEHAV ECOL, V17, P155, DOI 10.1093/beheco/arj010; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; Mougeot F, 2000, ANIM BEHAV, V60, P647, DOI 10.1006/anbe.2000.1491; Nemeth E, 2006, J ACOUST SOC AM, V119, P620, DOI 10.1121/1.2139072; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Nemeth E, 2009, ANIM BEHAV, V78, P637, DOI 10.1016/j.anbehav.2009.06.016; Patricelli GL, 2006, AUK, V123, P639, DOI 10.1642/0004-8038(2006)123[639:ACIUNC]2.0.CO;2; Patten MA, 2004, EVOLUTION, V58, P2144; PEDERSEN SB, 1998, SIGPRO 3 23; RICHARDS DG, 1981, AUK, V98, P127; Ripmeester EAP, 2010, BEHAV ECOL, V21, P876, DOI 10.1093/beheco/arq075; Salaberria C, 2010, ARDEOLA, V57, P3; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2002, CONDOR, V104, P564, DOI 10.1650/0010-5422(2002)104[0564:BASTTB]2.0.CO;2; Slabbekoorn H, 2002, EVOLUTION, V56, P1849; Slabbekoorn H, 2007, CONDOR, V109, P67, DOI 10.1650/0010-5422(2007)109[67:STASDA]2.0.CO;2; Slabbekoorn H, 2006, CURR BIOL, V16, P2326, DOI 10.1016/j.cub.2006.10.008; Thomas RJ, 2003, BEHAVIOUR, V140, P387, DOI 10.1163/156853903321826693; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Verzijden MN, 2010, J EXP BIOL, V213, P2575, DOI 10.1242/jeb.038299; Warren PS, 2006, ANIM BEHAV, V71, P491, DOI 10.1016/j.anbehav.2005.07.014; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047; Wood WE, 2006, AUK, V123, P650, DOI 10.1642/0004-8038(2006)123[650:SSMMSV]2.0.CO;2	47	29	29	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28242	10.1371/journal.pone.0028242	http://dx.doi.org/10.1371/journal.pone.0028242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174781	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600010
J	Cremers, H; van Tol, MJ; Roelofs, K; Aleman, A; Zitman, FG; van Buchem, MA; Veltman, DJ; van der Wee, NJA				Cremers, Henk; van Tol, Marie-Jose; Roelofs, Karin; Aleman, Andre; Zitman, Frans G.; van Buchem, Mark A.; Veltman, Dick J.; van der Wee, Nic J. A.			Extraversion Is Linked to Volume of the Orbitofrontal Cortex and Amygdala	PLOS ONE			English	Article							ANXIETY DISORDERS; INDIVIDUAL-DIFFERENCES; PERSONALITY-TRAITS; BRAIN; NEUROTICISM; DEPRESSION; METAANALYSIS; ACTIVATION; LATERALIZATION; NEUROANATOMY	Neuroticism and extraversion are personality factors associated with the vulnerability for developing depression and anxiety disorders, and are possibly differentially related to brain structures implicated in the processing of emotional information and the generation of mood states. To date, studies on brain morphology mainly focused on neuroticism, a dimension primarily related to negative affect, yielding conflicting findings concerning the association with personality, partially due to methodological issues and variable population samples under study. Recently, extraversion, a dimension primarily related to positive affect, has been repeatedly inversely related to with symptoms of depression and anxiety disorders. In the present study, high resolution structural T1-weighted MR images of 65 healthy adults were processed using an optimized Voxel Based Morphometry (VBM) approach. Multiple regression analyses were performed to test for associations of neuroticism and extraversion with prefrontal and subcortical volumes. Orbitofrontal and right amygdala volume were both positively related to extraversion. Extraversion was differentially related to volume of the anterior cingulate cortex in males (positive) and females (negative). Neuroticism scores did not significantly correlate with these brain regions. As extraversion is regarded a protective factor for developing anxiety disorders and depression and has been related to the generation of positive affect, the present results indicate that the reduced likelihood of developing affective disorders in individuals high on extraversion is related to modulation of emotion processing through the orbitofrontal cortex and the amygdala.	[Cremers, Henk; Roelofs, Karin] Leiden Univ, Clin Hlth & Neuropsychol Unit, Inst Psychol Res, Leiden, Netherlands; [Cremers, Henk; van Tol, Marie-Jose; Roelofs, Karin; van Buchem, Mark A.; van der Wee, Nic J. A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Tol, Marie-Jose; Zitman, Frans G.; van der Wee, Nic J. A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van Tol, Marie-Jose; Aleman, Andre] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [van Buchem, Mark A.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Cremers, H (corresponding author), Leiden Univ, Clin Hlth & Neuropsychol Unit, Inst Psychol Res, Leiden, Netherlands.	cremershr@fsw.leidenuniv.nl	Roelofs, Karin/D-6780-2012; Aleman, Andre/E-1341-2012; van Buchem, Mark/AAC-9843-2022	van Buchem, Mark/0000-0003-1881-1998; Roelofs, Karin/0000-0002-8863-8978	Netherlands Organization of Scientific Research (NWO) [452-07-008]; Netherlands Organisation for Health Research and Development (Zon-Mw) [10-000-1002]; VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (Zon-Mw)(Netherlands Organization for Health Research and Development); VU University Medical Center; GGZ inGeest; Arkin; Leiden University Medical Center; GGZ Rivierduinen; University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Scientific Institute for Quality of Healthcare (IQ healthcare); Netherlands Institute for Health Services Research (NIVEL); Netherlands Institute of Mental Health and Addiction (Trimbos Institute)	Henk Cremers and Karin Roelofs are supported by the Netherlands Organization of Scientific Research (NWO), VIDI grant #452-07-008. The infrastructure for the NESDA study (www.nesda.nl) is funded through the Geestkracht program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant number 10-000-1002) and is supported by participating universities and mental health care organizations (VU University Medical Center, GGZ inGeest, Arkin, Leiden University Medical Center, GGZ Rivierduinen, University Medical Center Groningen, Lentis, GGZ Friesland, GGZ Drenthe, Scientific Institute for Quality of Healthcare (IQ healthcare), Netherlands Institute for Health Services Research (NIVEL) and Netherlands Institute of Mental Health and Addiction (Trimbos Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004; Bienvenu OJ, 2004, DEPRESS ANXIETY, V20, P92, DOI 10.1002/da.20026; Blankstein U, 2009, NEUROPSYCHOLOGIA, V47, P599, DOI 10.1016/j.neuropsychologia.2008.10.014; Canli T, 2004, J PERS, V72, P1105, DOI 10.1111/j.1467-6494.2004.00292.x; Canli T, 2002, SCIENCE, V296, P2191, DOI 10.1126/science.1068749; CLARK LA, 1994, J ABNORM PSYCHOL, V103, P103, DOI 10.1037/0021-843X.103.1.103; Costa PT, 2007, REVISED NEO PERSONAL; Costafreda SG, 2008, BRAIN RES REV, V58, P57, DOI 10.1016/j.brainresrev.2007.10.012; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; JACKSON J, 2009, NEUROBIOL AGING; Jylha P, 2006, DEPRESS ANXIETY, V23, P281, DOI 10.1002/da.20167; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Milad MR, 2007, ANN NY ACAD SCI, V1121, P546, DOI 10.1196/annals.1401.006; Omura K, 2005, NEUROREPORT, V16, P1905, DOI 10.1097/01.wnr.0000186596.64458.76; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Price JL, 2003, ANN NY ACAD SCI, V985, P50; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rauch SL, 2005, NEUROREPORT, V16, P1909, DOI 10.1097/01.wnr.0000186599.66243.50; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Spinhoven P, 2011, J NERV MENT DIS, V199, P684, DOI 10.1097/NMD.0b013e318229d21f; van Tol MJ, 2010, ARCH GEN PSYCHIAT, V67, P1002, DOI 10.1001/archgenpsychiatry.2010.121; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; Wright CI, 2007, NEUROIMAGE, V35, P263, DOI 10.1016/j.neuroimage.2006.11.039; Wright CI, 2006, CEREB CORTEX, V16, P1809, DOI 10.1093/cercor/bhj118	37	65	66	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28421	10.1371/journal.pone.0028421	http://dx.doi.org/10.1371/journal.pone.0028421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FK	22174802	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700033
J	Chen, LH; Lee, WC				Chen, Lan-Hsin; Lee, Wen-Chung			Two-Way Minimization: A Novel Treatment Allocation Method for Small Trials	PLOS ONE			English	Article							CLINICAL-TRIALS	Randomization is a hallmark of clinical trials. If a trial entails very few subjects and has many prognostic factors (or many factor levels) to be balanced, minimization is a more efficient method to achieve balance than a simple randomization. We propose a novel minimization method, the 'two-way minimization'. The method separately calculates the 'imbalance in the total numbers of subjects' and the 'imbalance in the distributions of prognostic factors'. And then to allocate a subject, it chooses-by probability-to minimize either one of these two aspects of imbalances. As such, it is a method that is both treatment-adaptive and covariate-adaptive. We perform Monte-Carlo simulations to examine its statistical properties. The two-way minimization (with proper regression adjustment of the force-balanced prognostic factors) has the correct type I error rates. It also produces point estimates that are unbiased and variance estimates that are accurate. When there are important prognostic factors to be balanced in the study, the method achieves the highest power and the smallest variance among randomization methods that are resistant to selection bias. The allocation can be done in real time and the subsequent data analysis is straightforward. The two-way minimization is recommended to balance prognostic factors in small trials.	[Chen, Lan-Hsin; Lee, Wen-Chung] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Coll Publ Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Chen, LH (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw	Huang, HsiaoYuan/F-5985-2012	Lee, Wen-Chung/0000-0003-3171-7672	National Science Council, Taiwan, Republic of China [NSC 99-2628-B-002-061-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council, Taiwan, Republic of China (NSC 99-2628-B-002-061-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BIRKETT NJ, 1985, CONTROL CLIN TRIALS, V6, P146, DOI 10.1016/0197-2456(85)90120-5; Chow SC, 2007, ADAPTIVE DESIGN METH; KALISH LA, 1985, STAT MED, V4, P129, DOI 10.1002/sim.4780040204; Perry M, 2010, J CLIN EPIDEMIOL, V63, P1118, DOI 10.1016/j.jclinepi.2009.11.014; POCOCK SJ, 1979, BIOMETRICS, V35, P183, DOI 10.2307/2529944; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rovers MM, 2000, EUR J EPIDEMIOL, V16, P1123, DOI 10.1023/A:1010907912024; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Yu K, 2011, BIOSTATISTICS, V12, P582, DOI 10.1093/biostatistics/kxq078	9	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28604	10.1371/journal.pone.0028604	http://dx.doi.org/10.1371/journal.pone.0028604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163317	gold, Green Submitted, Green Published			2022-12-27	WOS:000298161900053
J	Kramer, P; Bressan, P; Grassi, M				Kramer, Peter; Bressan, Paola; Grassi, Massimo			Time Estimation Predicts Mathematical Intelligence	PLOS ONE			English	Article							MENTAL NUMBER LINE; INDIVIDUAL-DIFFERENCES; SPATIAL NEGLECT; PARIETAL CORTEX; WORKING-MEMORY; PERCEPTION; SPACE; REPRESENTATION; INFORMATION; MAGNITUDE	Background: Performing mental subtractions affects time (duration) estimates, and making time estimates disrupts mental subtractions. This interaction has been attributed to the concurrent involvement of time estimation and arithmetic with general intelligence and working memory. Given the extant evidence of a relationship between time and number, here we test the stronger hypothesis that time estimation correlates specifically with mathematical intelligence, and not with general intelligence or working-memory capacity. Methodology/Principal Findings: Participants performed a (prospective) time estimation experiment, completed several subtests of the WAIS intelligence test, and self-rated their mathematical skill. For five different durations, we found that time estimation correlated with both arithmetic ability and self-rated mathematical skill. Controlling for non-mathematical intelligence (including working memory capacity) did not change the results. Conversely, correlations between time estimation and non-mathematical intelligence either were nonsignificant, or disappeared after controlling for mathematical intelligence. Conclusions/Significance: We conclude that time estimation specifically predicts mathematical intelligence. On the basis of the relevant literature, we furthermore conclude that the relationship between time estimation and mathematical intelligence is likely due to a common reliance on spatial ability.	[Kramer, Peter; Bressan, Paola; Grassi, Massimo] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua	Kramer, P (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	peter.kramer@unipd.it	Kramer, Peter/O-6633-2015; Bressan, Paola/O-6491-2015; Grassi, Massimo/I-8234-2012	Kramer, Peter/0000-0003-4807-7077; Bressan, Paola/0000-0003-2763-0902; Grassi, Massimo/0000-0002-3784-2784	University of Padova [CPDA084849]	University of Padova	This work was supported by a grant from the University of Padova (Progetto di Ricerca di Ateneo CPDA084849) to Paola Bressan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila A, 2002, NEUROPSYCHOL REV, V12, P179, DOI 10.1023/A:1021343508573; Basso G, 1996, NEUROREPORT, V7, P2111, DOI 10.1097/00001756-199609020-00009; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Calabria M, 2011, NEUROPSYCHOLOGY, V25, P193, DOI 10.1037/a0021304; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cappelletti M, 2009, NEUROPSYCHOLOGIA, V47, P2732, DOI 10.1016/j.neuropsychologia.2009.05.024; Conson M, 2008, EXP BRAIN RES, V187, P267, DOI 10.1007/s00221-008-1300-5; Danckert J, 2007, J COGNITIVE NEUROSCI, V19, P1706, DOI 10.1162/jocn.2007.19.10.1706; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Fink A, 2005, INTELLIGENCE, V33, P5, DOI 10.1016/j.intell.2004.09.001; Fink A, 2001, PERS INDIV DIFFER, V30, P1009, DOI 10.1016/S0191-8869(00)00089-1; Frassinetti F, 2009, PSYCHOL SCI, V20, P949, DOI 10.1111/j.1467-9280.2009.02390.x; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gevers W, 2006, J EXP PSYCHOL HUMAN, V32, P32, DOI 10.1037/0096-1523.32.1.32; Gobel SM, 2006, NEUROPSYCHOLOGIA, V44, P860, DOI 10.1016/j.neuropsychologia.2005.09.007; Grondin S, 2005, J EXP PSYCHOL HUMAN, V31, P869, DOI 10.1037/0096-1523.31.5.869; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Husain M, 2007, TRENDS COGN SCI, V11, P30, DOI 10.1016/j.tics.2006.10.011; Ishihara M, 2008, CORTEX, V44, P454, DOI 10.1016/j.cortex.2007.08.010; Kramer P, 2011, PSYCHON B REV, V18, P722, DOI 10.3758/s13423-011-0104-y; Longo MR, 2007, NEUROPSYCHOLOGIA, V45, P1400, DOI 10.1016/j.neuropsychologia.2006.11.002; Martin JS, 2010, J AUTISM DEV DISORD, V40, P640, DOI 10.1007/s10803-009-0904-3; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nicholls MER, 2010, EXP PSYCHOL, V57, P315, DOI 10.1027/1618-3169/a000037; Pardini L, 2006, REPROD NUTR DEV, V46, P463, DOI 10.1051/rnd:2006032; Rammsayer TH, 2010, ATTEN PERCEPT PSYCHO, V72, P1591, DOI 10.3758/APP.72.6.1591; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; Sigmundsson H, 2010, NEUROSCI LETT, V469, P248, DOI 10.1016/j.neulet.2009.12.005; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; Stoianov I, 2008, COGNITION, V106, P770, DOI 10.1016/j.cognition.2007.04.013; Vicario CM, 2007, BRAIN COGNITION, V64, P68, DOI 10.1016/j.bandc.2006.12.002; Vicario CM, 2011, PERCEPTION, V40, P23, DOI 10.1068/p6800; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Wallace GL, 2008, RES AUTISM SPECT DIS, V2, P447, DOI 10.1016/j.rasd.2007.09.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Walsh V, 2003, TRENDS COGN SCI, V7, P335, DOI 10.1016/S1364-6613(03)00166-9; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	42	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28621	10.1371/journal.pone.0028621	http://dx.doi.org/10.1371/journal.pone.0028621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163319	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900055
J	Lee, JT; Netuveli, G; Majeed, A; Millett, C				Lee, John Tayu; Netuveli, Gopalakrishnan; Majeed, Azeem; Millett, Christopher			The Effects of Pay for Performance on Disparities in Stroke, Hypertension, and Coronary Heart Disease Management: Interrupted Time Series Study	PLOS ONE			English	Article							INCENTIVE-BASED CONTRACT; PRIMARY-CARE; FOR-PERFORMANCE; HEALTH-CARE; FINANCIAL INCENTIVES; DIABETES MANAGEMENT; ETHNIC DISPARITIES; OUTCOMES FRAMEWORK; QUALITY; UK	Background: The Quality and Outcomes Framework (QOF), a major pay-for-performance programme, was introduced into United Kingdom primary care in April 2004. The impact of this programme on disparities in health care remains unclear. This study examines the following questions: has this pay for performance programme improved the quality of care for coronary heart disease, stroke and hypertension in white, black and south Asian patients? Has this programme reduced disparities in the quality of care between these ethnic groups? Did general practices with different baseline performance respond differently to this programme? Methodology/Principal Findings: Retrospective cohort study of patients registered with family practices in Wandsworth, London during 2007. Segmented regression analysis of interrupted time series was used to take into account the previous time trend. Primary outcome measures were mean systolic and diastolic blood pressure, and cholesterol levels. Our findings suggest that the implementation of QOF resulted in significant short term improvements in blood pressure control. The magnitude of benefit varied between ethnic groups with a statistically significant short term reduction in systolic BP in white and black but not in south Asian patients with hypertension. Disparities in risk factor control were attenuated only on few measures and largely remained intact at the end of the study period. Conclusions/Significance: Pay for performance programmes such as the QOF in the UK should set challenging but achievable targets. Specific targets aimed at reducing ethnic disparities in health care may also be needed.	[Lee, John Tayu; Netuveli, Gopalakrishnan; Majeed, Azeem; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London SW7 2AZ, England	Imperial College London	Lee, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Primary Care & Publ Hlth, Sch Publ Hlth, London SW7 2AZ, England.	t.lee@imperial.ac.uk		Millett, Christopher/0000-0002-0793-9884; Lee, John Tayu/0000-0002-1551-4923; Majeed, Azeem/0000-0002-2357-9858	National Institute for Health Research Service [08/1716/209]; National Institute for Health Research Biomedical Research Centre; National Institute for Health Research; Imperial Centre for Patient Safety and Service Quality; Department of Health	National Institute for Health Research Service; National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); Imperial Centre for Patient Safety and Service Quality; Department of Health	This study was funded by the National Institute for Health Research Service Delivery & Organisation programme (Grant Number 08/1716/209). The Department of Primary Care & Public Health at Imperial College is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding scheme, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme, and the Imperial Centre for Patient Safety and Service Quality. The Wandsworth Primary Care Research Centre has received funding from the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No potential conflicts of interest relevant to this article were reported.	Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; ASHWORTH M, 2008, BRIT MED J, V337, pA20; Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; CAMPBELL SM, 2005, BRIT MED J, V331, P11; Campbell S, 2007, NEW ENGL J MED, V357, P181, DOI 10.1056/NEJMsr065990; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Casalino LP, 2007, HEALTH AFFAIR, V26, pW405, DOI 10.1377/hlthaff.26.3.w405; Chien AT, 2007, MED CARE RES REV, V64, p283S, DOI 10.1177/1077558707305426; Conrad DA, 2009, ANNU REV PUBL HEALTH, V30, P357, DOI 10.1146/annurev.publhealth.031308.100243; Crawley D, 2009, J ROY SOC MED, V102, P103, DOI 10.1258/jrsm.2009.080389; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran T, 2010, HEALTH AFFAIR, V29, P1023, DOI 10.1377/hlthaff.2010.0069; EMMERICH M, 2011, ENZYKLOPADIE ERZIEHU, P1; Gray J, 2003, BRIT MED J, V326, P1130, DOI 10.1136/bmj.326.7399.1130; Guthrie B, 2006, BRIT J GEN PRACT, V56, P836; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kontopantelis E, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-61; LeGrand J, 1997, J SOC POLICY, V26, P149, DOI 10.1017/S0047279497004984; Marmot M, 2010, FAIR SOC HLTH LIVES; Marshall M, 2003, QUAL SAF HEALTH CARE, V12, P397, DOI 10.1136/qhc.12.6.397; McGovern MP, 2008, FAM PRACT, V25, P33, DOI 10.1093/fampra/cmm073; MCGUIRE T, 2000, HDB HLTH EC A, V1, P461; McLean G, 2006, J EPIDEMIOL COMMUN H, V60, P917, DOI 10.1136/jech.2005.044628; MILLETT C, 2011, BMJ, V342; Millett C, 2008, ANN FAM MED, V6, P490, DOI 10.1370/afm.907; Millett C, 2007, PLOS MED, V4, P1087, DOI 10.1371/journal.pmed.0040191; Millett C, 2009, J ROY SOC MED, V102, P369, DOI 10.1258/jrsm.2009.090171; Millett C, 2009, DIABETES CARE, V32, P404, DOI 10.2337/dc08-0912; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Saxena S, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-96; Simpson CR, 2006, STROKE, V37, P2354, DOI 10.1161/01.STR.0000236067.37267.88; Sutton M, 2006, BRIT MED J, V332, P389, DOI 10.1136/bmj.38742.554468.55; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440; Tahrani AA, 2007, BRIT J GEN PRACT, V57, P483; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walker S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X501859; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	39	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27236	10.1371/journal.pone.0027236	http://dx.doi.org/10.1371/journal.pone.0027236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866HE	22194781	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000298370400002
J	Jin, SH; Lin, P; Hallett, M				Jin, Seung-Hyun; Lin, Peter; Hallett, Mark			Abnormal Reorganization of Functional Cortical Small-World Networks in Focal Hand Dystonia	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; MUTUAL INFORMATION ANALYSIS; MOTOR AREAS; SENSORIMOTOR INTEGRATION; OSCILLATORY SYNCHRONY; WRITERS CRAMP; CONNECTIVITY; ACTIVATION; CORTEX; MOVEMENTS	We investigated the large-scale functional cortical connectivity network in focal hand dystonia (FHD) patients using graph theoretic measures to assess efficiency. High-resolution EEGs were recorded in 15 FHD patients and 15 healthy volunteers at rest and during a simple sequential finger tapping task. Mutual information (MI) values of wavelet coefficients were estimated to create an association matrix between EEG electrodes, and to produce a series of adjacency matrices or graphs, G, by thresholding with network cost. Efficiency measures of small-world networks were assessed. As a result, we found that FHD patients have economical small-world properties in their brain functional networks in the alpha and beta bands. During a motor task, in the beta band network, FHD patients have decreased efficiency of small-world networks, whereas healthy volunteers increase efficiency. Reduced efficient beta band network in FHD patients during the task was consistently observed in global efficiency, cost-efficiency, and maximum cost-efficiency. This suggests that the beta band functional cortical network of FHD patients is reorganized even during a task that does not induce dystonic symptoms, representing a loss of long-range communication and abnormal functional integration in large-scale brain functional cortical networks. Moreover, negative correlations between efficiency measures and duration of disease were found, indicating that the longer duration of disease, the less efficient the beta band network in FHD patients. In regional efficiency analysis, FHD patients at rest have high regional efficiency at supplementary motor cortex (SMA) compared with healthy volunteers; however, it is diminished during the motor task, possibly reflecting abnormal inhibition in FHD patients. The present study provides the first evidence with graph theory for abnormal reconfiguration of brain functional networks in FHD during motor task.	[Jin, Seung-Hyun; Lin, Peter; Hallett, Mark] NINDS, Human Motor Control Sect, NIH, Bethesda, MD 20892 USA; [Jin, Seung-Hyun] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Seoul National University (SNU); Seoul National University Hospital	Jin, SH (corresponding author), NINDS, Human Motor Control Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallettm@mail.nih.gov		Lin, Peter/0000-0003-1198-7763	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)	National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research program of the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbruzzese G, 2001, BRAIN, V124, P537, DOI 10.1093/brain/124.3.537; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bai O, 2005, CLIN NEUROPHYSIOL, V116, P1213, DOI 10.1016/j.clinph.2005.01.006; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carbonnell L, 2004, CLIN NEUROPHYSIOL, V115, P2164, DOI 10.1016/j.clinph.2004.04.012; CERUTTI S, 1988, IEEE T BIO-MED ENG, V35, P701, DOI 10.1109/10.7271; Connolly JD, 2000, J NEUROPHYSIOL, V84, P1645, DOI 10.1152/jn.2000.84.3.1645; Defazio G, 2007, BRAIN, V130, P1183, DOI 10.1093/brain/awl355; Delorme A, 2007, J NEUROSCI, V27, P11949, DOI 10.1523/JNEUROSCI.3477-07.2007; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Frasch MG, 2007, CLIN NEUROPHYSIOL, V118, P1969, DOI 10.1016/j.clinph.2007.05.071; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Gerloff C, 1998, BRAIN, V121, P1513, DOI 10.1093/brain/121.8.1513; Gerloff C, 2002, ACTA PSYCHOL, V110, P161, DOI 10.1016/S0001-6918(02)00032-X; Gordon AM, 1998, EXP BRAIN RES, V121, P153, DOI 10.1007/s002210050447; Gross J, 2005, NEUROIMAGE, V26, P91, DOI 10.1016/j.neuroimage.2005.01.025; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; Hummel F, 2003, CLIN NEUROPHYSIOL, V114, P605, DOI 10.1016/S1388-2457(02)00417-0; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Jin SH, 2006, INT J PSYCHOPHYSIOL, V62, P337, DOI 10.1016/j.ijpsycho.2006.06.003; Jin SH, 2006, BRAIN COGNITION, V62, P191, DOI 10.1016/j.bandc.2006.05.001; Jin SH, 2011, MOVEMENT DISORD, V26, P1274, DOI 10.1002/mds.23675; Jin SH, 2010, CLIN NEUROPHYSIOL, V121, P392, DOI 10.1016/j.clinph.2009.09.033; JIN SH, 2011, HUM BRAIN MAPP; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lerner A, 2004, NEUROIMAGE, V21, P904, DOI 10.1016/j.neuroimage.2003.10.019; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mima T, 1999, CLIN NEUROPHYSIOL, V110, P1892, DOI 10.1016/S1388-2457(99)00238-2; Mima T, 2000, NEUROSCI LETT, V287, P93, DOI 10.1016/S0304-3940(00)01165-4; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Oga T, 2002, BRAIN, V125, P895, DOI 10.1093/brain/awf083; Pollok B, 2005, NEUROIMAGE, V24, P646, DOI 10.1016/j.neuroimage.2004.10.009; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sadato N, 1996, J NEUROSCI, V16, P2693; Sakai K, 1998, J NEUROSCI, V18, P1827; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Serrien DJ, 2003, HUM BRAIN MAPP, V18, P296, DOI 10.1002/hbm.10086; Serrien DJ, 2002, EXP BRAIN RES, V147, P268, DOI 10.1007/s00221-002-1253-z; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Stam CJ, 2010, INT J PSYCHOPHYSIOL, V77, P186, DOI 10.1016/j.ijpsycho.2010.06.024; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Tallon-Baudry C, 2004, CEREB CORTEX, V14, P713, DOI 10.1093/cercor/bhh031; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tamburin S, 2002, BRAIN, V125, P2719, DOI 10.1093/brain/awf279; Tamura Y, 2009, BRAIN, V132, P749, DOI 10.1093/brain/awn348; Tinazzi M, 1999, NEUROREPORT, V10, P1547, DOI 10.1097/00001756-199905140-00028; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Witt ST, 2008, NEUROIMAGE, V42, P343, DOI 10.1016/j.neuroimage.2008.04.025; Wu CC, 2010, J NEUROL NEUROSUR PS, V81, P659, DOI 10.1136/jnnp.2009.185637; Wu T, 2007, NEUROSCI LETT, V422, P164, DOI 10.1016/j.neulet.2007.06.011	66	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28682	10.1371/journal.pone.0028682	http://dx.doi.org/10.1371/journal.pone.0028682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174867	Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300021
J	Lo, YH; Liu, SW; Sun, YJ; Lizz, HW; Hsiao, CD				Lo, Yu-Hua; Liu, Shih-Wei; Sun, Yuh-Ju; Lizz, Hung-Wen; Hsiao, Chwan-Deng			Mutations Altering the Interplay between GkDnaC Helicase and DNA Reveal an Insight into Helicase Unwinding	PLOS ONE			English	Article							SINGLE-STRANDED-DNA; REPLICATIVE HEXAMERIC HELICASE; TETHERED PARTICLE MOTION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN HEXAMER; NUCLEIC-ACID; MECHANISM; TRANSLOCATION; MOLECULE	Replicative helicases are essential molecular machines that utilize energy derived from NTP hydrolysis to move along nucleic acids and to unwind double-stranded DNA (dsDNA). Our earlier crystal structure of the hexameric helicase from Geobacillus kaustophilus HTA426 (GkDnaC) in complex with single-stranded DNA (ssDNA) suggested several key residues responsible for DNA binding that likely play a role in DNA translocation during the unwinding process. Here, we demonstrated that the unwinding activities of mutants with substitutions at these key residues in GkDnaC are 2-4-fold higher than that of wildtype protein. We also observed the faster unwinding velocities in these mutants using single-molecule experiments. A partial loss in the interaction of helicase with ssDNA leads to an enhancement in helicase efficiency, while their ATPase activities remain unchanged. In strong contrast, adding accessory proteins (DnaG or DnaI) to GkDnaC helicase alters the ATPase, unwinding efficiency and the unwinding velocity of the helicase. It suggests that the unwinding velocity of helicase could be modulated by two different pathways, the efficiency of ATP hydrolysis or protein-DNA interaction.	[Lo, Yu-Hua; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lo, Yu-Hua; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Liu, Shih-Wei; Lizz, Hung-Wen] Natl Taiwan Univ, Dept Chem, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University	Lo, YH (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	hsiao@gate.sinica.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532; LI, HUNG-WEN/0000-0002-5614-3727	Academia Sinica; National Science Council, Taiwan, Republic of China [NSC98-2311-B-001-009-MY3, NSC98-2113-M-002-013-MY2]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by research grants from Academia Sinica to C.-D.H. and the National Science Council (NSC98-2311-B-001-009-MY3 to C.-D.H., and NSC98-2113-M-002-013-MY2 to H.-W.L.), Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Berger JM, 2008, CELL, V134, DOI 10.1016/j.cell.2008.08.027; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; Chu JF, 2010, BIOPHYS J, V98, P1608, DOI 10.1016/j.bpj.2009.12.4328; Datta K, 2003, ANAL BIOCHEM, V317, P284, DOI 10.1016/S0003-2697(03)00168-4; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Fan HF, 2009, BIOPHYS J, V96, P1875, DOI [10.1016/j.bpj.2008.11.048, 10.1016/j.bpj.2()08.11.048]; Farge G, 2008, NUCLEIC ACIDS RES, V36, P393, DOI 10.1093/nar/gkm1025; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2129, DOI 10.1021/bi952345d; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Lo YH, 2009, NUCLEIC ACIDS RES, V37, P804, DOI 10.1093/nar/gkn999; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Manosas M, 2010, NUCLEIC ACIDS RES, V38, P5518, DOI 10.1093/nar/gkq273; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; Nelson PC, 2006, J PHYS CHEM B, V110, P17260, DOI 10.1021/jp0630673; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Pouget N, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh073; Ribeck N, 2010, BIOPHYS J, V99, P2170, DOI 10.1016/j.bpj.2010.07.039; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2002, NUCLEIC ACIDS RES, V30, P966, DOI 10.1093/nar/30.4.966; Spies M, 2005, J BIOL CHEM, V280, P37078, DOI 10.1074/jbc.M505521200; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tsai KL, 2009, J MOL BIOL, V393, P1056, DOI 10.1016/j.jmb.2009.09.002; van Oijen AM, 2010, ANNU REV BIOPHYS, V39, P429, DOI 10.1146/annurev.biophys.093008.131327; WAHLE E, 1989, J BIOL CHEM, V264, P2469; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29016	10.1371/journal.pone.0029016	http://dx.doi.org/10.1371/journal.pone.0029016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174946	Green Submitted, Green Published, gold			2022-12-27	WOS:000298367300040
J	Bharti, SK; Rex, K; Sreedhar, P; Krishnan, N; Varshney, U				Bharti, Sanjay Kumar; Rex, Kervin; Sreedhar, Pujari; Krishnan, Neeraja; Varshney, Umesh			Chimeras of Escherichia coli and Mycobacterium tuberculosis Single-Stranded DNA Binding Proteins: Characterization and Function in Escherichia coli	PLOS ONE			English	Article							DEINOCOCCUS-RADIODURANS; CRYSTAL-STRUCTURE; SSB GENE; X-RAY; REPLICATION; DOMAIN; COMPLEXES; SSDNA; MODES; GLYCOSYLASES	Single stranded DNA binding proteins (SSBs) are vital for the survival of organisms. Studies on SSBs from the prototype, Escherichia coli (EcoSSB) and, an important human pathogen, Mycobacterium tuberculosis (MtuSSB) had shown that despite significant variations in their quaternary structures, the DNA binding and oligomerization properties of the two are similar. Here, we used the X-ray crystal structure data of the two SSBs to design a series of chimeric proteins (m beta 1, m beta 1'beta 2, m beta 1-beta 5, m beta 1-beta 6 and m beta 4-beta 5) by transplanting beta 1, beta 1'beta 2, beta 1-beta 5, beta 1-beta 6 and beta 4-beta 5 regions, respectively of the N-terminal (DNA binding) domain of MtuSSB for the corresponding sequences in EcoSSB. In addition, m beta 1'beta 2(ESWR) SSB was generated by mutating the MtuSSB specific 'PRIY' sequence in the beta 2 strand of m beta 1'beta 2 SSB to EcoSSB specific 'ESWR' sequence. Biochemical characterization revealed that except for m beta 1 SSB, all chimeras and a control construct lacking the C-terminal domain (Delta C SSB) bound DNA in modes corresponding to limited and unlimited modes of binding. However, the DNA on MtuSSB may follow a different path than the EcoSSB. Structural probing by protease digestion revealed that unlike other SSBs used, m beta 1 SSB was also hypersensitive to chymotrypsin treatment. Further, to check for their biological activities, we developed a sensitive assay, and observed that m beta 1-beta 6, MtuSSB, m beta 1'beta 2 and m beta 1-beta 5 SSBs complemented E. coli Delta ssb in a dose dependent manner. Complementation by the m beta 1-beta 5 SSB was poor. In contrast, m beta 1'beta 2(ESWR) SSB complemented E. coli as well as EcoSSB. The inefficiently functioning SSBs resulted in an elongated cell/filamentation phenotype of E. coli. Taken together, our observations suggest that specific interactions within the DNA binding domain of the homotetrameric SSBs are crucial for their biological function.	[Bharti, Sanjay Kumar; Rex, Kervin; Sreedhar, Pujari; Krishnan, Neeraja; Varshney, Umesh] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Varshney, Umesh] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Bharti, SK (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	varshney@mcbl.iisc.ernet.in	Varshney, Umesh/Q-6914-2019	Krishnan, Neeraja/0000-0003-0982-4367	Department of Biotechnology, New Delhi; Indian Institute of Science, Bangalore	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); Indian Institute of Science, Bangalore	Work was funded by the Department of Biotechnology, New Delhi. NK was supported by the centenary post-doctoral fellowship from Indian Institute of Science, Bangalore. UV is a J. C. Bose fellow of the Department of Science and Technology (DST), New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI F, 2008, THESIS U EDINBURGH U; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bevington PR., 2002, DATA REDUCTION ERROR; Bochkarev A, 1997, NATURE, V385, P176, DOI 10.1038/385176a0; BUJALOWSKI W, 1988, J BIOL CHEM, V263, P4629; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CARLINI LE, 1993, MOL MICROBIOL, V10, P1067, DOI 10.1111/j.1365-2958.1993.tb00977.x; Chan KW, 2009, J MOL BIOL, V388, P508, DOI 10.1016/j.jmb.2009.03.022; Chedin F, 1998, TRENDS BIOCHEM SCI, V23, P273, DOI 10.1016/S0968-0004(98)01243-2; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Handa P, 2001, J BIOL CHEM, V276, P16992, DOI 10.1074/jbc.M100393200; Handa P, 2000, NUCLEIC ACIDS RES, V28, P3823, DOI 10.1093/nar/28.19.3823; Kaushal PS, 2010, ACTA CRYSTALLOGR D, V66, P1048, DOI 10.1107/S0907444910032208; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Kumar NV, 1997, NUCLEIC ACIDS RES, V25, P2336, DOI 10.1093/nar/25.12.2336; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LIEBERMAN HB, 1981, MOL GEN GENET, V183, P348, DOI 10.1007/BF00270639; LOHMAN TM, 1986, J MOL BIOL, V187, P603, DOI 10.1016/0022-2836(86)90338-4; LOHMAN TM, 1992, METHOD ENZYMOL, V212, P424; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P4034, DOI 10.1021/bi952555q; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; MEYER RR, 1979, P NATL ACAD SCI USA, V76, P1702, DOI 10.1073/pnas.76.4.1702; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; PORTER RD, 1990, BIO-TECHNOL, V8, P47, DOI 10.1038/nbt0190-47; Purnapatre K, 1999, NUCLEIC ACIDS RES, V27, P3487, DOI 10.1093/nar/27.17.3487; Purnapatre K, 1999, EUR J BIOCHEM, V264, P591, DOI 10.1046/j.1432-1327.1999.00684.x; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Raghunathan S, 1997, P NATL ACAD SCI USA, V94, P6652, DOI 10.1073/pnas.94.13.6652; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Saikrishnan K, 2003, J MOL BIOL, V331, P385, DOI 10.1016/S0022-2836(03)00729-0; Sambrook J., 2002, MOL CLONING LAB MANU; SANCAR A, 1981, P NATL ACAD SCI-BIOL, V78, P4274, DOI 10.1073/pnas.78.7.4274; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; Sharma A, 2009, FEBS J, V276, P519, DOI 10.1111/j.1742-4658.2008.06799.x; Suck D, 1997, NAT STRUCT BIOL, V4, P161, DOI 10.1038/nsb0397-161; WILLIAMS KR, 1983, J BIOL CHEM, V258, P3346; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2008, BIOPHYS J, V94, P2269, DOI 10.1529/biophysj.107.121533; Yang C, 1997, NAT STRUCT BIOL, V4, P153, DOI 10.1038/nsb0297-153	49	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27216	10.1371/journal.pone.0027216	http://dx.doi.org/10.1371/journal.pone.0027216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174737	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000298366600002
J	Druce, HC; Mackey, RL; Slotow, R				Druce, Heleen C.; Mackey, Robin L.; Slotow, Rob			How Immunocontraception Can Contribute to Elephant Management in Small, Enclosed Reserves: Munyawana Population as a Case Study	PLOS ONE			English	Article							LONG-TERM CONSERVATION; KRUGER-NATIONAL-PARK; PRIVATE GAME RESERVE; SOUTH-AFRICA; LOXODONTA-AFRICANA; MAKALALI CONSERVANCY; UNGULATE POPULATIONS; WILDLIFE MANAGEMENT; DENSITY; HORSES	Immunocontraception has been widely used as a management tool to reduce population growth in captive as well as wild populations of various fauna. We model the use of an individual-based rotational immunocontraception plan on a wild elephant, Loxodonta africana, population and quantify the social and reproductive advantages of this method of implementation using adaptive management. The use of immunocontraception on an individual, rotational basis stretches the inter-calving interval for each individual female elephant to a management-determined interval, preventing exposing females to unlimited long-term immunocontraception use (which may have as yet undocumented negative effects). Such rotational immunocontraception can effectively lower population growth rates, age the population, and alter the age structure. Furthermore, such structured intervention can simulate natural process such as predation or episodic catastrophic events (e. g., drought), which regulates calf recruitment within an abnormally structured population. A rotational immunocontraception plan is a feasible and useful elephant population management tool, especially in a small, enclosed conservation area. Such approaches should be considered for other long-lived, social species in enclosed areas where the long-term consequences of consistent contraception may be unknown.	[Druce, Heleen C.; Mackey, Robin L.; Slotow, Rob] Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Druce, HC (corresponding author), Univ KwaZulu Natal, Amarula Elephant Res Programme, Sch Biol & Conservat Sci, Westville Campus, Durban, South Africa.	slotow@ukzn.ac.za	Slotow, Rob/AAM-9053-2020	Slotow, Rob/0000-0001-9469-1508	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation; Wildlands Conservation Trust	Distell (Pty) Ltd; University of KwaZulu-Natal; National Research Foundation; Wildlands Conservation Trust	Funding received from Distell (Pty) Ltd to the Amarula Elephant Research Programme, University of KwaZulu-Natal, National Research Foundation and by the Conservation Internship Programme of the Wildlands Conservation Trust. The authors are grateful to &Beyond Africa, Phinda Private Game Reserve for providing accommodation and logistical support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Bertschinger Henk, 2008, P257; BERTSCHINGER HJ, 2005, ROLE IMMUNOCONTRACEP, P13; BERTSCHINGER HJ, 2011, IMMUNOCONTRACEPTION; Biggs Harry C., 2008, P537; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; CAUGHLEY G, 1976, E AFR WILDL J, V14, P265; CAUGHLEY G, 1970, ECOLOGY, V51, P53, DOI 10.2307/1933599; Cooper DW, 2001, REPROD FERT DEVELOP, V13, P451, DOI 10.1071/RD01072; Cumming DHM, 1997, S AFR J SCI, V93, P231; DELSINK A, 2005, ROLE IMMUNOCONTRACEP, P69; Delsink AK, 2007, J S AFR VET ASSOC, V78, P25; Delsink AK, 2006, S AFR J SCI, V102, P403; Druce Heleen, 2006, Koedoe, V49, P77; Druce HC, 2008, BIOL CONSERV, V141, P3127, DOI 10.1016/j.biocon.2008.09.024; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Fayrer-Hosken RA, 1999, THERIOGENOLOGY, V52, P835, DOI 10.1016/S0093-691X(99)00176-4; Fayrer-Hosken RA, 2000, NATURE, V407, P149, DOI 10.1038/35025136; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Garai Marion E., 2004, Pachyderm, V37, P28; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Hayward MW, 2010, ACTA THERIOL, V55, P289, DOI 10.4098/j.at.0001-7051.076.2009; Hayward MW, 2009, BIODIVERS CONSERV, V18, P887, DOI 10.1007/s10531-008-9452-y; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; Kerley GIH, 2007, S AFR J SCI, V103, P181; Kerley Graham I.H., 2008, P146; Kettles R, 2009, S AFR J WILDL RES, V39, P23, DOI 10.3957/056.039.0103; KIRKPATRICK JF, 1995, ZOO BIOL, V14, P403, DOI 10.1002/zoo.1430140503; KIRKPATRICK JF, 1992, J REPROD FERTIL, V94, P437, DOI 10.1530/jrf.0.0940437; KIRKPATRICK JF, 2005, ROLE IMMUNOCONTRACEP, P43; KREBS E, 2006, VASECTOMY BIRTH CONT; Laws RM., 1975, ELEPHANT THEIR HABIT; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; Lombard AT, 2001, BIOL CONSERV, V102, P191, DOI 10.1016/S0006-3207(01)00056-8; Low A.R., 1996, VEGETATION S AFRICA; Mackey RL, 2006, S AFR J WILDL RES, V36, P33; Mackey RL, 2009, AFR J ECOL, V47, P747, DOI 10.1111/j.1365-2028.2009.01075.x; McShea WJ, 1997, J WILDLIFE MANAGE, V61, P560, DOI 10.2307/3802615; Merrill JA, 2003, J WILDLIFE MANAGE, V67, P267, DOI 10.2307/3802768; Moss C, 1988, ELEPHANT MEMORIES 13; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; MOSS CJ, 2000, ELEPHANTS MAJESTIC C, P106; Naugle RE, 2002, REPRODUCTION, P143; Owen-Smith N, 2006, S AFR J SCI, V102, P389; Owen-Smith N, 2005, J ANIM ECOL, V74, P774, DOI 10.1111/j.1365-2656.2005.00974.x; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Perdok AA, 2007, PACHYDERM, P97; Poole JH, 1993, PACHYDERM, V16, P62; Poole Joyce H., 1994, P331; Powell D. M., 2001, Journal of Applied Animal Welfare Science, V4, P271, DOI 10.1207/S15327604JAWS0404_04; RIJKSEN HD, 1981, BEHAVIOUR, V78, P138, DOI 10.1163/156853981X00293; Shi DZ, 2002, J APPL ECOL, V39, P337, DOI 10.1046/j.1365-2664.2002.00716.x; Shideler SE, 2000, US FOR SERV RMRS-P, V3, P137; Sikes S.K, 1971, NATURAL HIST AFRICAN; Singh M, 2005, CURR SCI INDIA, V89, P1230; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Slotow R, 2005, S AFR J WILDL RES, V35, P23; Slotow Rob, 2004, CCA Ecological Journal, V6, P56; STOUT TAE, 2005, ROLE IMMUNOCONTRACEP, P7; Trinkel M, 2010, ANIM CONSERV, V13, P374, DOI 10.1111/j.1469-1795.2009.00344.x; Turner A, 2002, REPRODUCTION, P187; Turner JW, 2007, J WILDLIFE MANAGE, V71, P662, DOI 10.2193/2005-779; Walker B, 1998, WILDLIFE RES, V25, P1, DOI 10.1071/WR97030; Whitehouse AM, 2002, ORYX, V36, P243, DOI 10.1017/S0030605302000455; Whyte I, 1998, ANIM CONSERV, V1, P77, DOI 10.1111/j.1469-1795.1998.tb00014.x; Whyte Ian J., 1998, Pachyderm, V25, P45; Wiseman R, 2004, S AFR J WILDL RES, V34, P25; Wittemyer G, 2007, ECOGRAPHY, V30, P42, DOI 10.1111/j.2006.0906-7590.04900.x; Woolley LA, 2008, ORYX, V42, P49, DOI 10.1017/S0030605308000495; Woolley LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003233	71	21	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27952	10.1371/journal.pone.0027952	http://dx.doi.org/10.1371/journal.pone.0027952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174758	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700011
J	Liew, YX; Krishnan, P; Yeo, CL; Tan, TY; Lee, SY; Lim, WP; Lee, W; Hsu, LY				Liew, Yi-Xin; Krishnan, Prabha; Yeo, Chay-Leng; Tan, Thean-Yen; Lee, Siok-Ying; Lim, Wan-Peng; Lee, Winnie; Hsu, Li-Yang		Network Antimicrobial Resistance S	Surveillance of Broad-Spectrum Antibiotic Prescription in Singaporean Hospitals: A 5-Year Longitudinal Study	PLOS ONE			English	Article							EUROPEAN COUNTRIES; RESISTANCE; CONSUMPTION	Background: Inappropriate prescription of antibiotics may contribute towards higher levels antimicrobial resistance. A key intervention for improving appropriate antibiotic prescription is surveillance of prescription. This paper presents the results of a longitudinal surveillance of broad-spectrum antibiotic prescription in 5 public-sector hospitals in Singapore from 2006 to 2010. Methodology/Principal Findings: Quarterly antibiotic prescription data were obtained and converted to defined daily doses (DDDs) per 1,000 inpatient-days. The presence of significant trends in antibiotic prescription over time for both individual and combined hospitals was tested by regression analysis and corrected for autocorrelation between time-points. Excluding fluoroquinolones, there was a significant increase in prescription of all monitored antibiotics from an average of 233.12 defined daily doses (DDD)/1,000 inpatient-days in 2006 to 254.38 DDD/1,000 inpatient-days in 2010 (Coefficient = 1.13, 95% CI: 0.16-2.09, p = 0.025). Increasing utilization of carbapenems, piperacillin/tazobactam, and Gram-positive agents were seen in the majority of the hospitals, while cephalosporins were less prescribed over time. The combined expenditure for 5 hospitals increased from USD9.9 million in 2006 to USD16.7 million in 2010. Conclusions/Significance: The rate of prescription of broad-spectrum antibiotics in Singaporean hospitals is much higher compared to those of European hospitals. This may be due to high rates of antimicrobial resistance. The increase in expenditure on monitored antibiotics over the past 5 years outstripped the actual increase in DDD/1,000 inpatient-days of antibiotics prescribed. Longitudinal surveillance of antibiotic prescription on a hospital and countrywide level is important for detecting trends for formulating interventions or policies. Further research is needed to understand the causes for the various prescription trends and to act on these where necessary.	[Liew, Yi-Xin; Lee, Winnie] Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore; [Krishnan, Prabha] Tan Tock Seng Hosp, Dept Lab Med, Singapore, Singapore; [Yeo, Chay-Leng] Natl Univ Hlth Syst, Dept Pharm, Singapore, Singapore; [Tan, Thean-Yen] Changi Gen Hosp, Dept Lab Med, Singapore, Singapore; [Lee, Siok-Ying] Khoo Teck Puat Hosp, Dept Pharm, Singapore, Singapore; [Lim, Wan-Peng] Tan Tock Seng Hosp, Dept Pharm, Singapore, Singapore; [Hsu, Li-Yang] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	Singapore General Hospital; Tan Tock Seng Hospital; National University of Singapore; Changi General Hospital; Tan Tock Seng Hospital; National University of Singapore	Liew, YX (corresponding author), Singapore Gen Hosp, Dept Pharm, Singapore 0316, Singapore.	liyang_hsu@yahoo.com		Hsu, Li Yang/0000-0002-0396-066X; Tan, Thean Yen/0000-0003-4358-1098	SingHealth Foundation; Ministry of Health; Pfizer Singapore; Janssen-Cilag; Merck; Sharpe; Dohme; AstraZenea; Pfizer; AstraZeneca; Janssen Cilag; Sharpe Dohme	SingHealth Foundation(SingHealth); Ministry of Health; Pfizer Singapore(Pfizer); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Sharpe; Dohme; AstraZenea; Pfizer(Pfizer); AstraZeneca(AstraZeneca); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Sharpe Dohme	This work was supported by the following grants: SingHealth Foundation Grant 2006, Ministry of Health Healthcare Quality Improvement Fund 2006, and education grants from Pfizer Singapore, Janssen-Cilag, Merck, Sharpe and Dohme, AstraZenea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; L-YH has received research funding and speaker's honoraria from Pfizer, AstraZeneca, Janssen & Cilag, and Merck, Sharpe & Dohme. PK has received speaker's honorarium from Merck, Sharpe & Dohme. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ansari F, 2010, J ANTIMICROB CHEMOTH, V65, P2685, DOI 10.1093/jac/dkq378; Bergman M, 2009, ANTIMICROB AGENTS CH, V53, P912, DOI 10.1128/AAC.00856-08; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Dumartin C, 2010, J ANTIMICROB CHEMOTH, V65, P2028, DOI 10.1093/jac/dkq228; EAGYE KJ, 2011, J ANTIMICRO IN PRESS; Fridkin SK, 2002, EMERG INFECT DIS, V8, P702, DOI 10.3201/eid0807.010465; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hirakata Y, 2005, DIAGN MICR INFEC DIS, V52, P323, DOI 10.1016/j.diagmicrobio.2005.04.004; Hsu LY, 2007, EMERG INFECT DIS, V13, P1944, DOI 10.3201/eid1312.070299; Hsu LY, 2010, ANTIMICROB AGENTS CH, V54, P1173, DOI 10.1128/AAC.01076-09; LAI CC, 2011, J ANTIMICRO IN PRESS; Liew YX, 2011, INT J ANTIMICROB AG, V37, P87, DOI 10.1016/j.ijantimicag.2010.09.008; Muller A, 2006, BRIT J CLIN PHARMACO, V61, P585, DOI 10.1111/j.1365-2125.2006.02605.x; TEO J, 2011, EUR J CLIN IN PRESS; VanderStichele RH, 2006, J ANTIMICROB CHEMOTH, V58, P159, DOI 10.1093/jac/dkl147; WHO, 2001, WHO GLOB STRAT CONT; WHO International Working Group for Drug Statistics Methodology, 2011, WHO COLL CTR DRUG ST	17	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28751	10.1371/journal.pone.0028751	http://dx.doi.org/10.1371/journal.pone.0028751			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174889	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700070
J	Wu, HQ; Ma, HM; Ye, CT; Ramirez, D; Chen, SP; Montoya, J; Shankar, P; Wang, XZA; Manjunath, N				Wu, Haoquan; Ma, Hongming; Ye, Chunting; Ramirez, Danielle; Chen, Shuiping; Montoya, Jessica; Shankar, Premlata; Wang, Xiaozhong A.; Manjunath, N.			Improved siRNA/shRNA Functionality by Mismatched Duplex	PLOS ONE			English	Article							MEDIATE RNA INTERFERENCE; RATIONAL SIRNA DESIGN; CHEMICAL-MODIFICATIONS; ARGONAUTE PROTEINS; PRIMARY MICRORNAS; PASSENGER-STRAND; GUIDE STRAND; STABILITY; EFFICACY; DETERMINANTS	siRNA (small interfering RNA) and shRNA (small hairpin RNA) are powerful and commonly used tools in biomedical research. Currently, siRNAs are generally designed as two 21 nt strands of RNA that include a 19 nt completely complementary part and a 2 nt overhang. However, since the si/shRNAs use the endogenous miRNA machinery for gene silencing and the miRNAs are generally 22 nt in length and contain multiple internal mismatches, we tested if the functionality can be increased by designing the si/shRNAs to mimic a miRNA structure. We systematically investigated the effect of single or multiple mismatches introduced in the passenger strand at different positions on siRNA functionality. Mismatches at certain positions could significantly increase the functionality of siRNAs and also, in some cases decreased the unwanted passenger strand functionality. The same strategy could also be used to design shRNAs. Finally, we showed that both si and miRNA structured oligos (siRNA with or without mismatches in the passenger strand) can repress targets in all individual Ago containing cells, suggesting that the Ago proteins do not differentiate between si/miRNA-based structure for silencing activity.	[Wu, Haoquan; Ma, Hongming; Ye, Chunting; Ramirez, Danielle; Chen, Shuiping; Montoya, Jessica; Shankar, Premlata; Manjunath, N.] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX 79905 USA; [Wang, Xiaozhong A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL USA	Texas Tech University System; Texas Tech University; Northwestern University	Wu, HQ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX 79905 USA.	haoquan.wu@ttuhsc.edu; manjunath.swamy@ttuhsc.edu	ma, hongming/N-6099-2014	ma, hongming/0000-0001-5105-1332; Wu, Haoquan/0000-0001-9386-3187	National Institutes of Health [AI075419]; Paul L. Foster School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul L. Foster School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [grant number AI075419] to NM; and the Paul L. Foster School of Medicine seed grant to HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addepalli H, 2010, NUCLEIC ACIDS RES, V38, P7320, DOI 10.1093/nar/gkq568; Amarzguioui M, 2003, NUCLEIC ACIDS RES, V31, P589, DOI 10.1093/nar/gkg147; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Bramsen JB, 2007, NUCLEIC ACIDS RES, V35, P5886, DOI 10.1093/nar/gkm548; Bramsen JB, 2010, NUCLEIC ACIDS RES, V38, P5761, DOI 10.1093/nar/gkq341; Bramsen JB, 2009, NUCLEIC ACIDS RES, V37, P2867, DOI 10.1093/nar/gkp106; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hong J, 2008, BIOCHEM BIOPH RES CO, V368, P703, DOI 10.1016/j.bbrc.2008.01.116; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kawamata T, 2011, EMBO REP, V12, P944, DOI 10.1038/embor.2011.128; Kawamata T, 2009, NAT STRUCT MOL BIOL, V16, P953, DOI 10.1038/nsmb.1630; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Laursen MB, 2010, MOL BIOSYST, V6, P862, DOI 10.1039/b918869j; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Li LM, 2007, RNA, V13, P1765, DOI 10.1261/rna.599107; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Matveeva OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010180; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mittal V, 2004, NAT REV GENET, V5, P355, DOI 10.1038/nrg1323; Naito Y, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-80; Ohnishi Y, 2005, BIOCHEM BIOPH RES CO, V329, P516, DOI 10.1016/j.bbrc.2005.02.012; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Petrova NS, 2010, OLIGONUCLEOTIDES, V20, P297, DOI 10.1089/oli.2010.0246; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOINFORMATICS, V20, P3055, DOI 10.1093/bioinformatics/bth364; Sano M, 2008, NUCLEIC ACIDS RES, V36, P5812, DOI 10.1093/nar/gkn584; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Snyder LL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp657; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Sun XG, 2008, NAT BIOTECHNOL, V26, P1379, DOI 10.1038/nbt.1512; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wang BB, 2009, NAT STRUCT MOL BIOL, V16, P1259, DOI 10.1038/nsmb.1712; Wei JX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005382; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	66	24	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28580	10.1371/journal.pone.0028580	http://dx.doi.org/10.1371/journal.pone.0028580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174840	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700048
J	Bellucci, A; Navarria, L; Falarti, E; Zaltieri, M; Bono, F; Collo, G; Grazia, M; Missale, C; Spano, P				Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Grazia, Maria; Missale, Cristina; Spano, PierFranco			Redistribution of DAT/alpha-Synuclein Complexes Visualized by "In Situ" Proximity Ligation Assay in Transgenic Mice Modelling Early Parkinson's Disease	PLOS ONE			English	Article							DOPAMINE TRANSPORTER TRAFFICKING; TRUNCATED ALPHA-SYNUCLEIN; CELL-SURFACE EXPRESSION; LEWY BODIES; SYNTAXIN 1A; AGGREGATION; DEMENTIA; BRAIN; LOCALIZATION; BIOCHEMISTRY	Alpha-synuclein, the major component of Lewy bodies, is thought to play a central role in the onset of synaptic dysfunctions in Parkinson's disease (PD). In particular, a-synuclein may affect dopaminergic neuron function as it interacts with a key protein modulating dopamine (DA) content at the synapse: the DA transporter (DAT). Indeed, recent evidence from our "in vitro" studies showed that alpha-synuclein aggregation decreases the expression and membrane trafficking of the DAT as the DAT is retained into alpha-synuclein-immunopositive inclusions. This notwithstanding, "in vivo" studies on PD animal models investigating whether DAT distribution is altered by the pathological overexpression and aggregation of alpha-synuclein are missing. By using the proximity ligation assay, a technique which allows the "in situ" visualization of protein-protein interactions, we studied the occurrence of alterations in the distribution of DAT/alpha-synuclein complexes in the SYN120 transgenic mouse model, showing insoluble alpha-synuclein aggregates into dopaminergic neurons of the nigrostriatal system, reduced striatal DA levels and an altered distribution of synaptic proteins in the striatum. We found that DAT/alpha-synuclein complexes were markedly redistributed in the striatum and substantia nigra of SYN120 mice. These alterations were accompanied by a significant increase of DAT striatal levels in transgenic animals when compared to wild type littermates. Our data indicate that, in the early pathogenesis of PD, alpha-synuclein acts as a fine modulator of the dopaminergic synapse by regulating the subcellular distribution of key proteins such as the DAT.	[Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Missale, Cristina; Spano, PierFranco] Univ Brescia, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy; [Bellucci, Arianna; Navarria, Laura; Falarti, Elisa; Zaltieri, Michela; Bono, Federica; Collo, Ginetta; Missale, Cristina; Spano, PierFranco] Univ Brescia, Natl Inst Neurosci Italy, Sch Med, Brescia, Italy; [Grazia, Maria] Univ Cambridge, Dept Clin Neurosci, Brain Repair Ctr, Cambridge, England; [Spano, PierFranco] Ist Ricovero & Cura Carattere Sci San Camillo, Venice, Italy	University of Brescia; University of Brescia; University of Cambridge; IRCCS Ospedale San Camillo	Bellucci, A (corresponding author), Univ Brescia, Div Pharmacol, Dept Biomed Sci & Biotechnol, Brescia, Italy.	bellucci@med.unibs.it	BELLUCCI, Arianna/K-2063-2016; SPANO, PIERFRANCO/J-9944-2016	BELLUCCI, Arianna/0000-0002-9581-1919; SPANO, PIERFRANCO/0000-0002-9906-0964; BONO, Federica/0000-0001-9716-5327; COLLO, Ginetta/0000-0003-1888-5049	Italian Ministry of Education, University and Scientific Research; Italian Ministry of Health, Neurodegenerativo; University of Brescia; Regione Lombardia, Italy NEDD [CUPH81J09002660007]; Parkinson&quot;s UK [G-0701] Funding Source: researchfish	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health, Neurodegenerativo; University of Brescia; Regione Lombardia, Italy NEDD; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by grants from the Italian Ministry of Education, University and Scientific Research-PRIN 2006; by a grant from the Italian Ministry of Health, Neurodegenerativo 2005; by University of Brescia Research Fund EX 60% and by the Regione Lombardia, Italy NEDD Project (CUPH81J09002660007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2010, NEUROBIOL DIS, V40, P518, DOI 10.1016/j.nbd.2010.07.012; Baba M, 1998, AM J PATHOL, V152, P879; Bellani Serena, 2010, Commun Integr Biol, V3, P106; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; Bellucci A, 2008, J NEUROCHEM, V106, P560, DOI 10.1111/j.1471-4159.2008.05406.x; Bellucci A, 2006, NEUROBIOL DIS, V23, P260, DOI 10.1016/j.nbd.2006.03.012; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Blokzijl A, 2010, J INTERN MED, V268, P232, DOI 10.1111/j.1365-2796.2010.02256.x; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Chadchankar H, 2011, BRAIN RES, V1382, P37, DOI 10.1016/j.brainres.2011.01.064; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fountaine TM, 2007, J NEUROSCI RES, V85, P351, DOI 10.1002/jnr.21125; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Garcia-Reitbock P, 2010, BRAIN, V133, P2032, DOI 10.1093/brain/awq132; Hersch SM, 1997, J COMP NEUROL, V388, P211; Jellinger KA, 2005, J NEUROPATH EXP NEUR, V64, P554, DOI 10.1093/jnen/64.6.554; Jellinger KA, 2003, ACTA NEUROPATHOL, V106, P191, DOI 10.1007/s00401-003-0725-y; Kovacs GG, 2008, MOVEMENT DISORD, V23, P1608, DOI 10.1002/mds.22207; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Mori F, 2008, ACTA NEUROPATHOL, V115, P453, DOI 10.1007/s00401-007-0316-4; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Oaks AW, 2011, FEBS LETT, V585, P1001, DOI 10.1016/j.febslet.2011.03.009; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; Roy S, 2007, J NEUROSCI, V27, P3131, DOI 10.1523/JNEUROSCI.4999-06.2007; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sousa VL, 2009, MOL BIOL CELL, V20, P3725, DOI 10.1091/mbc.E08-03-0302; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Swant J, 2011, J BIOL CHEM      OCT; Tofaris GK, 2007, CELL MOL LIFE SCI, V64, P2194, DOI 10.1007/s00018-007-7217-5; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Wersinger C, 2004, NEUROSCI LETT, V358, P95, DOI 10.1016/j.neulet.2003.12.118; Wersinger C, 2003, MOL CELL NEUROSCI, V24, P91, DOI 10.1016/S1044-7431(03)00124-6; Zapata A, 2007, J BIOL CHEM, V282, P35842, DOI 10.1074/jbc.M611758200; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	60	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27959	10.1371/journal.pone.0027959	http://dx.doi.org/10.1371/journal.pone.0027959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163275	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900010
J	Frieman, M; Basu, D; Matthews, K; Taylor, J; Jones, G; Pickles, R; Baric, R; Engel, DA				Frieman, Matthew; Basu, Dipanwita; Matthews, Krystal; Taylor, Justin; Jones, Grant; Pickles, Raymond; Baric, Ralph; Engel, Daniel A.			Yeast Based Small Molecule Screen for Inhibitors of SARS-CoV	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; PAPAIN-LIKE PROTEASE; SYNDROME CORONAVIRUS; CILIATED CELLS; INFECTION; IDENTIFICATION; VIRUSES; SPREAD	Severe acute respiratory coronavirus (SARS-CoV) emerged in 2002, resulting in roughly 8000 cases worldwide and 10% mortality. The animal reservoirs for SARS-CoV precursors still exist and the likelihood of future outbreaks in the human population is high. The SARS-CoV papain-like protease (PLP) is an attractive target for pharmaceutical development because it is essential for virus replication and is conserved among human coronaviruses. A yeast-based assay was established for PLP activity that relies on the ability of PLP to induce a pronounced slow-growth phenotype when expressed in S. cerevisiae. Induction of the slow-growth phenotype was shown to take place over a 60-hour time course, providing the basis for conducting a screen for small molecules that restore growth by inhibiting the function of PLP. Five chemical suppressors of the slow-growth phenotype were identified from the 2000 member NIH Diversity Set library. One of these, NSC158362, potently inhibited SARS-CoV replication in cell culture without toxic effects on cells, and it specifically inhibited SARS-CoV replication but not influenza virus replication. The effect of NSC158362 on PLP protease, deubiquitinase and anti-interferon activities was investigated but the compound did not alter these activities. Another suppressor, NSC158011, demonstrated the ability to inhibit PLP protease activity in a cell-based assay. The identification of these inhibitors demonstrated a strong functional connection between the PLP-based yeast assay, the inhibitory compounds, and SARS-CoV biology. Furthermore the data with NSC158362 suggest a novel mechanism for inhibition of SARS-CoV replication that may involve an unknown activity of PLP, or alternatively a direct effect on a cellular target that modifies or bypasses PLP function in yeast and mammalian cells.	[Frieman, Matthew; Matthews, Krystal; Taylor, Justin; Jones, Grant] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Basu, Dipanwita; Engel, Daniel A.] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA; [Pickles, Raymond] Univ N Carolina, Dept Microbiol & Immunol, Gene Therapy Ctr, Chapel Hill, NC USA; [Baric, Ralph] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	University System of Maryland; University of Maryland Baltimore; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Frieman, M (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	dae2s@virginia.edu			Public Health Service [1R21NS063854, K22AI077797]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI077797] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063854] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grant 1R21NS063854 to DAE and RSB and K22AI077797 to MBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Basu D, 2009, J VIROL, V83, P1881, DOI 10.1128/JVI.01805-08; Chan PKS, 2003, EMERG INFECT DIS, V9, P1453, DOI 10.3201/eid0911.030421; Chan-Yeung M, 2003, RESPIROLOGY, V8, pS9, DOI 10.1046/j.1440-1843.2003.00518.x; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Cheung OY, 2004, HISTOPATHOLOGY, V45, P119, DOI 10.1111/j.1365-2559.2004.01926.x; Chong PY, 2004, ARCH PATHOL LAB MED, V128, P195; Daniel JA, 2006, GENETICS, V172, P709, DOI 10.1534/genetics.105.047662; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; GEE MH, 1990, J APPL PHYSIOL, V69, P822, DOI 10.1152/jappl.1990.69.3.822; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Katz JM, 2000, BIOMED PHARMACOTHER, V54, P178, DOI 10.1016/S0753-3322(00)89024-1; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Sheng WH, 2005, J FORMOS MED ASSOC, V104, P715; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Walkiewicz MP, 2011, J GEN VIROL, V92, P60, DOI 10.1099/vir.0.025015-0; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	22	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28479	10.1371/journal.pone.0028479	http://dx.doi.org/10.1371/journal.pone.0028479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164298	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400099
J	Miccio, A; Poletti, V; Tiboni, F; Rossi, C; Antonelli, A; Mavilio, F; Ferrari, G				Miccio, Annarita; Poletti, Valentina; Tiboni, Francesca; Rossi, Claudia; Antonelli, Antonella; Mavilio, Fulvio; Ferrari, Giuliana			The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a beta-globin Transgene	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; HEMATOPOIETIC STEM-CELLS; CREB-BINDING PROTEIN; ACTIVE CHROMATIN-STRUCTURE; LENTIVIRAL VECTORS; IN-VIVO; RETROVIRAL INTEGRATION; TARGETED DELETION; THALASSEMIA MAJOR; GENE DELIVERY	Gene therapy of genetic diseases requires persistent and position-independent expression of a therapeutic transgene. Transcriptional enhancers binding chromatin-remodeling and modifying complexes may play a role in shielding transgenes from repressive chromatin effects. We tested the activity of the HS2 enhancer of the GATA1 gene in protecting the expression of a beta-globin minigene delivered by a lentiviral vector in hematopoietic stem/progenitor cells. Gene expression from proviruses carrying GATA1-HS2 in both LTRs was persistent and resistant to silencing at most integration sites in the in vivo progeny of human hematopoietic progenitors and murine long-term repopulating stem cells. The GATA1-HS2-modified vector allowed correction of murine beta-thalassemia at low copy number without inducing clonal selection of erythroblastic progenitors. Chromatin immunoprecipitation studies showed that GATA1 and the CBP acetyltransferase bind to GATA1-HS2, significantly increasing CBP-specific histone acetylations at the LTRs and beta-globin promoter. Recruitment of CBP by the LTRs thus establishes an open chromatin domain encompassing the entire provirus, and increases the therapeutic efficacy of beta-globin gene transfer by reducing expression variegation and epigenetic silencing.	[Miccio, Annarita; Tiboni, Francesca; Rossi, Claudia; Antonelli, Antonella; Ferrari, Giuliana] Ist Sci H San Raffaele, H San Raffaele Telethon Inst Gene Therapy HSR TIG, Milan, Italy; [Miccio, Annarita; Mavilio, Fulvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy; [Poletti, Valentina; Mavilio, Fulvio] Ist Sci H San Raffaele, Gene Express Lab, Milan, Italy; [Ferrari, Giuliana] Univ Vita Salute San Raffaele, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Miccio, A (corresponding author), Ist Sci H San Raffaele, H San Raffaele Telethon Inst Gene Therapy HSR TIG, Milan, Italy.	giuliana.ferrari@hsr.it	Antonelli, Antonella/AAN-1856-2020; MAVILIO, Fulvio/J-6125-2013; Rossi, Claudia/AAO-4711-2020; Ferrari, Giuliana/AAB-5546-2019; Miccio, Annarita/H-9585-2017; Tiboni, Francesca/AAO-2772-2020; ANTONELLI, ANTONELLA/C-6238-2011; Poletti, Venerino/K-8821-2016	Ferrari, Giuliana/0000-0003-0790-3133; Miccio, Annarita/0000-0002-3409-9665; Antonelli, Antonella/0000-0003-1497-3586; Mavilio, Fulvio/0000-0003-0459-4320; Poletti, Venerino/0000-0002-8634-2284; Rossi, Claudia/0000-0002-3810-7247	Italian Telethon Foundation (Core Grant TIGET); Italian Ministry of University and Research; European Commission	Italian Telethon Foundation (Core Grant TIGET)(Fondazione Telethon); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by grants from the Italian Telethon Foundation (Core Grant TIGET), the Italian Ministry of University and Research (PRIN 2008), and the European Commission (FP7, PERSIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam PI, 2007, MOL THER, V15, P1863, DOI 10.1038/sj.mt.6300259; Blobel GA, 2000, BLOOD, V95, P745, DOI 10.1182/blood.V95.3.745.003k05_745_755; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Cho Y, 2008, NUCLEIC ACIDS RES, V36, P4521, DOI 10.1093/nar/gkn368; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; D'Apolito D, 2009, MOL THER, V17, P1434, DOI 10.1038/mt.2009.74; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Felice B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004571; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Follenzi A, 2002, HUM GENE THER, V13, P243, DOI 10.1089/10430340252769770; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Grande A, 1999, BLOOD, V93, P3276, DOI 10.1182/blood.V93.10.3276.410k08_3276_3285; Hanawa H, 2004, BLOOD, V104, P2281, DOI 10.1182/blood-2004-03-0863; Hino S, 2006, J MOL BIOL, V357, P18, DOI 10.1016/j.jmb.2005.12.057; Hino S, 2004, GENE THER, V11, P819, DOI 10.1038/sj.gt.3302227; Hung HL, 1999, MOL CELL BIOL, V19, P3496; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Jawaid K, 2010, BLOOD CELL MOL DIS, V45, P140, DOI 10.1016/j.bcmd.2010.05.006; Lamonica JM, 2006, BLOOD, V108, P3736, DOI 10.1182/blood-2006-07-032847; Letting DL, 2003, MOL CELL BIOL, V23, P1334, DOI 10.1128/MCB.23.4.1334-1340.2003; Lotti F, 2002, J VIROL, V76, P3996, DOI 10.1128/JVI.76.8.3996-4007.2002; Lucarelli G, 2002, BLOOD REV, V16, P81, DOI 10.1054/blre.2002.0192; Lutzko C, 2003, J VIROL, V77, P7341, DOI 10.1128/JVI.77.13.7341-7351.2003; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Martin DIK, 1996, CURR OPIN GENET DEV, V6, P488, DOI 10.1016/S0959-437X(96)80072-4; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miccio A, 2010, MOL CELL BIOL, V30, P3460, DOI 10.1128/MCB.00001-10; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Nielsen TT, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-13; Persons DA, 2003, BLOOD, V101, P2175, DOI 10.1182/blood-2002-07-2211; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; Ramezani A, 2003, BLOOD, V101, P4717, DOI 10.1182/blood-2002-09-2991; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Roselli EA, 2010, EMBO MOL MED, V2, P315, DOI 10.1002/emmm.201000083; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; Sutter NB, 2003, P NATL ACAD SCI USA, V100, P1105, DOI 10.1073/pnas.242732999; Trainor CD, 1996, MOL CELL BIOL, V16, P2238; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; Walters MC, 1996, GENE DEV, V10, P185, DOI 10.1101/gad.10.2.185; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zhang F, 2010, MOL THER, V18, P1640, DOI 10.1038/mt.2010.132; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	51	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27955	10.1371/journal.pone.0027955	http://dx.doi.org/10.1371/journal.pone.0027955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164220	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400021
J	Scheich, C; Szabadka, Z; Vertessy, B; Putter, V; Grolmusz, V; Schade, M				Scheich, Christoph; Szabadka, Zoltan; Vertessy, Beata; Puetter, Vera; Grolmusz, Vince; Schade, Markus			Discovery of Novel MDR-Mycobacterium tuberculosis Inhibitor by New FRIGATE Computational Screen	PLOS ONE			English	Article							ANTIGEN 85C; DRUGS; DESIGN; BIOSYNTHESIS; ALGORITHM; MECHANISM; DOCKING; INDEXES; ENZYME	With 1.6 million casualties annually and 2 billion people being infected, tuberculosis is still one of the most pressing healthcare challenges. Here we report on the new computational docking algorithm FRIGATE which unites continuous local optimization techniques (conjugate gradient method) with an inherently discrete computational approach in forcefield computation, resulting in equal or better scoring accuracies than several benchmark docking programs. By utilizing FRIGATE for a virtual screen of the ZINC library against the Mycobacterium tuberculosis (Mtb) enzyme antigen 85C, we identified novel small molecule inhibitors of multiple drug-resistant Mtb, which bind in vitro to the catalytic site of antigen 85C.	[Scheich, Christoph; Puetter, Vera; Schade, Markus] Combinat Biopharm AG, Berlin, Germany; [Szabadka, Zoltan; Grolmusz, Vince] Eotvos Lorand Univ, Dept Comp Sci, Budapest, Hungary; [Vertessy, Beata] Hungarian Acad Sci, Inst Enzymol, Budapest, Hungary; [Szabadka, Zoltan] Uratim Ltd, Budapest, Hungary; [Vertessy, Beata] Univ Technol & Econ, Dept Appl Biotechnol, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Budapest University of Technology & Economics	Scheich, C (corresponding author), Evotec AG, Hamburg, Germany.	grolmusz@cs.elte.hu; markus.schade@astrazeneca.com	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982; Schade, Markus/0000-0002-5538-5767; Grolmusz, Vince/0000-0001-9456-8876	European Union [012127]; Hungarian Scientific Research Fund [OTKA-A08 CK78646, OTKA NK-84008]; Howard Hughes Medical Institutes [55000342]; Alexander von Humboldt-Stiftung, Germany; New Hungary Development Plan [TAMOP-4.2.1/B-09/1/KMR-2010-0002, 0003, OMFB-00266/2010 REG-KM-09-1-2009-0050]	European Union(European Commission); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Howard Hughes Medical Institutes(Howard Hughes Medical Institute); Alexander von Humboldt-Stiftung, Germany(Alexander von Humboldt Foundation); New Hungary Development Plan	The authors are grateful for the financial support by the European Union FP6 grant scrIN-SILICO (Contract No. 012127), Hungarian Scientific Research Fund OTKA-A08 CK78646, OTKA NK-84008; Howard Hughes Medical Institutes #55000342, Alexander von Humboldt-Stiftung, Germany; New Hungary Development Plan (Project IDs: TAMOP-4.2.1/B-09/1/KMR-2010-0002, 0003); Baross program of the New Hungary Development Plan (Project ID: 3DSTRUCT, OMFB-00266/2010 REG-KM-09-1-2009-0050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Anderson DH, 2001, J MOL BIOL, V307, P671, DOI 10.1006/jmbi.2001.4461; Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Cosconati S, 2008, J MED CHEM, V51, P6627, DOI 10.1021/jm800571m; Coulson CJ, 1994, MOL MECH DRUG ACTION, P40; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; Ginsberg AM, 2008, SEMIN RESP CRIT CARE, V29, P552, DOI 10.1055/s-0028-1085706; Gobec S, 2007, EUR J MED CHEM, V42, P54, DOI 10.1016/j.ejmech.2006.08.007; Hajduk PJ, 2006, J MED CHEM, V49, P6972, DOI 10.1021/jm060511h; Harth G, 2002, P NATL ACAD SCI USA, V99, P15614, DOI 10.1073/pnas.242612299; Hawkins G.D., 2003, AMSOL VERSION 7 0; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x; Kellenberger E, 2004, PROTEINS, V57, P225, DOI 10.1002/prot.20149; Kovac A, 2006, J ENZYM INHIB MED CH, V21, P391, DOI 10.1080/14756360600703214; Kremer L, 2002, BIOCHEM J, V364, P423, DOI 10.1042/BJ20011628; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; MOLLER MF, 1993, NEURAL NETWORKS, V6, P525, DOI 10.1016/S0893-6080(05)80056-5; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Paul N, 2002, PROTEINS, V47, P521, DOI 10.1002/prot.10119; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Ronning DR, 2004, J BIOL CHEM, V279, P36771, DOI 10.1074/jbc.M400811200; Ronning DR, 2000, NAT STRUCT BIOL, V7, P141; Schade M, 2006, IDRUGS, V9, P110; Scheich C, 2010, J MED CHEM; Senderowitz H, 2009, CURR PHARM DESIGN, V15, P4049, DOI 10.2174/138161209789824821; Shandil RK, 2007, ANTIMICROB AGENTS CH, V51, P576, DOI 10.1128/AAC.00414-06; STEIHAUG T, 1983, SIAM J NUMER ANAL, V20, P626, DOI 10.1137/0720042; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Szabadka Z, 2007, PREDICTING PROTEIN L; Talukdar A, 2010, BIOORGAN MED CHEM, V18, P3518, DOI 10.1016/j.bmc.2010.03.072; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28428	10.1371/journal.pone.0028428	http://dx.doi.org/10.1371/journal.pone.0028428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164290	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400091
J	Sun, WK; Wang, K; Gao, W; Su, X; Qian, Q; Lu, X; Song, Y; Guo, YL; Shi, Y				Sun, Wenkui; Wang, Ke; Gao, Wei; Su, Xin; Qian, Qian; Lu, Xin; Song, Yong; Guo, Yaling; Shi, Yi			Evaluation of PCR on Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Aspergillosis: A Bivariate Metaanalysis and Systematic Review	PLOS ONE			English	Review							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; PULMONARY ASPERGILLOSIS; IMMUNOCOMPROMISED PATIENTS; NEUTROPENIC PATIENTS; FUNGAL-INFECTIONS; HEMATOLOGY PATIENTS; ANTIGEN-DETECTION; QUANTITATIVE PCR; CLINICAL-SAMPLES	Background: Nucleic acid detection by polymerase chain reaction (PCR) is emerging as a sensitive and rapid diagnostic tool. PCR assays on serum have the potential to be a practical diagnostic tool. However, PCR on bronchoalveolar lavage fluid (BALF) has not been well established. We performed a systematic review of published studies to evaluate the diagnostic accuracy of PCR assays on BALF for invasive aspergillosis (IA). Methods: Relevant published studies were shortlisted to evaluate the quality of their methodologies. A bivariate regression approach was used to calculate pooled values of the method sensitivity, specificity, and positive and negative likelihood ratios. Hierarchical summary receiver operating characteristic curves were used to summarize overall performance. We calculated the post-test probability to evaluate clinical usefulness. Potential heterogeneity among studies was explored by subgroup analyses. Results: Seventeen studies comprising 1191 at-risk patients were selected. The summary estimates of the BALF-PCR assay for proven and probable IA were as follows: sensitivity, 0.91 (95% confidence interval (CI), 0.79-0.96); specificity, 0.92 (95% CI, 0.87-0.96); positive likelihood ratio, 11.90 (95% CI, 6.80-20.80); and negative likelihood ratio, 0.10 (95% CI, 0.04-0.24). Subgroup analyses showed that the performance of the PCR assay was influenced by PCR assay methodology, primer design and the methods of cell wall disruption and DNA extraction. Conclusions: PCR assay on BALF is highly accurate for diagnosing IA in immunocompromised patients and is likely to be a useful diagnostic tool. However, further efforts towards devising a standard protocol are needed to enable formal validation of BALF-PCR.	[Sun, Wenkui; Su, Xin; Song, Yong; Shi, Yi] Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Wang, Ke] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Peoples R China; [Gao, Wei; Lu, Xin; Song, Yong; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp, Nanjing, Jiangsu, Peoples R China; [Qian, Qian] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing, Jiangsu, Peoples R China; [Guo, Yaling] Guangxi Med Univ, Sch Nursing, Dept Resp Dis, Nanning, Peoples R China	Naval Medical University; Guangxi Medical University; Nanjing University; Guangxi Medical University	Sun, WK (corresponding author), Second Mil Med Univ, Clin Sch Nanjing, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	shiyi56@126.com	Su, Xin/X-2589-2018	su, Xin/0000-0002-3910-9156	Hospital Foundation of Jinling Hospital [2011026]	Hospital Foundation of Jinling Hospital	This study was funded by a grant from the Hospital Foundation of Jinling Hospital (No. 2011026); no external funding was received for this study. The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Becker MJ, 2003, BRIT J HAEMATOL, V121, P448, DOI 10.1046/j.1365-2141.2003.04308.x; Bolehovska Radka, 2006, Biomedical Papers (Olomouc), V150, P245; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BRETAGNE S, 1995, J CLIN MICROBIOL, V33, P1164, DOI 10.1128/JCM.33.5.1164-1168.1995; Buchheidt D, 2002, BRIT J HAEMATOL, V116, P803, DOI 10.1046/j.0007-1048.2002.03337.x; Buchheidt D, 2001, CLIN INFECT DIS, V33, P428, DOI 10.1086/321887; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Donnelly JP, 2006, CLIN INFECT DIS, V42, P487, DOI 10.1086/499818; Einsele H, 1998, LANCET, V352, P1443, DOI 10.1016/S0140-6736(05)61265-2; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Frealle E, 2009, EUR J CLIN MICROBIOL, V28, P223, DOI 10.1007/s10096-008-0616-1; Guo YL, 2010, CHEST, V138, P817, DOI 10.1378/chest.10-0488; Hayette MP, 2001, J CLIN MICROBIOL, V39, P2338, DOI 10.1128/JCM.39.6.2338-2340.2001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hohenthal U, 2005, EUR J HAEMATOL, V74, P203, DOI 10.1111/j.1600-0609.2004.00373.x; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Huggett JF, 2008, THORAX, V63, P154, DOI 10.1136/thx.2007.081687; Hummel M, 2008, ANN HEMATOL, V87, P291, DOI 10.1007/s00277-007-0391-6; Imhof A, 2003, EUR J CLIN MICROBIOL, V22, P558, DOI 10.1007/s10096-003-0989-0; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Jones ME, 1998, J CLIN PATHOL, V51, P652, DOI 10.1136/jcp.51.9.652; Khot PD, 2009, EXPERT REV ANTI-INFE, V7, P1201, DOI [10.1586/eri.09.104, 10.1586/ERI.09.104]; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Kuehnhardt D, 2009, ANN HEMATOL, V88, P1249, DOI 10.1007/s00277-009-0747-1; Leeflang MM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007394; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Loeffler J, 1999, J CLIN MICROBIOL, V37, P1200, DOI 10.1128/JCM.37.4.1200-1202.1999; MELCHERS WJG, 1994, J CLIN MICROBIOL, V32, P1710, DOI 10.1128/JCM.32.7.1710-1717.1994; Mengoli C, 2009, LANCET INFECT DIS, V9, P89, DOI 10.1016/S1473-3099(09)70019-2; Musher B, 2004, J CLIN MICROBIOL, V42, P5517, DOI 10.1128/JCM.42.12.5517-5522.2004; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Raad I, 2002, CHEST, V121, P1171, DOI 10.1378/chest.121.4.1171; Rantakokko-Jalava K, 2003, J CLIN MICROBIOL, V41, P4304, DOI 10.1128/JCM.41.9.4304-4311.2003; Rapp RP, 2004, PHARMACOTHERAPY, V24, p4S, DOI 10.1592/phco.24.3.4S.33151; Reichenberger F, 1999, BONE MARROW TRANSPL, V24, P1195, DOI 10.1038/sj.bmt.1702045; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Sanguinetti M, 2003, J CLIN MICROBIOL, V41, P3922, DOI 10.1128/JCM.41.8.3922-3925.2003; Shahid M, 2008, CANCER-AM CANCER SOC, V113, P547, DOI 10.1002/cncr.23570; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Spiess B, 2003, J CLIN MICROBIOL, V41, P1811, DOI 10.1128/JCM.41.5.1811-1818.2003; SPREADBURY C, 1993, J CLIN MICROBIOL, V31, P615, DOI 10.1128/JCM.31.3.615-621.1993; TANG CM, 1993, AM REV RESPIR DIS, V148, P1313, DOI 10.1164/ajrccm/148.5.1313; Tuon Felipe Francisco, 2007, Revista Iberoamericana de Micologia, V24, P89; VERWEIJ PE, 1995, J CLIN MICROBIOL, V33, P3150, DOI 10.1128/JCM.33.12.3150-3153.1995; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250	50	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28467	10.1371/journal.pone.0028467	http://dx.doi.org/10.1371/journal.pone.0028467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164295	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400096
J	Lee, TC; Glynn, RJ; Pena, JM; Paynter, NP; Conen, D; Ridker, PM; Pradhan, AD; Buring, JE; Albert, MA				Lee, Timothy C.; Glynn, Robert J.; Pena, Jessica M.; Paynter, Nina P.; Conen, David; Ridker, Paul M.; Pradhan, Aruna D.; Buring, Julie E.; Albert, Michelle A.			Socioeconomic Status and Incident Type 2 Diabetes Mellitus: Data from the Women's Health Study	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; LIFE; ASSOCIATION	Objectives: We prospectively examined whether socioeconomic status (SES) predicts incident type II diabetes (diabetes), a cardiovascular risk equivalent and burgeoning public health epidemic among women. Methods: Participants include 23,992 women with Hb(A1c) levels <6% and no CVD or diabetes at baseline followed from February 1993 to March 2007. SES was measured by education and income while diabetes was self-reported. Results: Over 12.3 years of follow-up, 1,262 women developed diabetes. In age and race adjusted models, the relative risk of diabetes decreased with increasing education (<2 years of nursing, 2 to <4 years of nursing, bachelor's degree, master's degree, and doctorate: 1.0, 0.7 [95% Confidence Interval (CI), 0.6-0.8], 0.6 (95% CI, 0.5-0.7), 0.5 (95% CI, 0.4-0.6), 0.4 (95% CI, 0.3-0.5); p(trend)<0.001). Adjustment for traditional and non-traditional cardiovascular risk factors attenuated this relationship (education: p(trend)=0.96). Similar associations were observed between income categories and diabetes. Conclusion: Advanced education and increasing income were both inversely associated with incident diabetes even in this relatively well-educated cohort. This relationship was largely explained by behavioral factors, particularly body mass index.	[Lee, Timothy C.; Glynn, Robert J.; Pena, Jessica M.; Paynter, Nina P.; Conen, David; Ridker, Paul M.; Pradhan, Aruna D.; Buring, Julie E.; Albert, Michelle A.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; [Pena, Jessica M.; Ridker, Paul M.; Pradhan, Aruna D.; Albert, Michelle A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Conen, David] Univ Basel Hosp, Dept Med, CH-4031 Basel, Switzerland	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel	Albert, MA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA.	maalbert@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart Lung and Blood Institute [HL-080467, HL-043851, CA-047988]; National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, T32HL007575, R01HL043851] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Health study is supported by grants HL-080467, HL-043851 and CA-047988 from the National Heart Lung and Blood Institute and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh EE, 2007, INT J EPIDEMIOL, V36, P84, DOI 10.1093/ije/dyl269; Albert MA, 2006, CIRCULATION, V114, P2619, DOI 10.1161/CIRCULATIONAHA.106.660043; Boden G, 2003, EXP CLIN ENDOCR DIAB, V111, P121, DOI 10.1055/s-2003-39781; COX DR, 1972, J R STAT SOC B, V34, P187; Gavin JR, 1997, DIABETES CARE, V20, P1183; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; HOUSE JS, 1996, C SOC STAT CARD HLTH; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lee IM, 1999, J NATL CANCER I, V91, P2102, DOI 10.1093/jnci/91.24.2102; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Liu SM, 2006, DIABETES, V55, P2856, DOI 10.2337/db06-0456; Maty SC, 2005, INT J EPIDEMIOL, V34, P1274, DOI 10.1093/ije/dyi167; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mora S, 2007, CIRCULATION, V116, P2110, DOI 10.1161/CIRCULATIONAHA.107.729939; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Pradhan AD, 2009, DIABETES CARE, V32, P3, DOI 10.2337/dc08-1206; Rana JS, 2007, DIABETES CARE, V30, P53, DOI 10.2337/dc06-1456; Rathmann W, 2006, EUR J EPIDEMIOL, V21, P55, DOI 10.1007/s10654-005-5085-6; Rathmann W, 2005, EUR J PUBLIC HEALTH, V15, P627, DOI 10.1093/eurpub/cki037; Rhodes ET, 2007, DIABETES CARE, V30, P141, DOI 10.2337/dc06-1142; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Shishehbor MH, 2006, JAMA-J AM MED ASSOC, V295, P784, DOI 10.1001/jama.295.7.784; WANG Y, 2007, EPIDEMIOL REV, P296; Wilson PWF, 2007, ARCH INTERN MED, V167, P1068, DOI 10.1001/archinte.167.10.1068; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	28	68	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27670	10.1371/journal.pone.0027670	http://dx.doi.org/10.1371/journal.pone.0027670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194788	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100008
J	Fernandez-Jimenez, N; Castellanos-Rubio, A; Plaza-Izurieta, L; Gutierrez, G; Irastorza, I; Castano, L; Vitoria, JC; Bilbao, JR				Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Gutierrez, Galder; Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan; Ramon Bilbao, Jose			Accuracy in Copy Number Calling by qPCR and PRT: A Matter of DNA	PLOS ONE			English	Article							BETA-DEFENSIN	The possible implication of copy number variation (CNV) in the genetic susceptibility to human disease needs to be assessed using robust methods that can be applied at a population scale. In this report, we analyze the performance of the two major techniques, quantitative PCR (qPCR) and paralog ratio test (PRT), and investigate the influence of input DNA amount and template integrity on the reliability of both methods. Analysis of three genes (PRELID1, SYNPO and DEFB4) in a large sample set showed that both methods are prone to false copy number assignments if sufficient attention is not paid to DNA concentration and quality. Accurate normalization of samples is essential for reproducible qPCR because it avoids the effect of differential amplification efficiencies between target and control assays, whereas PRT is generally more sensitive to template degradation due to the fact that longer amplicons are usually needed to optimize sensitivity and specificity of paralog sequence PCR. The use of normalized, high quality genomic DNA yields comparable results with both methods.	[Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Gutierrez, Galder; Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan; Ramon Bilbao, Jose] Cruces Univ Hosp, Immunogenet Res Lab, Baracaldo, Basque Country, Spain; [Fernandez-Jimenez, Nora; Castellanos-Rubio, Ainara; Plaza-Izurieta, Leticia; Ramon Bilbao, Jose] Univ Basque Country, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Basque Country, Spain; [Irastorza, Inaki; Castano, Luis; Carlos Vitoria, Juan] Univ Basque Country, Dept Pediat, Bilbao, Basque Country, Spain	Hospital Universitario Cruces; University of Basque Country; University of Basque Country	Fernandez-Jimenez, N (corresponding author), Cruces Univ Hosp, Immunogenet Res Lab, Baracaldo, Basque Country, Spain.	joseramon.bilbaocatala@osakidetza.net	Vitoria, Juan Carlos/B-8914-2009; Fernandez-Jimenez, Nora/T-1535-2019; Irastorza, Inaki/AAN-7054-2021; Castellanos-Rubio, Ainara/AAB-9700-2022; Bilbao, Jose Ramon/A-9177-2008; Gutierrez, Galder/D-1286-2012	Vitoria, Juan Carlos/0000-0002-8741-8666; Irastorza, Inaki/0000-0002-1460-031X; Bilbao, Jose Ramon/0000-0002-3176-501X; Gutierrez, Galder/0000-0002-4877-3489; Castellanos Rubio, Ainara/0000-0003-3192-9544; Castano, Luis/0000-0003-0437-9401; Fernandez-Jimenez, Nora/0000-0001-6307-0880	Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation [PI10/0310]; Basque Departments of Health [2006/111030, SAIO-PE08BF03]; Basque Department of Education, Universities and Research [BIF-2009-099, BIF-2010-189]; Spanish Ministry of Health [CES05/036]	Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation(Spanish Government); Basque Departments of Health; Basque Department of Education, Universities and Research; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government)	This work was partially funded by research project grants from the Instituto de Salud Carlos III of the Spanish Ministry of Science and Innovation (PI10/0310) and from the Basque Departments of Health (2006/111030) and of Industry (SAIO-PE08BF03). NF-J and LP-I are predoctoral fellows supported by FPI grants from the Basque Department of Education, Universities and Research (BIF-2009-099 and BIF-2010-189, respectively). JRB is co-funded by the I3SNS Program of the Spanish Ministry of Health (CES05/036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Castellanos-Rubio A, 2008, GASTROENTEROLOGY, V134, P738, DOI 10.1053/j.gastro.2007.11.041; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fernandez-Jimenez N, 2010, HUM IMMUNOL, V71, P833, DOI 10.1016/j.humimm.2010.05.012; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Guescini M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-326; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Putkonen Mikko T, 2010, Investig Genet, V1, P9, DOI 10.1186/2041-2223-1-9; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schrider DR, 2010, MOL BIOL EVOL, V27, P103, DOI 10.1093/molbev/msp210; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Urban TJ, 2009, NAT MED, V15, P1110, DOI 10.1038/nm1009-1110	19	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28910	10.1371/journal.pone.0028910	http://dx.doi.org/10.1371/journal.pone.0028910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174923	gold, Green Published, Green Submitted			2022-12-27	WOS:000298367300031
J	Brites, D; Encinas-Viso, F; Ebert, D; Du Pasquier, L; Haag, CR				Brites, Daniela; Encinas-Viso, Francisco; Ebert, Dieter; Du Pasquier, Louis; Haag, Christoph R.			Population Genetics of Duplicated Alternatively Spliced Exons of the Dscam Gene in Daphnia and Drosophila	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; CODON-SUBSTITUTION MODELS; NUCLEOTIDE SUBSTITUTION; MOLECULAR EVOLUTION; BALANCING SELECTION; POLYMORPHISM; OVERDOMINANT; LOCUS; SOFTWARE; TESTS	In insects and crustaceans, the Down syndrome cell adhesion molecule (Dscam) occurs in many different isoforms. These are produced by mutually exclusive alternative splicing of dozens of tandem duplicated exons coding for parts or whole immunoglobulin (Ig) domains of the Dscam protein. This diversity plays a role in the development of the nervous system and also in the immune system. Structural analysis of the protein suggested candidate epitopes where binding to pathogens could occur. These epitopes are coded by regions of the duplicated exons and are therefore diverse within individuals. Here we apply molecular population genetics and molecular evolution analyses using Daphnia magna and several Drosophila species to investigate the potential role of natural selection in the divergence between orthologs of these duplicated exons among species, as well as between paralogous exons within species. We found no evidence for a role of positive selection in the divergence of these paralogous exons. However, the power of this test was low, and the fact that no signs of gene conversion between paralogous exons were found suggests that paralog diversity may nonetheless be maintained by selection. The analysis of orthologous exons in Drosophila and in Daphnia revealed an excess of non-synonymous polymorphisms in the epitopes putatively involved in pathogen binding. This may be a sign of balancing selection. Indeed, in Dr. melanogaster the same derived non-synonymous alleles segregate in several populations around the world. Yet other hallmarks of balancing selection were not found. Hence, we cannot rule out that the excess of non-synonymous polymorphisms is caused by segregating slightly deleterious alleles, thus potentially indicating reduced selective constraints in the putative pathogen binding epitopes of Dscam.	[Brites, Daniela; Ebert, Dieter; Du Pasquier, Louis] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Encinas-Viso, Francisco] Univ Groningen, Community & Conservat Ecol Grp, Haren, Netherlands; [Haag, Christoph R.] Univ Fribourg, Dept Biol Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Basel; University of Groningen; University of Fribourg	Brites, D (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	d.brites@unibas.ch	Ebert, Dieter/P-6134-2019; Haag, Christoph/B-6488-2009; Ebert, Dieter/B-5502-2009; Encinas-Viso, Francisco/M-8408-2013; Brites, Daniela/AGL-8378-2022	Ebert, Dieter/0000-0003-2653-3772; Haag, Christoph/0000-0002-8817-1431; Ebert, Dieter/0000-0003-2653-3772; Brites, Daniela/0000-0002-8090-2287	Portuguese Science Foundation; Roche Research Foundation; Swiss National Foundation	Portuguese Science Foundation(Portuguese Foundation for Science and Technology); Roche Research Foundation; Swiss National Foundation(Swiss National Science Foundation (SNSF))	DB was supported by the Portuguese Science Foundation and by the Roche Research Foundation. DE and CRH were supported by the Swiss National Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Bielawski JP, 2003, J STRUCT FUNCT GENOM, V3, P201, DOI DOI 10.1007/978-94-010-0263-9_20; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; CHARLESWORTH J, 2008, EVOLUTION, V25, P1007; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Chou PH, 2009, DEV COMP IMMUNOL, V33, P1258, DOI 10.1016/j.dci.2009.07.006; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haag CR, 2009, GENETICS, V182, P313, DOI 10.1534/genetics.109.101147; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; HUDSON RR, 1987, GENETICS, V116, P153; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HUGHES AL, 1989, P NATL ACAD SCI USA, V86, P958, DOI 10.1073/pnas.86.3.958; Innan H, 2009, GENETICA, V137, P19, DOI 10.1007/s10709-009-9355-1; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lee C, 2010, RNA, V16, P91, DOI 10.1261/rna.1812710; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Millard SS, 2007, NATURE, V447, P720, DOI 10.1038/nature05855; Miller M. A., 2010, CIPRES PORTALS; Muse SV, 1997, J MOL EVOL, V44, P492, DOI 10.1007/PL00006173; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rottschaefer SM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000600; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2001, AM J HUM GENET, V69, P912, DOI 10.1086/323623; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998; TAKAHATA N, 1990, GENETICS, V124, P967; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vlisidou I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000518; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Watthanasurorot A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002062; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; YANG ZH, 2002, EVOLUTION, V19, P908	53	17	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27947	10.1371/journal.pone.0027947	http://dx.doi.org/10.1371/journal.pone.0027947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174757	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000298366600005
J	Miyamura, T; Kanda, T; Nakamoto, S; Wu, S; Fujiwara, K; Imazeki, F; Yokosuka, O				Miyamura, Tatsuo; Kanda, Tatsuo; Nakamoto, Shingo; Wu, Shuang; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu			Hepatic STAT1-Nuclear Translocation and Interleukin 28B Polymorphisms Predict Treatment Outcomes in Hepatitis C Virus Genotype 1-Infected Patients	PLOS ONE			English	Article							SIGNALING PATHWAY; GENETIC-VARIATION; IL28B GENOTYPE; CORE PROTEIN; EXPRESSION; INFECTION; RIBAVIRIN; THERAPY; CELLS; IFN	Background: We investigated associations between signal transducer and activator of transcription (STAT) 1 in pretreated liver tissues, interleukin (IL) 28B polymorphism and treatment response in hepatitis C virus (HCV)-infected patients treated with peginterferon and ribavirin. Methods and Findings: We performed immunostaining analysis of STAT1 in liver tissues and determined IL28B polymorphism at rs8099917. We then compared the results with treatment outcomes in HCV genotype 1 patients with high viral load who were receiving peginterferon plus ribavirin. In univariate analysis, younger age, white blood cell counts, virological responder, early virological responder (EVR), mild activity (A1) of liver inflammation grading, and lower STAT1 nuclear-stain of hepatocytes in zone 1, zone 2 and total zones of liver were associated with sustained virological responder (SVR). Multivariate analysis showed that EVR, age and hepatic STAT1 nuclear-stain in zone 2 of liver were independent predictors of SVR. It was also revealed that IL28B and STAT1-nuclear translocation in hepatocytes are independent predictors of response to treatment with peginterferon and ribavirin in chronic hepatitis C patients. Conclusions: Concomitant assessment of lower STAT1 nuclear-stain of hepatocytes and IL28B polymorphism is useful for prediction of SVR in HCV genotype 1 patients.	[Miyamura, Tatsuo; Kanda, Tatsuo; Nakamoto, Shingo; Wu, Shuang; Fujiwara, Keiichi; Imazeki, Fumio; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan	Chiba University	Miyamura, T (corresponding author), Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan.	kandat-cib@umin.ac.jp		Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21590829, 21590828, 21390225]; Japan Society of Hepatology; Chiba University	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society of Hepatology; Chiba University	This work was supported by grants for Scientific Research 21590829, 21590828, and 21390225 from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (TK, FI, and OY), a grant from the Japan Society of Hepatology (TK) and a grant from Chiba University Young Research-Oriented Faculty Member Development Program in Bioscience Areas (TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J MED VIROL, V83, P1597, DOI 10.1002/jmv.22158; Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bacon Bruce R, 2011, Mo Med, V108, P255; Basu A, 2001, VIROLOGY, V288, P379, DOI 10.1006/viro.2001.1100; Basu A, 2006, VIROLOGY, V349, P347, DOI 10.1016/j.virol.2006.02.023; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Di Bisceglie AM, 2007, J VIRAL HEPATITIS, V14, P721, DOI 10.1111/j.1365-2893.2007.00862.x; Di Bisceglie AM, 2011, HEPATOLOGY, V53, P1100, DOI 10.1002/hep.24169; Di Bisceglie AM, 2002, HEPATOLOGY, V36, pS121, DOI 10.1053/jhep.2002.36228; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Honda M, 2010, J HEPATOL, V53, P817, DOI 10.1016/j.jhep.2010.04.036; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Kanda T, 2011, J VIRAL HEPATITIS, V18, pE292, DOI 10.1111/j.1365-2893.2010.01409.x; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Mowen K, 1998, J BIOL CHEM, V273, P30073, DOI 10.1074/jbc.273.46.30073; Nakamoto S, 2011, SCAND J GASTROENTERO, V46, P955, DOI 10.3109/00365521.2011.574731; RAPPAPORT AM, 1976, BEITR PATHOL, V157, P215, DOI 10.1016/S0005-8165(76)80083-2; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; TSUKIYAMAKOHARA K, 1993, VIROLOGY, V192, P430, DOI 10.1006/viro.1993.1058; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; VOLPES R, 1991, J HEPATOL, V12, P195, DOI 10.1016/0168-8278(91)90938-8; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	32	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28617	10.1371/journal.pone.0028617	http://dx.doi.org/10.1371/journal.pone.0028617			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174846	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600026
J	Pendse, GV; Borsook, D; Becerra, L				Pendse, Gautam V.; Borsook, David; Becerra, Lino			A Simple and Objective Method for Reproducible Resting State Network (RSN) Detection in fMRI	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; IDENTIFIABILITY; SEPARABILITY; UNIQUENESS	Spatial Independent Component Analysis (ICA) decomposes the time by space functional MRI (fMRI) matrix into a set of 1-D basis time courses and their associated 3-D spatial maps that are optimized for mutual independence. When applied to resting state fMRI (rsfMRI), ICA produces several spatial independent components (ICs) that seem to have biological relevance - the so-called resting state networks (RSNs). The ICA problem is well posed when the true data generating process follows a linear mixture of ICs model in terms of the identifiability of the mixing matrix. However, the contrast function used for promoting mutual independence in ICA is dependent on the finite amount of observed data and is potentially non-convex with multiple local minima. Hence, each run of ICA could produce potentially different IC estimates even for the same data. One technique to deal with this run-to-run variability of ICA was proposed by [1] in their algorithm RAICAR which allows for the selection of only those ICs that have a high run-to-run reproducibility. We propose an enhancement to the original RAICAR algorithm that enables us to assign reproducibility p-values to each IC and allows for an objective assessment of both within subject and across subjects reproducibility. We call the resulting algorithm RAICAR-N (N stands for null hypothesis test), and we have applied it to publicly available human rsfMRI data (http://www.nitrc.org). Our reproducibility analyses indicated that many of the published RSNs in rsfMRI literature are highly reproducible. However, we found several other RSNs that are highly reproducible but not frequently listed in the literature.	[Pendse, Gautam V.; Borsook, David; Becerra, Lino] Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Imaging & Anal Grp IMAG, Belmont, MA USA; [Borsook, David; Becerra, Lino] Massachusetts Gen Hosp, AA Martinos Ctr Biomed Imaging, Charlestown, MA USA	Harvard University; McLean Hospital; Harvard University; Massachusetts General Hospital	Pendse, GV (corresponding author), Harvard Univ, McLean Hosp, Sch Med, PAIN Grp,Imaging & Anal Grp IMAG, Belmont, MA USA.	gpendse@mclean.harvard.edu			National Institutes of Health (NIH) [K24NS064050, R01NS065051]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065051, K24NS064050] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (NIH) under the grants K24NS064050 (to DB) and R01NS065051 (to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias H, 1999, NEURAL COMPUT, V11, P803, DOI 10.1162/089976699300016458; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cardoso JF, 1998, P IEEE, V86, P2009, DOI 10.1109/5.720250; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Davies M, 2004, IEEE SIGNAL PROC LET, V11, P470, DOI 10.1109/LSP.2004.826508; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Eriksson J, 2006, IEEE T INFORM THEORY, V52, P1017, DOI 10.1109/TIT.2005.864440; Eriksson J, 2004, IEEE SIGNAL PROC LET, V11, P601, DOI 10.1109/LSP.2004.830118; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Feller W., 1966, INTRO PROBABILITY TH, VII; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Hastie T., 2009, UNSUPERVISED LEARNIN; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kritchman S, 2009, IEEE T SIGNAL PROCES, V57, P3930, DOI 10.1109/TSP.2009.2022897; MA S, 2011, IEEE T BIOMEDIC 0906; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; Minka T., 2000, 514 MIT MED LAB VIS; RAO CR, 1969, STATISTICS, V40, P1845; RATLIFF D, 1981, VEGETATIO, V48, P83, DOI 10.1007/BF00117364; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Theis FJ, 2004, NEURAL COMPUT, V16, P1827, DOI 10.1162/0899766041336404; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; van Albada SJ, 2007, J NEUROSCI METH, V161, P205, DOI 10.1016/j.jneumeth.2006.11.004; Vul E., 2010, FDN ISSUES HUMAN BRA, P71; Wlodzimierz  B., 1995, NORMAL DISTRIBUTION; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; [No title captured]	38	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27594	10.1371/journal.pone.0027594	http://dx.doi.org/10.1371/journal.pone.0027594			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174743	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600003
J	Wang, KY; Liu, YF; Li, YD; Guo, YM; Song, PP; Zhang, XH; Zeng, SQ; Wang, ZR				Wang, Kaiyu; Liu, Yafeng; Li, Yiding; Guo, Yanmeng; Song, Peipei; Zhang, Xiaohui; Zeng, Shaoqun; Wang, Zuoren			Precise Spatiotemporal Control of Optogenetic Activation Using an Acousto-Optic Device	PLOS ONE			English	Article							OPTICAL INTERROGATION; 2-PHOTON EXCITATION; NEURONAL NETWORK; CHANNELRHODOPSIN-2; MANIPULATION; BEHAVIOR; REVEALS	Light activation and inactivation of neurons by optogenetic techniques has emerged as an important tool for studying neural circuit function. To achieve a high resolution, new methods are being developed to selectively manipulate the activity of individual neurons. Here, we report that the combination of an acousto-optic device (AOD) and single-photon laser was used to achieve rapid and precise spatiotemporal control of light stimulation at multiple points in a neural circuit with millisecond time resolution. The performance of this system in activating ChIEF expressed on HEK 293 cells as well as cultured neurons was first evaluated, and the laser stimulation patterns were optimized. Next, the spatiotemporally selective manipulation of multiple neurons was achieved in a precise manner. Finally, we demonstrated the versatility of this high-resolution method in dissecting neural circuits both in the mouse cortical slice and the Drosophila brain in vivo. Taken together, our results show that the combination of AOD-assisted laser stimulation and optogenetic tools provides a flexible solution for manipulating neuronal activity at high efficiency and with high temporal precision.	[Wang, Kaiyu; Li, Yiding; Guo, Yanmeng; Song, Peipei; Zhang, Xiaohui; Wang, Zuoren] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China; [Wang, Kaiyu; Li, Yiding; Guo, Yanmeng] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China; [Liu, Yafeng; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Peoples R China; [Liu, Yafeng; Zeng, Shaoqun] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Biomed Photon, Wuhan 430074, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, KY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Inst Neurosci, Shanghai, Peoples R China.	xhzhang@ion.ac.cn; sqzeng@mail.hust.edu.cn; zuorenwang@ion.ac.cn	Zhang, Xiaohui/ABD-7056-2021; Li, Yiding/HII-3453-2022		China 973 [2011CBA00404, 2011CBA00403]; NSFC [30927001, 30925013]	China 973(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by China 973 project 2011CBA00404 to ZW, 2011CBA00403 to XZ and NSFC 30927001 & 30925013 to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Arrenberg AB, 2010, SCIENCE, V330, P971, DOI 10.1126/science.1195929; Bamann C, 2008, J MOL BIOL, V375, P686, DOI 10.1016/j.jmb.2007.10.072; Brown AEX, 2011, NAT METHODS, V8, P129, DOI 10.1038/nmeth0211-129; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Gouwens NW, 2009, J NEUROSCI, V29, P6239, DOI 10.1523/JNEUROSCI.0764-09.2009; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Guo ZV, 2009, NAT METHODS, V6, P891, DOI 10.1038/nmeth.1397; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Kantevari S, 2010, NAT METHODS, V7, P123, DOI [10.1038/NMETH.1413, 10.1038/nmeth.1413]; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Losavio BE, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/045002; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Lv XH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2190047; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; O'Connor DH, 2009, NATURE, V461, P923, DOI 10.1038/nature08539; Papagiakoumou E, 2010, NAT METHODS, V7, P848, DOI [10.1038/NMETH.1505, 10.1038/nmeth.1505]; Peron S, 2011, NAT METHODS, V8, P30, DOI 10.1038/NMETH.F.325; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Reddy GD, 2008, NAT NEUROSCI, V11, P713, DOI 10.1038/nn.2116; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Shoham S, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/040201; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Weissenberger S, 2011, J NEUROCHEM, V116, P616, DOI 10.1111/j.1471-4159.2010.07148.x; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Xie QW, 1996, P NATL ACAD SCI USA, V93, P4891, DOI 10.1073/pnas.93.10.4891; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	47	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28468	10.1371/journal.pone.0028468	http://dx.doi.org/10.1371/journal.pone.0028468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174813	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700038
J	Kolundzic, N; Bojic-Trbojevic, Z; Kovacevic, T; Stefanoska, I; Kadoya, T; Vicovac, L				Kolundzic, Nikola; Bojic-Trbojevic, Zanka; Kovacevic, Tamara; Stefanoska, Ivana; Kadoya, Toshihiko; Vicovac, Ljiljana			Galectin-1 Is Part of Human Trophoblast Invasion Machinery - A Functional Study In Vitro	PLOS ONE			English	Article							GALACTOSIDE-BINDING LECTIN; MATERNAL-FETAL INTERFACE; FRIEDENREICH TF ANTIGEN; HUMAN-PLACENTA; CELL-PROLIFERATION; EXTRACELLULAR-MATRIX; CANCER CELLS; EXPRESSION; ADHESION; DIFFERENTIATION	Background: Interactions of glycoconjugates with endogenous galectins, have been long proposed to participate in several reproductive processes including implantation. In human placenta gal-1, gal-3, gal-8, and gal-13 proteins are known to be present. Each of them has been proposed to play multiple functions, but so far no clear picture has emerged. We hypothesized that gal-1 participates in trophoblast invasion, and conducted Matrigel invasion assay using isolated cytotrophoblast from first trimester placenta and HTR-8/SVneo cell line to test it. Methods and Findings: Function blocking anti-gal-1 antibody was employed to assess participation of endogenous gal-1 in cell adhesion, cell invasion of HTR-8/SVneo cells. When gal-1 was blocked in isolated trophoblast cell invasion was reduced to 75% of control (SEM +/- 6.3, P<0.001) and to 66% of control (SEM +/- 1.7, P<0.001) in HTR-8/SVneo cell line. Increased availability of gal-1, as two molecular forms of recombinant human gal-1 (CS-gal-1 and Ox-gal-1), resulted in increased cell invasion by cytotrophoblast to 151% (SEM +/- 16, P<0.01) with 1 ng/ml of CS-gal-1, and to 192% (SEM +/- 51, P<0.05) with 1 mu g/ml of Ox-gal-1. Stimulation was also observed in HTR-8/SVneo cells, to 317% (SEM +/- 58, P<0.001) by CS-gal-1, and to 200% (SEM +/- 24, P<0.001) by Ox-gal-1 at 1 mu g/ml. Both sets of results confirmed involvement of gal-1 in trophoblast invasion. Galectin profile of isolated cytotrophoblast and HTR-8/SVneo cells was established using RT-PCR and real-time PCR and found to consist of gal-1, gal-3 and gal-8 for both cell types. Only gal-1 was located at the trophoblast cell membrane, as determined by FACS analysis, which is consistent with the results of the functional tests. Conclusion and Significance: These findings qualify gal-1 as a member of human trophoblast cell invasion machinery.	[Kolundzic, Nikola; Bojic-Trbojevic, Zanka; Kovacevic, Tamara; Stefanoska, Ivana; Vicovac, Ljiljana] Univ Belgrade, Inst INEP, Reprod Biol Lab, Belgrade, Serbia; [Kadoya, Toshihiko] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gunma, Japan	University of Belgrade	Kolundzic, N (corresponding author), Univ Belgrade, Inst INEP, Reprod Biol Lab, Belgrade, Serbia.	vicovac@inep.co.rs	Vicovac, Ljiljana/I-1973-2019	Vicovac, Ljiljana/0000-0002-2744-415X; Bojic-Trbojevic, Zanka/0000-0001-5619-1027	Ministry of Education and Science of the Government of Serbia [173004]	Ministry of Education and Science of the Government of Serbia	Research was funded by grant 173004 of Ministry of Education and Science of the Government of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin JD, 1999, BIOL REPROD, V60, P828, DOI 10.1095/biolreprod60.4.828; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; BEVAN BH, 1994, HISTOCHEM J, V26, P582, DOI 10.1007/BF00158592; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; Bojic-Trbojevic Z, 2008, ARCH BIOL SCI, V60, P11, DOI 10.2298/ABS0801011B; Bozic M, 2004, PLACENTA, V25, P797, DOI 10.1016/j.placenta.2004.03.006; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Colnot C, 1998, DEV DYNAM, V211, P306, DOI 10.1002/(SICI)1097-0177(199804)211:4<306::AID-AJA2>3.0.CO;2-L; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565; Endharti AT, 2005, EUR J IMMUNOL, V35, P86, DOI 10.1002/eji.200425340; Fischer I, 2009, PLACENTA, V30, P1078, DOI 10.1016/j.placenta.2009.10.003; FUJIWARA S, 1988, BIOCHEM J, V252, P453, DOI 10.1042/bj2520453; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hadari YR, 2000, J CELL SCI, V113, P2385; Hanisch FG, 1993, LECTINS GLYCOBIOLOGY, P411; He J, 2006, LAB INVEST, V86, P578, DOI 10.1038/labinvest.3700420; HIRABAYASHI J, 1984, BIOCHEM BIOPH RES CO, V122, P938, DOI 10.1016/0006-291X(84)91181-1; Horie H, 1999, J NEUROSCI, V19, P9964; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Inagaki Y, 2000, EUR J BIOCHEM, V267, P2955, DOI 10.1046/j.1432-1033.2000.01311.x; IRVING JA, 1995, PLACENTA, V16, P413, DOI 10.1016/0143-4004(95)90100-0; Jeschke U, 2007, PLACENTA, V28, P1165, DOI 10.1016/j.placenta.2007.06.006; Jeschke U, 2006, HISTOCHEM CELL BIOL, V126, P437, DOI 10.1007/s00418-006-0178-1; Jones CJP, 2009, GLYCOCONJUGATE J, V26, P359, DOI 10.1007/s10719-008-9152-6; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007; Kolundzic N, 2011, PLACENTA, V32, P909, DOI 10.1016/j.placenta.2011.07.087; Korhonen M, 1997, J HISTOCHEM CYTOCHEM, V45, P569, DOI 10.1177/002215549704500409; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Lei CX, 2009, HUM REPROD, V24, P2879, DOI 10.1093/humrep/dep250; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; Liu AX, 2006, BIOL REPROD, V75, P414, DOI 10.1095/biolreprod.105.049379; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 2008, HISTOCHEM CELL BIOL, V130, P567, DOI 10.1007/s00418-008-0465-0; Maquoi E, 1997, PLACENTA, V18, P433, DOI 10.1016/S0143-4004(97)80044-6; Masamune A, 2006, AM J PHYSIOL-GASTR L, V290, pG729, DOI 10.1152/ajpgi.00511.2005; Moiseeva EP, 2003, BBA-GEN SUBJECTS, V1619, P125, DOI 10.1016/S0304-4165(02)00447-6; Moiseeva EP, 2003, BIOCHEM BIOPH RES CO, V310, P1010, DOI 10.1016/j.bbrc.2003.09.112; Moiseeva EP, 2000, CARDIOVASC RES, V45, P493, DOI 10.1016/S0008-6363(99)00276-X; MOSS L, 1994, GLYCOBIOLOGY, V4, P567, DOI 10.1093/glycob/4.5.567; OZEKI Y, 1995, GLYCOBIOLOGY, V5, P255, DOI 10.1093/glycob/5.2.255; Park JW, 2001, NUCLEIC ACIDS RES, V29, P3595, DOI 10.1093/nar/29.17.3595; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; POIRIER F, 1993, DEVELOPMENT, V119, P1229; POIRIER F, 1992, DEVELOPMENT, V115, P143; Poirier F, 2002, BIOCHEM SOC SYMP, V69, P95; Poirier F, 1997, MOL HUM REPROD, V3, P907, DOI 10.1093/molehr/3.10.907; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Roda O, 2009, GASTROENTEROLOGY, V136, P1379, DOI 10.1053/j.gastro.2008.12.039; Satelli A, 2008, ONCOL REP, V19, P587; Spano D, 2010, MOL MED, V16, P102, DOI 10.2119/molmed.2009.00119; Takamoto M, 1987, J BIOCH, V106, P228; Than NG, 2004, EUR J BIOCHEM, V6, P1068; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; van den Brule F, 2003, LAB INVEST, V83, P377, DOI 10.1097/01.LAB.0000059949.01480.40; VANDENBRULE FA, 1995, BIOCHEM BIOPH RES CO, V209, P760, DOI 10.1006/bbrc.1995.1564; VANDENBRULE FA, 1994, BIOCHEM BIOPH RES CO, V201, P388, DOI 10.1006/bbrc.1994.1713; Vicovac L, 1998, HUM REPROD, V13, P730, DOI 10.1093/humrep/13.3.730; Vicovac L, 2007, PLACENTA, V28, P85, DOI 10.1016/j.placenta.2006.02.002; Tribulatti MV, 2009, J LEUKOCYTE BIOL, V86, P371, DOI 10.1189/jlb.0908529; von Wolff M, 2005, MOL HUM REPROD, V11, P189, DOI 10.1093/molehr/gah144; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Zhao XY, 2010, CARCINOGENESIS, V31, P1367, DOI 10.1093/carcin/bgq116; Zhou Y, 2003, ANN NY ACAD SCI, V995, P73, DOI 10.1111/j.1749-6632.2003.tb03211.x	71	55	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28514	10.1371/journal.pone.0028514	http://dx.doi.org/10.1371/journal.pone.0028514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174828	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163600030
J	Wrzeszczynski, KO; Varadan, V; Byrnes, J; Lum, E; Kamalakaran, S; Levine, DA; Dimitrova, N; Zhang, MQ; Lucito, R				Wrzeszczynski, Kazimierz O.; Varadan, Vinay; Byrnes, James; Lum, Elena; Kamalakaran, Sitharthan; Levine, Douglas A.; Dimitrova, Nevenka; Zhang, Michael Q.; Lucito, Robert			Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer	PLOS ONE			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; CIRCULAR BINARY SEGMENTATION; HIGH-RESOLUTION METHOD; COPY-NUMBER; BREAST-CANCER; DNA METHYLATION; GENE-EXPRESSION; HYPERMETHYLATION; HYBRIDIZATION; CARCINOMAS	The identification of genetic and epigenetic alterations from primary tumor cells has become a common method to identify genes critical to the development and progression of cancer. We seek to identify those genetic and epigenetic aberrations that have the most impact on gene function within the tumor. First, we perform a bioinformatic analysis of copy number variation (CNV) and DNA methylation covering the genetic landscape of ovarian cancer tumor cells. We separately examined CNV and DNA methylation for 42 primary serous ovarian cancer samples using MOMA-ROMA assays and 379 tumor samples analyzed by The Cancer Genome Atlas. We have identified 346 genes with significant deletions or amplifications among the tumor samples. Utilizing associated gene expression data we predict 156 genes with altered copy number and correlated changes in expression. Among these genes CCNE1, POP4, UQCRB, PHF20L1 and C19orf2 were identified within both data sets. We were specifically interested in copy number variation as our base genomic property in the prediction of tumor suppressors and oncogenes in the altered ovarian tumor. We therefore identify changes in DNA methylation and expression for all amplified and deleted genes. We statistically define tumor suppressor and oncogenic features for these modalities and perform a correlation analysis with expression. We predicted 611 potential oncogenes and tumor suppressors candidates by integrating these data types. Genes with a strong correlation for methylation dependent expression changes exhibited at varying copy number aberrations include CDCA8, ATAD2, CDKN2A, RAB25, AURKA, BOP1 and EIF2C3. We provide copy number variation and DNA methylation analysis for over 11,500 individual genes covering the genetic landscape of ovarian cancer tumors. We show the extent of genomic and epigenetic alterations for known tumor suppressors and oncogenes and also use these defined features to identify potential ovarian cancer gene candidates.	[Wrzeszczynski, Kazimierz O.; Byrnes, James; Lum, Elena; Zhang, Michael Q.; Lucito, Robert] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Varadan, Vinay; Kamalakaran, Sitharthan; Dimitrova, Nevenka] Philips Res N Amer, Briarcliff Manor, NY USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Zhang, Michael Q.] Univ Texas Dallas, Dept Mol & Cell Biol, Richardson, TX 75083 USA	Cold Spring Harbor Laboratory; Philips; Philips Research; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Dallas	Wrzeszczynski, KO (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	kwrzesz@cshl.edu	Varadan, Vinay/AAC-2520-2020; Lucito, Robert/AID-7159-2022	Levine, Douglas/0000-0003-1038-8232	Department of Defense [W81XWH-05-1-0068]; Starr Foundation; Philips Research North America	Department of Defense(United States Department of Defense); Starr Foundation; Philips Research North America	This work was supported by Department of Defense W81XWH-05-1-0068, The Starr Foundation (http://www.starrcancer.org) and Philips Research North America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, TRAFFIC, V10, P1561, DOI 10.1111/j.1600-0854.2009.00969.x; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Bapat SA, 2010, CANCER RES, V70, P4809, DOI 10.1158/0008-5472.CAN-10-0447; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bohnert KA, 2009, MOL BIOL CELL, V20, P3646, DOI 10.1091/mbc.E09-04-0289; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowtell DD, NAT REV CANC, V10, P803; Burrows JF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-250; Carden CP, 2010, DRUG DISCOV TODAY, V15, P88, DOI 10.1016/j.drudis.2009.11.006; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chari R, 2010, CANCER METAST REV, V29, P73, DOI 10.1007/s10555-010-9199-2; CHEN S, 2008, CANC BIOL THER, V7; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; de Pontual L, 2007, EUR J CANCER, V43, P2366, DOI 10.1016/j.ejca.2007.07.016; Degenhardt YY, 2008, CURR OPIN GENET DEV, V18, P68, DOI 10.1016/j.gde.2008.01.005; Delcuve GP, 2009, J CELL PHYSIOL, V219, P243, DOI 10.1002/jcp.21678; Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Haller F, 2005, CLIN CANCER RES, V11, P6589, DOI 10.1158/1078-0432.CCR-05-0329; Hansen KD, 2011, NAT GENET; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Iacobuzio-Donahue CA, 2009, ANNU REV PATHOL-MECH, V4, P229, DOI 10.1146/annurev.pathol.3.121806.151442; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kamalakaran S, 2011, MOL ONCOL, V5, P77, DOI 10.1016/j.molonc.2010.11.002; Kamalakaran S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp413; Kiechle M, 2001, CANCER, V91, P534, DOI 10.1002/1097-0142(20010201)91:3<534::AID-CNCR1031>3.3.CO;2-K; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Li ZY, 2010, INT J GYNECOL CANCER, V20, P9, DOI 10.1111/IGC.0b013e3181a9026d; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Lucito R, 2009, METHODS MOL BIOL, V556, P33, DOI 10.1007/978-1-60327-192-9_4; McDermott U, 2011, NEW ENGL J MED, V364, P340, DOI 10.1056/NEJMra0907178; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Narayan G, 2009, GENE CHROMOSOME CANC, V48, P983, DOI 10.1002/gcc.20703; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Reitman ZJ, 2010, J NATL CANC I; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Veeck J, 2010, J MAMMARY GLAND BIOL, V15, P5, DOI 10.1007/s10911-010-9165-1; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wimmer K, 2002, GENE CHROMOSOME CANC, V33, P285, DOI 10.1002/gcc.10030; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu JS, 2008, ONCOGENE, V27, P4657, DOI 10.1038/onc.2008.101	70	74	78	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28503	10.1371/journal.pone.0028503	http://dx.doi.org/10.1371/journal.pone.0028503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174824	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000298163600029
J	Bhatia, HS; Agrawal, R; Sharma, S; Huo, YX; Ying, Z; Gomez-Pinilla, F				Bhatia, Harsharan Singh; Agrawal, Rahul; Sharma, Sandeep; Huo, Yi-Xin; Ying, Zhe; Gomez-Pinilla, Fernando			Omega-3 Fatty Acid Deficiency during Brain Maturation Reduces Neuronal and Behavioral Plasticity in Adulthood	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; NEUROPEPTIDE-Y; RAT-BRAIN; FATTY-ACIDS; ANXIETY; EXPRESSION; DEPRESSION; DEPRIVATION; DISORDERS; INCREASES	Omega-3-fatty acid DHA is a structural component of brain plasma membranes, thereby crucial for neuronal signaling; however, the brain is inefficient at synthesizing DHA. We have asked how levels of dietary n-3 fatty acids during brain growth would affect brain function and plasticity during adult life. Pregnant rats and their male offspring were fed an n-3 adequate diet or n-3 deficient diets for 15 weeks. Results showed that the n-3 deficiency increased parameters of anxiety-like behavior using open field and elevated plus maze tests in the male offspring. Behavioral changes were accompanied by a level reduction in the anxiolytic-related neuropeptide Y-1 receptor, and an increase in the anxiogenic-related glucocorticoid receptor in the cognitive related frontal cortex, hypothalamus and hippocampus. The n-3 deficiency reduced brain levels of docosahexaenoic acid (DHA) and increased the ratio n-6/ n-3 assessed by gas chromatography. The n-3 deficiency reduced the levels of BDNF and signaling through the BDNF receptor TrkB, in proportion to brain DHA levels, and reduced the activation of the BDNF-related signaling molecule CREB in selected brain regions. The n-3 deficiency also disrupted the insulin signaling pathways as evidenced by changes in insulin receptor (IR) and insulin receptor substrate (IRS). DHA deficiency during brain maturation reduces plasticity and compromises brain function in adulthood. Adequate levels of dietary DHA seem crucial for building long-term neuronal resilience for optimal brain performance and aiding in the battle against neurological disorders.	[Bhatia, Harsharan Singh; Agrawal, Rahul; Sharma, Sandeep; Ying, Zhe; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, UCLA Brain Injury Res Ctr, Los Angeles, CA USA; [Huo, Yi-Xin] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bhatia, HS (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.	fgomezpi@ucla.edu	Sharma, Sandeep/AAU-7050-2021; Bhatia, Harsharan singh/AAR-4628-2021; Sharma, Sandeep/A-9248-2011; Agrawal, Rahul/F-6412-2015	Sharma, Sandeep/0000-0002-9680-7460; Sharma, Sandeep/0000-0002-9680-7460; Agrawal, Rahul/0000-0001-8128-3724; Bhatia, Harsharan Singh/0000-0001-9912-8263; huo, yixin/0000-0003-4644-999X	National Institutes of Health [NS50465, NS56413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS50465 and NS56413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altar CA, 1999, TRENDS PHARMACOL SCI, V20, P59, DOI 10.1016/S0165-6147(99)01309-7; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bergami Matteo, 2009, Commun Integr Biol, V2, P14; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Branchi I, 2006, BEHAV BRAIN RES, V172, P299, DOI 10.1016/j.bbr.2006.05.019; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; CLANDININ MT, 1980, EARLY HUM DEV, V4, P131, DOI 10.1016/0378-3782(80)90016-X; CRAWFORD MA, 1976, LANCET, V1, P452; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Ernst C, 2011, BIOL PSYCHIAT, V69, P604, DOI 10.1016/j.biopsych.2010.10.008; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Gomez-Pinilla F, 2010, NEUROSCIENCE, V168, P130, DOI 10.1016/j.neuroscience.2010.02.070; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; Igarashi M, 2007, J LIPID RES, V48, P1150, DOI 10.1194/jlr.M600549-JLR200; Jacka FN, 2011, PSYCHOSOM MED, V73, P483, DOI 10.1097/PSY.0b013e318222831a; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koponen E, 2005, CELL MOL NEUROBIOL, V25, P973, DOI 10.1007/s10571-005-8468-z; Lepine Jean-Pierre, 2011, Neuropsychiatr Dis Treat, V7, P3, DOI 10.2147/NDT.S19617; Moriguchi T, 2001, J LIPID RES, V42, P419; Nakajima M, 1998, PEPTIDES, V19, P359, DOI 10.1016/S0196-9781(97)00298-2; Nibuya M, 1996, J NEUROSCI, V16, P2365; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Pandey SC, 2003, TRENDS PHARMACOL SCI, V24, P456, DOI 10.1016/S0165-6147(03)00226-8; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Rao JS, 2007, MOL PSYCHIATR, V12, P36, DOI 10.1038/sj.mp.4001888; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; SINCLAIR AJ, 1975, LIPIDS, V10, P175, DOI 10.1007/BF02534156; Suganuma H, 2010, NEUROPATHOLOGY, V30, P597, DOI 10.1111/j.1440-1789.2010.01114.x; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Zhang HB, 2003, PEPTIDES, V24, P1397, DOI 10.1016/j.peptides.2003.08.008	38	128	129	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28451	10.1371/journal.pone.0028451	http://dx.doi.org/10.1371/journal.pone.0028451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163304	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900041
J	Geng, J; Liang, D; Jiang, K; Zhang, P				Geng, Jie; Liang, Dan; Jiang, Ke; Zhang, Peng			Molecular Evolution of the Infrared Sensory Gene TRPA1 in Snakes and Implications for Functional Studies	PLOS ONE			English	Article							SELECTION; RECEPTOR; ANKYRIN; VISION	TRPA1 is a calcium ion channel protein recently identified as the infrared receptor in pit organ-containing snakes. Therefore, understanding the molecular evolution of TRPA1 may help to illuminate the origin of "heat vision" in snakes and reveal the molecular mechanism of infrared sensitivity for TRPA1. To this end, we sequenced the infrared sensory gene TRPA1 in 24 snake species, representing nine snake families and multiple non-snake outgroups. We found that TRPA1 is under strong positive selection in the pit-bearing snakes studied, but not in other non-pit snakes and non-snake vertebrates. As a comparison, TRPV1, a gene closely related to TRPA1, was found to be under strong purifying selection in all the species studied, with no difference in the strength of selection between pit-bearing snakes and non-pit snakes. This finding demonstrates that the adaptive evolution of TRPA1 specifically occurred within the pit-bearing snakes and may be related to the functional modification for detecting infrared radiation. In addition, by comparing the TRPA1 protein sequences, we identified 11 amino acid sites that were diverged in pit-bearing snakes but conserved in non-pit snakes and other vertebrates, 21 sites that were diverged only within pit-vipers but conserved in the remaining snakes. These specific amino acid substitutions may be potentially functional important for infrared sensing.	[Geng, Jie; Liang, Dan; Jiang, Ke; Zhang, Peng] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Geng, J (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ, State Key Lab Biocontrol,Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	alarzhang@gmail.com	Zhang, Peng/F-9664-2013					Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; BULLOCK TH, 1956, J PHYSIOL-LONDON, V134, P47, DOI 10.1113/jphysiol.1956.sp005624; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Ebert J, 2007, THESIS RHEINISCHE F; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Goris RC, 2011, J HERPETOL, V45, P2, DOI 10.1670/10-238.1; Grace MS, 2001, BEHAV BRAIN RES, V119, P23, DOI 10.1016/S0166-4328(00)00336-3; Gracheva EO, 2010, NATURE, V464, P1006, DOI 10.1038/nature08943; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nylander JAA., 2004, BIOINFORMATICS; Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pride DT, 2000, SWAAP TOOL ANAL SUBS; Saito S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002041; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vidal Nicolas, 2009, P390; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Yokoyama S, 2011, MOL BIOL EVOL, V28, P45, DOI 10.1093/molbev/msq267; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812	36	15	16	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28644	10.1371/journal.pone.0028644	http://dx.doi.org/10.1371/journal.pone.0028644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163322	Green Submitted, gold, Green Published			2022-12-27	WOS:000298161900058
J	Kakishima, S; Yoshimura, J; Murata, H; Murata, J				Kakishima, Satoshi; Yoshimura, Jin; Murata, Hiroko; Murata, Jin			6-Year Periodicity and Variable Synchronicity in a Mass-Flowering Plant	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; SEED PRODUCTION; POLLINATION; VERSICOLOR; BEHAVIOR; CICADAS; BAMBOOS; TREES; LONG	Periodical organisms, such as bamboos and periodical cicadas, are very famous for their synchronous reproduction. In bamboos and other periodical plants, the synchronicity of mass-flowering and withering has been often reported indicating these species are monocarpic (semelparous) species. Therefore, synchronicity and periodicity are often suspected to be fairly tightly coupled traits in these periodical plants. We investigate the periodicity and synchronicity of Strobilanthes flexicaulis, and a closely related species S. tashiroi on Okinawa Island, Japan. The genus Strobilanthes is known for several periodical species. Based on 32-year observational data, we confirmed that S. flexicaulis is 6-year periodical mass-flowering monocarpic plant. All the flowering plants had died after flowering. In contrast, we found that S. tashiroi is a polycarpic perennial with no mass-flowering from three-year individual tracking. We also surveyed six local populations of S. flexicaulis and found variation in the synchronicity from four highly synchronized populations (> 98% of plants flowering in the mass year) to two less synchronized one with 11-47% of plants flowering before and after the mass year. This result might imply that synchrony may be selected for when periodicity is established in monocarpic species. We found the selective advantages for mass-flowering in pollinator activities and predator satiation. The current results suggest that the periodical S. flexicaulis might have evolved periodicity from a non-periodical close relative. The current report should become a key finding for understanding the evolution of periodical plants.	[Kakishima, Satoshi; Murata, Jin] Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 113, Japan; [Yoshimura, Jin] Shizuoka Univ, Dept Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Chiba, Japan; [Murata, Hiroko] Setsunan Univ, Fac Pharmaceut Sci, Hirakata, Osaka 57301, Japan	University of Tokyo; Shizuoka University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University; Setsunan University	Kakishima, S (corresponding author), Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 113, Japan.	kakishima@ns.bg.s.u-tokyo.ac.jp		Kakishima, Satoshi/0000-0001-6000-3068	Japan Society for the Promotion of Science; Global COE (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology, Japan;  [20370032];  [22255004];  [22370010]; Grants-in-Aid for Scientific Research [21570100, 22370010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE (Integrative Life Science Based on the Study of Biosignaling Mechanisms); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research to J.M. (no. 20370032) and J.Y. (nos. 22255004 and 22370010), and Grant-in-Aid for JSPS Fellows to S. K. from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html), and Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), The Ministry of Education, Culture, Sports, Science and Technology, Japan ( http://www.coe.s.u-tokyo.ac.jp/integr-life/english/index.html) to S. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R. D., 1962, U MICHIGAN MUSEUM ZO, V121, P1; Burd M, 2006, ECOLOGY, V87, P2755, DOI 10.1890/0012-9658(2006)87[2755:APFRIM]2.0.CO;2; Daniel Thomas F., 2006, Proceedings of the California Academy of Sciences, V57, P1011; Forget PM, 1999, J TROP ECOL, V15, P61, DOI 10.1017/S026646749900067X; Herrera CM, 1998, AM NAT, V152, P576, DOI 10.1086/286191; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Keeley JE, 1999, AM NAT, V154, P383, DOI 10.1086/303243; KELLY D, 1994, TRENDS ECOL EVOL, V9, P465, DOI 10.1016/0169-5347(94)90310-7; Kelly D, 2002, ANNU REV ECOL SYST, V33, P427, DOI 10.1146/annurev.ecolsys.33.020602.095433; Kelly D, 2001, ECOLOGY, V82, P117, DOI 10.1890/0012-9658(2001)082[0117:ETWPBO]2.0.CO;2; KITAJIMA K, 1989, ECOLOGY, V70, P1102, DOI 10.2307/1941379; Koenig WD, 2003, OIKOS, V102, P581, DOI 10.1034/j.1600-0706.2003.12272.x; Makita Akifumi, 1998, Plant Species Biology, V13, P85, DOI 10.1111/j.1442-1984.1998.tb00251.x; Read J, 2008, AM J BOT, V95, P558, DOI 10.3732/ajb.2007194; SILVERTOWN JW, 1980, BIOL J LINN SOC, V14, P235, DOI 10.1111/j.1095-8312.1980.tb00107.x; Soek DI, 2004, J JAP BOT, V79, P145; Tsvuura Z, 2011, ANN BOT-LONDON, V107, P379, DOI 10.1093/aob/mcq262; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Wood J. R. I., 2003, Kew Bulletin, V58, P83, DOI 10.2307/4119357; Wood J. R. I., 1994, Edinburgh Journal of Botany, V51, P175; YAMAZAKI T, 1991, Journal of Japanese Botany, V66, P303; Yoshimura J, 1997, AM NAT, V149, P112, DOI 10.1086/285981	24	19	19	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28140	10.1371/journal.pone.0028140	http://dx.doi.org/10.1371/journal.pone.0028140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163279	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900014
J	Gutierrez, RA; Sorn, S; Nicholls, JM; Buchy, P				Gutierrez, Ramona Alikiiteaga; Sorn, San; Nicholls, John M.; Buchy, Philippe			Eurasian Tree Sparrows, Risk for H5N1 Virus Spread and Human Contamination through Buddhist Ritual: An Experimental Approach	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUS; DOMESTIC DUCKS; WILD BIRDS; A H5N1; PATHOGENICITY; EVOLUTION; FEATHERS; SUSCEPTIBILITY; TRANSMISSION; INOCULATION	Background: The Highly Pathogenic Avian Influenza H5N1 virus has dramatically spread throughout Southeast Asia since its first detection in 1997. Merit Release Birds, such as the Eurasian Tree Sparrow, are believed to increase one's positive karma when kissed and released during Buddhist rituals. Since these birds are often in close contact with both poultry and humans, we investigated their potential role in the spread of H5N1 virus. Methodology/Principal Findings: Seven series of experiments were conducted in order to investigate the possible interactions between inoculated and exposed birds, including sparrow/sparrow, sparrow/chicken, duck/sparrow. Daily and post-mortem samples collected were tested for H5N1 virus by real-time RT-PCR and egg inoculation. When directly inoculated, Eurasian Tree Sparrows were highly susceptible to the H5N1 virus, with a fatality rate approaching 100% within 5 days post-inoculation. Although transmission of fatal infection between sparrows did not occur, seroconversion of the exposed birds was observed. Up to 100% chickens exposed to inoculated sparrows died of H5N1 infection, depending on the caging conditions of the birds, while a fatality rate of 50% was observed on sparrows exposed to infected ducks. Large quantities of H5N1 virus were detected in the sparrows, particularly in their feathers, from which infectious particles were recovered. Conclusions/Significance: Our study indicates that under experimental conditions, Eurasian Tree Sparrows are susceptible to H5N1 infection, either by direct inoculation or by contact with infected poultry. Their ability to transmit H5N1 infection to other birds is also demonstrated, suggesting that the sparrows may play a role in the dissemination of the virus. Finally, the presence of significant quantities of H5N1 virus on sparrows' feathers, including infectious particles, would suggest that Merit Release Birds represent a risk for human contamination in countries where avian influenza virus is circulating and where this religious ritual is practiced.	[Gutierrez, Ramona Alikiiteaga; Buchy, Philippe] Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia; [Sorn, San] Minist Agr Forestry & Fisheries, Natl Vet Inst, Phnom Penh, Cambodia; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Pok Fu Lam, Hong Kong, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Hong Kong	Gutierrez, RA (corresponding author), Inst Pasteur Cambodia, Virol Unit, Phnom Penh, Cambodia.	pbuchy@pasteur-kh.org	; Nicholls, John Malcolm/C-4375-2009	BUCHY, Philippe/0000-0003-1372-3008; Nicholls, John Malcolm/0000-0001-7217-7444	French Ministry of Research; Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	French Ministry of Research(Ministry of Research, FranceEuropean Commission); Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services	This work was supported by the French Ministry of Research and by the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boon ACM, 2007, EMERG INFECT DIS, V13, P1720, DOI 10.3201/eid1311.070114; Breithaupt A, 2011, VET PATHOL, V48, P924, DOI 10.1177/0300985810386467; Brooks-Moizer F, 2009, ECOL SOC, V14; Busquets N, 2010, J GEN VIROL, V91, P2307, DOI 10.1099/vir.0.021592-0; Central Intelligence Agency (Ed.), 2011, WORLD FACTB 2011; Edmunds K, 2011, ECOHEALTH, V8, P63, DOI 10.1007/s10393-011-0691-0; Forrest HL, 2010, J VIROL, V84, P3718, DOI 10.1128/JVI.02017-09; Fujimoto Y, 2010, AVIAN PATHOL, V39, P95, DOI 10.1080/03079451003599268; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Kalthoff D, 2008, PLOS ONE, V4, DOI 10.1371/journal.pone.0006170; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; KIDA H, 1980, INFECT IMMUN, V30, P547; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kou Z, 2005, J VIROL, V79, P15460, DOI 10.1128/JVI.79.24.15460-15466.2005; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Liu QF, 2010, VIRUS RES, V147, P25, DOI 10.1016/j.virusres.2009.09.014; Nemeth NM, 2010, AVIAN PATHOL, V39, P411, DOI 10.1080/03079457.2010.513043; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; OIE World Organisation for Animal Health, 2011, OUTBR HIGHL PATH AV; OIE World Organization for Animal Health, 2009, MAN DIAGN TESTS VACC; Perkins LEL, 2003, VET PATHOL, V40, P14, DOI 10.1354/vp.40-1-14; Perkins LEL, 2001, VET PATHOL, V38, P149, DOI 10.1354/vp.38-2-149; Poetranto ED, 2011, MICROBIOL IMMUNOL, V55, P666, DOI 10.1111/j.1348-0421.2011.00361.x; REED L. J., 1938, AMER JOUR HYG, V27, P493; Songserm T, 2006, EMERG INFECT DIS, V12, P575, DOI 10.3201/eid1204.051614; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Swayne DE, 2008, AVIAN DIS, V52, P455, DOI 10.1637/8229-012508-Reg.1; United States Commission on International Religious Freedom (USCRIF), 2010, US COMM INT REL FREE; USGS National Wildlife Health Center, 2011, LIST SPEC AFF H5N1 A; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2007, REC LAB PROC DET AV; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P149, DOI 10.3201/eid1401.071036; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2; Yamamoto Y, 2010, APPL ENVIRON MICROB, V76, P5496, DOI 10.1128/AEM.00563-10; Yamamoto Y, 2009, J VET MED SCI, V71, P1549, DOI 10.1292/jvms.001549	39	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28609	10.1371/journal.pone.0028609	http://dx.doi.org/10.1371/journal.pone.0028609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164310	Green Published, gold			2022-12-27	WOS:000298171400112
J	Hao, DP; Li, CX				Hao, Dapeng; Li, Chuanxing			The Dichotomy in Degree Correlation of Biological Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; HIERARCHICAL ORGANIZATION; MODULARITY	Most complex networks from different areas such as biology, sociology or technology, show a correlation on node degree where the possibility of a link between two nodes depends on their connectivity. It is widely believed that complex networks are either disassortative (links between hubs are systematically suppressed) or assortative (links between hubs are enhanced). In this paper, we analyze a variety of biological networks and find that they generally show a dichotomous degree correlation. We find that many properties of biological networks can be explained by this dichotomy in degree correlation, including the neighborhood connectivity, the sickle-shaped clustering coefficient distribution and the modularity structure. This dichotomy distinguishes biological networks from real disassortative networks or assortative networks such as the Internet and social networks. We suggest that the modular structure of networks accounts for the dichotomy in degree correlation and vice versa, shedding light on the source of modularity in biological networks. We further show that a robust and well connected network necessitates the dichotomy of degree correlation, suggestive of an evolutionary motivation for its existence. Finally, we suggest that a dichotomous degree correlation favors a centrally connected modular network, by which the integrity of network and specificity of modules might be reconciled.	[Hao, Dapeng; Li, Chuanxing] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Hao, DP (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	dapenghao@hotmail.com		Li, Chuan-Xing/0000-0003-2189-5010	National Natural Science Foundation of China [30600367]; Foundation of Harbin Medical University [WLD-QN1107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Harbin Medical University	This work is supported in part by the National Natural Science Foundation of China (Grant Nos. 30600367) and the Foundation of Harbin Medical University (WLD-QN1107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Aloy P, 2002, FEBS LETT, V530, P253, DOI 10.1016/S0014-5793(02)03427-0; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batada NN, 2007, PLOS BIOL, V5, P1202, DOI 10.1371/journal.pbio.0050154; Batada NN, 2006, PLOS BIOL, V4, P1720, DOI 10.1371/journal.pbio.0040317; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Durek P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-100; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.63; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Maslov S, 2004, PHYSICA A, V333, P529, DOI 10.1016/j.physa.2003.06.002; Maslov S, 2002, FEBS LETT, V530, P255, DOI 10.1016/S0014-5793(02)03428-2; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.258701; Pereira-Leal JB, 2005, MOL BIOL EVOL, V22, P421, DOI 10.1093/molbev/msi024; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Redner S, 2008, NATURE, V453, P47, DOI 10.1038/453047a; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Soffer SN, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.057101; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhu DX, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-8	47	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28322	10.1371/journal.pone.0028322	http://dx.doi.org/10.1371/journal.pone.0028322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164269	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400070
J	Tajima, A; Iwaizumi, M; Tseng-Rogenski, S; Cabrera, BL; Carethers, JM				Tajima, Akihiro; Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Cabrera, Betty L.; Carethers, John M.			Both hMutS alpha and hMutS beta DNA Mismatch Repair Complexes Participate in 5-Fluorouracil Cytotoxicity	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; MISPAIR-BINDING; COLON-CANCER; MUTS-ALPHA; IN-VITRO; MSH3; MUTATIONS; MSH2-MSH6	Background: Patients with advanced microsatellite unstable colorectal cancers do not show a survival benefit from 5-fluorouracil (5-FU)-based chemotherapy. We and others have shown that the DNA mismatch repair (MMR) complex hMutS alpha binds 5-FU incorporated into DNA. Although hMutS beta is known to interact with interstrand crosslinks (ICLs) induced by drugs such as cisplatin and psoralen, it has not been demonstrated to interact with 5-FU incorporated into DNA. Our aim was to examine if hMutS beta plays a role in 5-FU recognition. Methods: We compared the normalized growth of 5-FU treated cells containing either or both mismatch repair complexes using MTT and clonogenic assays. We utilized oligonucleotides containing 5-FU and purified baculovirus-synthesized hMutS alpha and hMutS beta in electromobility shift assays (EMSA) and further analyzed binding using surface plasmon resonance. Results: MTT and clonogenic assays after 5-FU treatment demonstrated the most cytotoxicity in cells with both hMutS alpha and hMutS beta, intermediate cytotoxicity in cells with hMutSa alone, and the least cytotoxicity in cells with hMutS beta alone, hMutS beta binds 5-FU-modified DNA, but its relative binding is less than the binding of 5-FU-modified DNA by hMutS alpha. Conclusion: Cytotoxicity induced by 5-FU is dependent on intact DNA MMR, with relative cell death correlating directly with hMutS alpha and/or hMutS beta 5-FU binding ability (hMutS alpha>hMutS beta). The MMR complexes provide a hierarchical chemosensitivity for 5-FU cell death, and may have implications for treatment of patients with certain MMR-deficient tumors.	[Tajima, Akihiro; Iwaizumi, Moriya; Cabrera, Betty L.; Carethers, John M.] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Iwaizumi, Moriya; Tseng-Rogenski, Stephanie; Carethers, John M.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Carethers, John M.] Univ Calif San Diego, Moores Comprehens Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of Michigan System; University of Michigan; University of California System; University of California San Diego	Tajima, A (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA.	jcarethe@umich.edu	Tajima, Akihiro/AAK-8017-2020; Iwaizumi, Moriya/AAG-3173-2019; Tajima, Akihiro/AAF-4912-2020	Tajima, Akihiro/0000-0003-4008-5048; Iwaizumi, Moriya/0000-0002-2629-0830; 	California Department of Health Services [99-86873]; United States Public Health Service [R01-CA90231, DK067287]; NATIONAL CANCER INSTITUTE [R01CA090231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067287] Funding Source: NIH RePORTER	California Department of Health Services; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the California Department of Health Services Cancer Research Program (#99-86873 to JC), and the United States Public Health Service (R01-CA90231 and DK067287 to JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 2000, GASTROENTEROLOGY, V118, pS115, DOI 10.1016/S0016-5085(00)70010-2; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; de Wind N, 1999, NAT GENET, V23, P359, DOI 10.1038/15544; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fischer F, 2007, GASTROENTEROLOGY, V133, P1858, DOI 10.1053/j.gastro.2007.09.003; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Iwaizumi M, 2011, CANC BIOL T IN PRESS; Johnson RE, 1996, J BIOL CHEM, V271, P7285, DOI 10.1074/jbc.271.13.7285; Jover R, 2009, EUR J CANCER, V45, P365, DOI 10.1016/j.ejca.2008.07.016; Kuraguchi M, 2001, CANCER RES, V61, P7934; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Liu A, 2008, J CELL BIOCHEM, V105, P245, DOI 10.1002/jcb.21824; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Meyers M, 2005, J BIOL CHEM, V280, P5516, DOI 10.1074/jbc.M412105200; Meyers M, 2001, CANCER RES, V61, P5193; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Tajima A, 2004, GASTROENTEROLOGY, V127, P1678, DOI 10.1053/j.gastro.2004.10.001; Takahashi M, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198804; Umar A, 1998, GENETICS, V148, P1637; Vasquez KM, 2010, ENVIRON MOL MUTAGEN, V51, P527, DOI 10.1002/em.20557; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	30	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28117	10.1371/journal.pone.0028117	http://dx.doi.org/10.1371/journal.pone.0028117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164234	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400035
J	Du, WG; Ye, H; Zhao, B; Pizzatto, L; Ji, X; Shine, R				Du, Wei-Guo; Ye, Hua; Zhao, Bo; Pizzatto, Ligia; Ji, Xiang; Shine, Richard			Patterns of Interspecific Variation in the Heart Rates of Embryonic Reptiles	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; OXYGEN-CONSUMPTION; SQUAMATE REPTILES; MITOCHONDRIAL; LIZARDS; DNA; NUCLEAR; SIZE; METABOLISM; LACERTIDAE	New non-invasive technologies allow direct measurement of heart rates (and thus, developmental rates) of embryos. We applied these methods to a diverse array of oviparous reptiles (24 species of lizards, 18 snakes, 11 turtles, 1 crocodilian), to identify general influences on cardiac rates during embryogenesis. Heart rates increased with ambient temperature in all lineages, but (at the same temperature) were faster in lizards and turtles than in snakes and crocodilians. We analysed these data within a phylogenetic framework. Embryonic heart rates were faster in species with smaller adult sizes, smaller egg sizes, and shorter incubation periods. Phylogenetic changes in heart rates were negatively correlated with concurrent changes in adult body mass and residual incubation period among the lizards, snakes (especially within pythons) and crocodilians. The total number of embryonic heart beats between oviposition and hatching was lower in squamates than in turtles or the crocodilian. Within squamates, embryonic iguanians and gekkonids required more heartbeats to complete development than did embryos of the other squamate families that we tested. These differences plausibly reflect phylogenetic divergence in the proportion of embryogenesis completed before versus after laying.	[Du, Wei-Guo] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Du, Wei-Guo; Pizzatto, Ligia; Shine, Richard] Univ Sydney, Sch Biol Sci A08, Sydney, NSW 2006, Australia; [Du, Wei-Guo; Ye, Hua; Zhao, Bo] Hangzhou Normal Univ, Coll Biol & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Ji, Xiang] Nanjing Normal Univ, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney; Hangzhou Normal University; Nanjing Normal University	Du, WG (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	duweiguo@ioz.ac.cn	Du, Wei-Guo/K-1071-2014		Chinese Academy of Sciences; Program for New Century Excellent Talents in University; University of Sydney; Australian Research Council; Natural Science Foundation of China	Chinese Academy of Sciences(Chinese Academy of Sciences); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); University of Sydney(University of Sydney); Australian Research Council(Australian Research Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the "One Hundred Talents Programme" of the Chinese Academy of Sciences, Program for New Century Excellent Talents in University, the University of Sydney (to W.-G. Du), the Australian Research Council (to R. Shine and L. Pizzatto), and the Natural Science Foundation of China (to X. Ji). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R.M., 2004, P75; ANDREWS RM, 1985, PHYSIOL ZOOL, V58, P214, DOI 10.1086/physzool.58.2.30158569; Ar A, 1999, COMP BIOCHEM PHYS A, V124, P491, DOI 10.1016/S1095-6433(99)00142-7; Austin JJ, 2006, MOL PHYLOGENET EVOL, V39, P503, DOI 10.1016/j.ympev.2005.12.011; Birchard GF, 1996, J COMP PHYSIOL B, V166, P461, DOI 10.1007/s003600050033; Booth D.T., 1991, P325, DOI 10.1017/CBO9780511585739.021; Brandley MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011375; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BURGGREN WW, 1997, DEV CARDIOVASCULAR S; CALDER WA, 1968, CONDOR, V70, P358, DOI 10.2307/1365930; Colbert PL, 2010, FUNCT ECOL, V24, P112, DOI 10.1111/j.1365-2435.2009.01602.x; CONGDON JD, 1987, P NATL ACAD SCI USA, V84, P4145, DOI 10.1073/pnas.84.12.4145; COWLEY AW, 1971, AM J CARDIOL, V28, P321, DOI 10.1016/0002-9149(71)90121-4; Crossley DA, 2005, J EXP BIOL, V208, P31, DOI 10.1242/jeb.01355; Du WG, 2008, COMP BIOCHEM PHYS A, V151, P102, DOI 10.1016/j.cbpa.2008.06.005; Du WG, 2011, P NATL ACAD SCI USA, V108, P9513, DOI 10.1073/pnas.1102965108; Du WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015308; Du WG, 2010, AM NAT, V176, P522, DOI 10.1086/656270; Du WG, 2010, COMP BIOCHEM PHYS A, V156, P491, DOI 10.1016/j.cbpa.2010.04.005; Du WG, 2009, J EXP BIOL, V212, P1302, DOI 10.1242/jeb.027425; Engstrom TN, 2004, SYST BIOL, V53, P693, DOI 10.1080/10635150490503053; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Feng J, 2007, ZOOL SCI, V24, P656, DOI 10.2108/zsj.24.656; Frost Darrel R., 2001, American Museum Novitates, V3343, P1, DOI 10.1206/0003-0082(2001)343<0001:TESAEO>2.0.CO;2; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GRUBB BR, 1983, AM J PHYSIOL, V245, pH567, DOI 10.1152/ajpheart.1983.245.4.H567; Han D, 2004, BIOL J LINN SOC, V83, P353, DOI 10.1111/j.1095-8312.2004.00393.x; Honda M, 2002, J ZOOL SYST EVOL RES, V40, P195, DOI 10.1046/j.1439-0469.2002.00176.x; Honda M, 2000, ZOOL SCI, V17, P527; Hugall AF, 2008, BIOL J LINN SOC, V93, P343, DOI 10.1111/j.1095-8312.2007.00911.x; Iwabe N, 2005, MOL BIOL EVOL, V22, P810, DOI 10.1093/molbev/msi075; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kluge Arnold G., 1993, Records of the Australian Museum Supplement, V19, P1; Krenz JG, 2005, MOL PHYLOGENET EVOL, V37, P178, DOI 10.1016/j.ympev.2005.04.027; Lee MSY, 2005, ORG DIVERS EVOL, V5, P25, DOI 10.1016/j.ode.2004.05.003; Maddison W.P., 2010, MESQUITE MODULAR SYS; McMahon BR, 1999, COMP BIOCHEM PHYS A, V124, P539, DOI 10.1016/S1095-6433(99)00147-6; Midford PE, 2010, PDAP PACKAGE MESQUIT; Moussalli A, 2005, MOL PHYLOGENET EVOL, V34, P190, DOI 10.1016/j.ympev.2004.08.022; Nechaeva MV, 2007, COMP BIOCHEM PHYS A, V148, P599, DOI 10.1016/j.cbpa.2007.08.005; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; PARADIS E, 2009, PACKAGE APE R VERSIO; Pavlicev M, 2009, MOL PHYLOGENET EVOL, V52, P727, DOI 10.1016/j.ympev.2009.04.020; Pearson JT, 2000, J COMP PHYSIOL B, V170, P429, DOI 10.1007/s003600000120; Radder R, 2006, BIOL LETTERS, V2, P415, DOI 10.1098/rsbl.2006.0495; Rawlings LH, 2008, BIOL J LINN SOC, V93, P603, DOI 10.1111/j.1095-8312.2007.00904.x; Reinhold K, 1999, FUNCT ECOL, V13, P217, DOI 10.1046/j.1365-2435.1999.00300.x; Rui JL, 2009, AMPHIBIA-REPTILIA, V30, P25, DOI 10.1163/156853809787392793; Scanlon JD, 2004, ZOOL SCR, V33, P335, DOI 10.1111/j.0300-3256.2004.00151.x; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; SHINE R, 1990, HERPETOLOGICA, V46, P283; Shine R, 2003, J EVOLUTION BIOL, V16, P823, DOI 10.1046/j.1420-9101.2003.00600.x; SHINE R, 1983, HERPETOLOGICA, V39, P1; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Stamps JA, 1998, ANIM BEHAV, V55, P461, DOI 10.1006/anbe.1997.0612; Stephens PR, 2003, BIOL J LINN SOC, V79, P577, DOI 10.1046/j.1095-8312.2003.00211.x; SWAN M, 2007, KEEPING BREEDING AUS; Tazawa H, 2001, J EXP BIOL, V204, P165; THOMPSON MB, 1989, RESP PHYSIOL, V76, P243, DOI 10.1016/0034-5687(89)90101-1; Utiger Urs, 2002, Russian Journal of Herpetology, V9, P105; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vidal Nicolas, 2009, P390; Vladimirova IG, 2005, BIOL BULL+, V32, P484, DOI 10.1007/s10525-005-0129-8; Wan LX, 2007, AMPHIBIA-REPTILIA, V28, P33; Warner DA, 2007, OECOLOGIA, V154, P65, DOI 10.1007/s00442-007-0809-9; Zardoya R, 2001, NATURWISSENSCHAFTEN, V88, P193, DOI 10.1007/s001140100228; Zbinden JA, 2006, J EXP MAR BIOL ECOL, V334, P151, DOI 10.1016/j.jembe.2006.01.021; ZHANG MW, 1998, FAUNA SINICA REPTILI, V1	72	23	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29027	10.1371/journal.pone.0029027	http://dx.doi.org/10.1371/journal.pone.0029027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174948	Green Submitted, Green Published			2022-12-27	WOS:000298367300041
J	Lussier, YA; Xing, HR; Salama, JK; Khodarev, NN; Huang, Y; Zhang, QB; Khan, SA; Yang, XN; Hasselle, MD; Darga, TE; Malik, R; Fan, HL; Perakis, S; Filippo, M; Corbin, K; Lee, Y; Posner, MC; Chmura, SJ; Hellman, S; Weichselbaum, RR				Lussier, Yves A.; Xing, H. Rosie; Salama, Joseph K.; Khodarev, Nikolai N.; Huang, Yong; Zhang, Qingbei; Khan, Sajid A.; Yang, Xinan; Hasselle, Michael D.; Darga, Thomas E.; Malik, Renuka; Fan, Hanli; Perakis, Samantha; Filippo, Matthew; Corbin, Kimberly; Lee, Younghee; Posner, Mitchell C.; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.			MicroRNA Expression Characterizes Oligometastasis(es)	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; STEREOTACTIC BODY RADIATION; METASTATIC BREAST-CANCER; MIR-200 FAMILY; COLORECTAL METASTASES; PANCREATIC-CANCER; LIVER METASTASES; TUMOR-METASTASIS; PROSTATE-CANCER; THERAPY	Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by <= 5 cumulative metastasis(es), termed oligometastases. In contrast to widespread polymetastases, oligometastatic patients may benefit from metastasis-directed local treatments. However, many patients who initially present with oligometastases progress to polymetastases. Predictors of progression could improve patient selection for metastasis-directed therapy. Methods: Here, we identified patterns of microRNA expression of tumor samples from oligometastatic patients treated with high-dose radiotherapy. Results: Patients who failed to develop polymetastases are characterized by unique prioritized features of a microRNA classifier that includes the microRNA-200 family. We created an oligometastatic-polymetastatic xenograft model in which the patient-derived microRNAs discriminated between the two metastatic outcomes. MicroRNA-200c enhancement in an oligometastatic cell line resulted in polymetastatic progression. Conclusions: These results demonstrate a biological basis for oligometastases and a potential for using microRNA expression to identify patients most likely to remain oligometastatic after metastasis-directed treatment.	[Lussier, Yves A.; Xing, H. Rosie; Khodarev, Nikolai N.; Huang, Yong; Weichselbaum, Ralph R.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Lussier, Yves A.; Xing, H. Rosie; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Ludwig Ctr Metastasis Res, Chicago, IL 60637 USA; [Lussier, Yves A.; Huang, Yong; Zhang, Qingbei; Yang, Xinan; Lee, Younghee] Univ Chicago, Dept Med, Ctr Biomed Informat, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Xing, H. Rosie; Khodarev, Nikolai N.; Hasselle, Michael D.; Darga, Thomas E.; Malik, Renuka; Perakis, Samantha; Filippo, Matthew; Corbin, Kimberly; Chmura, Steven J.; Hellman, Samuel; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Xing, H. Rosie; Zhang, Qingbei; Fan, Hanli] Univ Chicago, Dept Pathol, Comm Canc Biol, Chicago, IL 60637 USA; [Khan, Sajid A.; Posner, Mitchell C.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Salama, Joseph K.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC USA	Robert H. Lurie Comprehensive Cancer Center; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Duke University	Lussier, YA (corresponding author), Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA.	ylussier@uic.edu; rrw@radonc.uchicago.edu	khan, sajid/HGE-2406-2022; Lussier, Yves/N-4891-2017; Xie, Huangming/B-2260-2012; Chmura, Steven Joseph/ACU-8438-2022; Di Filippo, Mathilde/C-2234-2016	Lussier, Yves/0000-0001-9854-1005; Di Filippo, Mathilde/0000-0001-6206-5908; Darga, Thomas/0000-0002-8968-6701; Hasenleithner, Samantha O./0000-0002-9401-5224	Ludwig Center for Metastasis Research; Center for Radiation Therapy; Chicago Tumor Institute; Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation; Lung Cancer Research Foundation; Cancer Research Foundation; NIH [K22 LM008308-04, 5UL1RR024999-04]; University of Chicago Comprehensive Cancer Center [5P30CA014599-35]; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT) [5U54CA121852-5]; NATIONAL CANCER INSTITUTE [P30CA014599, U54CA121852] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Ludwig Center for Metastasis Research; Center for Radiation Therapy; Chicago Tumor Institute; Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation; Lung Cancer Research Foundation; Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Comprehensive Cancer Center; National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Ludwig Center for Metastasis Research Grant, the Center for Radiation Therapy, the Chicago Tumor Institute, Dr. Lloyd Old, Mr. and Mrs. Vincent Foglia and the Foglia foundation, Lung Cancer Research Foundation, the Cancer Research Foundation and the following NIH Grants: K22 LM008308-04, 5UL1RR024999-04, University of Chicago Comprehensive Cancer Center (5P30CA014599-35), National Center for the Multi Scale Analysis of Genomic and Cellular Networks (MAGNeT; 5U54CA121852-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Bendoraite A, 2010, GYNECOL ONCOL, V116, P117, DOI 10.1016/j.ygyno.2009.08.009; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Buck MB, 2004, CLIN CANCER RES, V10, P491, DOI 10.1158/1078-0432.CCR-0320-03; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Fong YM, 1997, J CLIN ONCOL, V15, P938, DOI 10.1200/JCO.1997.15.3.938; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Giavazzi R, 2001, Methods Mol Med, V58, P223, DOI 10.1385/1-59259-137-X:223; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; HAND DJT, 2001, MACHINE LEARNING, V45; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; Hoyer M, 2006, ACTA ONCOL, V45, P823, DOI 10.1080/02841860600904854; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Klein CA, 2002, LANCET, V360, P683, DOI 10.1016/S0140-6736(02)09838-0; KORPAL M, 2011, NAT MED; Korpal M, 2008, RNA BIOL, V5, P115, DOI 10.4161/rna.5.3.6558; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000730; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Metha N, 2004, INT J ONCOL, V25, P1677; Milano MT, 2008, CANCER-AM CANCER SOC, V112, P650, DOI 10.1002/cncr.23209; Milano MT, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-36; Nohata N, 2011, ONCOTARGET, V2, P29; Noonan EJ, 2010, ONCOTARGET, V1, P349, DOI 10.18632/oncotarget.167; Ory B, 2011, ONCOTARGET, V2, P259; Parmigiani G, 2003, ANAL GENE EXPRESSION, P120; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Rusthoven KE, 2009, J CLIN ONCOL, V27, P1579, DOI 10.1200/JCO.2008.19.6386; Salama JK, 2008, CLIN CANCER RES, V14, P5255, DOI 10.1158/1078-0432.CCR-08-0358; Schefter TE, 2005, INT J RADIAT ONCOL, V62, P1371, DOI 10.1016/j.ijrobp.2005.01.002; Schmidt-Kittler O, 2010, ONCOTARGET, V1, P339; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Smits M, 2010, ONCOTARGET, V1, P710, DOI 10.18632/oncotarget.205; SOOND SM, 2011, ONCOGENE; STAREN ED, 1992, ARCH SURG-CHICAGO, V127, P1282; Tanvetyanon T, 2008, J CLIN ONCOL, V26, P1142, DOI 10.1200/JCO.2007.14.2091; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Tryndyak VP, 2010, INT J CANCER, V126, P2575, DOI 10.1002/ijc.24972; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Weichselbaum R. R., 2011, NAT REV CLIN ONCOL; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang QB, 2011, MOL CANCER THER, V10, P1173, DOI 10.1158/1535-7163.MCT-11-0008; Zheng Y, 1996, J BIOL CHEM, V271, P33169, DOI 10.1074/jbc.271.52.33169	56	202	214	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28650	10.1371/journal.pone.0028650	http://dx.doi.org/10.1371/journal.pone.0028650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174856	Green Submitted, Green Published, gold			2022-12-27	WOS:000298367300017
J	Xu, HB; Wu, Q; Dang, SP; Jin, M; Xu, JW; Cheng, YJ; Pan, ML; Wu, YG; Zhang, CH; Zhang, YY				Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Pan, Minglin; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun			Alteration of CXCR7 Expression Mediated by TLR4 Promotes Tumor Cell Proliferation and Migration in Human Colorectal Carcinoma	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR-4; GENE-EXPRESSION; CANCER; PROTEIN; BREAST; LIPOPOLYSACCHARIDE; INVOLVEMENT; METASTASIS; ACTIVATION	The link between inflammation and colorectal carcinoma has been acknowledged. However, the impact of bacterial lipopolysaccharide (LPS) binding to Toll-like receptor 4 (TLR4) on chemokine receptors in human colorectal carcinoma cells still remains to be elucidated. The present study shows that exposure to LPS elevated CXC chemokine receptor 7 (CXCR7) expression in colorectal carcinoma SW480 and Colo 205 cell lines expressing TLR4/myeloid differential protein (MD-2). CXCR7 is associated with SW480 cell proliferation and migration. However, exposure of SW480 and Colo 205 cells to LPS had no effect on CXCR4 expression. To further support the above results, the expression of TLR4, MD-2, and CXCR7 was analyzed in human colorectal carcinoma tissues. Higher rates of TLR4 (53%), MD-2 (70%), and CXCR7 (29%) expression were found in colorectal carcinoma tissues than in normal tissues. We demonstrated that the recombination of TLR4, MD-2 and CXCR7 strongly correlated with tumor size, lymph node metastasis and distant metastasis in colorectal carcinoma tissue samples (p = 0.037, p = 0.002, p = 0.042, resp.). Accordingly, simultaneous examination of the expression of TLR4, MD-2 and CXCR7 in cancer tissues of colorectal carcinoma may provide valuable prognostic diagnosis of carcinoma growth and metastasis. Interplay of TLR4, MD-2 and CXCR7 may be of interest in the context of novel immunomodulatory therapies for colorectal carcinoma.	[Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun] SJTUSM, Inst Med Sci, Shanghai Inst Immunol, Shanghai, Peoples R China; [Xu, Huanbai; Wu, Qiong; Dang, Shipeng; Jin, Min; Xu, Jingwei; Cheng, Yiji; Wu, Yugang; Zhang, Chunhui; Zhang, Yanyun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Xu, Huanbai] Bengbu Med Coll, Affiliated Hosp 1, Dept Endocrinol, Bengbu, Peoples R China; [Pan, Minglin] Nanjing Med Univ, Affiliated Hosp 2, Dept Endocrinol, Nanjing, Peoples R China; [Wu, Yugang] Soochow Univ, Affiliated Hosp 3, Changzhou, Peoples R China; [Wu, Yugang] First Peoples Hosp Changzhou, Dept Surg, Changzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Bengbu Medical College; Nanjing Medical University; Soochow University - China	Xu, HB (corresponding author), SJTUSM, Inst Med Sci, Shanghai Inst Immunol, Shanghai, Peoples R China.	yyzhang@sibs.ac.cn			Ministry of Science and Technology of China [2011CB966200, 2010CB945600]; National Natural Science Foundation of China [30873045, 81071748, 30901317]; Chinese Academy of Sciences [XDA01040000, KSCX1-YW-22]; Shanghai Municipal Education Commission [J50207]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by the Ministry of Science and Technology of China (2011CB966200, 2010CB945600), National Natural Science Foundation of China (30873045, 81071748 and 30901317), Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040000), Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX1-YW-22), and Leading Academic Discipline Project of Shanghai Municipal Education Commission (J50207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Doan HQ, 2009, ANTICANCER RES, V29, P2473; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008; Gonzalez-Reyes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-665; Gunter MJ, 2006, CANCER RES, V66, P2483, DOI 10.1158/0008-5472.CAN-05-3631; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; Hoshino K, 1999, J IMMUNOL, V162, P3749; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Santin I, 2007, TISSUE ANTIGENS, V70, P495, DOI 10.1111/j.1399-0039.2007.00945.x; Strus M, 2009, J PHYSIOL PHARMACOL, V60, P49; Tarnowski M, 2010, MOL CANCER RES, V8, P1, DOI 10.1158/1541-7786.MCR-09-0259; Thuringer D, 2011, J BIOL CHEM, V286, P3418, DOI 10.1074/jbc.M110.154823; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Zhao CH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-419	28	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27399	10.1371/journal.pone.0027399	http://dx.doi.org/10.1371/journal.pone.0027399			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180778	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300006
J	Daily, JL; Nash, K; Jinwal, U; Golde, T; Rogers, J; Peters, MM; Burdine, RD; Dickey, C; Banko, JL; Weeber, EJ				Daily, Jennifer L.; Nash, Kevin; Jinwal, Umesh; Golde, Todd; Rogers, Justin; Peters, Melinda M.; Burdine, Rebecca D.; Dickey, Chad; Banko, Jessica L.; Weeber, Edwin J.			Adeno-Associated Virus-Mediated Rescue of the Cognitive Defects in a Mouse Model for Angelman Syndrome	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; CONTROLLED-TRIAL; RETT-SYNDROME; PRADER-WILLI; UBIQUITIN LIGASE; KINASE-II; EXPRESSION; MICE; CHROMOSOME-15; SUBSTRATE	Angelman syndrome (AS), a genetic disorder occurring in approximately one in every 15,000 births, is characterized by severe mental retardation, seizures, difficulty speaking and ataxia. The gene responsible for AS was discovered to be UBE3A and encodes for E6-AP, an ubiquitin ligase. A unique feature of this gene is that it undergoes maternal imprinting in a neuron-specific manner. In the majority of AS cases, there is a mutation or deletion in the maternally inherited UBE3A gene, although other cases are the result of uniparental disomy or mismethylation of the maternal gene. While most human disorders characterized by severe mental retardation involve abnormalities in brain structure, no gross anatomical changes are associated with AS. However, we have determined that abnormal calcium/calmodulin-dependent protein kinase II (CaMKII) regulation is seen in the maternal UBE3A deletion AS mouse model and is responsible for the major phenotypes. Specifically, there is an increased alpha CaMKII phosphorylation at the autophosphorylation sites Thr(286) and Thr(305/306), resulting in an overall decrease in CaMKII activity. CaMKII is not produced until after birth, indicating that the deficits associated with AS are not the result of developmental abnormalities. The present studies are focused on exploring the potential to rescue the learning and memory deficits in the adult AS mouse model through the use of an adeno-associated virus (AAV) vector to increase neuronal UBE3A expression. These studies show that increasing the levels of E6-AP in the brain using an exogenous vector can improve the cognitive deficits associated with AS. Specifically, the associative learning deficit was ameliorated in the treated AS mice compared to the control AS mice, indicating that therapeutic intervention may be possible in older AS patients.	[Daily, Jennifer L.; Nash, Kevin; Rogers, Justin; Peters, Melinda M.; Weeber, Edwin J.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Jinwal, Umesh] Univ S Florida, Dept Pharm, Tampa, FL USA; [Burdine, Rebecca D.] Princeton Univ, Dept Neurosci, Princeton, NJ 08544 USA; [Daily, Jennifer L.; Nash, Kevin; Jinwal, Umesh; Rogers, Justin; Peters, Melinda M.; Dickey, Chad; Banko, Jessica L.; Weeber, Edwin J.] Univ S Florida, Hlth Byrd Alzheimers Inst, Tampa, FL USA; [Golde, Todd] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Golde, Todd] Univ Florida, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Dickey, Chad; Banko, Jessica L.] Univ S Florida, Dept Mol Med, Tampa, FL USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Princeton University; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of South Florida	Daily, JL (corresponding author), Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	eweeber@health.usf.edu	Weeber, Edwin J/A-5396-2012; Nash, Kevin R/B-4567-2009; Banko, Jessica L/I-9354-2012	Nash, Kevin R/0000-0002-8607-1832; Burdine, Rebecca/0000-0001-6620-5015	National Institutes of Health (NIH) [R21NS0727851-02, R21HD062749-01]; Jerome Lejeune Foundation; Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD062749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031291] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jerome Lejeune Foundation; Angelman Syndrome Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was received from National Institutes of Health (NIH) Grant R21NS0727851-02, NIH Grant R21HD062749-01, The Jerome Lejeune Foundation, and the Angelman Syndrome Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; Berry-Kravis E, 2006, J CHILD ADOL PSYCHOP, V16, P525, DOI 10.1089/cap.2006.16.525; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; CLAYTONSMITH J, 1993, AM J MED GENET, V46, P12, DOI 10.1002/ajmg.1320460105; Curia G, 2009, CEREB CORTEX, V19, P1515, DOI 10.1093/cercor/bhn159; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; Ellaway C, 1999, J CHILD NEUROL, V14, P162, DOI 10.1177/088307389901400306; Ellaway C, 1998, J CHILD NEUROL, V13, P448, DOI 10.1177/088307389801300907; Freilinger M, 2011, J DEV BEHAV PEDIATR, V32, P454, DOI 10.1097/DBP.0b013e31822177a8; Gabriel JM, 1999, P NATL ACAD SCI USA, V96, P9258, DOI 10.1073/pnas.96.16.9258; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; HAGEBEUK EEO, 2011, J CHILD NEU IN PRESS; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; KAPLAN LC, 1987, AM J MED GENET, V28, P45, DOI 10.1002/ajmg.1320280107; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Mah C, 2003, HUM GENE THER, V14, P143, DOI 10.1089/104303403321070838; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; NICHOLLS RD, 1994, AM J HUM GENET, V54, P733; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Weeber EJ, 2003, J NEUROSCI, V23, P2634; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Xue J, 2002, DEV BRAIN RES, V138, P61, DOI 10.1016/S0165-3806(02)00460-1; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	29	71	76	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27221	10.1371/journal.pone.0027221	http://dx.doi.org/10.1371/journal.pone.0027221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174738	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700004
J	Liu, YL; Yang, SP; Dai, JJ; Xu, YT; Zhang, R; Jiang, HL; Yan, XX; Yang, KH				Liu, Yali; Yang, Shengping; Dai, Junjie; Xu, Yongteng; Zhang, Rui; Jiang, Huaili; Yan, Xianxia; Yang, Kehu			Risk of Bias Tool in Systematic Reviews/Meta-Analyses of Acupuncture in Chinese Journals	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; QUALITY ASSESSMENT	Background: Use of a risk of bias (ROB) tool has been encouraged and advocated to reviewers writing systematic reviews (SRs) and meta-analyses (MAs). Selective outcome reporting and other sources of bias are included in the Cochrane ROB tool. It is important to know how this specific tool for assessing ROB has been applied since its release. Our objectives were to evaluate whether and to what extent the new Cochrane ROB tool has been used in Chinese journal papers of acupuncture. Methods: We searched CBM, TCM database, CJFD, CSJD, and the Wanfang Database from inception to March 2011. Two reviewers independently selected SRs that primarily focused on acupuncture and moxibustion, from which the data was extracted and analyzed. Results: A total of 836 SRs were identified from the search, of which, 105 were included and four are awaiting assessment. Thirty-six of the 105 SRs were published before release of the Cochrane ROB tool (up to 2009). Most used the Cochrane Handbook 4.2 or Jadad's scale for risk or quality assessment. From 2009 to March 2011 69 SRs were identified. While "risk of bias" was reported for approximately two-thirds of SRs, only two SRs mentioned use of a "risk of bias tool" in their assessment. Only 5.8% (4/69) of reviews reported information on all six domains which are involved in the ROB tool. A risk of bias graph/summary figure was provided in 2.9% (2/69) of reviews. Most SRs gave information about sequence generation, allocation concealment, blindness, and incomplete outcome data, however, few reviews (5.8%; 4/69) described selective reporting or other potential sources of bias. Conclusions: The Cochrane "risk of bias" tool has not been used in all SRs/MAs of acupuncture published in Chinese Journals after 2008. When the ROB tool was used, reporting of relevant information was often incomplete.	[Liu, Yali; Yang, Shengping; Dai, Junjie; Xu, Yongteng; Zhang, Rui; Jiang, Huaili; Yan, Xianxia; Yang, Kehu] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China; [Liu, Yali; Yang, Kehu] Lanzhou Univ, Inst Integrated Tradit Chinese & Western Med, Lanzhou 730000, Peoples R China; [Yang, Shengping; Dai, Junjie; Xu, Yongteng; Zhang, Rui; Jiang, Huaili; Yan, Xianxia] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University	Liu, YL (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.	kehuyangebm2006@126.com		Liu, Yali/0000-0003-0037-6326				ARMIJOOLIVO S, 2010, J EVAL CLIN PRACT; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Crocetti MT, 2010, PEDIATRICS, V126, P298, DOI 10.1542/peds.2009-3121; Dennison DK, 1997, J PERIODONTAL RES, V32, P430, DOI 10.1111/j.1600-0765.1997.tb00555.x; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; EVANS M, 1985, BRIT J SURG, V72, P256, DOI 10.1002/bjs.1800720403; Ferreira CA, 2011, SAO PAULO MED J, V129, P85, DOI 10.1590/S1516-31802011000200006; Hartling L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017242; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; [李廷谦 LI Tingqian], 2007, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V7, P180; Liu Jian-ping, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P306; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; *SCOTT INT GUID NE, 2011, METH CHECKL, V2; TERRIET G, 1990, J CLIN EPIDEMIOL, V43, P1191, DOI 10.1016/0895-4356(90)90020-P; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; [杨声坪 Yang Shengping], 2010, [循证医学, The Journal of Evidence-Based Medicine], V10, P369; Zhang JH, 2007, J ALTERN COMPLEM MED, V13, P797, DOI 10.1089/acm.2007.7195	27	10	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28130	10.1371/journal.pone.0028130	http://dx.doi.org/10.1371/journal.pone.0028130			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174772	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700019
J	Cowin, RM; Bui, N; Graham, D; Green, JR; Grueninger, S; Yuva-Paylor, LA; Syed, AU; Weiss, A; Paylor, R				Cowin, Randi-Michelle; Bui, Nghiem; Graham, Deanna; Green, Jennie R.; Grueninger, Stephan; Yuva-Paylor, Lisa A.; Syed, Arsalan U.; Weiss, Andreas; Paylor, Richard			Onset and Progression of Behavioral and Molecular Phenotypes in a Novel Congenic R6/2 Line Exhibiting Intergenerational CAG Repeat Stability	PLOS ONE			English	Article							HUNTINGTONS-DISEASE MUTATION; KNOCK-IN MICE; YAC128 MOUSE MODEL; TRANSGENIC MICE; TRINUCLEOTIDE REPEAT; MUTANT HUNTINGTIN; STRIATAL NEURONS; ABNORMALITIES; EXPANSION; INSTABILITY	In the present study we report on the use of speed congenics to generate a C57BL/6J congenic line of HD-model R6/2 mice carrying 110 CAG repeats, which uniquely exhibits minimal intergenerational instability. We also report the first identification of the R6/2 transgene insertion site. The relatively stable line of 110 CAG R6/2 mice was characterized for the onset of behavioral impairments in motor, cognitive and psychiatric-related phenotypes as well as the progression of disease-related impairments from 4 to 10 weeks of age. 110Q mice exhibited many of the phenotypes commonly associated with the R6/2 model including reduced activity and impairments in rotarod performance. The onset of many of the phenotypes occurred around 6 weeks and was progressive across age. In addition, some phenotypes were observed in mice as early as 4 weeks of age. The present study also reports the onset and progression of changes in several molecular phenotypes in the novel R6/2 mice and the association of these changes with behavioral symptom onset and progression. Data from TR-FRET suggest an association of mutant protein state changes (soluble versus aggregated) in disease onset and progression.	[Cowin, Randi-Michelle; Bui, Nghiem; Graham, Deanna; Green, Jennie R.; Yuva-Paylor, Lisa A.; Syed, Arsalan U.; Paylor, Richard] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Grueninger, Stephan; Weiss, Andreas] Neurosci Discovery, Novartis Inst BioMed Res, Basel, Switzerland; [Paylor, Richard] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Baylor College of Medicine; Novartis; Baylor College of Medicine	Cowin, RM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	rpaylor@bcm.edu			Cure Huntington's Disease Initiative, Inc. (CHDI), USA; National Institutes of Health (NIH) [T32 GM08307]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008307] Funding Source: NIH RePORTER	Cure Huntington's Disease Initiative, Inc. (CHDI), USA; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was generously supported by Cure Huntington's Disease Initiative, Inc. (CHDI), USA (http://www.highqfoundation.org/). We would also like to acknowledge support from the National Institutes of Health (NIH) for training grant T32 GM08307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Brooks S., 2010, BRAIN RES B, DOI 10.106/j.brainresbull.2010.05.003; Brooks SP, 2011, BRAIN RES B; Carter RJ, 1999, J NEUROSCI, V19, P3248; Ciarnei A, 2008, NEUROBIOL LEARN MEM, V89, P533, DOI 10.1016/j.nlm.2007.10.009; Dragatsis I, 2009, NEUROBIOL DIS, V33, P315, DOI 10.1016/j.nbd.2008.10.009; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Graham RK, 2009, J NEUROSCI, V29, P2193, DOI 10.1523/JNEUROSCI.5473-08.2009; Hickey MA, 2005, NEUROBIOL DIS, V20, P1, DOI 10.1016/j.nbd.2005.01.024; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Klivenyi P, 2006, BEHAV BRAIN RES, V169, P137, DOI 10.1016/j.bbr.2006.01.003; Kovtun IV, 2004, HUM MOL GENET, V13, P3057, DOI 10.1093/hmg/ddh325; Kovtun IV, 2001, NAT GENET, V27, P407, DOI 10.1038/86906; Kung VWS, 2007, NEUROSCIENCE, V146, P1571, DOI 10.1016/j.neuroscience.2007.03.036; Laforet GA, 2001, J NEUROSCI, V21, P9112, DOI 10.1523/JNEUROSCI.21-23-09112.2001; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lione LA, 1999, J NEUROSCI, V19, P10428; LORENZINI CA, 1995, NEUROBIOL LEARN MEM, V63, P87, DOI 10.1006/nlme.1995.1008; Mangiarini L, 1997, NAT GENET, V15, P197, DOI 10.1038/ng0297-197; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; MATHIS C, 1994, BEHAV GENET, V24, P171, DOI 10.1007/BF01067821; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Morton AJ, 2009, NEUROBIOL DIS, V33, P331, DOI 10.1016/j.nbd.2008.11.015; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, P1869; PRADOALCALA RA, 1985, PHARMACOL BIOCHEM BE, V22, P243, DOI 10.1016/0091-3057(85)90385-5; Savouret C, 2004, MOL CELL BIOL, V24, P629, DOI 10.1128/MCB.24.2.629-637.2004; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shelbourne PF, 1999, HUM MOL GENET, V8, P763, DOI 10.1093/hmg/8.5.763; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Spencer CM, 2011, AUTISM RES, V4, P40, DOI 10.1002/aur.168; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; SWERDLOW NR, 1995, J NEUROL NEUROSUR PS, V58, P192, DOI 10.1136/jnnp.58.2.192; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P189, DOI 10.1016/j.nbd.2006.12.010; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wood NI, 2011, NEUROBIOL DIS, V42, P427, DOI 10.1016/j.nbd.2011.02.005	49	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28409	10.1371/journal.pone.0028409	http://dx.doi.org/10.1371/journal.pone.0028409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163300	Green Submitted, gold, Green Published			2022-12-27	WOS:000298161900037
J	Robillard, R; Prince, F; Filipini, D; Carrier, J				Robillard, Rebecca; Prince, Francois; Filipini, Daniel; Carrier, Julie			Aging Worsens the Effects of Sleep Deprivation on Postural Control	PLOS ONE			English	Article							ATTENTIONAL DEMANDS; ELDERLY POPULATION; QUIET STANCE; OLDER-PEOPLE; RISK-FACTORS; FALLS; COMMUNITY; BALANCE; PREDICTORS; ADULTS	Falls increase with age and cause significant injuries in the elderly. This study aimed to determine whether age modulates the interactions between sleep deprivation and postural control and to evaluate how attention influences these interactions in the elderly. Fifteen young (24 +/- 2.7 y.o.) and 15 older adults (64 +/- 3.2 y.o.) stood still on a force plate after a night of sleep and after total sleep deprivation. Center of pressure range and velocity were measured with eyes open and with eyes closed while participants performed an interference task, a control task, and no cognitive task. Sleep deprivation increased the antero-posterior range of center of pressure in both age groups and center of pressure speed in older participants only. In elderly participants, the destabilizing effects of sleep deprivation were more pronounced with eyes closed. The interference task did not alter postural control beyond the destabilization induced by sleep loss in older subjects. It was concluded that sleep loss has greater destabilizing effects on postural control in older than in younger participants, and may therefore increase the risk of falls in the elderly.	[Robillard, Rebecca; Filipini, Daniel; Carrier, Julie] Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada; [Prince, Francois] Univ Montreal, Dept Kinesiol, Montreal, PQ, Canada; [Carrier, Julie] Univ Montreal, Inst Univ Geriatrie Montreal, Montreal, PQ, Canada; [Robillard, Rebecca; Carrier, Julie] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Robillard, R (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, Montreal, PQ H4J 1C5, Canada.	julie.carrier.1@umontreal.ca	Prince, Francois/AAA-6763-2022; Robillard, Rebecca/G-9045-2017	Carrier, Julie/0000-0001-5311-2370	Fonds de la recherche en sante du Quebec; Fonds quebecois de la recherche sur la nature et les technologies; Canadian Institutes of Health Research; Institut de recherche Robert-Sauve en sante et en securite du travail	Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fonds quebecois de la recherche sur la nature et les technologies(FQRNT); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut de recherche Robert-Sauve en sante et en securite du travail	This work was supported by Fonds de la recherche en sante du Quebec (http://www.frsq.gouv.qc.ca), Fonds quebecois de la recherche sur la nature et les technologies (http://www.fqrnt.gouv.qc.ca), Canadian Institutes of Health Research (www.cihr-irsc.gc.ca), Institut de recherche Robert-Sauve en sante et en securite du travail (www.irsst.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiridis IG, 2003, NEUROSCI LETT, V350, P137, DOI 10.1016/S0304-3940(03)00878-4; Andersson G, 2002, BRAIN RES BULL, V58, P135, DOI 10.1016/S0361-9230(02)00770-0; Avidan AY, 2005, J AM GERIATR SOC, V53, P955, DOI 10.1111/j.1532-5415.2005.53304.x; Berger L, 2005, J MOTOR BEHAV, V37, P348, DOI 10.3200/JMBR.37.5.348-358; Blaszczyk JW, 2000, J BIOMECH, V33, P1243, DOI 10.1016/S0021-9290(00)00097-X; Brassington GS, 2000, J AM GERIATR SOC, V48, P1234, DOI 10.1111/j.1532-5415.2000.tb02596.x; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carrier J., 2003, SLEEP PHYSL INVESTIG, P297, DOI DOI 10.1007/978-1-4615-0217-3_24; Dault MC, 2001, GAIT POSTURE, V14, P248, DOI 10.1016/S0966-6362(01)00130-8; Dault MC, 2001, GAIT POSTURE, V14, P110, DOI 10.1016/S0966-6362(01)00113-8; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Gage WH, 2004, GAIT POSTURE, V19, P124, DOI 10.1016/S0966-6362(03)00037-7; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Hill EL, 2007, J GERONTOL A-BIOL, V62, P62, DOI 10.1093/gerona/62.1.62; HORAK FB, 1990, EXP BRAIN RES, V82, P167; Huxhold O, 2006, BRAIN RES BULL, V69, P294, DOI 10.1016/j.brainresbull.2006.01.002; Lord SR, 2000, GERONTOLOGY, V46, P306, DOI 10.1159/000022182; LORD SR, 1991, J AM GERIATR SOC, V39, P1194, DOI 10.1111/j.1532-5415.1991.tb03574.x; Lord SR, 2001, J AM GERIATR SOC, V49, P508, DOI 10.1046/j.1532-5415.2001.49107.x; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Maylor EA, 1996, J GERONTOL B-PSYCHOL, V51, pP143, DOI 10.1093/geronb/51B.3.P143; Painter Jane A, 2009, J Allied Health, V38, P201; Pajala S, 2008, J GERONTOL A-BIOL, V63, P171, DOI 10.1093/gerona/63.2.171; Patel M, 2008, EXP BRAIN RES, V185, P165, DOI 10.1007/s00221-007-1143-5; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Robillard R, 2011, CLIN NEUROPHYSIOL; Schechtman KB, 1997, J PSYCHOSOM RES, V43, P513, DOI 10.1016/S0022-3999(97)00117-7; Schlesinger A, 1998, NEUROREPORT, V9, P49, DOI 10.1097/00001756-199801050-00010; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Siu KC, 2007, GAIT POSTURE, V25, P121, DOI 10.1016/j.gaitpost.2006.02.002; Stone KL, 2008, ARCH INTERN MED, V168, P1768, DOI 10.1001/archinte.168.16.1768; Thapa PB, 1996, J GERONTOL A-BIOL, V51, pM239, DOI 10.1093/gerona/51A.5.M239; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vuillerme N, 2000, NEUROSCI LETT, V291, P77, DOI 10.1016/S0304-3940(00)01374-4; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334	38	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28731	10.1371/journal.pone.0028731	http://dx.doi.org/10.1371/journal.pone.0028731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163330	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900066
J	Tavares, ES; Goncalves, P; Miyaki, CY; Baker, AJ				Tavares, Erika Sendra; Goncalves, Priscila; Miyaki, Cristina Yumi; Baker, Allan J.			DNA Barcode Detects High Genetic Structure within Neotropical Bird Species	PLOS ONE			English	Article							PATTERNS; DIVERSIFICATION; EVOLUTION; AVES; DIFFERENTIATION; PASSERIFORMES; BIOGEOGRAPHY; HYPOTHESIS; MIOCENE; MAMMALS	Background: Towards lower latitudes the number of recognized species is not only higher, but also phylogeographic subdivision within species is more pronounced. Moreover, new genetically isolated populations are often described in recent phylogenies of Neotropical birds suggesting that the number of species in the region is underestimated. Previous COI barcoding of Argentinean bird species showed more complex patterns of regional divergence in the Neotropical than in the North American avifauna. Methods and Findings: Here we analyzed 1,431 samples from 561 different species to extend the Neotropical bird barcode survey to lower latitudes, and detected even higher geographic structure within species than reported previously. About 93% (520) of the species were identified correctly from their DNA barcodes. The remaining 41 species were not monophyletic in their COI sequences because they shared barcode sequences with closely related species (N = 21) or contained very divergent clusters suggestive of putative new species embedded within the gene tree (N = 20). Deep intraspecific divergences overlapping with among-species differences were detected in 48 species, often with samples from large geographic areas and several including multiple subspecies. This strong population genetic structure often coincided with breaks between different ecoregions or areas of endemism. Conclusions: The taxonomic uncertainty associated with the high incidence of non-monophyletic species and discovery of putative species obscures studies of historical patterns of species diversification in the Neotropical region. We showed that COI barcodes are a valuable tool to indicate which taxa would benefit from more extensive taxonomic revisions with multilocus approaches. Moreover, our results support hypotheses that the megadiversity of birds in the region is associated with multiple geographic processes starting well before the Quaternary and extending to more recent geological periods.	[Tavares, Erika Sendra; Baker, Allan J.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Goncalves, Priscila; Miyaki, Cristina Yumi] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias, Sao Paulo, Brazil; [Baker, Allan J.] Univ Toronto, Dept Zool, Toronto, ON, Canada	Royal Ontario Museum; Universidade de Sao Paulo; University of Toronto	Tavares, ES (corresponding author), Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada.	erika.tavares@utoronto.ca	Miyaki, Cristina Y/J-2431-2015; Tavares, Erika/ABB-9701-2020	Miyaki, Cristina Y/0000-0002-9708-9202; 	Canadian Barcode of Life Network, Genome Canada through the Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC); ROM Governors' Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES); Conselho Nacional de Pesquisa (CNPq)	Canadian Barcode of Life Network, Genome Canada through the Ontario Genomics Institute; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); ROM Governors' Fund; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funding through the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, Natural Sciences and Engineering Research Council of Canada (NSERC), and other sponsors, the ROM Governors' Fund, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de nivel Superior (CAPES) and Conselho Nacional de Pesquisa (CNPq). The funders of this research had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Baker AJ, 2009, MOL ECOL RESOUR, V9, P257, DOI 10.1111/j.1755-0998.2009.02650.x; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Blackburn TM, 2004, ECOGRAPHY, V27, P715, DOI 10.1111/j.0906-7590.2004.03999.x; Borges SH, 2007, REV BRAS ZOOL, V24, P919, DOI 10.1590/S0101-81752007000400008; Brumfield RT, 2007, EVOLUTION, V61, P346, DOI 10.1111/j.1558-5646.2007.00039.x; Bulgarella M, 2010, J AVIAN BIOL, V41, P186, DOI 10.1111/j.1600-048X.2009.04819.x; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Campagna L, 2010, MOL ECOL RESOUR, V10, P449, DOI 10.1111/j.1755-0998.2009.02799.x; Caranton-Ayala Diego, 2010, Ornitologia Colombiana, V9, P56; Cardillo M, 2005, ECOLOGY, V86, P2278, DOI 10.1890/05-0112; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Cracraft J, 1985, ORNITHOLOGICAL MONOG, V36, P49, DOI DOI 10.2307/40168278; de Queiroz Kevin, 2005, Proceedings of the California Academy of Sciences, V56, P196; DEAN AD, 1995, BIOTECHNIQUES, V18, P980; do Amaral FSR, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-10; Drummond AJ, 2010, GENEIOUS; Fitzpatrick JW, 2004, HDB BIRDS WORLD, V9, P170; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J., 1985, Ornithological Monographs, P113; Haffer J., 1974, Publications Nuttall Orn Club, VNo. 14, P1; Haffer Juergen, 1992, Boletim do Museu Paraense Emilio Goeldi Serie Zoologia, V8, P217; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Joseph L, 2004, MOL PHYLOGENET EVOL, V31, P139, DOI 10.1016/S1055-7903(03)00259-8; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kerr KCR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004379; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Marks BD, 2002, MOL PHYLOGENET EVOL, V24, P153, DOI 10.1016/S1055-7903(02)00233-6; Marroig G, 1997, J COMP BIOL, V2, P103; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; Mila B, 2000, P ROY SOC B-BIOL SCI, V267, P1033, DOI 10.1098/rspb.2000.1107; Miller MJ, 2008, P ROY SOC B-BIOL SCI, V275, P1133, DOI 10.1098/rspb.2008.0015; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Nyari AS, 2007, MOL PHYLOGENET EVOL, V44, P154, DOI 10.1016/j.ympev.2007.02.020; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Pessoa RO, 2008, SISTEMATICA BIOGEOGR; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price T, 2008, SPECIATION BIRDS; R Core Team, 2021, R LANGUAGE ENV STAT; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ribas CC, 2007, IBIS, V149, P564, DOI 10.1111/j.1474-919X.2007.00681.x; Ribas CC, 2004, MOL PHYLOGENET EVOL, V30, P663, DOI 10.1016/S1055-7903(03)00223-9; Rohde K, 1999, ECOGRAPHY, V22, P593, DOI 10.1111/j.1600-0587.1999.tb00509.x; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Sick H, 1967, ATL S BIOT AM ZOOL; Sigrist T, 2009, AVIS BRASILIS FIELD; Swofford DL., 2002, PAUP PHYL AN US PARS; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Vilaca Sibelle T., 2006, Revista Brasileira de Ornitologia, V14, P7; Yoo HS, 2006, MOL CELLS, V22, P323	60	54	58	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28543	10.1371/journal.pone.0028543	http://dx.doi.org/10.1371/journal.pone.0028543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163311	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900047
J	Borriello, A; Caldarelli, I; Basile, MA; Bencivenga, D; Tramontano, A; Perrotta, S; Della Ragione, F; Oliva, A				Borriello, Adriana; Caldarelli, Ilaria; Basile, Maria Assunta; Bencivenga, Debora; Tramontano, Annunziata; Perrotta, Silverio; Della Ragione, Fulvio; Oliva, Adriana			The Tyrosine Kinase Inhibitor Dasatinib Induces a Marked Adipogenic Differentiation of Human Multipotent Mesenchymal Stromal Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PATIENTS RECEIVING IMATINIB; GROWTH-FACTOR RECEPTOR; STEM-CELLS; PPAR-GAMMA; OSTEOBLAST DIFFERENTIATION; CHRONIC-PHASE; SRC KINASE; BONE; NILOTINIB	Background: The introduction of specific BCR-ABL inhibitors in chronic myelogenous leukemia therapy has entirely mutated the prognosis of this hematologic cancer from being a fatal disorder to becoming a chronic disease. Due to the probable long lasting treatment with tyrosine-kinase inhibitors (TKIs), the knowledge of their effects on normal cells is of pivotal importance. Design and Methods: We investigated the effects of dasatinib treatment on human bone marrow-derived mesenchymal stromal cells (MSCs). Results: Our findings demonstrate, for the first time, that dasatinib induces MSCs adipocytic differentiation. Particularly, when the TKI is added to the medium inducing osteogenic differentiation, a high MSCs percentage acquires adipocytic morphology and overexpresses adipocytic specific genes, including PPAR gamma, CEBP alpha, LPL and SREBP1c. Dasatinib also inhibits the activity of alkaline phosphatase, an osteogenic marker, and remarkably reduces matrix mineralization. The increase of PPAR gamma is also confirmed at protein level. The component of osteogenic medium required for dasatinib-induced adipogenesis is dexamethasone. Intriguingly, the increase of adipocytic markers is also observed in MSCs treated with dasatinib alone. The TKI effect is phenotype-specific, since fibroblasts do not undergo adipocytic differentiation or PPAR gamma increase. Conclusions: Our data demonstrate that dasatinib treatment affects bone marrow MSCs commitment and suggest that TKIs therapy might modify normal phenotypes with potential significant negative consequences.	[Borriello, Adriana; Caldarelli, Ilaria; Basile, Maria Assunta; Bencivenga, Debora; Tramontano, Annunziata; Della Ragione, Fulvio; Oliva, Adriana] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy; [Perrotta, Silverio] Univ Naples 2, Dept Pediat, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Borriello, A (corresponding author), Univ Naples 2, Dept Biochem & Biophys, Naples, Italy.	fulvio.dellaragione@unina2.it	Borriello, Adriana/K-3464-2018	Perrotta, Silverio/0000-0001-6149-6845; Della Ragione, Fulvio/0000-0002-0592-4283; BENCIVENGA, Debora/0000-0003-0977-5374; BORRIELLO, Adriana/0000-0002-9026-8048	Associazione Italiana per la Ricerca sul Cancro (AIRC); Progetti di Rilevante Interesse Nazionale (PRIN); Foreign Investment Review Board (FIRB)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Foreign Investment Review Board (FIRB)	This work was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro (AIRC), Progetti di Rilevante Interesse Nazionale (PRIN), and the Foreign Investment Review Board (FIRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas R, 2011, CANC CHEMOTHER  0121; Aguilera Dolly G, 2009, Ther Clin Risk Manag, V5, P281; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Blay JY, 2011, SEMIN ONCOL, V38, pS3, DOI 10.1053/j.seminoncol.2011.01.016; Borriello A, 2006, CANCER RES, V66, P4240, DOI 10.1158/0008-5472.CAN-05-2759; Borriello A, 2011, CARCINOGENESIS, V32, P10, DOI 10.1093/carcin/bgq211; Boufker HI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-298; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Dazzi F, 2006, BLOOD REV, V20, P161, DOI 10.1016/j.blre.2005.11.002; Dizdar O, 2008, BREAST CANCER RES TR, V107, P303, DOI 10.1007/s10549-007-9551-6; Donzelli E, 2011, J MOL CELL BIOL, V3, P123, DOI 10.1093/jmcb/mjq050; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; DRUKER J, 2006, J CLIN ONCOL, V24; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Fierro F, 2007, CELL PROLIFERAT, V40, P355, DOI 10.1111/j.1365-2184.2007.00438.x; Fitter S, 2008, BLOOD, V111, P2538, DOI 10.1182/blood-2007-07-104281; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Heijink DM, 2011, ONCOGENE, V30, P2026, DOI 10.1038/onc.2010.578; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Jonsson S, 2010, LEUKEMIA, V24, P1357, DOI 10.1038/leu.2010.84; Jonsson S, 2008, HAEMATOL-HEMATOL J, V93, P1101, DOI 10.3324/haematol.12373; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; Konecny GE, 2009, BRIT J CANCER, V101, P1699, DOI 10.1038/sj.bjc.6605381; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; le Coutre P, 2008, BLOOD, V111, P1834, DOI 10.1182/blood-2007-04-083196; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Nagaraj NS, 2010, MOL CANCER THER, V9, P2322, DOI 10.1158/1535-7163.MCT-09-1212; O'Brien SG, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50058; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; O'Sullivan S, 2011, CALCIFIED TISSUE INT, V88, P16, DOI 10.1007/s00223-010-9429-1; O'Sullivan S, 2009, J CLIN ENDOCR METAB, V94, P1131, DOI 10.1210/jc.2008-2324; Oliva A, 2005, Int J Immunopathol Pharmacol, V18, P47; Osorio S, 2007, AM J HEMATOL, V82, P394, DOI 10.1002/ajh.20778; Pichot CS, 2009, BRIT J CANCER, V101, P38, DOI 10.1038/sj.bjc.6605101; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; Radich JP, 2010, HEMATOL-AM SOC HEMAT, P122, DOI 10.1182/asheducation-2010.1.122; Reid IR, 2008, OSTEOPOROSIS INT, V19, P595, DOI 10.1007/s00198-007-0492-z; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Tibullo D, 2012, HEMATOL ONCOL, V30, P27, DOI 10.1002/hon.988; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Vallabhaneni S, 2010, BREAST CANC RES TREA; Wei GQ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-47; Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yu EY, 2011, UROLOGY, V77, P1166, DOI 10.1016/j.urology.2011.01.006	59	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28555	10.1371/journal.pone.0028555	http://dx.doi.org/10.1371/journal.pone.0028555			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164306	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400108
J	Lahrmann, B; Halama, N; Sinn, HP; Schirmacher, P; Jaeger, D; Grabe, N				Lahrmann, Bernd; Halama, Niels; Sinn, Hans-Peter; Schirmacher, Peter; Jaeger, Dirk; Grabe, Niels			Automatic Tumor-Stroma Separation in Fluorescence TMAs Enables the Quantitative High-Throughput Analysis of Multiple Cancer Biomarkers	PLOS ONE			English	Article							CELL-GRAPHS; TISSUE; CLASSIFICATION; TECHNOLOGY; EXPRESSION	The upcoming quantification and automation in biomarker based histological tumor evaluation will require computational methods capable of automatically identifying tumor areas and differentiating them from the stroma. As no single generally applicable tumor biomarker is available, pathology routinely uses morphological criteria as a spatial reference system. We here present and evaluate a method capable of performing the classification in immunofluorescence histological slides solely using a DAPI background stain. Due to the restriction to a single color channel this is inherently challenging. We formed cell graphs based on the topological distribution of the tissue cell nuclei and extracted the corresponding graph features. By using topological, morphological and intensity based features we could systematically quantify and compare the discrimination capability individual features contribute to the overall algorithm. We here show that when classifying fluorescence tissue slides in the DAPI channel, morphological and intensity based features clearly outpace topological ones which have been used exclusively in related previous approaches. We assembled the 15 best features to train a support vector machine based on Keratin stained tumor areas. On a test set of TMAs with 210 cores of triple negative breast cancers our classifier was able to distinguish between tumor and stroma tissue with a total overall accuracy of 88%. Our method yields first results on the discrimination capability of features groups which is essential for an automated tumor diagnostics. Also, it provides an objective spatial reference system for the multiplex analysis of biomarkers in fluorescence immunohistochemistry.	[Lahrmann, Bernd; Grabe, Niels] Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany; [Lahrmann, Bernd; Halama, Niels; Schirmacher, Peter; Grabe, Niels] BIOQUANT, Hamamatsu Tissue Imaging & Anal Ctr TIGA, Heidelberg, Germany; [Halama, Niels; Jaeger, Dirk] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany; [Sinn, Hans-Peter; Schirmacher, Peter] Univ Heidelberg Hosp, Dept Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Lahrmann, B (corresponding author), Univ Heidelberg Hosp, Inst Med Biometry & Informat, Heidelberg, Germany.	niels.grabe@bioquant.uni-heidelberg.de	Grabe, Niels/AAP-6493-2020; Grabe, Niels/I-6214-2016; Sinn, Hans-Peter/C-5661-2008	Sinn, Hans-Peter/0000-0003-2836-6699; Halama, Niels/0000-0003-0344-6027; Grabe, Niels/0000-0003-1732-3706	German Ministry for Research and Education (BMBF) [0315401B, 0315263]	German Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF))	Funding was provided by the German Ministry for Research and Education (BMBF) in their MEDSYS and FORSYS funding programs. Grant Numbers: 0315401B (MEDSYS), 0315263 (FORSYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral T, 2008, MED IMAGE UNDERSTAND, P999; Amaral T, 2008, I S BIOMED IMAGING, P999, DOI 10.1109/ISBI.2008.4541167; Beucher Serge, 1992, SCANNING MICROSCPY S, P299; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Bilgin CC, 2010, DATA MINING KNOWLEDG; Bilgin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012783; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Bubendorf L, 2001, J PATHOL, V195, P72, DOI 10.1002/path.893; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chen Y-wei, 2006, FEATURE EXTRACTION F, V315; Comeau JWD, 2006, BIOPHYS J, V91, P4611, DOI 10.1529/biophysj.106.089441; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Demir C, 2005, BIOINFORMATICS, V21, P7, DOI 10.1093/bioinformatics/bti1100; Dolled-Filhart M, 2006, CLIN CANCER RES, V12, P6459, DOI 10.1158/1078-0432.CCR-06-1383; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fuchs TJ, 2008, LECT NOTES COMPUT SC, V5242, P1, DOI 10.1007/978-3-540-85990-1_1; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gunduz-Demir C, 2007, MATH BIOSCI, V209, P514, DOI 10.1016/j.mbs.2007.03.005; Kallioniemi OP, 2001, HUM MOL GENET, V10, P657, DOI 10.1093/hmg/10.7.657; Karacali Bilge, 2007, BMC Med Imaging, V7, P2, DOI 10.1186/1471-2342-7-2; Lahrmann B, 2010, CYTOMETRY A; Lin G, 2003, CYTOM PART A, V56A, P23, DOI 10.1002/cyto.a.10079; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PADFIELD D, 2006, P 1 WORKSH MICR IM A, P86; Simon R, 2004, EXPERT REV MOL MED, V5, P1; Simon R, 2005, METH MOLEC MED, V114, P257; Soille P., 1999, MORPHOLOGICAL IMAGE, P170; Tabesh A, 2009, MED IMAGING 2009 COM, V7260; Teverovskiy M, 2008, I S BIOMED IMAGING, P300, DOI 10.1109/ISBI.2008.4540992; Vonesch C, 2006, IEEE SIGNAL PROC MAG, V23, P20, DOI 10.1109/MSP.2006.1628875; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015818; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	35	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28048	10.1371/journal.pone.0028048	http://dx.doi.org/10.1371/journal.pone.0028048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164226	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400027
J	Olojo, RO; Ziman, AP; Hernandez-Ochoa, EO; Allen, PD; Schneider, MF; Ward, CW				Olojo, Rotimi O.; Ziman, Andrew P.; Hernandez-Ochoa, Erick O.; Allen, Paul D.; Schneider, Martin F.; Ward, Christopher W.			Mice Null for Calsequestrin 1 Exhibit Deficits in Functional Performance and Sarcoplasmic Reticulum Calcium Handling	PLOS ONE			English	Article							SKELETAL-MUSCLE FIBERS; AMINO-ACID-SEQUENCE; CA2+ RELEASE; TWITCH FIBERS; TRANSIENTS; ENTRY; STORE; EXPRESSION; TRANSPORT; DEPLETION	In skeletal muscle, the release of calcium (Ca2+) by ryanodine sensitive sarcoplasmic reticulum (SR) Ca2+ release channels (i.e., ryanodine receptors; RyR1s) is the primary determinant of contractile filament activation. Much attention has been focused on calsequestrin (CASQ1) and its role in SR Ca2+ buffering as well as its potential for modulating RyR1, the L-type Ca2+ channel (dihydropyridine receptor, DHPR) and other sarcolemmal channels through sensing luminal [Ca2+]. The genetic ablation of CASQ1 expression results in significant alterations in SR Ca2+ content and SR Ca2+ release especially during prolonged activation. While these findings predict a significant loss-of-function phenotype in vivo, little information on functional status of CASQ1 null mice is available. We examined fast muscle in vivo and in vitro and identified significant deficits in functional performance that indicate an inability to sustain contractile activation. In single CASQ1 null skeletal myofibers we demonstrate a decrease in voltage dependent RyR Ca2+ release with single action potentials and a collapse of the Ca2+ release with repetitive trains. Under voltage clamp, SR Ca2+ release flux and total SR Ca2+ release are significantly reduced in CASQ1 null myofibers. The decrease in peak Ca2+ release flux appears to be solely due to elimination of the slowly decaying component of SR Ca2+ release, whereas the rapidly decaying component of SR Ca2+ release is not altered in either amplitude or time course in CASQ1 null fibers. Finally, intra-SR [Ca2+] during ligand and voltage activation of RyR1 revealed a significant decrease in the SR[Ca2+] free in intact CASQ1 null fibers and a increase in the release and uptake kinetics consistent with a depletion of intra-SR Ca2+ buffering capacity. Taken together we have revealed that the genetic ablation of CASQ1 expression results in significant functional deficits consistent with a decrease in the slowly decaying component of SR Ca2+ release.	[Olojo, Rotimi O.; Hernandez-Ochoa, Erick O.; Schneider, Martin F.] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA; [Ziman, Andrew P.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA; [Ward, Christopher W.] Univ Maryland, Sch Nursing, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Harvard University; Brigham & Women's Hospital; University System of Maryland; University of Maryland Baltimore	Olojo, RO (corresponding author), Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA.	ward@son.umaryland.edu			National Institutes of Health [R01AR055099, T32ARAR007592, P01AR044750, F32AR057647, RC2 NR011968]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057647, P01AR052354, P01AR044750, R01AR055099, R37AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [RC2NR011968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by the National Institutes of Health (R01AR055099 and T32ARAR007592 to MFS, P01AR044750 to PDA, F32AR057647 to APZ and RC2 NR011968 to CWW. ROO was partially supported by T32ARAR007592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramow-Newerly W, 2006, AMYOTROPH LATERAL SC, V7, P112, DOI 10.1080/14660820500443000; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERS DM, 1994, METHOD CELL BIOL, V40, P3; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Brown LD, 2007, AM J PHYSIOL-CELL PH, V292, pC1156, DOI 10.1152/ajpcell.00397.2006; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1197; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Cho JH, 2000, J CELL SCI, V113, P3947; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; DAMIANI E, 1990, BIOCHEM BIOPH RES CO, V172, P1253, DOI 10.1016/0006-291X(90)91584-F; Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104; DIRKSEN RT, 2009, J PHYSL; EDWARDS C, 1966, J PHYSIOL-LONDON, V186, P295, DOI 10.1113/jphysiol.1966.sp008035; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Holtmann B, 2005, J NEUROSCI, V25, P1778, DOI 10.1523/JNEUROSCI.4249-04.2005; Hume JR, 2009, VASC PHARMACOL, V50, P89, DOI 10.1016/j.vph.2008.11.001; INESI G, 1989, J BIOL CHEM, V264, P5929; KLEIN MG, 1988, BIOPHYS J, V53, P971, DOI 10.1016/S0006-3495(88)83178-3; Knollmann BC, 2006, J CLIN INVEST, V116, P2510, DOI 10.1172/JCI29128; Lan W, 2009, CELL CALCIUM, V45, P474, DOI 10.1016/j.ceca.2009.03.006; Launikonis BS, 2006, P NATL ACAD SCI USA, V103, P2982, DOI 10.1073/pnas.0511252103; LEBERER E, 1986, BIOCHEM J, V239, P295, DOI 10.1042/bj2390295; LEBERER E, 1988, EUR J BIOCHEM, V174, P247, DOI 10.1111/j.1432-1033.1988.tb14090.x; Liu YW, 1997, AM J PHYSIOL-CELL PH, V272, pC1919, DOI 10.1152/ajpcell.1997.272.6.C1919; MAKINOSE M, 1965, BIOCHEM Z, V343, P360; Massett MP, STRAIN DEPENDENT DIF, pR1006; MENDEZ J, 1960, METABOLISM, V9, P184; Murphy RM, 2009, J PHYSIOL-LONDON, V587, P443, DOI 10.1113/jphysiol.2008.163162; Olojo RO, 2011, BIOPHYS J, V100, P2367, DOI 10.1016/j.bpj.2011.04.012; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini Cecilia MQ, 2007, J PHYSL, DOI [10.1113/jphysiol, DOI 10.1113/JPHYSIOL]; PAPE PC, 1993, J GEN PHYSIOL, V102, P295, DOI 10.1085/jgp.102.2.295; Payne ET, 2006, MUSCLE NERVE, V33, P66, DOI 10.1002/mus.20436; Pizarro G, 2004, J GEN PHYSIOL, V124, P239, DOI 10.1085/jgp.200409071; Prosser BL, 2009, J PHYSIOL-LONDON, V587, P4523, DOI 10.1113/jphysiol.2009.177238; Prosser BL, 2009, J PHYSIOL-LONDON, V587, P4543, DOI 10.1113/jphysiol.2009.177246; Royer L, 2008, J PHYSIOL-LONDON, V586, P4609, DOI 10.1113/jphysiol.2008.157990; Royer L, 2010, J GEN PHYSIOL, V136, P325, DOI 10.1085/jgp.201010454; Rudolf R, 2006, J CELL BIOL, V173, P187, DOI 10.1083/jcb.200601160; SCHNEIDER MF, 1987, J PHYSIOL-LONDON, V392, P167, DOI 10.1113/jphysiol.1987.sp016775; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; Shirokova N, 1996, J GEN PHYSIOL, V107, P1, DOI 10.1085/jgp.107.1.1; SIMON BJ, 1988, BIOPHYS J, V54, P1159, DOI 10.1016/S0006-3495(88)83050-9; Stack EC, 2005, J COMP NEUROL, V490, P354, DOI 10.1002/cne.20680; Sztretye M, 2011, J GEN PHYSIOL, V138, P231, DOI 10.1085/jgp.201010592; Treves S, 2009, J PHYSL; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Wang ZM, 1999, BIOPHYS J, V77, P2709, DOI 10.1016/S0006-3495(99)77104-3; WEBER A, 1971, J GEN PHYSIOL, V57, P50, DOI 10.1085/jgp.57.1.50; Williams JH, 1998, J APPL PHYSIOL, V85, P619, DOI 10.1152/jappl.1998.85.2.619; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050; Ziman AP, 2010, BIOPHYS J, V99, P2705, DOI 10.1016/j.bpj.2010.08.032	56	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27036	10.1371/journal.pone.0027036	http://dx.doi.org/10.1371/journal.pone.0027036			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164205	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400005
J	Pereira, LA; Wong, MS; Lim, SM; Sides, A; Stanley, EG; Elefanty, AG				Pereira, Lloyd A.; Wong, Michael S.; Lim, Sue Mei; Sides, Alexandra; Stanley, Edouard G.; Elefanty, Andrew G.			Brachyury and Related Tbx Proteins Interact with the Mixl1 Homeodomain Protein and Negatively Regulate Mixl1 Transcriptional Activity	PLOS ONE			English	Article							T-BOX GENES; EMBRYONIC STEM-CELLS; PRIMITIVE STREAK; DIFFERENTIATING MOUSE; EXPRESSION ANALYSIS; ENDODERM FORMATION; VENTRAL MESODERM; XENOPUS; EOMESODERMIN; PATTERN	Mixl1 is a homeodomain transcription factor required for mesoderm and endoderm patterning during mammalian embryogenesis. Despite its crucial function in development, co-factors that modulate the activity of Mixl1 remain poorly defined. Here we report that Mixl1 interacts physically and functionally with the T-box protein Brachyury and related members of the T-box family of transcription factors. Transcriptional and protein analyses demonstrated overlapping expression of Mixl1 and Brachyury during embryonic stem cell differentiation. In vitro protein interaction studies showed that the Mixl1 with Brachyury associated via their DNA-binding domains and gel shift assays revealed that the Brachyury T-box domain bound to Mixl1-DNA complexes. Furthermore, luciferase reporter experiments indicated that association of Mixl1 with Brachyury and related T-box factors inhibited the transactivating potential of Mixl1 on the Gsc and Pdgfr alpha promoters. Our results indicate that the activity of Mixl1 can be modulated by protein-protein interactions and that T-box factors can function as negative regulators of Mixl1 activity.	[Pereira, Lloyd A.] Univ Melbourne, Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic, Australia; [Pereira, Lloyd A.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Wong, Michael S.; Lim, Sue Mei; Sides, Alexandra; Stanley, Edouard G.; Elefanty, Andrew G.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Monash University	Pereira, LA (corresponding author), Univ Melbourne, Peter MacCallum Canc Ctr, Differentiat & Transcript Lab, Melbourne, Vic, Australia.	ed.stanley@monash.edu; andrew.elefanty@monash.edu	Stanley, Ed G/A-2985-2013; Elefanty, Andrew G/A-6066-2008	Stanley, Ed G/0000-0002-6389-3665; Lim, Sue Mei/0000-0001-8287-5756; Elefanty, Andrew/0000-0001-6448-8314	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council (NHMRC) of Australia	Australian Stem Cell Centre; Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Stem Cell Centre (www.stemcellcentre.com.au), the Juvenile Diabetes Research Foundation (JDRF)(www.jdrf.org) and the National Health and Medical Research Council (NHMRC) of Australia (www.nhmrc.gov.au). AGE and EGS are Senior Research Fellows of the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; Barnett LD, 2000, METH MOL B, V158, P65; BLUM M, 1994, GENOMICS, V21, P388, DOI 10.1006/geno.1994.1281; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Casey ES, 1999, DEVELOPMENT, V126, P4193; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; CHO KWY, 1991, CELL, V67, P1111, DOI 10.1016/0092-8674(91)90288-A; Conlon FL, 2001, DEVELOPMENT, V128, P3749; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fischer A, 2005, MOL CELL BIOL, V25, P8960, DOI 10.1128/MCB.25.20.8960-8970.2005; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; Hart AH, 2002, DEVELOPMENT, V129, P3597; HERRMANN BG, 1991, DEVELOPMENT, V113, P913; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kasahara H, 2001, J BIOL CHEM, V276, P4570, DOI 10.1074/jbc.M004995200; Kikuchi Y, 2000, GENE DEV, V14, P1279; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kondow A, 2007, BIOCHEM BIOPH RES CO, V359, P959, DOI 10.1016/j.bbrc.2007.05.211; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Latinkic BV, 1999, DEVELOPMENT, V126, P1769; Leconte L, 2004, J BIOL CHEM, V279, P47272, DOI 10.1074/jbc.M406624200; Lemaire P, 1998, DEVELOPMENT, V125, P2371; LIM SM, 2009, STEM CELLS; Mead PE, 1996, NATURE, V382, P357, DOI 10.1038/382357a0; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mohn D, 2003, DEV DYNAM, V226, P446, DOI 10.1002/dvdy.10263; Mossman AK, 2005, STEM CELLS DEV, V14, P656, DOI 10.1089/scd.2005.14.656; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; PEREIRA LA, 2011, STEM CELL RES; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; RASHBASS P, 1991, NATURE, V353, P348, DOI 10.1038/353348a0; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; ROSA FM, 1989, CELL, V57, P965, DOI 10.1016/0092-8674(89)90335-8; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sahr K, 2002, GENE, V291, P135, DOI 10.1016/S0378-1119(02)00590-5; Showell C, 2004, DEV DYNAM, V229, P201, DOI 10.1002/dvdy.10480; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tada M, 1998, DEVELOPMENT, V125, P3997; Tam PPL, 2007, DEVELOPMENT, V134, P251, DOI 10.1242/dev.02724; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Willey S, 2006, BLOOD, V107, P3122, DOI 10.1182/blood-2005-10-4120; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON V, 1993, DEVELOPMENT, V117, P1321; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WILSON V, 1995, DEVELOPMENT, V121, P877; Zhang HL, 2009, STEM CELLS, V27, P2884, DOI 10.1002/stem.203	63	19	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28394	10.1371/journal.pone.0028394	http://dx.doi.org/10.1371/journal.pone.0028394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164283	Green Published, gold			2022-12-27	WOS:000298171400084
J	Syed, K; Porollo, A; Lam, YW; Yadav, JS				Syed, Khajamohiddin; Porollo, Aleksey; Lam, Ying Wai; Yadav, Jagjit S.			A Fungal P450 (CYP5136A3) Capable of Oxidizing Polycyclic Aromatic Hydrocarbons and Endocrine Disrupting Alkylphenols: Role of Trp(129) and Leu(324)	PLOS ONE			English	Article							CYTOCHROME-P450 3A4; HETEROLOGOUS EXPRESSION; PYRENE DEGRADATION; ARENE OXIDES; BISPHENOL-A; METABOLISM; PHENANTHRENE; NONYLPHENOL; OXIDATION; BIOTRANSFORMATION	The model white rot fungus Phanerochaete chrysosporium, which is known for its versatile pollutant-biodegradation ability, possesses an extraordinarily large repertoire of P450 monooxygenases in its genome. However, the majority of these P450s have hitherto unknown function. Our initial studies using a genome-wide gene induction strategy revealed multiple P450s responsive to individual classes of xenobiotics. Here we report functional characterization of a cytochrome P450 monooxygenase, CYP5136A3 that showed common responsiveness and catalytic versatility towards endocrine-disrupting alkylphenols (APs) and mutagenic/carcinogenic polycyclic aromatic hydrocarbons (PAHs). Using recombinant CYP5136A3, we demonstrated its oxidation activity towards APs with varying alkyl side-chain length (C3-C9), in addition to PAHs (3-4 ring size). AP oxidation involves hydroxylation at the terminal carbon of the alkyl side-chain (v-oxidation). Structure-activity analysis based on a 3D model indicated a potential role of Trp(129) and Leu(324) in the oxidation mechanism of CYP5136A3. Replacing Trp(129) with Leu (W129L) and Phe (W129F) significantly diminished oxidation of both PAHs and APs. The W129L mutation caused greater reduction in phenanthrene oxidation (80%) as compared to W129F which caused greater reduction in pyrene oxidation (88%). Almost complete loss of oxidation of C3-C8 APs (83-90%) was observed for the W129L mutation as compared to W129F (28-41%). However, the two mutations showed a comparable loss (60-67%) in C9-AP oxidation. Replacement of Leu(324) with Gly (L324G) caused 42% and 54% decrease in oxidation activity towards phenanthrene and pyrene, respectively. This mutation also caused loss of activity towards C3-C8 APs (20-58%), and complete loss of activity toward nonylphenol (C9-AP). Collectively, the results suggest that Trp(129) and Leu(324) are critical in substrate recognition and/or regio-selective oxidation of PAHs and APs. To our knowledge, this is the first report on an AP-oxidizing P450 from fungi and on structure-activity relationship of a eukaryotic P450 for fused-ring PAHs (phenanthrene and pyrene) and AP substrates.	[Syed, Khajamohiddin; Porollo, Aleksey; Lam, Ying Wai; Yadav, Jagjit S.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Syed, K (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Jagjit.Yadav@uc.edu	Syed, Khajamohiddin/L-8774-2013; Yadav, Jagjit S./AAN-8805-2020	Syed, Khajamohiddin/0000-0002-1497-3570; Yadav, Jagjit S./0000-0001-5036-3609; Porollo, Alexey/0000-0002-3202-5099	NIH's National Institute of Environmental Health Science (NIEHS) [R01ES10210, R01 ES015543]; Center for Environmental Genetics (CEG); NIEHS [P30-ES006096]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES010210, R01ES015543] Funding Source: NIH RePORTER	NIH's National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Environmental Genetics (CEG); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work was supported by the NIH's National Institute of Environmental Health Science (NIEHS) grants R01ES10210 and R01 ES015543 to JSY. This work was also supported in part by the Next Generation Biomedical Investigator Award to AP by the Center for Environmental Genetics (CEG), which is funded by NIEHS (P30-ES006096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezalel L, 1996, APPL ENVIRON MICROB, V62, P2554, DOI 10.1128/AEM.62.7.2554-2559.1996; BOYLAND E, 1964, BIOCHEM J, V90, P391, DOI 10.1042/bj0900391; BRUICE PY, 1976, J AM CHEM SOC, V98, P2965, DOI 10.1021/ja00426a048; Cabana H, 2007, CHEMOSPHERE, V67, P770, DOI 10.1016/j.chemosphere.2006.10.037; Capotorti G, 2004, BIODEGRADATION, V15, P79, DOI 10.1023/B:BIOD.0000015612.10481.e6; CERNIGLIA CE, 1989, APPL ENVIRON MICROB, V55, P2275, DOI 10.1128/AEM.55.9.2275-2279.1989; CERNIGLIA CE, 1986, CHEM-BIOL INTERACT, V57, P203, DOI 10.1016/0009-2797(86)90038-4; Cerniglia CE, 1997, J IND MICROBIOL BIOT, V19, P324, DOI 10.1038/sj.jim.2900459; CHATURAPIT S, 1978, BIOCHEM PHARMACOL, V27, P1865, DOI 10.1016/0006-2952(78)90034-5; Cirja M, 2006, ENVIRON SCI TECHNOL, V40, P6131, DOI 10.1021/es060668z; Coldham NG, 1998, DRUG METAB DISPOS, V26, P347; CORTI A, 1995, ENVIRON POLLUT, V90, P83, DOI 10.1016/0269-7491(94)00080-W; DALY JW, 1972, EXPERIENTIA, V28, P1129, DOI 10.1007/BF01946135; Deng P, 2010, CHEM RES TOXICOL, V23, P1617, DOI 10.1021/tx100223h; DeVore NM, 2008, DRUG METAB DISPOS, V36, P2582, DOI 10.1124/dmd.108.023770; Doddapaneni H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-92; Doddapaneni H, 2005, CURR MICROBIOL, V50, P292, DOI 10.1007/s00284-005-4480-2; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Domanski TL, 2001, BIOCHEMISTRY-US, V40, P10150, DOI 10.1021/bi010758a; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Fickers P, 2005, FEMS YEAST RES, V5, P527, DOI 10.1016/j.femsyr.2004.09.004; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guengerich FP, 1989, PRINCIPLES METHODS T, P777; Hammel KE, 1995, ENVIRON HEALTH PERSP, V103, P41, DOI 10.2307/3432477; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; He YA, 2003, ARCH BIOCHEM BIOPHYS, V409, P92, DOI 10.1016/S0003-9861(02)00484-8; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ieda T, 2005, ENVIRON SCI TECHNOL, V39, P7202, DOI 10.1021/es050568d; Iida Y, 2008, J MASS SPECTROM SOC, V56, P215; Jacob J, 1996, ENVIRON TOXICOL PHAR, V1, P1, DOI 10.1016/1382-6689(95)00003-8; JACOB J, 1982, TOXICOLOGY, V25, P333, DOI 10.1016/0300-483X(82)90111-1; JERINA DM, 1976, J AM CHEM SOC, V98, P5988, DOI 10.1021/ja00435a035; Johnston JB, 2011, ARCH BIOCHEM BIOPHYS, V507, P86, DOI 10.1016/j.abb.2010.08.011; Junghanns C, 2005, MICROBIOL-SGM, V151, P45, DOI 10.1099/mic.0.27431-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan KK, 2002, MOL PHARMACOL, V61, P495, DOI 10.1124/mol.61.3.495; Kim YD, 2004, ENVIRON RES, V94, P262, DOI 10.1016/S0013-9351(03)00134-8; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martin C, 2009, APPL ENVIRON MICROB, V75, P4398, DOI 10.1128/AEM.00139-09; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; Ning D, 2005, J BIOCHEM MOL BIOL, V38, P294; NORDQVIST M, 1981, MOL PHARMACOL, V19, P168; Ohe T, 2000, DRUG METAB DISPOS, V28, P110; OKAMOTO H, 1981, CANCER LETT, V11, P215, DOI 10.1016/0304-3835(81)90110-5; PASZCZYNSKI A, 1995, BIOTECHNOL PROGR, V11, P368, DOI 10.1021/bp00034a002; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Porollo A, 2010, NUCLEIC ACIDS RES, V38, pW662, DOI 10.1093/nar/gkq445; Rehmann K, 1998, CHEMOSPHERE, V36, P2977, DOI 10.1016/S0045-6535(97)10240-5; Rozalska S, 2010, J HAZARD MATER, V180, P323, DOI 10.1016/j.jhazmat.2010.04.034; Sack U, 1997, APPL ENVIRON MICROB, V63, P3919, DOI 10.1128/AEM.63.10.3919-3925.1997; Sack U, 1997, APPL ENVIRON MICROB, V63, P2906, DOI 10.1128/AEM.63.7.2906-2909.1997; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schober W, 2010, CHEM-BIOL INTERACT, V183, P57, DOI 10.1016/j.cbi.2009.09.008; Sharma VK, 2009, J ENVIRON SCI HEAL A, V44, P423, DOI 10.1080/10934520902719704; Shimada T, 2006, DRUG METAB PHARMACOK, V21, P257, DOI 10.2133/dmpk.21.257; SHOU MS, 1994, CANCER LETT, V83, P305, DOI 10.1016/0304-3835(94)90334-4; SOLBAKKEN JE, 1981, COMP BIOCHEM PHYS C, V70, P21, DOI 10.1016/0306-4492(81)90073-3; Subramanian V, 2008, ENZYME MICROB TECH, V43, P205, DOI 10.1016/j.enzmictec.2007.09.001; Subramanian V, 2009, APPL ENVIRON MICROB, V75, P5570, DOI 10.1128/AEM.02942-08; SUTHERLAND JB, 1991, APPL ENVIRON MICROB, V57, P3310, DOI 10.1128/AEM.57.11.3310-3316.1991; Syed K, 2011, ARCH BIOCHEM BIOPHYS, V509, P26, DOI 10.1016/j.abb.2011.02.023; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Tezuka Y, 2007, J HEALTH SCI, V53, P552, DOI 10.1248/jhs.53.552; Thibaut R, 2002, AQUAT TOXICOL, V56, P177, DOI 10.1016/S0166-445X(01)00204-1; Vallini G, 2001, INT BIODETER BIODEGR, V47, P133, DOI 10.1016/S0964-8305(01)00040-3; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Wunder T, 1997, ARCH MICROBIOL, V167, P310, DOI 10.1007/s002030050449; Yadav JS, 2001, BIODEGRADATION, V12, P443, DOI 10.1023/A:1015056530264; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200	71	47	49	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28286	10.1371/journal.pone.0028286	http://dx.doi.org/10.1371/journal.pone.0028286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164262	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400063
J	Klitzman, R				Klitzman, Robert			The Ethics Police?: IRBs' Views Concerning Their Power	PLOS ONE			English	Article							MULTICENTER	Background: In recent years, tensions between IRBs and principal investigators (PIs) have risen, posing the needs to understand these conflicts, their underlying causes, and possible solutions. Researchers frequently complain about IRBs, but how IRBs perceive and respond to these criticisms is unclear. Methods: I conducted in-depth, semi-structured interviews of two hours each with 46 chairs, administrators, and members. I contacted the leadership of 60 IRBs around the country (every fourth one in the list of the top 240 institutions by NIH funding) and interviewed IRB leaders from 34 of these institutions (response rate = 55%). Results: Interviewees suggest that IRBs and PIs may view the nature and causes of these conflicts very differently and misunderstand each other, exacerbating tensions. Interviewees often recognized that they were seen by PIs as having power, but many IRBs saw themselves as not having it (e.g., because they are "merely following the regulations,'' and their process is "open,'' impersonal and unbiased, and they are themselves subject to higher administrative agencies), or as having it, but feeling it is small, and/or justified (e.g., because it is based on overriding goals and "the community values,'' and IRBs are trying to help PIs). Questions emerge as to whether IRBs do or should have power, and if so, what kind, how much, and when. Several factors may affect these tensions. Conclusions: This study, the first to explore how IRBs perceive and understand conflicts and power relationships with PIs, suggests how IRBs and PIs may differ in viewing their respective roles and relationships, exacerbating tensions. These issues have critical implications for IRBs and PIs-to enhance their awareness and understanding of these conflicts (e.g., that IRBs may have discretionary power) and the underlying causes involved, and for increasing attention to research, practice, and policy concerning these areas of IRB functioning and interactions with PIs.	Columbia Univ, Dept Psychiat, New York, NY 10027 USA	Columbia University	Klitzman, R (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	RLK2@columbia.edu			NIH [R01-NG04214]; National Library of Medicine [5-G13-LM009996-02]; NATIONAL LIBRARY OF MEDICINE [G13LM009996] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The NIH (R01-NG04214) and the National Library of Medicine (5-G13-LM009996-02) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AH, 1996, J MED ETHICS, V22, P263, DOI 10.1136/jme.22.5.263; Aristotle, 1981, POLITICS, p1279b; Bell J, 1998, FINAL REPORT EVALUAT; Burris S, 2008, REGUL GOV, V2, P65, DOI 10.1111/j.1748-5991.2007.00025.x; Burris S, 2006, J EMPIR RES HUM RES, V1, P39, DOI 10.1525/jer.2006.1.2.39; Department of Health and Human Services, 2011, FED REGISTER, V76, P44512; Dziak K, 2005, HEALTH SERV RES, V40, P279, DOI 10.1111/j.1475-6773.2005.00353.x; Emanuel EJ, 2011, NEW ENGL J MED, V365, P1145, DOI 10.1056/NEJMsb1106942; Fleischman Alan R, 2005, Trans Am Clin Climatol Assoc, V116, P91; Geertz Clifford, 1973, INTERPRETATION CULTU; Greene SM, 2006, J CLIN EPIDEMIOL, V59, P784, DOI 10.1016/j.jclinepi.2005.11.018; Gunsalus CK, 2006, SCIENCE, V312, P1441, DOI 10.1126/science.1121479; Hamburger P, 2004, SUPREME COURT REV, P271; Hamilton Alexander, 2010, FEDERALIST PAPERS; Keith-Spiegel P, 2005, ETHICS BEHAV, V15, P339, DOI 10.1207/s15327019eb1504_5; Keith-Spiegel P, 2006, J EMPIR RES HUM RES, V1, P67, DOI 10.1525/jer.2006.1.1.67; KLITZMAN R, 2011, DEV WORLD B IN PRESS; KLITZMAN R, 2011, PLOS ONE IN PRESS; KLITZMAN R, 2011, J LAW MED E IN PRESS; KLITZMAN R, 2011, AM J BIOETH IN PRESS; Klitzman R., 2011, ACAD MED IN PRESS; Klitzman R, 2011, BMC MED ETHICS, V12, DOI 10.1186/1472-6939-12-13; Koerner AF, 2005, J APPL COMMUN RES, V33, P231, DOI 10.1080/00909880500149395; McWilliams R, 2003, JAMA-J AM MED ASSOC, V290, P360, DOI 10.1001/jama.290.3.360; Menikoff J, 2010, NEW ENGL J MED, V363, P1591, DOI 10.1056/NEJMp1005101; SMITH DA, 1984, J CRIM LAW CRIM, V75, P234, DOI 10.2307/1143211; Strauss A., 1990, BASICS QUALITATIVE R	27	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28773	10.1371/journal.pone.0028773	http://dx.doi.org/10.1371/journal.pone.0028773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22174893	Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300025
J	Li, AL; Zhang, RZ; Pan, L; Tang, LC; Zhao, GY; Zhu, MZ; Chu, JF; Sun, XH; Wei, B; Zhang, XQ; Jia, JZ; Mao, L				Li, Aili; Zhang, Rongzhi; Pan, Lei; Tang, Lichuan; Zhao, Guangyao; Zhu, Mingzhu; Chu, Jinfang; Sun, Xiaohong; Wei, Bo; Zhang, Xiangqi; Jia, Jizeng; Mao, Long			Transcriptome Analysis of H2O2-Treated Wheat Seedlings Reveals a H2O2-Responsive Fatty Acid Desaturase Gene Participating in Powdery Mildew Resistance	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; EARLY H2O2 ACCUMULATION; PROGRAMMED CELL-DEATH; NEAR-ISOGENIC LINES; HYDROGEN-PEROXIDE; DISEASE RESISTANCE; SIGNALING PATHWAYS; JASMONIC-ACID; ARABIDOPSIS-THALIANA; SALICYLIC-ACID	Hydrogen peroxide (H2O2) plays important roles in plant biotic and abiotic stress responses. However, the effect of H2O2 stress on the bread wheat transcriptome is still lacking. To investigate the cellular and metabolic responses triggered by H2O2, we performed an mRNA tag analysis of wheat seedlings under 10 mM H2O2 treatment for 6 hour in one powdery mildew (PM) resistant (PmA) and two susceptible (Cha and Han) lines. In total, 6,156, 6,875 and 3,276 transcripts were found to be differentially expressed in PmA, Han and Cha respectively. Among them, 260 genes exhibited consistent expression patterns in all three wheat lines and may represent a subset of basal H2O2 responsive genes that were associated with cell defense, signal transduction, photosynthesis, carbohydrate metabolism, lipid metabolism, redox homeostasis, and transport. Among genes specific to PmA, 'transport' activity was significantly enriched in Gene Ontology analysis. MapMan classification showed that, while both up-and down-regulations were observed for auxin, abscisic acid, and brassinolides signaling genes, the jasmonic acid and ethylene signaling pathway genes were all up-regulated, suggesting H2O2-enhanced JA/Et functions in PmA. To further study whether any of these genes were involved in wheat PM response, 19 H2O2-responsive putative defense related genes were assayed in wheat seedlings infected with Blumeria graminis f. sp. tritici (Bgt). Eight of these genes were found to be co-regulated by H2O2 and Bgt, among which a fatty acid desaturase gene TaFAD was then confirmed by virus induced gene silencing (VIGS) to be required for the PM resistance. Together, our data presents the first global picture of the wheat transcriptome under H2O2 stress and uncovers potential links between H2O2 and Bgt responses, hence providing important candidate genes for the PM resistance in wheat.	[Li, Aili; Zhang, Rongzhi; Pan, Lei; Tang, Lichuan; Zhao, Guangyao; Zhu, Mingzhu; Jia, Jizeng; Mao, Long] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, MOA Key Lab Germplasm & Biotechnol, Beijing, Peoples R China; [Chu, Jinfang; Sun, Xiaohong] Chinese Acad Sci, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Inst Genet & Dev Biol, Beijing, Peoples R China; [Wei, Bo; Zhang, Xiangqi] Chinese Acad Sci, State Key Lab Plant Cell & Chromosome Engn, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Li, AL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, MOA Key Lab Germplasm & Biotechnol, Beijing, Peoples R China.	maolong@caas.net.cn			Ministry of Science and Technology [2009AA02Z307]; National Transgenic Key Project [2009ZX08009-009B, 2011ZX08009-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Transgenic Key Project	This work is supported in part by the National "863" program of Ministry of Science and Technology (#2009AA02Z307), and the National Transgenic Key Project (#2009ZX08009-009B and #2011ZX08009-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An QL, 2006, NEW PHYTOL, V172, P563, DOI 10.1111/j.1469-8137.2006.01844.x; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Anthony RG, 2004, EMBO J, V23, P572, DOI 10.1038/sj.emboj.7600068; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Blee E, 2002, TRENDS PLANT SCI, V7, P315, DOI 10.1016/S1360-1385(02)02290-2; Bouchez O, 2007, PLANT PHYSIOL, V145, P465, DOI 10.1104/pp.107.106302; BOYD L, 2009, NEW PHYTOL, V184, P473; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Chain F, 2009, MOL PLANT MICROBE IN, V22, P1323, DOI 10.1094/MPMI-22-11-1323; Chang CCC, 2004, PLANT J, V38, P499, DOI 10.1111/j.1365-313X.2004.02066.x; Chaturvedi R, 2008, PLANT J, V54, P106, DOI 10.1111/j.1365-313X.2007.03400.x; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Coram TE, 2008, MOL PLANT PATHOL, V9, P479, DOI [10.1111/j.1364-3703.2008.00476.x, 10.1111/J.1364-3703.2008.00476.X]; Costa A, 2010, PLANT J, V62, P760, DOI 10.1111/j.1365-313X.2010.04190.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Desmond OJ, 2008, PHYSIOL MOL PLANT P, V73, P40, DOI 10.1016/j.pmpp.2008.12.001; Despres C, 2003, PLANT CELL, V15, P2181, DOI 10.1105/tpc.012849; Fryer MJ, 2003, PLANT J, V33, P691, DOI 10.1046/j.1365-313X.2003.01656.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; HOEN P, 2008, NUCLEIC ACIDS RES, P1; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; Jiang CJ, 2009, MOL PLANT MICROBE IN, V22, P820, DOI 10.1094/MPMI-22-7-0820; Kachroo A, 2003, PLANT CELL, V15, P2952, DOI 10.1105/tpc.017301; Kachroo A, 2008, MOL PLANT MICROBE IN, V21, P564, DOI 10.1094/MPMI-21-5-0564; Kachroo P, 2005, PLANT PHYSIOL, V139, P1717, DOI 10.1104/pp.105.071662; Kachroo P, 2003, MOL PLANT MICROBE IN, V16, P1022, DOI 10.1094/MPMI.2003.16.11.1022; Kachroo P, 2001, P NATL ACAD SCI USA, V98, P9448, DOI 10.1073/pnas.151258398; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Laudert D, 1998, PLANT J, V15, P675, DOI 10.1046/j.1365-313x.1998.00245.x; Lenucci MS, 2009, PLANT SIGNAL BEHAV, V4, P228, DOI 10.4161/psb.4.3.7883; Leshem Y, 2006, P NATL ACAD SCI USA, V103, P18008, DOI 10.1073/pnas.0604421103; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li AL, 2005, PLANT PATHOL, V54, P308, DOI 10.1111/j.1365-3059.2005.01173.x; Liu Y, 2005, SCI CHINA SER C, V48, P202, DOI 10.1360/04yc0088; Loggini B, 1999, PLANT PHYSIOL, V119, P1091, DOI 10.1104/pp.119.3.1091; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mackerness SAH, 1999, PLANT CELL ENVIRON, V22, P1413, DOI 10.1046/j.1365-3040.1999.00499.x; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; MATSUDA Y, 1994, BIOSCI BIOTECH BIOCH, V58, P906, DOI 10.1271/bbb.58.906; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Montillet JL, 2005, PLANT PHYSIOL, V138, P1516, DOI 10.1104/pp.105.059907; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Muhlenbock P, 2007, PLANT CELL, V19, P3819, DOI 10.1105/tpc.106.048843; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Overmyer K, 2005, PLANT PHYSIOL, V137, P1092, DOI 10.1104/pp.104.055681; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pellinen R, 1999, PLANT J, V20, P349, DOI 10.1046/j.1365-313X.1999.00613.x; PRASAD TK, 1994, PLANT CELL, V6, P65, DOI 10.1105/tpc.6.1.65; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thomma BPHJ, 2000, PLANT PHYSIOL BIOCH, V38, P421, DOI 10.1016/S0981-9428(00)00756-7; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x; Vanacker H, 2000, PLANT PHYSIOL, V123, P1289, DOI 10.1104/pp.123.4.1289; Vanderauwera S, 2005, PLANT PHYSIOL, V139, P806, DOI 10.1104/pp.105.065896; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Zeng LR, 2006, CELL RES, V16, P413, DOI 10.1038/sj.cr.7310053; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x; Zhou RH, 2005, THEOR APPL GENET, V110, P640, DOI 10.1007/s00122-004-1889-0	78	26	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28810	10.1371/journal.pone.0028810	http://dx.doi.org/10.1371/journal.pone.0028810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174904	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600040
J	Li, ZK; Musich, PR; Serrano, MA; Dong, ZP; Zou, Y				Li, Zhengke; Musich, Phillip R.; Serrano, Moises A.; Dong, Zhiping; Zou, Yue			XPA-Mediated Regulation of Global Nucleotide Excision Repair by ATR Is p53-Dependent and Occurs Primarily in S-Phase	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; CYCLOBUTANE PYRIMIDINE DIMERS; XERODERMA-PIGMENTOSUM; INDUCED PHOSPHORYLATION; P53; CHECKPOINTS; EFFICIENT; STRAND; RECOGNITION; RECRUITMENT	Cell cycle checkpoints play an important role in regulation of DNA repair pathways. However, how the regulation occurs throughout the cell cycle remains largely unknown. Here we demonstrate that nucleotide excision repair (NER) is regulated by the ATR/p53 checkpoint via modulation of XPA nuclear import and that this regulation occurs in a cell cycle-dependent manner. We show that depletion of p53 abrogated the UV-induced nuclear translocation of XPA, while silencing of Chk1 or MAPKAP Kinase-2 (MK2) had no effect. Inhibition of p53 transcriptional activities and silencing of p53-Ser15 phosphorylation also reduced the damage-induced XPA nuclear import. Furthermore, in G1-phase cells the majority of XPA remained in the cytoplasm even after UV treatment. By contrast, while most of the XPA in S-phase cells was initially located in the cytoplasm before DNA damage, UV irradiation stimulated bulk import of XPA into the nucleus. Interestingly, the majority of XPA molecules always were located in the nucleus in G2-phase cells no matter whether the DNA was damaged or not. Consistently, the UV-induced Ser15 phosphorylation of p53 occurred mainly in S-phase cells, and removal of cyclobutane pyrimidine dimers (CPDs) was much more efficient in S-phase cells than in G1-phase cells. Our results suggest that upon DNA damage in S phase, NER could be regulated by the ATR/p53-dependent checkpoint via modulation of the XPA nuclear import process. In contrast, the nuclear import of XPA in G(1) or G(2) phase appears to be largely independent of DNA damage and p53.	[Li, Zhengke; Musich, Phillip R.; Serrano, Moises A.; Dong, Zhiping; Zou, Yue] E Tennessee State Univ, Dept Biochem & Mol Biol, JH Quillen Coll Med, Johnson City, TN 37614 USA	East Tennessee State University	Li, ZK (corresponding author), E Tennessee State Univ, Dept Biochem & Mol Biol, JH Quillen Coll Med, Johnson City, TN 37614 USA.	zouy@etsu.edu	Li, Zhengke/J-8527-2016; Zou, Yue/ABA-8429-2020	Li, Zhengke/0000-0001-5560-343X; Serrano, Moises/0000-0002-1037-9304; Musich, Phillip/0000-0001-8816-4242	National Institutes of Health [CA86927, GM083307]; NATIONAL CANCER INSTITUTE [R56CA086927, R01CA086927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM083307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grants: CA86927 and GM083307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Besaratinia A, 2011, FASEB J, V25, P3079, DOI 10.1096/fj.11-187336; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Chen J, 2011, CELL CYCLE, V10, P1287, DOI 10.4161/cc.10.8.15341; de Lima-Bessa KM, 2008, DNA REPAIR, V7, P303, DOI 10.1016/j.dnarep.2007.11.003; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Fan W, 2010, MOL CELL, V39, P247, DOI 10.1016/j.molcel.2010.07.006; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Helt CE, 2005, J BIOL CHEM, V280, P1186, DOI 10.1074/jbc.M410873200; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; KRAEMER KH, 1994, ARCH DERMATOL, V130, P1018, DOI 10.1001/archderm.130.8.1018; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niida H, 2006, MUTAGENESIS, V21, P3, DOI 10.1093/mutage/gei063; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Park CJ, 2006, FEBS J, V273, P1600, DOI 10.1111/j.1742-4658.2006.05189.x; Rasey JS, 2002, J NUCL MED, V43, P1210; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; VREESWIJK MPG, 1994, J BIOL CHEM, V269, P31858; Wang QE, 2003, DNA REPAIR, V2, P483, DOI 10.1016/S1568-7864(03)00002-8; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Yang ZG, 2006, BIOCHEMISTRY-US, V45, P15921, DOI 10.1021/bi061626q; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	46	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28326	10.1371/journal.pone.0028326	http://dx.doi.org/10.1371/journal.pone.0028326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174788	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600011
J	Shi, DS; Li, YD; Cabrera-Luque, J; Jin, ZM; Yu, XL; Zhao, GX; Haskins, N; Allewell, NM; Tuchman, M				Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Jin, Zhongmin; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Allewell, Norma M.; Tuchman, Mendel			A Novel N-Acetylglutamate Synthase Architecture Revealed by the Crystal Structure of the Bifunctional Enzyme from Maricaulis maris	PLOS ONE			English	Article							L-GLUTAMATE KINASE; ARGININE-BIOSYNTHESIS; ESCHERICHIA-COLI; SWISS-MODEL; MOLECULAR REPLACEMENT; THERMOTOGA-MARITIMA; PROTEIN-STRUCTURE; GNAT SUPERFAMILY; WEB SERVER; HOMOLOGY	Novel bifunctional N-acetylglutamate synthase/kinases (NAGS/K) that catalyze the first two steps of arginine biosynthesis and are homologous to vertebrate N-acetylglutamate synthase (NAGS), an essential cofactor-producing enzyme in the urea cycle, were identified in Maricaulis maris and several other bacteria. Arginine is an allosteric inhibitor of NAGS but not NAGK activity. The crystal structure of M. maris NAGS/K (mmNAGS/K) at 2.7 angstrom resolution indicates that it is a tetramer, in contrast to the hexameric structure of Neisseria gonorrhoeae NAGS. The quaternary structure of crystalline NAGS/K from Xanthomonas campestris (xcNAGS/K) is similar, and cross-linking experiments indicate that both mmNAGS/K and xcNAGS are tetramers in solution. Each subunit has an amino acid kinase (AAK) domain, which is likely responsible for N-acetylglutamate kinase (NAGK) activity and has a putative arginine binding site, and an N-acetyltransferase (NAT) domain that contains the putative NAGS active site. These structures and sequence comparisons suggest that the linker residue 291 may determine whether arginine acts as an allosteric inhibitor or activator in homologous enzymes in microorganisms and vertebrates. In addition, the angle of rotation between AAK and NAT domains varies among crystal forms and subunits within the tetramer. A rotation of 26 degrees is sufficient to close the predicted AcCoA binding site, thus reducing enzymatic activity. Since mmNAGS/K has the highest degree of sequence homology to vertebrate NAGS of NAGS and NAGK enzymes whose structures have been determined, the mmNAGS/K structure was used to develop a structural model of human NAGS that is fully consistent with the functional effects of the 14 missense mutations that were identified in NAGS-deficient patients.	[Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Tuchman, Mendel] George Washington Univ, Med Genet Res Ctr, Washington, DC USA; [Shi, Dashuang; Li, Yongdong; Cabrera-Luque, Juan; Yu, Xiaolin; Zhao, Gengxiang; Haskins, Nantaporn; Tuchman, Mendel] George Washington Univ, Childrens Natl Med Ctr, Dept Integrat Syst Biol, Washington, DC USA; [Li, Yongdong] Gannan Normal Univ, Key Lab Organopharmaceut Chem, Ganzhou, Jiangxi, Peoples R China; [Jin, Zhongmin] Argonne Natl Lab, Adv Photon Source, SE Reg Collaborat Access Team, Argonne, IL 60439 USA; [Allewell, Norma M.] Univ Maryland, Coll Comp Math & Nat Sci, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Allewell, Norma M.] Univ Maryland, Dept Chem & Biochem, Coll Comp Math & Nat Sci, College Pk, MD 20742 USA	George Washington University; Children's National Health System; George Washington University; Gannan Normal University; United States Department of Energy (DOE); Argonne National Laboratory; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shi, DS (corresponding author), George Washington Univ, Med Genet Res Ctr, Washington, DC USA.	dshi@cnmcresearch.org		Shi, Dashuang/0000-0002-5491-1104	Public Health Service; National Institute of Diabetes, Digestive and Kidney Diseases [DK-DK064913, DK-067935]; National Institute of Child Health and Human Development [HD32652]; U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913, K01DK067935] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grants DK-DK064913 (MT) and DK-067935 (DS) from the National Institute of Diabetes, Digestive and Kidney Diseases and HD32652 from the National Institute of Child Health and Human Development. Use of the Advanced Photon Source was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burk DL, 2003, PROTEIN SCI, V12, P426, DOI 10.1110/ps.0233503; Caldovic L, 2004, J PEDIATR-US, V145, P552, DOI 10.1016/j.jpeds.2004.06.047; Caldovic L, 2007, HUM MUTAT, V28, P754, DOI 10.1002/humu.20518; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; DAVIES GE, 1970, P NATL ACAD SCI USA, V66, P651, DOI 10.1073/pnas.66.3.651; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errey JC, 2005, J BACTERIOL, V187, P3039, DOI 10.1128/JB.187.9.3039-3044.2005; Fernandez-Murga ML, 2004, J BACTERIOL, V186, P6142, DOI 10.1128/JB.186.18.6142-6149.2004; Gil F, 1999, ACTA CRYSTALLOGR D, V55, P1350, DOI 10.1107/S0907444999005351; Gil-Ortiz F, 2002, ACTA CRYSTALLOGR D, V58, P1892, DOI 10.1107/S0907444902013689; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Haskins Nantaporn, 2008, BMC Biochemistry, V9, P24, DOI 10.1186/1471-2091-9-24; He HZ, 2003, J MOL BIOL, V325, P1019, DOI 10.1016/S0022-2836(02)01284-6; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Marco-Marin C, 2005, J MOL BIOL, V352, P438, DOI 10.1016/j.jmb.2005.07.045; Marco-Marin C, 2007, J MOL BIOL, V367, P1431, DOI 10.1016/j.jmb.2007.01.073; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meyer PA, 2009, J BIOL CHEM, V284, P12933, DOI 10.1074/jbc.M809199200; Min L, 2009, J BIOL CHEM, V284, P4873, DOI 10.1074/jbc.M805348200; Mizuno Y, 2007, J BIOL CHEM, V282, P35733, DOI 10.1074/jbc.M707127200; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Qu Qiuhao, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-4; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2006, J MOL BIOL, V356, P695, DOI 10.1016/j.jmb.2005.11.079; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sancho-Vaello E, 2008, FEBS LETT, V582, P1081, DOI 10.1016/j.febslet.2008.02.060; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrodinger L., 2020, PYMOL; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi D, 2008, J BIOL CHEM, V283, P7176, DOI 10.1074/jbc.M707678200; Shi DS, 2006, ACTA CRYSTALLOGR F, V62, P1218, DOI 10.1107/S1744309106044101; Shi DS, 2005, ACTA CRYSTALLOGR F, V61, P676, DOI 10.1107/S1744309105018051; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tuchman M, 2008, PEDIATR RES, V64, P213, DOI 10.1203/PDR.0b013e318179454b; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Vetting MW, 2003, PROTEIN SCI, V12, P1954, DOI 10.1110/ps.03153703	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28825	10.1371/journal.pone.0028825	http://dx.doi.org/10.1371/journal.pone.0028825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174908	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600042
J	Tate, MLK; Chang, H; Moore, SR; Knothe, UR				Tate, Melissa L. Knothe; Chang, Hana; Moore, Shannon R.; Knothe, Ulf R.			Surgical Membranes as Directional Delivery Devices to Generate Tissue: Testing in an Ovine Critical Sized Defect Model	PLOS ONE			English	Article							BONE-TRANSPORT; ILIZAROV METHOD; CELL FATE; TIBIAL DEFECTS; PERIOSTEUM; LIMB; RECONSTRUCTION; FRACTURES; OSTEOINDUCTION; COMPLICATIONS	Purpose: Pluripotent cells residing in the periosteum, a bi-layered membrane enveloping all bones, exhibit a remarkable regenerative capacity to fill in critical sized defects of the ovine femur within two weeks of treatment. Harnessing the regenerative power of the periosteum appears to be limited only by the amount of healthy periosteum available. Here we use a substitute periosteum, a delivery device cum implant, to test the hypothesis that directional delivery of endogenous periosteal factors enhances bone defect healing. Methods: Newly adapted surgical protocols were used to create critical sized, middiaphyseal femur defects in four groups of five skeletally mature Swiss alpine sheep. Each group was treated using a periosteum substitute for the controlled addition of periosteal factors including the presence of collagen in the periosteum (Group 1), periosteum derived cells (Group 2), and autogenic periosteal strips (Group 3). Control group animals were treated with an isotropic elastomer membrane alone. We hypothesized that periosteal substitute membranes incorporating the most periosteal factors would show superior defect infilling compared to substitute membranes integrating fewer factors (i.e. Group 3>Group 2>Group 1>Control). Results: Based on micro-computed tomography data, bone defects enveloped by substitute periosteum enabling directional delivery of periosteal factors exhibit superior bony bridging compared to those sheathed with isotropic membrane controls (Group 3>Group 2>Group 1, Control). Quantitative histological analysis shows significantly increased de novo tissue generation with delivery of periosteal factors, compared to the substitute periosteum containing a collagen membrane alone (Group 1) as well as compared to the isotropic control membrane. Greatest tissue generation and maximal defect bridging was observed when autologous periosteal transplant strips were included in the periosteum substitute. Conclusion: Periosteum-derived cells as well as other factors intrinsic to periosteum play a key role for infilling of critical sized defects.	[Tate, Melissa L. Knothe; Chang, Hana; Moore, Shannon R.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Tate, Melissa L. Knothe] Case Western Reserve Univ, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Knothe, Ulf R.] Cleveland Clin, Dept Orthopaed Surg, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation	Tate, MLK (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	knothetate@case.edu	Knothe, Ulf/N-6545-2014; Knothe Tate, Melissa L./O-2086-2015	Knothe, Ulf/0000-0002-1406-6014; Knothe Tate, Melissa L./0000-0002-3552-2525	Case-Coulter Translational Research Partnership; Medtronic Fellowship; AO Foundation [F-07-99K]; Whitaker International Fellows and Scholars Program; Alexander von Humboldt Foundation	Case-Coulter Translational Research Partnership; Medtronic Fellowship; AO Foundation; Whitaker International Fellows and Scholars Program; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The surgical study was supported by the Case-Coulter Translational Research Partnership. Hana Chang was supported through a Medtronic Fellowship. Shannon Moore was supported in part through a grant from the AO Foundation (F-07-99K) and the Whitaker International Fellows and Scholars Program. Melissa Knothe Tate was supported in part through the Alexander von Humboldt Foundation's Fellowship for Senior Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282; Allen MR, 2004, BONE, V35, P1003, DOI 10.1016/j.bone.2004.07.014; ALONSO J, 1997, CLIN PLAST SURG, V18, P497; Arnsdorf EJ, 2009, TISSUE ENG PT A, V15, P2637, DOI [10.1089/ten.tea.2008.0244, 10.1089/ten.TEA.2008.0244]; Aronson J, 1997, J BONE JOINT SURG AM, V79A, P1243, DOI 10.2106/00004623-199708000-00019; Atesalp AS, 1998, INT ORTHOP, V22, P343, DOI 10.1007/s002640050274; Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003; DAGHER F, 1991, J BONE JOINT SURG BR, V73, P316, DOI 10.1302/0301-620X.73B2.2005164; DeCoster TA, 2004, J AM ACAD ORTHOP SUR, V12, P28, DOI 10.5435/00124635-200401000-00005; DECOSTER TA, 1992, CLIN ORTHOP RELAT R, V283, P116; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233; Gugenheim JJ, 1998, CLIN PLAST SURG, V25, P567; Knothe Tate ML, 2011, U.S. Patent No. US, Patent No. [US7879107 B2, 7879107, 7,879,107 B2]; KNOTHE U, 2005, WORLD J SURG ONCOL, V3, P5; Knothe UR, 2010, J BIOMECH, V43, P2728, DOI 10.1016/j.jbiomech.2010.06.026; Marsh DR, 1997, J BONE JOINT SURG BR, V79B, P273, DOI 10.1302/0301-620X.79B2.6636; McBride SH, 2011, J BIOMECH, V44, P1954, DOI 10.1016/j.jbiomech.2011.04.036; Meganck JA, 2009, BONE, V45, P1104, DOI 10.1016/j.bone.2009.07.078; Miller RM, 2011, T ORTHOP RES SOC, V36, P2213; NIELSEN FF, 1992, ACTA ORTHOP SCAND, V63, P66, DOI 10.3109/17453679209154853; Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010; PALEY D, 1990, CLIN ORTHOP RELAT R, P81; Paley D, 2000, J ORTHOP TRAUMA, V14, P76, DOI 10.1097/00005131-200002000-00002; Pavolini B, 2000, J Orthop Sci, V5, P108, DOI 10.1007/s007760050137; Polak WG, 2001, VASA-J VASCULAR DIS, V30, P138, DOI 10.1024/0301-1526.30.2.138; POLYZOIS D, 1997, ACTA ORHTOP SCAND  S, V275, P84; PROKUSKI LJ, 1994, ORTHOP CLIN N AM, V25, P753; Saleh M, 1999, BRIT MED BULL, V55, P870, DOI 10.1258/0007142991902682; SLOMKA R, CLIN ORTHOPAEDICS RE, V391, P115; Smrke D, 2000, INJURY, V31, P153, DOI 10.1016/S0020-1383(99)00253-3; Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011; Tate MLK, 2007, J BONE JOINT SURG AM, V89A, P307, DOI 10.2106/JBJS.E.00512; TATE MLK, 2011, Patent No. 2011109817; TATE MLK, 2009, Patent No. 20090053109; Taylor J, 1992, BONE, V4, P21; TUCKER HL, 1990, ORTHOP CLIN N AM, V21, P629; URIST MR, 1972, CLIN ORTHOP RELAT R, P132; WATSON JT, 1995, CLIN ORTHOP RELAT R, P138; Yamamiya K, 2008, J PERIODONTOL, V79, P811, DOI [10.1902/jop.2008.070518, 10.1902/jop.2008.070518 ]; Yiannakopoulos CK, 2008, ARCH ORTHOP TRAUM SU, V128, P117, DOI 10.1007/s00402-007-0433-5; ZHANG X, 2008, CLIN ORTHOP RELAT R, V466, P17777; Zhang XP, 2005, J BONE MINER RES, V20, P2124, DOI 10.1359/JBMR.050806; Zhao L, 2008, STRATEG TRAUMA LIMB, V3, P57, DOI 10.1007/s11751-008-0034-z	44	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28702	10.1371/journal.pone.0028702	http://dx.doi.org/10.1371/journal.pone.0028702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174873	Green Submitted, Green Published, gold			2022-12-27	WOS:000298366600031
J	Wang, C; Hu, YM; He, JW; Gu, JM; Zhang, H; Hu, WW; Yue, H; Gao, G; Xiao, WJ; Yu, JB; Ke, YH; Hu, YQ; Li, M; Liu, YJ; Fu, WZ; Ren, Y; Zhang, ZL				Wang, Chun; Hu, Yi-Ming; He, Jin-Wei; Gu, Jie-Mei; Zhang, Hao; Hu, Wei-Wei; Yue, Hua; Gao, Gao; Xiao, Wen-Jin; Yu, Jin-Bo; Ke, Yao-Hua; Hu, Yun-Qiu; Li, Miao; Liu, Yu-Juan; Fu, Wen-Zhen; Ren, Ying; Zhang, Zhen-Lin			Association between Low Density Lipoprotein Receptor-Related Protein 2 Gene Polymorphisms and Bone Mineral Density Variation in Chinese Population	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; NUCLEAR FAMILIES; PEAK BMD; OSTEOPOROSIS; WOMEN; MEN; SUNSHINE; FRACTURE; MASS	Low density lipoprotein receptor-related protein 2 gene (LRP2) is located next to the genomic region showing suggestive linkage with both hip and wrist bone mineral density (BMD) phenotypes. LRP2 knockout mice showed severe vitamin D deficiency and bone disease, indicating the involvement of LRP2 in the preservation of vitamin D metabolites and delivery of the precursor to the kidney for the generation of 1 alpha,25(OH)(2)D(3). In order to investigate the contribution of LRP2 gene polymorphisms to the variation of BMD in Chinese population, a total of 330 Chinese female-offspring nuclear families with 1088 individuals and 400 Chinese male-offspring nuclear families with 1215 individuals were genotyped at six tagSNPs of the LRP2 gene (rs2389557, rs2544381, rs7600336, rs10210408, rs2075252 and rs4667591). BMD values at the lumbar spine 1-4 (L1-4) and hip sites were measured by DXA. The association between LRP2 polymorphisms and BMD phenotypes was assessed by quantitative transmission disequilibrium tests (QTDTs) in female- and male-offspring nuclear families separately. In the female-offspring nuclear families, rs2075252 and haplotype GA of rs4667591 and rs2075252 were identified in the nominally significant total association with peak BMD at L1-4; however, no significant within-family association was found between peak BMD at the L1-4 and hip sites and six tagSNPs or haplotypes. In male-offspring nuclear families, neither the six tagSNPs nor the haplotypes was in total association or within-family association with the peak BMD variation at the L1-4 and hip sites by QTDT analysis. Our findings suggested that the polymorphisms of LRP2 gene is not a major factor that contributes to the peak BMD variation in Chinese population.	[Wang, Chun; He, Jin-Wei; Gu, Jie-Mei; Zhang, Hao; Hu, Wei-Wei; Yue, Hua; Gao, Gao; Xiao, Wen-Jin; Yu, Jin-Bo; Ke, Yao-Hua; Hu, Yun-Qiu; Li, Miao; Liu, Yu-Juan; Fu, Wen-Zhen; Zhang, Zhen-Lin] Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Hu, Yi-Ming; Ren, Ying] Shanghai Jiao Tong Univ, Dept Special Med Serv, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, C (corresponding author), Shanghai Jiao Tong Univ, Dept Osteoporosis & Bone Dis, Metab Bone Dis & Genet Res Unit, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	zzl2002@medmail.com.cn			National Natural Science Foundation of China (NSFC) [30570891, 30771019, 30800387]; Science and Technology commission of Shanghai municipality [08XD1403000, STCSM10DZ1950100, 08411963100, 11ZR1427300]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology commission of Shanghai municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (NSFC) (No. 30570891, 30771019, and 30800387), Science and Technology commission of Shanghai municipality (Project No. 08XD1403000, STCSM10DZ1950100, 08411963100, and 11ZR1427300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Choi YM, 2000, J HUM GENET, V45, P280, DOI 10.1007/s100380070016; Dundar U, 2009, CLIN RHEUMATOL, V28, P1187, DOI 10.1007/s10067-009-1220-1; FARQUHAR MG, 1995, J CLIN INVEST, V96, P1184, DOI 10.1172/JCI118149; Ferrari S, 2008, BEST PRACT RES CL EN, V22, P723, DOI 10.1016/j.beem.2008.08.007; Funakoshi Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P328, DOI 10.1007/s12199-009-0104-y; Gao G, 2008, J CLIN DENSITOM, V11, P360, DOI 10.1016/j.jocd.2008.04.005; Gao G, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-1; Gu JM, 2009, ACTA PHARMACOL SIN, V30, P1634, DOI 10.1038/aps.2009.169; Hsu YH, 2007, J BONE MINER RES, V22, P184, DOI 10.1359/JBMR.061015; Koller DL, 2005, J BONE MINER RES, V20, P75, DOI 10.1359/JBMR.041019; Kung Annie W. C., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P26; Laaksonen MML, 2009, J NUTRIGENET NUTRIGE, V2, P55, DOI 10.1159/000204960; Lau EMC, 2002, OSTEOPOROSIS INT, V13, P218, DOI 10.1007/s001980200017; Lopes JB, 2009, MATURITAS, V64, P218, DOI 10.1016/j.maturitas.2009.09.020; Lou YR, 2010, J STEROID BIOCHEM, V118, P162, DOI 10.1016/j.jsbmb.2009.11.011; Molgaard C, 2010, BONE, V46, P432, DOI 10.1016/j.bone.2009.08.056; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pekkarinen T, 2010, EUR J ENDOCRINOL, V162, P183, DOI 10.1530/EJE-09-0739; Qin YJ, 2004, ACTA PHARMACOL SIN, V25, P462; Qin YJ, 2003, J BONE MINER RES, V18, P1028, DOI 10.1359/jbmr.2003.18.6.1028; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; Remes T, 2005, ANN MED, V37, P383, DOI 10.1080/07853890510011958; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2009, ANN INTERN MED, V151, P528, DOI 10.7326/0003-4819-151-8-200910200-00006; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; SILVER J, 1986, J CLIN INVEST, V78, P1296, DOI 10.1172/JCI112714; Stechschulte SA, 2009, AM J MED, V122, P793, DOI 10.1016/j.amjmed.2009.02.029; Tavera LE, 2007, SCI AM, V297, P62, DOI 10.1038/scientificamerican1107-62; Tavera-Mendoza L. E., 2007, SCI AM, V297, P72; Tavera-Mendoza LE, 2007, SCI AM, P68; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Zhang ZL, 2008, OSTEOPOROSIS INT, V19, P39, DOI 10.1007/s00198-007-0435-8; Zhang ZL, 2006, ASIAN J ANDROL, V8, P419, DOI 10.1111/j.1745-7262.2006.00170.x; Zhang Zhen-lin, 2003, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V20, P5	37	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28874	10.1371/journal.pone.0028874	http://dx.doi.org/10.1371/journal.pone.0028874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174918	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700080
J	Barjaktarovic, Z; Schmaltz, D; Shyla, A; Azimzadeh, O; Schulz, S; Haagen, J; Dorr, W; Sarioglu, H; Schafer, A; Atkinson, MJ; Zischka, H; Tapio, S				Barjaktarovic, Zarko; Schmaltz, Dominik; Shyla, Alena; Azimzadeh, Omid; Schulz, Sabine; Haagen, Julia; Doerr, Wolfgang; Sarioglu, Hakan; Schaefer, Alexander; Atkinson, Michael J.; Zischka, Hans; Tapio, Soile			Radiation-Induced Signaling Results in Mitochondrial Impairment in Mouse Heart at 4 Weeks after Exposure to X-Rays	PLOS ONE			English	Article							OXIDATIVE STRESS; LONG-TERM; BREAST-CANCER; FOLLOW-UP; QUANTITATIVE-ANALYSIS; MORTALITY EXPERIENCE; DESMIN CYTOSKELETON; POLYACRYLAMIDE GELS; IONIZING-RADIATION; STATISTICAL-MODEL	Backround: Radiation therapy treatment of breast cancer, Hodgkin's disease or childhood cancers expose the heart to high local radiation doses, causing an increased risk of cardiovascular disease in the survivors decades after the treatment. The mechanisms that underlie the radiation damage remain poorly understood so far. Previous data show that impairment of mitochondrial oxidative metabolism is directly linked to the development of cardiovascular disease. Methodology/Principal findings: In this study, the radiation-induced in vivo effects on cardiac mitochondrial proteome and function were investigated. C57BL/6N mice were exposed to local irradiation of the heart with doses of 0.2 Gy or 2 Gy (Xray, 200 kV) at the age of eight weeks, the control mice were sham-irradiated. After four weeks the cardiac mitochondria were isolated and tested for proteomic and functional alterations. Two complementary proteomics approaches using both peptide and protein quantification strategies showed radiation-induced deregulation of 25 proteins in total. Three main biological categories were affected: the oxidative phophorylation, the pyruvate metabolism, and the cytoskeletal structure. The mitochondria exposed to high-dose irradiation showed functional impairment reflected as partial deactivation of Complex I (32%) and Complex III (11%), decreased succinate-driven respiratory capacity (13%), increased level of reactive oxygen species and enhanced oxidation of mitochondrial proteins. The changes in the pyruvate metabolism and structural proteins were seen with both low and high radiation doses. Conclusion/Significance: This is the first study showing the biological alterations in the murine heart mitochondria several weeks after the exposure to low-and high-dose of ionizing radiation. Our results show that doses, equivalent to a single dose in radiotherapy, cause long-lasting changes in mitochondrial oxidative metabolism and mitochondria-associated cytoskeleton. This prompts us to propose that these first pathological changes lead to an increased risk of cardiovascular disease after radiation exposure.	[Barjaktarovic, Zarko; Schmaltz, Dominik; Shyla, Alena; Azimzadeh, Omid; Atkinson, Michael J.; Tapio, Soile] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany; [Schulz, Sabine; Zischka, Hans] German Res Ctr Environm Hlth, Inst Toxicol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Haagen, Julia; Doerr, Wolfgang] Tech Univ Dresden, Dept Radiotherapy & Radiooncol, Med Fac Carl Gustav Carus, D-01062 Dresden, Germany; [Sarioglu, Hakan; Schaefer, Alexander] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Prot Sci, Prote Core Facil, Neuherberg, Germany; [Atkinson, Michael J.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-8000 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Barjaktarovic, Z (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Radiat Biol, Neuherberg, Germany.	zarko.barjaktarovic@helmholtz-muenchen.de	Zischka, Hans/M-1490-2017; Atkinson, Michael J/E-5537-2011; Atkinson, Michael/AAU-5127-2020; Tapio, Soile/CAJ-5871-2022; Tapio, Soile/M-7358-2014; Doerr, Wolfgang/J-9344-2014	Zischka, Hans/0000-0002-4047-1566; Atkinson, Michael J/0000-0003-3358-2089; Atkinson, Michael/0000-0003-3358-2089; Tapio, Soile/0000-0001-9860-3683; Azimzadeh, Omid/0000-0001-8984-0388; Doerr, Wolfgang/0000-0003-1477-6849	European Community [211403]	European Community(European Commission)	The research leading to these results is supported by a grant from the European Community's Seventh Framework Programme (EURATOM) contract no 211403 (CARDIORISK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; ALLAN IM, 1988, BRIT J CANCER, V58, P34, DOI 10.1038/bjc.1988.156; Azimzadeh O, 2011, PROTEOMICS, V11, P3299, DOI 10.1002/pmic.201100178; Azizova TV, 2010, RADIAT RES, V174; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Bayeva M, 2010, CURR HYPERTENS REP, V12, P426, DOI 10.1007/s11906-010-0149-8; Bindoff L, 2003, EUR HEART J, V24, P221, DOI 10.1016/S0195-668X(02)00694-2; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boja ES, 2009, J PROTEOME RES, V8, P4665, DOI 10.1021/pr900387b; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Boldogh IR, 2006, BBA-MOL CELL RES, V1763, P450, DOI 10.1016/j.bbamcr.2006.02.014; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6; Carr ZA, 2005, INT J RADIAT ONCOL, V61, P842, DOI 10.1016/j.ijrobp.2004.07.708; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Coyle CH, 2007, ASAIO J, V53, P17, DOI 10.1097/01.mat.0000247157.84350.e8; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Darby S, 2003, BRIT MED J, V326, P256, DOI 10.1136/bmj.326.7383.256; DARBY SC, 1987, BRIT J CANCER, V55, P179, DOI 10.1038/bjc.1987.35; Davidson SM, 2010, CARDIOVASC RES, V88, P58, DOI 10.1093/cvr/cvq195; DAVIS FG, 1989, CANCER RES, V49, P6130; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; EMERIT I, 1994, J CANCER RES CLIN, V120, P558, DOI 10.1007/BF01221035; Eny KM, 2005, LUPUS, V14, P351, DOI 10.1191/0961203305lu2091oa; Eriksson P, 2010, NEUROTOXICOLOGY, V31, P223, DOI 10.1016/j.neuro.2010.01.002; Fedorova M, 2009, BBA-MOL BASIS DIS, V1792, P1185, DOI 10.1016/j.bbadis.2009.09.011; Forner F, 2006, MOL CELL PROTEOMICS, V5, P608, DOI 10.1074/mcp.M500298-MCP200; Fu CX, 2008, J PROTEOME RES, V7, P3789, DOI 10.1021/pr800233r; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Geiger T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001090; GOH KO, 1968, RADIAT RES, V35, P171, DOI 10.2307/3572443; Hauptmann M, 2003, AM J EPIDEMIOL, V157, P239, DOI 10.1093/aje/kwf189; Hausenloy DJ, 2008, DIABETES OBES METAB, V10, P451, DOI 10.1111/j.1463-1326.2007.00762.x; Hayashi T, 2005, AM J MED, V118, P83, DOI 10.1016/j.amjmed.2004.06.045; Heather LC, 2010, CARDIOVASC RES, V85, P127, DOI 10.1093/cvr/cvp276; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; HOLLOWELL JG, 1968, P SOC EXP BIOL MED, V129, P240; Hu QS, 2009, AM J PHYSIOL-HEART C, V297, pH223, DOI 10.1152/ajpheart.00992.2008; Ivanov VK, 2007, HEALTH PHYS, V93, P470, DOI 10.1097/01.HP.0000282195.34508.b0; Kaczmarek A, 2004, STRUCT CHEM, V15, P517, DOI 10.1023/B:STUC.0000037910.26456.59; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KENNEDY CH, 1992, FREE RADICAL BIO MED, V12, P381, DOI 10.1016/0891-5849(92)90087-W; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Kreuzer M, 2006, RADIAT ENVIRON BIOPH, V45, P159, DOI 10.1007/s00411-006-0056-1; Kreuzer M, 2010, RADIAT ENVIRON BIOPH, V49, P177, DOI 10.1007/s00411-009-0249-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leach JK, 2001, CANCER RES, V61, P3894; Linden M, 2001, J BIOENERG BIOMEMBR, V33, P333, DOI 10.1023/A:1010611408007; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Mayburd AL, 2006, CLIN CANCER RES, V12, P1820, DOI 10.1158/1078-0432.CCR-05-2149; McGeoghegan D, 2008, INT J EPIDEMIOL, V37, P506, DOI 10.1093/ije/dyn018; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Misra MK, 2009, MED SCI MONITOR, V15, pRA209; Muirhead CR, 2009, BRIT J CANCER, V100, P206, DOI 10.1038/sj.bjc.6604825; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Nakachi K, 2008, MUTAT RES-REV MUTAT, V659, P109, DOI 10.1016/j.mrrev.2008.02.001; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Orrenius S, 2007, DRUG METAB REV, V39, P443, DOI 10.1080/03602530701468516; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Page B, 2008, CIRC RES, V102, P103, DOI 10.1161/CIRCRESAHA.107.155895; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Sarioglu H, 2006, PROTEOMICS, V6, P2407, DOI 10.1002/pmic.200500680; Schlattner U, 2006, BBA-MOL BASIS DIS, V1762, P164, DOI 10.1016/j.bbadis.2005.09.004; Schmidt Alexander, 2009, V492, P21, DOI 10.1007/978-1-59745-493-3_2; Shenker BJ, 2000, ENVIRON RES, V84, P89, DOI 10.1006/enrs.2000.4078; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Susin SA, 2000, METHOD ENZYMOL, V322, P205; Swerdlow AJ, 2007, J NATL CANCER I, V99, P206, DOI 10.1093/jnci/djk029; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Takano H, 2003, ANTIOXID REDOX SIGN, V5, P789, DOI 10.1089/152308603770380098; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Tang HL, 2008, BIOCHEM J, V410, P141, DOI 10.1042/BJ20071072; Tolstonog GV, 2001, DNA CELL BIOL, V20, P509, DOI 10.1089/104454901317094945; Tukenova M, 2010, J CLIN ONCOL, V28, P1308, DOI 10.1200/JCO.2008.20.2267; White MY, 2008, PROTEOM CLIN APPL, V2, P845, DOI 10.1002/prca.200780135; Wolf G, 2000, Curr Hypertens Rep, V2, P167, DOI 10.1007/s11906-000-0078-z; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876	85	120	125	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27811	10.1371/journal.pone.0027811	http://dx.doi.org/10.1371/journal.pone.0027811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174747	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600005
J	Arumugasundaram, S; Ghosh, M; Veerasamy, S; Ramasamy, Y				Arumugasundaram, Shanmugapriya; Ghosh, Modhumita; Veerasamy, Sivakumar; Ramasamy, Yasodha			Species Discrimination, Population Structure and Linkage Disequilibrium in Eucalyptus camaldulensis and Eucalyptus tereticornis Using SSR Markers	PLOS ONE			English	Article							ASSOCIATION GENETICS; NUCLEOTIDE DIVERSITY; MICROSATELLITE; L.; SOFTWARE; LOCI; WOOD; MAP; POLYMORPHISMS; CONSTRUCTION	Eucalyptus camaldulensis and E. tereticornis are closely related species commonly cultivated for pulp wood in many tropical countries including India. Understanding the genetic structure and linkage disequilibrium (LD) existing in these species is essential for the improvement of industrially important traits. Our goal was to evaluate the use of simple sequence repeat (SSR) loci for species discrimination, population structure and LD analysis in these species. Investigations were carried out with the most common alleles in 93 accessions belonging to these two species using 62 SSR markers through cross amplification. The polymorphic information content (PIC) ranged from 0.44 to 0.93 and 0.36 to 0.93 in E. camaldulensis and E. tereticornis respectively. A clear delineation between the two species was evident based on the analysis of population structure and species-specific alleles. Significant genotypic LD was found in E. camaldulensis, wherein out of 135 significant pairs, 17 pairs showed r(2) >= 0.1. Similarly, in E. tereticornis, out of 136 significant pairs, 18 pairs showed r(2) >= 0.1. The extent of LD decayed rapidly showing the significance of association analyses in eucalypts with higher resolution markers. The availability of whole genome sequence for E. grandis and the synteny and co-linearity in the genome of eucalypts, will allow genome-wide genotyping using microsatellites or single nucleotide polymorphims.	[Arumugasundaram, Shanmugapriya; Ghosh, Modhumita; Ramasamy, Yasodha] Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India; [Veerasamy, Sivakumar] Inst Forest Genet & Tree Breeding, Div Genet & Tree Breeding, Coimbatore, Tamil Nadu, India	Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB)	Arumugasundaram, S (corresponding author), Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India.	yasodha@icfre.org						Agrama HA, 2002, SILVAE GENET, V51, P201; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Balasaravanan T, 2005, TREE PHYSIOL, V25, P1295, DOI 10.1093/treephys/25.10.1295; Barnaud A, 2006, THEOR APPL GENET, V112, P708, DOI 10.1007/s00122-005-0174-1; Barnaud A, 2010, HEREDITY, V104, P431, DOI 10.1038/hdy.2009.143; Beaulieu J, 2011, GENETICS, V188, P197, DOI 10.1534/genetics.110.125781; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Brondani RPV, 2002, MOL GENET GENOMICS, V267, P338, DOI 10.1007/s00438-002-0665-6; Butcher PA, 2009, TREE GENET GENOMES, V5, P189, DOI 10.1007/s11295-008-0169-6; Chezhian P, 2010, NEW FOREST, V40, P85, DOI 10.1007/s11056-009-9184-1; Chu YG, 2009, GENETICA, V137, P141, DOI 10.1007/s10709-009-9371-1; da Silva JM, 2009, CONSERV GENET RESOUR, V1, P465, DOI 10.1007/s12686-009-9107-7; Doran J. C., 1993, Commonwealth Forestry Review, V72, P198; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Haussmann BIG, 2004, THEOR APPL GENET, V109, P1005, DOI 10.1007/s00122-004-1706-9; HILL WG, 1988, THEOR POPUL BIOL, V33, P54, DOI 10.1016/0040-5809(88)90004-4; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Ingvarson PK, 2010, PLANT GENET GENOMICS, V8, P91, DOI 10.1007/978-1-4419-1541-2_5; Ingvarsson PK, 2011, NEW PHYTOL, V189, P909, DOI 10.1111/j.1469-8137.2010.03593.x; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Aranzana MJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-69; Kirst M, 2005, J HERED, V96, P161, DOI 10.1093/jhered/esi023; Kirsten H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2683; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Kumar S, 2004, THEOR APPL GENET, V108, P292, DOI 10.1007/s00122-003-1352-7; Lewis P, 2001, GENETIC DATA ANAL GD; Li MH, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-32; Li MH, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-66; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Marques CM, 2002, THEOR APPL GENET, V105, P474, DOI 10.1007/s00122-002-0899-z; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Marroni F, 2011, TREE GENET GENOMES, V7, P1011, DOI 10.1007/s11295-011-0391-5; McRae AF, 2002, GENETICS, V160, P1113; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; Oraguzie NC, 2007, ASS MAPPING PLANTS; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Shepherd M, 2006, SILVAE GENET, V55, P228, DOI 10.1515/sg-2006-0030; Stich B, 2006, MOL BREEDING, V17, P217, DOI 10.1007/s11032-005-5296-2; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Thavamanikumar S, 2011, AUST FORESTRY, V74, P23, DOI 10.1080/00049158.2011.10676342; Thumma BR, 2010, TREE GENET GENOMES, V6, P877, DOI 10.1007/s11295-010-0298-6; Thumma BR, 2005, GENETICS, V171, P1257, DOI 10.1534/genetics.105.042028; Van Inghelandt D, 2011, THEOR APPL GENET, V123, P11, DOI 10.1007/s00122-011-1562-3; Varghese M, 2009, TREE GENET GENOMES, V5, P629, DOI 10.1007/s11295-009-0215-z; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; Verhaegen D., 1998, Forest Genetics, V5, P61; Weir BS., 1996, GENETIC DATA ANAL; Yasodha R, 2008, J GENET, V87, P21, DOI 10.1007/s12041-008-0003-9; Zapata C, 2001, ANN HUM GENET, V65, P395, DOI 10.1017/S0003480001008697	59	28	34	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28252	10.1371/journal.pone.0028252	http://dx.doi.org/10.1371/journal.pone.0028252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163287	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900022
J	Burrows, M; Borycz, JA; Shaw, SR; Elvin, CM; Meinertzhagen, IA				Burrows, Malcolm; Borycz, Jolanta A.; Shaw, Stephen R.; Elvin, Christopher M.; Meinertzhagen, Ian A.			Antibody Labelling of Resilin in Energy Stores for Jumping in Plant Sucking Insects	PLOS ONE			English	Article							RUBBER-LIKE PROTEIN; FROGHOPPER INSECTS; XENOPSYLLA-CHEOPIS; CUTICLE; MECHANISM; TIMBAL; CICADA; GENE; IDENTIFICATION; PERFORMANCE	The rubbery protein resilin appears to form an integral part of the energy storage structures that enable many insects to jump by using a catapult mechanism. In plant sucking bugs that jump (Hemiptera, Auchenorrhyncha), the energy generated by the slow contractions of huge thoracic jumping muscles is stored by bending composite bow-shaped parts of the internal thoracic skeleton. Sudden recoil of these bows powers the rapid and simultaneous movements of both hind legs that in turn propel a jump. Until now, identification of resilin at these storage sites has depended exclusively upon characteristics that may not be specific: its fluorescence when illuminated with specific wavelengths of ultraviolet (UV) light and extinction of that fluorescence at low pH. To consolidate identification we have labelled the cuticular structures involved with an antibody raised against a product of the Drosophila CG15920 gene. This encodes pro-resilin, the first exon of which was expressed in E. coli and used to raise the antibody. We show that in frozen sections from two species, the antibody labels precisely those parts of the metathoracic energy stores that fluoresce under UV illumination. The presence of resilin in these insects is thus now further supported by a molecular criterion that is immunohistochemically specific.	[Burrows, Malcolm] Univ Cambridge, Dept Zool, Cambridge, England; [Borycz, Jolanta A.; Shaw, Stephen R.; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Elvin, Christopher M.] Commonwealth Sci & Ind Res Org, Div Livestock Ind, St Lucia, Qld, Australia	University of Cambridge; Dalhousie University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Burrows, M (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	mb135@hermes.cam.ac.uk	elvin, chris/H-2333-2013	Meinertzhagen, Ian/0000-0002-6578-4526	CSIRO Australia; Natural Science and Engineering Council (Canada) [DIS0000065]	CSIRO Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Natural Science and Engineering Council (Canada)	This work was supported by: Emerging Science Grant (nanotechnology) from CSIRO Australia to C.M.E., Natural Science and Engineering Council (Canada) Discovery grant DIS0000065 to I.A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; ANDERSEN SO, 1963, BIOCHIM BIOPHYS ACTA, V69, P249, DOI 10.1016/0006-3002(63)91258-7; Andersen SO, 2002, ELASTOMERIC PROTEINS; ANDERSEN SVEND OLAV, 1964, ADVANCES INSECT PHYSIOL, V2, P1, DOI 10.1016/S0065-2806(08)60071-5; Andersen SO, 2011, INSECT BIOCHEM MOLEC, V41, P620, DOI 10.1016/j.ibmb.2011.03.015; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P541, DOI 10.1016/j.ibmb.2010.05.002; Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3; BENNETCLARK HC, 1967, J EXP BIOL, V47, P59; BennetClark HC, 1997, J EXP BIOL, V200, P1681; Burrows M, 2010, J EXP BIOL, V213, P469, DOI 10.1242/jeb.037861; Burrows M, 2006, J EXP BIOL, V209, P4607, DOI 10.1242/jeb.02539; Burrows M, 2009, J EXP BIOL, V212, P2844, DOI 10.1242/jeb.032326; Burrows M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-27; Burrows M, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-41; ELLIOTT GF, 1965, J MOL BIOL, V13, P791, DOI 10.1016/S0022-2836(65)80144-9; Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085; EVANS MEG, 1972, J ZOOL, V167, P319; EVANS MEG, 1973, J ZOOL, V169, P181; Fonseca PJ, 1998, J EXP BIOL, V201, P717; JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008; Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050; Lyons RE, 2011, INSECT BIOCHEM MOLEC, V41, P881, DOI 10.1016/j.ibmb.2011.08.002; Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454; Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107; Neff D, 2000, ARTHROPOD STRUCT DEV, V29, P75, DOI 10.1016/S1467-8039(00)00014-1; NEVILLE AC, 1976, J CELL SCI, V21, P73; NEVILLE AC, 1963, J INSECT PHYSIOL, V9, P265, DOI 10.1016/0022-1910(63)90103-3; REBERS JE, 1988, J MOL BIOL, V203, P411, DOI 10.1016/0022-2836(88)90009-5; Rebers JE, 2001, INSECT BIOCHEM MOLEC, V31, P1083, DOI 10.1016/S0965-1748(01)00056-X; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P499, DOI 10.1098/rstb.1975.0064; ROTHSCHILD M, 1975, PHILOS T ROY SOC B, V271, P457, DOI 10.1098/rstb.1975.0062; Sannasi A., 1969, Journal of the Georgia Entomological Society, V4, P31; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Vincent JFV, 2004, ARTHROPOD STRUCT DEV, V33, P187, DOI 10.1016/j.asd.2004.05.006; WEISFOGH T, 1960, J EXP BIOL, V37, P889; Wong CCD, 2007, IN VIVO IN VITRO EXP; YOUNG D, 1995, J EXP BIOL, V198, P1001	37	15	15	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28456	10.1371/journal.pone.0028456	http://dx.doi.org/10.1371/journal.pone.0028456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163306	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900043
J	Gillece, JD; Schupp, JM; Balajee, SA; Harris, J; Pearson, T; Yan, YP; Keim, P; DeBess, E; Marsden-Haug, N; Wohrle, R; Engelthaler, DM; Lockhart, SR				Gillece, John D.; Schupp, James M.; Balajee, S. Arunmozhi; Harris, Julie; Pearson, Talima; Yan, Yongpan; Keim, Paul; DeBess, Emilio; Marsden-Haug, Nicola; Wohrle, Ron; Engelthaler, David M.; Lockhart, Shawn R.			Whole Genome Sequence Analysis of Cryptococcus gattii from the Pacific Northwest Reveals Unexpected Diversity	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; BRITISH-COLUMBIA; OUTBREAK; LINEAGES; SOFTWARE; GENOTYPE; STRAINS	A recent emergence of Cryptococcus gattii in the Pacific Northwest involves strains that fall into three primarily clonal molecular subtypes: VGIIa, VGIIb and VGIIc. Multilocus sequence typing (MLST) and variable number tandem repeat analysis appear to identify little diversity within these molecular subtypes. Given the apparent expansion of these subtypes into new geographic areas and their ability to cause disease in immunocompetent individuals, differentiation of isolates belonging to these subtypes could be very important from a public health perspective. We used whole genome sequence typing (WGST) to perform fine-scale phylogenetic analysis on 20 C. gattii isolates, 18 of which are from the VGII molecular type largely responsible for the Pacific Northwest emergence. Analysis both including and excluding (289,586 SNPs and 56,845 SNPs, respectively) molecular types VGI and VGIII isolates resulted in phylogenetic reconstructions consistent, for the most part, with MLST analysis but with far greater resolution among isolates. The WGST analysis presented here resulted in identification of over 100 SNPs among eight VGIIc isolates as well as unique genotypes for each of the VGIIa, VGIIb and VGIIc isolates. Similar levels of genetic diversity were found within each of the molecular subtype isolates, despite the fact that the VGIIb clade is thought to have emerged much earlier. The analysis presented here is the first multi-genome WGST study to focus on the C. gattii molecular subtypes involved in the Pacific Northwest emergence and describes the tools that will further our understanding of this emerging pathogen.	[Gillece, John D.; Schupp, James M.; Engelthaler, David M.] Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA; [Balajee, S. Arunmozhi; Harris, Julie; Lockhart, Shawn R.] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Pearson, Talima; Keim, Paul] No Arizona Univ, Ctr Microbial Genet & Gen, Flagstaff, AZ 86011 USA; [Yan, Yongpan] Van Andel Inst, Ctr Genet Epidemiol & Prevent, Grand Rapids, MI USA; [DeBess, Emilio] Oregon State Dept Human Serv, Portland, OR USA; [Marsden-Haug, Nicola; Wohrle, Ron] Washington State Dept Hlth, Shoreline, WA USA; [Wohrle, Ron] Washington Dept Hlth, Tumwater, WA USA	Translational Genomics Research Institute; Centers for Disease Control & Prevention - USA; Northern Arizona University; Van Andel Institute	Gillece, JD (corresponding author), Translat Genom Res Inst, Pathogen Genom Div, Flagstaff, AZ USA.	jschupp@tgen.org	Pearson, Talima/O-7840-2019	Pearson, Talima/0000-0003-3696-041X	Translational Genomics Research Institute; Centers for Disease Control and Prevention	Translational Genomics Research Institute; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	All work was funded by the Translational Genomics Research Institute and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CRYPT GATT SEQ PROJ; Baro T, 1998, J CLIN MICROBIOL, V36, P458; Bovers M, 2008, FUNGAL GENET BIOL, V45, P400, DOI 10.1016/j.fgb.2007.12.004; Byrnes E.J., 2009, F1000 BIOL REP; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; D'Souza CA, 2011, MBIO, V2, DOI 10.1128/mBio.00342-10; dos Santos WRA, 2008, MEM I OSWALDO CRUZ, V103, P813, DOI 10.1590/S0074-02762008000800012; Engelthaler DM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001347; Engelthaler DM, 2011, EMERG INFECT DIS, V17, P227, DOI 10.3201/eid1702.100620; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Hendriksen RS, 2011, MBIO, V2, DOI [10.1128/mBio.00157-11, 10.1128/mBio.00305-11]; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; Iqbal N, 2010, J CLIN MICROBIOL, V48, P539, DOI 10.1128/JCM.01505-09; Kidd SE, 2005, EUKARYOT CELL, V4, P1629, DOI 10.1128/EC.4.10.1629-1638.2005; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Okamoto K, 2010, EMERG INFECT DIS, V16, P1155, DOI 10.3201/eid1607.100106; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Stephen C, 2002, CAN VET J, V43, P792; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	27	56	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28550	10.1371/journal.pone.0028550	http://dx.doi.org/10.1371/journal.pone.0028550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163313	Green Submitted, Green Published, gold			2022-12-27	WOS:000298161900049
J	Hallstrom, BM; Schneider, A; Zoller, S; Janke, A				Hallstroem, Bjoern M.; Schneider, Adrian; Zoller, Stefan; Janke, Axel			A Genomic Approach to Examine the Complex Evolution of Laurasiatherian Mammals	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INTERORDINAL RELATIONSHIPS; MITOCHONDRIAL GENOME; LIKELIHOOD; HYBRIDIZATION; RESOLUTION; PATTERNS; ELEMENTS; HISTORY; SINES	Recent phylogenomic studies have failed to conclusively resolve certain branches of the placental mammalian tree, despite the evolutionary analysis of genomic data from 32 species. Previous analyses of single genes and retroposon insertion data yielded support for different phylogenetic scenarios for the most basal divergences. The results indicated that some mammalian divergences were best interpreted not as a single bifurcating tree, but as an evolutionary network. In these studies the relationships among some orders of the super-clade Laurasiatheria were poorly supported, albeit not studied in detail. Therefore, 4775 protein-coding genes (6,196,263 nucleotides) were collected and aligned in order to analyze the evolution of this clade. Additionally, over 200,000 introns were screened in silico, resulting in 32 phylogenetically informative long interspersed nuclear elements (LINE) insertion events. The present study shows that the genome evolution of Laurasiatheria may best be understood as an evolutionary network. Thus, contrary to the common expectation to resolve major evolutionary events as a bifurcating tree, genome analyses unveil complex speciation processes even in deep mammalian divergences. We exemplify this on a subset of 1159 suitable genes that have individual histories, most likely due to incomplete lineage sorting or introgression, processes that can make the genealogy of mammalian genomes complex. These unexpected results have major implications for the understanding of evolution in general, because the evolution of even some higher level taxa such as mammalian orders may sometimes not be interpreted as a simple bifurcating pattern.	[Hallstroem, Bjoern M.; Janke, Axel] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Hallstroem, Bjoern M.; Janke, Axel] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Schneider, Adrian] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Zoller, Stefan] ETH, Computat Biochem Res Grp, Zurich, Switzerland; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Edinburgh; Swiss Federal Institutes of Technology Domain; ETH Zurich; Goethe University Frankfurt	Hallstrom, BM (corresponding author), Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany.	bjoern.hallstroem@senckenberg.de	Janke, Axel/M-2135-2013	Janke, Axel/0000-0002-9394-1904	Hesse's Ministry of Higher Education, Research, and the Arts	Hesse's Ministry of Higher Education, Research, and the Arts	The present study was funded by the research funding programme " LOEWE - Landes -Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1963, ANIMAL SPECIES EVOLU; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Arnason U, 2000, J MOL EVOL, V50, P569, DOI 10.1007/s002390010060; Asher RJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-102; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Benton Michael J., 2009, P35; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Cantrell MA, 2001, GENETICS, V158, P769; Churakov G, 2009, GENOME RES, V19, P868, DOI 10.1101/gr.090647.108; Clifford P, 1994, J R STAT SOC B, V56, P35; Curnoe D, 2006, J EVOLUTION BIOL, V19, P59, DOI 10.1111/j.1420-9101.2005.00989.x; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dress AWM, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ebersberger I, 2007, MOL BIOL EVOL, V24, P2266, DOI 10.1093/molbev/msm156; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Gray A.P., 1972, MAMMALIAN HYBRIDS CH; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kim TM, 2004, J KOREAN MED SCI, V19, P177, DOI 10.3346/jkms.2004.19.2.177; Kramerov DA, 2005, INT REV CYTOL, V247, P165, DOI 10.1016/S0074-7696(05)47004-7; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Kriegs JO, 2006, PLOS BIOL, V4, P537, DOI 10.1371/journal.pbio.0040091; Kunin V, 2005, GENOME RES, V15, P954, DOI 10.1101/gr.3666505; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; LEWONTIN RC, 1966, EVOLUTION, V20, P315, DOI 10.1111/j.1558-5646.1966.tb03369.x; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Montgelard C, 1997, MOL BIOL EVOL, V14, P550, DOI 10.1093/oxfordjournals.molbev.a025792; Mouchaty SK, 2000, MOL BIOL EVOL, V17, P60, DOI 10.1093/oxfordjournals.molbev.a026238; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Pumo DE, 1998, J MOL EVOL, V47, P709, DOI 10.1007/PL00006430; Pupko T, 2002, MOL BIOL EVOL, V19, P2294, DOI 10.1093/oxfordjournals.molbev.a004053; Rannala B, 2008, ANNU REV GENOM HUM G, V9, P217, DOI 10.1146/annurev.genom.9.081307.164407; Ray DA, 2006, SYSTEMATIC BIOL, V55, P928, DOI 10.1080/10635150600865419; Schneider A, 2009, MOL BIOL EVOL, V26, P1259, DOI 10.1093/molbev/msp034; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; van de Lagemaat LN, 2005, GENOME RES, V15, P1243, DOI 10.1101/gr.3910705; Waddell P J, 2001, Genome Inform, V12, P141; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Xu XF, 1996, MOL BIOL EVOL, V13, P1167, DOI 10.1093/oxfordjournals.molbev.a025681; Zoller S, 2010, J MOL EVOL, V70, P605, DOI 10.1007/s00239-010-9356-9	64	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28199	10.1371/journal.pone.0028199	http://dx.doi.org/10.1371/journal.pone.0028199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164244	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400045
J	Downey, MJ; Jeziorska, DM; Ott, S; Tamai, TK; Koentges, G; Vance, KW; Bretschneider, T				Downey, Mike J.; Jeziorska, Danuta M.; Ott, Sascha; Tamai, T. Katherine; Koentges, Georgy; Vance, Keith W.; Bretschneider, Till			Extracting Fluorescent Reporter Time Courses of Cell Lineages from High-Throughput Microscopy at Low Temporal Resolution	PLOS ONE			English	Article							SUBCELLULAR LOCATION; DYNAMIC PROTEOMICS; TRACKING; IDENTIFICATION; CONSTRUCTION; IMAGES; MODEL	The extraction of fluorescence time course data is a major bottleneck in high-throughput live-cell microscopy. Here we present an extendible framework based on the open-source image analysis software ImageJ, which aims in particular at analyzing the expression of fluorescent reporters through cell divisions. The ability to track individual cell lineages is essential for the analysis of gene regulatory factors involved in the control of cell fate and identity decisions. In our approach, cell nuclei are identified using Hoechst, and a characteristic drop in Hoechst fluorescence helps to detect dividing cells. We first compare the efficiency and accuracy of different segmentation methods and then present a statistical scoring algorithm for cell tracking, which draws on the combination of various features, such as nuclear intensity, area or shape, and importantly, dynamic changes thereof. Principal component analysis is used to determine the most significant features, and a global parameter search is performed to determine the weighting of individual features. Our algorithm has been optimized to cope with large cell movements, and we were able to semi-automatically extract cell trajectories across three cell generations. Based on the MTrackJ plugin for ImageJ, we have developed tools to efficiently validate tracks and manually correct them by connecting broken trajectories and reassigning falsely connected cell positions. A gold standard consisting of two time-series with 15,000 validated positions will be released as a valuable resource for benchmarking. We demonstrate how our method can be applied to analyze fluorescence distributions generated from mouse stem cells transfected with reporter constructs containing transcriptional control elements of the Msx1 gene, a regulator of pluripotency, in mother and daughter cells. Furthermore, we show by tracking zebrafish PAC2 cells expressing FUCCI cell cycle markers, our framework can be easily adapted to different cell types and fluorescent markers.	[Downey, Mike J.] Univ Warwick, Mol Org & Assembly Cells, Coventry CV4 7AL, W Midlands, England; [Jeziorska, Danuta M.; Koentges, Georgy] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Ott, Sascha; Vance, Keith W.; Bretschneider, Till] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Tamai, T. Katherine] UCL, Dept Cell & Dev Biol, London, England	University of Warwick; University of Warwick; University of Warwick; University of London; University College London	Downey, MJ (corresponding author), Univ Warwick, Mol Org & Assembly Cells, Coventry CV4 7AL, W Midlands, England.	T.Bretschneider@warwick.ac.uk	Bretschneider, Till/D-4667-2011; Ott, Sascha/A-1180-2011; Vance, Keith/AAK-5410-2021	Bretschneider, Till/0000-0002-5317-603X; Vance, Keith/0000-0002-3411-8213	EPSRC through the MOAC Doctoral Training Centre, University of Warwick; University of Warwick; WellcomeTrust [WT 066790/E/02/Z, 066745/Z/01/Z]; HFSP [RGP0029/2007 C]; BBSRC/ERASysBio+ [BB/I004823/1]; BBSRC [BB/I004823/1, BB/F005938/2, BB/F005938/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005938/2, BB/F005938/1, BB/I004823/1] Funding Source: researchfish	EPSRC through the MOAC Doctoral Training Centre, University of Warwick; University of Warwick; WellcomeTrust(Wellcome Trust); HFSP(Human Frontier Science Program); BBSRC/ERASysBio+; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MJD was funded by the EPSRC (www.epsrc.ac.uk) through the MOAC Doctoral Training Centre, University of Warwick. KWV was funded by a Senior Research Fellowship from the University of Warwick. The experimental work was funded by WellcomeTrust (WT 066790/E/02/Z and 066745/Z/01/Z, www.wellcome.ac.uk) and HFSP (RGP0029/2007 C, www.hfsp.org) programme grants awarded to GK. Fucci data provided by TKT was obtained through funding by BBSRC/ERASysBio+ (BB/I004823/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kofahi O, 2006, CELL CYCLE, V5, P327, DOI 10.4161/cc.5.3.2426; ALTINOK A, 2006, IEEE CVPR, V2, P1662; Bendall AJ, 2000, GENE, V247, P17, DOI 10.1016/S0378-1119(00)00081-0; BISE R, 2011, P ISBI 2011, P1004; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CHALFOUN J, 2010, 7663 NISTIR; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen AR, 2010, NAT METHODS, V7, P213, DOI [10.1038/NMETH.1424, 10.1038/nmeth.1424]; Debeir O, 2005, Eurocon 2005: The International Conference on Computer as a Tool, Vol 1 and 2 , Proceedings, P951; Downey M, 2011, I S BIOMED IMAGING, P1913, DOI 10.1109/ISBI.2011.5872783; Finkenstadt B, 2008, BIOINFORMATICS, V24, P2901, DOI 10.1093/bioinformatics/btn562; Giuliano KA, 2005, ASSAY DRUG DEV TECHN, V3, P501, DOI 10.1089/adt.2005.3.501; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Harder N, 2009, GENOME RES, V19, P2113, DOI 10.1101/gr.092494.109; Hu Y, 2010, BIOINFORMATICS, V26, P1630, DOI 10.1093/bioinformatics/btq239; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; JONKER R, 1986, OPER RES LETT, V5, P171, DOI 10.1016/0167-6377(86)90073-8; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Lehmussola A, 2008, P IEEE, V96, P1348, DOI 10.1109/JPROC.2008.925490; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Lidral AC, 2002, J DENT RES, V81, P274, DOI 10.1177/154405910208100410; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Loo LH, 2009, NAT METHODS, V6, P759, DOI [10.1038/NMETH.1375, 10.1038/nmeth.1375]; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Meijering E, 2008, MICROSCOPE IMAGE PROCESSING, P401, DOI 10.1016/B978-0-12-372578-3.00015-5; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Olariu V, 2009, BIOINFORMATICS, V25, P2824, DOI 10.1093/bioinformatics/btp456; PADFIELD D, 2010, MED IMAGE ANAL, V21, P374; Pepperkok R, 2006, NAT REV MOL CELL BIO, V7, P690, DOI 10.1038/nrm1979; Reyes-Aldasoro CC, 2008, J MICROSC-OXFORD, V229, P162, DOI 10.1111/j.1365-2818.2007.01877.x; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schrijver A., 2003, COMBINATORIAL OPTIMI; Shen H, 2006, J R SOC INTERFACE, V3, P787, DOI 10.1098/rsif.2006.0137; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Smal I, 2008, IEEE T MED IMAGING, V27, P789, DOI 10.1109/TMI.2008.916964; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Thomas N, 2010, J BIOMOL SCREEN, V15, P1, DOI 10.1177/1087057109353790; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Walter T, 2010, J STRUCT BIOL, V170, P1, DOI 10.1016/j.jsb.2009.10.004; Wang M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-32; Wang QL, 2010, CYTOM PART A, V77A, P101, DOI 10.1002/cyto.a.20812; WRIGHT MB, 1990, COMPUT OPER RES, V17, P95, DOI 10.1016/0305-0548(90)90031-2	47	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27886	10.1371/journal.pone.0027886	http://dx.doi.org/10.1371/journal.pone.0027886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194797	Green Published, gold, Green Submitted			2022-12-27	WOS:000298370400005
J	Kuhn, T; Garcia-Marquez, J; Klimpel, S				Kuhn, Thomas; Garcia-Marquez, Jaime; Klimpel, Sven			Adaptive Radiation within Marine Anisakid Nematodes: A Zoogeographical Modeling of Cosmopolitan, Zoonotic Parasites	PLOS ONE			English	Article							SIMPLEX-SENSU-STRICTO; MOLECULAR-IDENTIFICATION; GENETIC-RELATIONSHIPS; MORPHOLOGICAL DESCRIPTION; COMPLEX ASCARIDIDA; METAZOAN PARASITES; SPECIES NEMATODA; FISH PARASITES; BEAKED-WHALES; LIFE-CYCLE	Parasites of the nematode genus Anisakis are associated with aquatic organisms. They can be found in a variety of marine hosts including whales, crustaceans, fish and cephalopods and are known to be the cause of the zoonotic disease anisakiasis, a painful inflammation of the gastro-intestinal tract caused by the accidental consumptions of infectious larvae raw or semi-raw fishery products. Since the demand on fish as dietary protein source and the export rates of seafood products in general is rapidly increasing worldwide, the knowledge about the distribution of potential foodborne human pathogens in seafood is of major significance for human health. Studies have provided evidence that a few Anisakis species can cause clinical symptoms in humans. The aim of our study was to interpolate the species range for every described Anisakis species on the basis of the existing occurrence data. We used sequence data of 373 Anisakis larvae from 30 different hosts worldwide and previously published molecular data (n = 584) from 53 field-specific publications to model the species range of Anisakis spp., using a interpolation method that combines aspects of the alpha hull interpolation algorithm as well as the conditional interpolation approach. The results of our approach strongly indicate the existence of species-specific distribution patterns of Anisakis spp. within different climate zones and oceans that are in principle congruent with those of their respective final hosts. Our results support preceding studies that propose anisakid nematodes as useful biological indicators for their final host distribution and abundance as they closely follow the trophic relationships among their successive hosts. The modeling might although be helpful for predicting the likelihood of infection in order to reduce the risk of anisakiasis cases in a given area.	[Kuhn, Thomas; Klimpel, Sven] Goethe Univ Frankfurt, Biodivers & Climate Res Ctr, BiK F, Inst Ecol Evolut & Div,LOEWE, Frankfurt, Germany; [Garcia-Marquez, Jaime] Carbones Cerrejon Ltd, Dept Gest Ambiental, Bogota, Colombia	Goethe University Frankfurt	Kuhn, T (corresponding author), Goethe Univ Frankfurt, Biodivers & Climate Res Ctr, BiK F, Inst Ecol Evolut & Div,LOEWE, Frankfurt, Germany.	sven.klimpel@senckenberg.de			Biodiversity and Climate Research Centre, Frankfurt/Main; Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council [DFG KL 2087/1-1, 1-2]	Biodiversity and Climate Research Centre, Frankfurt/Main; Hesse's Ministry of Higher Education, Research, and the Arts; German Research Council(German Research Foundation (DFG))	This work was supported by the Biodiversity and Climate Research Centre (BiK-F, www.bik-f.de), Frankfurt/Main, the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz'' of Hesse's Ministry of Higher Education, Research, and the Arts as well as the German Research Council (grant no. DFG KL 2087/1-1, 1-2, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2005, J HELMINTHOL, V79, P303, DOI 10.1079/JOH2005290; Abollo E, 2001, PARASITOL RES, V87, P492, DOI 10.1007/s004360100389; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Anderson TJC, 1998, ADV PARASIT, V41, P219, DOI 10.1016/S0065-308X(08)60425-X; Audicana MT, 2008, CLIN MICROBIOL REV, V21, P360, DOI 10.1128/CMR.00012-07; Baylis H.A., 1923, Annals & Magazine of Natural History Series 9, V11, P211; Burgman MA, 2003, ANIM CONSERV, V6, P19, DOI 10.1017/S1367943003003044; CAMPANA-ROUGET Y., 1955, ANN PARASITOL HUMAINE ET COMP, V30, P477; Chai JY, 2005, INT J PARASITOL, V35, P1233, DOI 10.1016/j.ijpara.2005.07.013; Colon-Llavina MM, 2009, PARASITOL RES, V105, P1239, DOI 10.1007/s00436-009-1544-4; Cross MA, 2007, MAR BIOL, V151, P695, DOI 10.1007/s00227-006-0509-8; Diesing K.M., 1861, SITZUNGSBER KAISERL, V28, P595; Dollfus R. Ph., 1966, Annales de la Societe des Sciences Naturelles de la Charente-Maritime, V4, P3; Du CX, 2010, ELECTROPHORESIS, V31, P654, DOI 10.1002/elps.200900531; Dzido J, 2009, POLAR SCI, V3, P207, DOI 10.1016/j.polar.2009.08.003; EDELSBRUNNER H, 1983, IEEE T INFORM THEORY, V29, P551, DOI 10.1109/TIT.1983.1056714; Fang WZ, 2010, EXP PARASITOL, V124, P197, DOI 10.1016/j.exppara.2009.09.011; Farjallah S, 2008, PARASITOL INT, V57, P430, DOI 10.1016/j.parint.2008.05.002; Farjallah S, 2008, PARASITOL RES, V102, P371, DOI 10.1007/s00436-007-0771-9; Garcia A, 2008, J FISH BIOL, V73, P2274, DOI 10.1111/j.1095-8649.2008.02072.x; Garcia A, 2011, ICES J MAR SCI, V68, P175, DOI 10.1093/icesjms/fsq147; GASTON KJ, 1991, OIKOS, V61, P434, DOI 10.2307/3545251; GON O, FISHES SO OCEAN; Hochberg NS, 2010, CLIN INFECT DIS, V51, P806, DOI 10.1086/656238; Iniguez AM, 2011, VET PARASITOL, V178, P293, DOI 10.1016/j.vetpar.2011.01.001; Iniguez AM, 2009, VET PARASITOL, V165, P350, DOI 10.1016/j.vetpar.2009.07.012; *IUCN, IUCN RED LIST CAT CR; *IUCN, 2001, IUCN RED LIST CAT CR, P13; Kadmon R, 2004, ECOL APPL, V14, P401, DOI 10.1890/02-5364; Karl H, 2011, DIS AQUAT ORGAN, V94, P201, DOI 10.3354/dao02317; Kijewska A, 2009, J PARASITOL, V95, P1364, DOI 10.1645/GE-1950.1; Kijewska A, 2009, J PARASITOL, V95, P639, DOI 10.1645/GE-1796.1; Klimpel S, 2008, DEEP-SEA RES PT II, V55, P229, DOI 10.1016/j.dsr2.2007.09.006; Klimpel S, 2004, PARASITOL RES, V94, P1, DOI 10.1007/s00436-004-1154-0; Klimpel S, 2008, PARASITOL RES, V104, P43, DOI 10.1007/s00436-008-1157-3; Klimpel S, 2007, MAR BIOL, V152, P725, DOI 10.1007/s00227-007-0727-8; Klimpel S, 2011, POLAR BIOL, V34, P899, DOI 10.1007/s00300-010-0946-1; Klimpel S, 2010, DEEP-SEA RES PT I, V57, P596, DOI 10.1016/j.dsr.2010.01.002; Klimpel S, 2010, MAR ECOL PROG SER, V403, P1, DOI 10.3354/meps08501; Krabbe H, 1878, OVERSIGT KONGELIGE D, V1, P43; Marques JF, 2006, J HELMINTHOL, V80, P47, DOI 10.1079/JOH2005325; Mattiucci S, 2008, FISH RES, V89, P146, DOI 10.1016/j.fishres.2007.09.032; Mattiucci S, 2005, SYST PARASITOL, V61, P157, DOI 10.1007/s11230-005-3158-2; Mattiucci S, 2004, J FISH BIOL, V65, P495, DOI 10.1111/j.0022-1112.2004.00465.x; Mattiucci S, 1998, SYST PARASITOL, V40, P81, DOI 10.1023/A:1005914926720; Mattiucci S, 1997, J PARASITOL, V83, P401, DOI 10.2307/3284402; Mattiucci S, 2002, SYST PARASITOL, V51, P159, DOI 10.1023/A:1014554900808; MATTIUCCI S, 1986, PARASITOLOGY, V93, P383, DOI 10.1017/S0031182000051544; Mattiucci S, 2005, COLLECTIVE VOLUME SC, V58, P1470; MATTIUCCI S, 2001, INT J PARASITOL, V16, P633; Mattiucci S, 2008, ADV PARASIT, V66, P47, DOI 10.1016/S0065-308X(08)00202-9; Mattiucci S, 2007, VET PARASITOL, V148, P43, DOI 10.1016/j.vetpar.2007.05.009; Mattiucci S, 2009, SYST PARASITOL, V74, P199, DOI 10.1007/s11230-009-9212-8; Moravec F., 1994, Parasitic nematodes of freshwater fishes of Europe.; Murphy TM, 2010, J PARASITOL, V96, P77, DOI 10.1645/GE-2194.1; Nadler SA, 2005, J PARASITOL, V91, P1413, DOI 10.1645/GE-522R.1; NASCETTI G, 1986, INT J PARASITOL, V16, P633, DOI 10.1016/0020-7519(86)90032-9; Noguera P, 2009, DIS AQUAT ORGAN, V87, P199, DOI 10.3354/dao02141; Paggi L, 1998, SYST PARASITOL, V40, P161, DOI 10.1023/A:1006093201920; Palm HW, 2008, HELMINTHOLOGIA, V45, P3, DOI 10.2478/s11687-008-0001-8; Pateiro-Lopez B, 2010, J STAT SOFTW, V34, P1; Pontes T, 2005, J PARASITOL, V91, P1430, DOI 10.1645/GE-565R1.1; Quantum GIS Development Team, 2011, QUANT GIS GEOGR INF; Quiazon KMA, 2009, J PARASITOL, V95, P1227, DOI 10.1645/GE-1751.1; Quiazon KMA, 2008, PARASITOL INT, V57, P483, DOI 10.1016/j.parint.2008.06.003; R Core Team, 2020, R LANG ENV STAT COMP; Raedig C, 2010, BIODIVERS CONSERV, V19, P1523, DOI 10.1007/s10531-010-9785-1; Reddy S, 2003, J BIOGEOGR, V30, P1719, DOI 10.1046/j.1365-2699.2003.00946.x; Rudolphi C. A., 1819, ENTOZOORUM SYNOPSIS; Skov J, 2009, AQUACULTURE, V298, P24, DOI 10.1016/j.aquaculture.2009.09.024; Suzuki J, 2010, INT J FOOD MICROBIOL, V137, P88, DOI 10.1016/j.ijfoodmicro.2009.10.001; Umehara A., 2008, SE ASIAN J TROP MED, V39, P26; Umehara A, 2008, PARASITOL INT, V57, P49, DOI 10.1016/j.parint.2007.08.003; Umehara A, 2007, PARASITOL INT, V56, P211, DOI 10.1016/j.parint.2007.02.005; Umehara A, 2006, PARASITOL INT, V55, P267, DOI 10.1016/j.parint.2006.07.001; Umehara A, 2010, INT J FOOD MICROBIOL, V143, P161, DOI 10.1016/j.ijfoodmicro.2010.08.011; Valentini A, 2006, J PARASITOL, V92, P156, DOI 10.1645/GE-3504.1; West KL, 2009, MAR MAMMAL SCI, V25, P931, DOI 10.1111/j.1748-7692.2009.00295.x; Zhang LP, 2007, MOL CELL PROBE, V21, P386, DOI 10.1016/j.mcp.2007.05.004; Zhu XQ, 2007, PARASITOL RES, V101, P1703, DOI 10.1007/s00436-007-0699-0; Zhu XQ, 1998, INT J PARASITOL, V28, P1911, DOI 10.1016/S0020-7519(98)00150-7; Zhu XQ, 2000, PARASITOL RES, V86, P738, DOI 10.1007/PL00008561	83	55	58	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28642	10.1371/journal.pone.0028642	http://dx.doi.org/10.1371/journal.pone.0028642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180787	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300016
J	Song, YX; Gao, P; Wang, ZN; Tong, LL; Xu, YY; Sun, Z; Xing, CZ; Xu, HM				Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Tong, Lin-Lin; Xu, Ying-Ying; Sun, Zhe; Xing, Cheng-Zhong; Xu, Hui-Mian			Which Is the Most Suitable Classification for Colorectal Cancer, Log Odds, the Number or the Ratio of Positive Lymph Nodes?	PLOS ONE			English	Article							GASTRIC-CANCER; PROGNOSTIC-FACTOR; BREAST-CANCER; COLON-CANCER; SURVIVAL; IMPACT	Objective: The aim of the current study was to investigate which is the most suitable classification for colorectal cancer, log odds of positive lymph nodes (LODDS) classification or the classifications based on the number of positive lymph nodes (pN) and positive lymph node ratio(LNR) in a Chinese single institutional population. Design: Clinicopathologic and prognostic data of 1297 patients with colorectal cancer were retrospectively studied. The log-rank statistics, Cox's proportional hazards model, the Nagelkerke R-2 index and a Harrell's C statistic were used. Results: Univariate and three-step multivariate analyses identified that LNR was a significant prognostic factor and LNR classification was superior to both the pN and LODDS classifications. Moreover, the results of the Nagelkerke R-2 index (0.130) and a Harrell's C statistic (0.707) of LNR showed that LNR and LODDS classifications were similar and LNR was a little better than the other two classifications. Furthermore, for patients in each LNR classification, prognosis was homologous between those in different pN or LODDS classifications. However, for patients in pN1a, pN1b, LODDS2 and LODDS3 classifications, significant differences in survival were observed among patients in different LNR classifications. Conclusions: For patients with colorectal cancer, the LNR classification is more suitable than pN and LODDS classifications for prognostic assessment in a Chinese single institutional population.	[Song, Yong-Xi; Gao, Peng; Wang, Zhen-Ning; Tong, Lin-Lin; Xu, Ying-Ying; Sun, Zhe; Xing, Cheng-Zhong; Xu, Hui-Mian] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China	China Medical University	Wang, ZN (corresponding author), China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China.	josieon826@yahoo.com.cn	wang, zhen ning/E-1878-2011; Xu, Yingying/E-3884-2018; Gao, Peng/B-8031-2013	wang, zhen ning/0000-0003-0557-3097; Xu, Yingying/0000-0003-4924-9379; 	National Science Foundation of China [30972879, 81172370]; Specialized Research Fund for the Doctoral Program of Higher Education [200801590006]; Natural Science Foundation of Liaoning Province [20092129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	This work was supported by National Science Foundation of China (No. 30972879 and No. 81172370), Specialized Research Fund for the Doctoral Program of Higher Education (No. 200801590006) and Natural Science Foundation of Liaoning Province (No. 20092129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, AJCC CANC STAGING MA; Bhatti I, 2010, WORLD J SURG, V34, P768, DOI 10.1007/s00268-009-0336-4; Ceelen W, 2010, ANN SURG ONCOL, V17, P2847, DOI 10.1245/s10434-010-1158-1; Chok KSH, 2007, WORLD J SURG, V31, P1485, DOI 10.1007/s00268-007-9089-0; CROWLEY J, 1997, LECT NOTES STAT, P199; Downing SR, 2010, J SURG RES, V163, P264, DOI 10.1016/j.jss.2010.03.017; Edge SB, 2010, AJCC CANC STAGING MA; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Harrell FE, 2015, SPRINGER SER STAT, P453, DOI 10.1007/978-3-319-19425-7_19; Huh JW, 2010, ANN SURG ONCOL, V17, P2640, DOI 10.1245/s10434-010-1015-2; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Landau S., 2004, HDB STAT ANAL USING; Moug SJ, 2009, BRIT J CANCER, V100, P1530, DOI 10.1038/sj.bjc.6605049; Ng M, 2009, AM SURGEON, V75, P873; Ostadi MA, 2007, SURG ENDOSC, V21, P2142, DOI 10.1007/s00464-007-9414-6; Persiani R, 2008, EJSO-EUR J SURG ONC, V34, P519, DOI 10.1016/j.ejso.2007.05.009; Qiu HB, 2011, ANN SURG ONCOL, V18, P1568, DOI 10.1245/s10434-010-1528-8; Rosenberg R, 2010, ANN SURG, V251, P1070, DOI 10.1097/SLA.0b013e3181d7789d; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Sun Z, 2009, ANN ONCOL, V20, P897, DOI 10.1093/annonc/mdn707; Sun Z, 2010, CANCER-AM CANCER SOC, V116, P2571, DOI 10.1002/cncr.24989; Tong LL, 2011, ANN SURG ONCOL, V18, P2453, DOI 10.1245/s10434-011-1687-2; Vinh-Hung V, 2004, BREAST CANCER RES, V6, pR680, DOI 10.1186/bcr934; Vinh-Hung V, 2009, J CLIN ONCOL, V27, P1062, DOI 10.1200/JCO.2008.18.6965; Voordeckers M, 2004, RADIOTHER ONCOL, V70, P225, DOI 10.1016/j.radonc.2003.10.015; Wang JP, 2008, J GASTROINTEST SURG, V12, P1790, DOI 10.1007/s11605-008-0651-3; Xu An-gao, 2006, Zhonghua Nei Ke Za Zhi, V45, P9	28	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28937	10.1371/journal.pone.0028937	http://dx.doi.org/10.1371/journal.pone.0028937			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174929	Green Submitted, Green Published, gold			2022-12-27	WOS:000298367300033
J	Armstrong, GAB; Xiao, CF; Krill, JL; Seroude, L; Dawson-Scully, K; Robertson, RM				Armstrong, Gary A. B.; Xiao, Chengfeng; Krill, Jennifer L.; Seroude, Laurent; Dawson-Scully, Ken; Robertson, R. Meldrum			Glial Hsp70 Protects K+ Homeostasis in the Drosophila Brain during Repetitive Anoxic Depolarization	PLOS ONE			English	Article							CORTICAL SPREADING DEPRESSION; CEREBRAL-ARTERY OCCLUSION; OXYGEN REPERFUSION; NEURONAL DAMAGE; GENETIC-BASIS; TOLERANCE; MELANOGASTER; MECHANISMS; ISCHEMIA; HEAT-SHOCK-PROTEIN-70	Neural tissue is particularly vulnerable to metabolic stress and loss of ion homeostasis. Repetitive stress generally leads to more permanent dysfunction but the mechanisms underlying this progression are poorly understood. We investigated the effects of energetic compromise in Drosophila by targeting the Na+/.K+-ATPase. Acute ouabain treatment of intact flies resulted in subsequent repetitive comas that led to death and were associated with transient loss of K+ homeostasis in the brain. Heat shock pre-conditioned flies were resistant to ouabain treatment. To control the timing of repeated loss of ion homeostasis we subjected flies to repetitive anoxia while recording extracellular [K+] in the brain. We show that targeted expression of the chaperone protein Hsp70 in glial cells delays a permanent loss of ion homeostasis associated with repetitive anoxic stress and suggest that this is a useful model for investigating molecular mechanisms of neuroprotection.	[Armstrong, Gary A. B.; Xiao, Chengfeng; Seroude, Laurent; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Krill, Jennifer L.; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA	Queens University - Canada; State University System of Florida; Florida Atlantic University	Armstrong, GAB (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	gary.ab.armstrong@gmail.com	Robertson, Robert M/B-2482-2009; Xiao, Chengfeng/B-1432-2014	Robertson, Robert M/0000-0002-2666-7861; Armstrong, Gary/0000-0003-4613-8817; Xiao, Chengfeng/0000-0002-2301-1365; Seroude, Laurent/0000-0002-4785-3890	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC)(http://www.nserc-crsng.gc.ca/Index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW RD, 1994, NEUROSCIENCE, V62, P371, DOI 10.1016/0306-4522(94)90372-7; Armstrong GAB, 2010, BRAIN RES, V1311, P64, DOI 10.1016/j.brainres.2009.11.038; Armstrong GAB, 2009, J NEUROSCI, V29, P8225, DOI 10.1523/JNEUROSCI.1652-09.2009; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; BRANSTON NM, 1977, J NEUROL SCI, V32, P305, DOI 10.1016/0022-510X(77)90014-4; Brown CE, 2008, STROKE, V39, P1286, DOI 10.1161/STROKEAHA.107.498238; Busch E, 1996, J CEREBR BLOOD F MET, V16, P1090, DOI 10.1097/00004647-199611000-00002; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; Ekimova IV, 2010, J NEUROCHEM, V115, P1035, DOI 10.1111/j.1471-4159.2010.06989.x; Evans CG, 2010, J MED CHEM, V53, P4585, DOI 10.1021/jm100054f; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Giffard RG, 2004, J EXP BIOL, V207, P3213, DOI 10.1242/jeb.01034; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Hartings JA, 2003, J NEUROSCI, V23, P11602; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lighton JRB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001267; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Neal SJ, 2006, PHYSIOL GENOMICS, V25, P493, DOI 10.1152/physiolgenomics.00195.2005; Obeidat AS, 2000, J CEREBR BLOOD F MET, V20, P412, DOI 10.1097/00004647-200002000-00024; Peters O, 1998, J CEREBR BLOOD F MET, V18, P196, DOI 10.1097/00004647-199802000-00011; Plumier JCL, 1997, CELL STRESS CHAPERON, V2, P162, DOI 10.1379/1466-1268(1997)002<0162:TMETHI>2.3.CO;2; Rajdev S, 2000, ANN NEUROL, V47, P782, DOI 10.1002/1531-8249(200006)47:6<782::AID-ANA11>3.0.CO;2-3; Ransom CB, 2000, J PHYSIOL-LONDON, V522, P427, DOI 10.1111/j.1469-7793.2000.00427.x; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Rodgers CI, 2010, J INSECT PHYSIOL, V56, P980, DOI 10.1016/j.jinsphys.2010.03.030; Rodgers CI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001366; Rodgers CI, 2009, J INSECT PHYSIOL, V55, P599, DOI 10.1016/j.jinsphys.2009.03.004; Rodgers-Garlick CI, 2011, J NEUROSCI, V31, P3207, DOI 10.1523/JNEUROSCI.5215-10.2011; Sanchez-del-Rio M, 2006, CURR OPIN NEUROL, V19, P294, DOI 10.1097/01.wco.0000227041.23694.5c; Schilman PE, 2011, J EXP BIOL, V214, P1271, DOI 10.1242/jeb.052357; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; STRONG AJ, 2005, ADV TECHNICAL STANDA, P3; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Van Voorhies WA, 2009, J EXP BIOL, V212, P3132, DOI 10.1242/jeb.031179; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Xiao CF, 2007, DEV NEUROBIOL, V67, P438, DOI 10.1002/dneu.20344; Yenari MA, 1998, ANN NEUROL, V44, P584, DOI 10.1002/ana.410440403; Zhou D, 2009, PEDIATR RES, V66, P239, DOI 10.1203/PDR.0b013e3181b27275	49	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28994	10.1371/journal.pone.0028994	http://dx.doi.org/10.1371/journal.pone.0028994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174942	gold, Green Published			2022-12-27	WOS:000298366600056
J	Plissonnier, ML; Fauconnet, S; Bittard, H; Lascombe, I				Plissonnier, Marie-Laure; Fauconnet, Sylvie; Bittard, Hugues; Lascombe, Isabelle			The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; SENSITIZES TUMOR-CELLS; HUMAN UROTHELIAL CELLS; DOWN-REGULATION; C-FLIP; LIGAND; SURVIVIN; DEATH; PPAR; PROGRESSION	Background: Ciglitazone belongs to the thiazolidinediones class of antidiabetic drug family and is a high-affinity ligand for the Peroxisome Proliferator-Activated Receptor gamma (PPAR gamma). Apart from its antidiabetic activity, this molecule shows antineoplastic effectiveness in numerous cancer cell lines. Methodology/Principal Findings: Using RT4 (derived from a well differentiated grade I papillary tumor) and T24 (derived from an undifferentiated grade III carcinoma) bladder cancer cells, we investigated the potential of ciglitazone to induce apoptotic cell death and characterized the molecular mechanisms involved. In RT4 cells, the drug induced G2/M cell cycle arrest characterized by an overexpression of p53, p21(waf1/CIP1) and p27(Kip1) in concomitance with a decrease of cyclin B1. On the contrary, in T24 cells, it triggered apoptosis via extrinsic and intrinsic pathways. Cell cycle arrest and induction of apoptosis occurred at high concentrations through PPAR gamma activation-independent pathways. We show that in vivo treatment of nude mice by ciglitazone inhibits high grade bladder cancer xenograft development. We identified a novel mechanism by which ciglitazone kills cancer cells. Ciglitazone up-regulated soluble and membrane-bound TRAIL and let TRAIL-resistant T24 cells to respond to TRAIL through caspase activation, death receptor signalling pathway and Bid cleavage. We provided evidence that TRAIL-induced apoptosis is partially driven by ciglitazone-mediated down-regulation of c-FLIP and survivin protein levels through a proteasome-dependent degradation mechanism. Conclusions/Significance: Therefore, ciglitazone could be clinically relevant as chemopreventive or therapeutic agent for the treatment of TRAIL-refractory high grade urothelial cancers.	[Plissonnier, Marie-Laure; Fauconnet, Sylvie; Lascombe, Isabelle] Univ Franche Comte, Fac Sci Med & Pharmaceut, Inst Fed Rech 133, Lab Biol Cellulaire & Mol,Equipe Accueil 3181, F-25030 Besancon, France; [Fauconnet, Sylvie; Bittard, Hugues] CHRU Besancon, Serv Urol & Androl, Besancon, France	Universite de Franche-Comte; Universite de Franche-Comte; CHU Besancon	Plissonnier, ML (corresponding author), Univ Franche Comte, Fac Sci Med & Pharmaceut, Inst Fed Rech 133, Lab Biol Cellulaire & Mol,Equipe Accueil 3181, F-25030 Besancon, France.	isabelle.lascombe@univ-fcomte.fr	Plissonnier, Marie-Laure/Y-9491-2019	Plissonnier, Marie-Laure/0000-0003-4879-4586	Ligue Nationale Contre le Cancer (Comite du Doubs); Canceropole du Grand-Est	Ligue Nationale Contre le Cancer (Comite du Doubs); Canceropole du Grand-Est(Region Grand-Est)	This work was supported by research grants from Ligue Nationale Contre le Cancer (Comite du Doubs). M. L. Plissonnier was supported by a fellowship from the Canceropole du Grand-Est. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogazzi F, 2004, EUR J ENDOCRINOL, V150, P863, DOI 10.1530/eje.0.1500863; Boiteux G, 2009, INT J CANCER, V124, P1820, DOI 10.1002/ijc.24112; Bonavida B, 1999, INT J ONCOL, V15, P793; Chaffer CL, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-53; Chen F, 2005, CELL SIGNAL, V17, P1572, DOI 10.1016/j.cellsig.2005.03.012; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; Chintharlapalli S, 2005, MOL PHARMACOL, V68, P1782, DOI 10.1124/mol.105.017046; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Doonan F, 2009, J NEUROCHEM, V109, P631, DOI 10.1111/j.1471-4159.2009.05995.x; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF1013, DOI 10.1152/ajprenal.1997.273.6.F1013; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Jesenberger V, 2002, NAT REV MOL CELL BIO, V3, P112, DOI 10.1038/nrm731; Kamat A M, 2001, Curr Urol Rep, V2, P62, DOI 10.1007/s11934-001-0027-7; Keane MM, 1999, CANCER RES, V59, P734; Kim DJ, 2005, J BIOL CHEM, V280, P9519, DOI 10.1074/jbc.M413808200; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Ku JH, 2010, BJU INT, V106, P1812, DOI 10.1111/j.1464-410X.2010.09259.x; Lascombe I, 2006, CLIN CANCER RES, V12, P2780, DOI 10.1158/1078-0432.CCR-05-2387; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; Lee R, 2000, UROL CLIN N AM, V27, P1, DOI 10.1016/S0094-0143(05)70229-9; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Ludwig AT, 2004, CANCER RES, V64, P3386, DOI 10.1158/0008-5472.CAN-04-0374; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Ning S, 2004, INT J ONCOL, V25, P1065; O'Connor DS, 2000, P NATL ACAD SCI USA, V97, P13103, DOI 10.1073/pnas.240390697; Oka N, 2006, CANCER SCI, V97, P1093, DOI 10.1111/j.1349-7006.2006.00294.x; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rumi M. A. K., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P465, DOI 10.2174/1568011043352678; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Senthivinayagam S, 2009, J BIOL CHEM, V284, P13577, DOI 10.1074/jbc.M900248200; Shariat SF, 2007, UROL ONCOL-SEMIN ORI, V25, P468, DOI 10.1016/j.urolonc.2006.09.011; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Steele LP, 2006, CELL DEATH DIFFER, V13, P1564, DOI 10.1038/sj.cdd.4401846; STEWART N, 1995, ONCOGENE, V10, P109; Suzuki S, 2010, TOXICOL SCI, V113, P349, DOI 10.1093/toxsci/kfp256; Turturro F, 2004, CLIN CANCER RES, V10, P7022, DOI 10.1158/1078-0432.CCR-04-0879; VIKHANSKAYA F, 1994, NUCLEIC ACIDS RES, V22, P1012, DOI 10.1093/nar/22.6.1012; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Wolf BB, 1999, J BIOL CHEM, V274, P30651, DOI 10.1074/jbc.274.43.30651; Yoshimura R, 2003, INT J MOL MED, V12, P861; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299	50	24	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28354	10.1371/journal.pone.0028354	http://dx.doi.org/10.1371/journal.pone.0028354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174792	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600012
J	Roy, A; Chowdhury, S; Sengupta, S; Mandal, M; Jaisankar, P; D'Annessa, I; Desideri, A; Majumder, HK				Roy, Amit; Chowdhury, Sayan; Sengupta, Souvik; Mandal, Madhumita; Jaisankar, Parasuraman; D'Annessa, Ilda; Desideri, Alessandro; Majumder, Hemanta K.			Development of Derivatives of 3, 3 '-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons	PLOS ONE			English	Article							BREAST-CANCER CELLS; 3,3'-DIINDOLYLMETHANE DIM; DNA TOPOISOMERASES; MECHANISM; CAMPTOTHECIN; INHIBITION; CLEAVAGE; COMPLEX	Background: The development of 3, 3'-diindolyl methane (DIM) resistant parasite Leishmania donovani (LdDR50) by adaptation with increasing concentrations of the drug generates random mutations in the large and small subunits of heterodimeric DNA topoisomerase I of Leishmania (LdTOP1LS). Mutation of large subunit of LdTOP1LS at F270L is responsible for resistance to DIM up to 50 mu M concentration. Methodology/Principal Findings: In search of compounds that inhibit the growth of the DIM resistant parasite and inhibit the catalytic activity of mutated topoisomerase I (F270L), we have prepared three derivatives of DIM namely DPDIM (2,2'-diphenyl 3,3'-diindolyl methane), DMDIM (2,2'-dimethyl 3,3'-diindolyl methane) and DMODIM (5,5'-dimethoxy 3,3'-diindolyl methane) from parent compound DIM. All the compounds inhibit the growth of DIM resistant parasites, induce DNA fragmentation and stabilize topo1-DNA cleavable complex with the wild type and mutant enzyme. Conclusion: The results suggest that the three derivatives of DIM can act as promising lead molecules for the generation of new anti-leishmanial agents.	[Roy, Amit; Chowdhury, Sayan; Sengupta, Souvik; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata, India; [Mandal, Madhumita; Jaisankar, Parasuraman] Indian Inst Chem Biol, Dept Med Chem, Kolkata, India; [D'Annessa, Ilda; Desideri, Alessandro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Rome Tor Vergata	Roy, A (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata, India.	hkmajumder@iicb.res.in	Jaisankar, Parasuraman/C-1553-2009; Gupta, Souvik Sen/X-9547-2019	Jaisankar, Parasuraman/0000-0003-0583-4920; Gupta, Souvik Sen/0000-0001-7452-979X; D'Annessa, Ilda/0000-0002-6174-6899; desideri, alessandro/0000-0003-1541-4217	Council of Scientific and Industrial Research (CSIR), Government of India [NWP-38]	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grants from Network Project NWP-38 of Council of Scientific and Industrial Research (CSIR), Government of India, CSIR fellowship (to Dr. Roy, Dr. Chowdhury, Dr. Sengupta). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Das A, 2004, TRENDS PARASITOL, V20, P381, DOI 10.1016/j.pt.2004.06.005; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; DAS BB, 2004, LEISHMANIA, V565, P81; Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022; Gong YX, 2006, MOL PHARMACOL, V69, P1320, DOI 10.1124/mol.105.018978; Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9; Guharay J, 2001, PROTEINS, V43, P75, DOI 10.1002/1097-0134(20010501)43:2<75::AID-PROT1019>3.3.CO;2-Z; Hong C, 2002, BIOCHEM PHARMACOL, V63, P1085, DOI 10.1016/S0006-2952(02)00856-0; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pal C, 2007, BIOORG MED CHEM LETT, V17, P4924, DOI 10.1016/j.bmcl.2007.06.025; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Roy A, 2008, BIOCHEM J, V409, P611, DOI 10.1042/BJ20071286; Roy A, 2009, ANTIMICROB AGENTS CH, V53, P2589, DOI 10.1128/AAC.01648-08; Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599; Tesauro C, 2010, BIOCHEM J, V425, P531, DOI 10.1042/BJ20091127; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223	23	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28493	10.1371/journal.pone.0028493	http://dx.doi.org/10.1371/journal.pone.0028493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174820	Green Submitted, gold, Green Published			2022-12-27	WOS:000298366600022
J	Hayes, NVL; Josse, L; Smales, CM; Carden, MJ				Hayes, Nandini V. L.; Josse, Lyne; Smales, C. Mark; Carden, Martin J.			Modulation of Phosducin-Like Protein 3 (PhLP3) Levels Promotes Cytoskeletal Remodelling in a MAPK and RhoA-Dependent Manner	PLOS ONE			English	Article							CYTOSOLIC CHAPERONIN COMPLEX; CULTURED-MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; CYCLE PROGRESSION; GENE-EXPRESSION; COLD-SHOCK; IN-VITRO; CCT; KINASE; LINKING	Background: Phosducin-like protein 3 (PhLP3) forms a ternary complex with the ATP-dependent molecular chaperone CCT and its folding client tubulin. In vitro studies suggest PhLP3 plays an inhibitory role in beta-tubulin folding while conversely in vivo genetic studies suggest PhLP3 is required for the correct folding of beta-tubulin. We have a particular interest in the cytoskeleton, its chaperones and their role in determining cellular phenotypes associated with high level recombinant protein expression from mammalian cell expression systems. Methodology/Principal Findings: As studies into PhLP3 function have been largely carried out in non mammalian systems, we examined the effect of human PhLP3 over-expression and siRNA silencing using a single murine siRNA on both tubulin and actin systems in mammalian Chinese hamster ovary (CHO) cell lines. We show that over-expression of PhLP3 promotes an imbalance of alpha and beta tubulin subunits, microtubule disassembly and cell death. In contrast, beta-actin levels are not obviously perturbed. On-the-other-hand, RNA silencing of PhLP3 increases RhoA-dependent actin filament formation and focal adhesion formation and promotes a dramatic elongated fibroblast-like change in morphology. This was accompanied by an increase in phosphorylated MAPK which has been associated with promoting focal adhesion assembly and maturation. Transient overexpression of PhLP3 in knockdown experiments rescues cells from the morphological change observed during PhLP3 silencing but mitosis is perturbed, probably reflecting a tipping back of the balance of PhLP3 levels towards the overexpression state. Conclusions: Our results support the hypothesis that PhLP3 is important for the maintenance of beta-tubulin levels in mammalian cells but also that its modulation can promote actin-based cytoskeletal remodelling by a mechanism linked with MAPK phosphorylation and RhoA-dependent changes. PhLP3 levels in mammalian cells are thus finely poised and represents a novel target for engineering industrially relevant cell lines to evolve lines more suited to suspension or adherent cell growth.	[Hayes, Nandini V. L.] Univ Kent, Ctr Mol Proc, Canterbury, Kent, England; Univ Kent, Sch Biosci, Canterbury, Kent, England	University of Kent; University of Kent	Hayes, NVL (corresponding author), Univ Kent, Ctr Mol Proc, Canterbury, Kent, England.	c.m.smales@kent.ac.uk; m.j.carden@kent.ac.uk	Carden, Martin/D-4135-2019	Carden, Martin/0000-0002-0609-4605; Smales, Christopher Mark/0000-0002-2762-4724; JOSSE, Lyne/0000-0002-7856-7651	BBSRC [BB/E005969/1]; EPSRC; industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative; Biotechnology and Biological Sciences Research Council [BB/E005969/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by project grant BB/E005969/1 from the BBSRC, EPSRC and industrial club members via the Bioprocessing Research Industry Club (BRIC) initiative (www.bbsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Blaauw M, 2003, EMBO J, V22, P5047, DOI 10.1093/emboj/cdg508; Brackley KI, 2010, EXP CELL RES, V316, P543, DOI 10.1016/j.yexcr.2009.11.003; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; BURKE D, 1989, MOL CELL BIOL, V9, P1049, DOI 10.1128/MCB.9.3.1049; Camasses A, 2003, MOL CELL, V12, P87, DOI 10.1016/S1097-2765(03)00244-2; Castellano MM, 2008, PLANT CELL, V20, P969, DOI 10.1105/tpc.107.057737; Dinnis DM, 2006, BIOTECHNOL BIOENG, V94, P830, DOI 10.1002/bit.20899; Etchells SA, 2005, J BIOL CHEM, V280, P28118, DOI 10.1074/jbc.M504110200; Flanary PL, 2000, J BIOL CHEM, V275, P18462, DOI 10.1074/jbc.M002163200; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gourbatsi E, 2006, MOL BIOTECHNOL, V33, P1; Grantham J, 2002, CELL STRESS CHAPERON, V7, P235, DOI 10.1379/1466-1268(2002)007<0235:ECCTCP>2.0.CO;2; Hayes NVL, 2010, BIOTECHNOL BIOENG, V105, P770, DOI 10.1002/bit.22587; Josse L, 2010, BIOTECHNOL BIOENG, V105, P556, DOI 10.1002/bit.22572; Kabir MA, 2008, FEMS YEAST RES, V8, P1236, DOI 10.1111/j.1567-1364.2008.00425.x; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Lacefield S, 2003, GENETICS, V165, P531; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Lopez P, 2003, J BIOL CHEM, V278, P1751, DOI 10.1074/jbc.M207434200; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; Masterton RJ, 2010, BIOTECHNOL BIOENG, V105, P215, DOI 10.1002/bit.22533; McCormack EA, 2009, J MOL BIOL, V391, P192, DOI 10.1016/j.jmb.2009.06.003; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; McLaughlin JN, 2002, J BIOL CHEM, V277, P34885, DOI 10.1074/jbc.M205583200; Mead EJ, 2009, BIOTECHNOL BIOENG, V102, P1593, DOI 10.1002/bit.22201; Ogawa S, 2004, GENES CELLS, V9, P83, DOI 10.1111/j.1356-9597.2004.00708.x; Ohsaka Y, 2002, CELL PHYSIOL BIOCHEM, V12, P111, DOI 10.1159/000063787; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Pullikuth AK, 2010, MOL CELL BIOL, V30, P3233, DOI 10.1128/MCB.01178-09; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; ROOBOL A, 1995, J CELL SCI, V108, P1477; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Stirling PC, 2006, J BIOL CHEM, V281, P7012, DOI 10.1074/jbc.M513235200; Stirling PC, 2007, MOL BIOL CELL, V18, P2336, DOI 10.1091/mbc.E07-01-0069; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Underhill MF, 2005, BIOTECHNOL BIOENG, V89, P805, DOI 10.1002/bit.20403; Underhill MF, 2006, MOL BIOTECHNOL, V34, P141, DOI 10.1385/MB:34:2:141; Wilkinson JC, 2004, J BIOL CHEM, V279, P51091, DOI 10.1074/jbc.M409623200; Willardson BM, 2007, CELL SIGNAL, V19, P2417, DOI 10.1016/j.cellsig.2007.06.013	46	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28271	10.1371/journal.pone.0028271	http://dx.doi.org/10.1371/journal.pone.0028271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174782	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000298365700025
J	Henriksen, SB; Mortensen, RJ; Geertz-Hansen, HM; Neves-Petersen, MT; Arnason, O; Soring, J; Petersen, SB				Henriksen, Svend B.; Mortensen, Rasmus J.; Geertz-Hansen, Henrik M.; Neves-Petersen, Maria Teresa; Arnason, Omar; Soring, Jon; Petersen, Steffen B.			Hyperdimensional Analysis of Amino Acid Pair Distributions in Proteins	PLOS ONE			English	Article							COMPLEX SALT BRIDGES; CORRELATED MUTATIONS; ENERGETIC APPROACH; GLOBULAR-PROTEINS; DISULFIDE BRIDGES; RESIDUE CONTACTS; ALPHA-HELICES; BETA-PACKING; PREDICTION; CLASSIFICATION	Our manuscript presents a novel approach to protein structure analyses. We have organized an 8-dimensional data cube with protein 3D-structural information from 8706 high-resolution non-redundant protein-chains with the aim of identifying packing rules at the amino acid pair level. The cube contains information about amino acid type, solvent accessibility, spatial and sequence distance, secondary structure and sequence length. We are able to pose structural queries to the data cube using program ProPack. The response is a 1, 2 or 3D graph. Whereas the response is of a statistical nature, the user can obtain an instant list of all PDB-structures where such pair is found. The user may select a particular structure, which is displayed highlighting the pair in question. The user may pose millions of different queries and for each one he will receive the answer in a few seconds. In order to demonstrate the capabilities of the data cube as well as the programs, we have selected well known structural features, disulphide bridges and salt bridges, where we illustrate how the queries are posed, and how answers are given. Motifs involving cysteines such as disulphide bridges, zinc-fingers and iron-sulfur clusters are clearly identified and differentiated. ProPack also reveals that whereas pairs of Lys residues virtually never appear in close spatial proximity, pairs of Arg are abundant and appear at close spatial distance, contrasting the belief that electrostatic repulsion would prevent this juxtaposition and that Arg-Lys is perceived as a conservative mutation. The presented programs can find and visualize novel packing preferences in proteins structures allowing the user to unravel correlations between pairs of amino acids. The new tools allow the user to view statistical information and visualize instantly the structures that underpin the statistical information, which is far from trivial with most other SW tools for protein structure analysis.	[Henriksen, Svend B.; Mortensen, Rasmus J.; Geertz-Hansen, Henrik M.; Arnason, Omar; Soring, Jon] Univ Aalborg, Dept Phys & Nanotechnol, NanoBiotechnol Grp, Aalborg, Denmark; [Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Neves-Petersen, Maria Teresa] Univ Aalborg, Nanobiotechnol Grp, Dept Biotechnol Chem & Environm Sci, Aalborg, Denmark; [Petersen, Steffen B.] Univ Aalborg, Nanobiotechnol Grp, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	Aalborg University; International Iberian Nanotechnology Laboratory; Aalborg University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Henriksen, SB (corresponding author), Univ Aalborg, Dept Phys & Nanotechnol, NanoBiotechnol Grp, Aalborg, Denmark.	teresa.petersen@inl.int	Petersen, Steffen b/E-8727-2015	Petersen, Steffen b/0000-0002-0739-2751; Neves-Petersen, Maria Teresa/0000-0003-3178-3709; Geertz-Hansen, Henrik Marcus/0000-0003-0425-7551				Afonnikov DA, 2004, NUCLEIC ACIDS RES, V32, pW64, DOI 10.1093/nar/gkh451; ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; [Anonymous], 2010, MATLAB VERS 7 10 0 4; BAGLEY SC, 1995, PROTEIN SCI, V4, P622; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; BENHAM CJ, 1993, PROTEIN SCI, V2, P41; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya R, 2004, PROTEIN ENG DES SEL, V17, P795, DOI 10.1093/protein/gzh093; BOEL E, 1990, BIOCHEMISTRY-US, V29, P6244, DOI 10.1021/bi00478a019; CARLACCI L, 1991, J COMPUT CHEM, V12, P410, DOI 10.1002/jcc.540120315; CATH, PROT STRUCT CLASS DA; CHOU KC, 1988, P NATL ACAD SCI USA, V85, P4295, DOI 10.1073/pnas.85.12.4295; CHOU KC, 1984, J AM CHEM SOC, V106, P3161, DOI 10.1021/ja00323a017; CHOU KC, 1992, P NATL ACAD SCI USA, V89, P7315, DOI 10.1073/pnas.89.16.7315; CHOU KC, 1990, ACCOUNTS CHEM RES, V23, P134, DOI 10.1021/ar00173a003; CHOU KC, 1992, PROTEIN SCI, V1, P810, DOI 10.1002/pro.5560010613; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1986, J MOL BIOL, V188, P641, DOI 10.1016/S0022-2836(86)80012-2; CHOU KC, 1985, J MOL BIOL, V186, P591, DOI 10.1016/0022-2836(85)90133-0; CHOU KC, 1983, J PHYS CHEM-US, V87, P2869, DOI 10.1021/j100238a033; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Costantini S, 2008, BIOINFORMATION, V3, P137, DOI 10.6026/97320630003137; Creighton T.E., 1993, PROTEINS; FISER A, 1992, FEBS LETT, V302, P117, DOI 10.1016/0014-5793(92)80419-H; Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Govindarajan S, 1999, PROTEINS, V35, P408, DOI 10.1002/(SICI)1097-0134(19990601)35:4<408::AID-PROT4>3.0.CO;2-A; Gvritishvili AG, 2008, PROTEIN SCI, V17, P1285, DOI 10.1110/ps.034975.108; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; HARRISON PM, 1994, J MOL BIOL, V244, P448, DOI 10.1006/jmbi.1994.1742; Harrison PM, 1996, J MOL BIOL, V264, P603, DOI 10.1006/jmbi.1996.0664; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Jaenicke R, 2000, J BIOTECHNOL, V79, P193, DOI 10.1016/S0168-1656(00)00236-4; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; KARLIN S, 1994, J MOL BIOL, V239, P227, DOI 10.1006/jmbi.1994.1365; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kundrotas PJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-503; Lenffer J, 2004, NUCLEIC ACIDS RES, V32, pW350, DOI 10.1093/nar/gkh475; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; MAO B, 1989, J AM CHEM SOC, V111, P6132, DOI 10.1021/ja00198a022; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; MUSAFIA B, 1995, J MOL BIOL, V254, P761, DOI 10.1006/jmbi.1995.0653; MUSKAL SM, 1990, PROTEIN ENG, V3, P667, DOI 10.1093/protein/3.8.667; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Pal D, 1998, J BIOMOL STRUCT DYN, V15, P1059, DOI 10.1080/07391102.1998.10509001; Pazos F, 1997, COMPUT APPL BIOSCI, V13, P319; PERAHIA D, 1971, BIOCHEM BIOPH RES CO, V43, P65, DOI 10.1016/S0006-291X(71)80086-4; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1998, PREDICTION PROTEIN S, P1; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sarakatsannis JN, 2005, PROTEINS, V60, P732, DOI 10.1002/prot.20549; Sinha N, 2002, CURR PROTEIN PEPT SC, V3, P601, DOI 10.2174/1389203023380431; SRINIVASAN N, 1990, INT J PEPT PROT RES, V36, P147; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Zakeri P, 2011, J THEOR BIOL, V269, P208, DOI 10.1016/j.jtbi.2010.10.026	63	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e25638	10.1371/journal.pone.0025638	http://dx.doi.org/10.1371/journal.pone.0025638			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174733	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700001
J	Miteva, K; Haag, M; Peng, J; Savvatis, K; Becher, PM; Seifert, M; Warstat, K; Westermann, D; Ringe, J; Sittinger, M; Schultheiss, HP; Tschope, C; Van Linthout, S				Miteva, Kapka; Haag, Marion; Peng, Jun; Savvatis, Kostas; Becher, Peter Moritz; Seifert, Martina; Warstat, Katrin; Westermann, Dirk; Ringe, Jochen; Sittinger, Michael; Schultheiss, Heinz-Peter; Tschoepe, Carsten; Van Linthout, Sophie			Human Cardiac-Derived Adherent Proliferating Cells Reduce Murine Acute Coxsackievirus B3-Induced Myocarditis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INTERFERON-GAMMA; NITRIC-OXIDE; INDUCE APOPTOSIS; GENE-TRANSFER; RAT MODEL; MICE; RECEPTOR; ACTIVATION; INFARCTION	Background: Under conventional heart failure therapy, inflammatory cardiomyopathy typically has a progressive course, indicating a need for alternative therapeutic strategies to improve long-term outcomes. We recently isolated and identified novel cardiac-derived cells from human cardiac biopsies: cardiac-derived adherent proliferating cells (CAPs). They have similarities with mesenchymal stromal cells, which are known for their anti-apoptotic and immunomodulatory properties. We explored whether CAPs application could be a novel strategy to improve acute Coxsackievirus B3 (CVB3)-induced myocarditis. Methodology/Principal Findings: To evaluate the safety of our approach, we first analyzed the expression of the coxsackie- and adenovirus receptor (CAR) and the co-receptor CD55 on CAPs, which are both required for effective CVB3 infectivity. We could demonstrate that CAPs only minimally express both receptors, which translates to minimal CVB3 copy numbers, and without viral particle release after CVB3 infection. Co-culture of CAPs with CVB3-infected HL-1 cardiomyocytes resulted in a reduction of CVB3-induced HL-1 apoptosis and viral progeny release. In addition, CAPs reduced CD4 and CD8 T cell proliferation. All CAPs-mediated protective effects were nitric oxide- and interleukin-10-dependent and required interferon-gamma. In an acute murine model of CVB3-induced myocarditis, application of CAPs led to a decrease of cardiac apoptosis, cardiac CVB3 viral load and improved left ventricular contractility parameters. This was associated with a decline in cardiac mononuclear cell activity, an increase in T regulatory cells and T cell apoptosis, and an increase in left ventricular interleukin-10 and interferon-gamma mRNA expression. Conclusions: We conclude that CAPs are a unique type of cardiac-derived cells and promising tools to improve acute CVB3-induced myocarditis.	[Miteva, Kapka; Haag, Marion; Seifert, Martina; Warstat, Katrin; Ringe, Jochen; Sittinger, Michael; Tschoepe, Carsten; Van Linthout, Sophie] Charite, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany; [Haag, Marion; Ringe, Jochen; Sittinger, Michael] Charite, Lab Tissue Engn, D-13353 Berlin, Germany; [Peng, Jun; Savvatis, Kostas; Becher, Peter Moritz; Westermann, Dirk; Schultheiss, Heinz-Peter; Tschoepe, Carsten; Van Linthout, Sophie] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany; [Seifert, Martina] Charite, Inst Med Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Miteva, K (corresponding author), Charite, Berlin Brandenburg Ctr Regenerat Therapies, Campus Virchow, D-13353 Berlin, Germany.	carsten.tschoepe@charite.de	Westermann, Dirk/D-1344-2011	Tschope, Carsten/0000-0001-5243-8985; Westermann, Dirk/0000-0002-7542-1956; , Martina/0000-0002-6372-9769; Haag, Marion/0000-0002-9162-5131	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung) [0313911]; DFG (Deutsche Forschungsgemeinschaft) through the Berlin-Brandenburg School for Regenerative Therapies; DFG [Sonderforschungsbereich Transregio-19 Z3, B5]	Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); DFG (Deutsche Forschungsgemeinschaft) through the Berlin-Brandenburg School for Regenerative Therapies(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This study was supported by the Berlin-Brandenburg Center for Regenerative Therapies - BCRT (Bundesministerium fur Bildung und Forschung 0313911) to MH, MiS, CT, and SVL, by DFG (Deutsche Forschungsgemeinschaft) funding through the Berlin-Brandenburg School for Regenerative Therapies, and by the DFG Sonderforschungsbereich Transregio-19 Z3 and B5 to CT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bergelson JM, 1999, BIOCHEM PHARMACOL, V57, P975, DOI 10.1016/S0006-2952(98)00332-3; Carthy CM, 2003, VIROLOGY, V313, P147, DOI 10.1016/S0042-6822(03)00242-3; Choi YH, 2011, CARDIOVASC THER, V29, P2, DOI 10.1111/j.1755-5922.2010.00191.x; CHOW LH, 1992, LAB INVEST, V66, P24; De Geest BR, 2003, BLOOD, V101, P2551, DOI 10.1182/blood-2002-07-2146; Dhingra S, 2009, CARDIOVASC RES, V82, P59, DOI 10.1093/cvr/cvp040; Di Lanni M, 2008, EXP HEMATOL, V36, P309, DOI 10.1016/j.exphem.2007.11.007; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; HAAG M, J TISSUE EN IN PRESS; Haag M, 2010, J CELL BIOCHEM, V109, P564, DOI 10.1002/jcb.22433; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Henke A, 2003, VIROLOGY, V315, P335, DOI 10.1016/S0042-6822(03)00538-5; Hidaka C, 1999, J CLIN INVEST, V103, P579, DOI 10.1172/JCI5309; Huber SA, 2000, CARDIOVASC RES, V45, P579, DOI 10.1016/S0008-6363(99)00267-9; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jarasch N, 2005, VIRAL IMMUNOL, V18, P355, DOI 10.1089/vim.2005.18.355; KISHIMOTO C, 1989, CIRCULATION, V79, P1300, DOI 10.1161/01.CIR.79.6.1300; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Leuschner F, 2010, CIRC RES, V107, P1364, DOI 10.1161/CIRCRESAHA.110.227454; Levings MK, 2002, INT ARCH ALLERGY IMM, V129, P263, DOI 10.1159/000067596; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Martino TA, 1998, VIROLOGY, V244, P302, DOI 10.1006/viro.1998.9122; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447; Nishio R, 1999, CIRCULATION, V100, P1102, DOI 10.1161/01.CIR.100.10.1102; Oh I, 2007, BIOCHEM BIOPH RES CO, V355, P956, DOI 10.1016/j.bbrc.2007.02.054; Ohnishi S, 2007, J MOL CELL CARDIOL, V42, P88, DOI 10.1016/j.yjmcc.2006.10.003; Pinkert S, 2009, CIRCULATION, V120, P2358, DOI 10.1161/CIRCULATIONAHA.108.845339; Plumas J, 2005, LEUKEMIA, V19, P1597, DOI 10.1038/sj.leu.2403871; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Shi Y, 2010, CIRCULATION, V121, P2624, DOI 10.1161/CIRCULATIONAHA.109.893248; Szelid Z, 2010, BASIC RES CARDIOL, V105, P169, DOI 10.1007/s00395-009-0077-4; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; Van Linthout S, 2002, GENE THER, V9, P1520, DOI 10.1038/sj.gt.3301824; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; Wood KJ, 2006, TRENDS IMMUNOL, V27, P183, DOI 10.1016/j.it.2006.02.008; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Yerebakan C, 2007, CELL TRANSPLANT, V16, P935, DOI 10.3727/096368907783338280; Yuan JP, 2003, CELL RES, V13, P203, DOI 10.1038/sj.cr.7290165; Zell R, 2004, MED MICROBIOL IMMUN, V193, P91, DOI 10.1007/s00430-003-0198-6	49	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28513	10.1371/journal.pone.0028513	http://dx.doi.org/10.1371/journal.pone.0028513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174827	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700042
J	Sabbaj, S; Hel, Z; Richter, HE; Mestecky, J; Goepfert, PA				Sabbaj, Steffanie; Hel, Zdenek; Richter, Holly E.; Mestecky, Jiri; Goepfert, Paul A.			Menstrual Blood as a Potential Source of Endometrial Derived CD3+T Cells	PLOS ONE			English	Article							CD8(+) T-CELLS; FEMALE REPRODUCTIVE-TRACT; CHEMOKINE RECEPTOR EXPRESSION; BREAST-MILK; EARLY-PREGNANCY; STEM-CELLS; NK CELLS; LYMPHOCYTES; INFECTION; WOMEN	Studies of T cell-mediated immunity in the human female genital tract have been problematic due to difficulties associated with the collection of mucosal samples. Consequently, most studies rely on biopsies from the lower female genital tract or remnant tissue from hysterectomies. Availability of samples from healthy women is limited, as most studies are carried out in women with underlying pathologies. Menstruation is the cyclical sloughing off of endometrial tissue, and thus it should be a source of endometrial cells without the need for a biopsy. We isolated and phenotyped T cells from menstrual and peripheral blood and from endometrial biopsy-derived tissue from healthy women to determine the types of T cells present in this compartment. Our data demonstrated that T cells isolated from menstrual blood are a heterogeneous population of cells with markers reminiscent of blood and mucosal cells as well as unique phenotypes not represented in either compartment. T cells isolated from menstrual blood expressed increased levels of HLA-DR, alpha Eb7 and CXCR4 and reduced levels of CD62L relative to peripheral blood. Menstrual blood CD4+ T cells were enriched for cells expressing both CCR7 and CD45RA, markers identifying naive T cells and were functional as determined by antigen-specific intracellular cytokine production assays. These data may open new avenues of investigation for cell mediated immune studies involving the female reproductive tract without the need for biopsies.	[Sabbaj, Steffanie; Goepfert, Paul A.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Hel, Zdenek] Univ Alabama, Dept Mol & Cellular Pathol, Birmingham, AL USA; [Richter, Holly E.] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35294 USA; [Hel, Zdenek; Mestecky, Jiri; Goepfert, Paul A.] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sabbaj, S (corresponding author), Univ Alabama, Dept Med, Birmingham, AL 35294 USA.	sabbaj@uab.edu		Richter, Holly E/0000-0001-7741-5771; Hel, Zdenek/0000-0002-4923-4794; Sabbaj, Steffanie/0000-0003-4052-6819	National Institutes of Health [AI074438]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074438] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI074438. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; BULMER JN, 1986, EUR J OBSTET GYN R B, V23, P31, DOI 10.1016/0028-2243(86)90102-4; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; CHEN CK, 1995, HUM IMMUNOL, V42, P227, DOI 10.1016/0198-8859(94)00105-Y; Eriksson M, 2004, J LEUKOCYTE BIOL, V76, P667, DOI 10.1189/jlb.0204090; Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061; Givan AL, 1997, AM J REPROD IMMUNOL, V38, P350; Ho HN, 1996, HUM IMMUNOL, V49, P130, DOI 10.1016/0198-8859(96)00120-6; JALANTI R, 1977, INT ARCH ALLER A IMM, V53, P402, DOI 10.1159/000231778; KAMAT BR, 1987, AM J PATHOL, V127, P66; KELLY JK, 1979, J REPROD IMMUNOL, V1, P39, DOI 10.1016/0165-0378(79)90028-7; Lapidot T, 2002, LEUKEMIA, V16, P1992, DOI 10.1038/sj.leu.2402684; LOHMAN BL, 1995, J IMMUNOL, V155, P5855; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lynch L, 2007, HUM REPROD, V22, P919, DOI 10.1093/humrep/del456; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Meyer-Olson Dirk, 2010, HIV Therapy, V4, P413, DOI 10.2217/HIV.10.30; MORRIS H, 1985, J CLIN PATHOL, V38, P644, DOI 10.1136/jcp.38.6.644; Mulayim N, 2003, BIOL REPROD, V68, P1491, DOI 10.1095/biolreprod.102.009639; Musey L, 1997, J EXP MED, V185, P293, DOI 10.1084/jem.185.2.293; PARR EL, 1990, J REPROD FERTIL, V89, P619; Patel AN, 2008, CELL TRANSPLANT, V17, P303, DOI 10.3727/096368908784153922; Prakash M, 2002, J REPROD IMMUNOL, V54, P117, DOI 10.1016/S0165-0378(01)00125-5; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rosu-Myles M, 2000, P NATL ACAD SCI USA, V97, P14626, DOI 10.1073/pnas.97.26.14626; Russell MW, 2010, IMMUNOL INVEST, V39, P500, DOI 10.3109/08820131003674834; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Sabbaj S, 2002, J VIROL, V76, P7365, DOI 10.1128/JVI.76.15.7365-7373.2002; Sabbaj S, 2007, J INFECT DIS, V195, P108, DOI 10.1086/509510; Stevceva L, 2002, J VIROL, V76, P11659, DOI 10.1128/JVI.76.22.11659-11676.2002; Vassiliadou N, 1998, HUM REPROD, V13, P44, DOI 10.1093/humrep/13.1.44; White HD, 1997, J IMMUNOL, V158, P3017; White HD, 2001, J INFECT DIS, V183, P977, DOI 10.1086/319253; Yeaman GR, 1997, J LEUKOCYTE BIOL, V61, P427, DOI 10.1002/jlb.61.4.427; Yeaman GR, 2004, IMMUNOLOGY, V113, P524, DOI 10.1111/j.1365-2567.2004.01990.x; Yeaman GR, 2003, IMMUNOLOGY, V109, P137, DOI 10.1046/j.1365-2567.2003.01623.x; Yeaman GR, 2001, IMMUNOLOGY, V102, P434, DOI 10.1046/j.1365-2567.2001.01199.x	37	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28894	10.1371/journal.pone.0028894	http://dx.doi.org/10.1371/journal.pone.0028894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174921	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700081
J	Wilke, S; Groebe, L; Maffenbeier, V; Jager, V; Gossen, M; Josewski, J; Duda, A; Polle, L; Owens, RJ; Wirth, D; Heinz, DW; van den Heuvel, J; Bussow, K				Wilke, Sonja; Groebe, Lothar; Maffenbeier, Vitali; Jaeger, Volker; Gossen, Manfred; Josewski, Joern; Duda, Agathe; Polle, Lilia; Owens, Raymond J.; Wirth, Dagmar; Heinz, Dirk W.; van den Heuvel, Joop; Buessow, Konrad			Streamlining Homogeneous Glycoprotein Production for Biophysical and Structural Applications by Targeted Cell Line Development	PLOS ONE			English	Article							DEFINED CHROMOSOMAL LOCI; TRANSGENE EXPRESSION; FLP; GLYCOSYLATION; INTEGRATION; EXCHANGE; RMCE; MET	Studying the biophysical characteristics of glycosylated proteins and solving their three-dimensional structures requires homogeneous recombinant protein of high quality. We introduce here a new approach to produce glycoproteins in homogenous form with the well-established, glycosylation mutant CHO Lec3.2.8.1 cells. Using preparative cell sorting, stable, high-expressing GFP 'master' cell lines were generated that can be converted fast and reliably by targeted integration via Flp recombinase-mediated cassette exchange (RMCE) to produce any glycoprotein. Small-scale transient transfection of HEK293 cells was used to identify genetically engineered constructs suitable for constructing stable cell lines. Stable cell lines expressing 10 different proteins were established. The system was validated by expression, purification, deglycosylation and crystallization of the heavily glycosylated luminal domains of lysosome-associated membrane proteins (LAMP).	[Wilke, Sonja; Maffenbeier, Vitali; Jaeger, Volker; Josewski, Joern; Duda, Agathe; Polle, Lilia; Heinz, Dirk W.; van den Heuvel, Joop; Buessow, Konrad] Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany; [Groebe, Lothar] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Gossen, Manfred] Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Gossen, Manfred] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Owens, Raymond J.] Univ Oxford, Div Struct Biol, Oxford, England; [Wirth, Dagmar] Helmholtz Ctr Infect Res, Dept Gene Regulat & Differentiat, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Oxford; Helmholtz Association; Helmholtz-Center for Infection Research	Wilke, S (corresponding author), Helmholtz Ctr Infect Res, Dept Mol Struct Biol, Braunschweig, Germany.	konrad.buessow@helmholtz-hzi.de	Gossen, Manfred/K-9602-2013	Gossen, Manfred/0000-0002-1761-4063; Bussow, Konrad/0000-0003-2031-5942	Helmholtz Association of German Research Centres; MRC [G0701506] Funding Source: UKRI; Medical Research Council [G0701506, G1100525] Funding Source: researchfish	Helmholtz Association of German Research Centres(Helmholtz Association); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Helmholtz Association of German Research Centres through the Protein Sample Production Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1114, DOI 10.1107/S0907444906029805; Aricescu AR, 2007, SCIENCE, V317, P1217, DOI 10.1126/science.1144646; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Butters TD, 1999, PROTEIN SCI, V8, P1696, DOI 10.1110/ps.8.8.1696; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Kaufman WL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn508; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Mattanovich D, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-12; Nehlsen K, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-100; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Qiao JH, 2009, J MOL BIOL, V390, P579, DOI 10.1016/j.jmb.2009.05.012; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Schirrmann T, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P387, DOI 10.1007/978-3-642-01147-4_30; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schucht R, 2006, MOL THER, V14, P285, DOI 10.1016/j.ymthe.2005.12.003; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; TURAN S, 2011, J MOL BIOL IN PRESS; Turan S, 2010, J MOL BIOL, V402, P52, DOI 10.1016/j.jmb.2010.07.015; Verhoeyen E, 2001, HUM GENE THER, V12, P933, DOI 10.1089/104303401750195890; Wilke S, 2010, PROTEIN SCI, V19, P1264, DOI 10.1002/pro.390	23	20	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27829	10.1371/journal.pone.0027829	http://dx.doi.org/10.1371/journal.pone.0027829			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174749	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700008
J	Arranz, P; de Soto, NA; Madsen, PT; Brito, A; Bordes, F; Johnson, MP				Arranz, Patricia; Aguilar de Soto, Natacha; Madsen, Peter T.; Brito, Alberto; Bordes, Fernando; Johnson, Mark P.			Following a Foraging Fish-Finder: Diel Habitat Use of Blainville's Beaked Whales Revealed by Echolocation	PLOS ONE			English	Article							CUVIERS ZIPHIUS-CAVIROSTRIS; SOUTHERN ELEPHANT SEALS; DIVING BEHAVIOR; DEPTH; PREY; METABOLISM; MIGRATION; CETACEANS; PREDATOR; ECOLOGY	Simultaneous high resolution sampling of predator behavior and habitat characteristics is often difficult to achieve despite its importance in understanding the foraging decisions and habitat use of predators. Here we tap into the biosonar system of Blainville's beaked whales, Mesoplodon densirostris, using sound and orientation recording tags to uncover prey-finding cues available to echolocating predators in the deep-sea. Echolocation sounds indicate where whales search and encounter prey, as well as the altitude of whales above the sea-floor and the density of organisms around them, providing a link between foraging activity and the bio-physical environment. Tagged whales (n = 9) hunted exclusively at depth, investing most of their search time either in the lower part of the deep scattering layer (DSL) or near the sea-floor with little diel change. At least 43% (420/974) of recorded prey-capture attempts were performed within the benthic boundary layer despite a wide range of dive depths, and many dives included both meso-and bentho-pelagic foraging. Blainville's beaked whales only initiate searching when already deep in the descent and encounter prey suitable for capture within 2 min of the start of echolocation, suggesting that these whales are accessing prey in reliable vertical strata. Moreover, these prey resources are sufficiently dense to feed the animals in what is effectively four hours of hunting per day enabling a strategy in which long dives to exploit numerous deep-prey with low nutritional value require protracted recovery periods (average 1.5 h) between dives. This apparent searching efficiency maybe aided by inhabiting steep undersea slopes with access to both the DSL and the sea-floor over small spatial scales. Aggregations of prey in these biotopes are located using biosonar-derived landmarks and represent stable and abundant resources for Blainville's beaked whales in the otherwise food-limited deep-ocean.	[Arranz, Patricia; Aguilar de Soto, Natacha; Brito, Alberto] Univ La Laguna, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Dept Anim Biol, Tenerife, Spain; [Aguilar de Soto, Natacha] Univ Auckland, Leigh Marine Lab, Leigh, New Zealand; [Madsen, Peter T.] Aarhus Univ, Sect Zoophysiol, Dept Biosci, Aarhus, Denmark; [Madsen, Peter T.; Johnson, Mark P.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Bordes, Fernando] Inst Ciencias Marinas, Gran Canaria, Spain; [Johnson, Mark P.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland	Universidad de la Laguna; University of Auckland; Aarhus University; Woods Hole Oceanographic Institution; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); University of St Andrews	Arranz, P (corresponding author), Univ La Laguna, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Dept Anim Biol, Tenerife, Spain.	arranz@ull.es	Madsen, Peter T/K-5832-2013; De Soto, Natacha Aguilar/D-3002-2011; Arranz, Patricia/ABD-7328-2021	Madsen, Peter T/0000-0002-5208-5259; De Soto, Natacha Aguilar/0000-0001-9818-3527; Arranz, Patricia/0000-0001-8998-5149	Office of Naval Research; National Ocean Partnership Program (US); Canary Islands Government; Spanish Ministry of Environment; Spanish Ministry of Defense; Spanish Ministry of Science [CGL2009-13112]; 7th European Frame Program; Strategic Environmental Research Development Program; National Ocean Partnership Program; National Danish Science Foundation; Natural Environment Research Council [smru10001] Funding Source: researchfish	Office of Naval Research(Office of Naval Research); National Ocean Partnership Program (US); Canary Islands Government; Spanish Ministry of Environment(Spanish Government); Spanish Ministry of Defense; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 7th European Frame Program; Strategic Environmental Research Development Program; National Ocean Partnership Program; National Danish Science Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by the Office of Naval Research and the National Ocean Partnership Program (US), by a consortium consisting of the Canary Islands Government, the Spanish Ministry of Environment and the Spanish Ministry of Defense, and by the European environmental funding LIFE-INDEMARES program for the inventory and designation of the Natura 2000 network in marine areas of the Spanish territory, headed by Fundacion Biodiversidad, with additional support from the Cabildo Insular of El Hierro. PA is currently supported by the National Research Project: Cetacean, Oceanography and Biodiversity from La Palma and El Hierro (CGL2009-13112) of the Spanish Ministry of Science and NAS by a Marie Curie fellowship from the 7th European Frame Program. MJ was supported by grants from the Strategic Environmental Research Development Program and from the National Ocean Partnership Program. PTM was supported by frame grants from the National Danish Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL MV, 1990, PHILOS T R SOC A, V331, P15, DOI 10.1098/rsta.1990.0053; ARDITI R, 1988, AM NAT, V131, P837, DOI 10.1086/284825; Baird RW, 2006, CAN J ZOOL, V84, P1120, DOI 10.1139/Z06-095; BARHAM EG, 1966, SCIENCE, V151, P1399, DOI 10.1126/science.151.3716.1399; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2001, MAR ECOL PROG SER, V217, P1, DOI 10.3354/meps217001; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Butler PJ, 2001, NEWS PHYSIOL SCI, V16, P222; CARTWRIGHT BA, 1982, NATURE, V295, P560, DOI 10.1038/295560a0; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CHILDRESS JJ, 1973, DEEP-SEA RES, V20, P1093, DOI 10.1016/0011-7471(73)90023-5; Claridge DE, 2006, THESIS U ABERDEEN SC; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa Daniel P., 1999, P176; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 1998, MAR MAMMAL SCI, V14, P490, DOI 10.1111/j.1748-7692.1998.tb00738.x; De Robertis A, 2007, ICES J MAR SCI, V64, P1282, DOI 10.1093/icesjms/fsm112; Drazen JC, 2007, LIMNOL OCEANOGR, V52, P2306, DOI 10.4319/lo.2007.52.5.2306; Gee MJR, 2001, MAR GEOL, V177, P271, DOI 10.1016/S0025-3227(01)00153-0; Hazen EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019269; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; HOLLDOBLER B, 1980, SCIENCE, V210, P86, DOI 10.1126/science.210.4465.86; Jepson PD, 2003, NATURE, V425, P575, DOI 10.1038/425575a; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Johnson M, 2009, MAR ECOL PROG SER, V395, P55, DOI 10.3354/meps08255; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; JOHNSON MW, 1948, J MAR RES, V7, P443; Jones BA, 2008, J ACOUST SOC AM, V123, P1753, DOI 10.1121/1.2828210; KANE TC, 1976, ECOLOGY, V57, P793, DOI 10.2307/1936192; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Malakoff D, 2002, SCIENCE, V298, P722, DOI 10.1126/science.298.5594.722; MARSHALL N. B., 1965, DEEP SEA RES OCEANOGR ABSTR, V12, P299, DOI 10.1016/0011-7471(65)90004-5; MAUCHLINE J, 1991, MAR ECOL PROG SER, V74, P109, DOI 10.3354/meps074109; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McSweeney DJ, 2007, MAR MAMMAL SCI, V23, P666, DOI 10.1111/j.1748-7692.2007.00135.x; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Salvanes A. G. V, 2001, ENCY OCEAN SCI, V3, P1711, DOI DOI 10.1006/RWOS.2001.0012; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Soto NA, 2008, J ANIM ECOL, V77, P936, DOI 10.1111/j.1365-2656.2008.01393.x; Thompson D, 1998, J ZOOL, V246, P135, DOI 10.1111/j.1469-7998.1998.tb00142.x; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009; Waring GT, 2001, MAR MAMMAL SCI, V17, P703, DOI 10.1111/j.1748-7692.2001.tb01294.x; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; WILSON RP, 1993, MAR ECOL PROG SER, V94, P101; Wilson RP, 2002, ANIM BEHAV, V63, P85, DOI 10.1006/anbe.2001.1883	55	75	77	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28353	10.1371/journal.pone.0028353	http://dx.doi.org/10.1371/journal.pone.0028353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163295	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900031
J	Huang, LN; Xue, JY; He, Y; Wang, J; Sun, CH; Feng, RN; Teng, JH; He, YH; Li, Y				Huang, Lina; Xue, Jingyi; He, Ying; Wang, Jian; Sun, Changhao; Feng, Rennan; Teng, Jianhua; He, Yonghan; Li, Ying			Dietary Calcium but Not Elemental Calcium from Supplements Is Associated with Body Composition and Obesity in Chinese Women	PLOS ONE			English	Article							INSULIN-RESISTANCE; DAIRY-PRODUCTS; WEIGHT-LOSS; FAT-CONTENT; VITAMIN-D; BONE LOSS; MASS; DIGESTIBILITY; CONSUMPTION; POPULATION	Objective: We assessed whether dietary calcium intake or calcium supplements associated with body composition and obesity in a Chinese population. Methods: A cross-sectional survey was performed in a population of 8940, aged 20 to 74 y. 8127 participants responded (90.9%). Height, weight, fat mass (FM), waist circumference (WC) and hip circumference were measured. Obesity definition: body mass index (BMI) >= 28 kg/m(2) (overall obesity); WC >= 85 cm for men or >= 80 cm for women (abdominal obesity I) and waist hip ratio (WHR) >= 0.90 for men or >= 0.85 for women (abdominal obesity %). The data on dietary calcium and calcium supplements were collected using food-frequency questionnaire and self-report questionnaire. Multivariate linear and multivariable logistic regressions were used to examine the associations between dietary calcium intake or calcium supplements and body composition and obesity. Principal Findings: The average dietary calcium intake of all subjects was 430 mg/d. After adjusting for potential confounding factors, among women only, negative associations were observed between habitual dietary calcium intake and four measures of body composition (beta, -0.086, P < 0.001 for BMI; beta, -0.072, P < 0.001 for WC; beta, -0.044, P < 0.05 for WHR; and beta, -0.058, P < 0.01 for FM, respectively) and both measures of abdominal obesity (Odds Ratio [OR] = 0.86, 95% Confidence Interval [CI], 0.80-0.93; P < 0.001, for abdominal obesity I; OR = 0.92, 95% CI, 0.86-0.99; P = 0.026, for abdominal obesity II). These associations were not observed among men (P > 0.05). Similarly, among both men and women, we did not observe significant associations between calcium supplements and any measures of body composition or abdominal obesity (P > 0.05). Conclusions: Dietary calcium from food rather than elemental calcium from calcium supplements has beneficial effects on the maintenance of body composition and preventing abdominal obesity in Chinese women.	[Huang, Lina; He, Ying; Sun, Changhao; Feng, Rennan; Teng, Jianhua; He, Yonghan; Li, Ying] Harbin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China; [Xue, Jingyi] Harbin Med Univ, Dept Cardiol, Affiliated Hosp 1, Harbin, Peoples R China; [Wang, Jian] Ctr Dis Control & Prevent Harbin, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Huang, LN (corresponding author), Harbin Med Univ, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China.	liying_helen@163.com	He, Yonghan/P-7271-2014; SUN, CHANG/GXM-3680-2022	He, Yonghan/0000-0003-4409-4590; 	National Natural Science Foundation of China [81172649]; National High Technology Research and Development Program of China (863 program) [2010AA023002]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA023002, R00AA023002] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by the National Natural Science Foundation of China (No. 81172649) and the National High Technology Research and Development Program of China (863 program) (No. 2010AA023002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2001, P NUTR SOC, V60, P283; Barr SI, 2003, J NUTR, V133, p245S; Davies KM, 2000, J CLIN ENDOCR METAB, V85, P4635, DOI 10.1210/jc.85.12.4635; DENKE MA, 1993, J NUTR, V123, P1047; ELDERS PJM, 1994, J BONE MINER RES, V9, P963; Gunther CW, 2005, AM J CLIN NUTR, V81, P751, DOI 10.1093/ajcn/81.4.751; Heaney RP, 2001, MENOPAUSE, V8, P84, DOI 10.1097/00042192-200103000-00003; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Jacobsen R, 2005, INT J OBESITY, V29, P292, DOI 10.1038/sj.ijo.0802785; Jacqmain M, 2003, AM J CLIN NUTR, V77, P1448, DOI 10.1093/ajcn/77.6.1448; Jensen LB, 2001, J BONE MINER RES, V16, P141, DOI 10.1359/jbmr.2001.16.1.141; Kamycheva E, 2003, J NUTR, V133, P102, DOI 10.1093/jn/133.1.102; Lin YC, 2000, J AM COLL NUTR, V19, P754, DOI 10.1080/07315724.2000.10718075; Loos RJF, 2004, J NUTR, V134, P1772, DOI 10.1093/jn/134.7.1772; Lorenzen JK, 2006, AM J CLIN NUTR, V83, P18; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; MCCARRON DA, 1984, NUTR REV, V42, P223; Panel on Macronutrients. Institute of Medicine (U.S.). Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT EN CARB; Papakonstantinou E, 2003, OBES RES, V11, P387, DOI 10.1038/oby.2003.52; Pereira MA, 2002, JAMA-J AM MED ASSOC, V287, P2081, DOI 10.1001/jama.287.16.2081; Reid IR, 2005, J CLIN ENDOCR METAB, V90, P3824, DOI 10.1210/jc.2004-2205; Riggs BL, 1998, J BONE MINER RES, V13, P168, DOI 10.1359/jbmr.1998.13.2.168; Sampath V, 2008, OBESITY, V16, P2400, DOI 10.1038/oby.2008.380; Shahkhalili Y, 2001, AM J CLIN NUTR, V73, P246; Shapses SA, 2004, J CLIN ENDOCR METAB, V89, P632, DOI 10.1210/jc.2002-021136; Summerbell CD, 1998, BRIT MED J, V317, P1487, DOI 10.1136/bmj.317.7171.1487; Sun XC, 2004, J NUTR, V134, P3054, DOI 10.1093/jn/134.11.3054; Trowman R, 2006, BRIT J NUTR, V95, P1033, DOI 10.1079/BJN20051727; WELBERG JWM, 1994, ANN NUTR METAB, V38, P185, DOI 10.1159/000177810; Zemel MB, 2005, J AM COLL NUTR, V24, p537S, DOI 10.1080/07315724.2005.10719502; Zemel MB, 2005, OBES RES, V13, P1218, DOI 10.1038/oby.2005.144; Zemel MB, 1998, MOL CELL BIOCHEM, V188, P129, DOI 10.1023/A:1006880708475; Zemel MB, 2000, FASEB J, V14, P1132, DOI 10.1096/fasebj.14.9.1132; Zemel MB, 2001, J AM COLL NUTR, V20, p428S, DOI 10.1080/07315724.2001.10719180; Zemel MB, 2002, J AM COLL NUTR, V21, p146S, DOI 10.1080/07315724.2002.10719212; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	36	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27703	10.1371/journal.pone.0027703	http://dx.doi.org/10.1371/journal.pone.0027703			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163269	gold, Green Submitted, Green Published			2022-12-27	WOS:000298161900005
J	Inderbitzin, P; Bostock, RM; Davis, RM; Usami, T; Platt, HW; Subbarao, KV				Inderbitzin, Patrik; Bostock, Richard M.; Davis, R. Michael; Usami, Toshiyuki; Platt, Harold W.; Subbarao, Krishna V.			Phylogenetics and Taxonomy of the Fungal Vascular Wilt Pathogen Verticillium, with the Descriptions of Five New Species	PLOS ONE			English	Article							ALBO-ATRUM; V-TRICORPUS; VEGETATIVE COMPATIBILITY; SECTION PROSTRATA; PHENOTYPIC DESCRIPTION; MATING-TYPE; SP NOV.; DAHLIAE; REVISION; GENUS	Knowledge of pathogen biology and genetic diversity is a cornerstone of effective disease management, and accurate identification of the pathogen is a foundation of pathogen biology. Species names provide an ideal framework for storage and retrieval of relevant information, a system that is contingent on a clear understanding of species boundaries and consistent species identification. Verticillium, a genus of ascomycete fungi, contains important plant pathogens whose species boundaries have been ill defined. Using phylogenetic analyses, morphological investigations and comparisons to herbarium material and the literature, we established a taxonomic framework for Verticillium comprising ten species, five of which are new to science. We used a collection of 74 isolates representing much of the diversity of Verticillium, and phylogenetic analyses based on the ribosomal internal transcribed spacer region (ITS), partial sequences of the protein coding genes actin (ACT), elongation factor 1-alpha (EF), glyceraldehyde-3-phosphate dehydrogenase (GPD) and tryptophan synthase (TS). Combined analyses of the ACT, EF, GPD and TS datasets recognized two major groups within Verticillium, Clade Flavexudans and Clade Flavnonexudans, reflecting the respective production and absence of yellow hyphal pigments. Clade Flavexudans comprised V. albo-atrum and V. tricorpus as well as the new species V. zaregamsianum, V. isaacii and V. klebahnii, of which the latter two were morphologically indistinguishable from V. tricorpus but may differ in pathogenicity. Clade Flavnonexudans comprised V. nubilum, V. dahliae and V. longisporum, as well as the two new species V. alfalfae and V. nonalfalfae, which resembled the distantly related V. albo-atrum in morphology. Apart from the diploid hybrid V. longisporum, each of the ten species corresponded to a single clade in the phylogenetic tree comprising just one ex-type strain, thereby establishing a direct link to a name tied to a herbarium specimen. A morphology-based key is provided for identification to species or species groups.	[Inderbitzin, Patrik; Bostock, Richard M.; Davis, R. Michael; Subbarao, Krishna V.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Usami, Toshiyuki] Chiba Univ, Grad Sch Hort, Chiba, Japan; [Platt, Harold W.] Agr & Agri Food Canada, Charlottetown Res Ctr, Charlottetown, PE, Canada	University of California System; University of California Davis; Chiba University; Agriculture & Agri Food Canada	Inderbitzin, P (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	kvsubbarao@ucdavis.edu	Subbarao, Krishna/X-3870-2019; Usami, Toshiyuki/AAK-6550-2020	Subbarao, Krishna/0000-0002-2075-1835; Usami, Toshiyuki/0000-0001-8071-8167	California Leafy Greens Board; United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)	California Leafy Greens Board; United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA)(United States Department of Agriculture (USDA))	Financial support for this research was provided by the California Leafy Greens Board (www.caleafygreens.ca.gov/) and the United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA) (www.csrees.usda.gov/fo/specialtycropresearchinitiative.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbara DJ, 2003, MOL PLANT PATHOL, V4, P297, DOI 10.1046/J.1364-3703.2003.00172.X; BERKELEY G. H., 1926, Scientific Agriculture, V6, P261; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; CARDER JH, 1991, MYCOL RES, V95, P935, DOI 10.1016/S0953-7562(09)80090-7; CORRELL JC, 1988, PHYTOPATHOLOGY, V78, P1017, DOI 10.1094/Phyto-78-1017; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Crouch JA, 2009, MYCOLOGIA, V101, P717, DOI 10.3852/08-230; Domsch K.H., 1980, COMPENDIUM SOIL FUNG; DOWN G, 2007, B OEPP, V37, P528; Drummond A.J., 2010, GENEIOUS V4 8 5; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; FORDYCE C, 1964, PHYTOPATHOLOGY, V54, P795; Gams W, 2002, MYCOL RES, V106, P130, DOI 10.1017/S0953756202225824; Gams W, 2001, NOVA HEDWIGIA, V72, P329; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goud JKC, 2003, MYCOL RES, V107, P822, DOI 10.1017/S0953756203008050; Grunig CR, 2005, MYCOLOGIA, V97, P628, DOI 10.3852/mycologia.97.3.628; HAWKSWORTH DL, 1970, CMI DESCRIPTIONS PAT, V256; HEALE JB, 1965, BR MYCOL SOC TRANS, V48, P39; HEALE JB, 1963, ANN APPL BIOL, V52, P439, DOI 10.1111/j.1744-7348.1963.tb03768.x; Heale JB, 2000, ADVANCES IN VERTICILLIUM: RESEARCH AND DISEASE MANAGEMENT, P1; Hodge KT, 2005, TAXON, V54, P485, DOI 10.2307/25065318; Inderbitzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018260; Inderbitzin P, 2010, MYCOLOGIA, V102, P1350, DOI 10.3852/10-006; ISAAC IVOR, 1953, TRANS BRIT MYCOL SOC, V36, P180; ISAAC IVOR, 1949, TRANS BRIT MYCOL SOC, V32, P137; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; KEYWORTH W. G., 1952, PLANT DIS REPORTER, V36, P16; KIRK PM, 2001, DICT FUNGI; KLEBAHN H., 1937, Phytopathologische Zeitschrift, V10, P121; Klebahn H, 1913, MYCOLOGISCHES CENTRA, V3, P49; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Korolev N, 1999, MYCOL RES, V103, P65, DOI 10.1017/S0953756298006844; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Mahuku GS, 2002, MOL PLANT PATHOL, V3, P71, DOI 10.1046/j.1464-6722.2001.00096.x; Mandelc S, 2009, EUR J PLANT PATHOL, V125, P159, DOI 10.1007/s10658-009-9467-6; McKeen Colin D., 1943, CANADIAN JOUR RES SECT C BOT SCI, V21, P95; McNeill J., 2005, INT CODE BOT NOMENCL; METZENBERG RL, 1990, BIOESSAYS, V12, P53, DOI 10.1002/bies.950120202; MORTON A, 1995, PLANT PATHOL, V44, P183, DOI 10.1111/j.1365-3059.1995.tb02727.x; Nees von Esenbeck C. G., 1816, SYSTEM PILZE SCHWAMM; NOEL B, 1903, CR HEBD ACAD SCI, V137, P483; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; O'Donnell K, 2008, J CLIN MICROBIOL, V46, P2477, DOI 10.1128/JCM.02371-07; Pantou MP, 2005, FEMS MICROBIOL LETT, V245, P213, DOI 10.1016/j.femsle.2005.03.011; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Pethybridge GH., 1919, T BRIT MYCOL SOC, V6, P104; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Presley JT, 1941, PHYTOPATHOLOGY, V31, P1135; Qin QM, 2008, PLANT DIS, V92, P69, DOI 10.1094/PDIS-92-1-0069; Radisek S, 2004, PLANT DIS, V88, P1115, DOI 10.1094/PDIS.2004.88.10.1115; Radisek S, 2003, PLANT DIS, V87, P633, DOI 10.1094/PDIS.2003.87.6.633; Radisek S, 2006, EUR J PLANT PATHOL, V116, P301, DOI 10.1007/s10658-006-9061-0; Rasmussen H.N., 1995, TERRESTRIAL ORCHIDS, P444, DOI DOI 10.1017/CBO9780511525452; Reeb V, 2004, MOL PHYLOGENET EVOL, V32, P1036, DOI 10.1016/j.ympev.2004.04.012; REHNER SA, 1995, CAN J BOT, V73, pS816, DOI 10.1139/b95-327; Reinke J., 1879, UNTERSUCHUNGEN BOT L, V1, P67; ROBB J, 1993, PHYSIOL MOL PLANT P, V43, P423, DOI 10.1006/pmpp.1993.1070; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossman AY, 2008, PLANT DIS, V92, P1376, DOI 10.1094/PDIS-92-10-1376; Soltis DE, 1999, TRENDS ECOL EVOL, V14, P348, DOI 10.1016/S0169-5347(99)01638-9; STARK C., 1961, Gartenbauwissenschaft, V26, P493; Subbarao KV, 2007, PLANT DIS, V91, P964, DOI 10.1094/PDIS-91-8-0964; Subbarao K. V., 1997, COMPENDIUM LETTUCE D, P26; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TALBOYS P. W., 1960, PLANT PATHOL, V9, P57, DOI 10.1111/j.1365-3059.1960.tb01147.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; TROTTER A, 1972, SYLLOGE FUNGORUM, V26, P1299; USAMI T, 2010, J GEN PLANT PATHOL, P1, DOI DOI 10.1007/S10327-10010-10282-X; Usami T, 2009, J GEN PLANT PATHOL, V75, P422, DOI 10.1007/s10327-009-0197-6; Vallad GE, 2006, PHYTOPATHOLOGY, V96, P1380, DOI 10.1094/PHYTO-96-1380; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WILHELM S, 1955, PHYTOPATHOLOGY, V45, P180; WILHELM S, 1948, PHYTOPATHOLOGY, V38, P919; Zare R, 2007, NOVA HEDWIGIA, V85, P463, DOI 10.1127/0029-5035/2007/0085-0463; Zare R, 2004, MYCOL RES, V108, P576, DOI 10.1017/S0953756204009839; Zare R, 2001, NOVA HEDWIGIA, V73, P271; Zare R, 2001, NOVA HEDWIGIA, V73, P1; Zare R, 2001, NOVA HEDWIGIA, V73, P51; Zare R, 2008, MYCOL RES, V112, P811, DOI 10.1016/j.mycres.2008.01.019; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zhang N, 2006, MYCOLOGIA, V98, P1076, DOI 10.3852/mycologia.98.6.1076	86	202	221	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28341	10.1371/journal.pone.0028341	http://dx.doi.org/10.1371/journal.pone.0028341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22174791	Green Published, gold			2022-12-27	WOS:000298161900030
J	Mitchell, T; Armstrong, GL; Hu, DJ; Wasley, A; Painter, JA				Mitchell, Tarissa; Armstrong, Gregory L.; Hu, Dale J.; Wasley, Annemarie; Painter, John A.			The Increasing Burden of Imported Chronic Hepatitis B - United States, 1974-2008	PLOS ONE			English	Article							VIRUS-INFECTION; DISEASE BURDEN; VACCINATION; AGE	Background: Without intervention, up to 25% of individuals chronically infected with hepatitis B virus (HBV) die of late complications, including cirrhosis and liver cancer. The United States, which in 1991 implemented a strategy to eliminate HBV transmission through universal immunization, is a country of low prevalence. Approximately 3,000-5,000 U. S.-acquired cases of chronic hepatitis B have occurred annually since 2001. Many more chronically infected persons migrate to the United States yearly from countries of higher prevalence. Although early identification of chronic HBV infection can reduce the likelihood of transmission and late complications, immigrants are not routinely screened for HBV infection during or after immigration. Methods: To estimate the number of imported cases of chronic hepatitis B, we multiplied country-specific prevalence estimates by the yearly number of immigrants from each country during 1974-2008. Results: During 1974-2008, 27.9 million immigrants entered the U. S. Sixty-three percent were born in countries of intermediate or high chronic hepatitis B prevalence (range 2%-31%). On average, an estimated 53,800 chronic hepatitis B cases were imported to the U. S. yearly from 2004 through 2008. The Philippines, China, and Vietnam contributed the most imported cases (13.4%, 12.5%, and 11.0%, respectively). Imported cases increased from an estimated low of 105,750 during the period 1974-1977 to a high of 268,800 in 2004-2008. Conclusions: Imported chronic hepatitis B cases account for approximately 95% of new U. S. cases. Earlier case identification and management of infected immigrants would strengthen the U. S. strategy to eliminate HBV transmission, and could delay disease progression and prevent some deaths among new Americans.	[Mitchell, Tarissa; Painter, John A.] Ctr Dis Control & Prevent, Immigrant Refugee & Migrant Hlth Branch, Atlanta, GA 30333 USA; [Armstrong, Gregory L.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA USA; [Hu, Dale J.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA USA; [Wasley, Annemarie] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA; [Mitchell, Tarissa] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Emory University	Mitchell, T (corresponding author), Ctr Dis Control & Prevent, Immigrant Refugee & Migrant Hlth Branch, Atlanta, GA 30333 USA.	TMitchell1@cdc.gov						*CDC, 2009, HILTH INF INT TRAV 2; *CDC, 2010, MED EX IMM REF; *CDC, 2010, VACC REQ US IMM TECH; Center for Disease Control, 2009, STAT SURV; Coleman PJ, 1998, J INFECT DIS, V178, P954, DOI 10.1086/515696; *DHS, 2009, YB IMM STAT; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Fontana RJ, 2008, AM J MED, V121, P22, DOI 10.1016/j.amjmed.2008.09.026; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Grytdal SP, 2009, J COMMUN HEALTH, V34, P173, DOI 10.1007/s10900-008-9141-5; Hutton DW, 2007, ANN INTERN MED, V147, P460, DOI 10.7326/0003-4819-147-7-200710020-00004; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Khokhar A, 2008, AM J MED, V121, P33, DOI 10.1016/j.amjmed.2008.09.027; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Ma Grace X, 2007, J Immigr Minor Health, V9, P213, DOI 10.1007/s10903-006-9028-4; MCMAHON BJ, 1985, J INFECT DIS, V151, P599, DOI 10.1093/infdis/151.4.599; Nguyen VTT, 2009, J VIRAL HEPATITIS, V16, P453, DOI 10.1111/j.1365-2893.2009.01117.x; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; U.S. Census Bureau, 2010, STAT COUNTR QUICKF; *US CIT IMM SERV, 2007, GUID NEW IMM; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; *WHO, 2009, HEP B GLOB SIT	24	93	95	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27717	10.1371/journal.pone.0027717	http://dx.doi.org/10.1371/journal.pone.0027717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163270	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900006
J	Wang, GY; Arguelles, L; Liu, R; Zhang, SC; Brickman, WJ; Hong, XM; Tsai, HJ; Wang, BY; Xing, HX; Li, ZP; Xu, XP; Wang, XB				Wang, Guoying; Arguelles, Lester; Liu, Rong; Zhang, Shanchun; Brickman, Wendy J.; Hong, Xiumei; Tsai, Hui-Ju; Wang, Binyan; Xing, Houxun; Li, Zhiping; Xu, Xiping; Wang, Xiaobin			Tracking Blood Glucose and Predicting Prediabetes in Chinese Children and Adolescents: A Prospective Twin Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; INSULIN SENSITIVITY; BODY-COMPOSITION; RISK-FACTORS; CHILDHOOD; RESISTANCE; TOLERANCE; VARIABLES; GLYCEMIA; MEN	We examined the tracking of blood glucose, the development of prediabetes, and estimated their genetic contributions in a prospective, healthy, rural Chinese twin cohort. This report includes 1,766 subjects (998 males, 768 females) aged 6-21 years at baseline who completed a 6-year follow-up study. Oral glucose tolerance test was performed for all subjects at both baseline and follow-up. We found that subjects with low fasting plasma glucose (FPG) or 2 h post-load glucose (PG) levels at baseline tended to remain at the low level at follow-up. Subjects in the top tertile of baseline plasma glucose tended to have a higher risk of developing prediabetes at follow-up compared to the low tertile: in males, 37.6% vs. 27.6% for FPG and 37.2% vs. 25.7% for 2hPG, respectively; in females, 31.0% vs. 15.4% for FPG and 28.9% vs. 15.1% for 2 h PG, respectively. Genetic factors explained 43% and 41% of the variance of FPG, and 72% and 47% for impaired fasting glucose for males and females, respectively; environmental factors substantially contribute to 2hPG status and impaired glucose tolerance. In conclusion, in this cohort of healthy rural Chinese children and adolescents, we demonstrated that both FPG and 2hPG tracked well and was a strong predictor of prediabetes. The high proportion of children with top tertile of blood glucose progressed to prediabetes, and the incidence of prediabetes has a male predominance. Genetic factors play more important role in fasting than postload status, most of which was explained by unique environmental factors.	[Wang, Guoying; Arguelles, Lester; Liu, Rong; Zhang, Shanchun; Hong, Xiumei; Tsai, Hui-Ju; Wang, Binyan; Wang, Xiaobin] Childrens Mem Res Ctr, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL USA; [Brickman, Wendy J.] Northwestern Univ, Dept Pediat, Div Endocrinol, Feinberg Sch Med, Chicago, IL 60611 USA; [Brickman, Wendy J.] Childrens Mem Hosp, Chicago, IL 60614 USA; [Xing, Houxun; Li, Zhiping] Anhui Med Univ, Inst Biomed, Hefei, Peoples R China; [Xu, Xiping] Univ Illinois, Ctr Populat Genet, Div Epidemiol & Biostat, Chicago, IL USA; [Tsai, Hui-Ju] Natl Hlth Res Inst, Div Biostat & Bioinformat, Inst Populat Hlth Sci, Zhunan, Taiwan	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Anhui Medical University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Health Research Institutes - Taiwan	Wang, GY (corresponding author), Childrens Mem Res Ctr, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL USA.	xbwang@childrensmemorial.org	Tsai, Hui-Ju/E-3937-2010; Wang, Guoying/F-8908-2011		National Institute of Child Health and Human Development [R01 HD049059]; National Heart, Lung, and Blood Institute [R01 HL0864619]; National Institute of Aging [R01 AG032227]; Food Allergy Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032227] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Food Allergy Project; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is supported in part by grants R01 HD049059 from the National Institute of Child Health and Human Development; R01 HL0864619 from the National Heart, Lung, and Blood Institute; R01 AG032227 from the National Institute of Aging; and by the Food Allergy Project. (projectreporter.nih.gov/reporter.cfm.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TCM, 2005, HORM METAB RES, V37, P111, DOI 10.1055/s-2005-861160; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Baranowski T, 2006, DIABETES CARE, V29, P212; Brufani C, 2009, EUR J ENDOCRINOL, V160, P769, DOI 10.1530/EJE-08-0878; CHRISTIAN JC, 1995, GENET EPIDEMIOL, V12, P27, DOI 10.1002/gepi.1370120104; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Dietz WH, 2004, NEW ENGL J MED, V350, P855, DOI 10.1056/NEJMp048008; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Faerch K, 2009, DIABETES CARE, V32, P439, DOI 10.2337/dc08-1195; Genuth S, 2003, DIABETES CARE, V26, P3160; Jefferies CA, 2004, J PEDIATR-US, V144, P608, DOI 10.1016/S0022-3476(04)00112-X; Li CY, 2009, DIABETES CARE, V32, P342, DOI 10.2337/dc08-1128; Martos-Moreno GA, 2006, EUR J ENDOCRINOL, V155, P429, DOI 10.1530/eje.1.02227; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nguyen QM, 2008, DIABETES CARE, V31, P2044, DOI 10.2337/dc08-0898; Nguyen QM, 2010, DIABETES CARE, V33, P670, DOI 10.2337/dc09-1635; Nguyen QM, 2010, ARCH PEDIAT ADOL MED, V164, P124, DOI 10.1001/archpediatrics.2009.268; Rijsdijk Fruhling V, 2002, Brief Bioinform, V3, P119, DOI 10.1093/bib/3.2.119; Selvin E, 2005, ARCH INTERN MED, V165, P1910, DOI 10.1001/archinte.165.16.1910; Solorzano CMB, 2010, REPRODUCTION, V140, P399, DOI 10.1530/REP-10-0119; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; TWISK JWR, 1994, EPIDEMIOL REV, V16, P165, DOI 10.1093/oxfordjournals.epirev.a036149; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Wang BY, 2007, PREV MED, V45, P358, DOI 10.1016/j.ypmed.2007.07.014	24	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28573	10.1371/journal.pone.0028573	http://dx.doi.org/10.1371/journal.pone.0028573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163315	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900051
J	Gonzalez-Jara, P; Moreno-Letelier, A; Fraile, A; Pinero, D; Garcia-Arenal, F				Gonzalez-Jara, Pablo; Moreno-Letelier, Alejandra; Fraile, Aurora; Pinero, Daniel; Garcia-Arenal, Fernando			Impact of Human Management on the Genetic Variation of Wild Pepper, Capsicum annuum var. glabriusculum	PLOS ONE			English	Article							IN-SITU CONSERVATION; POLASKIA-CHICHIPE CACTACEAE; POPULATION-STRUCTURE; TEHUACAN VALLEY; DOMESTICATED POPULATIONS; DIVERSITY; DIFFERENTIATION; SOLANACEAE; PLANTS; RESOURCES	Management of wild peppers in Mexico has occurred for a long time without clear phenotypic signs of domestication. However, pre-domestication management could have implications for the population's genetic richness. To test this hypothesis we analysed 27 wild (W), let standing (LS) and cultivated (C) populations, plus 7 samples from local markets (LM), with nine polymorphic microsatellite markers. Two hundred and fifty two alleles were identified, averaging 28 per locus. Allele number was higher in W, and 15 and 40% less in LS and C populations, respectively. Genetic variation had a significant population structure. In W populations, structure was associated with ecological and geographic areas according to isolation by distance. When LM and C populations where included in the analysis, differentiation was no longer apparent. Most LM were related to distant populations from Sierra Madre Oriental, which represents their probable origin. Historical demography shows a recent decline in all W populations. Thus, pre-domestication human management is associated with a significant reduction of genetic diversity and with a loss of differentiation suggesting movement among regions by man. Measures to conserve wild and managed populations should be implemented to maintain the source and the architecture of genetic variation in this important crop relative.	[Gonzalez-Jara, Pablo; Fraile, Aurora; Garcia-Arenal, Fernando] Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, ETSI Agronomos, Pozuelo Del Alarcon, Madrid, Spain; [Moreno-Letelier, Alejandra; Pinero, Daniel] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City, DF, Mexico	Universidad Politecnica de Madrid; Universidad Nacional Autonoma de Mexico	Gonzalez-Jara, P (corresponding author), Univ Politecn Madrid, Ctr Biotecnol & Genom Plantas, ETSI Agronomos, Campus Montegancedo, Pozuelo Del Alarcon, Madrid, Spain.	fernando.garciaarenal@upm.es	Moreno-Letelier, Alejandra/AAF-8400-2020; Fraile, Aurora/H-1532-2015; Garcia-Arenal, Fernando/H-1603-2015	Moreno-Letelier, Alejandra/0000-0001-7524-7639; FRAILE PEREZ, AURORA/0000-0002-2785-7931; GARCIA-ARENAL RODRIGUEZ, FERNANDO/0000-0002-5327-3200; Pinero, Daniel/0000-0002-2509-2445	Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico") [BIOCON05/101]; Juan de la Cierva-UPM; Instituto de Ecologia	Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico")(BBVA Foundation); Juan de la Cierva-UPM; Instituto de Ecologia	This work was funded in part by a grant form Fundacion BBVA, Spain ("Impacto de los patogenos en la conservacion de especies amenazadas: aplicacion a las poblaciones silvestres de chiltepin en Mexico", BIOCON05/101) to FG-A. PG-J was supported also by a Juan de la Cierva-UPM contract. Financial support from Instituto de Ecologia to DP is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2004, MSVARL 3 UPDATE; Blanckaert I, 2007, AGR ECOSYST ENVIRON, V119, P39, DOI 10.1016/j.agee.2006.06.015; Buckler ES, 2001, GENET RES, V77, P213, DOI 10.1017/S0016672301005158; Carlo TA, 2009, ECOLOGY, V90, P3516, DOI 10.1890/08-1313.1; Carmona A, 2005, J ARID ENVIRON, V60, P115, DOI 10.1016/j.jaridenv.2004.03.007; Casas A, 1999, AM J BOT, V86, P522, DOI 10.2307/2656813; Casas A, 2001, ECON BOT, V55, P129, DOI 10.1007/BF02864551; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; Colunga-GarciaMarin P, 1999, AM J BOT, V86, P115, DOI 10.2307/2656960; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; D'Arcy W. G., 1974, Baileya, V19, P93; Damania AB, 2008, AGRON J, V100, P9, DOI 10.2134/agronj2005.0239c; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2004, HEREDITY, V92, P204, DOI 10.1038/sj.hdy.6800397; Dyer RJ, 2009, MOL ECOL RESOUR, V9, P110, DOI 10.1111/j.1755-0998.2008.02384.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Falush D, 2003, GENETICS, V164, P1567; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Gross BL, 2010, TRENDS PLANT SCI, V15, P529, DOI 10.1016/j.tplants.2010.05.008; Hernandez- -V erdugo S., 1999, B SOC BOT MEX, V64, P65, DOI DOI 10.17129/B0TSCI.1583; Hernandez-Verdugo S, 2001, PLANT SYST EVOL, V226, P129, DOI 10.1007/s006060170061; Hernandez-Verdugo S, 2001, PLANT ECOL, V155, P245, DOI 10.1023/A:1013234100003; Hernandez-Verdugo S, 2001, EUPHYTICA, V122, P31, DOI 10.1023/A:1012624830340; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; LOAIZAFIGUEROA F, 1989, PLANT SYST EVOL, V165, P159, DOI 10.1007/BF00936000; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Martinez-Castillo J, 2008, GENET RESOUR CROP EV, V55, P1065, DOI 10.1007/s10722-008-9314-1; Maxted N, 2009, ESTABLISHMENT GLOBAL, V266; Maxted N., 2008, CROP WILD RELATIVES; Meilleur BA, 2004, BIODIVERS CONSERV, V13, P663, DOI 10.1023/B:BIOC.0000011719.03230.17; Miller A, 2005, P NATL ACAD SCI USA, V102, P12801, DOI 10.1073/pnas.0505447102; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Nabhan G. P., 1990, Diversity, V6, P47; Nei M., 1987, MOL EVOLUTIONARY GEN; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Otero-Arnaiz A, 2003, AM J BOT, V90, P593, DOI 10.3732/ajb.90.4.593; Oyama K, 2006, GENET RESOUR CROP EV, V53, P553, DOI 10.1007/s10722-004-2363-1; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PICKERSGILL B, 1971, EVOLUTION, V25, P683, DOI 10.1111/j.1558-5646.1971.tb01926.x; Pickersgill B, 1997, EUPHYTICA, V96, P129, DOI 10.1023/A:1002913228101; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Meraz M, 2002, P 16 INT PEPP C TAMP; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Rodriguez delBosque L. A., 2002, P 16 INT PEPP C TAMP; Smith CE., 1967, PREHISTORY TEHUACAN, P220; SONNANTE G, 1994, THEOR APPL GENET, V89, P629, DOI 10.1007/BF00222458; Storz JF, 2002, EVOLUTION, V56, P154; Tang HB, 2010, CURR OPIN PLANT BIOL, V13, P160, DOI 10.1016/j.pbi.2009.10.008; Tewksbury JJ, 1999, CONSERV BIOL, V13, P98, DOI 10.1046/j.1523-1739.1999.97399.x; Tewksbury JJ, 2008, ECOLOGY, V89, P107, DOI 10.1890/07-0445.1; Votava EJ, 2002, CONSERV GENET, V3, P123, DOI 10.1023/A:1015216504565; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zizumbo-Villarreal D, 2005, CROP SCI, V45, P1073, DOI 10.2135/cropsci2004.0340	65	37	38	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2011	6	12							e28715	10.1371/journal.pone.0028715	http://dx.doi.org/10.1371/journal.pone.0028715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863OC	22163053	Green Published, Green Submitted, gold			2022-12-27	WOS:000298173500047
J	Lu, ZK; Cheng, ZY; Zhao, YM; Volchenboum, SL				Lu, Zhike; Cheng, Zhongyi; Zhao, Yingming; Volchenboum, Samuel L.			Bioinformatic Analysis and Post-Translational Modification Crosstalk Prediction of Lysine Acetylation	PLOS ONE			English	Article							HISTONE H3; PHOSPHORYLATION SITES; SECONDARY STRUCTURE; PROTEIN; DOMAIN; P53; UBIQUITINATION; METHYLATION; DATABASE; IDENTIFICATION	Recent proteomics studies suggest high abundance and a much wider role for lysine acetylation (K-Ac) in cellular functions. Nevertheless, cross influence between K-Ac and other post-translational modifications (PTMs) has not been carefully examined. Here, we used a variety of bioinformatics tools to analyze several available K-Ac datasets. Using gene ontology databases, we demonstrate that K-Ac sites are found in all cellular compartments. KEGG analysis indicates that the K-Ac sites are found on proteins responsible for a diverse and wide array of vital cellular functions. Domain structure prediction shows that K-Ac sites are found throughout a wide variety of protein domains, including those in heat shock proteins and those involved in cell cycle functions and DNA repair. Secondary structure prediction proves that K-Ac sites are preferentially found in ordered structures such as alpha helices and beta sheets. Finally, by mutating K-Ac sites in silico and predicting the effect on nearby phosphorylation sites, we demonstrate that the majority of lysine acetylation sites have the potential to impact protein phosphorylation, methylation, and ubiquitination status. Our work validates earlier smaller-scale studies on the acetylome and demonstrates the importance of PTM crosstalk for regulation of cellular function.	[Lu, Zhike; Cheng, Zhongyi; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Volchenboum, Samuel L.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Volchenboum, Samuel L.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Lu, ZK (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	Yingming.Zhao@uchicago.edu; SLV@uchicago.edu			NIH [RR020839, CA126832]; St. Baldrick's Foundation; Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Baldrick's Foundation; Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grants to Y.Z. (RR020839 and CA126832) and by the St. Baldrick's Foundation (http://www.stbaldricks.org) and the Cancer Research Foundation (http://www.cancerresearchfdn.org) to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JK, 2009, MOL ENDOCRINOL, V23, P1963, DOI 10.1210/me.2009-0188; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BATRA PP, 1990, J PROTEIN CHEM, V9, P37, DOI 10.1007/BF01024982; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boutet Emmanuel, 2007, V406, P89; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772; Edmondson DG, 2002, J BIOL CHEM, V277, P29496, DOI 10.1074/jbc.M200651200; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; Mollapour M, 2010, CELL CYCLE GEORGETOW, V9; Norris KL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.297pe76; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wiwanitkit V, 2007, DIABETES TECHNOL THE, V9, P145, DOI 10.1089/dia.2006.0022; XU XB, 1995, BIOPOLYMERS, V35, P93, DOI 10.1002/bip.360350110; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	64	54	60	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28228	10.1371/journal.pone.0028228	http://dx.doi.org/10.1371/journal.pone.0028228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164248	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400049
J	Yamada, H; Yamamoto, MT				Yamada, Hirokazu; Yamamoto, Masa-Toshi			Association between Circadian Clock Genes and Diapause Incidence in Drosophila triauraria	PLOS ONE			English	Article							PHOTOPERIODIC TIME MEASUREMENT; MITE TETRANYCHUS-URTICAE; REPRODUCTIVE DIAPAUSE; INSECT PHOTOPERIODISM; GEOGRAPHIC-VARIATION; NATURAL-SELECTION; MOLECULAR-BASES; LIFE-SPAN; MELANOGASTER; INDUCTION	Diapause is an adaptive response triggered by seasonal photoperiodicity to overcome unfavorable seasons. The photoperiodic clock is a system that controls seasonal physiological processes, but our knowledge about its physiological mechanisms and genetic architecture remains incomplete. The circadian clock is another system that controls daily rhythmic physiological phenomena. It has been argued that there is a connection between the two clocks. To examine the genetic connection between them, we analyzed the associations of five circadian clock genes (period, timeless, Clock, cycle and cryptochrome) with the occurrence of diapause in Drosophila triauraria, which shows a robust reproductive diapause with clear photoperiodicity. Non-diapause strains found in low latitudes were compared in genetic crosses with the diapause strain, in which the diapause trait is clearly dominant. Single nucleotide polymorphism and deletion analyses of the five circadian clock genes in backcross progeny revealed that allelic differences in timeless and cryptochrome between the strains were additively associated with the differences in the incidence of diapause. This suggests that there is a molecular link between certain circadian clock genes and the occurrence of diapause.	[Yamada, Hirokazu; Yamamoto, Masa-Toshi] Kyoto Inst Technol, Drosophila Genet Resource Ctr, Kyoto 606, Japan	Kyoto Institute of Technology	Yamada, H (corresponding author), Kyoto Inst Technol, Drosophila Genet Resource Ctr, Kyoto 606, Japan.	yamamoto@kit.jp			Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from the National Bio-Resource Project from the Ministry of Education, Science, Sports and Culture of Japan. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	B?nning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; Bock IR, 1972, U TEXAS PUBLS STUD G, V7, P7213; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; Bradshaw WE, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-115; Bradshaw WE, 2010, J BIOL RHYTHM, V25, P155, DOI 10.1177/0748730410365656; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Danks HV, 2003, EUR J ENTOMOL, V100, P209, DOI 10.14411/eje.2003.036; Danks HV, 2005, J INSECT PHYSIOL, V51, P609, DOI 10.1016/j.jinsphys.2005.01.005; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Goto SG, 2009, J INSECT PHYSIOL, V55, P401, DOI 10.1016/j.jinsphys.2008.11.008; Goto SG, 2006, J INSECT PHYSIOL, V52, P1213, DOI 10.1016/j.jinsphys.2006.09.003; Han B, 2009, J INSECT PHYSIOL, V55, P415, DOI 10.1016/j.jinsphys.2009.01.005; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ikeno T, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-116; KIMURA MT, 1990, J INSECT PHYSIOL, V36, P147, DOI 10.1016/0022-1910(90)90115-V; KIMURA MT, 1983, PHYSIOL ENTOMOL, V8, P181, DOI 10.1111/j.1365-3032.1983.tb00347.x; KIMURA MT, 1995, PHYSIOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-3032.1995.tb00009.x; KIMURA MT, 1984, PHYSIOL ENTOMOL, V9, P425, DOI 10.1111/j.1365-3032.1984.tb00784.x; KIMURA Y, 1993, PHYSIOL ENTOMOL, V18, P240, DOI 10.1111/j.1365-3032.1993.tb00594.x; King R. C., 1970, OVARIAN DEV DROSOPHI; Kostal V, 2001, J INSECT PHYSIOL, V47, P1269, DOI 10.1016/S0022-1910(01)00113-5; Kostal V, 2011, J INSECT PHYSIOL, V57, P538, DOI 10.1016/j.jinsphys.2010.10.006; LEES AD, 1986, J INSECT PHYSIOL, V32, P79, DOI 10.1016/0022-1910(86)90160-5; Mathias D, 2005, J INSECT PHYSIOL, V51, P661, DOI 10.1016/j.jinsphys.2005.03.011; Merrow M, 2005, EMBO REP, V6, P930, DOI 10.1038/sj.embor.7400541; NANDA K. K., 1958, BOT GAZ, V120, P14, DOI 10.1086/335992; Nunes MV, 1999, J BIOL RHYTHM, V14, P84, DOI 10.1177/074873049901400202; Nunes MV, 1997, ENTOMOL EXP APPL, V84, P195, DOI 10.1023/A:1003023307605; NUNES MV, 1986, J INSECT PHYSIOL, V32, P1029, DOI 10.1016/0022-1910(86)90122-8; NUNES MV, 1982, J INSECT PHYSIOL, V28, P1041, DOI 10.1016/0022-1910(82)90011-7; Nunes MV, 1998, J THEOR BIOL, V194, P299, DOI 10.1006/jtbi.1998.0767; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pavelka J, 2003, EUR J ENTOMOL, V100, P255, DOI 10.14411/eje.2003.041; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; Saunders DS, 2005, J INSECT PHYSIOL, V51, P599, DOI 10.1016/j.jinsphys.2004.12.002; Saunders DS, 2004, PHYSIOL ENTOMOL, V29, P1, DOI 10.1111/j.1365-3032.2004.0369.x; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; SAUNDERS DS, 1988, J COMP PHYSIOL A, V163, P365, DOI 10.1007/BF00604012; Saunders DS, 2002, INSECT CLOCKS; Schiesari L, 2011, FEBS LETT, V585, P1450, DOI 10.1016/j.febslet.2011.02.026; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schultz TF, 2003, SCIENCE, V301, P326, DOI 10.1126/science.1085935; Sheeba V, 2001, J INSECT PHYSIOL, V47, P1217, DOI 10.1016/S0022-1910(01)00107-X; Stehlik J, 2008, J BIOL RHYTHM, V23, P129, DOI 10.1177/0748730407313364; Suzuki L, 2001, J PHYCOL, V37, P933, DOI 10.1046/j.1529-8817.2001.01094.x; Syrova Z, 2003, CELL MOL LIFE SCI, V60, P2510, DOI 10.1007/s00018-003-3227-0; Takeda M, 1997, ANNU REV ENTOMOL, V42, P323, DOI 10.1146/annurev.ento.42.1.323; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tauber E, 2001, J BIOL RHYTHM, V16, P381, DOI 10.1177/074873001129002088; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; VEERMAN A, 1988, J INSECT PHYSIOL, V34, P1063, DOI 10.1016/0022-1910(88)90206-5; VEERMAN A, 1987, J COMP PHYSIOL A, V160, P421, DOI 10.1007/BF00615076; Veerman A, 2001, J INSECT PHYSIOL, V47, P1097, DOI 10.1016/S0022-1910(01)00106-8; Wager-Smith K, 2000, NAT GENET, V26, P23, DOI 10.1038/79134; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Wittwer F, 2005, DEV CELL, V8, P817, DOI 10.1016/j.devcel.2005.04.002; YOSHIDA T, 1994, APPL ENTOMOL ZOOL, V29, P499, DOI 10.1303/aez.29.499; YOSHIDA T, 1993, J INSECT PHYSIOL, V39, P101, DOI 10.1016/0022-1910(93)90100-6; YOSHIDA T, 1993, J INSECT PHYSIOL, V39, P223, DOI 10.1016/0022-1910(93)90092-6	69	41	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27493	10.1371/journal.pone.0027493	http://dx.doi.org/10.1371/journal.pone.0027493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164210	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400010
J	Little, R; Muimo, R; Robson, L; Harris, K; Grabowski, PS				Little, Robert; Muimo, Richmond; Robson, Louise; Harris, Kate; Grabowski, Peter S.			The Transient Receptor Potential Ion Channel TRPV6 Is Expressed at Low Levels in Osteoblasts and Has Little Role in Osteoblast Calcium Uptake	PLOS ONE			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; CELL-LINE SAOS-2; CA2+ CHANNEL; BONE-CELLS; ABSORPTION; EPITHELIA; GENE; TRANSPORT; KIDNEY; ECAC2	Background: TRPV6 ion channels are key mediators of regulated transepithelial absorption of Ca(2+) within the small intestine. Trpv6(-/-) mice were reported to have lower bone density than wild-type littermates and significant disturbances in calcium homeostasis that suggested a role for TRPV6 in osteoblasts during bone formation and mineralization. TRPV6 and molecules related to transepithelial Ca2+ transport have been reported to be expressed at high levels in human and mouse osteoblasts. Results: Transmembrane ion currents in whole cell patch clamped SaOS-2 osteoblasts did not show sensitivity to ruthenium red, an inhibitor of TRPV5/6 ion channels, and (45)Ca uptake was not significantly affected by ruthenium red in either SaOS-2 (P = 0.77) or TE-85 (P = 0.69) osteoblastic cells. In contrast, ion currents and (45)Ca uptake were both significantly affected in a human bronchial epithelial cell line known to express TRPV6. TRPV6 was expressed at lower levels in osteoblastic cells than has been reported in some literature. In SaOS-2 TRPV6 mRNA was below the assay detection limit; in TE-85 TRPV6 mRNA was detected at 6.90 +/- 1.9 x 10(-5) relative to B2M. In contrast, TRPV6 was detected at 7.7 +/- 3.0 x 10(-2) and 2.38 +/- 0.28 x 10(-4) the level of B2M in human carcinoma-derived cell lines LNCaP and CaCO-2 respectively. In murine primary calvarial osteoblasts TRPV6 was detected at 3.80 +/- 0.24 x 10(-5) relative to GAPDH, in contrast with 4.3 +/- 1.5 x 10(-2) relative to GAPDH in murine duodenum. By immunohistochemistry, TRPV6 was expressed mainly in myleocytic cells of the murine bone marrow and was observed only at low levels in murine osteoblasts, osteocytes or growth plate cartilage. Conclusions: TRPV6 is expressed only at low levels in osteoblasts and plays little functional role in osteoblastic calcium uptake.	[Little, Robert; Grabowski, Peter S.] Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England; [Muimo, Richmond] Univ Sheffield, Dept Infect & Immun, Sheffield, S Yorkshire, England; [Robson, Louise; Harris, Kate] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield; University of Sheffield	Little, R (corresponding author), Univ Sheffield, Dept Human Metab, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England.	p.grabowski@sheffield.ac.uk	Robson, Louise/Y-3794-2018; Grabowski, Peter S/G-2345-2010	Robson, Louise/0000-0003-2984-6520; Grabowski, Peter S/0000-0001-5924-1587; Little, Robert/0000-0003-1870-3241	Research into Ageing [305]	Research into Ageing	This work was funded by a PhD Studentship (Reference No. 305) from Research into Ageing (now Age UK; website url: http://www.ageuk.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; BALMAIN N, 1989, HISTOCHEMISTRY, V92, P359, DOI 10.1007/BF00492492; Berdal A, 1996, J BONE MINER RES, V11, P768; Bianco SDC, 2007, J BONE MINER RES, V22, P274, DOI 10.1359/JBMR.061110; BINDELS RJM, 1992, PFLUG ARCH EUR J PHY, V420, P566, DOI 10.1007/BF00374634; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Faucheux C, 1998, BIOCHEM J, V333, P817, DOI 10.1042/bj3330817; FEHER JJ, 1992, AM J PHYSIOL, V262, pC517, DOI 10.1152/ajpcell.1992.262.2.C517; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, BBA-PROTEINS PROTEOM, V1600, P6, DOI 10.1016/S1570-9639(02)00438-7; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hoenderop JGJ, 1999, J BIOL CHEM, V274, P8375, DOI 10.1074/jbc.274.13.8375; Irnaten M, 2008, CELL CALCIUM, V44, P441, DOI 10.1016/j.ceca.2008.02.007; Laketic-Ljubojevic I, 1999, BONE, V25, P631, DOI 10.1016/S8756-3282(99)00224-0; Lieben L, 2010, BONE, V47, P301, DOI 10.1016/j.bone.2010.04.595; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundquist P, 2000, CALCIFIED TISSUE INT, V67, P60, DOI 10.1007/s00223001098; Magyar CE, 2002, AM J PHYSIOL-RENAL, V283, pF29, DOI 10.1152/ajprenal.00252.2000; MCQUILLAN DJ, 1995, BONE, V16, P415; MESZAROS JG, 1993, J BONE MINER RES, V8, P1235; Moonga BS, 2002, AM J PHYSIOL-RENAL, V282, pF921, DOI 10.1152/ajprenal.00045.2000; Nijenhuis T, 2003, J AM SOC NEPHROL, V14, P2731, DOI 10.1097/01.ASN.0000094081.78893.E8; Peacock M, 2010, CLIN J AM SOC NEPHRO, V5, pS23, DOI 10.2215/CJN.05910809; Peet NM, 1999, FASEB J, V13, P2179, DOI 10.1096/fasebj.13.15.2179; Peng JB, 1999, J BIOL CHEM, V274, P22739, DOI 10.1074/jbc.274.32.22739; RODAN SB, 1987, CANCER RES, V47, P4961; Scutt A, 2003, METH MOLEC MED, V80, P29; Taparia S, 2006, EUR J NUTR, V45, P196, DOI 10.1007/s00394-005-0586-3; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Van der Eerden BCJ, 2012, J CELL PHYSIOL, V227, P1951, DOI 10.1002/jcp.22923; Weber K, 2001, BIOCHEM BIOPH RES CO, V289, P1287, DOI 10.1006/bbrc.2001.6121; Yellowley CE, 1998, CALCIFIED TISSUE INT, V62, P122, DOI 10.1007/s002239900405; YPEY DL, 1992, J BONE MINER RES, V7, pS377, DOI 10.1002/jbmr.5650071404; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhuang LY, 2002, LAB INVEST, V82, P1755, DOI 10.1097/01.LAB.0000043910.41414.E7	36	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2011	6	11							e28166	10.1371/journal.pone.0028166	http://dx.doi.org/10.1371/journal.pone.0028166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863LT	22163264	Green Accepted, Green Published, gold			2022-12-27	WOS:000298166300034
J	Schinzel, RT; Ahfeldt, T; Lau, FH; Lee, YK; Cowley, A; Shen, T; Peters, D; Lum, DH; Cowan, CA				Schinzel, Robert T.; Ahfeldt, Tim; Lau, Frank H.; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Lum, David H.; Cowan, Chad A.			Efficient Culturing and Genetic Manipulation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							SURVIVAL; LINES	Human pluripotent stem cells (hPSC) hold great promise as models for understanding disease and as a source of cells for transplantation therapies. However, the lack of simple, robust and efficient culture methods remains a significant obstacle for realizing the utility of hPSCs. Here we describe a platform for the culture of hPSCs that 1) allows for dissociation and replating of single cells, 2) significantly increases viability and replating efficiency, 3) improves freeze/thaw viability 4) improves cloning efficiency and 5) colony size variation. When combined with standard methodologies for genetic manipulation, we found that the enhanced culture platform allowed for lentiviral transduction rates of up to 95% and electroporation efficiencies of up to 25%, with a significant increase in the total number of antibiotic-selected colonies for screening for homologous recombination. We further demonstrated the utility of the enhanced culture platform by successfully targeting the ISL1 locus. We conclude that many of the difficulties associated with culturing and genetic manipulation of hPSCs can be addressed with optimized culture conditions, and we suggest that the use of the enhanced culture platform could greatly improve the ease of handling and general utility of hPSCs.	[Schinzel, Robert T.; Ahfeldt, Tim; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Schinzel, Robert T.; Ahfeldt, Tim; Lau, Frank H.; Lee, Youn-Kyoung; Cowley, Alicia; Shen, Tony; Peters, Derek; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Schinzel, Robert T.; Ahfeldt, Tim; Lee, Youn-Kyoung; Peters, Derek; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Schinzel, Robert T.] Free Univ Berlin, Inst Biol Mikrobiol, Fachbereich Biol, Berlin, Germany; [Cowley, Alicia; Shen, Tony] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA; [Lum, David H.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Lum, David H.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA	Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Free University of Berlin; Harvard University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Schinzel, RT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.	ccowan@fas.harvard.edu	Ahfeldt, Tim/E-2935-2017	Cowley, Alicia/0000-0001-8136-169X; Ahfeldt, Tim/0000-0001-6377-7376; Shen, Tony/0000-0002-7740-6389	Harvard Stem Cell Institute; Stowers Medical Research Institute	Harvard Stem Cell Institute; Stowers Medical Research Institute	Funding was provided by a Junior Faculty Program Award from Harvard Stem Cell Institute, and by the Stowers Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Yacoub N, 2007, J GENE MED, V9, P579, DOI 10.1002/jgm.1052; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	16	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2011	6	12							e27495	10.1371/journal.pone.0027495	http://dx.doi.org/10.1371/journal.pone.0027495			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866HE	22194785	Green Submitted, gold, Green Published			2022-12-27	WOS:000298370400004
J	Wessels, JM; Edwards, AK; Zettler, C; Tayade, C				Wessels, Jocelyn M.; Edwards, Andrew K.; Zettler, Candace; Tayade, Chandrakant			Selection and Validation of Reference Genes for miRNA Expression Studies during Porcine Pregnancy	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; RELATIVE QUANTIFICATION; RNA EXPRESSION; MICRORNAS; NORMALIZATION; IDENTIFICATION; PROFILES; IDENTIFY; TARGETS; CANCER	MicroRNAs comprise a family of small non-coding RNAs that modulate several developmental and physiological processes including pregnancy. Their ubiquitous presence is confirmed in mammals, worms, flies and plants. Although rapid advances have been made in microRNA research, information on stable reference genes for validation of microRNA expression is still lacking. Real time PCR is a widely used tool to quantify gene transcripts. An appropriate reference gene must be chosen to minimize experimental error in this system. A small difference in miRNA levels between experimental samples can be biologically meaningful as these entities can affect multiple targets in a pathway. This study examined the suitability of six commercially available reference genes (RNU1A, RNU5A, RNU6B, SNORD25, SCARNA17, and SNORA73A) in maternal-fetal tissues from healthy and spontaneously arresting/dying conceptuses from sows were separately analyzed at gestation day 20. Comparisons were also made with non-pregnant endometrial tissues from sows. Spontaneous fetal loss is a prime concern to the commercial pork industry. Our laboratory has previously identified deficits in vasculature development at maternal-fetal interface as one of the major participating causes of fetal loss. Using this well-established model, we have extended our studies to identify suitable microRNA reference genes. A methodical approach to assessing suitability was adopted using standard curve and melting curve analysis, PCR product sequencing, real time PCR expression in a panel of gestational tissues, and geNorm and NormFinder analysis. Our quantitative real time PCR analysis confirmed expression of all 6 reference genes in maternal and fetal tissues. All genes were uniformly expressed in tissues from healthy and spontaneously arresting conceptus attachment sites. Comparisons between tissue types (maternal/fetal/non-pregnant) revealed significant differences for RNU5A, RNU6B, SCARNA17, and SNORA73A expression. Based on our methodical assessment of all 6 reference genes, results suggest that RNU1A is the most stable reference gene for porcine pregnancy studies.	[Wessels, Jocelyn M.; Zettler, Candace; Tayade, Chandrakant] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Edwards, Andrew K.; Tayade, Chandrakant] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada	University of Guelph; Queens University - Canada	Wessels, JM (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tayadec@queensu.ca			Ontario Pork; Natural Sciences and Engineering Research Council of Canada; Agriculture and Agri-Food Canada; Ontario Ministry of Agriculture Food and Rural Affairs; Bioniche Life Sciences Inc., Belleville, Ontario, Canada	Ontario Pork; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Ontario Ministry of Agriculture Food and Rural Affairs; Bioniche Life Sciences Inc., Belleville, Ontario, Canada	This research was supported by funding from Ontario Pork, Natural Sciences and Engineering Research Council of Canada, Agriculture and Agri-Food Canada, Ontario Ministry of Agriculture Food and Rural Affairs, and Bioniche Life Sciences Inc., Belleville, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Alevizos I, 2011, ARTHRITIS RHEUM-US, V63, P535, DOI 10.1002/art.30131; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Kuijk EW, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-58; Kulcheski FR, 2010, ANAL BIOCHEM, V406, P185, DOI 10.1016/j.ab.2010.07.020; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mahn R, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.01.020; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Pope WF, 1994, EMBRYONIC MORTALITY, P53; *QIAGEN, 2011, HIGHL SPEC PCR PROD; Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148; Tayade C, 2007, J LEUKOCYTE BIOL, V82, P877, DOI 10.1189/jlb.0507330; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wessels JM, 2011, IMMUNOL CELL BIOL, V89, P304, DOI 10.1038/icb.2010.95; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009; ZHU HT, 2011, MOL BIOTECHNOL	36	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28940	10.1371/journal.pone.0028940	http://dx.doi.org/10.1371/journal.pone.0028940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174931	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600050
J	Gomez-Lopez, N; Vadillo-Ortega, F; Estrada-Gutierrez, G				Gomez-Lopez, Nardhy; Vadillo-Ortega, Felipe; Estrada-Gutierrez, Guadalupe			Combined Boyden-Flow Cytometry Assay Improves Quantification and Provides Phenotypification of Leukocyte Chemotaxis	PLOS ONE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; HUMAN NEUTROPHIL; MIGRATION; CELL; LOCOMOTION; MONOCYTES; RESPONSIVENESS; MOTILITY; AGAROSE; CAP37	Chemotaxis has been studied by classical methods that measure chemotactic and random motility responses in vitro, but these methods do not evaluate the total number and phenotype of migrating leukocytes simultaneously. Our objective was to develop and validate a novel assay, combined Boyden-flow cytometry chemotaxis assay (CBFCA), for simultaneous quantification and phenotypification of migrating leukocytes. CBFCA exhibited several important advantages in comparison to the classic Boyden chemotaxis assay (CBCA): 1) improved precision (intra-assay coefficients of variation (CVs): CBFCA-4.7 and 4.8% vs. CBCA-30.1 and 17.3%; inter-observer CVs: CBFCA-3.6% vs. CBCA 30.1%); 2) increased recovery of cells, which increased assay to provide increased sensitivity; 3) high specificity for determining the phenotype of migrating/attracted leukocytes; and 4) reduced performance time (CBFCA 120 min vs. CBCA 265 min). Other advantages of CBFCA are: 5) robustness, 6) linearity, 7) eliminated requirement for albumin and, importantly, 8) enabled recovery of migrating leukocytes for subsequent studies. This latter feature is of great benefit in the study of migrating leukocyte subsets. We conclude that the CBFCA is a novel and improved technique for experiments focused on understanding leukocyte trafficking during the inflammatory response.	[Gomez-Lopez, Nardhy] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Res Direct, Mexico City, DF, Mexico; [Gomez-Lopez, Nardhy] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Gomez-Lopez, Nardhy] Univ Adelaide, Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Vadillo-Ortega, Felipe] Univ Nacl Autonoma Mexico, Fac Med, Dept Biochem, Mexico City 04510, DF, Mexico; [Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa de los Reyes, Dept Infectol, Mexico City, DF, Mexico	University of Alberta; University of Adelaide; Universidad Nacional Autonoma de Mexico	Gomez-Lopez, N (corresponding author), Inst Nacl Perinatol Isidro Espinosa de los Reyes, Res Direct, Mexico City, DF, Mexico.	nardhy.gomez-lopez@adelaide.edu.au; gpestrad@gmail.com	Gomez-Lopez, Nardhy/R-7664-2016; Estrada, Guadalupe/AAT-3970-2021; Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Vadillo-Ortega, Felipe/I-5273-2017	Gomez-Lopez, Nardhy/0000-0002-3406-5262; Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Vadillo-Ortega, Felipe/0000-0001-7137-4200	Molly Towell Perinatal Research Foundation; CONACyT - SALUD [7036, 69353]	Molly Towell Perinatal Research Foundation; CONACyT - SALUD(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	NG-L is sponsored by the Molly Towell Perinatal Research Foundation. FV-O was supported by CONACyT - SALUD 7036 and 69353. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOXER LA, 1979, J LAB CLIN MED, V93, P506; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Constantin G, 2010, NAT IMMUNOL, V11, P463, DOI 10.1038/ni0610-463; CUTLER JE, 1974, P SOC EXP BIOL MED, V147, P471; Dunzendorfer S, 2000, IMMUNOL LETT, V71, P5, DOI 10.1016/S0165-2478(99)00161-3; Ellingsen T, 2000, SCAND J IMMUNOL, V52, P257; FALK W, 1980, INFECT IMMUN, V29, P953; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; GEE AP, 1984, MOL CELL BIOCHEM, V62, P5; HARVATH L, 1983, SURV IMMUNOL RES, V2, P145; KELLER H U, 1972, Journal of Immunological Methods, V1, P165, DOI 10.1016/0022-1759(72)90043-9; Koedel U, 1999, J IMMUNOL, V163, P1237; KRETSCHMER R, 1985, PARASITE IMMUNOL, V7, P527, DOI 10.1111/j.1365-3024.1985.tb00097.x; KRETSCHMER RR, 1976, J IMMUNOL, V117, P1303; Kushner EJ, 2010, J APPL PHYSIOL, V109, P1756, DOI 10.1152/japplphysiol.00601.2010; LAUFFENBURGER D, 1983, J IMMUNOL, V131, P940; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; MARTIN LS, 1988, J LEUKOCYTE BIOL, V44, P361, DOI 10.1002/jlb.44.5.361; NELSON RD, 1975, J IMMUNOL, V115, P1650; Patel MK, 2005, BRIT J PHARMACOL, V145, P811, DOI 10.1038/sj.bjp.0706237; PEREIRA HA, 1990, J CLIN INVEST, V85, P1468, DOI 10.1172/JCI114593; Pereira HA, 2004, INVEST OPHTH VIS SCI, V45, P4284, DOI 10.1167/iovs.03-1052; Rudack C, 2004, CLIN EXP IMMUNOL, V135, P511, DOI 10.1111/j.1365-2249.2003.02390.x; Sato E, 1999, AM J PHYSIOL-LUNG C, V277, pL1149, DOI 10.1152/ajplung.1999.277.6.L1149; SCHREINER A, 1978, ACTA PATH MICRO IM C, V86, P117; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; SNYDERMAN R, 1972, J IMMUNOL, V108, P857; SORG C, 1982, IMMUNOBIOLOGY, V162, P192, DOI 10.1016/S0171-2985(11)80030-6; WIERUSZWYSOCKA B, 1983, ARTIF ORGANS, V7, P159, DOI 10.1111/j.1525-1594.1983.tb04181.x; Wilkinson P. C., 1996, Methods (Orlando), V10, P74, DOI 10.1006/meth.1996.0081; WILKINSON PC, 1988, METHOD ENZYMOL, V162, P38; ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387	32	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28771	10.1371/journal.pone.0028771	http://dx.doi.org/10.1371/journal.pone.0028771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174892	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700071
J	Holtz, LR; Bauer, IK; Rajendran, P; Kang, G; Wang, D				Holtz, Lori R.; Bauer, Irma K.; Rajendran, Priya; Kang, Gagandeep; Wang, David			Astrovirus MLB1 Is Not Associated with Diarrhea in a Cohort of Indian Children	PLOS ONE			English	Article							BIRTH COHORT; GASTROENTERITIS; ROTAVIRUS; DISEASE; VOLUNTEERS; INFECTION; ETIOLOGY; ILLNESS; SLUM	Astroviruses are a known cause of human diarrhea. Recently the highly divergent astrovirus MLB1 (MLB1) was identified in a stool sample from a patient with diarrhea. It has subsequently been detected in stool from individuals with and without diarrhea. To determine whether MLB1 is associated with diarrhea, we conducted a case control study of MLB1. In parallel, the prevalence of the classic human astroviruses (HAstVs) was also determined in the same case control cohort. 400 cases and 400 paired controls from a longitudinal birth cohort in Vellore, India were analyzed by RT-PCR. While HAstVs were associated with diarrhea (p = 0.029) in this cohort, MLB1 was not; 14 of the controls and 4 cases were positive for MLB1. Furthermore, MLB1 viral load did not differ significantly between the cases and controls. The role of MLB1 in human health still remains unknown and future studies are needed.	[Holtz, Lori R.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bauer, Irma K.; Wang, David] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Bauer, Irma K.; Wang, David] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Rajendran, Priya; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Christian Medical College & Hospital (CMCH) Vellore	Holtz, LR (corresponding author), Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA.	davewang@borcim.wustl.edu	Holtz, Lori/AAA-4296-2020	Kang, Gagandeep/0000-0002-3656-564X; Holtz, Lori/0000-0002-5591-7794	National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS [KL2 RR024994]; NIH [R21 AI090199]; Burroughs Wellcome Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090199] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH)/National Center for Research Resources Washington University-ICTS grant number KL2 RR024994 and by NIH grant R21 AI090199. DW holds an Investigators in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, NOVEL ASTRO IN PRESS; Ajjampur SSR, 2008, J MED MICROBIOL, V57, P1364, DOI 10.1099/jmm.0.2008/003319-0; Albert MJ, 1999, J CLIN MICROBIOL, V37, P3458, DOI 10.1128/JCM.37.11.3458-3464.1999; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Banyai K, 2010, EMERG INFECT DIS, V16, P169, DOI [10.3201/eid1601.091120, 10.3201/eid1601.091563]; Bodhidatta L, 2010, AM J TROP MED HYG, V83, P1106, DOI 10.4269/ajtmh.2010.10-0367; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Ken BTT, 2007, J MED MICROBIOL, V56, P1086, DOI 10.1099/jmm.0.47093-0; Chu DKW, 2010, J GEN VIROL, V91, P2457, DOI 10.1099/vir.0.022764-0; Dennehy PH, 2001, J INFECT DIS, V184, P10, DOI 10.1086/321007; DM Knipe, 2007, FIELDS VIROLOGY, P981; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finkbeiner SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-161; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Finkbeiner SR, 2009, EMERG INFECT DIS, V15, P441, DOI 10.3201/eid1503.081213; Gladstone BP, 2008, ARCH DIS CHILD, V93, P479, DOI 10.1136/adc.2006.114546; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Gladstone BP, 2010, J TROP PEDIATRICS, V56, P221, DOI 10.1093/tropej/fmp116; Glass RI, 1996, ARCH VIROL, P287; HOLTZ LR, 2011, EMERGING INFECT DIS; KAPIKIAN AZ, 1983, J INFECT DIS, V147, P95, DOI 10.1093/infdis/147.1.95; Kapoor A, 2009, J GEN VIROL, V90, P2965, DOI 10.1099/vir.0.014449-0; Klein EJ, 2006, CLIN INFECT DIS, V43, P807, DOI 10.1086/507335; MADELEY CR, 1975, LANCET, V2, P451; MIDTHUN K, 1993, J CLIN MICROBIOL, V31, P955, DOI 10.1128/JCM.31.4.955-962.1993; Nguyen TA, 2008, J MED VIROL, V80, P298, DOI 10.1002/jmv.21032; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Phillips G, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-63; Quan PL, 2010, EMERG INFECT DIS, V16, P918, DOI 10.3201/eid1606.091536; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Soares CC, 2008, J MED VIROL, V80, P113, DOI 10.1002/jmv.21053; THORNHILL TS, 1975, J INFECT DIS, V132, P28, DOI 10.1093/infdis/132.1.28	32	43	44	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28647	10.1371/journal.pone.0028647	http://dx.doi.org/10.1371/journal.pone.0028647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174853	Green Published, gold			2022-12-27	WOS:000298365700054
J	Pask, GM; Jones, PL; Rutzler, M; Rinker, DC; Zwiebel, LJ				Pask, Gregory M.; Jones, Patrick L.; Ruetzler, Michael; Rinker, David C.; Zwiebel, Laurence J.			Heteromeric Anopheline Odorant Receptors Exhibit Distinct Channel Properties	PLOS ONE			English	Article							MOLECULAR-BASIS; BEHAVIOR	Background: Insect odorant receptors (ORs) function as odorant-gated ion channels consisting of a conventional, odorant-binding OR and the Orco coreceptor. While Orco can function as a homomeric ion channel, the role(s) of the conventional OR in heteromeric OR complexes has largely focused only on odorant recognition. Results: To investigate other roles of odorant-binding ORs, we have employed patch clamp electrophysiology to investigate the properties of the channel pore of several OR complexes formed by a range of different odorant-specific Anopheles gambiae ORs (AgOrs) each paired with AgOrco. These studies reveal significant differences in cation permeability and ruthenium red susceptibility among different AgOr complexes. Conclusions: With observable differences in channel function, the data support a model in which the odorant-binding OR also affects the channel pore. The variable effect contributed by the conventional OR on the conductive properties of odorant-gated sensory channels adds additional complexity to insect olfactory signaling, with differences in odor coding beginning with ORs on the periphery of the olfactory system.	[Pask, Gregory M.; Jones, Patrick L.; Ruetzler, Michael; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA; [Ruetzler, Michael] Univ Aarhus, Inst Anat, Water & Salt Res Ctr, Aarhus C, Denmark; [Rinker, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Biol Chem, Ctr Mol Neurosci,Dept Pharmacol, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Biol Chem, Ctr Human Genet Res,Dept Pharmacol, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Global Hlth, Nashville, TN USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Program Dev Biol, Nashville, TN USA	Vanderbilt University; Aarhus University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Pask, GM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37203 USA.	l.zwiebel@vanderbilt.edu	Rutzler, Michael/ABE-7914-2020	Rutzler, Michael/0000-0001-5597-8880; Zwiebel, Laurence/0000-0001-6686-7289	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative; NIH [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Foundation for the National Institutes of Health (NIH) through the Grand Challenges in Global Health Initiative and the NIH (AI056402) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2011, CHEM SENSES, V36, P149, DOI 10.1093/chemse/bjq105; Bonigk W, 1999, J NEUROSCI, V19, P5332; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Cibulsky SM, 1999, J PHARMACOL EXP THER, V289, P1447; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; EISENMAN G, 1987, ANNU REV BIOPHYS BIO, V16, P205; EISENMAN G, 1962, Biophys J, V2, P259; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kaissling K.-E, 1995, EXPT CELL BIOL TASTE, P361; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LEE CO, 1974, BIOPHYS J, V14, P46, DOI 10.1016/S0006-3495(74)85902-3; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; ZUFALL F, 1991, J NEUROSCI, V11, P956	28	56	60	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28774	10.1371/journal.pone.0028774	http://dx.doi.org/10.1371/journal.pone.0028774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174894	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700072
J	Sun, X; Chen, XJ; Feng, J; Zhao, JY; Li, YZ				Sun, Xia; Chen, Xiao-jing; Feng, Jing; Zhao, Jing-yi; Li, Yue-zhong			Characterization of the Partitioning System of Myxococcus Plasmid pMF1	PLOS ONE			English	Article							PARB PROTEIN; F-PLASMID; P1; SEGREGATION; COMPLEX; BINDING; REGION; GENE; TRANSCRIPTION; STABILITY	pMF1 is the only autonomously replicating plasmid that has been recently identified in myxobacteria. This study characterized the partitioning (par) system of this plasmid. The fragment that significantly increased the retaining stability of plasmids in Myxococcus cells in the absence of selective antibiotics contained three open reading frames (ORFs) pMF1.21-pMF1.23 (parCAB). The pMF1.22 ORF (parA) is homologous to members of the parA ATPase family, with the highest similarity (56%) to the Sphingobium japonicum ParA-like protein, while the other two ORFs had no homologs in GenBank. DNase I footprinting and electrophoretic mobility shift assays showed that the pMF1.23 (parB) product is a DNA-binding protein of iteron DNA sequences, while the product of pMF1.21 (parC) has no binding activity but is able to enhance the DNA-binding activity of ParB to iterons. The ParB protein autogenously repressed the expression of the par genes, consistent with the type Ib par pattern, while the ParC protein has less repressive activity. The ParB-binding iteron sequences are distributed not only near the partitioning gene loci but also along pMF1. These results indicate that the pMF1 par system has novel structural and functional characteristics.	[Sun, Xia; Chen, Xiao-jing; Feng, Jing; Zhao, Jing-yi; Li, Yue-zhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Sun, X (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	lilab@sdu.edu.cn	Li, Yuezhong/ACN-5179-2022	Li, Yuezhong/0000-0001-8336-6638	National Science Foundation for Distinguished Young Scholars [30825001]; National Natural Science Foundation of China [30971572]	National Science Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Science Foundation for Distinguished Young Scholars (grant 30825001) and the National Natural Science Foundation (grant 30971572) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode HB, 2006, J BACTERIOL, V188, P6524, DOI 10.1128/JB.00825-06; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DAVIS MA, 1988, EMBO J, V7, P1881, DOI 10.1002/j.1460-2075.1988.tb03021.x; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Dolowy P, 2005, PLASMID, V53, P239, DOI 10.1016/j.plasmid.2004.11.005; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Edgar R, 2001, MOL MICROBIOL, V42, P1363, DOI 10.1046/j.1365-2958.2001.02717.x; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; FUNNELL BE, 1993, J BIOL CHEM, V268, P3616; FUNNELL BE, 1991, J BIOL CHEM, V266, P14328; HAYES F, 1994, MOL MICROBIOL, V11, P249, DOI 10.1111/j.1365-2958.1994.tb00305.x; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kalnin K, 2000, J BACTERIOL, V182, P1889, DOI 10.1128/JB.182.7.1889-1894.2000; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Kwong SM, 2001, MOL MICROBIOL, V40, P621, DOI 10.1046/j.1365-2958.2001.02405.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lukaszewicz M, 2002, NUCLEIC ACIDS RES, V30, P1046, DOI 10.1093/nar/30.4.1046; Misselwitz R, 2001, FEBS LETT, V505, P436, DOI 10.1016/S0014-5793(01)02865-4; Moller-Jensen J, 2000, TRENDS MICROBIOL, V8, P313, DOI 10.1016/S0966-842X(00)01787-X; MORI H, 1989, J BIOL CHEM, V264, P15535; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; MOTALLEBIVESHAREH M, 1992, MOL MICROBIOL, V6, P907, DOI 10.1111/j.1365-2958.1992.tb01541.x; OGURA T, 1983, CELL, V32, P351, DOI 10.1016/0092-8674(83)90454-3; PANSEGRAU W, 1994, J MOL BIOL, V239, P623, DOI 10.1006/jmbi.1994.1404; Ravin N, 1999, J BACTERIOL, V181, P6898, DOI 10.1128/JB.181.22.6898-6906.1999; REICHENBACH H, 1993, BIOTECHNOL ADV, V11, P219, DOI 10.1016/0734-9750(93)90042-L; Sambrook J., 2001, MOL CLONING LAB MANU; SHIMKETS LJ, 1990, MICROBIOL REV, V54, P473, DOI 10.1128/MMBR.54.4.473-501.1990; Zhao JY, 2008, APPL ENVIRON MICROB, V74, P1980, DOI 10.1128/AEM.02143-07	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28122	10.1371/journal.pone.0028122	http://dx.doi.org/10.1371/journal.pone.0028122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174771	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700018
J	Taher, L; Collette, NM; Murugesh, D; Maxwell, E; Ovcharenko, I; Loots, GG				Taher, Leila; Collette, Nicole M.; Murugesh, Deepa; Maxwell, Evan; Ovcharenko, Ivan; Loots, Gabriela G.			Global Gene Expression Analysis of Murine Limb Development	PLOS ONE			English	Article							VERTEBRATE LIMB; T-BOX; TBX4; SPECIFICATION; BIOCONDUCTOR; IDENTITY; MODELS; LMX1B	Detailed information about stage-specific changes in gene expression is crucial for understanding the gene regulatory networks underlying development and the various signal transduction pathways contributing to morphogenesis. Here we describe the global gene expression dynamics during early murine limb development, when cartilage, tendons, muscle, joints, vasculature and nerves are specified and the musculoskeletal system of limbs is established. We used whole-genome microarrays to identify genes with differential expression at 5 stages of limb development E9.5 to 13.5), during fore- and hind-limb patterning. We found that the onset of limb formation is characterized by an up-regulation of transcription factors, which is followed by a massive activation of genes during E10.5 and E11.5 which levels off at later time points. Among the 3520 genes identified as significantly up-regulated in the limb, we find similar to 30% to be novel, dramatically expanding the repertoire of candidate genes likely to function in the limb. Hierarchical and stage-specific clustering identified expression profiles that are likely to correlate with functional programs during limb development and further characterization of these transcripts will provide new insights into specific tissue patterning processes. Here, we provide for the first time a comprehensive analysis of developmentally regulated genes during murine limb development, and provide some novel insights into the expression dynamics governing limb morphogenesis.	[Taher, Leila; Ovcharenko, Ivan] Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20894 USA; [Collette, Nicole M.; Murugesh, Deepa; Loots, Gabriela G.] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA USA; [Loots, Gabriela G.] Univ Calif Merced, Sch Nat Sci, Merced, CA USA; [Maxwell, Evan] Boston Univ, Bioinformat Program, Boston, MA 02215 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced; Boston University	Taher, L (corresponding author), Natl Lib Med, Natl Ctr Biotechnol Informat, Computat Biol Branch, Bethesda, MD 20894 USA.	loots1@llnl.gov	Loots, Gabriela G/AGA-4868-2022	Loots, Gabriela G/0000-0001-9546-5561; Collette, Nicole/0000-0002-9068-8712; Taher, Leila/0000-0002-2013-5426; Murugesh, Deepa/0000-0002-4232-8480	National Institutes of Health [DK075730, HG003963]; National Institutes of Health, National Library of Medicine; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075730] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM200881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	GGL, NMC and DM were supported by National Institutes of Health grants DK075730 and HG003963. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Carsten Jacobi and Michaela Kneissel from the Bone and Cartilage Group at Novartis Pharma and Shalini Mabery at LLNL for assistance with generating the microarray data. Special thanks to Jim Kent for giving us permission to use in situ images from Visigene; Nick Fischer for graphic design of Figure 1 and all members of the Loots group who have helped with animal husbandry, embryo isolation and engaged in insightful manuscript discussions. This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344.	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Dai JX, 2009, DEV GROWTH DIFFER, V51, P241, DOI 10.1111/j.1440-169X.2008.01083.x; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson-Brown JJ, 1998, DEVELOPMENT, V125, P2499; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, DEVELOPMENT, V125, P2825; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Margulies EH, 2001, GENOME RES, V11, P1686, DOI 10.1101/gr.192601; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Phadke SR, 2010, INDIAN J PEDIATR, V77, P277, DOI 10.1007/s12098-010-0033-1; Piette D, 2008, NAT PROTOC, V3, P1194, DOI 10.1038/nprot.2008.103; Qiu Q, 2009, GENESIS, V47, P224, DOI 10.1002/dvg.20430; *R FDN STAT COMP, RDC T R LANG ENV STA; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Tzchori I, 2009, DEVELOPMENT, V136, P1375, DOI 10.1242/dev.026476; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; WANEK N, 1989, J EXP ZOOL, V249, P41, DOI 10.1002/jez.1402490109; Wang Z, 2011, NATURE, V477, P583, DOI 10.1038/nature10391; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Xu B, 2011, P NATL ACAD SCI USA, V108, P4888, DOI 10.1073/pnas.1018161108	36	56	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28358	10.1371/journal.pone.0028358	http://dx.doi.org/10.1371/journal.pone.0028358			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174793	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700028
J	Ruploh, T; Kazek, A; Bischof, HJ				Ruploh, Tim; Kazek, Agnieszka; Bischof, Hans-Joachim			Spatial Orientation in Japanese Quails (Coturnix coturnix japonica)	PLOS ONE			English	Article							LOCAL CUES; LANDMARK INFORMATION; GALLUS-GALLUS; PIGEONS; MEMORY; GEOMETRY; BIRDS; REPRESENTATION; COGNITION; SYSTEM	Finding a given location can be based on a variety of strategies, for example on the estimation of spatial relations between landmarks, called spatial orientation. In galliform birds, spatial orientation has been demonstrated convincingly in very young domestic chicks. We wanted to know whether adult Japanese quails (Coturnix coturnix japonica) without food deprivation are also able to use spatial orientation. The quails had to learn the relation of a food location with four conspicuous landmarks which were placed in the corners of a square shaped arena. They were trained to find mealworms in three adjacent food cups in a circle of 20 such cups. The rewarded feeders were located during training between the same two landmarks each of which showed a distinct pattern. When the birds had learned the task, all landmarks were displaced clockwise by 90 degrees. When tested in the new situation, all birds redirected their choices with respect to the landmark shift. In subsequent tests, however, the previously correct position was also chosen. According to our results, quails are using conspicuous landmarks as a first choice for orientation. The orientation towards the previously rewarded location, however, indicates that the neuronal representation of space which is used by the birds also includes more fine grain, less conspicuous cues, which are probably also taken into account in uncertain situations. We also presume that the rare orientation towards never rewarded feeders may be due to a foraging strategy instead of being mistakes.	[Ruploh, Tim; Bischof, Hans-Joachim] Univ Bielefeld, Lehrstuhl Verhaltensforsch, D-33615 Bielefeld, Nordrhein Westf, Germany; [Kazek, Agnieszka] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, AG Neurosensor, D-2900 Oldenburg, Niedersachsen, Germany	University of Bielefeld; Carl von Ossietzky Universitat Oldenburg	Ruploh, T (corresponding author), Univ Bielefeld, Lehrstuhl Verhaltensforsch, D-33615 Bielefeld, Nordrhein Westf, Germany.	tim.ruploh@uni-bielefeld.de			Deutsche Forschungsgemeinschaft [Bi 245/19-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/index.jsp) grant number Bi 245/19-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett ATD, 1996, J EXP BIOL, V199, P219; BRODBECK DR, 1995, J EXP PSYCHOL ANIM B, V21, P64, DOI 10.1037/0097-7403.21.1.64; BRODBECK DR, 1994, ANIM LEARN BEHAV, V22, P119, DOI 10.3758/BF03199912; CHENG K, 1988, J COMP PHYSIOL A, V162, P815, DOI 10.1007/BF00610970; CLAYTON NS, 1994, J COMP PHYSIOL A, V174, P371; Della Chiesa A, 2006, BEHAV BRAIN RES, V175, P119, DOI 10.1016/j.bbr.2006.08.012; Della Chiesa A, 2006, ANIM COGN, V9, P281, DOI 10.1007/s10071-006-0050-7; DYER FC, 1981, SCIENCE, V214, P1041, DOI 10.1126/science.214.4524.1041; Feenders G, 2011, ANIM COGN, V14, P235, DOI 10.1007/s10071-010-0357-2; Gagliardo A, 1999, J NEUROSCI, V19, P311, DOI 10.1523/JNEUROSCI.19-01-00311.1999; GALLISTEL CR, 1989, ANNU REV PSYCHOL, V40, P155, DOI 10.1146/annurev.ps.40.020189.001103; Herborn K, 2011, ANIM COGN, V14, P269, DOI 10.1007/s10071-010-0360-7; Hodgson ZG, 2005, ANIM COGN, V8, P211, DOI 10.1007/s10071-004-0249-4; Inglis IR, 2001, ANIM BEHAV, V62, P543, DOI 10.1006/anbe.2001.1780; LaDage LD, 2009, ANIM COGN, V12, P419, DOI 10.1007/s10071-008-0201-0; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Mayer U, 2011, EXP BIOL IN PRESS; MEINECKE RO, 1974, J GERONTOL, V29, P172, DOI 10.1093/geronj/29.2.172; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Ottinger MA, 2001, EXP GERONTOL, V36, P859, DOI 10.1016/S0531-5565(00)00246-1; Pecchia T, 2010, J EXP BIOL, V213, P2987, DOI 10.1242/jeb.043315; PRAVOSUDOV VV, 1985, ZOOL ZH, V64, P1036; Rodriguez F, 2002, J NEUROSCI, V22, P2894, DOI 10.1523/JNEUROSCI.22-07-02894.2002; Schone H, 1980, ORIENTIERUNG RAUM FO, P377; Spetch ML, 1996, J COMP PSYCHOL, V110, P55, DOI 10.1037/0735-7036.110.1.55; SPETCH ML, 1988, ANIM BEHAV, V36, P293, DOI 10.1016/S0003-3472(88)80274-4; Tommasi L, 2004, BEHAV BRAIN RES, V155, P85, DOI 10.1016/j.bbr.2004.04.004; Tommasi L, 2003, EUR J NEUROSCI, V17, P1695, DOI 10.1046/j.1460-9568.2003.02593.x; Tommasi L, 2001, BEHAV NEUROSCI, V115, P602, DOI 10.1037//0735-7044.115.3.602; VANDERWALL SB, 1977, ECOL MONOGR, V47, P89, DOI 10.2307/1942225; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071	33	6	7	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28202	10.1371/journal.pone.0028202	http://dx.doi.org/10.1371/journal.pone.0028202			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163284	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900019
J	Saunier, EF; Vivar, OI; Rubenstein, A; Zhao, XY; Olshansky, M; Baggett, S; Staub, RE; Tagliaferri, M; Cohen, I; Speed, TP; Baxter, JD; Leitman, DC				Saunier, Elise F.; Vivar, Omar I.; Rubenstein, Andrea; Zhao, Xiaoyue; Olshansky, Moshe; Baggett, Scott; Staub, Richard E.; Tagliaferri, Mary; Cohen, Isaac; Speed, Terence P.; Baxter, John D.; Leitman, Dale C.			Estrogenic Plant Extracts Reverse Weight Gain and Fat Accumulation without Causing Mammary Gland or Uterine Proliferation	PLOS ONE			English	Article							POSTMENOPAUSAL HORMONE-THERAPY; RECEPTOR-BETA; BODY-WEIGHT; REPLACEMENT THERAPY; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; PLUS PROGESTIN; BREAST-CANCER; OB/OB MICE; ALPHA	Long-term estrogen deficiency increases the risk of obesity, diabetes and metabolic syndrome in postmenopausal women. Menopausal hormone therapy containing estrogens might prevent these conditions, but its prolonged use increases the risk of breast cancer, as wells as endometrial cancer if used without progestins. Animal studies indicate that beneficial effects of estrogens in adipose tissue and adverse effects on mammary gland and uterus are mediated by estrogen receptor alpha (ER alpha). One strategy to improve the safety of estrogens to prevent/treat obesity, diabetes and metabolic syndrome is to develop estrogens that act as agonists in adipose tissue, but not in mammary gland and uterus. We considered plant extracts, which have been the source of many pharmaceuticals, as a source of tissue selective estrogens. Extracts from two plants, Glycyrrhiza uralensis (RG) and Pueraria montana var. lobata (RP) bound to ER alpha, activated ER alpha responsive reporters, and reversed weight gain and fat accumulation comparable to estradiol in ovariectomized obese mice maintained on a high fat diet. Unlike estradiol, RG and RP did not induce proliferative effects on mammary gland and uterus. Gene expression profiling demonstrated that RG and RP induced estradiol-like regulation of genes in abdominal fat, but not in mammary gland and uterus. The compounds in extracts from RG and RP might constitute a new class of tissue selective estrogens to reverse weight gain, fat accumulation and metabolic syndrome in postmenopausal women.	[Saunier, Elise F.; Rubenstein, Andrea; Zhao, Xiaoyue; Baggett, Scott; Staub, Richard E.; Tagliaferri, Mary; Cohen, Isaac] Bionovo Inc, Emeryville, CA 94608 USA; [Vivar, Omar I.; Leitman, Dale C.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Olshansky, Moshe; Speed, Terence P.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Bioinformat, Parkville, Vic 3050, Australia; [Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Baxter, John D.] Methodist Hosp, Diabet Ctr & Canc Res Unit, Res Inst, Houston, TX 77030 USA	University of California System; University of California Berkeley; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of California System; University of California Berkeley; The Methodist Hospital System; The Methodist Hospital - Houston	Saunier, EF (corresponding author), Bionovo Inc, Emeryville, CA 94608 USA.	dale@leitmanlab.com		Olshansky, Moshe/0000-0003-2085-9851	National Institutes of Health/National Center for Complementary and Alternative Medicine [1R41AT005575]; Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R41AT005575] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Complementary & Alternative Medicine); Bionovo, Inc.; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by a grant (1R41AT005575) from the National Institutes of Health/National Center for Complementary and Alternative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; OIV and MO have nothing to declare. EFS, AR, SB, RES, MT and IC are employees of Bionovo, Inc. and are stock owners. JDB is a Director and owner of options of Bionovo. JDB and TPS are on the Scientific Advisory Board of Bionovo, Inc. JDB has stock ownership in Karo Bio, A.B., which has commercial interests in this area of research. DCL has received financial support for research from Bionovo, Inc. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	An JP, 1999, P NATL ACAD SCI USA, V96, P15161, DOI 10.1073/pnas.96.26.15161; An JP, 2001, J BIOL CHEM, V276, P17808, DOI 10.1074/jbc.M100953200; BAILEY CJ, 1980, DIABETOLOGIA, V19, P475, DOI 10.1007/BF00281829; Barros RPA, 2011, CELL METAB, V14, P289, DOI 10.1016/j.cmet.2011.08.005; Bonds DE, 2006, DIABETOLOGIA, V49, P459, DOI 10.1007/s00125-005-0096-0; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Cvoro A, 2007, ENDOCRINOLOGY, V148, P538, DOI 10.1210/en.2006-0803; Dahlman-Wright K, 2006, PHARMACOL REV, V58, P773, DOI 10.1124/pr.58.4.8; Espeland MA, 1997, J CLIN ENDOCR METAB, V82, P1549, DOI 10.1210/jc.82.5.1549; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gower BA, 2006, OBESITY, V14, P1046, DOI 10.1038/oby.2006.120; Grady D, 2009, MENOPAUSE, V16, P458, DOI 10.1097/gme.0b013e31818e64dd; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jensen L, 2003, J BONE MINER RES, V18, P333, DOI 10.1359/jbmr.2003.18.2.333; Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886; Kanaya AM, 2003, ANN INTERN MED, V138, P1, DOI 10.7326/0003-4819-138-1-200301070-00005; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; Leitman DC, 2010, CURR OPIN PHARMACOL, V10, P629, DOI 10.1016/j.coph.2010.09.009; Levy N, 2007, ENDOCRINOLOGY, V148, P3449, DOI 10.1210/en.2006-1632; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lundholm L, 2008, J ENDOCRINOL, V199, P275, DOI [10.1677/JOE-08-0192, 10.1530/JOE-08-0192e]; Mahady GB, 2003, MENOPAUSE, V10, P65, DOI 10.1097/01.GME.0000029028.95924.F9; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mattiasson I, 2002, HORM METAB RES, V34, P583, DOI 10.1055/s-2002-35420; Mersereau JE, 2008, MOL CELL ENDOCRINOL, V283, P49, DOI 10.1016/j.mce.2007.11.020; Meyers MJ, 2001, J MED CHEM, V44, P4230, DOI 10.1021/jm010254a; Minutolo F, 2011, MED RES REV, V31, P364, DOI 10.1002/med.20186; Misiti S, 1998, ENDOCRINOLOGY, V139, P2493, DOI 10.1210/en.139.5.2493; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Molenda HA, 2003, BIOL REPROD, V69, P1449, DOI 10.1095/biolreprod.103.019364; Mostafaie N, 2009, MOL CARCINOGEN, V48, P642, DOI 10.1002/mc.20510; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; PARUTHIYIL S, 2011, BREAST CANC RES TREA, V186, P4354; Paruthiyil S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006271; Roesch DM, 2006, PHYSIOL BEHAV, V87, P39, DOI 10.1016/j.physbeh.2005.08.035; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Saunier E, 2003, ENDOCRINOLOGY, V144, P2669, DOI 10.1210/en.2002-221038; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; Vivar OI, 2010, J BIOL CHEM, V285, P22059, DOI 10.1074/jbc.M110.114116; YI ST, 2008, CLIN PRACTICE CHINES, V2; Zhou YJ, 2009, J BIOL CHEM, V284, P11152, DOI 10.1074/jbc.M900754200	52	8	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28333	10.1371/journal.pone.0028333	http://dx.doi.org/10.1371/journal.pone.0028333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163294	Green Published, gold			2022-12-27	WOS:000298161900029
J	Bruce, CR; Smith, DA; Rodgers, D; Dantas, AD; MacCallum, DM; Morgan, BA; Quinn, J				Bruce, Catherine R.; Smith, Deborah A.; Rodgers, David; Dantas, Alessandra da Silva; MacCallum, Donna M.; Morgan, Brian A.; Quinn, Janet			Identification of a Novel Response Regulator, Crr1, That Is Required for Hydrogen Peroxide Resistance in Candida albicans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; 2-COMPONENT HISTIDINE KINASE; OXIDATIVE STRESS-RESPONSE; CELL-WALL BIOSYNTHESIS; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; HYPHAL DEVELOPMENT; GENE; PHOSPHORELAY	Candida albicans colonises numerous niches within humans and thus its success as a pathogen is dependent on its ability to adapt to diverse growth environments within the host. Two component signal transduction is a common mechanism by which bacteria respond to environmental stimuli and, although less common, two component-related pathways have also been characterised in fungi. Here we report the identification and characterisation of a novel two component response regulator protein in C. albicans which we have named CRR1 (Candida Response Regulator 1). Crr1 contains a receiver domain characteristic of response regulator proteins, including the conserved aspartate that receives phosphate from an upstream histidine kinase. Significantly, orthologues of CRR1 are present only in fungi belonging to the Candida CTG clade. Deletion of the C. albicans CRR1 gene, or mutation of the predicted phospho-aspartate, causes increased sensitivity of cells to the oxidising agent hydrogen peroxide. Crr1 is present in both the cytoplasm and nucleus, and this localisation is unaffected by oxidative stress or mutation of the predicted phospho-aspartate. Furthermore, unlike the Ssk1 response regulator, Crr1 is not required for the hydrogen peroxide-induced activation of the Hog1 stress-activated protein kinase pathway, or for the virulence of C. albicans in a mouse model of systemic disease. Taken together, our data suggest that Crr1, a novel response regulator restricted to the Candida CTG clade, regulates the response of C. albicans cells to hydrogen peroxide in a Hog1-independent manner that requires the function of the conserved phospho-aspartate.	[Bruce, Catherine R.; Smith, Deborah A.; Rodgers, David; Dantas, Alessandra da Silva; Morgan, Brian A.; Quinn, Janet] Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [MacCallum, Donna M.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen, Scotland	Newcastle University - UK; University of Aberdeen	Bruce, CR (corresponding author), Newcastle Univ, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	brian.morgan@ncl.ac.uk; janet.quinn@ncl.ac.uk	Quinn, Janet/AAR-9957-2021; MacCallum, Donna M./D-7897-2011; da Silva Dantas, Alessandra/B-9151-2015	MacCallum, Donna M./0000-0003-4833-0378; Quinn, Janet/0000-0002-8732-7676	Wellcome Trust [078779, 086048]; Nuffield Foundation [URB/BH081624]	Wellcome Trust(Wellcome TrustEuropean Commission); Nuffield Foundation	This work was supported by the Wellcome Trust (grant numbers 078779 and 086048, www.wellcome.ac.uk) and Nuffield Foundation (grant number URB/BH081624, www.nuffieldfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex LA, 1998, P NATL ACAD SCI USA, V95, P7069, DOI 10.1073/pnas.95.12.7069; Barelle CJ, 2004, YEAST, V21, P333, DOI 10.1002/yea.1099; Blackwell C, 2003, YEAST, V20, P1235, DOI 10.1002/yea.1036; Bonhomme J, 2011, MOL MICROBIOL, V80, P995, DOI 10.1111/j.1365-2958.2011.07626.x; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brown AJP, 2009, CURR OPIN MICROBIOL, V12, P384, DOI 10.1016/j.mib.2009.06.007; BROWN JL, 1994, EMBO J, V13, P5186, DOI 10.1002/j.1460-2075.1994.tb06849.x; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Calera JA, 1999, YEAST, V15, P1243, DOI 10.1002/(SICI)1097-0061(19990915)15:12&lt;1243::AID-YEA449&gt;3.0.CO;2-5; Calera JA, 2000, YEAST, V16, P1053, DOI 10.1002/1097-0061(200008)16:11&lt;1053::AID-YEA598&gt;3.0.CO;2-H; Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000; Calera JA, 1998, YEAST, V14, P665, DOI 10.1002/(SICI)1097-0061(199805)14:7&lt;665::AID-YEA246&gt;3.0.CO;2-#; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Dantas AD, 2010, MOL CELL BIOL, V30, P4550, DOI 10.1128/MCB.00313-10; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Deveau A, 2010, EUKARYOT CELL, V9, P569, DOI 10.1128/EC.00321-09; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; FONZI WA, 1993, GENETICS, V134, P717; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Kunze D, 2005, MICROBIOL-SGM, V151, P3381, DOI 10.1099/mic.0.28353-0; Li DM, 2004, MICROBIOL-SGM, V150, P3305, DOI 10.1099/mic.0.27237-0; Li S, 2002, MOL BIOL CELL, V13, P412, DOI 10.1091/mbc.01-09-0434; Lu JMY, 2003, EUKARYOT CELL, V2, P1304, DOI 10.1128/EC.2.6.1304-1314.2003; Menon V, 2006, MOL MICROBIOL, V62, P997, DOI 10.1111/j.1365-2958.2006.05438.x; Morgan BA, 1997, EMBO J, V16, P1035, DOI 10.1093/emboj/16.5.1035; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nagahashi S, 1998, MICROBIOL-UK, V144, P425, DOI 10.1099/00221287-144-2-425; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nikolaou E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-44; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Ohmiya R, 1999, J BIOCHEM, V125, P1061, DOI 10.1093/oxfordjournals.jbchem.a022387; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Quinn J, 2011, ANTIOXID REDOX SIGN, V15, P153, DOI 10.1089/ars.2010.3345; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Roman E, 2005, MOL CELL BIOL, V25, P10611, DOI 10.1128/MCB.25.23.10611-10627.2005; Roman E, 2009, EUKARYOT CELL, V8, P1235, DOI 10.1128/EC.00081-09; SANTOS JL, 2001, SCI STKE, pRE1, DOI DOI 10.1126/J.STKE.2001.98.RE1; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Smith DA, 2010, FEMS MICROBIOL LETT, V306, P1, DOI 10.1111/j.1574-6968.2010.01937.x; Srikantha T, 1998, MICROBIOL-SGM, V144, P2715, DOI 10.1099/00221287-144-10-2715; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989	52	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27979	10.1371/journal.pone.0027979	http://dx.doi.org/10.1371/journal.pone.0027979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164221	gold, Green Published			2022-12-27	WOS:000298171400022
J	Chai, RJ; Vukovic, J; Dunlop, S; Grounds, MD; Shavlakadze, T				Chai, Ruth Jinfen; Vukovic, Jana; Dunlop, Sarah; Grounds, Miranda D.; Shavlakadze, Thea			Striking Denervation of Neuromuscular Junctions without Lumbar Motoneuron Loss in Geriatric Mouse Muscle	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SKELETAL-MUSCLE; MORPHOLOGICAL-CHANGES; NEURONAL POPULATIONS; TOTAL NUMBER; SPINAL-CORD; FIBER TYPES; SARCOPENIA; CELLS; REINNERVATION	Reasons for the progressive age-related loss of skeletal muscle mass and function, namely sarcopenia, are complex. Few studies describe sarcopenia in mice, although this species is the mammalian model of choice for genetic intervention and development of pharmaceutical interventions for muscle degeneration. One factor, important to sarcopenia-associated neuromuscular change, is myofibre denervation. Here we describe the morphology of the neuromuscular compartment in young (3 month) compared to geriatric (29 month) old female C57Bl/6J mice. There was no significant difference in the size or number of motoneuron cell bodies at the lumbar level (L1-L5) of the spinal cord at 3 and 29 months. However, in geriatric mice, there was a striking increase (by similar to 2.5 fold) in the percentage of fully denervated neuromuscular junctions (NMJs) and associated deterioration of Schwann cells in fast extensor digitorum longus (EDL), but not in slow soleus muscles. There were also distinct changes in myofibre composition of lower limb muscles (tibialis anterior (TA) and soleus) with a shift at 29 months to a faster phenotype in fast TA muscle and to a slower phenotype in slow soleus muscle. Overall, we demonstrate complex changes at the NMJ and muscle levels in geriatric mice that occur despite the maintenance of motoneuron cell bodies in the spinal cord. The challenge is to identify which components of the neuromuscular system are primarily responsible for the marked changes within the NMJ and muscle, in order to selectively target future interventions to reduce sarcopenia.	[Chai, Ruth Jinfen; Grounds, Miranda D.; Shavlakadze, Thea] Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia; [Vukovic, Jana] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Dunlop, Sarah] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia	University of Western Australia; University of Queensland; University of Western Australia	Chai, RJ (corresponding author), Univ Western Australia, Sch Anat & Human Biol, Perth, WA 6009, Australia.	tea.shavlakadze@uwa.edu.au	Vukovic, Jana/B-4845-2013; Dunlop, Sarah A/G-9357-2013	Vukovic, Jana/0000-0002-3739-1688; Dunlop, Sarah/0000-0002-1306-3962; Chai, Ruth Jinfen/0000-0001-7597-6137; Grounds, Miranda/0000-0002-4530-9402	National Health and Medical Research Council of Australia [572654]; University of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia	This study was supported by funding from the National Health and Medical Research Council of Australia (grant ID 572654 to TS and MG), Research Collaboration Award from the University of Western Australia (MG, JV, TS) and the University of Western Australia Scholarships for International Research Fees and University International Stipend postgraduate scholarship to RJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Altun M, 2010, J BIOL CHEM, V285, P39597, DOI 10.1074/jbc.M110.129718; ANIANSSON A, 1986, MUSCLE NERVE, V9, P585, DOI 10.1002/mus.880090702; ARIZONO N, 1984, ACTA PATHOL JAPON, V34, P1243; Arthur PG, 2008, CURR OPIN CLIN NUTR, V11, P408, DOI 10.1097/MCO.0b013e328302f3fe; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Auld DS, 2003, NEURON, V40, P389, DOI 10.1016/S0896-6273(03)00607-X; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BUNGE RP, 1994, J NEUROL, V242, pS19, DOI 10.1007/BF00939235; CACCIA MR, 1979, MUSCLE NERVE, V2, P202, DOI 10.1002/mus.880020308; Ciavarro GL, 2003, J NEUROSCI METH, V129, P61, DOI 10.1016/S0165-0270(03)00201-2; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; COURTNEY J, 1981, J PHYSIOL-LONDON, V320, P435, DOI 10.1113/jphysiol.1981.sp013960; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dedkov EI, 2003, CELL TISSUE RES, V311, P401, DOI 10.1007/s00441-002-0686-9; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Edstrom E, 2007, PHYSIOL BEHAV, V92, P129, DOI 10.1016/j.physbeh.2007.05.040; FAHIM MA, 1982, J NEUROCYTOL, V11, P641, DOI 10.1007/BF01262429; FLOOD DG, 1988, NEUROBIOL AGING, V9, P453, DOI 10.1016/S0197-4580(88)80098-8; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; FUJISAWA K, 1976, EXP GERONTOL, V11, P43, DOI 10.1016/0531-5565(76)90010-3; Gadamski R, 2006, FOLIA NEUROPATHOL, V44, P154; GAMBINO DR, 1990, LARYNGOSCOPE, V100, P262; Gomez-Cabrera MC, 2008, FREE RADICAL BIO MED, V44, P126, DOI 10.1016/j.freeradbiomed.2007.02.001; GRIMBY G, 1982, ACTA PHYSIOL SCAND, V115, P125, DOI 10.1111/j.1748-1716.1982.tb07054.x; GUTMANN E, 1966, NATURE, V209, P921, DOI 10.1038/209921b0; Jacob JM, 1998, MECH AGEING DEV, V106, P205, DOI 10.1016/S0047-6374(98)00117-1; Jang YC, 2011, EXP GERONTOL, V46, P193, DOI 10.1016/j.exger.2010.08.029; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Kawabuchi M, 2001, ANAT RECORD, V264, P183, DOI 10.1002/ar.1159; Kawabuchi M, 1998, RESTOR NEUROL NEUROS, V13, P117; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P55, DOI 10.1111/j.1748-1716.1990.tb08975.x; KNOX CA, 1989, J NEUROPATH EXP NEUR, V48, P119, DOI 10.1097/00005072-198903000-00001; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; LUDATSCHER RM, 1985, EXP GERONTOL, V20, P81, DOI 10.1016/0531-5565(85)90043-9; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Lynch GS, 2005, AGING INTERVENTIONS AND THERAPIES, P63, DOI 10.1142/9789812701329_0004; MacIntosh B.R., 2006, SKELETAL MUSCLE FORM; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McLennan IS, 2002, INT J DEV BIOL, V46, P559; McMahon CD, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P393, DOI 10.1007/978-90-481-9713-2_17; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Naguib M, 2002, ANESTHESIOLOGY, V96, P202, DOI 10.1097/00000542-200201000-00035; O'Donnell KA, 1999, EXP NEUROL, V160, P300, DOI 10.1006/exnr.1999.7192; PARRY DJ, 1990, CAN J PHYSIOL PHARM, V68, P596, DOI 10.1139/y90-086; Rattan SIS, 2010, EXPT GERONTOLOGY, V31, P33; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; ROWE RWD, 1969, EXP GERONTOL, V4, P119, DOI 10.1016/0531-5565(69)90034-5; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Shavlakadze T, 2003, BIOL AGING MODULAT, V5, P139; Shavlakadze T, 2005, NEUROMUSCULAR DISORD, V15, P139, DOI 10.1016/j.nmd.2004.10.013; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Sheard PW, 2011, BIOGERONTOL IN PRESS; STANMORE A, 1978, J ANAT, V127, P101; Stephens B, 2006, J NEUROL SCI, V244, P41, DOI 10.1016/j.jns.2005.12.003; The Jackson Laboratory, 2011, WE DEF LIF HIST PHAS; Thornell LE, 2011, CURR OPIN CLIN NUTR, V14, P22, DOI 10.1097/MCO.0b013e3283412260; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Ulfhake B, 2000, MOL NEUROBIOL, V21, P109, DOI 10.1385/MN:21:3:109; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Wang ZM, 2005, J PHYSIOL-LONDON, V565, P757, DOI 10.1113/jphysiol.2005.087601; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; WOKKE JHJ, 1990, J NEUROL SCI, V95, P291, DOI 10.1016/0022-510X(90)90076-Y	67	139	143	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28090	10.1371/journal.pone.0028090	http://dx.doi.org/10.1371/journal.pone.0028090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164231	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400032
J	Chung, E; Hsu, CL; Kondo, M				Chung, Eva; Hsu, Chia-Lin; Kondo, Motonari			Constitutive MAP Kinase Activation in Hematopoietic Stem Cells Induces a Myeloproliferative Disorder	PLOS ONE			English	Article							WORLD-HEALTH-ORGANIZATION; BINDING PROTEIN-ALPHA; C-MYC; SIGNALING PATHWAYS; SOMATIC ACTIVATION; GENE-EXPRESSION; TRANSGENIC MICE; LINEAGE CHOICE; K-RAS; LEUKEMIA	Myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPNs) are a group of myeloid neoplasms in which abnormal activation of the Ras signaling pathway is commonly observed. The PI3K/Akt pathway is a known target of Ras; however, activation of the PI3K/Akt pathway has been shown to lead to neoplastic transformation of not only myeloid but also lymphoid cells, suggesting that pathways other than the PI3K/Akt pathway should play a central role in pathogenesis of Ras-mediated MDS/MPN. The MEK/ERK pathway is another downstream target of Ras, which is involved in regulation of cell survival and proliferation. However, the role of the MEK/ERK pathway in the pathogenesis of MDS/MPN remains unclear. Here, we show that introduction of a constitutively activated form of MEK into hematopoietic stem cells (HSCs) causes hematopoietic neoplasms that are limited to MDS/MPNs, despite the multipotent differentiation potential of HSCs. Active MEK-mediated MDS/MPNs are lethal, but are not considered a frank leukemia because it cannot be transplanted into naive animals. However, transplantation of MDS/MPNs co-expressing active MEK and an anti-apoptotic molecule, Bcl-2, results in T-cell acute lymphocytic leukemia (T-ALL), suggesting that longevity of cells may impact transplantability and alter disease phenotype. Our results clearly demonstrate the proto-oncogenic property of the MEK/ERK pathway in hematopoietic cells, which manifest in MDS/MPN development.	[Chung, Eva; Hsu, Chia-Lin; Kondo, Motonari] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA; [Kondo, Motonari] Toho Univ, Sch Med, Dept Immunol, Tokyo, Japan	Duke University; Toho University	Chung, E (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27708 USA.	motonari.kondo@med.toho-u.ac.jp			Alex's Lemonade Stand Foundation; NIH [AI056123, CA098129]; Ministry of Education, Culture, Sports, Science and Technology-Japan; Grant of Strategic Research Foundation, Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R01CA098129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056123] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant of Strategic Research Foundation, Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Alex's Lemonade Stand Foundation; NIH grants AI056123 and CA098129; Grant of the strategic basis on research grounds for non-governmental schools at Heisei 20th from Ministry of Education, Culture, Sports, Science and Technology-Japan; and Grant of Strategic Research Foundation Grant-aided Project for Private schools at Heisei 23rd from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2011-2015. MK is a scholar of the Leukemia & Lymphoma Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; ANTONSON P, 1995, EUR J BIOCHEM, V232, P397, DOI 10.1111/j.1432-1033.1995.tb20824.x; Blalock WL, 2001, LEUKEMIA, V15, P794, DOI 10.1038/sj.leu.2402109; Blalock WL, 2000, ONCOGENE, V19, P526, DOI 10.1038/sj.onc.1203337; BOS JL, 1989, CANCER RES, V49, P4682; Braun BS, 2006, BLOOD, V108, P2041, DOI 10.1182/blood-2006-01-013490; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Hsu CL, 2007, BLOOD, V110, P1420, DOI 10.1182/blood-2007-02-071761; Hsu CL, 2006, P NATL ACAD SCI USA, V103, P672, DOI 10.1073/pnas.0510304103; Johansen LM, 2001, MOL CELL BIOL, V21, P3789, DOI 10.1128/MCB.21.11.3789-3806.2001; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Lai AY, 2007, P NATL ACAD SCI USA, V104, P6311, DOI 10.1073/pnas.0609608104; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rodriguez-Abreu D, 2007, ANN ONCOL, V18, pI3, DOI 10.1093/annonc/mdl443; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Vardiman JW, 2010, CHEM-BIOL INTERACT, V184, P16, DOI 10.1016/j.cbi.2009.10.009; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	54	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28350	10.1371/journal.pone.0028350	http://dx.doi.org/10.1371/journal.pone.0028350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164275	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400076
J	Tweya, H; Kanyerere, H; Ben-Smith, A; Kwanjana, J; Jahn, A; Feldacker, C; Gareta, D; Mbetewa, L; Kagoli, M; Kalulu, MT; Weigel, R; Phiri, S; Edginton, M				Tweya, Hannock; Kanyerere, Henry; Ben-Smith, Anne; Kwanjana, John; Jahn, Andreas; Feldacker, Caryl; Gareta, Dickman; Mbetewa, Limbani; Kagoli, Mathew; Kalulu, Mike Tikhalenawo; Weigel, Ralf; Phiri, Sam; Edginton, Mary			Re-Treatment Tuberculosis Cases Categorised as "Other": Are They Properly Managed?	PLOS ONE			English	Article							NEGATIVE PULMONARY TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; TREATMENT OUTCOMES; MALAWI; DIAGNOSIS; INDIA	Background: Although the World Health Organization (WHO) provides information on the number of TB patients categorised as "other", there is limited information on treatment regimens or treatment outcomes for "other". Such information is important, as inappropriate treatment can lead to patients remaining infectious and becoming a potential source of drug resistance. Therefore, using a cohort of TB patients from a large registration centre in Lilongwe, Malawi, our study determined the proportion of all TB re-treatment patients who were registered as "other", and described their characteristics and treatment outcomes. Methods: This retrospective observational study used routine program data to determine the proportion of all TB retreatment patients who were registered as "other" and describe their characteristics and treatment outcomes between January 2006 and December 2008. Results: 1,384 (12%) of 11,663 TB cases were registered as re-treatment cases. Of these, 898 (65%) were categorised as "other": 707 (79%) had sputum smear-negative pulmonary TB and 191 (21%) had extra pulmonary TB. Compared to the smear-positive relapse, re-treatment after default (RAD) and failure cases, smear-negative "other" cases were older than 34 years and less likely to have their HIV status ascertained. Among those with known HIV status, "other" TB cases were more likely to be HIV positive. Of TB patients categorised as "other", 462 (51%) were managed on the first-line regimen with a treatment success rate of 63%. Conclusion: A large proportion of re-treatment patients were categorised as "other". Many of these patients were HIVinfected and over half were treated with a first-line regimen, contrary to national guidelines. Treatment success was low. More attention to recording, diagnosis and management of these patients is warranted as incorrect treatment regimen and poor outcomes could lead to the development of drug resistant forms of TB.	[Tweya, Hannock; Edginton, Mary] Int Union TB & Lung Dis, Paris, France; [Tweya, Hannock; Feldacker, Caryl; Gareta, Dickman; Kalulu, Mike Tikhalenawo; Weigel, Ralf; Phiri, Sam] Lighthouse Trust, Lilongwe, Malawi; [Kanyerere, Henry; Kwanjana, John; Mbetewa, Limbani; Kagoli, Mathew] Minist Hlth, Natl TB Control Programme, Lilongwe, Malawi; [Ben-Smith, Anne] Maame Akua, Lilongwe, Malawi; [Jahn, Andreas] Minist Hlth, Dept HIV & AIDS, Ctr Monitoring & Evaluat Dept, Lilongwe, Malawi; [Jahn, Andreas; Feldacker, Caryl] Univ Washington, Int Training & Educ Ctr Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Tweya, H (corresponding author), Int Union TB & Lung Dis, Paris, France.	h_tweya@lighthouse.org.mw	Weigel, Ralf/ABD-2310-2020; Jahn, Andreas/ABB-7796-2020	Weigel, Ralf/0000-0001-9034-2634; Jahn, Andreas/0000-0003-4645-1600; Feldacker, Caryl/0000-0002-8152-6754	United States Agency for International Development (USAID) via USAID	United States Agency for International Development (USAID) via USAID(United States Agency for International Development (USAID))	This research was made possible, in part, by the generous support of the American people through the United States Agency for International Development (USAID) via the USAID-funded TREAT TB Initiative. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. No additional external funding was received for this study.	Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Hargreaves NJ, 2001, T ROY SOC TROP MED H, V95, P402, DOI 10.1016/S0035-9203(01)90197-X; Hargreaves NJ, 2001, INT J TUBERC LUNG D, V5, P113; Harries AD, 2003, TROP DOCT, V33, P7, DOI 10.1177/004947550303300106; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1143; Johnson Jasmin, 2003, Indian J Chest Dis Allied Sci, V45, P105; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Kironde S, 2002, INT J TUBERC LUNG D, V6, P599; Korenromp EL, 2003, CLIN INFECT DIS, V37, P101, DOI 10.1086/375220; Lefebvre N, 2008, EUR RESPIR J, V31, P1256, DOI 10.1183/09031936.00131107; MacDougall D S, 1999, J Int Assoc Physicians AIDS Care, V5, P20; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; *MOH, 2007, MAL NAT TUB CONTR PR; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Srinath S, 2011, INT J TUBERC LUNG D, V15, P105; WHO, 2009, TREATM TUB GUID NAT; *WHO, 2006, STRENGTH TEACH TUB C; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; World Health Organization, 2009, GLOB TUB CONTR EP ST	20	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28034	10.1371/journal.pone.0028034	http://dx.doi.org/10.1371/journal.pone.0028034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194804	Green Published, gold, Green Submitted			2022-12-27	WOS:000298369100019
J	Sab, AB; Bouchard, MF; Beland, M; Prud'homme, B; Souchkova, O; Viger, RS; Pilon, N				Sab, Alain Boulende; Bouchard, Marie-France; Beland, Melanie; Prud'homme, Bruno; Souchkova, Ouliana; Viger, Robert S.; Pilon, Nicolas			An Ebox Element in the Proximal Gata4 Promoter Is Required for Gata4 Expression In Vivo	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; BINDING-SITES; MICE; HEART; DETERMINANTS; ENHANCER; RNA	GATA4 is an essential transcription factor required for the development and function of multiple tissues, including a major role in gonadogenesis. Despite its crucial role, the molecular mechanisms that regulate Gata4 expression in vivo remain poorly understood. We recently found that the Gata4 gene is expressed as multiple transcripts with distinct 5' origins. These co-expressed alternative transcripts are generated by different non-coding first exons with transcripts E1a and E1b being the most prominent. Moreover, we previously showed that an Ebox element, located in Gata4 5' flanking sequences upstream of exon 1a, is important for the promoter activity of these sequences in cell lines. To confirm the importance of this element in vivo, we generated and characterized Gata4 Ebox knockout mice. Quantitative PCR analyses realized on gonads, heart and liver at three developmental stages (embryonic, pre-pubertal and adult) revealed that the Ebox mutation leads to a robust and specific decrease (up to 89%) of Gata4 E1a transcript expression in all tissues and stages examined. However, a detailed characterization of the gonads revealed normal morphology and GATA4 protein levels in these mutants. Our qPCR data further indicate that this outcome is most likely due to the presence of Gata4 E1b mRNA, whose expression levels were not decreased by the Ebox mutation. In conclusion, our work clearly confirms the importance of the proximal Ebox element and suggests that adequate GATA4 protein expression is likely protected by a compensation mechanism between Gata4 E1a and E1b transcripts operating at the translational level.	[Sab, Alain Boulende; Beland, Melanie; Souchkova, Ouliana; Pilon, Nicolas] Univ Quebec Montreal, Fac Sci, Dept Biol Sci, Montreal, PQ, Canada; [Sab, Alain Boulende; Beland, Melanie; Souchkova, Ouliana; Pilon, Nicolas] Univ Quebec Montreal, Fac Sci, Biomed Res Ctr, Montreal, PQ, Canada; [Sab, Alain Boulende; Bouchard, Marie-France; Prud'homme, Bruno; Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet & Gynecol, CHUQ Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Sab, Alain Boulende; Bouchard, Marie-France; Prud'homme, Bruno; Viger, Robert S.] Univ Laval, Fac Med, Dept Obstet & Gynecol, CRBR, Quebec City, PQ G1K 7P4, Canada	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; Laval University; Laval University	Sab, AB (corresponding author), Univ Quebec Montreal, Fac Sci, Dept Biol Sci, Montreal, PQ, Canada.	robert.viger@crchul.ulaval.ca; pilon.nicolas@uqam.ca			(Universite a du Quebec a Montreal) UQAM; Canadian Institutes of Health Research (CIHR) [MOP-14796]	(Universite a du Quebec a Montreal) UQAM; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	ABS is supported by a (Universite a du Quebec a Montreal) UQAM scholarship, RSV holds the Canada Research Chair in Reproduction and Sex Development and NP is a Fonds de Recherche Sante (FRSQ) Jr1 Scholar. This work was supported by Canadian Institutes of Health Research (CIHR) grant MOP-14796 to RSV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Bossard P, 1998, DEVELOPMENT, V125, P4909; Burch JBE, 2005, SEMIN CELL DEV BIOL, V16, P71, DOI 10.1016/j.semcdb.2004.10.002; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Guittot SM, 2007, BIOL REPROD, V76, P85, DOI 10.1095/biolreprod.106.055137; Guittot SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008454; Heicklen-Klein A, 2004, DEV BIOL, V267, P490, DOI 10.1016/j.ydbio.2003.09.042; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Kyronlahti A, 2011, MOL CELL ENDOCRINOL, V333, P85, DOI 10.1016/j.mce.2010.12.019; Manuylov NL, 2011, DEV BIOL, V353, P229, DOI 10.1016/j.ydbio.2011.02.032; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; Molkentin JD, 2000, J BIOL CHEM, V275, P38949, DOI 10.1074/jbc.R000029200; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Nagy A., 2003, MANIPULATING MOUSE E; Narita N, 1997, DEV BIOL, V189, P270, DOI 10.1006/dbio.1997.8684; Nel-Themaat L, 2011, BIOL REPROD, V84, P342, DOI 10.1095/biolreprod.110.086900; Ohara Y, 2006, BIOL PHARM BULL, V29, P410, DOI 10.1248/bpb.29.410; Pilon N, 2008, DEV DYNAM, V237, P1133, DOI 10.1002/dvdy.21496; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; Rojas A, 2005, DEVELOPMENT, V132, P3405, DOI 10.1242/dev.01913; Rojas A, 2010, DEV BIOL, V346, P346, DOI 10.1016/j.ydbio.2010.07.032; Rojas A, 2009, DEV DYNAM, V238, P2588, DOI 10.1002/dvdy.22091; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Thurisch B, 2009, J MOL ENDOCRINOL, V43, P157, DOI 10.1677/JME-09-0030; Viger RS, 2008, MOL ENDOCRINOL, V22, P781, DOI 10.1210/me.2007-0513; Viger RS, 1998, DEVELOPMENT, V125, P2665; Wang LJ, 2001, PLANT PHYSIOL, V125, P1380, DOI 10.1104/pp.125.3.1380	30	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29038	10.1371/journal.pone.0029038	http://dx.doi.org/10.1371/journal.pone.0029038			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174950	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000298367300042
J	Gabriel, SI; Stevens, MI; Mathias, MD; Searle, JB				Gabriel, Sofia I.; Stevens, Mark I.; Mathias, Maria da Luz; Searle, Jeremy B.			Of Mice and 'Convicts': Origin of the Australian House Mouse, Mus musculus	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; COLONIZATION; PHYLOGEOGRAPHY; POPULATIONS; INVASIONS; EVOLUTION; PATTERNS; INSIGHTS; GENETICS	The house mouse, Mus musculus, is one of the most ubiquitous invasive species worldwide and in Australia is particularly common and widespread, but where it originally came from is still unknown. Here we investigated this origin through a phylogeographic analysis of mitochondrial DNA sequences (D-loop) comparing mouse populations from Australia with those from the likely regional source area in Western Europe. Our results agree with human historical associations, showing a strong link between Australia and the British Isles. This outcome is of intrinsic and applied interest and helps to validate the colonization history of mice as a proxy for human settlement history.	[Gabriel, Sofia I.; Searle, Jeremy B.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Gabriel, Sofia I.; Mathias, Maria da Luz] Univ Lisbon, Fac Ciencias, Dept Biol Anim, CESAM Ctr Environm & Marine Studies, Lisbon, Portugal; [Stevens, Mark I.] Univ Adelaide, S Australian Museum, Adelaide, SA, Australia; [Stevens, Mark I.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	University of York - UK; Universidade de Lisboa; University of Adelaide; University of Adelaide; Cornell University	Gabriel, SI (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jeremy.searle@cornell.edu	Gabriel, Sofia I/C-1770-2013; da Luz Mathias, Maria/V-9931-2018	Gabriel, Sofia I/0000-0003-3702-4631; da Luz Mathias, Maria/0000-0003-3876-958X; Searle, Jeremy/0000-0001-7710-5204	Fundacao para a Ciencia e a Tecnologia (Portugal); Microsoft Corporation	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Microsoft Corporation(Microsoft)	Fundacao para a Ciencia e a Tecnologia (Portugal) provided funding. Part of this work was carried out by using the resources of the Computational Biology Service Unit from Cornell University which is partially funded by Microsoft Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Bonhomme F, 2011, P ROY SOC B-BIOL SCI, V278, P1034, DOI 10.1098/rspb.2010.1228; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FIGUEROA F, 1986, CURR TOP MICROBIOL, V127, P229; Forster DW, 2009, MOL ECOL, V18, P4477, DOI 10.1111/j.1365-294X.2009.04344.x; Gabriel SI, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-131; Gunduz I, 2005, BIOL J LINN SOC, V84, P473, DOI 10.1111/j.1095-8312.2005.00448.x; Hardouin EA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-325; Ihle S, 2006, MOL BIOL EVOL, V23, P790, DOI 10.1093/molbev/msj096; Jones EP, 2011, J ZOOL, V283, P257, DOI 10.1111/j.1469-7998.2010.00767.x; Jones EP, 2011, BIOL J LINN SOC, V102, P471, DOI 10.1111/j.1095-8312.2010.01597.x; Jones EP, 2010, MOL ECOL, V19, P5252, DOI 10.1111/j.1365-294X.2010.04874.x; Jupp James, 2002, WHITE AUSTR WOOMERA; NACHMAN MW, 1994, GENETICS, V136, P1105; NELSON JG, 1961, CAN GEOGR-GEOGR CAN, V5, P18; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prager EM, 1996, GENETICS, V143, P427; PRAGER EM, 1993, BIOL J LINN SOC, V50, P85; Prager EM, 1998, GENETICS, V150, P835; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSS JOC, 1987, W STEWART SEALING CA; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schwarz Ernst, 1943, JOUR MAMMAL, V24, P59, DOI 10.2307/1374781; Searle JB, 2008, WILDLIFE RES, V35, P185, DOI 10.1071/WR07123; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P209, DOI 10.1098/rspb.2008.0959; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P201, DOI 10.1098/rspb.2008.0958; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; SINGLETON GR, 1990, BIOL J LINN SOC, V41, P285, DOI 10.1111/j.1095-8312.1990.tb00837.x; SINGLETON GR, 1995, MAMMALS AUSTR, P646; Singleton GR, 2007, J APPL ECOL, V44, P644, DOI 10.1111/j.1365-2664.2007.01296.x	31	35	37	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28622	10.1371/journal.pone.0028622	http://dx.doi.org/10.1371/journal.pone.0028622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174847	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600027
J	Henmi, Y; Tanabe, K; Takei, K				Henmi, Yuji; Tanabe, Kenji; Takei, Kohji			Disruption of Microtubule Network Rescues Aberrant Actin Comets in Dynamin2-Depleted Cells	PLOS ONE			English	Article							CLATHRIN-COATED PITS; LISTERIA-MONOCYTOGENES; MEDIATED ENDOCYTOSIS; BINDING PROTEIN; DYNAMIN; CORTACTIN; MOTILITY; GTPASE; IDENTIFICATION; ORGANIZATION	A large GTPase dynamin, which is required for endocytic vesicle formation, regulates the actin cytoskeleton through its interaction with cortactin. Dynamin2 mutants impair the formation of actin comets, which are induced by Listeria monocytogenes or phosphatidylinositol-4-phosphate 5-kinase. However, the role of dynamin2 in the regulation of the actin comet is still unclear. Here we show that aberrant actin comets in dynamin2-depleted cells were rescued by disrupting of microtubule networks. Depletion of dynamin2, but not cortactin, significantly reduced the length and the speed of actin comets induced by Listeria. This implies that dynamin2 may regulate the actin comet in a cortactin-independent manner. As dynamin regulates microtubules, we investigated whether perturbation of microtubules would rescue actin comet formation in dynamin2-depleted cells. Treatment with taxol or colchicine created a microtubule-free space in the cytoplasm, and made no difference between control and dynamin2 siRNA cells. This suggests that the alteration of microtubules by dynamin2 depletion reduced the length and the speed of the actin comet.	[Henmi, Yuji; Tanabe, Kenji; Takei, Kohji] Okayama Univ, Grad Sch Med, Dept Neurosci, Okayama 7008530, Japan	Okayama University	Henmi, Y (corresponding author), Okayama Univ, Grad Sch Med, Dept Neurosci, Okayama 7008530, Japan.	kt0911@gmail.com; kohji@md.okayama-u.ac.jp		Tanabe, Kenji/0000-0003-2645-9429; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Culture, Sports, Science and Technology of Japan [23113721, 15079206]; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (23113721, 15079206, http://kaken.nii.ac.jp/en/p/23113721, http://kaken.nii.ac.jp/en/p/15079206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Barroso C, 2006, CELL MOTIL CYTOSKEL, V63, P231, DOI 10.1002/cm.20119; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Cao H, 2003, MOL CELL BIOL, V23, P2162, DOI 10.1128/MCB.23.6.2162-2170.2003; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Gorvel JP, 2006, SCIENCE, V314, P931, DOI 10.1126/science.1135742; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Lambrechts A, 2008, TRENDS CELL BIOL, V18, P220, DOI 10.1016/j.tcb.2008.03.001; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; MAEDA K, 1992, MOL BIOL CELL, V3, P1181, DOI 10.1091/mbc.3.10.1181; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mesaki K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019764; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; NAKATA T, 1993, J CELL SCI, V105, P1; Ohashi E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019942; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Pfeuffer T, 2000, CELL MICROBIOL, V2, P101, DOI 10.1046/j.1462-5822.2000.00034.x; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Wittmann T, 2001, J CELL SCI, V114, P3795; Yoshida S, 2006, SCIENCE, V314, P985, DOI 10.1126/science.1133174; Zhu JW, 2005, J CELL SCI, V118, P807, DOI 10.1242/jcs.01668	32	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28603	10.1371/journal.pone.0028603	http://dx.doi.org/10.1371/journal.pone.0028603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174845	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600025
J	Huang, TH; Uthe, JJ; Bearson, SMD; Demirkale, CY; Nettleton, D; Knetter, S; Christian, C; Ramer-Tait, AE; Wannemuehler, MJ; Tuggle, CK				Huang, Ting-Hua; Uthe, Jolita J.; Bearson, Shawn M. D.; Demirkale, Cumhur Yusuf; Nettleton, Dan; Knetter, Susan; Christian, Curtis; Ramer-Tait, Amanda E.; Wannemuehler, Michael J.; Tuggle, Christopher K.			Distinct Peripheral Blood RNA Responses to Salmonella in Pigs Differing in Salmonella Shedding Levels: Intersection of IFNG, TLR and miRNA Pathways	PLOS ONE			English	Article							ENTERICA SEROVAR CHOLERAESUIS; DIFFERENTIAL GENE-EXPRESSION; NF-KAPPA-B; QUANTITATIVE TRAIT LOCI; IMMUNE-RESPONSE; INNATE IMMUNITY; BETA-CATENIN; SR PROTEINS; TRANSCRIPTIONAL RESPONSE; CYTOKINE EXPRESSION	Transcriptomic analysis of the response to bacterial pathogens has been reported for several species, yet few studies have investigated the transcriptional differences in whole blood in subjects that differ in their disease response phenotypes. Salmonella species infect many vertebrate species, and pigs colonized with Salmonella enterica serovar Typhimurium (ST) are usually asymptomatic, making detection of these Salmonella-carrier pigs difficult. The variable fecal shedding of Salmonella is an important cause of foodborne illness and zoonotic disease. To investigate gene pathways and biomarkers associated with the variance in Salmonella shedding following experimental inoculation, we initiated the first analysis of the whole blood transcriptional response induced by Salmonella. A population of pigs (n = 40) was inoculated with ST and peripheral blood and fecal Salmonella counts were collected between 2 and 20 days post-inoculation (dpi). Two groups of pigs with either low shedding (LS) or persistent shedding (PS) phenotypes were identified. Global transcriptional changes in response to ST inoculation were identified by Affymetrix Genechip (R) analysis of peripheral blood RNA at day 0 and 2 dpi. ST inoculation triggered substantial gene expression changes in the pigs and there was differential expression of many genes between LS and PS pigs. Analysis of the differential profiles of gene expression within and between PS and LS phenotypic classes identified distinct regulatory pathways mediated by IFN-gamma, TNF, NF-kappa B, or one of several miRNAs. We confirmed the activation of two regulatory factors, SPI1 and CEBPB, and demonstrated that expression of miR-155 was decreased specifically in the PS animals. These data provide insight into specific pathways associated with extremes in Salmonella fecal shedding that can be targeted for further exploration on why some animals develop a carrier state. This knowledge can also be used to develop rational manipulations of genetics, pharmaceuticals, nutrition or husbandry methods to decrease Salmonella colonization, shedding and spread.	[Huang, Ting-Hua; Uthe, Jolita J.; Knetter, Susan; Christian, Curtis; Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Bearson, Shawn M. D.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Demirkale, Cumhur Yusuf; Nettleton, Dan] Iowa State Univ, Dept Stat, Ames, IA USA; [Ramer-Tait, Amanda E.; Wannemuehler, Michael J.] Iowa State Univ, Coll Vet Med, Ames, IA USA	Iowa State University; United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Huang, TH (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	cktuggle@iastate.edu		Nettleton, Dan/0000-0002-6045-1036; Ramer-Tait, Amanda/0000-0003-0950-7548	USDA National Institute of Food and Agriculture [2009-35205-05192]; National Pork Board; USDA-CSREES; USDA [2005-38420-15810]; National Institute of Food and Agriculture	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Pork Board; USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); USDA(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by National Research Initiative Competitive Grant no. 2009-35205-05192 from the USDA National Institute of Food and Agriculture to CKT, SMDB, MJW and DN, as well as the National Pork Board in grants to both SMDB and CKT. Support is also gratefully acknowledged from the USDA-CSREES Special Grant to the Food Safety Consortium to CKT and MJW. CC gratefully acknowledges support from the USDA National Needs Graduate Fellowship Competitive Grant No. 2005-38420-15810 from the National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Belicha-Villanueva A, 2010, IMMUNOL RES, V46, P32, DOI 10.1007/s12026-009-8123-8; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bonadies N, 2010, ONCOGENE, V29, P1062, DOI 10.1038/onc.2009.371; Burkey TE, 2007, VET IMMUNOL IMMUNOP, V115, P309, DOI 10.1016/j.vetimm.2006.11.012; Burkey TE, 2009, VET IMMUNOL IMMUNOP, V130, P96, DOI 10.1016/j.vetimm.2008.12.027; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen HB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-64; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Clapperton M, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-54; Collado-Romero M, 2010, VET RES, V41, DOI 10.1051/vetres/2009072; Couture O, 2009, MAMM GENOME, V20, P768, DOI 10.1007/s00335-009-9234-1; Crawley AM, 2005, VET IMMUNOL IMMUNOP, V108, P71, DOI 10.1016/j.vetimm.2005.07.006; Dar A, 2008, VET IMMUNOL IMMUNOP, V123, P324, DOI 10.1016/j.vetimm.2008.02.007; Dar A, 2010, RES VET SCI, V88, P242, DOI 10.1016/j.rvsc.2009.10.003; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Dvorak CMT, 2006, PHYSIOL GENOMICS, V28, P5, DOI 10.1152/physiolgenomics.00104.2006; Edfors-Lilja I, 2000, ANIM GENET, V31, P186, DOI 10.1046/j.1365-2052.2000.00628.x; Edfors-Lilja I, 1998, J IMMUNOL, V161, P829; EDFORSLILJA I, 1994, VET IMMUNOL IMMUNOP, V40, P1, DOI 10.1016/0165-2427(94)90011-6; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Escudero-Paunetto L, 2010, VIROLOGY, V401, P155, DOI 10.1016/j.virol.2010.02.023; FEDORKACRAY PJ, 1995, INFECT IMMUN, V63, P2658, DOI 10.1128/IAI.63.7.2658-2664.1995; Flach CF, 2007, INFECT IMMUN, V75, P2343, DOI 10.1128/IAI.01900-06; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Galina-Pantoja L, 2009, ANIM GENET, V40, P795, DOI 10.1111/j.1365-2052.2009.01916.x; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gladue DP, 2010, VIRUS RES, V151, P10, DOI 10.1016/j.virusres.2010.03.007; Goncalves V, 2008, RNA, V14, P2538, DOI 10.1261/rna.1253408; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Hillenbrand A, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-26; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurd HS, 2001, J FOOD PROTECT, V64, P939, DOI 10.4315/0362-028X-64.7.939; Hyland KA, 2006, MOL IMMUNOL, V43, P1890, DOI 10.1016/j.molimm.2005.10.011; Jia R, 2009, J VIROL, V83, P167, DOI 10.1128/JVI.01719-08; JOHNSTON J, 1989, J BIOL CHEM, V264, P15754; Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015; Li J, 2010, VIRUS RES, V148, P60, DOI 10.1016/j.virusres.2009.12.004; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lkhagvadorj S, 2009, PHYSIOL GENOMICS, V38, P98, DOI 10.1152/physiolgenomics.90372.2008; Loynachan AT, 2004, J FOOD PROTECT, V67, P1484, DOI 10.4315/0362-028X-67.7.1484; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Lynn DJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-117; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Martinez-Nunez RT, 2009, J BIOL CHEM, V284, P16334, DOI 10.1074/jbc.M109.011601; McFarlane M, 2010, BIOCHEM SOC T, V38, P1116, DOI 10.1042/BST0381116; Mellman I, 2010, SCIENCE, V329, P767, DOI 10.1126/science.1194185; Meurens F, 2009, VET RES, V40, DOI 10.1051/vetres:2008043; Moriconi F, 2007, TRANSL RES, V150, P223, DOI 10.1016/j.trsl.2007.04.004; Moser RJ, 2008, VET IMMUNOL IMMUNOP, V121, P260, DOI 10.1016/j.vetimm.2007.10.007; Nhu QM, 2006, J ENDOTOXIN RES, V12, P285, DOI 10.1179/096805106X118834; Nishimura H, 2000, J EXP MED, V191, P157, DOI 10.1084/jem.191.1.157; Ote I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007882; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Ponsuksili S, 2008, DEV BIOLOGICALS, V132, P185, DOI 10.1159/000317159; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Renson P, 2010, VET RES, V41, DOI 10.1051/vetres/2009055; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sahoo A, 2010, INT REV IMMUNOL, V29, P77, DOI 10.3109/08830180903349651; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shi ZX, 2009, J GEN VIROL, V90, P1670, DOI 10.1099/vir.0.009415-0; Shimosato T, 2005, BIOCHEM BIOPH RES CO, V326, P782, DOI 10.1016/j.bbrc.2004.11.119; Skjolaas KA, 2006, VET IMMUNOL IMMUNOP, V111, P199, DOI 10.1016/j.vetimm.2006.01.002; Smith MF, 1998, J BIOL CHEM, V273, P24272, DOI 10.1074/jbc.273.37.24272; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takaoka Akinori, 2008, Virus (Nagoya), V58, P37; Takeshita F, 2008, CURR OPIN IMMUNOL, V20, P383, DOI 10.1016/j.coi.2008.05.009; Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060; Trieu A, 2009, IMMUNOL CELL BIOL, V87, P218, DOI 10.1038/icb.2008.95; Tuggle CK, 2010, VET IMMUNOL IMMUNOP, V138, P280, DOI 10.1016/j.vetimm.2010.10.006; Uthe JJ, 2009, VET MICROBIOL, V135, P384, DOI 10.1016/j.vetmic.2008.09.074; Uthe JJ, 2006, VET MICROBIOL, V114, P60, DOI 10.1016/j.vetmic.2005.10.042; Uthe JJ, 2007, MOL IMMUNOL, V44, P2900, DOI 10.1016/j.molimm.2007.01.016; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; van Diemen PM, 2002, VET IMMUNOL IMMUNOP, V88, P183, DOI 10.1016/S0165-2427(02)00165-4; Vartanian K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-2; Vigorito E, 2007, IMMUNITY, V27, P847, DOI 10.1016/j.immuni.2007.10.009; Wang YF, 2007, GENOMICS, V90, P72, DOI 10.1016/j.ygeno.2007.03.018; Wang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-437; Wattrang E, 2005, ANIM GENET, V36, P337, DOI 10.1111/j.1365-2052.2005.01315.x; Wigley P, 2004, RES VET SCI, V76, P165, DOI 10.1016/S0034-5288(03)00117-6; Wilkie B, 1999, VET IMMUNOL IMMUNOP, V72, P231, DOI 10.1016/S0165-2427(99)00136-1; Winn ME, 2010, MAMM GENOME, V21, P268, DOI 10.1007/s00335-010-9261-y; WOOD RL, 1992, AM J VET RES, V53, P653; Wurfel MM, 2005, J IMMUNOL, V175, P2570, DOI 10.4049/jimmunol.175.4.2570; Yanai H, 2009, CURR OPIN IMMUNOL, V21, P17, DOI 10.1016/j.coi.2009.01.005; Zhao SH, 2006, MAMM GENOME, V17, P777, DOI 10.1007/s00335-005-0155-3	96	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28768	10.1371/journal.pone.0028768	http://dx.doi.org/10.1371/journal.pone.0028768			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174891	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600037
J	Xia, HJ; Ma, JP; Zhang, GH; Han, JB; Wang, JH; Zheng, YT				Xia, Hou-Jun; Ma, Jian-Ping; Zhang, Gao-Hong; Han, Jian-Bao; Wang, Jian-Hua; Zheng, Yong-Tang			Effect of Plasma Viremia on Apoptosis and Immunophenotype of Dendritic Cells Subsets in Acute SIVmac239 Infection of Chinese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INTERFERON-PRODUCING CELLS; LYMPHOID-TISSUE; ALPHA PRODUCTION; HIV-1 INFECTION; SURFACE CCR5; IN-VITRO; BLOOD; MATURATION; NEF	Non-human primates such as Chinese rhesus macaques (Ch Rhs) provide good animal models for research on human infectious diseases. Similar to humans, there are two principal subsets of dendritic cells (DCs) in the peripheral blood of Ch Rhs: myeloid DCs (mDCs) and plasmacytoid DCs (pDCs). In this study, two-color fluorescence-activated cell sorting (FACS) analyses were used to identify the main DC subsets, namely CD1c(+) mDCs and pDCs from Ch Rhs. Then, the apoptosis and immunophenotype changes of DCs subsets were first described during the acute phase of SIVmac239 infection. Both the DCs subsets showed decreased CD4 expression and enhanced CCR5 expression; in particular, those of pDCs significantly changed at most time points. Interestingly, the plasma viral loads were negatively correlated with CD4 expression, but were positively correlated with CCR5 expression of pDCs. During this period, both CD1c(+) mDCs and pDCs were activated by enhancing expressions of co-stimulatory molecules, accompanied with increase in CCR7. Either CD80 or CD86 expressed on CD1c(+) mDCs and pDCs was positively correlated with the plasma viral loads. Our analysis demonstrates that the pDCs were more prone to apoptosis after infection during the acute phase of SIVmac239 infection, which may be due to their high expressions of CD4 and CCR5. Both DCs subsets activated through elevating the expression of co-stimulatory molecules, which was beneficial in controlling the replication of SIV. However, a mere broad immune activation initiated by activated DCs may lead to tragic AIDS progression.	[Xia, Hou-Jun; Ma, Jian-Ping; Zhang, Gao-Hong; Han, Jian-Bao; Zheng, Yong-Tang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China; [Wang, Jian-Hua] Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Xia, Hou-Jun; Ma, Jian-Ping] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xia, HJ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Chinese Acad Sci & Yunnan Prov, Kunming, Yunnan, Peoples R China.	zhengyt@mail.kiz.ac.cn	Zhang, Gao-Hong/AAJ-8843-2020	Zhang, Gao-Hong/0000-0003-3237-5352; Xia, Houjun/0000-0003-1045-1465	National Basic Research Program of China [2006CB504208, 2006CB504302, 2009CB522300]; National Natural Science Foundation of China [30872317, 30800113, U0832601]; CAS [KSCX1-YW-R-15, KSCX2-YW-R-128, KSCX2-YW-R-185]; Eleventh Five-Year Key Scientific and Technological Program of China [2008ZX10001-002, 2008ZX10001-015, 2008ZX10005-005, 2009ZX09501-029, 2009ZX09103-414]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); Eleventh Five-Year Key Scientific and Technological Program of China	This work was supported in part by grants from National Basic Research Program of China (2006CB504208, 2006CB504302, 2009CB522300), National Natural Science Foundation of China (30872317, 30800113, U0832601), the Knowledge Innovation Program of CAS (KSCX1-YW-R-15, KSCX2-YW-R-128, KSCX2-YW-R-185), and Eleventh Five-Year Key Scientific and Technological Program of China (2008ZX10001-002, 2008ZX10001-015, 2008ZX10005-005, 2009ZX09501-029, 2009ZX09103-414) and "Western Light" Projects of CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; Almeida M, 2005, AIDS, V19, P261; Anthony DD, 2004, J IMMUNOL, V172, P4907, DOI 10.4049/jimmunol.172.8.4907; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Brown KN, 2009, J MED PRIMATOL, V38, P272, DOI 10.1111/j.1600-0684.2009.00353.x; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Chung E, 2005, CLIN DIAGN LAB IMMUN, V12, P426, DOI 10.1128/CDLI.12.3.426-435.2005; Coates PTH, 2003, BLOOD, V102, P2513, DOI 10.1182/blood-2002-09-2929; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Dai JH, 2004, J IMMUNOL, V173, P1535, DOI 10.4049/jimmunol.173.3.1535; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Donaghy H, 2003, BLOOD, V101, P4505, DOI 10.1182/blood-2002-10-3189; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Fonteneau JF, 2004, J VIROL, V78, P5223, DOI 10.1128/JVI.78.10.5223-5232.2004; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; Hsieh SM, 2003, JAIDS-J ACQ IMM DEF, V33, P413, DOI 10.1097/00126334-200308010-00001; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Lindwasser OW, 2007, CURR MOL MED, V7, P171; Ling BH, 2002, AIDS, V16, P1489, DOI 10.1097/00002030-200207260-00005; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Malleret B, 2008, IMMUNOLOGY, V124, P223, DOI 10.1111/j.1365-2567.2007.02758.x; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Pandrea I, 2008, TRENDS IMMUNOL, V29, P419, DOI 10.1016/j.it.2008.05.004; Patterson S, 2001, J VIROL, V75, P6710, DOI 10.1128/JVI.75.14.6710-6713.2001; Piccioli D, 2007, BLOOD, V109, P5371, DOI 10.1182/blood-2006-08-038422; Reeves RK, 2007, VIROLOGY, V365, P356, DOI 10.1016/j.virol.2007.03.055; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Smed-Sorensen A, 2004, BLOOD, V104, P2810, DOI 10.1182/blood-2003-07-2314; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Xia HJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-102; Xia HJ, 2009, CELL MOL IMMUNOL, V6, P433, DOI 10.1038/cmi.2009.55; Yonezawa A, 2003, J VIROL, V77, P3777, DOI 10.1128/JVI.77.6.3777-3784.2003	44	4	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29036	10.1371/journal.pone.0029036	http://dx.doi.org/10.1371/journal.pone.0029036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174949	gold, Green Submitted, Green Published			2022-12-27	WOS:000298366600059
J	Field, H; de Jong, C; Melville, D; Smith, C; Smith, I; Broos, A; Kung, YH; McLaughlin, A; Zeddeman, A				Field, Hume; de Jong, Carol; Melville, Deb; Smith, Craig; Smith, Ina; Broos, Alice; Kung, Yu Hsin (Nina); McLaughlin, Amanda; Zeddeman, Anne			Hendra Virus Infection Dynamics in Australian Fruit Bats	PLOS ONE			English	Article							NIPAH VIRUS	Hendra virus is a recently emerged zoonotic agent in Australia. Since first described in 1994, the virus has spilled from its wildlife reservoir (pteropid fruit bats, or 'flying foxes') on multiple occasions causing equine and human fatalities. We undertook a three-year longitudinal study to detect virus in the urine of free-living flying foxes (a putative route of excretion) to investigate Hendra virus infection dynamics. Pooled urine samples collected off plastic sheets placed beneath roosting flying foxes were screened for Hendra virus genome by quantitative RT-PCR, using a set of primers and probe derived from the matrix protein gene. A total of 1672 pooled urine samples from 67 sampling events was collected and tested between 1 July 2008 and 30 June 2011, with 25% of sampling events and 2.5% of urine samples yielding detections. The proportion of positive samples was statistically associated with year and location. The findings indicate that Hendra virus excretion occurs periodically rather than continuously, and in geographically disparate flying fox populations in the state of Queensland. The lack of any detection in the Northern Territory suggests prevalence may vary across the range of flying foxes in Australia. Finally, our findings suggest that flying foxes can excrete virus at any time of year, and that the apparent seasonal clustering of Hendra virus incidents in horses and associated humans (70% have occurred June to October) reflects factors other than the presence of virus. Identification of these factors will strengthen risk minimization strategies for horses and ultimately humans.	[Field, Hume; de Jong, Carol; Melville, Deb; Smith, Craig; Broos, Alice; Kung, Yu Hsin (Nina); McLaughlin, Amanda; Zeddeman, Anne] Biosecur Queensland, Dept Employment Econ Dev & Innovat, Biosecur Sci Lab, Brisbane, Qld, Australia; [Smith, Ina] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Smith, Ina; Broos, Alice] Queensland Hlth, Queensland Hlth Forens & Sci Serv Lab, Brisbane, Qld, Australia; [Zeddeman, Anne] Univ Wageningen, Wageningen, Netherlands	Queensland Department of Agriculture & Fisheries; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Health; Wageningen University & Research	Field, H (corresponding author), Biosecur Queensland, Dept Employment Econ Dev & Innovat, Biosecur Sci Lab, Brisbane, Qld, Australia.	Hume.Field@deedi.qld.gov.au	Smith, Ina/H-7225-2013	Smith, Ina/0000-0001-5807-3737; Broos, Alice/0000-0001-7593-1000	Wildlife Exotic Diseases Preparedness Program [WEDPP08/09FIE, WEDPP09/10FIE WEDPP10/11FIE]	Wildlife Exotic Diseases Preparedness Program	Wildlife Exotic Diseases Preparedness Program, http://www.daff.gov.au/animal-plant-health/emergency/wedpp WEDPP08/09FIE; WEDPP09/10FIE WEDPP10/11FIE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, ECOLOGY HENDRA VIRUS; Chua KB, 2003, MICROBES INFECT, V5, P487, DOI 10.1016/S1286-4579(03)00067-4; Epstein J, 2011, ECOHEALTH, V7, pS38; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P R SOC B; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; 2011, GUIDELINES VETERINAR	12	93	94	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28678	10.1371/journal.pone.0028678	http://dx.doi.org/10.1371/journal.pone.0028678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174865	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000298365700059
J	Chakraborty, S; Minda, R; Salaye, L; Bhattacharjee, SK; Rao, BJ				Chakraborty, Sandeep; Minda, Renu; Salaye, Lipika; Bhattacharjee, Swapan K.; Rao, Basuthkar J.			Active Site Detection by Spatial Conformity and Electrostatic Analysis-Unravelling a Proteolytic Function in Shrimp Alkaline Phosphatase	PLOS ONE			English	Article							A BETA-LACTAMASES; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PROTEIN-STRUCTURE; PK(A) VALUES; STRUCTURAL BASIS; PREDICTION; ENZYME; MECHANISM; DATABASE	Computational methods are increasingly gaining importance as an aid in identifying active sites. Mostly these methods tend to have structural information that supplement sequence conservation based analyses. Development of tools that compute electrostatic potentials has further improved our ability to better characterize the active site residues in proteins. We have described a computational methodology for detecting active sites based on structural and electrostatic conformity - CataLytic Active Site Prediction (CLASP). In our pipelined model, physical 3D signature of any particular enzymatic function as defined by its active sites is used to obtain spatially congruent matches. While previous work has revealed that catalytic residues have large pKa deviations from standard values, we show that for a given enzymatic activity, electrostatic potential difference (PD) between analogous residue pairs in an active site taken from different proteins of the same family are similar. False positives in spatially congruent matches are further pruned by PD analysis where cognate pairs with large deviations are rejected. We first present the results of active site prediction by CLASP for two enzymatic activities - beta-lactamases and serine proteases, two of the most extensively investigated enzymes. The results of CLASP analysis on motifs extracted from Catalytic Site Atlas (CSA) are also presented in order to demonstrate its ability to accurately classify any protein, putative or otherwise, with known structure. The source code and database is made available at www.sanchak.com/clasp/. Subsequently, we probed alkaline phosphatases (AP), one of the well known promiscuous enzymes, for additional activities. Such a search has led us to predict a hitherto unknown function of shrimp alkaline phosphatase (SAP), where the protein acts as a protease. Finally, we present experimental evidence of the prediction by CLASP by showing that SAP indeed has protease activity in vitro.	[Chakraborty, Sandeep; Minda, Renu; Salaye, Lipika; Bhattacharjee, Swapan K.; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	bjrao@tifr.res.in	Minda, Renu/M-5476-2016	Minda, Renu/0000-0002-2359-9146	Tata Institute of Fundamental Research (Department of Atomic Energy)	Tata Institute of Fundamental Research (Department of Atomic Energy)	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-197; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angaran S, 2009, NUCLEIC ACIDS RES, V37, pW565, DOI 10.1093/nar/gkp405; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BASHFORD D, 1990, BIOCHEMISTRY-US, V29, P10219, DOI 10.1021/bi00496a010; Bate P, 2004, J MOL BIOL, V340, P263, DOI 10.1016/j.jmb.2004.04.070; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauer RA, 2008, NUCLEIC ACIDS RES, V36, pW47, DOI 10.1093/nar/gkn285; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Brown G, 2008, BIOCHEMISTRY-US, V47, P5724, DOI 10.1021/bi800097h; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Capra JA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000585; Catrina I, 2007, J AM CHEM SOC, V129, P5760, DOI 10.1021/ja069111+; Chen Y, 2007, J AM CHEM SOC, V129, P5378, DOI 10.1021/ja0712064; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; de Backer M, 2002, J MOL BIOL, V318, P1265, DOI 10.1016/S0022-2836(02)00035-9; Debret G, 2009, NUCLEIC ACIDS RES, V37, pW459, DOI 10.1093/nar/gkp304; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elcock AH, 2001, J MOL BIOL, V312, P885, DOI 10.1006/jmbi.2001.5009; Forsyth WR, 2002, PROTEINS, V48, P388, DOI 10.1002/prot.10174; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Golemi-Kotra D, 2004, J BIOL CHEM, V279, P34665, DOI 10.1074/jbc.M313143200; Gordon JC, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2956499; Goyal K, 2007, NUCLEIC ACIDS RES, V35, pW503, DOI 10.1093/nar/gkm252; Greaves R, 2005, J MOL BIOL, V349, P547, DOI 10.1016/j.jmb.2005.04.018; Grochowski P, 2008, BIOPOLYMERS, V89, P93, DOI 10.1002/bip.20877; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLM L, 1992, PROTEIN SCI, V1, P1691, DOI 10.1002/pro.5560011217; Holtz KM, 1999, FEBS LETT, V462, P7, DOI 10.1016/S0014-5793(99)01448-9; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Konc J, 2010, BIOINFORMATICS, V26, P1160, DOI 10.1093/bioinformatics/btq100; Koutsioulis D, 2010, PROTEIN SCI, V19, P75, DOI 10.1002/pro.284; Kurth T, 1997, BIOCHEMISTRY-US, V36, P10098, DOI 10.1021/bi970937l; Lamotte-Brasseur J, 1999, PROTEIN SCI, V8, P404; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Matagne A, 1998, BIOCHEM J, V330, P581, DOI 10.1042/bj3300581; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 1999, EUR J BIOCHEM, V264, P816, DOI 10.1046/j.1432-1327.1999.00664.x; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; NUSSINOV R, 1991, P NATL ACAD SCI USA, V88, P10495, DOI 10.1073/pnas.88.23.10495; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Olguin Luis F, 2008, J Am Chem Soc, V130, P16547, DOI 10.1021/ja8047943; Oliva M, 2003, PROTEINS, V53, P88, DOI 10.1002/prot.10450; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Panchenko AR, 2004, PROTEIN SCI, V13, P884, DOI 10.1110/ps.03465504; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Rapp CS, 2009, PROTEINS, V77, P52, DOI 10.1002/prot.22415; Raquet X, 1997, BIOPHYS J, V73, P2416, DOI 10.1016/S0006-3495(97)78270-5; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocchia W, 2007, GENET MOL RES, V6, P923; Rout AK, 2010, BIOMOL NMR ASSIGN, V4, P171, DOI 10.1007/s12104-010-9239-4; Russell RB, 1998, J MOL BIOL, V279, P1211, DOI 10.1006/jmbi.1998.1844; Sankararaman S, 2010, BIOINFORMATICS, V26, P617, DOI 10.1093/bioinformatics/btq008; Sarkany Z, 2003, BIOCHEMISTRY-US, V42, P516, DOI 10.1021/bi027004w; Shatsky M, 2006, J COMPUT BIOL, V13, P407, DOI 10.1089/cmb.2006.13.407; Shulman-Peleg A, 2008, NUCLEIC ACIDS RES, V36, pW260, DOI 10.1093/nar/gkn185; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Singh Rohit, 2003, Pac Symp Biocomput, P228; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Stec B, 2000, J MOL BIOL, V299, P1303, DOI 10.1006/jmbi.2000.3799; Teotico DG, 2009, P NATL ACAD SCI USA, V106, P7455, DOI 10.1073/pnas.0813029106; Tomatis PE, 2005, P NATL ACAD SCI USA, V102, P13761, DOI 10.1073/pnas.0503495102; Tong WX, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000266; Tseng YY, 2011, P NATL ACAD SCI USA, V108, P5313, DOI 10.1073/pnas.1102210108; Tsuruta H, 2010, BIOSCI BIOTECH BIOCH, V74, P69, DOI 10.1271/bbb.90563; Wang E, 2007, J MOL BIOL, V366, P1318, DOI 10.1016/j.jmb.2006.11.079; WARSHEL A, 1981, ACCOUNTS CHEM RES, V14, P284, DOI 10.1021/ar00069a004; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Wei Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-119; Wende A, 2010, J MOL BIOL, V400, P52, DOI 10.1016/j.jmb.2010.04.057; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101; Youn E, 2007, PROTEIN SCI, V16, P216, DOI 10.1110/ps.062523907; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059; Zalatan JG, 2006, J AM CHEM SOC, V128, P1293, DOI 10.1021/ja056528r	104	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28470	10.1371/journal.pone.0028470	http://dx.doi.org/10.1371/journal.pone.0028470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174814	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600023
J	Qi, P; Cheng, SQ; Wang, H; Li, N; Chen, YF; Gao, CF				Qi, Peng; Cheng, Shu-qun; Wang, Hao; Li, Nan; Chen, Yue-feng; Gao, Chun-fang			Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							NON-TUMOROUS TISSUES; CIRCULATING MICRORNAS; C VIRUS; EXPRESSION PATTERNS; PLASMA MICRORNAS; OVARIAN-CANCER; IN-VIVO; MIR-122; INJURY; CELLS	Background: MicroRNAs (miRNAs) have been shown to anticipate great cancer diagnostic potential. Recently, circulating miRNAs have been reported as promising biomarkers for various pathologic conditions. The objective of this study was to investigate the potential of serum miRNAs as novel biomarkers for hepatocellular carcinoma (HCC). Methodology/Principal Findings: This study was divided into four phases: (I) Ten candidate serum miRNAs were detected by using real-time RT-PCR, corresponding 10 HCC patients with chronic hepatitis B virus (HBV) infection and 10 age-and sex-matched healthy subjects. (II) Marker validation by real-time RT-PCR on HBV patients with (n = 48) or without HCC (n = 48), and healthy subjects (n = 24). (III) Marker detection by real-time RT-PCR in sera from another 14 HCC patients before and 1 month after surgical resection. (IV) We examined the correlation between the expressions of candidate serum miRNAs with clinical parameters of HCC patients. Although miR-222, miR-223 or miR-21 were significantly up-or down-regulated between HCC patients and healthy controls, no significant difference was observed in the levels of these miRNAs between HBV patients without and with HCC. MiR-122 in serum was significantly higher in HCC patients than healthy controls (p<0.001). More importantly, it was found that the levels of miR-122 were significantly reduced in the post-operative serum samples when compared to the pre-operative samples. Although serum miR-122 was also elevated in HBV patients with HCC comparing with those without HCC, the difference was at the border line (p = 0.043). Conclusions/Significance: Our results suggest that serum miR-122 might serve as a novel and potential noninvasive biomarker for detection of HCC in healthy subjects, moreover, it might serve as a novel biomarker for liver injury but not specifically for detection of HCC in chronic HBV infection patients.	[Qi, Peng; Chen, Yue-feng; Gao, Chun-fang] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Lab Med, Shanghai, Peoples R China; [Cheng, Shu-qun; Li, Nan] Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Oncol Comprehens Treatment, Shanghai, Peoples R China; [Wang, Hao] Second Mil Med Univ, Dept Lab Med, Changzheng Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Qi, P (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Hosp, Dept Lab Med, Shanghai, Peoples R China.	gaocf1115@163.com	cheng, sq/GPT-4112-2022		National Natural Science Foundation of China [30971345]; Youth Research Foundation of Second Military Medical University [2010QN22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Research Foundation of Second Military Medical University	This work was supported by the National Natural Science Foundation of China (No. 30971345) and the Youth Research Foundation of Second Military Medical University (No. 2010QN22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang JH, 2008, J VIROL, V82, P8215, DOI 10.1128/JVI.02575-07; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Ho AS, 2010, TRANSL ONCOL, V3, P109, DOI 10.1593/tlo.09256; Huang YS, 2008, J GASTROEN HEPATOL, V23, P87, DOI 10.1111/j.1440-1746.2007.05223.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ji X, 2009, CLIN CHEM, V55, P1944, DOI 10.1373/clinchem.2009.125310; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Markou A, 2008, CLIN CHEM, V54, P1696, DOI 10.1373/clinchem.2007.101741; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Qu KZ, 2011, J CLIN GASTROENTEROL, V45, P355, DOI 10.1097/MCG.0b013e3181f18ac2; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srivatanakul Petcharin, 2004, Asian Pac J Cancer Prev, V5, P118; Sukata T, 2011, TOXICOL LETT, V200, P46, DOI 10.1016/j.toxlet.2010.10.013; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang Y, 2008, J BIOL CHEM, V283, P13205, DOI 10.1074/jbc.M707629200; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Yu CH, 2009, DIGEST DIS SCI, V54, P2362, DOI 10.1007/s10620-008-0629-8; Zinkin NT, 2008, CLIN CANCER RES, V14, P470, DOI 10.1158/1078-0432.CCR-07-0586	45	231	246	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28486	10.1371/journal.pone.0028486	http://dx.doi.org/10.1371/journal.pone.0028486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174818	gold, Green Submitted, Green Published			2022-12-27	WOS:000298163600025
J	Albertazzi, L; Brondi, M; Pavan, GM; Sato, SS; Signore, G; Storti, B; Ratto, GM; Beltram, F				Albertazzi, Lorenzo; Brondi, Marco; Pavan, Giovanni M.; Sato, Sebastian Sulis; Signore, Giovanni; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio			Dendrimer-Based Fluorescent Indicators: In Vitro and In Vivo Applications	PLOS ONE			English	Article							RESOLUTION; PROBES; OXYGEN; PH	Background: The development of fluorescent proteins and synthetic molecules whose fluorescence properties are controlled by the environment makes it possible to monitor physiological and pathological events in living systems with minimal perturbation. A large number of small organic dyes are available and routinely used to measure biologically relevant parameters. Unfortunately their application is hindered by a number of limitations stemming from the use of these small molecules in the biological environment. Principal Findings: We present a novel dendrimer-based architecture leading to multifunctional sensing elements that can overcome many of these problems. Applications in vitro, in living cells and in vivo are reported. In particular, we image for the first time extracellular pH in the brain in a mouse epilepsy model. Conclusion: We believe that the proposed architecture can represent a useful and novel tool in fluorescence imaging that can be widely applied in conjunction with a broad range of sensing dyes and experimental setups.	[Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio] Scuola Normale Super Pisa, Lab NEST, Pisa, Italy; [Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Storti, Barbara; Ratto, Gian Michele; Beltram, Fabio] Ist Nanosci CNR, Pisa, Italy; [Albertazzi, Lorenzo; Brondi, Marco; Sato, Sebastian Sulis; Signore, Giovanni; Storti, Barbara; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, Pisa, Italy; [Pavan, Giovanni M.] Univ Appl Sci So Switzerland SUPSI, Lab Appl Math & Phys LaMFI, Manno, Switzerland	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Istituto Italiano di Tecnologia - IIT	Albertazzi, L (corresponding author), Scuola Normale Super Pisa, Lab NEST, Pisa, Italy.	l.albertazzi@sns.it	Albertazzi, Lorenzo/E-8323-2013; Pavan, Giovanni/E-7474-2011; Ratto, Gian Michele/AAX-8514-2020; Beltram, Fabio/L-9486-2019; signore, giovanni/GOV-6118-2022; Bizzarri, Ranieri/ABH-8343-2020; Storti, Barbara/AAB-7791-2019; Signore, Giovanni/A-3526-2010; Ratto, Gian Michele/AAB-8719-2021; Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Signore, Giovanni/J-8465-2019	Albertazzi, Lorenzo/0000-0002-6837-0812; Pavan, Giovanni/0000-0002-3473-8471; Beltram, Fabio/0000-0002-6081-436X; Storti, Barbara/0000-0002-2758-0426; Signore, Giovanni/0000-0002-0067-2240; Ratto, Gian Michele/0000-0001-9632-7769; Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Signore, Giovanni/0000-0002-0067-2240	Italian Ministry for University and Research (MiUR) [RBLA03ER38]	Italian Ministry for University and Research (MiUR)(Ministry of Education, Universities and Research (MIUR))	This work was partially supported by the Italian Ministry for University and Research (MiUR) under the framework of FIRB project RBLA03ER38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi L, 2010, J AM CHEM SOC, V132, P18158, DOI 10.1021/ja105689u; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Avoli Massimo, 2006, Epilepsy Curr, V6, P203, DOI 10.1111/j.1535-7511.2006.00146.x; Buccella D, 2011, J AM CHEM SOC, V133, P4101, DOI 10.1021/ja110907m; Case D.A., 2022, AMBER 2020; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FENG ZC, 1990, AM J PHYSIOL, V258, pR205, DOI 10.1152/ajpregu.1990.258.1.R205; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Huppert TJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3210779; Karton-Lifshin N, 2011, J AM CHEM SOC, V133, P10960, DOI 10.1021/ja203145v; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; MEUWIS K, 1995, BIOPHYS J, V68, P2469, DOI 10.1016/S0006-3495(95)80428-5; Mizukami S, 2009, CHEMBIOCHEM, V10, P1465, DOI 10.1002/cbic.200900214; Painter RG, 2006, ANAL CHEM, V78, P3133, DOI 10.1021/ac0521706; Pavan GM, 2010, J PHYS CHEM B, V114, P5686, DOI 10.1021/jp911439q; Pavan GM, 2010, BIOMACROMOLECULES, V11, P721, DOI 10.1021/bm901298t; Pavan GM, 2010, J PHYS CHEM B, V114, P2667, DOI 10.1021/jp100271w; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Signore G, 2010, J AM CHEM SOC, V132, P1276, DOI 10.1021/ja9050444; SILVER RA, 1992, PFLUG ARCH EUR J PHY, V420, P595, DOI 10.1007/BF00374639; Szmacinski H, 1993, ANAL CHEM, V65, P168; Wangler C, 2008, CHEM-EUR J, V14, P8116, DOI 10.1002/chem.200800328; Wang XJ, 2010, ANALYST, V135, P1585, DOI 10.1039/b922751b; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	31	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28450	10.1371/journal.pone.0028450	http://dx.doi.org/10.1371/journal.pone.0028450			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163303	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900040
J	Cunha, HA; Moraes, LC; Medeiros, BV; Lailson-Brito, J; da Silva, VMF; Sole-Cava, AM; Schrago, CG				Cunha, Haydee A.; Moraes, Lucas C.; Medeiros, Bruna V.; Lailson-Brito, Jose, Jr.; da Silva, Vera M. F.; Sole-Cava, Antonio M.; Schrago, Carlos G.			Phylogenetic Status and Timescale for the Diversification of Steno and Sotalia Dolphins	PLOS ONE			English	Article							CYTOCHROME-B; MOLECULAR PHYLOGENETICS; MULTILOCUS PHYLOGENY; BAYESIAN-INFERENCE; AMAZON RIVER; LIKELIHOOD; CETACEANS; EVOLUTION; RADIATION; WHALES	Molecular data have provided many insights into cetacean evolution but some unsettled issues still remain. We estimated the topology and timing of cetacean evolutionary relationships using Bayesian and maximum likelihood analyses of complete mitochondrial genomes. In order to clarify the phylogenetic placement of Sotalia and Steno within the Delphinidae, we sequenced three new delphinid mitogenomes. Our analyses support three delphinid clades: one joining Steno and Sotalia (supporting the revised subfamily Stenoninae); another placing Sousa within the Delphininae; and a third, the Globicephalinae, which includes Globicephala, Feresa, Pseudorca, Peponocephala and Grampus. We also conclude that Orcinus does not belong in the Globicephalinae, but Orcaella may be part of that subfamily. Divergence dates were estimated using the relaxed molecular clock calibrated with fossil data. We hypothesise that the timing of separation of the marine and Amazonian Sotalia species (2.3 Ma) coincided with the establishment of the modern Amazon River basin.	[Cunha, Haydee A.; Moraes, Lucas C.; Medeiros, Bruna V.; Sole-Cava, Antonio M.; Schrago, Carlos G.] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil; [Cunha, Haydee A.; Lailson-Brito, Jose, Jr.] Univ Fed Rio de Janeiro, Lab Mamiferos Aquat & Bioindicadores, Fac Oceanografia, Rio De Janeiro, Brazil; [da Silva, Vera M. F.] Inst Nacl de Pesquisas da Amazonia, Lab Mamiferos Aquat, Manaus, Amazonas, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Institute Nacional de Pesquisas da Amazonia	Cunha, HA (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, Rio De Janeiro, Brazil.	guerra@biologia.ufrj.br	Cunha, Haydée/I-5443-2013; Sole-Cava, Antonio M/G-4209-2011; Schrago, Carlos/E-4612-2012; Cunha, Haydee/O-1940-2017; Brito, Jose Lailson/B-3572-2013	Sole-Cava, Antonio M/0000-0003-0363-5821; Schrago, Carlos/0000-0001-6257-8906; Brito, Jose Lailson/0000-0001-8366-458X; Vieira de Medeiros, Bruna/0000-0002-8830-0053	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [103.136/2008, 110.838/2010, 110.028/2011, E26/100.209/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308147/2009-0]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by grants 103.136/2008, 110.838/2010 and 110.028/2011 from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and 308147/2009-0 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico to CS. HC is supported by a post-doctoral scholarship from FAPERJ (E26/100.209/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arnason U, 1996, MOL BIOL EVOL, V13, P407, DOI 10.1093/oxfordjournals.molbev.a025599; Arnason U, 2004, GENE, V333, P27, DOI 10.1016/j.gene.2004.02.010; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; BARNES LG, 1985, MAR MAMMAL SCI, V1, P149, DOI 10.1111/j.1748-7692.1985.tb00003.x; BARNES LG, 1976, SYST ZOOL, V25, P321, DOI 10.2307/2412508; BERTA A, 2006, MARINE MAMMALS EVOLU; Bianucci Giovanni, 1996, Palaeontographia Italica, V83, P73; Caballero S, 2007, MAR MAMMAL SCI, V23, P358, DOI 10.1111/j.1748-7692.2007.00110.x; Caballero S, 2008, MOL PHYLOGENET EVOL, V46, P252, DOI 10.1016/j.ympev.2007.10.015; Campbell KE, 2006, PALAEOGEOGR PALAEOCL, V239, P166, DOI 10.1016/j.palaeo.2006.01.020; Cassens I, 2000, P NATL ACAD SCI USA, V97, P11343, DOI 10.1073/pnas.97.21.11343; Cozzuol Mario A., 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P321; Cunha HA, 2010, WILDL PROT DESTR EXT, P261; Cunha HA, 2005, MAR BIOL, V148, P449, DOI 10.1007/s00227-005-0078-2; deGamero MLD, 1996, PALAEOGEOGR PALAEOCL, V123, P385, DOI 10.1016/0031-0182(96)00115-0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fordyce R.E., 2008, ENCY MARINE MAMMALS, P207; FORDYCE RE, 1994, ANNU REV EARTH PL SC, V22, P419, DOI 10.1146/annurev.ea.22.050194.002223; Fordyce RE, 2002, SM C PALEOB, P185; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gatesy J, 1996, MOL BIOL EVOL, V13, P954, DOI 10.1093/oxfordjournals.molbev.a025663; Gatesy J, 2001, TRENDS ECOL EVOL, V16, P562, DOI 10.1016/S0169-5347(01)02236-4; GEISLER JH, 2003, J MAMM EVOL, V10, P106; Geisler JH, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-112; Geisler JH, 2009, NATURE, V458, pE1, DOI 10.1038/nature07776; GRAUR D, 1994, MOL BIOL EVOL, V11, P357; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harlin-Cognato AD, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-87; Ho SYW, 2010, MITOCHONDR DNA, V21, P138, DOI 10.3109/19401736.2010.494727; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; LeDuc RG, 1999, MAR MAMMAL SCI, V15, P619, DOI 10.1111/j.1748-7692.1999.tb00833.x; May-Collado L, 2006, MOL PHYLOGENET EVOL, V38, P344, DOI 10.1016/j.ympev.2005.09.019; McGowen MR, 2011, MOL PHYLOGENET EVOL, V60, P345, DOI 10.1016/j.ympev.2011.05.003; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; Morin PA, 2010, GENOME RES, V20, P908, DOI 10.1101/gr.102954.109; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nikaido M, 1999, P NATL ACAD SCI USA, V96, P10261, DOI 10.1073/pnas.96.18.10261; Nikaido M, 2001, P NATL ACAD SCI USA, V98, P7384, DOI 10.1073/pnas.121139198; Perrin W.F., 1989, DOLPHINS PORPOISES W; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasaki T, 2005, SYST BIOL, V54, P77, DOI 10.1080/10635150590905939; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; Spaulding M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007062; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vilstrup JT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-65; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yan H, 2005, MOL PHYLOGENET EVOL, V37, P743, DOI 10.1016/j.ympev.2005.06.009; Yang XG, 2009, BIOLOGIA, V64, P811, DOI 10.2478/s11756-009-0121-8; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557	60	23	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28297	10.1371/journal.pone.0028297	http://dx.doi.org/10.1371/journal.pone.0028297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163290	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900025
J	Bhushan, S; Hossain, H; Lu, YN; Geisler, A; Tchatalbachev, S; Mikulski, Z; Schuler, G; Klug, J; Pilatz, A; Wagenlehner, F; Chakraborty, T; Meinhardt, A				Bhushan, Sudhanshu; Hossain, Hamid; Lu, Yongning; Geisler, Andreas; Tchatalbachev, Svetlin; Mikulski, Zbigniew; Schuler, Gerhard; Klug, Joerg; Pilatz, Adrian; Wagenlehner, Florian; Chakraborty, Trinad; Meinhardt, Andreas			Uropathogenic E. coli Induce Different Immune Response in Testicular and Peritoneal Macrophages: Implications for Testicular Immune Privilege	PLOS ONE			English	Article							LEYDIG-CELL STEROIDOGENESIS; ESCHERICHIA-COLI; MALE-INFERTILITY; SEMEN QUALITY; KAPPA-B; ACTIVATION; EXPRESSION; APOPTOSIS; NFAT; 25-HYDROXYCHOLESTEROL	Infertility affects one in seven couples and ascending bacterial infections of the male genitourinary tract by Escherichia coli are an important cause of male factor infertility. Thus understanding mechanisms by which immunocompetent cells such as testicular macrophages (TM) respond to infection and how bacterial pathogens manipulate defense pathways is of importance. Whole genome expression profiling of TM and peritoneal macrophages (PM) infected with uropathogenic E. coli (UPEC) revealed major differences in regulated genes. However, a multitude of genes implicated in calcium signaling pathways was a common feature which indicated a role of calcium-dependent nuclear factor of activated T cells (NFAT) signaling. UPEC-dependent NFAT activation was confirmed in both cultured TM and in TM in an in vivo UPEC infectious rat orchitis model. Elevated expression of NFATC2-regulated anti-inflammatory cytokines was found in TM (IL-4, IL-13) and PM (IL-3, IL-4, IL-13). NFATC2 is activated by rapid influx of calcium, an activity delineated to the pore forming toxin alpha-hemolysin by bacterial mutant analysis. Alpha-hemolysin suppressed IL-6 and TNF-alpha cytokine release from PM and caused differential activation of MAP kinase and AP-1 signaling pathways in TM and PM leading to reciprocal expression of key proinflammatory cytokines in PM (IL-1 alpha, IL-1 beta, IL-6 downregulated) and TM (IL-1 beta, IL-6 upregulated). In addition, unlike PM, LPS-treated TM were refractory to NF kappa B activation shown by the absence of degradation of I kappa B alpha and lack of pro-inflammatory cytokine secretion (IL-6, TNF-alpha). Taken together, these results suggest a mechanism to the conundrum by which TM initiate immune responses to bacteria, while maintaining testicular immune privilege with its ability to tolerate neo-autoantigens expressed on developing spermatogenic cells.	[Bhushan, Sudhanshu; Lu, Yongning; Mikulski, Zbigniew; Klug, Joerg; Meinhardt, Andreas] Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany; [Hossain, Hamid; Geisler, Andreas; Tchatalbachev, Svetlin; Chakraborty, Trinad] Univ Giessen, Dept Med Microbiol, Giessen, Germany; [Schuler, Gerhard] Univ Giessen, Clin Obstet Gynecol & Androl Large & Small Anim, Giessen, Germany; [Pilatz, Adrian; Wagenlehner, Florian] Univ Giessen, Clin Urol Pediat Urol & Androl, Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen	Bhushan, S (corresponding author), Univ Giessen, Dept Anat & Cell Biol, Reprod Biol Unit, Giessen, Germany.	trinad.chakraborty@mikrobio.med.uni-giessen.de; andreas.meinhardt@anatomie.med.uni-giessen.de	卢, 永宁/A-4650-2013; Mikulski, Zbigniew/AAB-4447-2020	Mikulski, Zbigniew/0000-0002-1918-9216; Schuler, Gerhard/0000-0002-9412-3743	Deutsche Forschungsgemeinschaft [KFO 181, ME 1323/6-1, 6-2]; Excellence Cluster "Cardiopulmonary System"; National Genome Research Network (NGFN), Germany [NGFN IE-S08T03];  [IntGK 1062]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG)); National Genome Research Network (NGFN), Germany; 	This study was supported by a grant of the Deutsche Forschungsgemeinschaft (Clinical Research Unit KFO 181, ME 1323/6-1 and 6-2), Excellence Cluster "Cardiopulmonary System" and IntGK 1062 and the National Genome Research Network (NGFN), Germany (NGFN IE-S08T03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhushan S, 2008, J IMMUNOL, V180, P5537, DOI 10.4049/jimmunol.180.8.5537; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; EggertKruse W, 1995, HUM REPROD UPDATE, V1, P462, DOI 10.1093/humupd/1.5.462; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; HALES DB, 1992, ENDOCRINOLOGY, V131, P2165, DOI 10.1210/en.131.5.2165; Hayes R, 1996, J ANDROL, V17, P41; Hecker A, 2009, J LEUKOCYTE BIOL, V86, P13, DOI [10.1189/JLB.1107722, 10.1189/jlb.1107722]; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hoffmann B, 1999, ANIM REPROD SCI, V57, P89, DOI 10.1016/S0378-4320(99)00050-0; HUTSON JC, 1994, INT REV CYTOL, V149, P99, DOI 10.1016/S0074-7696(08)62087-2; Hutson JC, 2006, EXP BIOL MED, V231, P1; KERN S, 1995, BIOL REPROD, V53, P1407, DOI 10.1095/biolreprod53.6.1407; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Ludwig M, 2002, BJU INT, V90, P933, DOI 10.1046/j.1464-410X.2002.03029.x; Lukyanenko Y, 2002, BIOL REPROD, V67, P1435, DOI 10.1095/biolreprod.102.007575; Lukyanenko YO, 2001, BIOL REPROD, V64, P790, DOI 10.1095/biolreprod64.3.790; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Maresz K, 2008, J REPROD IMMUNOL, V78, P140, DOI 10.1016/j.jri.2008.01.001; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; MERINO G, 1995, ARCH ANDROLOGY, V35, P209, DOI 10.3109/01485019508987872; Moon DO, 2008, CANCER LETT, V264, P316, DOI 10.1016/j.canlet.2008.02.011; Nieschlag E., 2000, ANDROLOGY MALE REPRO; Park S, 2004, J CELL BIOCHEM, V91, P973, DOI 10.1002/jcb.10768; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; Shen WH, 2002, BRAIN RES, V933, P23, DOI 10.1016/S0006-8993(02)02291-6; Shibata N, 2010, CIRC J, V74, P2045, DOI 10.1253/circj.CJ-10-0860; Soto SM, 2007, J UROLOGY, V177, P365, DOI 10.1016/j.juro.2006.08.081; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Weidner W, 1999, HUM REPROD UPDATE, V5, P421, DOI 10.1093/humupd/5.5.421; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; *WHO, 1987, INT J ANDROL S7; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Willen M, 1996, SCAND J UROL NEPHROL, V30, P387, DOI 10.3109/00365599609181315; Winnall WR, 2011, J LEUKOC BIOL; XIONG YT, 1993, ENDOCRINOLOGY, V132, P2438, DOI 10.1210/en.132.6.2438	40	58	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28452	10.1371/journal.pone.0028452	http://dx.doi.org/10.1371/journal.pone.0028452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164293	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400094
J	Gonzalez-del Pozo, M; Borrego, S; Barragan, I; Pieras, JI; Santoyo, J; Matamala, N; Naranjo, B; Dopazo, J; Antinolo, G				Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Santoyo, Javier; Matamala, Nerea; Naranjo, Belen; Dopazo, Joaquin; Antinolo, Guillermo			Mutation Screening of Multiple Genes in Spanish Patients with Autosomal Recessive Retinitis Pigmentosa by Targeted Resequencing	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; EYS GENE; FAMILIES; ORTHOLOG; IDENTIFICATION; DYSTROPHIES; PHENOTYPES; PUPASUITE	Retinitis Pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies characterised ultimately by the loss of photoreceptor cells. RP is the leading cause of visual loss in individuals younger than 60 years, with a prevalence of about 1 in 4000. The molecular genetic diagnosis of autosomal recessive RP (arRP) is challenging due to the large genetic and clinical heterogeneity. Traditional methods for sequencing arRP genes are often laborious and not easily available and a screening technique that enables the rapid detection of the genetic cause would be very helpful in the clinical practice. The goal of this study was to develop and apply microarray-based resequencing technology capable of detecting both known and novel mutations on a single high-throughput platform. Hence, the coding regions and exon/intron boundaries of 16 arRP genes were resequenced using microarrays in 102 Spanish patients with clinical diagnosis of arRP. All the detected variations were confirmed by direct sequencing and potential pathogenicity was assessed by functional predictions and frequency in controls. For validation purposes 4 positive controls for variants consisting of previously identified changes were hybridized on the array. As a result of the screening, we detected 44 variants, of which 15 are very likely pathogenic detected in 14 arRP families (14%). Finally, the design of this array can easily be transformed in an equivalent diagnostic system based on targeted enrichment followed by next generation sequencing.	[Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Matamala, Nerea; Naranjo, Belen; Antinolo, Guillermo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unidad Gest Clin Genet Reprod, Seville, Spain; [Gonzalez-del Pozo, Maria; Borrego, Salud; Barragan, Isabel; Pieras, Juan I.; Santoyo, Javier; Dopazo, Joaquin; Antinolo, Guillermo] CIBERER, Seville, Spain; [Santoyo, Javier; Matamala, Nerea; Dopazo, Joaquin; Antinolo, Guillermo] Andalusian Ctr Human Genom Sequencing, Med Genome Project, Seville, Spain; [Santoyo, Javier; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Dopazo, Joaquin] Funct Genom Node INB, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Prince Felipe Research Center	Gonzalez-del Pozo, M (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla,Unidad Gest Clin Genet Reprod, Seville, Spain.	jdopazo@cipf.es; guillermo.antinolo.sspa@juntadeandalucia.es	IBIS, GENETICA/P-3384-2015; Santoyo-Lopez, Javier/C-9714-2012; Borrego, Salud/M-6314-2015; Matamala, Nerea/AAA-5006-2020; Naranjo, Belen/E-2273-2019; Santoyo-Lopez, Javier/AHE-5002-2022; Barragan, Isabel/AAJ-6532-2020; Dopazo, Joaquin/A-9270-2014; González-del Pozo, María/N-1742-2015; IBIS, REPRODUCCION/P-3399-2015	Santoyo-Lopez, Javier/0000-0003-1988-5059; Naranjo, Belen/0000-0003-4586-3259; Santoyo-Lopez, Javier/0000-0003-1988-5059; Barragan, Isabel/0000-0002-8586-6502; Dopazo, Joaquin/0000-0003-3318-120X; González-del Pozo, María/0000-0003-4858-938X; Antinolo Gil, Guillermo/0000-0002-2113-074X; Matamala, Nerea/0000-0002-3082-2414	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria, Spain [PI081131]; Consejeria de Innovacion, Ciencia y Empresa [PI08-CTS-03687]; Junta de Andalucia, Spain; El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII; Spanish Ministry of Science and Innovation [BIO2008-04212]; Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER) [PROMETEO/2010/001]; Instituto Nacional de Bioinformatica (INB)	Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica; Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria, Spain; Consejeria de Innovacion, Ciencia y Empresa; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER); Instituto Nacional de Bioinformatica (INB)	This study was funded by Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011 (PN de I+ D+ I 2008-2011), Instituto de Salud Carlos III (ISCIII) - Subdireccion General de Evaluacion y Fomento de la Investigacion, Fondo de Investigacion Sanitaria (PI081131), Spain; Consejeria de Innovacion, Ciencia y Empresa (PI08-CTS-03687), Junta de Andalucia, Spain; El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the ISCIII. This work is also partly supported by grants from projects BIO2008-04212 from the Spanish Ministry of Science and Innovation, PROMETEO/2010/001 from Generalitat Valenciana-Fondo Europeo de Desarrollo Regional (GVA-FEDER) and the Instituto Nacional de Bioinformatica (INB), which is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Avila-Fernandez A, 2008, INVEST OPHTH VIS SCI, V49, P2709, DOI 10.1167/iovs.07-0865; Avila-Fernandez A, 2010, MOL VIS, V16, P2550; Bandah-Rozenfeld D, 2010, INVEST OPHTH VIS SCI, V51, P4387, DOI 10.1167/iovs.09-4732; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Booij JC, 2011, OPHTHALMOLOGY, V118, P160, DOI 10.1016/j.ophtha.2010.04.022; Bruce CK, 2010, HUM MUTAT, V31, P858, DOI 10.1002/humu.21261; Clark GR, 2010, OPHTHALMOLOGY, V117, P2169, DOI 10.1016/j.ophtha.2010.02.029; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Karaman MW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni034; Kothiyal P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-10; Lebet T, 2008, GENET MED, V10, P575, DOI [10.1097/GIM.0b013e31818063bc, 10.1097GIM.0b013e31818063bc]; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Lotery A J, 2001, Ophthalmic Genet, V22, P163, DOI 10.1076/opge.22.3.163.2222; Mandal MNA, 2005, INVEST OPHTH VIS SCI, V46, P3355, DOI 10.1167/iovs.05-0007; Ormond KE, 2010, LANCET, V375, P1749, DOI 10.1016/S0140-6736(10)60599-5; Pieras JI, 2011, INVEST OPHTH VIS SCI, V52, P5625, DOI 10.1167/iovs.11-7292; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; SOUIED E, 1994, HUM MOL GENET, V3, P1433, DOI 10.1093/hmg/3.8.1433; Splicing site Mutation by Berkeley Drosophila Genome Project (BDGP) website, SPLIC SIT MUT; STONE EM, 1993, INVEST OPHTH VIS SCI, V34, P1149; Vallespin E, 2007, INVEST OPHTH VIS SCI, V48, P5653, DOI 10.1167/iovs.07-0007; Walia S, 2008, ARCH OPHTHALMOL-CHIC, V126, P379, DOI 10.1001/archophthalmol.2007.72; Warrington JA, 2002, HUM MUTAT, V19, P402, DOI 10.1002/humu.10075; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717	38	24	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27894	10.1371/journal.pone.0027894	http://dx.doi.org/10.1371/journal.pone.0027894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164218	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400019
J	Hsu, WC; Okeke, E; Cheung, S; Keenan, H; Tsui, T; Cheng, K; King, GL				Hsu, William C.; Okeke, Eyiuche; Cheung, Sophia; Keenan, Hillary; Tsui, Tracy; Cheng, Kyle; King, George L.			A Cross-Sectional Characterization of Insulin Resistance by Phenotype and Insulin Clamp in East Asian Americans with Type 1 and Type 2 Diabetes	PLOS ONE			English	Article							ACID-BINDING PROTEIN; PREVALENCE; RETINOL-BINDING-PROTEIN-4; POPULATION	Objective: Classic features of type 1 and type 2 diabetes may not apply in Asian Americans, due to shared absence of common HLA DR-DQ genotype, low prevalence of positive anti-islet antibodies and low BMI in both types of diabetes. Our objective was to characterize diabetic phenotypes in Asian Americans by clamp and clinical features. Materials/Methods: This was a cross-sectional study conducted in a referral center. Thirty East young Asian American adult volunteers (27.6 +/- 5.5 years) with type 1, type 2 diabetes or controls underwent hyperinsulinemic euglycemic clamp to assess insulin resistance and DEXA to assess adiposity. Results: Gender, BMI, waist/hip ratio, leptin, LDL, anti-GAD, anti-IA2 antibodies and C-reactive protein were similar among three groups. Serum C-peptide, adiponectin, free fatty acid, HDL concentrations and truncal fat by DEXA, were different between diabetic groups. Glucose disposal rate by clamp was lowest in type 2 diabetes, followed by type 1 diabetes and controls (5.43 +/- 2.70, 7.62 +/- 2.59, 8.61 +/- 2.37 mg/min/kg, respectively, p = 0.001). Free fatty acid concentration universally plummeted during steady state of the clamp procedure regardless of diabetes types in all three groups. Adipocyte fatty acid binding protein in the entire cohort (r = -0.625, p = 0.04) and controls (r = -0.869, p = 0.046) correlated best with insulin resistance, independent of BMI. Conclusions: Type 2 diabetes in Asian Americans was associated with insulin resistance despite having low BMI as type 1 diabetes, suggesting a potential role for targeting insulin resistance apart from weight loss. Adipocyte fatty acid binding protein, strongly associated with insulin resistance, independent of adiposity in the young Asian American population, may potentially serve as a biomarker to identify at-risk individuals. Larger studies are needed to confirm this finding.	[Hsu, William C.; Okeke, Eyiuche; Cheung, Sophia; Tsui, Tracy; Cheng, Kyle; King, George L.] Joslin Diabet Ctr, Asian Amer Diabet Initiat, Boston, MA 02215 USA; [Keenan, Hillary; King, George L.] Joslin Diabet Ctr, Dianne Nunnally Hoppes Lab Diabet Complicat, Boston, MA 02215 USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Joslin Diabetes Center, Inc.	Hsu, WC (corresponding author), Joslin Diabet Ctr, Asian Amer Diabet Initiat, Boston, MA 02215 USA.	William.hsu@joslin.harvard.edu			Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; Joslin Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; Joslin Diabetes Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was conducted with support provided by Joslin Diabetes Center's Asian American Diabetes Fund, an internal fund. This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Boord JB, 2002, CURR OPIN LIPIDOL, V13, P141, DOI 10.1097/00041433-200204000-00005; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chiu KC, 2000, DIABETES CARE, V23, P1353, DOI 10.2337/diacare.23.9.1353; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; FUJIMOTO WY, 1987, DIABETES, V36, P721, DOI 10.2337/diabetes.36.6.721; Goldberg RB, 2005, DIABETES CARE, V28, P2472; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; International Diabetes Federation, 2009, IDF DIAB ATL; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Maskarinec G, 2009, ETHNIC DIS, V19, P49; McNeely MJ, 2004, DIABETES CARE, V27, P66, DOI 10.2337/diacare.27.1.66; Park Y, 2001, DIABETES-METAB RES, V17, P2, DOI 10.1002/1520-7560(2000)9999:9999<::AID-DMRR164>3.0.CO;2-M; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Raji A, 2004, J CLIN ENDOCR METAB, V89, P3965, DOI 10.1210/jc.2004-0087; Thorpe LE, 2009, DIABETES CARE, V32, P57, DOI 10.2337/dc08-0727; Todd AL, 2004, INTERN MED J, V34, P24, DOI 10.1111/j.1444-0903.2004.00482.x; Tso AWK, 2007, DIABETES CARE, V30, P2667, DOI 10.2337/dc07-0413; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503	20	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28311	10.1371/journal.pone.0028311	http://dx.doi.org/10.1371/journal.pone.0028311			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164267	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400068
J	Waldeisen, JR; Wang, T; Mitra, D; Lee, LP				Waldeisen, John R.; Wang, Tim; Mitra, Debkishore; Lee, Luke P.			A Real-Time PCR Antibiogram for Drug-Resistant Sepsis	PLOS ONE			English	Article							16S RDNA PCR; BACTERIAL PATHOGENS; BLOOD; IDENTIFICATION; BACTEREMIA; DIAGNOSIS; ASSAY	Current molecular diagnostic techniques for susceptibility testing of septicemia rely on genotyping for the presence of known resistance cassettes. This technique is intrinsically vulnerable due to the inability to detect newly emergent resistance genes. Traditional phenotypic susceptibility testing has always been a superior method to assay for resistance; however, relying on the multi-day growth period to determine which antimicrobial to administer jeopardizes patient survival. These factors have resulted in the widespread and deleterious use of broad-spectrum antimicrobials. The real-time PCR antibiogram, described herein, combines universal phenotypic susceptibility testing with the rapid diagnostic capabilities of PCR. We have developed a procedure that determines susceptibility by monitoring pathogenic load with the highly conserved 16S rRNA gene in blood samples exposed to different antimicrobial drugs. The optimized protocol removes heme and human background DNA from blood, which allows standard real-time PCR detection systems to be employed with high sensitivity (<100 CFU/mL). Three strains of E. coli, two of which were antimicrobial resistant, were spiked into whole blood and exposed to three different antibiotics. After real-time PCR-based determination of pathogenic load, a Delta C(t)<3.0 between untreated and treated samples was found to indicate antimicrobial resistance (P<0.01). Minimum inhibitory concentration was determined for susceptible bacteria and pan-bacterial detection was demonstrated with 3 Gram-negative and 2 Gram-positive bacteria. Species identification was performed via analysis of the hypervariable amplicons. In summary, we have developed a universal diagnostic phenotyping technique that assays for the susceptibility of drug-resistant septicemia with the speed of PCR. The real-time PCR antibiogram achieves detection, susceptibility testing, minimum inhibitory concentration determination, and identification in less than 24 hours.	[Waldeisen, John R.; Wang, Tim; Mitra, Debkishore; Lee, Luke P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Waldeisen, JR (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	lplee@berkeley.edu	Lee, Luke/AAN-6695-2021		Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology; National Science Foundation	Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology; National Science Foundation(National Science Foundation (NSF))	This work was supported by the Korea Institute for Advancement of Technology and Center for Nanostructured Materials Technology. JRW acknowledges support from an National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avolio M, 2010, SHOCK, V34, P27, DOI 10.1097/SHK.0b013e3181d49299; Bauer M, 2010, INT J MED MICROBIOL, V300, P411, DOI 10.1016/j.ijmm.2010.04.006; Blanc DS, 2011, J CLIN MICROBIOL, V49, P722, DOI 10.1128/JCM.01988-10; Boakes E, 2011, J CLIN MICROBIOL, V49, P684, DOI 10.1128/JCM.01917-10; Cleven BEE, 2006, J CLIN MICROBIOL, V44, P2389, DOI 10.1128/JCM.02291-05; Costa SF, 2008, SHOCK, V30, P23, DOI 10.1097/SHK.0b013e3181818990; Handschur M, 2009, COMP IMMUNOL MICROB, V32, P207, DOI 10.1016/j.cimid.2007.10.005; Kellogg JA, 2000, J CLIN MICROBIOL, V38, P2181; Lane DJ, 2004, NUCL ACID TECHNIQUES, p[16S/23S, 115]; Lindholm L, 2004, J CLIN MICROBIOL, V42, P5609, DOI 10.1128/JCM.42.12.5609-5613.2004; PHILLIPS SE, 1990, J CLIN MICROBIOL, V28, P1; Procop GW, 2007, CLIN INFECT DIS, V45, pS99, DOI 10.1086/519259; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Sener S, 2011, J CLIN MICROBIOL, V49, P1124, DOI 10.1128/JCM.02104-10; Shopsin B, 2000, J CLIN MICROBIOL, V38, P3453, DOI 10.1128/JCM.38.9.3453-3456.2000; Stutz K, 2011, J CLIN MICROBIOL, V49, P638, DOI 10.1128/JCM.01148-10; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Walsh AL, 1995, CLIN INFECT DIS, V21, P1498, DOI 10.1093/clinids/21.6.1498; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yanagihara K, 2010, CRIT CARE, V14, DOI 10.1186/cc9234; Zhang SX, 2011, J CLIN MICROBIOL, V49, P704, DOI 10.1128/JCM.01622-10	25	34	37	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28528	10.1371/journal.pone.0028528	http://dx.doi.org/10.1371/journal.pone.0028528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164303	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400104
J	Zauli, G; Monasta, L; Rimondi, E; Brumatti, LV; Radillo, O; Ronfani, L; Montico, M; D'Ottavio, G; Alberico, S; Secchiero, P				Zauli, Giorgio; Monasta, Lorenzo; Rimondi, Erika; Brumatti, Liza Vecchi; Radillo, Oriano; Ronfani, Luca; Montico, Marcella; D'Ottavio, Giuseppina; Alberico, Salvatore; Secchiero, Paola			Circulating TRAIL Shows a Significant Post-Partum Decline Associated to Stressful Conditions	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; INFLAMMATORY MARKERS; ENDOTHELIAL-CELLS; SERUM-LEVELS; OSTEOPROTEGERIN; PREGNANCY; EXPRESSION; RECEPTORS	Background: Since circulating levels of TNF-related apoptosis inducing ligand (TRAIL) may be important in the physiopathology of pregnancy, we tested the hypothesis that TRAIL levels change at delivery in response to stressful conditions. Methods/Principal Findings: We conducted a longitudinal study in a cohort of 73 women examined at week 12, week 16, delivery and in the corresponding cord blood (CB). Serum TRAIL was assessed in relationship with maternal characteristics and to biochemical parameters. TRAIL did not vary between 12 (67.6 +/- 27.6 pg/ml, means +/- SD) and 16 (64.0 +/- 16.2 pg/ml) weeks' gestation, while displaying a significant decline after partum (49.3 +/- 26.4 pg/ml). Using a cut-off decline >20 pg/ml between week 12 and delivery, the subset of women with the higher decline of circulating TRAIL (41.7%) showed the following characteristics: i) nullipara, ii) higher age, iii) operational vaginal delivery or urgent CS, iv) did not receive analgesia during labor, v) induced labor. CB TRAIL was significantly higher (131.6 +/- 52 pg/ml) with respect to the corresponding maternal TRAIL, and the variables significantly associated with the first quartile of CB TRAIL (<90 pg/ml) were higher prepregnancy BMI, induction of labor and fetal distress. With respect to the biochemical parameters, maternal TRAIL at delivery showed an inverse correlation with C-reactive protein (CRP), total cortisol, glycemia and insulin at bivariate analysis, but only with CRP at multivariate analysis. Conclusions: Stressful partum conditions and elevated CRP levels are associated with a decrease of circulating TRAIL.	[Zauli, Giorgio; Monasta, Lorenzo; Brumatti, Liza Vecchi; Radillo, Oriano; Ronfani, Luca; Montico, Marcella; D'Ottavio, Giuseppina; Alberico, Salvatore] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy; [Rimondi, Erika; Secchiero, Paola] Univ Ferrara, Dept Morphol & Embryol, I-44100 Ferrara, Italy; [Rimondi, Erika; Secchiero, Paola] Univ Ferrara, LTTA Ctr, I-44100 Ferrara, Italy	IRCCS Burlo Garofolo; University of Ferrara; University of Ferrara	Zauli, G (corresponding author), IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy.	paola.secchiero@unife.it	Montico, Marcella/B-5290-2013; Rimondi, Erika/AAB-8237-2022; secchiero, paola/G-9689-2015; Monasta, Lorenzo/B-1388-2012; Zauli, Giorgio/ABE-8001-2020; Vecchi Brumatti, Liza/J-4968-2016; RIMONDI, Erika/AAB-6206-2022; Ronfani, Luca/B-6668-2013	Montico, Marcella/0000-0003-0377-8232; secchiero, paola/0000-0003-4101-7987; Monasta, Lorenzo/0000-0001-7774-548X; Vecchi Brumatti, Liza/0000-0001-8149-1873; RIMONDI, Erika/0000-0002-8241-2513; Ronfani, Luca/0000-0001-5710-3914; Zauli, Giorgio/0000-0002-3750-8698	CRTrieste foundation; Associazione Amici del Cuore	CRTrieste foundation; Associazione Amici del Cuore	This study was supported by CRTrieste foundation (to GZ) and Associazione Amici del Cuore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alladina SJ, 2005, J VASC RES, V42, P337, DOI 10.1159/000086599; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Bai X, 2009, PLACENTA, V30, P855, DOI 10.1016/j.placenta.2009.07.006; Camozzi V, 2010, EUR J ENDOCRINOL, V162, P85, DOI 10.1530/EJE-09-0800; Chen LH, 2004, LIFE SCI, V74, P1479, DOI 10.1016/j.lfs.2003.07.044; Di Pietro R, 2004, J CELL PHYSIOL, V201, P331, DOI 10.1002/jcp.20099; Fluhr H, 2009, FERTIL STERIL, V92, P1420, DOI 10.1016/j.fertnstert.2009.04.017; Groebner AE, 2010, PLACENTA, V31, P168, DOI 10.1016/j.placenta.2009.12.017; Hofbauer LC, 2006, RHEUMATOLOGY, V45, P1218, DOI 10.1093/rheumatology/kel108; Jung C, 2011, J CLIN ENDOCR METAB, V96, P1533, DOI 10.1210/jc.2010-2395; Kawano N, 2011, DIABETES RES CLIN PR, V91, P316, DOI 10.1016/j.diabres.2010.11.034; Keogh RJ, 2007, CIRC RES, V100, P834, DOI 10.1161/01.RES.0000261352.81736.37; Klugman SD, 2008, PLACENTA, V29, P382, DOI 10.1016/j.placenta.2008.01.013; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Liguori A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.027; Lonergan M, 2003, J CLIN ENDOCR METAB, V88, P3835, DOI 10.1210/jc.2002-021905; Michowitz Y, 2005, J AM COLL CARDIOL, V45, P1018, DOI 10.1016/j.jacc.2004.12.065; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Naylor KE, 2003, J CLIN ENDOCR METAB, V88, P5361, DOI 10.1210/jc.2003-030486; Niessner A, 2009, EUR HEART J, V30, P789, DOI 10.1093/eurheartj/ehp004; Nomura S, 2007, TRANSPL IMMUNOL, V18, P115, DOI 10.1016/j.trim.2007.05.012; Phillips TA, 1999, J IMMUNOL, V162, P6053; Phillips TA, 2001, PLACENTA, V22, P663, DOI 10.1053/plac.2001.0703; Secchiero P, 2005, BLOOD, V105, P3413, DOI 10.1182/blood-2004-10-4111; Secchiero P, 2008, CURR OPIN HEMATOL, V15, P42, DOI 10.1097/MOH.0b013e3282f15fa6; Secchiero P, 2006, CIRCULATION, V114, P1522, DOI 10.1161/CIRCULATIONAHA.106.643841; Secchiero P, 2010, ATHEROSCLEROSIS, V211, P333, DOI 10.1016/j.atherosclerosis.2010.02.024; Secchiero P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004442; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Sokolov DI, 2009, B EXP BIOL MED+, V148, P766, DOI 10.1007/s10517-010-0812-8; Swellam M, 2009, DIS MARKERS, V26, P127, DOI [10.1155/2009/658943, 10.3233/DMA-2009-0622]; Volpato S, 2011, ATHEROSCLEROSIS, V215, P452, DOI 10.1016/j.atherosclerosis.2010.11.004; von Versen-Hoeynck FM, 2009, AM J HYPERTENS, V22, P687, DOI 10.1038/ajh.2009.54; Watt V, 2011, ATHEROSCLEROSIS, V215, P348, DOI 10.1016/j.atherosclerosis.2011.01.010; Zai-Xing Y, 2008, J CLIN LAB ANAL, V22, P138, DOI 10.1002/jcla.20231; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27011	10.1371/journal.pone.0027011	http://dx.doi.org/10.1371/journal.pone.0027011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194780	Green Published, Green Submitted, gold			2022-12-27	WOS:000298369100003
J	Ahmad, S; Simmons, T; Varagic, J; Moniwa, N; Chappell, MC; Ferrario, CM				Ahmad, Sarfaraz; Simmons, Tony; Varagic, Jasmina; Moniwa, Norihito; Chappell, Mark C.; Ferrario, Carlos M.			Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue	PLOS ONE			English	Article							MAST-CELL CHYMASE; CONVERTING ENZYME; HUMAN HEART; PROANGIOTENSIN-12 PA12; FORMING PATHWAYS; CARDIAC TISSUE; RENIN; SYSTEM; RAT; INHIBITION	Since angiotensin-(1-12) [Ang-(1-12)] is a non-renin dependent alternate precursor for the generation of cardiac Ang peptides in rat tissue, we investigated the metabolism of Ang-(1-12) by plasma membranes (PM) isolated from human atrial appendage tissue from nine patients undergoing cardiac surgery for primary control of atrial fibrillation (MAZE surgical procedure). PM was incubated with highly purified (125)I-Ang-(1-12) at 37 degrees C for 1 h with or without renin-angiotensin system (RAS) inhibitors [lisinopril for angiotensin converting enzyme (ACE), SCH39370 for neprilysin (NEP), MLN-4760 for ACE2 and chymostatin for chymase; 50 mu M each]. (125)I-Ang peptide fractions were identified by HPLC coupled to an inline gamma-detector. In the absence of all RAS inhibitor, (125)I-Ang-(1-12) was converted into Ang I (2 +/- 2%), Ang II (69 +/- 21%), Ang-(1-7) (5 +/- 2%), and Ang-(1-4) (2 +/- 1%). In the absence of all RAS inhibitor, only 22 +/- 10% of (125)I-Ang-(1-12) was unmetabolized, whereas, in the presence of the all RAS inhibitors, 98 +/- 7% of (125)I-Ang-(1-12) remained intact. The relative contribution of selective inhibition of ACE and chymase enzyme showed that (125)I-Ang-(1-12) was primarily converted into Ang II (65 +/- 18%) by chymase while its hydrolysis into Ang II by ACE was significantly lower or undetectable. The activity of individual enzyme was calculated based on the amount of Ang II formation. These results showed very high chymase-mediated Ang II formation (28 +/- 3.1 fmolxmin(-1) xmg(-1), n = 9) from (125)I-Ang-(1-12) and very low or undetectable Ang II formation by ACE (1.1 +/- 0.2 fmolxmin(-2) xmg(-1)). Paralleling these findings, these tissues showed significant content of chymase protein that by immunocytochemistry were primarily localized in atrial cardiac myocytes. In conclusion, we demonstrate for the first time in human cardiac tissue a dominant role of cardiac chymase in the formation of Ang II from Ang-(1-12).	[Ahmad, Sarfaraz; Varagic, Jasmina; Moniwa, Norihito; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27106 USA; [Varagic, Jasmina; Chappell, Mark C.] Wake Forest Univ, Bowman Gray Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC USA; [Varagic, Jasmina; Chappell, Mark C.; Ferrario, Carlos M.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Ahmad, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Surg Sci, Winston Salem, NC 27106 USA.	sahmad@wakehealth.edu	Chappell, Mark/AAX-9087-2021; Ferrario, Carlos/ABB-4165-2021; Ferrario, Carlos/ABD-2791-2020	Ferrario, Carlos/0000-0003-0792-6239	National Institutes of Health [2PO1 HL-051952, R01 HL-56973]; Farley-Hudson Foundation, Jacksonville, NC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051952, R01HL056973] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Farley-Hudson Foundation, Jacksonville, NC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Heart, Lung and Blood Institutes of the National Institutes of Health (2PO1 HL-051952 and R01 HL-56973). The authors also acknowledge partial support provided by the Farley-Hudson Foundation, Jacksonville, NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015759; Akasu M, 1998, HYPERTENSION, V32, P514, DOI 10.1161/01.HYP.32.3.514; Arakawa H, 2011, AM J PHYSIOL-HEART C, V300, pH951, DOI 10.1152/ajpheart.01144.2010; Arnold AC, 2010, AM J PHYSIOL-HEART C, V299, pH763, DOI 10.1152/ajpheart.00345.2010; Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Batlle M, 2006, J HEART LUNG TRANSPL, V25, P1117, DOI 10.1016/j.healun.2006.04.012; Becari C, 2011, AM J PHYSIOL-HEART C, V301, pH565, DOI 10.1152/ajpheart.00534.2010; Bujak-Gizycka B, 2010, J PHYSIOL PHARMACOL, V61, P679; Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005; Chen PM, 2005, CHINESE MED J-PEKING, V118, P1886; Chitravanshi VC, 2011, AM J PHYSIOL-HEART C, V300, pH230, DOI 10.1152/ajpheart.00861.2010; Cohen JA, 2010, AM J PHYSIOL-RENAL, V299, pF35, DOI 10.1152/ajprenal.00138.2010; Dell'Italia LJ, 2002, CURR PROB CARDIOLOGY, V27, P6, DOI 10.1067/mcd.2002.121580; Dell'Italia LJ, 2002, CURR OPIN CARDIOL, V17, P374, DOI 10.1097/00001573-200207000-00009; DellItalia LJ, 1995, AM J PHYSIOL-HEART C, V269, pH2065, DOI 10.1152/ajpheart.1995.269.6.H2065; DORER FE, 1975, BIOCHEM PHARMACOL, V24, P1137, DOI 10.1016/0006-2952(75)90207-5; Ferrario CM, 2010, AM J PHYSIOL-RENAL, V298, pF1297, DOI 10.1152/ajprenal.00110.2010; Ferrario CM, 2010, HYPERTENSION, V55, P445, DOI 10.1161/HYPERTENSIONAHA.109.145839; Ferrario CM, 2009, AM J PHYSIOL-HEART C, V296, pH1184, DOI 10.1152/ajpheart.01114.2008; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fukami H, 1998, CURR PHARM DESIGN, V4, P439; Gwathmey TM, 2009, AM J PHYSIOL-RENAL, V296, pF1484, DOI 10.1152/ajprenal.90766.2008; Huang XR, 2003, J AM SOC NEPHROL, V14, P1738, DOI 10.1097/01.ASN.0000071512.93927.4E; Inoue N, 2009, ATHEROSCLEROSIS, V204, P359, DOI 10.1016/j.atherosclerosis.2008.09.032; Isa K, 2009, AM J PHYSIOL-REG I, V297, pR111, DOI 10.1152/ajpregu.90588.2008; Jessup JA, 2008, AM J PHYSIOL-HEART C, V294, pH2614, DOI 10.1152/ajpheart.91521.2007; Kanemitsu H, 2008, EUR J CARDIO-THORAC, V33, P25, DOI 10.1016/j.ejcts.2007.09.040; KIELTY CM, 1993, BIOCHEM BIOPH RES CO, V191, P1230, DOI 10.1006/bbrc.1993.1349; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Komeda K, 2008, HEPATOL RES, V38, P501, DOI 10.1111/j.1872-034X.2007.00271.x; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P1475, DOI 10.1161/01.ATV.0000029782.84357.68; Maeda Y, 2010, AM J PHYSIOL-RENAL, V299, pF1328, DOI 10.1152/ajprenal.00337.2010; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Miyazaki M, 2006, J PHARMACOL SCI, V100, P391, DOI 10.1254/jphs.CPJ06008X; Nagata S, 2006, BIOCHEM BIOPH RES CO, V350, P1026, DOI 10.1016/j.bbrc.2006.09.146; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Prosser HC, 2010, PEPTIDES, V31, P1540, DOI 10.1016/j.peptides.2010.05.009; Prosser HCG, 2009, CARDIOVASC RES, V82, P40, DOI 10.1093/cvr/cvp003; Shaltout HA, 2007, AM J PHYSIOL-RENAL, V292, pF82, DOI 10.1152/ajprenal.00139.2006; SKEGGS LT, 1977, FED PROC, V36, P1755; Takai S, 1999, CIRCULATION, V100, P654, DOI 10.1161/01.CIR.100.6.654; Takai S, 1997, CLIN CHIM ACTA, V265, P13, DOI 10.1016/S0009-8981(97)00114-9; Takai S, 2010, J PHARMACOL SCI, V113, P301, DOI 10.1254/jphs.10R05FM; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Tchougounova E, 2001, FASEB J, V15, P2763, DOI 10.1096/fj.01-0486fje; Trask AJ, 2008, AM J PHYSIOL-HEART C, V294, pH2242, DOI 10.1152/ajpheart.00175.2008; URATA H, 1991, J BIOL CHEM, V266, P17173; URATA H, 1990, J BIOL CHEM, V265, P22348; URATA H, 1990, CIRC RES, V66, P883, DOI 10.1161/01.RES.66.4.883; URATA H, 1993, J CLIN INVEST, V91, P1269, DOI 10.1172/JCI116325; Varagic J, 2008, J MOL MED, V86, P663, DOI 10.1007/s00109-008-0340-4; Wei CC, 2010, J CLIN INVEST, V120, P1229, DOI 10.1172/JCI39345; WELCHES WR, 1993, LIFE SCI, V52, P1461, DOI 10.1016/0024-3205(93)90108-F	54	87	88	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28501	10.1371/journal.pone.0028501	http://dx.doi.org/10.1371/journal.pone.0028501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180785	gold, Green Published			2022-12-27	WOS:000298367300013
J	Axelsson, S; Cheramy, M; Hjorth, M; Pihl, M; Akerman, L; Martinuzzi, E; Mallone, R; Ludvigsson, J; Casas, R				Axelsson, Stina; Cheramy, Mikael; Hjorth, Maria; Pihl, Mikael; Akerman, Linda; Martinuzzi, Emanuela; Mallone, Roberto; Ludvigsson, Johnny; Casas, Rosaura			Long-Lasting Immune Responses 4 Years after GAD-Alum Treatment in Children with Type 1 Diabetes	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; T-CELL HOMEOSTASIS; MEMORY; RECEPTOR; SUBSETS; CD4(+); INTERLEUKIN-4; PATHOGENESIS; LYMPHOCYTES; EXPRESSION	A phase II clinical trial with glutamic acid decarboxylase (GAD) 65 formulated with aluminium hydroxide (GAD-alum) has shown efficacy in preserving residual insulin secretion in children and adolescents with recent-onset type 1 diabetes (T1D). We have performed a 4-year follow-up study of 59 of the original 70 patients to investigate long-term cellular and humoral immune responses after GAD-alum-treatment. Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with GAD(65). Frequencies of naive, central and effector memory CD4+ and CD8+ T cells were measured, together with cytokine secretion, proliferation, gene expression and serum GAD(65) autoantibody (GADA) levels. We here show that GAD-alum-treated patients display increased memory T-cell frequencies and prompt T-cell activation upon in vitro stimulation with GAD(65), but not with control antigens, compared with placebo subjects. GAD(65)-induced T-cell activation was accompanied by secretion of T helper (Th) 1, Th2 and T regulatory cytokines and by induction of T-cell inhibitory pathways. Moreover, post-treatment serum GADA titres remained persistently increased in the GAD-alum arm, but did not inhibit GAD(65) enzymatic activity. In conclusion, memory T- and B-cell responses persist 4 years after GAD-alum-treatment. In parallel to a GAD(65)-induced T-cell activation, our results show induction of T-cell inhibitory pathways important for regulating the GAD(65) immunity.	[Axelsson, Stina; Cheramy, Mikael; Hjorth, Maria; Pihl, Mikael; Akerman, Linda; Ludvigsson, Johnny; Casas, Rosaura] Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Clin & Expt Med, Linkoping, Sweden; [Martinuzzi, Emanuela; Mallone, Roberto] St Vincent de Paul Hosp, INSERM, U986, DeAR Lab Avenir, Paris, France; [Martinuzzi, Emanuela; Mallone, Roberto] Univ Paris 05, Fac Med, Paris, France; [Mallone, Roberto] Hop Cochin, AP HP, Paris, France; [Mallone, Roberto] Hop Hotel Dieu, Serv Diabetol, Paris, France	Linkoping University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Axelsson, S (corresponding author), Linkoping Univ, Fac Hlth Sci, Div Paediat, Dept Clin & Expt Med, Linkoping, Sweden.	stina.axelsson@liu.se	Mallone, Roberto/H-4430-2013; Martinuzzi, Emanuela/S-3053-2019; Ludvigsson, Johnny/AAI-2051-2020	Mallone, Roberto/0000-0002-9846-8861; Martinuzzi, Emanuela/0000-0001-5832-951X; Ludvigsson, Johnny/0000-0003-1695-5234	Swedish Research Council [K2008-55x-20652-01-3]; Swedish Child Diabetes Foundation (Barndiabetesfonden); Medical Research Council of Southeast Sweden; Juvenile Diabetes Research Foundation (JDRF) [1-2008-106]; Ile-de-France CODDIM; Inserm Avenir Program	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Child Diabetes Foundation (Barndiabetesfonden); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Ile-de-France CODDIM; Inserm Avenir Program(Institut National de la Sante et de la Recherche Medicale (Inserm))	This project was supported by grants from the Swedish Research Council (K2008-55x-20652-01-3), the Swedish Child Diabetes Foundation (Barndiabetesfonden) and the Medical Research Council of Southeast Sweden. R.M. has support from the Juvenile Diabetes Research Foundation (JDRF grant 1-2008-106), the Ile-de-France CODDIM and the Inserm Avenir Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh CD, 2005, J DIABETES COMPLICAT, V19, P238, DOI 10.1016/j.jdiacomp.2004.12.003; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Axelsson S, 2010, DIABETES-METAB RES, V26, P559, DOI 10.1002/dmrr.1126; BAEKKESKOV S, 1990, NATURE, V347, P151, DOI 10.1038/347151a0; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Cheramy M, 2010, CLIN IMMUNOL, V137, P31, DOI 10.1016/j.clim.2010.06.001; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Dooms H, 2006, IMMUNOL REV, V211, P23, DOI 10.1111/j.0105-2896.2006.00387.x; Fourlanos S, 2011, DIABETES, V60, P1237, DOI 10.2337/db10-1360; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; Hedman M, 2008, CLIN EXP IMMUNOL, V153, P360, DOI 10.1111/j.1365-2249.2008.03720.x; Hjorth M, 2011, CLIN IMMUNOL, V138, P117, DOI 10.1016/j.clim.2010.10.004; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Lord JD, 2000, J IMMUNOL, V164, P2533, DOI 10.4049/jimmunol.164.5.2533; Ludvigsson J, 2009, Diabetologia, V52, P175, DOI 10.1007/s00125-008-1211-9; Ludvigsson J, 2011, DIABETOLOGIA, V54, P634, DOI 10.1007/s00125-010-1988-1; Ludvigsson J, 2008, NEW ENGL J MED, V359, P1909, DOI 10.1056/NEJMoa0804328; Mallone R, 2008, CURR DIABETES REP, V8, P101, DOI 10.1007/s11892-008-0019-9; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; MARTINUZZI E, 2011, BLOOD; Martinuzzi E, 2008, DIABETES, V57, P1312, DOI 10.2337/db07-1594; McHeyzer-Williams LJ, 2006, IMMUNOL REV, V211, P255, DOI 10.1111/j.0105-2896.2006.00397.x; MICHIE CA, 1992, NATURE, V360, P264, DOI 10.1038/360264a0; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Raju R, 2005, J IMMUNOL, V175, P7755, DOI 10.4049/jimmunol.175.11.7755; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Vibhakar R, 1997, EXP CELL RES, V232, P25, DOI 10.1006/excr.1997.3493; Wherrett DK, 2011, LANCET, V378, P319, DOI 10.1016/S0140-6736(11)60895-7; ZURAWSKI SM, 1995, J BIOL CHEM, V270, P13869, DOI 10.1074/jbc.270.23.13869	35	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29008	10.1371/journal.pone.0029008	http://dx.doi.org/10.1371/journal.pone.0029008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174945	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600057
J	Lingappa, JR; Petrovski, S; Kahle, E; Fellay, J; Shianna, K; McElrath, MJ; Thomas, KK; Baeten, JM; Celum, C; Wald, A; de Bruyn, G; Mullins, JI; Nakku-Joloba, E; Farquhar, C; Essex, M; Donnell, D; Kiarie, J; Haynes, B; Goldstein, D				Lingappa, Jairam R.; Petrovski, Slave; Kahle, Erin; Fellay, Jacques; Shianna, Kevin; McElrath, M. Juliana; Thomas, Katherine K.; Baeten, Jared M.; Celum, Connie; Wald, Anna; de Bruyn, Guy; Mullins, James I.; Nakku-Joloba, Edith; Farquhar, Carey; Essex, Max; Donnell, Deborah; Kiarie, James; Haynes, Bart; Goldstein, David		Partners Prevention HSV HIV Transm	Genomewide Association Study for Determinants of HIV-1 Acquisition and Viral Set Point in HIV-1 Serodiscordant Couples with Quantified Virus Exposure	PLOS ONE			English	Article							MANNOSE-BINDING LECTIN; WIDE ASSOCIATION; GENETIC ASSOCIATION; HAPLOTYPE MAP; INFECTION; SUSCEPTIBILITY; POPULATION; AIDS; POLYMORPHISMS; TRANSMISSION	Background: Host genetic factors may be important determinants of HIV-1 sexual acquisition. We performed a genomewide association study (GWAS) for host genetic variants modifying HIV-1 acquisition and viral control in the context of a cohort of African HIV-1 serodiscordant heterosexual couples. To minimize misclassification of HIV-1 risk, we quantified HIV-1 exposure, using data including plasma HIV-1 concentrations, gender, and condom use. Methods: We matched couples without HIV-1 seroconversion to those with seroconversion by quantified HIV-1 exposure risk. Logistic regression of single nucleotide polymorphisms (SNPs) for 798 samples from 496 HIV-1 infected and 302 HIV-1 exposed, uninfected individuals was performed to identify factors associated with HIV-1 acquisition. In addition, a linear regression analysis was performed using SNP data from a subset (n = 403) of HIV-1 infected individuals to identify factors predicting plasma HIV-1 concentrations. Results: After correcting for multiple comparisons, no SNPs were significantly associated with HIV-1 infection status or plasma HIV-1 concentrations. Conclusion: This GWAS controlling for HIV-1 exposure did not identify common host genotypes influencing HIV-1 acquisition. Alternative strategies, such as large-scale sequencing to identify low frequency variation, should be considered for identifying novel host genetic predictors of HIV-1 acquisition.	[Lingappa, Jairam R.; Kahle, Erin; Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lingappa, Jairam R.; Thomas, Katherine K.; Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Petrovski, Slave; Fellay, Jacques; Shianna, Kevin; Haynes, Bart; Goldstein, David] Duke Univ, Sch Med, Ctr Human Genome Variat, Durham, NC USA; [Petrovski, Slave] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Fellay, Jacques; Shianna, Kevin; Haynes, Bart; Goldstein, David] Duke Univ, Sch Med, Ctr HIV AIDS Vaccine Immunol, Durham, NC USA; [McElrath, M. Juliana; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Baeten, Jared M.; Celum, Connie; Wald, Anna; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [de Bruyn, Guy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Mullins, James I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Nakku-Joloba, Edith] Makerere Univ, Mulago Hosp, Kampala, Uganda; [Essex, Max] Harvard Univ, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS, Seattle, WA 98104 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Duke University; Royal Melbourne Hospital; University of Melbourne; Duke University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Witwatersrand; University of Washington; University of Washington Seattle; Makerere University; Mulago National Referral Hospital; Harvard University; Fred Hutchinson Cancer Center; University of Nairobi	Lingappa, JR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lingappa@UW.edu	Fellay, Jacques/A-6681-2009; Lingappa, Jairam/N-7760-2017; Goldstein, David/AAY-8125-2020; Wald, Anna/B-6272-2012	Fellay, Jacques/0000-0002-8240-939X; Wald, Anna/0000-0003-3486-6438; Thomas, Katherine K/0000-0002-7024-468X; Kapiga, Saidi/0000-0003-1753-4060; Donnell, Deborah/0000-0002-0587-7480; de Bruyn, Guy/0000-0002-8028-4474; , Erin/0000-0001-6060-9852; kiarie, james/0000-0003-4180-7858; Petrovski, Slave/0000-0002-1527-961X; Were, Edwin/0000-0002-4783-0795	Bill and Melinda Gates Foundation [26469]; NIH/NIAID [AI27757, AI073115]; Center for HIV-1/AIDS Vaccine Immunology [AI067854]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R21AI073115, P01AI057005, U19AI067854, U01AI067854] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for HIV-1/AIDS Vaccine Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was through the Bill and Melinda Gates Foundation grant #26469 and NIH/NIAID grants AI27757, AI073115 and Center for HIV-1/AIDS Vaccine Immunology grant AI067854. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ball TB, 2007, AIDS, V21, P1091, DOI 10.1097/QAD.0b013e3280ef6ae1; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Boniotto M, 2003, AIDS, V17, P779, DOI 10.1097/00002030-200303280-00025; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001033; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garred P, 1997, LANCET, V349, P236, DOI 10.1016/S0140-6736(96)08440-1; Hughes JP, 2011, J INFECT DI IN PRESS; *ILL INC, 2010, HUM 1M DUO DNA AN BE; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Limou S, 2010, J INFECT DIS, V202, P908, DOI 10.1086/655782; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; LINGAPPA JR, 2011, 18 C RETR OPP INF FE; LINGAPPA JR, 2010, AIDS VACC 2010 SEPT; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MACKELPRANG R, 2011, 18 C RETR OPP INF FE; Malik S, 2003, IMMUNOGENETICS, V55, P49, DOI 10.1007/s00251-003-0550-4; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mombo LE, 2003, GENES IMMUN, V4, P362, DOI 10.1038/sj.gene.6363979; Pastinen T, 1998, AIDS RES HUM RETROV, V14, P695, DOI 10.1089/aid.1998.14.695; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; PURCELL AW, PLINK WHOL GEN ASS A; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Restrepo C, 2011, AIDS REV, V13, P30; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Vallinoto ACR, 2006, MOL IMMUNOL, V43, P1358, DOI 10.1016/j.molimm.2005.09.001	41	64	64	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28632	10.1371/journal.pone.0028632	http://dx.doi.org/10.1371/journal.pone.0028632			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174851	gold, Green Published			2022-12-27	WOS:000298366600028
J	Brown, A; Thatje, S				Brown, Alastair; Thatje, Sven			Respiratory Response of the Deep-Sea Amphipod Stephonyx biscayensis Indicates Bathymetric Range Limitation by Temperature and Hydrostatic Pressure	PLOS ONE			English	Article							OXYGEN-CONSUMPTION; CLIMATE-CHANGE; THERMAL TOLERANCE; BODY-SIZE; PATTERNS; ADAPTATIONS; METABOLISM; DEPTH; FISH	Depth zonation of fauna on continental margins is well documented. Whilst increasing hydrostatic pressure with depth has long been considered a factor contributing significantly to this pattern, discussion of the relative significance of decreasing temperature with depth has continued. This study investigates the physiological tolerances of fed and starved specimens of the bathyal lysianassoid amphipod Stephonyx biscayensis at varying temperature to acute pressure exposure by measuring the rate of oxygen consumption. Acclimation to atmospheric pressure is shown to have no significant interaction with temperature and/or pressure effects. Similarly, starvation is shown to have no significant effect on the interaction of temperature and pressure. Subsequently, the effect of pressure on respiration rate is revealed to be dependent on temperature: pressure equivalent to 2000 m depth was tolerated at 1 and 3 degrees C; pressure equivalent to 2500 m depth was tolerated at 5.5 degrees C; at 10 degrees C pressure equivalent to 3000 m depth was tolerated. The variation in tolerance is consistent with the natural distribution range reported for this species. There are clear implications for hypotheses relating to the observed phenomenon of a biodiversity bottleneck between 2000 and 3000 metres, and for the potential for bathymetric range shifts in response to global climate change.	[Brown, Alastair; Thatje, Sven] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	NERC National Oceanography Centre; University of Southampton	Brown, A (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England.	alastair.brown@noc.soton.ac.uk	Brown, Alastair/I-7875-2012	Brown, Alastair/0000-0002-2126-203X	Total Foundation [Abyss2100]; Natural Environment Research Council	Total Foundation(Total SA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was made possible through a grant (Abyss2100) from the Total Foundation to Sven Thatje. Alastair Brown was supported through a Natural Environment Research Council PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRRIESS CN, 1994, BIOL BULL, V187, P208, DOI 10.2307/1542243; Balny C, 2002, BBA-PROTEIN STRUCT M, V1595, P3, DOI 10.1016/S0167-4838(01)00331-4; BARNARD JL, 1990, SMITHSONIAN CONTRIBU, V499; Carney RS, 2005, OCEANOGR MAR BIOL, V43, P211; CHAPELLE G, 1994, J EXP MAR BIOL ECOL, V183, P63, DOI 10.1016/0022-0981(94)90157-0; Chase MR, 1998, MAR BIOL, V131, P301, DOI 10.1007/s002270050323; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; CHILDRESS JJ, 1977, MAR BIOL, V39, P19, DOI 10.1007/BF00395588; Clarke A., 1998, Society for Experimental Biology Seminar Series, V66, P3; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; GEORGE RY, 1979, SARSIA, V64, P61, DOI 10.1080/00364827.1979.10411364; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Hargrave BT, 1995, DEEP-SEA RES PT I, V42, P1905, DOI 10.1016/0967-0637(95)00080-1; HARGRAVE BT, 1994, DEEP-SEA RES PT I, V41, P1489, DOI 10.1016/0967-0637(94)90057-4; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; Levin LA, 2001, ANNU REV ECOL SYST, V32, P51, DOI 10.1146/annurev.ecolsys.32.081501.114002; LOWRY JK, 1997, MEMOIRS HOURGLASS CR, V10; MASSON D, 2009, RRS J COOK CRUISE, V36; McMahon BR, 2001, RESP PHYSIOL, V128, P349, DOI 10.1016/S0034-5687(01)00311-5; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mestre NC, 2009, P ROY SOC B-BIOL SCI, V276, P717, DOI 10.1098/rspb.2008.1376; MICKEL TJ, 1982, DEEP-SEA RES, V29, P1293, DOI 10.1016/0198-0149(82)90009-7; Oliphant A, 2011, J EXP BIOL, V214, P1109, DOI 10.1242/jeb.048058; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Pradillon Florence, 2007, Reviews in Environmental Science and Bio/Technology, V6, P181, DOI 10.1007/s11157-006-9111-2; Raupach MJ, 2009, P ROY SOC B-BIOL SCI, V276, P799, DOI 10.1098/rspb.2008.1063; Rex MA, 1999, EVOLUTION, V53, P1298, DOI 10.1111/j.1558-5646.1999.tb04543.x; Rex MA, 1998, DEEP-SEA RES PT II, V45, P103, DOI 10.1016/S0967-0645(97)00082-9; Samerotte AL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P197, DOI 10.1086/510566; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Seibel BA, 2007, PHILOS T R SOC B, V362, P2061, DOI 10.1098/rstb.2007.2101; Shillito B, 2006, J EXP BIOL, V209, P945, DOI 10.1242/jeb.02102; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Sokal R.R., 2012, BIOMETRY; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; SOMERO GN, 1992, ANNU REV PHYSIOL, V54, P557, DOI 10.1146/annurev.ph.54.030192.003013; Stouffer RJ, 2003, CLIM DYNAM, V20, P759, DOI 10.1007/s00382-002-0302-4; Thatje S, 2011, NATURWISSENSCHAFTEN, V98, P299, DOI 10.1007/s00114-011-0768-1; Thatje S, 2010, J EXP MAR BIOL ECOL, V390, P22, DOI 10.1016/j.jembe.2010.04.028; Thurston MH, 2002, J MAR BIOL ASSOC UK, V82, P205, DOI 10.1017/S0025315402005374; Treude T, 2002, DEEP-SEA RES PT I, V49, P1281, DOI 10.1016/S0967-0637(02)00023-7; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	48	29	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28562	10.1371/journal.pone.0028562	http://dx.doi.org/10.1371/journal.pone.0028562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174838	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000298365700047
J	Gerstein, AC; Otto, SP				Gerstein, Aleeza C.; Otto, Sarah P.			Cryptic Fitness Advantage: Diploids Invade Haploid Populations Despite Lacking Any Apparent Advantage as Measured by Standard Fitness Assays	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PLOIDY; EVOLUTION; MICROORGANISMS; REJECTION	Ploidy varies tremendously within and between species, yet the factors that influence when or why ploidy variants are adaptive remains poorly understood. Our previous work found that diploid individuals repeatedly arose within ten replicate haploid populations of Saccharomyces cerevisiae, and in each case we witnessed diploid takeover within similar to 1800 asexual generations of batch culture evolution in the lab. The character that allowed diploids to rise in frequency within haploid populations remains unknown. Here we present a number of experiments conducted with the goal to determine what this trait (or traits) might have been. Experiments were conducted both by sampling a small number of colonies from the stocks frozen every two weeks (similar to 93 generations) during the original experiment, as well through sampling a larger number of colonies at the two time points where polymorphism for ploidy was most prevalent. Surprisingly, none of our fitness component measures (lag phase, growth rate, biomass production) indicated an advantage to diploidy. Similarly, competition assays against a common competitor and direct competition between haploid and diploid colonies isolated from the same time point failed to indicate a diploid advantage. Furthermore, we uncovered a tremendous amount of trait variation among colonies of the same ploidy level. Only late-appearing diploids showed a competitive advantage over haploids, indicating that the fitness advantage that allowed eventual takeover was not diploidy per se but an attribute of a subset of diploid lineages. Nevertheless, the initial rise in diploids to intermediate frequency cannot be explained by any of the fitness measures used; we suggest that the resolution to this mystery is negative frequency-dependent selection, which is ignored in the standard fitness measures used.	[Gerstein, Aleeza C.; Otto, Sarah P.] Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia	Gerstein, AC (corresponding author), Univ British Columbia, Dept Zool, Biodivers Res Ctr, Vancouver, BC, Canada.	gerstein@zoology.ubc.ca	Gerstein, Aleeza/D-4139-2011; Otto, Sarah Perin/K-5625-2012	Gerstein, Aleeza/0000-0002-0781-9356; Otto, Sarah Perin/0000-0003-3042-0818	NSERC (Canadian National Science and Engineering Research Council); Killam Trusts	NSERC (Canadian National Science and Engineering Research Council); Killam Trusts	This research was funded by NSERC (Canadian National Science and Engineering Research Council) and the Killam Trusts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1985, GENETICS, V110, P173; ADAMS J, 1974, GENETICS, V76, P327; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; COWEN LE, 2001, J BACTERIOL; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; de Visser JAGM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-19; DYKHUIZEN DE, 1990, ANNU REV ECOL SYST, V21, P373, DOI 10.1146/annurev.ecolsys.21.1.373; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; GERSTEIN AC, 2011, J EVOLUTION BIOL, P531; Gerstein AC, 2008, BIOL LETTERS, V4, P91, DOI 10.1098/rsbl.2007.0476; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; GLAZUNOV A V, 1989, Mikrobiologiya, V58, P769; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Hall DW, 2010, GENETICS, V185, P1397, DOI 10.1534/genetics.110.118307; Mable BK, 2001, J EVOLUTION BIOL, V14, P157, DOI 10.1046/j.1420-9101.2001.00245.x; Mongold JA, 1996, J BACTERIOL, V178, P5333, DOI 10.1128/jb.178.17.5333-5334.1996; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SLATER ML, 1973, J BACTERIOL, V113, P263, DOI 10.1128/JB.113.1.263-270.1973; Stahl G, 2004, EUKARYOT CELL, V3, P331, DOI 10.1128/EC.3.2.331-338.2004; TEMINA A V, 1979, Mikrobiologiya, V48, P610; WEISS RL, 1975, P NATL ACAD SCI USA, V72, P794, DOI 10.1073/pnas.72.3.794; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523	28	36	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e26599	10.1371/journal.pone.0026599	http://dx.doi.org/10.1371/journal.pone.0026599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174734	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700002
J	Jakola, AS; Gulati, S; Weber, C; Unsgard, G; Solheim, O				Jakola, Asgeir S.; Gulati, Sasha; Weber, Clemens; Unsgard, Geirmund; Solheim, Ole			Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective Study	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; INTRAOPERATIVE 3D ULTRASOUND; RESECTION; EXTENT; OUTCOMES; MULTIFORME; EUROQOL; IMPACT; COMPLICATIONS; RADIOTHERAPY	Background: Studies indicate that acquired deficits negatively affect patients' self-reported health related quality of life (HRQOL) and survival, but the impact of HRQOL deterioration after surgery on survival has not been explored. Objective: Assess if change in HRQOL after surgery is a predictor for survival in patients with glioblastoma. Methods: Sixty-one patients with glioblastoma were included. The majority of patients (n = 56, 91.8%) were operated using a neuronavigation system which utilizes 3D preoperative MRI and updated intraoperative 3D ultrasound volumes to guide resection. HRQOL was assessed using EuroQol 5D (EQ-5D), a generic instrument. HRQOL data were collected 1-3 days preoperatively and after 6 weeks. The mean change in EQ-5D index was -0.05 (95% CI -0.15-0.05) 6 weeks after surgery (p = 0.285). There were 30 patients (49.2%) reporting deterioration 6 weeks after surgery. In a Cox multivariate survival analysis we evaluated deterioration in HRQOL after surgery together with established risk factors (age, preoperative condition, radiotherapy, temozolomide and extent of resection). Results: There were significant independent associations between survival and use of temozolomide (HR 0.30, p = 0.019), radiotherapy (HR 0.26, p = 0.030), and deterioration in HRQOL after surgery (HR 2.02, p = 0.045). Inclusion of surgically acquired deficits in the model did not alter the conclusion. Conclusion: Early deterioration in HRQOL after surgery is independently and markedly associated with impaired survival in patients with glioblastoma. Deterioration in patient reported HRQOL after surgery is a meaningful outcome in surgical neuro-oncology, as the measure reflects both the burden of symptoms and treatment hazards and is linked to overall survival.	[Jakola, Asgeir S.; Gulati, Sasha; Weber, Clemens; Unsgard, Geirmund; Solheim, Ole] St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, Med Imaging Lab, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Solheim, Ole] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Jakola, Asgeir S.; Unsgard, Geirmund; Solheim, Ole] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway; [Gulati, Sasha] Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Jakola, AS (corresponding author), St Olavs Univ Hosp, Dept Neurosurg, Trondheim, Norway.	asgeir.s.jakola@ntnu.no	Jakola, Asgeir S/J-1738-2018	Jakola, Asgeir S/0000-0002-2860-9331; Solheim, Ole/0000-0002-5954-4817; Weber, Clemens/0000-0001-7007-5719				ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Brown PD, 2006, J NEURO-ONCOL, V76, P283, DOI 10.1007/s11060-005-7020-9; Brown PD, 2005, NEUROSURGERY, V57, P495, DOI 10.1227/01.NEU.0000170562.25335.C7; Burstrom K, 2001, QUAL LIFE RES, V10, P621, DOI 10.1023/A:1013171831202; Chaichana KL, 2011, J NEUROSURG, V114, P587, DOI 10.3171/2010.8.JNS1081; Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175; Cheng JX, 2009, NEURO-ONCOLOGY, V11, P41, DOI 10.1215/15228517-2008-050; DEGROOT JF, 2011, J CLIN ONCOLOGY; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Gotay CC, 2008, J CLIN ONCOL, V26, P1355, DOI 10.1200/JCO.2007.13.3439; Gulati S, 2009, MINIM INVAS NEUROSUR, V52, P17, DOI 10.1055/s-0028-1104566; GULATI S, 2011, WORLD NEURO IN PRESS; Jakola AS, 2011, J NEUROSURG, V114, P1622, DOI 10.3171/2011.1.JNS101657; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Ibanez FAL, 2011, WORLD NEUROSURG, V75, P709, DOI 10.1016/j.wneu.2010.11.010; Lutterbach J, 2005, CANCER, V103, P1234, DOI 10.1002/cncr.20895; LYDICK E, 1993, QUAL LIFE RES, V2, P221, DOI 10.1007/BF00435226; MARINA O, 2011, J NEUROSURG, P1; Mauer M, 2007, BRIT J CANCER, V97, P302, DOI 10.1038/sj.bjc.6603876; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; NORD E, 1991, HEALTH POLICY, V18, P25, DOI 10.1016/0168-8510(91)90141-J; Quinten C, 2009, LANCET ONCOL, V10, P865, DOI 10.1016/S1470-2045(09)70200-1; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rasmussen IA, 2007, ACTA NEUROCHIR, V149, P365, DOI 10.1007/s00701-006-1110-0; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Sanai N, 2011, J NEUROSURG, V115, P3, DOI 10.3171/2011.2.JNS10998; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; SOLHEIM O, 2010, ACTA NEUROCHIR, P1; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Unsgaard G, 2006, ACTA NEUROCHIR, V148, P235, DOI 10.1007/s00701-005-0688-y; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	37	53	54	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28592	10.1371/journal.pone.0028592	http://dx.doi.org/10.1371/journal.pone.0028592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FK	22174842	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700049
J	Kornblatt, MJ; Kornblatt, JA; Hancock, MA				Kornblatt, M. Judith; Kornblatt, Jack A.; Hancock, Mark A.			The Interaction of Canine Plasminogen with Streptococcus pyogenes Enolase: They Bind to One Another but What Is the Nature of the Structures Involved?	PLOS ONE			English	Article							ALPHA-ENOLASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CELL-SURFACE; LACTOBACILLUS-CRISPATUS; PROTEIN; PNEUMONIAE; IDENTIFICATION; PLASMIN(OGEN); ACTIVATION; CLONING	For years it has been clear that plasminogen from different sources and enolase from different sources interact strongly. What is less clear is the nature of the structures required for them to interact. This work examines the interaction between canine plasminogen (dPgn) and Streptococcus pyogenes enolase (Str enolase) using analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), fluorescence polarization, dynamic light scattering (DLS), isothermal titration calorimetry (ITC), and simple pull-down reactions. Overall, our data indicate that a non-native structure of the octameric Str enolase (monomers or multimers) is an important determinant of its surface-mediated interaction with host plasminogen. Interestingly, a non-native structure of plasminogen is capable of interacting with native enolase. As far as we can tell, the native structures resist forming stable mixed complexes.	[Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Kornblatt, M. Judith; Kornblatt, Jack A.] Concordia Univ, Ctr Struct & Funct Genom, Montreal, PQ H3G 1M8, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ, Canada	Concordia University - Canada; Concordia University - Canada; Concordia University - Canada; McGill University	Kornblatt, MJ (corresponding author), Concordia Univ, Dept Biol, 1455 De Maisonneuve Blvd W, Montreal, PQ H3G 1M8, Canada.	krnbltt@alcor.concordia.ca		kornblatt, jack/0000-0002-9802-8321	Natural Sciences and Engineering Research Council, Canada [9988-6]; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The research was generously supported by the Natural Sciences and Engineering Research Council, Canada (Grant Number 9988-6 to JAK). The Sheldon Biotechnology Centre is supported by a Research Resource Grant from the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, BBA-PROTEINS PROTEOM, V1784, P986, DOI 10.1016/j.bbapap.2008.03.017; Andronicos NM, 1997, BBA-PROTEIN STRUCT M, V1337, P27, DOI 10.1016/S0167-4838(96)00146-X; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; BACHMANN F, 1994, HAEMOSTASIS THROMBOS, P525; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Bernal D, 2004, FEBS LETT, V563, P203, DOI 10.1016/S0014-5793(04)00306-0; BREWER JM, 1995, PHYS ASPECTS PROTEIN, P57; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Candela M, 2009, MICROBIOL-SGM, V155, P3294, DOI 10.1099/mic.0.028795-0; Chhatwal GS, 2002, TRENDS MICROBIOL, V10, P205, DOI 10.1016/S0966-842X(02)02351-X; Chung MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018119; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; de la Torre-Escudero E, 2010, VET PARASITOL, V173, P76, DOI 10.1016/j.vetpar.2010.06.011; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Esgleas M, 2008, MICROBIOL-SGM, V154, P2668, DOI 10.1099/mic.0.2008/017145-0; Fox D, 2001, MED MYCOL, V39, P495, DOI 10.1080/714031070; Ge JP, 2004, INFECT IMMUN, V72, P6748, DOI 10.1128/IAI.72.11.6748-6752.2004; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Hurmalainen V, 2007, MICROBIOL-SGM, V153, P1112, DOI 10.1099/mic.0.2006/000901-0; Itzek A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013826; Jolodar A, 2003, BBA-GENE STRUCT EXPR, V1627, P111, DOI 10.1016/S0167-4781(03)00083-6; Jones MN, 2007, BIOCHEM BIOPH RES CO, V364, P924, DOI 10.1016/j.bbrc.2007.10.098; Jong AY, 2003, J MED MICROBIOL, V52, P615, DOI 10.1099/jmm.0.05060-0; Karbassi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008810; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kolberg J, 2006, MICROBIOL-SGM, V152, P1307, DOI 10.1099/mic.0.28747-0; Kornblatt JA, 1999, EUR J BIOCHEM, V265, P120, DOI 10.1046/j.1432-1327.1999.00695.x; Kornblatt JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006196; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; Lee JH, 2006, FEMS MICROBIOL LETT, V259, P240, DOI 10.1111/j.1574-6968.2006.00274.x; LEWIS JH, 1951, AM J PHYSIOL, V166, P594, DOI 10.1152/ajplegacy.1951.166.3.594; Lopez-Alemany R, 2005, FRONT BIOSCI-LANDMRK, V10, P30, DOI 10.2741/1503; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1989, BIOCHEMISTRY-US, V28, P9337, DOI 10.1021/bi00450a014; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Molkanen T, 2002, FEBS LETT, V517, P72, DOI 10.1016/S0014-5793(02)02580-2; Mundodi V, 2008, INFECT IMMUN, V76, P523, DOI 10.1128/IAI.01352-07; Myszka DG, 1998, ANAL BIOCHEM, V265, P326, DOI 10.1006/abio.1998.2937; NAKAJIMA K, 1994, J NEUROCHEM, V63, P2048; Nogueira SV, 2010, INFECT IMMUN, V78, P4040, DOI 10.1128/IAI.00221-10; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, MICROB PATHOGENESIS, V35, P293, DOI 10.1016/j.micpath.2003.08.004; PLOW EF, 1991, THROMB HAEMOSTASIS, V66, P32; Ramajo-Hernandez A, 2007, EXP PARASITOL, V115, P83, DOI 10.1016/j.exppara.2006.07.003; REDLITZ A, 1995, EUR J BIOCHEM, V227, P407, DOI 10.1111/j.1432-1033.1995.tb20403.x; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seweryn Ewa, 2007, Postepy Hig Med Dosw (Online), V61, P672; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Sha J, 2009, J BACTERIOL, V191, P3095, DOI 10.1128/JB.00005-09; Vanegas G, 2007, PARASITOL RES, V101, P1511, DOI 10.1007/s00436-007-0668-7; Whiting GC, 2002, J MED MICROBIOL, V51, P837, DOI 10.1099/0022-1317-51-10-837; Wygrecka M, 2009, BLOOD, V113, P5588, DOI 10.1182/blood-2008-08-170837; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	62	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28481	10.1371/journal.pone.0028481	http://dx.doi.org/10.1371/journal.pone.0028481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174817	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000298365700039
J	Ravenscroft, G; Jackaman, C; Sewry, CA; McNamara, E; Squire, SE; Potter, AC; Papadimitriou, J; Griffiths, LM; Bakker, AJ; Davies, KE; Laing, NG; Nowak, KJ				Ravenscroft, Gianina; Jackaman, Connie; Sewry, Caroline A.; McNamara, Elyshia; Squire, Sarah E.; Potter, Allyson C.; Papadimitriou, John; Griffiths, Lisa M.; Bakker, Anthony J.; Davies, Kay E.; Laing, Nigel G.; Nowak, Kristen J.			Actin Nemaline Myopathy Mouse Reproduces Disease, Suggests Other Actin Disease Phenotypes and Provides Cautionary Note on Muscle Transgene Expression	PLOS ONE			English	Article							DOMINANT CONGENITAL MYOPATHY; CORE-LIKE LESIONS; SKELETAL-MUSCLE; ALPHA-ACTIN; MDX MICE; MUSCULAR-DYSTROPHY; RYANODINE RECEPTOR; MAMMALIAN MUSCLE; GENE ACTA1; MUTATIONS	Mutations in the skeletal muscle alpha-actin gene (ACTA1) cause congenital myopathies including nemaline myopathy, actin aggregate myopathy and rod-core disease. The majority of patients with ACTA1 mutations have severe hypotonia and do not survive beyond the age of one. A transgenic mouse model was generated expressing an autosomal dominant mutant (D286G) of ACTA1 (identified in a severe nemaline myopathy patient) fused with EGFP. Nemaline bodies were observed in multiple skeletal muscles, with serial sections showing these correlated to aggregates of the mutant skeletal muscle alpha-actin-EGFP. Isolated extensor digitorum longus and soleus muscles were significantly weaker than wild-type (WT) muscle at 4 weeks of age, coinciding with the peak in structural lesions. These 4 week-old mice were, similar to 30% less active on voluntary running wheels than WT mice. The alpha-actin-EGFP protein clearly demonstrated that the transgene was expressed equally in all myosin heavy chain (MHC) fibre types during the early postnatal period, but subsequently became largely confined to MHCIIB fibres. Ringbinden fibres, internal nuclei and myofibrillar myopathy pathologies, not typical features in nemaline myopathy or patients with ACTA1 mutations, were frequently observed. Ringbinden were found in fast fibre predominant muscles of adult mice and were exclusively MHCIIB-positive fibres. Thus, this mouse model presents a reliable model for the investigation of the pathobiology of nemaline body formation and muscle weakness and for evaluation of potential therapeutic interventions. The occurrence of core-like regions, internal nuclei and ringbinden will allow analysis of the mechanisms underlying these lesions. The occurrence of ringbinden and features of myofibrillar myopathy in this mouse model of ACTA1 disease suggests that patients with these pathologies and no genetic explanation should be screened for ACTA1 mutations.	[Ravenscroft, Gianina; Jackaman, Connie; McNamara, Elyshia; Laing, Nigel G.; Nowak, Kristen J.] Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Bakker, Anthony J.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Sewry, Caroline A.] Robert Jones & Agnes Hunt Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry SY10 7AG, Shrops, England; [Squire, Sarah E.; Potter, Allyson C.; Davies, Kay E.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genet Unit, Oxford, England; [Papadimitriou, John] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Griffiths, Lisa M.] Royal Perth Hosp, Perth, WA, Australia; [Griffiths, Lisa M.] PathW Anat Pathol, Perth, WA, Australia	University of Western Australia; University of Western Australia; Keele University; University of Oxford; University of Western Australia; Royal Perth Hospital; University of Western Australia	Ravenscroft, G (corresponding author), Univ Western Australia, Med Res Ctr, Western Australian Inst Med Res, Nedlands, WA 6009, Australia.	Kristen.Nowak@uwa.edu.au	Ravenscroft, Gina/H-5695-2014; Bakker, Anthony/B-8163-2014	Ravenscroft, Gina/0000-0003-3634-211X; Bakker, Anthony/0000-0002-6889-8932; Jackaman, Connie/0000-0002-4583-7029; Laing, Nigel/0000-0001-5111-3732	National Health and Medical Research Council of Australia [212086, 403941, 403904]; Association Francaise contre les Myopathies; United States Muscular Dystrophy Association; Foundation Building Strength for Nemaline Myopathy; UK Medical Research Council; Ada Bartholomew Medical Research Trust; West Australian Government; Western Australian Institute for Medical Research; Australian Postgraduate Award; University, State and Commonwealth Governments; MRC [MC_U137761449] Funding Source: UKRI; Medical Research Council [MC_U137761449] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); United States Muscular Dystrophy Association; Foundation Building Strength for Nemaline Myopathy; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ada Bartholomew Medical Research Trust; West Australian Government; Western Australian Institute for Medical Research; Australian Postgraduate Award(Australian Government); University, State and Commonwealth Governments; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Health and Medical Research Council of Australia [CJ Martin Fellowship #212086 to KJN, Project Grant #403941, Fellowship #403904 to NGL]; the Association Francaise contre les Myopathies; the United States Muscular Dystrophy Association; A Foundation Building Strength for Nemaline Myopathy; the UK Medical Research Council; the Ada Bartholomew Medical Research Trust; the West Australian Government's Medical and Health Research Infrastructure Fund; the Western Australian Institute for Medical Research, and an Australian Postgraduate Award [GR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof Edna Hardeman for providing the plasmid containing the HSA promoter and TnI enhancer. We gratefully acknowledge the professional staff at the Animal Resources Centre. The authors acknowledge the facilities, scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy, Characterisation & Analysis, The University of Western Australia, a facility funded by The University, State and Commonwealth Governments.	ABE H, 1993, EXP CELL RES, V206, P1, DOI 10.1006/excr.1993.1113; Agrawal PB, 2007, AM J HUM GENET, V80, P162, DOI 10.1086/510402; Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Banks GB, 2008, HUM MOL GENET, V17, P3975, DOI 10.1093/hmg/ddn301; BETHLEM J, 1978, ARCH NEUROL-CHICAGO, V35, P555, DOI 10.1001/archneur.1978.00500330003002; BETHLEM J, 1963, J NEUROL NEUROSUR PS, V26, P326, DOI 10.1136/jnnp.26.4.326; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Corbett MA, 2001, HUM MOL GENET, V10, P317, DOI 10.1093/hmg/10.4.317; CORIN SJ, 1994, J BIOL CHEM, V269, P10651; Domazetovska A, 2007, BRAIN, V130, P3275, DOI 10.1093/brain/awm247; Donner K, 2002, NEUROMUSCULAR DISORD, V12, P151, DOI 10.1016/S0960-8966(01)00252-8; Dubowitz V, 2007, MUSCLE BIOPSY PRACTI, P626; Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1; Engel A.G., 2004, MYOLOGY; Feinberg DM, 1998, NEUROLOGY, V50, P529, DOI 10.1212/WNL.50.2.529; Feng JJ, 2009, J MUSCLE RES CELL M, V30, P85, DOI 10.1007/s10974-009-9178-9; Gommans IMP, 2003, BRAIN, V126, P1545, DOI 10.1093/brain/awg162; Ilkovski B, 2004, HUM MOL GENET, V13, P1727, DOI 10.1093/hmg/ddh185; Ilkovski B, 2001, AM J HUM GENET, V68, P1333, DOI 10.1086/320605; Jackaman C, 2007, CELL MOTIL CYTOSKEL, V64, P914, DOI 10.1002/cm.20239; Jeannet PY, 2007, NEUROMUSCULAR DISORD, V17, P6, DOI 10.1016/j.nmd.2006.10.005; JOCKUSCH BM, 1980, EXP CELL RES, V127, P409, DOI 10.1016/0014-4827(80)90445-0; Jockusch H, 2003, J HISTOCHEM CYTOCHEM, V51, P401, DOI 10.1177/002215540305100315; Johnston JJ, 2000, AM J HUM GENET, V67, P814, DOI 10.1086/303089; Joya JE, 2004, HUM MOL GENET, V13, P2633, DOI 10.1093/hmg/ddh285; Jungbluth H, 2001, NEUROMUSCULAR DISORD, V11, P35, DOI 10.1016/S0960-8966(00)00167-X; Kaindl AM, 2004, J MED GENET, V41, P842, DOI 10.1136/jmg.2004.020271; KARPATI G, 1972, ARCH NEUROL-CHICAGO, V27, P237, DOI 10.1001/archneur.1972.00490150045008; Laing NG, 2004, ANN NEUROL, V56, P689, DOI 10.1002/ana.20260; LAING NG, 1995, NAT GENET, V9, P75, DOI 10.1038/ng0195-75; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Li ZB, 2004, OTOLARYNG HEAD NECK, V130, P217, DOI 10.1016/j.otohns.2003.09.009; MENDEZ J, 1960, METABOLISM, V9, P184; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Mologni L, 2005, BIOCHEM BIOPH RES CO, V329, P1001, DOI 10.1016/j.bbrc.2005.02.074; Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; MORRIS WR, 1959, ARCH PATHOL, V68, P438; Nair-Shalliker V, 2004, MUSCLE NERVE, V30, P470, DOI 10.1002/mus.20138; Neville C, 1996, DEV GENET, V19, P157, DOI 10.1002/(SICI)1520-6408(1996)19:2<157::AID-DVG7>3.0.CO;2-8; NORTH K, 2008, ADV EXPT MED BIOL LA, P15; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nowak KJ, 2009, J CELL BIOL, V185, P903, DOI 10.1083/jcb.200812132; ONO S, 1993, J MUSCLE RES CELL M, V14, P195, DOI 10.1007/BF00115454; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; Pena J, 2001, PATHOL RES PRACT, V197, P21, DOI 10.1078/0344-0338-00004; Plant DR, 2005, J APPL PHYSIOL, V98, P1998, DOI 10.1152/japplphysiol.01381.2004; Ravenscroft G, 2011, BRAIN, V134, P1101, DOI 10.1093/brain/awr004; Ravenscroft G, 2011, NEUROMUSCULAR DISORD, V21, P31, DOI 10.1016/j.nmd.2010.08.005; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Scacheri PC, 2000, NEUROLOGY, V55, P1689, DOI 10.1212/WNL.55.11.1689; Schroder R, 2003, NEUROMUSCULAR DISORD, V13, P451, DOI 10.1016/S0960-8966(03)00064-6; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; SHY GM, 1963, BRAIN, V86, P793, DOI 10.1093/brain/86.4.793; Tai PWL, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-25; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Vandamme D, 2009, BBA-MOL CELL RES, V1793, P1259, DOI 10.1016/j.bbamcr.2009.04.004; von der Hagen M, 2008, EUR J NEUROL, V15, pE31, DOI 10.1111/j.1468-1331.2008.02094.x; Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1; Wallefeld W, 2006, NEUROMUSCULAR DISORD, V16, P541, DOI 10.1016/j.nmd.2006.07.018; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wallgren-Pettersson C, 1999, NEUROMUSCULAR DISORD, V9, P564, DOI 10.1016/S0960-8966(99)00061-9; WALLGRENPETTERSSON C, 1995, NEUROMUSCULAR DISORD, V5, P93, DOI 10.1016/0960-8966(94)00035-8; YAMAGUCHI M, 1982, J NEUROL SCI, V56, P35, DOI 10.1016/0022-510X(82)90059-4	65	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28699	10.1371/journal.pone.0028699	http://dx.doi.org/10.1371/journal.pone.0028699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174871	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700063
J	van Meegen, MA; Terheggen-Lagro, SWJ; van der Ent, CK; Beekman, JM				van Meegen, Marit A.; Terheggen-Lagro, Suzanne W. J.; van der Ent, Cornelis K.; Beekman, Jeffrey M.			CFTR Expression Analysis in Human Nasal Epithelial Cells by Flow Cytometry	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; WILD-TYPE; RESPIRATORY EPITHELIA; DELTA-F508 CFTR; AIRWAY CELLS; IDENTIFICATION; LOCALIZATION; PROTEASOME; PROTEIN	Rationale: Unbiased approaches that study aberrant protein expression in primary airway epithelial cells at single cell level may profoundly improve diagnosis and understanding of airway diseases. We here present a flow cytometric procedure to study CFTR expression in human primary nasal epithelial cells from patients with Cystic Fibrosis (CF). Our novel approach may be important in monitoring of therapeutic responses, and better understanding of CF disease at the molecular level. Objectives: Validation of a panel of CFTR-directed monoclonal antibodies for flow cytometry and CFTR expression analysis in nasal epithelial cells from healthy controls and CF patients. Methods: We analyzed CFTR expression in primary nasal epithelial cells at single cell level using flow cytometry. Nasal cells were stained for pan-Cytokeratin, E cadherin, and CD45 (to discriminate epithelial cells and leukocytes) in combination with intracellular staining of CFTR. Healthy individuals and CF patients were compared. Measurements and Main Results: We observed various cellular populations present in nasal brushings that expressed CFTR protein at different levels. Our data indicated that CF patients homozygous for F508del express varying levels of CFTR protein in nasal epithelial cells, although at a lower level than healthy controls. Conclusion: CFTR protein is expressed in CF patients harboring F508del mutations but at lower levels than in healthy controls. Multicolor flow cytometry of nasal cells is a relatively simple procedure to analyze the composition of cellular subpopulations and protein expression at single cell level.	[van Meegen, Marit A.; Terheggen-Lagro, Suzanne W. J.; van der Ent, Cornelis K.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands; [van Meegen, Marit A.; Beekman, Jeffrey M.] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Meegen, MA (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands.	J.Beekman@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756; Van der Ent, Cornelis/0000-0002-2501-4121	Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands	Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands	This work was supported by the Wilhelmina Childrens Hospital (WKZ) Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman JM, 2009, BLOOD, V114, P3917, DOI 10.1182/blood-2009-03-208850; Beekman JM, 2004, J BIOL CHEM, V279, P33875, DOI 10.1074/jbc.M401018200; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dormer RL, 2001, PFLUG ARCH EUR J PHY, V443, pS117; DUPUIT F, 1995, J CLIN INVEST, V96, P1601, DOI 10.1172/JCI118199; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Harris Ceinwen M, 2004, J Cyst Fibros, V3 Suppl 2, P43, DOI 10.1016/j.jcf.2004.05.009; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Nicolis E, 1999, GENE THER MOL BIOL, V4, P221; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6	27	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e27658	10.1371/journal.pone.0027658	http://dx.doi.org/10.1371/journal.pone.0027658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163268	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900004
J	Bartova, E; Sustackova, G; Stixova, L; Kozubek, S; Legartova, S; Foltankova, V				Bartova, Eva; Sustackova, Gabriela; Stixova, Lenka; Kozubek, Stanislav; Legartova, Sona; Foltankova, Veronika			Recruitment of Oct4 Protein to UV-Damaged Chromatin in Embryonic Stem Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX PHOSPHORYLATION; DNA-DAMAGE; ES CELLS; HETEROCHROMATIN PROTEIN-1; GENE-EXPRESSION; POU DOMAIN; DIFFERENTIATION; REPAIR; NANOG	Background Oct4 is a specific marker of embryonic stem cell (ESC) pluripotency. However, little is known regarding how Oct4 responds to DNA damage. Here, we investigated whether Oct4 recognizes damaged chromatin in mouse ESCs stably expressing GFP-Oct4. These experiments should contribute to the knowledge of how ESC genomic integrity is maintained, which is crucial for potential application of human ESCs in regenerative medicine. Methodology/Principal Findings: We used time-lapse confocal microscopy, microirradiation by UV laser (355 nm), induction of DNA lesions by specific agents, and GFP technology to study the Oct4 response to DNA damage. We found that Oct4 accumulates in UV-damaged regions immediately after irradiation in an adenosine triphosphate-dependent manner. Intriguingly, this event was not accompanied by pronounced Nanog and c-MYC recruitment to the UV-damaged sites. The accumulation of Oct4 to UV-damaged chromatin occurred simultaneously with H3K9 deacetylation and H2AX phosphorylation (gamma H2AX). Moreover, we observed an ESC-specific nuclear distribution of gamma H2AX after interference to cellular processes, including histone acetylation, transcription, and cell metabolism. Inhibition of histone deacetylases mostly prevented pronounced Oct4 accumulation at UV-irradiated chromatin. Conclusions/Significance: Our studies demonstrate pluripotency-specific events that accompany DNA damage responses. Here, we discuss how ESCs might respond to DNA damage caused by genotoxic injury that might lead to unwanted genomic instability.	[Bartova, Eva; Sustackova, Gabriela; Stixova, Lenka; Kozubek, Stanislav; Legartova, Sona; Foltankova, Veronika] Acad Sci Czech Republ, Inst Biophys, Dept Mol Cytol & Cytometry, CS-61265 Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Bartova, E (corresponding author), Acad Sci Czech Republ, Inst Biophys, Dept Mol Cytol & Cytometry, Kralovopolska 135, CS-61265 Brno, Czech Republic.	bartova@ibp.cz	Stixová, Lenka/H-1909-2014; Bartova, Eva/H-1945-2014; Kozubek, Stanislav/H-1953-2014; Kozubek, Stanislav/N-2490-2013	Bartova, Eva/0000-0003-1299-0470; Kozubek, Stanislav/0000-0003-3016-2687	Ministry of Education Youth and Sports of the Czech Republic [LC535, LC06027, ME 919]; Academy of Sciences of the Czech Republic [AVOZ50040702, AVOZ50040507]; Grant Agency of the Czech Republic [P302/10/1022]; European Union [TD09/05]; Maria Curie project [PIRSES-GA-2010-269156]	Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); European Union(European Commission); Maria Curie project	This work was supported by the Ministry of Education Youth and Sports of the Czech Republic; the research projects LC535, LC06027, and ME 919. The Academy of Sciences of the Czech Republic supported this work by projects AVOZ50040702 and AVOZ50040507 and the Grant Agency of the Czech Republic by grant no. P302/10/1022. The work was also supported by European Union project COST TD09/05 and corresponding national COST-CZ project LC11020. This study was partly supported by Maria Curie project PIRSES-GA-2010-269156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Bartova E, 2000, LEUKEMIA RES, V24, P233, DOI 10.1016/S0145-2126(99)00174-5; Bartova E, 2008, DIFFERENTIATION, V76, P24, DOI 10.1111/j.1432-0436.2007.00192.x; Bartova E, 2011, J MOL BIOL, V405, P679, DOI 10.1016/j.jmb.2010.11.001; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Giglia-Mari G, 2010, DNA DAMAGE RESPONSE, P361; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Jiang JM, 2008, CELL STEM CELL, V3, P127, DOI 10.1016/j.stem.2008.07.011; Jin TR, 1999, INT J CANCER, V81, P104, DOI 10.1002/(SICI)1097-0215(19990331)81:1<104::AID-IJC18>3.0.CO;2-Q; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kong X, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp221; Krejci J, 2009, J CELL PHYSIOL, V219, P677, DOI 10.1002/jcp.21714; Kruhlak MJ, 2006, CELL CYCLE, V5, P1910, DOI 10.4161/cc.5.17.3169; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luijsterburg MS, 2009, J CELL BIOL, V185, P577, DOI 10.1083/jcb.200810035; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; RAMANATHAN B, 1989, J BIOL CHEM, V264, P11026; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Reim G, 2004, DEV CELL, V6, P91, DOI 10.1016/S1534-5807(03)00396-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Stixova L, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-5; Sustackova G, 2011, J CELL PHYSL; Sustackova G., 2011, STEM CELLS DEV; Suzuki K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq226; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613	50	36	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27281	10.1371/journal.pone.0027281	http://dx.doi.org/10.1371/journal.pone.0027281			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164208	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400008
J	Correia, C; Grayson, WL; Park, M; Hutton, D; Zhou, B; Guo, XE; Niklason, L; Sousa, RA; Reis, RL; Vunjak-Novakovic, G				Correia, Cristina; Grayson, Warren L.; Park, Miri; Hutton, Daphne; Zhou, Bin; Guo, X. Edward; Niklason, Laura; Sousa, Rui A.; Reis, Rui L.; Vunjak-Novakovic, Gordana			In Vitro Model of Vascularized Bone: Synergizing Vascular Development and Osteogenesis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED BONE; ENDOTHELIAL-CELLS; OSTEOBLAST DIFFERENTIATION; MATURE OSTEOBLASTS; HOST VASCULATURE; BLOOD-VESSELS; ANGIOGENESIS; COMMUNICATION; ANASTOMOSIS	Tissue engineering provides unique opportunities for regenerating diseased or damaged tissues using cells obtained from tissue biopsies. Tissue engineered grafts can also be used as high fidelity models to probe cellular and molecular interactions underlying developmental processes. In this study, we co-cultured human umbilical vein endothelial cells (HUVECs) and human mesenchymal stem cells (MSCs) under various environmental conditions to elicit synergistic interactions leading to the colocalized development of capillary-like and bone-like tissues. Cells were encapsulated at the 1:1 ratio in fibrin gel to screen compositions of endothelial growth medium (EGM) and osteogenic medium (OM). It was determined that, to form both tissues, co-cultures should first be supplied with EGM followed by a 1:1 cocktail of the two media types containing bone morphogenetic protein-2. Subsequent studies of HUVECs and MSCs cultured in decellularized, trabecular bone scaffolds for 6 weeks assessed the effects on tissue construct of both temporal variations in growth-factor availability and addition of fresh cells. The resulting grafts were implanted subcutaneously into nude mice to determine the phenotype stability and functionality of engineered vessels. Two important findings resulted from these studies: (i) vascular development needs to be induced prior to osteogenesis, and (ii) the addition of additional hMSCs at the osteogenic induction stage improves both tissue outcomes, as shown by increased bone volume fraction, osteoid deposition, close proximity of bone proteins to vascular networks, and anastomosis of vascular networks with the host vasculature. Interestingly, these observations compare well with what has been described for native development. We propose that our cultivation system can mimic various aspects of endothelial cell -osteogenic precursor interactions in vivo, and could find utility as a model for studies of heterotypic cellular interactions that couple blood vessel formation with osteogenesis.	[Correia, Cristina; Grayson, Warren L.; Park, Miri; Zhou, Bin; Guo, X. Edward; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Grayson, Warren L.; Hutton, Daphne] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Niklason, Laura] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Correia, Cristina; Sousa, Rui A.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal	Columbia University; Johns Hopkins University; Yale University; Universidade do Minho	Correia, C (corresponding author), Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.	gv2131@columbia.edu	Reis, Rui L./A-8938-2008; vunjak-novakovic, gordana/J-9279-2012	Reis, Rui L./0000-0002-4295-6129; Sousa, Rui/0000-0003-0362-7418; Correia, Cristina/0000-0002-4979-3254; Vunjak-Novakovic, Gordana/0000-0002-9382-1574; UMinho, 3B's Research Group/0000-0002-5195-3456	National Institutes of Health [DE161525, EB02520]; Orthopaedic Research Society (ORS); Fundacao para a Ciencia e a Tecnologia of Portugal; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Orthopaedic Research Society (ORS); Fundacao para a Ciencia e a Tecnologia of Portugal(Portuguese Foundation for Science and Technology); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding support of this work was provided by the National Institutes of Health (DE161525 and EB02520 to GVN), the Orthopaedic Research Society (ORS) Career Development Award (to WLG), and the Fundacao para a Ciencia e a Tecnologia of Portugal (PhD grant to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058; Bidarra SJ, 2011, STEM CELL RES, V7, P186, DOI 10.1016/j.scr.2011.05.006; Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033; Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314; Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521; Clarkin CE, 2008, EXP CELL RES, V314, P3152, DOI 10.1016/j.yexcr.2008.07.027; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Grayson WL, 2010, OSTEOARTHR CARTILAGE, V18, P714, DOI 10.1016/j.joca.2010.01.008; Grayson WL, 2008, TISSUE ENG PT A, V14, P1809, DOI 10.1089/ten.tea.2007.0255; Grayson WL, 2011, BIOTECHNOL BIOENG, V108, P1159, DOI 10.1002/bit.23024; Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106; Grellier M, 2009, BIOMATERIALS, V30, P3271, DOI 10.1016/j.biomaterials.2009.02.033; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707; Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Koob S, 2010, BRIT J SURG, V97, pS55; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu XWS, 2006, J BONE MINER RES, V21, P1608, DOI 10.1359/JBMR.060716; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Meury T, 2006, J CELL BIOCHEM, V98, P992, DOI 10.1002/jcb.20818; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009; Rouwkema J, 2006, TISSUE ENG, V12, P2685, DOI 10.1089/ten.2006.12.2685; Tsigkou O, 2010, P NATL ACAD SCI USA, V107, P3311, DOI 10.1073/pnas.0905445107; Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057; Usami K, 2009, J BIOMED MATER RES A, V90A, P730, DOI 10.1002/jbm.a.32142; VILLANUEVA JE, 1990, J BONE MINER RES, V5, P733; Villars F, 2002, AM J PHYSIOL-CELL PH, V282, pC775, DOI 10.1152/ajpcell.00310.2001; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Zhang FJ, 2009, J BONE MINER RES, V24, P1224, DOI [10.1359/JBMR.090204, 10.1359/jbmr.090204]	41	94	99	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28352	10.1371/journal.pone.0028352	http://dx.doi.org/10.1371/journal.pone.0028352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164277	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400078
J	Wardman, JH; Berezniuk, I; Di, S; Tasker, JG; Fricker, LD				Wardman, Jonathan H.; Berezniuk, Iryna; Di, Shi; Tasker, Jeffrey G.; Fricker, Lloyd D.			ProSAAS-Derived Peptides are Colocalized with Neuropeptide Y and Function as Neuropeptides in the Regulation of Food Intake	PLOS ONE			English	Article							HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE POLYPEPTIDE 7B2; PROHORMONE CONVERTASE PC2; MOUSE-BRAIN; MASS-SPECTROMETRY; GENE-EXPRESSION; ARCUATE NUCLEUS; NEURONS; RAT; NPY	ProSAAS is the precursor of a number of peptides that have been proposed to function as neuropeptides. Because proSAAS mRNA is highly expressed in the arcuate nucleus of the hypothalamus, we examined the cellular localization of several proSAAS-derived peptides in the mouse hypothalamus and found that they generally colocalized with neuropeptide Y (NPY), but not a-melanocyte stimulating hormone. However, unlike proNPY mRNA, which is upregulated by food deprivation in the mediobasal hypothalamus, neither proSAAS mRNA nor proSAAS-derived peptides were significantly altered by 1-2 days of food deprivation in wild-type mice. Furthermore, while proSAAS mRNA levels in the mediobasal hypothalamus were significantly lower in Cpe(fat/fat) mice as compared to wild-type littermates, proNPY mRNA levels in the mediobasal hypothalamus and in other subregions of the hypothalamus were not significantly different between wild-type and Cpe(fat/fat) mice. Intracerebroventricular injections of antibodies to two proSAAS-derived peptides (big LEN and PEN) significantly reduced food intake in fasted mice, while injections of antibodies to two other proSAAS-derived peptides (little LEN and little SAAS) did not. Whole-cell patch clamp recordings of parvocellular neurons in the hypothalamic paraventricular nucleus, a target of arcuate NPY projections, showed that big LEN produced a rapid and reversible inhibition of synaptic glutamate release that was spike independent and abolished by blocking postsynaptic G protein activity, suggesting the involvement of a postsynaptic G protein-coupled receptor and the release of a retrograde synaptic messenger. Taken together with previous studies, these findings support a role for proSAAS-derived peptides such as big LEN as neuropeptides regulating food intake.	[Wardman, Jonathan H.; Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10333 USA; [Berezniuk, Iryna; Fricker, Lloyd D.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY USA; [Di, Shi; Tasker, Jeffrey G.] Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA; [Tasker, Jeffrey G.] Tulane Univ, Neurosci Program, New Orleans, LA 70118 USA	Yeshiva University; Yeshiva University; Tulane University; Tulane University	Wardman, JH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, New York, NY 10333 USA.	lloyd.fricker@einstein.yu.edu	Tasker, Jeffrey/J-4879-2014	Tasker, Jeffrey/0000-0003-1977-4199	National Institutes of Health [DA-04494, MH066958]; FAPESP; INCT Bioanalitica; CNPq; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCT Bioanalitica; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported primarily by National Institutes of Health grants DA-04494 (to LDF) and MH066958 (to JGT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Mass spectrometry was performed in the Dalton Mass Spectrometry Laboratory at the Institute of Chemistry, University of Campinas, Brazil, directed by Prof. Fabio Gozzo and supported by FAPESP, INCT Bioanalitica and CNPq. Thanks to Leandro Castro and Dr. Emer Ferro for assistance with the mass spectrometry. Thanks to Dr. Clemence Blouet and Dr. Gary Schwartz for the gift of the NPY-GFP mice and advice on qRTPCR and immunohistochemistry. Thanks to Dr. Iris Lindberg for the gift of an antiserum to little LEN.	Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Atkins N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012612; Berezniuk I, 2011, RECEPT SER, P93, DOI 10.1007/978-1-60761-993-2_5; Berti DA, 2009, J BIOL CHEM, V284, P14105, DOI 10.1074/jbc.M807916200; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2005, J BIOL CHEM, V280, P4451, DOI 10.1074/jbc.M411178200; Che FY, 2002, ANAL CHEM, V74, P3190, DOI 10.1021/ac015681a; DAVIES L, 1994, AM J PHYSIOL, V266, pR1687, DOI 10.1152/ajpregu.1994.266.5.R1687; DICKERSON IM, 1990, J BIOL CHEM, V265, P2462; EIPPER BA, 1986, TRENDS NEUROSCI, V9, P463, DOI 10.1016/0166-2236(86)90149-9; Feng Y, 2001, NEUROSCIENCE, V105, P469, DOI 10.1016/S0306-4522(01)00200-7; Feng Yun, 2002, Brain Res Gene Expr Patterns, V1, P135; Fricker LD, 2000, J NEUROSCI, V20, P639, DOI 10.1523/JNEUROSCI.20-02-00639.2000; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; FRICKER LD, 1998, HDB PROTEOLYTIC ENZY, P1341; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HSI KL, 1982, FEBS LETT, V147, P261, DOI 10.1016/0014-5793(82)81055-7; Legradi G, 1998, ENDOCRINOLOGY, V139, P3262, DOI 10.1210/en.139.7.3262; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lindberg I., 1991, PEPTIDE BIOSYNTHESIS; Luque RM, 2007, ENDOCRINOLOGY, V148, P300, DOI 10.1210/en.2006-0592; Luther JA, 2000, J PHYSIOL-LONDON, V523, P193, DOI 10.1111/j.1469-7793.2000.t01-1-00193.x; MAINS RE, 1990, FRONT NEUROENDOCRIN, V11, P52; MARTENS GJM, 1994, P NATL ACAD SCI USA, V91, P5784, DOI 10.1073/pnas.91.13.5784; Mercer JG, 1996, PHYSIOL BEHAV, V60, P121, DOI 10.1016/0031-9384(95)02255-4; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Morgan DJ, 2010, J NEUROCHEM; Mzhavia N, 2002, BIOCHEM J, V361, P67, DOI 10.1042/0264-6021:3610067; Mzhavia N, 2001, J BIOL CHEM, V276, P6207, DOI 10.1074/jbc.M009067200; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; PAEZ X, 1991, PEPTIDES, V12, P609, DOI 10.1016/0196-9781(91)90109-3; PAEZ XM, 1991, PHARMACOL BIOCHEM BE, V38, P379, DOI 10.1016/0091-3057(91)90295-D; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Qian YM, 2000, J BIOL CHEM, V275, P23596, DOI 10.1074/jbc.M001583200; Sayah M, 2001, J NEUROCHEM, V76, P1833, DOI 10.1046/j.1471-4159.2001.00165.x; SCHWARTZ MW, 1993, BRAIN RES BULL, V31, P361, DOI 10.1016/0361-9230(93)90228-4; Seidah NG, 1998, HDB PROTEOLYTIC ENZY; STANLEY BG, 1985, P NATL ACAD SCI USA, V82, P3940, DOI 10.1073/pnas.82.11.3940; TASKER JG, 1991, J PHYSIOL-LONDON, V434, P271, DOI 10.1113/jphysiol.1991.sp018469; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; VANHORSSEN AM, 1995, J BIOL CHEM, V270, P14292; Wardman JH, QUANTITATIV IN PRESS; Wardman JH, 2010, J NEUROCHEM, V114, P215, DOI 10.1111/j.1471-4159.2010.06760.x; Wei SW, 2004, J ENDOCRINOL, V180, P357, DOI 10.1677/joe.0.1800357; Yokosuka M, 1999, ENDOCRINOLOGY, V140, P4494, DOI 10.1210/en.140.10.4494; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	49	39	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28152	10.1371/journal.pone.0028152	http://dx.doi.org/10.1371/journal.pone.0028152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164236	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400037
J	Brown, LE; Doole, R; Malfait, N				Brown, Liana E.; Doole, Robert; Malfait, Nicole			The Role of Motor Learning in Spatial Adaptation near a Tool	PLOS ONE			English	Article							PERIPERSONAL SPACE; HAND; ARM; ATTENTION; DYNAMICS; REPRESENTATION; COMPENSATION; FACILITATION; EXTINCTION; PERCEPTION	Some visual-tactile (bimodal) cells have visual receptive fields (vRFs) that overlap and extend moderately beyond the skin of the hand. Neurophysiological evidence suggests, however, that a vRF will grow to encompass a hand-held tool following active tool use but not after passive holding. Why does active tool use, and not passive holding, lead to spatial adaptation near a tool? We asked whether spatial adaptation could be the result of motor or visual experience with the tool, and we distinguished between these alternatives by isolating motor from visual experience with the tool. Participants learned to use a novel, weighted tool. The active training group received both motor and visual experience with the tool, the passive training group received visual experience with the tool, but no motor experience, and finally, a no-training control group received neither visual nor motor experience using the tool. After training, we used a cueing paradigm to measure how quickly participants detected targets, varying whether the tool was placed near or far from the target display. Only the active training group detected targets more quickly when the tool was placed near, rather than far, from the target display. This effect of tool location was not present for either the passive-training or control groups. These results suggest that motor learning influences how visual space around the tool is represented.	[Brown, Liana E.; Doole, Robert] Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada; [Malfait, Nicole] CNRS, INT, Marseille, France	Trent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Brown, LE (corresponding author), Trent Univ, Dept Psychol, Peterborough, ON K9J 7B8, Canada.	lianabrown@trentu.ca			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Bagesteiro LB, 2003, J NEUROPHYSIOL, V90, P1503, DOI 10.1152/jn.00189.2003; Bernstein N, 1967, COORDINATION REGULAT; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown LE, 2008, NEUROPSYCHOLOGIA, V46, P786, DOI 10.1016/j.neuropsychologia.2007.10.006; Brown LE, 2009, NEUROPSYCHOLOGIA, V47, P1621, DOI 10.1016/j.neuropsychologia.2008.11.021; Cardinali L, 2009, BRAIN TOPOGR, V21, P252, DOI 10.1007/s10548-009-0092-7; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Carello C, 2004, CURR DIR PSYCHOL SCI, V13, P25, DOI 10.1111/j.0963-7214.2004.01301007.x; Carello C, 1998, PERCEPT PSYCHOPHYS, V60, P89, DOI 10.3758/BF03211920; Cohen J.E., 1988, STAT POWER ANAL BEHA; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Debicki DB, 2005, EXP BRAIN RES, V163, P252, DOI 10.1007/s00221-005-2229-6; Debicki DB, 2004, J NEUROPHYSIOL, V92, P754, DOI 10.1152/jn.00119.2004; di Pellegrino G, 2000, CURR BIOL, V10, P1475, DOI 10.1016/S0960-9822(00)00809-5; Farne A, 2005, COGN NEUROPSYCHOL, V22, P408, DOI 10.1080/02643290442000112; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Farne A, 2007, CORTEX, V43, P436, DOI 10.1016/S0010-9452(08)70468-4; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flanagan JR, 2003, CURR BIOL, V13, P146, DOI 10.1016/S0960-9822(03)00007-1; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; GIELEN SCAM, 1983, PERCEPT PSYCHOPHYS, V34, P161, DOI 10.3758/BF03211343; GOZLI DG, PERCEPTION IN PRESS; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, EXP BRAIN RES, V135, P259, DOI 10.1007/s002210000518; Gribble PL, 1999, J NEUROPHYSIOL, V82, P2310, DOI 10.1152/jn.1999.82.5.2310; Haruno M, 2001, NEURAL COMPUT, V13, P2201, DOI 10.1162/089976601750541778; Holmes NP, 2007, EXP BRAIN RES, V183, P465, DOI 10.1007/s00221-007-1060-7; Holmes NP, 2007, CORTEX, V43, P469, DOI 10.1016/S0010-9452(08)70471-4; Holmes NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003502; Iriki A, 1996, NEUROREPORT, V7, P2325; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; Kao KLC, 2009, NEUROPSYCHOLOGIA, V47, P2454, DOI 10.1016/j.neuropsychologia.2009.04.016; Ladavas E, 1998, J COGNITIVE NEUROSCI, V10, P581, DOI 10.1162/089892998562988; MACMILLAN NA, 2002, DETECTION THEORY USE; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Maravita A, 2002, NEUROCASE, V8, P411, DOI 10.1093/neucas/8.6.411; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Obayashi S, 2000, NEUROREPORT, V11, P3499, DOI 10.1097/00001756-200011090-00020; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; RAAB DH, 1962, T NEW YORK ACAD SCI, V24, P574, DOI 10.1111/j.2164-0947.1962.tb01433.x; Reed CL, 2010, ATTEN PERCEPT PSYCHO, V72, P236, DOI 10.3758/APP.72.1.236; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; Sainburg RL, 1999, J NEUROPHYSIOL, V81, P1045, DOI 10.1152/jn.1999.81.3.1045; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Schendel K, 2004, J COGNITIVE NEUROSCI, V16, P935, DOI 10.1162/0898929041502698; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; VANSTRIEN JW, 2002, NED TIJDSCHR PSYCHOL, V47, P88; VONHELMHOLTZ H, 1962, HDB PHYSL OPTICS; VONHOLST E, 1950, BEHAV PHYSL ANIMALS, V1; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	61	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28999	10.1371/journal.pone.0028999	http://dx.doi.org/10.1371/journal.pone.0028999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22174944	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300039
J	Feng, R; Wu, YH; Jang, GH; Ordovas, JM; Arnett, D				Feng, Rui; Wu, Yinghua; Jang, Gun Ho; Ordovas, Jose M.; Arnett, Donna			A Powerful Test of Parent-of-Origin Effects for Quantitative Traits Using Haplotypes	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LINKAGE ANALYSIS; VARIANCE-COMPONENTS; BIPOLAR DISORDER; SIB-PAIR; GENE; LOCI; ASSOCIATION; FAMILIES; MODELS	Imprinting is an epigenetic phenomenon where the same alleles have unequal transcriptions and thus contribute differently to a trait depending on their parent of origin. This mechanism has been found to affect a variety of human disorders. Although various methods for testing parent-of-origin effects have been proposed in linkage analysis settings, only a few are available for association analysis and they are usually restricted to small families and particular study designs. In this study, we develop a powerful maximum likelihood test to evaluate the parent-of-origin effects of SNPs on quantitative phenotypes in general family studies. Our method incorporates haplotype distribution to take advantage of inter-marker LD information in genome-wide association studies (GWAS). Our method also accommodates missing genotypes that often occur in genetic studies. Our simulation studies with various minor allele frequencies, LD structures, family sizes, and missing schemes have uniformly shown that using the new method significantly improves the power of detecting imprinted genes compared with the method using the SNP at the testing locus only. Our simulations suggest that the most efficient strategy to investigate parent-of-origin effects is to recruit one parent and as many offspring as possible under practical constraints. As a demonstration, we applied our method to a dataset from the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) to test the parent-of-origin effects of the SNPs within the PPARGC1A, MTP and FABP2 genes on diabetes-related phenotypes, and found that several SNPs in the MTP gene show parent-of-origin effects on insulin and glucose levels.	[Feng, Rui; Wu, Yinghua; Jang, Gun Ho] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] Ctr Nacl Invest Cardiovasc, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Arnett, Donna] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	University of Pennsylvania; Tufts University; United States Department of Agriculture (USDA); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Alabama System; University of Alabama Birmingham	Feng, R (corresponding author), Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA.	ruifeng@upenn.edu	Ordovas, Jose/B-8727-2013	Ordovas, Jose/0000-0002-7581-5680	National Institutes of Health [R01GM088566]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health grant R01GM088566 (www.nigms.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amos CI, 2001, HUM HERED, V51, P133, DOI 10.1159/000053334; BAIN SC, 1994, DIABETES, V43, P1462, DOI 10.2337/diabetes.43.12.1462; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen JB, 2004, HUM HERED, V58, P18, DOI 10.1159/000081453; Clerget-Darpoux F, 2007, HUM HERED, V64, P91, DOI 10.1159/000101960; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Falls JG, 1999, AM J PATHOL, V154, P635, DOI 10.1016/S0002-9440(10)65309-6; Gao GM, 2004, GENETICS, V167, P2055, DOI 10.1534/genetics.103.021055; Genovese G, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-58; Gorlova OY, 2007, HUM GENET, V122, P159, DOI 10.1007/s00439-007-0387-2; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; Knapp M, 2004, GENET EPIDEMIOL, V26, P273, DOI 10.1002/gepi.10320; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lai CQ, 2007, ARTERIOSCL THROM VAS, V27, P1417, DOI 10.1161/ATVBAHA.107.140103; Li MY, 2006, GENETICS, V173, P2317, DOI 10.1534/genetics.105.054650; LIN MCM, 1995, J LIPID RES, V36, P1073; Liu NJ, 2009, COMMUN STAT-THEOR M, V38, P3445, DOI 10.1080/03610920802696588; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McInnis MG, 2003, BIOL PSYCHIAT, V54, P1265, DOI 10.1016/j.biopsych.2003.08.001; Morral N, 2007, J LIPID RES, V48, P1499, DOI 10.1194/jlr.M700090-JLR200; Niu TH, 2004, GENET EPIDEMIOL, V27, P334, DOI 10.1002/gepi.20024; O'Connell JR, 2000, GENET EPIDEMIOL, V19, pS64, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI10>3.0.CO;2-G; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Pratt SC, 2000, AM J HUM GENET, V66, P1153, DOI 10.1086/302830; Pugh EW, 1997, GENET EPIDEMIOL, V14, P867, DOI 10.1002/(SICI)1098-2272(1997)14:6<867::AID-GEPI51>3.0.CO;2-K; Qian DJ, 2002, AM J HUM GENET, V70, P1434, DOI 10.1086/340610; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Shete S, 2003, AM J HUM GENET, V73, P933, DOI 10.1086/378592; Shugart YY, 1999, EUR J HUM GENET, V7, P103, DOI 10.1038/sj.ejhg.5200280; STINE OC, 1995, AM J HUM GENET, V57, P1384; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Vincent Q, 2006, BIOMETRICS, V62, P1071, DOI 10.1111/j.1541-0420.2006.00610.x; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; Whittaker JC, 2003, AM J HUM GENET, V72, P1035, DOI 10.1086/374382; Williams JT, 1997, GENET EPIDEMIOL, V14, P1065, DOI 10.1002/(SICI)1098-2272(1997)14:6<1065::AID-GEPI84>3.0.CO;2-F; Williams JT, 1999, GENET EPIDEMIOL, V16, P113, DOI 10.1002/(SICI)1098-2272(1999)16:2<113::AID-GEPI1>3.0.CO;2-6; Wu MC, 2010, AM J HUM GENET, V86, P929, DOI 10.1016/j.ajhg.2010.05.002	45	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28909	10.1371/journal.pone.0028909	http://dx.doi.org/10.1371/journal.pone.0028909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174922	Green Published, gold, Green Submitted			2022-12-27	WOS:000298367300030
J	Zhang, X; Yaseen, ZS; Galynker, II; Hirsch, J; Winston, A				Zhang, Xian; Yaseen, Zimri S.; Galynker, Igor I.; Hirsch, Joy; Winston, Arnold			Can Depression be Diagnosed by Response to Mother's Face? A Personalized Attachment-Based Paradigm for Diagnostic fMRI	PLOS ONE			English	Article							MAJOR DEPRESSION; NEUROBIOLOGICAL MARKERS; INDIVIDUAL-DIFFERENCES; DISORDER; BRAIN; EMOTION; CORTEX; ACTIVATION; CHILDHOOD; CONFLICT	Objective measurement of depression remains elusive. Depression has been associated with insecure attachment, and both have been associated with changes in brain reactivity in response to viewing standard emotional and neutral faces. In this study, we developed a method to calculate predicted scores for the Beck Depression Inventory II (BDI-II) using personalized stimuli: fMRI imaging of subjects viewing pictures of their own mothers. Methods: 28 female subjects ages 18-30 (14 healthy controls and 14 unipolar depressed diagnosed by MINI psychiatric interview) were scored on the Beck Depression Inventory II (BDI-II) and the Adult Attachment Interview (AAI) coherence of mind scale of global attachment security. Subjects viewed pictures of Mother (M), Friend (F) and Stranger (S), during functional magnetic resonance imaging (fMRI). Using a principal component regression method (PCR), a predicted Beck Depression Inventory II (BDI-II) score was obtained from activity patterns in the paracingulate gyrus (Brodmann area 32) and compared to clinical diagnosis and the measured BDI-II score. The same procedure was performed for AAI coherence of mind scores. Results: Activity patterns in BA-32 identified depressed subjects. The categorical agreement between the derived BDI-II score (using the standard clinical cut-score of 14 on the BDI-II) and depression diagnosis by MINI psychiatric interview was 89%, with sensitivity 85.7% and specificity 92.8%. Predicted and measured BDI-II scores had a correlation of 0.55. Prediction of attachment security was not statistically significant. Conclusions: Brain activity in response to viewing one's mother may be diagnostic of depression. Functional magnetic resonance imaging using personalized paradigms has the potential to provide objective assessments, even when behavioral measures are not informative. Further, fMRI based diagnostic algorithms may enhance our understanding of the neural mechanisms of depression by identifying distinctive neural features of the illness.	[Zhang, Xian; Hirsch, Joy] Columbia Univ, Dept Psychol, Hatch Res Ctr, Dept Radiol,Neurol Inst, New York, NY 10027 USA; [Winston, Arnold] Beth Israel Deaconess Med Ctr, Dept Psychiat & Behav Sci, Albert Einstein Sch Med, New York, NY 10003 USA	Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University	Zhang, X (corresponding author), Columbia Univ, Dept Psychol, Hatch Res Ctr, Dept Radiol,Neurol Inst, New York, NY 10027 USA.	zsyaseen@gmail.com	Galynker, Igor/AAC-9629-2021	Hirsch, Joy/0000-0002-1418-6489; Yaseen, Zimri/0000-0003-4103-2511	Hope for Depression Research Foundation; Family Center for Bipolar Disorder; Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY; Empire Clinical Research Investigator Program (ECRIP)	Hope for Depression Research Foundation; Family Center for Bipolar Disorder; Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY; Empire Clinical Research Investigator Program (ECRIP)	This work was supported by a grant from the Hope for Depression Research Foundation and received additional funding from the Family Center for Bipolar Disorder and the Zirinsky Mood Disorders Center at Beth Israel Medical Center, New York, NY, as well as support from the Empire Clinical Research Investigator Program (ECRIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anda RF, 2006, EUR ARCH PSY CLIN N, V256, P174, DOI 10.1007/s00406-005-0624-4; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Bradley B, 2011, DEV PSYCHOPATHOL, V23, P439, DOI 10.1017/S0954579411000162; Brennan KA, 1998, J PERS, V66, P835, DOI 10.1111/1467-6494.00034; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Chen AC, 2010, NEUROIMAGE, V51, P930, DOI 10.1016/j.neuroimage.2010.02.044; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; Desmet C, 2011, J NEUROSCI, V31, P1366, DOI 10.1523/JNEUROSCI.5371-10.2011; Ende G, 2006, PROG BRAIN RES, V156, P481, DOI 10.1016/S0079-6123(06)56027-3; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Freed PJ, 2007, AM J PSYCHIAT, V164, P28, DOI 10.1176/appi.ajp.164.1.28; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Fuchs T, 2010, J COMP PSYCHOL, V124, P166, DOI 10.1037/a0018704; George C., 1996, ADULT ATTACHME UNPUB; Giessing C, 2007, J COGNITIVE NEUROSCI, V19, P658, DOI 10.1162/jocn.2007.19.4.658; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Herrington JD, 2010, PSYCHOPHYSIOLOGY, V47, P442, DOI 10.1111/j.1469-8986.2009.00958.x; Hsieh WW, 2007, NEURAL NETWORKS, V20, P434, DOI 10.1016/j.neunet.2007.04.018; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Kessler H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015712; Levitan RD, 2009, J CLIN PSYCHIAT, V70, P879, DOI 10.4088/JCP.07m03306; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Mikulincer M, 2002, J PERS SOC PSYCHOL, V83, P881, DOI 10.1037//0022-3514.83.4.881; Mitchell DGV, 2007, NEUROIMAGE, V34, P1299, DOI 10.1016/j.neuroimage.2006.10.012; Monk CS, 2006, AM J PSYCHIAT, V163, P1091, DOI 10.1176/appi.ajp.163.6.1091; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pizzagalli D, 2001, AM J PSYCHIAT, V158, P405, DOI 10.1176/appi.ajp.158.3.405; Pochon JB, 2008, J NEUROSCI, V28, P3468, DOI 10.1523/JNEUROSCI.4195-07.2008; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stensland MD, 2008, J CLIN PSYCHIAT, V69, P749, DOI 10.4088/JCP.v69n0508; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Swaab DF, 2000, PROG BRAIN RES, V126, P369; van Eijndhoven P, 2011, NEUROIMAGE, V54, P1677, DOI 10.1016/j.neuroimage.2010.08.040; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yoshimura S, 2010, J AFFECT DISORDERS, V122, P76, DOI 10.1016/j.jad.2009.06.017; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	42	5	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27253	10.1371/journal.pone.0027253	http://dx.doi.org/10.1371/journal.pone.0027253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180777	Green Published, Green Submitted, gold			2022-12-27	WOS:000298367300004
J	He, P; Zhang, J; Liu, NY; Zhang, YN; Yang, K; Dong, SL				He, Peng; Zhang, Jin; Liu, Nai-Yong; Zhang, Ya-Nan; Yang, Ke; Dong, Shuang-Lin			Distinct Expression Profiles and Different Functions of Odorant Binding Proteins in Nilaparvata lugens Stal	PLOS ONE			English	Article							RICE BROWN PLANTHOPPER; PHEROMONE-SENSITIVE NEURONS; CHEMOSENSORY PROTEINS; ELECTROANTENNOGRAM RESPONSES; DROSOPHILA-MELANOGASTER; RNA INTERFERENCE; BOMBYX-MORI; PLANT; VOLATILES; DELPHACIDAE	Background: Odorant binding proteins (OBPs) play important roles in insect olfaction. The brown planthopper (BPH), Nilaparvata lugens Stal (Delphacidae, Auchenorrhyncha, Hemiptera) is one of the most important rice pests. Its monophagy (only feeding on rice), wing form (long and short wing) variation, and annual long distance migration (seeking for rice plants of high nutrition) imply that the olfaction would play a central role in BPH behavior. However, the olfaction related proteins have not been characterized in this insect. Methodology/Principal Findings: Full length cDNA of three OBPs were obtained and distinct expression profiles were revealed regarding to tissue, developmental stage, wing form and gender for the first time for the species. The results provide important clues in functional differentiation of these genes. Binding assays with 41 compounds demonstrated that NlugOBP3 had markedly higher binding ability and wider binding spectrum than the other two OBPs. Terpenes and Ketones displayed higher binding while Alkanes showed no binding to the three OBPs. Focused on NlugOBP3, RNA interference experiments showed that NlugOBP3 not only involved in nymph olfaction on rice seedlings, but also had non-olfactory functions, as it was closely related to nymph survival. Conclusions: NlugOBP3 plays important roles in both olfaction and survival of BPH. It may serve as a potential target for developing behavioral disruptant and/or lethal agent in N. lugens.	[He, Peng; Zhang, Jin; Liu, Nai-Yong; Zhang, Ya-Nan; Yang, Ke; Dong, Shuang-Lin] Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	He, P (corresponding author), Nanjing Agr Univ, Educ Minist, Key Lab Integrated Management Crop Dis & Pests, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China.	sldong@njau.edu.cn	He, Peng/ABF-9928-2020; He, Peng/H-1098-2013; Liu, Naiyong/C-1862-2012	He, Peng/0000-0003-2934-0044; Zhang, Jin/0000-0002-0077-0748	National 973 Project [2010CB126200]; National Natural Science Foundation of China [31071978]; Priority Academic Program Development of Jiangsu Higher Education Institutions, China	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions, China	This work was in part supported by the National 973 Project (2010CB126200), National Natural Science Foundation (31071978) of China, and the Priority Academic Program Development of Jiangsu Higher Education Institutions, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471; Blomquist Gary J., 2003, P3, DOI 10.1016/B978-012107151-6/50003-7; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; CHENIER JVR, 1989, J CHEM ECOL, V15, P1729, DOI 10.1007/BF01012261; Cu S.H., 2011, ARCH INSECT BIOCH PH; Dani FR, 2010, J PROTEOME RES, V9, P1822, DOI 10.1021/pr900969k; Dickens JC, 1998, J EXP BIOL, V201, P33; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Forstner Maike, 2009, Int J Biol Sci, V5, P745; Fu Q, 2001, APPL ENTOMOL ZOOL, V36, P111, DOI 10.1303/aez.2001.111; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HE XL, 2010, J CHEM ECOLOGY; HERNANDEZ HP, 1989, PHYTOCHEMISTRY, V28, P2959, DOI 10.1016/0031-9422(89)80261-4; KHAN ZR, 1986, J ECON ENTOMOL, V79, P928, DOI 10.1093/jee/79.4.928; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Liu SH, 2010, INSECT BIOCHEM MOLEC, V40, P666, DOI 10.1016/j.ibmb.2010.06.007; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Lou YG, 2003, BIOCONTROL, V48, P73, DOI 10.1023/A:1021291427256; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; OBATA T, 1981, JPN J APPL ENTOMOL Z, V25, P47, DOI 10.1303/jjaez.25.47; OBATA T, 1983, APPL ENTOMOL ZOOL, V18, P161, DOI 10.1303/aez.18.161; PELLETIER J, 2010, J CHEM ECOLOGY; Pelosi P, 1998, ANN NY ACAD SCI, V855, P281, DOI 10.1111/j.1749-6632.1998.tb10584.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao H.-L, 2010, CELLULAR MOL LIFE SC, P1; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; VANSAMBEEK JW, 1980, Z ANGEW ENTOMOL, V89, P479; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Visser JH, 1996, ENTOMOL EXP APPL, V80, P35, DOI 10.1007/BF00194719; VISSER JH, 1995, J APPL ENTOMOL, V119, P539, DOI 10.1111/j.1439-0418.1995.tb01332.x; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; Vogt RG, 2002, J EXP BIOL, V205, P719; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; YAMAMOTO R. T., 1962, NATURE, V196, P908, DOI 10.1038/196908b0; Yan Feng, 2010, Chinese Bulletin of Entomology, V47, P96; Youn YN, 2002, J ECON ENTOMOL, V95, P269, DOI 10.1603/0022-0493-95.2.269; Zhai Bao-Ping, 2005, Kunchong Zhishi, V42, P217; Zhang SA, 2009, CHEM SENSES, V34, P503, DOI 10.1093/chemse/bjp027; ZHANG ZQ, 1983, ACTA ENTOMOL SINICA, V26, P260; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou Yao-zhen, 2009, Nanjing Nongye Daxue Xuebao, V32, P58	55	108	115	5	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28921	10.1371/journal.pone.0028921	http://dx.doi.org/10.1371/journal.pone.0028921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174925	Green Submitted, gold, Green Published			2022-12-27	WOS:000298365700083
J	Roose, JL; Frankel, LK; Bricker, TM				Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.			Developmental Defects in Mutants of the PsbP Domain Protein 5 in Arabidopsis thaliana	PLOS ONE			English	Article							DEHYDROGENASE-LIKE COMPLEX; CYCLIC ELECTRON FLOW; PHOTOSYSTEM-II; CHLOROPHYLL FLUORESCENCE; SUPERCOMPLEX FORMATION; CHLOROPLAST LUMEN; STRIGOLACTONE; PHOTOSYNTHESIS; TRANSFORMATION; STABILIZATION	Plants contain an extensive family of PsbP-related proteins termed PsbP-like (PPL) and PsbP domain (PPD) proteins, which are localized to the thylakoid lumen. The founding member of this family, PsbP, is an established component of the Photosystem II (PS II) enzyme, and the PPL proteins have also been functionally linked to other photosynthetic processes. However, the functions of the remaining seven PPD proteins are unknown. To elucidate the function of the PPD5 protein (At5g11450) in Arabidopsis, we have characterized a mutant T-DNA insertion line (SALK_061118) as well as several RNAi lines designed to suppress the expression of this gene. The functions of the photosynthetic electron transfer reactions are largely unaltered in the ppd5 mutants, except for a modest though significant decrease in NADPH dehydrogenase (NDH) activity. Interestingly, these mutants show striking plant developmental and morphological defects. Relative to the wildtype Col-0 plants, the ppd5 mutants exhibit both increased lateral root branching and defects associated with axillary bud formation. These defects include the formation of additional rosettes originating from axils at the base of the plant as well as aerial rosettes formed at the axils of the first few nodes of the shoot. The root-branching phenotype is chemically complemented by treatment with the synthetic strigolactone, GR24. We propose that the developmental defects observed in the ppd5 mutants are related to a deficiency in strigolactone biosynthesis.	[Roose, Johnna L.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Roose, JL (corresponding author), Louisiana State Univ, Biochem & Mol Biol Sect, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jroose@lsu.edu			Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division [DE-FG02-98ER20310]; USDA National Institute of Food and Agriculture [2008-35318-04605]	Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division(United States Department of Energy (DOE)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was supported by a grant to TMB and LKF from the Department of Energy, Office of Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division, Photosynthetic Systems Program (#DE-FG02-98ER20310) and a postdoctoral fellowship to JLR from the USDA National Institute of Food and Agriculture Grant # 2008-35318-04605. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Antal T, 2008, PHOTOSYNTH RES, V96, P217, DOI 10.1007/s11120-008-9301-6; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Booker J, 2005, DEV CELL, V8, P443, DOI 10.1016/j.devcel.2005.01.009; Booker J, 2004, CURR BIOL, V14, P1232, DOI 10.1016/j.cub.2004.06.061; Bricker TM, 2008, J BIOL CHEM, V283, P29022, DOI 10.1074/jbc.M805122200; Bricker TM, 2005, ADV PHOTO RESPIRAT, V22, P95; BRICKER TM, EXTRINSIC P IN PRESS, V2; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; Dreuw A, 2005, BIOCHEM SOC T, V33, P858, DOI 10.1042/BST0330858; Dun EA, 2009, TRENDS PLANT SCI, V14, P364, DOI 10.1016/j.tplants.2009.04.003; Ferguson BJ, 2009, PLANT PHYSIOL, V149, P1929, DOI 10.1104/pp.109.135475; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Ifuku K, 2005, PLANT PHYSIOL, V139, P1175, DOI 10.1104/pp.105.068643; Ifuku K, 2010, J INTEGR PLANT BIOL, V52, P723, DOI 10.1111/j.1744-7909.2010.00976.x; Ishihara S, 2007, PLANT PHYSIOL, V145, P668, DOI 10.1104/pp.107.105866; Kapulnik Y, 2011, PLANTA, V233, P209, DOI 10.1007/s00425-010-1310-y; Kieselbach T, 2003, PHOTOSYNTH RES, V78, P249, DOI 10.1023/B:PRES.0000006913.86689.f1; Koltai H, 2010, J EXP BOT, V61, P1739, DOI 10.1093/jxb/erq041; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lin H, 2009, PLANT CELL, V21, P1512, DOI 10.1105/tpc.109.065987; Matusova R, 2005, PLANT PHYSIOL, V139, P920, DOI 10.1104/pp.105.061382; Mayzlish-Gati E, 2010, J EXP BOT, V61, P3129, DOI 10.1093/jxb/erq138; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nashilevitz S, 2010, PLANT CELL, V22, P1977, DOI 10.1105/tpc.110.074716; Nedbal L, 1999, J PHOTOCH PHOTOBIO B, V48, P154, DOI 10.1016/S1011-1344(99)00032-9; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Peltier JB, 2004, J BIOL CHEM, V279, P49367, DOI 10.1074/jbc.M406763200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2011, PLANT PHYSIOL, V155, P1629, DOI 10.1104/pp.110.171264; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Rova EM, 1996, J BIOL CHEM, V271, P28918, DOI 10.1074/jbc.271.46.28918; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Sato N, 2010, MOL PHYLOGENET EVOL, V56, P176, DOI 10.1016/j.ympev.2009.11.021; Schubert M, 2002, J BIOL CHEM, V277, P8354, DOI 10.1074/jbc.M108575200; Shikanai T, 1998, P NATL ACAD SCI USA, V95, P9705, DOI 10.1073/pnas.95.16.9705; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Stirbet A, 2011, J PHOTOCH PHOTOBIO B, V104, P236, DOI 10.1016/j.jphotobiol.2010.12.010; Suorsa M, 2009, MOL PLANT, V2, P1127, DOI 10.1093/mp/ssp052; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Vogel JT, 2010, PLANT J, V61, P300, DOI 10.1111/j.1365-313X.2009.04056.x; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; YAMORI W, 2011, PLANT J; Yi XP, 2007, J BIOL CHEM, V282, P24833, DOI 10.1074/jbc.M705011200; Yi XP, 2009, FEBS LETT, V583, P2142, DOI 10.1016/j.febslet.2009.05.048; Yu QJ, 2011, J BIOL CHEM, V286, P8666, DOI 10.1074/jbc.M110.208017	57	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28624	10.1371/journal.pone.0028624	http://dx.doi.org/10.1371/journal.pone.0028624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174848	gold, Green Submitted, Green Published			2022-12-27	WOS:000298365700051
J	Taylor, NG; McAllister, MK; Lawson, GL; Carruthers, T; Block, BA				Taylor, Nathan G.; McAllister, Murdoch K.; Lawson, Gareth L.; Carruthers, Tom; Block, Barbara A.			Atlantic Bluefin Tuna: A Novel Multistock Spatial Model for Assessing Population Biomass	PLOS ONE			English	Article							THUNNUS-THYNNUS; MEDITERRANEAN SEA; DIVING BEHAVIOR; THERMAL BIOLOGY; ARCHIVAL TAGS; AGE; FISHERIES; MOVEMENTS	Atlantic bluefin tuna (Thunnus thynnus) is considered to be overfished, but the status of its populations has been debated, partly because of uncertainties regarding the effects of mixing on fishing grounds. A better understanding of spatial structure and mixing may help fisheries managers to successfully rebuild populations to sustainable levels while maximizing catches. We formulate a new seasonally and spatially explicit fisheries model that is fitted to conventional and electronic tag data, historic catch-at-age reconstructions, and otolith microchemistry stock-composition data to improve the capacity to assess past, current, and future population sizes of Atlantic bluefin tuna. We apply the model to estimate spatial and temporal mixing of the eastern (Mediterranean) and western (Gulf of Mexico) populations, and to reconstruct abundances from 1950 to 2008. We show that western and eastern populations have been reduced to 17% and 33%, respectively, of 1950 spawning stock biomass levels. Overfishing to below the biomass that produces maximum sustainable yield occurred in the 1960s and the late 1990s for western and eastern populations, respectively. The model predicts that mixing depends on season, ontogeny, and location, and is highest in the western Atlantic. Assuming that future catches are zero, western and eastern populations are predicted to recover to levels at maximum sustainable yield by 2025 and 2015, respectively. However, the western population will not recover with catches of 1750 and 12,900 tonnes (the "rebuilding quotas") in the western and eastern Atlantic, respectively, with or without closures in the Gulf of Mexico. If future catches are double the rebuilding quotas, then rebuilding of both populations will be compromised. If fishing were to continue in the eastern Atlantic at the unregulated levels of 2007, both stocks would continue to decline. Since populations mix on North Atlantic foraging grounds, successful rebuilding policies will benefit from trans-Atlantic cooperation.	[Taylor, Nathan G.; McAllister, Murdoch K.; Carruthers, Tom] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada; [Lawson, Gareth L.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA	University of British Columbia; Woods Hole Oceanographic Institution; Stanford University	Taylor, NG (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	nathan.taylor@dfo-mpo.gc.ca		Taylor, Nathan/0000-0002-7110-0995	TAG A Giant Foundation; Monterey Bay Aquarium Foundation; Lenfest Ocean Program, Washington, DC, USA; Canadian Fisheries and Oceans International Governance Strategies Fund; National Oceanic and Atmospheric Administration (NOAA) of the United States; Lenfest Ocean Program	TAG A Giant Foundation; Monterey Bay Aquarium Foundation; Lenfest Ocean Program, Washington, DC, USA; Canadian Fisheries and Oceans International Governance Strategies Fund; National Oceanic and Atmospheric Administration (NOAA) of the United States; Lenfest Ocean Program	This work was supported by grants from the TAG A Giant Foundation, the Monterey Bay Aquarium Foundation, the Lenfest Ocean Program, Washington, DC, USA, the Canadian Fisheries and Oceans International Governance Strategies Fund and the National Oceanic and Atmospheric Administration (NOAA) of the United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Robert Ahrens, Hiroyuki Kurota, Andre Boustany, Shelley Clarke, and Daniel Pauly for reviewing early drafts of the manuscript. We thank Shana Miller for considerable help on all portions of the study. Mr. James Ganong and Mike Castleton helped extract and parse out electronic tag data. Funding for this project was provided by the Tag-A-Giant Foundation, the Lenfest Ocean Program, the Canadian Fisheries and Oceans International Governance Strategies Fund, the Monterey Bay Aquarium Foundation and the U.S. National Oceanic and Atmospheric Administration. Early drafts were greatly improved by the feedback of two anonymous reviewers.	Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Corriero A, 2005, J APPL ICHTHYOL, V21, P483, DOI 10.1111/j.1439-0426.2005.00700.x; Cort J. L., 1991, COL VOL SCI PAP ICCA, V35, P213; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; DIAZ GA, 2006, COL VOL SCI PAP ICCA, V60, P160; Dickhut RM, 2009, ENVIRON SCI TECHNOL, V43, P8522, DOI 10.1021/es901810e; Fromentin JM, 2009, FISH FISH, V10, P197, DOI 10.1111/j.1467-2979.2008.00311.x; FROMENTIN JM, 2002, COLLECTIVE VOLUME SC, V54, P353; GAVARIS S, 1988, 882930 CAN ATL FISH; Gelman A., 2004, BAYESIAN DATA ANAL; GIBBS RH, 1967, US FISH WLD S FISH B, V66, P65; GOODYEAR CP, 1977, C ASS EFF POW PLANT, P184; *ICCAT, 2006, REC ICCAT EST MULT R; ICCAT, 2010, REP 2010 ATL BLUEF T; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2009, EXT 2009 SCRS M CONS; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2008, REP 2008 ATL BLUEF T; Kurota H, 2009, CAN J FISH AQUAT SCI, V66, P321, DOI 10.1139/F08-197; Maigret J., 1986, POISSONS MER MAURITA; Martell SJD, 2008, CAN J FISH AQUAT SCI, V65, P1586, DOI 10.1139/F08-055; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; Neilson JD, 2008, CAN J FISH AQUAT SCI, V65, P1523, DOI 10.1139/F08-127; PORCH CE, 2001, COLLECTIVE VOLUME SC, V52, P1022; Punt A.E., 1995, COLLECTIVE VOLUME SC, V44, P166; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Senina I, 2008, PROG OCEANOGR, V78, P319, DOI 10.1016/j.pocean.2008.06.003; Sibert JR, 2006, CAN J FISH AQUAT SCI, V63, P2154, DOI 10.1139/F06-114; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Teo SLH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010756; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; WALTERS C, 1994, CAN J FISH AQUAT SCI, V51, P713, DOI 10.1139/f94-071; 2001, COL VOL SCI PAP ICCA, V54, P261	34	87	87	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27693	10.1371/journal.pone.0027693	http://dx.doi.org/10.1371/journal.pone.0027693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174745	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700007
J	Bi, M; Ittner, A; Ke, YD; Gotz, J; Ittner, LM				Bi, Mian; Ittner, Arne; Ke, Yazi D.; Goetz, Juergen; Ittner, Lars M.			Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; MOUSE MODEL; PHOSPHORYLATED TAU; PATHOLOGY; IMMUNOTHERAPY; DEFICITS; NEURODEGENERATION; MUTATIONS; TAUOPATHY; TANGLES	In Alzheimer's disease (AD) brains, the microtubule-associated protein tau and amyloid-beta (A beta) deposit as intracellular neurofibrillary tangles (NFTs) and extracellular plaques, respectively. Tau deposits are furthermore found in a significant number of frontotemporal dementia cases. These diseases are characterized by progressive neurodegeneration, the loss of intellectual capabilities and behavioral changes. Unfortunately, the currently available therapies are limited to symptomatic relief. While active immunization against A beta has shown efficacy in both various AD mouse models and patients with AD, immunization against pathogenic tau has only recently been shown to prevent pathology in young tau transgenic mice. However, if translated to humans, diagnosis and treatment would be routinely done when symptoms are overt, meaning that the histopathological changes have already progressed. Therefore, we used active immunization to target pathogenic tau in 4, 8, and 18 months-old P301L tau transgenic pR5 mice that have an onset of NFT pathology at 6 months of age. In all age groups, NFT pathology was significantly reduced in treated compared to control pR5 mice. Similarly, phosphorylation of tau at pathological sites was reduced. In addition, increased astrocytosis was found in the oldest treated group. Taken together, our data suggests that tau-targeted immunization slows the progression of NFT pathology in mice, with practical implications for human patients.	[Bi, Mian; Ittner, Arne; Ke, Yazi D.; Ittner, Lars M.] Univ Sydney, Lab Translat Neurodegenerat, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Ittner, Arne; Goetz, Juergen] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia	University of Sydney; University of Sydney	Bi, M (corresponding author), Univ Sydney, Lab Translat Neurodegenerat, Brain & Mind Res Inst, Camperdown, NSW, Australia.	lars.ittner@sydney.edu.au	Ittner, Arne/ABD-3072-2021; Ke, Yazi/ABC-3052-2020; Götz, Jürgen/C-2448-2014	Ittner, Arne/0000-0001-5244-6897; Ke, Yazi/0000-0002-1423-0451; Götz, Jürgen/0000-0001-8501-7896; Ittner, Lars/0000-0001-6738-3825; Bi, Mian/0000-0002-4383-3606	National Health & Medical Research Council (NHMRC) of Australia; Australian Research Council (ARC)	National Health & Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This work has been funded by the National Health & Medical Research Council (NHMRC) of Australia and the Australian Research Council (ARC). L. M. I. is an NHMRC Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Brunden KR, 2009, NAT REV DRUG DISCOV, V8, P783, DOI 10.1038/nrd2959; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Deters N, 2008, EUR J NEUROSCI, V28, P137, DOI 10.1111/j.1460-9568.2008.06318.x; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ittner LM, 2008, P NATL ACAD SCI USA, V105, P15997, DOI 10.1073/pnas.0808084105; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ittner LM, 2009, J BIOL CHEM, V284, P20909, DOI 10.1074/jbc.M109.014472; Liscic RM, 2008, EUR J NEUROL, V15, P772, DOI 10.1111/j.1468-1331.2008.02195.x; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Morgan D, 2011, J INTERN MED, V269, P54, DOI 10.1111/j.1365-2796.2010.02315.x; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenmann H, 2006, ARCH NEUROL-CHICAGO, V63, P1459, DOI 10.1001/archneur.63.10.1459; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107	28	135	144	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e26860	10.1371/journal.pone.0026860	http://dx.doi.org/10.1371/journal.pone.0026860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174735	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600001
J	Acosta-Martin, AE; Panchaud, A; Chwastyniak, M; Dupont, A; Juthier, F; Gautier, C; Jude, B; Amouyel, P; Goodlett, DR; Pinet, F				Acosta-Martin, Adelina E.; Panchaud, Alexandre; Chwastyniak, Maggy; Dupont, Annabelle; Juthier, Francis; Gautier, Corinne; Jude, Brigitte; Amouyel, Philippe; Goodlett, David R.; Pinet, Florence			Quantitative Mass Spectrometry Analysis Using PAcIFIC for the Identification of Plasma Diagnostic Biomarkers for Abdominal Aortic Aneurysm	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; OXIDATIVE STRESS; RISK-FACTORS; PROTEIN; INHIBITOR; PATHOGENESIS; INFLAMMATION; PROJECT; HEALTH; MODEL	Background: Abdominal aortic aneurysm (AAA) is characterized by increased aortic vessel wall diameter (>1.5 times normal) and loss of parallelism. This disease is responsible for 1-4% mortality occurring on rupture in males older than 65 years. Due to its asymptomatic nature, proteomic techniques were used to search for diagnostic biomarkers that might allow surgical intervention under nonlife threatening conditions. Methodology/Principal Findings: Pooled human plasma samples of 17 AAA and 17 control patients were depleted of the most abundant proteins and compared using a data-independent shotgun proteomic strategy, Precursor Acquisition Independent From Ion Count (PAcIFIC), combined with spectral counting and isobaric tandem mass tags. Both quantitative methods collectively identified 80 proteins as statistically differentially abundant between AAA and control patients. Among differentially abundant proteins, a subgroup of 19 was selected according to Gene Ontology classification and implication in AAA for verification by Western blot (WB) in the same 34 individual plasma samples that comprised the pools. From the 19 proteins, 12 were detected by WB. Five of them were verified to be differentially up-regulated in individual plasma of AAA patients: adiponectin, extracellular superoxide dismutase, protein AMBP, kallistatin and carboxypeptidase B2. Conclusions/Significance: Plasma depletion of high abundance proteins combined with quantitative PAcIFIC analysis offered an efficient and sensitive tool for the screening of new potential biomarkers of AAA. However, WB analysis to verify the 19 PAcIFIC identified proteins of interest proved inconclusive save for five proteins. We discuss these five in terms of their potential relevance as biological markers for use in AAA screening of population at risk.	[Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Amouyel, Philippe; Pinet, Florence] INSERM, U744, F-59045 Lille, France; [Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Dupont, Annabelle; Juthier, Francis; Jude, Brigitte; Amouyel, Philippe; Pinet, Florence] Univ Lille Nord France, USDL, Lille, France; [Acosta-Martin, Adelina E.; Chwastyniak, Maggy; Amouyel, Philippe; Pinet, Florence] Inst Pasteur, F-59019 Lille, France; [Panchaud, Alexandre; Goodlett, David R.] Univ Washington, Seattle, WA 98195 USA; [Juthier, Francis; Gautier, Corinne; Jude, Brigitte; Amouyel, Philippe; Pinet, Florence] Ctr Hosp Reg & Univ Lille, F-59037 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Washington; University of Washington Seattle; Universite de Lille - ISITE; CHU Lille	Acosta-Martin, AE (corresponding author), INSERM, U744, F-59045 Lille, France.	florence.pinet@pasteur-lille.fr	dupont, annabelle/K-5890-2013; Pinet, Florence/F-2892-2013	Pinet, Florence/0000-0002-5471-1487; Amouyel, Philippe/0000-0001-9088-234X; Acosta Martin, Adelina E/0000-0002-4047-5487; Juthier, Francis/0000-0002-5072-9073	European Fighting Aneurysmal Disease [Health-F2-2008-200647]; "Societe Francaise d'Hypertension Arterielle'' fellowship; SERVIER; Swiss National Science Foundation [PBLAA-119623]	European Fighting Aneurysmal Disease; "Societe Francaise d'Hypertension Arterielle'' fellowship; SERVIER(Servier); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a European Fighting Aneurysmal Disease grant (Health-F2-2008-200647). A.E. Acosta-Martin is a recipient of "Societe Francaise d'Hypertension Arterielle'' and SERVIER fellowships. A. Panchaud is a recipient of a Swiss National Science Foundation Grant (PBLAA-119623). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P172, DOI 10.1016/S0167-4838(00)00157-6; Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P995, DOI 10.1074/mcp.M800446-MCP200; Anderson NL, 2009, MOL CELL PROTEOMICS, V8, P883, DOI 10.1074/mcp.R800015-MCP200; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Blackburn K, 2010, J PROTEOME RES, V9, P3621, DOI 10.1021/pr100144z; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chao J, 2001, BIOL CHEM, V382, P15, DOI 10.1515/BC.2001.003; DAVON L, 2008, ANAL CHEM, V80, P2921; Dejouvencel T, 2010, ARTERIOSCL THROM VAS, V30, P269, DOI 10.1161/ATVBAHA.109.198309; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Dupont A, 2010, AM J CARDIOL, V105, P1545, DOI 10.1016/j.amjcard.2010.01.011; Fortin T, 2009, ANAL CHEM, V81, P9343, DOI 10.1021/ac901447h; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n; Giron P, 2011, J PROTEOME RES, V10, P249, DOI 10.1021/pr100535f; Golledge J, 2007, CIRCULATION, V116, P2275, DOI 10.1161/CIRCULATIONAHA.107.717926; Golledge J, 2008, CIRCULATION, V118, P2382, DOI 10.1161/CIRCULATIONAHA.108.802074; Haab BB, 2005, PROTEOMICS, V5, P3278, DOI 10.1002/pmic.200401276; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Kaschina E, 2004, PHYSIOL GENOMICS, V19, P41, DOI 10.1152/physiolgenomics.00035.2004; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lamblin N, 2010, J PROTEOME RES, V9, P3720, DOI 10.1021/pr100250s; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Martinez-Pinna R, 2011, ARTERIOSCL THROM VAS, V31, P935, DOI 10.1161/ATVBAHA.110.214429; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nordon IM, 2010, VASCULAR, V18, P264, DOI 10.2310/6670.2010.00046; Panchaud A, 2011, ANAL CHEM, V83, P2250, DOI 10.1021/ac103079q; Panchaud A, 2009, ANAL CHEM, V81, P6481, DOI 10.1021/ac900888s; Ramos H, 2008, BIOINFORMATICS, V24, P2110, DOI 10.1093/bioinformatics/btn363; Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; Thompson MM, 2000, BRIT MED J, V320, P1193, DOI 10.1136/bmj.320.7243.1193; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Urbonavicius S, 2009, J VASC SURG, V49, P455, DOI 10.1016/j.jvs.2008.08.097; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	43	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28698	10.1371/journal.pone.0028698	http://dx.doi.org/10.1371/journal.pone.0028698			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163325	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900061
J	Hayes, J; Prah, P; Nazareth, I; King, M; Walters, K; Petersen, I; Osborn, D				Hayes, Joseph; Prah, Philip; Nazareth, Irwin; King, Michael; Walters, Kate; Petersen, Irene; Osborn, David			Prescribing Trends in Bipolar Disorder: Cohort Study in the United Kingdom THIN Primary Care Database 1995-2009	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; I DISORDER; LITHIUM; MANIA; VALPROATE; DISCONTINUATION; RECOMMENDATIONS; ANTIPSYCHOTICS; PRESCRIPTION; COMBINATION	Objectives: To determine changes in prescribing patterns in primary care of antipsychotic and mood stabiliser medication in a representative sample of patients with bipolar disorder in the United Kingdom over a fifteen year period and association with socio-demographic factors. Methods: We identified 4700 patients in the Health Improvement Network (THIN) primary care database, who had received treatment for bipolar disorder between 1995 and 2009. The proportion of time for which each individual was prescribed a particular medication was studied, along with variation by sex, age and social depravation status (quintiles of Townsend scores). The number of drugs an individual was taking within a particular year was also examined. Results: In 1995, 40.6% of patients with bipolar disorder were prescribed a psychotropic medication at least twice. By 2009 this had increased to 78.5% of patients. Valproate registered with the greatest increase in use (22.7%) followed by olanzapine (15.7%) and quetiapine (9.9%). There were differences by age and sex; with young (18-30 year old) women having the biggest increase in proportion of time on medication. There were no differences by social deprivation status. By 2009, 34.2% of women of childbearing age were treated with valproate. Conclusions: Lithium use overall remained relatively constant, whilst second generation antipsychotic and valproate use increased dramatically. Changes in prescribing practice preceded published trial evidence, especially with the use of second generation antipsychotics, perhaps with inferences being made from treatment of schizophrenia and use of first generation antipsychotics. Women of childbearing age were prescribed valproate frequently, against best advice.	[Hayes, Joseph; King, Michael; Osborn, David] UCL, Mental Hlth Sci Unit, London, England; [Prah, Philip; Nazareth, Irwin] MRC Gen Practice Res Framework, London, England; [Nazareth, Irwin; Walters, Kate; Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England	University of London; University College London; University of London; University College London	Hayes, J (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	j.hayes@medsch.ucl.ac.uk	Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009; King, Michael B/D-7477-2011; Osborn PhD FRCPsych, David/B-8165-2009	Petersen, Irene/0000-0002-0037-7524; King, Michael B/0000-0003-4715-7171; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Prah, Philip/0000-0002-4742-9686; Walters, Kate/0000-0003-2173-2430; Nazareth, Irwin/0000-0003-2146-9628	Medical Research Council [G0900701] Funding Source: Medline; MRC [G0900701] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alda M, 2010, BIPOLAR DISORD, V12, P678, DOI 10.1111/j.1399-5618.2010.00862.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ascher-Svanum H, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-8; Baldessarini RJ, 2002, CNS DRUGS, V16, P721, DOI 10.2165/00023210-200216110-00001; Berk M, 1999, INT CLIN PSYCHOPHARM, V14, P339, DOI 10.1097/00004850-199911000-00003; Biel MG, 2007, BIPOLAR DISORD, V9, P435, DOI 10.1111/j.1399-5618.2007.00389.x; Blanco C, 2002, AM J PSYCHIAT, V159, P1005, DOI 10.1176/appi.ajp.159.6.1005; Bourke Alison, 2004, Inform Prim Care, V12, P171; Castells X, 2006, J AFFECT DISORDERS, V91, P273, DOI 10.1016/j.jad.2006.01.005; Citrome L, 1998, PSYCHIAT QUART, V69, P283, DOI 10.1023/A:1022130130855; CRUMP BJ, 1995, BRIT MED J, V310, P509, DOI 10.1136/bmj.310.6978.509; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Depp C, 2008, PSYCHIAT SERV, V59, P1169, DOI 10.1176/appi.ps.59.10.1169; DILIBERTI JH, 1984, AM J MED GENET, V19, P473, DOI 10.1002/ajmg.1320190308; Fenn HH, 1996, AM J PSYCHIAT, V153, P711; Frangou S, 2002, BIPOLAR DISORD, V4, P378, DOI 10.1034/j.1399-5618.2002.01223.x; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; GOODWIN GM, 1994, BRIT J PSYCHIAT, V164, P149, DOI 10.1192/bjp.164.2.149; Holmes LB, 2004, ARCH NEUROL-CHICAGO, V61, P673, DOI 10.1001/archneur.61.5.673; Kaye JA, 2003, BRIT J CLIN PHARMACO, V56, P569, DOI 10.1046/j.1365-2125.2003.01905.x; Keck Jr PE, 2004, POSTGRAD MED SPECIAL, P1; Kessing LV, 2011, BRIT J PSYCHIAT, V199, P57, DOI 10.1192/bjp.bp.110.084822; Levine J, 2000, BIPOLAR DISORD, V2, P120, DOI 10.1034/j.1399-5618.2000.020205.x; Lloyd AJ, 2003, J PSYCHOPHARMACOL, V17, P230, DOI 10.1177/0269881103017002013; Maj M, 1998, AM J PSYCHIAT, V155, P30, DOI 10.1176/ajp.155.1.30; MANDER AJ, 1988, LANCET, V2, P15; Maudsley Prescribing Guidelines, 2009, MAUDSL PRESCR GUID; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; NICE, 2011, CG38 BIP DIS REV CON; NICE, 2006, NIC GUID, P38; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Paton C, 2010, J PSYCHOPHARMACOL, V24, P1739, DOI 10.1177/0269881110367728; Rait G, 2009, BRIT J PSYCHIAT, V195, P520, DOI 10.1192/bjp.bp.108.058636; Saunders KE., 2010, ADV PSYCHIAT TREAT, V16, P318, DOI DOI 10.1192/APT.BP.107.004903; Segal J, 1998, CLIN NEUROPHARMACOL, V21, P176; Tohen M, 1999, AM J PSYCHIAT, V156, P702; Townsend P., 1986, INEQUALITIES HLTH NO; Vajda FJ, 2004, CRITICAL RELATIONSHI; Verdoux H, 2010, ACTA PSYCHIAT SCAND, V121, P4, DOI 10.1111/j.1600-0447.2009.01425.x; Weisler R H, 1997, Ann Clin Psychiatry, V9, P259, DOI 10.1023/A:1022312612221; Yatham LN, 2004, J CLIN PSYCHOPHARM, V24, P599, DOI 10.1097/01.jcp.0000144887.66319.2f	44	92	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28725	10.1371/journal.pone.0028725	http://dx.doi.org/10.1371/journal.pone.0028725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163329	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900065
J	Kaufman, HW; Williams, FR; Odeh, MA				Kaufman, Harvey W.; Williams, Fred R.; Odeh, Mouneer A.			Value of Laboratory Tests in Employer-Sponsored Health Risk Assessments for Newly Identifying Health Conditions: Analysis of 52,270 Participants	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; UNITED-STATES; ASSOCIATION; PREVALENCE; MANAGEMENT; TRENDS	Background: Employer-sponsored health risk assessments (HRA) may include laboratory tests to provide evidence of disease and disease risks for common medical conditions. We evaluated the ability of HRA-laboratory testing to provide new disease-risk information to participants. Methodology/Principal Findings: We performed a cross-sectional analysis of HRA-laboratory results for participating adult employees and their eligible spouses or their domestic partners, focusing on three common health conditions: hyperlipidemia, diabetes mellitus, and chronic kidney disease. HRA with laboratory results of 52,270 first-time participants were analyzed. Nearly all participants had access to health insurance coverage. Twenty-four percent (12,392) self-reported one or more of these medical conditions: 21.1% (11,017) self-identified as having hyperlipidemia, 4.7% (2,479) self-identified as having diabetes, and 0.7% (352) self-identified as having chronic kidney disease. Overall, 36% (n = 18,540) of participants had laboratory evidence of at least one medical condition newly identified: 30.7% (16,032) had laboratory evidence of hyperlipidemia identified, 1.9% (984) had laboratory evidence of diabetes identified, and 5.5% (2,866) had laboratory evidence of chronic kidney disease identified. Of all participants with evidence of hyperlipidemia 59% (16,030 of 27,047), were newly identified through the HRA. Among those with evidence of diabetes 28% (984 of 3,463) were newly identified. The highest rate of newly identified disease risk was for chronic kidney disease: 89% (2,866 of 3,218) of participants with evidence of this condition had not self-reported it. Men (39%) were more likely than women (33%) to have at least one newly identified condition (p < 0.0001). Among men, lower levels of educational achievement were associated with modestly higher rates of newly identified disease risk (p < 0.0001); the association with educational achievement among women was unclear. Even among the youngest age range (20 to 29 year olds), nearly 1 in 4 participants (24%) had a newly identified risk for disease. Conclusions/Significance: These results support the important role of employer-sponsored laboratory testing as an integral element of HRA for identifying evidence of previously undiagnosed common medical conditions in individuals of all working age ranges, regardless of educational level and gender.	[Kaufman, Harvey W.; Williams, Fred R.; Odeh, Mouneer A.] Quest Diagnost, Madison, NJ USA		Kaufman, HW (corresponding author), Quest Diagnost, Madison, NJ USA.	Harvey.W.Kaufman@QuestDiagnostics.com						Afridi Mohammad Abdur Rahman, 2003, J Coll Physicians Surg Pak, V13, P558; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Diabetes Association, 2011, NAT DIAB FACT SHEET; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2010, EMPL SURV PURCH VAL; Caliskan D, 2006, PATIENT EDUC COUNS, V62, P142, DOI 10.1016/j.pec.2005.06.018; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Fox News website, 2010, FOX NEWS WEBSITE; Kausz AT, 2001, J AM SOC NEPHROL, V12, P1501, DOI 10.1681/ASN.V1271501; Kleinbeck Connie, 2005, Home Healthc Nurse, V23, P16; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; Lee JM, 2007, DIABETES CARE, V30, P3035, DOI 10.2337/dc07-0769; Loeppke R, 2007, J OCCUP ENVIRON MED, V49, P712, DOI 10.1097/JOM.0b013e318133a4be; Mills Peter R, 2005, Environ Health, V4, P1, DOI 10.1186/1476-069X-4-1; *NAT HEART LUNG BL, 2002, 3 REP NAT CHOL ED PR; National Center for Health Statistics, 2009, NAT CTR HLTH STAT PR; National diabetes statistics, 2011, NAT DIAB INF CLEAR; National Kidney Foundation, 2000, PRACT GUID CHRON KID; Ozminkowski RJ, 1999, AM J HEALTH PROMOT, V14, P31, DOI 10.4278/0890-1171-14.1.31; Ozminkowski RJ, 2006, J OCCUP ENVIRON MED, V48, P1125, DOI 10.1097/01.jom.0000240709.01860.8a; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sacks DB, 2011, DIABETES CARE, V34, P518, DOI 10.2337/dc10-1546; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Schappert SM, 2006, DATA NATL HLTH SU 13, V159, P1; Schoolwerth Anton C, 2006, Prev Chronic Dis, V3, pA57; Selvin E, 2007, ARCH INTERN MED, V167, P1545, DOI 10.1001/archinte.167.14.1545; SMITH KW, 1991, AM J PUBLIC HEALTH, V81, P466, DOI 10.2105/AJPH.81.4.466; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; Sullivan S, 2007, J MANAGE CARE PHARM, V13, pS19; U.S. Census Bureau, 2010, US CENS BUR RES POP; U.S. Census Bureau, 2011, 2011 STAT ABSTR; United States Department of Education, 2003, ED STAT NAT ASS AD L; *US PREV SERV TASK, 2008, SCREEN LIP DIS AD; Yen L, 2003, J OCCUP ENVIRON MED, V45, P1049, DOI 10.1097/01.jom.0000088875.85321.b9	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28201	10.1371/journal.pone.0028201	http://dx.doi.org/10.1371/journal.pone.0028201			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863KK	22163283	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900018
J	Lockwood, S; Krishnamoorthy, B; Ye, P				Lockwood, Svetlana; Krishnamoorthy, Bala; Ye, Ping			Neighborhood Properties Are Important Determinants of Temperature Sensitive Mutations	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; AMINO-ACID SUBSTITUTIONS; PROTEIN-STRUCTURE; BACTERIOPHAGE-T4 LYSOZYME; SATURATION MUTAGENESIS; SOLVENT ACCESSIBILITY; BINDING SITES; PREDICTION; MUTANTS; SEQUENCE	Temperature-sensitive (TS) mutants are powerful tools to study gene function in vivo. These mutants exhibit wild-type activity at permissive temperatures and reduced activity at restrictive temperatures. Although random mutagenesis can be used to generate TS mutants, the procedure is laborious and unfeasible in multicellular organisms. Further, the underlying molecular mechanisms of the TS phenotype are poorly understood. To elucidate TS mechanisms, we used a machine learning method-logistic regression-to investigate a large number of sequence and structure features. We developed and tested 133 features, describing properties of either the mutation site or the mutation site neighborhood. We defined three types of neighborhood using sequence distance, Euclidean distance, and topological distance. We discovered that neighborhood features outperformed mutation site features in predicting TS mutations. The most predictive features suggest that TS mutations tend to occur at buried and rigid residues, and are located at conserved protein domains. The environment of a buried residue often determines the overall structural stability of a protein, thus may lead to reversible activity change upon temperature switch. We developed TS prediction models based on logistic regression and the Lasso regularized procedure. Through a ten-fold cross-validation, we obtained the area under the curve of 0.91 for the model using both sequence and structure features. Testing on independent datasets suggested that the model predicted TS mutations with a 50% precision. In summary, our study elucidated the molecular basis of TS mutants and suggested the importance of neighborhood properties in determining TS mutations. We further developed models to predict TS mutations derived from single amino acid substitutions. In this way, TS mutants can be efficiently obtained through experimentally introducing the predicted mutations.	[Lockwood, Svetlana; Ye, Ping] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Lockwood, Svetlana] Washington State Univ, Sch Elect Engn & Comp Sci, Pullman, WA 99164 USA; [Krishnamoorthy, Bala] Washington State Univ, Dept Math, Pullman, WA 99164 USA	Washington State University; Washington State University; Washington State University	Lockwood, S (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	pye@wsu.edu	Krishnamoorthy, Bala/GVR-7967-2022	Lockwood, Svetlana/0000-0002-9401-239X	Washington State University; NSF [EF 0531870]	Washington State University; NSF(National Science Foundation (NSF))	This work was supported by a Washington State University start-up grant to PY, and the NSF Grant EF 0531870 to SL, BK, and PY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aita T, 2010, COMPUT BIOL CHEM, V34, P53, DOI 10.1016/j.compbiolchem.2009.10.005; ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; Bajaj K, 2008, BIOCHEMISTRY-US, V47, P12964, DOI 10.1021/bi8014345; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Cai ZH, 2004, HUM MUTAT, V24, P178, DOI 10.1002/humu.20063; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; CORMACK BP, 1993, SCIENCE, V262, P244, DOI 10.1126/science.8211143; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Dobson RJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-217; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; Huang ZW, 2008, NAT METHODS, V5, P167, DOI 10.1038/NMETH.1173; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karchin R, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P397; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Krishnamoorthy B, 2003, BIOINFORMATICS, V19, P1540, DOI 10.1093/bioinformatics/btg186; Krishnan VG, 2003, BIOINFORMATICS, V19, P2199, DOI 10.1093/bioinformatics/btg297; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; MANCHESTER M, 1994, J BIOL CHEM, V269, P7689; Masso M, 2007, BIOINFORMATICS, V23, P3155, DOI 10.1093/bioinformatics/btm509; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Poultney CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023947; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Razak ZRA, 2004, MOL CELL BIOL, V24, P5967, DOI 10.1128/MCB.24.13.5967-5977.2004; RENNELL D, 1991, J MOL BIOL, V222, P67, DOI 10.1016/0022-2836(91)90738-R; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Sawicki SG, 2005, PLOS PATHOG, V1, P310, DOI 10.1371/journal.ppat.0010039; Scholkopf B., 2002, LEARNING KERNELS; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shiraishi K, 2004, J BIOL CHEM, V279, P348, DOI 10.1074/jbc.M310815200; SIMCHEN G, 1978, ANNU REV GENET, V12, P161, DOI 10.1146/annurev.ge.12.120178.001113; Singh RK, 1996, J COMPUT BIOL, V3, P213, DOI 10.1089/cmb.1996.3.213; Stuart AC, 2002, BIOINFORMATICS, V18, P200, DOI 10.1093/bioinformatics/18.1.200; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Varadarajan R, 1996, P NATL ACAD SCI USA, V93, P13908, DOI 10.1073/pnas.93.24.13908; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Ye ZQ, 2007, BIOINFORMATICS, V23, P1444, DOI 10.1093/bioinformatics/btm119; Yip YL, 2004, HUM MUTAT, V23, P464, DOI 10.1002/humu.20021; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	56	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28507	10.1371/journal.pone.0028507	http://dx.doi.org/10.1371/journal.pone.0028507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164302	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400103
J	Brenner, JL; Kabakyenga, J; Kyomuhangi, T; Wotton, KA; Pim, C; Ntaro, M; Bagenda, FN; Gad, NR; Godel, J; Kayizzi, J; McMillan, D; Mulogo, E; Nettel-Aguirre, A; Singhal, N				Brenner, Jennifer L.; Kabakyenga, Jerome; Kyomuhangi, Teddy; Wotton, Kathryn A.; Pim, Carolyn; Ntaro, Moses; Bagenda, Fred Norman; Gad, Ndaruhutse Ruzazaaza; Godel, John; Kayizzi, James; McMillan, Douglas; Mulogo, Edgar; Nettel-Aguirre, Alberto; Singhal, Nalini			Can Volunteer Community Health Workers Decrease Child Morbidity and Mortality in Southwestern Uganda? An Impact Evaluation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SURVIVAL; NEWBORN; INTERVENTION; STRATEGIES	Background: The potential for community health workers to improve child health in sub-Saharan Africa is not well understood. Healthy Child Uganda implemented a volunteer community health worker child health promotion model in rural Uganda. An impact evaluation was conducted to assess volunteer community health workers' effect on child morbidity, mortality and to calculate volunteer retention. Methodology/Principal Findings: Two volunteer community health workers were selected, trained and promoted child health in each of 116 villages (population similar to 61,000) during 2006-2009. Evaluation included a household survey of mothers at baseline and post-intervention in intervention/control areas, retrospective reviews of community health worker birth/child death reports and post-intervention focus group discussions. Retention was calculated from administrative records. Main outcomes were prevalence of recent child illness/underweight status, community health worker reports of child deaths, focus group perception of effect, and community health worker retention. After 18-36 months, 86% of trained volunteers remained active. Post-intervention surveys in intervention households revealed absolute reductions of 10.2% [95% CI (-17.7%, -2.6%)] in diarrhea prevalence and 5.8% [95% CI (-11.5%, -0.003%)] in fever/malaria; comparative decreases in control households were not statistically significant. Underweight prevalence was reduced by 5.1% [95% CI (-10.7%, 0.4%)] in intervention households. Community health worker monthly reports revealed a relative decline of 53% in child deaths (<5 years old), during the first 18 months of intervention. Focus groups credited community health workers with decreasing child deaths, improved care-seeking practices, and new income-generating opportunities. Conclusions/Significance: A low-cost child health promotion model using volunteer community health workers demonstrated decreased child morbidity, dramatic mortality trend declines and high volunteer retention. This sustainable model could be scaled-up to sub-Saharan African communities with limited resources and high child health needs.	[Brenner, Jennifer L.; Nettel-Aguirre, Alberto; Singhal, Nalini] Univ Calgary, Dept Pediat, Fac Med, Calgary, AB T2N 1N4, Canada; [Kabakyenga, Jerome; Kyomuhangi, Teddy; Wotton, Kathryn A.; Ntaro, Moses; Bagenda, Fred Norman; Gad, Ndaruhutse Ruzazaaza; Mulogo, Edgar] Mbarara Univ Sci & Technol, Fac Med, Dept Community Hlth, Mbarara, Uganda; [Pim, Carolyn] Univ Calgary, Dept Community Hlth Sci, Fac Med, Calgary, AB T2N 1N4, Canada; [Godel, John] Univ Alberta, Fac Med, Dept Pediat, Edmonton, AB, Canada; [Kayizzi, James] Iceland Int Dev Agcy, Dept Hlth & Educ, Kampala, Uganda; [McMillan, Douglas] Dalhousie Univ, Fac Med, Dept Pediat, Halifax, NS B3H 3J5, Canada	University of Calgary; Mbarara University of Science & Technology; University of Calgary; University of Alberta; Dalhousie University	Brenner, JL (corresponding author), Univ Calgary, Dept Pediat, Fac Med, Calgary, AB T2N 1N4, Canada.	hcu@ucalgary.ca	Nettel-Aguirre, Alberto/ABB-9412-2021	Nettel-Aguirre, Alberto/0000-0001-6604-0652	Canadian International Development Agency [S61268-569/I]; Healthy Generations Foundation	Canadian International Development Agency; Healthy Generations Foundation	This work was supported by the Canadian International Development Agency through the University Partnerships in Cooperation and Development program (Strengthening Child Health Rural Uganda Project S61268-569/I, http://www.aucc.ca/upcd-pucd/index_e.html). Support for specific field activities was provided by the Healthy Generations Foundation, Buy-A-Net, Mayfield Rotary Club and University of Calgary Annual Giving Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JB, JK, NS, DM, JKY, FNB, EM, MN, NRG, CP, KW, JG and TK received reimbursement for travel costs associated with this study from the Canadian International Development Agency and/or Mayfield Rotary Club. TK served as project manager for Healthy Child Uganda during the study; Healthy Generations Foundation supported her salary. ANA has no competing interests, financial or otherwise, that may be relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhattacharya K, 2001, COMMUNITY HLTH WORKE; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; *GOV UG MOH, 2009, HLTH SECT STRAT PLAN; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Olang'o CO, 2010, HEALTH POLICY, V97, P232, DOI 10.1016/j.healthpol.2010.05.004; Perry H, 2009, EFFECTIVE IS COMMUNI; *PROJ CSTS, 2003, KNOWL PRACT COV SURV; Rahman SM, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-12; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; *STAT UBO, 2008, MBAR DISTR TARG POP; *STAT UBO, 2008, BUSH DISTR POP EST 2; *STAT UBO, 2006, 2002 UG POP HOUS CEN; Team RDC, 2009, R LANG ENV STAT COMP; WALT G, 1989, SOC SCI MED, V29, P599, DOI 10.1016/0277-9536(89)90179-2; *WHO, 2011, WHO INT MAN CHILD IL; *WHO, 2010, WHO ANTHR; World Health Organization, 2006, MAN SICK CHILDR COMM	25	69	70	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27997	10.1371/journal.pone.0027997	http://dx.doi.org/10.1371/journal.pone.0027997			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GS	22194801	Green Published, gold, Green Submitted			2022-12-27	WOS:000298369100017
J	Graham, K; Moran-Jones, K; Sansom, OJ; Brunton, VG; Frame, MC				Graham, Kathryn; Moran-Jones, Kim; Sansom, Owen J.; Brunton, Valerie G.; Frame, Margaret C.			FAK Deletion Promotes p53-Mediated Induction of p21, DNA-Damage Responses and Radio-Resistance in Advanced Squamous Cancer Cells	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; EPITHELIAL-SPECIFIC DISRUPTION; HUMAN BREAST-CANCER; IONIZING-RADIATION; GROWTH-FACTOR; OVARIAN-CARCINOMA; TUMOR-FORMATION; INHIBITOR; EXPRESSION; ADENOCARCINOMA	Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is elevated in a variety of human cancers. While FAK is implicated in many cellular processes that are perturbed in cancer, including proliferation, actin and adhesion dynamics, polarisation and invasion, there is only some limited information regarding the role of FAK in radiation survival. We have evaluated whether FAK is a general radio-sensitising target, as has been suggested by previous reports. We used a clean genetic system in which FAK was deleted from mouse squamous cell carcinoma (SCC) cells (FAK -/-), and reconstituted with exogenous FAK wild type (wt). Surprisingly, the absence of FAK was associated with increased radio-resistance in advanced SCC cells. FAK re-expression inhibited p53-mediated transcriptional up-regulation of p21, and a sub-set of other p53 target genes involved in DNA repair, after treatment with ionizing radiation. Moreover, p21 depletion promoted radio-sensitisation, implying that FAK-mediated inhibition of p21 induction is responsible for the relative radio-sensitivity of FAK-proficient SCC cells. Our work adds to a growing body of evidence that there is a close functional relationship between integrin/FAK signalling and the p53/p21 pathway, but demonstrates that FAK's role in survival after stress is context-dependent, at least in cancer cells. We suggest that there should be caution when considering inhibiting FAK in combination with radiation, as this may not always be clinically advantageous.	[Graham, Kathryn; Moran-Jones, Kim; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Brunton, Valerie G.; Frame, Margaret C.] Univ Edinburgh, Edinburgh Canc Res Ctr, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Beatson Institute; University of Edinburgh	Graham, K (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	m.frame@ed.ac.uk		Frame, Margaret/0000-0001-5882-1942; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK [C157/A9148]; Cancer Research UK [12481] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK Program Grant (C157/A9148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton GH, 2010, DEV CELL, V19, P259, DOI 10.1016/j.devcel.2010.07.015; Beinke C, 2003, INT J RADIAT BIOL, V79, P721, DOI 10.1080/09553000310001610231; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Ceballos E, 2005, ONCOGENE, V24, P4559, DOI 10.1038/sj.onc.1208652; Chen YY, 2009, CANCER SCI, V100, P1708, DOI 10.1111/j.1349-7006.2009.01217.x; Cordes N, 2007, ONCOGENE, V26, P6851, DOI 10.1038/sj.onc.1210498; Cosaceanu D, 2007, ONCOGENE, V26, P2423, DOI 10.1038/sj.onc.1210037; Cuneo KC, 2006, INT J RADIAT ONCOL, V64, P1197, DOI 10.1016/j.ijrobp.2005.11.014; Dittmann K, 2009, RADIOTHER ONCOL, V92, P379, DOI 10.1016/j.radonc.2009.06.003; Dittmann K, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-69; Duxbury MS, 2004, SURGERY, V135, P555, DOI 10.1016/j.surg.2003.10.017; Duxbury MS, 2003, BIOCHEM BIOPH RES CO, V311, P786, DOI 10.1016/j.bbrc.2003.10.060; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Gabarra-Niecko V, 2003, CANCER METAST REV, V22, P359, DOI 10.1023/A:1023725029589; Golubovskaya V, 2004, BBA-GENE STRUCT EXPR, V1678, P111, DOI 10.1016/j.bbaexp.2004.03.002; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P373, DOI 10.1002/mc.20395; Golubovskaya VM, 2009, INT J CANCER, V125, P1735, DOI 10.1002/ijc.24486; Halder J, 2005, CLIN CANCER RES, V11, P8829, DOI 10.1158/1078-0432.CCR-05-1728; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Hauck CR, 2001, CANCER RES, V61, P7079; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hungerford JE, 1996, J CELL BIOL, V135, P1383, DOI 10.1083/jcb.135.5.1383; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kasahara T, 2002, ANTIOXID REDOX SIGN, V4, P491, DOI 10.1089/15230860260196290; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li ZP, 2006, BIOCHEM BIOPH RES CO, V341, P363, DOI 10.1016/j.bbrc.2005.12.193; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Meyn RE, 2009, RADIOTHER ONCOL, V92, P316, DOI 10.1016/j.radonc.2009.06.031; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Roberts WG, 2008, CANCER RES, V68, P1935, DOI 10.1158/0008-5472.CAN-07-5155; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SERRELS A, 2011, INT J CANC IN PRESS; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Sieg DJ, 1999, J CELL SCI, V112, P2677; Sieg DJ, 2000, NAT CELL BIOL, V2, P249, DOI 10.1038/35010517; Siesser PMF, 2006, CLIN CANCER RES, V12, P3233, DOI 10.1158/1078-0432.CCR-06-0456; Slack-Davis JK, 2009, MOL CANCER THER, V8, P2470, DOI 10.1158/1535-7163.MCT-09-0262; Smith CS, 2005, MELANOMA RES, V15, P357, DOI 10.1097/00008390-200510000-00003; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Zhang Y, 2004, J BIOL CHEM, V279, P48342, DOI 10.1074/jbc.M407953200	48	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27806	10.1371/journal.pone.0027806	http://dx.doi.org/10.1371/journal.pone.0027806			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194793	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000298369100013
J	Baiden, F; Owusu-Agyei, S; Bawah, J; Bruce, J; Tivura, M; Delmini, R; Gyaase, S; Amenga-Etego, S; Chandramohan, D; Webster, J				Baiden, Frank; Owusu-Agyei, Seth; Bawah, Justina; Bruce, Jane; Tivura, Mathilda; Delmini, Rupert; Gyaase, Stephaney; Amenga-Etego, Seeba; Chandramohan, Daniel; Webster, Jayne			An Evaluation of the Clinical Assessments of Under-Five Febrile Children Presenting to Primary Health Facilities in Rural Ghana	PLOS ONE			English	Article							CHILDHOOD ILLNESS IMCI; INTEGRATED MANAGEMENT; MALARIA; QUALITY; WORKERS; PNEUMONIA; COUNTRIES; DIARRHEA; SIGNS; COST	Background: The shift to test-based management of malaria represents an important departure from established practice under the Integrated Management of Childhood Illnesses (IMCI). The possibility of false results of tests for malaria and co-morbidity, however, make it important that guidelines in IMCI case assessment are still followed. Methods and Findings: We conducted a cross-sectional observational study to evaluate current practices in IMCI-based assessment of febrile children in 10 health centres and 5 district hospitals, with follow up of a subset of children to determine day 7-10 post-treatment clinical outcome. Clinical consultation, examination and prescribing practices were recorded using a checklist by trained non-medical observers. The facility case management of 1,983 under-five years old febrile children was observed and 593 followed up at home on days 5-10. The mean number of tasks performed from the 11 tasks expected to be done by the IMCI guidelines was 6 (SD 1.6). More than 6 tasks were performed in only 35% of children and this varied substantially between health facilities (range 3-85%). All 11 tasks were performed in only 1% of children. The most commonly performed tasks were temperature measurement (91%) and weighing (88%). Respiratory rate was checked in only 4% of children presenting with cough or difficulty in breathing. The likelihood of performing "better than average number of tasks" (> 6) was higher when the consultation was done by medical assistants than doctors (O.R. = 3.16, 1.02-9.20). The number of tasks performed during assessment did not, however, influence clinical outcome (O.R. = 1.02, 0.83-1.24). Conclusion: Facility-tailored interventions are needed to improve adherence to IMCI guidelines incorporating test-based management of malaria. Studies are needed to re-evaluate the continued validity of tasks defined in IMCI case assessment guidelines.	[Baiden, Frank; Owusu-Agyei, Seth; Bawah, Justina; Tivura, Mathilda; Delmini, Rupert; Gyaase, Stephaney; Amenga-Etego, Seeba] Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana; [Owusu-Agyei, Seth; Bruce, Jane; Chandramohan, Daniel; Webster, Jayne] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine	Baiden, F (corresponding author), Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana.	baidenf@yahoo.co.uk	Baiden, Frank/Q-2018-2019; Baiden, Frank/AAF-7309-2020	Baiden, Frank/0000-0003-0141-6561; Webster, Jayne/0000-0002-0498-8883; Owusu-Agyei, Seth/0000-0002-0807-1781	ACT Consortium through Bill and Melinda Gates Foundation	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This research was funded by the ACT Consortium (www.actconsortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Bishai D, 2008, HEALTH ECON, V17, P5, DOI 10.1002/hec.1231; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; FALADE AG, 1995, B WORLD HEALTH ORGAN, V73, P299; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; JONES SRG, 1992, AM J SOCIOL, V98, P451, DOI 10.1086/230046; Kaiser R, 2006, DISASTERS, V30, P199, DOI 10.1111/j.0361-3666.2006.00315.x; KATZ J, 1993, AM J EPIDEMIOL, V138, P994, DOI 10.1093/oxfordjournals.aje.a116820; Kolstad PR, 1997, B WORLD HEALTH ORGAN, V75, P77; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; [Anonymous], 2006, Bull World Health Organ, V84, P595; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; *MIN HLTH, 2005, INT MAN CHILDH ILLN; Moti M., 2008, Papua New Guinea Medical Journal, V51, P138; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nicoll A, 2000, T ROY SOC TROP MED H, V94, P9, DOI 10.1016/S0035-9203(00)90418-8; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Rowe AK, 2001, AM J PUBLIC HEALTH, V91, P1625, DOI 10.2105/AJPH.91.10.1625; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; TULLOCH J, 1993, MED J AUSTRALIA, V159, P46, DOI 10.5694/j.1326-5377.1993.tb137705.x; Tulloch J, 1999, LANCET, V354, pS16; *UNICEF, 2010, STAT WORLDS CHILDR R; Wasunna B, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-261; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; *WHO, 1997, IMCI IN SERV TRAIN G; WHO, 2010, GUID TREATM MAL, V2nd; *WHO, 1999, WHOCHSCAH981AREV1; WHO, 2005, HDB IMCI INT MAN CHI; WHO, 2003, HLTH FAC SURV TOOL E; *WHO GHAN, 2004, IMCI DOCUMENTATION E	41	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28944	10.1371/journal.pone.0028944	http://dx.doi.org/10.1371/journal.pone.0028944			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866GA	22174932	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000298367300034
J	Bessen, RA; Robinson, CJ; Seelig, DM; Watschke, CP; Lowe, D; Shearin, H; Martinka, S; Babcock, AM				Bessen, Richard A.; Robinson, Cameron J.; Seelig, Davis M.; Watschke, Christopher P.; Lowe, Diana; Shearin, Harold; Martinka, Scott; Babcock, Alex M.			Transmission of Chronic Wasting Disease Identifies a Prion Strain Causing Cachexia and Heart Infection in Hamsters	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; DEER ODOCOILEUS-HEMIONUS; EARLY BEHAVIORAL-CHANGES; CERVUS-ELAPHUS-NELSONI; RANGING MULE DEER; TRANSGENIC MICE; SPONGIFORM ENCEPHALOPATHY; MINK ENCEPHALOPATHY; INTERSPECIES TRANSMISSION; ORAL-TRANSMISSION	Chronic wasting disease (CWD) is an emerging prion disease of free-ranging and captive cervids in North America. In this study we established a rodent model for CWD in Syrian golden hamsters that resemble key features of the disease in cervids including cachexia and infection of cardiac muscle. Following one to three serial passages of CWD from white-tailed deer into transgenic mice expressing the hamster prion protein gene, CWD was subsequently passaged into Syrian golden hamsters. In one passage line there were preclinical changes in locomotor activity and a loss of body mass prior to onset of subtle neurological symptoms around 340 days. The clinical symptoms included a prominent wasting disease, similar to cachexia, with a prolonged duration. Other features of CWD in hamsters that were similar to cervid CWD included the brain distribution of the disease-specific isoform of the prion protein, PrPSc, prion infection of the central and peripheral neuroendocrine system, and PrPSc deposition in cardiac muscle. There was also prominent PrPSc deposition in the nasal mucosa on the edge of the olfactory sensory epithelium with the lumen of the nasal airway that could have implications for CWD shedding into nasal secretions and disease transmission. Since the mechanism of wasting disease in prion diseases is unknown this hamster CWD model could provide a means to investigate the physiological basis of cachexia, which we propose is due to a prion-induced endocrinopathy. This prion disease phenotype has not been described in hamsters and we designate it as the 'wasting' or WST strain of hamster CWD.	[Bessen, Richard A.; Watschke, Christopher P.; Lowe, Diana; Shearin, Harold; Martinka, Scott] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA; [Robinson, Cameron J.; Babcock, Alex M.] Montana State Univ, Dept Psychol, Bozeman, MT 59717 USA; [Seelig, Davis M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Colorado State University	Bessen, RA (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	rbessen@montana.edu			Public Health Service from the National Institutes of Health [R01 AI055043, P20 RR020185]; National Research Initiative of the United States Department of Agriculture [2006-35201-16626]; Murphy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055043] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; National Research Initiative of the United States Department of Agriculture; Murphy Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI055043 and P20 RR020185 from the National Institutes of Health, by the National Research Initiative of the United States Department of Agriculture grant 2006-35201-16626, and The Murphy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; Bailey JD, 2008, J ENDOCRINOL, V197, P251, DOI 10.1677/JOE-07-0516; Balachandran A, 2010, CAN VET J, V51, P169; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bartz JC, 2002, J VIROL, V76, P5759, DOI 10.1128/JVI.76.11.5759-5768.2002; Bartz JC, 1998, VIROLOGY, V251, P297, DOI 10.1006/viro.1998.9427; Belay ED, 2004, EMERG INFECT DIS, V10, P977, DOI 10.3201/eid1006.031082; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1992, J GEN VIROL, V73, P329, DOI 10.1099/0022-1317-73-2-329; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; Bessen RA, 2009, J VIROL, V83, P6435, DOI 10.1128/JVI.00018-09; Bondiolotti G, 2010, NEUROBIOL DIS, V37, P114, DOI 10.1016/j.nbd.2009.09.014; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Capucchio MT, 2001, J VET MED A, V48, P23, DOI 10.1046/j.1439-0442.2001.00312.x; CARP RI, 1990, J INFECT DIS, V161, P462, DOI 10.1093/infdis/161.3.462; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Corona C, 2009, J VIROL, V83, P3657, DOI 10.1128/JVI.01966-08; DeJoia C, 2006, J VIROL, V80, P4546, DOI 10.1128/JVI.80.9.4546-4556.2006; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; Georgsson G, 2008, ARCH VIROL, V153, P637, DOI 10.1007/s00705-008-0035-8; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; GUIROY DC, 1991, ACTA NEUROPATHOL, V81, P475, DOI 10.1007/BF00310125; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; HADLOW WJ, 1974, J INFECT DIS, V129, P559, DOI 10.1093/infdis/129.5.559; Hamir AN, 2006, J VET DIAGN INVEST, V18, P558, DOI 10.1177/104063870601800606; Hamir AN, 2005, J VET DIAGN INVEST, V17, P276, DOI 10.1177/104063870501700313; Hamir AN, 2001, J VET DIAGN INVEST, V13, P91, DOI 10.1177/104063870101300121; Harrington RD, 2008, J GEN VIROL, V89, P1086, DOI 10.1099/vir.0.83422-0; Heisey DM, 2010, J VIROL, V84, P210, DOI 10.1128/JVI.00560-09; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Keane DP, 2008, J VET DIAGN INVEST, V20, P698, DOI 10.1177/104063870802000534; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KIMBERLIN RH, 1975, J INFECT DIS, V131, P97, DOI 10.1093/infdis/131.2.97; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; MANUELIDIS EE, 1978, P NATL ACAD SCI USA, V75, P3432, DOI 10.1073/pnas.75.7.3432; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Masujin K, 2007, J GEN VIROL, V88, P1850, DOI 10.1099/vir.0.82779-0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden AH, 2007, J GEN VIROL, V88, P1068, DOI 10.1099/vir.0.81913-0; Pollera C, 2007, VET RES COMMUN, V31, P249, DOI 10.1007/s11259-007-0089-1; PORTALUPPI F, 1994, HYPERTENSION, V23, P569, DOI 10.1161/01.HYP.23.5.569; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; RACE RE, 1995, NEURON, V15, P1183, DOI 10.1016/0896-6273(95)90105-1; Raymond GJ, 2007, J VIROL, V81, P4305, DOI 10.1128/JVI.02474-06; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Seelig DM, 2010, AM J PATHOL, V176, P2785, DOI 10.2353/ajpath.2010.090710; Shu YJ, 2011, PRION, V5, P103, DOI 10.4161/pri.5.2.15847; Sigurdson CJ, 2008, J COMP PATHOL, V138, P189, DOI 10.1016/j.jcpa.2008.01.004; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 2010, VET PATHOL, V47, P536, DOI 10.1177/0300985810363702; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Spraker TR, 2002, VET PATHOL, V39, P110, DOI 10.1354/vp.39-1-110; SRINIVASAPPA J, 1989, MICROB PATHOGENESIS, V7, P189, DOI 10.1016/0882-4010(89)90054-5; Tabaton M, 2004, ANN NEUROL, V55, P294, DOI 10.1002/ana.20038; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Tomzig A, 2004, J BIOL CHEM, V279, P33847, DOI 10.1074/jbc.M403730200; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; *WI DEP NAT RES, 2009, CHRON WAST DIS TEST; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; YE X, 1995, HISTOL HISTOPATHOL, V10, P995; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043	82	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28026	10.1371/journal.pone.0028026	http://dx.doi.org/10.1371/journal.pone.0028026			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174765	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600007
J	Kariyat, RR; Scanlon, SR; Mescher, MC; De Moraes, CM; Stephenson, AG				Kariyat, Rupesh R.; Scanlon, Sarah R.; Mescher, Mark C.; De Moraes, Consuelo M.; Stephenson, Andrew G.			Inbreeding Depression in Solanum carolinense (Solanaceae) under Field Conditions and Implications for Mating System Evolution	PLOS ONE			English	Article							GAMETOPHYTIC SELF-INCOMPATIBILITY; PLANT VOLATILES; POLLEN PERFORMANCE; SPATIAL-PATTERN; GENETIC LOAD; LEAF DAMAGE; HERBIVORY; REPRODUCTION; RESISTANCE; DEFENSE	The clonal weed Solanum carolinense exhibits plasticity in the strength of its self-incompatibility (SI) system and suffers low levels of inbreeding depression (delta) in the greenhouse. We planted one inbred and one outbred plant from each of eight maternal plants in a ring (replicated twice) and monitored clonal growth, herbivory, and reproduction over two years. Per ramet delta was estimated to be 0.63 in year one and 0.79 in year two, and outbred plants produced 2.5 times more ramets than inbred plants in the spring of year two. Inbred plants also suffered more herbivore damage than outbred plants in both fields, suggesting that inbreeding compromises herbivore resistance. Total per genet delta was 0.85 over the two years, indicating that S. carolinense is unlikely to become completely self-compatible, and suggesting that plasticity in the SI system is part of a stable mixed-mating system permitting self-fertilization when cross pollen limits seed production.	[Kariyat, Rupesh R.; Scanlon, Sarah R.; Stephenson, Andrew G.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Mescher, Mark C.; De Moraes, Consuelo M.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kariyat, RR (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	as4@psu.edu	kariyat, rupesh/AAN-2347-2020		National Science Foundation [DEB1050998]; USDA National Institute of Food and Agriculture [2008-35302-04577, 2009-33120-20093]; Division Of Environmental Biology [1050998] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (http://www.nsf.gov/) grant DEB1050998 and by grants 2008-35302-04577 and 2009-33120-20093 from USDA National Institute of Food and Agriculture (http://www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Sakar G, 2003, J ECOL, V91, P867, DOI 10.1046/j.1365-2745.2003.00819.x; Avila-Sakar G, 2006, INT J PLANT SCI, V167, P1021, DOI 10.1086/505609; Baker H. G., 1965, The genetics of colonizing species., P147; Barrett S.C.H., 1990, BIOL APPROACHES EVOL, P229, DOI DOI 10.1016/B978-0-12-402960-6.50019-6; BASSETT IJ, 1986, CAN J PLANT SCI, V66, P977, DOI 10.4141/cjps86-120; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Bello-Bedoy R, 2010, ANN BOT-LONDON, V105, P747, DOI 10.1093/aob/mcq038; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; BYERS DL, 1992, HEREDITY, V68, P353, DOI 10.1038/hdy.1992.50; Carr DE, 2002, EVOLUTION, V56, P22, DOI 10.1111/j.0014-3820.2002.tb00846.x; Carr DE, 1997, EVOLUTION, V51, P1797, DOI 10.1111/j.1558-5646.1997.tb05103.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Cheptou PO, 2000, J EVOLUTION BIOL, V13, P522, DOI 10.1046/j.1420-9101.2000.00175.x; Cipollini ML, 1997, ECOLOGY, V78, P782; Cipollini ML, 2002, J CHEM ECOL, V28, P2377, DOI 10.1023/A:1021494315786; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Delph LF, 1997, ECOLOGY, V78, P1632, DOI 10.1890/0012-9658(1997)078[1632:HEFAPP]2.0.CO;2; Delphia CM, 2009, ECOL ENTOMOL, V34, P513, DOI 10.1111/j.1365-2311.2009.01097.x; Delphia CM, 2009, INT J PLANT SCI, V170, P12, DOI 10.1086/593039; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; DOLE J, 1993, EVOLUTION, V47, P361, DOI 10.1111/j.1558-5646.1993.tb02099.x; Du DL, 2008, AM J BOT, V95, P84, DOI 10.3732/ajb.95.1.84; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; DUDASH MR, 1990, EVOLUTION, V44, P1129, DOI 10.1111/j.1558-5646.1990.tb05220.x; Ferrari MJ, 2007, INT J PLANT SCI, V168, P603, DOI 10.1086/513487; Good-Avila S. V., 2008, P33, DOI 10.1007/978-3-540-68486-2_2; HARDIN J W, 1972, Southwestern Naturalist, V16, P403, DOI 10.2307/3670071; Hauser TP, 1996, EVOLUTION, V50, P1119, DOI 10.2307/2410652; Hayes CN, 2005, J EVOLUTION BIOL, V18, P147, DOI 10.1111/j.1420-9101.2004.00785.x; Helenurm K, 1996, AM J BOT, V83, P1585, DOI 10.2307/2445835; Hull-Sanders HM, 2005, ECOLOGY, V86, P897, DOI 10.1890/04-0935; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; ILNICKI RD, 1962, B U RHODE ISLAND, V368; Imura O, 2003, APPL ENTOMOL ZOOL, V38, P293, DOI 10.1303/aez.2003.293; Ivey CT, 2005, AM J BOT, V92, P1641, DOI 10.3732/ajb.92.10.1641; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Koelewijn HP, 1998, EVOLUTION, V52, P692, DOI 10.1111/j.1558-5646.1998.tb03694.x; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Levin DA, 1996, AM NAT, V148, P321, DOI 10.1086/285927; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; LLOYD DG, 1979, AM NAT, V113, P67, DOI 10.1086/283365; Lu Y, 2006, HEREDITY, V96, P22, DOI 10.1038/sj.hdy.6800740; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; Mena-Ali JI, 2007, GENETICS, V177, P501, DOI 10.1534/genetics.107.073775; Mena-Ali JI, 2009, SEX PLANT REPROD, V22, P63, DOI 10.1007/s00497-008-0092-x; Mena-Ali JI, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-10; Mutikainen P, 1996, OIKOS, V75, P353, DOI 10.2307/3545874; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Porcher E, 2005, EVOLUTION, V59, P46, DOI 10.1111/j.0014-3820.2005.tb00893.x; Ramsey M, 1998, INT J PLANT SCI, V159, P98, DOI 10.1086/297525; RICHMAN AD, 1995, HEREDITY, V75, P405, DOI 10.1038/hdy.1995.153; SCHMITT J, 1990, EVOLUTION, V44, P269, DOI [10.2307/2409406, 10.1111/j.1558-5646.1990.tb05197.x]; SOLOMON BP, 1985, ECOLOGY, V66, P1321, DOI 10.2307/1939185; SOLOMON BP, 1980, ENVIRON ENTOMOL, V9, P821, DOI 10.1093/ee/9.6.821; SOLOMON BP, 1983, J ECOL, V71, P681, DOI 10.2307/2259585; SOLOMON BP, 1981, ECOLOGY, V62, P1205, DOI 10.2307/1937285; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Steets JA, 2007, EVOLUTION, V61, P2043, DOI 10.1111/j.1558-5646.2007.00184.x; Stephenson AG, 2004, ECOLOGY, V85, P3023, DOI 10.1890/04-0005; Stephenson AG, 2003, PHILOS T R SOC B, V358, P1009, DOI 10.1098/rstb.2003.1290; Strauss SY, 2001, AM NAT, V158, P496, DOI 10.1086/323116; Travers SE, 2004, PLANT SPEC BIOL, V19, P127, DOI 10.1111/j.1442-1984.2004.00109.x; Uyenoyama M.K., 1993, OXFORD SURVEYS EVOLU, V9, P327, DOI [DOI 10.1016/0040-5809(91)90046-I, 10.1016/0040-5809(91)90046-I]; Uyenoyama MK, 2003, THEOR POPUL BIOL, V63, P281, DOI 10.1016/S0040-5809(03)00020-0; Vallejo-Marin M, 2004, EVOLUTION, V58, P1924, DOI 10.1111/j.0014-3820.2004.tb00480.x; Wise MJ, 2007, SOUTHEAST NAT, V6, P505, DOI 10.1656/1528-7092(2007)6[505:THOSCH]2.0.CO;2; Wise MJ, 2007, NEW PHYTOL, V175, P773, DOI 10.1111/j.1469-8137.2007.02143.x; Wise MJ, 2002, ECOL ENTOMOL, V27, P115, DOI 10.1046/j.0307-6946.2001.00383.x; Wise MJ, 1996, OECOLOGIA, V108, P328, DOI 10.1007/BF00334658; WOLFE LM, 1993, EVOLUTION, V47, P374, DOI 10.1111/j.1558-5646.1993.tb02100.x; Yuan JS, 2008, PLANT J, V55, P491, DOI 10.1111/j.1365-313X.2008.03524.x	75	33	33	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28459	10.1371/journal.pone.0028459	http://dx.doi.org/10.1371/journal.pone.0028459			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174810	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600018
J	Paukner, A; Ferrari, PF; Suomi, SJ				Paukner, Annika; Ferrari, Pier F.; Suomi, Stephen J.			Delayed Imitation of Lipsmacking Gestures by Infant Rhesus Macaques (Macaca mulatta)	PLOS ONE			English	Article							NEONATAL IMITATION; TONGUE PROTRUSION; FACIAL GESTURES; MANUAL GESTURES; NEURONS	Human infants are capable of accurately matching facial gestures of an experimenter within a few hours after birth, a phenomenon called neonatal imitation. Recent studies have suggested that rather than being a simple reflexive-like behavior, infants exert active control over imitative responses and 'provoke' previously imitated gestures even after a delay of up to 24 h. Delayed imitation is regarded as the hallmark of a sophisticated capacity to control and flexibly engage in affective communication and has been described as an indicator of innate protoconversational readiness. However, we are not the only primates to exhibit neonatal imitation, and delayed imitation abilities may not be uniquely human. Here we report that 1-week-old infant rhesus macaques (Macaca mulatta) who show immediate imitation of a lipsmacking gesture also show delayed imitation of lipsmacking, facilitated by a tendency to refrain from lipsmacking toward a still face during baseline measurements. Individual differences in delayed imitation suggest that differentially matured cortical mechanisms may be involved, allowing some newborns macaques to actively participate in communicative exchanges from birth. Macaque infants are endowed with basic social competencies of intersubjective communication that indicate cognitive and emotional commonality between humans and macaques, which may have evolved to nurture an affective mother-infant relationship in primates.	[Paukner, Annika; Suomi, Stephen J.] NIH, Comparat Ethol Lab, Anim Ctr, Poolesville, MD USA; [Ferrari, Pier F.] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Ferrari, Pier F.] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy	National Institutes of Health (NIH) - USA; University of Parma; University of Parma	Paukner, A (corresponding author), NIH, Comparat Ethol Lab, Anim Ctr, Poolesville, MD USA.	pauknera@mail.nih.gov	Ferrari, Pier Francesco/G-5547-2017; Paukner, Annika/ABA-3275-2020	Paukner, Annika/0000-0002-3421-1864	Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD064653]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001107, P01HD064653] Funding Source: NIH RePORTER	Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development. PFF was supported by Eunice Kennedy Shriver National Institute of Child Health and Human Development P01 HD064653. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVANEL E, 1984, CHILD DEV, V55, P381, DOI 10.2307/1129950; Anisfeld M, 1996, DEV REV, V16, P149, DOI 10.1006/drev.1996.0006; Anisfeld M., 2005, PERSPECTIVES IMITATI, P107; Bard KA, 2007, ANIM COGN, V10, P233, DOI 10.1007/s10071-006-0062-3; Barr R, 1996, INFANT BEHAV DEV, V19, P159, DOI 10.1016/S0163-6383(96)90015-6; Ferrari PF, 2009, PHILOS T R SOC B, V364, P2311, DOI 10.1098/rstb.2009.0062; Ferrari PF, 2006, PLOS BIOL, V4, P1501, DOI 10.1371/journal.pbio.0040302; Ferrari PF, 2009, CURR BIOL, V19, P1768, DOI 10.1016/j.cub.2009.08.055; Ferrari PF, 2009, CHILD DEV, V80, P1057, DOI 10.1111/j.1467-8624.2009.01316.x; HAYES L, 1981, DEV PSYCHOL, V177, P660; HEIMANN M, 1989, SCAND J PSYCHOL, V30, P90, DOI 10.1111/j.1467-9450.1989.tb01072.x; Heimann M., 2002, IMITATIVE MIND DEV E, P74, DOI DOI 10.1017/CB09780511489969.005; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; JACOBSON SW, 1979, CHILD DEV, V50, P425, DOI 10.2307/1129418; Jones SS, 2006, INFANT BEHAV DEV, V29, P126, DOI 10.1016/j.infbeh.2005.08.004; Jones SS, 2009, PHILOS T R SOC B, V364, P2325, DOI 10.1098/rstb.2009.0045; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Kugiumutzakis G., 1999, IMITATION INFANCY, P22; Maestripieri D, 1997, EVOL COMMUN, V1, P193, DOI [10.1075/eoc.1.2.03mae, DOI 10.1075/E0C.1.2.03MAE]; MCKENZIE B, 1983, INFANT BEHAV DEV, V6, P85, DOI 10.1016/S0163-6383(83)80011-3; MELTZOFF AN, 1994, INFANT BEHAV DEV, V17, P83, DOI 10.1016/0163-6383(94)90024-8; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; Myowa M, 1996, PRIMATES, V37, P207, DOI 10.1007/BF02381408; Nagy E, 2005, PEDIATR RES, V58, P749, DOI 10.1203/01.PDR.0000180570.28111.D9; Nagy E, 2004, INFANT BEHAV DEV, V27, P54, DOI 10.1016/j.infbeh.2003.06.004; Ray E, 2011, DEVELOPMENTAL SCI, V14, P92, DOI 10.1111/j.1467-7687.2010.00961.x; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rogers SJ, 2008, J CHILD PSYCHOL PSYC, V49, P449, DOI 10.1111/j.1469-7610.2007.01866.x; Ross MD, 2008, BIOL LETTERS, V4, P27, DOI 10.1098/rsbl.2007.0535; Shannon C, 1998, AM J PRIMATOL, V46, P311, DOI 10.1002/(SICI)1098-2345(1998)46:4<311::AID-AJP3>3.0.CO;2-L; STERN DN, 1985, INTERPERSONAL WORLD, P352; Trevarthen C, 2001, J CHILD PSYCHOL PSYC, V42, P3, DOI 10.1111/1469-7610.00701; Ullstadius E, 1998, EARLY DEV PARENTING, V7, P1, DOI 10.1002/(SICI)1099-0917(199803)7:1<1::AID-EDP158>3.0.CO;2-J	34	23	24	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28848	10.1371/journal.pone.0028848	http://dx.doi.org/10.1371/journal.pone.0028848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174913	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000298366600044
J	Kumar, A; Swanwick, CC; Johnson, N; Menashe, I; Basu, SN; Bales, ME; Banerjee-Basu, S				Kumar, Ajay; Swanwick, Catherine Croft; Johnson, Nicole; Menashe, Idan; Basu, Saumyendra N.; Bales, Michael E.; Banerjee-Basu, Sharmila			A Brain Region-Specific Predictive Gene Map for Autism Derived by Profiling a Reference Gene Set	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; RECEPTOR SUBUNIT GENES; SPECTRUM DISORDERS; ASSOCIATION ANALYSIS; HEAD CIRCUMFERENCE; LINKAGE; CHILDREN; MODEL; IDENTIFICATION; EXPRESSION	Molecular underpinnings of complex psychiatric disorders such as autism spectrum disorders (ASD) remain largely unresolved. Increasingly, structural variations in discrete chromosomal loci are implicated in ASD, expanding the search space for its disease etiology. We exploited the high genetic heterogeneity of ASD to derive a predictive map of candidate genes by an integrated bioinformatics approach. Using a reference set of 84 Rare and Syndromic candidate ASD genes (AutRef84), we built a composite reference profile based on both functional and expression analyses. First, we created a functional profile of AutRef84 by performing Gene Ontology (GO) enrichment analysis which encompassed three main areas: 1) neurogenesis/projection, 2) cell adhesion, and 3) ion channel activity. Second, we constructed an expression profile of AutRef84 by conducting DAVID analysis which found enrichment in brain regions critical for sensory information processing (olfactory bulb, occipital lobe), executive function (prefrontal cortex), and hormone secretion (pituitary). Disease specificity of this dual AutRef84 profile was demonstrated by comparative analysis with control, diabetes, and non-specific gene sets. We then screened the human genome with the dual AutRef84 profile to derive a set of 460 potential ASD candidate genes. Importantly, the power of our predictive gene map was demonstrated by capturing 18 existing ASD-associated genes which were not part of the AutRef84 input dataset. The remaining 442 genes are entirely novel putative ASD risk genes. Together, we used a composite ASD reference profile to generate a predictive map of novel ASD candidate genes which should be prioritized for future research.	[Kumar, Ajay; Swanwick, Catherine Croft; Johnson, Nicole; Menashe, Idan; Basu, Saumyendra N.; Banerjee-Basu, Sharmila] MindSpec, Mclean, VA USA; [Bales, Michael E.] NMBI Syst, New York, NY USA		Kumar, A (corresponding author), MindSpec, Mclean, VA USA.	sharmila@mindspec.org	Menashe, Idan/W-6214-2019; Menashe, Idan/AAC-8670-2020; Bales, Michael/B-4731-2008	Menashe, Idan/0000-0003-1961-1461; Kumar, Ajay/0000-0003-3904-592X; Bales, Michael/0000-0001-7988-5195	Simons Foundation	Simons Foundation	AutDB is currently funded by the Simons Foundation, which licenses it as SFARI Gene (http://gene.sfari.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashley-Koch AE, 2006, ANN HUM GENET, V70, P281, DOI 10.1111/j.1469-1809.2006.00253.x; Aylward EH, 2002, NEUROLOGY, V59, P175, DOI 10.1212/WNL.59.2.175; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BALES ME, 2009, AM MED INF ASS ANN S; Banerjee-Basu S, 2010, DIS MODEL MECH, V3, P133, DOI 10.1242/dmm.005439; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Bennetto L, 2007, BIOL PSYCHIAT, V62, P1015, DOI 10.1016/j.biopsych.2007.04.019; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; BOUCHER J, 1992, J CHILD PSYCHOL PSYC, V33, P843, DOI 10.1111/j.1469-7610.1992.tb01960.x; Braun Kim Van Naarden, 2007, Morbidity and Mortality Weekly Report, V56, P29; Buxbaum JD, 2002, MOL PSYCHIATR, V7, P311, DOI 10.1038/sj.mp.4001011; Chakrabarti S, 2001, JAMA-J AM MED ASSOC, V285, P3093, DOI 10.1001/jama.285.24.3093; CHAMBERLAIN RS, 1990, BIOL PSYCHIAT, V28, P773, DOI 10.1016/0006-3223(90)90513-2; Cohen D, 2005, J AUTISM DEV DISORD, V35, P103, DOI 10.1007/s10803-004-1038-2; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; CRESPI B, 2010, NATURE, V455, P919; Curran S, 2005, AM J MED GENET B, V137B, P25, DOI 10.1002/ajmg.b.30126; Davidovitch M, 1996, J CHILD NEUROL, V11, P389, DOI 10.1177/088307389601100509; Delahanty RJ, 2011, MOL PSYCHIATR, V16, P86, DOI 10.1038/mp.2009.118; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; El-Fishawy P, 2010, PSYCHIAT CLIN N AM, V33, P83, DOI 10.1016/j.psc.2009.12.002; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Fombonne E, 2005, J CLIN PSYCHIAT, V66, P3; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Garber K, 2007, SCIENCE, V317, P190, DOI 10.1126/science.317.5835.190; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillis J, 2010, NAT PROTOC, V5, P1148, DOI 10.1038/nprot.2010.78; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; Kumar A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-15; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Li H, 2008, AM J MED GENET B, V147B, P194, DOI 10.1002/ajmg.b.30584; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCauley JL, 2004, AM J MED GENET B, V131B, P51, DOI 10.1002/ajmg.b.30038; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Melin M, 2006, NEUROPSYCHOBIOLOGY, V54, P64, DOI 10.1159/000096040; Menold MM, 2001, J NEUROGENET, V15, P245, DOI 10.3109/01677060109167380; Mercadante MT, 2008, MED HYPOTHESES, V70, P352, DOI 10.1016/j.mehy.2007.05.018; MOURIDSEN SE, 2010, BRAIN DEV; Nass R, 1998, DEV MED CHILD NEUROL, V40, P453; Nicholas B, 2007, MOL PSYCHIATR, V12, P581, DOI 10.1038/sj.mp.4001953; Nurmi EL, 2003, J AM ACAD CHILD PSY, V42, P856, DOI 10.1097/01.CHI.0000046868.56865.0F; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Serajee FJ, 2006, GENOMICS, V87, P75, DOI 10.1016/j.ygeno.2005.09.008; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Skaar DA, 2005, MOL PSYCHIATR, V10, P563, DOI 10.1038/sj.mp.4001614; Suzuki Y, 2003, J NEUROPSYCH CLIN N, V15, P105, DOI 10.1176/appi.neuropsych.15.1.105; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Tan GCY, 2010, NEUROIMAGE, V53, P1030, DOI 10.1016/j.neuroimage.2010.02.018; Toro R, 2010, TRENDS GENET, V26, P363, DOI 10.1016/j.tig.2010.05.007; VOLKMAR FR, 1990, J AM ACAD CHILD PSY, V29, P127, DOI 10.1097/00004583-199001000-00020; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; Yang MS, 2007, INT J DEV NEUROSCI, V25, P69, DOI 10.1016/j.ijdevneu.2006.12.002; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	72	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28431	10.1371/journal.pone.0028431	http://dx.doi.org/10.1371/journal.pone.0028431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174805	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700035
J	Molavian, HR; Kohandel, M; Milosevic, M; Sivaloganathan, S				Molavian, Hamid R.; Kohandel, Mohammad; Milosevic, Michael; Sivaloganathan, Sivabal			Deriving Mechanisms Responsible for the Lack of Correlation between Hypoxia and Acidity in Solid Tumors	PLOS ONE			English	Article							PH; METASTASES; GROWTH; ANGIOGENESIS; MANIPULATION; VASCULATURE; THERAPY	Hypoxia and acidity are two main microenvironmental factors intimately associated with solid tumors and play critical roles in tumor growth and metastasis. The experimental results of Helmlinger and colleagues ( Nature Medicine 3, 177, 1997) provide evidence of a lack of correlation between these factors on the micrometer scale in vivo and further show that the distribution of pH and pO(2) are heterogeneous. Here, using computational simulations, grounded in these experimental results, we show that the lack of correlation between pH and pO(2) and the heterogeneity in their shapes are related to the heterogeneous concentration of buffers and oxygen in the blood vessels, further amplified by the network of blood vessels and the cell metabolism. We also demonstrate that, although the judicious administration of anti-angiogenesis agents ( normalization process) in tumors may lead to recovery of the correlation between hypoxia and acidity, it may not normalize the pH throughout the whole tumor. However, an increase in the buffering capacity inside the blood vessels does appear to increase the extracellular pH throughout the whole tumor. Based on these results, we propose that the application of anti-angiogenic agents and at the same time increasing the buffering capacity of the tumor extracellular environment may be the most efficient way of normalizing the tumor microenvironment. As a by-product of our simulation we show that the recently observed lack of correlation between glucose consumption and hypoxia in cells which rely on respiration is related to the inhomogeneous consumption of glucose to oxygen concentration. We also demonstrate that this lack of correlation in cells which rely on glycolysis could be related to the heterogeneous concentration of oxygen inside the blood vessels.	[Molavian, Hamid R.; Kohandel, Mohammad; Sivaloganathan, Sivabal] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Kohandel, Mohammad; Sivaloganathan, Sivabal] Fields Inst Res Math Sci, Ctr Math Med, Toronto, ON, Canada; [Milosevic, Michael] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Milosevic, Michael] Univ Toronto, Radiat Med Program, Princess Margaret Hosp, Toronto, ON, Canada	University of Waterloo; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Molavian, HR (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada.	kohandel@math.uwaterloo.ca		Milosevic, Michael/0000-0002-9620-6876	Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Natural Sciences and Engineering Research Council and the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brizel DM, 1996, CANCER RES, V56, P941; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Fatt I, 1998, BIOPHYS J, V74, P475, DOI 10.1016/S0006-3495(98)77805-1; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 1996, CANCER RES, V56, P4509; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; MOLAVIAN HR, 2009, CANCER RES, V9141, P47; Raghunand N, 1999, BRIT J CANCER, V80, P1005, DOI 10.1038/sj.bjc.6690455; Rasey JS, 1996, INT J RADIAT ONCOL, V36, P417, DOI 10.1016/S0360-3016(96)00325-2; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SILVA AS, 2009, CANCER RES, V69, P4484; TANNOCK IF, 1989, CANCER RES, V49, P4373; Zhong H, 1999, CANCER RES, V59, P5830	18	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28101	10.1371/journal.pone.0028101	http://dx.doi.org/10.1371/journal.pone.0028101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174768	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700017
J	Rivadulla, C; de Labra, C; Grieve, KL; Cudeiro, J				Rivadulla, Casto; de Labra, Carmen; Grieve, Kenneth L.; Cudeiro, Javier			Vasomotion and Neurovascular Coupling in the Visual Thalamus In Vivo	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; RAT SOMATOSENSORY CORTEX; SMOOTH-MUSCLE-CELLS; BLOOD-FLOW; NEURAL ACTIVITY; CEREBRAL VASOMOTION; SYNTHASE INHIBITION; NEURONAL-ACTIVITY; BASILAR ARTERY; OXYGENATION	Spontaneous contraction and relaxation of arteries (and in some instances venules) has been termed vasomotion and has been observed in an extensive variety of tissues and species. However, its functions and underlying mechanisms are still under discussion. We demonstrate that in vivo spectrophotometry, measured simultaneously with extracellular recordings at the same locations in the visual thalamus of the cat, reveals vasomotion, measured as an oscillation (0.14hz) in the recorded oxyhemoglobin (OxyHb) signal, which appears spontaneously in the microcirculation and can last for periods of hours. During some non-oscillatory periods, maintained sensory stimulation evokes vasomotion lasting, similar to 30s, resembling an adaptive vascular phenomenon. This oscillation in the oxyhaemoblobin signal is sensitive to pharmacological manipulation: it is inducible by chloralose anaesthesia and it can be temporarily blocked by systemic administration of adrenaline or acetylcholine (ACh). During these oscillatory periods, neurovascular coupling (i.e. the relationship between local neural activity and the rate of blood supply to that location) appears significantly altered. This raises important questions with regard to the interpretation of results from studies currently dependent upon a linear relationship between neural activity and blood flow, such as neuroimaging.	[Rivadulla, Casto; de Labra, Carmen; Cudeiro, Javier] Univ A Coruna, Dept Med INEF Galicia, Lab Neurosci & Motor Control Neurocom, Coruna, Spain; [Rivadulla, Casto; de Labra, Carmen; Cudeiro, Javier] Inst Biomed Res Coruna INIBIC, Coruna, Spain; [Grieve, Kenneth L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Universidade da Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University of Manchester	Rivadulla, C (corresponding author), Univ A Coruna, Dept Med INEF Galicia, Lab Neurosci & Motor Control Neurocom, Coruna, Spain.	casto@udc.es	RIVADULLA, CASTO/K-8425-2012; de Labra, Carmen/C-9992-2017	RIVADULLA, CASTO/0000-0001-5580-3917; de Labra, Carmen/0000-0002-5306-0475; , Gerontology Research Group/0000-0001-7207-9481; Cudeiro, Javier/0000-0002-6597-6077	Ministerio de Educacion y Ciencia (MEC) [BFU2009-08169]; Xunta de Galicia, Spain [Conselleria de Educacion-2007/000140-0]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Xunta de Galicia, Spain(Xunta de Galicia)	This work was supported by Ministerio de Educacion y Ciencia (MEC) (BFU2009-08169) and Xunta de Galicia (Conselleria de Educacion-2007/000140-0), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; AUER LM, 1981, EUR NEUROL, V20, P448, DOI 10.1159/000115278; Biswal BB, 1996, MICROVASC RES, V52, P1, DOI 10.1006/mvre.1996.0039; Boorman L, 2010, J NEUROSCI, V30, P4285, DOI 10.1523/JNEUROSCI.6063-09.2010; BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478, DOI 10.1152/ajpheart.1992.262.2.H478; Brown LA, 2002, AUTON NEUROSCI-BASIC, V95, P137, DOI 10.1016/S1566-0702(01)00395-2; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; COLANTUONI A, 1984, MICROVASC RES, V28, P143, DOI 10.1016/0026-2862(84)90014-1; Colantuoni A, 2001, AUTON NEUROSCI-BASIC, V90, P148, DOI 10.1016/S1566-0702(01)00281-8; de Labra C, 2007, CEREB CORTEX, V17, P1376, DOI 10.1093/cercor/bhl048; de Labra C, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.009.2009; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FUJII K, 1990, AM J PHYSIOL, V258, pH1829, DOI 10.1152/ajpheart.1990.258.6.H1829; GOLANOV EV, 1995, AM J PHYSIOL-REG I, V268, pR454, DOI 10.1152/ajpregu.1995.268.2.R454; GUSTAFSSON H, 1993, ACTA PHYSIOL SCAND, V148, P153, DOI 10.1111/j.1748-1716.1993.tb09545.x; Haddock RE, 2005, J PHYSIOL-LONDON, V566, P645, DOI 10.1113/jphysiol.2005.086405; Haddock RE, 2002, J PHYSIOL-LONDON, V545, P615, DOI 10.1113/jphysiol.2002.027904; Haddock RE, 2006, AM J PHYSIOL-HEART C, V291, pH2047, DOI 10.1152/ajpheart.00484.2006; Hempelmann RG, 1998, NEUROL RES, V20, P63; Hill CE, 1999, J PHYSIOL-LONDON, V521, P507, DOI 10.1111/j.1469-7793.1999.00507.x; HUNDLEY WG, 1988, AM J PHYSIOL, V254, pH67, DOI 10.1152/ajpheart.1988.254.1.H67; JACKSON WF, 1991, AM J PHYSIOL, V260, pH248, DOI 10.1152/ajpheart.1991.260.1.H248; JOHNSON PC, 1967, AM J PHYSIOL, V212, P1405, DOI 10.1152/ajplegacy.1967.212.6.1405; Jones T.W., 1852, PHILOS T R SOC LOND, V142, P131; Lauritzen M, 2001, J CEREBR BLOOD F MET, V21, P1367, DOI 10.1097/00004647-200112000-00001; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Leithner C, 2010, J CEREBR BLOOD F MET, V30, P311, DOI 10.1038/jcbfm.2009.211; Li B, 2007, J NEUROSCI, V27, P10223, DOI 10.1523/JNEUROSCI.1505-07.2007; Lindauer Ute, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00025; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 2002, PHILOS T R SOC B, V357, P1003, DOI 10.1098/rstb.2002.1114; Matchkov VV, 2004, J GEN PHYSIOL, V123, P121, DOI 10.1085/jgp.200308972; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; Paulson OB, 2010, J CEREBR BLOOD F MET, V30, P2, DOI 10.1038/jcbfm.2009.188; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; Rasmussen T, 2009, NEUROIMAGE, V45, P96, DOI 10.1016/j.neuroimage.2008.10.023; Razavi M, 2008, J MAGN RESON IMAGING, V27, P891, DOI 10.1002/jmri.21283; Roy C S, 1890, J Physiol, V11, P85; Schuster A, 2001, AM J PHYSIOL-HEART C, V280, pH1088, DOI 10.1152/ajpheart.2001.280.3.H1088; Sheth SA, 2004, J NEUROSCI, V24, P634, DOI 10.1523/JNEUROSCI.4526-03.2004; Thompson JK, 2005, J NEUROSCI, V25, P9046, DOI 10.1523/JNEUROSCI.2127-05.2005; Toga A.W., 2002, BRAIN MAPPING METHOD; Ursino M, 1996, MICROVASC RES, V51, P229, DOI 10.1006/mvre.1996.0023; Vetri F, 2007, NEUROIMAGE, V38, P25, DOI 10.1016/j.neuroimage.2007.07.017	52	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28746	10.1371/journal.pone.0028746	http://dx.doi.org/10.1371/journal.pone.0028746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174886	Green Published, gold			2022-12-27	WOS:000298365700068
J	Schloss, CA; Lawler, JJ; Larson, ER; Papendick, HL; Case, MJ; Evans, DM; Delap, JH; Langdon, JGR; Hall, SA; Mcrae, BH				Schloss, Carrie A.; Lawler, Joshua J.; Larson, Eric R.; Papendick, Hilary L.; Case, Michael J.; Evans, Daniel M.; Delap, Jack H.; Langdon, Jesse G. R.; Hall, Sonia A.; Mcrae, Brad H.			Systematic Conservation Planning in the Face of Climate Change: Bet-Hedging on the Columbia Plateau	PLOS ONE			English	Article							CHANGE ADAPTATION STRATEGIES; ECOLOGICAL RESTORATION; SPECIES DISTRIBUTIONS; RESOURCE-MANAGEMENT; PLANT-COMMUNITIES; RESERVE-SELECTION; PROTECTED AREAS; LAND FACETS; BIODIVERSITY; FOREST	Systematic conservation planning efforts typically focus on protecting current patterns of biodiversity. Climate change is poised to shift species distributions, reshuffle communities, and alter ecosystem functioning. In such a dynamic environment, lands selected to protect today's biodiversity may fail to do so in the future. One proposed approach to designing reserve networks that are robust to climate change involves protecting the diversity of abiotic conditions that in part determine species distributions and ecological processes. A set of abiotically diverse areas will likely support a diversity of ecological systems both today and into the future, although those two sets of systems might be dramatically different. Here, we demonstrate a conservation planning approach based on representing unique combinations of abiotic factors. We prioritize sites that represent the diversity of soils, topographies, and current climates of the Columbia Plateau. We then compare these sites to sites prioritized to protect current biodiversity. This comparison highlights places that are important for protecting both today's biodiversity and the diversity of abiotic factors that will likely determine biodiversity patterns in the future. It also highlights places where a reserve network designed solely to protect today's biodiversity would fail to capture the diversity of abiotic conditions and where such a network could be augmented to be more robust to climate-change impacts.	[Schloss, Carrie A.; Lawler, Joshua J.; Papendick, Hilary L.; Case, Michael J.; Delap, Jack H.; Langdon, Jesse G. R.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Larson, Eric R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Evans, Daniel M.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Hall, Sonia A.] Nature Conservancy, Wenatchee, WA USA; [Mcrae, Brad H.] Nature Conservancy, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Nature Conservancy	Schloss, CA (corresponding author), Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA.	cschloss@u.washington.edu	Larson, Eric/H-3528-2012; Larson, Eric R/P-8253-2016	Larson, Eric R/0000-0002-9232-5907; Case, Michael/0000-0003-4111-2298; Hall, Sonia A/0000-0002-3442-814X	Bullitt Foundation	Bullitt Foundation	This work was produced as part of the Conservation of Living Systems Graduate Program at the University of Washington and was funded in part by the Bullitt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson M, 1998, INT CLASSIFICATION E; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ardron JA, MARXAN GOOD PRACTICE; Ball I.R., 2000, MARXAN 1 8 2 MARINE; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; BELBIN L, 1993, BIOL CONSERV, V66, P223, DOI 10.1016/0006-3207(93)90007-N; Brost B, 2011, ECOLOGICAL IN PRESS; Carlson Brian, 2004, Journal for Nature Conservation (Jena), V12, P15, DOI 10.1016/j.jnc.2003.07.001; Carroll C, 2007, CONSERV BIOL, V21, P1092, DOI 10.1111/j.1523-1739.2007.00719.x; Carvalho SB, 2011, BIOL CONSERV, V144, P2020, DOI 10.1016/j.biocon.2011.04.024; Comer P., 2003, ECOLOGICAL SYSTEMS U; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Davis F.W., 1999, PARKS, V9, P31; Eeley HAC, 1999, J BIOGEOGR, V26, P595, DOI 10.1046/j.1365-2699.1999.00307.x; Fairbanks DHK, 2000, LANDSCAPE URBAN PLAN, V50, P237, DOI 10.1016/S0169-2046(00)00068-2; Game ET, 2008, MARXAN USER MANUAL M; Groves C.R., 2003, DRAFTING CONSERVATIO; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2005, BIOSCIENCE, V55, P231, DOI 10.1641/0006-3568(2005)055[0231:TVFTCE]2.0.CO;2; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Harris JA, 2006, RESTOR ECOL, V14, P170, DOI 10.1111/j.1526-100X.2006.00136.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hobbs RJ, 2008, ANNU REV ENV RESOUR, V33, P39, DOI 10.1146/annurev.environ.33.020107.113631; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Iwamura T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015103; Jackson ST, 2009, SCIENCE, V325, P567, DOI 10.1126/science.1172977; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Lawler JJ, 2010, FRONT ECOL ENVIRON, V8, P35, DOI 10.1890/070146; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MACKEY BG, 1988, ENVIRON MANAGE, V12, P502; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mawdsley JR, 2009, CONSERV BIOL, V23, P1080, DOI 10.1111/j.1523-1739.2009.01264.x; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; NOSS RF, 1987, BIOL CONSERV, V41, P11, DOI 10.1016/0006-3207(87)90045-0; Olson LT, 2009, J GEOGRAPHY REGIONAL, V2, P20; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PETERS RL, 1985, BIOSCIENCE, V35, P707, DOI 10.2307/1310052; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Pyke CR, 2005, BIOL CONSERV, V121, P429, DOI 10.1016/j.biocon.2004.05.019; Saxon E, 2005, ECOL LETT, V8, P53, DOI 10.1111/j.1461-0248.2004.00694.x; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Seaber P.R., 1987, US GEOLOGICAL SURVEY; Team RDC, 2010, R LANG ENV STAT COMP; Tear TH, 2005, BIOSCIENCE, V55, P835, DOI 10.1641/0006-3568(2005)055[0835:HMIETR]2.0.CO;2; Theobald DM, 2010, LANDSCAPE ECOL, V25, P999, DOI 10.1007/s10980-010-9484-z; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tyre AJ, 2003, ECOL APPL, V13, P1790, DOI 10.1890/02-5078; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warman LD, 2004, ECOL LETT, V7, P374, DOI 10.1111/j.1461-0248.2004.00590.x; Washington Biodiversity Project, 2011, COL PLAT EC BIOD; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Wiens JA, 2010, CONSERV BIOL, V24, P51, DOI 10.1111/j.1523-1739.2009.01409.x; [No title captured]	67	37	37	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28788	10.1371/journal.pone.0028788	http://dx.doi.org/10.1371/journal.pone.0028788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174897	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600042
J	Tian, L; Meng, C; Yan, H; Zhao, Q; Liu, Q; Yan, J; Han, YH; Yuan, HS; Wang, LF; Yue, WH; Zhang, YB; Li, XM; Zhu, CZ; He, Y; Zhang, D				Tian, Lin; Meng, Chun; Yan, Hao; Zhao, Qiang; Liu, Qi; Yan, Jun; Han, Yonghua; Yuan, Huishu; Wang, Lifang; Yue, Weihua; Zhang, Yanbo; Li, Xinmin; Zhu, Chaozhe; He, Yong; Zhang, Dai			Convergent Evidence from Multimodal Imaging Reveals Amygdala Abnormalities in Schizophrenic Patients and Their First-Degree Relatives	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; VOXEL-BASED MORPHOMETRY; HIGH-RISK; HIPPOCAMPAL VOLUME; PSYCHIATRIC-DISORDERS; NONPSYCHOTIC SIBLINGS; SYNAPTIC PLASTICITY; EMOTION PERCEPTION; BRAIN VOLUMES; FMRI	Background: Shared neuropathological features between schizophrenic patients and their first-degree relatives have potential as indicators of genetic vulnerability to schizophrenia. We sought to explore genetic influences on brain morphology and function in schizophrenic patients and their relatives. Methods: Using a multimodal imaging strategy, we studied 33 schizophrenic patients, 55 of their unaffected parents, 30 healthy controls for patients, and 29 healthy controls for parents with voxel-based morphometry of structural MRI scans and functional connectivity analysis of resting-state functional MRI data. Results: Schizophrenic patients showed widespread gray matter reductions in the bilateral frontal cortices, bilateral insulae, bilateral occipital cortices, left amygdala and right thalamus, whereas their parents showed more localized reductions in the left amygdala, left thalamus and right orbitofrontal cortex. Patients and their parents shared gray matter loss in the left amygdala. Further investigation of the resting-state functional connectivity of the amygdala in the patients showed abnormal functional connectivity with the bilateral orbitofrontal cortices, bilateral precunei, bilateral dorsolateral frontal cortices and right insula. Their parents showed slightly less, but similar changes in the pattern in the amygdala connectivity. Co-occurrences of abnormal connectivity of the left amygdala with the left orbitofrontal cortex, right dorsolateral frontal cortex and right precuneus were observed in schizophrenic patients and their parents. Conclusions: Our findings suggest a potential genetic influence on structural and functional abnormalities of the amygdala in schizophrenia. Such information could help future efforts to identify the endophenotypes that characterize the complex disorder of schizophrenia.	[Tian, Lin; Yan, Hao; Liu, Qi; Yan, Jun; Han, Yonghua; Wang, Lifang; Yue, Weihua; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Tian, Lin; Yan, Hao; Liu, Qi; Yan, Jun; Han, Yonghua; Wang, Lifang; Yue, Weihua; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Meng, Chun; Zhu, Chaozhe; He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhao, Qiang; Yuan, Huishu] Peking Univ, Dept Radiol, Hosp 3, Beijing 100871, Peoples R China; [Zhang, Yanbo; Li, Xinmin] Univ Manitoba, Dept Psychiat, Fac Med, Winnipeg, MB R3T 2N2, Canada	Peking University; Beijing Normal University; Peking University; University of Manitoba	Tian, L (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	hao_y@hsc.pku.edu.cn; daizhang@hsc.pku.edu.cn	He, Yong/C-2161-2009; Chaozhe, Zhu/AAK-7737-2020; He, Yong/Q-5756-2018; Yan, Hao/U-1330-2017	Chaozhe, Zhu/0000-0002-9247-9607; Yan, Hao/0000-0003-0376-9037; Zhang, Yanbo/0000-0002-2421-157X	National Basic Research Program of China [2011CB707805, 2007CB512301]; National Natural Science Foundation of China [81071088, 81000580]; International Science & Technology Cooperation Program of China [2010DFB30820]; Capital Foundation of Medical Developments [2007-1001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Capital Foundation of Medical Developments	This work was supported by grants from the National Basic Research Program of China (2011CB707805, 2007CB512301), National Natural Science Foundation of China (81071088, 81000580), International Science & Technology Cooperation Program of China (2010DFB30820), and Capital Foundation of Medical Developments (2007-1001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1997, AM J HUM GENET, V60, P676; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bai YM, 2007, J CLIN PSYCHIAT, V68, P1218, DOI 10.4088/JCP.v68n0808; BOGERTS B, 1993, BIOL PSYCHIAT, V33, P236, DOI 10.1016/0006-3223(93)90289-P; Boos H.B., 2011, SCHIZOPHR B; Boos HBM, 2007, ARCH GEN PSYCHIAT, V64, P297, DOI 10.1001/archpsyc.64.3.297; Bora E, 2011, SCHIZOPHR RES, V127, P46, DOI 10.1016/j.schres.2010.12.020; BRACHA HS, 1991, SCHIZOPHRENIA BULL, V17, P551, DOI 10.1093/schbul/17.4.551; Calhoun VD, 2006, HUM BRAIN MAPP, V27, P47, DOI 10.1002/hbm.20166; Calhoun VD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.017.2009; Chan RCK, 2011, SCHIZOPHRENIA BULL, V37, P177, DOI 10.1093/schbul/sbp073; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Exner C, 2004, SCHIZOPHR RES, V71, P493, DOI 10.1016/j.schres.2004.02.023; Fornito A, 2009, SCHIZOPHR RES, V108, P104, DOI 10.1016/j.schres.2008.12.011; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Glahn DC, 2008, BIOL PSYCHIAT, V64, P774, DOI 10.1016/j.biopsych.2008.03.031; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Gur RE, 2002, AM J PSYCHIAT, V159, P1992, DOI 10.1176/appi.ajp.159.12.1992; Habel U, 2004, AM J PSYCHIAT, V161, P1806, DOI 10.1176/appi.ajp.161.10.1806; Harms MP, 2007, J NEUROSCI, V27, P13835, DOI 10.1523/JNEUROSCI.2571-07.2007; Honea RA, 2008, BIOL PSYCHIAT, V63, P465, DOI 10.1016/j.biopsych.2007.05.027; Hoptman MJ, 2010, SCHIZOPHRENIA BULL, V36, P1020, DOI 10.1093/schbul/sbp012; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jang JH, 2011, SCHIZOPHR RES, V127, P58, DOI 10.1016/j.schres.2010.12.022; Jiang AP, 1995, HUM BRAIN MAPP, V3, P224, DOI 10.1002/hbm.460030306; Job DE, 2003, SCHIZOPHR RES, V64, P1, DOI 10.1016/S0920-9964(03)00158-0; Job DE, 2005, NEUROIMAGE, V25, P1023, DOI 10.1016/j.neuroimage.2005.01.006; Joyal CC, 2003, BIOL PSYCHIAT, V54, P1302, DOI 10.1016/S0006-3223(03)00597-3; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Ke M, 2008, LECT NOTES ARTIF INT, V5009, P628; Keshavan MS, 2002, SCHIZOPHR RES, V58, P173, DOI 10.1016/S0920-9964(01)00404-2; Lawrie SM, 2003, ANN NY ACAD SCI, V985, P445; Lawrie SM, 1998, BRIT J PSYCHIAT, V172, P110, DOI 10.1192/bjp.172.2.110; Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1; Liu H., 2010, SCHIZOPHR B; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2009, PSYCHIAT RES-NEUROIM, V171, P71, DOI 10.1016/j.pscychresns.2008.02.004; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P1142, DOI 10.1093/schbul/sbn053; MCGUFFIN P, 1995, LANCET, V346, P678, DOI 10.1016/S0140-6736(95)92285-7; McIntosh AM, 2004, BIOL PSYCHIAT, V56, P544, DOI 10.1016/j.biopsych.2004.07.020; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; Moorhead TWJ, 2009, PSYCHIAT RES-NEUROIM, V174, P105, DOI 10.1016/j.pscychresns.2009.04.003; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Niu L, 2004, PSYCHIAT RES-NEUROIM, V132, P41, DOI 10.1016/j.pscychresns.2004.06.002; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Driscoll GA, 2001, PSYCHIAT RES-NEUROIM, V107, P75, DOI 10.1016/S0925-4927(01)00095-6; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pearlson GD, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.037.2009; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pol HEH, 2001, ARCH GEN PSYCHIAT, V58, P1118; Pomarol-Clotet E, 2010, MOL PSYCHIATR, V15, P823, DOI 10.1038/mp.2009.146; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P15, DOI 10.1093/schbul/sbn159; Prasad KM, 2008, SCHIZOPHRENIA BULL, V34, P774, DOI 10.1093/schbul/sbn017; Qiu AQ, 2009, NEUROIMAGE, V47, P1221, DOI 10.1016/j.neuroimage.2009.05.054; Qiu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025805; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Salvadore G, 2011, NEUROIMAGE, V54, P2643, DOI 10.1016/j.neuroimage.2010.11.011; Sawa A, 2002, SCIENCE, V296, P692, DOI 10.1126/science.1070532; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Seidman LJ, 1999, BIOL PSYCHIAT, V46, P941, DOI 10.1016/S0006-3223(99)00075-X; Seidman LJ, 2002, ARCH GEN PSYCHIAT, V59, P839, DOI 10.1001/archpsyc.59.9.839; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Steel RM, 2002, J NEUROL NEUROSUR PS, V72, P455; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Takahashi H, 2004, NEUROIMAGE, V22, P1247, DOI 10.1016/j.neuroimage.2004.03.028; Tregellas J, 2009, AM J PSYCHIAT, V166, P134, DOI 10.1176/appi.ajp.2008.08111685; Tsuang M, 2000, BIOL PSYCHIAT, V47, P210, DOI 10.1016/S0006-3223(99)00289-9; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; van Haren NE, 2008, CURR OPIN PSYCHIATR, V21, P161, DOI 10.1097/YCO.0b013e3282f4f25b; van Rijn S, 2005, NEUROSCI BIOBEHAV R, V29, P385, DOI 10.1016/j.neubiorev.2004.11.005; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Venables NC, 2009, SCHIZOPHRENIA BULL, V35, P826, DOI 10.1093/schbul/sbn021; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Williams LM, 2007, PSYCHIAT RES-NEUROIM, V155, P29, DOI 10.1016/j.pscychresns.2006.12.018; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Wolf DH, 2007, PSYCHIAT RES-NEUROIM, V154, P221, DOI 10.1016/j.pscychresns.2006.11.008; Woods SW, 2003, J CLIN PSYCHIAT, V64, P663, DOI 10.4088/JCP.v64n0607; World Health Organization, 1993, ICD 10 CLASS MENT BE, Vxiii; Wright IC, 2000, AM J PSYCHIAT, V157, P16, DOI 10.1176/ajp.157.1.16; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	93	28	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28794	10.1371/journal.pone.0028794	http://dx.doi.org/10.1371/journal.pone.0028794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174900	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600043
J	Zuniga, J; Cancino, M; Medina, F; Varela, P; Vargas, R; Tapia, G; Videla, LA; Fernandez, V				Zuniga, Jessica; Cancino, Milena; Medina, Fernando; Varela, Patricia; Vargas, Romina; Tapia, Gladys; Videla, Luis A.; Fernandez, Virginia			N-3 PUFA Supplementation Triggers PPAR-alpha Activation and PPAR-alpha/NF-kappa B Interaction: Anti-Inflammatory Implications in Liver Ischemia-Reperfusion Injury	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; OMEGA-3-FATTY-ACIDS; EXPRESSION; PROTEINS; INFLAMMATION; MECHANISMS; PROTECTION; RESOLVINS; DEFENSE; CELLS	Dietary supplementation with the n-3 polyunsaturated fatty acids (n-3 PUFA) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) to rats preconditions the liver against ischemia-reperfusion (IR) injury, with reduction of the enhanced nuclear factor-kappa B (NF-kappa B) functionality occurring in the early phase of IR injury, and recovery of IR-induced proinflammatory cytokine response. The aim of the present study was to test the hypothesis that liver preconditioning by n-3 PUFA is exerted through peroxisone proliferator-activated receptor alpha (PPAR-alpha) activation and interference with NF-kappa B activation. For this purpose we evaluated the formation of PPAR-alpha/NF-kappa Bp65 complexes in relation to changes in PPAR-alpha activation, I kappa B-alpha phosphorylation and serum levels and expression of interleukin (IL)-1 beta and tumor necrosis factor (TNF)-alpha in a model of hepatic IR-injury (1 h of ischemia and 20 h of reperfusion) or sham laparotomy (controls) in male Sprague Dawley rats. Animals were previously supplemented for 7 days with encapsulated fish oil (General Nutrition Corp., Pittsburg, PA) or isovolumetric amounts of saline (controls). Normalization of IR-altered parameters of liver injury (serum transaminases and liver morphology) was achieved by dietary n-3 PUFA supplementation. EPA and DHA suppression of the early IR-induced NF-kappa B activation was paralleled by generation of PPAR-alpha/NF-kappa Bp65 complexes, in concomitance with normalization of the IR-induced IkB-alpha phosphorylation. PPAR-alpha activation by n-3 PUFA was evidenced by enhancement in the expression of the PPAR-alpha-regulated Acyl-CoA oxidase (Acox) and Carnitine-Palmitoyl-CoA transferase I (CPT-I) genes. Consistent with these findings, normalization of IR-induced expression and serum levels of NF-kappa B-controlled cytokines IL-I beta and TNF-alpha was observed at 20 h of reperfusion. Taken together, these findings point to an antagonistic effect of PPAR-alpha on NF-kappa B-controlled transcription of pro-inflammatory mediators. This effect is associated with the formation of PPAR-alpha/NF-kappa Bp65 complexes and enhanced cytosolic I kappa B-alpha stability, as major preconditioning mechanisms induced by n-3 PUFA supplementation against IR liver injury.	[Zuniga, Jessica; Cancino, Milena; Medina, Fernando; Varela, Patricia; Vargas, Romina; Tapia, Gladys; Videla, Luis A.; Fernandez, Virginia] Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago 7, Chile	Universidad de Chile	Zuniga, J (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Mol & Clin Pharmacol Program, Santiago 7, Chile.	vfernand@med.uchile.cl	Medina Ferrer, Fernando/F-1931-2017; Zuñiga-Hernandez, Jessica/AGC-4271-2022	Medina Ferrer, Fernando/0000-0001-9864-7627; Zuniga, Jessica/0000-0003-2930-991X	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile [1080039, 1110006]	FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	These studies were supported by grants 1080039 and 1110006 (to VF) from FONDECYT (Fondo Nacional de Desarrollo Cientifico y Tecnologico), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Araki Y, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/374542; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Beg AA, 1996, SCIENCE, V274, P782, DOI 10.1126/science.274.5288.782; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Casillas-Ramirez A, 2006, LIFE SCI, V79, P1881, DOI 10.1016/j.lfs.2006.06.024; Chen HH, 2009, AM J PHYSIOL-RENAL, V297, pF1109, DOI 10.1152/ajprenal.00057.2009; Chen WY, 2012, J NUTR BIOCHEM, V23, P252, DOI 10.1016/j.jnutbio.2010.11.022; De Caterina R, 2005, J MEMBRANE BIOL, V206, P103, DOI 10.1007/s00232-005-0783-2; de Roos B, 2009, BRIT J PHARMACOL, V158, P413, DOI 10.1111/j.1476-5381.2009.00189.x; de Rougemont O, 2009, LIVER TRANSPLANT, V15, P1172, DOI 10.1002/lt.21876; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; DEMOZ A, 1992, LIPIDS, V27, P968, DOI 10.1007/BF02535573; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; El-Badry AM, 2007, HEPATOLOGY, V45, P855, DOI 10.1002/hep.21625; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Giakoustidis D, 2006, SURG TODAY, V36, P450, DOI 10.1007/s00595-005-3162-9; Gonzalez-Periz A, 2006, FASEB J, V20, P2537, DOI 10.1096/fj.06-6250fje; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Iwasaki W, 2010, SHOCK, V33, P306, DOI 10.1097/SHK.0b013e3181b2ffd2; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mishra A, 2004, ARTERIOSCL THROM VAS, V24, P1621, DOI 10.1161/01.ATV.0000137191.02577.86; Okayasu T, 2008, LIFE SCI, V82, P884, DOI 10.1016/j.lfs.2008.02.002; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; SEVANIAN A, 1985, ANNU REV NUTR, V5, P365, DOI 10.1146/annurev.nu.05.070185.002053; Sierra S., 2004, Nutr. Hosp., V19, P376; Takahashi Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1175, DOI 10.1152/ajpgi.00515.2001; Tapia G, 2003, FREE RADICAL BIO MED, V35, P257, DOI 10.1016/S0891-5849(03)00209-0; Tapia G, 2010, MOL CELL ENDOCRINOL, V323, P292, DOI 10.1016/j.mce.2010.03.014; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsukamoto H, 1997, CELLS OF THE HEPATIC SINUSOID, VOL 6, P244; Wanner GA, 1996, SHOCK, V5, P34, DOI 10.1097/00024382-199601000-00008; Ye D, 2002, J PHARMACOL EXP THER, V303, P768, DOI 10.1124/jpet.303.2.768; ZHONG Z, 1995, HEPATOLOGY, V22, P929, DOI 10.1016/0270-9139(95)90317-8; Zuniga J, 2010, FREE RADICAL RES, V44, P854, DOI 10.3109/10715762.2010.485995	44	145	147	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28502	10.1371/journal.pone.0028502	http://dx.doi.org/10.1371/journal.pone.0028502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174823	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600028
J	Ferrero, M; Ferragud, J; Orlando, L; Valero, L; del Pino, MS; Farras, R; de Mora, JF				Ferrero, Macarena; Ferragud, Juan; Orlando, Leonardo; Valero, Luz; Sanchez del Pino, Manuel; Farras, Rosa; Font de Mora, Jaime			Phosphorylation of AIB1 at Mitosis Is Regulated by CDK1/CYCLIN B	PLOS ONE			English	Article							NUCLEAR RECEPTOR COACTIVATOR; PROTEIN PHOSPHATASE 1; CDK1 ACTIVITY; MITOTIC EXIT; AURORA-A; ACTIVATION; DEPHOSPHORYLATION; KINASE	Background: Although the AIB1 oncogene has an important role during the early phase of the cell cycle as a coactivator of E2F1, little is known about its function during mitosis. Methodology/Principal Findings: Mitotic cells isolated by nocodazole treatment as well as by shake-off revealed a post-translational modification occurring in AIB1 specifically during mitosis. This modification was sensitive to the treatment with phosphatase, suggesting its modification by phosphorylation. Using specific inhibitors and in vitro kinase assays we demonstrate that AIB1 is phosphorylated on Ser728 and Ser867 by Cdk1/cyclin B at the onset of mitosis and remains phosphorylated until exit from M phase. Differences in the sensitivity to phosphatase inhibitors suggest that PP1 mediates dephosphorylation of AIB1 at the end of mitosis. The phosphorylation of AIB1 during mitosis was not associated with ubiquitylation or degradation, as confirmed by western blotting and flow cytometry analysis. In addition, luciferase reporter assays showed that this phosphorylation did not alter the transcriptional properties of AIB1. Importantly, fluorescence microscopy and sub-cellular fractionation showed that AIB1 phosphorylation correlated with the exclusion from the condensed chromatin, thus preventing access to the promoters of AIB1-dependent genes. Phospho-specific antibodies developed against Ser728 further demonstrated the presence of phosphorylated AIB1 only in mitotic cells where it was localized preferentially in the periphery of the cell. Conclusions: Collectively, our results describe a new mechanism for the regulation of AIB1 during mitosis, whereby phosphorylation of AIB1 by Cdk1 correlates with the subcellular redistribution of AIB1 from a chromatin-associated state in interphase to a more peripheral localization during mitosis. At the exit of mitosis, AIB1 is dephosphorylated, presumably by PP1. This exclusion from chromatin during mitosis may represent a mechanism for governing the transcriptional activity of AIB1.	[Ferrero, Macarena; Ferragud, Juan; Orlando, Leonardo; Font de Mora, Jaime] CIPF, Lab Cellular & Mol Biol, Valencia, Spain; [Valero, Luz; Sanchez del Pino, Manuel] CIPF, Lab Prote, Valencia, Spain; [Farras, Rosa] CIPF, Lab Cyt, Valencia, Spain	Prince Felipe Research Center; Prince Felipe Research Center; Prince Felipe Research Center	Ferrero, M (corresponding author), CIPF, Lab Cellular & Mol Biol, Valencia, Spain.	jfont@cipf.es	del Pino, Manuel/Q-6254-2019; del Pino, Manuel M. Sánchez/I-3977-2015; de Mora, Jaime Font/AAK-7591-2021; Farràs, Rosa/B-5180-2014; de Mora, Jaime Font/H-6304-2015	del Pino, Manuel/0000-0001-6048-0657; del Pino, Manuel M. Sánchez/0000-0001-9696-7600; de Mora, Jaime Font/0000-0002-6816-2095; Farràs, Rosa/0000-0003-4931-1494; de Mora, Jaime Font/0000-0002-6816-2095; Ferrero Gimeno, Macarena/0000-0001-9470-9800	Spanish Ministry of Science and Innovation [SAF2009-08334]; Conselleria d'Educacio, Generalitat Valenciana	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Conselleria d'Educacio, Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF))	This work was supported by SAF2009-08334 grant from the Spanish Ministry of Science and Innovation. Ferrero was supported by a pre-doctoral fellowship from Conselleria d'Educacio, Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avivar A, 2006, FEBS LETT, V580, P5222, DOI 10.1016/j.febslet.2006.08.057; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Christova R, 2002, NAT CELL BIOL, V4, P79, DOI 10.1038/ncb733; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Ferrero M, 2008, CANCER RES, V68, P5450, DOI 10.1158/0008-5472.CAN-07-6433; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Horiguchi K, 2006, J BIOCHEM, V140, P409, DOI 10.1093/jb/mvj167; Kajiro M, 2009, NAT CELL BIOL; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lahusen T, 2007, CANCER RES, V67, P7256, DOI 10.1158/0008-5472.CAN-07-1013; Li C, 2008, MOL CELL, V31, P835, DOI 10.1016/j.molcel.2008.07.019; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Louie MC, 2006, MOL CELL BIOL, V26, P3810, DOI 10.1128/MCB.26.10.3810-3823.2006; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lu YY, 1996, BIOCHEM J, V317, P321, DOI 10.1042/bj3170321; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Macurek L, 2009, CANCER RES, V69, P4555, DOI 10.1158/0008-5472.CAN-09-0142; Mani A, 2006, CANCER RES, V66, P8680, DOI 10.1158/0008-5472.CAN-06-0557; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; O'Connell MJ, 2003, TRENDS CELL BIOL, V13, P221, DOI 10.1016/S0962-8924(03)00056-4; Planas-Silva MD, 2001, CANCER RES, V61, P3858; Potapova TA, 2006, NATURE, V440, P954, DOI 10.1038/nature04652; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28602	10.1371/journal.pone.0028602	http://dx.doi.org/10.1371/journal.pone.0028602			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163316	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900052
J	Gu, Q; Sood, N				Gu, Qian; Sood, Neeraj			Do People Taking Flu Vaccines Need Them the Most?	PLOS ONE			English	Article							INFLUENZA VACCINATION RATES; PNEUMOCOCCAL VACCINATION; RACIAL/ETHNIC DISPARITIES; MEDICARE BENEFICIARIES; IMMUNIZATION; OLDER; US; ADULTS; BARRIERS; DETERMINANTS	Background A well targeted flu vaccine strategy can ensure that vaccines go to those who are at the highest risk of getting infected if unvaccinated. However, prior research has not explicitly examined the association between the risk of flu infection and vaccination rates. Purpose: This study examines the relationship between the risk of flu infection and the probability of getting vaccinated. Methods: Nationally representative data from the US and multivariate regression models were used to estimate what individual characteristics are associated with (1) the risk of flu infection when unvaccinated and (2) flu vaccination rates. These results were used to estimate the correlation between the probability of infection and the probability of getting vaccinated. Separate analyses were performed for the general population and the high priority population that is at increased risk of flu related complications. Results: We find that the high priority population was more likely to get vaccinated compared to the general population. However, within both the high priority and general populations the risk of flu infection when unvaccinated was negatively correlated with vaccination rates (r = -0.067, p<0.01). This negative association between the risk of infection when unvaccinated and the probability of vaccination was stronger for the high priority population (r = -0.361, p<0.01). Conclusions: There is a poor match between those who get flu vaccines and those who have a high risk of flu infection within both the high priority and general populations. Targeting vaccination to people with low socioeconomic status, people who are engaged in unhealthy behaviors, working people, and families with kids will likely improve effectiveness of flu vaccine policy.	[Gu, Qian] KNG Hlth Consulting, Rockville, MD USA; [Sood, Neeraj] Univ So Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	University of Southern California	Gu, Q (corresponding author), KNG Hlth Consulting, Rockville, MD USA.	nsood@usc.edu		Sood, Neeraj/0000-0001-9805-213X				BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Blanton L., 2007, Morbidity and Mortality Weekly Report, V56, P789; Blue Carolyn L, 2002, AAOHN J, V50, P227; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bonito AJ, 2004, AM J PREV MED, V27, P153, DOI 10.1016/j.amepre.2004.04.004; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Chen JY, 2005, AM J PREV MED, V29, P388, DOI 10.1016/j.amepre.2005.08.006; Chi RC, 2004, AM J MED SCI, V327, P113, DOI 10.1097/00000441-200403000-00001; Clark SJ, 2009, AM J INFECT CONTROL, V37, P551, DOI 10.1016/j.ajic.2009.02.012; COUCH RB, 1971, J INFECT DIS, V124, P473, DOI 10.1093/infdis/124.5.473; CUMMINGS KM, 1979, MED CARE, V17, P639, DOI 10.1097/00005650-197906000-00008; Ding H., 2010, Morbidity and Mortality Weekly Report, V59, P477; DUCLOS P, 1993, CAN J PUBLIC HEALTH, V84, P311; Egede LE, 2003, AM J PUBLIC HEALTH, V93, P2074, DOI 10.2105/AJPH.93.12.2074; Enserink M, 2004, SCIENCE, V306, P385, DOI 10.1126/science.306.5695.385; Ettner SL, 2010, SOC SCI MED, V71, P134, DOI 10.1016/j.socscimed.2010.03.029; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Kee SY, 2007, J INFECTION, V55, P273, DOI 10.1016/j.jinf.2007.04.354; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; King JC, 2005, PEDIATRICS, V116, pE868, DOI 10.1542/peds.2005-1301; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Lees KA, 2005, AM J PREV MED, V29, P404, DOI 10.1016/j.amepre.2005.08.009; Li Y, 2010, AM J PUBLIC HEALTH, V100, pS256, DOI 10.2105/AJPH.2009.173468; Li Z, 2010, VACCINE, V28, P3462, DOI 10.1016/j.vaccine.2010.02.068; Lindley MC, 2006, AM J PREV MED, V31, P281, DOI 10.1016/j.amepre.2006.06.025; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Logan JL, 2009, J NATL MED ASSOC, V101, P161, DOI 10.1016/S0027-9684(15)30830-0; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Lu PJ, 2009, AM J PREV MED, V37, P109, DOI 10.1016/j.amepre.2009.03.021; Lu PJ, 2005, ARCH INTERN MED, V165, P1849, DOI 10.1001/archinte.165.16.1849; Marin MG, 2002, PREV MED, V34, P235, DOI 10.1006/pmed.2001.0983; Mark TL, 1996, AM J PUBLIC HEALTH, V86, P1545, DOI 10.2105/AJPH.86.11.1545; McNeil Jr DG, 2009, NY TIMES        1104; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moore BS, 2009, AAOHN J, V57, P475, DOI 10.3928/08910162-20091027-02; Nichol KL, 1996, J GEN INTERN MED, V11, P673, DOI 10.1007/BF02600158; Nowalk MP, 2004, J AM GERIATR SOC, V52, P25, DOI 10.1111/j.1532-5415.2004.52006.x; O'Malley AS, 2006, AM J PREV MED, V31, P150, DOI 10.1016/j.amepre.2006.03.021; O'Reilly FW, 2005, OCCUP MED-OXFORD, V55, P474, DOI 10.1093/occmed/kqi099; Ostbye T, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-41; Pearson WS, 2009, PREV MED, V48, P180, DOI 10.1016/j.ypmed.2008.11.001; Rangel MC, 2005, J GEN INTERN MED, V20, P426, DOI 10.1111/j.1525-1497.2005.0097.x; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Santibanez TA, 2002, J AM GERIATR SOC, V50, P1711, DOI 10.1046/j.1532-5415.2002.50466.x; Santibanez TA, 2010, AM J HEALTH BEHAV, V34, P77; Schneider EC, 2001, JAMA-J AM MED ASSOC, V286, P1455, DOI 10.1001/jama.286.12.1455; Singleton JA, 2005, AM J PREV MED, V29, P412, DOI 10.1016/j.amepre.2005.08.012; Straits-Troster KA, 2006, AM J PREV MED, V31, P375, DOI 10.1016/j.amepre.2006.07.018; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; VANDEVEN WPMM, 1981, J ECONOMETRICS, V17, P229, DOI 10.1016/0304-4076(81)90028-2; vanEssen GA, 1997, AGE AGEING, V26, P275; Winston CA, 2006, J AM GERIATR SOC, V54, P303, DOI 10.1111/j.1532-5415.2005.00585.x; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	63	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26347	10.1371/journal.pone.0026347	http://dx.doi.org/10.1371/journal.pone.0026347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164202	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400002
J	Han, WD; Sun, J; Feng, LF; Wang, KF; Li, D; Pan, Q; Chen, Y; Jin, W; Wang, X; Pan, HM; Jin, HC				Han, Weidong; Sun, Jie; Feng, Lifeng; Wang, KaiFeng; Li, Da; Pan, Qin; Chen, Yan; Jin, Wei; Wang, Xian; Pan, Hongming; Jin, Hongchuan			Autophagy Inhibition Enhances Daunorubicin-Induced Apoptosis in K562 Cells	PLOS ONE			English	Article							COLON-CANCER CELLS; SIGNALING PATHWAYS; DRUG-RESISTANCE; JNK ACTIVATION; DEPENDENT ERK; DEATH; INDUCTION; PROTEIN; THERAPY	Anthracycline daunorubicin (DNR) is one of the major antitumor agents widely used in the treatment of myeloid leukemia. Unfortunately, the clinical efficacy of DNR was limited because of its cytotoxity at high dosage. As a novel cytoprotective mechanism for tumor cell to survive under unfavorable conditions, autophagy has been proposed to play a role in drug resistance of tumor cells. Whether DNR can activate to impair the sensitivity of cancer cells remains unknown. Here, we first report that DNR can induce a high level of autophagy, which was associated with the activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Moreover, cell death induced by DNR was greatly enhanced after autophagy inhibition by the pharmacological inhibitor chloroquine (CQ) and siRNAs targeting Atg5 and Atg7, the most important components for the formation of autophagosome. In conclusion, we found that DNR can induce cytoprotective autophagy by activation of ERK in myeloid leukemia cells. Autophagy inhibition thus represents a promising approach to improve the efficacy of DNR in the treatment of patients with myeloid leukemia.	[Han, Weidong; Wang, KaiFeng; Li, Da; Pan, Qin; Chen, Yan; Jin, Wei; Wang, Xian; Pan, Hongming] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jie; Feng, Lifeng; Jin, Hongchuan] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Biomed Res Ctr,Canc Biol Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, HM (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China.	panhongming@medmail.com.cn; jinhc@zju.edu.cn	Jin, Hongchuan/C-3686-2009	Wang, Xian/0000-0003-0041-7589; Jin, Hongchuan/0000-0002-6697-3097	National Natural Science Foundation of China [30901740]; China National Ministry of Education [20090101120124]; Zhejiang Natural Sciences Foundation [Y2090166]; Science Technology Department of Zhejiang Province [2010c33168]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Ministry of Education; Zhejiang Natural Sciences Foundation(Natural Science Foundation of Zhejiang Province); Science Technology Department of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No.:30901740), China National Ministry of Education Grant (No.: 20090101120124), Zhejiang Natural Sciences Foundation Grant (No.: Y2090166) and Research Projects of Science Technology Department of Zhejiang Province (No.: 2010c33168) to WH and the Fundamental Research Funds for the Central Universities to HJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; BOOSER DJ, 1994, DRUGS, V47, P223, DOI 10.2165/00003495-199447020-00002; Chen SY, 2011, AUTOPHAGY, V7, P217, DOI 10.4161/auto.7.2.14212; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Cui Q, 2007, BIOL PHARM BULL, V30, P859, DOI 10.1248/bpb.30.859; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Ellington AA, 2006, CARCINOGENESIS, V27, P298, DOI 10.1093/carcin/bgi214; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Han W., 2011, PLOS ONE, V6; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Laurent G, 2001, BLOOD, V98, P913, DOI 10.1182/blood.V98.4.913; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; MARAL RJ, 1981, CANCER TREAT REP, V65, P9; MCCULLOCH EA, 1983, BLOOD, V62, P1; Moretti E, 2009, CURR OPIN ONCOL, V21, P507, DOI 10.1097/CCO.0b013e328331a501; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Ohtake S, 2011, BLOOD, V117, P2358, DOI 10.1182/blood-2010-03-273243; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Wojnowski L, 2005, CIRCULATION, V112, P3754, DOI 10.1161/CIRCULATIONAHA.105.576850; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1	30	91	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28491	10.1371/journal.pone.0028491	http://dx.doi.org/10.1371/journal.pone.0028491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164300	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400101
J	Marino, IAM; Pujolar, JM; Zane, L				Marino, Ilaria A. M.; Pujolar, Jose Martin; Zane, Lorenzo			Reconciling Deep Calibration and Demographic History: Bayesian Inference of Post Glacial Colonization Patterns in Carcinus aestuarii (Nardo, 1847) and C. maenas (Linnaeus, 1758)	PLOS ONE			English	Article							POPULATION-STRUCTURE; TIME DEPENDENCY; MITOCHONDRIAL PHYLOGEOGRAPHY; MEDITERRANEAN SEA; GENETIC-STRUCTURE; MOLECULAR-RATES; ICE-SHEET; DIVERGENCE; EVOLUTION; MODEL	A precise inference of past demographic histories including dating of demographic events using Bayesian methods can only be achieved with the use of appropriate molecular rates and evolutionary models. Using a set of 596 mitochondrial cytochrome c oxidase I (COI) sequences of two sister species of European green crabs of the genus Carcinus (C. maenas and C. aestuarii), our study shows how chronologies of past evolutionary events change significantly with the application of revised molecular rates that incorporate biogeographic events for calibration and appropriate demographic priors. A clear signal of demographic expansion was found for both species, dated between 10,000 and 20,000 years ago, which places the expansions events in a time frame following the Last Glacial Maximum (LGM). In the case of C. aestuarii, a population expansion was only inferred for the Adriatic-Ionian, suggestive of a colonization event following the flooding of the Adriatic Sea (18,000 years ago). For C. maenas, the demographic expansion inferred for the continental populations of West and North Europe might result from a northward recolonization from a southern refugium when the ice sheet retreated after the LGM. Collectively, our results highlight the importance of using adequate calibrations and demographic priors in order to avoid considerable overestimates of evolutionary time scales.	[Marino, Ilaria A. M.; Pujolar, Jose Martin; Zane, Lorenzo] Univ Padua, Dept Biol, Padua, Italy	University of Padua	Marino, IAM (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	lorenzo.zane@unipd.it	Zane, Lorenzo/G-6249-2010	Zane, Lorenzo/0000-0002-6963-2132; pujolar, marti/0000-0002-5037-8840	CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System); University of Padova	CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System); University of Padova	This work was supported by a CORILA (Consortium for Coordination of Research Activities Concerning the Venice Lagoon System) grant to LZ and a PhD Fellowship in "Biologia Evoluzionistica'' from the University of Padova to IAMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astolfi L, 2005, MAR ECOL PROG SER, V297, P233, DOI 10.3354/meps297233; Ayala FJ, 1997, P NATL ACAD SCI USA, V94, P7776, DOI 10.1073/pnas.94.15.7776; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Behrens Yamada S, 2001, GLOBAL INVADER EUROP; Borrero-Perez GH, 2011, MOL ECOL, V20, P1964, DOI 10.1111/j.1365-294X.2011.05068.x; Brown J, 1999, ESTUAR COAST SHELF S, V48, P343, DOI 10.1006/ecss.1999.0426; Bucklin A, 2003, MAR BIOL, V142, P333, DOI 10.1007/s00227-002-0943-1; Bulnheim HP, 1996, INT REV GES HYDROBIO, V81, P611, DOI 10.1002/iroh.19960810417; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Congiu L, 2002, MAR ECOL PROG SER, V229, P279, DOI 10.3354/meps229279; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dawson AG, 1992, ICE AGE EARTH LATE Q; Debes PV, 2008, MOL ECOL, V17, P3873, DOI 10.1111/j.1365-294X.2008.03872.x; Debruyne R, 2009, SYST BIOL, V58, P348, DOI 10.1093/sysbio/syp028; DEMEUSY NOELLE, 1958, ARCH ZOOL EXPTL ET GEN, V95, P253; Domingues CP, 2010, MAR ECOL PROG SER, V410, P111, DOI 10.3354/meps08610; Dov Por Francis, 2010, P13; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foss A, 1998, J FISH BIOL, V53, P901, DOI 10.1111/j.1095-8649.1998.tb01845.x; Fu YX, 1997, GENETICS, V147, P915; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Gysels ES, 2004, MOL ECOL, V13, P403, DOI 10.1046/j.1365-294X.2003.02087.x; HASEGAWA M, 1989, JPN J GENET, V64, P243, DOI 10.1266/jjg.64.243; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2008, BIOL LETTERS, V4, P370, DOI 10.1098/rsbl.2008.0073; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hoarau G, 2004, J SEA RES, V51, P183, DOI 10.1016/j.seares.2003.12.002; Hofreiter M, 2004, CURR BIOL, V14, P40, DOI 10.1016/j.cub.2003.12.035; Howell N, 2008, HEREDITY, V101, P107, DOI 10.1038/hdy.2008.52; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Huelsenbeck JP, 2000, GENETICS, V154, P1879; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lecomte F, 2004, MOL ECOL, V13, P2169, DOI 10.1111/j.1365-294X.2004.02229.x; Lepage T, 2006, MATH BIOSCI, V199, P216, DOI 10.1016/j.mbs.2005.11.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Maltagliati F, 2010, BIOL J LINN SOC, V100, P910, DOI 10.1111/j.1095-8312.2010.01482.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Mona S, 2007, MOL PHYLOGENET EVOL, V45, P757, DOI 10.1016/j.ympev.2007.05.025; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Pampoulie C, 2008, BIOL J LINN SOC, V94, P315, DOI 10.1111/j.1095-8312.2008.00995.x; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; PATWARY MU, 1994, J SHELLFISH RES, V13, P547; Penny D, 2005, NATURE, V436, P183, DOI 10.1038/436183a; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Por FD, 2006, MARE NOSTRUM NEOGENE; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pujolar JM, 2010, MOL PHYLOGENET EVOL, V57, P942, DOI 10.1016/j.ympev.2010.08.002; Ramakrishnan U, 2009, MOL ECOL, V18, P4341, DOI 10.1111/j.1365-294X.2009.04334.x; Rambaut A, 2007, TRACER VERSION 1 5 M; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RICE A L, 1975, Bulletin of the British Museum (Natural History) Zoology, V28, P101; Ritten RJ, 1986, SCIENCE, V231, P1393; Rogl F, 1999, GEOL CARPATH, V50, P339; Rogl F., 1983, ANN NATURH MUS WIEN, V85, P135; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Saarma U, 2007, MOL ECOL, V16, P401, DOI 10.1111/j.1365-294X.2006.03130.x; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shaw PW, 1999, HEREDITY, V83, P490, DOI 10.1038/sj.hdy.6885860; Siegert MJ, 2004, QUATERNARY SCI REV, V23, P1273, DOI 10.1016/j.quascirev.2003.12.010; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THIEDE J, 1978, NATURE, V276, P680, DOI 10.1038/276680a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Van Vliet-Lanoe B, 2007, CR GEOSCI, V339, P1, DOI 10.1016/j.crte.2006.12.001; Villacorta C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-7; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Zane L, 2006, MOL ECOL, V15, P4499, DOI 10.1111/j.1365-294X.2006.03105.x; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	94	34	34	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28567	10.1371/journal.pone.0028567	http://dx.doi.org/10.1371/journal.pone.0028567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164307	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400109
J	Marko, K; Kohidi, T; Hadinger, N; Jelitai, M; Mezo, G; Madarasz, E				Marko, Karoly; Kohidi, Timea; Hadinger, Nora; Jelitai, Marta; Mezo, Gabor; Madarasz, Emilia			Isolation of Radial Glia-Like Neural Stem Cells from Fetal and Adult Mouse Forebrain via Selective Adhesion to a Novel Adhesive Peptide-Conjugate	PLOS ONE			English	Article							CEREBRAL-CORTEX; IN-VITRO; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NERVOUS-SYSTEM; OLFACTORY-BULB; DIFFERENTIATION; INTEGRINS; ASTROCYTES; GROWTH	Preferential adhesion of neural stem cells to surfaces covered with a novel synthetic adhesive polypeptide (AK-cyclo[RGDfC]) provided a unique, rapid procedure for isolating radial glia-like cells from both fetal and adult rodent brain. Radial glia-like (RGl) neural stem/progenitor cells grew readily on the peptide-covered surfaces under serum-free culture conditions in the presence of EGF as the only growth factor supplement. Proliferating cells derived either from fetal (E 14.5) forebrain or from different regions of the adult brain maintained several radial glia-specific features including nestin, RC2 immunoreactivity and Pax6, Sox2, Blbp, Glast gene expression. Proliferating RGl cells were obtained also from non-neurogenic zones including the parenchyma of the adult cerebral cortex and dorsal midbrain. Continuous proliferation allowed isolating one-cell derived clones of radial glia-like cells. All clones generated neurons, astrocytes and oligodendrocytes under appropriate inducing conditions. Electrophysiological characterization indicated that passive conductance with large delayed rectifying potassium current might be a uniform feature of non-induced radial glia-like cells. Upon induction, all clones gave rise to GABAergic neurons. Significant differences were found, however, among the clones in the generation of glutamatergic and cathecolamine-synthesizing neurons and in the production of oligodendrocytes.	[Marko, Karoly; Kohidi, Timea; Hadinger, Nora; Jelitai, Marta; Madarasz, Emilia] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Mezo, Gabor] Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Peptide Chem, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Eotvos Lorand University; Hungarian Academy of Sciences	Marko, K (corresponding author), Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.	marko@koki.hu			National Office for Research and Technology (NKTH); Hungarian Scientific Research Fund [OTKA 68940, K-68939]; Hungarian Academy of Sciences	National Office for Research and Technology (NKTH)(National Office for Research and Technology); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	The study was supported by the National Office for Research and Technology (NKTH) NTP grant "Bio-Surf'', the grants of Hungarian Scientific Research Fund (OTKA 68940 and K-68939) and by the "Janos Bolyai'' scholarship of the Hungarian Academy of Sciences to J.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; Aplin AE, 1998, PHARMACOL REV, V50, P197; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Baron W, 2005, GLIA, V49, P467, DOI 10.1002/glia.20132; Birchmeier C, 2009, EXP CELL RES, V315, P611, DOI 10.1016/j.yexcr.2008.10.035; Bithell A, 2008, STEM CELLS, V26, P1565, DOI 10.1634/stemcells.2007-0832; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Campos LS, 2005, BIOESSAYS, V27, P698, DOI 10.1002/bies.20256; Carstea BV, 2007, CLONING STEM CELLS, V9, P247, DOI 10.1089/clo.2006.0055; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; ffrench-Constant C, 2004, TRENDS CELL BIOL, V14, P678, DOI 10.1016/j.tcb.2004.10.005; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Ghashghaei HT, 2007, GENE DEV, V21, P3258, DOI 10.1101/gad.1580407; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Goodman SL, 2002, J MED CHEM, V45, P1045, DOI 10.1021/jm0102598; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gubert F, 2009, BRAIN RES, V1258, P43, DOI 10.1016/j.brainres.2008.12.021; Hadinger N, 2009, INT J DEV NEUROSCI, V27, P365, DOI 10.1016/j.ijdevneu.2009.02.004; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; HUDECZ F, 1995, ANTI-CANCER DRUG, V6, P171, DOI 10.1097/00001813-199504000-00001; Jelitai M, 2007, J NEUROSCI RES, V85, P1606, DOI 10.1002/jnr.21282; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KOIVUNEN E, 1995, BIO-TECHNOL, V13, P265, DOI 10.1038/nbt0395-265; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8; Marko K, 2008, BIOCONJUGATE CHEM, V19, P1757, DOI 10.1021/bc8000134; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nelson AD, 2008, STEM CELLS, V26, P348, DOI 10.1634/stemcells.2007-0299; Nolte C, 2001, GLIA, V33, P72; Onorati M, 2010, CELL MOL LIFE SCI; Patten BA, 2003, J NEUROSCI, V23, P6132, DOI 10.1523/JNEUROSCI.23-14-06132.2003; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schlett K, 1997, J NEUROSCI RES, V47, P405; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; Tarnok K, 2002, EUR J CELL BIOL, V81, P403, DOI 10.1078/0171-9335-00262; Varga BV, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-89; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x	45	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28538	10.1371/journal.pone.0028538	http://dx.doi.org/10.1371/journal.pone.0028538			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22163310	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400105
J	Taylor, AH; Elliffe, DM; Hunt, GR; Emery, NJ; Clayton, NS; Gray, RD				Taylor, Alex H.; Elliffe, Douglas M.; Hunt, Gavin R.; Emery, Nathan J.; Clayton, Nicola S.; Gray, Russell D.			New Caledonian Crows Learn the Functional Properties of Novel Tool Types	PLOS ONE			English	Article							CORVUS-MONEDULOIDES; HOOK-TOOLS; MANUFACTURE; COGNITION	New Caledonian crows were presented with Bird and Emery's (2009a) Aesop's fable paradigm, which requires stones to be dropped into a water-filled tube to bring floating food within reach. The crows did not spontaneously use stones as tools, but quickly learned to do so, and to choose objects and materials with functional properties. Some crows discarded both inefficient and non-functional objects before observing their effects on the water level. Interestingly, the crows did not learn to discriminate between functional and non-functional objects and materials when there was an arbitrary, rather than causal, link between object and reward. This finding suggests that the crows' performances were not based on associative learning alone. That is, learning was not guided solely by the covariation rate between stimuli and outcomes or the conditioned reinforcement properties acquired by functional objects. Our results, therefore, show that New Caledonian crows can process causal information not only when it is linked to sticks and stick-like tools but also when it concerns the functional properties of novel types of tool.	[Taylor, Alex H.; Elliffe, Douglas M.; Hunt, Gavin R.; Gray, Russell D.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Emery, Nathan J.] Queen Mary Univ, Sch Biol & Chem Sci, London, England; [Taylor, Alex H.; Clayton, Nicola S.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Auckland; University of London; Queen Mary University London; University of Cambridge	Taylor, AH (corresponding author), Univ Auckland, Dept Psychol, Auckland, New Zealand.	at564@cam.ac.uk	Taylor, Alex H/D-6428-2012; Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Clayton, Nicola/0000-0003-1835-423X; Elliffe, Douglas/0000-0001-9449-9540; Taylor, Alex/0000-0003-3492-7667	Cogito Foundation; Corpus Christi College, Cambridge; New Zealand Marsden Fund; Royal Society University	Cogito Foundation; Corpus Christi College, Cambridge; New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society University(Royal Society of London)	This work was supported by the Cogito Foundation and a Junior Research Fellowship from Corpus Christi College, Cambridge (Dr. Taylor). Additional support was provided by a grant from the New Zealand Marsden Fund (Dr. Hunt, Dr. Taylor and Dr. Gray). Dr. Elliffe was supported by a Royal Society University Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bird CD, 2009, CURR BIOL, V19, P1410, DOI 10.1016/j.cub.2009.07.033; Cheke LG, 2011, ANIM COGN, V14, P441, DOI 10.1007/s10071-011-0379-4; Hunt GR, 2000, P ROY SOC B-BIOL SCI, V267, P403, DOI 10.1098/rspb.2000.1015; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2004, P ROY SOC B-BIOL SCI, V271, pS88, DOI 10.1098/rsbl.2003.0085; Hunt GR, 2004, ANIM COGN, V7, P114, DOI 10.1007/s10071-003-0200-0; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; McGrew WC, 2010, SCIENCE, V328, P579, DOI 10.1126/science.1187921; Sterelny K, 2003, THOUGHT HOSTILE WORL; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; TAYLOR AH, 2011, BIOL LETT IN PRESS; Taylor Alex, 2009, Communicative & Integrative Biology, V2, P311; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; VANLAWIC.J, 1966, NATURE, V212, P1468, DOI 10.1038/2121468a0; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5	21	50	50	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e26887	10.1371/journal.pone.0026887	http://dx.doi.org/10.1371/journal.pone.0026887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194779	Green Published, Green Submitted, gold			2022-12-27	WOS:000298369100002
J	Guerra, S; Abaitua, F; Martinez-Sobrido, L; Esteban, M; Garcia-Sastre, A; Rodriguez, D				Guerra, Susana; Abaitua, Fernando; Martinez-Sobrido, Luis; Esteban, Mariano; Garcia-Sastre, Adolfo; Rodriguez, Dolores			Host-Range Restriction of Vaccinia Virus E3L Deletion Mutant Can Be Overcome In Vitro, but Not In Vivo, by Expression of the Influenza Virus NS1 Protein	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INTERFERON REGULATORY FACTOR-3; HUMAN HELA-CELLS; Z-DNA-BINDING; NF-KAPPA-B; KINASE PKR; IMMUNE-RESPONSE; GENE-EXPRESSION; INFECTED-CELLS; SIGNALING PATHWAY	During the last decades, research focused on vaccinia virus (VACV) pathogenesis has been intensified prompted by its potential beneficial application as a vector for vaccine development and anti-cancer therapies, but also due to the fear of its potential use as a bio-terrorism threat. Recombinant viruses lacking a type I interferon (IFN) antagonist are attenuated and hence good vaccine candidates. However, vaccine virus growth requires production in IFN-deficient systems, and thus viral IFN antagonists that are active in vitro, yet not in vivo, are of great value. The VACV E3 and influenza virus NS1 proteins are distinct double-stranded RNA-binding proteins that play an important role in pathogenesis by inhibiting the mammalian IFN-regulated innate antiviral response. Based on the functional similarities between E3 and NS1, we investigated the ability of NS1 to replace the biological functions of E3 of VACV in both in vitro and in vivo systems. For this, we generated a VACV recombinant virus lacking the E3L gene, yet expressing NS1 (VV Delta E3L/NS1). Our study revealed that NS1 can functionally replace E3 in cultured cells, rescuing the protein synthesis blockade, and preventing apoptosis and RNA breakdown. In contrast, in vivo the VV Delta E3L/NS1 virus was highly attenuated after intranasal inoculation, as it was unable to spread to the lungs and other organs. These results indicate that there are commonalities but also functional differences in the roles of NS1 and E3 as inhibitors of the innate antiviral response, which could potentially be utilized for vaccine production purposes in the future.	[Guerra, Susana; Abaitua, Fernando; Esteban, Mariano; Rodriguez, Dolores] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Guerra, Susana] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [Martinez-Sobrido, Luis] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Autonomous University of Madrid; University of Rochester; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Guerra, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	susana.guerra@uam.es; drodrig@cnb.csic.es	guerra, susana/K-5972-2014; Martinez-Sobrido, Luis/ACJ-7853-2022; Esteban, Mariano/ABG-5375-2020; Rodriguez, Dolores/ABF-9855-2020	guerra, susana/0000-0001-9067-2991; Martinez-Sobrido, Luis/0000-0001-7084-0804; Esteban, Mariano/0000-0003-0846-2827; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Rodriguez, Dolores/0000-0001-6365-4501	Ramon y Cajal of Spain; Spanish Ministry of Health [FIS 2009-80145]; Comunidad de Madrid [UAM-CM-CCG10-4911]; UAM-Banco de Santander; Spanish Ministry of Science and Technology [CSD2006-00007, AGL2010-15495]; NIAID [R01AI046954, U19AI083025, HHSN266200700010C]; CRIP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046954, U19AI083025] Funding Source: NIH RePORTER	Ramon y Cajal of Spain; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Comunidad de Madrid(Comunidad de Madrid); UAM-Banco de Santander; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CRIP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	SG holds a research contract from the program Ramon y Cajal of Spain. This work was supported by grants from the Spanish Ministry of Health FIS 2009-80145, Comunidad de Madrid UAM-CM-CCG10-4911 and UAM-Banco de Santander to S. Guerra and from the Spanish Ministry of Science and Technology CONSOLIDER-PORCIVIR CSD2006-00007 and AGL2010-15495 to D. Rodriguez. This work is also partly supported by NIAID grants R01AI046954, U19AI083025, and by CRIP, an NIAID-funded Center of Excellence for Influenza Research and Surveillance (HHSN266200700010C) to AG-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcami A, 2002, J GEN VIROL, V83, P545, DOI 10.1099/0022-1317-83-3-545; BEATTIE E, 1995, J VIROL, V69, P499, DOI 10.1128/JVI.69.1.499-505.1995; Beattie E, 1996, VIRUS GENES, V12, P89, DOI 10.1007/BF00370005; Brandt T, 2005, VIROLOGY, V333, P263, DOI 10.1016/j.virol.2005.01.006; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; CHANG HW, 1993, VIROLOGY, V194, P537, DOI 10.1006/viro.1993.1292; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; CHANG HW, 1995, J VIROL, V69, P6605, DOI 10.1128/JVI.69.10.6605-6608.1995; COLAMONICI OR, 1995, J BIOL CHEM, V270, P15974, DOI 10.1074/jbc.270.27.15974; DAVIES MV, 1993, J VIROL, V67, P1688, DOI 10.1128/JVI.67.3.1688-1692.1993; Deng L, 2006, J VIROL, V80, P9977, DOI 10.1128/JVI.00354-06; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gherardi MM, 1999, J IMMUNOL, V162, P6724; Gomez CE, 2011, CURR GENE THER, V11, P189; Guerra S, 2003, J VIROL, V77, P6493, DOI 10.1128/JVI.77.11.6493-6506.2003; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Hrincius ER, 2010, CELL MICROBIOL, V12, P831, DOI 10.1111/j.1462-5822.2010.01436.x; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Kwon JA, 2005, P NATL ACAD SCI USA, V102, P12759, DOI 10.1073/pnas.0506011102; Langland JO, 2006, J VIROL, V80, P10083, DOI 10.1128/JVI.00607-06; Langland JO, 2004, VIROLOGY, V324, P419, DOI 10.1016/j.virol.2004.03.012; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; LANGLAND JO, 1994, J VIROL, V68, P3821, DOI 10.1128/JVI.68.6.3821-3829.1994; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Moss B, 2001, SEMIN IMMUNOL, V13, P59, DOI 10.1006/smim.2000.0296; MOSS B, 2007, FIELDS VIROLOGY, V2; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; Osiak A, 2005, MOL CELL BIOL, V25, P6338, DOI 10.1128/MCB.25.15.6338-6345.2005; Pang QS, 2002, J BIOL CHEM, V277, P49638, DOI 10.1074/jbc.M209386200; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; Rice AD, 2011, J VIROL, V85, P550, DOI 10.1128/JVI.00254-10; Rivas C, 1998, VIROLOGY, V243, P406, DOI 10.1006/viro.1998.9072; RODRIGUEZ JR, 1992, J VIROL, V66, P183, DOI 10.1128/JVI.66.1.183-189.1992; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; SEN, 1992, J BIOL CHEM, V267, P5017; Shors ST, 1998, J INTERF CYTOK RES, V18, P721, DOI 10.1089/jir.1998.18.721; SIMPSONHOLLEY M, 2010, J VIROL; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Smith EJ, 2001, J BIOL CHEM, V276, P8951, DOI 10.1074/jbc.M008717200; Smith GL, 1997, IMMUNOL REV, V159, P137, DOI 10.1111/j.1600-065X.1997.tb01012.x; Sroller V, 2001, ARCH VIROL, V146, P239, DOI 10.1007/s007050170172; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Tan SL, 1998, J INTERF CYTOK RES, V18, P757, DOI 10.1089/jir.1998.18.757; Valentine R, 2010, J GEN VIROL, V91, P2221, DOI 10.1099/vir.0.021998-0; Varga ZT, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002067; Vijaysri S, 2003, VIROLOGY, V314, P305, DOI 10.1016/S0042-6822(03)00433-1; Vijaysri S, 2008, VACCINE, V26, P664, DOI 10.1016/j.vaccine.2007.11.045; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Xiang Y, 2002, J VIROL, V76, P5251, DOI 10.1128/JVI.76.10.5251-5259.2002; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	60	11	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28677	10.1371/journal.pone.0028677	http://dx.doi.org/10.1371/journal.pone.0028677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174864	Green Published, gold			2022-12-27	WOS:000298367300020
J	Mourad, R; Sinoquet, C; Dina, C; Leray, P				Mourad, Raphael; Sinoquet, Christine; Dina, Christian; Leray, Philippe			Visualization of Pairwise and Multilocus Linkage Disequilibrium Structure Using Latent Forests	PLOS ONE			English	Article							GRAPHICAL MODELS; HUMAN GENOME; HAPLOTYPE; MAP; INFERENCE; SNPS; LOCI	Linkage disequilibrium study represents a major issue in statistical genetics as it plays a fundamental role in gene mapping and helps us to learn more about human history. The linkage disequilibrium complex structure makes its exploratory data analysis essential yet challenging. Visualization methods, such as the triangular heat map implemented in Haploview, provide simple and useful tools to help understand complex genetic patterns, but remain insufficient to fully describe them. Probabilistic graphical models have been widely recognized as a powerful formalism allowing a concise and accurate modeling of dependences between variables. In this paper, we propose a method for short-range, long-range and chromosome-wide linkage disequilibrium visualization using forests of hierarchical latent class models. Thanks to its hierarchical nature, our method is shown to provide a compact view of both pairwise and multilocus linkage disequilibrium spatial structures for the geneticist. Besides, a multilocus linkage disequilibrium measure has been designed to evaluate linkage disequilibrium in hierarchy clusters. To learn the proposed model, a new scalable algorithm is presented. It constrains the dependence scope, relying on physical positions, and is able to deal with more than one hundred thousand single nucleotide polymorphisms. The proposed algorithm is fast and does not require phase genotypic data.	[Mourad, Raphael; Leray, Philippe] Univ Nantes, Ecole Polytech, UMR CNRS 6241, LINA, Nantes, France; [Dina, Christian] INSERM, UMR 915, Inst Thorax, Nantes, France	Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Mourad, R (corresponding author), Univ Nantes, Ecole Polytech, UMR CNRS 6241, LINA, BP 50609, Nantes, France.	raphael.mourad@univ-nantes.fr; christine.sinoquet@nantes.fr	Dina, Christian R/D-3535-2015; Leray, Philippe/AAR-5500-2020	Dina, Christian R/0000-0002-7722-7348; Leray, Philippe/0000-0002-0207-9280	Pays de la Loire Region, France	Pays de la Loire Region, France(Region Pays de la Loire)	This work was supported by the BIL Bioinformatics Research Project of Pays de la Loire Region, France. The funder supported the PhD grant of the first author, Raphael Mourad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson EC, 2003, AM J HUM GENET, V73, P336, DOI 10.1086/377106; Azuaje F, 2005, DATA ANALYSIS AND VISUALIZATION IN GENOMICS AND PROTEOMICS, P1, DOI 10.1002/0470094419; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben-Dor A, 1999, P 3 ANN INT C COMP M, P33; Cannings C, 2007, HDB STAT GENETICS, P878; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DAVID J, 2001, PRINCIPLES DATA MINI; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FRY B, 2004, THESIS MIT; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kullback S., 1968, INFORM THEORY STAT; Kumasaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010207; MCVEAN G, 2007, HDB STAT GENETICS, V2, P909; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; MORRIS AP, 2007, HDB STAT GENETICS, V2, P1238; MOURAD R, 2010, 19 INT C COMP STAT C, P549; Mourad R, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-16; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Robbins MD, 2011, J EXP BOT, V62, P1831, DOI 10.1093/jxb/erq367; Simoff SJ, 2008, LECT NOTES COMPUT SC, V4404, P1, DOI 10.1007/978-3-540-71080-6; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Thomas A, 2004, AM J HUM GENET, V74, P1088, DOI 10.1086/421249; Thomas A, 2009, COMPUT STAT DATA AN, V53, P1818, DOI 10.1016/j.csda.2008.02.003; Thomas A, 2009, BIOINFORMATICS, V25, P1287, DOI 10.1093/bioinformatics/btp146; Verzilli CJ, 2006, AM J HUM GENET, V79, P100, DOI 10.1086/505313; WATANABE S, 1960, IBM J RES DEV, V4, P6682	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e27320	10.1371/journal.pone.0027320	http://dx.doi.org/10.1371/journal.pone.0027320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174739	gold, Green Published			2022-12-27	WOS:000298367300005
J	Li, WL; Wang, W; Sun, SP; Sun, Y; Pan, Y; Wang, LN; Zhang, R; Zhang, K; Li, JM				Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang; Wang, Lunan; Zhang, Rui; Zhang, Kuo; Li, Jinming			Autoantibodies against the Catalytic Domain of BRAF Are Not Specific Serum Markers for Rheumatoid Arthritis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; INTERLEUKIN-6; RESPONSES; LUPUS; MAPKS	Background: Autoantibodies to the catalytic domain of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) have been recently identified as a new family of autoantibodies involved in rheumatoid arthritis (RA). The objective of this study was to determine antibody responses to the catalytic domain of BRAF in RA and other autoimmune diseases. The association between RA-related clinical indices and these antibodies was also assessed. Methodology/Principal Findings: The presence of autoantibodies to the catalytic domain of BRAF (anti-BRAF) or to peptide P25 (amino acids 656-675 of the catalytic domain of BRAF; anti-P25) was determined in serum samples from patients with RA, primary Sjogren's syndrome (pSS), systemic lupus erythematosus (SLE), and healthy controls by using indirect enzyme-linked immunosorbent assays (ELISAs) based on the recombinant catalytic domain of BRAF or a synthesized peptide, respectively. Associations of anti-BRAF or anti-P25 with disease variables of RA patients were also evaluated. Our results show that the BRAF-specific antibodies anti-BRAF and anti-P25 are equally present in RA, pSS, and SLE patients. However, the erythrocyte sedimentation rate (ESR) used to detect inflammation was significantly different between patients with and without BRAF-specific antibodies. The anti-BRAF-positive patients were found to have prolonged disease, and active disease occurred more frequently in anti-P25-positive patients than in anti-P25-negative patients. A weak but significant correlation between anti-P25 levels and ESRs was observed (r = 0.319, p = 0.004). Conclusions/Significance: The antibody response against the catalytic domain of BRAF is not specific for RA, but the higher titers of BRAF-specific antibodies may be associated with increased inflammation in RA.	[Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang; Wang, Lunan; Zhang, Rui; Zhang, Kuo; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Li, Wenli; Wang, Wei; Sun, Shipeng; Sun, Yu; Pan, Yang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing 100730, Peoples R China	Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, WL (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.	ljm63hn@yahoo.com.cn	Wang, Lunan/AAS-9785-2021	Wang, Lunan/0000-0003-3163-7891	National High Technology Reseach and Development Program of China (863 Program) [2011AA02A116]	National High Technology Reseach and Development Program of China (863 Program)	This work was supported by a grant from the National High Technology Reseach and Development Program of China (863 Program) (No. 2011AA02A116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Auger I, 2009, ANN RHEUM DIS, V68, P591, DOI 10.1136/ard.2008.096917; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Charpin C, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3165; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Bonito Paola, 2006, Infect Agent Cancer, V1, P6, DOI 10.1186/1750-9378-1-6; Fensterle J, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-62; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Lacki JK, 1997, CLIN RHEUMATOL, V16, P275, DOI 10.1007/BF02238963; Luo SF, 2010, ARTHRITIS RHEUM-US, V62, P105, DOI 10.1002/art.25060; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Raptopoulou A, 2007, CRIT REV CL LAB SCI, V44, P339, DOI 10.1080/10408360701295623; Richards HB, 1998, J EXP MED, V188, P985, DOI 10.1084/jem.188.5.985; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Strumberg D, 2002, Int J Clin Pharmacol Ther, V40, P580; Sweeney SE, 2004, CURR OPIN RHEUMATOL, V16, P231, DOI 10.1097/00002281-200405000-00011; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Wang W, 2011, CLIN RHEUMATOL, V30, P563, DOI 10.1007/s10067-010-1671-4; Westermarck J, 2001, MOL CELL BIOL, V21, P2373, DOI 10.1128/MCB.21.7.2373-2383.2001; Yang JC, 1996, INFECT IMMUN, V64, P3584, DOI 10.1128/IAI.64.9.3584-3591.1996	22	0	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28975	10.1371/journal.pone.0028975	http://dx.doi.org/10.1371/journal.pone.0028975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174938	Green Submitted, Green Published, gold			2022-12-27	WOS:000298366600054
J	Liao, HH; Irvine, AD; MacEwen, CJ; Weed, KH; Porter, L; Corden, LD; Gibson, AB; Moore, JE; Smith, FJD; McLean, WHI; Moore, CBT				Liao, Haihui; Irvine, Alan D.; MacEwen, Caroline J.; Weed, Kathryn H.; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Moore, Jonathan E.; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara			Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy	PLOS ONE			English	Article							KANGAROO PTK2 CELLS; MUTATIONS; GENE; DISORDERS; DISEASE; EXPRESSION; SPECTRUM; CLONING; RNAI; K12	Background: Meesmann epithelial corneal dystrophy (MECD) is an inherited eye disorder caused by dominant-negative mutations in either keratins K3 or K12, leading to mechanical fragility of the anterior corneal epithelium, the outermost covering of the eye. Typically, patients suffer from lifelong irritation of the eye and/or photophobia but rarely lose visual acuity; however, some individuals are severely affected, with corneal scarring requiring transplant surgery. At present no treatment exists which addresses the underlying pathology of corneal dystrophy. The aim of this study was to design and assess the efficacy and potency of an allele-specific siRNA approach as a future treatment for MECD. Methods and Findings: We studied a family with a consistently severe phenotype where all affected persons were shown to carry heterozygous missense mutation Leu132Pro in the KRT12 gene. Using a cell-culture assay of keratin filament formation, mutation Leu132Pro was shown to be significantly more disruptive than the most common mutation, Arg135Thr, which is associated with typical, mild MECD. A siRNA sequence walk identified a number of potent inhibitors for the mutant allele, which had no appreciable effect on wild-type K12. The most specific and potent inhibitors were shown to completely block mutant K12 protein expression with negligible effect on wild-type K12 or other closely related keratins. Cells transfected with wild-type K12-EGFP construct show a predominantly normal keratin filament formation with only 5% aggregate formation, while transfection with mutant K12-EGFP construct resulted in a significantly higher percentage of keratin aggregates (41.75%; p<0.001 with 95% confidence limits). The lead siRNA inhibitor significantly rescued the ability to form keratin filaments (74.75% of the cells contained normal keratin filaments; p<0.001 with 95% confidence limits). Conclusions: This study demonstrates that it is feasible to design highly potent siRNA against mutant alleles with single-nucleotide specificity for future treatment of MECD.	[Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Life Sci & Med, Div Mol Med, Dundee, Scotland; [Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Dent, Div Mol Med, Dundee, Scotland; [Liao, Haihui; Porter, Louise; Corden, Laura D.; Gibson, A. Bethany; Smith, Frances J. D.; McLean, W. H. Irwin; Moore, C. B. Tara] Univ Dundee, Coll Nursing, Div Mol Med, Dundee, Scotland; [Irvine, Alan D.] Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; [Irvine, Alan D.] Trinity Coll Dublin, Inst Mol Med, Dublin, Ireland; [MacEwen, Caroline J.; Weed, Kathryn H.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Ophthalmol, Dundee DD1 9SY, Scotland; [Moore, Jonathan E.; Moore, C. B. Tara] Univ Ulster, Sch Biomed Sci, Coleraine, Londonderry, North Ireland	University of Dundee; University of Dundee; University of Dundee; Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; Ulster University	Liao, HH (corresponding author), Univ Dundee, Coll Life Sci & Med, Div Mol Med, Dundee, Scotland.	w.h.i.mclean@dundee.ac.uk	Irvine, Alan D/A-3982-2008; Porter, Louise/GQP-6108-2022	Irvine, Alan D/0000-0002-9048-2044; Moore, Johnny/0000-0001-8451-9421; Moore, Tara/0000-0002-7659-9326; Porter, Louise/0000-0002-7406-0319; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research Council [G0801742, G0802780]; Fight for Sight; MRC [G0801742, G0802780] Funding Source: UKRI; National Institute for Health Research [ACF-2007-06-011] Funding Source: researchfish; Fight for Sight [1879/80] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	This work was funded by grants from The Medical Research Council (grant numbers G0801742 and G0802780, to WHIM and FJDS) and Fight for Sight (to WHIM and CBTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASEHOAR G, 1973, SCIENCE, V179, P1333, DOI 10.1126/science.179.4080.1333; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boutboul S, 2006, HUM MUTAT, V27, P553, DOI 10.1002/humu.20331; Bumcrot D, 2006, NAT CHEM BIOL, V2, P711, DOI 10.1038/nchembio839; Chiou AGY, 1998, CORNEA, V17, P566; Corden LD, 2000, EXP EYE RES, V70, P41, DOI 10.1006/exer.1999.0769; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392; Goldberg A, 1997, INT OPHTHALMOL, V21, P117, DOI 10.1023/A:1026456232212; HANNA C, 1960, ARCH OPHTHALMOL-CHIC, V64, P536; Hao J, 2010, BRAIN RES BULL, V81, P256, DOI 10.1016/j.brainresbull.2009.06.011; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Irvine AD, 2002, BRIT J OPHTHALMOL, V86, P729, DOI 10.1136/bjo.86.7.729; Irvine AD, 1997, NAT GENET, V16, P184, DOI 10.1038/ng0697-184; Irvine AD, 1999, BRIT J DERMATOL, V140, P815, DOI 10.1046/j.1365-2133.1999.02810.x; Kao WWY, 1996, INVEST OPHTH VIS SCI, V37, P2572; Kaspar RL, 2005, J INVEST DERM SYMP P, V10, P62, DOI 10.1111/j.1087-0024.2005.10208.x; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; LANE EB, 2008, DRUG DISCOV TODAY, V5, pE93; Leachman SA, 2008, J DERMATOL SCI, V51, P151, DOI 10.1016/j.jdermsci.2008.04.003; Lewin AS, 2005, J INVEST DERM SYMP P, V10, P47, DOI 10.1111/j.1087-0024.2005.10207.x; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Meesmann A, 1938, BER ZUSAMMENKUNFT DT, V52, P154; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Rugg EL, 1994, KERATINOCYTE METHODS, P127; Smith FJD, 2000, EXP DERMATOL, V9, P170, DOI 10.1034/j.1600-0625.2000.009003170.x; Smith FJD, 2002, BIOCHEM BIOPH RES CO, V297, P818, DOI 10.1016/S0006-291X(02)02288-X; Smith FJD, 2008, J INVEST DERMATOL, V128, P50, DOI 10.1038/sj.jid.5701040; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; Yokota T, 2004, BIOCHEM BIOPH RES CO, V314, P283, DOI 10.1016/j.bbrc.2003.12.098	35	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28582	10.1371/journal.pone.0028582	http://dx.doi.org/10.1371/journal.pone.0028582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174841	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600024
J	Romero-Granados, R; Fontan-Lozano, A; Aguilar-Montilla, FJ; Carrion, AM				Romero-Granados, Rocio; Fontan-Lozano, Angela; Javier Aguilar-Montilla, Francisco; Manuel Carrion, Angel			Postnatal Proteasome Inhibition Induces Neurodegeneration and Cognitive Deficiencies in Adult Mice: A New Model of Neurodevelopment Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DOMOIC ACID EXPOSURE; PROTEIN-DEGRADATION; HIPPOCAMPAL NEUROGENESIS; STATUS EPILEPTICUS; OXIDATIVE STRESS; DEVELOPING BRAIN; UBIQUITIN; NEURONS; ROLES	Defects in the ubiquitin-proteasome system have been related to aging and the development of neurodegenerative disease, although the effects of deficient proteasome activity during early postnatal development are poorly understood. Accordingly, we have assessed how proteasome dysfunction during early postnatal development, induced by administering proteasome inhibitors daily during the first 10 days of life, affects the behaviour of adult mice. We found that this regime of exposure to the proteasome inhibitors MG132 or lactacystin did not produce significant behavioural or morphological changes in the first 15 days of life. However, towards the end of the treatment with proteasome inhibitors, there was a loss of mitochondrial markers and activity, and an increase in DNA oxidation. On reaching adulthood, the memory of mice that were injected with proteasome inhibitors postnatally was impaired in hippocampal and amygdala-dependent tasks, and they suffered motor dysfunction and imbalance. These behavioural deficiencies were correlated with neuronal loss in the hippocampus, amygdala and brainstem, and with diminished adult neurogenesis. Accordingly, impairing proteasome activity at early postnatal ages appears to cause morphological and behavioural alterations in adult mice that resemble those associated with certain neurodegenerative diseases and/or syndromes of mental retardation.	[Romero-Granados, Rocio; Fontan-Lozano, Angela; Javier Aguilar-Montilla, Francisco; Manuel Carrion, Angel] Univ Pablo Olavide, Dept Fisiol Anat & Biol Celular, Seville, Spain	Universidad Pablo de Olavide	Romero-Granados, R (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Dept Cell Therapy & Regenerat Med, Seville, Spain.	amancar@upo.es	Romero-Granados, Rocío/AAD-6360-2019; FONTÁN-LOZANO, ÁNGELA/R-9081-2019; Carrion, Angel Manuel/K-5875-2014	FONTÁN-LOZANO, ÁNGELA/0000-0003-1646-0952; Carrion, Angel Manuel/0000-0001-8158-9512	Junta de Andalucia [BIO-122]; Fundacion Ramon Areces; DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas) [BFU2008-01552]; Juan de la Cierva; Spanish Science Ministry	Junta de Andalucia(Junta de Andalucia); Fundacion Ramon Areces; DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas); Juan de la Cierva(Instituto de Salud Carlos III); Spanish Science Ministry(Spanish Government)	This work was supported by grants from the Junta de Andalucia (BIO-122), Fundacion Ramon Areces and DGICYT (Departmento Governmental de Investigaciones Cientificas y Tecnologicas) (BFU2008-01552). AFL and RRG were supported by a Juan de la Cierva and FPU programs from Spanish Science Ministry respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; BURGARD EC, 1993, J NEUROPHYSIOL, V69, P230, DOI 10.1152/jn.1993.69.1.230; Crusio WE, 1996, PHYSIOL BEHAV, V59, P1171, DOI 10.1016/0031-9384(95)02251-1; de Kloet ER, 2005, NEUROSCI BIOBEHAV R, V29, P271, DOI 10.1016/j.neubiorev.2004.10.008; de los Santos-Arteaga M, 2003, J NEUROSCI, V23, P11120; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; DOBBING J, 1974, BRIT MED BULL, V30, P164, DOI 10.1093/oxfordjournals.bmb.a071188; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; FOX WM, 1965, ANIM BEHAV, V13, P234, DOI 10.1016/0003-3472(65)90041-2; Galvan CD, 2000, J NEUROSCI, V20, P2904; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Gill DA, 2010, BRAIN RES, V1331, P114, DOI 10.1016/j.brainres.2010.03.054; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 1997, BIOL CHEM, V378, P131; Groenewegen Henk J., 2003, Neural Plasticity, V10, P107, DOI 10.1155/NP.2003.107; Gruart A, 2007, GENES BRAIN BEHAV, V6, P24, DOI 10.1111/j.1601-183X.2007.00319.x; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Havekes R, 2007, HIPPOCAMPUS, V17, P338, DOI 10.1002/hipo.20272; Hegde AN, 2011, BBA-GENE REGUL MECH, V1809, P128, DOI 10.1016/j.bbagrm.2010.07.006; Heo JM, 2011, INT J BIOCHEM CELL B, V43, P1422, DOI 10.1016/j.biocel.2011.06.002; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hougaard KS, 2005, DEV BRAIN RES, V159, P55, DOI 10.1016/j.devbrainres.2005.06.014; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Levin ED, 2005, NEUROTOXICOL TERATOL, V27, P719, DOI 10.1016/j.ntt.2005.06.017; Levin ED, 2006, NEUROTOXICOL TERATOL, V28, P673, DOI 10.1016/j.ntt.2006.08.005; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matilla-Duenas A, 2010, CEREBELLUM, V9, P148, DOI 10.1007/s12311-009-0144-2; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Murphey RK, 2002, NEURON, V36, P5, DOI 10.1016/S0896-6273(02)00943-1; Nakano K, 2000, J NEUROL, V247, P1; NOUWS JFM, 1992, J ANIM SCI, V70, P3627, DOI 10.2527/1992.70113627x; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Pines J, 2005, NAT CELL BIOL, V7, P731, DOI 10.1038/ncb0805-731; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Santos NF, 2000, EPILEPSIA, V41, pS57, DOI 10.1111/j.1528-1157.2000.tb01558.x; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Stafstrom CE, 2005, EPILEPSY BEHAV, V7, pS18, DOI 10.1016/j.yebeh.2005.08.005; STAFSTROM CE, 1992, DEV BRAIN RES, V65, P227, DOI 10.1016/0165-3806(92)90184-X; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Tyzio R, 1999, J NEUROSCI, V19, P10372; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhao MR, 2007, BIOL PSYCHIAT, V62, P381, DOI 10.1016/j.biopsych.2006.10.019	57	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28927	10.1371/journal.pone.0028927	http://dx.doi.org/10.1371/journal.pone.0028927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174927	Green Submitted, Green Published, gold			2022-12-27	WOS:000298366600048
J	Lucio, KA; Rocha, GD; Moncao-Ribeiro, LC; Fernandes, J; Takiya, CM; Gattass, CR				Lucio, Kelly Araujo; Rocha, Gleice da Graca; Moncao-Ribeiro, Leonardo Campos; Fernandes, Janaina; Takiya, Christina Maeda; Gattass, Cerli Rocha			Oleanolic Acid Initiates Apoptosis in Non-Small Cell Lung Cancer Cell Lines and Reduces Metastasis of a B16F10 Melanoma Model In Vivo	PLOS ONE			English	Article							RESISTANCE-ASSOCIATED PROTEIN; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; URSOLIC ACID; TUMOR-GROWTH; EXPRESSION; SURVIVIN; MRP1; TRITERPENES; GLUTATHIONE	Background: Drug resistance, a process mediated by multiple mechanisms, is a critical determinant for treating lung cancer. The aim of this study is to determine if oleanolic acid (OA), a pentacyclic triterpene present in several plants, is able to circumvent the mechanisms of drug resistance present in non-small cell lung cancer (NSCLC) cell lines and to induce their death. Principal Findings: OA decreased the cell viability of the NSCLC cell lines A459 and H460 despite the presence of active, multidrug-resistant (MDR) MRP1/ABCC1 proteins and the anti-apoptotic proteins Bcl-2 and survivin. These effects are due to apoptosis, as evidenced by the capacity of OA to induce fragmentation of DNA and activate caspase 3. Induction of NSCLC cell death by OA cannot be explained by inhibition of the MDR proteins, since treatment with triterpene had little or no effect on the activity or expression of MRP1. Moreover, treatment with OA had no effect on the expression of the antiapoptotic protein Bcl-2, but increased the expression of the pro-apoptotic protein Bax, altering the Bcl-2/Bax balance towards a pro-apoptotic profile. OA also decreased the expression of the anti-apoptotic protein survivin. Furthermore, OA decreased the expression of the angiogenic vascular endothelial growth factor (VEGF) and decreased the development of melanoma-induced lung metastasis. Conclusion: Our data provide a significant insight into the antitumoral and antimetastatic activity of OA in NSCLC and suggest that including OA in the NSCLC regimens may help to decrease the number of relapses and reduce the development of metastases.	[Lucio, Kelly Araujo; Rocha, Gleice da Graca; Fernandes, Janaina; Gattass, Cerli Rocha] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Imunol Celular, Rio De Janeiro, Brazil; [Moncao-Ribeiro, Leonardo Campos; Takiya, Christina Maeda] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Lab Patol Celular, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Lucio, KA (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Imunol Celular, Rio De Janeiro, Brazil.	cerli@chagas.biof.ufrj.br	Takiya, Christina/AAU-5959-2021; Fernandes, Janaina/AAY-3331-2020; Fernandes, Janaina/E-8888-2015; Monção-Ribeiro, Leonardo/F-8633-2012	Takiya, Christina/0000-0002-8019-628X; Fernandes, Janaina/0000-0002-3442-6101; Fernandes, Janaina/0000-0002-3442-6101; Fernandes, Jennifer/0000-0002-9491-916X	Financiadora de Estudos e Projetos [FINEP/FNDCT/NQTN Conv.01.06.0390.00]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.135/2009]; Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT) [57.3695/2008-3]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)	Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Financiadora de Estudos e Projetos (FINEP/FNDCT/NQTN Conv.01.06.0390.00), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, grant number E-26/110.135/2009), Instituto Nacional para Pesquisa Translacional em Saude e Ambiente na Regiao Amazonica (INCT-INPeTAm/CNPq/MCT Conv. # 57.3695/2008-3) and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES, PhD fellowship to KAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Zaher AO, 2007, TOXICOLOGY, V234, P124, DOI 10.1016/j.tox.2007.02.014; Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; Braga F, 2007, CANCER LETT, V248, P147, DOI 10.1016/j.canlet.2006.06.008; Cheng YJ, 2010, EUR J PHARMACOL, V627, P75, DOI 10.1016/j.ejphar.2009.11.003; Dean EJ, 2010, BRIT J CANCER, V102, P97, DOI 10.1038/sj.bjc.6605418; Fernandes J, 2003, CANCER LETT, V190, P165, DOI 10.1016/S0304-3835(02)00593-1; Fernandes J, 2009, J MED CHEM, V52, P1214, DOI 10.1021/jm801389m; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gao GH, 2009, LUNG CANCER, V65, P339, DOI 10.1016/j.lungcan.2008.11.019; GEKELER V, 1995, BIOCHEM BIOPH RES CO, V208, P345, DOI 10.1006/bbrc.1995.1344; Giaccone G, 1996, INT J CANCER, V66, P760, DOI 10.1002/(SICI)1097-0215(19960611)66:6<760::AID-IJC9>3.3.CO;2-F; Giner-Larza EM, 2001, EUR J PHARMACOL, V428, P137, DOI 10.1016/S0014-2999(01)01290-0; Haura Eric B, 2004, Clin Lung Cancer, V6, P113, DOI 10.3816/CLC.2004.n.025; Hsu HY, 1997, CANCER LETT, V111, P7, DOI 10.1016/S0304-3835(96)04481-3; Ikuta K, 2005, ONCOL REP, V13, P1229; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kim YK, 2000, PLANTA MED, V66, P485, DOI 10.1055/s-2000-8585; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Krysan K, 2004, CANCER RES, V64, P6359, DOI 10.1158/0008-5472.CAN-04-1681; Laupeze B, 1999, INT J ONCOL, V15, P571; Li J, 2002, WORLD J GASTROENTERO, V8, P493, DOI 10.3748/wjg.v8.i3.493; Li J, 2008, CANCER CHEMOTH PHARM, V61, P525, DOI 10.1007/s00280-007-0499-3; Li XQ, 2009, INT J BIOL MARKER, V24, P230, DOI 10.1177/172460080902400403; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mehrotra S, 2010, CANCER CELL, V17, P53, DOI 10.1016/j.ccr.2009.11.021; Mena S, 2007, CLIN CANCER RES, V13, P2658, DOI 10.1158/1078-0432.CCR-06-2642; MICKLEY LA, 1989, J BIOL CHEM, V264, P18031; Mita AC, 2008, CLIN CANCER RES, V14, P5000, DOI 10.1158/1078-0432.CCR-08-0746; Olie RA, 2000, CANCER RES, V60, P2805; Oshika Y, 1998, MODERN PATHOL, V11, P1059; Patil CR, 2010, PHYTOTHER RES, V24, P33, DOI 10.1002/ptr.2861; Pesic M, 2009, INVEST NEW DRUG, V27, P99, DOI 10.1007/s10637-008-9140-5; Reck M, 2008, TARGET ONCOL, V3, P135, DOI 10.1007/s11523-008-0082-9; Rocha GD, 2012, INVEST NEW DRUG, V30, P105, DOI 10.1007/s10637-010-9524-1; Sawada N, 2004, BRIT J CANCER, V90, P1672, DOI 10.1038/sj.bjc.6601746; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Torky ARW, 2005, TOXICOLOGY, V207, P437, DOI 10.1016/j.tox.2004.10.014; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Young LC, 2001, CLIN CANCER RES, V7, P1798; Young LC, 1999, CLIN CANCER RES, V5, P673; Zhang PX, 2007, ACTA BIOCH BIOPH SIN, V39, P803, DOI 10.1111/j.1745-7270.2007.00335.x	43	83	86	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28596	10.1371/journal.pone.0028596	http://dx.doi.org/10.1371/journal.pone.0028596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174843	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700050
J	Rochira, V; Zirilli, L; Orlando, G; Santi, D; Brigante, G; Diazzi, C; Carli, F; Carani, C; Guaraldi, G				Rochira, Vincenzo; Zirilli, Lucia; Orlando, Gabriella; Santi, Daniele; Brigante, Giulia; Diazzi, Chiara; Carli, Federica; Carani, Cesare; Guaraldi, Giovanni			Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ERECTILE DYSFUNCTION; ANDROGEN DEFICIENCY; ANTIRETROVIRAL THERAPY; INTERNATIONAL INDEX; BINDING GLOBULIN; GONADAL-FUNCTION; ELDERLY-MEN; WEIGHT-LOSS; AGING MEN	Background: Testosterone (T) deficiency remains a poorly understood issue in men with Human Immunodeficiency Virus (HIV). We investigated the gonadal status in HIV-infected men in order to characterize T deficiency and to identify predictive factors for low serum T. Methodology/Principal Findings: We performed a cross-sectional, observational study on 1325 consecutive HIV male outpatients, most of them having lipodystrophy. Serum total T<300 ng/dL was used as the threshold for biochemical T deficiency. Morning serum total T, luteinizing hormone (LH), estradiol, HIV parameters, and body composition parameters by CT-scan and Dual-Energy-X-ray-Absorptiometry were measured in each case. Sexual behavior was evaluated in a subset of 247 patients. T deficiency was found in 212 subjects, especially in the age range 40-59, but was frequent even in younger patients. T deficiency occurred mainly in association with low/normal serum LH. Adiposity was higher in subjects with T deficiency (p<0.0001) and both visceral adipose tissue and body mass index were the main negative predictors of serum total T. Osteoporosis and erectile dysfunction were present in a similar percentage in men with or without T deficiency. Conclusions/Significance: Premature decline of serum T is common (16%) among young/middle-aged HIV-infected men and is associated with inappropriately low/normal LH and increased visceral fat. T deficiency occurs at a young age and may be considered an element of the process of premature or accelerated aging known to be associated with HIV infection. The role of HIV and/or HIV infection treatments, as well as the role of the general health state on the gonadal axis, remains, in fact, to be elucidated. Due to the low specificity of signs and symptoms of hypogonadism in the context of HIV, caution is needed in the diagnosis of hypogonadism in HIV-infected men with biochemical low serum T levels.	[Rochira, Vincenzo; Zirilli, Lucia; Santi, Daniele; Brigante, Giulia; Diazzi, Chiara; Carani, Cesare] Univ Modena & Reggio Emilia, Azienda AUSL NOCSAE Baggiovara, Chair & Unit Endocrinol & Metab, Dept Med Endocrinol & Metab Geriatr, Modena, Italy; [Orlando, Gabriella; Carli, Federica; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Dept Med & Med Specialties, Metab Clin, Infect & Trop Dis Unit, Modena, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Rochira, V (corresponding author), Univ Modena & Reggio Emilia, Azienda AUSL NOCSAE Baggiovara, Chair & Unit Endocrinol & Metab, Dept Med Endocrinol & Metab Geriatr, Modena, Italy.	vincenzo.rochira@unimore.it	Guaraldi, Giovanni/J-9467-2018; Rochira, Vincenzo/F-4225-2015; Santi, Daniele/J-7005-2018; Brigante, Giulia/J-8775-2018; Orlando, Gabriella/K-3954-2018; Rochira, Vincenzo/S-7340-2019; Diazzi, Chiara/J-8708-2018	Rochira, Vincenzo/0000-0001-8169-0696; Santi, Daniele/0000-0001-6607-7105; Brigante, Giulia/0000-0001-8426-4502; Orlando, Gabriella/0000-0002-4590-9045; Rochira, Vincenzo/0000-0001-8169-0696; Diazzi, Chiara/0000-0002-6259-2481; Guaraldi, Giovanni/0000-0002-5724-3914	Department of Medicine, Endocrinology & Metabolism, University of Modena	Department of Medicine, Endocrinology & Metabolism, University of Modena	The authors wish to thank Prof. Manuela Simoni, Department of Medicine, Endocrinology & Metabolism, University of Modena, and Reggio Emilia for proofreading the manuscript, careful copyediting, thoughtful assistance in the preparation of this paper, and continuous support and trust.	Araujo AB, 2004, J CLIN ENDOCR METAB, V89, P5920, DOI 10.1210/jc.2003-031719; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Arver S, 1999, J ANDROL, V20, P611; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Brambilla DJ, 2007, CLIN ENDOCRINOL, V67, P853, DOI 10.1111/j.1365-2265.2007.02976.x; Brambilla DJ, 2009, J CLIN ENDOCR METAB, V94, P907, DOI 10.1210/jc.2008-1902; Cappelleri JC, 1999, UROLOGY, V54, P346, DOI 10.1016/S0090-4295(99)00099-0; Collazos Julio, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P43, DOI 10.1177/1545109708330908; Cotter AG, 2011, BEST PRACT RES CL EN, V25, P501, DOI 10.1016/j.beem.2010.11.003; Crum NF, 2005, AIDS PATIENT CARE ST, V19, P655, DOI 10.1089/apc.2005.19.655; Crum-Cianflone NF, 2007, AIDS PATIENT CARE ST, V21, P9, DOI 10.1089/apc.2006.0071; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dobs AS, 1996, J CLIN ENDOCR METAB, V81, P4108, DOI 10.1210/jc.81.11.4108; Dube MP, 2007, CLIN INFECT DIS, V45, P120, DOI 10.1086/518620; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Grinspoon S, 1996, J CLIN ENDOCR METAB, V81, P4051, DOI 10.1210/jc.81.11.4051; Guaraldi G, 2007, ANTIVIR THER, V12, pL58; Handelsman DJ, 2011, ASIAN J ANDROL, V13, P125, DOI 10.1038/aja.2010.154; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Kalyani Rita R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P226, DOI 10.1097/MED.0b013e32814db856; Kalyani RR, 2007, ENDOCRIN METAB CLIN, V36, P333, DOI 10.1016/j.ecl.2007.03.014; Kaufman JM, 1997, BAILLIERE CLIN ENDOC, V11, P289, DOI 10.1016/S0950-351X(97)80302-3; Klein RS, 2005, CLIN INFECT DIS, V41, P1794, DOI 10.1086/498311; Ly LP, 2010, CLIN ENDOCRINOL, V73, P382, DOI 10.1111/j.1365-2265.2010.03804.x; Martin J, 2010, ANN INTERN MED, V153, P477, DOI 10.7326/0003-4819-153-7-201010050-00013; MARTIN ME, 1992, J ENDOCRINOL INVEST, V15, P597, DOI 10.1007/BF03344932; McLachlan RI, 2010, J CLIN ENDOCR METAB, V95, P2610, DOI 10.1210/jc.2010-0838; Moreno-Perez O, 2010, J SEX MED, V7, P2873, DOI 10.1111/j.1743-6109.2010.01886.x; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Mylonakis E, 2001, CLIN INFECT DIS, V33, P857, DOI 10.1086/322695; Ofotokun I, 2010, CURR OPIN ENDOCRINOL, V17, P523, DOI 10.1097/MED.0b013e32833f48d6; Onen Nur F, 2011, Curr Aging Sci, V4, P33; Palella FJ, 2004, CLIN INFECT DIS, V38, P903, DOI 10.1086/381684; Park YW, 2002, INT J OBESITY, V26, P978, DOI 10.1038/sj.ijo.0801982; Rietschel P, 2000, CLIN INFECT DIS, V31, P1240, DOI 10.1086/317457; Rochira V, 2006, EUR J ENDOCRINOL, V155, P513, DOI 10.1530/eje.1.02254; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Sartorius G, 2009, ANN CLIN BIOCHEM, V46, P137, DOI 10.1258/acb.2008.008171; Sartorius GA, 2010, ANDROLOGY: MALE REPRODUCTIVE HEALTH AND DYSFUNCTION, THIRD EDITION, P339, DOI 10.1007/978-3-540-78355-8_18; Schneider HJ, 2009, CLIN ENDOCRINOL, V70, P446, DOI 10.1111/j.1365-2265.2008.03370.x; Shiels MS, 2010, ANN INTERN MED, V153, P452, DOI 10.7326/0003-4819-153-7-201010050-00008; Tajar A, 2010, J CLIN ENDOCR METAB, V95, P1810, DOI 10.1210/jc.2009-1796; Travison TG, 2007, J CLIN ENDOCR METAB, V92, P549, DOI 10.1210/jc.2006-1859; Travison TG, 2006, J CLIN ENDOCR METAB, V91, P2509, DOI 10.1210/jc.2005-2508; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Wasserman P, 2008, J SEX MED, V5, P241, DOI 10.1111/j.1743-6109.2007.00634.x; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Wunder DM, 2008, HIV MED, V9, P427, DOI 10.1111/j.1468-1293.2008.00578.x; Zirilli L, 2008, J Endocrinol Invest, V31, P33	51	87	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28512	10.1371/journal.pone.0028512	http://dx.doi.org/10.1371/journal.pone.0028512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174826	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700041
J	Gutierrez, C; Diaz, L; Vallejo, A; Hernandez-Novoa, B; Abad, M; Madrid, N; Dahl, V; Rubio, R; Moreno, AM; Dronda, F; Casado, JL; Navas, E; Perez-Elias, MJ; Zamora, J; Palmer, S; Munoz, E; Munoz-Fernandez, MA; Moreno, S				Gutierrez, Carolina; Diaz, Laura; Vallejo, Alejandro; Hernandez-Novoa, Beatriz; Abad, Maria; Madrid, Nadia; Dahl, Viktor; Rubio, Rafael; Moreno, Ana M.; Dronda, Fernando; Luis Casado, Jose; Navas, Enrique; Jesus Perez-Elias, Maria; Zamora, Javier; Palmer, Sarah; Munoz, Eduardo; Angeles Munoz-Fernandez, Maria; Moreno, Santiago			Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LOW-LEVEL VIREMIA; PLASMA VIREMIA; RALTEGRAVIR INTENSIFICATION; IMMUNE ACTIVATION; EXTENDED PERIODS; IN-VIVO; RESERVOIR; REPLICATION; COMBINATION	Objective: The primary objective was to assess the effect of MVC intensification on latently infected CD4(+) T cells in chronically HIV-1-infected patients receiving antiretroviral therapy. Methods: We performed an open-label pilot phase II clinical trial involving chronically HIV-1-infected patients receiving stable antiretroviral therapy whose regimen was intensified with 48 weeks of maraviroc therapy. We analyzed the latent reservoir, the residual viremia and episomal 2LTR DNA to examine the relationship between these measures and the HIV-1 latent reservoir, immune activation, lymphocyte subsets (including effector and central memory T cells), and markers associated with bacterial translocation. Results: Overall a non significant reduction in the size of the latent reservoir was found (p = 0.068). A mean reduction of 1.82 IUPM was observed in 4 patients with detectable latent reservoir at baseline after 48 weeks of intensification. No effect on plasma residual viremia was observed. Unexpectedly, all the patients had detectable 2LTR DNA circles at week 24, while none of them showed those circles at the end of the study. No changes were detected in CD4(+) or CD8(+) counts, although a significant decrease was found in the proportion of HLA-DR(+)/CD38(+) CD4(+) and CD8(+) T-cells. LPS and sCD14 levels increased. Conclusions: Intensification with MVC was associated with a trend to a decrease in the size of the latent HIV-1 reservoir in memory T cells. No impact on residual viremia was detected. Additional studies with larger samples are needed to confirm the results.	[Gutierrez, Carolina; Vallejo, Alejandro; Hernandez-Novoa, Beatriz; Abad, Maria; Madrid, Nadia; Moreno, Ana M.; Dronda, Fernando; Luis Casado, Jose; Navas, Enrique; Jesus Perez-Elias, Maria; Moreno, Santiago] Hosp Univ Ramon Y Cajal, Dept Infect Dis, Madrid, Spain; [Gutierrez, Carolina; Vallejo, Alejandro; Hernandez-Novoa, Beatriz; Abad, Maria; Madrid, Nadia; Moreno, Ana M.; Dronda, Fernando; Luis Casado, Jose; Navas, Enrique; Jesus Perez-Elias, Maria; Zamora, Javier; Moreno, Santiago] IRYCIS, Madrid, Spain; [Diaz, Laura; Angeles Munoz-Fernandez, Maria] Hosp Gen Univ Gregorio Maranon, Inmunobiol Lab, Madrid, Spain; [Dahl, Viktor; Palmer, Sarah] Karolinska Inst, Stockholm, Sweden; [Rubio, Rafael] Hosp Gen Univ Doce Octubre, Infect Dis Unit, Madrid, Spain; [Zamora, Javier] Hosp Univ Ramon Y Cajal, Dept Biostat, Madrid, Spain; [Munoz, Eduardo] Univ Cordoba, Dept Immunol, Cordoba, Spain	Hospital Universitario Ramon y Cajal; General University Gregorio Maranon Hospital; Karolinska Institutet; Hospital Universitario 12 de Octubre; Hospital Universitario Ramon y Cajal; Universidad de Cordoba	Gutierrez, C (corresponding author), Hosp Univ Ramon Y Cajal, Dept Infect Dis, Madrid, Spain.	smoreno.hrc@salud.madrid.org	Zamora, Javier/B-1722-2009; Abad, Maria/AAC-3146-2020; Elias, Maria Jesus Perez/AAD-8652-2020; Vallejo, Alejandro/I-5881-2015; Zamora, Javier/AEO-0608-2022; Munoz, Eduardo/I-5225-2012	Zamora, Javier/0000-0003-4901-588X; Vallejo, Alejandro/0000-0001-5360-878X; Zamora, Javier/0000-0003-4901-588X; Munoz, Eduardo/0000-0001-8478-5842; Rubio Garcia, Rafael/0000-0001-8132-4303; Casado, Jose Luis/0000-0002-7639-8591; Dahl, Viktor/0000-0001-9921-5172; Munoz-Fernandez/0000-0002-0813-4500; Perez Elias/0000-0001-5700-5257	Spanish AIDS Network Red Tematica Cooperativa de Investigacion en SIDA [RD06/0006]; Spanish National of Health, "Instituto de Salud Carlos III" [FIS-PI080958, CP08/00046]; Foundation of Investigation and prevention of AIDS [FIPSE-36-0844/09]	Spanish AIDS Network Red Tematica Cooperativa de Investigacion en SIDA; Spanish National of Health, "Instituto de Salud Carlos III"; Foundation of Investigation and prevention of AIDS	This work was supported in part by the Spanish AIDS Network "Red Tematica Cooperativa de Investigacion en SIDA (RD06/0006), the Spanish National of Health, "Instituto de Salud Carlos III", grants (FIS-PI080958 and CP08/00046), and by the Foundation of Investigation and prevention of AIDS (FIPSE-36-0844/09). Pfizer Inc provided the drug. The Regional Blood Transfusion Center in Madrid provided the buffy coats from healthy donors. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anderson JA, 2011, J VIROL, V85, P5220, DOI 10.1128/JVI.00284-11; Baroncelli S, 2009, J CLIN VIROL, V46, P367, DOI 10.1016/j.jcv.2009.09.011; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Chavez HH, 2007, JAIDS-J ACQ IMM DEF, V45, P247, DOI 10.1097/QAI.0b013e3180415dc2; Chege D, 2011, AIDS, V25, P741, DOI 10.1097/QAD.0b013e328344cefb; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2011, J INFECT DIS, V204, P135, DOI 10.1093/infdis/jir208; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Funderburg N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013188; Gandhi RT, 2010, J INFECT DIS, V201, P293, DOI 10.1086/649569; Gandhi RT, 2010, PLOS MED, V10, P7; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Hunt PW, 2011, 18 C RETR OPP INF FE; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kotler DP, 1999, J INFECT DIS, V179, pS454, DOI 10.1086/314803; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Markowitz M, 2011, 18 C RETR OPP INF FE, V152LB; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; Northfield JW, 2007, J VIROL, V81, P5759, DOI 10.1128/JVI.00045-07; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Ramratnam B, 2004, JAIDS-J ACQ IMM DEF, V35, P33, DOI 10.1097/00126334-200401010-00004; Sharkey M, 2005, J VIROL, V79, P5203, DOI 10.1128/JVI.79.8.5203-5210.2005; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Sheth PM, 2008, MUCOSAL IMMUNOL, V1, P382, DOI 10.1038/mi.2008.23; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Wiegand A, 2010, 17 C RET OPP INF OR; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yilmaz A, 2010, J ACQ IMMUN DEF SYND, V15, P590; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb; Zazzi M, 1997, J MED VIROL, V52, P20, DOI 10.1002/(SICI)1096-9071(199705)52:1&lt;20::AID-JMV4&gt;3.0.CO;2-T	50	75	75	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27864	10.1371/journal.pone.0027864	http://dx.doi.org/10.1371/journal.pone.0027864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174752	Green Published, gold			2022-12-27	WOS:000298163600008
J	Tadaishi, M; Miura, S; Kai, Y; Kano, Y; Oishi, Y; Ezaki, O				Tadaishi, Miki; Miura, Shinji; Kai, Yuko; Kano, Yutaka; Oishi, Yuichi; Ezaki, Osamu			Skeletal Muscle-Specific Expression of PGC-1 alpha-b, an Exercise-Responsive Isoform, Increases Exercise Capacity and Peak Oxygen Uptake	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID OXIDATION; ALL-CAUSE MORTALITY; INTENSITY EXERCISE; CARDIORESPIRATORY FITNESS; INDUCED ANGIOGENESIS; RECEPTOR ACTIVATION; UNTRAINED MEN; MESSENGER-RNA; TRAINED MEN	Background: Maximal oxygen uptake (VO2max) predicts mortality and is associated with endurance performance. Trained subjects have a high VO2max due to a high cardiac output and high metabolic capacity of skeletal muscles. Peroxisome proliferator-activated receptor c coactivator 1 alpha (PGC-1 alpha), a nuclear receptor coactivator, promotes mitochondrial biogenesis, a fiber-type switch to oxidative fibers, and angiogenesis in skeletal muscle. Because exercise training increases PGC-1 alpha in skeletal muscle, PGC-1 alpha-mediated changes may contribute to the improvement of exercise capacity and VO2max. There are three isoforms of PGC-1 alpha mRNA. PGC-1 alpha-b protein, whose amino terminus is different from PGC-1 alpha-a protein, is a predominant PGC-1a isoform in response to exercise. We investigated whether alterations of skeletal muscle metabolism by overexpression of PGC-1 alpha-b in skeletal muscle, but not heart, would increase VO(2ma)x and exercise capacity. Methodology/Principal Findings: Transgenic mice showed overexpression of PGC-1 alpha-b protein in skeletal muscle but not in heart. Overexpression of PGC-1 alpha-b promoted mitochondrial biogenesis 4-fold, increased the expression of fatty acid transporters, enhanced angiogenesis in skeletal muscle 1.4 to 2.7-fold, and promoted exercise capacity (expressed by maximum speed) by 35% and peak oxygen uptake by 20%. Across a broad range of either the absolute exercise intensity, or the same relative exercise intensities, lipid oxidation was always higher in the transgenic mice than wild-type littermates, suggesting that lipid is the predominant fuel source for exercise in the transgenic mice. However, muscle glycogen usage during exercise was absent in the transgenic mice. Conclusions/Significance: Increased mitochondrial biogenesis, capillaries, and fatty acid transporters in skeletal muscles may contribute to improved exercise capacity via an increase in fatty acid utilization. Increases in PGC-1 alpha-b protein or function might be a useful strategy for sedentary subjects to perform exercise efficiently, which would lead to prevention of life-style related diseases and increased lifespan.	[Tadaishi, Miki; Miura, Shinji; Kai, Yuko; Ezaki, Osamu] Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan; [Tadaishi, Miki; Oishi, Yuichi] Tokyo Univ Agr, Fac Appl Biosci, Dept Nutr Sci, Tokyo, Japan; [Kano, Yutaka] Univ Electrocommun, Dept Engn Sci, Tokyo, Japan	National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture; University of Electro-Communications - Japan	Tadaishi, M (corresponding author), Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo 162, Japan.	shinjim@nih.go.jp; ezaki@nih.go.jp	Miura, Shinji/K-6516-2013; Kano, Yutaka/I-9003-2014	Miura, Shinji/0000-0001-8806-9763; Kano, Yutaka/0000-0003-0913-9714	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo) [21300240]; Nakatomi Foundation (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation (Tokyo, Japan); Takeda Science Foundation (Osaka, Japan)(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research (KAKENHI, 21300240) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT, Tokyo), The Nakatomi Foundation (Tokyo, Japan) and The Takeda Science Foundation (Osaka, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Bloor Colin M., 2005, Angiogenesis, V8, P263, DOI 10.1007/s10456-005-9013-x; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Brand M, 1995, MITOCHONDRIA PRACTIC; Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395; Bruce CR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1231, DOI 10.1152/ajpendo.00561.2006; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Coggan AR, 2000, METABOLISM, V49, P122, DOI 10.1016/S0026-0495(00)90963-6; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Davis JM, 1997, J APPL PHYSIOL, V83, P1461, DOI 10.1152/jappl.1997.83.5.1461; Davis JM, 1998, MED SCI SPORT EXER, V30, P863, DOI 10.1097/00005768-199806000-00014; Egginton S, 2009, PFLUG ARCH EUR J PHY, V457, P963, DOI 10.1007/s00424-008-0563-9; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Friedlander AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE853, DOI 10.1152/ajpendo.1998.275.5.E853; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hawley JA, 1998, SPORTS MED, V25, P241, DOI 10.2165/00007256-199825040-00003; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HORAK ER, 1992, LANCET, V340, P1120, DOI 10.1016/0140-6736(92)93150-L; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JANSSON E, 1987, J APPL PHYSIOL, V62, P999, DOI 10.1152/jappl.1987.62.3.999; Jiang LQ, 2010, AM J PHYSIOL-ENDOC M, V298, pE8, DOI 10.1152/ajpendo.00403.2009; KLEIN S, 1994, AM J PHYSIOL-ENDOC M, V267, pE934, DOI 10.1152/ajpendo.1994.267.6.E934; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee DC, 2011, BRIT J SPORT MED, V45, P504, DOI 10.1136/bjsm.2009.066209; Lee DC, 2010, J PSYCHOPHARMACOL, V24, P27, DOI 10.1177/1359786810382057; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Muoio DM, 2010, NEW ENGL J MED, V363, P291, DOI 10.1056/NEJMcibr1005397; Nagy TR, 2000, OBES RES, V8, P392, DOI 10.1038/oby.2000.47; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Prior BM, 2004, J APPL PHYSIOL, V97, P1119, DOI 10.1152/japplphysiol.00035.2004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Quinlan KGR, 2010, HUM MOL GENET, V19, P1335, DOI 10.1093/hmg/ddq010; Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005; Scarpulla RC, 1996, TRENDS CARDIOVAS MED, V6, P39, DOI 10.1016/1050-1738(95)00129-8; Sidossis LS, 1998, AM J PHYSIOL-ENDOC M, V274, pE510, DOI 10.1152/ajpendo.1998.274.3.E510; SUTER E, 1995, INT J SPORTS MED, V16, P160, DOI 10.1055/s-2007-972985; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Tjonna AE, 2008, CIRCULATION, V118, P346, DOI 10.1161/CIRCULATIONAHA.108.772822; Tonkonogi M, 1997, ACTA PHYSIOL SCAND, V161, P345, DOI 10.1046/j.1365-201X.1997.00222.x; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041; Yoshioka T, 2009, BIOCHEM BIOPH RES CO, V381, P537, DOI 10.1016/j.bbrc.2009.02.077	62	112	124	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28290	10.1371/journal.pone.0028290	http://dx.doi.org/10.1371/journal.pone.0028290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174785	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600017
J	Weseler, AR; Ruijters, EJB; Drittij-Reijnders, MJ; Reesink, KD; Haenen, GRMM; Bast, A				Weseler, Antje R.; Ruijters, Erik J. B.; Drittij-Reijnders, Marie-Jose; Reesink, Koen D.; Haenen, Guido R. M. M.; Bast, Aalt			Pleiotropic Benefit of Monomeric and Oligomeric Flavanols on Vascular Health - A Randomized Controlled Clinical Pilot Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; MEDITERRANEAN DIET; ARGINASE ACTIVITY; BRACHIAL-ARTERY; HUMAN PLASMA; IN-VITRO; ATHEROSCLEROSIS	Background: Cardiovascular diseases are expanding to a major social-economic burden in the Western World and undermine man's deep desire for healthy ageing. Epidemiological studies suggest that flavanol-rich foods (e. g. grapes, wine, chocolate) sustain cardiovascular health. For an evidenced-based application, however, sound clinical data on their efficacy are strongly demanded. Methods: In a double-blind, randomized, placebo-controlled intervention study we supplemented 28 male smokers with 200 mg per day of monomeric and oligomeric flavanols (MOF) from grape seeds. At baseline, after 4 and 8 weeks we measured macro-and microvascular function and a cluster of systemic biomarkers for major pathological processes occurring in the vasculature: disturbances in lipid metabolism and cellular redox balance, and activation of inflammatory cells and platelets. Results: In the MOF group serum total cholesterol and LDL decreased significantly (P <= 0.05) by 5% (n = 11) and 7% (n = 9), respectively in volunteers with elevated baseline levels. Additionally, after 8 weeks the ratio of glutathione to glutathione disulphide in erythrocytes rose from baseline by 22% (n = 15, P < 0.05) in MOF supplemented subjects. We also observed that MOF supplementation exerts anti-inflammatory effects in blood towards ex vivo added bacterial endotoxin and significantly reduces expression of inflammatory genes in leukocytes. Conversely, alterations in macro-and microvascular function, platelet aggregation, plasma levels of nitric oxide surrogates, endothelin-1, C-reactive protein, fibrinogen, prostaglandin F2alpha, plasma antioxidant capacity and gene expression levels of antioxidant defense enzymes did not reach statistical significance after 8 weeks MOF supplementation. However, integrating all measured effects into a global, so-called vascular health index revealed a significant improvement of overall vascular health by MOF compared to placebo (P <= 0.05). Conclusion: Our integrative multi-biomarker approach unveiled the pleiotropic vascular health benefit of an 8 weeks supplementation with 200 mg/d MOF in humans.	[Weseler, Antje R.; Ruijters, Erik J. B.; Drittij-Reijnders, Marie-Jose; Haenen, Guido R. M. M.; Bast, Aalt] Maastricht Univ, Dept Toxicol, Maastricht, Netherlands; [Reesink, Koen D.] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands	Maastricht University; Maastricht University	Weseler, AR (corresponding author), Maastricht Univ, Dept Toxicol, Maastricht, Netherlands.	a.weseler@maastrichtuniversity.nl	Haenen, Guido/H-9209-2013; Bast, Aalt/I-7809-2013; Stefanadis, Christodoulos/ABH-2232-2020	Haenen, Guido/0000-0001-6986-290X; Reesink, Koen/0000-0003-2354-883X; Stefanadis, Christodoulos/0000-0001-5974-6454; Bast, Aalt/0000-0002-5383-2789	International Nutrition Company BV, Loosdrecht, The Netherlands; European Union [226588]	International Nutrition Company BV, Loosdrecht, The Netherlands(Netherlands Government); European Union(European Commission)	The study was financially supported by International Nutrition Company BV, Loosdrecht, The Netherlands. Further support was obtained via a European Union (grant 226588, entitled Flaviola) within the Seventh Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Bazzano LA, 2003, ANN INTERN MED, V138, P891, DOI 10.7326/0003-4819-138-11-200306030-00010; Bermudez EA, 2002, AM J CARDIOL, V89, P1117, DOI 10.1016/S0002-9149(02)02284-1; Blade C, 2010, MOL NUTR FOOD RES, V54, P37, DOI 10.1002/mnfr.200900476; Busch MCM, 2004, 270555007 RIVM MIN V; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; CHANG WC, 1989, PROSTAG LEUKOTR ESS, V38, P181, DOI 10.1016/0952-3278(89)90070-7; Corder R, 2004, CLIN SCI, V107, P513, DOI 10.1042/CS20040189; CORRALIZA IM, 1994, J IMMUNOL METHODS, V174, P231, DOI 10.1016/0022-1759(94)90027-2; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; de Lorgeril M, 2002, CARDIOVASC RES, V54, P503, DOI 10.1016/S0008-6363(01)00545-4; Ernst E, 2005, FUND CLIN PHARMACOL, V19, P405, DOI 10.1111/j.1472-8206.2005.00335.x; European Heart Network, 2008, CARD DIS STAT 2008; Fennessy FM, 2003, CIRCULATION, V107, P410, DOI 10.1161/01.CIR.0000046447.72402.47; Fischer MAJG, 2005, CLIN CHEM LAB MED, V43, P735, DOI 10.1515/CCLM.2005.125; Fletcher B, 2005, CIRCULATION, V112, P3184, DOI 10.1161/CIRCULATIONAHA.105.169180; Giustarini D, 2008, METHOD ENZYMOL, V440, P361, DOI 10.1016/S0076-6879(07)00823-3; Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Heaney RP, 2008, J NUTR, V138, P1591, DOI 10.1093/jn/138.9.1591; Heitzer T, 1996, CIRCULATION, V94, P6, DOI 10.1161/01.CIR.94.1.6; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; JULICHER RHM, 1984, ARCH TOXICOL, V56, P83, DOI 10.1007/BF00349076; Kakafika AI, 2007, CURR PHARM DESIGN, V13, P1647, DOI 10.2174/138161207780831310; Leone A, 2003, CURR PHARM DESIGN, V9, P2417, DOI 10.2174/1381612033453802; Mallika V, 2007, ANGIOLOGY, V58, P513, DOI 10.1177/0003319707303443; Moriarty SE, 2003, FREE RADICAL BIO MED, V35, P1582, DOI 10.1016/j.freeradbiomed.2003.09.006; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; MOSHAGE H, 1995, CLIN CHEM, V41, P892; Oligomeric proanthocyanidins (OPCs), 2003, ALTERNATIVE MED REV, V8, P442; Orhan H, 2005, J BIOCHEM MOL TOXIC, V19, P226, DOI 10.1002/jbt.20088; Ostertag LM, 2010, MOL NUTR FOOD RES, V54, P60, DOI 10.1002/mnfr.200900172; Panagiotakos D, 2007, J MED FOOD, V10, P239, DOI 10.1089/jmf.2006.251; Park YC, 2000, FEBS LETT, V465, P93, DOI 10.1016/S0014-5793(99)01735-4; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Petruzzelli S, 1997, AM J RESP CRIT CARE, V156, P1902, DOI 10.1164/ajrccm.156.6.9702075; Powell J T, 1998, Vasc Med, V3, P21, DOI 10.1191/135886398670269973; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Reilly M, 1996, CIRCULATION, V94, P19, DOI 10.1161/01.CIR.94.1.19; Sano T, 2005, THROMB RES, V115, P115, DOI 10.1016/j.thromres.2004.07.015; Schnorr O, 2008, ARCH BIOCHEM BIOPHYS, V476, P211, DOI 10.1016/j.abb.2008.02.040; Shanmuganayagam D, 2002, J NUTR, V132, P3592, DOI 10.1093/jn/132.12.3592; Simoons M L, 1998, Ned Tijdschr Geneeskd, V142, P2096; Swennen ELR, 2005, EUR J IMMUNOL, V35, P852, DOI 10.1002/eji.200425423; Takajo Y, 2001, J AM COLL CARDIOL, V38, P1320, DOI 10.1016/S0735-1097(01)01583-2; TARALLO P, 1992, EUR J CLIN CHEM CLIN, V30, P745; van Mierlo LAJ, 2010, J NUTR, V140, P1769, DOI 10.3945/jn.110.125518; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Witte DR, 2005, ATHEROSCLEROSIS, V182, P323, DOI 10.1016/j.atherosclerosis.2005.02.012; Witte DR, 2005, J AM COLL CARDIOL, V45, P1987, DOI 10.1016/j.jacc.2005.02.073; World Health Organization, 2021, CARD DIS CVDS; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	55	60	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28460	10.1371/journal.pone.0028460	http://dx.doi.org/10.1371/journal.pone.0028460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174811	Green Submitted, gold, Green Published			2022-12-27	WOS:000298163600022
J	Kosmider, B; Messier, EM; Chu, HW; Mason, RJ				Kosmider, Beata; Messier, Elise M.; Chu, Hong Wei; Mason, Robert J.			Human Alveolar Epithelial Cell Injury Induced by Cigarette Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG FIBROBLASTS; OXIDATIVE STRESS; N-ACETYLCYSTEINE; INDUCED EMPHYSEMA; HEME OXYGENASE-1; IN-VITRO; CIS-PT(II) COMPLEX; INDUCED APOPTOSIS; TOBACCO-SMOKE	Background: Cigarette smoke (CS) is a highly complex mixture and many of its components are known carcinogens, mutagens, and other toxic substances. CS induces oxidative stress and cell death, and this cell toxicity plays a key role in the pathogenesis of several pulmonary diseases. Methodology/Principal Findings: We studied the effect of cigarette smoke extract (CSE) in human alveolar epithelial type I-like (ATI-like) cells. These are isolated type II cells that are differentiating toward the type I cell phenotype in vitro and have lost many type II cell markers and express type I cell markers. ATI-like cells were more sensitive to CSE than alveolar type II cells, which maintained their differentiated phenotype in vitro. We observed disruption of mitochondrial membrane potential, apoptosis and necrosis that were detected by double staining with acridine orange and ethidium bromide or Hoechst 33342 and propidium iodide and TUNEL assay after treatment with CSE. We also detected caspase 3 and caspase 7 activities and lipid peroxidation. CSE induced nuclear translocation of Nrf2 and increased expression of Nrf2, HO-1, Hsp70 and Fra1. Moreover, we found that Nrf2 knockdown sensitized ATI-like cells to CSE and Nrf2 overexpression provided protection against CSE-induced cell death. We also observed that two antioxidant compounds N-acetylcysteine and trolox protected ATI-like cells against injury by CSE. Conclusions: Our study indicates that Nrf2 activation is a major factor in cellular defense of the human alveolar epithelium against CSE-induced toxicity and oxidative stress. Therefore, antioxidant agents that modulate Nrf2 would be expected to restore antioxidant and detoxifying enzymes and to prevent CS-related lung injury and perhaps lessen the development of emphysema.	[Kosmider, Beata; Messier, Elise M.; Chu, Hong Wei; Mason, Robert J.] Natl Jewish Hlth, Dept Med, Denver, CO USA	National Jewish Health	Kosmider, B (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.	KosmiderB@NJHealth.org		Messier, Elise/0000-0003-3554-9282	Flight Attendant Medical Research Institute; National Heart, Lung and Blood Institute of the National Institutes of Health [HL029891]; ExxonMobil Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL029891, R37HL029891] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ExxonMobil Foundation(Exxon Mobil Corporation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Young Clinical Scientist Award from the Flight Attendant Medical Research Institute (B.K.), National Heart, Lung and Blood Institute of the National Institutes of Health (HL029891 to R.J.M.) and by ExxonMobil Foundation (R.J.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Baqir M, 2008, RESP MED, V102, P1604, DOI 10.1016/j.rmed.2008.05.002; Bernhard David, 2004, Journal of Pharmacological and Toxicological Methods, V50, P45, DOI 10.1016/j.vascn.2004.01.003; Bhalla DK, 2009, J TOXICOL ENV HEAL B, V12, P45, DOI 10.1080/10937400802545094; Boutten A, 2010, EXPERT OPIN THER TAR, V14, P329, DOI 10.1517/14728221003629750; Boutten A, 2011, TRENDS MOL IN PRESS; Cai S, 2009, RESPIROLOGY, V14, P354, DOI 10.1111/j.1440-1843.2009.01511.x; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chirino YI, 2010, TOXICOL LETT, V193, P209, DOI 10.1016/j.toxlet.2010.01.009; Cho HY, 2006, ANTIOXID REDOX SIGN, V8, P76, DOI 10.1089/ars.2006.8.76; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; De Flora S, 2001, CARCINOGENESIS, V22, P999, DOI 10.1093/carcin/22.7.999; Demiralay R, 2007, HUM EXP TOXICOL, V26, P595, DOI 10.1177/0960327106070079551; Dobbs LG, 2007, RESP PHYSIOL NEUROBI, V159, P283, DOI 10.1016/j.resp.2007.06.011; Donnelly LE, 2001, AM J RESP CELL MOL, V24, P295, DOI 10.1165/ajrcmb.24.3.4001; Ferguson HE, 2009, AM J PHYSIOL-LUNG C, V297, pL912, DOI 10.1152/ajplung.00148.2009; Galicia-Moreno M, 2008, BASIC CLIN PHARMACOL, V103, P476, DOI 10.1111/j.1742-7843.2008.00324.x; Gebel S, 2010, TOXICOL SCI, V115, P238, DOI 10.1093/toxsci/kfq039; Ginzberg HH, 2004, AM J PHYSIOL-GASTR L, V287, pG286, DOI 10.1152/ajpgi.00350.2003; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Hogan AE, 2011, CLIN IMMUNOL, V140, P229, DOI 10.1016/j.clim.2011.01.011; Hogg JC, 2002, THORAX, V57, P830, DOI 10.1136/thorax.57.9.830; Hoshino Y, 2001, AM J PHYSIOL-LUNG C, V281, pL509, DOI 10.1152/ajplung.2001.281.2.L509; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189, DOI 10.1152/ajplung.2001.280.6.L1189; Ji L, 2010, INHAL TOXICOL, V22, P535, DOI 10.3109/08958370903525183; Johnson MD, 2009, CANCER EPIDEM BIOMAR, V18, P3263, DOI 10.1158/1055-9965.EPI-09-0965; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kosmider B, 2006, MUTAT RES-GEN TOX EN, V604, P28, DOI 10.1016/j.mrgentox.2005.12.006; Kosmider B, 2004, MUTAT RES-GEN TOX EN, V558, P169, DOI 10.1016/j.mrgentox.2003.12.004; Kosmider B, 2010, FREE RADICAL BIO MED, V48, P1513, DOI 10.1016/j.freeradbiomed.2010.02.032; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Luo XP, 1999, FREE RADICAL BIO MED, V26, P1357, DOI 10.1016/S0891-5849(98)00334-7; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Morley N, 2003, J PHOTOCH PHOTOBIO B, V72, P55, DOI 10.1016/j.jphotobiol.2003.06.004; Nakajima Y, 2008, BRAIN RES, V1226, P226, DOI 10.1016/j.brainres.2008.06.026; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Sadowska AM, 2006, RESPIROLOGY, V11, P741, DOI 10.1111/j.1440-1843.2006.00943.x; Serviddio G, 2011, CURR PHARM IN PRESS; Shapiro SD, 1995, P ASSOC AM PHYSICIAN, V107, P346; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Stav D, 2009, CHEST, V136, P381, DOI 10.1378/chest.09-0421; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Thaikoottathil JV, 2009, EUR RESPIR J, V33, P835, DOI 10.1183/09031936.00080708; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; Vayssier-Taussat M, 2001, AM J PHYSIOL-HEART C, V280, pH1293, DOI 10.1152/ajpheart.2001.280.3.H1293; Vercelino R, 2008, BASIC CLIN PHARMACOL, V102, P370, DOI 10.1111/j.1742-7843.2007.00181.x; Villeneuve NF, 2009, CELL CYCLE, V8, P3255, DOI 10.4161/cc.8.20.9565; Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901; Wang J, 2011, AM J RESP C IN PRESS; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626; Yung HW, 2007, FASEB J, V21, P872, DOI 10.1096/fj.06-6054com	58	90	96	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e26059	10.1371/journal.pone.0026059	http://dx.doi.org/10.1371/journal.pone.0026059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163265	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900001
J	Zhao, KN; Masci, PP; Lavin, MF				Zhao, Kong-Nan; Masci, Paul P.; Lavin, Martin F.			Disruption of Spectrin-Like Cytoskeleton in Differentiating Keratinocytes by PKC delta Activation Is Associated with Phosphorylated Adducin	PLOS ONE			English	Article							PROTEIN-KINASE-C; HUMAN EPIDERMAL-KERATINOCYTES; CULTURED HUMAN KERATINOCYTES; TERMINAL DIFFERENTIATION; IN-VIVO; HEREDITARY SPHEROCYTOSIS; INVOLUCRIN EXPRESSION; CELL-DIFFERENTIATION; MOUSE KERATINOCYTES; PLATELET ACTIVATION	Spectrin is a central component of the cytoskeletal protein network in a variety of erythroid and non-erythroid cells. In keratinocytes, this protein has been shown to be pericytoplasmic and plasma membrane associated, but its characteristics and function have not been established in these cells. Here we demonstrate that spectrin increases dramatically in amount and is assembled into the cytoskeleton during differentiation in mouse and human keratinocytes. The spectrin-like cytoskeleton was predominantly organized in the granular and cornified layers of the epidermis and disrupted by actin filament inhibitors, but not by anti-mitotic drugs. When the cytoskeleton was disrupted PKC delta was activated by phosphorylation on Thr505. Specific inhibition of PKC delta((Thr505)) activation with rottlerin prevented disruption of the spectrin-like cytoskeleton and the associated morphological changes that accompany differentiation. Rottlerin also inhibited specific phosphorylation of the PKC delta substrate adducin, a cytoskeletal protein. Furthermore, knock-down of endogenous adducin affected not only expression of adducin, but also spectrin and PKC delta, and severely disrupted organization of the spectrin-like cytoskeleton and cytoskeletal distribution of both adducin and PKC delta. These results demonstrate that organization of a spectrin-like cytoskeleton is associated with keratinocytes differentiation, and disruption of this cytoskeleton is mediated by either PKC delta((Thr505)) phosphorylation associated with phosphorylated adducin or due to reduction of endogenous adducin, which normally connects and stabilizes the spectrin-actin complex.	[Zhao, Kong-Nan; Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Masci, Paul P.] Univ Queensland, Princess Alexandra Hosp, Ctr Integrat Clin & Mol Med, Sch Med, Brisbane, Qld, Australia; [Zhao, Kong-Nan; Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Zhao, KN (corresponding author), Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia.	k.zhao@uq.edu.au	Lavin, Martin F/F-5961-2014	Lavin, Martin F/0000-0002-5940-4769	National Health and Medical Research Council of Australia [301256]; Cancer Council of Queensland [401623, 511210]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Queensland(Cancer Council Queensland)	This work was funded by a National Health and Medical Research Council of Australia Industry Research Fellowship (301256 to KNZ) and grants from Cancer Council of Queensland (401623 and 511210 to KNZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aho S, 2000, J CELL BIOL, V148, P1165, DOI 10.1083/jcb.148.6.1165; Banan A, 2004, AM J PHYSIOL-CELL PH, V287, pC218, DOI 10.1152/ajpcell.00575.2003; Barkalow KL, 2003, J CELL BIOL, V161, P557, DOI 10.1083/jcb.200211122; Baumann O, 1998, CELL MOTIL CYTOSKEL, V41, P74, DOI 10.1002/(SICI)1097-0169(1998)41:1<74::AID-CM7>3.0.CO;2-F; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2008, TRENDS MOL MED, V14, P28, DOI 10.1016/j.molmed.2007.11.005; Cerda SR, 2006, ONCOGENE, V25, P3123, DOI 10.1038/sj.onc.1209360; De Matteis MA, 2000, J CELL SCI, V113, P2331; Deucher A, 2002, J BIOL CHEM, V277, P17032, DOI 10.1074/jbc.M109076200; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Dubreuil RR, 2000, J CELL BIOL, V149, P647, DOI 10.1083/jcb.149.3.647; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Fan Y, 2009, NEUROSCI BULL, V25, P187, DOI 10.1007/s12264-009-0416-3; Fang NX, 2007, VIROLOGY, V365, P187, DOI 10.1016/j.virol.2007.03.038; FOWLER VM, 1992, J CELL BIOL, V119, P1559, DOI 10.1083/jcb.119.6.1559; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; George A, 2010, BLOOD CELL MOL DIS, V45, P41, DOI 10.1016/j.bcmd.2010.02.006; Gilligan DM, 2002, BLOOD, V99, P2418, DOI 10.1182/blood.V99.7.2418; GOODMAN SR, 1981, P NATL ACAD SCI-BIOL, V78, P7570, DOI 10.1073/pnas.78.12.7570; GRANGER BL, 1985, NATURE, V313, P238, DOI 10.1038/313238a0; GREGORIO CC, 1994, J CELL BIOL, V125, P345, DOI 10.1083/jcb.125.2.345; Hammarlund M, 2000, J CELL BIOL, V149, P931, DOI 10.1083/jcb.149.4.931; Hassoun H, 1995, J CLIN INVEST, V96, P2623, DOI 10.1172/JCI118327; HILLER G, 1977, NATURE, V266, P181, DOI 10.1038/266181a0; Hoben GM, 2008, CELL TISSUE RES, V334, P469, DOI 10.1007/s00441-008-0705-6; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Johansen C, 2000, J INVEST DERMATOL, V114, P1174, DOI 10.1046/j.1523-1747.2000.00003.x; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; KAISER HW, 1993, J INVEST DERMATOL, V101, P783, DOI 10.1111/1523-1747.ep12371695; KARINIEMI AL, 1984, J CUTAN PATHOL, V11, P541, DOI 10.1111/j.1600-0560.1984.tb00416.x; KARINIEMI AL, 1984, BRIT J DERMATOL, V111, P139, DOI 10.1111/j.1365-2133.1984.tb04036.x; Khurana RN, 2003, EXP EYE RES, V76, P39, DOI 10.1016/S0014-4835(02)00255-5; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee YS, 1997, MOL CARCINOGEN, V18, P44, DOI 10.1002/(SICI)1098-2744(199701)18:1<44::AID-MC6>3.0.CO;2-R; LEWIS L, 1987, DIFFERENTIATION, V36, P228, DOI 10.1111/j.1432-0436.1987.tb00197.x; Li B, 2008, DIFFERENTIATION, V76, P1068, DOI 10.1111/j.1432-0436.2008.00300.x; Li XL, 1996, J BIOL CHEM, V271, P15695, DOI 10.1074/jbc.271.26.15695; Liedtke CM, 2003, AM J PHYSIOL-CELL PH, V284, pC487, DOI 10.1152/ajpcell.00357.2002; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; LUX SE, 1990, NATURE, V345, P736, DOI 10.1038/345736a0; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MANGEAT PH, 1984, J CELL BIOL, V98, P1363, DOI 10.1083/jcb.98.4.1363; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Matsuoka Y, 1998, J CELL BIOL, V142, P485, DOI 10.1083/jcb.142.2.485; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Moorthy S, 2000, J CELL BIOL, V149, P915, DOI 10.1083/jcb.149.4.915; Morton WM, 2000, NAT CELL BIOL, V2, P376, DOI 10.1038/35014075; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; PAINTER RG, 1975, P NATL ACAD SCI USA, V72, P1359, DOI 10.1073/pnas.72.4.1359; Parekh D, 1999, J BIOL CHEM, V274, P34758, DOI 10.1074/jbc.274.49.34758; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Perrotta S, 2001, LEUKEMIA, V15, P440, DOI 10.1038/sj.leu.2402047; PETERS LL, 1992, P NATL ACAD SCI USA, V89, P5749, DOI 10.1073/pnas.89.13.5749; Pinder JC, 2000, NATURE, V406, P253, DOI 10.1038/35018679; PINES J, 1990, New Biologist, V2, P389; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; ROOP D, 1995, SCIENCE, V267, P474, DOI 10.1126/science.7529942; Rutberg SE, 1996, ONCOGENE, V13, P167; SATO S, 1986, J BIOCHEM-TOKYO, V100, P643, DOI 10.1093/oxfordjournals.jbchem.a121756; SHIMIZU T, 1995, HISTOCHEM CELL BIOL, V103, P363, DOI 10.1007/BF01457811; Sihag RK, 1998, J NEUROCHEM, V71, P2220; Sikorski AF, 2000, BRAIN RES, V852, P161, DOI 10.1016/S0006-8993(99)02253-2; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; Stanwell C, 1996, J INVEST DERMATOL, V106, P482, DOI 10.1111/1523-1747.ep12343690; STECK TL, 1974, J CELL BIOL, V62, P1, DOI 10.1083/jcb.62.1.1; Tamaru S, 2005, BIOCHEM BIOPH RES CO, V332, P347, DOI 10.1016/j.bbrc.2005.04.127; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Tuominen H, 1996, BRIT J DERMATOL, V135, P576, DOI 10.1046/j.1365-2133.1996.d01-1043.x; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhu L, 2008, J INVEST DERMATOL, V128, P833, DOI 10.1038/sj.jid.5701103	77	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28267	10.1371/journal.pone.0028267	http://dx.doi.org/10.1371/journal.pone.0028267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163289	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900024
J	Chen, W; Lim, CED; Kang, HJ; Liu, JP				Chen, Wei; Lim, Chi Eung Danforn; Kang, Hong-Jun; Liu, Jianping			Chinese Herbal Medicines for the Treatment of Type A H1N1 Influenza: A Systematic Review of Randomized Controlled Trials	PLOS ONE			English	Review							QUALITY; THERAPY	Background: Chinese herbs are thought to be effective for type A H1N1 influenza. Series of Chinese herbs have been authorized recommended by the Chinese government, and until now a number of clinical trials of Chinese herbs for H1N1 influenza have been conducted. However, there is no critically appraised evidence such as systematic reviews or meta-analyses on potential benefits and harms of medicinal herbs for H1N1 influenza to justify their clinical use and their recommendation. Methods and Findings: CENTRAL, MEDLINE, EMBASE, CBM, CNKI, VIP, China Important Conference Papers Database, China Dissertation Database, and online clinical trial registry websites were searched for published and unpublished randomized controlled trials (RCTs) of Chinese herbs for H1N1 influenza till 31 August, 2011. A total of 26 RCTs were identified and reviewed. Most of the RCTs were of high risk of bias with flawed study design and poor methodological quality. The combination of several Chinese herbal medicines with or without oseltamivir demonstrated positive effect on fever resolution, relief of symptoms, and global effectiveness rate compared to oseltamivir alone. However, only one herbal medicine showed positive effect on viral shedding. Most of the trials did not report adverse events, and the safety of herbal medicines is still uncertain. Conclusions: Some Chinese herbal medicines demonstrated potential positive effect for 2009 type A H1N1 influenza; however, due to the lack of placebo controlled trial and lack of repeated test of the intervention, we could not draw confirmative conclusions on the beneficial effect of Chinese herbs for H1N1 influenza. More rigorous trials are warranted to support their clinical use.	[Chen, Wei; Liu, Jianping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Lim, Chi Eung Danforn] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Sydney, NSW, Australia; [Kang, Hong-Jun] Chinese Peoples Liberat Army Gen Hosp, Intens Care Unit, Beijing, Peoples R China; [Liu, Jianping] Univ Tromso, NAFKAM, Tromso, Norway	Beijing University of Chinese Medicine; University of New South Wales Sydney; Chinese People's Liberation Army General Hospital; UiT The Arctic University of Tromso	Chen, W (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	jianping_l@hotmail.com			Specific Professional Research Grant in Traditional Chinese Medicine (TCM); State Administration of TCM of China [200907001-2A]; international collaboration project; Ministry of Science and Technology of China [2009DFA31460]	Specific Professional Research Grant in Traditional Chinese Medicine (TCM); State Administration of TCM of China; international collaboration project; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by a 2009 Specific Professional Research Grant in Traditional Chinese Medicine (TCM) funded by the State Administration of TCM of China: Clinical Study on Traditional Chinese Medicine for Severe Cases of (H1N1) Influenza A (No. 200907001-2A), and partly supported by an international collaboration project funded by the Ministry of Science and Technology of China (No. 2009DFA31460). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Center for Desease Control and Prevention, 2010, SEAS INFL FLU 2009 2; Chai LX, 2010, CRITICAL J CHINESE M, V2, P36; Chen F, 2010, J ZHEJIANG U TRADITI, V34, P658; Chen H, 2010, SICHUAN MED J, V31, P1050; Deng WL, 1998, PHARM TRADITIONAL CH; Dou AH, 2010, MODERN J INTEGRATED, V19, P3289; GOTTIEB S, 2000, BMJ-BRIT MED J, V320, P1623; Han JT, 2011, JILIN MED J CHIN, V32, P1491; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hu J., 2011, CHINESE J PRACTICAL, V26, P388; Huang M, 2010, CHINESE J MISDIAGNOS, V10, P2079; Ishizaki T, 1996, EUR RESPIR J, V9, P2691, DOI 10.1183/09031936.96.09122691; Jin F, 2010, J SICHUAN TRADITIONA, V28, P81; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kou GX, 2011, JETCM, V20, p[872, 876]; Li BF, 2009, J MED FORUM, V30, P91; Li G, 2010, J EMERG TRADIT CHIN, V19, P1681; [李同霞 Li Tongxia], 2010, [中国现代医学杂志, China Journal of Modern Medicine], V20, P3479; Li XQ, 2010, NAT CHIN W INT MED C; Lin CZ, 2011, ACTA ACAD MED QINGDA, V47, P132; Liu DaFeng, 2011, Modern Preventive Medicine, V38, P338; Liu GW, 2001, CHINESE HERBAL MED; Liu GX, 2010, CHIN J DIFFIC COMPL, V9, P14; Liu J, 2010, CONT MED, V16, P158; Liu JP, 2009, FOCUS ALTERNATIVE CO, V14, P92; Liu YL, 2010, CLIN FOCUS, V25, P439; Ma YP, 2010, SHANXI ZHONG YI, V31, P1351; Melchart D, 1999, JAMA-J AM MED ASSOC, V282, P28, DOI 10.1001/jama.282.1.28; Ministry of Health of the People's Republic of China, 2009, GUID MAN PAND H1N1 2; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moscona A, 2005, NEW ENGL J MED, V353, P2633, DOI 10.1056/NEJMp058291; Narain JP, 2009, INDIAN J MED RES, V129, P465; OuYang HX, 2010, CHINA MED HERALD, V7, P6; Poon PMK, 2006, AM J CHINESE MED, V34, P13, DOI 10.1142/S0192415X0600359X; Qian J, 2011, JILIN MED J CHIN, V32, P266; Qin XY, 2010, MED INFORM, V23, P155; Qiu YJ, 2010, GUIDING J TRADITIONA, V16, P36; Qu JL, 2010, CHINESE MED MODERN D, V8, P196; Ru GX, 2010, INT MED HLTH GUIDANC, V16, P1897; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Song K, 2010, MED FOR ROL CHIN MED; Tan X. Y., 2010, J GUANGZHOU U TRADIT, V27, P441; Tang CB, 2010, CHINESE COMMUNITY DO, V12, P141; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Tian G, 2011, CHINESE J INFORM TCM, V18, p[81, 112]; Vickers A, 1998, CONTROL CLIN TRIALS, V19, P159, DOI 10.1016/S0197-2456(97)00150-5; Wang C, 2011, ANN INTERN MED, V155, P217, DOI 10.7326/0003-4819-155-4-201108160-00005; Wang S, 2011, INFECT DIS INFO, V24, P46; Wei Q, 2010, GUANGMING J CHINESE, V25, P2318; Wen XM, 2010, J SICHUAN TRADITIONA, V28, P56; Weng BX, 2010, INT MED HLTH GUIDANC, V16, P979; World Health Organization, 2009, PAND H1N1 2009 UPD 8; Xia BS, 2010, PEOPLES MILIT SURG, V53, P645; Xie Y, 2010, CHINA MODERN DOCTOR, V48, P47; Xie YZ, 2010, CHINA FOREIGN MED TR, V33, P38; Yang C, 2010, J COMMUNITY MED, V8, P69; Ye YM, 2010, SICHUAN MED J, V31, P1533; Zeng YiLan, 2011, Modern Preventive Medicine, V38, P2227; Zhang WS, 2011, GANSU ZHONG YI, V24, P20; Zhang ZQ, 2010, HEBEI J TRADITIONAL, V32, P1192; Zhao WN, 2007, PRACTICAL PREVENTIVE, V14, P178; Zhao ZL, 2010, NINGXIA MED J, V32, P376; Zheng HaiPeng, 2010, China Journal of Traditional Chinese Medicine and Pharmacy, V25, P780; Zheng HJ, 2010, HEBEI J TRADITIONAL, V32, P1621; Zhu Y.H., 2010, SHANDONG J TRADIT CH, V29, P535	65	59	60	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28093	10.1371/journal.pone.0028093	http://dx.doi.org/10.1371/journal.pone.0028093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164232	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400033
J	Kouznetsova, A; Benavente, R; Pastink, A; Hoog, C				Kouznetsova, Anna; Benavente, Ricardo; Pastink, Albert; Hoog, Christer			Meiosis in Mice without a Synaptonemal Complex	PLOS ONE			English	Article							CHROMOSOME SYNAPSIS; MEIOTIC CHROMOSOMES; CAENORHABDITIS-ELEGANS; DNA RECOMBINATION; MAMMALIAN MEIOSIS; STRAND-EXCHANGE; AXIAL ELEMENTS; CROSSING-OVER; MOUSE MEIOSIS; PROTEIN ZYP1	The synaptonemal complex (SC) promotes fusion of the homologous chromosomes (synapsis) and crossover recombination events during meiosis. The SC displays an extensive structural conservation between species; however, a few organisms lack SC and execute meiotic process in a SC-independent manner. To clarify the SC function in mammals, we have generated a mutant mouse strain (Sycp1(-/-) Sycp3(-/-), here called SC-null) in which all known SC proteins have been displaced from meiotic chromosomes. While transmission electron microscopy failed to identify any remnants of the SC in SC-null spermatocytes, neither formation of the cohesion axes nor attachment of the chromosomes to the nuclear membrane was perturbed. Furthermore, the meiotic chromosomes in SC-null meiocytes achieved pre-synaptic pairing, underwent early homologous recombination events and sustained a residual crossover formation. In contrast, in SC-null meiocytes synapsis and MLH1-MLH3-dependent crossovers maturation were abolished, whereas the structural integrity of chromosomes was drastically impaired. The variable consequences that SC inactivation has on the meiotic process in different organisms, together with the absence of SC in some unrelated species, imply that the SC could have originated independently in different taxonomic groups.	[Kouznetsova, Anna; Hoog, Christer] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Benavente, Ricardo] Univ Wurzburg, Dept Cell & Dev Biol, Bioctr, Wurzburg, Germany; [Pastink, Albert] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands	Karolinska Institutet; University of Wurzburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kouznetsova, A (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Anna.Kouznetsova@ki.se	Kouznetsova, Anna/AAF-2312-2019; Benavente, Ricardo/GNW-2855-2022	Kouznetsova, Anna/0000-0001-9059-4567; 	Swedish Cancer Society; Swedish Research Council, Torsten; Ragnar Soderbergs Stiftelser; Karolinska Institutet; DFG [Be1168/7-1]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council, Torsten(Swedish Research Council); Ragnar Soderbergs Stiftelser; Karolinska Institutet(Karolinska Institutet); DFG(German Research Foundation (DFG))	This work was supported by grants from the Swedish Cancer Society, the Swedish Research Council, Torsten and Ragnar Soderbergs Stiftelser and Karolinska Institutet. R.B. was supported by grant Be1168/7-1 (Priority Program 1384 "Mechanisms of genome haploidization'', DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister LA, 2004, CYTOGENET GENOME RES, V107, P191, DOI 10.1159/000080597; Bhalla N, 2005, SCIENCE, V310, P1683, DOI 10.1126/science.1117468; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Chicheportiche A, 2007, J CELL SCI, V120, P1733, DOI 10.1242/jcs.004945; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Costa Y, 2005, J CELL SCI, V118, P2755, DOI 10.1242/jcs.02402; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; de Boer E, 2006, CHROMOSOMA, V115, P220, DOI 10.1007/s00412-006-0057-5; de Boer E, 2007, J CELL SCI, V120, P731, DOI 10.1242/jcs.003186; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DIETRICH AJJ, 1983, CHROMOSOMA, V88, P377, DOI 10.1007/BF00285860; Fukuda T, 2010, EXP CELL RES, V316, P158, DOI 10.1016/j.yexcr.2009.08.007; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; Hamer G, 2008, THERIOGENOLOGY, V69, P333, DOI 10.1016/j.theriogenology.2007.09.029; Hamer G, 2006, J CELL SCI, V119, P4025, DOI 10.1242/jcs.03182; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Khetani RS, 2007, J CELL SCI, V120, P3123, DOI 10.1242/jcs.009977; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Kouznetsova A, 2007, NAT GENET, V39, P966, DOI 10.1038/ng2065; Li XCL, 2011, GENETICS, V189, P71, DOI 10.1534/genetics.111.130674; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Loidl J, 2006, CHROMOSOMA, V115, P260, DOI 10.1007/s00412-006-0047-7; Loidl J, 2004, J CELL SCI, V117, P5791, DOI 10.1242/jcs.01504; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; Manheim EA, 2003, CURR BIOL, V13, P276, DOI 10.1016/S0960-9822(03)00050-2; Mehrotra S, 2006, PLOS GENET, V2, P1883, DOI 10.1371/journal.pgen.0020200; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Osman K, 2006, CHROMOSOMA, V115, P212, DOI 10.1007/s00412-005-0042-4; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Revenkova E, 2006, CHROMOSOMA, V115, P235, DOI 10.1007/s00412-006-0060-x; Schild-Prufert K, 2011, GENETICS, V189, P411, DOI 10.1534/genetics.111.132431; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; Wang H, 2006, J CELL BIOL, V173, P485, DOI 10.1083/jcb.200512077; Wang KJ, 2011, MOL BIOL CELL, V22, P12, DOI 10.1091/mbc.E10-08-0667; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; Wilkins AS, 2009, GENETICS, V181, P3, DOI 10.1534/genetics.108.099762; Woltering D, 2000, MOL CELL BIOL, V20, P6646, DOI 10.1128/MCB.20.18.6646-6658.2000; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Yang F., 2009, V5, P69, DOI 10.1159/000166620; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	59	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28255	10.1371/journal.pone.0028255	http://dx.doi.org/10.1371/journal.pone.0028255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164254	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400055
J	Lucentini, L; Puletti, ME; Ricciolini, C; Gigliarelli, L; Fontaneto, D; Lanfaloni, L; Bilo, F; Natali, M; Panara, F				Lucentini, Livia; Puletti, Maria Elena; Ricciolini, Claudia; Gigliarelli, Lilia; Fontaneto, Diego; Lanfaloni, Luisa; Bilo, Fabiana; Natali, Mauro; Panara, Fausto			Molecular and Phenotypic Evidence of a New Species of Genus Esox (Esocidae, Esociformes, Actinopterygii): The Southern Pike, Esox flaviae	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; AFLP(TM) MARKERS; DNA; POLYMORPHISM; EVOLUTION; CONSERVATION; PHYLOGENIES; INVASIONS; TAXONOMY; CLADES	We address the taxonomic position of the southern European individuals of pike, performing a series of tests and comparisons from morphology, DNA taxonomy and population genetics parameters, in order to support the hypothesis that two species of pike, and not only one, exist in Europe. A strong relationship emerged between a northern genotype supported by COI, Cytb, AFLP and specific fragments, and a phenotype with round spot skin colour pattern and a large number of scales in the lateral line, clearly separated from a southern genotype with other skin colour pattern and a low number of scales in the lateral line. DNA taxonomy, based on a coalescent approach (GMYC) from phylogenetic reconstructions on COI and Cytb together with AFLP admixture analysis, supported the existence of two independently evolving entities. Such differences are not simply due to geographic distances, as northern European samples are more similar to Canadian and Chinese samples than the southern Europe ones. Thus, given that the differences between the two groups of European pike are significant at the phenotypic, genotypic and geographical levels, we propose the identification of two pike species: the already known northern pike (Esox lucius) and the southern pike (E. flaviae n. sp.). The correct identification of these two lineages as independent species should give rise to a ban on the introduction of northern pikes in southern Europe for recreational fishing, due to potential problems of hybridisation.	[Lucentini, Livia; Puletti, Maria Elena; Ricciolini, Claudia; Gigliarelli, Lilia; Lanfaloni, Luisa; Panara, Fausto] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Bilo, Fabiana] Veneto Agr Viale Univ, Legnaro, Italy; [Natali, Mauro] Prov Perugia, Perugia, Italy	University of Perugia	Lucentini, L (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy.	livia@unipg.it	Fontaneto, Diego/B-9710-2008; lucentini, livia/E-6187-2014; lucentini, livia/AAW-7479-2020	Fontaneto, Diego/0000-0002-5770-0353; lucentini, livia/0000-0001-5051-610X; lucentini, livia/0000-0001-5051-610X; Ricciolini, Claudia/0000-0001-5956-313X	NERC [NE/G013179/1] Funding Source: UKRI; Natural Environment Research Council [NE/G013179/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Alfei L, 1996, J FISH BIOL, V48, P1051, DOI 10.1111/j.1095-8649.1996.tb01803.x; Amorosi A, 2003, J GEOL, V111, P39, DOI 10.1086/344577; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Bensch S, 2002, MOL ECOL, V11, P2359, DOI 10.1046/j.1365-294X.2002.01629.x; Birky CW, 2011, ZOOL J LINN SOC-LOND, V161, P723, DOI 10.1111/j.1096-3642.2010.00674.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Crawley M.J., 2007, R BOOK; David L, 2001, MOL GENET GENOMICS, V266, P353, DOI 10.1007/s004380100569; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Economidis PS, 2000, FISHERIES MANAG ECOL, V7, P239, DOI 10.1046/j.1365-2400.2000.00197.x; Epifanio J, 2000, REV FISH BIOL FISHER, V10, P245, DOI 10.1023/A:1016729132297; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FICKLING NJ, 1982, FISH MANAGE, V13, P79; Fitzhugh TW, 2004, BIOSCIENCE, V54, P741, DOI 10.1641/0006-3568(2004)054[0741:QUTGCA]2.0.CO;2; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Grande Terry, 2004, Copeia, V2004, P743, DOI 10.1643/CG-04-007R1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kottelat M., 2007, HDB EUROPEAN FRESHWA, P646; Kyle CJ, 2007, FORENSIC SCI INT, V166, P68, DOI 10.1016/j.forsciint.2006.03.025; Larsen PF, 2005, HEREDITY, V95, P136, DOI 10.1038/sj.hdy.6800671; Launey S, 2006, J FISH BIOL, V68, P193, DOI 10.1111/j.0022-1112.2006.001059.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Linnaeus C, 1758, SYSTEMA NATURAE; Logan JA, 1999, ENVIRON ENTOMOL, V28, P143, DOI 10.1093/ee/28.2.143; Lorenzoni M, 2002, FISH RES, V59, P239, DOI 10.1016/S0165-7836(02)00013-9; Lucentini L., 2010, Journal of Water Resource and Protection, V2, P167; Lucentini L, 2009, FISH RES, V96, P139, DOI 10.1016/j.fishres.2008.10.007; Lucentini L, 2009, ENDANGERED SPECIES N; Lucentini L, 2006, CONSERV GENET, V7, P1009, DOI 10.1007/s10592-006-9137-6; Lucentini L, 2006, FISH RES, V80, P251, DOI 10.1016/j.fishres.2006.04.002; Lucentini L, 2011, HYDROBIOLOGIA, V673, P215, DOI 10.1007/s10750-011-0778-1; Ma GC, 2006, ZOOL SCR, V35, P341, DOI 10.1111/j.1463-6409.2006.00232.x; MELOTTO S, 1990, J FISH BIOL, V37, P687, DOI 10.1111/j.1095-8649.1990.tb02533.x; Meraner A, 2010, CONSERV GENET, V11, P985, DOI 10.1007/s10592-009-9942-9; Oksanen J, 2010, R PACKAGE VERSION 1; Orti G, 1996, MOL BIOL EVOL, V13, P556, DOI 10.1093/oxfordjournals.molbev.a025616; Papa R, 2005, J ANIM BREED GENET, V122, P62, DOI 10.1111/j.1439-0388.2004.00476.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Raat A. J. P., 1988, FAO FISHERIES SYNOPS, V2, P178; Rex M, 2007, GENOME, V50, P90, DOI 10.1139/G06-141; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sevilla RG, 2007, MOL ECOL NOTES, V7, P730, DOI 10.1111/j.1471-8286.2007.01863.x; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Susnik S, 2007, MOL PHYLOGENET EVOL, V44, P63, DOI 10.1016/j.ympev.2006.08.021; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Welcomme RL., 1988, FAO FISHERIES TECHNI; Zaragueta-Bagils R, 2002, CR BIOL, V325, P1191, DOI 10.1016/S1631-0691(02)01535-4; Zardoya R, 1996, MOL BIOL EVOL, V13, P933, DOI 10.1093/oxfordjournals.molbev.a025661	65	31	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e25218	10.1371/journal.pone.0025218	http://dx.doi.org/10.1371/journal.pone.0025218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164201	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400001
J	Tang, J; Chen, X; Tu, WF; Guo, YB; Zhao, ZL; Xue, Q; Lin, CS; Xiao, JF; Sun, XG; Tao, T; Gu, MN; Liu, YT				Tang, Jing; Chen, Xi; Tu, Weifeng; Guo, Yuanbo; Zhao, Zhenlong; Xue, Qiong; Lin, Chunshui; Xiao, Jinfang; Sun, Xuegang; Tao, Tao; Gu, Miaoning; Liu, Youtan			Propofol Inhibits the Activation of p38 through Up-Regulating the Expression of Annexin A1 to Exert Its Anti-Inflammation Effect	PLOS ONE			English	Article							ACUTE LUNG INJURY; NITRIC-OXIDE; LIPOCORTIN 1; ENDOTOXIN; GLUCOCORTICOIDS; DEXAMETHASONE; SUPEROXIDE; MECHANISMS; MEMBRANE; RELEASE	Inflammatory response is a kind of nonspecific immune response, with the central link of vascular response, which is mainly manifested by changes in neutrophils and vascular endothelial cells. In recent years, the in vivo and in vitro role of intravenous anesthetic propofol in inhibiting inflammatory response has been attracting more and more attention, but the anti- inflammatory mechanisms of propofol for mononuclear cells still remain undefined. In this study, proteomics analysis was applied to investigate protein expression profile changes in serum mononuclear cells following intervention of rats with endotoxemia using propofol. After two-dimensional electrophoresis and mass spectrometric identification, it has been found that the protein Annexin A1 was up-regulated in the propofol intervention group. Annexin A1 is a glucocorticoiddependent anti-inflammatory protein. After detection using ELISA and Western blot assays, it has also been found that propofol can not only promote the expression of Annexin A1, but also inhibit the phosphorylation level of p38 and release of inflammatory factors (IL-1 beta, IL-6 and TNF-alpha) in rats with endotoxemia. In order to further determine the role of upregulated expression of Annexin A1 in anti-inflammation of propofol, this gene was silenced in vitro in human THP-1 cells, to detect the phosphorylation status of p38 and release of inflammatory factors. The results show that Annexin A1 can negatively regulate phosphorylation of p38 and release of IL-1 beta, IL-6 and TNF-alpha in THP-1 cells following propofol intervention and lipopolysaccharide (LPS) stimulation. Our results clearly indicate that propofol can up-regulate Annexin A1 to inhibit the phosphorylation level of p38 and release of IL-1 beta, IL-6 and TNF-alpha, so as to inhibit inflammatory response. Therefore, it can be speculated that Annexin A1 might be the key signaling protein in the in vivo and in vitro antiinflammatory mechanisms of propofol.	[Tang, Jing; Guo, Yuanbo; Zhao, Zhenlong; Xue, Qiong; Lin, Chunshui; Xiao, Jinfang; Tao, Tao; Gu, Miaoning] So Med Univ, Nanfang Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China; [Chen, Xi; Tu, Weifeng] Guangzhou Mil Command, Guangzhou Gen Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China; [Sun, Xuegang] So Med Univ, Sch Tradit Chinese Med, State Adm Tradit Chinese Med, Key Lab Mol Biol, Guangzhou, Guangdong, Peoples R China; [Liu, Youtan] Univ Hong Kong, Shenzhen Hosp, Dept Anesthesia, Shenzhen, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Southern Medical University - China; University of Hong Kong	Tang, J (corresponding author), So Med Univ, Nanfang Hosp, Dept Anesthesia, Guangzhou, Guangdong, Peoples R China.	taotao@126.com; gumiaoning@126.com; Youtanliuhao@163.com	Tao, Tao/S-6992-2016	Tao, Tao/0000-0002-6348-719X	National Natural Science Foundation of China [30872431]; Nanfang Hospital [2009A001, 2010C013]; Medical Scientific Research Foundation of Guangdong Province [B2011202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanfang Hospital; Medical Scientific Research Foundation of Guangdong Province	This work was supported by the National Natural Science Foundation of China (30872431), President Fund of Nanfang Hospital (2009A001), President Fund of Nanfang Hospital (2010C013), and Medical Scientific Research Foundation of Guangdong Province (B2011202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; Brunkhorst FM, 2009, INTERNIST, V50, P810, DOI 10.1007/s00108-008-2287-5; BRYSON HM, 1995, DRUGS, V50, P513, DOI 10.2165/00003495-199550030-00008; Chen RM, 2005, ANN NY ACAD SCI, V1042, P262, DOI 10.1196/annals.1338.030; CROXTALL JD, 1992, P NATL ACAD SCI USA, V89, P3571, DOI 10.1073/pnas.89.8.3571; Diakonova M, 1997, J CELL SCI, V110, P1199; Ferlazzo V, 2003, INT IMMUNOPHARMACOL, V3, P1363, DOI 10.1016/S1567-5769(03)00133-4; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; Gao J, 2004, BRIT J ANAESTH, V92, P277, DOI 10.1093/bja/aeh050; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; Hsing CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017598; Hsu BG, 2005, CLIN EXP PHARMACOL P, V32, P24, DOI 10.1111/j.1440-1681.2005.04155.x; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; LYNN WA, 1995, J INFECTION, V30, P207, DOI 10.1016/S0163-4453(95)90670-3; Mathy-Hartert M, 2000, ANAESTHESIA, V55, P1066, DOI 10.1046/j.1365-2044.2000.01606.x; MOLLOY RG, 1993, BRIT J SURG, V80, P289, DOI 10.1002/bjs.1800800308; Perretti M, 2000, CELL BIOL INT, V24, P163, DOI 10.1006/cbir.1999.0468; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Philip JG, 1997, NEUROREPORT, V8, P1871, DOI 10.1097/00001756-199705260-00016; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Renshaw D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012771; SEBEL PS, 1989, ANESTHESIOLOGY, V71, P260, DOI 10.1097/00000542-198908000-00015; STOUT RD, 1993, CURR OPIN IMMUNOL, V5, P398, DOI 10.1016/0952-7915(93)90059-2; Tabbutt S, 2001, CRIT CARE MED, V29, pS231, DOI 10.1097/00003246-200110001-00005; Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C; Takemoto Y, 2003, J ANESTH, V19, P40; Traverso V, 1998, J CELL SCI, V111, P1405; Tsao CM, 2003, EUR J PHARMACOL, V477, P183, DOI 10.1016/j.ejphar.2003.08.005; VIOLETTE SM, 1990, J CELL PHYSIOL, V142, P70, DOI 10.1002/jcp.1041420110; WEST MA, 1995, SURGERY, V118, P220, DOI 10.1016/S0039-6060(05)80327-7; WEST MA, 1994, J TRAUMA, V37, P82, DOI 10.1097/00005373-199407000-00015; Yang YH, 2004, ARTHRITIS RHEUM-US, V50, P976, DOI 10.1002/art.20201; Yang YH, 2006, J IMMUNOL, V177, P8148, DOI 10.4049/jimmunol.177.11.8148	37	37	42	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27890	10.1371/journal.pone.0027890	http://dx.doi.org/10.1371/journal.pone.0027890			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164217	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400018
J	Wilson, K; Hawken, S; Kwong, JC; Deeks, S; Crowcroft, NS; Van Walraven, C; Potter, BK; Chakraborty, P; Keelan, J; Pluscauskas, M; Manuel, D				Wilson, Kumanan; Hawken, Steven; Kwong, Jeffrey C.; Deeks, Shelley; Crowcroft, Natasha S.; Van Walraven, Carl; Potter, Beth K.; Chakraborty, Pranesh; Keelan, Jennifer; Pluscauskas, Michael; Manuel, Doug			Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis	PLOS ONE			English	Article							VACCINES; MEASLES; MUMPS; IMMUNIZATION; PERTUSSIS; SEIZURES; RISK	Background: Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks after administration. In the province of Ontario, Canada, live MMR vaccine is currently recommended at age 12 months and 18 months. Methods: Using the self-controlled case series design we examined 271,495 12 month vaccinations and 184,312 18 month vaccinations to examine the relative incidence of the composite endpoint of emergency room visits or hospital admissions in consecutive one day intervals following vaccination. These were compared to a control period 20 to 28 days later. In a post-hoc analysis we examined the reasons for emergency room visits and the average acuity score at presentation for children during the at-risk period following the 12 month vaccine. Results: Four to 12 days post 12 month vaccination, children had a 1.33 (1.29-1.38) increased relative incidence of the combined endpoint compared to the control period, or at least one event during the risk interval for every 168 children vaccinated. Ten to 12 days post 18 month vaccination, the relative incidence was 1.25 (95%, 1.17-1.33) which represented at least one excess event for every 730 children vaccinated. The primary reason for increased events was statistically significant elevations in emergency room visits following all vaccinations. There were non-significant increases in hospital admissions. There were an additional 20 febrile seizures for every 100,000 vaccinated at 12 months. Conclusions: There are significantly elevated risks of primarily emergency room visits approximately one to two weeks following 12 and 18 month vaccination. Future studies should examine whether these events could be predicted or prevented.	[Wilson, Kumanan; Van Walraven, Carl] Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Wilson, Kumanan; Van Walraven, Carl; Potter, Beth K.; Manuel, Doug] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Wilson, Kumanan; Chakraborty, Pranesh; Pluscauskas, Michael] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Deeks, Shelley; Crowcroft, Natasha S.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Keelan, Jennifer] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Chakraborty, Pranesh] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Manuel, Doug] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Toronto; University of Ottawa; University of Ottawa	Wilson, K (corresponding author), Univ Ottawa, Dept Med, Ottawa Hosp Res Inst, Ottawa, ON, Canada.	kwilson@ohri.ca	; Manuel, Doug/D-7100-2014	Hawken, Steven/0000-0002-3341-9022; Manuel, Doug/0000-0003-0912-0845	Canadian Foundation for Innovation; Population Health Improvement Research Network (PHIRN); Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); Department of Family and Community Medicine, University of Toronto	Canadian Foundation for Innovation(Canada Foundation for Innovation); Population Health Improvement Research Network (PHIRN); Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Department of Family and Community Medicine, University of Toronto(University of Toronto)	This study was supported by the Canadian Foundation for Innovation, the Population Health Improvement Research Network (PHIRN), and by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, Ontario MOHLTC or PHIRN is intended or should be inferred. Dr. Wilson holds the Canada Research Chair in Public Health Policy. Dr. Manuel holds the CIHR Chair in Applied Public Health. Dr. Kwong and Professor Keelan are supported by a Career Scientist award from the Ontario Ministry of Health and Long-Term Care. Dr Kwong is also supported by a Clinician Scientist award from the Department of Family and Community Medicine, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CAN IMM GUID; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Centers for Disease Control and Prevention, POSS SID EFF VACC; Davis RL, 1997, PEDIATRICS, V100, P767, DOI 10.1542/peds.100.5.767; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON P, 1995, LANCET, V345, P567, DOI 10.1016/S0140-6736(95)90471-9; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Fritzell B, 2001, VACCINE, V20, pS47, DOI 10.1016/S0264-410X(01)00291-2; GRIFFIN MR, 1991, PEDIATRICS, V88, P881; KLEIN NP, PEDIATRICS, V126, pE1; Koskiniemi M, 1997, EUR J PEDIATR, V156, P541, DOI 10.1007/s004310050658; Salkind N., 2007, ENCY MEASUREMENT STA; Shui IM, 2009, VACCINE, V27, P5307, DOI 10.1016/j.vaccine.2009.06.092; Siegrist CA, 2007, J COMP PATHOL, V137, pS46, DOI 10.1016/j.jcpa.2007.04.012; Stratton K.R., 1994, ADVERSE EVENTS ASS C; Strebel P., 2004, VACCINES; Vestergaard M, 2004, JAMA-J AM MED ASSOC, V292, P351, DOI 10.1001/jama.292.3.351; Virtanen M, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.5.e62; Warren DW, 2008, CAN J EMERG MED, V10, P224; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Wilson K, 2011, VACCINE, V29, P3746, DOI 10.1016/j.vaccine.2011.03.044	21	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e27897	10.1371/journal.pone.0027897	http://dx.doi.org/10.1371/journal.pone.0027897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174753	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600004
J	Siman, R; Giovannone, N; Toraskar, N; Frangos, S; Stein, SC; Levine, JM; Kumar, MA				Siman, Robert; Giovannone, Nicholas; Toraskar, Nikhil; Frangos, Suzanne; Stein, Sherman C.; Levine, Joshua M.; Kumar, Monisha A.			Evidence that a Panel of Neurodegeneration Biomarkers Predicts Vasospasm, Infarction, and Outcome in Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							SPECTRIN BREAKDOWN PRODUCTS; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; CEREBRAL VASOSPASM; SURROGATE MARKERS; CALPAIN-I; DAMAGE; ISCHEMIA; CASPASE	Biomarkers for neurodegeneration could be early prognostic measures of brain damage and dysfunction in aneurysmal subarachnoid hemorrhage (aSAH) with clinical and medical applications. Recently, we developed a new panel of neurodegeneration biomarkers, and report here on their relationships with pathophysiological complications and outcomes following severe aSAH. Fourteen patients provided serial cerebrospinal fluid samples for up to 10 days and were evaluated by ultrasonography, angiography, magnetic resonance imaging, and clinical examination. Functional outcomes were assessed at hospital discharge and 6-9 months thereafter. Eight biomarkers for acute brain damage were quantified: calpain-derived alpha-spectrin N- and C-terminal fragments (CCSntf and CCSctf), hypophosphorylated neurofilament H, 14-3-3 beta and zeta, ubiquitin C-terminal hydrolase L1, neuron-specific enolase, and S100 beta. All 8 biomarkers rose up to 100-fold in a subset of patients. Better than any single biomarker, a set of 6 correlated significantly with cerebral vasospasm, brain infarction, and poor outcome. Furthermore, CSF levels of 14-3-3 beta, CCSntf, and NSE were early predictors of subsequent moderate-to-severe vasospasm. These data provide evidence that a panel of neurodegeneration biomarkers may predict lasting brain dysfunction and the pathophysiological processes that lead to it following aSAH. The panel may be valuable as surrogate endpoints for controlled clinical evaluation of treatment interventions and for guiding aSAH patient care.	[Siman, Robert; Giovannone, Nicholas; Toraskar, Nikhil; Frangos, Suzanne; Stein, Sherman C.; Levine, Joshua M.; Kumar, Monisha A.] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Levine, Joshua M.; Kumar, Monisha A.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Siman, R (corresponding author), Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA.	siman@mail.med.upenn.edu		Giovannone, Nicholas/0000-0001-5391-8729	National Institute of Health [NS048234]; Groff Foundation; Sharps Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048234] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Groff Foundation; Sharps Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to RS from the National Institute of Health (NS048234) and to JML from the Groff Foundation and Sharps Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Hoh BL, 2004, NEUROSURGERY, V55, P779, DOI 10.1227/01.NEU.0000137628.51839.D5; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Kramer A, 2009, STROKE, V40, P3403, DOI 10.1161/STROKEAHA.109.560243; LAD SP, 2011, J STROKE CE IN PRESS; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Lewis SB, 2010, J NEUROSCI RES, V88, P1475, DOI 10.1002/jnr.22323; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Nylen K, 2006, NEUROSCI LETT, V404, P132, DOI 10.1016/j.neulet.2006.05.029; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Petzold A, 2006, J NEUROL NEUROSUR PS, V77, P753, DOI 10.1136/jnnp.2005.085175; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROBERTSLEWIS JM, 1993, ANN NY ACAD SCI, V679, P78; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Shirao S, 2010, CEREBROVASC DIS, V30, P105, DOI 10.1159/000314713; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; SIMAN R, 1989, J NEUROSCI, V9, P1579; Siman R, 2008, BRAIN RES, V1213, P1, DOI 10.1016/j.brainres.2008.03.034; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Smith ML, 2005, SURG NEUROL, V63, P229, DOI 10.1016/j.surneu.2004.06.017; Vergouwen MDI, 2011, J CEREBR BLOOD F MET, V31, P1545, DOI 10.1038/jcbfm.2011.56; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Zhang C, 2002, NEUROBIOL DIS, V10, P289, DOI 10.1006/nbdi.2002.0526	35	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28938	10.1371/journal.pone.0028938	http://dx.doi.org/10.1371/journal.pone.0028938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174930	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700084
J	Sokolowski, B; Orchard, S; Harvey, M; Sridhar, S; Sakai, Y				Sokolowski, Bernd; Orchard, Sandra; Harvey, Margaret; Sridhar, Settu; Sakai, Yoshihisa			Conserved BK Channel-Protein Interactions Reveal Signals Relevant to Cell Death and Survival	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; POTASSIUM CHANNELS; SMOOTH-MUSCLE; CA CHANNELS; KINASE-C; CALCIUM; ACTIVATION; EXPRESSION; PHOSPHORYLATION; APOPTOSIS	The large-conductance Ca2+-activated K+ (BK) channel and its beta-subunit underlie tuning in non-mammalian sensory or hair cells, whereas in mammals its function is less clear. To gain insights into species differences and to reveal putative BK functions, we undertook a systems analysis of BK and BK-Associated Proteins (BKAPS) in the chicken cochlea and compared these results to other species. We identified 110 putative partners from cytoplasmic and membrane/cytoskeletal fractions, using a combination of coimmunoprecipitation, 2-D gel, and LC-MS/MS. Partners included 14-3-3 gamma, valosin-containing protein (VCP), stathmin (STMN), cortactin (CTTN), and prohibitin (PHB), of which 16 partners were verified by reciprocal coimmunoprecipitation. Bioinformatics revealed binary partners, the resultant interactome, subcellular localization, and cellular processes. The interactome contained 193 proteins involved in 190 binary interactions in subcellular compartments such as the ER, mitochondria, and nucleus. Comparisons with mice showed shared hub proteins that included N-methyl-D-aspartate receptor (NMDAR) and ATP-synthase. Ortholog analyses across six species revealed conserved interactions involving apoptosis, Ca2+ binding, and trafficking, in chicks, mice, and humans. Functional studies using recombinant BK and RNAi in a heterologous expression system revealed that proteins important to cell death/survival, such as annexinA5, gamma-actin, lamin, superoxide dismutase, and VCP, caused a decrease in BK expression. This revelation led to an examination of specific kinases and their effectors relevant to cell viability. Sequence analyses of the BK C-terminus across 10 species showed putative binding sites for 14-3-3, RAC-alpha serine/threonine-protein kinase 1 (Akt), glycogen synthase kinase-3 beta (GSK3 beta) and phosphoinositide-dependent kinase-1 (PDK1). Knockdown of 14-3-3 and Akt caused an increase in BK expression, whereas silencing of GSK3b and PDK1 had the opposite effect. This comparative systems approach suggests conservation in BK function across different species in addition to novel functions that may include the initiation of signals relevant to cell death/survival.	[Sokolowski, Bernd; Harvey, Margaret; Sakai, Yoshihisa] Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Otol Lab, Tampa, FL 33620 USA; [Orchard, Sandra] Wellcome Trust Genome Campus, European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Sridhar, Settu] Univ Bergen, Dept Informat, N-5008 Bergen, Norway	State University System of Florida; University of South Florida; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Bergen	Sokolowski, B (corresponding author), Univ S Florida, Coll Med, Dept Otolaryngol Head & Neck Surg, Otol Lab, Tampa, FL 33620 USA.	bsokolow@health.usf.edu	Orchard, Sandra/ABC-1609-2020	Orchard, Sandra/0000-0002-8878-3972	National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC004295]; European Commission under PSIMEx [FP7-HEALTH-2007-223411]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004295] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); European Commission under PSIMEx; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by the National Institutes of Health/National Institute on Deafness and Other Communication Disorders Grant R01DC004295 to BS (http://www.nidcd.nih.gov/Pages/default.aspx). SO is supported by the European Commission under PSIMEx, contract number FP7-HEALTH-2007-223411 http://www.psimex.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownawell AM, 1996, BIOCHEMISTRY-US, V35, P6839, DOI 10.1021/bi952585t; Case RM, 2007, CELL CALCIUM, V42, P345, DOI 10.1016/j.ceca.2007.05.001; Cenni V, 2008, J PROTEOME RES, V7, P4727, DOI 10.1021/pr800262g; Chae KS, 2005, J NEUROPHYSIOL, V93, P1174, DOI 10.1152/jn.00796.2004; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Denson DD, 2001, J BIOL CHEM, V276, P7136, DOI 10.1074/jbc.M009566200; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Han GC, 2007, AM J PHYSIOL-HEART C, V293, pH314, DOI 10.1152/ajpheart.01342.2006; Harvey Margaret C., 2009, V493, P299, DOI 10.1007/978-1-59745-523-7_18; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Isaacson JS, 2001, NEURON, V31, P1027, DOI 10.1016/S0896-6273(01)00428-7; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kim MJ, 2002, P NATL ACAD SCI USA, V99, P9870, DOI 10.1073/pnas.152336999; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; LAZEBNIK YA, 1995, P NATL ACAD SCI USA, V92, P9042, DOI 10.1073/pnas.92.20.9042; Lhuillier L, 2002, J NEUROPHYSIOL, V88, P954, DOI 10.1152/jn.2002.88.2.954; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mwangi S, 2006, NEUROSCIENCE, V143, P241, DOI 10.1016/j.neuroscience.2006.07.050; Nakano T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000670; Nordang L, 2000, ACTA OTO-LARYNGOL, V120, P359, DOI 10.1080/000164800750000568; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Rajan S, 2002, J PHYSIOL-LONDON, V545, P13, DOI 10.1113/jphysiol.2002.027052; Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761; Ruel J, 2008, J NEUROSCI, V28, P7313, DOI 10.1523/JNEUROSCI.5335-07.2008; Sakai Y, 2011, J NEUROSCI RES, V89, P1747, DOI 10.1002/jnr.22713; Salwinski L, 2009, NAT METHODS, V6, P860, DOI 10.1038/nmeth1209-860; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Sokolowski B, 2009, BIOCHEM BIOPH RES CO, V387, P671, DOI 10.1016/j.bbrc.2009.07.074; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Stoop MP, 2008, J PROTEOME RES, V7, P4841, DOI 10.1021/pr800489a; Sunesson L, 2008, J BIOL CHEM, V283, P16653, DOI 10.1074/jbc.M710436200; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnay J, 2002, BIOPHYS J, V83, P2280, DOI 10.1016/S0006-3495(02)73988-X; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754; WALLACE RW, 1981, COLD SPRING HARB SYM, V46, P893; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; White RE, 2000, CIRC RES, V86, P897, DOI 10.1161/01.RES.86.8.897; Xu H, 2005, HYPERTENSION, V46, P1154, DOI 10.1161/01.HYP.0000186278.50275.fa; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang CL, 2010, J NEUROSCI, V30, P3555, DOI 10.1523/JNEUROSCI.4551-09.2010; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhou Y, 2007, NUCLEIC ACIDS RES, V35, pW678, DOI 10.1093/nar/gkm278; Zou SW, 2008, MOL PHARMACOL, V73, P359, DOI 10.1124/mol.107.039743	59	35	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28532	10.1371/journal.pone.0028532	http://dx.doi.org/10.1371/journal.pone.0028532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174833	gold, Green Published			2022-12-27	WOS:000298365700046
J	Zheng, LL; Niu, S; Hao, P; Feng, K; Cai, YD; Li, YX				Zheng, Lu-Lu; Niu, Shen; Hao, Pei; Feng, KaiYan; Cai, Yu-Dong; Li, Yixue			Prediction of Protein Modification Sites of Pyrrolidone Carboxylic Acid Using mRMR Feature Selection and Analysis	PLOS ONE			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; THYROTROPIN-RELEASING HORMONE; GENE-EXPRESSION PROFILES; POSTTRANSLATIONAL MODIFICATIONS; PYROGLUTAMIC ACID; QUALITY ASSESSMENT; PEPTIDES; PHOSPHORYLATION; DATABASE; IDENTIFICATION	Pyrrolidone carboxylic acid (PCA) is formed during a common post-translational modification (PTM) of extracellular and multi-pass membrane proteins. In this study, we developed a new predictor to predict the modification sites of PCA based on maximum relevance minimum redundancy (mRMR) and incremental feature selection (IFS). We incorporated 727 features that belonged to 7 kinds of protein properties to predict the modification sites, including sequence conservation, residual disorder, amino acid factor, secondary structure and solvent accessibility, gain/loss of amino acid during evolution, propensity of amino acid to be conserved at protein-protein interface and protein surface, and deviation of side chain carbon atom number. Among these 727 features, 244 features were selected by mRMR and IFS as the optimized features for the prediction, with which the prediction model achieved a maximum of MCC of 0.7812. Feature analysis showed that all feature types contributed to the modification process. Further site-specific feature analysis showed that the features derived from PCA's surrounding sites contributed more to the determination of PCA sites than other sites. The detailed feature analysis in this paper might provide important clues for understanding the mechanism of the PCA formation and guide relevant experimental validations.	[Zheng, Lu-Lu; Li, Yixue] Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Zheng, Lu-Lu; Hao, Pei; Feng, KaiYan; Li, Yixue] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Niu, Shen; Hao, Pei; Li, Yixue] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Zheng, LL (corresponding author), Huazhong Univ Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China.	cai_yud@yahoo.com.cn; yxli@sibs.ac.cn	zheng, lu/GXH-7035-2022	cai, yudong/0000-0001-5664-7979; Hao, Pei/0000-0002-1498-7059	National Basic Research Program of China [2011CB510102, 2011CB510101, 2012CB517905]; National High-Tech Research and Development Program of China [2009AA02Z308]; Shanghai Municipal Education Commission [12ZZ087]; SA-SIBS	National Basic Research Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); SA-SIBS	This work was supporeted by the National Basic Research Program of China (2011CB510102, 2011CB510101, and 2012CB517905), National High-Tech Research and Development Program of China (863) (grant 2009AA02Z308) and Innovation Program of Shanghai Municipal Education Commission (12ZZ087). PH gratefully acknowledges the support of the SA-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM GN, 1981, MOL CELL BIOCHEM, V38, P181, DOI 10.1007/BF00235695; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; AWADE AC, 1994, PROTEINS, V20, P34, DOI 10.1002/prot.340200106; Cai YD, 2009, J PROTEOME RES, V8, P999, DOI 10.1021/pr800717y; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cummins PM, 1998, BBA-PROTEIN STRUCT M, V1429, P1, DOI 10.1016/S0167-4838(98)00248-9; DANNIES PS, 1973, J BIOL CHEM, V248, P6174; DIMARCHI RD, 1982, INT J PEPT PROT RES, V19, P88; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; ELEMANS CPH, 2011, SUPERFAST MUSCLES SE, P1885; Fenves AZ, 2006, CLIN J AM SOC NEPHRO, V1, P441, DOI 10.2215/CJN.01411005; FernandezGarcia A, 2003, J AGR FOOD CHEM, V51, P8093, DOI 10.1021/jf0348471; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gray VE, 2011, MOL BIOL EVOL, V28, P1565, DOI 10.1093/molbev/msr013; HINKLE PM, 1973, J BIOL CHEM, V248, P6180; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jain E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-136; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Liu MC, 2007, IUBMB LIFE, V59, P622, DOI 10.1080/15216540701589320; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Mandal AK, 2007, ANAL BIOCHEM, V370, P118, DOI 10.1016/j.ab.2007.06.027; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Marsella L, 2009, BIOINFORMATICS, V25, pI289, DOI 10.1093/bioinformatics/btp232; Nesvizhskii AI, 2006, MOL CELL PROTEOMICS, V5, P652, DOI 10.1074/mcp.M500319-MCP200; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pellegrini-Giampietro D E, 1989, Recenti Prog Med, V80, P160; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Popelier PLA, 2003, J AM CHEM SOC, V125, P1284, DOI 10.1021/ja0284198; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Silva AR, 2001, NEUROCHEM RES, V26, P1277, DOI 10.1023/A:1014289232039; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Wilkins MR, 1999, J MOL BIOL, V289, P645, DOI 10.1006/jmbi.1999.2794; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28221	10.1371/journal.pone.0028221	http://dx.doi.org/10.1371/journal.pone.0028221			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174779	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700023
J	Xiong, Y; Xia, JF; Zhang, W; Liu, J				Xiong, Yi; Xia, Junfeng; Zhang, Wen; Liu, Juan			Exploiting a Reduced Set of Weighted Average Features to Improve Prediction of DNA-Binding Residues from 3D Structures	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTION; ACCURATE PREDICTION; SECONDARY STRUCTURE; WEB SERVER; SITES; PROTEINS; EVOLUTIONARY; INFORMATION; RECOGNITION; NETWORK	Predicting DNA-binding residues from a protein three-dimensional structure is a key task of computational structural proteomics. In the present study, based on machine learning technology, we aim to explore a reduced set of weighted average features for improving prediction of DNA-binding residues on protein surfaces. Via constructing the spatial environment around a DNA-binding residue, a novel weighting factor is first proposed to quantify the distance-dependent contribution of each neighboring residue in determining the location of a binding residue. Then, a weighted average scheme is introduced to represent the surface patch of the considering residue. Finally, the classifier is trained on the reduced set of these weighted average features, consisting of evolutionary profile, interface propensity, betweenness centrality and solvent surface area of side chain. Experimental results on 5-fold cross validation and independent tests indicate that the new feature set are effective to describe DNA-binding residues and our approach has significantly better performance than two previous methods. Furthermore, a brief case study suggests that the weighted average features are powerful for identifying DNA-binding residues and are promising for further study of protein structure-function relationship. The source code and datasets are available upon request.	[Xiong, Yi; Zhang, Wen; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China; [Xia, Junfeng] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA	Wuhan University; Vanderbilt University	Xiong, Y (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Peoples R China.	liujuan@whu.edu.cn	Zhang, Wen/W-7471-2019; Xia, Junfeng/S-2456-2019; Xiong, Yi/F-7377-2012	Zhang, Wen/0000-0001-5221-2628; Xia, Junfeng/0000-0003-3024-1705; Xiong, Yi/0000-0003-2910-6725	National Science Foundation of China [60970063, 61103126]; program for New Century Excellent Talents in Universities [NCET-10-0644]; Foundation of Ministry of Education of China [20090141110026, 20100141120049]; Fundamental Research Funds for the Central Universities [6081007, 3101054]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for New Century Excellent Talents in Universities(Program for New Century Excellent Talents in University (NCET)); Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the grants from the National Science Foundation of China (60970063, 61103126), the program for New Century Excellent Talents in Universities (NCET-10-0644), the Ph.D. Programs Foundation of Ministry of Education of China (20090141110026, 20100141120049) and the Fundamental Research Funds for the Central Universities (6081007, 3101054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-33; Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Ahmad S, 2008, NUCLEIC ACIDS RES, V36, P5922, DOI 10.1093/nar/gkn573; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrabi M, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-30; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Chen YC, 2007, PROTEINS, V67, P671, DOI 10.1002/prot.21366; Chiu TK, 2002, EMBO J, V21, P801, DOI 10.1093/emboj/21.4.801; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; del Sol A, 2005, PROTEINS, V58, P672, DOI 10.1002/prot.20348; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Gao M, 2008, NUCLEIC ACIDS RES, V36, P3978, DOI 10.1093/nar/gkn332; Gao M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000341; Gromiha MM, 2011, J CHEM INF MODEL, V51, P721, DOI 10.1021/ci1003703; Gromiha MM, 2010, CURR PROTEIN PEPT SC, V11, P629; Hubbard S. J., 1993, NACCESS; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones S, 2003, NUCLEIC ACIDS RES, V31, P7189, DOI 10.1093/nar/gkg922; Koike A, 2004, PROTEIN ENG DES SEL, V17, P165, DOI 10.1093/protein/gzh020; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Li J, 2008, PROTEINS, V71, P1899, DOI 10.1002/prot.21891; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016932; Liu ZJ, 2008, PROTEINS, V72, P1114, DOI 10.1002/prot.22002; Luscombe NM, 2000, GENOME BIOL, V1; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Nadassy K, 1999, BIOCHEMISTRY-US, V38, P1999, DOI 10.1021/bi982362d; Nimrod G, 2009, J MOL BIOL, V387, P1040, DOI 10.1016/j.jmb.2009.02.023; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ozbek P, 2010, NUCLEIC ACIDS RES, V38, pW417, DOI 10.1093/nar/gkq396; Sathyapriya R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000170; Shazman S, 2007, NUCLEIC ACIDS RES, V35, pW526, DOI 10.1093/nar/gkm401; Si JN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S7; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Tjong H, 2007, NUCLEIC ACIDS RES, V35, P1465, DOI 10.1093/nar/gkm008; Tsuchiya Y, 2004, PROTEINS, V55, P885, DOI 10.1002/prot.20111; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Xiong Y, 2011, PROTEINS, V79, P509, DOI 10.1002/prot.22898; Yan CH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-262; Zen A, 2009, BIOINFORMATICS, V25, P1876, DOI 10.1093/bioinformatics/btp339; Zeng T, 2011, PROTEINS, V79, P598, DOI 10.1002/prot.22908; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhang T, 2010, CURR PROTEIN PEPT SC, V11, P609, DOI 10.2174/138920310794109193; Zhang W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-341; Zhao HY, 2010, BIOINFORMATICS, V26, P1857, DOI 10.1093/bioinformatics/btq295	54	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28440	10.1371/journal.pone.0028440	http://dx.doi.org/10.1371/journal.pone.0028440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174808	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163600021
J	Chauvenet, ALM; Durant, SM; Hilborn, R; Pettorelli, N				Chauvenet, Alienor L. M.; Durant, Sarah M.; Hilborn, Ray; Pettorelli, Nathalie			Unintended Consequences of Conservation Actions: Managing Disease in Complex Ecosystems	PLOS ONE			English	Article							DOGS LYCAON-PICTUS; LONG-TERM; REPRODUCTIVE SUCCESS; SERENGETI; VACCINATION; CHEETAHS; PREY; DYNAMICS; PATTERNS; MANAGEMENT	Infectious diseases are increasingly recognised to be a major threat to biodiversity. Disease management tools such as control of animal movements and vaccination can be used to mitigate the impact and spread of diseases in targeted species. They can reduce the risk of epidemics and in turn the risks of population decline and extinction. However, all species are embedded in communities and interactions between species can be complex, hence increasing the chance of survival of one species can have repercussions on the whole community structure. In this study, we use an example from the Serengeti ecosystem in Tanzania to explore how a vaccination campaign against Canine Distemper Virus (CDV) targeted at conserving the African lion (Panthera leo), could affect the viability of a coexisting threatened species, the cheetah (Acinonyx jubatus). Assuming that CDV plays a role in lion regulation, our results suggest that a vaccination programme, if successful, risks destabilising the simple two-species system considered, as simulations show that vaccination interventions could almost double the probability of extinction of an isolated cheetah population over the next 60 years. This work uses a simple example to illustrate how predictive modelling can be a useful tool in examining the consequence of vaccination interventions on non-target species. It also highlights the importance of carefully considering linkages between human-intervention, species viability and community structure when planning species-based conservation actions.	[Chauvenet, Alienor L. M.; Durant, Sarah M.; Pettorelli, Nathalie] Zool Soc London, Inst Zool, London NW1 4RY, England; [Chauvenet, Alienor L. M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, Ascot, Berks, England; [Durant, Sarah M.] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Durant, Sarah M.] Wildlife Conservat Soc, Bronx, NY USA; [Hilborn, Ray] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Zoological Society of London; Imperial College London; Wildlife Conservation Society; University of Washington; University of Washington Seattle	Chauvenet, ALM (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	Nathalie.Pettorelli@ioz.ac.uk	Chauvenet, Alienor/A-7952-2011; Hilborn, Ray W/D-6332-2013; Durant, Sarah M/AAB-9659-2019; Pettorelli, Nathalie/AAW-8438-2021; Chauvenet, Alienor/L-9135-2015	Chauvenet, Alienor/0000-0002-3743-7375; Durant, Sarah M/0000-0003-0724-0878; Chauvenet, Alienor/0000-0002-3743-7375	Howard G. Buffett Foundation; Wildlife Conservation Society; Frankfurt Zoological Society (FZS); National Geographic Society; Leverhulme Trust; Royal Society UK; Times Christmas Appeal; Messerli Foundation; People's Trust for Endangered Species	Howard G. Buffett Foundation; Wildlife Conservation Society; Frankfurt Zoological Society (FZS); National Geographic Society(National Geographic Society); Leverhulme Trust(Leverhulme Trust); Royal Society UK(Royal Society of London); Times Christmas Appeal; Messerli Foundation; People's Trust for Endangered Species	The authors gratefully acknowledge the many organisations that have funded the project, principally The Howard G. Buffett Foundation, Wildlife Conservation Society, Frankfurt Zoological Society (FZS), National Geographic Society, Leverhulme Trust, Royal Society UK, Times Christmas Appeal 1998, Messerli Foundation and People's Trust for Endangered Species. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, MILLENNIUM ECOSYSTEM; Begon M., 1996, ECOLOGY; Benkman Craig W., 1993, American Birds, V47, P225; Bergstrom DM, 2009, J APPL ECOL, V46, P73, DOI 10.1111/j.1365-2664.2008.01601.x; Brauer F., 2000, MATH MODELS POPULATI; Breed Andrew C., 2009, P215, DOI 10.1007/978-4-431-77134-0_11; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Cabezas S, 2006, J WILDLIFE MANAGE, V70, P1125, DOI 10.2193/0022-541X(2006)70[1125:VSABCI]2.0.CO;2; Caro T., 1994, CHEETAHS SERENGETI P; CARO TM, 1987, BEHAV ECOL SOCIOBIOL, V20, P351, DOI 10.1007/BF00300681; Cleaveland S, 2009, ANIM CONSERV, V12, P187, DOI 10.1111/j.1469-1795.2009.00276.x; Cleaveland S, 1997, ORYX, V31, P13; Cleaveland S, 2008, MULTIPLE ROLE INFECT, P209; Cleaveland S, 2011, PROJECT LIFE LION SY; Cleaveland S, 2007, CONSERV BIOL, V21, P612, DOI 10.1111/j.1523-1739.2007.00701.x; Clutton-Brock T. H., 1988, REPROD SUCCESS; Cooper AB, 2007, ANIM BEHAV, V73, P651, DOI 10.1016/j.anbehav.2006.06.013; Craft ME, 2011, J R SOC INTERFACE, V8, P776, DOI 10.1098/rsif.2010.0511; DEVOS V, 1996, SALISBURY MED B S, V87, P116; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Durant Sarah M., 2010, P373; Durant SM, 2000, ANIM BEHAV, V60, P121, DOI 10.1006/anbe.2000.1433; Durant SM, 2004, BEHAV ECOL, V15, P11, DOI 10.1093/beheco/arg098; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; GASCOYNE SC, 1993, J WILDLIFE DIS, V29, P396, DOI 10.7589/0090-3558-29.3.396; Goodall J, 1971, SHADOW MAN; Guiserix M, 2007, J R SOC INTERFACE, V4, P1127, DOI 10.1098/rsif.2007.0235; Guldemond R, 2008, J WILDLIFE MANAGE, V72, P892, DOI 10.2193/2007-072; Hanby JP, 1995, SERENGETI; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; HASTINGS BE, 1991, PROCEEDINGS : AMERICAN ASSOCIATION OF ZOO VETERINARIANS - ANNUAL MEETING 1991, P198; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; JESSUP D, 1992, P 2 INT GAM RANCH S, P429; Kelly MJ, 2000, CONSERV BIOL, V14, P786, DOI 10.1046/j.1523-1739.2000.98329.x; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Laurenson M. Karen, 1995, P385; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; LAURENSON MK, 1992, RES EXPLOR, V8, P64; LEVER C., 2001, CANE TOAD HIST ECOLO; Mbaiwa J.E., 2006, INT J WILDERNESS, V12, P41; Munson L, 2004, J WILDLIFE DIS, V40, P23, DOI 10.7589/0090-3558-40.1.23; Ogutu JO, 2002, AFR J ECOL, V40, P120, DOI 10.1046/j.1365-2028.2002.00343.x; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 1999, J ANIM ECOL, V68, P1161, DOI 10.1046/j.1365-2656.1999.00360.x; Pettorelli N, 2007, J ANIM ECOL, V76, P908, DOI 10.1111/j.1365-2656.2007.01266.x; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pomeroy LW, 2008, J MOL EVOL, V66, P98, DOI 10.1007/s00239-007-9040-x; Possingham HP, 2002, NATURE AUSTR, V27, P84; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Roelke Melody E., 1992, American Association of Zoo Veterinarians Annual Proceedings, V1992, P38; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Scheel D, 1995, SERENGETI; Shannon G, 2009, DIVERS DISTRIB, V15, P776, DOI 10.1111/j.1472-4642.2009.00581.x; Sinclair ARE, 2003, NATURE, V425, P288, DOI 10.1038/nature01934; SINCLAIR ARE, 1995, SERENGETI, V2; Williams ES, 1996, J WILDLIFE DIS, V32, P417, DOI 10.7589/0090-3558-32.3.417; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Woodroffe R, 2007, J MAMMAL, V88, P181, DOI 10.1644/05-MAMM-A-405R1.1	61	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28671	10.1371/journal.pone.0028671	http://dx.doi.org/10.1371/journal.pone.0028671			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163323	Green Published, gold, Green Submitted			2022-12-27	WOS:000298161900059
J	Delva, W; Richter, M; De Koker, P; Chersich, M; Temmerman, M				Delva, Wim; Richter, Marlise; De Koker, Petra; Chersich, Matthew; Temmerman, Marleen			Sex Work during the 2010 FIFA World Cup: Results from a Three-Wave Cross-Sectional Survey	PLOS ONE			English	Article							SOUTH-AFRICA; CONFIDENCE	Background: In the months leading up to the 2010 FIFA World Cup in South Africa, international media postulated that at least 40,000 foreign sex workers would enter South Africa, and that an increased HIV incidence would follow. To strengthen the evidence base of future HIV prevention and sexual health programmes during international sporting events, we monitored the supply and demand of female sex work in the weeks before, during and after the 2010 FIFA World Cup. Methodology/Principal Findings: We conducted three telephonic surveys of female sex workers advertising online and in local newspapers, in the last week of May, June and July 2010. The overall response rate was 73.4% (718/978). The number of sex workers advertising online was 5.9% higher during the World Cup than before. The client turnover rate did not change significantly during (adjusted rate ratio [aRR] = 1.05; 95% CI: 0.90-1.23) or after (aRR = 1.06; 95% CI: 0.91-1.24) the World Cup. The fraction of non-South African sex workers declined during (adjusted odds ratio [aOR] = 0.50; 95% CI: 0.32-0.79) and after (aOR = 0.56; 95% CI: 0.37-0.86) the World Cup. Relatively more clients were foreign during the World Cup among sex workers advertising in the newspapers (aOR = 2.74; 95% CI: 1.37-5.48) but not among those advertising online (aOR = 1.06; 95% CI: 0.60-1.90). Self-reported condom use was high (99.0%) at baseline, and did not change during (aOR = 1.07; 95% CI: 0.16-7.30) or after (aOR = 1.13; 95% CI: 0.16-8.10) the Word Cup. Conclusions/Significance: Our findings do not provide evidence for mass-immigration of foreign sex workers advertising online and in local newspapers, nor a spike in sex work or risk of HIV transmission in this subpopulation of sex workers during the World Cup. Public health programmes focusing on sex work and HIV prevention during international sporting events should be based on evidence, not media-driven sensationalism that further heightens discrimination against sex workers and increases their vulnerability.	[Delva, Wim] S African Ctr Epidemiol Modelling & Anal SACEMA, Stellenbosch, South Africa; [Delva, Wim; Richter, Marlise; De Koker, Petra; Chersich, Matthew; Temmerman, Marleen] Univ Ghent, Int Ctr Reproduct Hlth ICRH, B-9000 Ghent, Belgium; [Richter, Marlise] Univ Witwatersrand, African Ctr Migrat & Soc, Johannesburg, South Africa; [Chersich, Matthew] Univ Witwatersrand, Ctr Hlth Policy, Johannesburg, South Africa	Ghent University; University of Witwatersrand; University of Witwatersrand	Delva, W (corresponding author), S African Ctr Epidemiol Modelling & Anal SACEMA, Stellenbosch, South Africa.	Wim.Delva@ugent.be	Delva, Wim/E-9950-2012	Delva, Wim/0000-0001-8054-1904; chersich, matthew/0000-0002-4320-9168	United Nations Population Fund (UNFPA)	United Nations Population Fund (UNFPA)	This study was funded by the United Nations Population Fund (UNFPA). UNFPA had full access to the study protocol and participated in the review process of the manuscript submitted for publication. The UNFPA approved the study design proposed by the consortium of researchers who conducted the study, but were not involved in the data analysis, nor in writing up the first draft of the manuscript. The UNFPA made the following suggestions on the first draft: 1. Improve the description of the context and rationale of the survey. 2. To make sure that no claims about an increase or decrease of human trafficking could be wrongly inferred from the manuscript, since the survey did not explicitly collect data to investigate the incidence of human trafficking. These decisions had been independently reached by the research consortium and hence, the revised draft took them into account. The revised draft was approved by UNFPA without further suggestions. The choice to submit the manuscript to PLoS Medicine, and thereafter to PLoS One was made by the researchers, independently of UNFPA.	[Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2010, WORLD CUP 2010 40000; Battersby M, 2010, INSIDE S AFRICAS BRO; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DEAN AG, 1991, AM J PREV MED, V7, P178, DOI 10.1016/S0749-3797(18)30936-X; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Johnson L, 2007, SAMJ S AFR MED J, V97, P658; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Loewenberg S, 2006, LANCET, V368, P105, DOI 10.1016/S0140-6736(06)68984-8; Minister of Police, 2010, 172010 MIN POL; R Development Core Team, 2005, R LANG ENV STAT COMP; Richter M, 2010, SEX WORK 2010 SOCCER; Richter M, 2010, SAMJ S AFR MED J, V100, P222, DOI 10.7196/SAMJ.4117; Richter ML, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-1; Ridge S, 2009, KILLER WORLD CUPENGL; [SAPA IOL], 2010, THOUS PROST WORLD CU; Shaw Marc T M, 2007, Travel Med Infect Dis, V5, P365, DOI 10.1016/j.tmaid.2007.09.003; Smith Derek R, 2008, Travel Med Infect Dis, V6, P161, DOI 10.1016/j.tmaid.2008.01.010; Smith DR, 2008, TRAVEL MED INFECT DI, V6; The German Delegation to Multidisciplinary Group on Organised Crime/Article 36 Committee, 2007, EXP REP HUM TRAFF PU; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; UNFPA Sex Worker Education & Advocacy Taskforce Sisonke Sex Worker Movement, 2011, MAYB IT WILL BE BETT	22	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28363	10.1371/journal.pone.0028363	http://dx.doi.org/10.1371/journal.pone.0028363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163298	Green Published, gold			2022-12-27	WOS:000298161900034
J	Li, JQ; Tang, KL; Wang, J; Li, QY; Xu, HT; Yang, HF; Tan, LW; Liu, KJ; Zhang, SX				Li, Jin-qing; Tang, Kang-lai; Wang, Jian; Li, Qi-yu; Xu, Hao-tong; Yang, Hui-feng; Tan, Li-wen; Liu, Kai-jun; Zhang, Shao-xiang			MRI Findings for Frozen Shoulder Evaluation: Is the Thickness of the Coracohumeral Ligament a Valuable Diagnostic Tool?	PLOS ONE			English	Article							ADHESIVE CAPSULITIS; ROTATOR INTERVAL; ARTHROGRAPHY; CONTRACTURE; PATHOLOGY	Background: Recent studies have demonstrated that the coracohumeral ligament (CHL) is shortened and thickened in a frozen shoulder. We analyzed the rate in CHL visualization between patients with frozen shoulder and normal volunteers using Magnetic Resonance Imaging (MRI) to determine the CHL thickness in the patients with a frozen shoulder. Methods and Findings: There were 72 shoulder joints in 72 patients (50 femles and 22 males with a mean age of 53.5 years) with clinical evidence and MR imaging evidence of frozen shoulder. These were prospectively analyzed to identify and measure the maximum thickness of the CHL. The control group, which included 120 shoulder joints in 60 normal volunteer individuals (30 females and 30 males with a mean age of 50.5 years) was also referred for MR imaging. A chi-square test was used to analyze the data of the rate of CHL visualization between the patients with frozen shoulder and the control group. A two-way ANOVA was used to analyze the mean maximal thickness of CHL. The CHL was visualized in 110 out of 120 shoulders in the control group (91.7%), and in 57 out of 72 shoulders for the frozen shoulder group (79.2%), there was significant difference, using a chi-square test (P<0.05). The CHL was not visualized in 10 out of 120 shoulders in the control group (8.3%), and 15 out of 72 shoulders in the frozen shoulder group (20.8%), there was a significant difference (P<0.05). The CHL thickness (3.99 +/- 1.68 mm) in the patients with frozen shoulder was significantly greater than that thickness (3.08 +/- 1.32 mm) in the control group, using a two-way ANOVA (P<0.001). The CHL thickness (3.52 +/- 1.52 mm, n = 97) in the female shoulders was no significantly greater than that thickness (3.22 +/- 1.49 mm, n = 70) in the male shoulders, using a two-way ANOVA (P>0.05). Conclusions: MR Imaging is a satisfactory method for CHL depiction, and a thickened CHL is highly suggestive of frozen shoulder.	[Li, Jin-qing; Li, Qi-yu; Xu, Hao-tong; Tan, Li-wen; Liu, Kai-jun; Zhang, Shao-xiang] Third Mil Med Univ, Coll Basic Med Sci, Dept Anat, Chongqing, Peoples R China; [Tang, Kang-lai; Yang, Hui-feng] Third Mil Med Univ, Southwest Hosp, Dept Orthopaed Surg, Chongqing, Peoples R China; [Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, JQ (corresponding author), 324 Hosp PLA, Dept Radiol, Chongqing, Peoples R China.	zhangsx1021@yahoo.com		Xu, Hao-tong/0000-0003-0352-1795; Xu, Haotong/0000-0001-6416-9970	National Science Foundation of China [60871099]; Study on Key Science and Technology Program of Chongqing [2009AB5196]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Study on Key Science and Technology Program of Chongqing	This research received funding from a National Science Foundation of China (No. 60871099; http://www.nsfc.gov.cn/) and a Study on Key Science and Technology Program of Chongqing (No. 2009AB5196; http://www.ctin.ac.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Carrillon Y, 1999, REV RHUM, V66, P201; Chung CB, 2000, J COMPUT ASSIST TOMO, V24, P738, DOI 10.1097/00004728-200009000-00014; Codman E., 1934, RUPTURE SUPRASPINATU; Connell D, 2002, EUR RADIOL, V12, P2100, DOI 10.1007/s00330-002-1349-7; Hand GCR, 2007, J BONE JOINT SURG BR, V89B, P928, DOI 10.1302/0301-620X.89B7.19097; Homsi C, 2006, SKELETAL RADIOL, V35, P673, DOI 10.1007/s00256-006-0136-y; Krief OP, 2005, AM J ROENTGENOL, V184, P1490, DOI 10.2214/ajr.184.5.01841490; Magee T, 2009, AM J ROENTGENOL, V192, P86, DOI 10.2214/AJR.08.1097; Matsen FA, 1993, SHOULDER BALANCE MOB; Mengiardi B, 2004, RADIOLOGY, V233, P486, DOI 10.1148/radiol.2332031219; NEER CS, 1992, CLIN ORTHOP RELAT R, P182; NEVIASER JS, 1945, J BONE JOINT SURG, V27, P211; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; OZAKI J, 1989, J BONE JOINT SURG AM, V71A, P1511, DOI 10.2106/00004623-198971100-00009; Sano H, 2010, J SHOULDER ELB SURG, V19, P262, DOI 10.1016/j.jse.2009.05.010; Tamai K, 1997, J SHOULDER ELB SURG, V6, P534, DOI 10.1016/S1058-2746(97)90086-0; Zuckerman JD, 1994, J SHOULDER ELB SURG, V3, pS72	18	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28704	10.1371/journal.pone.0028704	http://dx.doi.org/10.1371/journal.pone.0028704			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163326	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900062
J	Kuo, CY; Huang, YC; Huang, CG; Tsao, KC; Lin, TY				Kuo, Chen-Yen; Huang, Yhu-Chering; Huang, Chung-Guei; Tsao, Kuo-Chien; Lin, Tzou-Yien			Symptomatic Predictors for 2009 Influenza A Virus (H1N1) Infection with an Emphasis for Patients with a Negative Rapid Diagnostic Test	PLOS ONE			English	Article							NEW-YORK-CITY; UNITED-STATES; ANTIVIRAL TREATMENT; CASE-DEFINITION; PREGNANT-WOMEN; PERFORMANCE; CHILDREN; OUTCOMES; WORKING	Background: The clinical diagnosis of influenza is difficult because it shares nonspecific symptoms with a variety of diseases. Emergency departments and clinics were overwhelmed by a surge of anxious patients during the 2009 influenza A virus (H1N1) outbreak. Our objective was to identify symptomatic predictors of influenza virus infection for patients with a negative rapid diagnostic test. Methodology/Principal Findings: We conducted a retrospective review of 805 patients who presented at Chang Gung Memorial Hospital, from August 1, 2009, to September 30, 2009. Respiratory specimens from these patients were subjected to rapid influenza tests and reverse-transcription polymerase chain reactions. In total, 36% of 308 children and 23% of 497 adults were positive for 2009 influenza A virus (H1N1) infection by polymerase chain reaction or virus culture. For pediatric patients, sore throat and influenza-like illness significantly increased the odds of having 2009 influenza A virus (H1N1) infection, by more than 3-fold (95% confidence interval (CI): 1.9-7.3) and 7-fold (95% CI: 4.00-14.2), respectively. For adult patients, cough and constitutional symptoms increased the odds of having 2009 influenza A virus (H1N1) by greater than 5-fold (95% CI: 3.1-10.2) and 3-fold (95% CI: 2.1-6.7), respectively. The negative likelihood ratio of the combination of fever and cough was 0.096 (95% CI: 0.01-0.69) for children with negative results of rapid influenza diagnostic tests. Conclusion/Significance: In influenza epidemic settings, clinicians should be aware that rapid influenza diagnostic tests are relatively insensitive for the diagnosis of influenza virus infection. For patients with negative rapid influenza diagnostic tests, those lacking fever and cough have a low probability of influenza virus infection. The management strategy should be made individually and depend on the severity of illness.	[Kuo, Chen-Yen; Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan; [Kuo, Chen-Yen] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Huang, Chung-Guei; Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Kuo, CY (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Pediat, Tao Yuan, Taiwan.	ychuang@cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 470132]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by a grant from Chang Gung Memorial Hospital (CMRPG 470132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MED LETT DRUGS THER, V41, P121; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Lee N, 2007, ANTIVIR THER, V12, P501; LEONARDI GP, 1994, J CLIN MICROBIOL, V32, P70, DOI 10.1128/JCM.32.1.70-74.1994; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nichol KL, 2001, ARCH INTERN MED, V161, P749, DOI 10.1001/archinte.161.5.749; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Storch GA, 2003, CURR OPIN PEDIATR, V15, P77, DOI 10.1097/00008480-200302000-00013; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Ward CL, 2004, J CLIN VIROL, V29, P179, DOI 10.1016/S1386-6532(03)00122-7; *WHO, 2009, WHO GUID CDC PROT RE, DOI DOI 10.1016/S1386-6532(03)00122-7; 2009, MMWR MORB MORTAL WKL, V58, P470; 2009, MORB MORTAL WKLY REP, V58, P453	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28102	10.1371/journal.pone.0028102	http://dx.doi.org/10.1371/journal.pone.0028102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164233	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400034
J	Terrile, M; Bryan, K; Vaughan, L; Hallsworth, A; Webber, H; Chesler, L; Stallings, RL				Terrile, Marta; Bryan, Kenneth; Vaughan, Lynsey; Hallsworth, Albert; Webber, Hannah; Chesler, Louis; Stallings, Raymond L.			miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs	PLOS ONE			English	Article							TRANSCRIPTIONAL TARGET; CHROMOSOMAL IMBALANCES; MALIGNANT PROGRESSION; MICRORNA EXPRESSION; TRANSGENIC MODEL; DOWN-REGULATION; RETINOIC ACID; CELL LINES; P53; SUPPRESSOR	Background: MicroRNAs are small molecules which regulate gene expression post-transcriptionally and aberrant expression of several miRNAs is associated with neuroblastoma, a childhood cancer arising from precursor cells of the sympathetic nervous system. Amplification of the MYCN transcription factor characterizes the most clinically aggressive subtype of this disease, and although alteration of p53 signaling is not commonly found in primary tumors, deregulation of proteins involved in this pathway frequently arise in recurrent disease after pharmacological treatment. TH-MYCN is a well-characterized transgenic model of MYCN-driven neuroblastoma which recapitulates many clinicopathologic features of the human disease. Here, we evaluate the dysregulation of miRNAs in tumors from TH-MYCN mice that are either wild-type (TH-MYCN) or deficient (TH-MYCN/p53ER(TAM)) for the p53 tumor suppressor gene. Principal Findings: We analyzed the expression of 591 miRNAs in control (adrenal) and neuroblastoma tumor tissues derived from either TH-MYCN or TH-MYCN/p53ER(TAM) mice, respectively wild-type or deficient in p53. Comparing miRNA expression in tumor and control samples, we identified 159 differentially expressed miRNAs. Using data previously obtained from human neuroblastoma samples, we performed a comparison of miRNA expression between murine and human tumors to assess the concordance between murine and human expression data. Notably, the miR-17-5p-92 oncogenic polycistronic cluster, which is over-expressed in human MYCN amplified tumors, was over-expressed in mouse tumors. Moreover, analyzing miRNAs expression in a mouse model (TH-MYCN/p53ER(TAM)) possessing a transgenic p53 allele that drives the expression of an inactive protein, we identified miR-125b-3p and miR-676 as directly or indirectly regulated by the level of functional p53. Significance: Our study represents the first miRNA profiling of an important mouse model of neuroblastoma. Similarities and differences in miRNAs expression between human and murine neuroblastoma were identified, providing important insight into the efficacy of this mouse model for assessing miRNA involvement in neuroblastoma and their potential effectiveness as therapeutic targets.	[Terrile, Marta; Bryan, Kenneth; Stallings, Raymond L.] Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland; [Terrile, Marta; Bryan, Kenneth; Stallings, Raymond L.] Our Ladys Childrens Hosp, Ireland & Natl Childrens Res Ctr, Dublin, Ireland; [Vaughan, Lynsey; Hallsworth, Albert; Webber, Hannah; Chesler, Louis] Inst Canc Res, Div Canc Therapeut, Sutton, Surrey, England	Royal College of Surgeons - Ireland; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; University of London; Institute of Cancer Research - UK	Terrile, M (corresponding author), Royal Coll Surgeons Ireland, Dept Canc Genet, Dublin 2, Ireland.	rstallings@rcsi.ie	Stallings, Raymond/A-7213-2008; Xie, Huangming/B-2260-2012	Chesler, Louis/0000-0001-7842-2068; Bryan, Kenneth/0000-0002-9550-8354	Science Foundation Ireland [07/IN.1/B1776]; Children's Medical and Research Foundation; Neuroblastoma Society [NES003X]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Children's Medical and Research Foundation; Neuroblastoma Society	This work was supported in part by Science Foundation Ireland (07/IN.1/B1776), Children's Medical and Research Foundation, and The Neuroblastoma Society, grant NES003X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Bohlig L, 2011, NUCLEIC ACIDS RES, V39, P440, DOI 10.1093/nar/gkq796; Boominathan L, 2010, CANCER METAST REV, V29, P613, DOI 10.1007/s10555-010-9257-9; Bray I, 2011, CANCER LETT, V303, P56, DOI 10.1016/j.canlet.2011.01.016; Bray I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007850; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Buckley PG, 2010, CLIN CANCER RES, V16, P2971, DOI 10.1158/1078-0432.CCR-09-3215; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Chesler L, 2007, CANCER RES, V67, P9435, DOI 10.1158/0008-5472.CAN-07-1316; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Das S, 2010, CANCER RES, V70, P7874, DOI 10.1158/0008-5472.CAN-10-1534; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; Foley NH, 2011, CELL DEATH DIFFER, V18, P1089, DOI 10.1038/cdd.2010.172; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Gueta K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-20; Hackett CS, 2003, CANCER RES, V63, P5266; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Le MTN, 2009, MOL CELL BIOL, V29, P5290, DOI 10.1128/MCB.01694-08; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lin RJ, 2010, CANCER RES, V70, P7841, DOI 10.1158/0008-5472.CAN-10-0970; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Mestdagh P, 2010, ONCOGENE, V29, P1394, DOI 10.1038/onc.2009.429; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Murphy DM, 2011, MOL CARCINOGEN, V50, P403, DOI 10.1002/mc.20722; Murphy DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008154; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schulte JH, 2008, INT J CANCER, V122, P699, DOI 10.1002/ijc.23153; Schulte JH, 2010, INT J CANCER, V127, P2374, DOI 10.1002/ijc.25436; Slack A, 2005, CANCER LETT, V228, P21, DOI 10.1016/j.canlet.2005.01.050; Stallings RL, 2009, CURR PHARM DESIGN, V15, P456, DOI 10.2174/138161209787315837; Stallings RL, 2007, TRENDS GENET, V23, P278, DOI 10.1016/j.tig.2007.03.009; Stallings RL, 2011, SEMIN CANCER BIOL, V21, P283, DOI 10.1016/j.semcancer.2011.07.001; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Zhu M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r77	51	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28356	10.1371/journal.pone.0028356	http://dx.doi.org/10.1371/journal.pone.0028356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164278	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400079
J	Uceyler, N; Topuzoglu, T; Schiesser, P; Hahnenkamp, S; Sommer, C				Ueceyler, Nurcan; Topuzoglu, Tengue; Schiesser, Peter; Hahnenkamp, Saskia; Sommer, Claudia			IL-4 Deficiency Is Associated with Mechanical Hypersensitivity in Mice	PLOS ONE			English	Article							DORSAL-ROOT GANGLIA; PROINFLAMMATORY CYTOKINE EXPRESSION; PERIPHERAL NEUROPATHIC PAIN; MU-OPIOID RECEPTORS; MOUSE SCIATIC-NERVE; DIFFERENTIAL EXPRESSION; UP-REGULATION; INTERLEUKIN-4; INFLAMMATION; HYPERALGESIA	Interleukin-4 (IL-4) is an anti-inflammatory and analgesic cytokine that induces opioid receptor transcription. We investigated IL-4 knockout (ko) mice to characterize their pain behavior before and after chronic constriction injury (CCI) of the sciatic nerve as a model for neuropathic pain. We investigated opioid responsivity and measured cytokine and opioid receptor gene expression in the peripheral and central nervous system (PNS, CNS) of IL-4 ko mice in comparison with wildtype (wt) mice. Naive IL-4 ko mice displayed tactile allodynia (wt: 0.45 g; ko: 0.18 g; p<0.001), while responses to heat and cold stimuli and to muscle pressure were not different. No compensatory changes in the gene expression of tumor necrosis factor-alpha (TNF), IL-1 beta, IL-10, and IL-13 were found in the PNS and CNS of naive IL-4 ko mice. However, IL-1 beta gene expression was stronger in the sciatic nerve of IL-4 ko mice (p<0.001) 28 days after CCI and only IL-4 ko mice had elevated IL-10 gene expression (p = 0.014). Remarkably, CCI induced TNF (p<0.01), IL-1 beta (p<0.05), IL-10 (p<0.05), and IL-13 (p<0.001) gene expression exclusively in the ipsilateral spinal cord of IL-4 ko mice. The compensatory overexpression of the anti-inflammatory and analgesic cytokines IL-10 and IL-13 in the spinal cord of IL-4 ko mice may explain the lack of genotype differences for pain behavior after CCI. Additionally, CCI induced gene expression of mu, kappa, and delta opioid receptors in the contralateral cortex and thalamus of IL-4 ko mice, paralleled by fast onset of morphine analgesia, but not in wt mice. We conclude that a lack of IL-4 leads to mechanical sensitivity; the compensatory hyperexpression of analgesic cytokines and opioid receptors after CCI, in turn, protects IL-4 ko mice from enhanced pain behavior after nerve lesion.	[Ueceyler, Nurcan; Topuzoglu, Tengue; Schiesser, Peter; Hahnenkamp, Saskia; Sommer, Claudia] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany	University of Wurzburg	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	ueceyler_n@klinik.uni-wuerzburg.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428	University of Wurzburg; Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)	University of Wurzburg; Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by research funds of the University of Wurzburg, and by the Bundesministerium fur Bildung und Forschung (BMBF), Deutscher Forschungsverbund Neuropathischer Schmerz (DFNS). Additional funds provided by the German Research Foundation (DFG) and the University of Wurzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Borner C, 2004, J NEUROCHEM, V91, P1493, DOI 10.1111/j.1471-4159.2004.02846.x; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cunha FQ, 1999, BRIT J PHARMACOL, V126, P45, DOI 10.1038/sj.bjp.0702266; Gabay E, 2011, EUR J PAIN, V15, P242, DOI 10.1016/j.ejpain.2010.07.012; Gendron L, 2006, J NEUROSCI, V26, P953, DOI 10.1523/JNEUROSCI.3598-05.2006; Hao SL, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-6; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Honore P, 2006, BEHAV BRAIN RES, V167, P355, DOI 10.1016/j.bbr.2005.09.024; Hoot MR, 2011, BRAIN RES, V1406, P1, DOI 10.1016/j.brainres.2011.06.023; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Karam MC, 2011, J NEUROIMMUNOL, V234, P49, DOI 10.1016/j.jneuroim.2011.02.003; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lee HL, 2004, NEUROREPORT, V15, P2807; Leger T, 2011, J NEUROIMMUNOL, V234, P19, DOI 10.1016/j.jneuroim.2011.01.005; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Martin G, 2008, EXP PHYSIOL, V93, P908, DOI 10.1113/expphysiol.2008.042432; MCCANN FV, 1991, CELL SIGNAL, V3, P483, DOI 10.1016/0898-6568(91)90078-9; Milligan ED, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-9; Niikura K, 2010, TRENDS PHARMACOL SCI, V31, P299, DOI 10.1016/j.tips.2010.04.003; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Puehler W, 2006, NEUROSCIENCE, V141, P989, DOI 10.1016/j.neuroscience.2006.03.078; Saadoun D, 2005, ARTHRITIS RHEUM-US, V52, P2917, DOI 10.1002/art.21270; Sommer C, 1998, BRAIN RES, V784, P154, DOI 10.1016/S0006-8993(97)01327-9; Thacker MA, 2007, ANESTH ANALG, V105, P838, DOI 10.1213/01.ane.0000275190.42912.37; Tu HL, 2003, J NEUROIMMUNOL, V139, P145, DOI 10.1016/S0165-5728(03)00126-7; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2008, NEUROSCI LETT, V437, P194, DOI 10.1016/j.neulet.2008.03.050; Uceyler N, 2008, NEUROSCI LETT, V436, P259, DOI 10.1016/j.neulet.2008.03.037; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; Uceyler N, 2010, EXP NEUROL, V222, P153, DOI 10.1016/j.expneurol.2009.12.026; Vale ML, 2003, J PHARMACOL EXP THER, V304, P102, DOI 10.1124/jpet.102.038703; Vidal EL, 1998, IMMUNOPHARMACOLOGY, V38, P261, DOI 10.1016/S0162-3109(97)00085-4; Vogel C, 2006, J PERIPHER NERV SYST, V11, P294, DOI 10.1111/j.1529-8027.2006.00101.x; Xu XJ, 1997, CYTOKINE, V9, P1028, DOI 10.1006/cyto.1997.0243	42	40	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28205	10.1371/journal.pone.0028205	http://dx.doi.org/10.1371/journal.pone.0028205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164245	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400046
J	Wang, YP; Wang, XY; Tang, HB; Tan, X; Ficklin, SP; Feltus, FA; Paterson, AH				Wang, Yupeng; Wang, Xiyin; Tang, Haibao; Tan, Xu; Ficklin, Stephen P.; Feltus, F. Alex; Paterson, Andrew H.			Modes of Gene Duplication Contribute Differently to Genetic Novelty and Redundancy, but Show Parallels across Divergent Angiosperms	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; ARABIDOPSIS-THALIANA; EXPRESSION DIVERSITY; CONCERTED EVOLUTION; DNA METHYLATION; YEAST; CONSERVATION; ACTIVATION; FAMILIES; DIVERSIFICATION	Background: Both single gene and whole genome duplications (WGD) have recurred in angiosperm evolution. However, the evolutionary effects of different modes of gene duplication, especially regarding their contributions to genetic novelty or redundancy, have been inadequately explored. Results: In Arabidopsis thaliana and Oryza sativa (rice), species that deeply sample botanical diversity and for which expression data are available from a wide range of tissues and physiological conditions, we have compared expression divergence between genes duplicated by six different mechanisms (WGD, tandem, proximal, DNA based transposed, retrotransposed and dispersed), and between positional orthologs. Both neo-functionalization and genetic redundancy appear to contribute to retention of duplicate genes. Genes resulting from WGD and tandem duplications diverge slowest in both coding sequences and gene expression, and contribute most to genetic redundancy, while other duplication modes contribute more to evolutionary novelty. WGD duplicates may more frequently be retained due to dosage amplification, while inferred transposon mediated gene duplications tend to reduce gene expression levels. The extent of expression divergence between duplicates is discernibly related to duplication modes, different WGD events, amino acid divergence, and putatively neutral divergence (time), but the contribution of each factor is heterogeneous among duplication modes. Gene loss may retard inter-species expression divergence. Members of different gene families may have non-random patterns of origin that are similar in Arabidopsis and rice, suggesting the action of pan-taxon principles of molecular evolution. Conclusion: Gene duplication modes differ in contribution to genetic novelty and redundancy, but show some parallels in taxa separated by hundreds of millions of years of evolution.	[Wang, Yupeng; Wang, Xiyin; Tang, Haibao; Tan, Xu; Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wang, Yupeng; Paterson, Andrew H.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Wang, Xiyin] Hebei United Univ, Coll Life Sci, Tangshan, Hebei, Peoples R China; [Tang, Haibao; Tan, Xu; Paterson, Andrew H.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Feltus, F. Alex] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Paterson, Andrew H.] Univ Georgia, Dept Crop & Soil Sci, Athens, GA 30602 USA; [Paterson, Andrew H.] Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; North China University of Science & Technology; University System of Georgia; University of Georgia; Clemson University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wang, YP (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@plantbio.uga.edu	Tang, Haibao/A-6715-2011; Ficklin, Stephen/L-4324-2019; Wang, Yupeng/B-7986-2009	Tang, Haibao/0000-0002-3460-8570; Ficklin, Stephen/0000-0001-9138-6292; Wang, Yupeng/0000-0002-3002-8069; Feltus, Frank/0000-0002-2123-6114	National Science Foundation (NSF) [DBI 0849896, MCB 0821096, MCB 1021718]; University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer; Direct For Biological Sciences [0849896, 0821096] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AHP appreciates funding from the National Science Foundation (NSF: DBI 0849896, MCB 0821096, MCB 1021718). This study was supported in part by resources and technical expertise from the University of Georgia Research Computing Center, a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Briggs GC, 2006, TRENDS PLANT SCI, V11, P492, DOI 10.1016/j.tplants.2006.08.005; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; Chen ZJ, 1997, P NATL ACAD SCI USA, V94, P3442, DOI 10.1073/pnas.94.7.3442; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Cusack BP, 2007, MOL BIOL EVOL, V24, P679, DOI 10.1093/molbev/msl199; Dean EJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000113; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; DeLuna A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000347; Dutilh BE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-10; Elbez Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-136; Englbrecht CC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-39; Essien K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003122; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Ganko EW, 2007, MOL BIOL EVOL, V24, P2298, DOI 10.1093/molbev/msm158; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; HUGHES MK, 1993, MOL BIOL EVOL, V10, P1360; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Jukes TH, 1969, EVOLUTION PROTEIN MO; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kafri R, 2008, P NATL ACAD SCI USA, V105, P1243, DOI 10.1073/pnas.0711043105; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kassahn KS, 2009, GENOME RES, V19, P1404, DOI 10.1101/gr.086827.108; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lee HS, 2001, P NATL ACAD SCI USA, V98, P6753, DOI 10.1073/pnas.121064698; Li Z, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S8; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mizutani M, 1998, PLANT MOL BIOL, V37, P39, DOI 10.1023/A:1005921406884; Musso G, 2008, GENOME RES, V18, P1092, DOI 10.1101/gr.076174.108; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson David R., 2009, Human Genomics, V4, P59; O'Neill RJW, 1998, NATURE, V393, P68, DOI 10.1038/29985; Ohno S., 1970, EVOLUTION GENE DUPLI; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Paterson AH, 2010, ANNU REV PLANT BIOL, V61, P349, DOI 10.1146/annurev-arplant-042809-112235; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Rodin SN, 2003, J MOL EVOL, V56, P718, DOI 10.1007/s00239-002-2446-6; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; Stebbins G L, 1982, Prog Clin Biol Res, V96, P21; Tan XP, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-56; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; Wang XY, 2007, GENETICS, V177, P1753, DOI 10.1534/genetics.107.073197; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; Wang XY, 2009, GENOME RES, V19, P1026, DOI 10.1101/gr.087288.108; Wang YP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013239; Wang YP, 2009, EVOL BIOINFORM, V5, P81; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Woodhouse MR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000949; Xu WY, 2001, GENE, V272, P61, DOI 10.1016/S0378-1119(01)00516-9; Zhang GJ, 2008, CURR OPIN GENET DEV, V18, P387, DOI 10.1016/j.gde.2008.07.009; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	93	85	89	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28150	10.1371/journal.pone.0028150	http://dx.doi.org/10.1371/journal.pone.0028150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164235	gold, Green Submitted, Green Published			2022-12-27	WOS:000298171400036
J	Dyer, GA; Gonzalez, C; Lopera, DC				Dyer, George A.; Gonzalez, Carolina; Lopera, Diana Carolina			Informal "Seed'' Systems and the Management of Gene Flow in Traditional Agroecosystems: The Case of Cassava in Cauca, Colombia	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; MAIZE LANDRACES; DIVERSITY; CROP; CONSERVATION; PERSPECTIVE; TRANSGENES; ECOLOGY; OAXACA	Our ability to manage gene flow within traditional agroecosystems and their repercussions requires understanding the biology of crops, including farming practices' role in crop ecology. That these practices' effects on crop population genetics have not been quantified bespeaks lack of an appropriate analytical framework. We use a model that construes seed-management practices as part of a crop's demography to describe the dynamics of cassava (Manihot esculenta Crantz) in Cauca, Colombia. We quantify several management practices for cassava-the first estimates of their kind for a vegetatively-propagated crop-describe their demographic repercussions, and compare them to those of maize, a sexually-reproduced grain crop. We discuss the implications for gene flow, the conservation of cassava diversity, and the biosafety of vegetatively-propagated crops in centers of diversity. Cassava populations are surprisingly open and dynamic: farmers exchange germplasm across localities, particularly improved varieties, and distribute it among neighbors at extremely high rates vis-a-vis maize. This implies that a large portion of cassava populations consists of non-local germplasm, often grown in mixed stands with local varieties. Gene flow from this germplasm into local seed banks and gene pools via pollen has been documented, but its extent remains uncertain. In sum, cassava's biology and vegetative propagation might facilitate pre-release confinement of genetically-modified varieties, as expected, but simultaneously contribute to their diffusion across traditional agroecosystems if released. Genetically-modified cassava is unlikely to displace landraces or compromise their diversity; but rapid diffusion of improved germplasm and subsequent incorporation into cassava landraces, seed banks or wild populations could obstruct the tracking and eradication of deleterious transgenes. Attempts to regulate traditional farming practices to reduce the risks could compromise cassava populations' adaptive potential and ultimately prove ineffectual.	[Dyer, George A.] James Hutton Inst, Aberdeen, Scotland; [Gonzalez, Carolina] Ctr Int Agr Trop, LACBiosafety Project, Cali, Colombia; [Gonzalez, Carolina] Int Food Policy Res Inst, Washington, DC 20036 USA; [Lopera, Diana Carolina] Ctr Int Agr Trop, LACBiosafety Project, Cali, Colombia	James Hutton Institute; Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Food Policy Research Institute (IFPRI); Alliance; International Center for Tropical Agriculture - CIAT	Dyer, GA (corresponding author), James Hutton Inst, Aberdeen, Scotland.	georgie.dyer@gmail.com		Gonzalez, Carolina/0000-0003-3613-1769	LACBiosafety Project	LACBiosafety Project	This work was supported by the LACBiosafety Project (http://www.lacbiosafety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Celis C, 2004, NATURE, V432, P222, DOI 10.1038/nature03048; Duputie A, 2007, MOL ECOL, V16, P3025, DOI 10.1111/j.1365-294X.2007.03340.x; Dyer GA, 2008, P NATL ACAD SCI USA, V105, P470, DOI 10.1073/pnas.0706321105; Dyer GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005734; Elias M, 2001, EUPHYTICA, V120, P143, DOI 10.1023/A:1017501017031; Elias Marianne, 2000, Journal of Ethnobiology, V20, P239; ELSHARKAWY MA, 1993, BIOSCIENCE, V43, P441, DOI 10.2307/1311903; Gepts Paul, 2003, Environmental Biosafety Research, V2, P89, DOI 10.1051/ebr:2003009; Halsey ME, 2008, CROP SCI, V48, P49, DOI 10.2135/cropsci2007.05.0279; HERSHEY CH, 1987, CASSAVA BREEDING MUL, P1; JARAMILLO G, 2008, DIAGNOSTICO CULTIVO; Jarvis DI, 2008, P NATL ACAD SCI USA, V105, P5326, DOI 10.1073/pnas.0800607105; Lavigne C, 2008, J APPL ECOL, V45, P1104, DOI 10.1111/j.1365-2664.2008.01504.x; Louette D, 1997, ECON BOT, V51, P20, DOI 10.1007/BF02910401; Ma JKC, 2005, TRENDS PLANT SCI, V10, P580, DOI 10.1016/j.tplants.2005.10.009; McKey D, 2010, NEW PHYTOL, V186, P318, DOI 10.1111/j.1469-8137.2010.03210.x; Morris M.L., 1999, 9907 CIMMYT; PALACIOS JD, 2007, DESARROLLO CAPACIDAD, P85; Parzies HK, 2004, GENET RESOUR CROP EV, V51, P471, DOI 10.1023/B:GRES.0000024157.67531.88; Perales H, 2003, ECON BOT, V57, P21, DOI 10.1663/0013-0001(2003)057[0007:LOMICM]2.0.CO;2; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pujol B, 2002, ECON BOT, V56, P366, DOI [10.1663/0013-0001(2002)056[0366:GEOCME]2.0.CO;2, 10.1111/j.1461-0248.2004.00708.x]; Pujol B, 2007, BIOL CONSERV, V136, P541, DOI 10.1016/j.biocon.2006.12.025; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Raven PH, 2005, P NATL ACAD SCI USA, V102, P13003, DOI 10.1073/pnas.0506082102; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Serratos J. Antonio, 1997, GENE FLOW MAIZE LAND; Smale M, 1997, WORLD DEV, V25, P1257, DOI 10.1016/S0305-750X(97)00038-7; Sokal R.R., 2012, BIOMETRY; Spok A, 2007, TRENDS BIOTECHNOL, V25, P74, DOI 10.1016/j.tibtech.2006.12.003; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Thomas M, 2011, GENET RESOUR CROP EV, V58, P321, DOI 10.1007/s10722-011-9662-0; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; Zeven AC, 1999, EUPHYTICA, V110, P181, DOI 10.1023/A:1003701529155; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237	38	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e29067	10.1371/journal.pone.0029067	http://dx.doi.org/10.1371/journal.pone.0029067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174952	gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600060
J	Guo, X; Ba, YN; Ma, X; An, JZ; Shang, YK; Huang, QH; Yang, HS; Chen, ZN; Xing, JL				Guo, Xu; Ba, Yanna; Ma, Xi; An, Jiaze; Shang, Yukui; Huang, Qichao; Yang, Hushan; Chen, Zhinan; Xing, Jinliang			A Meta-Analysis of Array-CGH Studies Implicates Antiviral Immunity Pathways in the Development of Hepatocellular Carcinoma	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY-NUMBER; TUMOR-SUPPRESSOR GENE; CHROMOSOMAL-ABERRATIONS; HEPATITIS-C; LIVER; GAIN; IDENTIFICATION; MECHANISMS; DIAGNOSIS	Background: The development and progression of hepatocellular carcinoma (HCC) is significantly correlated to the accumulation of genomic alterations. Array-based comparative genomic hybridization (array CGH) has been applied to a wide range of tumors including HCCs for the genome-wide high resolution screening of DNA copy number changes. However, the relevant chromosomal variations that play a central role in the development of HCC still are not fully elucidated. Methods: In present study, in order to further characterize the copy number alterations (CNAs) important to HCC development, we conducted a meta-analysis of four published independent array-CGH datasets including total 159 samples. Results: Eighty five significant gains (frequency >= 25%) were mostly mapped to five broad chromosomal regions including 1q, 6p, 8q, 17q and 20p, as well as two narrow regions 5p15.33 and 9q34.2-34.3. Eighty eight significant losses (frequency >= 25%) were most frequently present in 4q, 6q, 8p, 9p, 13q, 14q, 16q, and 17p. Significant correlations existed between chromosomal aberrations either located on the same chromosome or the different chromosomes. HCCs with different etiologies largely exhibited surprisingly similar profiles of chromosomal aberrations with only a few exceptions. Furthermore, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis indicated that the genes affected by these chromosomal aberrations were significantly enriched in 31 canonical pathways with the highest enrichment observed for antiviral immunity pathways. Conclusions: Taken together, our findings provide novel and important clues for the implications of antiviral immunity-related gene pathways in the pathogenesis and progression of HCC.	[Guo, Xu; Ma, Xi; Shang, Yukui; Huang, Qichao; Chen, Zhinan; Xing, Jinliang] Fourth Mil Med Univ, Dept Cell Biol, State Key Lab Canc Biol, Cell Engn Res Ctr, Xian 710032, Peoples R China; [Ba, Yanna] Fourth Mil Med Univ, Xijing Hosp, Dept Clin Immunol, Xian 710032, Peoples R China; [An, Jiaze] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Peoples R China; [Yang, Hushan] Thomas Jefferson Univ, Dept Med Oncol, Kimmel Canc Ctr, Div Populat Sci, Philadelphia, PA 19107 USA	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Jefferson University	Guo, X (corresponding author), Fourth Mil Med Univ, Dept Cell Biol, State Key Lab Canc Biol, Cell Engn Res Ctr, Xian 710032, Peoples R China.	znchen@fmmu.edu.cn; xingjl@fmmu.edu.cn			National Natural Science Foundation of China [30872927]; National Basic Research Program [2009CB521704]; NATIONAL CANCER INSTITUTE [R03CA153099] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant 30872927 from the National Natural Science Foundation of China and grant 2009CB521704 from the National Basic Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai T, 2010, J UROLOGY, V183, P1738, DOI 10.1016/j.juro.2009.12.105; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chari R, 2006, CANCER INFORM, V2, P48; Chochi Y, 2009, J PATHOL, V217, P677, DOI 10.1002/path.2491; Chung MY, 2000, INT J MOL MED, V5, P521; Coleman WB, 2003, CURR MOL MED, V3, P573, DOI 10.2174/1566524033479546; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Guan XY, 2000, GENE CHROMOSOME CANC, V29, P110; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Hermsen MAJA, 1996, HUM PATHOL, V27, P342, DOI 10.1016/S0046-8177(96)90106-9; Ioannidis J P, 1999, Jt Comm J Qual Improv, V25, P462; Jong K, 2007, ONCOGENE, V26, P1499, DOI 10.1038/sj.onc.1209919; Kakar S, 2009, HISTOPATHOLOGY, V55, P197, DOI 10.1111/j.1365-2559.2009.03343.x; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JU, 2010, INT J ONCOL, V37, P327, DOI 10.3892/ijo_00000681; Kaposi-Novak P, 2009, CANCER RES, V69, P2775, DOI 10.1158/0008-5472.CAN-08-3357; Katoh H, 2005, J HEPATOL, V43, P863, DOI 10.1016/j.jhep.2005.05.033; Katoh H, 2007, GASTROENTEROLOGY, V133, P1475, DOI 10.1053/j.gastro.2007.08.038; Kim TM, 2008, INT J CANCER, V123, P2808, DOI 10.1002/ijc.23901; Kubler K, 2008, INT J CANCER, V123, P1350, DOI 10.1002/ijc.23624; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; NISHIDA N, 1994, CANCER RES, V54, P3107; Okamura Y, 2011, CANCER LETT, V312, P150, DOI 10.1016/j.canlet.2011.07.028; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Pehlivan D, 2008, J CANCER RES CLIN, V134, P1267, DOI 10.1007/s00432-008-0423-1; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Roman E, 2008, ONCOL REP, V20, P825, DOI 10.3892/or_00000080; Schlaeger C, 2008, HEPATOLOGY, V47, P511, DOI 10.1002/hep.22033; Sicklick JK, 2006, CARCINOGENESIS, V27, P748, DOI 10.1093/carcin/bgi292; Tada M, 2008, CLIN CANCER RES, V14, P3768, DOI 10.1158/1078-0432.CCR-07-1181; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tomioka N, 2010, CANCER GENET CYTOGEN, V201, P6, DOI 10.1016/j.cancergencyto.2010.04.017; Veltman JA, 2003, CANCER RES, V63, P2872; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang T, 2009, ONCOGENE, V28, P555, DOI 10.1038/onc.2008.399; Wilhelm M, 2002, CANCER RES, V62, P957; Wong N, 2000, HEPATOLOGY, V32, P1060, DOI 10.1053/jhep.2000.19349; Wu JC, 2010, J CANCER RES CLIN, V136, P595, DOI 10.1007/s00432-009-0695-0; Yamamoto Y, 2007, ONCOLOGY-BASEL, V72, P132, DOI 10.1159/000111132; Yeh IT, 2009, MODERN PATHOL, V22, P1169, DOI 10.1038/modpathol.2009.78; Yeh SH, 2006, CLIN CANCER RES, V12, P1097, DOI 10.1158/1078-0432.CCR-05-1383; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang NR, 2010, BIOINFORMATICS, V26, P153, DOI 10.1093/bioinformatics/btp653; Zondervan PE, 2000, J PATHOL, V192, P207, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH690&gt;3.0.CO;2-#	47	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28404	10.1371/journal.pone.0028404	http://dx.doi.org/10.1371/journal.pone.0028404			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174799	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600015
J	Lim, YA; Grimm, A; Giese, M; Mensah-Nyagan, AG; Villafranca, JE; Ittner, LM; Eckert, A; Gotz, J				Lim, Yun-An; Grimm, Amandine; Giese, Maria; Mensah-Nyagan, Ayikoe Guy; Villafranca, J. Ernest; Ittner, Lars M.; Eckert, Anne; Goetz, Juergen			Inhibition of the Mitochondrial Enzyme ABAD Restores the Amyloid-beta-Mediated Deregulation of Estradiol	PLOS ONE			English	Article							TAU TRANSGENIC MICE; ALCOHOL-DEHYDROGENASE ABAD; COENZYME-A DEHYDROGENASE; DISEASE MOUSE MODEL; ALZHEIMERS-DISEASE; METABOLIC DYSFUNCTION; DIABETES-MELLITUS; BINDING; TOXICITY; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	Alzheimer's disease (AD) is a conformational disease that is characterized by amyloid-beta (A beta) deposition in the brain. A beta exerts its toxicity in part by receptor-mediated interactions that cause down-stream protein misfolding and aggregation, as well as mitochondrial dysfunction. Recent reports indicate that A beta may also interact directly with intracellular proteins such as the mitochondrial enzyme ABAD (A beta binding alcohol dehydrogenase) in executing its toxic effects. Mitochondrial dysfunction occurs early in AD, and A beta's toxicity is in part mediated by inhibition of ABAD as shown previously with an ABAD decoy peptide. Here, we employed AG18051, a novel small ABAD-specific compound inhibitor, to investigate the role of ABAD in A beta toxicity. Using SH-SY5Y neuroblastoma cells, we found that AG18051 partially blocked the A beta-ABAD interaction in a pull-down assay while it also prevented the A beta 42-induced down-regulation of ABAD activity, as measured by levels of estradiol, a known hormone and product of ABAD activity. Furthermore, AG18051 is protective against A beta 42 toxicity, as measured by LDH release and MTT absorbance. Specifically, AG18051 reduced A beta 42-induced impairment of mitochondrial respiration and oxidative stress as shown by reduced ROS (reactive oxygen species) levels. Guided by our previous finding of shared aspects of the toxicity of A beta and human amylin (HA), with the latter forming aggregates in Type 2 diabetes mellitus (T2DM) pancreas, we determined whether AG18051 would also confer protection from HA toxicity. We found that the inhibitor conferred only partial protection from HA toxicity indicating distinct pathomechanisms of the two amyloidogenic agents. Taken together, our results present the inhibition of ABAD by compounds such as AG18051 as a promising therapeutic strategy for the prevention and treatment of AD, and suggest levels of estradiol as a suitable readout.	[Lim, Yun-An; Ittner, Lars M.; Goetz, Juergen] Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia; [Grimm, Amandine; Giese, Maria; Eckert, Anne] Univ Basel, Neurobiol Lab, Psychiat Univ Clin Basel, Basel, Switzerland; [Mensah-Nyagan, Ayikoe Guy] Univ Strasbourg, Equipe Steroides Neuromodulateurs & Neuropathol, Strasbourg, France; [Villafranca, J. Ernest] Villafranca Consulting, San Diego, CA USA	University of Sydney; University of Basel; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Lim, YA (corresponding author), Univ Sydney, Alzheimers & Parkinsons Dis Lab, Brain & Mind Res Inst, Camperdown, NSW, Australia.	Anne.Eckert@upkbs.ch; juergen.goetz@sydney.edu.au	Götz, Jürgen/C-2448-2014; Grimm, Amandine/ABE-5634-2020; Mensah-Nyagan, Ayikoe G/D-5951-2011	Götz, Jürgen/0000-0001-8501-7896; Grimm, Amandine/0000-0003-3323-1756; Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Ittner, Lars/0000-0001-6738-3825; Eckert, Anne/0000-0002-9341-3669	Australian Research Council (ARC); NHMRC (National Health and Medical Research Council); Judith Jane Mason & Harold Stannett Williams Memorial Foundation; Swiss National Science Foundation [310000-108223]	Australian Research Council (ARC)(Australian Research Council); NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia); Judith Jane Mason & Harold Stannett Williams Memorial Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by grants to JG from the Australian Research Council (ARC), the NHMRC (National Health and Medical Research Council), and the Judith Jane Mason & Harold Stannett Williams Memorial Foundation, to LMI from the NHMRC and ARC, and to AE from the Swiss National Science Foundation (SNF #310000-108223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev I, 2010, OXID MED CELL LONGEV, V3, P361, DOI 10.4161/oxim.3.6.14415; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Borger E, 2011, BIOCHEM SOC T, V39, P868, DOI 10.1042/BST0390868; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Budd SL, 1997, FEBS LETT, V415, P21, DOI 10.1016/S0014-5793(97)01088-0; Cappai R, 2008, NEUROCHEM RES, V33, P526, DOI 10.1007/s11064-007-9469-8; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chen X, 2006, IUBMB LIFE, V58, P686, DOI 10.1080/15216540601047767; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; David DC, 2005, J BIOL CHEM, V280, P23802, DOI 10.1074/jbc.M500356200; David DC, 2006, PROTEOMICS, V6, P6566, DOI 10.1002/pmic.200600634; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; DUMONT M, 2010, FREE RADIC BIOL MED; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Eckert A, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt74; Ferrari A, 2003, J BIOL CHEM, V278, P40162, DOI 10.1074/jbc.M308243200; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Gotz Jurgen, 2008, Neuropsychiatr Dis Treat, V4, P1033; HALLIWELL B, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3432205; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; He XY, 2002, MOL BRAIN RES, V99, P46, DOI 10.1016/S0169-328X(02)00102-X; He XY, 2001, EUR J BIOCHEM, V268, P4899, DOI 10.1046/j.0014-2956.2001.02421.2421.x; He XY, 2000, BBA-MOL CELL BIOL L, V1484, P267, DOI 10.1016/S1388-1981(00)00014-7; Henderson VW, 2010, PROG BRAIN RES, V182, P77, DOI 10.1016/S0079-6123(10)82003-5; Hoerndli F, 2005, PROG NEUROBIOL, V76, P169, DOI 10.1016/j.pneurobio.2005.07.002; Hoerndli FJ, 2004, ANAL BIOCHEM, V335, P30, DOI 10.1016/j.ab.2004.08.028; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Holzmann J, 2009, MITOCHONDRION, V9, P284, DOI 10.1016/j.mito.2009.03.008; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Ivell R, 2003, ENDOCRINOLOGY, V144, P3130, DOI 10.1210/en.2002-0082; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Kenney AM, 1998, J NEUROSCI, V18, P1318; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Lim YA, 2008, FEBS LETT, V582, P2188, DOI 10.1016/j.febslet.2008.05.006; Lim YA, 2010, PROTEOMICS, V10, P1621, DOI 10.1002/pmic.200900651; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marques AT, 2008, BIOORGAN MED CHEM, V16, P9511, DOI 10.1016/j.bmc.2008.09.043; Marques AT, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-202; Moeller G, 2006, MOL CELL ENDOCRINOL, V248, P47, DOI 10.1016/j.mce.2005.11.031; Moreira PI, 2009, J ALZHEIMERS DIS, V16, P741, DOI 10.3233/JAD-2009-0972; Muirhead KEA, 2010, ACS CHEM BIOL, V5, P1105, DOI 10.1021/cb100199m; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oppermann UCT, 1999, FEBS LETT, V451, P238, DOI 10.1016/S0014-5793(99)00586-4; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Rauschenberger K, 2010, EMBO MOL MED, V2, P51, DOI 10.1002/emmm.200900055; RHEIN V, 2009, CELL MOL NEUROBIOL; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Seo JS, 2011, FREE RADICAL BIO MED, V50, P1526, DOI 10.1016/j.freeradbiomed.2011.02.035; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; TILLEMENT L, 2011, NEURODEGENER DIS; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Yan SD, 1997, NATURE, V389, P689; Yan YL, 2007, BIOCHEMISTRY-US, V46, P1724, DOI 10.1021/bi061314n; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yao J., 2011, NEUROBIOL AGING; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011	68	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28887	10.1371/journal.pone.0028887	http://dx.doi.org/10.1371/journal.pone.0028887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174920	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600047
J	Delyfer, MN; Raffelsberger, W; Mercier, D; Korobelnik, JF; Gaudric, A; Charteris, DG; Tadayoni, R; Metge, F; Caputo, G; Barale, PO; Ripp, R; Muller, JD; Poch, O; Sahel, JA; Leveillard, T				Delyfer, Marie-Noelle; Raffelsberger, Wolfgang; Mercier, David; Korobelnik, Jean-Francois; Gaudric, Alain; Charteris, David G.; Tadayoni, Ramin; Metge, Florence; Caputo, Georges; Barale, Pierre-Olivier; Ripp, Raymond; Muller, Jean-Denis; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry			Transcriptomic Analysis of Human Retinal Detachment Reveals Both Inflammatory Response and Photoreceptor Death	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; INTERCELLULAR-ADHESION MOLECULE-1; CONE VIABILITY FACTOR; PROLIFERATIVE VITREORETINOPATHY; MATRIX METALLOPROTEINASES; EPIRETINAL MEMBRANES; MUTUAL INFORMATION; GENE-EXPRESSION; PROTEIN; MOUSE	Background: Retinal detachment often leads to a severe and permanent loss of vision and its therapeutic management remains to this day exclusively surgical. We have used surgical specimens to perform a differential analysis of the transcriptome of human retinal tissues following detachment in order to identify new potential pharmacological targets that could be used in combination with surgery to further improve final outcome. Methodology/Principal Findings: Statistical analysis reveals major involvement of the immune response in the disease. Interestingly, using a novel approach relying on coordinated expression, the interindividual variation was monitored to unravel a second crucial aspect of the pathological process: the death of photoreceptor cells. Within the genes identified, the expression of the major histocompatibility complex I gene HLA-C enables diagnosis of the disease, while PKD2L1 and SLCO4A1 - which are both down-regulated-act synergistically to provide an estimate of the duration of the retinal detachment process. Our analysis thus reveals the two complementary cellular and molecular aspects linked to retinal detachment: an immune response and the degeneration of photoreceptor cells. We also reveal that the human specimens have a higher clinical value as compared to artificial models that point to IL6 and oxidative stress, not implicated in the surgical specimens studied here. Conclusions/Significance: This systematic analysis confirmed the occurrence of both neurodegeneration and inflammation during retinal detachment, and further identifies precisely the modification of expression of the different genes implicated in these two phenomena. Our data henceforth give a new insight into the disease process and provide a rationale for therapeutic strategies aimed at limiting inflammation and photoreceptor damage associated with retinal detachment and, in turn, improving visual prognosis after retinal surgery.	[Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] INSERM, U968, Paris, France; [Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] Univ Paris 06, UMR S 968, Inst Vis, Paris, France; [Delyfer, Marie-Noelle; Poch, Olivier; Sahel, Jose-Alain; Leveillard, Thierry] CNRS, UMR 7210, Paris, France; [Delyfer, Marie-Noelle; Korobelnik, Jean-Francois] Ctr Hosp Univ Bordeaux, Dept Ophtalmol, Unite Retine Uveite & Neuroophtalmol, Bordeaux, France; [Raffelsberger, Wolfgang; Ripp, Raymond; Poch, Olivier] CNRS, UMR 7104, Inst Genet & Biol Mol & Cellulaire, Lab BioInformat & Genom Integrat, Strasbourg, France; [Mercier, David; Muller, Jean-Denis] CEA, LIST, Informat Models & Learning Lab, Gif Sur Yvette, France; [Gaudric, Alain; Tadayoni, Ramin] Hop Lariboisiere, Dept Ophtalmol, F-75475 Paris, France; [Charteris, David G.] Moorfields Eye Hosp, Vitreoretinal Unit, London, England; [Metge, Florence; Caputo, Georges; Sahel, Jose-Alain] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Barale, Pierre-Olivier; Sahel, Jose-Alain] Ctr Ophtalmol Quinze Vingts, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Delyfer, MN (corresponding author), INSERM, U968, Paris, France.	thierry.leveillard@inserm.fr	Delyfer, Marie-Noelle/T-3304-2019; Sahel, Jose-Alain/F-3172-2017; Léveillard, Thierry/AAR-1804-2020; KOROBELNIK, Jean-Francois/A-5448-2016	Sahel, Jose-Alain/0000-0002-4831-1153; Léveillard, Thierry/0000-0001-5692-8770; Gaudric, Alain/0000-0002-2486-4722	Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg; network Reseaux National de Genopoles [RNG 209]	Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg; network Reseaux National de Genopoles	The work was supported by the Institut National de la Sante et de la Recherche Medicale, CNRS, University of Strasbourg and the network Reseaux National de Genopoles (RNG 209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando A, 2000, BRIT J OPHTHALMOL, V84, P1306, DOI 10.1136/bjo.84.11.1306; Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; BONNLANDER BV, 1994, P INT S ART NEUR NET, P42; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Burgi S, 2009, MOL VIS, V15, P1631; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CHARTERIS DG, 1992, OPHTHALMOLOGY, V99, P1364; Charteris DG, 2002, EYE, V16, P369, DOI 10.1038/sj.eye.6700194; Cheema RA, 2007, OPHTHAL SURG LAS IM, V38, P365, DOI 10.3928/15428877-20070901-02; Cox RA., 1968, METHODS ENZYMOL, V12, P120, DOI 10.1016/0076-6879(67)12123-X; El Ghrably I, 2004, INVEST OPHTH VIS SCI, V45, P1473, DOI 10.1167/iovs.03-0060; ELNER SG, 1992, LAB INVEST, V66, P200; ELNER SG, 1992, EXP EYE RES, V55, P21, DOI 10.1016/0014-4835(92)90087-9; Farjo R, 2008, INVEST OPHTH VIS SCI, V49, P511, DOI 10.1167/iovs.07-1013; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Ganti R, 2007, INVEST OPHTH VIS SCI, V48, P1853, DOI 10.1167/iovs.06-0198; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HEIDENKUMMER HP, 1992, GRAEF ARCH CLIN EXP, V230, P483, DOI 10.1007/BF00175938; Hollborn M, 2008, INVEST OPHTH VIS SCI, V49, P1262, DOI 10.1167/iovs.07-0879; Isernhagen R D, 1988, Trans Am Ophthalmol Soc, V86, P291; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Kalathur RKR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-208; Kawaguchi H, 2010, J BIOL CHEM, V285, P17277, DOI 10.1074/jbc.C110.132944; Klitten LL, 2008, EXP EYE RES, V87, P471, DOI 10.1016/j.exer.2008.08.004; Kon CH, 1998, INVEST OPHTH VIS SCI, V39, P1524; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kubay OV, 2005, SURV OPHTHALMOL, V50, P463, DOI 10.1016/j.survophthal.2005.06.004; Kullback S., 1968, INFORM THEORY STAT; LENDASSE A, 2004, SELECTION VARIABLES, P44; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Limb GA, 1997, INVEST OPHTH VIS SCI, V38, P1043; LIMB GA, 1993, GRAEF ARCH CLIN EXP, V231, P331, DOI 10.1007/BF00919029; Liu LL, 2005, MOL BIOL REP, V32, P41, DOI 10.1007/s11033-004-4250-4; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; MICHELS RG, 1996, MICHELS RETINAL DETA, P935; Mitry D, 2010, BRIT J OPHTHALMOL, V94, P678, DOI 10.1136/bjo.2009.157727; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1066, DOI 10.1001/archopht.1995.01100080118039; OWARIBE K, 1988, CELL TISSUE RES, V254, P301; Padgett LC, 1997, EXP EYE RES, V64, P927, DOI 10.1006/exer.1997.0287; PASANTESMORALES H, 1985, BRAIN RES, V330, P154, DOI 10.1016/0006-8993(85)90018-6; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Ploner A, 2006, BIOINFORMATICS, V22, P556, DOI 10.1093/bioinformatics/btk013; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Rossi F, 2006, CHEMOMETR INTELL LAB, V80, P215, DOI 10.1016/j.chemolab.2005.06.010; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Symeonidis C, 2007, RETINA-J RET VIT DIS, V27, P1279, DOI 10.1097/IAE.0b013e3180592c00; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Webster L, 1999, EXP EYE RES, V68, P91, DOI 10.1006/exer.1998.0585; Wickham L, 2007, OPHTHALMOLOGY, V114, P698, DOI 10.1016/j.ophtha.2006.08.042; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zacks DN, 2006, INVEST OPHTH VIS SCI, V47, P1691, DOI 10.1167/iovs.05-1209	67	37	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28791	10.1371/journal.pone.0028791	http://dx.doi.org/10.1371/journal.pone.0028791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174898	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700074
J	Jakobsen, JC; Hansen, JL; Storebo, OJ; Simonsen, E; Gluud, C				Jakobsen, Janus Christian; Hansen, Jane Lindschou; Storebo, Ole Jakob; Simonsen, Erik; Gluud, Christian			The Effects of Cognitive Therapy versus 'No Intervention' for Major Depressive Disorder	PLOS ONE			English	Article							RANDOMIZED-TRIALS; RATING-SCALE; METAANALYSIS; EFFICACY; QUALITY; RELAPSE; LIFE	Background: Major depressive disorder afflicts an estimated 17% of individuals during their lifetimes at tremendous suffering and costs. Cognitive therapy may be an effective treatment option for major depressive disorder, but the effects have only had limited assessment in systematic reviews. Methods/Principal Findings: We used The Cochrane systematic review methodology with meta-analyses and trial sequential analyses of randomized trials comparing the effects of cognitive therapy versus 'no intervention' for major depressive disorder. Participants had to be older than 17 years with a primary diagnosis of major depressive disorder to be eligible. Altogether, we included 12 trials randomizing a total of 669 participants. All 12 trials had high risk of bias. Meta-analysis on the Hamilton Rating Scale for Depression showed that cognitive therapy significantly reduced depressive symptoms (four trials; mean difference -3.05 (95% confidence interval (CI), -5.23 to -0.87; P<0.006)) compared with 'no intervention'. Trial sequential analysis could not confirm this result. Meta-analysis on the Beck Depression Inventory showed that cognitive therapy significantly reduced depressive symptoms (eight trials; mean difference on -4.86 (95% CI -6.44 to -3.28; P = 0.00001)). Trial sequential analysis on these data confirmed the result. Only a few trials reported on 'no remission', suicide inclination, suicide attempts, suicides, and adverse events without significant differences between the compared intervention groups. Discussion: Cognitive therapy might be an effective treatment for depression measured on Hamilton Rating Scale for Depression and Beck Depression Inventory, but these outcomes may be overestimated due to risks of systematic errors (bias) and random errors (play of chance). Furthermore, the effects of cognitive therapy on no remission, suicidality, adverse events, and quality of life are unclear. There is a need for randomized trials with low risk of bias, low risk of random errors, and longer follow-up assessing both benefits and harms with clinically relevant outcome measures.	[Jakobsen, Janus Christian; Storebo, Ole Jakob; Simonsen, Erik] Copenhagen Univ Hosp & Reg Zealand, Psychiat Res Unit, Roskilde, Denmark; [Jakobsen, Janus Christian; Hansen, Jane Lindschou; Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res,Dept 3344, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Jakobsen, JC (corresponding author), Copenhagen Univ Hosp & Reg Zealand, Psychiat Res Unit, Roskilde, Denmark.	janusjakobsen@mac.com	Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022; Jakobsen, Janus Christian/N-2419-2013; Simonsen, Erik/N-6615-2014	Gluud, Christian/0000-0002-8861-0799; Jakobsen, Janus Christian/0000-0002-3642-2120; Simonsen, Erik/0000-0002-6134-2392				Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ARNOW BA, 2003, EFFECTIVENESS PSYCHO, P893; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; BECH P, 1999, PSYKIATRIFONDENS FOR; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1979, AUST NZ J PSYCHIAT, V36, P275; BLACKBURN IM, 1981, BRIT J PSYCHIAT, V139, P181, DOI 10.1192/bjp.139.3.181; BLACKBURN IM, 1983, CHANGES COGNITION PH, P609; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Chakraborty R, 2007, INTERNET J MENTAL HL, V4; Cipriani A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006532.pub2; Davidson KW, 2010, ARCH INTERN MED, V170, P600, DOI 10.1001/archinternmed.2010.29; Dozois DJA, 2009, J CONSULT CLIN PSYCH, V77, P1078, DOI 10.1037/a0016886; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; FAWCETT J, 1993, INT CLIN PSYCHOPHARM, V8, P217, DOI 10.1097/00004850-199300840-00002; FITZGIBBON ML, 1988, J CLIN PSYCHOL, V44, P372, DOI 10.1002/1097-4679(198805)44:3<372::AID-JCLP2270440310>3.0.CO;2-E; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Gluud C, 2006, J HEPATOL, V44, P607, DOI 10.1016/j.jhep.2005.12.006; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heo M, 2007, AM J GERIAT PSYCHIAT, V15, P899, DOI 10.1097/JGP.0b013e318098614e; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higginson IJ, 2001, BRIT MED J, V322, P1297, DOI 10.1136/bmj.322.7297.1297; HOLLON SD, 1992, COGNITIVE THERAPY PH, P774; Hopewell S, 2008, J CLIN EPIDEMIOL, V61, P597, DOI 10.1016/j.jclinepi.2007.10.005; Howard I, 2006, J CLIN PSYCHOL, V62, P1197, DOI 10.1002/jclp.20274; Jakobsen J, 2010, EFFECT COGNITIVE THE; Jakobsen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022890; JAKOBSEN JC, 2011, J AFFECTIVE DIS 0416; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Levav I, 2002, ISRAEL J PSYCHIAT, V39, P50; MILLER IW, 1991, TREATMENT RESPONSE H, P62; MILLER IW, 1989, COGNITIVE BEHAV TREA, P1274; MILLER IW, 1989, COGNITIVE BEHAV TREA, P25; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; MURPHY GE, 1984, ARCH GEN PSYCHIAT, V41, P33; *NORD COCHR CTR TC, 2008, REV MAN REVMAN VERS; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; ROSS M, 1985, J ROY COLL GEN PRACT, V35, P239; SCOTT C, 1997, ACUTE ONE YEAR OUTCO, P131; SCOTT MJ, 1990, GROUP COGNITIVE THER, P1; Shamsaei F, 2008, HONG KONG J PSYCHIAT, V18, P76; SIMONS AD, 1984, PATIENT ATTRITION CO, P163; Sofuoglu M, 2010, EXP CLIN PSYCHOPHARM, V18, P109, DOI 10.1037/a0019295; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; TEASDALE JD, 1984, COGNITIVE THERAPY MA, P400; Thorlund K., 2011, USER MANUAL TRIAL SE; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; USAF SO, 1990, MECH IMPROVEMENT TRE, P51; Vittengl JR, 2007, J CONSULT CLIN PSYCH, V75, P475, DOI 10.1037/0022-006X.75.3.475; Walwyn R, 2010, STAT METHODS MED RES, V19, P291, DOI 10.1177/0962280209105017; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; WHISMAN MA, 1991, COGNITIVE THERAPY DE, P282; Wilkins CH, 2009, CLIN INTERV AGING, V4, P51; Wong DFK, 2008, DEPRESS ANXIETY, V25, P142, DOI 10.1002/da.20286; Wong DFK, 2009, BEHAV CHANGE, V26, P130; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 1992, INT STAT CLASS DIS R; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	68	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28299	10.1371/journal.pone.0028299	http://dx.doi.org/10.1371/journal.pone.0028299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	866FK	22174786	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700027
J	Lu, B; Asara, JM; Sanda, MG; Arredouani, MS				Lu, Bin; Asara, John M.; Sanda, Martin G.; Arredouani, Mohamed S.			The Role of the Transcription Factor SIM2 in Prostate Cancer	PLOS ONE			English	Article							DRUG-THERAPY TARGET; SINGLE-MINDED GENE; DOWNS-SYNDROME; EXPRESSION; CELLS; IDENTIFICATION; REPRESSION; SINGLEMINDED-2S; OLIGONUCLEOTIDE; INHIBITION	Background: Recent reports have suggested a possible involvement of Single-minded homolog 2 (SIM2) in human solid cancers, including prostate cancer. However, the exact role of SIM2 in cancer in general, and in prostate cancer in particular, remains largely unknown. This study was designed to elucidate the role of SIM2 in prostate cancer using a shRNA-based approach in the PC3 prostate cancer cell line. Methods: Lentiviral shRNAs were used to inhibit SIM2 gene and protein levels in PC3 cells. Quantitative RT-PCR and branched DNA were performed to evaluate transcript expression. SIM2 protein expression level was measured by western blot. Profiling of gene expression spanning the whole genome, as well as polar metabolomics of several major metabolic pathways was performed to identify major pathway dysregulations. Results: SIM2 gene and protein products were significantly downregulated by lenti-shRNA in PC3 cell line. This low expression of SIM2 affected gene expression profile, revealing significant changes in major signaling pathways, networks and functions. In addition, major metabolic pathways were affected. Conclusion: Taken together, our results suggest an involvement of SIM2 in key traits of prostate tumor cell biology and might underlie a contribution of this transcription factor to prostate cancer onset and progression.	[Lu, Bin; Sanda, Martin G.; Arredouani, Mohamed S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Lu, B (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.	msanda@bidmc.harvard.edu; marredou@bidmc.harvard.edu	Sanda, Martin G/B-2023-2015; Sanda, Martin G/A-6202-2013		NIH-NCI Early Detection Research Network [UO1-CA11391]; Department of Defense [W81XWH-09-1-0626]; Prostate Cancer Foundation	NIH-NCI Early Detection Research Network; Department of Defense(United States Department of Defense); Prostate Cancer Foundation	This work is supported by NIH-NCI Early Detection Research Network grant UO1-CA11391 (M. Sanda), Department of Defense Prostate Cancer Training Award W81XWH-09-1-0626 (B. Lu), and Prostate Cancer Foundation Young Investigator Award (M.S. Arredouani). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chrast R, 1997, GENOME RES, V7, P615, DOI 10.1101/gr.7.6.615; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; DeYoung MP, 2003, CANCER LETT, V200, P25, DOI 10.1016/S0304-3835(03)00409-9; DeYoung MP, 2003, P NATL ACAD SCI USA, V100, P4760, DOI 10.1073/pnas.0831000100; Deyoung MP, 2002, ANTICANCER RES, V22, P3149; Ema M, 1999, HUM MOL GENET, V8, P1409, DOI 10.1093/hmg/8.8.1409; Farrall AL, 2009, ONCOGENE, V28, P3671, DOI 10.1038/onc.2009.228; Gustafson TL, 2009, ONCOGENE, V28, P1561, DOI 10.1038/onc.2008.497; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Haram KM, 2008, PROSTATE, V68, P1517, DOI 10.1002/pros.20803; HE Q, CANC BIOL THER, V9, P430; Jones J, 2005, CLIN CANCER RES, V11, P5730, DOI 10.1158/1078-0432.CCR-04-2225; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Laffin B, 2008, MOL CELL BIOL, V28, P1936, DOI 10.1128/MCB.01701-07; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; LI X, CYTOKINE, V49, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Moffett P, 1997, MOL CELL BIOL, V17, P4933, DOI 10.1128/MCB.17.9.4933; Moffett P, 2000, FEBS LETT, V466, P80, DOI 10.1016/S0014-5793(99)01750-0; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Shimada K, 2008, CANCER SCI, V99, P39, DOI 10.1111/j.1349-7006.2007.00655.x; Vaday GG, 2006, PROSTATE, V66, P124, DOI 10.1002/pros.20306; WELLBERG E, DEVELOPMENT, V137, P945; XIA J, NAT PROTOC, V6, P743; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamaki A, 2001, GENE, V270, P265, DOI 10.1016/S0378-1119(01)00450-4; Yamanaka R, 2006, ONCOGENE, V25, P5994, DOI 10.1038/sj.onc.1209585; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48	33	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28837	10.1371/journal.pone.0028837	http://dx.doi.org/10.1371/journal.pone.0028837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174909	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700075
J	Hirst, MB; Kita, KN; Dawson, SC				Hirst, Marissa B.; Kita, Kelley N.; Dawson, Scott C.			Uncultivated Microbial Eukaryotic Diversity: A Method to Link ssu rRNA Gene Sequences with Morphology	PLOS ONE			English	Article							SITU HYBRIDIZATION FISH; IDENTIFICATION; PROTISTS; ECOLOGY; COMMUNITIES; PERSPECTIVE; ATLANTIC; PROTOZOA; AMEBAS	Protists have traditionally been identified by cultivation and classified taxonomically based on their cellular morphologies and behavior. In the past decade, however, many novel protist taxa have been identified using cultivation independent ssu rRNA sequence surveys. New rRNA "phylotypes" from uncultivated eukaryotes have no connection to the wealth of prior morphological descriptions of protists. To link phylogenetically informative sequences with taxonomically informative morphological descriptions, we demonstrate several methods for combining whole cell rRNA-targeted fluorescent in situ hybridization (FISH) with cytoskeletal or organellar immunostaining. Either eukaryote or ciliate-specific ssu rRNA probes were combined with an anti-a-tubulin antibody or phalloidin, a common actin stain, to define cytoskeletal features of uncultivated protists in several environmental samples. The eukaryote ssu rRNA probe was also combined with Mitotracker (R) or a hydrogenosomal-specific anti-Hsp70 antibody to localize mitochondria and hydrogenosomes, respectively, in uncultivated protists from different environments. Using rRNA probes in combination with immunostaining, we linked ssu rRNA phylotypes with microtubule structure to describe flagellate and ciliate morphology in three diverse environments, and linked Naegleria spp. to their amoeboid morphology using actin staining in hay infusion samples. We also linked uncultivated ciliates to morphologically similar Colpoda-like ciliates using tubulin immunostaining with a ciliate-specific rRNA probe. Combining rRNA-targeted FISH with cytoskeletal immunostaining or stains targeting specific organelles provides a fast, efficient, high throughput method for linking genetic sequences with morphological features in uncultivated protists. When linked to phylotype, morphological descriptions of protists can both complement and vet the increasing number of sequences from uncultivated protists, including those of novel lineages, identified in diverse environments.	[Hirst, Marissa B.; Kita, Kelley N.; Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of California System; University of California Davis	Hirst, MB (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	scdawson@ucdavis.edu		Dawson, Scott/0000-0002-0843-1759	National Institutes of Health National Institute of Allergy and Infectious Diseases [3R01AI077571-01A1S1]; University of California Davis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077571] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California Davis(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases 3R01AI077571-01A1S1 (http://www.niaid.nih.gov/) to SD. This study was also additionally supported by the University of California Davis Marjorie and Charles Elliot pre-doctoral Fellowship to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM RD, 1991, MICROBIOL REV, V55, P706, DOI 10.1128/MMBR.55.4.706-732.1991; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Baker BJ, 2004, APPL ENVIRON MICROB, V70, P6264, DOI 10.1128/AEM.70.10.6264-6271.2004; Bass D, 2009, PROTIST, V160, P483, DOI 10.1016/j.protis.2009.01.004; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Countway PD, 2005, J EUKARYOT MICROBIOL, V52, P95, DOI 10.1111/j.1550-7408.2005.05202006.x; Dawson SC, 2002, P NATL ACAD SCI USA, V99, P8324, DOI 10.1073/pnas.062169599; Dawson Scott C, 2009, J Biol, V8, P105, DOI 10.1186/jbiol201; Dawson SC, 2009, ENVIRON MICROBIOL, V11, P1627, DOI 10.1111/j.1462-2920.2009.01965.x; DEHORITY BA, 1994, J EUKARYOT MICROBIOL, V41, P103, DOI 10.1111/j.1550-7408.1994.tb01481.x; Duff RJ, 2008, J EUKARYOT MICROBIOL, V55, P306, DOI 10.1111/j.1550-7408.2008.00328.x; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; Fried J, 2002, SYST APPL MICROBIOL, V25, P555, DOI 10.1078/07232020260517706; HONIGBERG BM, 1972, J PROTOZOOL, V19, P446, DOI 10.1111/j.1550-7408.1972.tb03499.x; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; KEMP PF, 1993, APPL ENVIRON MICROB, V59, P2594, DOI 10.1128/AEM.59.8.2594-2601.1993; Lopez-Garcia P, 2001, NATURE, V409, P603, DOI 10.1038/35054537; Lopez-Garcia P, 2003, P NATL ACAD SCI USA, V100, P697, DOI 10.1073/pnas.0235779100; Lopez-Garcia P, 2007, ENVIRON MICROBIOL, V9, P546, DOI 10.1111/j.1462-2920.2006.01158.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; MULLER M, 1988, ANNU REV MICROBIOL, V42, P465, DOI 10.1146/annurev.mi.42.100188.002341; Regensbogenova M, 2004, FEMS MICROBIOL LETT, V238, P307, DOI [10.1111/j.1574-6968.2004.tb09771.x, 10.1016/j.femsle.2004.07.049]; RODRIGUEZZARAGOZA S, 1994, CRIT REV MICROBIOL, V20, P225, DOI 10.3109/10408419409114556; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Sims GP, 2002, J EUKARYOT MICROBIOL, V49, P478, DOI 10.1111/j.1550-7408.2002.tb00232.x; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoeck T, 2003, APPL ENVIRON MICROB, V69, P6856, DOI 10.1128/AEM.69.11.6856-6863.2003; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; van der Giezen M, 2003, MOL BIOL EVOL, V20, P1051, DOI 10.1093/molbev/msg103; WOODS A, 1989, J CELL SCI, V93, P491	35	6	6	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28158	10.1371/journal.pone.0028158	http://dx.doi.org/10.1371/journal.pone.0028158			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174774	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600014
J	Crider, KS; Quinlivan, EP; Berry, RJ; Hao, L; Li, Z; Maneval, D; Yang, TP; Rasmussen, SA; Yang, QH; Zhu, JH; Hu, DJ; Bailey, LB				Crider, Krista S.; Quinlivan, Eoin P.; Berry, Robert J.; Hao, Ling; Li, Zhu; Maneval, David; Yang, Thomas P.; Rasmussen, Sonja A.; Yang, Quanhe; Zhu, Jiang-Hui; Hu, Dale J.; Bailey, Lynn B.			Genomic DNA Methylation Changes in Response to Folic Acid Supplementation in a Population-Based Intervention Study among Women of Reproductive Age	PLOS ONE			English	Article							MODERATE FOLATE-DEPLETION; METHYLENETETRAHYDROFOLATE REDUCTASE; MEGALOBLASTIC-ANEMIA; VENOUS THROMBOSIS; POLYMORPHISM; HOMOCYSTEINE; DEFICIENCY; MTHFR; HYPOMETHYLATION; DECREASES	Folate is a source of one-carbons necessary for DNA methylation, a critical epigenetic modification necessary for genomic structure and function. The use of supplemental folic acid is widespread however; the potential influence on DNA methylation is unclear. We measured global DNA methylation using DNA extracted from samples from a population-based, double-blind randomized trial of folic acid supplementation (100, 400, 4000 mu g per day) taken for 6 months; including a 3 month post-supplementation sample. We observed no changes in global DNA methylation in response to up to 4,000 mu g/day for 6 months supplementation in DNA extracted from uncoagulated blood (approximates circulating blood). However, when DNA methylation was determined in coagulated samples from the same individuals at the same time, significant time, dose, and MTHFR genotype-dependent changes were observed. The baseline level of DNA methylation was the same for uncoagulated and coagulated samples; marked differences between sample types were observed only after intervention. In DNA from coagulated blood, DNA methylation decreased (-14%; P < 0.001) after 1 month of supplementation and 3 months after supplement withdrawal, methylation decreased an additional 23% (P < 0.001) with significant variation among individuals (max+17%; min-94%). Decreases in methylation of >= 25% (vs. < 25%) after discontinuation of supplementation were strongly associated with genotype: MTHFR CC vs. TT (adjusted odds ratio [aOR] 12.9, 95%CI 6.4, 26.0). The unexpected difference in DNA methylation between DNA extracted from coagulated and uncoagulated samples in response to folic acid supplementation is an important finding for evaluating use of folic acid and investigating the potential effects of folic acid supplementation on coagulation.	[Crider, Krista S.; Berry, Robert J.; Hao, Ling; Rasmussen, Sonja A.; Yang, Quanhe; Hu, Dale J.] Ctr Dis Control & Prevent, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Quinlivan, Eoin P.] Univ Florida, Gen Clin Res Ctr, Biomed Mass Spectrometry Lab, Gainesville, FL USA; [Hao, Ling; Li, Zhu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Maneval, David; Zhu, Jiang-Hui; Bailey, Lynn B.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA; [Yang, Thomas P.] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Ctr Epigenet,Div Pediat Genet, Gainesville, FL 32610 USA	Centers for Disease Control & Prevention - USA; State University System of Florida; University of Florida; Peking University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Crider, KS (corresponding author), Ctr Dis Control & Prevent, Div Birth Defects & Dev Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	kcrider@cdc.gov	Quinlivan, Eoin/AAJ-1979-2021; Quinlivan, Eoin P/B-8454-2008	Quinlivan, Eoin/0000-0002-0908-1762; Quinlivan, Eoin P/0000-0002-0908-1762; Crider, Krista/0000-0001-6997-5955; Berry, Robert/0000-0002-7162-5046	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention)	BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention)	Funding for this study was provided by a cooperative agreement from BDB/DBDDD/NCBDDD/CDC (Birth Defects Branch, Division of Birth Defects and Developmental Disabilities, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention). As a part of a public health scientific agency, CDC employees were directly involved in the study design, analysis, decision to publish and preparation of the manuscript.	Adkins KK, 2002, ARCH PATHOL LAB MED, V126, P266; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; BALAGHI M, 1993, BIOCHEM BIOPH RES CO, V193, P1184, DOI 10.1006/bbrc.1993.1750; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bezemer ID, 2007, ARCH INTERN MED, V167, P497, DOI 10.1001/archinte.167.5.497; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.3.CO;2-K; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Daniels V.G., 1979, FUNCTIONAL HISTOLOGY; Den Heijer M, 2005, J THROMB HAEMOST, V3, P292, DOI 10.1111/j.1538-7836.2005.01141.x; Deol PS, 2004, BRIT J HAEMATOL, V127, P204, DOI 10.1111/j.1365-2141.2004.05172.x; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Duthie SJ, 2010, J PROTEOME RES, V9, P1941, DOI 10.1021/pr901103n; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; Gonzalgo ML, 1997, MUTAT RES-REV MUTAT, V386, P107, DOI 10.1016/S1383-5742(96)00047-6; Green R, 1999, SEMIN HEMATOL, V36, P47; Guzman N, 2010, GENET TEST MOL BIOMA, P14; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Health D. O., 1996, FED REGISTER, V61, P8781; HOFFBRAND AV, 1993, BRIT J HAEMATOL, V83, P643, DOI 10.1111/j.1365-2141.1993.tb04704.x; Hultberg B, 2000, TOXICOLOGY, V147, P69, DOI 10.1016/S0300-483X(00)00189-X; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Khan R, 2008, EXP HEMATOL, V36, P149, DOI 10.1016/j.exphem.2007.10.002; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Prince JA, 2001, GENOME RES, V11, P152, DOI 10.1101/gr.150201; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Quinlivan EP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn534; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Shelnutt KP, 2003, J NUTR, V133, P4107, DOI 10.1093/jn/133.12.4107; Smith AD, 2008, AM J CLIN NUTR, V87, P517; von Castel-Dunwoody KM, 2005, AM J CLIN NUTR, V81, P1436; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Yamagata K, 2011, CELL MOL LIFE SCI, P15	38	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28144	10.1371/journal.pone.0028144	http://dx.doi.org/10.1371/journal.pone.0028144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163281	gold, Green Published			2022-12-27	WOS:000298161900016
J	Fukushiro, M; Takeuchi, T; Takeuchi, Y; Hur, SP; Sugama, N; Takemura, A; Kubo, Y; Okano, K; Okano, T				Fukushiro, Masato; Takeuchi, Takahiro; Takeuchi, Yuki; Hur, Sung-Pyo; Sugama, Nozomi; Takemura, Akihiro; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki			Lunar Phase-Dependent Expression of Cryptochrome and a Photoperiodic Mechanism for Lunar Phase-Recognition in a Reef Fish, Goldlined Spinefoot	PLOS ONE			English	Article							MOLECULAR EVOLUTION; LIGHT; PHOTORECEPTOR; GENE; SYNCHRONIZATION; RABBITFISH; MATURATION; RHODOPSIN; GUTTATUS; CLOCK	Lunar cycle-associated physiology has been found in a wide variety of organisms. Recent study has revealed that mRNA levels of Cryptochrome (Cry), one of the circadian clock genes, were significantly higher on a full moon night than on a new moon night in coral, implying the involvement of a photoreception system in the lunar-synchronized spawning. To better establish the generalities surrounding such a mechanism and explore the underlying molecular mechanism, we focused on the relationship between lunar phase, Cry gene expression, and the spawning behavior in a lunar-synchronized spawner, the goldlined spinefoot (Siganus guttatus), and we identified two kinds of Cry genes in this animal. Their mRNA levels showed lunar cycle-dependent expression in the medial part of the brain (mesencephalon and diencephalon) peaking at the first quarter moon. Since this lunar phase coincided with the reproductive phase of the goldlined spinefoot, Cry gene expression was considered a state variable in the lunar phase recognition system. Based on the expression profiles of SgCrys together with the moonlight's pattern of timing and duration during its nightly lunar cycle, we have further speculated on a model of lunar phase recognition for reproductive control in the goldlined spinefoot, which integrates both moonlight and circadian signals in a manner similar to photoperiodic response.	[Fukushiro, Masato; Takeuchi, Takahiro; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan; [Takeuchi, Yuki; Hur, Sung-Pyo; Sugama, Nozomi; Takemura, Akihiro] Univ Ryukyus, Dept Chem Biol & Marine Sci, Fac Sci, Nishihara, Okinawa 90301, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, Tokyo, Japan	Waseda University; University of the Ryukyus; Japan Science & Technology Agency (JST)	Fukushiro, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Dept Elect Engn & Biosci, Tokyo, Japan.	okano@waseda.jp	Takeuchi, Yuki/B-2643-2018; TAKEUCHI, Tsutomu/I-7071-2014	Takeuchi, Yuki/0000-0002-8480-5206; TAKEUCHI, Tsutomu/0000-0001-8416-7673; Okano, Toshiyuki/0000-0001-6740-6265; Takemura, Akihiro/0000-0002-5024-4930	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Society for the Promotion of Science (JSPS) of Japan; Grants-in-Aid for Scientific Research [22657042] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japanese Society for the Promotion of Science (JSPS) of Japan awarded to A.T. and T.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	AMANO M, 1995, GEN COMP ENDOCR, V99, P22, DOI 10.1006/gcen.1995.1080; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Choi S, 2010, ZOOL SCI, V27, P24, DOI 10.2108/zsj.27.24; COLIN PL, 1987, B MAR SCI, V40, P220; Domeier ML, 1997, B MAR SCI, V60, P698; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Foley LE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1364; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harahap AP, 2001, FISHERIES SCI, V67, P888, DOI 10.1046/j.1444-2906.2001.00337.x; HARRISON PL, 1984, SCIENCE, V223, P1186, DOI 10.1126/science.223.4641.1186; Hoque MM, 1999, J FISH BIOL, V55, P1213, DOI 10.1111/j.1095-8649.1999.tb02071.x; Hsu DS, 1996, BIOCHEMISTRY-US, V35, P13871, DOI 10.1021/bi962209o; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kaiser TS, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-49; Kanai S, 1997, J MOL EVOL, V45, P535, DOI 10.1007/PL00006258; Kubo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009273; Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Meseguer C, 2008, CHRONOBIOL INT, V25, P666, DOI 10.1080/07420520802380018; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NEUMANN D, 1976, BIOL RHYTHMS MARINE, P115; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; Rahman MS, 2003, J FISH BIOL, V62, P495, DOI 10.1046/j.1095-8649.2003.00036.x; Rahman MS, 2000, COMP BIOCHEM PHYS B, V127, P113, DOI 10.1016/S0305-0491(00)00240-6; Rosato E, 2001, CURR BIOL, V11, P909, DOI 10.1016/S0960-9822(01)00259-7; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Sugama N, 2008, J PINEAL RES, V45, P133, DOI 10.1111/j.1600-079X.2008.00566.x; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Takemura A, 2004, J EXP ZOOL PART A, V301A, P844, DOI 10.1002/jez.a.105; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; Vize PD, 2005, GULF MEXICO SCI, V23, P107, DOI DOI 10.18785/G0MS.2301.08; Wada Y, 1998, FEBS LETT, V424, P53, DOI 10.1016/S0014-5793(98)00138-0; Yasuo S, 2004, ENDOCRINOLOGY, V145, P1612, DOI 10.1210/en.2003-1285; Yoshimura T, 2006, COMP BIOCHEM PHYS A, V144, P345, DOI 10.1016/j.cbpa.2005.09.009	44	29	29	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28643	10.1371/journal.pone.0028643	http://dx.doi.org/10.1371/journal.pone.0028643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163321	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900057
J	Chu, VC; Bhattacharya, S; Nomoto, A; Lin, JH; Zaidi, SK; Oberley, TD; Weinman, SA; Azhar, S; Huang, TT				Chu, Victor C.; Bhattacharya, Sayanti; Nomoto, Ann; Lin, Jiahui; Zaidi, Syed Kashif; Oberley, Terry D.; Weinman, Steven A.; Azhar, Salman; Huang, Ting-Ting			Persistent Expression of Hepatitis C Virus Non-Structural Proteins Leads to Increased Autophagy and Mitochondrial Injury in Human Hepatoma Cells	PLOS ONE			English	Article							CORE PROTEIN; OXIDATIVE STRESS; MICROVILLAR LOCALIZATION; SUPEROXIDE-DISMUTASE; SCAVENGER RECEPTOR; ER STRESS; CLASS-B; REPLICATION; NS5A; MACHINERY	HCV infection is a major cause of chronic liver disease and liver cancer in the United States. To address the pathogenesis caused by HCV infection, recent studies have focused on the direct cytopathic effects of individual HCV proteins, with the objective of identifying their specific roles in the overall pathogenesis. However, this approach precludes examination of the possible interactions between different HCV proteins and organelles. To obtain a better understanding of the various cytopathic effects of and cellular responses to HCV proteins, we used human hepatoma cells constitutively replicating HCV RNA encoding either the full-length polyprotein or the non-structural proteins, or cells constitutively expressing the structural protein core, to model the state of persistent HCV infection and examined the combination of various HCV proteins in cellular pathogenesis. Increased reactive oxygen species (ROS) generation in the mitochondria, mitochondrial injury and degeneration, and increased lipid accumulation were common among all HCV protein-expressing cells regardless of whether they expressed the structural or non-structural proteins. Expression of the non-structural proteins also led to increased oxidative stress in the cytosol, membrane blebbing in the endoplasmic reticulum, and accumulation of autophagocytic vacuoles. Alterations of cellular redox state, on the other hand, significantly changed the level of autophagy, suggesting a direct link between oxidative stress and HCV-mediated activation of autophagy. With the widespread cytopathic effects, cells with the full-length HCV polyprotein showed a modest antioxidant response and exhibited a significant increase in population doubling time and a concomitant decrease in cyclin D1. In contrast, cells expressing the non-structural proteins were able to launch a vigorous antioxidant response with up-regulation of antioxidant enzymes. The population doubling time and cyclin D1 level were also comparable to that of control cells. Finally, the cytopathic effects of core protein appeared to focus on the mitochondria without remarkable disturbances in the cytosol.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Nomoto, Ann; Zaidi, Syed Kashif; Azhar, Salman; Huang, Ting-Ting] VA Palo Alto Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Palo Alto, CA USA; [Oberley, Terry D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA; [Oberley, Terry D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Weinman, Steven A.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Kansas; University of Kansas Medical Center	Chu, VC (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	tthuang@stanford.edu	Zaidi, Syed Kashif M/A-6160-2013; Zaidi, Syed Kashif/AAA-3924-2022	Zaidi, Syed Kashif M/0000-0003-2391-414X; Zaidi, Syed Kashif/0000-0003-2391-414X	National Institutes of Health [AA012863, HL33881, CA122499]; Stanford Digestive Disease Center; NATIONAL CANCER INSTITUTE [R01CA122499] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL033881, R01HL033881] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Digestive Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is supported by funding from National Institutes of Health grant AA012863 to SW, HL33881 to SA, and CA122499 to T-TH, and from Stanford Digestive Disease Center to T-TH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla MY, 2005, J MED VIROL, V76, P489, DOI 10.1002/jmv.20388; Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Ait-Goughoulte M, 2008, J VIROL, V82, P2241, DOI 10.1128/JVI.02093-07; Baumert TF, 1999, GASTROENTEROLOGY, V117, P1397, DOI 10.1016/S0016-5085(99)70290-8; Benali-Furet NL, 2005, ONCOGENE, V24, P4921, DOI 10.1038/sj.onc.1208673; BERRYMAN MA, 1990, J HISTOCHEM CYTOCHEM, V38, P159, DOI 10.1177/38.2.1688894; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Choi J, 2006, AM J PHYSIOL-GASTR L, V290, pG847, DOI 10.1152/ajpgi.00522.2005; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Huang TT, 2001, FREE RADICAL BIO MED, V31, P1101, DOI 10.1016/S0891-5849(01)00694-3; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Katsarou K, 2010, CELL MOL LIFE SCI, V67, P2491, DOI 10.1007/s00018-010-0351-5; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Lundin M, 2006, J GEN VIROL, V87, P3263, DOI 10.1099/vir.0.82211-0; Mahmood S, 2004, ANTIOXID REDOX SIGN, V6, P19, DOI 10.1089/152308604771978318; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nishina S, 2010, LIVER INT, V30, P683, DOI 10.1111/j.1478-3231.2010.02210.x; O'Donnell V, VIROLOGY, V142-150; Oberley TD, 2002, AM J PATHOL, V160, P403, DOI 10.1016/S0002-9440(10)64857-2; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Otani K, 2005, GASTROENTEROLOGY, V128, P96, DOI 10.1053/j.gastro.2004.10.045; Paradis V, 1997, J CLIN PATHOL, V50, P401, DOI 10.1136/jcp.50.5.401; Park JS, 2000, BIOCHEM BIOPH RES CO, V267, P581, DOI 10.1006/bbrc.1999.1999; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; Qadri I, 2004, BIOCHEM J, V378, P919, DOI 10.1042/BJ20031587; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Reaven E, 2000, J LIPID RES, V41, P343; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Seronello S, 2007, FREE RADICAL BIO MED, V43, P869, DOI 10.1016/j.freeradbiomed.2007.05.036; Shi ST, 2002, VIROLOGY, V292, P198, DOI 10.1006/viro.2001.1225; Shimakami T, 2004, J VIROL, V78, P2738, DOI 10.1128/JVI.78.6.2738-2748.2004; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Siu L, 2009, SEMIN LIVER DIS, V29, P188, DOI 10.1055/s-0029-1214374; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Thoren F, 2004, J LEUKOCYTE BIOL, V76, P1180, DOI 10.1189/jlb.0704387; TOMEI L, 1993, J VIROL, V67, P4017, DOI 10.1128/JVI.67.7.4017-4026.1993; Tsutsumi T, 2002, VIROLOGY, V304, P415, DOI 10.1006/viro.2002.1702; Wang T, 2010, J VIRAL HEPATITIS, V17, P784, DOI 10.1111/j.1365-2893.2009.01238.x; Wang T, J VIRAL HEPAT, V17, P784; Wang T, 2006, J GASTROEN HEPATOL, V21, pS34, DOI 10.1111/j.1440-1746.2006.04591.x; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yi MK, 2002, VIROLOGY, V304, P197, DOI 10.1006/viro.2002.1652	58	35	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28551	10.1371/journal.pone.0028551	http://dx.doi.org/10.1371/journal.pone.0028551			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164304	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400106
J	Ioannidis, JPA; Manzoli, L; De Vito, C; D'Addario, M; Villari, P				Ioannidis, John P. A.; Manzoli, Lamberto; De Vito, Corrado; D'Addario, Maddalena; Villari, Paolo			Publication Delay of Randomized Trials on 2009 Influenza A (H1N1) Vaccination	PLOS ONE			English	Article							CLINICAL-RESEARCH; REPORTING BIAS; IMMUNOGENICITY; COHORT	Background: Randomized evidence for vaccine immunogenicity and safety is urgently needed in the setting of pandemics with new emerging infectious agents. We carried out an observational survey to evaluate how many randomized controlled trials testing 2009 H1N1 vaccines were published among those registered, and what was the time lag from their start to publication and from their completion to publication. Methods: PubMed, EMBASE and 9 clinical trial registries were searched for eligible randomized controlled trials. The units of the analysis were single randomized trials on any individual receiving influenza vaccines in any setting. Results: 73 eligible trials were identified that had been registered in 2009-2010. By June 30, 2011 only 21 (29%) of these trials had been published, representing 38% of the randomized sample size (19905 of 52765). Trials starting later were published less rapidly (hazard ratio 0.42 per month; 95% Confidence Interval: 0.27 to 0.64; p<0.001). Similarly, trials completed later were published less rapidly (hazard ratio 0.43 per month; 95% CI: 0.27 to 0.67; p<0.001). Randomized controlled trials were completed promptly (median, 5 months from start to completion), but only a minority were subsequently published. Conclusions: Most registered randomized trials on vaccines for the H1N1 pandemic are not published in the peer-reviewed literature.	[Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Manzoli, Lamberto] Univ G DAnnunzio Chieti, Sect Hyg Epidemiol Pharmacol & Legal Med, Chieti, Italy; [De Vito, Corrado; D'Addario, Maddalena; Villari, Paolo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Rome, Italy	Stanford University; Stanford University; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome	Ioannidis, JPA (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.	lmanzoli@post.harvard.edu	Ioannidis, John P. A./G-9836-2011; Manzoli, Lamberto/K-1895-2018	Manzoli, Lamberto/0000-0002-8129-9344; villari, paolo/0000-0002-3139-0668; DE VITO, CORRADO/0000-0002-7846-672X				[Anonymous], PLOS CURRENTS INFLUE; [Anonymous], 2010, PLOS MED, V7; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; European Medicines Agency, 2011, MED AUTH PAND; European Medicines Agency, 2009, EMEA6082592009; European Medicines Agency, 2011, EUR PUBL HLTH ASS RE; Food and Drug Administration, 2010, INFL A H1N1 2009 MON; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Ioannidis JPA, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4875; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Jackson LA, 2011, J INFECT DIS, V204, P854, DOI 10.1093/infdis/jir440; Krzyzanowska MK, 2003, JAMA-J AM MED ASSOC, V290, P495, DOI 10.1001/jama.290.4.495; Lee K, 2008, PLOS MED, V5, P1348, DOI 10.1371/journal.pmed.0050191; Leung GM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000346; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Lopez-Macias C, 2011, VACCINE, V29, P7826, DOI 10.1016/j.vaccine.2011.07.099; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Xing WJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000272; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	28	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28346	10.1371/journal.pone.0028346	http://dx.doi.org/10.1371/journal.pone.0028346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164274	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400075
J	Jia, X; He, WZ; Murchie, AIH; Chen, DR				Jia, Xu; He, Weizhi; Murchie, Alastair I. H.; Chen, Dongrong			The Global Transcriptional Response of Fission Yeast to Hydrogen Sulfide	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; NITRIC-OXIDE; RAT; PROLIFERATION; APOPTOSIS; H2S; ANGIOGENESIS; ACTIVATION	Background: Hydrogen sulfide (H(2)S) is a newly identified member of the small family of gasotransmitters that are endogenous gaseous signaling molecules that have a fundamental role in human biology and disease. Although it is a relatively recent discovery and the mechanism of H(2)S activity is not completely understood, it is known to be involved in a number of cellular processes; H(2)S can affect ion channels, transcription factors and protein kinases in mammals. Methodology/Principal Findings: In this paper, we have used fission yeast as a model organism to study the global gene expression profile in response to H(2)S by microarray. We initially measured the genome-wide transcriptional response of fission yeast to H(2)S. Through the functional classification of genes whose expression profile changed in response to H(2)S, we found that H(2)S mainly influences genes that encode putative or known stress proteins, membrane transporters, cell cycle/meiotic proteins, transcription factors and respiration protein in the mitochondrion. Our analysis showed that there was a significant overlap between the genes affected by H(2)S and the stress response. We identified that the target genes of the MAPK pathway respond to H(2)S; we also identified that a number of transporters respond to H(2)S, these include sugar/carbohydrate transporters, ion transporters, and amino acid transporters. We found many mitochondrial genes to be down regulated upon H(2)S treatment and that H(2)S can reduce mitochondrial oxygen consumption. Conclusion/Significance: This study identifies potential molecular targets of the signaling molecule H(2)S in fission yeast and provides clues about the identity of homologues human proteins and will further the understanding of the cellular role of H(2)S in human diseases.	[Jia, Xu; He, Weizhi; Murchie, Alastair I. H.; Chen, Dongrong] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Jia, Xu; Murchie, Alastair I. H.; Chen, Dongrong] Fudan Univ, Sch Pharm, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Jia, X (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China.	aihm@fudan.edu.cn; drchen@fudan.edu.cn	He, Weizhi/GQQ-5629-2022	He, Weizhi/0000-0002-8061-4947	National Key 973 grant [2010CB912602]; Natural Science Foundation [30970061, 31070666]; City of Shanghai Key project [09DJ1400601]; National Key Project 985	National Key 973 grant(National Basic Research Program of China); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); City of Shanghai Key project; National Key Project 985	This work was supported by National Key 973 grant (2010CB912602), Natural Science Foundation grant 30970061 to DC, 31070666 to AM, City of Shanghai Key project grant (09DJ1400601) and National Key Project 985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Budde MW, 2010, MOL BIOL CELL, V21, P212, DOI 10.1091/mbc.E09-03-0199; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Du JB, 2004, HEART VESSELS, V19, P75, DOI 10.1007/s00380-003-0743-7; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eshaghi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011620; Hosoki R, 1997, BIOCHEM BIOPH RES CO, V237, P527, DOI 10.1006/bbrc.1997.6878; Hu LF, 2009, MOL PHARMACOL, V75, P27, DOI 10.1124/mol.108.047985; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong SO, 2006, BIOCHEM BIOPH RES CO, V345, P938, DOI 10.1016/j.bbrc.2006.05.002; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1990, NATURE, V344, P549, DOI 10.1038/344549a0; Osipov RM, 2010, INTERACT CARDIOV TH, V10, P506, DOI 10.1510/icvts.2009.219535; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sivarajah A, 2006, SHOCK, V26, P154, DOI 10.1097/01.shk.0000225722.56681.64; Tang GH, 2010, CLIN EXP PHARMACOL P, V37, P753, DOI 10.1111/j.1440-1681.2010.05351.x; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang Guang-Dong, 2007, Shengli Xuebao, V59, P133; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599; Zuin A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002842	36	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28275	10.1371/journal.pone.0028275	http://dx.doi.org/10.1371/journal.pone.0028275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164259	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400060
J	Li, BS; Wang, XY; Ma, FL; Jiang, B; Song, XX; Xu, AG				Li, Bing-Sheng; Wang, Xin-Ying; Ma, Feng-Li; Jiang, Bo; Song, Xiao-Xiao; Xu, An-Gao			Is High Resolution Melting Analysis (HRMA) Accurate for Detection of Human Disease-Associated Mutations? A Meta Analysis	PLOS ONE			English	Article							KIT-ACTIVATING MUTATIONS; GROWTH-FACTOR RECEPTOR; RAPID DETECTION; SENSITIVE DETECTION; SYSTEMATIC REVIEWS; DIAGNOSTIC-TOOL; DNA; SINGLE; GENE; CANCER	Background: High Resolution Melting Analysis (HRMA) is becoming the preferred method for mutation detection. However, its accuracy in the individual clinical diagnostic setting is variable. To assess the diagnostic accuracy of HRMA for human mutations in comparison to DNA sequencing in different routine clinical settings, we have conducted a meta-analysis of published reports. Methodology/Principal Findings: Out of 195 publications obtained from the initial search criteria, thirty-four studies assessing the accuracy of HRMA were included in the meta-analysis. We found that HRMA was a highly sensitive test for detecting disease-associated mutations in humans. Overall, the summary sensitivity was 97.5% (95% confidence interval (CI): 96.8-98.5; I-2 = 27.0%). Subgroup analysis showed even higher sensitivity for non-HR-1 instruments (sensitivity 98.7% (95% CI: 97.7-99.3; I-2 = 0.0%)) and an eligible sample size subgroup (sensitivity 99.3% (95% CI: 98.1-99.8; I-2 = 0.0%)). HRMA specificity showed considerable heterogeneity between studies. Sensitivity of the techniques was influenced by sample size and instrument type but by not sample source or dye type. Conclusions/Significance: These findings show that HRMA is a highly sensitive, simple and low-cost test to detect human disease-associated mutations, especially for samples with mutations of low incidence. The burden on DNA sequencing could be significantly reduced by the implementation of HRMA, but it should be recognized that its sensitivity varies according to the number of samples with/without mutations, and positive results require DNA sequencing for confirmation.	[Li, Bing-Sheng; Wang, Xin-Ying; Ma, Feng-Li; Jiang, Bo] So Med Univ, Dept Gastroenterol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Li, Bing-Sheng; Wang, Xin-Ying; Ma, Feng-Li; Jiang, Bo] Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Song, Xiao-Xiao] Kunming Med Univ, Sch Publ Hlth, Kunming, Peoples R China; [Xu, An-Gao] Huizhou First Hosp, Huizhou Med Inst, Huizhou, Guangdong, Peoples R China	Southern Medical University - China; Kunming Medical University	Li, BS (corresponding author), So Med Univ, Dept Gastroenterol, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China.	angao62@21cn.com	li, bing/GWQ-9617-2022		Natural Science Foundation of Guangdong Province [10151600301]; Medical Science and Technology of Guangdong Province [A2010692]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Medical Science and Technology of Guangdong Province	This study was supported by a Natural Science Foundation of Guangdong Province Grant (No. 10151600301), and a Medical Science and Technology of Guangdong Province Grant (A2010692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493; Bastien R, 2008, HUM MUTAT, V29, P757, DOI 10.1002/humu.20726; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bocker S, 2007, BIOINFORMATICS, V23, pE5, DOI 10.1093/bioinformatics/btl291; Dagar V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-437; De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; Doi Y, 2009, INT J HEMATOL, V90, P37, DOI 10.1007/s12185-009-0337-y; Erali M, 2008, EXP MOL PATHOL, V85, P50, DOI 10.1016/j.yexmp.2008.03.012; FARRAR JS, 2009, HIGH RESOLUTION MELT; Fassina A, 2009, J CLIN PATHOL, V62, P1096, DOI 10.1136/jcp.2009.067587; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; FU X, 2009, CHIN ARCH GEN SURG E, V3, P376; Fukui T, 2008, CLIN CANCER RES, V14, P4751, DOI 10.1158/1078-0432.CCR-07-5207; Fuster O, 2009, J MOL DIAGN, V11, P458, DOI 10.2353/jmoldx.2009.090043; Gaucher C, 2009, HUM GENET, V125, P401, DOI 10.1007/s00439-009-0631-z; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2007, CLIN CHEM, V53, P150, DOI 10.1373/clinchem.2006.081240; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hung CC, 2008, CLIN BIOCHEM, V41, P162, DOI 10.1016/j.clinbiochem.2007.08.014; Kramer D, 2009, CELL ONCOL, V31, P161, DOI 10.3233/CLO-2009-0466; Krenkova P, 2009, FOLIA BIOL-PRAGUE, V55, P238; Krypuy M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-168; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; Li QB, 2002, ELECTROPHORESIS, V23, P1499, DOI 10.1002/1522-2683(200205)23:10<1499::AID-ELPS1499>3.0.CO;2-X; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lijmer JG, 2002, STAT MED, V21, P1525, DOI 10.1002/sim.1185; Liyanage KE, 2008, ANN CLIN BIOCHEM, V45, P170, DOI 10.1258/acb.2007.007077; Lopez-Villar I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-408; Lu Yong-ping, 2010, Journal of China Medical University, V39, P281; Ma ESK, 2009, J CLIN PATHOL, V62, P886, DOI 10.1136/jcp.2008.063677; Macaskill P, 2004, J CLIN EPIDEMIOL, V57, P925, DOI 10.1016/j.jclinepi.2003.12.019; Montgomery JL, 2010, EXPERT REV MOL DIAGN, V10, P219, DOI [10.1586/erm.09.84, 10.1586/ERM.09.84]; Nomoto K, 2006, AM J CLIN PATHOL, V126, P608, DOI 10.1309/N5PQNGW2QKMX09X7; Obuchowski NA, 2001, AM J ROENTGENOL, V176, P1357, DOI 10.2214/ajr.176.6.1761357; Olsen RKJ, 2010, J INHERIT METAB DIS, V33, P247, DOI 10.1007/s10545-010-9101-y; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Polakova KM, 2008, LEUKEMIA RES, V32, P1236, DOI 10.1016/j.leukres.2008.01.010; Provaznikova D, 2008, PLATELETS, V19, P471, DOI 10.1080/09537100802140013; Rapado I, 2009, J MOL DIAGN, V11, P155, DOI 10.2353/jmoldx.2009.080110; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; REES WA, 1993, BIOCHEMISTRY-US, V32, P137, DOI 10.1021/bi00052a019; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; SACKETT DL, 1992, CLIN EPIDEMIOLOGY BA; Simi L, 2008, AM J CLIN PATHOL, V130, P247, DOI 10.1309/LWDY1AXHXUULNVHQ; Song FJ, 2002, INT J EPIDEMIOL, V31, P88, DOI 10.1093/ije/31.1.88; Straus SE, 2005, EVIDENCE BASED MED P; Takano T, 2007, CLIN CANCER RES, V13, P5385, DOI 10.1158/1078-0432.CCR-07-0627; Tan AYC, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-10; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Ugo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008893; *US DEP VET AFF, 1996, 1 US DEP VET AFF; van der Stoep N, 2009, HUM MUTAT, V30, P899, DOI 10.1002/humu.21004; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Whitehall V, 2009, J MOL DIAGN, V11, P543, DOI 10.2353/jmoldx.2009.090057; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Willmore C, 2004, AM J CLIN PATHOL, V122, P206, DOI 10.1309/4E6UYBY62N2FCA6N; Willmore-Payne C, 2006, MODERN PATHOL, V19, P634, DOI 10.1038/modpathol.3800552; Willmore-Payne C, 2005, HUM PATHOL, V36, P486, DOI 10.1016/j.humpath.2005.03.015; Willmore-Payne C, 2006, HUM PATHOL, V37, P755, DOI 10.1016/j.humpath.2006.02.004; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Xiao J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-24; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; ZAMORA, 2006, BMC MED RES METHODOL, V6, P31, DOI DOI 10.1186/1471-2288-6-31; ZHIHONG C, 2010, CHIN J LAB MED, V33, P209; 2001, CLIN CHEM, V47, P1331; 2010, J MOL DIAGN, V12, P27	80	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28078	10.1371/journal.pone.0028078	http://dx.doi.org/10.1371/journal.pone.0028078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194806	gold, Green Published, Green Submitted			2022-12-27	WOS:000298369100021
J	Colles, FM; McCarthy, ND; Layton, R; Maiden, MCJ				Colles, Frances M.; McCarthy, Noel D.; Layton, Ruth; Maiden, Martin C. J.			The Prevalence of Campylobacter amongst a Free-Range Broiler Breeder Flock Was Primarily Affected by Flock Age	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; THERMOPHILIC CAMPYLOBACTER; JEJUNI; COLONIZATION; CHICKENS; INFECTION; COLI; SEASONALITY; POPULATIONS; POULTRY	Campylobacter successfully colonizes broiler chickens, but little is known about the longer term natural history of colonization, since most flocks are slaughtered at an immature age. In this study, the prevalence and genetic diversity of Campylobacter colonizing a single free-range broiler breeder flock was investigated over the course of a year. The age of the flock was the most important factor in determining both the prevalence and diversity of Campylobacter over time. There was no correlation with season, temperature, the amount of rain and sunshine, or the dynamics of colonization amongst geographically and temporally matched broiler flocks. The higher prevalence rates coincided with the age at which broiler chickens are typically slaughtered, but then in the absence of bio-security or other intervention methods, and despite changes in flock management, the prevalence fell to significantly lower levels for the remainder of the study. The genetic diversity of Campylobacter increased as the flock aged, implying that genotypes were accumulated within the flock and may persist for a long time. A better understanding of the ecology of Campylobacter within commercial chicken flocks will allow the design of more effective farm-based interventions.	[Colles, Frances M.; McCarthy, Noel D.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Layton, Ruth] Wytham, Food Anim Initiat, Oxford, England	University of Oxford	Colles, FM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	frances.colles@zoo.ox.ac.uk	Maiden, Martin C J/C-5055-2014; Maiden, Martin/N-6805-2019; McCarthy, Noel D/K-3314-2012	Maiden, Martin C J/0000-0001-6321-5138; Maiden, Martin/0000-0001-6321-5138; McCarthy, Noel/0000-0003-1113-1017; Colles, Frances/0000-0002-3322-2991	UK Department for Environment, Food and Rural Affairs (DEFRA) [OZ0604]	UK Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This work and the maintenance of the Campylobacter MLST database (http://pubmlst.org/campylobacter/) was funded by the UK Department for Environment, Food and Rural Affairs (DEFRA), Contract Number OZ0604. MCJM is a Welcome Trust Senior Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen M, 1998, AVIAN DIS, V42, P732, DOI 10.2307/1592708; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Baker Michael, 2006, N Z Med J, V119, pU2264; Berndtson E, 1996, INT J FOOD MICROBIOL, V32, P35, DOI 10.1016/0168-1605(96)01102-6; Bi P, 2008, J INFECTION, V57, P317, DOI 10.1016/j.jinf.2008.08.004; Cogan TA, 2007, GUT, V56, P1060, DOI 10.1136/gut.2006.114926; Colles FM, 2008, APPL ENVIRON MICROB, V74, P3583, DOI 10.1128/AEM.02491-07; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; COLLES FM, 2008, APPL ENV MICROBIOLOG; Colles FM, 2008, ENVIRON MICROBIOL, V10, P2042, DOI 10.1111/j.1462-2920.2008.01623.x; Corry JEL, 2001, J APPL MICROBIOL, V90, p96S, DOI 10.1046/j.1365-2672.2001.01358.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Frost JA, 2001, J APPL MICROBIOL, V90, p85S, DOI 10.1046/j.1365-2672.2001.01357.x; Gillespie IA, 2002, EMERG INFECT DIS, V8, P937, DOI 10.3201/eid0809.010817; Hald B, 2008, POULTRY SCI, V87, P1428, DOI 10.3382/ps.2007-00301; Heuer OE, 2001, LETT APPL MICROBIOL, V33, P269, DOI 10.1046/j.1472-765X.2001.00994.x; Humphrey T, 2006, BRIT POULTRY SCI, V47, P379, DOI 10.1080/00071660600829084; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; Johnsen G, 2006, POULTRY SCI, V85, P2278, DOI 10.1093/ps/85.12.2278; Ketley JM, 1997, MICROBIOL-UK, V143, P5, DOI 10.1099/00221287-143-1-5; Louis VR, 2005, APPL ENVIRON MICROB, V71, P85, DOI 10.1128/AEM.71.1.85-92.2005; Meinersmann RJ, 1997, J CLIN MICROBIOL, V35, P2810, DOI 10.1128/JCM.35.11.2810-2814.1997; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Ridley AM, 2008, J APPL MICROBIOL, V105, P95, DOI 10.1111/j.1365-2672.2008.03759.x; Sheppard SK, 2010, APPL ENVIRON MICROB, V76, P5269, DOI 10.1128/AEM.00124-10; Van Overbeke I, 2006, AVIAN DIS, V50, P196, DOI 10.1637/7448-093005R.1; Wallace JS, 1997, J APPL MICROBIOL, V82, P219, DOI 10.1111/j.1365-2672.1997.tb03576.x; Whyte P, 2001, POULTRY SCI, V80, P817, DOI 10.1093/ps/80.6.817; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Wilson DL, 2010, MICROBIOL-SGM, V156, P2046, DOI 10.1099/mic.0.035717-0	32	15	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e22825	10.1371/journal.pone.0022825	http://dx.doi.org/10.1371/journal.pone.0022825			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174732	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600001
J	Guo, W; Wu, SH; Wang, L; Wei, XL; Liu, XY; Wang, J; Lu, ZM; Hollingshead, M; Fang, BL				Guo, Wei; Wu, Shuhong; Wang, Li; Wei, Xiaoli; Liu, Xiaoying; Wang, Ji; Lu, Zhimin; Hollingshead, Melinda; Fang, Bingliang			Antitumor Activity of a Novel Oncrasin Analogue Is Mediated by JNK Activation and STAT3 Inhibition	PLOS ONE			English	Article							RNA-POLYMERASE-II; HUMAN CANCER-CELLS; INDUCED APOPTOSIS; SELICICLIB CYC202; MULTIPLE-MYELOMA; DOWN-REGULATION; SMALL-MOLECULE; R-ROSCOVITINE; P-TEFB; FLAVOPIRIDOL	Background: To optimize the antitumor activity of oncrasin-1, a small molecule identified through synthetic lethality screening on isogenic K-Ras mutant tumor cells, we developed several analogues and determined their antitumor activities. Here we investigated in vitro and in vivo antitumor activity of NSC-743380 (1-[(3-chlorophenyl) methyl]-1H-indole-3-methanol, oncrasin-72), one of most potent analogues of oncrasin-1. Methodology and Principal Findings: In vitro antitumor activity was determined in NCI-60 cancer cell line panel using cell viability assay. In vivo antitumor activity was determined in parallel with NSC-741909 (oncrasin-60) in xenograft tumors established in nude mice from A498, a human renal cancer cell line. Changes in gene expression levels and signaling pathway activities upon treatment with NSC-743380 were analyzed in breast and renal cancer cells by Western blot analysis. Apoptosis was demonstrated by Western blot analysis and flow cytometric analysis. NSC-743380 is highly active against a subset of cancer cell lines derived from human lung, colon, ovary, kidney, and breast cancers. The 50% growth-inhibitory concentration (GI(50)) for eight of the most sensitive cell lines was <= 10 nM. In vivo study showed that NSC-743380 has a better safety profile and greater antitumor activity than NSC-741909. Treatment with NSC-743380 caused complete regression of A498 xenograft tumors in nude mice at the tested doses ranging from 67 mg/kg to 150 mg/kg. Mechanistic characterization revealed that NSC-743380 suppressed the phosphorylation of C-terminal domain of RNA polymerase II, induced JNK activation, inhibited JAK2/STAT3 phosphorylation and suppressed cyclin D1 expression in sensitive human cancer cells. Blocking JNK activation or overexpression of constitutively active STAT3 partially blocked NSC-743380-induced antitumor activity. Conclusions: NSC-743380 induces antitumor activity through modulation of functions in multiple cancer related pathways and could be a potential anticancer agent for some solid tumors.	[Guo, Wei; Wu, Shuhong; Wang, Li; Wei, Xiaoli; Liu, Xiaoying; Wang, Ji; Fang, Bingliang] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Hollingshead, Melinda] NCI, Biol Testing Branch, Frederick, MD 21701 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Guo, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA.	Bfang@mdanderson.org			National Institutes of Health (NIH) [R01 CA 092481, R01 CA 124951]; Rapid Access to Interventional Development (RAID) Program; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH; University of Texas MD Anderson Cancer Center [CA-016672]; National Cancer Institute, National Institutes of Health [NO1-CO-12400]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA124951] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rapid Access to Interventional Development (RAID) Program; Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH; University of Texas MD Anderson Cancer Center; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health (NIH) through R01 CA 092481 and R01 CA 124951 to B. Fang, the Rapid Access to Interventional Development (RAID) Program, the Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), NIH, The University of Texas MD Anderson Cancer Center Support Grant CA-016672, Lung Program, Nuclear Magnetic Resonance, DNA Analysis and Flow Cytometry, and Cellular Imaging Core Facility. Additional support was provided with federal funds from the National Cancer Institute, National Institutes of Health, under contract NO1-CO-12400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen R, 2005, BLOOD, V106, P2513, DOI 10.1182/blood-2005-04-1678; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; Guo W, 2009, MOL CANCER THER, V8, P441, DOI 10.1158/1535-7163.MCT-08-0839; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; HOPERT A, 1993, J IMMUNOL METHODS, V164, P91, DOI 10.1016/0022-1759(93)90279-G; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kennedy NJ, 2003, GENE DEV, V17, P629, DOI 10.1101/gad.1062903; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; Koumenis C, 1997, MOL CELL BIOL, V17, P7306, DOI 10.1128/MCB.17.12.7306; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; MacCallum DE, 2005, CANCER RES, V65, P5399, DOI 10.1158/0008-5472.CAN-05-0233; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; PLOWMAN J, 1988, INVEST NEW DRUG, V6, P147; Raje N, 2005, BLOOD, V106, P1042, DOI 10.1182/blood-2005-01-0320; Sanchez-Perez I, 1998, ONCOGENE, V16, P533, DOI 10.1038/sj.onc.1201578; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Toji LH, 1998, IN VITRO CELL DEV-AN, V34, P356; Torrance CJ, 2001, NAT BIOTECHNOL, V19, P940, DOI 10.1038/nbt1001-940; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Wei XL, 2009, J BIOL CHEM, V284, P16948, DOI 10.1074/jbc.M109.010256; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wittmann S, 2003, CANCER RES, V63, P93; Wu SH, 2011, J MED CHEM, V54, P2668, DOI 10.1021/jm101417n	34	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28487	10.1371/journal.pone.0028487	http://dx.doi.org/10.1371/journal.pone.0028487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174819	Green Published, gold, Green Submitted			2022-12-27	WOS:000298366600021
J	Van der Velden, J; Barker, D; Barcham, G; Koumoundouros, E; Snibson, K				Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth			Assessment of Peripheral Airway Function following Chronic Allergen Challenge in a Sheep Model of Asthma	PLOS ONE			English	Article							HOUSE-DUST MITE; COLLATERAL VENTILATION; DISEASE; INFLAMMATION; RESISTANCE; LUNGS; ANTIGEN	Background: There is increasing evidence that the small airways contribute significantly to the pathophysiology of asthma. However, due to the difficulty in accessing distal lung regions in clinical settings, functional changes in the peripheral airways are often overlooked in studies of asthmatic patients. The aim of the current study was to characterize progressive changes in small airway function in sheep repeatedly challenged with house dust mite (HDM) allergen. Methodology/Principal Findings: Four spatially separate lung segments were utilized for HDM challenges. The right apical, right medial, right caudal and left caudal lung segments received 0, 8, 16 and 24 weekly challenges with HDM respectively. A wedged-bronchoscope technique was used to assess changes in peripheral resistance (R(p)) at rest, and in response to specific and non-specific stimuli throughout the trial. Allergen induced inflammatory cell infiltration into bronchoalveolar lavage and increases in R(p) in response to HDM and methacholine were localized to treated lung segments, with no changes observed in adjacent lung segments. The acute response to HDM was variable between sheep, and was significantly correlated to airway responsiveness to methacholine (r(s) = 0.095, P<0.01). There was no correlation between resting Rp and the number of weeks of HDM exposure. Nor was there a correlation between the magnitude of early-phase airway response and the number of HDM-challenges. Conclusions: Our findings indicate that airway responses to allergic and non-allergic stimuli are localized to specific treated areas of the lung. Furthermore, while there was a decline in peripheral airway function with HDM exposure, this decrease was not correlated with the length of allergen challenge.	[Van der Velden, Joanne; Barker, Donna; Barcham, Garry; Koumoundouros, Emmanuel; Snibson, Kenneth] Univ Melbourne, Ctr Anim Biotechnol, Melbourne, Vic, Australia; [Koumoundouros, Emmanuel] Univ Melbourne, Sch Engn, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Van der Velden, J (corresponding author), Univ Melbourne, Ctr Anim Biotechnol, Melbourne, Vic, Australia.	ksnibson@unimelb.edu.au	KOUMOUNDOUROS, EMMANUEL/H-5766-2016	KOUMOUNDOUROS, EMMANUEL/0000-0002-6419-329X; Barker, Donna/0000-0003-2005-5239; Snibson, Kenneth/0000-0003-4772-9408	National Health and Medical Research Council (NHMRC) of Australia [566904]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (Project no. 566904; http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM WM, 1983, AM REV RESPIR DIS, V128, P839; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; BOSSE J, 1987, J ALLERGY CLIN IMMUN, V79, P339, DOI 10.1016/0091-6749(87)90152-7; Corren J, 2008, CURR ALLERGY ASTHM R, V8, P533, DOI 10.1007/s11882-008-0097-4; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; Hamid Q, 1997, J ALLERGY CLIN IMMUN, V100, P44, DOI 10.1016/S0091-6749(97)70193-3; HOGG JC, 1969, J CLIN INVEST, V48, P421, DOI 10.1172/JCI105999; KLEEBERGER SR, 1986, J APPL PHYSIOL, V61, P1309, DOI 10.1152/jappl.1986.61.4.1309; Klug B, 1997, EUR RESPIR J, V10, P1599, DOI 10.1183/09031936.97.10071599; Koumoundouros E, 2006, EXP LUNG RES, V32, P321, DOI 10.1080/01902140600916960; Palmans E, 2000, AM J RESP CRIT CARE, V161, P627, DOI 10.1164/ajrccm.161.2.9902094; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; Shaw RJ, 1997, VET IMMUNOL IMMUNOP, V57, P253, DOI 10.1016/S0165-2427(97)00010-X; Shaw RJ, 2002, RESP MED, V96, P67, DOI 10.1053/rmed.2001.1216; Snibson KJ, 2005, CLIN EXP ALLERGY, V35, P146, DOI 10.1111/j.1365-2222.2005.02137.x; TERRY PB, 1978, NEW ENGL J MED, V298, P10, DOI 10.1056/NEJM197801052980103; Tsai LW, 2007, RESPIRATION, V74, P565, DOI 10.1159/000103514; Vanacker NJ, 2002, CLIN EXP ALLERGY, V32, P914, DOI 10.1046/j.1365-2222.2002.01394.x; Wagner EM, 1998, AM J RESP CRIT CARE, V157, P447, DOI 10.1164/ajrccm.157.2.9611043; WAGNER EM, 1990, AM REV RESPIR DIS, V141, P584, DOI 10.1164/ajrccm/141.3.584; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x	21	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28740	10.1371/journal.pone.0028740	http://dx.doi.org/10.1371/journal.pone.0028740			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174883	Green Published, gold			2022-12-27	WOS:000298366600033
J	Kamita, SG; Samra, AI; Liu, JY; Cornel, AJ; Hammock, BD				Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Cornel, Anthony J.; Hammock, Bruce D.			Juvenile Hormone (JH) Esterase of the Mosquito Culex quinquefasciatus Is Not a Target of the JH Analog Insecticide Methoprene	PLOS ONE			English	Article							IN-VITRO EXPRESSION; MOLECULAR-CLONING; DEVELOPMENTAL EXPRESSION; CATALYTIC MECHANISM; TENEBRIO-MOLITOR; TRICHOPLUSIA-NI; GENE; RESISTANCE; CDNA; IDENTIFICATION	Juvenile hormones (JHs) are essential sesquiterpenes that control insect development and reproduction. JH analog (JHA) insecticides such as methoprene are compounds that mimic the structure and/or biological activity of JH. In this study we obtained a full-length cDNA, cqjhe, from the southern house mosquito Culex quinquefasciatus that encodes CqJHE, an esterase that selectively metabolizes JH. Unlike other recombinant esterases that have been identified from dipteran insects, CqJHE hydrolyzed JH with specificity constant (k(cat)/K-M ratio) and V-max values that are common among JH esterases (JHEs). CqJHE showed picomolar sensitivity to OTFP, a JHE-selective inhibitor, but more than 1000-fold lower sensitivity to DFP, a general esterase inhibitor. To our surprise, CqJHE did not metabolize the isopropyl ester of methoprene even when 25 pmol of methoprene was incubated with an amount of CqJHE that was sufficient to hydrolyze 7,200 pmol of JH to JH acid under the same assay conditions. In competition assays in which both JH and methoprene were available to CqJHE, methoprene did not show any inhibitory effects on the JH hydrolysis rate even when methoprene was present in the assay at a 10-fold higher concentration relative to JH. Our findings indicated that JHE is not a molecular target of methoprene. Our findings also do not support the hypothesis that methoprene functions in part by inhibiting the action of JHE.	[Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Cornel, Anthony J.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Kamita, Shizuo G.; Samra, Aman I.; Liu, Jun-Yan; Hammock, Bruce D.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kamita, SG (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	bdhammock@ucdavis.edu	LIU, JUNYAN/B-2515-2010; liu, junyan/HGV-1505-2022	LIU, JUNYAN/0000-0002-3018-0335; 	National Institute of Environmental Health Sciences [RO1 ES002710, P42 ES004699]; National Institites of Health/National Institute of Allergy and Infectious Diseases [U01 AI068855]; U.S. Department of Agriculture [2007-35607-17830]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710, P42ES004699] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institites of Health/National Institute of Allergy and Infectious Diseases; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially funded by grants from the National Institute of Environmental Health Sciences (RO1 ES002710 and P42 ES004699), National Institites of Health/National Institute of Allergy and Infectious Diseases (U01 AI068855), and the U.S. Department of Agriculture (2007-35607-17830). B. D. H. is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAAL YAI, 1986, SCIENCE, V233, P1073, DOI 10.1126/science.3738525; ABDELAAL YAI, 1985, INSECT BIOCHEM, V15, P111, DOI 10.1016/0020-1790(85)90051-4; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Aronov PA, 2005, J AGR FOOD CHEM, V53, P3306, DOI 10.1021/jf0485842; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai H, 2007, INSECT BIOCHEM MOLEC, V37, P829, DOI 10.1016/j.ibmb.2007.05.010; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BROWN TM, 1979, PESTIC BIOCHEM PHYS, V12, P79, DOI 10.1016/0048-3575(79)90097-X; BROWN TM, 1974, J ECON ENTOMOL, V67, P799, DOI 10.1093/jee/67.6.799a; Campbell PM, 2001, INSECT BIOCHEM MOLEC, V31, P513, DOI 10.1016/S0965-1748(01)00035-2; Campbell PM, 1998, INSECT BIOCHEM MOLEC, V28, P501, DOI 10.1016/S0965-1748(98)00037-X; Cornel AJ, 2002, PEST MANAG SCI, V58, P791, DOI 10.1002/ps.521; COTRUVO J, 2008, METHOPRENE DRINKING, P1; Crone EJ, 2007, INSECT BIOCHEM MOLEC, V37, P540, DOI 10.1016/j.ibmb.2007.02.010; Dame DA, 1998, J AM MOSQUITO CONTR, V14, P200; Feng QL, 1999, MOL CELL ENDOCRINOL, V148, P95, DOI 10.1016/S0303-7207(98)00228-7; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hammock B.D., 1985, P431; HAMMOCK BD, 1977, PESTIC BIOCHEM PHYS, V7, P517, DOI 10.1016/0048-3575(77)90046-3; HAMMOCK BD, 1984, PESTIC BIOCHEM PHYS, V22, P209, DOI 10.1016/0048-3575(84)90092-0; HAMMOCK BD, 1977, ANAL BIOCHEM, V82, P573, DOI 10.1016/0003-2697(77)90196-8; HANZLIK TN, 1989, J BIOL CHEM, V264, P12419; HARMON MA, 1995, P NATL ACAD SCI USA, V92, P6157, DOI 10.1073/pnas.92.13.6157; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Henrick CA, 2007, J AM MOSQUITO CONTR, V23, P225, DOI 10.2987/8756-971X(2007)23[225:M]2.0.CO;2; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P477, DOI 10.1016/S0965-1748(03)00010-9; Hinton AC, 2003, INSECT BIOCHEM MOLEC, V33, P317, DOI 10.1016/S0965-1748(02)00246-1; Hinton AC, 2001, INSECT BIOCHEM MOLEC, V32, P57, DOI 10.1016/S0965-1748(01)00079-0; Hirai M, 2002, INSECT BIOCHEM MOLEC, V32, P627, DOI 10.1016/S0965-1748(01)00141-2; Kamita SG, 2003, INSECT BIOCHEM MOLEC, V33, P1261, DOI 10.1016/j.ibmb.2003.08.004; Kamita SG, 2010, J PESTIC SCI, V35, P265, DOI 10.1584/jpestics.R10-09; Kotaki T, 2009, ORG LETT, V11, P5234, DOI 10.1021/ol902161x; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Liu SH, 2008, J INSECT PHYSIOL, V54, P1495, DOI 10.1016/j.jinsphys.2008.08.010; Mackert A, 2008, COMP BIOCHEM PHYS B, V150, P33, DOI 10.1016/j.cbpb.2008.01.004; MASTROPAOLO W, 1981, ANAL BIOCHEM, V115, P188, DOI 10.1016/0003-2697(81)90544-3; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; MCCUTCHEN BF, 1993, ARCH BIOCHEM BIOPHYS, V307, P231, DOI 10.1006/abbi.1993.1584; Merrington CL, 1999, PRACT APPROACH SER, V202, P101; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Munyiri FN, 2007, INSECT BIOCHEM MOLEC, V37, P497, DOI 10.1016/j.ibmb.2007.02.006; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Rasband W.S., 2006, IMAGE J; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; RUSSEL RM, 1977, ESA B, V23, P209; SLADE M, 1973, SCIENCE, V181, P672, DOI 10.1126/science.181.4100.672; SPARKS TC, 1980, PESTIC BIOCHEM PHYS, V14, P290, DOI 10.1016/0048-3575(80)90037-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Thomas BA, 1999, PROTEINS, V34, P184, DOI 10.1002/(SICI)1097-0134(19990201)34:2<184::AID-PROT4>3.3.CO;2-#; Tsubota T, 2010, INSECT BIOCHEM MOLEC, V40, P100, DOI 10.1016/j.ibmb.2009.12.015; Vinogradova E.B., 2000, CULEX PIPIENS PIPIEN; WARD VK, 1992, INT J BIOCHEM, V24, P1933, DOI 10.1016/0020-711X(92)90289-D; WEIRICH G, 1973, LIFE SCI, V13, P213, DOI 10.1016/0024-3205(73)90020-9; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2004, J INSECT PHYSIOL, V50, P111, DOI 10.1016/j.jinsphys.2003.12.004; Wogulis M, 2006, BIOCHEMISTRY-US, V45, P4045, DOI 10.1021/bi0521644	58	23	23	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28392	10.1371/journal.pone.0028392	http://dx.doi.org/10.1371/journal.pone.0028392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174797	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700030
J	Miettinen, HM				Miettinen, Heini M.			Regulation of Human Formyl Peptide Receptor 1 Synthesis: Role of Single Nucleotide Polymorphisms, Transcription Factors, and Inflammatory Mediators	PLOS ONE			English	Article							NADPH OXIDASE COMPONENTS; LEUKEMIA-CELL LINE; INTERFERON-GAMMA; GENE-EXPRESSION; CHEMOATTRACTANT RECEPTORS; TRANSLATION EFFICIENCY; DIMETHYL-SULFOXIDE; PROMOTER ACTIVITY; MYELOID CELLS; BONE-MARROW	The gene encoding the human formyl peptide receptor 1 (FPR1) is heterogeneous, containing numerous single nucleotide polymorphisms (SNPs). Here, we examine the effect of these SNPs on gene transcription and protein translation. We also identify gene promoter sequences and putative FPR1 transcription factors. To test the effect of codon bias and codon pair bias on FPR1 expression, four FPR1 genetic variants were expressed in human myeloid U937 cells fused to a reporter gene encoding firefly luciferase. No significant differences in luciferase activity were detected, suggesting that the translational regulation and protein stability of FPR1 are modulated by factors other than the SNP codon bias and the variant amino acid properties. Deletion and mutagenesis analysis of the FPR1 promoter showed that a CCAAT box is not required for gene transcription. A -88/41 promoter construct resulted in the strongest transcriptional activity, whereas a -72/41 construct showed large reduction in activity. The region between -88 and -72 contains a consensus binding site for the transcription factor PU.1. Mutagenesis of this site caused significant reduction in reporter gene expression. The PU.1 binding was confirmed in vivo by chromatin immunoprecipitation, and the binding to nucleotides -84 to -76 (TTCCTATTT) was confirmed in vitro by an electrophoretic mobility shift assay. Thus, similar to many other myeloid genes, FPR1 promoter activity requires PU.1. Two single nucleotide polymorphisms at -56 and -54 did not significantly affect FPR1 gene expression, despite differences in binding of transcription factor IRF1 in vitro. Inflammatory mediators such as interferon-c, tumor necrosis factor-alpha, and lipopolysaccharide did not increase FPR1 promoter activity in myeloid cells, whereas differentiation induced by DMSO and retinoic acid enhanced the activity. This implies that the expression of FPR1 in myeloid cells is developmentally regulated, and that the differentiated cells are equipped for immediate response to microbial infections.	Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Miettinen, HM (corresponding author), Montana State Univ, Dept Microbiol, Bozeman, MT 59717 USA.	heini@montana.edu			National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID) [1R21 AI83244-02]; NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence) [P20 RR016455]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083244] Funding Source: NIH RePORTER	National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by National Institutes of Health(NIH)/National Institute of Allergy and Infectious Diseases (NIAID) 1R21 AI83244-02. The Montana State University Functional Genomics Core Facility was funded by the NIH/National Center for Research Resources INBRE (IDeA Networks of Biomedical Research Excellence) award P20 RR016455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Buchan JR, 2006, NUCLEIC ACIDS RES, V34, P1015, DOI 10.1093/nar/gkj488; CASSATELLA MA, 1990, J BIOL CHEM, V265, P20241; Chateau MT, 1996, ANAL CELL PATHOL, V10, P75; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; ERBECK K, 1993, J IMMUNOL, V150, P1913; Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gauss KA, 2002, J LEUKOCYTE BIOL, V71, P163; GREEN SP, 1994, J LEUKOCYTE BIOL, V55, P530, DOI 10.1002/jlb.55.4.530; Gripentrog JM, 2008, IMMUNOGENETICS, V60, P83, DOI 10.1007/s00251-008-0277-3; HARRIS PE, 1985, CANCER RES, V45, P9; HAVILAND DL, 1993, BIOCHEMISTRY-US, V32, P4168, DOI 10.1021/bi00067a003; Jormsjo S, 2000, CIRC RES, V86, P998, DOI 10.1161/01.RES.86.9.998; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LEVY R, 1991, J IMMUNOL, V147, P3066; LEWIN B, 2007, GENES, V9, P609; Li SL, 1997, J BIOL CHEM, V272, P17802, DOI 10.1074/jbc.272.28.17802; Li SL, 2002, BLOOD, V99, P4578, DOI 10.1182/blood.V99.12.4578; Mandal P, 2005, J IMMUNOL, V175, P6085, DOI 10.4049/jimmunol.175.9.6085; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MURPHY PM, 1993, GENE, V133, P285, DOI 10.1016/0378-1119(93)90653-K; PEREZ HD, 1992, BIOCHEMISTRY-US, V31, P11595, DOI 10.1021/bi00161a044; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Rockman MV, 2003, CURR BIOL, V13, P2118, DOI 10.1016/j.cub.2003.11.025; Sahagun-Ruiz A, 2001, GENES IMMUN, V2, P335, DOI 10.1038/sj.gene.6363787; SAKANO T, 1988, CELL IMMUNOL, V111, P390, DOI 10.1016/0008-8749(88)90102-5; SHERF BA, 1996, PROMEGA NOTES MAGAZI, P2; Suzuki S, 1998, P NATL ACAD SCI USA, V95, P6085, DOI 10.1073/pnas.95.11.6085; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; Tamura T, 1996, BIOCHEM BIOPH RES CO, V229, P21, DOI 10.1006/bbrc.1996.1752; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Waldman YY, 2010, NUCLEIC ACIDS RES, V38, P2964, DOI 10.1093/nar/gkq009; Ye R D, 1997, Adv Pharmacol, V39, P221, DOI 10.1016/S1054-3589(08)60073-3; Zella D, 1998, BLOOD, V91, P4444, DOI 10.1182/blood.V91.12.4444.412k46_4444_4450; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zhang Y, 2003, GENES IMMUN, V4, P22, DOI 10.1038/sj.gene.6363900	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28712	10.1371/journal.pone.0028712	http://dx.doi.org/10.1371/journal.pone.0028712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174875	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700064
J	Raj, A; Dewar, M; Palacios, G; Rabadan, R; Wiggins, CH				Raj, Anil; Dewar, Michael; Palacios, Gustavo; Rabadan, Raul; Wiggins, Christopher H.			Identifying Hosts of Families of Viruses: A Machine Learning Approach	PLOS ONE			English	Article							RNA-BINDING; 2C	Identifying emerging viral pathogens and characterizing their transmission is essential to developing effective public health measures in response to an epidemic. Phylogenetics, though currently the most popular tool used to characterize the likely host of a virus, can be ambiguous when studying species very distant to known species and when there is very little reliable sequence information available in the early stages of the outbreak of disease. Motivated by an existing framework for representing biological sequence information, we learn sparse, tree-structured models, built from decision rules based on subsequences, to predict viral hosts from protein sequence data using popular discriminative machine learning tools. Furthermore, the predictive motifs robustly selected by the learning algorithm are found to show strong host-specificity and occur in highly conserved regions of the viral proteome.	[Raj, Anil; Wiggins, Christopher H.] Columbia Univ, Dept Appl Phys & Appl Math, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA; [Palacios, Gustavo] Columbia Univ, Ctr Infect & Immun, Mailman Sch Publ Hlth, New York, NY USA; [Rabadan, Raul] Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, Ctr Computat Biol & Bioinformat, New York, NY USA	Columbia University; Columbia University; Columbia University	Raj, A (corresponding author), Columbia Univ, Dept Appl Phys & Appl Math, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA.	ar2384@columbia.edu	Rabadan, Raul/AAZ-7367-2020; Palacios, Gustavo/I-7773-2015	Palacios, Gustavo/0000-0001-5062-1938; Rabadan, Raul/0000-0001-7946-9255	National Institutes of Health [U54 CA121852-05]; Northeast Biodefence Center [U54-AI057158]; National Library of Medicine [1R01LM010140-01]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefence Center; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	RR and CW are supported by the National Institutes of Health (U54 CA121852-05). RR and GP are supported by the Northeast Biodefence Center (U54-AI057158). RR is also supported by the National Library of Medicine (1R01LM010140-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V206, P64, DOI 10.1006/bbrc.1995.1010; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Busa-Fekete R, 2009, J MACHINE LEARNING R, V7, P111; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; GORBALENYA AE, 1989, J MOL EVOL, V28, P256, DOI 10.1007/BF02102483; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Jimenez-Baranda S, 2011, J VIROL, V85, P3893, DOI 10.1128/JVI.01908-10; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kusov YY, 1998, ARCH VIROL, V143, P931, DOI 10.1007/s007050050343; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pfister T, 1999, J BIOL CHEM, V274, P6992, DOI 10.1074/jbc.274.11.6992; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Schapire RE, 1999, MACH LEARN, V37, P297, DOI 10.1023/A:1007614523901; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Touchon M, 2008, BIOCHIMIE, V90, P648, DOI 10.1016/j.biochi.2007.09.015; Trifonov V, 2010, MBIO, V1, DOI 10.1128/mBio.00156-10; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27631	10.1371/journal.pone.0027631	http://dx.doi.org/10.1371/journal.pone.0027631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174744	gold, Green Published, Green Submitted			2022-12-27	WOS:000298365700006
J	Zheng, F; Zhou, XJ; Luo, YN; Xiao, H; Wayman, G; Wang, HB				Zheng, Fei; Zhou, Xianju; Luo, Yongneng; Xiao, Hua; Wayman, Gary; Wang, Hongbing			Regulation of Brain-Derived Neurotrophic Factor Exon IV Transcription through Calcium Responsive Elements in Cortical Neurons	PLOS ONE			English	Article							LONG-TERM POTENTIATION; CREB-BINDING PROTEIN; HIPPOCAMPAL-NEURONS; BDNF EXPRESSION; INDEPENDENT MECHANISMS; GENE-TRANSCRIPTION; SIGNALING PATHWAY; NUCLEAR-PROTEIN; FEAR MEMORY; MAP KINASE	Activity-dependent transcription of brain-derived neurotrophic factor (BDNF) has been studied as an important model to elucidate the mechanisms underlying numerous aspects of neuroplasticity. It has been extensively emphasized that Ca(2+) influx through different routes may have significantly different effects on BDNF transcription. Here, we examined the regulatory property of the major calcium responsive elements (CaRE) in BDNF promoter IV in cultured rat cortical neurons. BDNF promoter IV, as well as CaRE1 and CaRE3, was significantly activated by Ca(2+) influx through L-type voltage-gated calcium channel (L-VGCC) or NMDA receptor (NMDAR). However, the L-VGCC- and NMDAR-mediated activation of CaRE was differentially regulated by different Ca(2+)-stimulated protein kinases. Specifically, PKA, CaMKI, and CaMKIV activity were required for L-VGCC-, but not NMDAR-mediated CaRE1 activation. CaMKI activity was required for NMDAR- but not L-VGCC-mediated CaRE3 activation. Surprisingly, the activation of CaRF, a previously identified transcription factor for CaRE1, was stimulated via L-VGCC but not NMDAR, and required MEK, PI3K and CaMKII activity. These results suggest a new working model that activity-dependent BDNF IV up-regulation may be coordinately mediated by CaRE1 and CaRE3 activity, which show different responses to Ca(2+)-stimulated kinases. Our data also explain how the individual cis-element in BDNF promoter is distinctively coupled to different Ca(2+) routes.	[Zheng, Fei] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Zhou, Xianju; Luo, Yongneng; Xiao, Hua; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Wang, Hongbing] Michigan State Univ, Cellular & Mol Biol Program, E Lansing, MI 48824 USA; [Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Wayman, Gary] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Washington State University	Zheng, F (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	wangho@msu.edu			National Institute of Health [MH076906, DK066110, MH086032]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032, R01MH076906] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Health Grants MH076906 (H.W.), DK066110 (H.X.), and MH086032 (G.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Chen WG, 2003, J NEUROSCI, V23, P2572; Chen X, 2005, NAT NEUROSCI, V8, P925, DOI 10.1038/nn1482; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; DUGICHDJORDJEVIC MM, 1992, NEURON, V8, P1127, DOI 10.1016/0896-6273(92)90133-X; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grewal SS, 2000, J BIOL CHEM, V275, P34433, DOI 10.1074/jbc.M004728200; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ji YY, 2005, NAT NEUROSCI, V8, P164, DOI 10.1038/nn1381; Kawanishi Y, 1999, J HUM GENET, V44, P428, DOI 10.1007/s100380050196; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; LESSMANN V, 1994, NEUROREPORT, V6, P21; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McDowell KA, 2010, J NEUROSCI, V30, P7453, DOI 10.1523/JNEUROSCI.3997-09.2010; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; Newton SS, 2002, J NEUROSCI, V22, P10883; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Opazo P, 2003, J NEUROSCI, V23, P3679; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Shaywitz AJ, 2000, MOL CELL BIOL, V20, P9409, DOI 10.1128/MCB.20.24.9409-9422.2000; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tabuchi A, 2000, J BIOL CHEM, V275, P17269, DOI 10.1074/jbc.M909538199; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zheng F, 2009, NEUROCHEM INT, V54, P385, DOI 10.1016/j.neuint.2009.01.006; ZHOU X, 2009, J NEUROSCI RES; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	58	56	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28441	10.1371/journal.pone.0028441	http://dx.doi.org/10.1371/journal.pone.0028441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174809	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700037
J	Chan, KYK; Wong, CM; Kwan, JSH; Lee, JMF; Cheung, KW; Yuen, MF; Lai, CL; Poon, RTP; Sham, PC; Ng, IOL				Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Kwan, Johnny Sheung-Him; Lee, Joyce Man-Fong; Cheung, Ka Wai; Yuen, Man Fung; Lai, Ching Lung; Poon, Ronnie Tung-Ping; Sham, Pak Chung; Ng, Irene Oi-Lin			Genome-Wide Association Study of Hepatocellular Carcinoma in Southern Chinese Patients with Chronic Hepatitis B Virus Infection	PLOS ONE			English	Article							GENE POLYMORPHISMS; SUSCEPTIBILITY LOCUS; NONCODING RNA; RISK; CYTOKINE	One of the most relevant risk factors for hepatocellular carcinoma (HCC) development is chronic hepatitis B virus (HBV) infection, but only a fraction of chronic HBV carriers develop HCC, indicating that complex interactions among viral, environmental and genetic factors lead to HCC in HBV-infected patients. So far, host genetic factors have incompletely been characterized. Therefore, we performed a genome-wide association (GWA) study in a Southern Chinese cohort consisting of 95 HBV-infected HCC patients (cases) and 97 HBV-infected patients without HCC (controls) using the Illumina Human610-Quad BeadChips. The top single nucleotide polymorphisms (SNPs) were then validated in an independent cohort of 500 cases and 728 controls. 4 SNPs (rs12682266, rs7821974, rs2275959, rs1573266) at chromosome 8p12 showed consistent association in both the GWA and replication phases (ORcombined = 1.31-1.39; p(combined) = 2.71x10(-5)-5.19x10(-4); PAR(combined) = 26-31%). We found a 2.3-kb expressed sequence tag (EST) in the region using in-silico data mining and verified the existence of the full-length EST experimentally. The expression level of the EST was significantly reduced in human HCC tumors in comparison to the corresponding non-tumorous liver tissues (P<0.001). Results from sequence analysis and in-vitro protein translation study suggest that the transcript might function as a long non-coding RNA. In summary, our study suggests that variations at chromosome 8p12 may promote HCC in patients with HBV. Further functional studies of this region may help understand HBV-associated hepatocarcinogenesis.	[Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Lee, Joyce Man-Fong; Cheung, Ka Wai; Yuen, Man Fung; Lai, Ching Lung; Poon, Ronnie Tung-Ping; Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Chan, Kelvin Yuen-Kwong; Wong, Chun-Ming; Lee, Joyce Man-Fong; Cheung, Ka Wai; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwan, Johnny Sheung-Him; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Yuen, Man Fung; Lai, Ching Lung] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie Tung-Ping] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, KYK (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	pcsham@hku.hk; iolng@hku.hk	WONG, Chun-Ming/A-6739-2009; Chan, Kelvin/HGA-3097-2022	WONG, Chun-Ming/0000-0002-2497-7858; Ng, Irene Oi-lin/0000-0001-7532-2029; Lai, Ching-Lung/0000-0002-5927-2436	Hong Kong Research Grants Council [HKU 1/06C, HKU 7/CRG/09]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The study was supported by Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09). I.O.L. Ng is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Arason A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2608; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chan KL, 2002, CANCER, V94, P3179, DOI 10.1002/cncr.10612; Chen CC, 2005, INT J EPIDEMIOL, V34, P1310, DOI 10.1093/ije/dyi191; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Kummee P, 2007, J VIRAL HEPATITIS, V14, P841, DOI 10.1111/j.1365-2893.2007.00880.x; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee TKW, 2011, HEPATOLOGY, V53, P160, DOI 10.1002/hep.24000; Migita K, 2005, J HEPATOL, V42, P505, DOI 10.1016/j.jhep.2004.11.026; Ng IOL, 2000, CANCER RES, V60, P6581; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Su WH, 2007, NUCLEIC ACIDS RES, V35, pD727, DOI 10.1093/nar/gkl845; Tseng CS, 2005, AM J GASTROENTEROL, V100, P1758, DOI 10.1111/j.1572-0241.2005.41857.x; Yu MW, 2000, GUT, V47, P703, DOI 10.1136/gut.47.5.703; Yu MW, 2002, HEPATOLOGY, V36, P156, DOI 10.1053/jhep.2002.33897; Yu SZ, 2002, JPN J CANCER RES, V93, P1287, DOI 10.1111/j.1349-7006.2002.tb01236.x; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	29	49	52	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28798	10.1371/journal.pone.0028798	http://dx.doi.org/10.1371/journal.pone.0028798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174901	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163600044
J	LaTuga, MS; Ellis, JC; Cotton, CM; Goldberg, RN; Wynn, JL; Jackson, RB; Seed, PC				LaTuga, Mariam Susan; Ellis, Joseph Christopher; Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Jackson, Robert B.; Seed, Patrick C.			Beyond Bacteria: A Study of the Enteric Microbial Consortium in Extremely Low Birth Weight Infants	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTENSIVE-CARE-UNIT; NECROTIZING ENTEROCOLITIS; PRETERM INFANTS; INVASIVE CANDIDIASIS; GENOME SEQUENCE; ORAL NYSTATIN; ONSET SEPSIS; COLONIZATION; PROBIOTICS	Extremely low birth weight (ELBW) infants have high morbidity and mortality, frequently due to invasive infections from bacteria, fungi, and viruses. The microbial communities present in the gastrointestinal tracts of preterm infants may serve as a reservoir for invasive organisms and remain poorly characterized. We used deep pyrosequencing to examine the gut-associated microbiome of 11 ELBW infants in the first postnatal month, with a first time determination of the eukaryote microbiota such as fungi and nematodes, including bacteria and viruses that have not been previously described. Among the fungi observed, Candida sp. and Clavispora sp. dominated the sequences, but a range of environmental molds were also observed. Surprisingly, seventy-one percent of the infant fecal samples tested contained ribosomal sequences corresponding to the parasitic organism Trichinella. Ribosomal DNA sequences for the roundworm symbiont Xenorhabdus accompanied these sequences in the infant with the greatest proportion of Trichinella sequences. When examining ribosomal DNA sequences in aggregate, Enterobacteriales, Pseudomonas, Staphylococcus, and Enterococcus were the most abundant bacterial taxa in a low diversity bacterial community (mean Shannon-Weaver Index of 1.02 +/- 0.69), with relatively little change within individual infants through time. To supplement the ribosomal sequence data, shotgun sequencing was performed on DNA from multiple displacement amplification (MDA) of total fecal genomic DNA from two infants. In addition to the organisms mentioned previously, the metagenome also revealed sequences for gram positive and gram negative bacteriophages, as well as human adenovirus C. Together, these data reveal surprising eukaryotic and viral microbial diversity in ELBW enteric microbiota dominated bytypes of bacteria known to cause invasive disease in these infants.	[LaTuga, Mariam Susan] Albert Einstein Coll Med, Dept Pediat, New York, NY USA; [Ellis, Joseph Christopher; Jackson, Robert B.] Duke Univ, Dept Biol, Durham, NC USA; [Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Seed, Patrick C.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Jackson, Robert B.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jackson, Robert B.] Duke Univ, Ctr Global Change, Durham, NC USA; [Seed, Patrick C.] Duke Univ, Ctr Microbial Pathogenesis, Durham, NC USA; [Cotton, Charles Michael; Goldberg, Ronald N.; Wynn, James L.; Seed, Patrick C.] Duke Univ, Jean & George Brumley Jr Neonatal Perinatal Res I, Durham, NC USA	Yeshiva University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	LaTuga, MS (corresponding author), Albert Einstein Coll Med, Dept Pediat, New York, NY USA.	patrick.seed@duke.edu	Ellis, Joseph/G-6335-2011	LaTuga, Mariam/0000-0001-8330-3477; Jackson, Robert/0000-0001-8846-7147; Wynn, James/0000-0001-7052-4836	Duke Institute for Genome Sciences and Policy; Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine; Jean and George Brumley, Jr Neonatal-Perinatal Research Network; Center on Global Change at Duke University; Gerber Foundation; Hartwell Foundation	Duke Institute for Genome Sciences and Policy; Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine; Jean and George Brumley, Jr Neonatal-Perinatal Research Network; Center on Global Change at Duke University; Gerber Foundation; Hartwell Foundation	This research was supported by a pilot grant from the Duke Institute for Genome Sciences and Policy, the Duke Department of Pediatrics Division of Perinatal-Neonatal Medicine, the Jean and George Brumley, Jr Neonatal-Perinatal Research Network, and by the Center on Global Change at Duke University. MSL received support from the Gerber Foundation. PCS received support from the Hartwell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Aydemir C, 2010, ARCH DIS CHILD FETAL; Ben XM, 2004, CHINESE MED J-PEKING, V117, P927; Benjamin DK, 2006, PEDIATRICS, V117, P84, DOI 10.1542/peds.2004-2292; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Braga TD, 2011, AM J CLIN NUTR, V93, P81, DOI 10.3945/ajcn.2010.29799; Caplan MS, 2009, J PERINATOL, V29, pS2, DOI 10.1038/jp.2009.21; Cerikcioglu N, 2004, TURKISH J PEDIATR, V46, P245; Chanchalchaovivat A, 2007, BIOL CONTROL, V42, P326, DOI 10.1016/j.biocontrol.2007.05.016; CHAO A, 1984, SCAND J STAT, V11, P265; Chavan P, 2009, FOOD MICROBIOL, V26, P801, DOI 10.1016/j.fm.2009.05.005; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Coates EW, 2005, PEDIATRICS, V116, pE241, DOI 10.1542/peds.2004-2537; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cotten CM, 2006, PEDIATRICS, V118, P717, DOI 10.1542/peds.2005-2677; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; DAMJANOVIC V, 1993, J HOSP INFECT, V24, P245, DOI 10.1016/0195-6701(93)90057-7; Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; Disz T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-319; Duarte W, 2009, J IND MICROBIOL BIOT, V36, P557, DOI 10.1007/s10295-009-0526-y; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Embleton NE, 2001, PEDIATRICS, V107, P270, DOI 10.1542/peds.107.2.270; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Fridkin SK, 2006, PEDIATRICS, V117, P1680, DOI 10.1542/peds.2005-1996; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Guillet R, 2006, PEDIATRICS, V117, pE137, DOI 10.1542/peds.2005-1543; Guthmann F, 2010, KLIN PADIATR, V222, P284, DOI 10.1055/s-0030-1254113; Huys G, 2008, CURR MICROBIOL, V56, P553, DOI 10.1007/s00284-008-9122-z; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kunin V, 2010, OPEN J, V1, P1; Li SS, 2010, INT J FOOD MICROBIOL, V138, P85, DOI 10.1016/j.ijfoodmicro.2010.01.009; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Liu J, 2001, J INVERTEBR PATHOL, V77, P87, DOI 10.1006/jipa.2001.5007; Lutgendorff F, 2008, CURR MOL MED, V8, P282, DOI 10.2174/156652408784533779; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Millar MR, 1996, J CLIN MICROBIOL, V34, P2506, DOI 10.1128/JCM.34.10.2506-2510.1996; Morowitz MJ, 2011, P NATL ACAD SCI USA, V108, P1128, DOI 10.1073/pnas.1010992108; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Nechvatal JM, 2008, J MICROBIOL METH, V72, P124, DOI 10.1016/j.mimet.2007.11.007; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; ORMALA T, 1992, SCAND J INFECT DIS, V24, P781, DOI 10.3109/00365549209062464; Ozturk MA, 2006, MYCOSES, V49, P484, DOI 10.1111/j.1439-0507.2006.01274.x; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Parra-Herran CE, 2010, FETAL PEDIATR PATHOL, V29, P172, DOI 10.3109/15513811003777342; Ramet M, 2011, PEDIATR PULM, V46, P101, DOI 10.1002/ppul.21348; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; SIMS ME, 1988, AM J PERINAT, V5, P33, DOI 10.1055/s-2007-999649; Smith A, 2010, PEDIATR INFECT DIS J, V29, P831, DOI 10.1097/INF.0b013e3181e7884f; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657; [US Department of Health and Human Services HRaSA Maternal and Child Health Bureau Services UDoHaH], 2010, CHILD HLTH US 2010; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Westerlund E, 2011, BLOOD COAGUL FIBRIN, V22, P127, DOI 10.1097/MBC.0b013e32834363ea; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221	64	87	91	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27858	10.1371/journal.pone.0027858	http://dx.doi.org/10.1371/journal.pone.0027858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174751	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600007
J	Montane, F; Casals, P; Dale, MRT				Montane, Francesc; Casals, Pere; Dale, Mark R. T.			How Spatial Heterogeneity of Cover Affects Patterns of Shrub Encroachment into Mesic Grasslands	PLOS ONE			English	Article							JUNIPERUS-VIRGINIANA; PLANT ESTABLISHMENT; DISTRIBUTION MODELS; SAFE SITES; FACILITATION; CONSEQUENCES; VEGETATION; REGENERATION; COMMUNITIES; MECHANISMS	We used a multi-method approach to analyze the spatial patterns of shrubs and cover types (plant species, litter or bare soil) in grassland-shrubland ecotones. This approach allows us to assess how fine-scale spatial heterogeneity of cover types affects the patterns of Cytisus balansae shrub encroachment into mesic mountain grasslands (Catalan Pyrenees, Spain). Spatial patterns and the spatial associations between juvenile shrubs and different cover types were assessed in mesic grasslands dominated by species with different palatabilities (palatable grass Festuca nigrescens and unpalatable grass Festuca eskia). A new index, called RISES ("Relative Index of Shrub Encroachment Susceptibility"), was proposed to calculate the chances of shrub encroachment into a given grassland, combining the magnitude of the spatial associations and the surface area for each cover type. Overall, juveniles showed positive associations with palatable F. nigrescens and negative associations with unpalatable F. eskia, although these associations shifted with shrub development stage. In F. eskia grasslands, bare soil showed a low scale of pattern and positive associations with juveniles. Although the highest RISES values were found in F. nigrescens plots, the number of juvenile Cytisus was similar in both types of grasslands. However, F. nigrescens grasslands showed the greatest number of juveniles in early development stage (i.e. height<10 cm) whereas F. eskia grasslands showed the greatest number of juveniles in late development stages (i.e. height>30 cm). We concluded that in F. eskia grasslands, where establishment may be constrained by the dominant cover type, the low scale of pattern on bare soil may result in higher chances of shrub establishment and survival. In contrast, although grasslands dominated by the palatable F. nigrescens may be more susceptible to shrub establishment; current grazing rates may reduce juvenile survival.	[Montane, Francesc; Casals, Pere] Forest Sci Ctr Catalonia CTFC, Solsona, Spain; [Dale, Mark R. T.] Univ No British Columbia, Prince George, BC V2L 5P2, Canada	Centre Tecnologic Forestal de Catalunya (CTFC); University of Northern British Columbia	Montane, F (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	francesc.montane@gmail.com	Montane, Francesc/B-7780-2008; Casals, Pere/M-2418-2014	Montane, Francesc/0000-0001-8126-8612; Casals, Pere/0000-0002-0372-988X	Academic Mission at the University of Northern British Columbia [2008 BE-1 00493]; DURSI-Generalitat de Catalunya [2005FI 00801]; European Social Fund; Spanish Ministerio de Educacion y Ciencia (VULCA) [CGL2005-08133-CO3]; Ministerio de Medio Ambiente y Medio Rural y Marino [69/2005]; Ministerio de Ciencia e Innovacion, Spain	Academic Mission at the University of Northern British Columbia; DURSI-Generalitat de Catalunya(Generalitat de Catalunya); European Social Fund(European Social Fund (ESF)); Spanish Ministerio de Educacion y Ciencia (VULCA)(Spanish Government); Ministerio de Medio Ambiente y Medio Rural y Marino(Spanish Government); Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by a grant for an Academic Mission at the University of Northern British Columbia (2008 BE-1 00493) awarded to FM, a PhD fellowship (2005FI 00801) awarded by DURSI-Generalitat de Catalunya, and by the European Social Fund. Additional support was receive from the Spanish Ministerio de Educacion y Ciencia (VULCA, CGL2005-08133-CO3) and Ministerio de Medio Ambiente y Medio Rural y Marino (Parques Nacionales 69/2005). PC was supported by a Ramon y Cajal contract (Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS R, 1991, OECOLOGIA, V87, P551, DOI 10.1007/BF00320419; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Baraza E, 2006, OIKOS, V113, P148, DOI 10.1111/j.0030-1299.2006.14265.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Browning DM, 2011, ECOLOGICAL APPL, DOI [10.1890/10-0542.1, DOI 10.1890/10-0542.1]; Burke IC, 1998, BIOGEOCHEMISTRY, V42, P121, DOI 10.1023/A:1005987807596; Callaway R. M., 2007, POSITIVE INTERACTION; Castro J, 2004, J ECOL, V92, P266, DOI 10.1111/j.0022-0477.2004.00870.x; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Daget P, 1972, ANN ARGON, V22, P5; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; DEBUSSCHE M, 1980, VEGETATIO, V43, P73; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hovstad KA, 2008, PLANT ECOL, V196, P251, DOI 10.1007/s11258-007-9349-y; Jurena PN, 2003, ECOLOGY, V84, P907, DOI 10.1890/0012-9658(2003)084[0907:WPEASH]2.0.CO;2; LAVOREL S, 1994, OIKOS, V71, P75, DOI 10.2307/3546174; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liu F, 2011, GLOBAL CHANGE BIOL, V17, P1119, DOI 10.1111/j.1365-2486.2010.02251.x; Maestre FT, 2001, ECOL APPL, V11, P1641, DOI 10.1890/1051-0761(2001)011[1641:PFUFBG]2.0.CO;2; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McKinley DC, 2008, ECOSYSTEMS, V11, P454, DOI 10.1007/s10021-008-9133-4; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Montane F, 2010, PLANT ECOL, V211, P267, DOI 10.1007/s11258-010-9788-8; Montane F, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2009050; Nelson TA, 2008, ECOGRAPHY, V31, P556, DOI 10.1111/j.0906-7590.2008.05548.x; Olff H, 1999, PLANT BIOLOGY, V1, P127, DOI 10.1111/j.1438-8677.1999.tb00236.x; Palmer SCF, 2003, ECOLOGY, V84, P2877, DOI 10.1890/02-0245; Pasche F, 2004, BIOL CONSERV, V118, P101, DOI 10.1016/j.biocon.2003.07.012; Pornon A, 2007, AM J BOT, V94, P1778, DOI 10.3732/ajb.94.11.1778; Purves DW, 2002, J ECOL, V90, P121, DOI 10.1046/j.0022-0477.2001.00652.x; Rosenberg MS, 2009, PASSAGE PATTERN ANAL; Roura-Pascual N, 2005, MT RES DEV, V25, P252, DOI 10.1659/0276-4741(2005)025[0252:TOARLI]2.0.CO;2; RUSCH G, 1995, J VEG SCI, V6, P417, DOI 10.2307/3236241; SKARPE C, 1991, J VEG SCI, V2, P565, DOI 10.2307/3236039; Smit C, 2006, J APPL ECOL, V43, P305, DOI 10.1111/j.1365-2664.2006.01147.x; Smit C, 2005, J VEG SCI, V16, P209, DOI 10.1111/j.1654-1103.2005.tb02357.x; Soliveres S, 2010, PERSPECT PLANT ECOL, V12, P227, DOI 10.1016/j.ppees.2010.02.003; TURKINGTON R, 1979, J ECOL, V67, P201, DOI 10.2307/2259345; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; Van Uytvanck J, 2008, BIOL CONSERV, V141, P78, DOI 10.1016/j.biocon.2007.09.001; WATT AS, 1947, J ECOL, V35, P1, DOI 10.2307/2256497; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x	50	6	6	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28652	10.1371/journal.pone.0028652	http://dx.doi.org/10.1371/journal.pone.0028652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174858	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600037
J	Gallagher, AM; Smeeth, L; Seabroke, S; Leufkens, HGM; van Staa, TP				Gallagher, Arlene M.; Smeeth, Liam; Seabroke, Suzie; Leufkens, Hubert G. M.; van Staa, Tjeerd P.			Risk of Death and Cardiovascular Outcomes with Thiazolidinediones: A Study with the General Practice Research Database and Secondary Care Data	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; ACUTE MYOCARDIAL-INFARCTION; RETROSPECTIVE COHORT; OLDER PATIENTS; ROSIGLITAZONE; PIOGLITAZONE; EVENTS; ASSOCIATION	Objective: To describe the likely extent of confounding in evaluating the risks of cardiovascular (CV) events and mortality in patients using diabetes medication. Methods: The General Practice Research Database was used to identify inception cohorts of insulin and different oral antidiabetics. An analysis of bias and incidence of mortality, acute coronary syndrome, stroke and heart failure were analysed in GPRD, Hospital Episode Statistics and death certificates. Results: 206,940 patients were identified. The bias analysis showed that past thiazolidinedione users had a lower mortality risk compared to past metformin users. There were no differences between past users of rosiglitazone and pioglitazone (adjusted RR of 1.04; 95% CI 0.93-1.18). Current rosiglitazone users had an increased risk of death (adjusted RR 1.20; 95% CI 1.08-1.34) and of hospitalisation for heart failure (adjusted RR of 1.73; 95% CI 1.19-2.51) compared to current pioglitazone users. Risk of mortality was increased two-fold shortly after starting rosiglitazone. Excess risk of death over 3 years with rosiglitazone was 0.3 per 100 in those aged 50-64 years, 2.0 aged 65-74, 3.0 aged 75-84, and 7.0 aged 85+. The cause of death with rosiglitazone was more likely to be due to a disease of the circulatory system. Conclusions: Higher risks for death (overall and due to cardiovascular disease) and heart failure were found for rosiglitazone compared to pioglitazone. These excess risks were largest in patients aged 65 years or older. The European regulatory decision to suspend rosiglitazone is supported by this study.	[Gallagher, Arlene M.; van Staa, Tjeerd P.] Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England; [Gallagher, Arlene M.; Leufkens, Hubert G. M.; van Staa, Tjeerd P.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands; [Smeeth, Liam] London Sch Hyg & Trop Med, London WC1, England; [Seabroke, Suzie] Med & Healthcare Prod Regulatory Agcy, Div Vigilance & Risk Management Med, London, England	The Medicines & Healthcare Products Regulatory Agency; Utrecht University; University of London; London School of Hygiene & Tropical Medicine; The Medicines & Healthcare Products Regulatory Agency	Gallagher, AM (corresponding author), Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England.	Tjeerd.vanstaa@GPRD.com	Swaibu, Ramadhani A/H-3164-2011; Smeeth, Liam/X-5862-2018	van Staa, Tjeerd/0000-0001-9363-742X; Smeeth, Liam/0000-0002-9168-6022	Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK; MHRA; Wellcome Trust; Medical Research Council; NIHR; Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board; Dutch Ministry of Health; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK; MHRA; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU(European Commission); GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board; Dutch Ministry of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Division of Vigilance and Risk Management of the Medicines and Healthcare products Regulatory Agency (MHRA), UK. GPRD is owned by the Secretary of State of the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency (MHRA). The General Practice Research Database (GPRD) is owned by the UK Department of Health and operates within the Medicines and Healthcare products Regulatory Agency (MHRA). GPRD has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies. The department of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private-public funded Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azoulay L, 2010, PHARMACOEPIDEM DR S, V19, P343, DOI 10.1002/pds.1883; Bilik D, 2010, PHARMACOEPIDEM DR S, V19, P715, DOI 10.1002/pds.1954; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; de Vries F, 2006, INT J EPIDEMIOL, V35, P1301, DOI 10.1093/ije/dyl147; Dore DD, 2009, PHARMACOTHERAPY, V29, P775, DOI 10.1592/phco.29.7.775; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006080; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Habib ZA, 2009, PHARMACOEPIDEM DR S, V18, P437, DOI 10.1002/pds.1722; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Hsiao FY, 2009, DRUG SAFETY, V32, P675, DOI 10.2165/00002018-200932080-00006; Johannes CB, 2007, PHARMACOEPIDEM DR S, V16, P504, DOI 10.1002/pds.1356; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Karter AJ, 2005, DIABETIC MED, V22, P986, DOI 10.1111/j.1464-5491.2005.01704.x; Koro CE, 2008, PHARMACOEPIDEM DR S, V17, P989, DOI 10.1002/pds.1640; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Lash TL, APPL QUANTITATIVE BI; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Loke YK, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1309; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Masoudi FA, 2005, CIRCULATION, V111, P583, DOI 10.1161/01.CIR.0000154542.13412.B1; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2010, ARCH INTERN MED 0628; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Rajagopalan R, 2004, CLIN THER, V26, P1400, DOI 10.1016/j.clinthera.2004.09.016; RAMLAUHANSEN H, 1983, ANN STAT, V11, P453, DOI 10.1214/aos/1176346152; Shaya Fadia T, 2009, P T, V34, P490; Stockl KM, 2009, PHARMACOEPIDEM DR S, V18, P166, DOI 10.1002/pds.1700; Tzoulaki I, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4731; van Staa TP, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000194; Vanasse A, 2009, DIABETES VASC DIS RE, V6, P87, DOI 10.1177/1479164109336047; Walker AM, 2008, PHARMACOEPIDEM DR S, V17, P760, DOI 10.1002/pds.1598; Wertz DA, 2010, CIRC-CARDIOVASC QUAL, V3, P538, DOI 10.1161/CIRCOUTCOMES.109.911461; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Ziyadeh N, 2009, CLIN THER, V31, P2665, DOI 10.1016/j.clinthera.2009.11.003	39	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28157	10.1371/journal.pone.0028157	http://dx.doi.org/10.1371/journal.pone.0028157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164237	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000298171400038
J	Ghimenti, S; Lomonaco, T; Onor, M; Murgia, L; Paolicchi, A; Fuoco, R; Ruocco, L; Pellegrini, G; Trivella, MG; Di Francesco, F				Ghimenti, Silvia; Lomonaco, Tommaso; Onor, Massimo; Murgia, Laura; Paolicchi, Aldo; Fuoco, Roger; Ruocco, Lucia; Pellegrini, Giovanni; Trivella, Maria Giovanna; Di Francesco, Fabio			Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy	PLOS ONE			English	Article							INTERNATIONAL NORMALIZED RATIO; LIQUID-CHROMATOGRAPHY; BLEEDING COMPLICATIONS; DOSE REQUIREMENT; SELF-MANAGEMENT; VITAMIN-K; SALIVA; CYP2C9; DRUG; PHARMACOKINETICS	Background: Patients on warfarin therapy undergo invasive and expensive checks for the coagulability of their blood. No information on coagulation levels is currently available between two controls. Methodology: A method was developed to determine warfarin in oral fluid by HPLC and fluorimetric detection. The chromatographic separation was performed at room temperature on a C-18 reversed-phase column, 65% PBS and 35% methanol mobile phase, flow rate 0.7 mL/min, injection volume 25 mu L, excitation wavelength 310 nm, emission wavelength 400 nm. Findings: The method was free from interference and matrix effect, linear in the range 0.2-100 ng/mL, with a detection limit of 0.2 ng/mL. Its coefficient of variation was,3% for intra-day measurements and,5% for inter-day measurements. The average concentration of warfarin in the oral fluid of 50 patients was 2.5 +/- 1.6 ng/mL (range 0.8-7.6 ng/mL). Dosage was not correlated to INR (r = 20.03, p = 0.85) but positively correlated to warfarin concentration in the oral fluid (r = 0.39, p = 0.006). The correlation between warfarin concentration and pH in the oral fluid (r = 0.37, p = 0.009) confirmed the importance of pH in regulating the drug transfer from blood. A correlation between warfarin concentration in the oral fluid and INR was only found in samples with pH values >= 7.2 (r = 0.84, p = 0.004). Conclusions: Warfarin diffuses from blood to oral fluid. The method allows to measure its concentration in this matrix and to analyze correlations with INR and other parameters.	[Ghimenti, Silvia; Lomonaco, Tommaso; Murgia, Laura; Fuoco, Roger; Di Francesco, Fabio] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy; [Onor, Massimo] CNR, Ist Chim Composti Organometall, I-56100 Pisa, Italy; [Paolicchi, Aldo] Univ Pisa, Dipartimento Patol Sperimentale BMIE, Sez Patol Gen & Clin, Pisa, Italy; [Ruocco, Lucia; Pellegrini, Giovanni] Azienda Osped Univ Pisana, Lab Anal Chim Clin, Pisa, Italy; [Trivella, Maria Giovanna] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); University of Pisa; University of Pisa; Azienda Ospedaliero Universitaria Pisana; Consiglio Nazionale delle Ricerche (CNR)	Ghimenti, S (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	fdifra@dcci.unipi.it	Pellegrini, Giovanni/ABF-4802-2020; Onor, Massimo/A-4382-2012; Paolicchi, Aldo/K-3946-2018; Lomonaco, Tommaso/K-8276-2016; Di Francesco, Fabio/I-8756-2012	Pellegrini, Giovanni/0000-0003-3131-1605; Onor, Massimo/0000-0003-3023-1072; Paolicchi, Aldo/0000-0002-9940-8481; Lomonaco, Tommaso/0000-0002-1822-7399; Di Francesco, Fabio/0000-0002-9285-1595; RUOCCO, LUCIA/0000-0002-2637-2705; Trivella, Maria Giovanna/0000-0001-8702-2859	University of Pisa	University of Pisa	This research was supported by the University of Pisa funds for basic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; ANDERSON DR, 1993, ARCH INTERN MED, V153, P1441, DOI 10.1001/archinte.153.12.1441; [Anonymous], PHARM TIMES; Booth SL, 1999, NUTR REV, V57, P288; Corran P, 1999, WHO TECH REP SER, V889, P1; DANHOF M, 1978, CLIN PHARMACOKINET, V3, P39, DOI 10.2165/00003088-197803010-00003; Furuya H, 1995, PHARMACOGENETICS, V5, P389, DOI 10.1097/00008571-199512000-00008; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; HAECKEL R, 1990, J INT FED CLIN CHEM, V2, P208; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Hirsh J, 2003, J AM COLL CARDIOL, V41, P1633, DOI 10.1016/S0735-1097(03)00416-9; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Huang CR, 2008, CLIN CHIM ACTA, V393, P85, DOI 10.1016/j.cca.2008.03.008; IUPAC, 1978, SPECTROCHIM ACTA B, V33, P241; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Katzung B.G, 2012, BASIC CLIN PHARMACOL; Kidwell DA, 1998, J CHROMATOGR B, V713, P111, DOI 10.1016/S0378-4347(97)00572-0; Lombardi R, 2003, THROMB RES, V111, P281, DOI 10.1016/j.thromres.2003.09.006; MATIN SB, 1974, CLIN PHARMACOL THER, V16, P1052; MUCKLOW JC, 1978, CLIN PHARMACOL THER, V24, P563; Paxton J W, 1979, Methods Find Exp Clin Pharmacol, V1, P11; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; SELLERS EM, 1970, CLIN PHARMACOL THER, V11, P524; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; SORANO GG, 1993, HAEMOSTASIS, V23, P77; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009; WHITE RH, 1989, ANN INTERN MED, V111, P730, DOI 10.7326/0003-4819-111-9-730; WONG YWJ, 1989, J CHROMATOGR, V469, P281, DOI 10.1016/S0021-9673(01)96463-5; YACOBI A, 1977, J PHARMACOKINET BIOP, V5, P123, DOI 10.1007/BF01066216	32	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28182	10.1371/journal.pone.0028182	http://dx.doi.org/10.1371/journal.pone.0028182			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164240	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400041
J	Jafari, N; Broer, L; van Duijn, CM; Janssens, ACJW; Hintzen, RQ				Jafari, Naghmeh; Broer, Linda; van Duijn, Cornelia M.; Janssens, A. Cecile J. W.; Hintzen, Rogier Q.			Perspectives on the Use of Multiple Sclerosis Risk Genes for Prediction	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASES; REPLICATION; POPULATION; GENETICS; ALLELES; VARIANT	Objective: A recent collaborative genome-wide association study replicated a large number of susceptibility loci and identified novel loci. This increase in known multiple sclerosis (MS) risk genes raises questions about clinical applicability of genotyping. In an empirical set we assessed the predictive power of typing multiple genes. Next, in a modelling study we explored current and potential predictive performance of genetic MS risk models. Materials and Methods: Genotype data on 6 MS risk genes in 591 MS patients and 600 controls were used to investigate the predictive value of combining risk alleles. Next, the replicated and novel MS risk loci from the recent and largest international genome-wide association study were used to construct genetic risk models simulating a population of 100,000 individuals. Finally, we assessed the required numbers, frequencies, and ORs of risk SNPs for higher discriminative accuracy in the future. Results: Individuals with 10 to 12 risk alleles had a significantly increased risk compared to individuals with the average population risk for developing MS (OR 2.76 (95% CI 2.02-3.77)). In the simulation study we showed that the area under the receiver operating characteristic curve (AUC) for a risk score based on the 6 SNPs was 0.64. The AUC increases to 0.66 using the well replicated 24 SNPs and to 0.69 when including all replicated and novel SNPs (n = 53) in the risk model. An additional 20 SNPs with allele frequency 0.30 and ORs 1.1 would be needed to increase the AUC to a slightly higher level of 0.70, and at least 50 novel variants with allele frequency 0.30 and ORs 1.4 would be needed to obtain an AUC of 0.85. Conclusion: Although new MS risk SNPs emerge rapidly, the discriminatory ability in a clinical setting will be limited.	[Jafari, Naghmeh; Hintzen, Rogier Q.] Erasmus MC, ErasMS Ctr, Dept Neurol, Rotterdam, Netherlands; [Broer, Linda; van Duijn, Cornelia M.; Janssens, A. Cecile J. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jafari, N (corresponding author), Erasmus MC, ErasMS Ctr, Dept Neurol, Rotterdam, Netherlands.	r.hintzen@erasmusmc.nl		Janssens, A Cecile/0000-0002-6153-4976; Broer, Linda/0000-0003-0011-123X; Van Duijn, Cornelia/0000-0002-2374-9204	Dutch MS Research Foundation, The Netherlands	Dutch MS Research Foundation, The Netherlands(Netherlands Government)	The ErasMS Center Rotterdam is financially supported by the Dutch MS Research Foundation, The Netherlands. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Aulchenko YS, 2008, NAT GENET, V40, P1402, DOI 10.1038/ng.251; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; D'Netto MJ, 2009, NEUROLOGY, V72, P1984, DOI 10.1212/WNL.0b013e3181a92c25; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Gourraud PA, 2011, ANN NEUROL, V69, P65, DOI 10.1002/ana.22323; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2009, J HUM GENET, V54, P676, DOI 10.1038/jhg.2009.96; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2006, GENET MED, V8, P395, DOI 10.1097/01.gim.0000229689.18263.f4; Kieseier BC, 2008, J NEUROL, V255, P15, DOI 10.1007/s00415-008-6004-z; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Oksenberg JR, 2008, NAT REV GENET, V9, P516, DOI 10.1038/nrg2395; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Pepe MS, 2010, CANCER EPIDEM BIOMAR, V19, P655, DOI 10.1158/1055-9965.EPI-09-0510; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ramagopalan SV, 2009, NEUROEPIDEMIOLOGY, V32, P257, DOI 10.1159/000201564; Sackett D.L., 1985, CLIN EPIDEMIOLOGY BA; SADOVNICK AD, 1988, AM J MED GENET, V29, P533, DOI 10.1002/ajmg.1320290310; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2010, ANN NEUROL, V67, P3, DOI 10.1002/ana.21911; Simon KC, 2010, NEUROLOGY, V74, P1365, DOI 10.1212/WNL.0b013e3181dad57e; Sundstrom P, 2008, MULT SCLER J, V14, P1120, DOI 10.1177/1352458508092353; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; van Zitteren M, 2011, CANCER EPIDEM BIOMAR, V20, P9, DOI 10.1158/1055-9965.EPI-10-0329; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zeggini E, 2011, NAT GENET, V43, P287, DOI 10.1038/ng0411-287	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e26493	10.1371/journal.pone.0026493	http://dx.doi.org/10.1371/journal.pone.0026493			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164203	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400003
J	Zhang, Y; Jiang, WK; Gao, LZ				Zhang, Yun; Jiang, Wen-kai; Gao, Li-zhi			Evolution of MicroRNA Genes in Oryza sativa and Arabidopsis thaliana: An Update of the Inverted Duplication Model	PLOS ONE			English	Article							SMALL RNAS; GENOME; MIRNA; DIVERSIFICATION; CANALIZATION; SUPPRESSION; EXPRESSION; SEQUENCES; PETUNIA; BIOLOGY	The origin and evolution of microRNA (miRNA) genes, which are of significance in tuning and buffering gene expressions in a number of critical cellular processes, have long attracted evolutionary biologists. However, genome-wide perspectives on their origins, potential mechanisms of their de novo generation and subsequent evolution remain largely unsolved in flowering plants. Here, genome-wide analyses of Oryza sativa and Arabidopsis thaliana revealed apparently divergent patterns of miRNA gene origins. A large proportion of miRNA genes in O. sativa were TE-related and MITE-related miRNAs in particular, whereas the fraction of these miRNA genes much decreased in A. thaliana. Our results show that the majority of TE-related and pseudogene-related miRNA genes have originated through inverted duplication instead of segmental or tandem duplication events. Based on the presented findings, we hypothesize and illustrate the four likely molecular mechanisms to de novo generate novel miRNA genes from TEs and pseudogenes. Our rice genome analysis demonstrates that non-MITEs and MITEs mediated inverted duplications have played different roles in de novo generating miRNA genes. It is confirmed that the previously proposed inverted duplication model may give explanations for non-MITEs mediated duplication events. However, many other miRNA genes, known from the earlier proposed model, were rather arisen from MITE transpositions into target genes to yield binding sites. We further investigated evolutionary processes spawned from de novo generated to maturely-formed miRNA genes and their regulatory systems. We found that miRNAs increase the tunability of some gene regulatory systems with low gene copy numbers. The results also suggest that gene balance effects may have largely contributed to the evolution of miRNA regulatory systems.	[Zhang, Yun; Jiang, Wen-kai; Gao, Li-zhi] Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Plant Germplasm & Genom Ctr, Kunming Inst Bot, Kunming, Peoples R China.	Lgao@mail.kib.ac.cn	Zhang, Yun/AAG-9646-2021		Chinese Academy of Sciences (CAS) [KSCX2-YW-N-029]; Talents Program of Yunnan Province [20080A009]; Chinese Department of Science and Technology [2007CB815703]; Kunming Institute of Botany, CAS	Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences); Talents Program of Yunnan Province; Chinese Department of Science and Technology; Kunming Institute of Botany, CAS(Chinese Academy of Sciences)	This work was supported by the Hundreds Talents Program of the Chinese Academy of Sciences (CAS), Talents Program of Yunnan Province (20080A009), a grant from the Chinese Academy of Science (KSCX2-YW-N-029), a grant from Chinese Department of Science and Technology (973 Program 2007CB815703) and a startup grant from Kunming Institute of Botany, CAS to Dr. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Bartel B, 2005, NAT STRUCT MOL BIOL, V12, P569, DOI 10.1038/nsmb0705-569; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Devor EJ, 2006, J HERED, V97, P186, DOI 10.1093/jhered/esj022; Dewannieux M, 2005, CYTOGENET GENOME RES, V110, P35, DOI 10.1159/000084936; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grosshans H, 2008, NATURE, V451, P414, DOI 10.1038/451414a; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Guo XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-454; Ha M, 2009, P NATL ACAD SCI USA, V106, P17835, DOI 10.1073/pnas.0907003106; Hennig W, 2004, CELL RES, V14, P1, DOI 10.1038/sj.cr.7290196; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jansen RK, 2007, P NATL ACAD SCI USA, V104, P19369, DOI 10.1073/pnas.0709121104; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Li JJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r132; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Mello CC, 2007, CELL DEATH DIFFER, V14, P2013, DOI 10.1038/sj.cdd.4402252; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, GENETICS, V176, P1323, DOI 10.1534/genetics.107.072553; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Sharp PA, 2009, CELL, V136, P577, DOI 10.1016/j.cell.2009.02.007; Smalheiser NR, 2006, TRENDS GENET, V22, P532, DOI 10.1016/j.tig.2006.08.007; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Takuno S, 2008, TRENDS GENET, V24, P56, DOI 10.1016/j.tig.2007.11.002; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Vazquez F, 2008, NUCLEIC ACIDS RES, V36, P6429, DOI 10.1093/nar/gkn670; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zeller G, 2008, GENOME RES, V18, P918, DOI 10.1101/gr.070169.107; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81	58	21	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e28073	10.1371/journal.pone.0028073	http://dx.doi.org/10.1371/journal.pone.0028073			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194805	gold, Green Submitted, Green Published			2022-12-27	WOS:000298369100020
J	Punyadarsaniya, D; Liang, CH; Winter, C; Petersen, H; Rautenschlein, S; Hennig-Pauka, I; Schwegmann-Wessels, C; Wu, CY; Wong, CH; Herrler, G				Punyadarsaniya, Darsaniya; Liang, Chi-Hui; Winter, Christine; Petersen, Henning; Rautenschlein, Silke; Hennig-Pauka, Isabel; Schwegmann-Wessels, Christel; Wu, Chung-Yi; Wong, Chi-Huey; Herrler, Georg			Infection of Differentiated Porcine Airway Epithelial Cells by Influenza Virus: Differential Susceptibility to Infection by Porcine and Avian Viruses	PLOS ONE			English	Article							CUT LUNG SLICES; A VIRUSES; PIGS; H9N2; SPECIFICITY; CULTURES; STRAINS; PCLS	Background: Swine are important hosts for influenza A viruses playing a crucial role in the epidemiology and interspecies transmission of these viruses. Respiratory epithelial cells are the primary target cells for influenza viruses. Methodology/Principal Findings: To analyze the infection of porcine airway epithelial cells by influenza viruses, we established precision-cut lung slices as a culture system for differentiated respiratory epithelial cells. Both ciliated and mucus-producing cells were found to be susceptible to infection by swine influenza A virus (H3N2 subtype) with high titers of infectious virus released into the supernatant already one day after infection. By comparison, growth of two avian influenza viruses (subtypes H9N2 and H7N7) was delayed by about 24 h. The two avian viruses differed both in the spectrum of susceptible cells and in the efficiency of replication. As the H9N2 virus grew to titers that were only tenfold lower than that of a porcine H3N2 virus this avian virus is an interesting candidate for interspecies transmission. Lectin staining indicated the presence of both alpha-2,3- and alpha-2,6-linked sialic acids on airway epithelial cells. However, their distribution did not correlate with pattern of virus infection indicating that staining by plant lectins is not a reliable indicator for the presence of cellular receptors for influenza viruses. Conclusions/Significance: Differentiated respiratory epithelial cells significantly differ in their susceptibility to infection by avian influenza viruses. We expect that the newly described precision-cut lung slices from the swine lung are an interesting culture system to analyze the infection of differentiated respiratory epithelial cells by different pathogens (viral, bacterial and parasitic ones) of swine.	[Punyadarsaniya, Darsaniya; Winter, Christine; Schwegmann-Wessels, Christel; Herrler, Georg] Univ Vet Med, Inst Virol, Hannover, Germany; [Winter, Christine; Petersen, Henning; Rautenschlein, Silke] Univ Vet Med, Clin Poultry, Hannover, Germany; [Hennig-Pauka, Isabel] Univ Vet Med, Clin Swine & Small Ruminants, Hannover, Germany; [Liang, Chi-Hui; Wu, Chung-Yi; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; Academia Sinica - Taiwan	Punyadarsaniya, D (corresponding author), Univ Vet Med, Inst Virol, Hannover, Germany.	Georg.Herrler@tiho-hannover.de	Wu, Chung-Yi/K-8334-2018		Mahanakorn University of Technology Bangkok, Thailand; German FluResearchNet, a nationwide research network on zoonotic influenza; Ministry of Education and Research	Mahanakorn University of Technology Bangkok, Thailand; German FluResearchNet, a nationwide research network on zoonotic influenza; Ministry of Education and Research	D.P. was a recipient of a fellowship from Mahanakorn University of Technology Bangkok, Thailand. This work was supported by a fund to C.S.-W., G.H., and S. R. from the German FluResearchNet, a nationwide research network on zoonotic influenza sponsored by the Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Rahman S, 2010, J VIROL, V84, P8949, DOI 10.1128/JVI.00463-10; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Blazejewska P, 2011, VIROLOGY, V412, P36, DOI 10.1016/j.virol.2010.12.047; De Vleeschauwer A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006662; Ebsen M, 2002, PATHOL RES PRACT, V198, P747, DOI 10.1078/0344-0338-00331; Goris K, 2009, J VIROL, V83, P1962, DOI 10.1128/JVI.01271-08; Guan Y, 1996, J VIROL, V70, P8041, DOI 10.1128/JVI.70.11.8041-8046.1996; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Liao HY, 2010, J AM CHEM SOC, V132, P14849, DOI 10.1021/ja104657b; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Martin C, 2001, AM J RESP CELL MOL, V24, P139, DOI 10.1165/ajrcmb.24.2.3545; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Nelli RK, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-4; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; SCHMIDT RC, 1974, J INFECT DIS, V129, P28, DOI 10.1093/infdis/129.1.28; SCHOLTISSEK C, 1985, VIROLOGY, V147, P287, DOI 10.1016/0042-6822(85)90131-X; Sriwilaijaroen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016302; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Van Poucke SGM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-38	25	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28429	10.1371/journal.pone.0028429	http://dx.doi.org/10.1371/journal.pone.0028429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174804	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700034
J	Yasar, S; Ko, JY; Nothelle, S; Mielke, MM; Carlson, MC				Yasar, Sevil; Ko, Jean Y.; Nothelle, Stephanie; Mielke, Michelle M.; Carlson, Michelle C.			Evaluation of the Effect of Systolic Blood Pressure and Pulse Pressure on Cognitive Function: The Women's Health and Aging Study II	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; MINI-MENTAL-STATE; HYPERTENSION; DECLINE; ASSOCIATION; OLDER; AGE; DEMENTIA; DISEASE; PREVALENCE	Background: Evidence suggests that elevated systolic blood pressure (SBP) and pulse pressure (PP) in midlife is associated with increased risk for cognitive impairment later in life. There is mixed evidence regarding the effects of late life elevated SBP or PP on cognitive function, and limited information on the role of female gender. Methods/Principal Findings: Effects of SBPand PPon cognitive abilities at baseline and over a 9-year period were evaluated in 337 non-demented community-dwelling female participants over age 70 in the Women's Health and Aging Study II using logistic and Cox proportional hazards regression analyses. Participants aged 76-80 years with SBP >= 160 mmHg or PP >= 84 mmHg showed increased incidence of impairment on Trail Making Test-Part B (TMT, Part B), a measure of executive function, over time when compared to the control group that included participants with normal and pre-hypertensive SBP (<120 and 120-139 mmHg) or participants with low PP (<68 mmHg) (HR = 5.05 [95%CI = 1.42, 18.04], [HR = 5.12 [95%CI = 1.11; 23.62], respectively). Participants aged 70-75 years with PP >= 71 mmHg had at least a two-fold higher incidence of impairment on HVLT-I, a measure of verbal learning, over time when compared to participants with low PP (< 68 mmHg) (HR = 2.44 [95%CI = 1.11, 5.39]). Conclusions/Significance: Our data suggest that elevated SBP or PP in older non-demented women increases risk for late-life cognitive impairment and that PP could be used when assessing the risk for impairment in cognitive abilities. These results warrant further, larger studies to evaluate possible effects of elevated blood pressure in normal cognitive aging.	[Yasar, Sevil] Johns Hopkins Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD USA; [Yasar, Sevil; Mielke, Michelle M.; Carlson, Michelle C.] Johns Hopkins Sch Med, Ctr Aging & Hlth, Baltimore, MD USA; [Ko, Jean Y.; Carlson, Michelle C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Nothelle, Stephanie] Indiana Univ Sch Med, Indianapolis, IN USA; [Mielke, Michelle M.] Mayo Clin, Div Epidemiol, Rochester, MN USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Indiana University System; Indiana University Bloomington; Mayo Clinic	Yasar, S (corresponding author), Johns Hopkins Sch Med, Dept Med, Div Geriatr Med & Gerontol, Baltimore, MD USA.	syasar1@jhmi.edu		Yasar, Sevil/0000-0002-5080-6534; Mielke, Michelle/0000-0001-7177-1185	NIH from the National Institute on Aging, National Institutes of Health [RO1 AG19825-02, RO1 AG11703-10]; National Institute of Aging [NIA: 1F31AG030908-01-A1]; Medical Student Training in Aging Research (MSTAR); NATIONAL INSTITUTE ON AGING [F31AG030908, R01AG019825, R01AG011703] Funding Source: NIH RePORTER	NIH from the National Institute on Aging, National Institutes of Health; National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Student Training in Aging Research (MSTAR); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by NIH grants RO1 AG19825-02 and RO1 AG11703-10 from the National Institute on Aging, National Institutes of Health. Jean Y. Ko was supported by the National Institute of Aging (NIA: 1F31AG030908-01-A1) and Stephanie Nothelle was supported by the 2008 Medical Student Training in Aging Research (MSTAR) Program by The American Federation for Aging Research (AFAR) and the National Institute on Aging (NIA). The funders had no role in the study design, data collection, and analysis, decision to publish or preparation of the manuscript.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Birns J, 2009, J HUM HYPERTENS, V23, P86, DOI 10.1038/jhh.2008.80; Bohannon AD, 2002, J AM GERIATR SOC, V50, P424, DOI 10.1046/j.1532-5415.2002.50104.x; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; de Simone G, 2005, HYPERTENSION, V45, P575, DOI 10.1161/01.HYP.0000158268.95012.08; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; ELIAS MF, 1993, AM J EPIDEMIOL, V138, P353, DOI 10.1093/oxfordjournals.aje.a116868; Elias PK, 2004, HYPERTENSION, V44, P631, DOI 10.1161/01.HYP.0000145858.07252.99; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1999, J CLIN EPIDEMIOL, V52, P27, DOI 10.1016/S0895-4356(98)00124-3; Froehlich TE, 2001, J AM GERIATR SOC, V49, P477, DOI 10.1046/j.1532-5415.2001.49096.x; Glynn RJ, 1999, JAMA-J AM MED ASSOC, V281, P438, DOI 10.1001/jama.281.5.438; Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106; Hebert LE, 2004, NEUROLOGY, V62, P2021, DOI 10.1212/01.WNL.0000129258.93137.4B; Ivnik RJ, 1996, CLIN NEUROPSYCHOL, V10, P262, DOI 10.1080/13854049608406689; Kannel WB, 1998, AM HEART J, V136, P205, DOI 10.1053/hj.1998.v136.90226; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kilander L, 2000, AGE AGEING, V29, P243, DOI 10.1093/ageing/29.3.243; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Knopman D, 2001, NEUROLOGY, V56, P42, DOI 10.1212/WNL.56.1.42; Kuller LH, 2010, J CLIN HYPERTENS, V12, P203, DOI 10.1111/j.1751-7176.2009.00234.x; LAUNER LJ, 1995, JAMA-J AM MED ASSOC, V274, P1846, DOI 10.1001/jama.274.23.1846; Legato MJ, 1998, J WOMENS HEALTH, V7, P199, DOI 10.1089/jwh.1998.7.199; Martins D, 2001, J Gend Specif Med, V4, P10; Obisesan TO, 2008, J AM GERIATR SOC, V56, P501, DOI 10.1111/j.1532-5415.2007.01592.x; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Piguet O, 2003, NEUROEPIDEMIOLOGY, V22, P165, DOI 10.1159/000069886; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Qiu CX, 2003, STROKE, V34, P594, DOI 10.1161/01.STR.0000060127.96986.F4; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; SHARP ES, 2011, ALZHEIMER D IN PRESS; Swan GE, 1998, NEUROLOGY, V51, P986, DOI 10.1212/WNL.51.4.986; Tzourio C, 1999, NEUROLOGY, V53, P1948, DOI 10.1212/WNL.53.9.1948; Waldstein SR, 2008, HYPERTENSION, V51, P99, DOI 10.1161/HYPERTENSIONAHA.107.093674; Waldstein SR, 2005, HYPERTENSION, V45, P374, DOI 10.1161/01.HYP.0000156744.44218.74; WILKIE F, 1971, SCIENCE, V172, P959, DOI 10.1126/science.172.3986.959; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	42	12	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e27976	10.1371/journal.pone.0027976	http://dx.doi.org/10.1371/journal.pone.0027976			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174760	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700013
J	Ge, XM; Luo, D; Xu, JF				Ge, Xumeng; Luo, Dan; Xu, Jianfeng			Cell-Free Protein Expression under Macromolecular Crowding Conditions	PLOS ONE			English	Article							IN-VITRO; SYNTHESIS SYSTEM; BIOCHEMICAL REACTIONS; HIGHLY EFFICIENT; DNA-POLYMERASE; CONFINEMENT; ENVIRONMENT; STABILITY; INCREASES	Background: Cell-free protein expression (CFPE) comprised of in vitro transcription and translation is currently manipulated in relatively dilute solutions, in which the macromolecular crowding effects present in living cells are largely ignored. This may not only affect the efficiency of protein synthesis in vitro, but also limit our understanding of the functions and interactions of biomolecules involved in this fundamental biological process. Methodology/Principal Findings: Using cell-free synthesis of Renilla luciferase in wheat germ extract as a model system, we investigated the CFPE under macromolecular crowding environments emulated with three different crowding agents: PEG-8000, Ficoll-70 and Ficoll-400, which vary in chemical properties and molecular size. We found that transcription was substantially enhanced in the macromolecular crowding solutions; up to 4-fold increase in the mRNA production was detected in the presence of 20% (w/v) of Ficoll-70. In contrast, translation was generally inhibited by the addition of each of the three crowding agents. This might be due to PEG-induced protein precipitation and non-specific binding of translation factors to Ficoll molecules. We further explored a two-stage CFPE in which transcription and translation was carried out under high then low macromolecular crowding conditions, respectively. It produced 2.2-fold higher protein yield than the coupled CFPE control. The macromolecular crowding effects on CFPE were subsequently confirmed by cell-free synthesis of an approximately two-fold larger protein, Firefly luciferase, under macromolecular crowding environments. Conclusions/Significance: Three macromolecular crowding agents used in this research had opposite effects on transcription and translation. The results of this study should aid researchers in their choice of macromolecular crowding agents and shows that two-stage CFPE is more efficient than coupled CFPE.	[Ge, Xumeng; Xu, Jianfeng] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA; [Ge, Xumeng; Xu, Jianfeng] Arkansas State Univ, Coll Agr & Technol, Jonesboro, AR USA; [Luo, Dan] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Arkansas State University; Arkansas State University; Cornell University	Ge, XM (corresponding author), Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA.	jxu@astate.edu			Plant Powered Production (P3) Center; NSF RII Arkansas ASSET Initiative; Arkansas Biosciences Institute	Plant Powered Production (P3) Center; NSF RII Arkansas ASSET Initiative; Arkansas Biosciences Institute	This work was supported by the Plant Powered Production (P3) Center funds provided through an NSF RII Arkansas ASSET Initiative (AR EPSCoR) grant and the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke CK, 2006, PROTEIN EXPRES PURIF, V45, P381, DOI 10.1016/j.pep.2005.08.001; Ballantyne KN, 2006, ANAL BIOCHEM, V355, P298, DOI 10.1016/j.ab.2006.04.039; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Chattopadhaya S, 2006, NAT PROTOC, V1, P2386, DOI 10.1038/nprot.2006.338; Du F, 2006, J MOL BIOL, V364, P469, DOI 10.1016/j.jmb.2006.09.018; Elcock AH, 2010, CURR OPIN STRUC BIOL, V20, P196, DOI 10.1016/j.sbi.2010.01.008; Elcock AH, CURR OPIN STRUCT BIO, V20, P196; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Ellis RJ, 2003, NATURE, V425, P27, DOI 10.1038/425027a; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Fedorov AN, 1998, METHOD ENZYMOL, V290, P1, DOI 10.1016/S0076-6879(98)90003-9; Foley PL, 2010, BIOTECHNOL BIOENG, V105, P26, DOI 10.1002/bit.22575; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Harve KS, 2008, P NATL ACAD SCI USA, V105, pE119, DOI 10.1073/pnas.0810077106; He MY, 2008, NEW BIOTECHNOL, V25, P126, DOI 10.1016/j.nbt.2008.08.004; Iskakova MB, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl462; Jewett MC, 2004, BIOTECHNOL BIOENG, V86, P19, DOI 10.1002/bit.20026; Jewett MC, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.57; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Kern JA, 1997, BIOTECHNOL PROGR, V13, P747, DOI 10.1021/bp970094p; Khnouf R, 2010, ANAL CHEM, V82, P7021, DOI 10.1021/ac1015479; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; Kim JS, 2009, BIOPHYS J, V96, P1333, DOI 10.1016/j.bpj.2008.11.030; Kim KO, 2009, BIOTECHNOL BIOENG, V102, P303, DOI 10.1002/bit.22022; Kim TW, 2008, BIOTECHNOL BIOPROC E, V13, P464, DOI 10.1007/s12257-008-0139-8; Kinjo AR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051902; Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x; Kurotani A, 2010, FASEB J, V24, P1095, DOI 10.1096/fj.09-139527; Li GW, 2009, NAT PHYS, V5, P294, DOI 10.1038/NPHYS1222; Madin K, 2005, MOL CELL PROTEOMICS, V4, pS371; Madono M, 2011, NEW BIOTECHNOL, V28, P211, DOI 10.1016/j.nbt.2010.08.009; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Minton AP, 2006, J CELL SCI, V119, P2863, DOI 10.1242/jcs.03063; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2001, J BIOL CHEM, V276, P10577, DOI 10.1074/jbc.R100005200; Muhuri S, 2009, J AM CHEM SOC, V131, P9268, DOI 10.1021/ja900744e; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; Nakano H, 1996, J BIOTECHNOL, V46, P275, DOI 10.1016/0168-1656(96)00022-3; NAKANO H, 1994, BIOSCI BIOTECH BIOCH, V58, P631, DOI 10.1271/bbb.58.631; Nakano S, 2009, J AM CHEM SOC, V131, P16881, DOI 10.1021/ja9066628; Noireaux V, 2005, PHYS BIOL, V2, pP1, DOI 10.1088/1478-3975/2/3/P01; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Park N, 2009, NAT PROTOC, V4, P1759, DOI 10.1038/nprot.2009.174; Park N, 2009, NAT MATER, V8, P432, DOI [10.1038/NMAT2419, 10.1038/nmat2419]; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; SANDERS GM, 1994, P NATL ACAD SCI USA, V91, P7703, DOI 10.1073/pnas.91.16.7703; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Sasaki Yoshiharu, 2006, Biotechnology Journal, V1, P440, DOI 10.1002/biot.200500032; Sasaki Y, 2007, NUCLEIC ACIDS RES, V35, P4086, DOI 10.1093/nar/gkm445; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Spirin AS, 2004, TRENDS BIOTECHNOL, V22, P538, DOI 10.1016/j.tibtech.2004.08.012; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Takai K, 2010, CURR PHARM BIOTECHNO, V11, P272, DOI 10.2174/138920110791111933; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; Totani K, 2008, J AM CHEM SOC, V130, P2101, DOI 10.1021/ja077570k; Underwood KA, 2005, BIOTECHNOL BIOENG, V91, P425, DOI 10.1002/bit.20529; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Vinarov DA, 2004, NAT METHODS, V1, P149, DOI 10.1038/NMETH716; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; Xu ZN, 2005, APPL BIOCHEM BIOTECH, V127, P53, DOI 10.1385/ABAB:127:1:053; Zhang C, 2009, P NATL ACAD SCI USA, V106, P16651, DOI 10.1073/pnas.0904741106; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1983, P NATL ACAD SCI-BIOL, V80, P5852, DOI 10.1073/pnas.80.19.5852; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; ZIMMERMAN SB, 1987, P NATL ACAD SCI USA, V84, P1871, DOI 10.1073/pnas.84.7.1871	67	70	73	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28707	10.1371/journal.pone.0028707	http://dx.doi.org/10.1371/journal.pone.0028707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174874	gold, Green Published, Green Submitted			2022-12-27	WOS:000298163600039
J	Zimmermann, J; Goebel, R; De Martino, F; van de Moortele, PF; Feinberg, D; Adriany, G; Chaimow, D; Shmuel, A; Ugurbil, K; Yacoub, E				Zimmermann, Jan; Goebel, Rainer; De Martino, Federico; van de Moortele, Pierre-Francois; Feinberg, David; Adriany, Gregor; Chaimow, Denis; Shmuel, Amir; Ugurbil, Kamil; Yacoub, Essa			Mapping the Organization of Axis of Motion Selective Features in Human Area MT Using High-Field fMRI	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; OCULAR DOMINANCE COLUMNS; MULTIPLE VISUAL AREAS; FUNCTIONAL ARCHITECTURE; 7 TESLA; RECEPTIVE FIELDS; COMPLETE PATTERN; MACAQUE MONKEY; SIGNAL CHANGES; CEBUS-APELLA	Functional magnetic resonance imaging (fMRI) at high magnetic fields has made it possible to investigate the columnar organization of the human brain in vivo with high degrees of accuracy and sensitivity. Until now, these results have been limited to the organization principles of early visual cortex (V1). While the middle temporal area (MT) has been the first identified extra-striate visual area shown to exhibit a columnar organization in monkeys, evidence of MT's columnar response properties and topographic layout in humans has remained elusive. Research using various approaches suggests similar response properties as in monkeys but failed to provide direct evidence for direction or axis of motion selectivity in human area MT. By combining state of the art pulse sequence design, high spatial resolution in all three dimensions (0.8 mm isotropic), optimized coil design, ultrahigh field magnets (7 Tesla) and novel high resolution cortical grid sampling analysis tools, we provide the first direct evidence for large-scale axis of motion selective feature organization in human area MT closely matching predictions from topographic columnar-level simulations.	[Zimmermann, Jan; Goebel, Rainer; De Martino, Federico] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Zimmermann, Jan; Goebel, Rainer; De Martino, Federico] Maastricht Univ, M BIC, Maastricht, Netherlands; [Goebel, Rainer] Netherlands Inst Neurosci, Dept Neuroimaging & Neuromodeling, Amsterdam, Netherlands; [De Martino, Federico; van de Moortele, Pierre-Francois; Adriany, Gregor; Chaimow, Denis; Shmuel, Amir; Ugurbil, Kamil; Yacoub, Essa] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Feinberg, David] Adv MRI Technol, Sebastopol, CA USA; [Feinberg, David] Univ Calif Berkeley, Helen Wills Inst Neurosci, Berkeley, CA 94720 USA; [Feinberg, David] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Chaimow, Denis] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Shmuel, Amir] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	Maastricht University; Maastricht University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California San Francisco; Max Planck Society; McGill University	Zimmermann, J (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	r.goebel@maastrichtuniversity.nl; kamil@cmrr.umn.edu	Shmuel, Amir/G-8690-2013; De Martino, Federico/ABF-9850-2021; Van de Moortele, Pierre-François/H-5087-2011; De Martino, Federico/I-1817-2012; Adriany, Gregor/AAK-1323-2020; Chaimow, Denis/AAX-8518-2021; Adriany, Gregor/R-6656-2016; Yacoub, Essa/AAS-7757-2021; Ugurbil, Kamil/AAD-6058-2022	De Martino, Federico/0000-0002-0352-0648; Van de Moortele, Pierre-François/0000-0002-6941-5947; De Martino, Federico/0000-0002-0352-0648; Chaimow, Denis/0000-0003-4532-3084; Adriany, Gregor/0000-0002-6428-9005; Zimmermann, Jan/0000-0003-3345-6074; Goebel, Rainer/0000-0003-1780-2467	National Institutes of Health (NIH) [R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079, S10 RR1395]; W. M. Keck Foundation; NSERC [RGPIN 375457-09]; NSF [DBI-9907842]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079, P41RR001395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091, R44NS063537] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Work supported in part by the National Institutes of Health (R01 EB000331, R44NS063537, P30 NS057091, P41 RR08079) the W. M. Keck Foundation, and NSERC (RGPIN 375457-09). The 7 T magnet purchase was funded in part by NSF DBI-9907842 and NIH S10 RR1395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DL, 2007, J NEUROSCI, V27, P10391, DOI 10.1523/JNEUROSCI.2923-07.2007; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; Bartels A, 2008, TRENDS NEUROSCI, V31, P444, DOI 10.1016/j.tins.2008.06.004; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Chaimow D, 2010, NEUROIMAGE; Cheng K, 2001, NEURON, V32, P359, DOI 10.1016/S0896-6273(01)00477-9; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Diogo ACM, 2003, J NEUROSCI, V23, P3881; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Duyn JH, 2007, P NATL ACAD SCI USA, V104, P11796, DOI 10.1073/pnas.0610821104; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Feinberg DA, 2008, 7 TESL P INT SOC MAG, P2373; Geesaman BJ, 1997, CEREB CORTEX, V7, P749, DOI 10.1093/cercor/7.8.749; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goerke U, 2007, MAGN RESON MED, V58, P754, DOI 10.1002/mrm.21369; Goodyear BG, 2001, HUM BRAIN MAPP, V14, P210, DOI 10.1002/hbm.1053; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Huk AC, 2002, J NEUROSCI, V22, P7195; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nelissen K, 2006, J NEUROSCI, V26, P5929, DOI 10.1523/JNEUROSCI.0824-06.2006; OSHIO K, 1991, MAGNET RESON MED, V20, P344, DOI 10.1002/mrm.1910200219; Park J, 2005, P ISMRM 13 SCI M MIA, P31; QIAN N, 1994, J NEUROSCI, V14, P7367; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; ROSA MGP, 1988, EXP BRAIN RES, V72, P645; SAITO H, 1986, J NEUROSCI, V6, P145; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shmuel A, 2007, NEUROIMAGE, V35, P539, DOI 10.1016/j.neuroimage.2006.12.030; Shmuel A, 2010, NEUROIMAGE, V49, P1957, DOI 10.1016/j.neuroimage.2009.08.040; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Sun P, 2007, NAT NEUROSCI, V10, P1404, DOI 10.1038/nn1983; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka S, 2011, NEURAL NETWORKS OFFI; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; Tolias AS, 2001, J NEUROSCI, V21, P8594, DOI 10.1523/JNEUROSCI.21-21-08594.2001; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ugurbil K, 2003, MAGN RESON IMAGING, V21, P1263, DOI 10.1016/j.mri.2003.08.027; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; Van de Moortele P-F, 2005, P INT SOC MAGN RESON, V13, P2748; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WORGOTTER F, 1991, J NEUROPHYSIOL, V66, P444, DOI 10.1152/jn.1991.66.2.444; Yacoub E, 2008, P NATL ACAD SCI USA, V105, P10607, DOI 10.1073/pnas.0804110105; Yacoub E, 2007, NEUROIMAGE, V37, P1161, DOI 10.1016/j.neuroimage.2007.05.020; ZEKI S, 1991, J NEUROSCI, V11, P641	60	116	116	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28716	10.1371/journal.pone.0028716	http://dx.doi.org/10.1371/journal.pone.0028716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163328	gold, Green Published, Green Submitted			2022-12-27	WOS:000298161900064
J	Bates, ME; Buckman, JF; Vaschillo, EG; Fonoberov, VA; Fonoberova, M; Vaschillo, B; Mun, EY; Mezic, A; Mezic, I				Bates, Marsha E.; Buckman, Jennifer F.; Vaschillo, Evgeny G.; Fonoberov, Vladimir A.; Fonoberova, Maria; Vaschillo, Bronya; Mun, Eun-Young; Mezic, Adriana; Mezic, Igor			The Redistribution of Power: Neurocardiac Signaling, Alcohol and Gender	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; BIOFEEDBACK; BAROREFLEX; DEPRESSION; AGE	Human adaptability involves interconnected biological and psychological control processes that determine how successful we are in meeting internal and environmental challenges. Heart rate variability (HRV), the variability in consecutive R-wave to R-wave intervals (RRI) of the electrocardiogram, captures synergy between the brain and cardiovascular control systems that modulate adaptive responding. Here we introduce a qualitatively new dimension of adaptive change in HRV quantified as a redistribution of spectral power by applying the Wasserstein distance with exponent 1 metric (W-1) to RRI spectral data. We further derived a new index, D, to specify the direction of spectral redistribution and clarify physiological interpretation. We examined gender differences in real time RRI spectral power response to alcohol, placebo and visual cue challenges. Adaptive changes were observed as changes in power of the various spectral frequency bands (i.e., standard frequency domain HRV indices) and, during both placebo and alcohol intoxication challenges, as changes in the structure (shape) of the RRI spectrum, with a redistribution towards lower frequency oscillations. The overall conclusions from the present study are that the RRI spectrum is capable of a fluid and highly flexible response, even when oscillations (and thus activity at the sinoatrial node) are pharmacologically suppressed, and that low frequency oscillations serve a crucial but less studied role in physical and mental health.	[Bates, Marsha E.; Buckman, Jennifer F.; Vaschillo, Evgeny G.; Vaschillo, Bronya; Mun, Eun-Young] Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA; [Fonoberov, Vladimir A.; Fonoberova, Maria; Mezic, Adriana; Mezic, Igor] AIMdyn Inc, Santa Barbara, CA USA; [Mezic, Igor] Univ Calif Santa Barbara, Ctr Control Dynam Syst & Computat, Santa Barbara, CA 93106 USA	Rutgers State University New Brunswick; University of California System; University of California Santa Barbara	Bates, ME (corresponding author), Rutgers State Univ, Ctr Alcohol Studies, Piscataway, NJ 08854 USA.	mebates@rutgers.edu	Mun, Eun-Young/AAA-2811-2020; Bates, Marsha/AAD-6426-2020; Mezic, Igor/R-9659-2018	Mun, Eun-Young/0000-0002-1820-615X; Vaschillo, Bronya/0000-0002-1316-2434; Mezic, Igor/0000-0002-2873-9013; Buckman, Jennifer/0000-0002-1898-5499	National Institute on Alcohol Abuse and Alcoholism [HHSN275201000003C, R01 AA015248]; American Recovery and Reinvestment Act Administrative Supplement [R01 AA015248, K02 AA00325, K01 AA017473]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA017473, R01AA015248, K02AA000325] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); American Recovery and Reinvestment Act Administrative Supplement; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by the National Institute on Alcohol Abuse and Alcoholism through HHSN275201000003C, R01 AA015248, American Recovery and Reinvestment Act Administrative Supplement to R01 AA015248, K02 AA00325, and K01 AA017473. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud FM, 2010, AM J PHYSIOL-REG I, V298, pR1449, DOI 10.1152/ajpregu.00130.2010; Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Aljuri N, 2004, AM J PHYSIOL-HEART C, V287, pH2252, DOI 10.1152/ajpheart.00489.2003; Barford A, 2006, BMJ-BRIT MED J, V332, P808, DOI 10.1136/bmj.332.7545.808; BATTIG WF, 1969, J EXP PSYCHOL, V80, P1, DOI 10.1037/h0027577; Beekwilder JP, 2010, J CLIN NEUROPHYSIOL, V27, P130, DOI 10.1097/WNP.0b013e3181d64d8a; Benarroch EE, 2008, NEUROLOGY, V71, P1733, DOI 10.1212/01.wnl.0000335246.93495.92; Benarroch EE., 1997, CENTRAL AUTONOMIC NE; Camm AJ, 1996, CIRCULATION, V93, P1043; Evans JM, 2001, J APPL PHYSIOL, V91, P2611, DOI 10.1152/jappl.2001.91.6.2611; Goldstein DS, 2011, EXP PHYSIOL, V96, P1255, DOI 10.1113/expphysiol.2010.056259; Goldstein DS, 2001, AUTONOMIC NERVOUS SY; JENNINGS JR, 1992, PSYCHOPHYSIOLOGY, V29, P742, DOI 10.1111/j.1469-8986.1992.tb02052.x; Julien C, 2006, J APPL PHYSIOL, V101, P684, DOI 10.1152/japplphysiol.00562.2006; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kraemer S, 2000, BRIT MED J, V321, P1609, DOI 10.1136/bmj.321.7276.1609; Labiner DM, 2007, ACTA NEUROL SCAND, V115, P23, DOI 10.1111/j.1600-0404.2006.00732.x; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; Lehrer PM, 2004, CHEST, V126, P352, DOI 10.1378/chest.126.2.352; Lehrer PM, 2000, APPL PSYCHOPHYS BIOF, V25, P177, DOI 10.1023/A:1009554825745; Li ZB, 2009, INT J PSYCHOPHYSIOL, V73, P212, DOI 10.1016/j.ijpsycho.2009.03.002; LIAO DP, 1995, AM J CARDIOL, V76, P906, DOI 10.1016/S0002-9149(99)80260-4; Malpas SC, 2002, AM J PHYSIOL-HEART C, V282, pH6, DOI 10.1152/ajpheart.2002.282.1.H6; Mezic I, 2008, AUTOMATICA, V44, P3003, DOI 10.1016/j.automatica.2008.04.020; Muskulus M, 2011, PHYSICA D, V240, P45, DOI 10.1016/j.physd.2010.08.005; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Porges Stephen W, 2009, Cleve Clin J Med, V76 Suppl 2, pS86, DOI 10.3949/ccjm.76.s2.17; Romanowicz M, 2011, ALCOHOL CLIN EXP RES, V35, P1092, DOI 10.1111/j.1530-0277.2011.01442.x; Rossy LA, 1998, PSYCHOSOM MED, V60, P773, DOI 10.1097/00006842-199811000-00022; Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99; Siegle G. J, 1994, BALANCED AFFECTIVE W; Soroko SI, 2010, NEUROPHYSIOLOGICAL P; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Tolkunov D, 2010, NEUROIMAGE, V50, P72, DOI 10.1016/j.neuroimage.2009.12.021; Udo T, 2009, PSYCHOL ADDICT BEHAV, V23, P196, DOI 10.1037/a0015015; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Vaschillo EG, 2008, PSYCHOPHYSIOLOGY, V45, P847, DOI 10.1111/j.1469-8986.2008.00673.x; Vaschillo EG, 2011, COMM COM INF SC, V127, P224; Vasilevskii N. N., 1993, Fiziologiya Cheloveka, V19, P91; Yasumasu T, 2006, PSYCHOPHYSIOLOGY, V43, P41, DOI 10.1111/j.1469-8986.2006.00377.x	41	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28281	10.1371/journal.pone.0028281	http://dx.doi.org/10.1371/journal.pone.0028281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	863NO	22164260	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400061
J	Bhat, N; Riley, BB				Bhat, Neha; Riley, Bruce B.			Integrin-alpha 5 Coordinates Assembly of Posterior Cranial Placodes in Zebrafish and Enhances Fgf-Dependent Regulation of Otic/Epibranchial Cells	PLOS ONE			English	Article							ERK MAP KINASE; SENSORY GANGLIA; EPIBRANCHIAL PLACODE; BIOLOGICAL-ACTIVITY; OLFACTORY PLACODES; OTIC PLACODE; INDUCTION; CHEMOKINE; SPECIFICATION; MIGRATION	Vertebrate sensory organs develop in part from cranial placodes, a series of ectodermal thickenings that coalesce from a common domain of preplacodal ectoderm. Mechanisms coordinating morphogenesis and differentiation of discrete placodes are still poorly understood. We have investigated whether placodal assembly in zebrafish requires Integrin-alpha 5 (itga5), an extracellular matrix receptor initially expressed throughout the preplacodal ectoderm. Morpholino knockdown of itga5 had no detectable effect on anterior placodes (pituitary, nasal and lens), but posterior placodes developed abnormally, resulting in disorganization of trigeminal and epibranchial ganglia and reduction of the otic vesicle. Cell motion analysis in GFP-transgenic embryos showed that cell migration in itga5 morphants was highly erratic and unfocused, impairing convergence and blocking successive recruitment of new cells into these placodes. Further studies revealed genetic interactions between itga5 and Fgf signaling. First, itga5 morphants showed changes in gene expression mimicking modest reduction in Fgf signaling. Second, itga5 morphants showed elevated apoptosis in the otic/epibranchial domain, which was rescued by misexpression of Fgf8. Third, knockdown of the Fgf effector erm had no effect by itself but strongly enhanced defects in itga5 morphants. Finally, proper regulation of itga5 requires dlx3b/4b and pax8, which are themselves regulated by Fgf. These findings support a model in which itga5 coordinates cell migration into posterior placodes and augments Fgf signaling required for patterning of these tissues and cell survival in otic/epibranchial placodes.	[Bhat, Neha; Riley, Bruce B.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Bhat, N (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	briley@mail.bio.tamu.edu			National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD) [R01-DC03806]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003806] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	National Institutes of Health-National Institute of Deafness and other Communication Disorders (NIDCD), grant R01-DC03806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bhattacharyya S, 2004, DEV BIOL, V271, P403, DOI 10.1016/j.ydbio.2004.04.010; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; Carballada R, 2001, DEVELOPMENT, V128, P35; Chodniewicz D, 2004, EXP CELL RES, V301, P31, DOI 10.1016/j.yexcr.2004.08.006; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Glavic A, 2004, DEV BIOL, V272, P89, DOI 10.1016/j.ydbio.2004.04.020; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hans S, 2004, DEVELOPMENT, V131, P5091, DOI 10.1242/dev.01346; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Hirsch E, 2002, J CELL BIOL, V157, P481, DOI 10.1083/jcb.200111065; James BP, 2007, MOL BIOL CELL, V18, P4190, DOI 10.1091/mbc.E06-07-0659; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kaji T, 2004, DEV BIOL, V276, P523, DOI 10.1016/j.ydbio.2004.09.020; Knaut H, 2005, NEURON, V47, P653, DOI 10.1016/j.neuron.2005.07.014; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kwon HJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001133; Lee SA, 2003, DEVELOPMENT, V130, P2669, DOI 10.1242/dev.00502; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Long QM, 2000, MECH DEVELOP, V97, P183, DOI 10.1016/S0925-4773(00)00408-1; Ma H, 2009, J CELL SCI, V122, P4303, DOI 10.1242/jcs.057646; Mackereth MD, 2005, DEVELOPMENT, V132, P371, DOI 10.1242/dev.01587; Maves L, 2002, DEVELOPMENT, V129, P3825; McCabe KL, 2009, DEV BIOL, V332, P189, DOI 10.1016/j.ydbio.2009.05.572; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Miyasaka N, 2007, DEVELOPMENT, V134, P2459, DOI 10.1242/dev.001958; Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0; Mori S, J BIOL CHEM, V283, P18066, DOI 1074/jbc.M801213200; Mould AP, 2009, BIOCHEM J, V424, P179, DOI 10.1042/BJ20090992; Nikaido M, 2007, DEV DYNAM, V236, P564, DOI 10.1002/dvdy.21050; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Padanad MS, 2011, DEV BIOL, V351, P90, DOI 10.1016/j.ydbio.2010.12.036; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Picker A, 2002, DEVELOPMENT, V129, P3227; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Rusnati M, 1997, MOL BIOL CELL, V8, P2449, DOI 10.1091/mbc.8.12.2449; Schlosser G, 2010, INT REV CEL MOL BIO, V283, P129, DOI 10.1016/S1937-6448(10)83004-7; Solomon KS, 2002, DEVELOPMENT, V129, P3127; Streit A, 2007, INT J DEV BIOL, V51, P447, DOI 10.1387/ijdb.072327as; Sun SK, 2007, DEV BIOL, V303, P675, DOI 10.1016/j.ydbio.2006.12.008; Tanghetti E, 2002, ONCOGENE, V21, P3889, DOI 10.1038/sj.onc.1205407; Toro S, 2007, SEMIN CELL DEV BIOL, V18, P534, DOI 10.1016/j.semcdb.2007.04.003; Trinh LA, 2004, DEV CELL, V6, P371; Ward SG, 2009, BIOCHEM J, V418, P13, DOI 10.1042/BJ20081969; Whitlock KE, 2000, DEVELOPMENT, V127, P3645; Znosko WA, 2010, DEV BIOL, V342, P11, DOI 10.1016/j.ydbio.2010.03.011	54	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27778	10.1371/journal.pone.0027778	http://dx.doi.org/10.1371/journal.pone.0027778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164214	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400014
J	Krammer, EM; Homble, F; Prevost, M				Krammer, Eva-Maria; Homble, Fabrice; Prevost, Martine			Concentration Dependent Ion Selectivity in VDAC: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; PORE-FORMING PROTEIN; ANION CHANNEL; BROWNIAN DYNAMICS; ESCHERICHIA-COLI; OMPF-PORIN; BIOLOGICAL CHANNEL; NEUROSPORA-CRASSA; ALPHA-HEMOLYSIN; PURIFICATION	The voltage-dependent anion channel (VDAC) forms the major pore in the outer mitochondrial membrane. Its high conducting open state features a moderate anion selectivity. There is some evidence indicating that the electrophysiological properties of VDAC vary with the salt concentration. Using a theoretical approach the molecular basis for this concentration dependence was investigated. Molecular dynamics simulations and continuum electrostatic calculations performed on the mouse VDAC1 isoform clearly demonstrate that the distribution of fixed charges in the channel creates an electric field, which determines the anion preference of VDAC at low salt concentration. Increasing the salt concentration in the bulk results in a higher concentration of ions in the VDAC wide pore. This event induces a large electrostatic screening of the charged residues promoting a less anion selective channel. Residues that are responsible for the electrostatic pattern of the channel were identified using the molecular dynamics trajectories. Some of these residues are found to be conserved suggesting that ion permeation between different VDAC species occurs through a common mechanism. This inference is buttressed by electrophysiological experiments performed on bean VDAC32 protein akin to mouse VDAC.	[Krammer, Eva-Maria; Homble, Fabrice; Prevost, Martine] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles	Krammer, EM (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	mprevost@ulb.ac.be	Homble, Fabrice/AAH-3780-2020; Krammer, Eva-Maria/H-2543-2013	Homble, Fabrice/0000-0001-6031-136X; Krammer, Eva-Maria/0000-0002-4821-2550	Brussels region (Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles); Brussels region (Fonds de la Recherche Scientifique )	Brussels region (Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles); Brussels region (Fonds de la Recherche Scientifique )	The funders of this study are the Brussels region (BB2B post-doctoral fellowship of the Institut d'encouragement de la recherche scientifique et de l'innovation de Bruxelles (http://www.iwoib.irisnet.be/site/index9dd4.html? page_id=1681(= nl) and the Fonds de la Recherche Scientifique (http://www1.frs-fnrs.be/). FH is a Research Director and MP is a Senior Research Associate at the FRS-FNRS (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrecht H, 2000, PLANT PHYSIOL, V124, P1181, DOI 10.1104/pp.124.3.1181; Abrecht H, 2000, J BIOL CHEM, V275, P40992, DOI 10.1074/jbc.M006437200; Aksimentiev A, 2005, BIOPHYS J, V88, P3745, DOI 10.1529/biophysj.104.058727; Al Bitar F, 2003, BBA-GENE STRUCT EXPR, V1625, P43, DOI 10.1016/S0167-4781(02)00590-0; Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414; Alcaraz A, 2009, BIOPHYS J, V96, P56, DOI [10.1016/j.bpj.2008.09.024, 10.1016/j.hpj.2008.09.024]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3; BLACHLYDYSON E, 1990, SCIENCE, V247, P1233, DOI 10.1126/science.1690454; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Colombini M, 1980, Ann N Y Acad Sci, V341, P552, DOI 10.1111/j.1749-6632.1980.tb47198.x; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Colombini M, 2009, TRENDS BIOCHEM SCI, V34, P382, DOI 10.1016/j.tibs.2009.05.001; Corry B, 2004, BBA-BIOMEMBRANES, V1663, P2, DOI 10.1016/j.bbamem.2004.02.006; CORTESE JD, 1991, J CELL BIOL, V113, P1331, DOI 10.1083/jcb.113.6.1331; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Degreve L, 1999, J CHEM PHYS, V111, P5150, DOI 10.1063/1.479783; DEPINTO V, 1987, BIOCHIM BIOPHYS ACTA, V894, P109, DOI 10.1016/0005-2728(87)90180-0; DEPINTO V, 1991, BIOCHEMISTRY-US, V30, P10191, DOI 10.1021/bi00106a017; DEPINTO V, 1993, J BIOL CHEM, V268, P12977; Egwolf B, 2010, J PHYS CHEM B, V114, P2901, DOI 10.1021/jp906791b; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FREITAG H, 1982, EUR J BIOCHEM, V123, P629; Garcia-Gimenez E, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021912; GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004; Henin J, 2008, J PHYS CHEM B, V112, P7008, DOI 10.1021/jp800687p; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Hodge T, 1997, J MEMBRANE BIOL, V157, P271, DOI 10.1007/s002329900235; HOLST M, 1993, J COMPUT CHEM, V14, P105, DOI 10.1002/jcc.540140114; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7; Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451; KOBAYASHI Y, 1985, EUR J BIOCHEM, V151, P231, DOI 10.1111/j.1432-1033.1985.tb09093.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Koppel DA, 1998, J BIOL CHEM, V273, P13794, DOI 10.1074/jbc.273.22.13794; Lee KI, 2011, BIOPHYS J, V100, P611, DOI 10.1016/j.bpj.2010.12.3708; Levine BG, 2011, J COMPUT PHYS, V230, P3556, DOI 10.1016/j.jcp.2011.01.048; Lopez ML, 2009, J PHYS CHEM B, V113, P8745, DOI 10.1021/jp902267g; LIU MY, 1992, BIOCHIM BIOPHYS ACTA, V1098, P255, DOI 10.1016/S0005-2728(05)80344-5; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; LUDWIG O, 1988, EUR BIOPHYS J BIOPHY, V15, P269, DOI 10.1007/BF00256477; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954; MARRINK SJ, 1994, J PHYS CHEM-US, V98, P4155, DOI 10.1021/j100066a040; Mlayeh L, 2010, BIOPHYS J, V99, P2097, DOI 10.1016/j.bpj.2010.07.067; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; PENG S, 1992, BIOPHYS J, V62, P123, DOI 10.1016/S0006-3495(92)81799-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinto D., 2004, STRUCTURE FUNCTION P, P309; Popp B, 1996, J BIOL CHEM, V271, P13593, DOI 10.1074/jbc.271.23.13593; Ramirez P, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011910; Raschle T, 2009, J AM CHEM SOC, V131, P17777, DOI 10.1021/ja907918r; ROOS N, 1982, BIOCHIM BIOPHYS ACTA, V686, P204, DOI 10.1016/0005-2736(82)90114-6; Rui HA, 2011, BIOPHYS J, V100, P602, DOI 10.1016/j.bpj.2010.12.3711; Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326; Schneider R, 2010, ANGEW CHEM INT EDIT, V49, P1882, DOI 10.1002/anie.200906241; Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066; Shao L, 1996, BIOPHYS J, V71, P778, DOI 10.1016/S0006-3495(96)79277-9; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SMACK DP, 1985, PLANT PHYSIOL, V79, P1094, DOI 10.1104/pp.79.4.1094; Smeyers M., 2003, MEMBRANE SCI TECHNOL, P449; Summers WAT, 2010, BIOCHEM CELL BIOL, V88, P425, DOI [10.1139/O09-115, 10.1139/o09-115]; Tai K, 2009, EUR BIOPHYS J BIOPHY, V38, P347, DOI 10.1007/s00249-008-0377-x; Tateda C, 2011, J EXP BOT, V62, P4773, DOI 10.1093/jxb/err113; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROLL H, 1992, J BIOL CHEM, V267, P21072; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Villinger S, 2010, P NATL ACAD SCI USA, V107, P22546, DOI 10.1073/pnas.1012310108; Wandrey M, 2004, PLANT PHYSIOL, V134, P182, DOI 10.1104/pp.103.031484; Wang Y, 2007, J STRUCT BIOL, V157, P534, DOI 10.1016/j.jsb.2006.11.008; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Young MJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-31; ZAMBROWICZ EB, 1993, BIOPHYS J, V65, P1093, DOI 10.1016/S0006-3495(93)81148-2	83	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27994	10.1371/journal.pone.0027994	http://dx.doi.org/10.1371/journal.pone.0027994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164223	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400024
J	Sormani, R; Masclaux-Daubresse, C; Daniele-Vedele, F; Chardon, F				Sormani, Rodnay; Masclaux-Daubresse, Celine; Daniele-Vedele, Francoise; Chardon, Fabien			Transcriptional Regulation of Ribosome Components Are Determined by Stress According to Cellular Compartments in Arabidopsis thaliana	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN GENES; CHLOROPLAST PROTEOME; CYCLING CELLS; S SUBUNIT; IDENTIFICATION; TRANSLATION; GENOME; PLANTS; PREDICTION	Plants have to coordinate eukaryotic ribosomes (cytoribosomes) and prokaryotic ribosomes (plastoribosomes and mitoribosomes) production to balance cellular protein synthesis in response to environmental variations. We identified 429 genes encoding potential ribosomal proteins (RP) in Arabidopsis thaliana. Because cytoribosome proteins are encoded by small nuclear gene families, plastid RP by nuclear and plastid genes and mitochondrial RP by nuclear and mitochondrial genes, several transcriptional pathways were attempted to control ribosome amounts. Examining two independent genomic expression datasets, we found two groups of RP genes showing very different and specific expression patterns in response to environmental stress. The first group represents the nuclear genes coding for plastid RP whereas the second group is composed of a subset of cytoribosome genes coding for RP isoforms. By contrast, the other cytoribosome genes and mitochondrial RP genes show less constraint in their response to stress conditions. The two subsets of cytoribosome genes code for different RP isoforms. During stress, the response of the intensively regulated subset leads to dramatic variation in ribosome diversity. Most of RP genes have same promoter structure with two motifs at conserved positions. The stress-response of the nuclear genes coding plastid RP is related with the absence of an interstitial telomere motif known as telo box in their promoters. We proposed a model for the "ribosome code" that influences the ribosome biogenesis by three main transcriptional pathways. The first pathway controls the basal program of cytoribosome and mitoribosome biogenesis. The second pathway involves a subset of cytoRP genes that are co-regulated under stress condition. The third independent pathway is devoted to the control of plastoribosome biosynthesis by regulating both nuclear and plastid genes.	[Sormani, Rodnay; Masclaux-Daubresse, Celine; Daniele-Vedele, Francoise; Chardon, Fabien] AgroParisTech, INRA, UMR1318, Inst Jean Pierre Bourgin,Saclay Plant Sci, Versailles, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Sormani, R (corresponding author), AgroParisTech, INRA, UMR1318, Inst Jean Pierre Bourgin,Saclay Plant Sci, Versailles, France.	rodnay.sormani@versailles.inra.fr	Masclaux-Daubresse, Celine/ABG-3128-2020; Chardon, Fabien/G-4826-2013; Chardon, Fabien/J-1963-2019	Masclaux-Daubresse, Celine/0000-0003-0719-9350; Chardon, Fabien/0000-0001-7909-3884; Chardon, Fabien/0000-0001-7909-3884; sormani, rodnay/0000-0002-0939-8639	Agence Nationale de la Recherche (ANR) [Blanc06-3-135436]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was partly supported by a grant from Agence Nationale de la Recherche to RS (ANR Blanc06-3-135436). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beligni MV, 2004, PLANT CELL, V16, P3357, DOI 10.1105/tpc.104.026708; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bonen L, 2006, MOL BIOL EVOL, V23, P701, DOI 10.1093/molbev/msj080; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chang IF, 2005, PLANT PHYSIOL, V137, P848, DOI 10.1104/pp.104.053637; Creff A, 2010, PLANT MOL BIOL, V73, P533, DOI 10.1007/s11103-010-9639-y; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Heazlewood JL, 2004, PLANT CELL, V16, P241, DOI 10.1105/tpc.016055; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Imai A, 2008, PLANT J, V56, P881, DOI 10.1111/j.1365-313X.2008.03647.x; Kawaguchi R, 2005, NUCLEIC ACIDS RES, V33, P955, DOI 10.1093/nar/gki240; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KOSUGI S, 1995, PLANT J, V7, P877, DOI 10.1046/j.1365-313X.1995.07060877.x; Lange H, 2009, TRENDS PLANT SCI, V14, P497, DOI 10.1016/j.tplants.2009.06.007; LENVIK TR, 1994, PLANT PHYSIOL, V105, P1027, DOI 10.1104/pp.105.3.1027; Matsuura H, 2010, BIOSCI BIOTECH BIOCH, V74, P2110, DOI 10.1271/bbb.100330; McIntosh KB, 2006, CAN J BOT, V84, P342, DOI 10.1139/B06-014; Mollier P, 2002, CURR GENET, V40, P405, DOI 10.1007/s00294-002-0271-5; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; REGAD F, 1995, MOL GEN GENET, V248, P703, DOI 10.1007/BF02191710; Richly E, 2003, EMBO REP, V4, P491, DOI 10.1038/sj.embor.embor828; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sormani R, 2011, PLANT CELL PHYSIOL, V52, P436, DOI 10.1093/pcp/pcr001; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; THOMPSON MD, 1992, PLANT MOL BIOL, V18, P931, DOI 10.1007/BF00019207; Tremousaygue D, 2003, PLANT J, V33, P957, DOI 10.1046/j.1365-313X.2003.01682.x; Tremousaygue D, 1999, PLANT J, V20, P553, DOI 10.1046/j.1365-313X.1999.00627.x; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Welchen E, 2006, PLANT PHYSIOL, V141, P540, DOI 10.1104/pp.105.075366; Whittle CA, 2009, PLANT CELL, V21, P2203, DOI 10.1105/tpc.109.068411; WITTMANN HG, 1982, ANNU REV BIOCHEM, V51, P155, DOI 10.1146/annurev.bi.51.070182.001103; Yamaguchi K, 2000, J BIOL CHEM, V275, P28455, DOI 10.1074/jbc.M004350200; Yamaguchi K, 2000, J BIOL CHEM, V275, P28466, DOI 10.1074/jbc.M005012200; Yamaguchi K, 2003, EUR J BIOCHEM, V270, P190, DOI 10.1046/j.1432-1033.2003.03359.x; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	51	58	60	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28070	10.1371/journal.pone.0028070	http://dx.doi.org/10.1371/journal.pone.0028070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164228	Green Published, gold, Green Submitted			2022-12-27	WOS:000298171400029
J	Srinivasakumar, N				Srinivasakumar, Narasimhachar			Rev-Free HIV-1 Gene Delivery System for Targeting Rev-RRE-Crm1 Nucleocytoplasmic RNA Transport Pathway	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; EXPRESSION; EXPORT; REPLICATION; INHIBITION; ELEMENT; PROTEIN; CELLS; SAM68; LOCALIZATION	The use of RNA transport elements from different viruses can provide novel attributes to HIV-1-based gene delivery systems such as improved safety or Rev independence. We previously described an HIV-1 based gene delivery system that utilized the simian immunodeficiency virus Rev-response element (RRE) in place of the HIV-1 RRE. Despite the use of Rev for the production of vector stocks, we showed the utility of this system for delivery of Rev M10, a dominant-negative mutant of HIV-1 Rev, into T-cells. Here, we investigated the use of RNA transport elements from Mason-Pfizer monkey virus or MPMV for the creation of high-titered Rev-free HIV-1-based packaging systems. The HIV-1 gag/pol expression constructs containing one or more copies of MPMV constitutive RNA transport element (CTE) were used to package similarly modified gene-transfer vectors in the presence or absence of Rev. An inverse correlation between the number of CTE modules and Rev dependency was noted for vector stock production. While packaging systems containing multiple CTEs were resistant to exogenously expressed Rev M10, the titers of vectors encoding Rev M10 were nevertheless reduced in comparison to vectors encoding only green fluorescent protein (GFP). In contrast, a gene transfer vector encoding the Rev M10 transgene and containing both RNA transport elements exhibited almost no loss in titer in comparison to a corresponding vector encoding only GFP. The optimized Rev-independent gene delivery system was used for delivery of Rev M10 transgene into T-lymphocytes. Upon challenge in single round infection assays with HIV-1, the modified T-cells produced fewer virus particles than control cells expressing GFP. This Rev-free packaging system may prove useful for targeting the Rev-RRE-Crm1 nucleocytoplasmic RNA transport pathway for inhibiting HIV replication.	St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA	Saint Louis University	Srinivasakumar, N (corresponding author), St Louis Univ, Dept Internal Med, Div Hematol Oncol, St Louis, MO 63103 USA.	skumar15@slu.edu			United States National Institutes of Health [AI 054211]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054211] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The manuscript was supported by funds from the United States National Institutes of Health (AI 054211) to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY M, 1994, P NATL ACAD SCI USA, V91, P1256, DOI 10.1073/pnas.91.4.1256; Coyle JH, 2003, MOL CELL BIOL, V23, P92, DOI 10.1128/MCB.23.1.92-103.2003; Cullen BR, 2005, NATURE, V433, P26, DOI 10.1038/433026a; Ernst RK, 1997, MOL CELL BIOL, V17, P135, DOI 10.1128/MCB.17.1.135; Ernst RK, 1997, RNA, V3, P210; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Hakata Y, 1998, J VIROL, V72, P6602, DOI 10.1128/JVI.72.8.6602-6607.1998; HAMMARSKJOLD ML, 1989, J VIROL, V63, P1959; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Helga-Maria C, 1999, J VIROL, V73, P4127, DOI 10.1128/JVI.73.5.4127-4135.1999; Jeang K T, 1991, AIDS, V5 Suppl 2, pS3, DOI 10.1097/00002030-199101001-00002; Jin L, 2003, GENE DEV, V17, P3075, DOI 10.1101/gad.1155703; Kang YB, 1999, GENE DEV, V13, P1126, DOI 10.1101/gad.13.9.1126; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Lu XB, 2004, J VIROL, V78, P7079, DOI 10.1128/JVI.78.13.7079-7088.2004; MALIM MH, 1990, CELL, V60, P675, DOI 10.1016/0092-8674(90)90670-A; MANN DA, 1994, J MOL BIOL, V241, P193, DOI 10.1006/jmbi.1994.1488; Mautino MR, 2000, GENE THER, V7, P1421, DOI 10.1038/sj.gt.3301262; Mautino MR, 2000, HUM GENE THER, V11, P895, DOI 10.1089/10430340050015509; Mautino MR, 2001, J VIROL, V75, P3590, DOI 10.1128/JVI.75.8.3590-3599.2001; Mclaren M, 2004, RNA, V10, P1119, DOI 10.1261/rna.5263904; McLaren M, 2009, VIROLOGY, V385, P93, DOI 10.1016/j.virol.2008.10.049; Oh T, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-38; Reddy TR, 2000, ONCOGENE, V19, P3110, DOI 10.1038/sj.onc.1203637; Reddy TR, 1999, NAT MED, V5, P635, DOI 10.1038/9479; Srinivasakumar N, 1999, J VIROL, V73, P9589, DOI 10.1128/JVI.73.11.9589-9598.1999; Srinivasakumar N, 2000, J VIROL, V74, P6659, DOI 10.1128/JVI.74.14.6659-6668.2000; Srinivasakumar N, 2002, J VIROL, V76, P7334, DOI 10.1128/JVI.76.14.7334-7342.2002; Srinivasakumar N, 1997, J VIROL, V71, P5841, DOI 10.1128/JVI.71.8.5841-5848.1997; Srinivasakumar N, 2001, HIV 1 VECTOR SYSTEMS; Srinivasakumar N, 2002, PACKAGING CELL SYSTE, P275; Srinivasakumar Narasimhachar, 2008, AIDS Res Ther, V5, P11, DOI 10.1186/1742-6405-5-11; Ward AM, 2009, J VIROL, V83, P940, DOI 10.1128/JVI.01520-08; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Zaboikin M, 2004, HUM GENE THER, V15, P383, DOI 10.1089/104303404322959533; ZOLOTUKHIN AS, 1994, J VIROL, V68, P7944, DOI 10.1128/JVI.68.12.7944-7952.1994	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28462	10.1371/journal.pone.0028462	http://dx.doi.org/10.1371/journal.pone.0028462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164294	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400095
J	Yoon, SY; Kim, KT; Jo, SJ; Cho, AR; Jeon, SI; Choi, HD; Kim, KH; Park, GS; Pack, JK; Kwon, OS; Park, WY				Yoon, Sun-Young; Kim, Kyu-Tae; Jo, Seong Jin; Cho, A-Ri; Jeon, Soon-Ik; Choi, Hyung-Do; Kim, Kyu Han; Park, Gun-Sik; Pack, Jeong-Ki; Kwon, Oh Sang; Park, Woong-Yang			Induction of Hair Growth by Insulin-Like Growth Factor-1 in 1,763 MHz Radiofrequency-Irradiated Hair Follicle Cells	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; ACTIVATION; APOPTOSIS; STRESS; CANCER; PROLIFERATION; EXPRESSION; RADIATION; EXPOSURE; ABLATION	Radiofrequency (RF) radiation does not transfer high energy to break the covalent bonds of macromolecules, but these low energy stimuli might be sufficient to induce molecular responses in a specific manner. We monitored the effect of 1,763 MHz RF radiation on cultured human dermal papilla cells (hDPCs) by evaluating changes in the expression of cytokines related to hair growth. The expression of insulin-like growth factor-1 (IGF-1) mRNA in hDPCs was significantly induced upon RF radiation at the specific absorption rate of 10 W/kg, which resulted in increased expression of B-cell chronic lymphocytic leukemia/lymphoma 2 (BCL-2) and cyclin D1 (CCND1) proteins and increased phosphorylation of MAPK1 protein. Exposure to 10 W/kg RF radiation 1 h per day for 7 days significantly enhanced hair shaft elongation in ex vivo hair organ cultures. In RF-exposed follicular matrix keratinocytes in the hair bulb, the expression of Ki-67 was increased, while the signal for terminal deoxynucleotidyl transferase dUTP nick end labeling was reduced. From these results, we suggest that 1,763 MHz RF exposure stimulates hair growth in vitro through the induction of IGF-1 in hDPCs.	[Yoon, Sun-Young; Jo, Seong Jin; Cho, A-Ri; Kim, Kyu Han; Kwon, Oh Sang] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Kyu-Tae; Park, Woong-Yang] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Park, Gun-Sik] Seoul Natl Univ, Coll Nat Sci, Dept Phys & Astron, Seoul 151742, South Korea; [Jeon, Soon-Ik; Choi, Hyung-Do] Commun & Broadcasting Covergence Elect & Telecomm, Radio Technol Res Dept, Taejon, South Korea; [Pack, Jeong-Ki] Chungnam Natl Univ, Ctr Electromagnet Res, Taejon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Chungnam National University	Yoon, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.	oskwon@snu.ac.kr; wypark@snu.ac.kr	park, woongyang/D-5727-2012; Kim, Kyu Han/E-7814-2012; Park, Gunsik/A-1415-2014; Kwon, Ohsang/J-2733-2012	Kwon, Ohsang/0000-0003-0464-5124; Jo, Seong Jin/0000-0002-2501-7672	Korea Communications Commission, Korea [KCA-2011-11911-01108]; National Research Foundation of Korea; Ministry of Education, Science and Technology [2011-0001300]	Korea Communications Commission, Korea(Korea Communications Commission (KCC)); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Funding provided by Korea Communications Commission, Korea, under the Research & Development program supervised by the Korea Communications Agency (KCA; KCA-2011-11911-01108) and the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2011-0001300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2008, AM J REPROD IMMUNOL, V59, P2, DOI 10.1111/j.1600-0897.2007.00559.x; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Han JH, 2004, J DERMATOL SCI, V34, P91, DOI 10.1016/j.jdermsci.2004.01.002; Hilmi C, 2008, J INVEST DERMATOL, V128, P1499, DOI 10.1038/sj.jid.5701185; Huang TQ, 2008, INT J RADIAT BIOL, V84, P734, DOI 10.1080/09553000802317760; Huang TQ, 2008, INT J RADIAT BIOL, V84, P909, DOI 10.1080/09553000802460123; Hurbin A, 2005, J BIOL CHEM, V280, P19757, DOI 10.1074/jbc.M413516200; Hwang KA, 2011, INT J MOL MED; Inui S, 2011, J DERMATOL SCI, V61, P1, DOI 10.1016/j.jdermsci.2010.10.015; Jahoda C, 1984, INDUCTION HAIR GROWT; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Karinen A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-77; Lee JS, 2006, BIOELECTROMAGNETICS, V27, P578, DOI 10.1002/bem.20235; Lee JJ, 2008, BIOELECTROMAGNETICS, V29, P615, DOI 10.1002/bem.20427; Leszczynski D, 2002, DIFFERENTIATION, V70, P120, DOI 10.1046/j.1432-0436.2002.700207.x; MADDIN WS, 1990, INT J DERMATOL, V29, P446, DOI 10.1111/j.1365-4362.1990.tb03837.x; McAchran SE, 2005, UROLOGY, V66, P15, DOI 10.1016/j.urology.2005.06.127; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Meltz ML, 2003, BIOELECTROMAGNETICS, pS196, DOI 10.1002/bem.10176; MESSENGER AG, 1984, BRIT J DERMATOL, V110, P685, DOI 10.1111/j.1365-2133.1984.tb04705.x; Moulder JE, 1999, RADIAT RES, V151, P513, DOI 10.2307/3580028; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Otomo Susumu, 2002, Folia Pharmacologica Japonica, V119, P167, DOI 10.1254/fpj.119.167; Ozeki M, 2002, BIOMATERIALS, V23, P2367, DOI 10.1016/S0142-9612(01)00372-6; Ozguner F, 2004, TOXICOL IND HEALTH, V20, P133, DOI 10.1191/0748233704th207oa; Peus D, 1996, DERMATOL CLIN, V14, P559, DOI 10.1016/S0733-8635(05)70384-3; PHILPOTT MP, 1994, J INVEST DERMATOL, V102, P857, DOI 10.1111/1523-1747.ep12382494; PHILPOTT MP, 1990, J CELL SCI, V97, P463; RANDALL VA, 1991, ANN NY ACAD SCI, V642, P355; SCHERER WF, 1954, P SOC EXP BIOL MED, V87, P480; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Smith TM, 2008, J INVEST DERMATOL, V128, P1286, DOI 10.1038/sj.jid.5701155; Solbiati L, 1997, RADIOLOGY, V202, P195, DOI 10.1148/radiology.202.1.8988211; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tsuboi R., 1997, J INVEST DERMATOL, V4, P103; Vijayalaxmi, 2004, RADIAT RES, V162, P481, DOI 10.1667/RR3252; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Zhao JA, 2011, J NUTR BIOCHEM, V22, P227, DOI 10.1016/j.jnutbio.2010.01.008	41	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28474	10.1371/journal.pone.0028474	http://dx.doi.org/10.1371/journal.pone.0028474			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164296	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400097
J	Beuving, J; Verbon, A; Gronthoud, FA; Stobberingh, EE; Wolffs, PFG				Beuving, Judith; Verbon, Annelies; Gronthoud, Firza A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.			Antibiotic Susceptibility Testing of Grown Blood Cultures by Combining Culture and Real-Time Polymerase Chain Reaction Is Rapid and Effective	PLOS ONE			English	Article							GRAM-POSITIVE COCCI; DIRECT INOCULATION; ANTIMICROBIAL THERAPY; MICROBIOLOGY SYSTEM; STREAM INFECTIONS; CLINICAL IMPACT; PHOENIX SYSTEM; UNITED-STATES; SEVERE SEPSIS; IDENTIFICATION	Background: Early administration of appropriate antibiotic therapy in bacteraemia patients dramatically reduces mortality. A new method for RApid Molecular Antibiotic Susceptibility Testing (RAMAST) that can be applied directly to positive blood cultures was developed and evaluated. Methodology/Principal Findings: Growth curves and antibiotic susceptibility of blood culture isolates (Staphylococcus aureus, enterococci and (facultative) aerobic Gram-negative rods) were determined by incubating diluted blood cultures with and without antibiotics, followed by a quantitative universal 16S PCR to detect the presence or absence of growth. Testing 114 positive blood cultures, RAMAST showed an agreement with microbroth dilution of 96.7% for Gram-negative rods, with a minor error (false-susceptibility with a intermediate resistant strain) rate of 1.9%, a major error (false resistance) rate of 0.8% and a very major error (false susceptibility) rate of 0.6%. Agreement for S. aureus was 97.9%, with a very major error rate of 2.1%. Enterococcus species showed 95.0% agreement, with a major error rate of 5.0%. These agreements are comparable with those of the Phoenix system. Starting from a positive blood culture, the test was completed within 9 hours. Conclusions/Significance: This new rapid method for antibiotic susceptibility testing can potentially provide accurate results for most relevant bacteria commonly isolated from positive blood cultures in less time than routine methods.	[Beuving, Judith; Verbon, Annelies; Gronthoud, Firza A.; Stobberingh, Ellen E.; Wolffs, Petra F. G.] Maastricht Univ, Dept Med Microbiol, CAPHRI, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Beuving, J (corresponding author), Maastricht Univ, Dept Med Microbiol, CAPHRI, Med Ctr, Maastricht, Netherlands.	p.wolffs@mumc.nl		Wolffs, Petra/0000-0002-5326-3985	Profileringsfonds azM [PF245]	Profileringsfonds azM	This work was supported by Profileringsfonds azM (PF245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barenfanger J, 1999, J CLIN MICROBIOL, V37, P1415, DOI 10.1128/JCM.37.5.1415-1418.1999; Bearman GML, 2005, ARCH MED RES, V36, P646, DOI 10.1016/j.arcmed.2005.02.005; Beuving J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-156; Bouza E, 2004, CLIN INFECT DIS, V39, P1161, DOI 10.1086/424520; Bruins M, 2005, EUR J CLIN MICROBIOL, V24, P305, DOI 10.1007/s10096-005-1309-7; Bruins MJ, 2004, J CLIN MICROBIOL, V42, P7, DOI 10.1128/JCM.42.1.7-11.2004; Byl B, 1999, CLIN INFECT DIS, V29, P60, DOI 10.1086/520182; Chapin KC, 2003, J CLIN MICROBIOL, V41, P4751, DOI 10.1128/JCM.41.10.4751-4754.2003; Chapin KC, 2003, J CLIN MICROBIOL, V41, P1951, DOI 10.1128/JCM.41.5.1951-1956.2003; CLSI (Clinical and Laboratory Standards Institute), 2007, M10017 CLSI; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Dombrovskiy VY, 2005, CRIT CARE MED, V33, P2555, DOI 10.1097/01.CCM.0000186748.64438.7B; Donay JL, 2004, J CLIN MICROBIOL, V42, P1542, DOI 10.1128/JCM.42.4.1542-1546.2004; Edelmann A, 2007, J MED MICROBIOL, V56, P202, DOI 10.1099/jmm.0.46937-0; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Funke G, 2004, J CLIN MICROBIOL, V42, P1466, DOI 10.1128/JCM.42.4.1466-1470.2004; Hansen WLJ, 2010, J CLIN MICROBIOL, V48, P4432, DOI 10.1128/JCM.00562-10; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; JORGENSEN JH, 1993, J CLIN MICROBIOL, V31, P2841, DOI 10.1128/JCM.31.11.2841-2844.1993; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kerremans JJ, 2004, EUR J CLIN MICROBIOL, V23, P892, DOI 10.1007/s10096-004-1247-9; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Livermore DM, 2005, LANCET INFECT DIS, V5, P450, DOI 10.1016/S1473-3099(05)70166-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Menozzi MG, 2006, J CLIN MICROBIOL, V44, P4085, DOI 10.1128/JCM.00614-06; Rolain JM, 2004, J ANTIMICROB CHEMOTH, V54, P538, DOI 10.1093/jac/dkh324; Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006; TRENHOLME GM, 1989, J CLIN MICROBIOL, V27, P1342, DOI 10.1128/JCM.27.6.1342-1345.1989; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Waites KB, 1998, J CLIN MICROBIOL, V36, P2052, DOI 10.1128/JCM.36.7.2052-2056.1998; Wellinghausen N, 2007, J CLIN MICROBIOL, V45, P789, DOI 10.1128/JCM.01856-06	35	25	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e27689	10.1371/journal.pone.0027689	http://dx.doi.org/10.1371/journal.pone.0027689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194790	gold, Green Published, Green Submitted			2022-12-27	WOS:000298369100010
J	Yu, TH; Luo, J				Yu, Tinghe; Luo, Jun			Adverse Events of Extracorporeal Ultrasound-Guided High Intensity Focused Ultrasound Therapy	PLOS ONE			English	Article							CANCER; TUMORS; MICROBUBBLES; ABLATION; EXPOSURE; SURGERY; SAFETY; LIVER	Background: High-intensity focused ultrasound (HIFU) is considered to be an alternative to surgery. Extracorporeal ultrasound-guided HIFU (USgFU) has been clinically used to treat solid tumors. Preliminary trials in a small sample of a Western population suggested that this modality was safe. Most trials are performed in China thereby providing comprehensive data for understanding the safety profile. The aim of this study was to evaluate adverse events of USgFU therapy. Methods and Findings: Clinical data were searched in 2 Chinese databases. Adverse events of USgFU were summarized and compared with those of magnetic resonance-guided HIFU (MRgFU; for uterine, bone or breast tumor) and transrectal ultrasound-guided HIFU (for prostate cancer or benign prostate hyperplasia). USgFU treatment was performed using 7 types of device. Side effects were evaluated in 13262 cases. There were fewer adverse events in benign lesions than in malignant lesions (11.81% vs. 21.65%, p<0.0001). Rates of adverse events greatly varied between the disease types (0-280%, p<0.0001) and between the applied HIFU devices in both malignant (10.58-44.38%, p<0.0001) and benign lesions (1.67-17.57%, p<0.0001). Chronological analysis did not demonstrate a decrease in the rate of adverse events. Based upon evaluable adverse events, incidences in USgFU were consistent with those in MRgFU or transrectal HIFU. Some side effects frequently occurred following transrectal HIFU were not reported in USgFU. Several events including intrahepatic metastasis, intraoperative high fever, and occlusions of the superior mesenteric artery should be of particular concern because they have not been previously noted. The types of adverse events suggested that they were ultrasonic lesions. Conclusion: The frequency of adverse events depended on the location of the lesion and the type of HIFU device; however, side effects of USgFU were not yet understood. USgFU did not decrease the incidence of adverse events compared with MRgFU.	[Yu, Tinghe] Chongqing Med Univ, Lab Obstet & Gynecol, Affiliated Hosp 2, Chongqing, Peoples R China; [Yu, Tinghe] Chongqing Bur Hlth, Key Lab Obstet & Gynecol, Chongqing, Peoples R China; [Luo, Jun] Chongqing Med Univ, Hosp Stomatol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Yu, TH (corresponding author), Chongqing Med Univ, Lab Obstet & Gynecol, Affiliated Hosp 2, Chongqing, Peoples R China.	yutinghe@hotmail.com		Yu, T/0000-0002-9014-7967	Natural Science Foundation of China [11174376]; Natural Science Foundation of Chongqing [CSTC 2009BA5049]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	The work was supported with grants from the Natural Science Foundation of China (11174376) and Natural Science Foundation of Chongqing (CSTC 2009BA5049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Wenzhi, 2004, Chinese Journal of Clinical Oncology, V1, P15; DORR LN, 1992, INT J HYPERTHER, V8, P45, DOI 10.3109/02656739209052878; FRY FJ, 1993, EUR UROL, V23, P2; Furusawa H, 2006, J AM COLL SURGEONS, V203, P54, DOI 10.1016/j.jamcollsurg.2006.04.002; HE H, 2004, W CHINA MED J, V19, P281; HE X, 2008, MODERN MED HLTH, V24, P2237; Illing RO, 2005, BRIT J CANCER, V93, P890, DOI 10.1038/sj.bjc.6602803; Jung SE, 2011, ABDOM IMAGING, V36, P185, DOI 10.1007/s00261-010-9628-2; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Li CX, 2010, CANCER-AM CANCER SOC, V116, P3934, DOI 10.1002/cncr.25192; Li JJ, 2009, TECHNOL CANCER RES T, V8, P217, DOI 10.1177/153303460900800306; [黎建军 Li Jianjun], 2007, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V23, P797; [黎建军 LI Jianjun], 2006, [中华超声影像学杂志, Chinese Journal of Ultrasonography], V15, P668; Liberman B, 2009, ANN SURG ONCOL, V16, P140, DOI 10.1245/s10434-008-0011-2; Liu XT, 2004, CHIN J PRAC NURS, V20, P9; Miller DL, 2006, ULTRASOUND MED BIOL, V32, P1097, DOI 10.1016/j.ultrasmedbio.2006.03.013; Ohigashi T, 2007, INT J UROL, V14, P326, DOI 10.1111/j.1442-2042.2007.01692.x; Rebillard X, 2008, BJU INT, V101, P1205, DOI 10.1111/j.1464-410X.2008.07504.x; Ren X. L., 2009, J ULTRAS MED, V28, P95; Ritchie RW, 2010, BJU INT, V106, P1004, DOI 10.1111/j.1464-410X.2010.09289.x; Taran FA, 2009, ULTRASOUND OBST GYN, V34, P572, DOI 10.1002/uog.7435; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Visioli A G, 1999, Eur J Ultrasound, V9, P11, DOI 10.1016/S0929-8266(99)00009-9; Wang J, 2004, MIL MED J S CHINA, V18, P17; Warmuth M, 2010, EUR UROL, V58, P803, DOI 10.1016/j.eururo.2010.09.009; Yi Jiang, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P426; YU T, 2011, AFR J PHARM IN PRESS; Yu TH, 2004, ULTRASON SONOCHEM, V11, P95, DOI 10.1016/S1350-4177(03)00157-3; Yu TH, 2008, ULTRASOUND MED BIOL, V34, P1343, DOI 10.1016/j.ultrasmedbio.2008.01.012; Yu TH, 2006, EUR RADIOL, V16, P1557, DOI 10.1007/s00330-006-0176-7; Yu TH, 2011, MOL PHARMACEUT, V8, P1408, DOI 10.1021/mp2001846; ZHOU Y, 2002, GUANGZHOU MED J, V33, P4	32	36	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2011	6	12							e26110	10.1371/journal.pone.0026110	http://dx.doi.org/10.1371/journal.pone.0026110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GS	22194777	Green Submitted, Green Published, gold			2022-12-27	WOS:000298369100001
J	Wolf, AI; Mozdzanowska, K; Williams, KL; Singer, D; Richter, M; Hoffmann, R; Caton, AJ; Otvos, L; Erikson, J				Wolf, Amaya I.; Mozdzanowska, Krystyna; Williams, Katie L.; Singer, David; Richter, Monique; Hoffmann, Ralf; Caton, Andrew J.; Otvos, Laszlo; Erikson, Jan			Vaccination with M2e-Based Multiple Antigenic Peptides: Characterization of the B Cell Response and Protection Efficacy in Inbred and Outbred Mice	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; INTEGRAL MEMBRANE-PROTEIN; MATRIX PROTEIN-2; M2 PROTEIN; T-CELL; EXTRACELLULAR DOMAIN; CONJUGATE VACCINES; ANTIBODY-RESPONSE; MONOCLONAL-ANTIBODY; RESPIRATORY-TRACT	Background: The extracellular domain of the influenza A virus protein matrix protein 2 (M2e) is remarkably conserved between various human isolates and thus is a viable target antigen for a universal influenza vaccine. With the goal of inducing protection in multiple mouse haplotypes, M2e-based multiple antigenic peptides (M2e-MAP) were synthesized to contain promiscuous T helper determinants from the Plasmodium falciparum circumsporozoite protein, the hepatitis B virus antigen and the influenza virus hemagglutinin. Here, we investigated the nature of the M2e-MAP-induced B cell response in terms of the distribution of antibody (Ab) secreting cells (ASCs) and Ab isotypes, and tested the protective efficacy in various mouse strains. Methodology/Principal Findings: Immunization of BALB/c mice with M2e-MAPs together with potent adjuvants, CpG 1826 oligonucleotides (ODN) and cholera toxin (CT) elicited high M2e-specific serum Ab titers that protected mice against viral challenge. Subcutaneous (s.c.) and intranasal (i.n.) delivery of M2e-MAPs resulted in the induction of IgG in serum and airway secretions, however only i.n. immunization induced anti-M2e IgA ASCs locally in the lungs, correlating with M2-specific IgA in the bronchio-alveolar lavage (BAL). Interestingly, both routes of vaccination resulted in equal protection against viral challenge. Moreover, M2e-MAPs induced cross-reactive and protective responses to diverse M2e peptides and variant influenza viruses. However, in contrast to BALB/c mice, immunization of other inbred and outbred mouse strains did not induce protective Abs. This correlated with a defect in T cell but not B cell responsiveness to the M2e-MAPs. Conclusion/Significance: Anti-M2e Abs induced by M2e-MAPs are highly cross-reactive and can mediate protection to variant viruses. Although synthetic MAPs are promising designs for vaccines, future constructs will need to be optimized for use in the genetically heterogeneous human population.	[Wolf, Amaya I.; Mozdzanowska, Krystyna; Williams, Katie L.; Caton, Andrew J.; Erikson, Jan] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Singer, David; Richter, Monique; Hoffmann, Ralf] Univ Leipzig, Inst Bioanalyt Chem, Ctr Biotechnol & Biomed, Leipzig, Germany; [Otvos, Laszlo] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	The Wistar Institute; Leipzig University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wolf, AI (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA.	jan@wistar.org	Hoffmann, Ralf/ABD-8779-2020		National Institutes of Health [U19 AI083022]; Commonwealth of Pennsylvania; Wistar Cancer Center [P30 CA10815, CA09171-32]; NATIONAL CANCER INSTITUTE [T32CA009171, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; Wistar Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by the National Institutes of Health grant U19 AI083022 to J.E. and A.J.C., a grant from the Commonwealth of Pennsylvania to J.E., A.J.C. and L.O., the Wistar Cancer Center Core Grant P30 CA10815, and a T32 Training grant CA09171-32 to A.I.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahi Y, 2002, J IMMUNOL, V168, P2930, DOI 10.4049/jimmunol.168.6.2930; Beerli RR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-224; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; BLACK RA, 1993, J GEN VIROL, V74, P143, DOI 10.1099/0022-1317-74-1-143; Calvo-Calle JM, 2006, INFECT IMMUN, V74, P6929, DOI 10.1128/IAI.01151-06; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082; DEFILETTE M, 2008, VACCINE; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Falugi F, 2001, EUR J IMMUNOL, V31, P3816, DOI 10.1002/1521-4141(200112)31:12<3816::AID-IMMU3816>3.0.CO;2-K; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fiers W, 2009, VACCINE, V27, P6280, DOI 10.1016/j.vaccine.2009.07.007; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; GREENSTEIN JL, 1992, J IMMUNOL, V148, P3970; Hagenaars N, 2008, VACCINE, V26, P6555, DOI 10.1016/j.vaccine.2008.09.057; HAMMER J, 1993, CELL, V74, P197, DOI 10.1016/0092-8674(93)90306-B; HIRABAYASHI Y, 1991, IMMUNOLOGY, V72, P329; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Joo HM, 2010, VACCINE, V28, P2186, DOI 10.1016/j.vaccine.2009.12.058; Kitikoon P, 2009, VACCINE, V28, P523, DOI 10.1016/j.vaccine.2009.09.130; Klinman DM, 2004, IMMUNOL REV, V199, P201, DOI 10.1111/j.0105-2896.2004.00148.x; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; LIANG SH, 1994, J IMMUNOL, V152, P1653; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003; Milich DR, 2003, AUTOIMMUN REV, V2, P248, DOI 10.1016/S1568-9972(03)00031-4; Misplon JA, 2010, VACCINE, V28, P5817, DOI 10.1016/j.vaccine.2010.06.069; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Mozdzanowska K, 1999, VIROLOGY, V254, P138, DOI 10.1006/viro.1998.9534; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Otvos Laszlo Jr., 2008, V494, P263, DOI 10.1007/978-1-59745-419-3_15; PEJOSKI D, 2010, IMMUNOL CELL BIOL; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; RENEGAR KB, 1991, J VIROL, V65, P2146, DOI 10.1128/JVI.65.4.2146-2148.1991; SCHERLE PA, 1992, J IMMUNOL, V148, P212; SINIGAGLIA F, 1988, NATURE, V336, P778, DOI 10.1038/336778a0; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Talbot HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014442; TAMURA S, 1991, EUR J IMMUNOL, V21, P1337, DOI 10.1002/eji.1830210602; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990; Wolf AI, 2009, J IMMUNOL, V182, P871, DOI 10.4049/jimmunol.182.2.871; WU F, 2009, VACCINE; WU F, 2008, VACCINE; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang MX, 2006, MOL IMMUNOL, V43, P2195, DOI 10.1016/j.molimm.2005.12.015; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-151; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhou DM, 2010, MOL THER, V18, P2182, DOI 10.1038/mt.2010.202	63	31	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28445	10.1371/journal.pone.0028445	http://dx.doi.org/10.1371/journal.pone.0028445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22180783	gold, Green Submitted, Green Published			2022-12-27	WOS:000298367300011
J	Bazzini, AA; Manacorda, CA; Tohge, T; Conti, G; Rodriguez, MC; Nunes-Nesi, A; Villanueva, S; Fernie, AR; Carrari, F; Asurmendi, S				Bazzini, Ariel A.; Manacorda, Carlos A.; Tohge, Takayuki; Conti, Gabriela; Rodriguez, Maria C.; Nunes-Nesi, Adriano; Villanueva, Sofia; Fernie, Alisdair R.; Carrari, Fernando; Asurmendi, Sebastian			Metabolic and miRNA Profiling of TMV Infected Plants Reveals Biphasic Temporal Changes	PLOS ONE			English	Article							TOBACCO-MOSAIC-VIRUS; SYSTEMIC ACQUIRED-RESISTANCE; PROTEIN-MEDIATED RESISTANCE; RNA SILENCING SUPPRESSORS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSGENIC TOBACCO; DISEASE RESISTANCE; GAS-CHROMATOGRAPHY; NICOTIANA-TABACUM	Plant viral infections induce changes including gene expression and metabolic components. Identification of metabolites and microRNAs (miRNAs) differing in abundance along infection may provide a broad view of the pathways involved in signaling and defense that orchestrate and execute the response in plant-pathogen interactions. We used a systemic approach by applying both liquid and gas chromatography coupled to mass spectrometry to determine the relative level of metabolites across the viral infection, together with a miRs profiling using a micro-array based procedure. Systemic changes in metabolites were characterized by a biphasic response after infection. The first phase, detected at one dpi, evidenced the action of a systemic signal since no virus was detected systemically. Several of the metabolites increased at this stage were hormone-related. miRs profiling after infection also revealed a biphasic alteration, showing miRs alteration at 5 dpi where no virus was detected systemically and a late phase correlating with virus accumulation. Correlation analyses revealed a massive increase in the density of correlation networks after infection indicating a complex reprogramming of the regulatory pathways, either in response to the plant defense mechanism or to the virus infection itself. Our data propose the involvement of a systemic signaling on early miRs alteration.	[Bazzini, Ariel A.; Manacorda, Carlos A.; Conti, Gabriela; Rodriguez, Maria C.; Villanueva, Sofia; Carrari, Fernando; Asurmendi, Sebastian] CICVyA INTA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Rodriguez, Maria C.; Carrari, Fernando; Asurmendi, Sebastian] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Tohge, Takayuki; Nunes-Nesi, Adriano; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society	Bazzini, AA (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	sasurmendi@cnia.inta.gov.ar	Tohge, Takayuki/G-7924-2017; Nunes-Nesi, Adriano/D-6430-2013; Asurmendi, Sebastian/AAJ-1400-2021	Tohge, Takayuki/0000-0001-5555-5650; Asurmendi, Sebastian/0000-0001-9516-5948; Conti, Gabriela/0000-0003-4221-3760; Nunes-Nesi, Adriano/0000-0002-9581-9355	Instituto Nacional de Tecnologia Agropecuaria (INTA) (Argentina) [PE243532]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT) [2005 32598]; Max Planck Society (Germany); European Molecular Biology Organization (EMBO); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); INTA; ANPCyT; Alexander von Humdoldt foundation	Instituto Nacional de Tecnologia Agropecuaria (INTA) (Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT); Max Planck Society (Germany)(Max Planck Society); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INTA; ANPCyT(ANPCyT); Alexander von Humdoldt foundation	This work was supported by grants from Instituto Nacional de Tecnologia Agropecuaria (INTA) PE243532 (Argentina), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) (Argentina) Proyecto de Investigacion Cientifica y Tecnologica (PICT) 2005 32598, and Max Planck Society (Germany). A. B. is INTA research assistant and held a fellowship from European Molecular Biology Organization (EMBO) and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). C. A. M. holds a fellowship from INTA and G. C. holds an ANPCyT fellowship. T. T. is a recipient of a fellowship from the Alexander von Humdoldt foundation. M. C. R. hold a CONICET Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Asurmendi S, 2007, VIROLOGY, V366, P98, DOI 10.1016/j.virol.2007.03.014; Asurmendi S, 2004, P NATL ACAD SCI USA, V101, P1415, DOI 10.1073/pnas.0307778101; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzini AA, 2007, P NATL ACAD SCI USA, V104, P12157, DOI 10.1073/pnas.0705114104; Bazzini AA, 2006, PHYTOPATHOLOGY, V96, P1175, DOI 10.1094/PHYTO-96-1175; Bazzini AA, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-152; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Choi YH, 2006, J NAT PROD, V69, P742, DOI 10.1021/np050535b; Cillo F, 2009, MOL PLANT MICROBE IN, V22, P1239, DOI 10.1094/MPMI-22-10-1239; Csorba T, 2007, J VIROL, V81, P11768, DOI 10.1128/JVI.01230-07; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; Fernie AR, 2007, PHYTOCHEMISTRY, V68, P2861, DOI 10.1016/j.phytochem.2007.07.010; Foyer CH, 2009, ANNU REV PLANT BIOL, V60, P455, DOI 10.1146/annurev.arplant.043008.091948; Frazier TP, 2010, PLANTA, V232, P1289, DOI 10.1007/s00425-010-1255-1; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; He XF, 2008, FEBS LETT, V582, P2445, DOI 10.1016/j.febslet.2008.06.011; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; HORAI H, 2008, P INT C BIOMEDICAL E, P853; Hu QA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019549; Hull R., 2002, MATTHEWS PLANT VIROL; Jahangir M, 2008, J PLANT PHYSIOL, V165, P1429, DOI 10.1016/j.jplph.2008.04.011; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Junker BH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-109; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; KHRAIWESH B, 2011, BIOCH BIOPHYS ACTA; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kurihara Y, 2007, J GEN VIROL, V88, P2347, DOI 10.1099/vir.0.82994-0; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Liu YJ, 2009, PLANT PHYSIOL, V150, P1248, DOI 10.1104/pp.109.136242; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luo J, 2008, PLANT J, V56, P316, DOI 10.1111/j.1365-313X.2008.03597.x; MAHER EA, 1994, P NATL ACAD SCI USA, V91, P7802, DOI 10.1073/pnas.91.16.7802; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martin RC, 2010, J EXP BOT, V61, P2229, DOI 10.1093/jxb/erq063; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Niggeweg R, 2004, NAT BIOTECHNOL, V22, P746, DOI 10.1038/nbt966; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Lopez-Gresa MP, 2010, PHYTOCHEM ANALYSIS, V21, P89, DOI 10.1002/pca.1179; Reichel C, 1998, P NATL ACAD SCI USA, V95, P11169, DOI 10.1073/pnas.95.19.11169; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Silhavy D, 2004, TRENDS PLANT SCI, V9, P76, DOI 10.1016/j.tplants.2003.12.010; SUNKAR R, 2010, SEMIN CELL DEV BIOL; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Trindade I, 2010, PLANTA, V231, P705, DOI 10.1007/s00425-009-1078-0; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Varallyay E, 2010, EMBO J, V29, P3507, DOI 10.1038/emboj.2010.215; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Vogler H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000038; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yonekura-Sakakibara K, 2009, NAT PROD REP, V26, P1466, DOI 10.1039/b817077k; ZAITLIN M, 1987, ANNU REV PLANT PHYS, V38, P291, DOI 10.1146/annurev.pp.38.060187.001451	86	51	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28466	10.1371/journal.pone.0028466	http://dx.doi.org/10.1371/journal.pone.0028466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174812	Green Published, Green Submitted, gold			2022-12-27	WOS:000298366600019
J	Cantalapiedra, JL; Fernandez, MH; Morales, J				Cantalapiedra, Juan L.; Hernandez Fernandez, Manuel; Morales, Jorge			Biomic Specialization and Speciation Rates in Ruminants (Cetartiodactyla, Mammalia): A Test of the Resource-Use Hypothesis at the Global Scale	PLOS ONE			English	Article							EXTINCTION RATES; RED QUEEN; EVOLUTION; PATTERNS	The resource-use hypothesis proposed by E.S. Vrba predicts that specialist species have higher speciation and extinction rates than generalists because they are more susceptible to environmental changes and vicariance. In this work, we test some of the predictions derived from this hypothesis on the 197 extant and recently extinct species of Ruminantia (Cetartiodactyla, Mammalia) using the biomic specialization index (BSI) of each species, which is based on its distribution within different biomes. We ran 10000 Monte Carlo simulations of our data in order to get a null distribution of BSI values against which to contrast the observed data. Additionally, we drew on a supertree of the ruminants and a phylogenetic likelihood-based method (QuaSSE) for testing whether the degree of biomic specialization affects speciation rates in ruminant lineages. Our results are consistent with the predictions of the resource-use hypothesis, which foretells a higher speciation rate of lineages restricted to a single biome (BSI = 1) and higher frequency of specialist species in biomes that underwent high degree of contraction and fragmentation during climatic cycles. Bovids and deer present differential specialization across biomes; cervids show higher specialization in biomes with a marked hydric seasonality (tropical deciduous woodlands and schlerophyllous woodlands), while bovids present higher specialization in a greater variety of biomes. This might be the result of divergent physiological constraints as well as a different biogeographic and evolutionary history.	[Cantalapiedra, Juan L.; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Hernandez Fernandez, Manuel] Univ Complutense Madrid, Dept Paleontol, Fac Ciencias Geol, Madrid, Spain; [Hernandez Fernandez, Manuel] CSIC, UCM, Inst Geociencias, Dept Cambio Ambiental, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Cantalapiedra, JL (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain.	jlopezcant@gmail.com	Fernández, Manuel Hernández/I-5012-2013; Morales, Jorge/L-1476-2014; Cantalapiedra, Juan L/L-2135-2014	Fernández, Manuel Hernández/0000-0001-5640-9647; Morales, Jorge/0000-0001-5170-5754; Cantalapiedra, Juan L/0000-0003-0913-7735	Spanish Ministry of Science and Innovation [CGL2006-01773/BTE, CGL2008-05813-C02-01/BTE, CGL2010-19116/BOS]; Complutensian University of Madrid [PR1/06-14470-B]; UCM [UCM 910607]; Ministerio de Educacion y Ciencia of Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Complutensian University of Madrid; UCM; Ministerio de Educacion y Ciencia of Spain(Spanish Government)	This research was made possible by grants from the Spanish Ministry of Science and Innovation (CGL2006-01773/BTE, CGL2008-05813-C02-01/BTE and CGL2010-19116/BOS) and from the Complutensian University of Madrid (PR1/06-14470-B). The authors acknowledge additional financial support from the UCM through a grant to the Research Group UCM 910607 on Evolution of Cenozoic Mammals and Continental Palaeoenvironments. During the development of this research, MHF had a UCM contract from the Program "Ramon y Cajal" of the Ministerio de Educacion y Ciencia of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2011, PALEOBIOLOGY DATABAS; Ansell W. F. H., 1971, P1; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bibi F, 2009, PALAEONTOL ELECTRON, V12; Bigelow NH, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002558; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Bofarull AM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-97; Bruch AA, 2007, PALAEOGEOGR PALAEOCL, V253, P1, DOI 10.1016/j.palaeo.2007.03.030; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Corbet GB, 1992, MAMMALS INDO MALAYAN; DeMiguel D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-13; Doherty DA, 2004, J BIOGEOGR, V31, P57, DOI 10.1111/j.1365-2699.2004.00943.x; Eeley HAC, 1999, BIODIVERS CONSERV, V8, P1033, DOI 10.1023/A:1008831320469; Eisenberg H. J. F., 1989, MAMMALS NEOTROPICS, V1; Eisenberg H. J. F., 2000, MAMMALS NEOTROPICS, V3; Eronen JT, 2010, EVOL ECOL RES, V12, P235; Eronen JT, 2010, EVOLUTION, V64, P398, DOI 10.1111/j.1558-5646.2009.00830.x; European Commission, 2020, GUID GEOGR IND GIS S; Fernandez MH, 2005, EVOL ECOL, V19, P199, DOI 10.1007/s10682-004-8152-7; Fernandez MH, 2005, BIOL REV, V80, P269, DOI 10.1017/S1464793104006670; Fernandez MH, 2001, GLOBAL ECOL BIOGEOGR, V10, P189, DOI 10.1046/j.1466-822x.2001.00218.x; FitzJohn R. G., 2011, DIVERSITREE COMP PHY; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Fortelius M., 2011, NEOGENE OLD WORLD DA; Geist V., 1998, DEER WORLD THEIR EVO, P1; Gentry Alan W., 2000, P11; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Grubb Peter, 1993, P377; Hall E. R., 1981, MAMMALS N AM; Harcourt AH, 2002, J BIOGEOGR, V29, P445, DOI 10.1046/j.1365-2699.2002.00685.x; Harcourt AH, 2000, J BIOGEOGR, V27, P1169, DOI 10.1046/j.1365-2699.2000.00482.x; Hassanin A, 1999, MOL PHYLOGENET EVOL, V13, P227, DOI 10.1006/mpev.1999.0619; IUCN, 2008, DIG DISTR MAPS MAMM; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Liow LH, 2008, P NATL ACAD SCI USA, V105, P6097, DOI 10.1073/pnas.0709763105; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; McKenna M.C., 1997, CLASSIFICATION MAMMA, P640; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; MORALES J, 1993, GEOBIOS-LYON, V26, P207, DOI 10.1016/S0016-6995(93)80016-K; PICKFORD M, 1994, PALAEOGEOGR PALAEOCL, V112, P297, DOI 10.1016/0031-0182(94)90078-7; R Core Team, 2018, R LANG ENV STAT COMP; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Redford KH, 1992, MAMMALS NEOTROPICS, V2; SCHALLER GB, 1977, MOUNTAIN MONARCHS WI, P45; Scopoli J.A., 1777, INTRODVCTIO AD HIST; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Vrba E.S., 1980, P247; Vrba E. S., 1997, Palaeontologia Africana, V34, P127; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Vrba Elizabeth S., 1995, PALEOCLIMATE EVOLUTI; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; VRBA ES, 1980, S AFR J SCI, V76, P61; VRBA ES, 1992, J MAMMAL, V73, P1, DOI 10.2307/1381862; Vrba ES, 1999, HUMAN EVOLUT SER, P19; VRBA ES, 1993, AM J SCI, V293A, P418, DOI 10.2475/ajs.293.A.418; Walter H., 1970, VEGETATION CLIMA; WILSON DE, 1993, MAMMAL SPECIES WORLD, P377	64	24	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28749	10.1371/journal.pone.0028749	http://dx.doi.org/10.1371/journal.pone.0028749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174888	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000298366600035
J	Papayannopoulos, V; Staab, D; Zychlinsky, A				Papayannopoulos, Venizelos; Staab, Doris; Zychlinsky, Arturo			Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy	PLOS ONE			English	Article							EXTRACELLULAR TRAPS; DISEASE; PATHOGENESIS; INFLAMMATION; INHIBITOR; PROTEASES	Cystic fibrosis patients suffer from chronic lung infection and inflammation due to the secretion of viscous sputum. Sputum viscosity is caused by extracellular DNA, some of which originates from the release of neutrophil extracellular traps (NETs). During NET formation neutrophil elastase (NE) partially processes histones to decondense chromatin. NE is abundant in CF sputum and is thought to contribute to tissue damage. Exogenous nucleases are a palliative treatment in CF as they promote sputum solubilization. We show that in a process reminiscent of NET formation, NE enhances sputum solubilization by cleaving histones to enhance the access of exogenous nucleases to DNA. In addition, we find that in Cf sputum NE is predominantly bound to DNA, which is known to downregulate its proteolytic activity and may restrict host tissue damage. The beneficial role of NE in CF sputum solubilization may have important implications for the development of CF therapies targeting NE.	[Papayannopoulos, Venizelos; Zychlinsky, Arturo] Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany; [Staab, Doris] Charite, Christiane Herzog Cyst Fibrosis Ctr, Clin Pediat Pneumol & Immunol, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Papayannopoulos, V (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	veni@mpiib-berlin.mpg.de		Papayannopoulos, Venizelos/0000-0002-3741-8190	May Planck Society; European Molecular Biology Organization (EMBO)	May Planck Society; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	This study was funded by the May Planck Society. Dr. Papayannopoulos was also funded by and by Postdoctoral Fellowship from the European Molecular Biology Organization (EMBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiter K, 2006, CURR BIOL, V16, P401, DOI 10.1016/j.cub.2006.01.056; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cantin AM, 1998, AM J RESP CRIT CARE, V157, P464, DOI 10.1164/ajrccm.157.2.9608033; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fujie K, 1999, EUR J PHARMACOL, V374, P117, DOI 10.1016/S0014-2999(99)00268-X; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; LETHEM MI, 1990, EUR RESPIR J, V3, P19; LIEBERMAN J, 1967, J LAB CLIN MED, V70, P595; Marcos V, 2010, NAT MED, V16, P1018, DOI 10.1038/nm.2209; MCINTOSH I, 1992, FASEB J, V6, P2775, DOI 10.1096/fasebj.6.10.1378801; Oermann C M, 2001, Curr Opin Investig Drugs, V2, P900; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; Ratjen F, 2008, PAEDIATR RESPIR REV, V9, P144, DOI 10.1016/j.prrv.2008.01.004; Roghanian A, 2008, J AEROSOL MED PULM D, V21, P125, DOI 10.1089/jamp.2007.0653; Shah PL, 2001, RESPIRATION, V68, P160, DOI 10.1159/000050486; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vogelmeier C, 1996, EUR RESPIR J, V9, P2193, DOI 10.1183/09031936.96.09112193; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005	24	158	164	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28526	10.1371/journal.pone.0028526	http://dx.doi.org/10.1371/journal.pone.0028526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174830	Green Submitted, Green Published, gold			2022-12-27	WOS:000298365700044
J	Tibbetts, EA; Skaldina, O; Zhao, V; Toth, AL; Skaldin, M; Beani, L; Dale, J				Tibbetts, Elizabeth A.; Skaldina, Oksana; Zhao, Vera; Toth, Amy L.; Skaldin, Maksim; Beani, Laura; Dale, James			Geographic Variation in the Status Signals of Polistes dominulus Paper Wasps	PLOS ONE			English	Article							BODY-SIZE; SEXUAL SELECTION; CHARACTER DISPLACEMENT; QUALITY SIGNALS; COLOR PATTERNS; XENOS-VESPARUM; BIRD-SONG; SPECIATION; HYMENOPTERA; EVOLUTION	Understanding intraspecific geographic variation in animal signals poses a challenging evolutionary problem. Studies addressing geographic variation typically focus on signals used in mate-choice, however, geographic variation in intrasexual signals involved in competition is also known to occur. In Polistes dominulus paper wasps, females have black facial spots that signal dominance: individuals wasps with more complex 'broken' facial patterns are better fighters and are avoided by rivals. Recent work suggests there is dramatic geographic variation in these visual signals of quality, though this variation has not been explicitly described or quantified. Here, we analyze variation in P. dominulus signals across six populations and explore how environmental conditions may account for this variation. Overall, we found substantial variation in facial pattern brokenness across populations and castes. Workers have less broken facial patterns than gynes and queens, which have similar facial patterns. Strepsipteran parasitism, body size and temperature are all correlated with the facial pattern variation, suggesting that developmental plasticity likely plays a key role in this variation. First, the extent of parasitism varies across populations and parasitized individuals have lower facial pattern brokenness than unparasitized individuals. Second, there is substantial variation in body size across populations and a weak but significant relationship between facial pattern brokenness and body size. Wasps from populations with smaller body size (e. g. Italy) tend to have less broken facial patterns than wasps from populations with larger body size (e. g. New York, USA). Third, there is an apparent association between facial patterns and climate, with wasp from cooler locations tending to have higher facial pattern brokenness than wasps from warmer locations. Additional experimental work testing the causes and consequences of facial pattern variation will be important, as geographic variation in signals has important consequences for the evolution of communication systems and social behavior.	[Tibbetts, Elizabeth A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Skaldina, Oksana] Natl Sci Ctr Nikita, Dept Nat Protect Nikitsky Bot Garden, Yalta, Crimea, Ukraine; [Zhao, Vera; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Zhao, Vera; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Skaldin, Maksim] Univ Turku, Dept Chem, Joint Biotechnol Lab, Math & Nat Sci Fac, Turku, Finland; [Beani, Laura] Univ Florence, Dept Evolutionary Biol Leo Pardi, Florence, Italy; [Dale, James] Massey Univ, Inst Nat Sci, Auckland, New Zealand	University of Michigan System; University of Michigan; Iowa State University; Iowa State University; University of Turku; University of Florence; Massey University	Tibbetts, EA (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	tibbetts@umich.edu		Tibbetts, Elizabeth/0000-0002-5625-892X	University of Michigan	University of Michigan(University of Michigan System)	Funding was provided by the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CN, 2010, P ROY SOC B-BIOL SCI, V277, P3669, DOI 10.1098/rspb.2010.0935; Arnett AE, 2003, ECOL ENTOMOL, V28, P645, DOI 10.1111/j.1365-2311.2003.00554.x; BAKER MC, 1985, BEHAV BRAIN SCI, V8, P85, DOI 10.1017/S0140525X00019750; BEANI L, ANIMAL BEHAV; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Cervo R, 2008, P ROY SOC B-BIOL SCI, V275, P1189, DOI 10.1098/rspb.2007.1779; Cervo R, 2006, ANN ZOOL FENN, V43, P531; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Dapporto L, 2007, PARASITOLOGY, V134, P545, DOI 10.1017/S0031182006001739; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Foster SA, 1999, TRENDS ECOL EVOL, V14, P190, DOI 10.1016/S0169-5347(98)01577-8; Fucini S, 2009, INSECT SOC, V56, P347, DOI 10.1007/s00040-009-0030-4; GERHARDT HC, 1994, ANNU REV ECOL SYST, V25, P293, DOI 10.1146/annurev.es.25.110194.001453; Giusti F, 2007, ARTHROPOD STRUCT DEV, V36, P183, DOI 10.1016/j.asd.2007.01.001; Green JP, 2011, ANIM BEHAV, V81, P205, DOI 10.1016/j.anbehav.2010.10.002; Hochberg ME, 2003, EVOLUTION, V57, P154, DOI 10.1554/0014-3820(2003)057[0154:SMS]2.0.CO;2; Hughes DP, 2005, OIKOS, V110, P428, DOI 10.1111/j.0030-1299.2005.13791.x; MANFREDINI F, 2010, ETHOL ECOL EVOL, V22, P1; NONACS P, 1995, ECOLOGY, V76, P953, DOI 10.2307/1939359; Ortolani I, 2010, ANIM BEHAV, V80, P683, DOI 10.1016/j.anbehav.2010.07.003; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pickett KM, 2004, J KANSAS ENTOMOL SOC, V77, P742, DOI 10.2317/E-18.1; Podos J, 2007, ADV STUD BEHAV, V37, P403, DOI 10.1016/S0065-3454(07)37009-5; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Price TD, 2006, J EXP BIOL, V209, P2368, DOI 10.1242/jeb.02183; Reeve H.K., 1991, P99; Rusina LYu, 2007, ENTOMOL REV, V87, P1155, DOI DOI 10.1134/S0013873807090060; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Stillwell RC, 2010, OIKOS, V119, P1387, DOI 10.1111/j.1600-0706.2010.18670.x; Tibbetts EA, 2004, NATURE, V432, P218, DOI 10.1038/nature02949; Tibbetts EA, 2008, BIOL LETTERS, V4, P237, DOI 10.1098/rsbl.2008.0048; Tibbetts EA, 2006, ANN ZOOL FENN, V43, P575; Tibbetts EA, 2007, BEHAV ECOL, V18, P602, DOI 10.1093/beheco/arm013; Tibbetts EA, 2011, BEHAV ECOL SOCIOBIOL, V65, P1123, DOI 10.1007/s00265-010-1126-6; Tibbetts EA, 2010, P ROY SOC B-BIOL SCI, V277, P3461, DOI 10.1098/rspb.2010.1003; Tibbetts EA, 2010, AM NAT, V175, P495, DOI 10.1086/651596; Tibbetts EA, 2010, BIOL LETTERS, V6, P10, DOI 10.1098/rsbl.2009.0420; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Toth AL, 2009, INSECT SOC, V56, P77, DOI 10.1007/s00040-008-1041-2; TURILLAZZI S, 1980, MONIT ZOOL ITAL, V14, P63; TURILLAZZI S, 1981, MONIT ZOOL ITAL, V15, P275; Wilczynski W, 1999, GEOGRAPHIC VARIATION IN BEHAVIOR, P234; Zanette L, 2009, BEHAV ECOL, V20, P773, DOI 10.1093/beheco/arp060	45	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28173	10.1371/journal.pone.0028173	http://dx.doi.org/10.1371/journal.pone.0028173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174776	Green Submitted, gold, Green Published			2022-12-27	WOS:000298365700020
J	Yee, J; White, RE; Anderton, E; Allday, MJ				Yee, Jade; White, Robert E.; Anderton, Emma; Allday, Martin J.			Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression	PLOS ONE			English	Article							BURKITTS-LYMPHOMA CELLS; DEATH; PROTEIN; BCL-2; P53; EBNA2; LINES; DNA; PERSISTENCE; ACTIVATION	Latent Epstein-Barr virus (EBV) has been shown to protect Burkitt's lymphoma-derived B cells from apoptosis induced by agents that cause damage to DNA, in the context of mutant p53. This protection requires expression of the latency-associated nuclear proteins EBNA3A and EBNA3C and correlates with their ability to cooperate in the repression of the gene encoding the pro-apoptotic, BH3-only protein BIM. Here we confirm that latent EBV in B cells also inhibits apoptosis induced by two other agents - ionomycin and staurosporine - and show that these act by a distinct pathway that involves a p53-independent increase in expression of another pro-apoptotic, BH3-only protein, NOXA. Analyses employing a variety of B cells infected with naturally occurring EBV or B95.8 EBV-BAC recombinant mutants indicated that the block to NOXA induction does not depend on the well-characterized viral latency-associated genes (EBNAs 1, 2, 3A, 3B, 3C, the LMPs or the EBERs) or expression of BIM. Regulation of NOXA was shown to be at least partly at the level of mRNA and the requirement for NOXA to induce cell death in this context was demonstrated by NOXA-specific shRNA-mediated depletion experiments. Although recombinant EBV with a deletion removing the BHRF1 locus - that encodes the BCL2-homologue BHRF1 and three microRNAs - partially abrogates protection against ionomycin and staurosporine, the deletion has no effect on the EBV-mediated block to NOXA accumulation.	[Yee, Jade; White, Robert E.; Anderton, Emma; Allday, Martin J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, Virol Sect, London, England	Imperial College London	Yee, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Infect Dis, Virol Sect, London, England.	m.allday@imperial.ac.uk		White, Robert/0000-0002-5115-2173	Wellcome Trust [077489]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was supported by a Wellcome Trust programme grant (077489). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allday MJ, 2009, SEMIN CANCER BIOL, V19, P366, DOI 10.1016/j.semcancer.2009.07.007; ALLDAY MJ, 1995, EMBO J, V14, P1382, DOI 10.1002/j.1460-2075.1995.tb07124.x; Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668; Babcock GJ, 1999, J EXP MED, V190, P567, DOI 10.1084/jem.190.4.567; Bornkamm GW, 2001, PHILOS T R SOC B, V356, P437, DOI 10.1098/rstb.2000.0781; CasciolaRosen L, 1996, J EXP MED, V183, P1957, DOI 10.1084/jem.183.5.1957; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Feederle R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001294; FINKE J, 1987, J VIROL, V61, P3870, DOI 10.1128/JVI.61.12.3870-3878.1987; Garibal J, 2007, J VIROL, V81, P7598, DOI 10.1128/JVI.02435-06; GREGORY CD, 1991, NATURE, V349, P612, DOI 10.1038/349612a0; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; Inman GJ, 2001, J VIROL, V75, P2400, DOI 10.1128/JVI.75.5.2400-2410.2001; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758; Kelly Gemma L, 2007, Hematology Am Soc Hematol Educ Program, P277; Kelly GL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000341; Kelly GL, 2005, J VIROL, V79, P10709, DOI 10.1128/JVI.79.16.10709-10717.2005; Kennedy G, 2003, P NATL ACAD SCI USA, V100, P14269, DOI 10.1073/pnas.2336099100; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Leao M, 2007, J VIROL, V81, P248, DOI 10.1128/JVI.01096-06; Lee JM, 2002, P NATL ACAD SCI USA, V99, P11878, DOI 10.1073/pnas.182552499; Lindstrom MS, 2002, SEMIN CANCER BIOL, V12, P381, DOI 10.1016/S1044-579X(02)00058-5; Neuhierl B, 2002, P NATL ACAD SCI USA, V99, P15036, DOI 10.1073/pnas.232381299; O'Nions J, 2004, J GEN VIROL, V85, P881, DOI 10.1099/vir.0.19704-0; O'Nions J, 2006, J VIROL, V80, P12408, DOI 10.1128/JVI.01363-06; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; PEARSON GR, 1987, VIROLOGY, V160, P151, DOI 10.1016/0042-6822(87)90055-9; ROUGHAN JE, 2009, J VIROL; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Speck SH, 2002, NAT MED, V8, P1086, DOI 10.1038/nm1002-1086; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Tafani M, 2001, CANCER RES, V61, P2459; TAKADA K, 1991, VIRUS GENES, V5, P147, DOI 10.1007/BF00571929; Thorley-Lawson DA, 2004, NEW ENGL J MED, V350, P1328, DOI 10.1056/NEJMra032015; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Touitou R, 2001, J VIROL, V75, P7749, DOI 10.1128/JVI.75.16.7749-7755.2001; Wang S, 1996, CANCER RES, V56, P4610; White RE, 2003, J GEN VIROL, V84, P3393, DOI 10.1099/vir.0.19387-0; White RE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013979; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	47	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28506	10.1371/journal.pone.0028506	http://dx.doi.org/10.1371/journal.pone.0028506			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174825	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700040
J	Liu, WB; Li, DF; Liu, JF; Chen, SR; Qu, LJ; Zheng, JX; Xu, GY; Yang, N				Liu, Wenbo; Li, Dongfeng; Liu, Jianfeng; Chen, Sirui; Qu, Lujiang; Zheng, Jiangxia; Xu, Guiyun; Yang, Ning			A Genome-Wide SNP Scan Reveals Novel Loci for Egg Production and Quality Traits in White Leghorn and Brown-Egg Dwarf Layers	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; QUANTITATIVE TRAITS; GENETIC-VARIATION; INSULIN-RECEPTOR; RED JUNGLEFOWL; ASSOCIATION; CHICKENS; CATTLE; POULTRY; IDENTIFICATION	Availability of the complete genome sequence as well as high-density SNP genotyping platforms allows genome-wide association studies (GWAS) in chickens. A high-density SNP array containing 57,636 markers was employed herein to identify associated variants underlying egg production and quality traits within two lines of chickens, i.e., White Leghorn and brown-egg dwarf layers. For each individual, age at first egg (AFE), first egg weight (FEW), and number of eggs (EN) from 21 to 56 weeks of age were recorded, and egg quality traits including egg weight (EW), eggshell weight (ESW), yolk weight (YW), eggshell thickness (EST), eggshell strength (ESS), albumen height(AH) and Haugh unit(HU) were measured at 40 and 60 weeks of age. A total of 385 White Leghorn females and 361 brown-egg dwarf dams were selected to be genotyped. The genome-wide scan revealed 8 SNPs showing genome-wise significant (P<1.51E-06, Bonferroni correction) association with egg production and quality traits under the Fisher's combined probability method. Some significant SNPs are located in known genes including GRB14 and GALNT1 that can impact development and function of ovary, but more are located in genes with unclear functions in layers, and need to be studied further. Many chromosome-wise significant SNPs were also detected in this study and some of them are located in previously reported QTL regions. Most of loci detected in this study are novel and the follow-up replication studies may be needed to further confirm the functional significance for these newly identified SNPs.	[Liu, Wenbo] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; China Agr Univ, MOA Key Lab Anim Genet & Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Liu, WB (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	nyang@cau.edu.cn		Liu, Jian-Feng/0000-0002-5766-7864; Yang, Ning/0000-0001-5772-3320	Chinese Agricultural Research System [CARS-41]; National Scientific Supporting Projects of China [2011BAD28B03]	Chinese Agricultural Research System; National Scientific Supporting Projects of China	This work was supported by funds of the Chinese Agricultural Research System (CARS-41) and the National Scientific Supporting Projects of China (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Abasht B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S2; [Anonymous], 1990, POULTRY BREEDING GEN; Arnett DK, 2011, CIRC RES, V108, P279, DOI 10.1161/CIRCRESAHA.110.239210; Bereziat V, 2002, J BIOL CHEM, V277, P4845, DOI 10.1074/jbc.M106574200; Besbes B, 1999, ANIM SCI, V68, P433, DOI 10.1017/S135772980005044X; Bhattacharya TK, 2010, THERIOGENOLOGY; Bolormaa S, 2011, J ANIM SCI; CARRASQUILLO MM, 2011, J ALZHEIMERS DIS; Chen CF, 2007, THERIOGENOLOGY, V68, P1305, DOI 10.1016/j.theriogenology.2007.08.032; Daly RJ, 1996, J BIOL CHEM, V271, P12502, DOI 10.1074/jbc.271.21.12502; Dekkers J C M, 2004, J Anim Sci, V82 E-Suppl, pE313; Dunn IC, 2009, ANIM GENET, V40, P110, DOI 10.1111/j.1365-2052.2008.01794.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Han B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000456; Hemming R, 2001, BIOCHEM CELL BIOL, V79, P21, DOI 10.1139/bcb-79-1-21; Hess A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-96; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kenzelmann D, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-30; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Kim MH, 2004, POULTRY SCI, V83, P1203, DOI 10.1093/ps/83.7.1203; Kurz EU, 2004, DNA REPAIR, V3, P889, DOI 10.1016/j.dnarep.2004.03.029; Lamont SJ, 1996, ANIM GENET, V27, P1, DOI 10.1111/j.1365-2052.1996.tb01170.x; Lewis PD, 2010, POULTRY SCI, V89, P108, DOI 10.3382/ps.2009-00312; Lewis PD, 1999, POULTRY SCI, V78, P1227, DOI 10.1093/ps/78.8.1227; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McMurtry JP, 1997, DOMEST ANIM ENDOCRIN, V14, P199, DOI 10.1016/S0739-7240(97)00019-2; Meuwissen THE, 2001, GENETICS, V157, P1819; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rubin BP, 1999, DEV BIOL, V216, P195, DOI 10.1006/dbio.1999.9503; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Sakai T, 2003, DNA RES, V10, P155, DOI 10.1093/dnares/10.4.155; Sasaki O, 2004, ANIM GENET, V35, P188, DOI 10.1111/j.1365-2052.2004.01133.x; Sellers TA, 2008, CANCER EPIDEM BIOMAR, V17, P397, DOI 10.1158/1055-9965.EPI-07-0565; Smith TPL, 2001, GENOME RES, V11, P626, DOI 10.1101/gr.170101; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Takahashi H, 2010, ANIM GENET, V41, P541, DOI 10.1111/j.1365-2052.2010.02034.x; Tuiskula-Haavisto M, 2002, POULTRY SCI, V81, P919, DOI 10.1093/ps/81.7.919; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; WEI M, 1993, J ANIM SCI, V71, P57, DOI 10.2527/1993.71157x; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wright D, 2006, ANIM GENET, V37, P529, DOI 10.1111/j.1365-2052.2006.01515.x; Yang N., 1996, P 20 WORLDS POULTR C, V1, P447; Yao JF, 2010, POULTRY SCI, V89, P883, DOI 10.3382/ps.2009-00613; Zhang LC, 2005, POULTRY SCI, V84, P1209, DOI 10.1093/ps/84.8.1209	49	76	91	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28600	10.1371/journal.pone.0028600	http://dx.doi.org/10.1371/journal.pone.0028600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174844	Green Published, Green Submitted, gold			2022-12-27	WOS:000298163600036
J	Davies, TW; Jenkins, SR; Kingham, R; Kenworthy, J; Hawkins, SJ; Hiddink, JG				Davies, Thomas W.; Jenkins, Stuart R.; Kingham, Rachel; Kenworthy, Joseph; Hawkins, Stephen J.; Hiddink, Jan G.			Dominance, Biomass and Extinction Resistance Determine the Consequences of Biodiversity Loss for Multiple Coastal Ecosystem Processes	PLOS ONE			English	Article							FUNCTIONAL CONSEQUENCES; GRASSLAND EXPERIMENT; EUROPEAN GRASSLANDS; PARTICLE RETENTION; MARINE ECOSYSTEMS; PLANT DIVERSITY; FILTRATION-RATE; SPECIES LOSS; COMMUNITIES; PRODUCTIVITY	Key ecosystem processes such as carbon and nutrient cycling could be deteriorating as a result of biodiversity loss. However, currently we lack the ability to predict the consequences of realistic species loss on ecosystem processes. The aim of this study was to test whether species contributions to community biomass can be used as surrogate measures of their contribution to ecosystem processes. These were gross community productivity in a salt marsh plant assemblage and an intertidal macroalgae assemblage; community clearance of microalgae in sessile suspension feeding invertebrate assemblage; and nutrient uptake in an intertidal macroalgae assemblage. We conducted a series of biodiversity manipulations that represented realistic species extinction sequences in each of the three contrasting assemblages. Species were removed in a subtractive fashion so that biomass was allowed to vary with each species removal, and key ecosystem processes were measured at each stage of community disassembly. The functional contribution of species was directly proportional to their contribution to community biomass in a 1:1 ratio, a relationship that was consistent across three contrasting marine ecosystems and three ecosystem processes. This suggests that the biomass contributed by a species to an assemblage can be used to approximately predict the proportional decline in an ecosystem process when that species is lost. Such predictions represent "worst case scenarios" because, over time, extinction resilient species can offset the loss of biomass associated with the extinction of competitors. We also modelled a "best case scenario" that accounts for compensatory responses by the extant species with the highest per capita contribution to ecosystem processes. These worst and best case scenarios could be used to predict the minimum and maximum species required to sustain threshold values of ecosystem processes in the future.	[Davies, Thomas W.; Jenkins, Stuart R.; Kingham, Rachel; Kenworthy, Joseph; Hawkins, Stephen J.; Hiddink, Jan G.] Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales; [Davies, Thomas W.; Jenkins, Stuart R.; Hawkins, Stephen J.] Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England	Bangor University; Marine Biological Association United Kingdom	Davies, TW (corresponding author), Bangor Univ, Sch Ocean Sci, Menai Bridge, Anglesey, Wales.	Thomas.Davies@exeter.ac.uk	Jenkins, Stuart R/D-2032-2010; Davies, Thomas W/H-8103-2013; Hiddink, Jan Geert/C-1238-2009	Jenkins, Stuart R/0000-0002-2299-6318; Davies, Thomas W/0000-0002-4673-9893; Hiddink, Jan Geert/0000-0001-7114-830X; Kenworthy, Joseph/0000-0001-8655-137X	NERC [G00226 CASE]; University of Plymouth, UK; Oceans 2025 programme	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Plymouth, UK; Oceans 2025 programme	This work was funded under a NERC PhD studentship G00226 CASE partnered by the Marine Biological Association of the United Kingdom (MBA). Additional funding for the CO2 flux apparatus was provided by Dr Richard Thompson, University of Plymouth, UK. The MBA were supported by NERC grant-in-aid and the Oceans 2025 programme (theme 4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; [Anonymous], 1975, COMMUNITIES ECOSYSTE; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Fox DL, 1937, BIOL BULL-US, V72, P417, DOI 10.2307/1537700; Gaston KJ, 2010, SCIENCE, V327, P154, DOI 10.1126/science.1182818; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Gross K, 2005, ECOL LETT, V8, P409, DOI 10.1111/j.1461-0248.2005.00733.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Ives AR, 2004, NATURE, V429, P174, DOI 10.1038/nature02515; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JORGENSEN CB, 1984, MAR ECOL PROG SER, V15, P283, DOI 10.3354/meps015283; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; McIntyre PB, 2007, P NATL ACAD SCI USA, V104, P4461, DOI 10.1073/pnas.0608148104; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PIMM SL, 1988, AM NAT, V132, P757, DOI 10.1086/284889; Power ME, 1996, BIOSCIENCE, V46, P609, DOI 10.2307/1312990; RANDLOV A, 1979, MAR ECOL PROG SER, V1, P55, DOI 10.3354/meps001055; RIISGARD HU, 1988, MAR ECOL PROG SER, V45, P217, DOI 10.3354/meps045217; Ritz C, 2008, USE R, P1; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Sasaki T, 2011, DOMINANT SPECIES RAT, P1; Schmid Bernhard, 2009, P14; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Turon X, 1997, J EXP ZOOL, V278, P22, DOI 10.1002/(SICI)1097-010X(19970501)278:1<22::AID-JEZ3>3.0.CO;2-8; Ulbrich U, 1999, CLIM DYNAM, V15, P551, DOI 10.1007/s003820050299; van Hulzen JB, 2006, J VEG SCI, V17, P291, DOI 10.1111/j.1654-1103.2006.tb02448.x; Wardle DA, 1997, SCIENCE, V277, P1296, DOI 10.1126/science.277.5330.1296; Winfree R, 2009, P R SOC B, V276, P229, DOI 10.1098/rspb.2008.0709; Zavaleta E, 2009, ANN NY ACAD SCI, V1162, P311, DOI 10.1111/j.1749-6632.2009.04448.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	50	24	24	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28362	10.1371/journal.pone.0028362	http://dx.doi.org/10.1371/journal.pone.0028362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163297	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000298161900033
J	Somaweera, R; Webb, JK; Shine, R				Somaweera, Ruchira; Webb, Jonathan K.; Shine, Richard			Determinants of Habitat Selection by Hatchling Australian Freshwater Crocodiles	PLOS ONE			English	Article							AMERICAN CROCODILE; CAIMAN-CROCODILUS; CROCODYLUS-NILOTICUS; PREDATION RISK; MOLECULAR ASSESSMENT; TROPICAL AUSTRALIA; NESTING ECOLOGY; FOREST HABITAT; SITE SELECTION; DIET	Animals almost always use habitats non-randomly, but the costs and benefits of using specific habitat types remain unknown for many types of organisms. In a large lake in northwestern Australia (Lake Argyle), most hatchling (<12-month-old) freshwater crocodiles (Crocodylus johnstoni) are found in floating vegetation mats or grassy banks rather than the more widely available open banks. Mean body sizes of young crocodiles did not differ among the three habitat types. We tested four potential explanations for non-random habitat selection: proximity to nesting sites, thermal conditions, food availability, and exposure to predation. The three alternative habitat types did not differ in proximity to nesting sites, or in thermal conditions. Habitats with higher food availability harboured more hatchlings, and feeding rates (obtained by stomach-flushing of recently-captured crocodiles) were highest in such areas. Predation risk may also differ among habitats: we were twice as likely to capture a crocodile after seeing it in open-bank sites than in the other two habitat types. Thus, habitat selection of hatchling crocodiles in this system may be driven both by prey availability and by predation risk.	[Somaweera, Ruchira; Webb, Jonathan K.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Somaweera, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	ruchira.somaweera@gmail.com	Somaweera, Ruchira/G-7531-2014	Somaweera, Ruchira/0000-0002-7470-8736; Webb, Jonathan/0000-0003-4822-6829	Australian Research Council; University of Sydney	Australian Research Council(Australian Research Council); University of Sydney(University of Sydney)	This project was funded by the Australian Research Council grant to Richard Shine (http://www.arc.gov.au/) and the Postgraduate research support scheme grant of University of Sydney to Ruchira Somaweera (http://sydney.edu.au/scholarships/research/prss.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1989, ETHOLOGY, V82, P116; Abramsky Z, 2002, BEHAV ECOL, V13, P497, DOI 10.1093/beheco/13.4.497; ALLSTEADT J, 1994, J HERPETOL, V28, P12, DOI 10.2307/1564674; Barr AD, 2002, 2202 CSIRO LAND WAT; Barr B.R., 1997, THESIS U MIAMI CORAL; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Byrom AE, 2002, J APPL ECOL, V39, P67, DOI 10.1046/j.1365-2664.2002.00689.x; Campos Z, 2006, HERPETOL J, V16, P123; CONNER RN, 1991, WILSON BULL, V103, P446; Cooper-Preston H., 1991, THESIS U NEW ENGLAND; Da Silveira R, 1997, J HERPETOL, V31, P514; Di Stefano J, 2009, AUSTRAL ECOL, V34, P143, DOI 10.1111/j.1442-9993.2008.01890.x; Downes S, 1998, ANIM BEHAV, V55, P1373, DOI 10.1006/anbe.1997.0704; Dreitz VJ, 2004, AUK, V121, P894, DOI 10.1642/0004-8038(2004)121[0894:EONDAW]2.0.CO;2; Endo H, 2002, ANAT HISTOL EMBRYOL, V31, P206, DOI 10.1046/j.1439-0264.2002.00396.x; Fujisaki I, 2007, J WILDLIFE MANAGE, V71, P2284, DOI 10.2193/2006-278; G. Webb Pty Ltd, 1989, RES CROC SURV LAK KU; Games I, 1990, THESIS U ZIMBABWE; GARRICK LD, 1977, NAT HIST, V86, P54; Glen AS, 2010, ECOL RES, V25, P311, DOI 10.1007/s11284-009-0653-y; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Hekkala ER, 2010, CONSERV GENET, V11, P1435, DOI 10.1007/s10592-009-9970-5; How RA, 2009, J ZOOL, V278, P206, DOI 10.1111/j.1469-7998.2009.00569.x; Hultgren KM, 2010, BEHAV ECOL, V21, P329, DOI 10.1093/beheco/arp192; JOANEN T, 1989, AM ZOOL, V29, P987; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; KUSHLAN JA, 1989, J HERPETOL, V23, P7, DOI 10.2307/1564310; LANG JW, 1981, J THERM BIOL, V6, P73, DOI 10.1016/0306-4565(81)90056-5; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Lecomte N, 2008, J ANIM ECOL, V77, P439, DOI 10.1111/j.1365-2656.2008.01354.x; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LIND AJ, 1994, ANIM BEHAV, V48, P1261, DOI 10.1006/anbe.1994.1362; MAZZOTTI FJ, 1986, HERPETOLOGICA, V42, P191; MAZZOTTI FJ, 1989, B MAR SCI, V44, P220; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; OGDEN JC, 1978, J HERPETOL, V12, P183, DOI 10.2307/1563406; OUBOTER PE, 1988, J HERPETOL, V22, P283, DOI 10.2307/1564151; Peterson MS, 2003, REV FISH SCI, V11, P291, DOI 10.1080/10641260390255844; Platt SG, 2000, COPEIA, P869, DOI 10.1643/0045-8511(2000)000[0869:NEOTAC]2.0.CO;2; Platt SG, 2002, HERPETOL J, V12, P81; POWER ME, 1984, J ANIM ECOL, V53, P357, DOI 10.2307/4521; Reagan S.R., 2000, THESIS LOUISIANA STA; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; Russello MA, 2007, CONSERV GENET, V8, P777, DOI 10.1007/s10592-006-9225-7; Sadleir RW, 2008, J EVOLUTION BIOL, V21, P1578, DOI 10.1111/j.1420-9101.2008.01602.x; Somaweera R, 2011, ECOL RES, V26, P957, DOI 10.1007/s11284-011-0853-0; Somaweera R, 2011, WILDLIFE RES, V38, P380, DOI 10.1071/WR11026; STEFFE AS, 1989, MAR ECOL PROG SER, V55, P23, DOI 10.3354/meps055023; Temsiripong Y, 1999, THESIS U FLORIDA; Tucker AD, 1997, J HERPETOL, V31, P114, DOI 10.2307/1565339; Tucker AD, 1996, COPEIA, P978, DOI 10.2307/1447661; Wallace KM, 2008, J HERPETOL, V42, P361, DOI 10.1670/07-1071.1; Webb G., 1998, CROCODILES AUSTR; WEBB GJW, 1982, AUST J ZOOL, V30, P877, DOI 10.1071/ZO9820877; WMI Pty Ltd, 2009, RES SPOTL SURV CROC; WMI Pty Ltd, 2005, RES SPOTL SURV CROC	58	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28533	10.1371/journal.pone.0028533	http://dx.doi.org/10.1371/journal.pone.0028533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163308	Green Published, gold			2022-12-27	WOS:000298161900045
J	Yang, SL; Zhang, H; Mao, HM; Yan, DW; Lu, SX; Lian, LS; Zhao, GY; Yan, YL; Deng, WD; Shi, XW; Han, SX; Li, S; Wang, XJ; Gou, X				Yang, Shuli; Zhang, Hao; Mao, Huaming; Yan, Dawei; Lu, Shaoxiong; Lian, Linsheng; Zhao, Guiying; Yan, Yulin; Deng, Weidong; Shi, Xianwei; Han, Shuxin; Li, Shuai; Wang, Xiujuan; Gou, Xiao			The Local Origin of the Tibetan Pig and Additional Insights into the Origin of Asian Pigs	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANCIENT DNA; SUS-SCROFA; WILD BOARS; MICROSATELLITE MARKERS; GENETIC-RELATIONSHIP; DOMESTIC PIGS; HIGH-ALTITUDE; BREEDS; POPULATIONS	Background: The domestic pig currently indigenous to the Tibetan highlands is supposed to have been introduced during a continuous period of colonization by the ancestors of modern Tibetans. However, there is no direct genetic evidence of either the local origin or exotic migration of the Tibetan pig. Methods and Findings: We analyzed mtDNA hypervariable segment I (HVI) variation of 218 individuals from seven Tibetan pig populations and 1,737 reported mtDNA sequences from domestic pigs and wild boars across Asia. The Bayesian consensus tree revealed a main haplogroup M and twelve minor haplogroups, which suggested a large number of small scale in situ domestication episodes. In particular, haplogroups D1 and D6 represented two highly divergent lineages in the Tibetan highlands and Island Southeastern Asia, respectively. Network analysis of haplogroup M further revealed one main subhaplogroup M1 and two minor subhaplogroups M2 and M3. Intriguingly, M2 was mainly distributed in Southeastern Asia, suggesting for a local origin. Similar with haplogroup D6, M3 was mainly restricted in Island Southeastern Asia. This pattern suggested that Island Southeastern Asia, but not Southeastern Asia, might be the center of domestication of the so-called Pacific clade (M3 and D6 here) described in previous studies. Diversity gradient analysis of major subhaplogroup M1 suggested three local origins in Southeastern Asia, the middle and downstream regions of the Yangtze River, and the Tibetan highlands, respectively. Conclusions: We identified two new origin centers for domestic pigs in the Tibetan highlands and in the Island Southeastern Asian region.	[Yang, Shuli; Mao, Huaming; Yan, Dawei; Lu, Shaoxiong; Lian, Linsheng; Zhao, Guiying; Yan, Yulin; Deng, Weidong; Shi, Xianwei; Han, Shuxin; Li, Shuai; Wang, Xiujuan; Gou, Xiao] Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China; [Zhang, Hao] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Yunnan Agricultural University; China Agricultural University	Yang, SL (corresponding author), Yunnan Agr Univ, Coll Anim Sci & Technol, Kunming, Peoples R China.	gouxiaosa@163.com		Zhang, Hao/0000-0001-9576-3059	National Natural Science Foundation of China [30760165, 31060301, 30860182]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (grant No. 30760165, 31060301 and 30860182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDELT HJ, 1995, GENETICS, V141, P743; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Fan B, 2002, ANIM GENET, V33, P422, DOI 10.1046/j.1365-2052.2002.00898.x; Fang M, 2005, ANIM GENET, V36, P7, DOI 10.1111/j.1365-2052.2004.01234.x; Giuffra E, 2000, GENETICS, V154, P1785; Groves Colin P., 1993, P107; Guo SC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-73; Kijas JMH, 2001, J MOL EVOL, V52, P302, DOI 10.1007/s002390010158; Kim KI, 2002, ANIM GENET, V33, P19, DOI 10.1046/j.1365-2052.2002.00784.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, P NATL ACAD SCI US, V104, P15276; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Lum JK, 2006, P NATL ACAD SCI USA, V103, P17190, DOI 10.1073/pnas.0608220103; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIE M, 1993, MOL BIOL EVOL, V10, P927; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Qian Y., 1979, ORIGIN DOMESTICATED; Qian YP, 2000, HUM GENET, V106, P453, DOI 10.1007/s004390000259; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tanaka K, 2008, ANIM SCI J, V79, P417, DOI 10.1111/j.1740-0929.2008.00546.x; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Ursing BM, 1998, J MOL EVOL, V47, P302, DOI 10.1007/PL00006388; Van Driem G., 2005, PEOPLING E ASIA PUTT, P81, DOI DOI 10.4324/9780203343685_CHAPTER_6; Watanabe T, 2001, J MOL EVOL, V52, P281, DOI 10.1007/s002390010156; Watanobe T, 2003, ZOOL SCI, V20, P1477, DOI 10.2108/zsj.20.1477; Watanobe T, 2002, J MOL EVOL, V55, P222, DOI 10.1007/s00239-002-2320-6; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Xu W, 2000, NONGYEKAOGU, V1, P248; Yang SL, 2003, GENET SEL EVOL, V35, P657, DOI 10.1051/gse:2003045; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	34	49	56	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28215	10.1371/journal.pone.0028215	http://dx.doi.org/10.1371/journal.pone.0028215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163285	gold, Green Submitted, Green Published			2022-12-27	WOS:000298161900020
J	De Silva, TM; Brait, VH; Drummond, GR; Sobey, CG; Miller, AA				De Silva, T. Michael; Brait, Vanessa H.; Drummond, Grant R.; Sobey, Christopher G.; Miller, Alyson A.			Nox2 Oxidase Activity Accounts for the Oxidative Stress and Vasomotor Dysfunction in Mouse Cerebral Arteries following Ischemic Stroke	PLOS ONE			English	Article							NADPH-OXIDASE; SUPEROXIDE-PRODUCTION; SYSTEMIC ARTERIES; ANGIOTENSIN-II; MICE; REPERFUSION; RESPONSES; MECHANISMS; GENDER; HYPERCHOLESTEROLEMIA	Background and Purpose: Post-ischemic oxidative stress and vasomotor dysfunction in cerebral arteries may increase the likelihood of cognitive impairment and secondary stroke. However, the underlying mechanisms of post-stroke vascular abnormalities, as distinct from those causing primary brain injury, are poorly understood. We tested whether augmented superoxide-dependent dysfunction occurs in the mouse cerebral circulation following ischemia-reperfusion, and evaluated the role of Nox2 oxidase. Methods: Cerebral ischemia was induced in male C57Bl6/J wild-type (WT) and Nox2-deficient (Nox2(-/-)) mice by middle cerebral artery occlusion (MCAO; 0.5 h), followed by reperfusion (23.5 h). Superoxide production by MCA was measured by L-012-enhanced chemiluminescence. Nitric oxide (NO) function was assessed in cannulated and pressurized MCA via the vasoconstrictor response to N (R)-nitro-L-arginine methyl ester (L-NAME; 100 mu mol/L). Expression of Nox2, the nitration marker 3-nitrotyrosine, and leukocyte marker CD45 was assessed in cerebral arteries by Western blotting. Results: Following ischemia-reperfusion, superoxide production was markedly increased in the MCA of WT, but not Nox2(-/-) mice. In WT mice, L-NAME-induced constriction was reduced by similar to 50% in ischemic MCA, whereas ischemia-reperfusion had no effect on responses to L-NAME in vessels from Nox2(-/-) mice. In ischemic MCA from WT mice, expression of Nox2 and 3-nitrotyrosine were similar to 1.4-fold higher than in the contralateral MCA, or in ischemic or contralateral vessels from Nox2(-/-) mice. Vascular CD45 levels were unchanged by ischemia-reperfusion. Conclusions: Excessive superoxide production, impaired NO function and nitrosative stress occur in mouse cerebral arteries after ischemia-reperfusion. These abnormalities appear to be exclusively due to increased activity of vascular Nox2 oxidase.	[De Silva, T. Michael; Brait, Vanessa H.; Drummond, Grant R.; Sobey, Christopher G.; Miller, Alyson A.] Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia	Monash University	De Silva, TM (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3168, Australia.	Chris.Sobey@monash.edu		De Silva, Travice/0000-0001-6351-7304; Brait, Vanessa Helena/0000-0002-0911-355X; Drummond, Grant/0000-0001-8556-9738	National Health and Medical Research Council of Australia (NHMRC) [350477, 491133]; Australian Postgraduate Award; Monash Graduate Scholarship	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Monash Graduate Scholarship(Monash University)	These studies were supported by grants from the National Health and Medical Research Council of Australia (NHMRC) (ID 350477 & 491133). TMD was the recipient of an Australian Postgraduate Award and VHB was the recipient of a Monash Graduate Scholarship. GRD and CGS are NHMRC Senior Research Fellows. AAM is a NHMRC Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brait VH, 2010, J CEREBR BLOOD F MET, V30, P1306, DOI 10.1038/jcbfm.2010.14; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Budzyn K, 2004, AM J PHYSIOL-REG I, V287, pR342, DOI 10.1152/ajpregu.00156.2004; Bullen ML, 2011, AM J PHYSIOL-HEART C, V301, pH1405, DOI 10.1152/ajpheart.00489.2011; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cipolla MJ, 2009, STROKE, V40, P1451, DOI 10.1161/STROKEAHA.108.535435; De Silva TM, 2009, STROKE, V40, P1091, DOI 10.1161/STROKEAHA.108.531707; Drummond GR, 2011, NAT REV DRUG DISCOV, V10, P453, DOI 10.1038/nrd3403; Edvinsson LIH, 2011, J CEREBR BLOOD F MET, V31, P1554, DOI 10.1038/jcbfm.2011.70; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Girouard H, 2006, ARTERIOSCL THROM VAS, V26, P826, DOI 10.1161/01.ATV.0000205849.22807.6e; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Ishikawa M, 2004, CIRC RES, V94, P239, DOI 10.1161/01.RES.0000111524.05779.60; Jackman KA, 2009, BRIT J PHARMACOL, V156, P680, DOI 10.1111/j.1476-5381.2008.00073.x; Jackman KA, 2009, BRAIN RES, V1286, P215, DOI 10.1016/j.brainres.2009.06.056; Judkins CP, 2010, AM J PHYSIOL-HEART C, V298, pH24, DOI 10.1152/ajpheart.00799.2009; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kahles T, 2010, NEUROBIOL DIS, V40, P185, DOI 10.1016/j.nbd.2010.05.023; Kim GS, 2009, J NEUROSCI, V29, P14779, DOI 10.1523/JNEUROSCI.4161-09.2009; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; KONTOS CD, 1992, AM J PHYSIOL, V263, pH1234, DOI 10.1152/ajpheart.1992.263.4.H1234; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Marrelli SP, 1999, AM J PHYSIOL-HEART C, V276, pH33, DOI 10.1152/ajpheart.1999.276.1.H33; MAYHAN WG, 1988, AM J PHYSIOL, V255, pH879, DOI 10.1152/ajpheart.1988.255.4.H879; Miller AA, 2005, CIRC RES, V97, P1055, DOI 10.1161/01.RES.0000189301.10217.87; Miller AA, 2007, STROKE, V38, P2142, DOI 10.1161/STROKEAHA.106.477406; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Miller AA, 2006, PHARMACOL THERAPEUT, V111, P928, DOI 10.1016/j.pharmthera.2006.02.005; Miller AA, 2010, STROKE, V41, P784, DOI 10.1161/STROKEAHA.109.575365; Miller AA, 2009, AM J PHYSIOL-HEART C, V296, pH220, DOI 10.1152/ajpheart.00987.2008; Miyazaki T, 2011, STROKE, V42, P1097, DOI 10.1161/STROKEAHA.110.598359; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; PARK L, 2007, J CEREB BLOOD FLOW M, V11, P11; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Walder CE, 1997, STROKE, V28, P2252, DOI 10.1161/01.STR.28.11.2252; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Xie H, 2005, STROKE, V36, P1047, DOI 10.1161/01.STR.0000157664.34308.cc; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	41	65	65	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28393	10.1371/journal.pone.0028393	http://dx.doi.org/10.1371/journal.pone.0028393			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164282	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000298171400083
J	Fang, YD; Xu, X; Dang, YM; Zhang, YM; Zhang, JP; Hu, JY; Zhang, Q; Dai, X; Teng, M; Zhang, DX; Huang, YS				Fang, Ya-dong; Xu, Xue; Dang, Yong-ming; Zhang, Yi-ming; Zhang, Jia-ping; Hu, Jiong-yu; Zhang, Qiong; Dai, Xia; Teng, Miao; Zhang, Dong-xia; Huang, Yue-sheng			MAP4 Mechanism that Stabilizes Mitochondrial Permeability Transition in Hypoxia: Microtubule Enhancement and DYNLT1 Interaction with VDAC1	PLOS ONE			English	Article							LIGHT-CHAIN TCTEX-1; CYTOCHROME-C; CELL-DEATH; PROTEIN; DYNEIN; PORE; DYSFUNCTION; DEPOLARIZATION; TRAFFICKING; REPERFUSION	Mitochondrial membrane permeability has received considerable attention recently because of its key role in apoptosis and necrosis induced by physiological events such as hypoxia. The manner in which mitochondria interact with other molecules to regulate mitochondrial permeability and cell destiny remains elusive. Previously we verified that hypoxia-induced phosphorylation of microtubule-associated protein 4 (MAP4) could lead to microtubules (MTs) disruption. In this study, we established the hypoxic (1% O-2) cell models of rat cardiomyocytes, H9c2 and HeLa cells to further test MAP4 function. We demonstrated that increase in the pool of MAP4 could promote the stabilization of MT networks by increasing the synthesis and polymerization of tubulin in hypoxia. Results showed MAP4 overexpression could enhance cell viability and ATP content under hypoxic conditions. Subsequently we employed a yeast two-hybrid system to tag a protein interacting with mitochondria, dynein light chain Tctex-type 1 (DYNLT1), by hVDAC1 bait. We confirmed that DYNLT1 had protein-protein interactions with voltage-dependent anion channel 1 (VDAC1) using co-immunoprecipitation; and immunofluorescence technique showed that DYNLT1 was closely associated with MTs and VDAC1. Furthermore, DYNLT1 interactions with MAP4 were explored using a knockdown technique. We thus propose two possible mechanisms triggered by MAP4: (1) stabilization of MT networks, (2) DYNLT1 modulation, which is connected with VDAC1, and inhibition of hypoxia-induced mitochondrial permeabilization.	[Fang, Ya-dong; Dang, Yong-ming; Zhang, Jia-ping; Hu, Jiong-yu; Zhang, Qiong; Teng, Miao; Zhang, Dong-xia; Huang, Yue-sheng] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Xu, Xue] 324 Hosp PLA, Chongqing, Peoples R China; [Zhang, Yi-ming] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China; [Dai, Xia] Third Mil Med Univ, Southwest Hosp, Dept Plast & Cosmet Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Fang, YD (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	yshuang.tmmu@gmail.com			National Natural Science Foundation of China [81000833, 81071547, 30901563]; Key Project of China National Programs for Basic Research and Development ("973" Program in China) [2012CB518101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of China National Programs for Basic Research and Development ("973" Program in China)	This work was supported by National Natural Science Foundation of China (No. 81000833, 81071547 and 30901563), and partly by the Key Project of China National Programs for Basic Research and Development ("973" Program in China, 2012CB518101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Cao LC, 2004, KIDNEY INT, V66, P1890, DOI 10.1111/j.1523-1755.2004.00963.x; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; Cheng GM, 2002, AM J PHYSIOL-HEART C, V283, pH2379, DOI 10.1152/ajpheart.00410.2002; Cheng Tsung-Lin, 2007, V408, P223, DOI 10.1007/978-1-59745-547-3_13; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Feng PH, 2007, PLOS PATHOG, V3, P1849, DOI 10.1371/journal.ppat.0030174; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Henze K, 2003, NATURE, V426, P127, DOI 10.1038/426127a; Hu JY, 2010, CELL MOL LIFE SCI, V67, P321, DOI 10.1007/s00018-009-0187-z; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Krestinina OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P421, DOI 10.1134/S0006297909040105; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Li DD, 2005, EUR J NEUROSCI, V22, P1319, DOI 10.1111/j.1460-9568.2005.04335.x; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McNaughton L, 2010, J BIOL CHEM, V285, P15994, DOI 10.1074/jbc.M109.083535; Morrison EE, 2007, CELL MOL LIFE SCI, V64, P307, DOI 10.1007/s00018-007-6360-3; Nadano D, 2002, BIOCHEM J, V364, P669, DOI 10.1042/BJ20011836; Nagano F, 1998, J BIOL CHEM, V273, P30065, DOI 10.1074/jbc.273.46.30065; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Permana S, 2005, CELL STRUCT FUNCT, V29, P147, DOI 10.1247/csf.29.147; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Putnam AJ, 1998, J CELL SCI, V111, P3379; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rogers SL, 2000, CURR OPIN CELL BIOL, V12, P57, DOI 10.1016/S0955-0674(99)00057-5; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Saeed U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002459; SATO H, 1993, CIRC RES, V72, P361, DOI 10.1161/01.RES.72.2.361; Sato H, 1997, J CELL BIOL, V139, P963, DOI 10.1083/jcb.139.4.963; Scharstuhl A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006688; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Seko Y, 1997, BIOCHEM BIOPH RES CO, V239, P840, DOI 10.1006/bbrc.1997.7570; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Takahashi M, 2003, AM J PHYSIOL-HEART C, V285, pH2072, DOI 10.1152/ajpheart.00396.2003; Tomasello F, 2009, CELL RES, V19, P1363, DOI 10.1038/cr.2009.98; Vandroux D, 2004, MOL CELL BIOCHEM, V258, P99, DOI 10.1023/B:MCBI.0000012840.67616.cc; Webster DR, 1997, J MOL CELL CARDIOL, V29, P1747, DOI 10.1006/jmcc.1997.0421; White RJ, 1996, J NEUROSCI, V16, P5688; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Zhdanov AV, 2011, CELL MOL LIFE SCI, V68, P903, DOI 10.1007/s00018-010-0502-8	47	19	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28052	10.1371/journal.pone.0028052	http://dx.doi.org/10.1371/journal.pone.0028052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164227	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400028
J	Gorny, MK; Sampson, J; Li, HG; Jiang, XQ; Totrov, M; Wang, XH; Williams, C; O'Neal, T; Volsky, B; Li, LZ; Cardozo, T; Nyambi, P; Zolla-Pazner, S; Kong, XP				Gorny, Miroslaw K.; Sampson, Jared; Li, Huiguang; Jiang, Xunqing; Totrov, Maxim; Wang, Xiao-Hong; Williams, Constance; O'Neal, Timothy; Volsky, Barbara; Li, Liuzhe; Cardozo, Timothy; Nyambi, Phillipe; Zolla-Pazner, Susan; Kong, Xiang-Peng			Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN IMMUNE-RESPONSE; B-CELL RESPONSES; CROSS-REACTIVITY; V3 DOMAIN; HYPERVARIABLE REGIONS; HUMAN CYTOMEGALOVIRUS; BINDING-SITE; NEUTRALIZATION; GP120	Preferential usage of immunoglobulin (Ig) genes that encode antibodies (Abs) against various pathogens is rarely observed and the nature of their dominance is unclear in the context of stochastic recombination of Ig genes. The hypothesis that restricted usage of Ig genes predetermines the antibody specificity was tested in this study of 18 human anti-V3 monoclonal Abs (mAbs) generated from unrelated individuals infected with various subtypes of HIV-1, all of which preferentially used pairing of the VH5-51 and VL lambda genes. Crystallographic analysis of five VH5-51/VL lambda-encoded Fabs complexed with various V3 peptides revealed a common three dimensional (3D) shape of the antigen-binding sites primarily determined by the four complementarity determining regions (CDR) for the heavy (H) and light (L) chains: specifically, the H1, H2, L1 and L2 domains. The CDR H3 domain did not contribute to the shape of the binding pocket, as it had different lengths, sequences and conformations for each mAb. The same shape of the binding site was further confirmed by the identical backbone conformation exhibited by V3 peptides in complex with Fabs which fully adapted to the binding pocket and the same key contact residues, mainly germline-encoded in the heavy and light chains of five Fabs. Finally, the VH5-51 anti-V3 mAbs recognized an epitope with an identical 3D structure which is mimicked by a single mimotope recognized by the majority of VH5-51-derived mAbs but not by other V3 mAbs. These data suggest that the identification of preferentially used Ig genes by neutralizing mAbs may define conserved epitopes in the diverse virus envelopes. This will be useful information for designing vaccine immunogen inducing cross-neutralizing Abs.	[Gorny, Miroslaw K.; Williams, Constance; O'Neal, Timothy; Volsky, Barbara; Li, Liuzhe; Nyambi, Phillipe; Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY 10003 USA; [Sampson, Jared; Li, Huiguang; Jiang, Xunqing; Kong, Xiang-Peng] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Totrov, Maxim] Molsoft LLC, La Jolla, CA USA; [Wang, Xiao-Hong; Nyambi, Phillipe; Zolla-Pazner, Susan] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Cardozo, Timothy] NYU, Sch Med, Dept Pharmacol, New York, NY USA	New York University; New York University; New York University	Gorny, MK (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10003 USA.	mirek.gorny@med.nyu.edu	Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666; Kong, Xiang-Peng/0000-0001-5773-2681; totrov, maxim/0000-0001-8594-274X; Sampson, Jared/0000-0001-6441-1579; Gorny, Miroslaw/0000-0002-2714-8780	National Institutes of Health [AI77451, AI36085, HL59725]; New York University Center for AIDS Research [AI27742]; Bill and Melinda Gates Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036085, P30AI027742, R21AI077451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Center for AIDS Research; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by the National Institutes of Health grants AI77451, AI36085 and HL59725, by the Immunology Core of the New York University Center for AIDS Research (grant AI27742), by research funds from Department of Veterans Affairs, and by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Andrus L, 1998, J INFECT DIS, V177, P889, DOI 10.1086/515251; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke V, 2009, STRUCTURE, V17, P1538, DOI 10.1016/j.str.2009.09.012; Chi SW, 2007, P NATL ACAD SCI USA, V104, P9230, DOI 10.1073/pnas.0701279104; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davis MM, 2004, SEMIN IMMUNOL, V16, P239, DOI 10.1016/j.smim.2004.08.003; Eda Y, 2006, J VIROL, V80, P5563, DOI 10.1128/JVI.02095-05; EMINI EA, 1992, NATURE, V355, P728, DOI 10.1038/355728a0; Gorny M.K., 1994, CELL BIOL LAB HDB, P276; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 1997, J IMMUNOL, V159, P5114; GORNY MK, 1991, P NATL ACAD SCI USA, V88, P3238, DOI 10.1073/pnas.88.8.3238; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Jiang XQ, 2010, NAT STRUCT MOL BIOL, V17, P955, DOI 10.1038/nsmb.1861; Lucas AH, 2003, CLIN IMMUNOL, V108, P119, DOI 10.1016/S1521-6616(03)00094-9; Mage M G, 1980, Methods Enzymol, V70, P142; McLean GR, 2005, J IMMUNOL, V174, P4768, DOI 10.4049/jimmunol.174.8.4768; OHLIN M, 1993, J VIROL, V67, P703, DOI 10.1128/JVI.67.2.703-710.1993; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Stanfield RL, 2006, J VIROL, V80, P6093, DOI 10.1128/JVI.00205-06; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Vagin A, 1998, ACTA CRYSTALLOGR D, V54, P400, DOI 10.1107/S0907444997014923; Weitkamp JH, 2003, J IMMUNOL, V171, P4680, DOI 10.4049/jimmunol.171.9.4680; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; Yu Y, 2011, TRENDS BIOTECHNOL, V29, P18, DOI 10.1016/j.tibtech.2010.10.004; Zolla-Pazner S, 2011, J VIROL, V85, P9887, DOI 10.1128/JVI.05086-11; Zolla-Pazner S, 2009, VIROLOGY, V392, P82, DOI 10.1016/j.virol.2009.05.039	40	39	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e27780	10.1371/journal.pone.0027780	http://dx.doi.org/10.1371/journal.pone.0027780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164215	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400015
J	Takemura, H; Samejima, K; Vogels, R; Sakagami, M; Okuda, J				Takemura, Hiromasa; Samejima, Kazuyuki; Vogels, Rufin; Sakagami, Masamichi; Okuda, Jiro			Stimulus-Dependent Adjustment of Reward Prediction Error in the Midbrain	PLOS ONE			English	Article							TEMPORAL DIFFERENCE MODELS; DOPAMINE RESPONSES; HUMAN BRAIN; DECISION; REPRESENTATION; SENSITIVITY; INFERENCE; NEURONS; HUMANS; CORTEX	Previous reports have described that neural activities in midbrain dopamine areas are sensitive to unexpected reward delivery and omission. These activities are correlated with reward prediction error in reinforcement learning models, the difference between predicted reward values and the obtained reward outcome. These findings suggest that the reward prediction error signal in the brain updates reward prediction through stimulus-reward experiences. It remains unknown, however, how sensory processing of reward-predicting stimuli contributes to the computation of reward prediction error. To elucidate this issue, we examined the relation between stimulus discriminability of the reward-predicting stimuli and the reward prediction error signal in the brain using functional magnetic resonance imaging (fMRI). Before main experiments, subjects learned an association between the orientation of a perceptually salient (high-contrast) Gabor patch and a juice reward. The subjects were then presented with lower-contrast Gabor patch stimuli to predict a reward. We calculated the correlation between fMRI signals and reward prediction error in two reinforcement learning models: a model including the modulation of reward prediction by stimulus discriminability and a model excluding this modulation. Results showed that fMRI signals in the midbrain are more highly correlated with reward prediction error in the model that includes stimulus discriminability than in the model that excludes stimulus discriminability. No regions showed higher correlation with the model that excludes stimulus discriminability. Moreover, results show that the difference in correlation between the two models was significant from the first session of the experiment, suggesting that the reward computation in the midbrain was modulated based on stimulus discriminability before learning a new contingency between perceptually ambiguous stimuli and a reward. These results suggest that the human reward system can incorporate the level of the stimulus discriminability flexibly into reward computations by modulating previously acquired reward values for a typical stimulus.	[Takemura, Hiromasa] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Samejima, Kazuyuki; Sakagami, Masamichi; Okuda, Jiro] Tamagawa Univ, Brain Sci Inst, Brain Sci Res Ctr, Machida, Tokyo, Japan; [Vogels, Rufin] Katholieke Univ Leuven, Sch Med, Lab Neuroen Psychofysiol, Louvain, Belgium; [Okuda, Jiro] Kyoto Sangyo Univ, Fac Comp Sci & Engn, Dept Intelligent Syst, Khoyama Ctr Neurosci, Kyoto 603, Japan	University of Tokyo; KU Leuven; Kyoto Sangyo University	Takemura, H (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	hiromasa@fechner.c.u-tokyo.ac.jp	Takemura, Hiromasa/AAD-6065-2019	Takemura, Hiromasa/0000-0002-2096-2384; Lauwereyns, Jan/0000-0003-0551-2550	Tamagawa University) of the Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology, Japan [19330161]; Grants-in-Aid for Scientific Research [21120007, 23243077] Funding Source: KAKEN	Tamagawa University) of the Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the 21st Century Center of Excellence (COE) program (Integrative Human Science Program, Tamagawa University) of the Japan Society for the Promotion of Science (JSPS) and Grants-in-Aid for Scientific Research (#19330161) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (J.O., M.S., K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hampton AN, 2006, J NEUROSCI, V26, P8360, DOI 10.1523/JNEUROSCI.1010-06.2006; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nichols T, 2003, STAT METHODS MED RES, V12, P419, DOI 10.1191/0962280203sm341ra; Nomoto K, 2010, J NEUROSCI, V30, P10692, DOI 10.1523/JNEUROSCI.4828-09.2010; O'Doherty JP, 2006, NEURON, V49, P157, DOI 10.1016/j.neuron.2005.11.014; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodriguez PF, 2006, HUM BRAIN MAPP, V27, P306, DOI 10.1002/hbm.20186; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28337	10.1371/journal.pone.0028337	http://dx.doi.org/10.1371/journal.pone.0028337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164273	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400074
J	Tatti, O; Arjama, M; Ranki, A; Weiss, SJ; Keski-Oja, J; Lehti, K				Tatti, Olga; Arjama, Mariliina; Ranki, Annamari; Weiss, Stephen J.; Keski-Oja, Jorma; Lehti, Kaisa			Membrane-Type-3 Matrix Metalloproteinase (MT3-MMP) Functions as a Matrix Composition-Dependent Effector of Melanoma Cell Invasion	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MALIGNANT-MELANOMA; TUMOR PROGRESSION; BREAST-CANCER; A ACTIVATION; EXPRESSION; MT1-MMP; TRANSITION; GROWTH; METASTASIS	In primary human melanoma, the membrane-type matrix metalloproteinase, MT3-MMP, is overexpressed in the most aggressive nodular-type tumors. Unlike MT1-MMP and MT2-MMP, which promote cell invasion through basement membranes and collagen type I-rich tissues, the function of MT3-MMP in tumor progression remains unclear. Here, we demonstrate that MT3-MMP inhibits MT1-MMP-driven melanoma cell invasion in three-dimensional collagen, while yielding an altered, yet MT1-MMP-dependent, form of expansive growth behavior that phenocopies the formation of nodular cell colonies. In melanoma cell lines originating from advanced primary or metastatic lesions, endogenous MT3-MMP expression was associated with limited collagen-invasive potential. In the cell lines with highest MT3-MMP expression relative to MT1-MMP, collagen-invasive activity was increased following stable MT3-MMP gene silencing. Consistently, MT3-MMP overexpression in cells derived from less advanced superficially spreading melanoma lesions, or in the MT3-MMP knockdown cells, reduced MT1-MMP-dependent collagen invasion. Rather than altering MT1-MMP transcription, MT3-MMP interacted with MT1-MMP in membrane complexes and reduced its cell surface expression. By contrast, as a potent fibrinolytic enzyme, MT3-MMP induced efficient invasion of the cells in fibrin, a provisional matrix component frequently found at tumor-host tissue interfaces and perivascular spaces of melanoma. Since MT3-MMP was significantly upregulated in biopsies of human melanoma metastases, these results identify MT3-MMP as a matrix-dependent modifier of the invasive tumor cell functions during melanoma progression.	[Tatti, Olga; Lehti, Kaisa] Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland; [Tatti, Olga; Arjama, Mariliina; Keski-Oja, Jorma; Lehti, Kaisa] Univ Helsinki, Dept Pathol, Haartman Inst, Cent Hosp, Helsinki, Finland; [Tatti, Olga; Arjama, Mariliina; Keski-Oja, Jorma; Lehti, Kaisa] Univ Helsinki, Dept Virol, Haartman Inst, Cent Hosp, Helsinki, Finland; [Ranki, Annamari] Univ Helsinki, Cent Hosp, Dept Dermatol & Allergol, Skin & Allergy Hosp, Helsinki, Finland; [Weiss, Stephen J.] Univ Michigan, Div Mol Med & Genet, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Michigan System; University of Michigan	Tatti, O (corresponding author), Univ Helsinki, Res Programs Unit, Biomedicum Helsinki, Helsinki, Finland.	kaisa.lehti@helsinki.fi		Lehti, Kaisa/0000-0001-9110-8719; Bugaeva, Olga/0000-0002-7960-7950	Academy of Finland; University of Helsinki Foundations; Finnish Cancer Foundation; Finnish Cancer Institute; Sigrid Juselius Foundation; Helsinki Univ. Hospital; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Helsinki Biomedical Graduate School; Emil Aaltonen Foundation	Academy of Finland(Academy of Finland); University of Helsinki Foundations; Finnish Cancer Foundation; Finnish Cancer Institute; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Helsinki Univ. Hospital; Magnus Ehrnrooth Foundation; Biocentrum Helsinki; Helsinki Biomedical Graduate School; Emil Aaltonen Foundation	This work was supported by the Academy of Finland (J.K.-O., K.L.), University of Helsinki Foundations (K.L., O.T.), Finnish Cancer Foundation (J.K.-O., K.L.), Finnish Cancer Institute (K.L.), Sigrid Juselius Foundation (J.K.-O., K.L.), Helsinki Univ. Hospital Fund (J.K.-O.), Magnus Ehrnrooth Foundation (K.L.), Biocentrum Helsinki (J.K.-O.), Helsinki Biomedical Graduate School (O.T., M.A.), and Emil Aaltonen Foundation (O.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airola K, 1999, BRIT J CANCER, V80, P733, DOI 10.1038/sj.bjc.6690417; Arai I, 2007, HEPATO-GASTROENTEROL, V54, P167; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Bardos H, 1996, BLOOD COAGUL FIBRIN, V7, P536; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; CASLEYS.J, 1961, Q J EXP PHYSIOL CMS, V46, P101, DOI 10.1113/expphysiol.1961.sp001502; COSTANTINI V, 1992, CANCER METAST REV, V11, P283, DOI 10.1007/BF01307183; Ferraro GB, 2011, J BIOL CHEM, V286, P31418, DOI 10.1074/jbc.M111.249169; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HERLYN M, 1985, CANCER RES, V45, P5670; Hofmann UB, 2000, J PATHOL, V191, P245; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Illman SA, 2006, J CELL SCI, V119, P3856, DOI 10.1242/jcs.03157; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jiang WG, 2006, INT J MOL MED, V17, P583; Kang TB, 2000, FASEB J, V14, P2559, DOI 10.1096/fj.00-0269com; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Lehti K, 2000, J BIOL CHEM, V275, P15006, DOI 10.1074/jbc.M910220199; Lehti K, 1998, BIOCHEM J, V334, P345, DOI 10.1042/bj3340345; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Llano E, 1999, CANCER RES, V59, P2570; Lowy AM, 2006, CANCER RES, V66, P4734, DOI 10.1158/0008-5472.CAN-05-4268; MacDougall JR, 1999, BRIT J CANCER, V80, P504, DOI 10.1038/sj.bjc.6690385; Masters JRW, 1998, HUMAN CELL CULTURE, VI; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Morris MJ, 2009, BIOCHEMISTRY-US, V48, P5313, DOI 10.1021/bi900498z; Moss NM, 2009, MOL CANCER RES, V7, P809, DOI 10.1158/1541-7786.MCR-08-0571; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohnishi Y, 2001, EUR J DERMATOL, V11, P420; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Pagenstecher A, 2001, J NEUROPATH EXP NEUR, V60, P598, DOI 10.1093/jnen/60.6.598; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2002, CANCER RES, V62, P6966; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Poetsch M, 2003, CELL MOL LIFE SCI, V60, P1923, DOI 10.1007/s00018-003-2324-4; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Sohail A, 2008, CANCER METAST REV, V27, P289, DOI 10.1007/s10555-008-9129-8; Sugiyama N, 2010, CANCER RES, V70, P7851, DOI 10.1158/0008-5472.CAN-10-1223; TAKINO T, 1995, J BIOL CHEM, V270, P23013, DOI 10.1074/jbc.270.39.23013; Tatti O, 2008, EXP CELL RES, V314, P2501, DOI 10.1016/j.yexcr.2008.05.018; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Uchibori M, 2006, INT J ONCOL, V28, P33; Vuoriluoto K, 2011, MATRIX BIOL, V30, P207, DOI 10.1016/j.matbio.2011.03.003; WOJTUKIEWICZ MZ, 1990, AM J CLIN PATHOL, V93, P516, DOI 10.1093/ajcp/93.4.516; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	58	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28325	10.1371/journal.pone.0028325	http://dx.doi.org/10.1371/journal.pone.0028325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164270	Green Submitted, gold, Green Published			2022-12-27	WOS:000298171400071
J	Tsibris, AMN; Pal, U; Schure, AL; Veazey, RS; Kunstman, KJ; Henrich, TJ; Klasse, PJ; Wolinsky, SM; Kuritzkes, DR; Moore, JP				Tsibris, Athe M. N.; Pal, Urboshi; Schure, Allison L.; Veazey, Ronald S.; Kunstman, Kevin J.; Henrich, Timothy J.; Klasse, P. J.; Wolinsky, Steven M.; Kuritzkes, Daniel R.; Moore, John P.			SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses	PLOS ONE			English	Article							R5 HIV-1 INFECTION; CCR5 INHIBITORS; SHIV CHALLENGE; IN-VIVO; TYPE-1; TRANSMISSION; PROGRESSION; CORECEPTOR; PROTECTION; ENVELOPE	Maraviroc (MVC) gels are effective at protecting rhesus macaques from vaginal SHIV transmission, but breakthrough infections can occur. To determine the effects of a vaginal MVC gel on infecting SHIV populations in a macaque model, we analyzed plasma samples from three rhesus macaques that received a MVC vaginal gel (day 0) but became infected after high-dose SHIV-162P3 vaginal challenge. Two infected macaques that received a placebo gel served as controls. The infecting SHIV-162P3 stock had an overall mean genetic distance of 0.294 +/- 0.027%; limited entropy changes were noted across the envelope (gp160). No envelope mutations were observed consistently in viruses isolated from infected macaques at days 14-21, the time of first detectable viremia, nor selected at later time points, days 42-70. No statistically significant differences in MVC susceptibilities were observed between the SHIV inoculum (50% inhibitory concentration [IC50] 1.87 nM) and virus isolated from the three MVC-treated macaques (MVC IC50 1.18 nM, 1.69 nM, and 1.53 nM, respectively). Highlighter plot analyses suggested that infection was established in each MVC-treated animal by one founder virus genotype. The expected Poisson distribution of pairwise Hamming Distance frequency counts was observed and a phylogenetic analysis did not identify infections with distinct lineages from the challenge stock. These data suggest that breakthrough infections most likely result from incomplete viral inhibition and not the selection of MVC-resistant variants.	[Tsibris, Athe M. N.; Schure, Allison L.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Tsibris, Athe M. N.; Henrich, Timothy J.; Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Pal, Urboshi] Cornell Univ, Ithaca, NY USA; [Veazey, Ronald S.] Tulane Natl Primate Res Ctr, Covington, LA USA; [Kunstman, Kevin J.; Wolinsky, Steven M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Henrich, Timothy J.; Kuritzkes, Daniel R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Klasse, P. J.; Moore, John P.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Cornell University; Tulane University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Cornell University	Tsibris, AMN (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.	atsibris@partners.org	Klasse, P.J./AEX-0142-2022; Wolinsky, Steven/B-2893-2012; Pal, Umapada/AAC-4930-2022	Klasse, P.J./0000-0001-8222-278X; Wolinsky, Steven/0000-0002-9625-6697	Harvard Clinical and Translational Science Center [UL1 RR025758]; Pfizer;  [K08 AI081547];  [R37 AI055357];  [U19 AI076982]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI076982, K08AI081547, R37AI055357, T32AI007387] Funding Source: NIH RePORTER	Harvard Clinical and Translational Science Center; Pfizer(Pfizer); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AMNT was supported by K08 AI081547. TJH was supported by the KL2 Medical Research Investigator Training (MeRIT) program of Harvard Catalyst, The Harvard Clinical and Translational Science Center UL1 RR025758. This work was supported in part by R37 AI055357 (DRK) and U19 AI076982 (JPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AMNT has served as a consultant to Merck. DRK has served as a consultant to and has received honoraria and/or research grant support from Pfizer. All other authors report no conflicts. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anastassopoulou CG, 2009, P NATL ACAD SCI USA, V106, P5318, DOI 10.1073/pnas.0811713106; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Drummond A., 2011, GENEIOUS V5 4 6; Dudley DM, 2009, J VIROL, V83, P5067, DOI 10.1128/JVI.00055-09; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Forbes CJ, 2011, J CONTROL RELEASE; Giorgi EE, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-532; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Greenier JL, 2001, J VIROL, V75, P3753, DOI 10.1128/JVI.75.8.3753-3765.2001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Henrich TJ, 2010, JAIDS-J ACQ IMM DEF, V55, P420, DOI 10.1097/QAI.0b013e3181f25574; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kirchherr JL, 2007, J VIROL METHODS, V143, P104, DOI 10.1016/j.jviromet.2007.02.015; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Kuiken CL, 1996, AIDS, V10, P31, DOI 10.1097/00002030-199601000-00005; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lin NH, 2010, J VIROL METHODS, V169, P39, DOI 10.1016/j.jviromet.2010.06.012; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Nedellec R, 2010, J VIROL, V84, P5842, DOI 10.1128/JVI.01907-09; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pirrone V, 2011, ANTIMICROB AGENTS CH, V55, P1831, DOI 10.1128/AAC.00976-10; Roche M, 2011, RETROVIROLO IN PRESS; Sagar M, 2004, J VIROL, V78, P7279, DOI 10.1128/JVI.78.13.7279-7283.2004; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stone M, 2010, J VIROL, V84, P7083, DOI 10.1128/JVI.00481-10; Supervie V, 2010, P NATL ACAD SCI USA, V107, P12381, DOI 10.1073/pnas.1006061107; Tamura K, 2011, MOL BIOL EVOL; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Tsai L, 2007, VIROLOGY, V362, P207, DOI 10.1016/j.virol.2006.12.024; Tsibris AMN, 2008, J VIROL, V82, P8210, DOI 10.1128/JVI.00444-08; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; *UNAIDS, 2008, UNAIDS REP GLOB AIDS; Valley-Omar Z, 2011, CAPRISA 004 TNV MICR; Varela M, J VIROL; Veazey RS, 2010, J INFECT DIS, V202, P739, DOI 10.1086/655661; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; YANG ZB, 1994, J MOL EVOL, V39, P105; ZHANG LQ, 1993, J VIROL, V67, P3345, DOI 10.1128/JVI.67.6.3345-3356.1993; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	51	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28047	10.1371/journal.pone.0028047	http://dx.doi.org/10.1371/journal.pone.0028047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164225	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400026
J	Tu, YH; Ho, YH; Chuang, YC; Chen, PC; Chen, CS				Tu, Yu-Hsuan; Ho, Yu-Hsuan; Chuang, Ying-Chih; Chen, Po-Chung; Chen, Chien-Sheng			Identification of Lactoferricin B Intracellular Targets Using an Escherichia coli Proteome Chip	PLOS ONE			English	Article							D-LACTATE PRODUCTION; FLUORESCENCE POLARIZATION; RIBONUCLEOTIDE REDUCTASE; ANTIMICROBIAL PEPTIDES; BIOLOGICAL NETWORKS; GENE KNOCKOUT; MICROARRAYS; METABOLISM; INHIBITORS; CYTOSCAPE	Lactoferricin B (LfcinB) is a well-known antimicrobial peptide. Several studies have indicated that it can inhibit bacteria by affecting intracellular activities, but the intracellular targets of this antimicrobial peptide have not been identified. Therefore, we used E. coli proteome chips to identify the intracellular target proteins of LfcinB in a high-throughput manner. We probed LfcinB with E. coli proteome chips and further conducted normalization and Gene Ontology (GO) analyses. The results of the GO analyses showed that the identified proteins were associated with metabolic processes. Moreover, we validated the interactions between LfcinB and chip assay-identified proteins with fluorescence polarization (FP) assays. Sixteen proteins were identified, and an E. coli interaction database (EcID) analysis revealed that the majority of the proteins that interact with these 16 proteins affected the tricarboxylic acid (TCA) cycle. Knockout assays were conducted to further validate the FP assay results. These results showed that phosphoenolpyruvate carboxylase was a target of LfcinB, indicating that one of its mechanisms of action may be associated with pyruvate metabolism. Thus, we used pyruvate assays to conduct an in vivo validation of the relationship between LfcinB and pyruvate level in E. coli. These results showed that E. coli exposed to LfcinB had abnormal pyruvate amounts, indicating that LfcinB caused an accumulation of pyruvate. In conclusion, this study successfully revealed the intracellular targets of LfcinB using an E. coli proteome chip approach.	[Tu, Yu-Hsuan; Ho, Yu-Hsuan; Chen, Po-Chung; Chen, Chien-Sheng] Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan; [Chuang, Ying-Chih] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan	National Central University; National Taiwan Ocean University	Tu, YH (corresponding author), Natl Cent Univ, Grad Inst Syst Biol & Bioinformat, Jhongli, Taiwan.	cchen103@gmail.com	Chen, Chien-Sheng/ACO-7414-2022		National Science Council, Taiwan [NSC97-2311-B-008-004-MY2, NSC98-2627-M-008-004]; Veterans General Hospitals and University System of Taiwan [VGHUST99-G4-1]; Cathy General Hospital [99CGH-NCU-A3]; Ministry of Education of Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals and University System of Taiwan; Cathy General Hospital; Ministry of Education of Taiwan(Ministry of Education, Taiwan)	This work is supported mainly by National Science Council, Taiwan (NSC97-2311-B-008-004-MY2 and NSC98-2627-M-008-004) and partly by Veterans General Hospitals and University System of Taiwan (VGHUST99-G4-1), Cathy General Hospital (99CGH-NCU-A3) and the Ministry of Education of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2000, J BIOMOL SCREEN, V5, P63, DOI 10.1177/108705710000500202; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beranova-Giorgianni S, 2003, TRAC-TREND ANAL CHEM, V22, P273, DOI 10.1016/S0165-9936(03)00508-9; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Chandra H, 2011, EXPERT REV PROTEOMIC, V8, P61, DOI 10.1586/EPR.10.99; Chen CS, 2008, NAT METHODS, V5, P69, DOI 10.1038/NMETH1148; Chen CS, 2009, MOL CELL PROTEOMICS, V8, P1765, DOI 10.1074/mcp.M800593-MCP200; Chen CS, 2006, BIOTECHNIQUES, V40, P423, DOI 10.2144/06404TE01; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cudic M, 2002, CURR DRUG TARGETS, V3, P101, DOI 10.2174/1389450024605445; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haukland HH, 2001, FEBS LETT, V508, P389, DOI 10.1016/S0014-5793(01)03100-3; Hwang PM, 1998, BIOCHEMISTRY-US, V37, P4288, DOI 10.1021/bi972323m; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; Knight SMG, 2002, ANAL BIOCHEM, V300, P230, DOI 10.1006/abio.2001.5468; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Lueking A, 2003, MOL CELL PROTEOMICS, V2, P1342, DOI 10.1074/mcp.T300001-MCP200; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Moerke NJ, FLUORESCENCE POLARIZ; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Parker GJ, 2000, J BIOMOL SCREEN, V5, P77, DOI 10.1177/108705710000500204; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Saka K, 2005, DNA RES, V12, P63, DOI 10.1093/dnares/12.1.63; Thao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015123; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; WEBB M, 1968, BIOCHEM J, V106, P375, DOI 10.1042/bj1060375; Yang LN, 2011, ACTA BIOCH BIOPH SIN, V43, P161, DOI 10.1093/abbs/gmq127; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu J, 2004, APPL MICROBIOL BIOT, V64, P367, DOI 10.1007/s00253-003-1499-9; Zhu JF, 2005, METAB ENG, V7, P104, DOI 10.1016/j.ymben.2004.10.004; Zhu XW, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r110	37	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28197	10.1371/journal.pone.0028197	http://dx.doi.org/10.1371/journal.pone.0028197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164243	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400044
J	Xu, Y; Liu, Z; Sun, J; Pan, QR; Sun, FF; Yan, ZY; Hu, X				Xu, Yang; Liu, Zhen; Sun, Jie; Pan, Qiangrong; Sun, Feifei; Yan, Zhiyu; Hu, Xun			Schisandrin B Prevents Doxorubicin-Induced Chronic Cardiotoxicity and Enhances Its Anticancer Activity In Vivo	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; GLUTATHIONE ANTIOXIDANT STATUS; P-GLYCOPROTEIN; ANTITUMOR-ACTIVITY; CANCER-CELLS; RAT HEARTS; ANTHRACYCLINE; ADRIAMYCIN; TOXICITY; PROTECTS	Background: To mitigate the cardiotoxicity of anthracycline antibiotics without compromising their anticancer activities is still an issue to be solved. We previously demonstrated that schisandrin B (Sch B) could protect against doxorubicin (Dox)-induced acute cardiotoxicity via enhancing cardiomyocytic glutathione redox cycling that could attenuate oxidative stress generated from Dox. In this study, we attempted to prove if Sch B could also protect against Dox-induced chronic cardiotoxicity, a more clinically relevant issue, without compromising its anticancer activity. Methodology: Rat was given intragastrically either vehicle or Sch B (50 mg/kg) two hours prior to i.p. Dox (2.5 mg/kg) weekly over a 5-week period with a cumulative dose of Dox 12.5 mg/kg. At the 6th and 12th week after last dosing, rats were subjected to cardiac function measurement, and left ventricles were processed for histological and ultrastructural examination. Dox anticancer activity enhanced by Sch B was evaluated by growth inhibition of 4T1, a breast cancer cell line, and S180, a sarcoma cell line, in vitro and in vivo. Principal Findings: Pretreatment with Sch B significantly attenuated Dox-induced loss of cardiac function and damage of cardiomyocytic structure. Sch B substantially enhanced Dox cytotoxicities toward S180 in vitro and in vivo in mice, and increased Dox cytotoxcity against 4T1 in vitro. Although we did not observe this enhancement against the implanted 4T1 primary tumor, the spontaneous metastasis to lung was significantly reduced in combined treatment group than Dox alone group. Conclusion: Sch B is capable of protecting Dox-induced chronic cardiotoxicity and enhancing its anticancer activity. To the best of our knowledge, Sch B is the only molecule ever proved to function as a cardioprotective agent as well as a chemotherapeutic sensitizer, which is potentially applicable for cancer treatment.	[Xu, Yang; Liu, Zhen; Sun, Jie; Pan, Qiangrong; Sun, Feifei; Yan, Zhiyu; Hu, Xun] Natl Minist Educ, Key Lab Canc Prevent & Intervent, Inst Canc, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Yang] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Hematol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xu, Y (corresponding author), Natl Minist Educ, Key Lab Canc Prevent & Intervent, Inst Canc, Key Lab Mol Biol Med Sci, Hangzhou, Zhejiang, Peoples R China.	huxun@zju.edu.cn		Liu, Zhen/0000-0002-8910-9664	Natural Sciences Foundation of China [30772544]; China National 863 project [2007AA02Z143]; National Ministry of Health, China [WKJ2006-2-011]; Bureau for Traditional Chinese Medicine, Zhejiang Province, China [2006Z013A, 2008CA055]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); China National 863 project(National High Technology Research and Development Program of China); National Ministry of Health, China; Bureau for Traditional Chinese Medicine, Zhejiang Province, China	This study was supported by Natural Sciences Foundation of China grant 30772544, China National 863 project 2007AA02Z143, National Ministry of Health grant WKJ2006-2-011, China; Bureau for Traditional Chinese Medicine grants 2006Z013A, 2008CA055, Zhejiang Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen N, 2010, BIOL PHARM BULL, V33, P825, DOI 10.1248/bpb.33.825; Chiu PY, 2011, MOL CELL BIOCHEM, V350, P237, DOI 10.1007/s11010-010-0703-3; CUSACK BJ, 1988, CANCER CHEMOTH PHARM, V22, P294; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Fogli S, 2004, FASEB J, V18, P664, DOI 10.1096/fj.03-0724rev; Fong WF, 2007, PLANTA MED, V73, P212, DOI 10.1055/s-2007-967120; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; GREENE RF, 1983, CANCER RES, V43, P3417; Hu X, 2004, China Patent, Patent No. 200410059603; Hu X, 2006, China patent: application number, Patent No. 200610111128; Hu X, 2006, China patent: application number, Patent No. 200610111123; Hu X, 2004, China Patent, Patent No. [Z1200410059607, 200410059607]; Huang M, 2008, CANCER CHEMOTH PHARM, V62, P1015, DOI 10.1007/s00280-008-0691-0; Ip SP, 1996, FREE RADICAL BIO MED, V21, P709, DOI 10.1016/0891-5849(96)00179-7; Kang YJ, 1997, J CLIN INVEST, V100, P1501, DOI 10.1172/JCI119672; Kelland LR, 2004, EUR J CANCER, V40, P827, DOI 10.1016/j.ejca.2003.11.028; Ko KM, 2002, MOL CELL BIOCHEM, V238, P181, DOI 10.1023/A:1019907316129; Ko KM, 2001, MOL CELL BIOCHEM, V220, P141, DOI 10.1023/A:1010979404447; Li L, 2006, BIOCHEM PHARMACOL, V71, P584, DOI 10.1016/j.bcp.2005.11.026; Li L, 2007, CLIN CANCER RES, V13, P6753, DOI 10.1158/1078-0432.CCR-07-1579; Li L, 2007, LIFE SCI, V80, P741, DOI 10.1016/j.lfs.2006.11.002; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Pacher P, 2002, J PHARMACOL EXP THER, V300, P862, DOI 10.1124/jpet.300.3.862; Pan QR, 2006, CANCER CHEMOTH PHARM, V58, P99, DOI 10.1007/s00280-005-0133-1; Pan QR, 2005, BIOCHEM BIOPH RES CO, V335, P406, DOI 10.1016/j.bbrc.2005.07.097; Peng XY, 2005, MOL INTERV, V5, P163, DOI 10.1124/mi.5.3.6; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Sacco G, 2003, BRIT J PHARMACOL, V139, P641, DOI 10.1038/sj.bjp.0705270; SIVESKIILISKOVIC N, 1995, CIRCULATION, V91, P10, DOI 10.1161/01.CIR.91.1.10; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; Sun M, 2007, CANCER LETT, V246, P300, DOI 10.1016/j.canlet.2006.03.009; Varvaresou A, 2004, ANTICANCER RES, V24, P907; Wan CK, 2006, BIOCHEM PHARMACOL, V72, P824, DOI 10.1016/j.bcp.2006.06.036; Winyard PG, 2005, TRENDS BIOCHEM SCI, V30, P453, DOI 10.1016/j.tibs.2005.06.001; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Yim TK, 1999, MOL CELL BIOCHEM, V196, P151, DOI 10.1023/A:1006927926495; Yoshida M, 2009, J MOL CELL CARDIOL, V47, P698, DOI 10.1016/j.yjmcc.2009.07.024; Zhu WQ, 2009, CIRCULATION, V119, P99, DOI 10.1161/CIRCULATIONAHA.108.799700	40	37	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28335	10.1371/journal.pone.0028335	http://dx.doi.org/10.1371/journal.pone.0028335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164272	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400073
J	Fisher, CA; Bhattarai, EK; Osterstock, JB; Dowd, SE; Seabury, PM; Vikram, M; Whitlock, RH; Schukken, YH; Schnabel, RD; Taylor, JF; Womack, JE; Seabury, CM				Fisher, Colleen A.; Bhattarai, Eric K.; Osterstock, Jason B.; Dowd, Scot E.; Seabury, Paul M.; Vikram, Meenu; Whitlock, Robert H.; Schukken, Ynte H.; Schnabel, Robert D.; Taylor, Jeremy F.; Womack, James E.; Seabury, Christopher M.			Evolution of the Bovine TLR Gene Family and Member Associations with Mycobacterium avium Subspecies paratuberculosis Infection	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; PROTEIN DOMAIN ARCHITECTURES; TOLL-LIKE RECEPTORS; BALANCING SELECTION; HAPLOTYPE RECONSTRUCTION; SEQUENCE VARIABILITY; FREQUENCY ESTIMATION; PURIFYING SELECTION; STATISTICAL-METHOD; RECOGNITION	Members of the Toll-like receptor (TLR) gene family occupy key roles in the mammalian innate immune system by functioning as sentries for the detection of invading pathogens, thereafter provoking host innate immune responses. We utilized a custom next-generation sequencing approach and allele-specific genotyping assays to detect and validate 280 biallelic variants across all 10 bovine TLR genes, including 71 nonsynonymous single nucleotide polymorphisms (SNPs) and one putative nonsense SNP. Bayesian haplotype reconstructions and median joining networks revealed haplotype sharing between Bos taurus taurus and Bos taurus indicus breeds at every locus, and specialized beef and dairy breeds could not be differentiated despite an average polymorphism density of 1 marker/158 bp. Collectively, 160 tagSNPs and two tag insertion-deletion mutations (indels) were sufficient to predict 100% of the variation at 280 variable sites for both Bos subspecies and their hybrids, whereas 118 tagSNPs and 1 tagIndel predictively captured 100% of the variation at 235 variable sites for B. t. taurus. Polyphen and SIFT analyses of amino acid (AA) replacements encoded by bovine TLR SNPs indicated that up to 32% of the AA substitutions were expected to impact protein function. Classical and newly developed tests of diversity provide strong support for balancing selection operating on TLR3 and TLR8, and purifying selection acting on TLR10. An investigation of the persistence and continuity of linkage disequilibrium (r(2) >= 0.50) between adjacent variable sites also supported the presence of selection acting on TLR3 and TLR8. A case-control study employing validated variants from bovine TLR genes recognizing bacterial ligands revealed six SNPs potentially eliciting small effects on susceptibility to Mycobacterium avium spp paratuberculosis infection in dairy cattle. The results of this study will broadly impact domestic cattle research by providing the necessary foundation to explore several avenues of bovine translational genomics, and the potential for marker-assisted vaccination.	[Fisher, Colleen A.; Bhattarai, Eric K.; Vikram, Meenu; Womack, James E.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Osterstock, Jason B.] Pfizer Anim Genet, Kalamazoo, MI USA; [Dowd, Scot E.] Med Biofilm Res Inst, Res & Testing Lab, Lubbock, TX USA; [Seabury, Paul M.] ElanTech Inc, Greenbelt, MD USA; [Whitlock, Robert H.] Univ Penn, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA; [Schukken, Ynte H.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Schnabel, Robert D.; Taylor, Jeremy F.] Univ Missouri, Div Anim Sci, Columbia, MO USA	Texas A&M University System; Texas A&M University College Station; Pfizer; University of Pennsylvania; Cornell University; University of Missouri System; University of Missouri Columbia	Osterstock, JB (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Schukken, Ynte/ABD-3352-2021; Schukken, Ynte H/C-3405-2008; Dowd, Scot E/M-5386-2017	Schukken, Ynte/0000-0002-8250-4194; Schukken, Ynte H/0000-0002-8250-4194; Dowd, Scot E/0000-0002-6296-1427; Schnabel, Robert/0000-0001-5018-7641	United States Department of Agriculture National Institute of Food and Agriculture [2009-35205-05058]; National Institute of Food and Agriculture [3951-TAMU-USDA-8710, 2010-590119]; Texas AgriLife Research; College of Veterinary Medicine, Texas AM University	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Texas AgriLife Research; College of Veterinary Medicine, Texas AM University	This project was supported by National Research Initiative Competitive Grant no. 2009-35205-05058 from the United States Department of Agriculture National Institute of Food and Agriculture to CMS. Likewise, research activities described herein were also supported by a National Institute of Food and Agriculture Johne's Disease Integrated Program Grant 3951-TAMU-USDA-8710 to JBO, CMS, and YHS, as well as a National Institute of Food and Agriculture Formula Animal Health Grant 2010-590119 to CMS and JBO. The authors also acknowledge support from Texas AgriLife Research and the College of Veterinary Medicine, Texas A&M University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Bovine HAPMAP Consortium, 2009, SCIENCE, V324, P529, DOI [10.1126/science.1167936, DOI 10.1126/SCIENCE.1167936]; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Cahn CM, 2005, MERCK VET MANUAL, P441; Cargill EJ, 2007, GENOMICS, V89, P745, DOI 10.1016/j.ygeno.2007.02.008; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fauquet C.M., 2005, VIRUS TAXONOMY DOUBL, P441, DOI [10.1016/B978-0-12-249951-7.50013-4, DOI 10.1016/B978-0-12-249951-7.50013-4]; Fu YX, 1997, GENETICS, V147, P915; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glass EJ, 2011, VET IMMUNOL IN PRESS; Govindaraj RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012713; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Heyen DW, 1999, PHYSIOL GENOMICS, V1, P165, DOI 10.1152/physiolgenomics.1999.1.3.165; Hiwatashi T, 2010, MOL BIOL EVOL, V27, P453, DOI 10.1093/molbev/msp262; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; Hughes AL, 2003, P NATL ACAD SCI USA, V100, P15754, DOI 10.1073/pnas.2536718100; Ingman M, 2009, EUR J HUM GENET, V17, P383, DOI 10.1038/ejhg.2008.182; Jann OC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-216; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kataria RS, 2011, IMMUNOGENETICS, V63, P115, DOI 10.1007/s00251-010-0484-6; Kuhn C, 2003, J DAIRY SCI, V86, P360, DOI 10.3168/jds.S0022-0302(03)73614-5; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li N, 2003, GENETICS, V165, P2213; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Merx Sabine, 2006, Hum Mutat, V27, P293, DOI 10.1002/humu.9409; Mucha R, 2009, VET IMMUNOL IMMUNOP, V128, P381, DOI 10.1016/j.vetimm.2008.12.007; Mukhopadhyay S, 2004, IMMUNOLOGY, V112, P521, DOI 10.1111/j.1365-2567.2004.01941.x; Neibergs HL, 2010, MAMM GENOME, V21, P419, DOI 10.1007/s00335-010-9278-2; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Osier FHA, 2010, INFECT IMMUN, V78, P4625, DOI 10.1128/IAI.00576-10; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Pinedo PJ, 2009, PREV VET MED, V91, P189, DOI 10.1016/j.prevetmed.2009.05.020; Pinedo PJ, 2009, MAMM GENOME, V20, P124, DOI 10.1007/s00335-008-9167-0; Plain KM, 2010, VET IMMUNOL IMMUNOP, V137, P142, DOI 10.1016/j.vetimm.2010.04.002; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pradhan AK, 2011, J CLIN MICROBIOL, V49, P893, DOI 10.1128/JCM.01107-10; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rosenthal Kenneth L, 2006, Can J Infect Dis Med Microbiol, V17, P307; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; Ruiz-Larranaga O, 2011, J DAIRY SCI, V94, P3635, DOI 10.3168/jds.2010-3788; Seabury CM, 2008, GENOMICS, V92, P235, DOI 10.1016/j.ygeno.2008.06.005; Seabury CM, 2007, GENOMICS, V90, P502, DOI 10.1016/j.ygeno.2007.07.001; Seabury CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015811; Seabury CM, 2010, P NATL ACAD SCI USA, V107, P151, DOI 10.1073/pnas.0913006107; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; SIMONSEN KL, 1995, GENETICS, V141, P413; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Subramanian S, 2006, MOL BIOL EVOL, V23, P2283, DOI 10.1093/molbev/msl123; TAJIMA F, 1989, GENETICS, V123, P585; Tennessen JA, 2008, MOL BIOL EVOL, V25, P2669, DOI 10.1093/molbev/msn208; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; White SN, 2003, P NATL ACAD SCI USA, V100, P10364, DOI 10.1073/pnas.1333957100; Zanella R, 2011, ANIM GENET, V42, P28, DOI 10.1111/j.1365-2052.2010.02076.x	69	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2011	6	11							e27744	10.1371/journal.pone.0027744	http://dx.doi.org/10.1371/journal.pone.0027744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863MI	22164200	gold, Green Published, Green Submitted			2022-12-27	WOS:000298168100017
J	Acharya, BK; Sanders, NJ; Vijayan, L; Chettri, B				Acharya, Bhoj Kumar; Sanders, Nathan J.; Vijayan, Lalitha; Chettri, Basundhara			Elevational Gradients in Bird Diversity in the Eastern Himalaya: An Evaluation of Distribution Patterns and Their Underlying Mechanisms	PLOS ONE			English	Article							SPECIES RICHNESS PATTERNS; SMALL MAMMAL DIVERSITY; GEOMETRIC CONSTRAINTS; RAPOPORTS RULE; RANGE-SIZE; BIOGEOGRAPHICAL PATTERNS; SCALE PATTERNS; ENERGY; AREA; EXPLAIN	Background: Understanding diversity patterns and the mechanisms underlying those patterns along elevational gradients is critically important for conservation efforts in montane ecosystems, especially those that are biodiversity hotspots. Despite recent advances, consensus on the underlying causes, or even the relative influence of a suite of factors on elevational diversity patterns has remained elusive. Methods and Principal Findings: We examined patterns of species richness, density and range size distribution of birds, and the suite of biotic and abiotic factors (primary productivity, habitat variables, climatic factors and geometric constraints) that governs diversity along a 4500-m elevational gradient in the Eastern Himalayan region, a biodiversity hotspot within the world's tallest mountains. We used point count methods for sampling birds and quadrats for estimating vegetation at 22 sites along the elevational gradient. We found that species richness increased to approximately 2000 m, then declined. We found no evidence that geometric constraints influenced this pattern, whereas actual evapotranspiration (a surrogate for primary productivity) and various habitat variables (plant species richness, shrub density and basal area of trees) accounted for most of the variation in bird species richness. We also observed that ranges of most bird species were narrow along the elevation gradient. We find little evidence to support Rapoport's rule for the birds of Sikkim region of the Himalaya. Conclusions and Significance: This study in the Eastern Himalaya indicates that species richness of birds is highest at intermediate elevations along one of the most extensive elevational gradients ever examined. Additionally, primary productivity and factors associated with habitat accounted for most of the variation in avian species richness. The diversity peak at intermediate elevations and the narrow elevational ranges of most species suggest important conservation implications: not only should mid-elevation areas be conserved, but the entire gradient requires equal conservation attention.	[Acharya, Bhoj Kumar; Vijayan, Lalitha; Chettri, Basundhara] Salim Ali Ctr Ornithol & Nat Hist, Div Conservat Ecol, Coimbatore, Tamil Nadu, India; [Sanders, Nathan J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Salim Ali Center for Ornithology & Natural History (SACON); University of Tennessee System; University of Tennessee Knoxville	Acharya, BK (corresponding author), Sikkim Govt Coll, Dept Zool, Gangtok, Sikkim, India.	acharya2skm@gmail.com	Sanders, Nathan/ABE-4335-2020; Sanders, Nathan/A-6945-2009	Sanders, Nathan/0000-0001-6220-6731; Vijayan, Lalitha/0000-0002-4074-5002	MoEF, Government of India, through CISMHE, University of Delhi; Danish National Research Foundation [DOE-PER DE-FG02]	MoEF, Government of India, through CISMHE, University of Delhi; Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was funded by MoEF, Government of India, through CISMHE, University of Delhi. NJS was supported by DOE-PER DE-FG02 a grant from the Danish National Research Foundation to the Center for Macroecology, Evolution and Climate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Bhattarai KR, 2006, DIVERS DISTRIB, V12, P373, DOI 10.1111/j.1366-9516.2006.00244.x; Bhattarai KR, 2004, J BIOGEOGR, V31, P389, DOI 10.1046/j.0305-0270.2003.01013.x; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, AM NAT, V144, P570, DOI 10.1086/285695; Colwell RK, 2004, AM NAT, V163, pE1, DOI 10.1086/382056; COLWELL RK, ESTIMATES DATA ANAL; CUERTO VR, 1999, J BIOGEOGR, V26, P487; Currie DJ, 2008, ECOL MONOGR, V78, P3, DOI 10.1890/06-1302.1; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; De Klerk HM, 2002, DIVERS DISTRIB, V8, P147, DOI 10.1046/j.1472-4642.2002.00142.x; Ding TS, 2006, J BIOGEOGR, V33, P683, DOI 10.1111/j.1365-2699.2006.01419.x; Ding TS, 2005, GLOBAL ECOL BIOGEOGR, V14, P299, DOI 10.1111/j.1466-822x.2005.00159.x; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dunn RR, 2007, GLOBAL ECOL BIOGEOGR, V16, P305, DOI 10.1111/j.1466-8238.2006.00284.x; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Freifeld HB, 1999, J BIOGEOGR, V26, P1191, DOI 10.1046/j.1365-2699.1999.00349.x; Fu CZ, 2007, BIODIVERS CONSERV, V16, P707, DOI 10.1007/s10531-005-4382-4; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gaston KJ, 1998, TRENDS ECOL EVOL, V13, P70, DOI 10.1016/S0169-5347(97)01236-6; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; GRAHAM GL, 1990, J BIOGEOGR, V17, P657, DOI 10.2307/2845147; Grau O, 2007, J BIOGEOGR, V34, P1907, DOI 10.1111/j.1365-2699.2007.01745.x; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Haribal M., 1992, BUTTERFLIES SIKKIM H; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hawkins AFA, 1999, J BIOGEOGR, V26, P447, DOI 10.1046/j.1365-2699.1999.00306.x; Hawkins BA, 2005, AM NAT, V166, pE140, DOI 10.1086/491686; Hawkins BA, 2002, GLOBAL ECOL BIOGEOGR, V11, P419, DOI 10.1046/j.1466-822x.2002.00299.x; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Heaney LR, 2001, GLOBAL ECOL BIOGEOGR, V10, P15, DOI 10.1046/j.1466-822x.2001.00227.x; Hernandez CE, 2005, ECOGRAPHY, V28, P363, DOI 10.1111/j.0906-7590.2005.04013.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hofer U, 1999, ECOLOGY, V80, P976, DOI 10.2307/177031; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jetz W, 2001, P NATL ACAD SCI USA, V98, P5661, DOI 10.1073/pnas.091100998; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kessler Michael, 2001, Diversity and Distributions, V7, P61, DOI 10.1046/j.1472-4642.2001.00097.x; Kluge J, 2006, GLOBAL ECOL BIOGEOGR, V15, P358, DOI [10.1111/j.1466-822X.2006.00223.x, 10.1111/j.1466-822x.2006.00223.x]; Korner C, 2000, TRENDS ECOL EVOL, V15, P513, DOI 10.1016/S0169-5347(00)02004-8; Kozak KH, 2010, AM NAT, V176, P40, DOI 10.1086/653031; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; MACARTHUR R, 1966, AM NAT, V100, P319, DOI 10.1086/282425; Machac A, 2011, ECOGRAPHY, V34, P364, DOI 10.1111/j.1600-0587.2010.06629.x; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2003, J MAMMAL, V84, P967, DOI 10.1644/BJK-026; Naniwadekar R, 2007, J BIOGEOGR, V34, P842, DOI 10.1111/j.1365-2699.2006.01648.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Nor SM, 2001, GLOBAL ECOL BIOGEOGR, V10, P41, DOI 10.1046/j.1466-822x.2001.00231.x; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; OLSON DM, 1994, J TROP ECOL, V10, P129, DOI 10.1017/S0266467400007793; Oommen MA, 2005, ECOLOGY, V86, P3039, DOI 10.1890/04-1837; Orme CDL, 2006, PLOS BIOL, V4, P1276, DOI 10.1371/journal.pbio.0040208; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Rahbek C, 1997, AM NAT, V149, P875, DOI 10.1086/286028; Rahbek C, 2007, P ROY SOC B-BIOL SCI, V274, P165, DOI 10.1098/rspb.2006.3700; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rasmussen PC., 2005, BIRDS S ASIA RIPLEY; REYNOLDS RT, 1980, CONDOR, V82, P309, DOI 10.2307/1367399; Rohde Klaus, 1996, Biodiversity Letters, V3, P10, DOI 10.2307/2999704; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG ML, 1992, J MAMMAL, V73, P715, DOI 10.2307/1382191; Rowe RJ, 2009, GLOBAL ECOL BIOGEOGR, V18, P163, DOI 10.1111/j.1466-8238.2008.00438.x; Sanders NJ, 2007, GLOBAL ECOL BIOGEOGR, V16, P640, DOI 10.1111/j.1466-8238.2007.00316.x; Sanders NJ, 2010, DATA MINING FOR GLOBAL TRENDS IN MOUNTAIN BIODIVERSITY, P75; Sanders NJ, 2002, ECOGRAPHY, V25, P25, DOI 10.1034/j.1600-0587.2002.250104.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; SANDERS NJ, ECOGRAPHY IN PRESS; Smith TB, 2005, J EVOLUTION BIOL, V18, P257, DOI 10.1111/j.1420-9101.2004.00825.x; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; TURC L., 1954, Annales Agronomiques, V5, P491; Vazquez JA, 1998, J ECOL, V86, P999, DOI 10.1046/j.1365-2745.1998.00325.x; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Willson MF, 1996, CONDOR, V98, P350, DOI 10.2307/1369153	91	65	78	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e29097	10.1371/journal.pone.0029097	http://dx.doi.org/10.1371/journal.pone.0029097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174953	gold, Green Submitted, Green Published			2022-12-27	WOS:000298367300044
J	Caspersen, JP; Vanderwel, MC; Cole, WG; Purves, DW				Caspersen, John P.; Vanderwel, Mark C.; Cole, William G.; Purves, Drew W.			How Stand Productivity Results from Size- and Competition-Dependent Growth and Mortality	PLOS ONE			English	Article							NORTHERN HARDWOOD FORESTS; GROWING SPACE EFFICIENCY; CANOPY TREE COMPETITION; WOODY DEBRIS DYNAMICS; PLANT-POPULATIONS; MULTISPECIES MODEL; METABOLIC ECOLOGY; CENTRAL ONTARIO; DECAYING LOGS; SELECTION	Background: A better understanding of the relationship between stand structure and productivity is required for the development of: a) scalable models that can accurately predict growth and yield dynamics for the world's forests; and b) stand management regimes that maximize wood and/or timber yield, while maintaining structural and species diversity. Methods: We develop a cohort-based canopy competition model ("CAIN''), parameterized with inventory data from Ontario, Canada, to examine the relationship between stand structure and productivity. Tree growth, mortality and recruitment are quantified as functions of diameter and asymmetric competition, using a competition index (CAI(h)) defined as the total projected area of tree crowns at a given tree's mid-crown height. Stand growth, mortality, and yield are simulated for inventoried stands, and also for hypothetical stands differing in total volume and tree size distribution. Results: For a given diameter, tree growth decreases as CAI(h) increases, whereas the probability of mortality increases. For a given CAI(h), diameter growth exhibits a humped pattern with respect to diameter, whereas mortality exhibits a U-shaped pattern reflecting senescence of large trees. For a fixed size distribution, stand growth increases asymptotically with total density, whereas mortality increases monotonically. Thus, net productivity peaks at an intermediate volume of 100-150 m(3)/ha, and approaches zero at 250 m(3)/ha. However, for a fixed stand volume, mortality due to senescence decreases if the proportion of large trees decreases as overall density increases. This size-related reduction in mortality offsets the density-related increase in mortality, resulting in a 40% increase in yield. Conclusions: Size-related variation in growth and mortality exerts a profound influence on the relationship between stand structure and productivity. Dense stands dominated by small trees yield more wood than stands dominated by fewer large trees, because the relative growth rate of small trees is higher, and because they are less likely to die.	[Caspersen, John P.] Univ Toronto, Fac Forestry, Toronto, ON, Canada; [Vanderwel, Mark C.; Purves, Drew W.] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England; [Cole, William G.] Ontario Forest Res Inst, Sault Ste Marie, ON, Canada	University of Toronto; Microsoft	Caspersen, JP (corresponding author), Univ Toronto, Fac Forestry, Toronto, ON, Canada.	john.caspersen@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [90439956]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant to JPC (grant #90439956) (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS D M, 1974, Canadian Journal of Forest Research, V4, P274, DOI 10.1139/x74-041; Adams TP, 2007, P ROY SOC B-BIOL SCI, V274, P3039, DOI 10.1098/rspb.2007.0891; [Anonymous], 2004, TROPICAL FOREST DIVE; Assmann E., 1970, PRINCIPLES FOREST YI; BAKER F. S., 1949, JOUR FOREST, V47, P179; Bowman JC, 1997, WILDLIFE BIOL, V3, P97, DOI 10.2981/wlb.1997.012; Brunner A, 1998, FOREST ECOL MANAG, V107, P19, DOI 10.1016/S0378-1127(97)00325-3; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; BUONGIORNO J, 1980, FOREST SCI, V26, P609; Buongiorno J, 2000, SILVA FENN, V34, P223, DOI 10.14214/sf.627; Burns R. M., 1990, AGR HDB, V2, P877, DOI DOI 10.1093/JHERED/ESP102; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Caspersen JP, 2006, CAN J FOREST RES, V36, P1255, DOI 10.1139/X06-034; Coates KD, 2009, J ECOL, V97, P118, DOI 10.1111/j.1365-2745.2008.01458.x; COLE WG, 1995, HARDWOOD TREE CROWN; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Fisher R, 2010, NEW PHYTOL, V187, P666, DOI 10.1111/j.1469-8137.2010.03340.x; Groot A, 2008, FOREST ECOL MANAG, V255, P1647, DOI 10.1016/j.foreco.2007.11.024; HAIGHT RG, 1985, FOREST SCI, V31, P451; Hanewinkel M, 2002, FORESTRY, V75, P473, DOI 10.1093/forestry/75.4.473; HANSEN GD, 1987, CAN J FOREST RES, V17, P1, DOI 10.1139/x87-001; HARA T, 1988, TRENDS ECOL EVOL, V3, P129, DOI 10.1016/0169-5347(88)90175-9; HARA T, 1992, ANN BOT-LONDON, V69, P509, DOI 10.1093/oxfordjournals.aob.a088380; Hayden J., 1995, FIELD MANUAL ESTABLI; Herault B, 2011, J ECOL, V99, P1431, DOI 10.1111/j.1365-2745.2011.01883.x; HIX DM, 1990, FOREST SCI, V36, P1032; Holloway GL, 2006, J WILDLIFE MANAGE, V70, P1735, DOI 10.2193/0022-541X(2006)70[1735:SHRIFM]2.0.CO;2; Holloway GL, 2007, FOREST ECOL MANAG, V239, P191, DOI 10.1016/j.foreco.2006.12.004; Jung TS, 1999, J WILDLIFE MANAGE, V63, P1306, DOI 10.2307/3802849; KOHYAMA T, 1992, FUNCT ECOL, V6, P206, DOI 10.2307/2389756; KOHYAMA T, 1992, ANN BOT-LONDON, V70, P451, DOI 10.1093/oxfordjournals.aob.a088502; Kraft NJB, 2010, NEW PHYTOL, V188, P1124, DOI 10.1111/j.1469-8137.2010.03444.x; LAHDE E, 1994, ANN SCI FOREST, V51, P97, DOI 10.1051/forest:19940201; Lichstein JW, 2010, ECOL APPL, V20, P684, DOI 10.1890/08-2334.1; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; Lopez-Gonzalez G, 2011, J VEG SCI, V22, P610, DOI 10.1111/j.1654-1103.2011.01312.x; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; McGee GG, 2001, J TORREY BOT SOC, V128, P370, DOI 10.2307/3088669; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; *MILL EC ASS, 2005, BIOD WHAT IS IT IS I; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Nyland RD, 1998, J FOREST, V96, P18; O'Hara KL, 2006, FOREST SCI, V52, P290; *ONT MIN NAT RES, 2000, SILV GUID TOL HARDW; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; Poulin JF, 2010, ECOSCIENCE, V17, P20, DOI 10.2980/17-1-3297; Pretzsch H, 2005, PLANT BIOLOGY, V7, P628, DOI 10.1055/s-2005-865965; Price CA, 2010, NEW PHYTOL, V188, P696, DOI 10.1111/j.1469-8137.2010.03442.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; Rowe J.S., 1972, CANADIAN FOREST SERV, V1300; *ROY SOC, 2001, GLOB CARB STOCKS SIN; Silvertown J., 2001, INTRO PLANT POPULATI; Straus MA, 2011, CAN J FOREST RES, V41, P1004, DOI [10.1139/X11-012, 10.1139/x11-012]; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Vanderwel MC, 2011, FOREST ECOL MANAG, V261, P1362, DOI 10.1016/j.foreco.2011.01.016; Vanderwel MC, 2009, CAN J FOREST RES, V39, P1709, DOI 10.1139/X09-087; Vanderwel MC, 2008, CAN J FOREST RES, V38, P2850, DOI 10.1139/X08-130; Vanderwel MC, 2006, FOREST ECOL MANAG, V225, P190, DOI 10.1016/j.foreco.2005.12.051; Webster CR, 2003, FOREST ECOL MANAG, V177, P361, DOI 10.1016/S0378-1127(02)00394-8; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WELLER DE, 1987, ECOL MONOGR, V57, P23, DOI 10.2307/1942637	68	41	42	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28660	10.1371/journal.pone.0028660	http://dx.doi.org/10.1371/journal.pone.0028660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174861	gold, Green Published			2022-12-27	WOS:000298367300019
J	Zhang, B; Zhu, W; Yang, P; Liu, T; Jiang, M; He, ZN; Zhang, SX; Chen, WQ; Chen, W				Zhang, Bo; Zhu, Wei; Yang, Ping; Liu, Tao; Jiang, Mei; He, Zhi-Ni; Zhang, Shi-Xin; Chen, Wei-Qing; Chen, Wen			Cigarette Smoking and p16INK4 alpha Gene Promoter Hypermethylation in Non-Small Cell Lung Carcinoma Patients: A Meta-Analysis	PLOS ONE			English	Article							CPG ISLAND METHYLATION; DNA METHYLTRANSFERASES; ABERRANT METHYLATION; TUMOR-SUPPRESSOR; MULTIPLE GENES; NEVER SMOKERS; TOBACCO-SMOKE; EARLY EVENT; CANCER; P16	Background: Aberrant methylation of promoter DNA and transcriptional repression of specific tumor suppressor genes play an important role in carcinogenesis. Recently, many studies have investigated the association between cigarette smoking and p16(INK4 alpha) gene hypermethylation in lung cancer, but could not reach a unanimous conclusion. Methods and Findings: Nineteen cross-sectional studies on the association between cigarette smoking and p16(INK4 alpha) methylation in surgically resected tumor tissues from non-small cell lung carcinoma (NSCLC) patients were identified in PubMed database until June 2011. For each study, a 262 cross-table was extracted. In total, 2,037 smoker and 765 nonsmoker patients were pooled with a fixed-effects model weighting for the inverse of the variance. Overall, the frequency of p16(INK4 alpha) hypermethylation was higher in NSCLC patients with smoking habits than that in non-smoking patients (OR = 2.25, 95% CI = 1.81-2.80). The positive association between cigarette smoking and p16(INK4 alpha) hypermethylation was similar in adenocarcinoma and squamous-cell carcinoma. In the stratified analyses, the association was stronger in Asian patients and in the studies with larger sample sizes. Conclusion: Cigarette smoking is positively correlated to p16(INK4 alpha) gene hypermethylation in NSCLC patients.	[Zhang, Bo; Yang, Ping; He, Zhi-Ni; Zhang, Shi-Xin; Chen, Wen] Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Toxicol, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Wei] Guangzhou Ctr Dis Control & Prevent, Dept Toxicol, Guangzhou, Guangdong, Peoples R China; [Liu, Tao; Jiang, Mei; Chen, Wei-Qing] Sun Yat Sen Univ, Sch Publ Hlth, Fac Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Tao] Guangdong Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Liu, Tao] Ctr Dis Control & Prevent Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhang, B (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Food Nutr & Hlth, Dept Toxicol, Sch Publ Hlth, Guangzhou 510275, Guangdong, Peoples R China.	chenwq@mail.sysu.edu.cn; chenwen@mail.sysu.edu.cn	ZHANG, BO/K-4561-2013	ZHANG, BO/0000-0002-6352-1757	Distinguished Young Scholar of National Nature Science Foundation of China (NSFC) [30925029]; NSFC [30771832, 30901211]; National Key Basic Research and Development Program [2010CB912803]; National High Technology Research and Development Key Program of China [2008AA062504]; Ministry of Health of China [200902006]; Fundamental Research Funds for the Central Universities [10ykjc05, 10lgzd10]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS	Distinguished Young Scholar of National Nature Science Foundation of China (NSFC); NSFC(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program(National Basic Research Program of China); National High Technology Research and Development Key Program of China(National High Technology Research and Development Program of China); Ministry of Health of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS	This work was supported by a Distinguished Young Scholar of National Nature Science Foundation of China (NSFC) (30925029), NSFC (30771832 and 30901211), National Key Basic Research and Development Program (2010CB912803), National High Technology Research and Development Key Program of China (2008AA062504), Ministry of Health of China (200902006), the Fundamental Research Funds for the Central Universities (10ykjc05, 10lgzd10), Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme GDUPS (2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Belinsky SA, 2005, CLIN CANCER RES, V11, P6505, DOI 10.1158/1078-0432.CCR-05-0625; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Brait M, 2009, CANCER EPIDEM BIOMAR, V18, P2984, DOI 10.1158/1055-9965.EPI-08-1245; Brennan P, 2004, INT J CANCER, V109, P125, DOI 10.1002/ijc.11682; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; de Fraipont F, 2005, LUNG CANCER, V50, P199, DOI 10.1016/j.lungcan.2005.05.019; Divine KK, 2005, INT J CANCER, V114, P400, DOI 10.1002/ijc.20761; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fujiwara K, 2005, CLIN CANCER RES, V11, P1219; Georgiou E, 2007, EUR J CANCER PREV, V16, P396, DOI 10.1097/01.cej.0000236260.26265.d6; Guzman LM, 2007, BIOL RES, V40, P365, DOI [10.4067/S0716-97602007000400011, /S0716-97602007000400011]; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; IARC, 2004, IARC MON EV CARC RIS, V83; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; Kim DH, 2001, CANCER RES, V61, P3419; Kim DS, 2007, LUNG CANCER, V58, P1, DOI 10.1016/j.lungcan.2007.04.008; Kim H, 2004, J CLIN ONCOL, V22, P2363, DOI 10.1200/JCO.2004.10.077; Kim JS, 2004, CARCINOGENESIS, V25, P2165, DOI 10.1093/carcin/bgh217; Konno S, 2004, CANCER CYTOPATHOL, V102, P348, DOI 10.1002/cncr.20643; Kurahashi N, 2008, INT J CANCER, V122, P653, DOI 10.1002/ijc.23116; Liggett WH, 1998, J CLIN ONCOL, V16, P1197, DOI 10.1200/JCO.1998.16.3.1197; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Liu G, 2005, SEMIN RESP CRIT CARE, V26, P265, DOI 10.1055/s-2005-871983; Liu Y, 2006, NEOPLASIA, V8, P46, DOI 10.1593/neo.05586; Lu C, 2004, J CLIN ONCOL, V22, P4575, DOI 10.1200/JCO.2004.01.091; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; *MIN HLTH PEOPL RE, 2008, CAUS DEATH CHIN 3 RE; Nakata S, 2006, CANCER-AM CANCER SOC, V106, P2190, DOI 10.1002/cncr.21870; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Palmisano WA, 2000, CANCER RES, V60, P5954; [彭再梅 PENG Zaimei], 2010, [中南大学学报. 医学版, Journal of Central South University. Medical Sciences], V35, P247; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saatci C, 2009, CANCER EPIDEMIOL, V33, P47, DOI 10.1016/j.canep.2009.04.018; Sanchez-Cespedes M, 2001, CANCER RES, V61, P2092; Sato M, 2002, ONCOGENE, V21, P4822, DOI 10.1038/sj.onc.1205581; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tessema M, 2009, CARCINOGENESIS, V30, P1132, DOI 10.1093/carcin/bgp114; Toh CK, 2007, J CLIN PATHOL, V60, P337, DOI 10.1136/jcp.2006.040576; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Toyooka S, 2004, INT J CANCER, V110, P462, DOI 10.1002/ijc.20125; Toyooka S, 2006, CANCER RES, V66, P1371, DOI 10.1158/0008-5472.CAN-05-2625; VILLENEUVE PJ, 1994, CAN J PUBLIC HEALTH, V85, P385; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang DY, 2011, EXP MOL PATHOL, V90, P131, DOI 10.1016/j.yexmp.2010.10.014; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Yanagawa N, 2002, JPN J CANCER RES, V93, P1107, DOI 10.1111/j.1349-7006.2002.tb01212.x; Yanagawa N, 2011, ANTICANCER RES, V31, P1211; Zhang Chen-ye, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P23, DOI 10.3760/cma.j.issn.1003-9406.2011.01.006; Zhong LJ, 2000, LUNG CANCER, V27, P3, DOI 10.1016/S0169-5002(99)00093-8; Zochbauer-Muller S, 2001, CANCER RES, V61, P249; Zochbauer-Muller S, 2003, INT J CANCER, V107, P612, DOI 10.1002/ijc.11458	63	68	70	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2011	6	12							e28882	10.1371/journal.pone.0028882	http://dx.doi.org/10.1371/journal.pone.0028882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866GA	22174919	Green Submitted, gold, Green Published			2022-12-27	WOS:000298367300029
J	Conroy, AL; Liles, WC; Molyneux, ME; Rogerson, SJ; Kain, KC				Conroy, Andrea L.; Liles, W. Conrad; Molyneux, Malcolm E.; Rogerson, Stephen J.; Kain, Kevin C.			Performance Characteristics of Combinations of Host Biomarkers to Identify Women with Occult Placental Malaria: A Case-Control Study from Malawi	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; PREGNANT-WOMEN; BLOOD; SERUM; HYPERTENSION; ASSOCIATION; INFECTION; SFLT1	Background: Because of its propensity to sequester in the placental intervillous space, Plasmodium falciparum can evade detection by peripheral smear in women with placental malaria (PM). We evaluated host biomarkers as potential indicators of occult PM infections. Methods and Findings: Using a case-control design, we evaluated the ability of biomarkers to identify PM in the absence of circulating peripheral parasites (n = 24) compared to placental smear-negative controls (n = 326). We measured levels of biomarkers (C3a, C5a, CRP, angiopoietin-1, angiopoietin-2, sTie-2, sEndoglin, VEGF, sFlt-1, tissue factor, and leptin) in maternal peripheral plasma at delivery. Using ROC curve analysis, we assessed the ability of clinical parameters and biomarkers to accurately detect PM infections identified by placental smear. We show that decreases in sFlt-1 and leptin and increases in CRP were associated with occult PM infections (p<0.01) and correlated with placental parasitaemia (p<0.01). Individually, all markers had moderate ability to diagnose occult PM infections with areas under the ROC between 0.62 and 0.72. In order to improve diagnostic performance, we generated simple scoring systems to identify PM infections using either a clinical score (0-2), a biomarker score (0-3) or a clinical plus biomarker score (0-5). The combinatorial model that incorporated both clinical parameters and biomarkers had an area under curve (AUC) of 0.85 (95% CI, 0.81-0.89), which was significantly better at identifying occult PM infections than the clinical score alone (p = 0.001). Conclusion: These data suggest that host biomarkers in the maternal peripheral blood may improve the detection of PM in the absence of peripheral parasitaemia.	[Conroy, Andrea L.; Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada; [Molyneux, Malcolm E.] Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Malawi, Coll Med, Blantyre, Malawi; [Molyneux, Malcolm E.] Univ Liverpool, Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Rogerson, Stephen J.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Parkville, Vic, Australia; [Liles, W. Conrad; Kain, Kevin C.] Univ Toronto, Dept Med, Div Infect Dis, Trop Dis Unit, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Malawi; University of Malawi; Liverpool School of Tropical Medicine; University of Liverpool; Royal Melbourne Hospital; University of Melbourne; University of Toronto	Conroy, AL (corresponding author), Univ Toronto, Sandra A Rotman Labs, McLaughlin Rotman Ctr Global Hlth, Univ Hlth Network Toronto Gen Hosp, Toronto, ON, Canada.	kevin.kain@uhn.on.ca	Conroy, Andrea/AAA-8356-2020; Conroy, Andrea/ABC-5715-2020	Conroy, Andrea/0000-0002-5328-6511; Conroy, Andrea/0000-0002-5328-6511; Rogerson, Stephen/0000-0003-4287-1982; Kain, Kevin/0000-0001-6068-1272	Canadian Institutes of Health Research [MOP-13721, MOP-115160]; Genome Canada through the Ontario Genomics Institute; CIHR Canada Research Chairs; Wellcome Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada); CIHR Canada Research Chairs(Canada Research ChairsCanadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Canadian Institutes of Health Research grants MOP-13721 and MOP-115160 (KCK), Genome Canada through a grant by the Ontario Genomics Institute (KCK), and CIHR Canada Research Chairs (KCK, WCL). ALC was supported by a CIHR PhD studentship. SJR was supported by a Wellcome Trust Senior Research Fellowship. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegnika AA, 2006, AM J TROP MED HYG, V75, P798, DOI 10.4269/ajtmh.2006.75.798; [Anonymous], 2004, STRATEGIC FRAMEWORK; Conroy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004953; Conroy AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015291; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; DESOWITZ RS, 1992, ANN TROP MED PARASIT, V86, P95, DOI 10.1080/00034983.1992.11812638; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Hirokoshi K, 2007, NEPHRON CLIN PRACT, V106, pC43, DOI 10.1159/000101483; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Leke RFG, 1999, J CLIN MICROBIOL, V37, P2992, DOI 10.1128/JCM.37.9.2992-2996.1999; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Linnemann K, 2000, J CLIN ENDOCR METAB, V85, P4298, DOI 10.1210/jc.85.11.4298; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Mockenhaupt FP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-119; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Muehlenbachs A, 2008, P NATL ACAD SCI USA, V105, P14488, DOI 10.1073/pnas.0803657105; Muehlenbachs A, 2006, PLOS MED, V3, P2124, DOI 10.1371/journal.pmed.0030446; Pighetti M, 2003, OBSTET GYNECOL, V102, P535, DOI 10.1016/S0029-7844(03)00668-9; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Smith LA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-18; Tagbor H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014425; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; van de Laar R, 2009, EUR J OBSTET GYN R B, V147, P124, DOI 10.1016/j.ejogrb.2009.09.017; Yildiz L, 2002, CLIN CHEM LAB MED, V40, P1114, DOI 10.1515/CCLM.2002.195	28	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28540	10.1371/journal.pone.0028540	http://dx.doi.org/10.1371/journal.pone.0028540			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174834	Green Published, gold			2022-12-27	WOS:000298366600023
J	Gomez, F; Stoop, R				Gomez, Florian; Stoop, Ruedi			Quantitative Assessment of the Log-Log-Step Method for Pattern Detection in Noise-Prone Environments	PLOS ONE			English	Article							CORRELATION DIMENSION	Staircase-like structures in the log-log correlation plot of a time series indicate patterns against a noisy background, even under condition of strong jitter. We analyze the method for different jitter-noise-combinations, using quantitative criteria to measure the achievement by the method. A phase diagram shows the remarkable potential of this method even under very unfavorable conditions of noise and jitter. Moreover, we provide a novel and compact analytical derivation of the upper and lower bounds on the number of steps observable in the ideal noiseless case, as a function of pattern length and embedding dimension. The quantitative measure developed combined with the ideal bounds can serve as guiding lines for determining potential periodicity in noisy data.	[Gomez, Florian] ETH, Inst Neuroinformat, Zurich, Switzerland; Univ Zurich, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Gomez, F (corresponding author), ETH, Inst Neuroinformat, Zurich, Switzerland.	ruedi@ini.phys.ethz.ch						ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; Castro R, 1997, PHYS REV E, V55, P287, DOI 10.1103/PhysRevE.55.287; Christen M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011901; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1334, DOI 10.1152/jn.1983.49.6.1334; DING MZ, 1993, PHYS REV LETT, V70, P3872, DOI 10.1103/PhysRevLett.70.3872; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Kantz H., 2003, NONLINEAR TIME SERIE; Kern A, 1999, Z NATURFORSCH A, V54, P404, DOI 10.1515/zna-1999-6-710; Lestienne R, 1998, NEUROSCIENCE, V82, P315; LESTIENNE R, 1987, BRAIN RES, V437, P214, DOI 10.1016/0006-8993(87)91638-6; Pecora LM, 2009, UNDERST COMPLEX SYST, P3, DOI 10.1007/978-1-4020-9143-8_1; PEINKE J, 1992, ENCOUNTER CHAOS; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Rieke F., 1999, SPIKES EXPLORING NEU; SAUER T, 1994, PHYS REV LETT, V72, P3811, DOI 10.1103/PhysRevLett.72.3811; Stoop R, 2000, BIOL CYBERN, V83, P481, DOI 10.1007/PL00007975; Stoop R, 2002, COGNITIVE BRAIN RES, V13, P293, DOI 10.1016/S0926-6410(01)00123-9; STOOP R, 2003, J ELECT ELECT ENG IS, V3, P693; Stoop R, 2010, UNDERST COMPLEX SYST, P271, DOI 10.1007/978-3-642-04629-2_12	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2011	6	12							e28107	10.1371/journal.pone.0028107	http://dx.doi.org/10.1371/journal.pone.0028107			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FT	22174769	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000298366600008
J	De Lucia, M; Constantinescu, I; Sterpenich, V; Pourtois, G; Seeck, M; Schwartz, S				De Lucia, Marzia; Constantinescu, Irina; Sterpenich, Virginie; Pourtois, Gilles; Seeck, Margitta; Schwartz, Sophie			Decoding Sequence Learning from Single-Trial Intracranial EEG in Humans	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; HIDDEN MARKOV-MODELS; PREFRONTAL CORTEX; MICROSTATE DURATION; MEMORY; HIPPOCAMPUS; CLASSIFICATION; SLEEP; IMPLICIT; REPLAY	We propose and validate a multivariate classification algorithm for characterizing changes in human intracranial electroencephalographic data (iEEG) after learning motor sequences. The algorithm is based on a Hidden Markov Model (HMM) that captures spatio-temporal properties of the iEEG at the level of single trials. Continuous intracranial iEEG was acquired during two sessions (one before and one after a night of sleep) in two patients with depth electrodes implanted in several brain areas. They performed a visuomotor sequence (serial reaction time task, SRTT) using the fingers of their non-dominant hand. Our results show that the decoding algorithm correctly classified single iEEG trials from the trained sequence as belonging to either the initial training phase (day 1, before sleep) or a later consolidated phase (day 2, after sleep), whereas it failed to do so for trials belonging to a control condition (pseudo-random sequence). Accurate single-trial classification was achieved by taking advantage of the distributed pattern of neural activity. However, across all the contacts the hippocampus contributed most significantly to the classification accuracy for both patients, and one fronto-striatal contact for one patient. Together, these human intracranial findings demonstrate that a multivariate decoding approach can detect learning-related changes at the level of single-trial iEEG. Because it allows an unbiased identification of brain sites contributing to a behavioral effect (or experimental condition) at the level of single subject, this approach could be usefully applied to assess the neural correlates of other complex cognitive functions in patients implanted with multiple electrodes.	[De Lucia, Marzia] Vaudois Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland; [De Lucia, Marzia] Univ Lausanne, Lausanne, Switzerland; [Constantinescu, Irina; Sterpenich, Virginie; Schwartz, Sophie] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Constantinescu, Irina; Sterpenich, Virginie; Schwartz, Sophie] Univ Geneva, Geneva Neurosci Ctr, Geneva, Switzerland; [Pourtois, Gilles] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Seeck, Margitta] Univ Hosp Geneva, Dept Clin Neurol, Geneva, Switzerland; [Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [De Lucia, Marzia] Ctr Biomed Imaging, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of Geneva; Ghent University; University of Geneva; University of Geneva	De Lucia, M (corresponding author), Vaudois Univ Hosp Ctr, Dept Radiol, Lausanne, Switzerland.	marzia.de-lucia@chuv.ch	De Lucia, Marzia/O-6523-2015	De Lucia, Marzia/0000-0001-8792-7885; Schwartz, Sophie/0000-0001-7718-4053; Sterpenich, Virginie/0000-0002-2125-833X; Pourtois, Gilles/0000-0002-5109-2801	Swiss National Science Foundation [K-33K1_122518/1, 310000-114008]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grants from the Swiss National Science Foundation (K-33K1_122518/1 to M.D.L. and 310000-114008 to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agster KL, 2002, J NEUROSCI, V22, P5760; Albouy G, 2006, BRAIN RES, V1090, P163, DOI 10.1016/j.brainres.2006.03.076; Andres FG, 1999, J CLIN NEUROPHYSIOL, V16, P520, DOI 10.1097/00004691-199911000-00004; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Birbaumer N, 2006, CLIN NEUROPHYSIOL, V117, P479, DOI 10.1016/j.clinph.2005.11.002; Bishop C.M., 1995, NEURAL NETWORKS PATT; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Britz J, 2010, NEUROIMAGE, V52, P1162, DOI 10.1016/j.neuroimage.2010.02.052; CINCOTTI F, 2003, P 1 INT IEEE EMBS C; Clemens Z, 2007, BRAIN, V130, P2868, DOI 10.1093/brain/awm146; Dastjerdi M, 2011, P NATL ACAD SCI USA, V108, P3023, DOI 10.1073/pnas.1017098108; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030; DELUCIA M, 2007, INT J BIOELECTROMAGN, P168; DELUCIA M, 2007, P IEEE EMBS REG 8 IN, P95; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Destrebecqz A, 2005, LEARN MEMORY, V12, P480, DOI 10.1101/lm.95605; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Ergorul C, 2004, LEARN MEMORY, V11, P397, DOI 10.1101/lm.73304; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Galan F, 2008, CLIN NEUROPHYSIOL, V119, P2159, DOI 10.1016/j.clinph.2008.06.001; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Haynes JD, 2011, NEUROIMAGE, V56, P385, DOI 10.1016/j.neuroimage.2011.03.057; Iber C., 2007, AASM MANUAL SCORING; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kali S, 2004, NAT NEUROSCI, V7, P286, DOI 10.1038/nn1202; KINDLER J, 2010, CLIN NEUROPHYSIOL; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lefevre J, 2009, HUM BRAIN MAPP, V30, P1887, DOI 10.1002/hbm.20781; Lehmann D, 2005, PSYCHIAT RES-NEUROIM, V138, P141, DOI 10.1016/j.pscychresns.2004.05.007; Lehmann D., 1987, HDB ELECTROENCEPHALO, V1, P309; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; Michel CM, 2001, BRAIN RES REV, V36, P108, DOI 10.1016/S0165-0173(01)00086-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Murray MM, 2009, BRAIN SIGNAL ANALYSIS: ADVANCES IN NEUROELECTRIC AND NEUROMAGNETIC METHODS, P21; Murray MM, 2006, J NEUROSCI, V26, P1293, DOI 10.1523/JNEUROSCI.4511-05.2006; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nahum L, 2011, HIPPOCAMPUS, V21, P689, DOI 10.1002/hipo.20819; Nestor A, 2011, P NATL ACAD SCI USA, V108, P9998, DOI 10.1073/pnas.1102433108; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Obermaier B, 2001, PATTERN RECOGN LETT, V22, P1299, DOI 10.1016/S0167-8655(01)00075-7; Obermaier B, 2001, IEEE T NEUR SYS REH, V9, P283, DOI 10.1109/7333.948456; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Peyrache A, 2009, NAT NEUROSCI, V12, P919, DOI 10.1038/nn.2337; Pourtois G, 2010, J COGNITIVE NEUROSCI, V22, P2086, DOI 10.1162/jocn.2009.21404; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rasch B, 2007, CURR OPIN NEUROBIOL, V17, P698, DOI 10.1016/j.conb.2007.11.007; Ratcliff R, 2009, P NATL ACAD SCI USA, V106, P6539, DOI 10.1073/pnas.0812589106; Rieger JW, 2008, NEUROIMAGE, V42, P1056, DOI 10.1016/j.neuroimage.2008.06.014; Robertson EM, 2001, CEREB CORTEX, V11, P628, DOI 10.1093/cercor/11.7.628; Ryan L, 2010, HIPPOCAMPUS, V20, P11, DOI 10.1002/hipo.20607; Shima K, 2007, NATURE, V445, P315, DOI 10.1038/nature05470; Simanova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014465; Staeren N, 2009, CURR BIOL, V19, P498, DOI 10.1016/j.cub.2009.01.066; Strik WK, 1997, PSYCHIAT RES-NEUROIM, V75, P183, DOI 10.1016/S0925-4927(97)00054-1; SWETS JA, 1979, SCIENCE, V205, P753, DOI 10.1126/science.462188; Tzovara A, 2012, PATTERN RECOGN, V45, P2109, DOI 10.1016/j.patcog.2011.04.007; Van de Ville D, 2010, P NATL ACAD SCI USA, V107, P18179, DOI 10.1073/pnas.1007841107; VANDEVILLE D, 2011, PATTERN RECOGN, DOI DOI 10.1016/J.PAT-COG.2011.06.001; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wolpaw JR, 2007, J PHYSIOL-LONDON, V579, P613, DOI 10.1113/jphysiol.2006.125948; Yamashita O, 2008, NEUROIMAGE, V42, P1414, DOI 10.1016/j.neuroimage.2008.05.050	75	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28630	10.1371/journal.pone.0028630	http://dx.doi.org/10.1371/journal.pone.0028630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	22174850	Green Published, Green Submitted, gold			2022-12-27	WOS:000298365700053
J	Goatman, K; Charnley, A; Webster, L; Nussey, S				Goatman, Keith; Charnley, Amanda; Webster, Laura; Nussey, Stephen			Assessment of Automated Disease Detection in Diabetic Retinopathy Screening Using Two-Field Photography	PLOS ONE			English	Article							VISUAL-LOSS; OPHTHALMOSCOPY	Aim: To assess the performance of automated disease detection in diabetic retinopathy screening using two field mydriatic photography. Methods Images from 8,271 sequential patient screening episodes from a South London diabetic retinopathy screening service were processed by the Medalytix iGrading (TM) automated grading system. For each screening episode macular-centred and disc-centred images of both eyes were acquired and independently graded according to the English national grading scheme. Where discrepancies were found between the automated result and original manual grade, internal and external arbitration was used to determine the final study grades. Two versions of the software were used: one that detected microaneurysms alone, and one that detected blot haemorrhages and exudates in addition to microaneurysms. Results for each version were calculated once using both fields and once using the macula-centred field alone. Results: Of the 8,271 episodes, 346 (4.2%) were considered unassessable. Referable disease was detected in 587 episodes (7.1%). The sensitivity of the automated system for detecting unassessable images ranged from 97.4% to 99.1% depending on configuration. The sensitivity of the automated system for referable episodes ranged from 98.3% to 99.3%. All the episodes that included proliferative or pre-proliferative retinopathy were detected by the automated system regardless of configuration (192/192, 95% confidence interval 98.0% to 100%). If implemented as the first step in grading, the automated system would have reduced the manual grading effort by between 2,183 and 3,147 patient episodes (26.4% to 38.1%). Conclusion: Automated grading can safely reduce the workload of manual grading using two field, mydriatic photography in a routine screening service.	[Goatman, Keith] Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland; [Charnley, Amanda; Webster, Laura; Nussey, Stephen] St George Hosp, London, England	University of Aberdeen; St Georges University London	Goatman, K (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen, Scotland.	Stephen.Nussey@stgeorges.nhs.uk			NIHR [HTA 06/402/49]	NIHR(National Institute for Health Research (NIHR))	KAG was supported by NIHR grant HTA 06/402/49 and the remaining authors were personally salaried by their institutions during the period of writing (though no specific salary was set aside or given for the writing of this paper). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; Arun CS, 2009, DIABETIC MED, V26, P489, DOI 10.1111/j.1464-5491.2009.02718.x; Fleming AD, 2010, BRIT J OPHTHALMOL, P1; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Gardner TW, 2009, ACTA OPHTHALMOL, V87, P709, DOI 10.1111/j.1755-3768.2009.01545.x; Goatman KA, DIABETIC ME IN PRESS; HARDING SP, 1995, BMJ-BRIT MED J, V311, P1131, DOI 10.1136/bmj.311.7013.1131; Olson JA, 2003, DIABETIC MED, V20, P528, DOI 10.1046/j.1464-5491.2003.00969.x; Philip S, 2007, BRIT J OPHTHALMOL, V91, P1512, DOI 10.1136/bjo.2007.119453; Ruamviboonsuk P, 2006, OPHTHALMOLOGY, V113, P826, DOI 10.1016/j.ophtha.2005.11.021; Sanchez CI, 2011, INVEST OPHTH VIS SCI, V52, P4866, DOI 10.1167/iovs.10-6633; Scanlon PH, 2003, DIABETIC MED, V20, P467, DOI 10.1046/j.1464-5491.2003.00954.x; Stellingwerf C, 2004, DOC OPHTHALMOL, V108, P203, DOI 10.1007/s10633-004-5733-2; UK National Screening Committee, 2009, ESS EL DEV DIAB RET; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	15	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e27524	10.1371/journal.pone.0027524	http://dx.doi.org/10.1371/journal.pone.0027524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174741	Green Submitted, Green Published, gold			2022-12-27	WOS:000298163600003
J	Konopova, B; Smykal, V; Jindra, M				Konopova, Barbora; Smykal, Vlastimil; Jindra, Marek			Common and Distinct Roles of Juvenile Hormone Signaling Genes in Metamorphosis of Holometabolous and Hemimetabolous Insects	PLOS ONE			English	Article							BEETLE TRIBOLIUM-CASTANEUM; RED FLOUR BEETLE; RHODNIUS-PROLIXUS HEMIPTERA; LARVAL-PUPAL METAMORPHOSIS; BHLH-PAS FAMILY; DROSOPHILA-MELANOGASTER; METHOPRENE-TOLERANT; BROAD-COMPLEX; ADULT STRUCTURES; KRUPPEL-HOMOLOG-1	Insect larvae metamorphose to winged and reproductive adults either directly (hemimetaboly) or through an intermediary pupal stage (holometaboly). In either case juvenile hormone (JH) prevents metamorphosis until a larva has attained an appropriate phase of development. In holometabolous insects, JH acts through its putative receptor Methoprene-tolerant (Met) to regulate Kruppel-homolog 1 (Kr-h1) and Broad-Complex (BR-C) genes. While Met and Kr-h1 prevent precocious metamorphosis in pre-final larval instars, BR-C specifies the pupal stage. How JH signaling operates in hemimetabolous insects is poorly understood. Here, we compare the function of Met, Kr-h1 and BR-C genes in the two types of insects. Using systemic RNAi in the hemimetabolous true bug, Pyrrhocoris apterus, we show that Met conveys the JH signal to prevent premature metamorphosis by maintaining high expression of Kr-h1. Knockdown of either Met or Kr-h1 (but not of BR-C) in penultimate-instar Pyrrhocoris larvae causes precocious development of adult color pattern, wings and genitalia. A natural fall of Kr-h1 expression in the last larval instar normally permits adult development, and treatment with an exogenous JH mimic methoprene at this time requires both Met and Kr-h1 to block the adult program and induce an extra larval instar. Met and Kr-h1 therefore serve as JH-dependent repressors of deleterious precocious metamorphic changes in both hemimetabolous and holometabolous juveniles, whereas BR-C has been recruited for a new role in specifying the holometabolous pupa. These results show that despite considerable evolutionary distance, insects with diverse developmental strategies employ a common-core JH signaling pathway to commit to adult morphogenesis.	[Konopova, Barbora; Jindra, Marek] Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic; [Smykal, Vlastimil] Univ S Bohemia, Dept Mol Biol, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Konopova, B (corresponding author), Acad Sci Czech Republic, Ctr Biol, Ceske Budejovice, Czech Republic.	jindra@entu.cas.cz	Jindra, Marek/H-2082-2014; Konopova, Barbora/AAI-9163-2020; Smýkal, Vlastimil/Q-7706-2018	Jindra, Marek/0000-0002-2196-9924; Konopova, Barbora/0000-0002-8456-9530; Smýkal, Vlastimil/0000-0002-7383-5506	Academy of Sciences [500960906]; Ministry of Education of the Czech Republic [6007665801]; Czech Science Foundation [204/07/1032, 204/09/H058]	Academy of Sciences(Egyptian Academy of Scientific Research & Technology (ASRT)); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by grants 500960906 from the Academy of Sciences and 6007665801 from the Ministry of Education of the Czech Republic, and by projects 204/07/1032 and 204/09/H058 from the Czech Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Belles X, 2011, ORIGIN EVOLUTION INS, DOI [10.1002/9780470015902.a0022854, DOI 10.1002/9780470015902.A0022854, 10.1002/9780470015902]; Dolezel D, 2008, CELL MOL LIFE SCI, V65, P964, DOI 10.1007/s00018-008-7506-7; Erezyilmaz DF, 2009, DEV GENES EVOL, V219, P535, DOI 10.1007/s00427-009-0315-7; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; FUKUDA SOICHI, 1944, JOUR FAC SCI IMP UNIV TOKYO SECT IV, V6, P477; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Hinton H, 1963, P R ENTOMOL SOC LOND, V38, P77; KISS I, 1988, GENETICS, V118, P247; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Kristensen NP, 1999, EUR J ENTOMOL, V96, P237; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Nijhout H.F., 1994, INSECT HORMONES; NIJHOUT HF, 1983, J INSECT PHYSIOL, V29, P669, DOI 10.1016/0022-1910(83)90041-0; Novak V, 1966, INSECT HORMONES; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Sehnal Frantisek, 1996, P3, DOI 10.1016/B978-012283245-1/50003-8; SLAMA K, 1965, P NATL ACAD SCI USA, V54, P411, DOI 10.1073/pnas.54.2.411; SLAMA K., 1965, J INSECT PHYSIOL, V11, P113, DOI 10.1016/0022-1910(65)90098-3; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Truman JW, 1999, NATURE, V401, P447, DOI 10.1038/46737; Truman JW, 2002, ANNU REV ENTOMOL, V47, P467, DOI 10.1146/annurev.ento.47.091201.145230; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Wigglesworth V.B.S., 1954, PHYSL INSECT METAMOR; Wigglesworth VB, 1936, Q J MICROSC SCI, V79, P91; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Williams C, 1961, BIOL BULL, V116, P323; WILLIS JH, 1982, J EMBRYOL EXP MORPH, V71, P25; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Zhou XF, 2002, DEVELOPMENT, V129, P2259	36	170	178	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2011	6	12							e28728	10.1371/journal.pone.0028728	http://dx.doi.org/10.1371/journal.pone.0028728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KY	22174880	Green Published, gold, Green Submitted			2022-12-27	WOS:000298163600040
J	Forero-Medina, G; Terborgh, J; Socolar, SJ; Pimm, SL				Forero-Medina, German; Terborgh, John; Socolar, S. Jacob; Pimm, Stuart L.			Elevational Ranges of Birds on a Tropical Montane Gradient Lag behind Warming Temperatures	PLOS ONE			English	Article							CLIMATE-CHANGE; SHIFTS; DISTRIBUTIONS; IMPACT	Background: Species may respond to a warming climate by moving to higher latitudes or elevations. Shifts in geographic ranges are common responses in temperate regions. For the tropics, latitudinal temperature gradients are shallow; the only escape for species may be to move to higher elevations. There are few data to suggest that they do. Yet, the greatest loss of species from climate disruption may be for tropical montane species. Methodology/Principal Findings: We repeat a historical transect in Peru and find an average upward shift of 49 m for 55 bird species over a 41 year interval. This shift is significantly upward, but also significantly smaller than the 152 m one expects from warming in the region. To estimate the expected shift in elevation we first determined the magnitude of warming in the locality from historical data. Then we used the temperature lapse rate to infer the required shift in altitude to compensate for warming. The range shifts in elevation were similar across different trophic guilds. Conclusions: Endothermy may provide birds with some flexibility to temperature changes and allow them to move less than expected. Instead of being directly dependent on temperature, birds may be responding to gradual changes in the nature of the habitat or availability of food resources, and presence of competitors. If so, this has important implications for estimates of mountaintop extinctions from climate change.	[Forero-Medina, German; Terborgh, John; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Durham, NC 27708 USA; [Socolar, S. Jacob] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	Duke University; Duke University; Swarthmore College	Forero-Medina, G (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	stuartpimm@me.com	Socolar, Jacob/U-9136-2019; pimm, stuart/ABF-1082-2020	Socolar, Jacob/0000-0002-9126-9093; 	German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety; German cooperation; Peruvian ministry of the environment (MINAM); Peruvian National Service for Protected Areas; ECOSIRA; Fulbright-Colciencias-DNP grant; Graduate School at Duke University; Deutsche Gesellschaft fur Internationale Zusammenarbeit	German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety; German cooperation; Peruvian ministry of the environment (MINAM); Peruvian National Service for Protected Areas; ECOSIRA; Fulbright-Colciencias-DNP grant; Graduate School at Duke University; Deutsche Gesellschaft fur Internationale Zusammenarbeit	Data collection was conducted during the Conserving Biodiversity in Peru's Tropical Forests While Fostering Climate Change Mitigation (BMU-GIZ) project, funded by the German Federal Ministry of the Environment, Nature Conservation and Nuclear Safety (BMU), executed by the German cooperation (GIZ), the Peruvian ministry of the environment (MINAM), & the Peruvian National Service for Protected Areas and ECOSIRA. G.F.M. is sponsored by a Fulbright-Colciencias-DNP grant and the Graduate School at Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project was partially funded by Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Chambers LE, 2005, EMU, V105, P1, DOI 10.1071/MU04033; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; DIAMOND JM, 1970, P NATL ACAD SCI USA, V67, P529, DOI 10.1073/pnas.67.2.529; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; FEINSINGER P, 1978, AM ZOOL, V18, P779; Forero-Medina G, 2011, CONSERV BIOL, V25, P163, DOI 10.1111/j.1523-1739.2010.01572.x; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Larsen T.H., 2011, CLIMATE CHANGE BIODI; LOISELLE BA, 1992, BIOSCIENCE, V42, P838, DOI 10.2307/1312083; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2005, CLIMATE CHANGE BIODI; Peh KSH, 2007, CONDOR, V109, P437, DOI 10.1650/0010-5422(2007)109[437:PEOCCO]2.0.CO;2; Pimm SL, 2010, CONSERVATION BIOLOGY FOR ALL, P181; Pimm SL, 2009, CURR BIOL, V19, pR595, DOI 10.1016/j.cub.2009.05.055; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Raxworthy CJ, 2008, GLOBAL CHANGE BIOL, V14, P1703, DOI 10.1111/j.1365-2486.2008.01596.x; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; SIMBERLOFF D, 1991, ANNU REV ECOL SYST, V22, P115, DOI 10.1146/annurev.es.22.110191.000555; TERBORGH J, 1973, AM NAT, V107, P481, DOI 10.1086/282852; TERBORGH J, 1985, ECOLOGY, V66, P1237, DOI 10.2307/1939177; TERBORGH J, 1975, ECOLOGY, V56, P562, DOI 10.2307/1935491; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335	40	99	105	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2011	6	12							e28535	10.1371/journal.pone.0028535	http://dx.doi.org/10.1371/journal.pone.0028535			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863KK	22163309	Green Published, Green Submitted, gold			2022-12-27	WOS:000298161900046
J	Ahmad, I; Lamprokostopoulou, A; Le Guyon, S; Streck, E; Barthel, M; Peters, V; Hardt, WD; Romling, U				Ahmad, Irfan; Lamprokostopoulou, Agaristi; Le Guyon, Soazig; Streck, Elena; Barthel, Melanie; Peters, Verena; Hardt, Wolf-Dieter; Romling, Ute			Complex c-di-GMP Signaling Networks Mediate Transition between Virulence Properties and Biofilm Formation in Salmonella enterica Serovar Typhimurium	PLOS ONE			English	Article							GGDEF DOMAIN PROTEINS; CYCLIC DIGUANYLATE; III SECRETION; PHOSPHODIESTERASES REVEALS; MULTICELLULAR BEHAVIOR; ALLOSTERIC CONTROL; RDAR MORPHOTYPE; ANIMAL-MODELS; IDENTIFICATION; CELLULOSE	Upon Salmonella enterica serovar Typhimurium infection of the gut, an early line of defense is the gastrointestinal epithelium which senses the pathogen and intrusion along the epithelial barrier is one of the first events towards disease. Recently, we showed that high intracellular amounts of the secondary messenger c-di-GMP in S. typhimurium inhibited invasion and abolished induction of a pro-inflammatory immune response in the colonic epithelial cell line HT-29 suggesting regulation of transition between biofilm formation and virulence by c-di-GMP in the intestine. Here we show that highly complex c-di-GMP signaling networks consisting of distinct groups of c-di-GMP synthesizing and degrading proteins modulate the virulence phenotypes invasion, IL-8 production and in vivo colonization in the streptomycin-treated mouse model implying a spatial and timely modulation of virulence properties in S. typhimurium by c-di-GMP signaling. Inhibition of the invasion and IL-8 induction phenotype by c-di-GMP (partially) requires the major biofilm activator CsgD and/or BcsA, the synthase for the extracellular matrix component cellulose. Inhibition of the invasion phenotype is associated with inhibition of secretion of the type three secretion system effector protein SipA, which requires c-di-GMP metabolizing proteins, but not their catalytic activity. Our findings show that c-di-GMP signaling is at least equally important in the regulation of Salmonella-host interaction as in the regulation of biofilm formation at ambient temperature.	[Ahmad, Irfan; Lamprokostopoulou, Agaristi; Le Guyon, Soazig; Streck, Elena; Peters, Verena; Romling, Ute] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Barthel, Melanie; Hardt, Wolf-Dieter] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	Karolinska Institutet; Swiss Federal Institutes of Technology Domain; ETH Zurich	Ahmad, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	Ute.Romling@ki.se	Lamprokostopoulou, Agaristi/ABE-4406-2021; Ahmad, Irfan/C-6523-2019	Lamprokostopoulou, Agaristi/0000-0002-6786-4407; Romling, Ute/0000-0003-3812-6621; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Le Guyon, Soazig/0000-0001-9447-9777	European Commission [MEST-CT-2004-008475]; Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet [621-2004-3979]; Higher Education Commission in Pakistan	European Commission(European CommissionEuropean Commission Joint Research Centre); Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet; Higher Education Commission in Pakistan(Higher Education Commission of Pakistan)	This work was supported by the European Commission under contract number MEST-CT-2004-008475, and the Petrus and Augusta Hedlund Stiftelse and Vetenskapsradet (621-2004-3979). Irfan Ahmad receives a scholarship from the Higher Education Commission in Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bobrov AG, 2011, MOL MICROBIOL, V79, P533, DOI 10.1111/j.1365-2958.2010.07470.x; BOYD JF, 1985, GUT, V26, P935, DOI 10.1136/gut.26.9.935; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Christen M, 2010, SCIENCE, V328, P1295, DOI 10.1126/science.1188658; ECKMANN L, 1993, INFECT IMMUN, V61, P4569, DOI 10.1128/IAI.61.11.4569-4574.1993; Ehrbar K, 2002, INT J MED MICROBIOL, V291, P479; FINLAY BB, 1989, J CELL SCI, P99; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x; Geddes K, 2007, PLOS PATHOG, V3, P2017, DOI 10.1371/journal.ppat.0030196; Gerlach RG, 2007, CELL MICROBIOL, V9, P1834, DOI 10.1111/j.1462-5822.2007.00919.x; Gerstel U, 2001, ENVIRON MICROBIOL, V3, P638, DOI 10.1046/j.1462-2920.2001.00235.x; Hanisch J, 2010, CELL MICROBIOL, V12, P84, DOI 10.1111/j.1462-5822.2009.01380.x; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Hornef MW, 2008, CURR OPIN INFECT DIS, V21, P304, DOI 10.1097/QCO.0b013e3282f88ba3; Hurley BP, 2003, TRENDS MICROBIOL, V11, P562, DOI 10.1016/j.tim.2003.10.002; Jarvik T, 2010, J BACTERIOL, V192, P560, DOI 10.1128/JB.01233-09; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumagai Y, 2010, J BACTERIOL, V192, P4122, DOI 10.1128/JB.00132-10; Lamprokostopoulou A, 2010, ENVIRON MICROBIOL, V12, P40, DOI 10.1111/j.1462-2920.2009.02032.x; Lee HS, 2010, INFECT IMMUN, V78, P1832, DOI 10.1128/IAI.00446-09; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Ogasawara H, 2011, J BACTERIOL, V193, P2587, DOI 10.1128/JB.01468-10; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2009, J BACTERIOL, V191, P4697, DOI 10.1128/JB.00651-09; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryan RP, 2010, VIRULENCE, V1, P404, DOI 10.4161/viru.1.5.12704; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013; Simm R, 2007, J BACTERIOL, V189, P3613, DOI 10.1128/JB.01719-06; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Solano C, 2009, P NATL ACAD SCI USA, V106, P7997, DOI 10.1073/pnas.0812573106; Song MY, 2004, J BIOL CHEM, V279, P34183, DOI 10.1074/jbc.M313491200; Srikanth CV, 2010, SCIENCE, V330, P390, DOI 10.1126/science.1194598; Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; White AP, 2008, INFECT IMMUN, V76, P1048, DOI 10.1128/IAI.01383-07; White AP, 2006, J BACTERIOL, V188, P3219, DOI 10.1128/JB.188.9.3219-3227.2006; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zakikhany K, 2010, TYPHIMURIUM MOL MICR, V77, P771	66	66	68	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28351	10.1371/journal.pone.0028351	http://dx.doi.org/10.1371/journal.pone.0028351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164276	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400077
J	Buscariollo, DL; Breuer, GA; Wendler, CC; Rivkees, SA				Buscariollo, Daniela L.; Breuer, Gregory A.; Wendler, Christopher C.; Rivkees, Scott A.			Caffeine Acts via A1 Adenosine Receptors to Disrupt Embryonic Cardiac Function	PLOS ONE			English	Article							FETAL HEART-RATE; BLOOD-FLOW; IN-VIVO; SPONTANEOUS-ABORTION; DEVELOPING CHICK; A(1) RECEPTOR; MOUSE EMBRYOS; BIRTH-WEIGHT; LONG-TERM; HYPOXIA	Background: Evidence suggests that adenosine acts via cardiac A1 adenosine receptors (A1ARs) to protect embryos against hypoxia. During embryogenesis, A1ARs are the dominant regulator of heart rate, and A1AR activation reduces heart rate. Adenosine action is inhibited by caffeine, which is widely consumed during pregnancy. In this study, we tested the hypothesis that caffeine influences developing embryos by altering cardiac function. Methodology/Principal Findings: Effects of caffeine and adenosine receptor-selective antagonists on heart rate were studied in vitro using whole murine embryos at E9.5 and isolated hearts at E12.5. Embryos were examined in room air (21% O-2) or hypoxic (2% O-2) conditions. Hypoxia decreased heart rates of E9.5 embryos by 15.8% and in E12.5 isolated hearts by 27.1%. In room air, caffeine (200 mu M) had no effect on E9.5 heart rates; however, caffeine increased heart rates at E12.5 by 37.7%. Caffeine abolished hypoxia-mediated bradycardia at E9.5 and blunted hypoxia-mediated bradycardia at E12.5. Real-time PCR analysis of RNA from isolated E9.5 and E12.5 hearts showed that A1AR and A2aAR genes were expressed at both ages. Treatment with adenosine receptor-selective antagonists revealed that SCH-58261 (A2aAR-specific antagonist) had no affects on heart function, whereas DPCPX (A1AR-specific antagonist) had effects similar to caffeine treatment at E9.5 and E12.5. At E12.5, embryonic hearts lacking A1AR expression (A1AR-/-) had elevated heart rates compared to A1AR+/- littermates, A1AR-/- heart rates failed to decrease to levels comparable to those of controls. Caffeine did not significantly affect heart rates of A1AR-/- embryos. Conclusions/Significance: These data show that caffeine alters embryonic cardiac function and disrupts the normal cardiac response to hypoxia through blockade of A1AR action. Our results raise concern for caffeine exposure during embryogenesis, particularly in pregnancies with increased risk of embryonic hypoxia.	[Buscariollo, Daniela L.; Breuer, Gregory A.; Wendler, Christopher C.; Rivkees, Scott A.] Yale Univ, Sch Med, Dept Pediat, Sect Dev Endocrinol & Biol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA	Yale University	Buscariollo, DL (corresponding author), Yale Univ, Sch Med, Dept Pediat, Sect Dev Endocrinol & Biol,Yale Child Hlth Res Ct, New Haven, CT 06510 USA.	scott.rivkees@yale.edu		Breuer, Gregory/0000-0002-7830-3250	National Institutes of Health [R01HD058086-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant R01HD058086-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PAW, 1986, J PHYSIOL-LONDON, V372, P557, DOI 10.1113/jphysiol.1986.sp016025; Bennet L, 2009, CLIN PERINATOL, V36, P655, DOI 10.1016/j.clp.2009.06.009; Browne ML, 2006, EPIDEMIOLOGY, V17, P324, DOI 10.1097/01.ede.0000208476.36988.44; CLARK EB, 1989, AM J PHYSIOL, V257, pH55, DOI 10.1152/ajpheart.1989.257.1.H55; Cnattingius S, 2003, FOOD CHEM TOXICOL, V41, P1202, DOI 10.1016/S0278-6915(03)00103-0; Cnattingius S, 2000, NEW ENGL J MED, V343, P1839, DOI 10.1056/NEJM200012213432503; CUNEO B, 1991, AM J PHYSIOL, V260, pH1864, DOI 10.1152/ajpheart.1991.260.6.H1864; Cuneo B, 1993, AM J PHYSL HEART CIR, P264; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; DEVOE LD, 1993, AM J OBSTET GYNECOL, V168, P1105, DOI 10.1016/0002-9378(93)90353-K; Dunnigan A, 1987, PEDIAT RES, P22; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Franco D, 1997, ANAT REC, V248, P110; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Fredholm BB, 2011, METHYLXANTHINES PREG, P373; Furukawa S, 2007, J OBSTET GYNAECOL RE, V33, P114, DOI 10.1111/j.1447-0756.2007.00499.x; Ghatpande SK, 2008, BIRTH DEFECTS RES A, V82, P121, DOI 10.1002/bdra.20438; Gui YH, 1996, PEDIATR RES, V40, P633, DOI 10.1203/00006450-199610000-00020; Hart ML, 2011, J IMMUNOL, V186, P4367, DOI 10.4049/jimmunol.0903617; HOFMAN PL, 1997, AM J PHYSIOL-REG I, V273, pR1374; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Huisman M, 1997, J REPROD MED, V42, P731; Jensen GM, 1997, AM J PUBLIC HEALTH, V87, P1003, DOI 10.2105/AJPH.87.6.1003; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KAUFMAN MH, 1998, ATLAS MOUSE DEV; Keller BB, 1996, CIRC RES, V79, P247, DOI 10.1161/01.RES.79.2.247; Kirby M. L., 2007, CARDIAC DEV; KIRKINEN P, 1983, AM J OBSTET GYNECOL, V147, P939, DOI 10.1016/0002-9378(83)90250-8; Koeppen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006784; Langley-Evans SC, 1998, NUTRITION, V14, P39, DOI 10.1016/S0899-9007(97)00391-2; LARROQUE B, 1993, AM J EPIDEMIOL, V137, P941, DOI 10.1093/oxfordjournals.aje.a116764; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Linden J, 2011, ADV PHARMACOL, V61, P95, DOI 10.1016/B978-0-12-385526-8.00004-7; MacLennan MJ, 1999, ULTRASOUND MED BIOL, V25, P361, DOI 10.1016/S0301-5629(98)00147-1; MCGOWAN J, 1987, AM J OBSTET GYNECOL, V157, P726, DOI 10.1016/S0002-9378(87)80038-8; MERCHIERS EH, 1991, AM J OBSTET GYNECOL, V165, P11, DOI 10.1016/0002-9378(91)90214-C; Miller CE, 2003, AM J PHYSIOL-HEART C, V285, pH1849, DOI 10.1152/ajpheart.00384.2002; MILLER RC, 1994, AM J PERINAT, V11, P132, DOI 10.1055/s-2007-994573; Miller SL, 2002, AM J OBSTET GYNECOL, V186, P261, DOI 10.1067/mob.2002.119629; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Mulder EJH, 2010, J PSYCHOPHARMACOL, V24, P1641, DOI 10.1177/0269881109106310; Ohta A, 2009, CURR OPIN PHARMACOL, V9, P501, DOI 10.1016/j.coph.2009.05.005; PAPPANO AJ, 1977, PHARMACOL REV, V29, P3; Patterson AJ, 2010, CURR MOL MED, V10, P653; Porter GA, 2001, AM J PHYSIOL-REG I, V281, pR401, DOI 10.1152/ajpregu.2001.281.2.R401; Poulsen SA, 1998, BIOORGAN MED CHEM, V6, P619, DOI 10.1016/S0968-0896(98)00038-8; RESCH BA, 1983, AM J OBSTET GYNECOL, V146, P231, DOI 10.1016/0002-9378(83)91070-0; RESCH BA, 1987, ZBL GYNAKOL, V109, P945; RESCH BA, 1985, ZBL GYNAKOL, V107, P1249; RIVKEES SA, 1995, DEV BRAIN RES, V89, P202, DOI 10.1016/0165-3806(95)00120-3; Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf; SALVADOR HS, 1989, AM J OBSTET GYNECOL, V160, P1043, DOI 10.1016/0002-9378(89)90157-9; Sedmera D, 2002, AM J PHYSIOL-REG I, V283, pR379, DOI 10.1152/ajpregu.00534.2001; Severi FM, 2000, FETAL DIAGN THER, V15, P8, DOI 10.1159/000020969; Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7; Tanaka N, 1997, AM J PHYSIOL-HEART C, V273, pH1368, DOI 10.1152/ajpheart.1997.273.3.H1368; Tobita K, 2005, ANAT REC PART A, V283A, P193, DOI 10.1002/ar.a.20133; Turner CP, 2003, P NATL ACAD SCI USA, V100, P11718, DOI 10.1073/pnas.1931975100; Wendler CC, 2006, DEV BIOL, V291, P264, DOI 10.1016/j.ydbio.2005.12.013; Wendler CC, 2007, P NATL ACAD SCI USA, V104, P9697, DOI 10.1073/pnas.0703557104; Wendler CC, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-57; Wendler CC, 2009, FASEB J, V23, P1272, DOI 10.1096/fj.08-124941; Weng XP, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.803; Xiang F, 2010, CLIN EXP PHARMACOL P, V37, P343, DOI 10.1111/j.1440-1681.2009.05300.x; Yang JN, 2009, J APPL PHYSIOL, V106, P631, DOI 10.1152/japplphysiol.90971.2008; Zhang LB, 2005, J SOC GYNECOL INVEST, V12, P2, DOI 10.1016/j.jsgi.2004.09.004	68	19	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28296	10.1371/journal.pone.0028296	http://dx.doi.org/10.1371/journal.pone.0028296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164264	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400065
J	Guerra, C; Morris, D; Sipin, A; Kung, S; Franklin, M; Gray, D; Tanzil, M; Guilford, F; Khasawneh, FT; Venketaraman, V				Guerra, Carlos; Morris, Devin; Sipin, Andrea; Kung, Steven; Franklin, Mesharee; Gray, Dennis; Tanzil, Michelle; Guilford, Frederick; Khasawneh, Fadi T.; Venketaraman, Vishwanath			Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR-BETA; PULMONARY TUBERCULOSIS; SEROPOSITIVE INDIVIDUALS; LYMPHOCYTES; ACTIVATION; NITROSOGLUTATHIONE; INTERLEUKIN-2; MODULATION; CHEMOKINES	Glutathione (GSH), a tripeptide antioxidant, is essential for cellular homeostasis and plays a vital role in diverse cellular functions. Individuals who are infected with Human immuno deficiency virus (HIV) are known to be susceptible to Mycobacterium tuberculosis (M. tb) infection. We report that by enhancing GSH levels, T-cells are able to inhibit the growth of M. tb inside macrophages. In addition, those GSH-replenished T cell cultures produced increased levels of Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-gamma), cytokines, which are known to be crucial for the control of intracellular pathogens. Our study reveals that T lymphocytes that are derived from HIV infected individuals are deficient in GSH, and that this deficiency correlates with decreased levels of Th1 cytokines and enhanced growth of M. tb inside human macrophages.	[Guerra, Carlos; Gray, Dennis; Tanzil, Michelle; Venketaraman, Vishwanath] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA; [Morris, Devin; Franklin, Mesharee; Gray, Dennis; Tanzil, Michelle; Venketaraman, Vishwanath] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA USA; [Sipin, Andrea; Kung, Steven] Calif State Polytech Univ Pomona, Pomona, CA 91768 USA; [Guilford, Frederick] Your Energy Syst, Palo Alto, CA USA; [Khasawneh, Fadi T.] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA	Western University of Health Sciences; Western University of Health Sciences; California State University System; California State Polytechnic University Pomona; Western University of Health Sciences	Guerra, C (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA 91766 USA.	vvenketaraman@westernu.edu	Gray, Dennis/AAN-1041-2020; venketaraman, Vishwanath/AAW-6945-2020	Gray, Dennis/0000-0001-6692-5848; venketaraman, Vishwanath/0000-0002-2586-1160; Morris, Devin/0000-0002-4602-8987	Western University of Health Sciences; Potts Memorial Foundation	Western University of Health Sciences; Potts Memorial Foundation	The study was supported by start-up funds from Western University of Health Sciences and Potts Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P122; Bahia MS, 2010, CHEM BIOL DRUG DES, V75, P415, DOI 10.1111/j.1747-0285.2010.00950.x; Bautista AP, 2001, FREE RADICAL BIO MED, V31, P1527, DOI 10.1016/S0891-5849(01)00745-6; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; BUHL R, 1989, LANCET, V2, P1294; CLERICI M, 1993, J CLIN INVEST, V91, P759, DOI 10.1172/JCI116294; Dayaram YK, 2006, J BACTERIOL, V188, P1364, DOI 10.1128/JB.188.4.1364-1372.2006; Dobmeyer TS, 1997, FREE RADICAL BIO MED, V22, P775, DOI 10.1016/S0891-5849(96)00403-0; DUH EJ, 1989, P NATL ACAD SCI USA, V86, P5974, DOI 10.1073/pnas.86.15.5974; FAVIER A, 1994, CHEM-BIOL INTERACT, V91, P165, DOI 10.1016/0009-2797(94)90037-X; Fernandez-Ortega C, 2004, BIOCHEM BIOPH RES CO, V325, P1075, DOI 10.1016/j.bbrc.2004.10.142; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hirsch CS, 1997, P NATL ACAD SCI USA, V94, P3926, DOI 10.1073/pnas.94.8.3926; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaruga P, 2002, FREE RADICAL BIO MED, V32, P414, DOI 10.1016/S0891-5849(01)00821-8; Klein SA, 1997, AIDS, V11, P1111, DOI 10.1097/00002030-199709000-00005; Leghmari K, 2008, CELL IMMUNOL, V253, P45, DOI 10.1016/j.cellimm.2008.04.015; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Millman AC, 2008, J INTERFERON CYTOKIN, V28, P1; Osakwe Chukwunomso E, 2010, Roum Arch Microbiol Immunol, V69, P24; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Staal FJT, 1998, EUR J CLIN INVEST, V28, P194; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; SUTHANTHIRAN M, 1990, P NATL ACAD SCI USA, V87, P3343, DOI 10.1073/pnas.87.9.3343; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; World Health Organization, 2009, GLOB TUB CONTR EP ST; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	34	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28378	10.1371/journal.pone.0028378	http://dx.doi.org/10.1371/journal.pone.0028378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164280	gold, Green Published, Green Submitted			2022-12-27	WOS:000298171400081
J	Hundahl, CA; Luuk, H; Ilmjarv, S; Falktoft, B; Raida, Z; Vikesaa, J; Friis-Hansen, L; Hay-Schmidt, A				Hundahl, Christian Ansgar; Luuk, Hendrik; Ilmjaerv, Sten; Falktoft, Birgitte; Raida, Zindy; Vikesaa, Jonas; Friis-Hansen, Lennart; Hay-Schmidt, Anders			Neuroglobin-Deficiency Exacerbates Hif1A and c-FOS Response, but Does Not Affect Neuronal Survival during Severe Hypoxia In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; PROTECTS NEURONS; MESSENGER-RNA; BRAIN; CYTOGLOBIN; BINDING; GLOBIN; OXYGEN; ADAPTATION; STRESS	Background: Neuroglobin (Ngb), a neuron-specific globin that binds oxygen in vitro, has been proposed to play a key role in neuronal survival following hypoxic and ischemic insults in the brain. Here we address whether Ngb is required for neuronal survival following acute and prolonged hypoxia in mice genetically Ngb-deficient (Ngb-null). Further, to evaluate whether the lack of Ngb has an effect on hypoxia-dependent gene regulation, we performed a transcriptome-wide analysis of differential gene expression using Affymetrix Mouse Gene 1.0 ST arrays. Differential expression was estimated by a novel data analysis approach, which applies non-parametric statistical inference directly to probe level measurements. Principal Findings: Ngb-null mice were born in expected ratios and were normal in overt appearance, home-cage behavior, reproduction and longevity. Ngb deficiency had no effect on the number of neurons, which stained positive for surrogate markers of endogenous Ngb-expressing neurons in the wild-type (wt) and Ngb-null mice after 48 hours hypoxia. However, an exacerbated hypoxia-dependent increase in the expression of c-FOS protein, an immediate early transcription factor reflecting neuronal activation, and increased expression of Hif1A mRNA were observed in Ngb-null mice. Large-scale gene expression analysis identified differential expression of the glycolytic pathway genes after acute hypoxia in Ngb-null mice, but not in the wts. Extensive hypoxia-dependent regulation of chromatin remodeling, mRNA processing and energy metabolism pathways was apparent in both genotypes. Significance: According to these results, it appears unlikely that the loss of Ngb affects neuronal viability during hypoxia in vivo. Instead, Ngb-deficiency appears to enhance the hypoxia-dependent response of Hif1A and c-FOS protein while also altering the transcriptional regulation of the glycolytic pathway. Bioinformatic analysis of differential gene expression yielded novel predictions suggesting that chromatin remodeling and mRNA metabolism are among the key regulatory mechanisms when adapting to prolonged hypoxia.	[Hundahl, Christian Ansgar; Luuk, Hendrik; Falktoft, Birgitte] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Luuk, Hendrik; Ilmjaerv, Sten] Univ Tartu, Dept Physiol, EE-50090 Tartu, Estonia; [Ilmjaerv, Sten] Quretec Ltd, Tartu, Estonia; [Raida, Zindy; Hay-Schmidt, Anders] Univ Copenhagen, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark; [Vikesaa, Jonas; Friis-Hansen, Lennart] Univ Copenhagen, Rigshosp, Dept Genom Med, DK-2100 Copenhagen, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Tartu; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hundahl, CA (corresponding author), Univ Copenhagen, Bispebjerg Hosp, Dept Clin Biochem, Copenhagen, Denmark.	c.hundahl@gmail.com; hendrik.luuk@gmail.com; a.hay@sund.ku.dk	Luuk, Hendrik/AAI-7945-2021; Hundahl, Christian Ansgar/H-3938-2015	Friis-Hansen, Lennart/0000-0002-7222-0163; Luuk, Hendrik/0000-0001-6104-4021	Lundbeck Foundation; Novo Nordisk Foundation; King Christian the Xth Foundation; Simon Fougner Hartmanns Family Foundation; Fonden til Laegevidenskabens Fremme; Lundbeck Foundation [R77-2010-7108] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); King Christian the Xth Foundation; Simon Fougner Hartmanns Family Foundation; Fonden til Laegevidenskabens Fremme; Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Lundbeck Foundation, The Novo Nordisk Foundation, King Christian the Xth Foundation, Simon Fougner Hartmanns Family Foundation and Fonden til Laegevidenskabens Fremme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbor TA, 2011, J BIOL CHEM, V286, P4718, DOI 10.1074/jbc.M110.115931; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brunori M, 2007, CELL MOL LIFE SCI, V64, P1259, DOI 10.1007/s00018-007-7090-2; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2007, ADV EXP MED BIOL, V618, P169; Burmester T, 2009, J EXP BIOL, V212, P1423, DOI 10.1242/jeb.000729; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fish JE, 2010, J BIOL CHEM, V285, P810, DOI 10.1074/jbc.M109.067868; Fordel E, 2004, BIOCHEM BIOPH RES CO, V319, P342, DOI 10.1016/j.bbrc.2004.05.010; Geuens E, 2003, J BIOL CHEM, V278, P30417, DOI 10.1074/jbc.C300203200; Greenberg DA, 2008, CURR OPIN PHARMACOL, V8, P20, DOI 10.1016/j.coph.2007.09.003; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1317, DOI 10.1097/01.WCB.0000141558.40491.75; Horn EM, 2000, NEUROSCIENCE, V99, P711, DOI 10.1016/S0306-4522(00)00221-9; Hundahl C, 2005, NEUROPATH APPL NEURO, V31, P610, DOI 10.1111/j.1365-2990.2005.00657.x; Hundahl CA, 2010, J COMP NEUROL, V518, P1556, DOI 10.1002/cne.22290; Hundahl C, 2006, BRAIN RES, V1085, P19, DOI 10.1016/j.brainres.2006.02.040; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P183, DOI 10.1159/000135617; Hundahl CA, 2008, NEUROENDOCRINOLOGY, V88, P173, DOI 10.1159/000129698; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Islam KN, 2006, MOL CELL BIOL, V26, P2901, DOI 10.1128/MCB.26.8.2901-2912.2006; Jin KL, 2010, STROKE, V41, P557, DOI 10.1161/STROKEAHA.109.567149; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Johnson AB, 2007, MUTAT RES-FUND MOL M, V618, P149, DOI 10.1016/j.mrfmmm.2006.10.007; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2006, P NATL ACAD SCI USA, V103, P17944, DOI 10.1073/pnas.0607497103; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Li Q, 2009, BIOCHIMIE, V91, P1307, DOI 10.1016/j.biochi.2009.07.001; Li RC, 2006, BRAIN RES, V1096, P173, DOI 10.1016/j.brainres.2006.04.063; Li RC, 2010, J CEREBR BLOOD F MET, V30, P1874, DOI 10.1038/jcbfm.2010.90; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammen PPA, 2002, J HISTOCHEM CYTOCHEM, V50, P1591, DOI 10.1177/002215540205001203; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rodriguez-Enriquez S, 2010, INT J BIOCHEM CELL B, V42, P1744, DOI 10.1016/j.biocel.2010.07.010; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Sun YJ, 2001, P NATL ACAD SCI USA, V98, P15306, DOI 10.1073/pnas.251466698; Sun YJ, 2003, P NATL ACAD SCI USA, V100, P3497, DOI 10.1073/pnas.0637726100; Tang Y, 2006, NEUROBIOL DIS, V21, P18, DOI 10.1016/j.nbd.2005.06.002; Teppema LJ, 1997, J COMP NEUROL, V388, P169, DOI 10.1002/(SICI)1096-9861(19971117)388:2<169::AID-CNE1>3.0.CO;2-#; Wang XY, 2008, STROKE, V39, P1869, DOI 10.1161/STROKEAHA.107.506022; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	54	38	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28160	10.1371/journal.pone.0028160	http://dx.doi.org/10.1371/journal.pone.0028160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164238	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400039
J	Kadota, M; White, EJ; Torisawa, S; Komeyama, K; Takagi, T				Kadota, Minoru; White, Eric J.; Torisawa, Shinsuke; Komeyama, Kazuyoshi; Takagi, Tsutomu			Employing Relative Entropy Techniques for Assessing Modifications in Animal Behavior	PLOS ONE			English	Article							TUNA THUNNUS-THYNNUS; PHYSIOLOGY	In order to make quantitative statements regarding behavior patterns in animals, it is important to establish whether new observations are statistically consistent with the animal's equilibrium behavior. For example, traumatic stress from the presence of a telemetry transmitter may modify the baseline behavior of an animal, which in turn can lead to a bias in results. From the perspective of information theory such a bias can be interpreted as the amount of information gained from a new measurement, relative to an existing equilibrium distribution. One important concept in information theory is the relative entropy, from which we develop a framework for quantifying time-dependent differences between new observations and equilibrium. We demonstrate the utility of the relative entropy by analyzing observed speed distributions of Pacific bluefin tuna, recorded within a 48-hour time span after capture and release. When the observed and equilibrium distributions are Gaussian, we show that the tuna's behavior is modified by traumatic stress, and that the resulting modification is dominated by the difference in central tendencies of the two distributions. Within a 95% confidence level, we find that the tuna's behavior is significantly altered for approximately 5 hours after release. Our analysis reveals a periodic fluctuation in speed corresponding to the moment just before sunrise on each day, a phenomenon related to the tuna's daily diving pattern that occurs in response to changes in ambient light.	[Kadota, Minoru; Torisawa, Shinsuke; Takagi, Tsutomu] Kinki Univ, Fac Agr, Dept Fisheries, Naka, Ibaraki, Japan; [White, Eric J.] Univ Cincinnati, Dept Phys, Cincinnati, OH 45221 USA; [Komeyama, Kazuyoshi] Kagoshima Univ, Fac Fisheries, Kagoshima 890, Japan	Kindai University (Kinki University); University System of Ohio; University of Cincinnati; Kagoshima University	Kadota, M (corresponding author), Kinki Univ, Fac Agr, Dept Fisheries, Naka, Ibaraki, Japan.	kadota@cims.nyu.edu	Torisawa, Shinsuke/A-9704-2010; Takagi, Tsutomu/AAC-8250-2022	Torisawa, Shinsuke/0000-0002-5060-2128; 	Kinki University; International education and research center for aquaculture science of bluefin tuna and other cultured fish under the Global COE; Ministry of Education, Culture, Science, Sport and Technology, Japan [80399097]; Japan Society for the Promotion of Science [21880047]	Kinki University; International education and research center for aquaculture science of bluefin tuna and other cultured fish under the Global COE; Ministry of Education, Culture, Science, Sport and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by a scientific research grant from Kinki University and the "International education and research center for aquaculture science of bluefin tuna and other cultured fish", under the Global COE Program; a Grant-in-Aid for Scientific Research (no. 80399097) from the Ministry of Education, Culture, Science, Sport and Technology, Japan; and a Grant-in-Aid for Research Activity Start-up (no. 21880047) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Bridger CJ, 2003, REV FISH SCI, V11, P13, DOI 10.1080/16226510390856510; Cover T. M., 1991, ELEMENTS INFORM THEO; Gardiner C. W., 1990, HDB STOCHASTIC METHO; Godfrey J, 2003, EFFECTS RADIO TRANSM, P83; Goldman S., 1953, INFORM THEORY; Hawkins P., 2004, MEM NATL I POLAR RES, V58, P58; James MC, 2006, CAN J ZOOL, V84, P754, DOI 10.1139/Z06-046; Kitagawa T, 2004, FISH OCEANOGR, V13, P161, DOI 10.1111/j.1365-2419.2004.00282.x; Kleeman R, 2002, J ATMOS SCI, V59, P2057, DOI 10.1175/1520-0469(2002)059<2057:MDPUUR>2.0.CO;2; Majda A., 2002, METH APPL ANAL, V9, P425, DOI DOI 10.4310/MAA.2002.V9.N3.A8; Masuma S, 2001, FISHERIES SCI, V67, P228, DOI 10.1046/j.1444-2906.2001.00244.x; National Research Council (US), 2003, OC NOIS MAR MAMM, DOI 10.17226/10564; Popper AN, 2003, MAR TECHNOL SOC J, V37, P35, DOI 10.4031/002533203787537050; Reza F M, 1961, INTRO INFORM THEORY; Sardeshmukh PD, 2000, J CLIMATE, V13, P4268, DOI 10.1175/1520-0442(2000)013<4268:COPAWE>2.0.CO;2; Shannon C. E., 1948, BELL SYST TECH J, V27, P370; Shannon C. E., 1949, MATH THEORY COMMUNIC; U.S. National Research Council, 2000, MAR MAMM LOW FREQ SO; U.S. National Research Council, 2005, MAR MAMM POP OC NOIS; U.S. National Research Council, 1994, LOW FREQ SOUND MAR M; Willis J, 2009, BEHAV ECOL SOCIOBIOL, V64, P57, DOI 10.1007/s00265-009-0818-2; Wilson RP, 2006, FRONT ECOL ENVIRON, V4, P147, DOI 10.1890/1540-9295(2006)004[0147:MDOWAW]2.0.CO;2	23	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28241	10.1371/journal.pone.0028241	http://dx.doi.org/10.1371/journal.pone.0028241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164249	Green Published, Green Submitted, gold			2022-12-27	WOS:000298171400050
J	Sakib, MN; Tang, JJ; Zheng, WJ; Huang, CT				Sakib, Muhammad Nazmus; Tang, Jijun; Zheng, W. Jim; Huang, Chin-Tser			Improving Transmission Efficiency of Large Sequence Alignment/Map (SAM) Files	PLOS ONE			English	Article								Research in bioinformatics primarily involves collection and analysis of a large volume of genomic data. Naturally, it demands efficient storage and transfer of this huge amount of data. In recent years, some research has been done to find efficient compression algorithms to reduce the size of various sequencing data. One way to improve the transmission time of large files is to apply a maximum lossless compression on them. In this paper, we present SAMZIP, a specialized encoding scheme, for sequence alignment data in SAM (Sequence Alignment/Map) format, which improves the compression ratio of existing compression tools available. In order to achieve this, we exploit the prior knowledge of the file format and specifications. Our experimental results show that our encoding scheme improves compression ratio, thereby reducing overall transmission time significantly.	[Sakib, Muhammad Nazmus; Tang, Jijun; Huang, Chin-Tser] Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA; [Zheng, W. Jim] Med Univ S Carolina, Dept Biochem, Charleston, SC 29425 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Sakib, MN (corresponding author), Univ S Carolina, Dept Comp Sci & Engn, Columbia, SC 29208 USA.	huangct@cec.sc.edu	Tang, Jijun/ABH-6528-2020		National Science Foundation (NSF) [NSF CNS 0916857, NSF OCI 0904179]; NIH/NIGMS [R01GM063265-09S1]; NIH/NCRR [P20 RR017677]; PhRMA Foundation;  [1UL RR029882-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063265] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [0916857] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PhRMA Foundation; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	MS and CH's work is partially supported by National Science Foundation (NSF) under the grant NSF CNS 0916857. JT's work is partially supported by National Science Foundation (NSF) under the grant NSF OCI 0904179. WJZ's work is partially supported by 1UL RR029882-01, NIH/NIGMS R01GM063265-09S1; and a pilot project from grant NIH/NCRR P20 RR017677 and PhRMA Foundation Research Starter Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Deorowicz S, 2011, BIOINFORMATICS, V27, P860, DOI 10.1093/bioinformatics/btr014; Kozanitis C, 2011, J COMPUT BIOL, V18, P401, DOI 10.1089/cmb.2010.0253; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; SAM, 2009, SAM FORM SPEC VERS 0; Wang CM, 2011, NUCLEIC ACIDS RES, V39, pE45, DOI 10.1093/nar/gkr009	5	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28251	10.1371/journal.pone.0028251	http://dx.doi.org/10.1371/journal.pone.0028251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	22164252	Green Submitted, Green Published, gold			2022-12-27	WOS:000298171400053
J	Zhang, ZC; Wlodarczyk, BJ; Niederreither, K; Venugopalan, S; Florez, S; Finnell, RH; Amendt, BA				Zhang, Zichao; Wlodarczyk, Bogdan J.; Niederreither, Karen; Venugopalan, Shankar; Florez, Sergio; Finnell, Richard H.; Amendt, Brad A.			Fuz Regulates Craniofacial Development through Tissue Specific Responses to Signaling Factors	PLOS ONE			English	Article							PLANAR CELL POLARITY; PRIMARY CILIA FORMATION; AUTOSOMAL SEX REVERSAL; CRANIAL NEURAL CREST; SONIC-HEDGEHOG; MECKELS CARTILAGE; CONVERGENT EXTENSION; CAMPOMELIC DYSPLASIA; NEGATIVE REGULATOR; GENE	The planar cell polarity effector gene Fuz regulates ciliogenesis and Fuz loss of function studies reveal an array of embryonic phenotypes. However, cilia defects can affect many signaling pathways and, in humans, cilia defects underlie several craniofacial anomalies. To address this, we analyzed the craniofacial phenotype and signaling responses of the Fuz(-/-) mice. We demonstrate a unique role for Fuz in regulating both Hedgehog (Hh) and Wnt/beta-catenin signaling during craniofacial development. Fuz expression first appears in the dorsal tissues and later in ventral tissues and craniofacial regions during embryonic development coincident with cilia development. The Fuz(-/-) mice exhibit severe craniofacial deformities including anophthalmia, agenesis of the tongue and incisors, a hypoplastic mandible, cleft palate, ossification/skeletal defects and hyperplastic malformed Meckel's cartilage. Hh signaling is down-regulated in the Fuz null mice, while canonical Wnt signaling is up-regulated revealing the antagonistic relationship of these two pathways. Meckel's cartilage is expanded in the Fuz(-/-) mice due to increased cell proliferation associated with the up-regulation of Wnt canonical target genes and decreased non-canonical pathway genes. Interestingly, cilia development was decreased in the mandible mesenchyme of Fuz null mice, suggesting that cilia may antagonize Wnt signaling in this tissue. Furthermore, expression of Fuz decreased expression of Wnt pathway genes as well as a Wnt-dependent reporter. Finally, chromatin IP experiments demonstrate that beta-catenin/TCF-binding directly regulates Fuz expression. These data demonstrate a new model for coordination of Hh and Wnt signaling and reveal a Fuz-dependent negative feedback loop controlling Wnt/beta-catenin signaling.	[Zhang, Zichao; Venugopalan, Shankar; Florez, Sergio; Amendt, Brad A.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Wlodarczyk, Bogdan J.; Niederreither, Karen; Finnell, Richard H.] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78712 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Austin	Amendt, BA (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA.	bamendt@ibt.tamhsc.edu	Rengasamy Venugopalan, Shankar/GPX-7671-2022; Zuo, Xi-Nian/A-7273-2009; Finnell, Richard/D-8174-2018	Wlodarczyk, Bogdan J./0000-0001-5249-5832; Amendt, Brad A./0000-0001-6524-1006; Zuo, Xi-Nian/0000-0001-9110-585X; Finnell, Richard/0000-0002-5962-8754	National Institutes of Health [DE016315, DE13941, DE18885]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013941, R01DE018885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health grants DE016315 to RHF, DE13941 and DE18885 to BAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Aoto K, 2009, DEV BIOL, V327, P106, DOI 10.1016/j.ydbio.2008.11.022; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Brugmann SA, 2010, AM J MED GENET A, V152A, P2995, DOI 10.1002/ajmg.a.33727; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Carda C, 2005, TISSUE CELL, V37, P247, DOI 10.1016/j.tice.2005.03.002; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 1998, INT J DEV BIOL, V42, P87; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; CHEN LS, 1992, ARCH ORAL BIOL, V37, P771, DOI 10.1016/0003-9969(92)90110-T; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Collier S, 1997, DEVELOPMENT, V124, P4029; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Dai D, 2010, J INVEST DERMATOL, V130, pS103; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Finetti F, 2009, NAT CELL BIOL, V11, P1332, DOI 10.1038/ncb1977; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; FRANCO B, 2008, INBORN ERRORS DEV, P1379; FROMMER J, 1971, J DENT RES, V50, P1260, DOI 10.1177/00220345710500052801; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; HALL BK, 1980, J EMBRYOL EXP MORPH, V56, P71; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; Heydeck W, 2009, DEV DYNAM, V238, P3035, DOI 10.1002/dvdy.22130; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kolpakova-Hart E, 2007, DEV BIOL, V309, P273, DOI 10.1016/j.ydbio.2007.07.018; Lee H, 2002, GENETICS, V160, P1535; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lopes SS, 2010, DEVELOPMENT, V137, P3625, DOI 10.1242/dev.054452; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Melnick M, 2005, CELLS TISSUES ORGANS, V179, P146, DOI 10.1159/000085950; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minoux M, 2010, DEVELOPMENT, V137, P2605, DOI 10.1242/dev.040048; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Ohazama A, 2009, DEVELOPMENT, V136, P897, DOI 10.1242/dev.027979; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ramaesh T, 2003, J ANAT, V203, P213, DOI 10.1046/j.1469-7580.2003.00210.x; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saegusa M, 2005, LAB INVEST, V85, P768, DOI 10.1038/labinvest.3700273; SAVOSTIN.I, 1973, ANAT RECORD, V176, P345, DOI 10.1002/ar.1091760310; Schneider FT, 2010, AM J PATHOL, V177, P404, DOI 10.2353/ajpath.2010.091079; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Tamakoshi T, 2006, BIOCHEM BIOPH RES CO, V339, P932, DOI 10.1016/j.bbrc.2005.11.097; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Zhang QH, 2003, DEV DYNAM, V227, P78, DOI 10.1002/dvdy.10289; Zhang ZC, 2010, J BIOL CHEM, V285, P34718, DOI 10.1074/jbc.M110.126441; Zhao H, 2008, DEV BIOL, V320, P19, DOI 10.1016/j.ydbio.2008.03.045	95	113	114	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e24608	10.1371/journal.pone.0024608	http://dx.doi.org/10.1371/journal.pone.0024608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	22174905	Green Submitted, Green Published, gold			2022-12-27	WOS:000295039700030
J	da Silva, JM; dos Santos, A; Cunha, MR; Costa, FO; Creer, S; Carvalho, GR				da Silva, Joana Matzen; dos Santos, Antonina; Cunha, Marina R.; Costa, Filipe O.; Creer, Simon; Carvalho, Gary R.			Multigene Molecular Systematics Confirm Species Status of Morphologically Convergent Pagurus Hermit Crabs	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; MITOCHONDRIAL 16S; DNA-SEQUENCES; DECAPODA; CRUSTACEA; PHYLOGENY; ANOMURA; POPULATIONS; BRACHYURA; EVOLUTION	Introduction: In spite of contemporary morphological taxonomy appraisals, apparent high morphological similarity raises uncertainty about the species status of certain Pagurus hermit crabs. This is exemplified between two European species, Pagurus excavatus (Herbst, 1791) and Pagurus alatus (Fabricius 1775), whose species status is still difficult to resolve using morphological criteria alone. Methodology/Principal Findings: To address such ambiguities, we used combinations of Maximum Likelihood (ML) and Bayesian Inference (BI) methods to delineate species boundaries of P. alatus and P. excavatus and formulate an intermediate Pagurus phylogenetic hypothesis, based upon single and concatenated mitochondrial (cytochrome oxidase I [COI]) and nuclear (16S and 28s ribosomal RNA) gene partitions. The molecular data supported the species status of P. excavatus and P. alatus and also clearly resolved two divergent clades within hermit crabs from the Northeast Atlantic Ocean and the Mediterranean Sea. Conclusions/Significance: Despite the abundance and prominent ecological role of hermit crabs, Pagurus, in North East Atlantic Ocean and Mediterranean Sea ecosystems, many important aspects of their taxonomy, biology, systematics and evolution remain poorly explored. The topologies presented here should be regarded as hypotheses that can be incorporated into the robust and integrated understanding of the systematic relationships within and between species of the genus Pagurus inhabiting the Northeast Atlantic Ocean and the Mediterranean Sea.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Dept Biol, Ctr Estudos Ambiente & Mar, P-3800 Aveiro, Portugal; [dos Santos, Antonina] L IPIMAR, Inst Nacl Recursos Biol, Lisbon, Portugal; [Costa, Filipe O.] Univ Minho, Dept Biol, Ctr Biol Mol Ambiental CBMA, Braga, Portugal	Bangor University; Universidade de Aveiro; Portuguese Institute of Sea & Fisheries Research (IPIMAR); Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com; g.r.carvalho@bangor.ac.uk	Costa, Ana/HDL-9297-2022; Costa, Filipe/GSD-2439-2022; Cunha, Marina R/B-7644-2008; Costa, Ana Cristina M R/L-8023-2013; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/M-9623-2019	Costa, Filipe/0000-0001-5398-3942; Cunha, Marina R/0000-0001-8833-6980; Costa, Ana Cristina M R/0000-0002-0258-3460; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460; Costa, Filipe/0000-0001-5398-3942; 	Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; European Centre for Arctic Environmental Research [ARCFAC-026129-2008-21]; LusoMarBol FCT [PTDC/MAR/69892/2006]	Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); European Centre for Arctic Environmental Research; LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the European Centre for Arctic Environmental Research ARCFAC-026129-2008-21 and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Appel M, 2009, ANIM BEHAV, V78, P1373, DOI 10.1016/j.anbehav.2009.09.008; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Brian JV, 2006, J EXP MAR BIOL ECOL, V329, P47, DOI 10.1016/j.jembe.2005.08.002; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Cruickshank Robert H., 2002, Systematic and Applied Acarology, V7, P3; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; da Silva JM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028233, 10.1371/journal.pone.0019449]; DACOZ CD, 2001, ARQUIPELAGO A, V18, P61; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2009, RAFFLES B ZOOL, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; ELWOOD RW, 1985, ANIM BEHAV, V33, P620, DOI 10.1016/S0003-3472(85)80086-5; ELWOOD RW, 1981, ANIM BEHAV, V29, P1239, DOI 10.1016/S0003-3472(81)80075-9; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Groeneveld JC, 2007, MOL PHYLOGENET EVOL, V45, P102, DOI 10.1016/j.ympev.2007.06.002; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hiller A, 2006, MOL PHYLOGENET EVOL, V40, P547, DOI 10.1016/j.ympev.2006.03.030; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGLE RW, 1985, J NAT HIST, V19, P745, DOI 10.1080/00222938500770461; JACKSON NW, 1989, ANIM BEHAV, V37, P529, DOI 10.1016/0003-3472(89)90032-8; JACKSON NW, 1989, ANIM BEHAV, V38, P951, DOI 10.1016/S0003-3472(89)80136-8; JAGT JWM, 2003, REV MEXICANA CIENCIA, V23, P364; KELLOGG CW, 1976, J EXP MAR BIOL ECOL, V22, P101, DOI 10.1016/0022-0981(76)90112-X; Kumar S, 1996, GENETICS, V143, P537; LANCASTER I, 1988, Field Studies, V7, P189; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Mantelatto FLM, 2006, ZOOSYSTEMA, V28, P495; Mantelatto FL, 2009, ZOOTAXA, P20, DOI 10.11646/zootaxa.2133.1.2; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Mathews LM, 2002, MOL ECOL, V11, P1427, DOI 10.1046/j.1365-294X.2002.01539.x; MCLAUGHLIN PA, 1988, J CRUSTACEAN BIOL, V8, P262, DOI 10.2307/1548319; McLaughlin PA, 1997, CONTRIB ZOOL, V67, P79, DOI 10.1163/18759866-06702001; McLaughlin PA, 2007, J CRUSTACEAN BIOL, V27, P97, DOI 10.1651/S-2675.1; McLaughlin PA, 2010, RAFFLES B ZOOL, P5; McLaughlin Patsy A., 2003, Memoirs of Museum Victoria, V60, P111; NEIL SJ, 1985, J EXP MAR BIOL ECOL, V94, P99, DOI 10.1016/0022-0981(85)90052-8; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Rivera M Jorge, 2006, Rev. biol. mar. oceanogr., V41, P239; Scelzo MA, 2010, ZOOL STUD, V49, P421; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; SCHUBART CD, 2005, NAUPLIUS, V12, P99; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Schwentner M, 2009, MOL PHYLOGENET EVOL, V53, P716, DOI 10.1016/j.ympev.2009.07.021; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spivak ED, 2003, J CRUSTACEAN BIOL, V23, P212, DOI 10.1651/0278-0372(2003)023[0212:SSIQAM]2.0.CO;2; STAMATAKIS A, 2008, RAXML; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR PR, 1982, J EXP MAR BIOL ECOL, V57, P229, DOI 10.1016/0022-0981(82)90194-0; TAYLOR PR, 1981, J EXP MAR BIOL ECOL, V52, P205, DOI 10.1016/0022-0981(81)90037-X; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 1999, J MOL EVOL, V48, P274, DOI 10.1007/PL00006470; Young AM, 2002, MAR BIOL, V140, P1059, DOI 10.1007/s00227-002-0780-2; [Заславская Н.И. Zaslavskaya N.I.], 2009, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V6, P147	71	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2011	6	12							e28233	10.1371/journal.pone.0028233	http://dx.doi.org/10.1371/journal.pone.0028233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	866FK	21589909	Green Published, gold, Green Submitted			2022-12-27	WOS:000298365700024
J	Wei, GX; Zhang, YC; Jiang, TZ; Luo, J				Wei, Gaoxia; Zhang, Yuanchao; Jiang, Tianzi; Luo, Jing			Increased Cortical Thickness in Sports Experts: A Comparison of Diving Players with the Controls	PLOS ONE			English	Article							SPATIAL MEMORY DEFICITS; SURFACE-BASED ANALYSIS; GRAY-MATTER DENSITY; BRAIN; CORTEX; MEDITATION; PLASTICITY; NAVIGATION; INTERVENTION; HIPPOCAMPUS	Sports experts represent a population of people who have acquired expertise in sports training and competition. Recently, the number of studies on sports experts has increased; however, neuroanatomical changes following extensive training are not fully understood. In this study, we used cortical thickness measurement to investigate the brain anatomical characteristics of professional divers with extensive training experience. A comparison of the brain anatomical characteristics of the non-athlete group with those of the athlete group revealed three regions with significantly increased cortical thickness in the athlete group. These regions included the left superior temporal sulcus, the right orbitofrontal cortex and the right parahippocampal gyrus. Moreover, a significant positive correlation between the mean cortical thickness of the right parahippocampal gyrus and the training experience was detected, which might indicate the effect of extensive training on diving players' brain structure.	[Wei, Gaoxia; Luo, Jing] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Yuanchao] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhang, Yuanchao; Jiang, Tianzi] Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Institute of Automation, CAS	Wei, GX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	jiangtz@nlpr.ia.ac.cn; luoj@psych.ac.cn	Jiang, Tianzi/I-4256-2012	Jiang, Tianzi/0000-0001-9531-291X; Wei, Gao-Xia/0000-0002-6350-9096; Peng, Tao/0000-0001-5260-7128	Institute of Psychology [YOCX111S01]; National Basic Research Program of China [2010CB833904]; National Natural Science Foundation of China [30970890, 30770708]; National Hi-Tech Research and Development Program of China [2008AA022604]; Chinese Academy of Sciences [KSCX2-EW-J-8]	Institute of Psychology; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by Young Scientists Fund of Institute of Psychology (Grant NO.: YOCX111S01), National Basic Research Program of China (Grant NO.: 2010CB833904), National Natural Science Foundation of China (Grant NO.: 30970890 and 30770708), National Hi-Tech Research and Development Program of China (Grant NO.: 2008AA022604) and the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant NO.: KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Barrash J, 2000, NEUROPSYCHOLOGIA, V38, P820, DOI 10.1016/S0028-3932(99)00131-1; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Chung MK, 2005, NEUROIMAGE, V25, P1256, DOI 10.1016/j.neuroimage.2004.12.052; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davids K., 2006, MOVEMENT SYSTEM VARI; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Gaser C, 2003, J NEUROSCI, V23, P9240; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Jacini Wantuir F S, 2009, J Sci Med Sport, V12, P688, DOI 10.1016/j.jsams.2008.11.004; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Jiang JF, 2009, J NEUROSCI, V29, P2205, DOI 10.1523/JNEUROSCI.5451-08.2009; Kim H, 2007, INT J DEV NEUROSCI, V25, P243, DOI 10.1016/j.ijdevneu.2007.03.003; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lay BS, 2002, HUM MOVEMENT SCI, V21, P807, DOI 10.1016/S0167-9457(02)00166-5; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; May A, 2007, CEREB CORTEX, V17, P205, DOI 10.1093/cercor/bhj138; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Park IS, 2006, J KOREAN MED SCI, V21, P342, DOI 10.3346/jkms.2006.21.2.342; Park IS, 2010, HUMAN MOVEM IN PRESS; Ploner CJ, 2000, CEREB CORTEX, V10, P1211, DOI 10.1093/cercor/10.12.1211; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Singh V, 2006, BRAIN, V129, P2885, DOI 10.1093/brain/awl256; Sluming V, 2002, NEUROIMAGE, V17, P1613, DOI 10.1006/nimg.2002.1288; Snowden JS, 2001, J NEUROL NEUROSUR PS, V70, P323, DOI 10.1136/jnnp.70.3.323; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Starkes JL, 2003, ADV RES SPORT EXPERT, P371; Starkes JL, 2003, RECENT ADV RES SPORT, P49; Ste-Marie DM, 1999, APPL COGNITIVE PSYCH, V13, P269, DOI 10.1002/(SICI)1099-0720(199906)13:3<269::AID-ACP567>3.3.CO;2-P; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wei GX, 2009, PROG NAT SCI-MATER, V19, P1397, DOI 10.1016/j.pnsc.2008.12.009; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Wyk BCV, 2009, PSYCHOL SCI, V20, P771, DOI 10.1111/j.1467-9280.2009.02359.x	55	60	63	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e17112	10.1371/journal.pone.0017112	http://dx.doi.org/10.1371/journal.pone.0017112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	22164266	Green Published, Green Submitted, gold			2022-12-27	WOS:000287392700050
J	Xia, HB; Wang, W; Xia, H; Zhao, W; Lu, BR				Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong			Conspecific Crop-Weed Introgression Influences Evolution of Weedy Rice (Oryza sativa f. spontanea) across a Geographical Range	PLOS ONE			English	Article							GENETIC DIVERSITY; RED RICE; OUTBREEDING DEPRESSION; INBREEDING DEPRESSION; POPULATION-GENETICS; CULTIVATED RICE; HYBRIDIZATION; FLOW; TRAITS; EXTENSIONS	Background: Introgression plays an important role in evolution of plant species via its influences on genetic diversity and differentiation. Outcrossing determines the level of introgression but little is known about the relationships of outcrossing rates, genetic diversity, and differentiation particularly in a weedy taxon that coexists with its conspecific crop. Methodology/Principal Findings: Eleven weedy rice (Oryza sativa f. spontanea) populations from China were analyzed using microsatellite (SSR) fingerprints to study outcrossing rate and its relationship with genetic variability and differentiation. To estimate outcrossing, six highly polymorphic SSR loci were used to analyze >5500 progeny from 216 weedy rice families, applying a mixed mating model; to estimate genetic diversity and differentiation, 22 SSR loci were analyzed based on 301 weedy individuals. Additionally, four weed-crop shared SSR loci were used to estimate the influence of introgression from rice cultivars on weedy rice differentiation. Outcrossing rates varied significantly (0.4 similar to 11.7%) among weedy rice populations showing relatively high overall Nei's genetic diversity (0.635). The observed heterozygosity was significantly correlated with outcrossing rates among populations (r(2) = 0.783; P<0.001) although no obvious correlation between outcrossing rates and genetic diversity parameters was observed. Allelic introgression from rice cultivars to their coexisting weedy rice was detected. Weedy rice populations demonstrated considerable genetic differentiation that was correlated with their spatial distribution (r(2) = 0.734; P<0.001), and possibly also influenced by the introgression from rice cultivars. Conclusions/Significance: Outcrossing rates can significantly affect heterozygosity of populations, which may shape the evolutionary potential of weedy rice. Introgression from the conspecific crop rice can influence the genetic differentiation and possibly evolution of its coexisting weedy rice populations.	[Xia, Han-Bing; Wang, Wei; Xia, Hui; Zhao, Wei; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China	Fudan University	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; Xia, Hui/L-7129-2019	Lu, Bao-Rong/0000-0002-0214-2390; Xia, Hui/0000-0003-2446-5171	Nature Science Foundation of China [30730066, 30871503]; Chinese Ministry of Science and Technology [2006CB100205, 2007CB109202]; National Program of Development of Transgenic New Species of China [2008ZX08011-006]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Program of Development of Transgenic New Species of China	This work was supported by the Nature Science Foundation of China (grant numbers 30730066, 30871503), Chinese Ministry of Science and Technology (grant numbers 2006CB100205, 2007CB109202), and the National Program of Development of Transgenic New Species of China (2008ZX08011-006). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2005, CROP SCI, V45, P98, DOI 10.2135/cropsci2005.0098; ANDERSON E, 1954, EVOLUTION, V8, P378, DOI 10.2307/2405784; Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; Baack EJ, 2007, CURR OPIN GENET DEV, V17, P513, DOI 10.1016/j.gde.2007.09.001; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Burgos NR, 2008, WEED TECHNOL, V22, P200, DOI 10.1614/WT-07-075.1; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Campbell LG, 2006, ECOL LETT, V9, P1198, DOI 10.1111/j.1461-0248.2006.00974.x; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; CHARLESWORTH D, 1990, EVOLUTION, V44, P870, DOI 10.1111/j.1558-5646.1990.tb03811.x; Charlesworth D, 2003, PHILOS T R SOC B, V358, P1051, DOI 10.1098/rstb.2003.1296; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fischer M, 1997, AM J BOT, V84, P1685, DOI 10.2307/2446466; Fishman L, 2002, EVOLUTION, V56, P2138, DOI 10.1111/j.0014-3820.2002.tb00139.x; Gealy DR, 2009, WEED SCI, V57, P627, DOI 10.1614/WS-09-018.1; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hansen LB, 2001, GENET RESOUR CROP EV, V48, P621, DOI 10.1023/A:1013825816443; HARLAN JR, 1965, EUPHYTICA, V14, P173, DOI 10.1007/BF00038984; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hiscock SJ, 2003, PHILOS T R SOC B, V358, P1037, DOI 10.1098/rstb.2003.1297; HOLTSFORD TP, 1989, THEOR APPL GENET, V78, P480, DOI 10.1007/BF00290831; Husband BC, 1996, EVOLUTION, V50, P54, DOI [10.2307/2410780, 10.1111/j.1558-5646.1996.tb04472.x]; Ishikawa R, 2005, GENET RESOUR CROP EV, V52, P395, DOI 10.1007/s10722-005-2257-x; Jarne P, 2008, HEREDITY, V100, P431, DOI 10.1038/hdy.2008.2; LANGEVIN SA, 1990, EVOLUTION, V44, P1000, DOI 10.1111/j.1558-5646.1990.tb03820.x; Lewis PO, 2001, GENETIC DATA ANAL GD; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Lu BR, 2009, BIOTECHNOL ADV, V27, P1083, DOI 10.1016/j.biotechadv.2009.05.018; Lu BR, 2005, BIOSCIENCE, V55, P669, DOI 10.1641/0006-3568(2005)055[0669:GFFGMR]2.0.CO;2; NEI M, 1974, GENETICS, V76, P379; Oka H. I., 1988, Origin of cultivated rice.; OKA H. I. W. T. CHANG, 1959, PHYTON REV INTERNAC BOT EXPTL ARGENTINA, V13, P105; Quilichini A, 2001, HEREDITY, V87, P190, DOI 10.1046/j.1365-2540.2001.00897.x; Reagon M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-180; Rieseberg LH, 1998, NEW PHYTOL, V140, P599, DOI 10.1046/j.1469-8137.1998.00315.x; RITLAND K, 1989, EVOLUTION, V43, P848, DOI [10.2307/2409312, 10.1111/j.1558-5646.1989.tb05182.x]; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Rong J, 2010, PLANT BIOTECHNOL J, V8, P452, DOI 10.1111/j.1467-7652.2009.00488.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Olguin ERS, 2009, TRANSGENIC RES, V18, P633, DOI 10.1007/s11248-009-9255-2; SHAW DV, 1981, P NATL ACAD SCI-BIOL, V78, P1298, DOI 10.1073/pnas.78.2.1298; Shivrain VK, 2008, WEED SCI, V56, P807, DOI 10.1614/WS-08-026.1; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Song ZP, 2003, THEOR APPL GENET, V107, P1492, DOI 10.1007/s00122-003-1380-3; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Suh H., 2008, WEEDY RICE; Suh H. S., 1996, International Rice Research Notes, V21, P7; Thurber CS, 2010, MOL ECOL, V19, P3271, DOI 10.1111/j.1365-294X.2010.04708.x; Vaughan DA, 2002, W CROP SCI, P27; Vaughan LK, 2001, WEED SCI, V49, P468, DOI 10.1614/0043-1745(2001)049[0468:IARRFI]2.0.CO;2; Wright S, 1921, GENETICS, V6, P111; Wright S, 1978, VARIABILITY NATURAL; Yu GQ, 2005, BIOCHEM GENET, V43, P261, DOI 10.1007/s10528-005-5218-3; Zhang DL, 2009, THEOR APPL GENET, V119, P1105, DOI 10.1007/s00122-009-1112-4; Zhao R, 2009, AM J BOT, V96, P1138, DOI 10.3732/ajb.0800173	62	95	101	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2011	6	1							e16189	10.1371/journal.pone.0016189	http://dx.doi.org/10.1371/journal.pone.0016189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710ME	22174836	Green Published, gold, Green Submitted			2022-12-27	WOS:000286515000030
J	Yu, X; Zheng, J				Yu, Xiang; Zheng, Jie			Polymorphic Structures of Alzheimer's beta-Amyloid Globulomers	PLOS ONE			English	Article							EXPERIMENTAL CONSTRAINTS; SOLUBLE OLIGOMERS; ION CHANNELS; PROTEIN; FIBRIL; PEPTIDE; SHEET; DISEASE; BETA(2)-MICROGLOBULIN; ORGANIZATION	Background: Misfolding and self-assembly of Amyloid-beta (A beta) peptides into amyloid fibrils is pathologically linked to the development of Alzheimer's disease. Polymorphic A beta structures derived from monomers to intermediate oligomers, protofilaments, and mature fibrils have been often observed in solution. Some aggregates are on-pathway species to amyloid fibrils, while the others are off-pathway species that do not evolve into amyloid fibrils. Both on-pathway and off-pathway species could be biologically relevant species. But, the lack of atomic-level structural information for these A beta species leads to the difficulty in the understanding of their biological roles in amyloid toxicity and amyloid formation. Methods and Findings: Here, we model a series of molecular structures of A beta globulomers assembled by monomer and dimer building blocks using our peptide-packing program and explicit-solvent molecular dynamics (MD) simulations. Structural and energetic analysis shows that although A beta globulomers could adopt different energetically favorable but structurally heterogeneous conformations in a rugged energy landscape, they are still preferentially organized by dynamic dimeric subunits with a hydrophobic core formed by the C-terminal residues independence of initial peptide packing and organization. Such structural organizations offer high structural stability by maximizing peptide-peptide association and optimizing peptide-water solvation. Moreover, curved surface, compact size, and less populated beta-structure in A beta globulomers make them difficult to convert into other high-order A beta aggregates and fibrils with dominant beta-structure, suggesting that they are likely to be off-pathway species to amyloid fibrils. These A beta globulomers are compatible with experimental data in overall size, subunit organization, and molecular weight from AFM images and H/D amide exchange NMR. Conclusions: Our computationally modeled A beta globulomers provide useful insights into structure, dynamics, and polymorphic nature of A beta globulomers which are completely different from A beta fibrils, suggesting that these globulomers are likely off-pathway species and explaining the independence of the aggregation kinetics between A beta globulomers and fibrils.	[Yu, Xiang; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Yu, X (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	zhengj@uakron.edu	Yu, Xiang/A-9765-2012; Zheng, Jie/B-5057-2013	Yu, Xiang/0000-0002-0486-1110; Zheng, Jie/0000-0003-1547-3612	National Science Foundation [CBET-0952624]; 3M Non-Tenured Faculty Award	National Science Foundation(National Science Foundation (NSF)); 3M Non-Tenured Faculty Award(3M)	This work is supported by a National Science Foundation CAREER Award (CBET-0952624) and a 3M Non-Tenured Faculty Award. This study utilized the high-performance Biowulf PC cluster at the Ohio Supercomputer Center and our ATOM Biowulf cluster at the University of Akron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; CATRIONA AM, 1999, ANN NEUROL, V46, P860; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chaudhary N, 2008, BIOPOLYMERS, V90, P783, DOI 10.1002/bip.21087; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; DICARLO M, 2009, EURO BIOPHYS J; DOMINIC M, 2007, J NEUROCHEM, V101, P1172; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Goda R, 2008, BIOMED CHROMATOGR, V22, P1279, DOI 10.1002/bmc.1058; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447894; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Mukherjee S, 2009, J PHYS CHEM B, V113, P531, DOI 10.1021/jp809817s; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ravault S, 2005, PROTEIN SCI, V14, P1181, DOI 10.1110/ps.041291405; Reddy G, 2010, P NATL ACAD SCI USA, V107, P21459, DOI 10.1073/pnas.1008616107; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Rezaei-Ghaleh N, 2009, BIOPOLYMERS, V91, P28, DOI 10.1002/bip.21079; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Wray S, 2009, J NEUROSCI, V29, P9665, DOI 10.1523/JNEUROSCI.2234-09.2009; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yu XA, 2010, BIOPHYS J, V99, P666, DOI 10.1016/j.bpj.2010.05.006; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zheng J, 2010, J PHYS CHEM B, V114, P463, DOI 10.1021/jp907608s; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	62	87	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20575	10.1371/journal.pone.0020575	http://dx.doi.org/10.1371/journal.pone.0020575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	22174866	Green Submitted, gold, Green Published			2022-12-27	WOS:000291607000013
J	da Silva, JM; Creer, S; dos Santos, A; Costa, AC; Cunha, MR; Costa, FO; Carvalho, GR				da Silva, Joana Matzen; Creer, Simon; dos Santos, Antonina; Costa, Ana C.; Cunha, Marina R.; Costa, Filipe O.; Carvalho, Gary R.			Systematic and Evolutionary Insights Derived from mtDNA COI Barcode Diversity in the Decapoda (Crustacea: Malacostraca)	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; GENUS MACROBRACHIUM BATE; DNA BARCODES; MITOCHONDRIAL PSEUDOGENES; DEMERSAL FISH; BODY-SIZE; BIOLOGICAL IDENTIFICATIONS; MOLECULAR SYSTEMATICS; SPECIES COMPLEX; MUTATIONAL BIAS	Background: Decapods are the most recognizable of all crustaceans and comprise a dominant group of benthic invertebrates of the continental shelf and slope, including many species of economic importance. Of the 17635 morphologically described Decapoda species, only 5.4% are represented by COI barcode region sequences. It therefore remains a challenge to compile regional databases that identify and analyse the extent and patterns of decapod diversity throughout the world. Methodology/Principal Findings: We contributed 101 decapod species from the North East Atlantic, the Gulf of Cadiz and the Mediterranean Sea, of which 81 species represent novel COI records. Within the newly-generated dataset, 3.6% of the species barcodes conflicted with the assigned morphological taxonomic identification, highlighting both the apparent taxonomic ambiguity among certain groups, and the need for an accelerated and independent taxonomic approach. Using the combined COI barcode projects from the Barcode of Life Database, we provide the most comprehensive COI data set so far examined for the Order (1572 sequences of 528 species, 213 genera, and 67 families). Patterns within families show a general predicted molecular hierarchy, but the scale of divergence at each taxonomic level appears to vary extensively between families. The range values of mean K2P distance observed were: within species 0.285% to 1.375%, within genus 6.376% to 20.924% and within family 11.392% to 25.617%. Nucleotide composition varied greatly across decapods, ranging from 30.8 % to 49.4 % GC content. Conclusions/Significance: Decapod biological diversity was quantified by identifying putative cryptic species allowing a rapid assessment of taxon diversity in groups that have until now received limited morphological and systematic examination. We highlight taxonomic groups or species with unusual nucleotide composition or evolutionary rates. Such data are relevant to strategies for conservation of existing decapod biodiversity, as well as elucidating the mechanisms and constraints shaping the patterns observed.	[da Silva, Joana Matzen; Creer, Simon; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales; [da Silva, Joana Matzen; Cunha, Marina R.] Univ Aveiro, Ctr Estudos Ambiente & Mar, Dept Biol, P-3800 Aveiro, Portugal; [dos Santos, Antonina] Inst Nacl Recursos Biol L IPIMAR, Lisbon, Portugal; [Costa, Ana C.] Univ Acores, Dept Biol, Sao Miguel, Portugal; [Costa, Filipe O.] Univ Minho, CBMA, Dept Biol, Braga, Portugal	Bangor University; Universidade de Aveiro; Universidade dos Acores; Universidade do Minho	da Silva, JM (corresponding author), Bangor Univ, Mol Ecol & Fisheries Genet Lab, Sch Biol Sci, Environm Ctr Wales, Bangor, Gwynedd, Wales.	joanamatzen@yahoo.com	Costa, Ana/HDL-9297-2022; Costa, Filipe/GSD-2439-2022; Cunha, Marina R/B-7644-2008; Costa, Ana Cristina M R/L-8023-2013; Dos Santos, Antonina/B-9055-2011; Costa, Ana Cristina de Matos Ricardo/H-3775-2019; Costa, Filipe/B-5890-2009; Costa, Filipe/M-9623-2019	Costa, Filipe/0000-0001-5398-3942; Cunha, Marina R/0000-0001-8833-6980; Costa, Ana Cristina M R/0000-0002-0258-3460; Dos Santos, Antonina/0000-0002-2238-9315; Costa, Ana Cristina de Matos Ricardo/0000-0002-0258-3460; Costa, Filipe/0000-0001-5398-3942; 	The Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/25568/2006]; HERMES; European Commission [GOCE-CT-2005-511234]; LusoMarBol FCT [PTDC/MAR/69892/2006]	The Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); HERMES(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); LusoMarBol FCT	The Fundacao para a Ciencia e Tecnologia (Portugal) provided a doctoral fellowship (SFRH/BD/25568/2006) to Joana Matzen da Silva. This research was partially supported by the HERMES project, EC contract GOCE-CT-2005-511234, funded by the European Commission's Sixth Framework Programme under the priority Sustainable Development, Global Change and Ecosystems and LusoMarBol FCT research grant PTDC/MAR/69892/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekhnovich AV, 2001, RUSS J ECOL+, V32, P420, DOI 10.1023/A:1012586218096; Apte S, 2007, MOL ECOL, V16, P1897, DOI 10.1111/j.1365-294X.2007.03224.x; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Banerjee T, 2005, BIOSYSTEMS, V81, P11, DOI 10.1016/j.biosystems.2005.01.002; Baratti M, 2005, J EXP MAR BIOL ECOL, V315, P225, DOI 10.1016/j.jembe.2004.09.020; Barber PH, 2006, EVOLUTION, V60, P1825; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 1995, ANNU REV GENET, V29, P445, DOI 10.1146/annurev.ge.29.120195.002305; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Boero Ferdinando, 2010, Diversity, V2, P115; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Brokeland W, 2008, ZOOL J LINN SOC-LOND, V152, P655, DOI 10.1111/j.1096-3642.2008.00362.x; Bucciarelli G, 2002, GENE, V295, P153, DOI 10.1016/S0378-1119(02)00733-3; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Calado R, 2006, SCI MAR, V70, P389, DOI 10.3989/scimar.2006.70n3389; Cartes JE, 2002, SCI MAR, V66, P209, DOI 10.3989/scimar.2002.66s2209; CARTES JE, 2007, DEEP-SEA RES, V1, P263; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chan TY, 2004, MEMOIR MUS NATL HIST, V191, P293; CHAN TY, 1991, P BIOL SOC WASH, V104, P545; CHAN TY, NEW DEEP SEA SHRIMP, P119; Chandor A, 2007, CR CHIM, V10, P756, DOI 10.1016/j.crci.2007.02.019; Chang CH, 2009, PEDOBIOLOGIA, V52, P171, DOI 10.1016/j.pedobi.2008.08.002; CHILDRESS JJ, 1990, DEEP-SEA RES, V37, P929, DOI 10.1016/0198-0149(90)90104-4; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; CINZIA V, 2006, ANTARCTIC SCI, V19, P271; Clare EL, 2008, J MOL EVOL, V66, P362, DOI 10.1007/s00239-008-9088-2; Company JB, 1998, DEEP-SEA RES PT I, V45, P1861, DOI 10.1016/S0967-0637(98)00034-X; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; Cuesta JA, 2000, HYDROBIOLOGIA, V436, P119, DOI 10.1023/A:1026576614590; Cuesta JA, 1998, J NAT HIST, V32, P1499, DOI 10.1080/00222939800771031; CUNNINGHAM CW, 1992, NATURE, V355, P539, DOI 10.1038/355539a0; DACOZ CD, 1999, INVENTAIRE DISTRIBUT; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; De Grave S, 2009, RAFFLES B ZOOL, P1; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dimmock A, 2004, AQUACULT INT, V12, P435, DOI 10.1023/B:AQUI.0000042140.48340.c8; Drake JW, 2006, GENETICS, V173, P1; Drake JW, 1998, GENETICS, V148, P1667; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORTUNATO C, 1998, 4 INT CRUST C AMST; Foster PG, 1997, J MOL EVOL, V44, P282, DOI 10.1007/PL00006145; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Garcia Raso J.E., 1989, Miscellania Zoologica (Barcelona), V11, P113; Garcia-Castrillo Gerardo, 1995, ICES Marine Science Symposia, V199, P151; Gerstein M, 2006, SCI AM, V295, P48, DOI 10.1038/scientificamerican0806-48; Gillooly JF, 2007, ECOLOGY, V88, P1890, DOI 10.1890/06-1935.1; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; GONZALEZGORILLO JI, 2001, INVERTEBRATE REPROD, V39, P165; Gouws G, 2006, MAR FRESHWATER RES, V57, P837, DOI 10.1071/MF05248; Grabowski Michal, 2006, Aquatic Invasions, V1, P116; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guerao G, 1997, J CRUSTACEAN BIOL, V17, P459, DOI 10.2307/1549440; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall S, 2009, J BIOGEOGR, V36, P2125, DOI 10.1111/j.1365-2699.2009.02153.x; Harris DJ, 2003, TRENDS ECOL EVOL, V18, P317, DOI 10.1016/S0169-5347(03)00150-2; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hebert PDN, 2002, EVOLUTION, V56, P909; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Holthuis L. B., 1950, Siboga Expeditie Leiden, V39a9, P1; Hultgren KM, 2008, MOL PHYLOGENET EVOL, V48, P986, DOI 10.1016/j.ympev.2008.05.004; IVANOVA NV, 2007, MOL ECOL NOTES, P1; Jones GP, 2007, OCEANOGRAPHY, V20, P100, DOI 10.5670/oceanog.2007.33; JONG G, 2004, NEW PHYTOL, V166, P101; KIRKPATRICK K, 1985, J EXP MAR BIOL ECOL, V93, P61, DOI 10.1016/0022-0981(85)90148-0; Komai T, 1999, J NAT HIST, V33, P1265, DOI 10.1080/002229399299914; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; LEVESQUE R, 2008, SPSS PROGRAMMING DAT; Liu MY, 2007, ZOOL STUD, V46, P272; MACPHERSON E, 1991, MAR ECOL PROG SER, V71, P103, DOI 10.3354/meps071103; Maki H, 2002, ANNU REV GENET, V36, P279, DOI 10.1146/annurev.genet.36.042602.094806; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MALLET J, 2007, TRENDS ECOL EVOL, V18, P57; Marin IN, 2005, ZOOL STUD, V44, P234; MARKLE DF, 1988, CAN J ZOOL, V66, P1952, DOI 10.1139/z88-286; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN AP, 1992, NATURE, V357, P153, DOI 10.1038/357153a0; Martin J.W., 2001, UPDATED CLASSIFICATI, VVolume 39, P1; Martin JW, 2009, DECAPOD CRUSTACEAN P; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mathews LM, 2007, MAR BIOL, V152, P645, DOI 10.1007/s00227-007-0718-9; Mathews LM, 2009, MOL PHYLOGENET EVOL, V50, P268, DOI 10.1016/j.ympev.2008.10.026; Matz MV, 2005, PHILOS T R SOC B, V360, P1969, DOI 10.1098/rstb.2005.1728; MATZ MV, 2005, SCIENCE; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miller SE, 2007, P NATL ACAD SCI USA, V104, P4775, DOI 10.1073/pnas.0700466104; Min XJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000325; Minelli A, 2003, TRENDS ECOL EVOL, V18, P75, DOI 10.1016/S0169-5347(02)00051-4; Mooers AO, 2000, TRENDS ECOL EVOL, V15, P365, DOI 10.1016/S0169-5347(00)01934-0; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Nguyen TTT, 2002, ANIM GENET, V33, P304, DOI 10.1046/j.1365-2052.2002.00867.x; NOEL PY, 1992, CLE PRELIMINAIRE IDE, P1; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Olaso I., 1995, ICES Marine Science Symposia, V199, P209; OLIVER I, 1993, CONSERV BIOL, V7, P562, DOI 10.1046/j.1523-1739.1993.07030562.x; Ostrow D, 2007, GENETICS, V176, P1653, DOI 10.1534/genetics.107.074666; PAGE RDM, 1998, BIOL LETTERS, V1, P139; Palumbi SR, 2003, ECOL APPL, V13, pS146; Payne RW, 2009, WILEY INTERDISCIP RE, V1, P255, DOI 10.1002/wics.32; Perez-Barros P, 2008, BIOL J LINN SOC, V94, P421, DOI 10.1111/j.1095-8312.2008.00987.x; Pfeiler E, 2005, MAR BIOL, V146, P559, DOI 10.1007/s00227-004-1463-y; Polunin NVC, 2001, MAR ECOL PROG SER, V220, P13; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Puillandre N, 2009, MOL ECOL RESOUR, V9, P1311, DOI 10.1111/j.1755-0998.2009.02576.x; Radulovici Adriana E., 2010, Diversity, V2, P450; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reuschel S, 2010, MOL PHYLOGENET EVOL, V55, P765, DOI 10.1016/j.ympev.2010.03.021; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; SALMAN DS, 2006, AQUAT INVASIONS, V1, P109; Sanchez JA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-122; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; SCHUBART CD, 1996, PHYLOGENY N ATLANTIC, P83; Schubart Christoph D., 2009, Crustacean Issues, V18, P47; Seibel BA, 1997, BIOL BULL, V192, P262, DOI 10.2307/1542720; Seibel BA, 2000, DEEP-SEA RES PT I, V47, P1247, DOI 10.1016/S0967-0637(99)00103-X; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Shih HT, 2007, ZOOL SCI, V24, P57, DOI 10.2108/zsj.24.57; Sicot FX, 2000, J MOL BIOL, V302, P811, DOI 10.1006/jmbi.2000.4505; Silliman BR, 2003, J CRUSTACEAN BIOL, V23, P876, DOI 10.1651/C-2410; Smith MA, 2008, MOL ECOL RESOUR, V8, P235, DOI 10.1111/j.1471-8286.2007.01964.x; Somero GN, 2003, COMP BIOCHEM PHYS B, V136, P577, DOI 10.1016/S1096-4959(03)00215-X; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stevens Bradley G., 2000, Journal of Northwest Atlantic Fishery Science, V27, P77, DOI 10.2960/J.v27.a7; Summerbell RC, 2005, PHILOS T R SOC B, V360, P1897, DOI 10.1098/rstb.2005.1721; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR AC, 1987, MAR BIOL, P521; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; TSANG LM, 2009, MOL PHYLOGENET EVOL, P1; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; WILLIAMSON D I, 1972, Crustaceana (Leiden), V23, P282, DOI 10.1163/156854072X00174; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wilson EO, 2003, ISSUES SCI TECHNOL, V19, P45; Wilson EO, 2003, PALEOBIOLOGY, V29, P14, DOI 10.1666/0094-8373(2003)029<0014:OGBE>2.0.CO;2; WONG JTY, 1990, AQUACULTURE, V88, P151, DOI 10.1016/0044-8486(90)90290-4; Zaklan SD, 2002, LOW WAKE FI, V19, P751; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x; ZANG AB, 2010, MOL PHYLOGENET EVOL, P1035; ZARIQUIEY-ALVAREZ R, 1968, Investigacion Pesquera (Barcelona), V32, P1	174	147	151	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 12	2011	6	5							e19449	10.1371/journal.pone.0019449	http://dx.doi.org/10.1371/journal.pone.0019449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763CL	21589909	Green Published, Green Submitted, gold			2022-12-27	WOS:000290531100010
J	Santana, SE; Geipel, I; Dumont, ER; Kalka, MB; Kalko, EKV				Santana, Sharlene E.; Geipel, Inga; Dumont, Elizabeth R.; Kalka, Margareta B.; Kalko, Elisabeth K. V.			All You Can Eat: High Performance Capacity and Plasticity in the Common Big-Eared Bat, Micronycteris microtis (Chiroptera: Phyllostomidae)	PLOS ONE			English	Article							BITE FORCE; FOOD HARDNESS; DIET; ECHOLOCATION; INSECTIVORY; ASSEMBLAGE; EVOLUTION; BEHAVIOR; FOREST; SIZE	Ecological specialization and resource partitioning are expected to be particularly high in the species-rich communities of tropical vertebrates, yet many species have broader ecological niches than expected. In Neotropical ecosystems, Neotropical leaf-nosed bats (Phyllostomidae) are one of the most ecologically and functionally diverse vertebrate clades. Resource partitioning in phyllostomids might be achieved through differences in the ability to find and process food. We selected Micronycteris microtis, a very small (5-7 g) animalivorous phyllostomid, to explore whether broad resource use is associated with specific morphological, behavioral and performance traits within the phyllostomid radiation. We documented processing of natural prey and measured bite force in free-ranging M. microtis and other sympatric phyllostomids. We found that M. microtis had a remarkably broad diet for prey size and hardness. For the first time, we also report the consumption of vertebrates (lizards), which makes M. microtis the smallest carnivorous bat reported to date. Compared to other phyllostomids, M. microtis had the highest bite force for its size and cranial shape and high performance plasticity. Bite force and cranial shape appear to have evolved rapidly in the M. microtis lineage. High performance capacity and high efficiency in finding motionless prey might be key traits that allow M. microtis, and perhaps other species, to successfully co-exist with other gleaning bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Geipel, Inga; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Dumont, Elizabeth R.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kalka, Margareta B.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Kalko, Elisabeth K. V.] Smithsonian Trop Res Inst, Balboa, Panama	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Ulm University; University of Massachusetts System; University of Massachusetts Amherst; University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian Tropical Research Institute	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD; NSF [IOB 0447616]; European Union	University of Massachusetts; Institute of Experimental Ecology, University of Ulm; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NSF(National Science Foundation (NSF)); European Union(European Commission)	S.E.S. was supported by University of Massachusetts Graduate School Fellowship and travel funds from the Institute of Experimental Ecology, University of Ulm; M.B.K. by a DAAD fellowship; E.R.D. by a NSF grant (IOB 0447616); and G.G. and E.K.V.K. by the European Union project ChiRoPing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2003, FUNCT ECOL, V17, P201, DOI 10.1046/j.1365-2435.2003.00721.x; Albrecht L, 2007, ACTA THERIOL, V52, P141, DOI 10.1007/BF03194209; Bumrungsri S, 2007, BIOTROPICA, V39, P241, DOI 10.1111/j.1744-7429.2006.00245.x; Dondini G, 2000, J ZOOL, V251, P233, DOI 10.1111/j.1469-7998.2000.tb00606.x; Dumont ER, 1999, J ZOOL, V248, P219, DOI 10.1017/S0952836999006093; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Evans AR, 2005, AUST J ZOOL, V53, P9, DOI 10.1071/ZO04018; FREEMAN PW, 1984, BIOL J LINN SOC, V21, P387, DOI 10.1111/j.1095-8312.1984.tb01601.x; FREEMAN PW, 1979, J MAMMAL, V60, P467, DOI 10.2307/1380088; Geipel I, 2007, PREY DETECTION NEOTR; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Giannini NP, 2005, ACTA CHIROPTEROL, V7, P131, DOI 10.3161/1733-5329(2005)7[131:TGSOAL]2.0.CO;2; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Herrel A, 2008, J EXP BIOL, V211, P86, DOI 10.1242/jeb.012211; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; Kalka M, 2006, J TROP ECOL, V22, P1, DOI 10.1017/S0266467405002920; Kalko EKV, 2004, BAT ECHOLOCATION RES, P63; Kalko EKV, 2008, INTEGR COMP BIOL, V48, P60, DOI 10.1093/icb/icn030; Kalko Elisabeth K.V., 1998, P197; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; Meyer CFJ, 2008, J BIOGEOGR, V35, P1711, DOI 10.1111/j.1365-2699.2008.01916.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NORBERG UM, 1988, BIOL J LINN SOC, V33, P383, DOI 10.1111/j.1095-8312.1988.tb00451.x; Paradis E., 2006, APE ANAL PHYLOGENETI; Rojas D, 2011, MOL ECOL, V20, P2217, DOI 10.1111/j.1365-294X.2011.05082.x; Santana SE, 2009, J EVOLUTION BIOL, V22, P2131, DOI 10.1111/j.1420-9101.2009.01827.x; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Santana SE, 2011, BIOL J LINN SOC, V102, P1, DOI 10.1111/j.1095-8312.2010.01551.x; Santana SE, 2010, FUNCT ECOL, V24, P776, DOI 10.1111/j.1365-2435.2010.01703.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS N.B., 1998, B AM MUSEUM NATURAL, V237; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; STRAIT SG, 1993, J MAMMAL, V74, P391, DOI 10.2307/1382395; TOFT CA, 1980, OECOLOGIA, V45, P131, DOI 10.1007/BF00346717; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; van de Sand M, 2004, OKOLOGIE VERHALTEN N; Wetterer AL, 2000, B AM MUS NAT HIST, P4, DOI 10.1206/0003-0090(2000)248<0001:POPBMC>2.0.CO;2; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	43	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2011	6	12							e28584	10.1371/journal.pone.0028584	http://dx.doi.org/10.1371/journal.pone.0028584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863NO	21991371	gold, Green Published			2022-12-27	WOS:000298171400110
J	Zhang, PF; Dong, GH; Sun, BJ; Zhang, LW; Chen, X; Ma, NN; Yu, F; Guo, HM; Huang, H; Lee, YL; Tang, NJ; Chen, J				Zhang, Pengfei; Dong, Guanghui; Sun, Baijun; Zhang, Liwen; Chen, Xi; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui; Lee, Yungling Leo; Tang, Naijun; Chen, Jie			Long-Term Exposure to Ambient Air Pollution and Mortality Due to Cardiovascular Disease and Cerebrovascular Disease in Shenyang, China	PLOS ONE			English	Article							PARTICULATE MATTER; HEALTH; WOMEN; ASSOCIATIONS; VARIABILITY; ADMISSIONS; DEPOSITION; COMPONENTS; PARTICLES; EDUCATION	Background: The relationship between ambient air pollution exposure and mortality of cardiovascular and cerebrovascular diseases in human is controversial, and there is little information about how exposures to ambient air pollution contribution to the mortality of cardiovascular and cerebrovascular diseases among Chinese. The aim of the present study was to examine whether exposure to ambient-air pollution increases the risk for cardiovascular and cerebrovascular disease. Methodology/Principal Findings: We conducted a retrospective cohort study among humans to examine the association between compound-air pollutants [particulate matter <10 mu m in aerodynamic diameter (PM10), sulfur dioxide (SO2) and nitrogen dioxide (NO2)] and mortality in Shenyang, China, using 12 years of data (1998-2009). Also, stratified analysis by sex, age, education, and income was conducted for cardiovascular and cerebrovascular mortality. The results showed that an increase of 10 mu g/m(3) in a year average concentration of PM10 corresponds to 55% increase in the risk of a death cardiovascular disease (hazard ratio [HR], 1.55; 95% confidence interval [CI], 1.51 to 1.60) and 49% increase in cerebrovascular disease (HR, 1.49; 95% CI, 1.45 to 1.53), respectively. The corresponding figures of adjusted HR (95% CI) for a 10 mu g/m(3) increase in NO2 was 2.46 (2.31 to 2.63) for cardiovascular mortality and 2.44 (2.27 to 2.62) for cerebrovascular mortality, respectively. The effects of air pollution were more evident in female that in male, and nonsmokers and residents with BMI < 18.5 were more vulnerable to outdoor air pollution. Conclusion/Significance: Long-term exposure to ambient air pollution is associated with the death of cardiovascular and cerebrovascular diseases among Chinese populations.	[Zhang, Pengfei; Dong, Guanghui; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui] China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China; [Dong, Guanghui; Chen, Jie] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [Sun, Baijun] Shenyang Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Zhang, Liwen; Chen, Xi; Tang, Naijun] Tianjin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Tianjin, Peoples R China; [Lee, Yungling Leo] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	China Medical University; China Medical University; Tianjin Medical University; National Taiwan University	Zhang, PF (corresponding author), China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Lee, Yungling/S-7011-2018; Dong, Guanghui/AAN-4630-2020	Lee, Yungling/0000-0002-2234-9479; Zhang, Liwen/0000-0002-5077-9732; Dong, Guang-Hui/0000-0002-2578-3369	Welfare Profession of China Environmental Protection Foundation [200709048]	Welfare Profession of China Environmental Protection Foundation	The funding for this study is supported by grants from the Special Scientific Research Fund of Welfare Profession of China Environmental Protection Foundation (200709048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Brauer Michael, 2010, Proc Am Thorac Soc, V7, P111, DOI 10.1513/pats.200908-093RM; Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; DOCKERY DW, 1992, ENVIRON RES, V59, P362, DOI 10.1016/S0013-9351(05)80042-8; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Finkelstein MM, 2005, J EPIDEMIOL COMMUN H, V59, P481, DOI 10.1136/jech.2004.026203; Frampton MW, 2006, ENVIRON HEALTH PERSP, V114, P51, DOI 10.1289/ehp.7962; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Jousilahti P, 1996, LANCET, V348, P567, DOI 10.1016/S0140-6736(96)02374-4; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; Kim E, 2005, ENVIRON SCI TECHNOL, V39, P4172, DOI 10.1021/es049824x; Kim SB, 2008, J AIR WASTE MANAGE, V58, P965, DOI 10.3155/1047-3289.58.7.965; Kohlhaufl M, 1999, AM J RESP CRIT CARE, V159, P902, DOI 10.1164/ajrccm.159.3.9805036; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Lipfert FW, 2006, INHAL TOXICOL, V18, P645, DOI 10.1080/08958370600742946; Lippmann M, 2006, ENVIRON HEALTH PERSP, V114, P1662, DOI 10.1289/ehp.9150; Lippmann M, 2009, CRIT REV TOXICOL, V39, P865, DOI 10.3109/10408440903300080; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Moolgavkar SH, 1996, EPIDEMIOLOGY, V7, P420, DOI 10.1097/00001648-199607000-00014; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Pererz L, 2009, ENVIRON SCI TECHNOL, V43, P4707, DOI 10.1021/es8031488; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Ren DY, 2004, INT J COAL GEOL, V57, P187, DOI 10.1016/j.coal.2003.10.001; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; Townend JN, 2005, THORAX, V60, P441, DOI 10.1136/thx.2004.037903; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; ZHAO DW, 1986, JAPCA J AIR WASTE MA, V36, P371, DOI 10.1080/00022470.1986.10466074	41	125	132	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20827	10.1371/journal.pone.0020827	http://dx.doi.org/10.1371/journal.pone.0020827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	22164211	Green Submitted, gold, Green Published			2022-12-27	WOS:000291612600030
J	Santana, SE; Dial, TO; Eiting, TP; Alfaro, ME				Santana, Sharlene E.; Dial, Thomas O.; Eiting, Thomas P.; Alfaro, Michael E.			Roosting Ecology and the Evolution of Pelage Markings in Bats	PLOS ONE			English	Article							FRUIT-EATING BATS; DISRUPTIVE COLORATION; SPERM COMPETITION; ECHOLOCATION; STRIPES; CRYPSIS; DISCRIMINATION; CHIROPTERA; CAMOUFLAGE; PATTERNS	Multiple lineages of bats have evolved striking facial and body pelage makings, including spots, stripes and countershading. Although researchers have hypothesized that these markings mainly evolved for crypsis, this idea has never been tested in a quantitative and comparative context. We present the first comparative study integrating data on roosting ecology (roost type and colony size) and pelage coloration patterns across bats, and explore the hypothesis that the evolution of bat pelage markings is associated with roosting ecologies that benefit from crypsis. We find that lineages that roost in the vegetation have evolved pelage markings, especially stripes and neck collars, which may function in crypsis through disruptive coloration and a type of countershading that might be unique to bats. We also demonstrate that lineages that live in larger colonies and are larger in size tend not to have pelage markings, possibly because of reduced predation pressures due to the predator dilution effect and a lower number of potential predators. Although social functions for pelage color patterns are also possible, our work provides strong support for the idea that roosting ecology has driven the evolution of pelage markings in bats.	[Santana, Sharlene E.] Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA; [Santana, Sharlene E.; Dial, Thomas O.; Alfaro, Michael E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Eiting, Thomas P.] Univ Massachusetts, Amherst, MA 01003 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Massachusetts System; University of Massachusetts Amherst	Santana, SE (corresponding author), Univ Calif Los Angeles, Ctr Soc & Genet, Los Angeles, CA 90095 USA.	sesantana@ucla.edu	D, Betsy/ABD-1855-2020; Alfaro, Michael/Q-2113-2017	Eiting, Thomas/0000-0001-8544-0993; Geipel, Inga/0000-0003-3118-2460; Alfaro, Michael/0000-0002-8898-8230	Center for Society and Genetics; National Science Foundation [0918748]	Center for Society and Genetics; National Science Foundation(National Science Foundation (NSF))	Funding was provided by a Center for Society and Genetics (http://socgen.ucla.edu) Postdoctoral Fellowship to SES and National Science Foundation grant 0918748 to MEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham John D., 2005, P280; Baron G, 1996, COMP NEUROBIOLOGY CH; Bates P, 1998, BATS INDIAN SUBCONTI; Behrens RR, 2009, PHILOS T R SOC B, V364, P497, DOI 10.1098/rstb.2008.0250; Bonaccorso FJ, 1998, BATS PAPUA NEW GUINE; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2011, EVOL ECOL, V25, P1231, DOI 10.1007/s10682-011-9479-5; Caro T, 2010, BEHAV ECOL, V21, P78, DOI 10.1093/beheco/arp165; Caro Tim, 2005, pXIII; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Cott H.B., 1940, ADAPTIVE COLORATION; Csorba G., 2003, HORSESHOE BATS WORLD; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; DEFANIS E, 1995, ANIM BEHAV, V49, P835; EDMUNDS M, 1994, BIOL J LINN SOC, V51, P447, DOI 10.1006/bijl.1994.1034; Edmunds M., 1974, DEFENCE ANIMALS; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Ewer RF, 1997, CARNIVORES; Fenton BM, 2008, KOEDOE AFRICAN PROTE, V35, P49; FENTON MB, 1994, ANIM BEHAV, V48, P9, DOI 10.1006/anbe.1994.1207; Frey JK, 2006, J MAMMAL, V87, P1175, DOI 10.1644/05-MAMM-A-374R2.1; Garnett Stephen, 1999, Australian Zoologist, V31, P38; GITTLEMAN JL, 1985, OECOLOGIA, V67, P540, DOI 10.1007/BF00790026; GODFREY D, 1987, BIOL J LINN SOC, V32, P427, DOI 10.1111/j.1095-8312.1987.tb00442.x; GUSTIN MK, 1987, ANIM BEHAV, V35, P13, DOI 10.1016/S0003-3472(87)80205-1; Hodgkison R, 2003, J TROP ECOL, V19, P667, DOI 10.1017/S0266467403006060; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Hosken DJ, 1997, P ROY SOC B-BIOL SCI, V264, P385, DOI 10.1098/rspb.1997.0055; Hosken DJ, 1998, BEHAV ECOL SOCIOBIOL, V44, P169, DOI 10.1007/s002650050529; Hutson A, 2001, MICROCHIROPTERAN BAT; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kamilar JM, 2011, J ZOOL, V283, P227, DOI 10.1111/j.1469-7998.2010.00765.x; KILTIE RA, 1989, ANIM BEHAV, V38, P542, DOI 10.1016/S0003-3472(89)80048-X; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Kunz T.H., 1982, P1; Kunz TH, 2003, BAT ECOLOGY, P3; LANGEVIN P, 1990, Mammalian Species, P1, DOI 10.2307/3504110; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Majerus M, 1998, MELANISM EVOLUTION A; Marshall Justin, 2011, P186; Merilaita S, 2005, P ROY SOC B-BIOL SCI, V272, P665, DOI 10.1098/rspb.2004.3000; Merilaita S, 1998, P ROY SOC B-BIOL SCI, V265, P1059, DOI 10.1098/rspb.1998.0399; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Nowak RM, 1994, WALKERS BATS WORLD; Ortolani A, 1999, BIOL J LINN SOC, V67, P433; Plumpton D.L., 1992, Mammalian Species, P1, DOI 10.2307/3504230; Poulton E.B., 1890, COLOURS ANIMALS THEI, DOI [10.1126/science.ns-16.407.286.a, DOI 10.1126/SCIENCE.NS-16.407.286.A]; Reid F., 2009, FIELD GUIDE MAMMALS, V2nd; Safi K, 2003, ANIM BEHAV, V65, P363, DOI 10.1006/anbe.2003.2067; Sandoval CP, 2008, BIOL J LINN SOC, V94, P1, DOI 10.1111/j.1095-8312.2007.00941.x; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SIMMONS NB, 2004, MAMMAL SPECIES WORLD, P2; Stankowich T, 2011, EVOLUTION, V65, P3090, DOI 10.1111/j.1558-5646.2011.01334.x; Stevens M, 2006, P R SOC B, V273, P2141, DOI 10.1098/rspb.2006.3556; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Stoner CJ, 2003, BEHAV ECOL, V14, P823, DOI 10.1093/beheco/arg072; TAYLOR PJ, 2000, BATS SO AFRICA; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; Tullberg BS, 2005, P ROY SOC B-BIOL SCI, V272, P1315, DOI 10.1098/rspb.2005.3079; Voigt CC, 1999, BEHAV ECOL SOCIOBIOL, V47, P29, DOI 10.1007/s002650050646; von Helversen D, 1999, NATURE, V398, P759, DOI 10.1038/19648; von Helversen O, 2000, J COMP PHYSIOL A, V186, P143, DOI 10.1007/s003590050014; WICKLER W, 1976, Z TIERPSYCHOL, V40, P345; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x	68	53	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2011	6	10							e25845	10.1371/journal.pone.0025845	http://dx.doi.org/10.1371/journal.pone.0025845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834EU	21991371	Green Submitted, Green Published, gold			2022-12-27	WOS:000295943000084
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Li, Ping/0000-0002-3314-943X; Speicher, Andreas/0000-0001-6608-3994; Lin, Jinxing/0000-0001-9338-1356	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22163016	Green Submitted, gold, Green Published			2022-12-27	WOS:000291663300033
